PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Trujillo-Gonzalez, I; Wang, YY; Friday, WB; Vickers, KC; Toth, CL; Molina-Torres, L; Surzenko, N; Zeisel, SH				Trujillo-Gonzalez, Isis; Wang, Yanyan; Friday, Walter B.; Vickers, Kasey C.; Toth, Cynthia L.; Molina-Torres, Lorian; Surzenko, Natalia; Zeisel, Steven H.			MicroRNA-129-5p is regulated by choline availability and controls EGF receptor synthesis and neurogenesis in the cerebral cortex	FASEB JOURNAL			English	Article						cortical development; EGFR; maternal nutrition; brain development	DIETARY-INTAKE; MESSENGER-RNA; STEM-CELLS; S-ADENOSYLMETHIONINE; DNA METHYLATION; EXPRESSION; MICE; DIFFERENTIATION; MIR-129-5P; TARGETS	Choline availability modulates neurogenesis and cerebral cortex development through the regulation of neural progenitor cell (NPC) proliferative and differentiation capacity. In this study, we demonstrated that cortical NPC self-renewal is controlled by choline via the expression of a microRNA (miR-129-5p), whose role in the developing brain has not been examined, and which, in turn, inhibits synthesis of the epidermal growth factor receptor (EGFR) protein. Specifically, we found that low choline (LC) availability led to the upregulation of miR-129-5p expression in cortical NPCs in vitro and in vivo, causing the downregulation of EGFR and thereby disrupting NPC self-renewal and cortical neurogenesis. Furthermore, in response to LC availability, methylation potential (the S-adenosylmethionine:S-adenosylhomocysteine ratio) in the developing brain was reduced. Restoring methylation potential in LC cortical NPCs led to the re-establishment of normal miR-129-5p expression. We concluded that inhibiting miR-129-5p function and restoring EGFR protein levels in vivo is sufficient to reverse LC-induced defects in cortical NPC self-renewal. For the first time, to our knowledge, we have identified the molecular links that explain how a change in the availability of the diet metabolite choline impacts the essential cellular processes underlying brain development.Trujillo-Gonzalez, I., Wang, Y., Friday, W. B., Vickers, K. C., Toth, C. L., Molina-Torres, L., Surzenko, N., Zeisel, S. H. MicroRNA-129-5p is regulated by choline availability and controls EGF receptor synthesis and neurogenesis in the cerebral cortex.	[Trujillo-Gonzalez, Isis; Wang, Yanyan; Friday, Walter B.; Molina-Torres, Lorian; Surzenko, Natalia; Zeisel, Steven H.] Univ North Carolina Chapel Hill, Nutr Res Inst, 500 Laureate Way,Room 2218, Kannapolis, NC 28078 USA; [Wang, Yanyan] Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China; [Vickers, Kasey C.; Toth, Cynthia L.] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Surzenko, Natalia; Zeisel, Steven H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; Army Medical University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill	Surzenko, N; Zeisel, SH (corresponding author), Univ North Carolina Chapel Hill, Nutr Res Inst, 500 Laureate Way,Room 2218, Kannapolis, NC 28078 USA.	surzenko@email.unc.edu; steven_zeisel@unc.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK056350, DK115380]; Balchem (New Hampton NY, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128996, R01HL127173, P01HL116263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115380, P30DK056350] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Balchem (New Hampton NY, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Praveen Sethupathy (Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA) for providing support in the use of miR analysis tools; Dr. Eva Anton (UNC Neuroscience Center, Department of Cell Biology and Physiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA) and Dr. David Horita (Nutrition Research Institute) for critically evaluating the manuscript; Dr. Jiami Guo (UNC Neuroscience Center) for providing assistance with in utero electroporations; Dr. Ying Wang (Nutrition Research Institute) for help with metabolites assessment; Dr. Steve Orena (Nutrition Research Institute) for providing FACS services; Dr. Daniel Lupu (Nutrition Research Institute) for help with pyrosequencing; and Dr. Eneda Pjetri (Nutrition Research Institute) for help with statistical analyses. The study was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK056350 and DK115380 (to S.H.Z.). Dr. Zeisel has received research funding for other studies from Balchem (New Hampton NY, USA), a manufacturer of choline. The remaining authors declare no conflicts of interest.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Caric D, 2001, DEVELOPMENT, V128, P4203; Close JL, 2006, GLIA, V54, P94, DOI 10.1002/glia.20361; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Cremisi F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00141; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; FERRI RT, 1995, DEVELOPMENT, V121, P1151; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Gebhardt ML, 2014, NUCLEIC ACIDS RES, V42, P5436, DOI 10.1093/nar/gku231; Gossell-Williams M, 2005, W INDIAN MED J, V54, P355; Gstrein T, 2018, NAT NEUROSCI, V21, P207, DOI 10.1038/s41593-017-0053-5; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lillien L, 1998, MOL CELL NEUROSCI, V10, P296, DOI 10.1006/mcne.1997.0659; Lillien L, 2006, CEREB CORTEX, V16, pI74, DOI 10.1093/cercor/bhj169; Luan QX, 2016, EUR REV MED PHARMACO, V20, P4257; Lupu DS, 2017, FASEB J, V31, P2090, DOI 10.1096/fj.201601169R; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Reiter JL, 2001, GENOMICS, V71, P1, DOI 10.1006/geno.2000.6341; Resseguie ME, 2011, J BIOL CHEM, V286, P1649, DOI 10.1074/jbc.M110.106922; Scremin OU, 2015, NEUROSCIENCE, V301, P520, DOI 10.1016/j.neuroscience.2015.06.036; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Sinor-Anderson A, 2011, DEV NEUROBIOL, V71, P759, DOI 10.1002/dneu.20878; Sosanya NM, 2013, J CELL BIOL, V202, P53, DOI 10.1083/jcb.201212089; Tayebati SK, 2015, CURR MED CHEM, V22, P4328, DOI 10.2174/0929867322666151029104152; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Wallace TC, 2016, J AM COLL NUTR, V35, P108, DOI 10.1080/07315724.2015.1080127; Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806; Wang J, 2013, P NATL ACAD SCI USA, V110, P19137, DOI 10.1073/pnas.1307224110; Wang YY, 2016, FASEB J, V30, P1566, DOI 10.1096/fj.15-282426; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Wu Q, 2014, ONCOTARGET, V5, P11552, DOI 10.18632/oncotarget.2594; Yokota Y, 2007, NEURON, V54, P429, DOI 10.1016/j.neuron.2007.04.016; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zeisel SH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050445; Zongaro S, 2013, HUM MOL GENET, V22, P1971, DOI 10.1093/hmg/ddt044	62	12	12	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3601	3612		10.1096/fj.201801094RR	http://dx.doi.org/10.1096/fj.201801094RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521373	Green Submitted, Green Published			2022-12-26	WOS:000459794800041
J	Roland, BP; Naito, T; Best, JT; Arnaiz-Yepez, C; Takatsu, H; Yu, RJ; Shin, HW; Graham, TR				Roland, Bartholomew P.; Naito, Tomoki; Best, Jordan T.; Arnaiz-Yepez, Cayetana; Takatsu, Hiroyuki; Yu, Roger J.; Shin, Hye-Won; Graham, Todd R.			Yeast and human P4-ATPases transport glycosphingolipids using conserved structural motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; glycolipid; lipid transport; membrane bilayer; enzyme mechanism; cerebroside; flippase; glucosylceramide; membrane asymmetry; P4-ATPase; membrane biology; glycosphingolipids	P-TYPE ATPASE; AMINOPHOSPHOLIPID TRANSLOCASE; PLASMA-MEMBRANE; PHOSPHOLIPID TRANSLOCATION; CRYSTAL-STRUCTURE; APOPTOTIC CELLS; CDC50 PROTEINS; GOLGI NETWORK; PHOSPHATIDYLSERINE; MECHANISM	Lipid transport is an essential process with manifest importance to human health and disease. Phospholipid flippases (P4-ATPases) transport lipids across the membrane bilayer and are involved in signal transduction, cell division, and vesicular transport. Mutations in flippase genes cause or contribute to a host of diseases, such as cholestasis, neurological deficits, immunological dysfunction, and metabolic disorders. Genome-wide association studies have shown that ATP10A and ATP10D variants are associated with an increased risk of diabetes, obesity, myocardial infarction, and atherosclerosis. Moreover, ATP10D SNPs are associated with elevated levels of glucosylceramide (GlcCer) in plasma from diverse European populations. Although sphingolipids strongly contribute to metabolic disease, little is known about how GlcCer is transported across cell membranes. Here, we identify a conserved clade of P4-ATPases from Saccharomyces cerevisiae (Dnf1, Dnf2), Schizosaccharomyces pombe (Dnf2), and Homo sapiens (ATP10A, ATP10D) that transport GlcCer bearing an sn2 acyl-linked fluorescent tag. Further, we establish structural determinants necessary for recognition of this sphingolipid substrate. Using enzyme chimeras and site-directed mutagenesis, we observed that residues in transmembrane (TM) segments 1, 4, and 6 contribute to GlcCer selection, with a conserved glutamine in the center of TM4 playing an essential role. Our molecular observations help refine models for substrate translocation by P4-ATPases, clarify the relationship between these flippases and human disease, and have fundamental implications for membrane organization and sphingolipid homeostasis.	[Roland, Bartholomew P.; Best, Jordan T.; Arnaiz-Yepez, Cayetana; Yu, Roger J.; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Naito, Tomoki; Takatsu, Hiroyuki; Shin, Hye-Won] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Vanderbilt University; Kyoto University	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu	Shin, Hye-Won/P-5398-2018	Shin, Hye-Won/0000-0002-9138-9554; Arnaiz, Cayetana/0000-0001-5069-1469; Naito, Tomoki/0000-0002-8393-3601; Roland, Bartholomew/0000-0002-9033-9942	National Institutes of Health [R01-GM107978, F32-GM116310]; Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16H00764, JP17H03655]; Japan Foundation for Applied Enzymology;  [JP16J05381]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Foundation for Applied Enzymology; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01-GM107978 (to T.R.G.) and F32-GM116310 (to B.P.R.), Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP16H00764 and JP17H03655 and a grant from the Japan Foundation for Applied Enzymology (to H.-W.S), and Grant-in-Aid for JSPS Research Fellow JP16J05381 (to T.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Astudillo L, 2016, BIOCHIMIE, V125, P267, DOI 10.1016/j.biochi.2015.11.009; Baldridge RD, 2013, J BIOL CHEM, V288, P19516, DOI 10.1074/jbc.M113.476911; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; DAWSON G, 1976, J LIPID RES, V17, P125; Dhar M, 2002, OBES RES, V10, P695, DOI 10.1038/oby.2002.94; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Flamant S, 2003, MAMM GENOME, V14, P21, DOI 10.1007/s00335-002-3032-3; Focht D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00202; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gantzel RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10741-z; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052; Jensen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17742-y; Jiang YN, 2017, SCIENCE, V356, P1172, DOI 10.1126/science.aam9970; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Kazmier K, 2017, CURR OPIN STRUC BIOL, V45, P100, DOI 10.1016/j.sbi.2016.12.006; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kengia JT, 2013, ATHEROSCLEROSIS, V231, P158, DOI 10.1016/j.atherosclerosis.2013.08.034; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Lopez-Marques RL, 2015, BBA-GEN SUBJECTS, V1850, P461, DOI 10.1016/j.bbagen.2014.04.008; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Primeau JO, 2018, SUBCELL BIOCHEM, V87, P229, DOI 10.1007/978-981-10-7757-9_8; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Roland BP, 2016, CRIT REV BIOCHEM MOL, V51, P513, DOI 10.1080/10409238.2016.1237934; Roland BP, 2016, P NATL ACAD SCI USA, V113, pE4460, DOI 10.1073/pnas.1525730113; Sabourdy F, 2015, BBA-MOL CELL BIOL L, V1851, P1040, DOI 10.1016/j.bbalip.2015.01.010; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sawada K, 2015, APPL ENVIRON MICROB, V81, P3688, DOI 10.1128/AEM.00454-15; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Sigruener A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178368; Stone A, 2012, J BIOL CHEM, V287, P41139, DOI 10.1074/jbc.M112.413039; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Takada N, 2018, EMBO J, V37, DOI 10.15252/embj.201797705; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Uchida K, 1998, J BIOCHEM-TOKYO, V123, P1073; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Vance D. E., 2008, BIOCH LIPIDS LIPOPRO, P364; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Vitner Einat B, 2013, Handb Exp Pharmacol, P405, DOI 10.1007/978-3-7091-1511-4_20; Xu P, 2013, J CELL BIOL, V202, P875, DOI 10.1083/jcb.201305094; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	72	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1794	1806		10.1074/jbc.RA118.005876	http://dx.doi.org/10.1074/jbc.RA118.005876			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30530492	Green Published, hybrid			2022-12-26	WOS:000459711400003
J	Chu, KY; O'Reilly, L; Mellet, N; Meikle, PJ; Bartley, C; Biden, TJ				Chu, Kwan Yi; O'Reilly, Liam; Mellet, Natalie; Meikle, Peter J.; Bartley, Clarissa; Biden, Trevor J.			Oleate disrupts cAMP signaling, contributing to potent stimulation of pancreatic beta-cell autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreatic islet; lipid; autophagy; cyclic AMP (cAMP); beta cell (B-cell)	ENDOPLASMIC-RETICULUM STRESS; FREE FATTY-ACIDS; INSULIN-SECRETION; PROTEIN-KINASE; MAMMALIAN TARGET; ACTIVATION; APOPTOSIS; MASS; HOMEOSTASIS; INHIBITION	Autophagy is critical for maintaining cellular function via clearance of excess nutrients and damaged organelles. In pancreatic beta-cells, it helps counter the endoplasmic reticulum (ER) stress that impairs insulin secretory capacity during Type 2 diabetes. Chronic exposure of beta-cells to saturated fatty acids (FAs) such as palmitate stimulates ER stress and modulates autophagy, but the effects of unsaturated FAs such as oleate, which are also elevated during obesity, are less well understood. We therefore treated MIN6 cells and mouse islets for 8-48 h with either palmitate or oleate, and then monitored autophagic flux, signaling pathways, lysosomal biology, and phospholipid profiles. Compared with palmitate, oleate more effectively stimulated both autophagic flux and clearance of autophagosomes. The flux stimulation occurred independently of ER stress, nutrient-sensing (mTOR) and signaling pathways (protein kinases A, C, and D). Instead the mechanism involved the exchange factor directly activated by cAMP 2 (EPAC2). Oleate reduced cellular cAMP, and its effects on autophagic flux were reproduced or inhibited, respectively, by Epac2 knockdown or activation. Oleate also increased lysosomal acidity and increased phospholipid saturation, consistent with improved autophagosomal fusion with lysosomes. We conclude that a potent stimulation of autophagy might help explain the known benefits of unsaturated FAs in countering the toxicity of saturated FAs in beta-cells during obesity and lipid loading.	[Chu, Kwan Yi; O'Reilly, Liam; Bartley, Clarissa; Biden, Trevor J.] Garvan Inst Med Res, Div Diabet & Metab, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Chu, Kwan Yi; Biden, Trevor J.] UNSW Sydney, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Mellet, Natalie; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Prahran, Vic 3004, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Baker Heart and Diabetes Institute	Biden, TJ (corresponding author), Garvan Inst Med Res, Div Diabet & Metab, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	t.biden@garvan.org.au	Biden, Trevor/AAW-2829-2021	Biden, Trevor/0000-0001-5211-0234; Meikle, Peter/0000-0002-2593-4665	National Health and Medical Research Council of Australia [1051658, 1024961]; Diabetes Australia Research Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by Projects Grant 1051658 and Fellowship 1024961 from the National Health and Medical Research Council of Australia (to T. J. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Diabetes Australia Research Trust.	Abe H, 2013, ENDOCRINOLOGY, V154, P4512, DOI 10.1210/en.2013-1578; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Bartolome A, 2012, AUTOPHAGY, V8, P1757, DOI 10.4161/auto.21994; Mestre MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002664; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Boslem E, 2013, J BIOL CHEM, V288, P26569, DOI 10.1074/jbc.M113.489310; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Carlessi R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02838-2; Chen ML, 2013, AUTOPHAGY, V9, P2033, DOI 10.4161/auto.26336; Cheng CI, 2017, J CELL BIOCHEM, V118, P1249, DOI 10.1002/jcb.25784; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Chu KY, 2015, DIABETOLOGIA, V58, P2074, DOI 10.1007/s00125-015-3665-x; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eisenberg-Lerner A, 2012, CELL DEATH DIFFER, V19, P788, DOI 10.1038/cdd.2011.149; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Goginashvili A, 2015, SCIENCE, V347, P878, DOI 10.1126/science.aaa2628; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Hatanaka M, 2014, DIABETES, V63, P3404, DOI 10.2337/db14-0105; Holen I, 1996, EUR J BIOCHEM, V236, P163, DOI 10.1111/j.1432-1033.1996.00163.x; Janikiewicz J, 2015, J LIPID RES, V56, P1901, DOI 10.1194/jlr.M059980; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kim J, 2014, J CLIN INVEST, V124, P3311, DOI 10.1172/JCI69625; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Kondo M, 2018, DIABETOLOGIA, V61, P2189, DOI 10.1007/s00125-018-4679-y; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Laurent AC, 2015, CARDIOVASC RES, V105, P55, DOI 10.1093/cvr/cvu242; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee MS, 2014, TRENDS ENDOCRIN MET, V25, P620, DOI 10.1016/j.tem.2014.08.005; Lim SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29921; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Mir SUR, 2015, J BIOL CHEM, V290, P6071, DOI 10.1074/jbc.M114.605345; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Nakatogawa H, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1073416; Niso-Santano M, 2015, EMBO J, V34, P1025, DOI 10.15252/embj.201489363; Pearson GL, 2014, DIABETOLOGIA, V57, P129, DOI 10.1007/s00125-013-3083-x; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Rehmann H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03032; Riahi Y, 2016, DIABETOLOGIA, V59, P1480, DOI 10.1007/s00125-016-3868-9; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; Seino S, 2012, DIABETES OBES METAB, V14, P9, DOI 10.1111/j.1463-1326.2011.01507.x; Shahnazari S, 2011, AUTOPHAGY, V7, P957, DOI 10.4161/auto.7.9.16435; Shaked M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028804; Sheng QF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16485-0; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Stienstra R, 2014, DIABETOLOGIA, V57, P1505, DOI 10.1007/s00125-014-3255-3; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Ugland H, 2011, AUTOPHAGY, V7, P1199, DOI 10.4161/auto.7.10.16649; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Velazquez AR, 2016, J CELL BIOL, V212, P621, DOI 10.1083/jcb.201508102; Wang X, 2007, BIOCHEM BIOPH RES CO, V352, P463, DOI 10.1016/j.bbrc.2006.11.032; Watada H, 2015, MOL ENDOCRINOL, V29, P338, DOI 10.1210/me.2014-1367; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Xie JL, 2012, CELL MOL LIFE SCI, V69, P1289, DOI 10.1007/s00018-011-0874-4; Yuan T, 2018, J MOL BIOL, V430, P904, DOI 10.1016/j.jmb.2018.02.013; Zummo FP, 2017, DIABETES, V66, P1272, DOI 10.2337/db16-1009	72	13	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1218	1229		10.1074/jbc.RA118.004833	http://dx.doi.org/10.1074/jbc.RA118.004833			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30518550	Green Published, hybrid			2022-12-26	WOS:000457879500013
J	Blanco, CL; Gastaldelli, A; Anzueto, DG; Winter, LA; Seidner, SR; McCurnin, DC; Liang, HY; Javors, MA; DeFronzo, RA; Musi, N				Blanco, Cynthia L.; Gastaldelli, Amalie; Anzueto, Diana G.; Winter, Lauryn A.; Seidner, Steven R.; McCurnin, Donald C.; Liang, Hanyu; Javors, Martin A.; DeFronzo, Ralph A.; Musi, Nicolas			Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; PRETERM BIRTH; RISK-FACTOR; AMPK; METABOLISM; TRANSLOCATION; HYPERGLYCEMIA; PGC-1-ALPHA; INCREASES	Premature baboons exhibit peripheral insulin resistance and impaired insulin signaling. 5' AMP-activated protein kinase (AMPK) activation improves insulin sensitivity by enhancing glucose uptake (via increased glucose transporter type 4 [GLUT4] translocation and activation of the extracellular signal-regulated kinase [ERN/atypical protein kinase C [aPKC] pathway), and increasing fatty acid oxidation (via inhibition of acetyl-CoA carboxylase 1 [ACC]), while downregulating gluconeogenesis (via induction of small heterodimer partner [SHP] and subsequent downregulation of the gluconeogenic enzymes: phosphoenolpyruvate carboxykinase [PEPCK], glucose 6-phosphatase [G6PASE], fructose-1,6-bispho-sphatase 1 [FBP1], and forkhead box protein 1 [FOX01]). The purpose of this study was to investigate whether pharmacologic activation of AMPK with AICAR (5-aminoimidazole-4-carboximide riboside) administration improves peripheral insulin sensitivity in preterm baboons. 11 baboons were delivered prematurely at 125 2 days (67%) gestation. 5 animals were randomized to receive 5 days of continuous AICAR infusion at a dose of 0.5 mg-g(-1).day(-1). 6 animals were in the placebo group. Euglycemic hyperinsulinemic clamps were performed at 5+/-2 and 14+/-2 days of life. Key molecules potentially altered by AICAR (AMPK, GLUT4, ACC, PEPCK, G6PASE, FBP1, and FOXO1), and the insulin signaling molecules: insulin receptor (INSR), insulin receptor substrate 1 (IRS-1), protein kinase B (AKT), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1 alpha) were measured using RT-PCR and western blotting. AICAR infusion did not improve whole body insulin-stimulated glucose disposal in preterm baboons (12.8+/-2.4 vs 12.4+/-2.0 mg/(kg.min), p = 0.8, placebo vs AICAR). One animal developed complications during treatment. In skeletal muscle, AICAR infusion did not increase phosphorylation of ACC, AKT, or AMPK whereas it increased mRNA expression of ACACA (ACC), AKT, and PPARGC1A (PGC1 alpha). In the liver, INSR, IRS1, G6PC3, AKT, PCK1, FOXO1, and FBP1 were unchanged, whereas PPARGC1A mRNA expression increased after AICAR infusion. This study provides evidence that AICAR does not improve insulin sensitivity in premature euglycemic baboons, and may have adverse effects.	[Blanco, Cynthia L.; Anzueto, Diana G.; Winter, Lauryn A.; Seidner, Steven R.; McCurnin, Donald C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Neonatol, San Antonio, TX 78229 USA; [Gastaldelli, Amalie; Liang, Hanyu; DeFronzo, Ralph A.; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA; [Gastaldelli, Amalie] CNR, Inst Clin Physiol, Pisa, Italy; [Javors, Martin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Javors, Martin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [DeFronzo, Ralph A.; Musi, Nicolas] Texas Diabet Inst, San Antonio, TX USA; [Musi, Nicolas] Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Blanco, CL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Neonatol, San Antonio, TX 78229 USA.	blanco@uthscsa.edu	Gastaldelli, Amalia/H-3319-2014	Gastaldelli, Amalia/0000-0003-2594-1651	American Diabetes Association; Robert Wood Johnson Foundation; University Health System Research Fund; University of Texas Health Science Center at San Antonio CTSA [UL1RR025767]; National Institutes of Health [AG030979, R01-DK80157, R01-DK089229, DK080157, DK24092]; San Antonio Nathan Shock Center [AG013319]; San Antonio Claude D. Pepper Older Americans Independence Center [AG044271]; University of Texas Health Science Center at San Antonio Executive Research Committee; South Texas Health Research Center; U.S Department of Veterans Affairs	American Diabetes Association(American Diabetes Association); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); University Health System Research Fund; University of Texas Health Science Center at San Antonio CTSA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Antonio Nathan Shock Center; San Antonio Claude D. Pepper Older Americans Independence Center; University of Texas Health Science Center at San Antonio Executive Research Committee; South Texas Health Research Center; U.S Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the American Diabetes Association [http://www.diabetes.org](C.B., R.A.D., and N.M.), the Robert Wood Johnson Foundation [http://www.rwjf.org] (C.B.), University Health System Research Fund for C.B., University of Texas Health Science Center at San Antonio CTSA (UL1RR025767 to C.B.), the National Institutes of Health [http://www.nih.gov] (AG030979, R01-DK80157, R01-DK089229, and DK080157 to N.M.; DK24092 to R.A.D), the San Antonio Nathan Shock Center [https://nathanshock.barshop.uthscsa.edu/] (AG013319 to N.M.), San Antonio Claude D. Pepper Older Americans Independence Center [http://sapepper.barshop.uthscsa.edu](AG044271 to N.M.), the University of Texas Health Science Center at San Antonio Executive Research Committee (N.M.), the South Texas Health Research Center (N.M.), and the U.S Department of Veterans Affairs (R.A.D.). No individuals contracted or employed by the funders, other than the named authors, played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrou G, 2010, PEDIATRICS, V125, pE584, DOI 10.1542/peds.2009-0449; Blanco CL, 2015, ENDOCRINOLOGY, V156, P813, DOI 10.1210/en.2014-1757; Blanco CL, 2013, PEDIATR RES, V73, P337, DOI 10.1038/pr.2012.184; Blanco CL, 2010, ENDOCRINOLOGY, V151, P1990, DOI 10.1210/en.2009-0777; Bonen A, 2009, APPL PHYSIOL NUTR ME, V34, P307, DOI 10.1139/H09-008; Boon H, 2008, DIABETOLOGIA, V51, P1893, DOI 10.1007/s00125-008-1108-7; Bosselaar M, 2011, J CLIN PHARMACOL, V51, P1449, DOI 10.1177/0091270010382912; Chavez AO, 2008, DIABETES, V57, P899, DOI 10.2337/db07-0790; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Glass HC, 2015, ANESTH ANALG, V120, P1337, DOI 10.1213/ANE.0000000000000705; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Kajantie E, 2010, DIABETES CARE, V33, P2623, DOI 10.2337/dc10-0912; Kao LS, 2006, J PERINATOL, V26, P730, DOI 10.1038/sj.jp.7211593; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kjobsted R, 2017, DIABETES, V66, P598, DOI 10.2337/db16-0530; Kjobsted R, 2015, DIABETES, V64, P2042, DOI 10.2337/db14-1402; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Li S, 2014, OBES REV, V15, P804, DOI 10.1111/obr.12214; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008; Livi CB, 2013, AGING-US, V5, P100, DOI 10.18632/aging.100533; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; McGill-Vargas L, 2017, ENDOCRINOLOGY, V158, P1140, DOI 10.1210/en.2016-1806; McGill-Vargas LL, 2014, PHYSL REP, V2, P1; Merill GF, 1997, AICA RIBOSIDE INCREA, P1107; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mitanchez-Mokhtari D, 2004, PEDIATRICS, V113, P537, DOI 10.1542/peds.113.3.537; Musi N, 2001, DIABETES, V50, P921, DOI 10.2337/diabetes.50.5.921; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Slidsborg C, 2017, EARLY POSTNATAL HYPE, P1; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Winder WW, 2008, DIABETOLOGIA, V51, P1761, DOI 10.1007/s00125-008-1115-8; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208757	10.1371/journal.pone.0208757	http://dx.doi.org/10.1371/journal.pone.0208757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540820	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600085
J	Djebbari, F; Srinivasan, A; Valiance, G; Moore, S; Kothari, J; Ramasamy, K				Djebbari, Faouzi; Srinivasan, Anandagopal; Valiance, Grant; Moore, Sally; Kothari, Jaime; Ramasamy, Karthik			Clinical outcomes of bortezomib-based therapy in myeloma	PLOS ONE			English	Article							MULTIPLE-MYELOMA; DEXAMETHASONE; PREDNISONE; MELPHALAN; SURVIVAL	Bortezomib, a first generation proteasome inhibitor, is used in both newly diagnosed and relapsed myeloma settings. Considerable differences exist in the usage of bortezomib therapy in the clinical practice setting in comparison to clinical trial setting as well manufacturer's recommendations. These differences include route of administration (intravenous (iv) vs. subcutaneous (sc)), frequency from twice to once weekly, choice of alkylating agent used in combination with bortezomib (melphalan or cyclophosphamide), and choice of glucocorticoids (dexamethasone or prednisolone). We reviewed data from 272 consecutive bortezomib-treated myeloma patients, who received therapy within the regional Thames Valley Cancer Network for both newly diagnosed myeloma (NDMM, n = 120) and relapsed MM (RMM, n = 152). We investigated the influence of age, sex, transplant, bortezomib combinations (doublet vs. triplet), cumulative bortezomib dose per treatment line (<50mg vs. >= 50mg), and route of administration (iv vs. sc) on time to next treatment (TTNT) and on overall survival (OS). Route of bortezomib administration (iv vs. sc) influenced neither OS (41 vs 35 months, p = 0.5), nor TTNT (14 vs. 19 months, p = 0.052). Our study showed a statistically significant improvement in median OS in patients receiving a cumulative dose >= 50mg compared to <50mg (42 vs. 33months, p = 0.003), although presence of confounders need to be taken into account, such as disease stage, performance status, genetic changes and prior therapies. Median OS was longer using triplet therapies compared to a doublet in the RMM cohort (37 vs. 29 months, p = 0.06), although this did not reach statistical significance. Multivariate Cox Regression analysis showed that cumulative bortezomib dose >50mg (p = 0.002, HR = 1.83, 95% CI 1.25-2.67) and autologous transplant (p = 0.002, HR = 2.6, 95% CI 1.41-3.98) were both significant factors associated with improved OS. Our data argues in favour of continuing bortezomib for the recommended duration as per Summary of Product Characteristics (SPC), subject to good tolerability, in order to deepen response or extend the duration of best response.	[Djebbari, Faouzi; Srinivasan, Anandagopal; Valiance, Grant; Moore, Sally; Kothari, Jaime; Ramasamy, Karthik] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England; [Kothari, Jaime; Ramasamy, Karthik] NIHR BRC Blood Theme, Oxford, England; [Kothari, Jaime; Ramasamy, Karthik] Oxford Myeloma Ctr Translat Res, Oxford, England	Oxford University Hospitals NHS Foundation Trust	Djebbari, F (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England.	faouzi.djebbari@ouh.nhs.uk		DJEBBARI, Faouzi/0000-0001-9578-7632; Ramasamy, Karthik/0000-0003-3385-3707				[Anonymous], 2016, INTRO MYELOMA; Bianchi G, 2014, CA-CANCER J CLIN, V64, P422, DOI 10.3322/caac.21252; Bringhen S, 2010, BLOOD, V116, P4745, DOI 10.1182/blood-2010-07-294983; Cancer Research UK, MYEL STAT; Larocca A, 2016, LEUKEMIA, V30, P1320, DOI 10.1038/leu.2016.36; Mangiacavalli S, 2018, LEUKEMIA LYMPHOMA, V59, P1505, DOI 10.1080/10428194.2017.1382695; Minarik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123866; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; National Institute for Care and Clinical Excellence, BORT THAL 1 LIN TREA; National Institute for Care and Clinical Excellence, BORT IND THER MULT M; National Institute for Care and Clinical Excellence, BORT MON REL MULT MY; Niesvizky R, 2015, J CLIN ONCOL, V33, P3921, DOI 10.1200/JCO.2014.58.7618; Palumbo A, 2015, BLOOD, V125, P2068, DOI 10.1182/blood-2014-12-615187; Ramasamy K, 2015, FAST FACTS MULTIPLE; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Mateos MV, 2015, AM J HEMATOL, V90, P314, DOI 10.1002/ajh.23933	18	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208920	10.1371/journal.pone.0208920	http://dx.doi.org/10.1371/journal.pone.0208920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540831	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600099
J	Hidalgo, J; Jougla, R				Hidalgo, Julia; Jougla, Renaud			On the use of local weather types classification to improve climate understanding: An application on the urban climate of Toulouse	PLOS ONE			English	Article							PROGRESS; FRANCE; ENERGY; IMPACT; ISLAND	This paper proposes a method based on a local weather type classification approach to facilitate analysis and communication of climate information in local climate studies. Presented herein is an application to urban climatology in Toulouse, France, but the method can be used in other applied fields of climatology as well. To describe the climatic context of this urbanized area, the local weather types that explain the plurality of weather situations Toulouse faces are presented in depth. In order to show the potential for use of this approach, this information is applied to the study of changes in local weather types in terms of frequency and intensity within a series of future climate projections, a classic urban canopy and a series of atmospheric boundary layer analyses, and as a support for communication aimed to initiate urban climate awareness in urban planning practices. The proposed classification method has been coded in an R script and is provided as a supporting information file. The paper concludes that a systematic pre-study using this kind of climatic analysis is a good practice for performing climatic contextualization in local scale applied studies, both for scientific analysis and communication.	[Hidalgo, Julia] Toulouse II Univ 5, Natl Ctr Sci Res CNRS, LISST, Toulouse, France; [Jougla, Renaud] Toulouse II Univ 5, Univ Toulouse Jean Jaures, LISST, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Hidalgo, J (corresponding author), Toulouse II Univ 5, Natl Ctr Sci Res CNRS, LISST, Toulouse, France.	julia.hidalgo@univ-tise2.fr		Hidalgo, Julia/0000-0002-1764-0536	French National Research Agency (Agence Nationale de la Recherche) [ANR-13-VBDU-004]	French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR))	This work was funded by the French National Research Agency (Agence Nationale de la Recherche) under grant #ANR-13-VBDU-004, http://www.agence-nationale-recherche.fr/en/.	Alcoforado MJ, 2004, ADV TOURISM CLIMATOL; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Barlow JF, 2014, URBAN CLIM, V10, P216, DOI 10.1016/j.uclim.2014.03.011; Boe J, 2008, J CLIMATE, V21, P3118, DOI 10.1175/2007JCLI1796.1; Cantat O., 2004, NOROIS, P191; Cantat O, 2014, CATALOG WEATHER TYPE, P11; Chandler TJ, 1968, URBAN CLIMATES; Chandler TJ, 1962, WEATHER, V17, P235, DOI DOI 10.1002/J.1477-8696.1962.TB05125.X; Corti S, 1999, NATURE, V398, P799, DOI 10.1038/19745; Dabberdt WF, 2004, METEOROL ATMOS PHYS, V87, P57, DOI 10.1007/s00703-003-0061-8; He J., 2002, INFORM RETRIEVAL CLU; Hidalgo J, 2008, METEOROL ATMOS PHYS, V102, P223, DOI 10.1007/s00703-008-0329-0; Hidalgo J., 2018, ICUC 10; Hidalgo J, 2015, URBAN CLIMATE MAPS S; Hidalgo J, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00040; Hoffmann P, 2016, GERMANY METEOROLOGIS, DOI [10.1127/metz/2016/0773, DOI 10.1127/METZ/2016/0773]; Jougla R, SITUATIONS METEOROLO; Kanda M, 2006, THEOR APPL CLIMATOL, V84, P23, DOI 10.1007/s00704-005-0141-4; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Lau K, 2018, ICUC 10; LOWRY WP, 1977, J APPL METEOROL, V16, P129, DOI 10.1175/1520-0450(1977)016<0129:EEOUEO>2.0.CO;2; Masson V, 2006, THEOR APPL CLIMATOL, V84, P35, DOI 10.1007/s00704-005-0142-3; Masson V, 2008, METEOROL ATMOS PHYS, V102, P135, DOI 10.1007/s00703-008-0289-4; Mithieux C., 2015, PROFIL CLIMATIQUE TO; Najac J, 2011, INT J CLIMATOL, V31, P415, DOI 10.1002/joc.2075; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; Oke TR, 2006, THEOR APPL CLIMATOL, V84, P179, DOI 10.1007/S00704-005-0153-0; OKE TR, 1988, PROG PHYS GEOG, V12, P471, DOI 10.1177/030913338801200401; Oke TR, 2009, TR OK S 8 S URB ENV; PARRY M, 1956, Q J ROY METEOR SOC, V82, P45, DOI 10.1002/qj.49708235105; Philipp A, 2010, PHYS CHEM EARTH, V35, P360, DOI 10.1016/j.pce.2009.12.010; Pigeon G, 2007, INT J CLIMATOL, V27, P1969, DOI 10.1002/joc.1530; Pigeon G, 2006, BOUND-LAY METEOROL, V120, P315, DOI 10.1007/s10546-006-9050-z; Shephard JM, 2005, EARTH INTERACT, V9; Stewart ID, 2011, INT J CLIMATOL, V31, P200, DOI 10.1002/joc.2141; Stewart I.D., 2007, ACTA CLIMATOL CHOROL, V40, P111; Stone DA, 2001, J CLIMATE, V14, P3551, DOI 10.1175/1520-0442(2001)014<3551:POCCOM>2.0.CO;2; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8	40	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208138	10.1371/journal.pone.0208138	http://dx.doi.org/10.1371/journal.pone.0208138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540801	gold, Green Submitted, Green Published			2022-12-26	WOS:000452898600059
J	Lohmus, A; Lohmus, P; Runnel, K				Lohmus, Asko; Lohmus, Piret; Runnel, Kadri			A simple survey protocol for assessing terrestrial biodiversity in a broad range of ecosystems	PLOS ONE			English	Article							LICHEN ASSEMBLAGES; ENVIRONMENTAL DNA; STAND STRUCTURE; OBSERVER BIAS; RAIN-FORESTS; CONSERVATION; VEGETATION; DIVERSITY; SITE; TAXONOMISTS	Finding standard cost-effective methods for monitoring biodiversity is challenging due to trade-offs between survey costs (including expertise), specificity, and range of applicability. These trade-offs cause a lack of comparability among datasets collected by ecologists and conservationists, which is most regrettable in taxonomically demanding work on megadiverse inconspicuous taxon groups. We have developed a site-scale survey method for diverse sessile land organisms, which can be analyzed over multiple scales and linked with ecological insights and management. The core idea is that field experts can effectively allocate observation effort when the time, area, and priority sequence of tasks are fixed. We present the protocol, explain its specifications (taxon group; expert qualification; plot size; effort) and applications based on >800 original surveys of four taxon groups; and we analyze its effectiveness using data on polypores in hemiboreal and tropical forests. We demonstrate consistent effort-species richness curves and among-survey variation in contrasting ecosystems, and high effectiveness compared with casual observations both at local and regional scales. Bias related to observer experience appeared negligible compared with typical assemblage variation. Being flexible in terms of sampling design, the method has enabled us to compile data from various projects to assess conservation status and habitat requirements of most species (specifically rarities and including discovery of new species); also, when linked with site descriptions, to complete environmental assessments and select indicator species for management. We conclude that simple rules can significantly improve expert-based biodiversity surveys. Ideally, define (i) a common plot size that addresses multiple taxon groups and management goals; (ii) taxon groups based on field expertise and feasible number of species; (iii) sufficient and practical search time; (iv) a procedure for recording within-plot heterogeneity. Such a framework, combined with freedom to allocate effort on-site, helps utilizing full expertise of observers without losing technical rigor.	[Lohmus, Asko; Runnel, Kadri] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia; [Lohmus, Piret] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Lohmus, A (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia.	asko.lohmus@ut.ee		Lohmus, Piret/0000-0003-4664-1682; Lohmus, Asko/0000-0001-7283-8716	Estonian Research Council [SF0180012s09, IUT-34, ETF6457]; Estonian Environmental Board [LLTOM16048]; Estonian Environmental Investments Centre [SLTOM16028]; Norwegian Centre for International Cooperation in Education project [CAPES-SIU-2013/10057]; European Social Fund	Estonian Research Council(Estonian Research Council); Estonian Environmental Board; Estonian Environmental Investments Centre(Estonian Research Council); Norwegian Centre for International Cooperation in Education project; European Social Fund(European Social Fund (ESF))	This work was supported by: 1) Estonian Research Council < www.etag.ee/en/> grants SF0180012s09, IUT-34, and ETF6457 to AL; 2) Estonian Environmental Board < www.keskkonnaamet.ee/en > grant LLTOM16048 to PL; 3) Estonian Environmental Investments Centre < kik.ee/en > grant SLTOM16028 to KR; 4) Norwegian Centre for International Cooperation in Education project CAPES-SIU-2013/10057 to KR (project leader K.-H. Larsson); 5) the Estonian Doctoral School of Earth Sciences and Ecology 2009-2015, created under the auspices of European Social Fund, to KR.	Abrego N, 2015, FUNGAL ECOL, V15, P82, DOI 10.1016/j.funeco.2015.01.005; Ah-Peng C, 2012, ACTA OECOL, V42, P58, DOI 10.1016/j.actao.2012.04.010; Ahrends A, 2011, BIOL CONSERV, V144, P131, DOI 10.1016/j.biocon.2010.08.008; Aime MC, 2003, MYCOLOGIA, V95, P614, DOI 10.2307/3761937; [Anonymous], 2007, INFORM FORAGING THEO; [Anonymous], 2015, PC ORD MULTIVARIATE; Asta J, 2002, NATO SCI S SS IV EAR, V7, P273; Balmford A, 1999, NATURE, V398, P204, DOI 10.1038/18339; Bertuol-Garcia D, 2018, BIOL REV, V93, P1032, DOI 10.1111/brv.12385; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Burke DA, 2008, FOREST ECOL MANAG, V255, P2204, DOI 10.1016/j.foreco.2007.12.032; BUSING RT, 1993, LANDSCAPE ECOL, V8, P119, DOI 10.1007/BF00141591; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Casanovas P, 2014, BIOL CONSERV, V171, P1, DOI 10.1016/j.biocon.2013.12.020; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Dahlberg A, 2011, FUNGAL ECOL, V4, P147, DOI 10.1016/j.funeco.2010.11.001; Danielsen F, 2003, ORYX, V37, P407, DOI 10.1017/S0030605303000735; De Palma A, 2018, ADV ECOL RES, V58, P163, DOI 10.1016/bs.aecr.2017.12.004; Dengler J, 2011, J VEG SCI, V22, P582, DOI 10.1111/j.1654-1103.2011.01265.x; Edwards TC, 2004, ECOL APPL, V14, P414, DOI 10.1890/02-5236; Ehinger KA, 2016, ATTEN PERCEPT PSYCHO, V78, P2135, DOI 10.3758/s13414-016-1128-1; Ellis CJ, 2017, LICHENOLOGIST, V49, P141, DOI 10.1017/S0024282917000056; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Geiger MF, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e10671; Giordani P, 2009, J ENVIRON MONITOR, V11, P730, DOI 10.1039/b818173j; Gotelli Nicholas J., 2011, P39; GRADSTEIN SR, 2003, SELBYANA, V24, P87; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hallingback T, 2007, BIOL CONSERV, V135, P334, DOI 10.1016/j.biocon.2006.10.020; Halme P, 2015, BIODIVERS CONSERV, V24, P1831, DOI 10.1007/s10531-015-0899-3; Hamalainen A, 2015, CAN J FOREST RES, V45, P1239, DOI 10.1139/cjfr-2014-0532; Helm A, 2015, DIVERS DISTRIB, V21, P711, DOI 10.1111/ddi.12285; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; Humphrey JW, 2002, BIOL CONSERV, V107, P165, DOI 10.1016/S0006-3207(02)00057-5; Hunter ML, 2002, CONSERV BIOL, V16, P660, DOI 10.1046/j.1523-1739.2002.01108.x; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Johansson P, 2001, CAN J FOREST RES, V31, P1617, DOI 10.1139/cjfr-31-9-1617; Junninen K, 2011, BIOL CONSERV, V144, P11, DOI 10.1016/j.biocon.2010.07.010; Kadlec T, 2012, J INSECT CONSERV, V16, P275, DOI 10.1007/s10841-011-9414-7; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kull T, 2008, BIODIVERS CONSERV, V17, P3383, DOI 10.1007/s10531-008-9432-2; Lewis RJ, 2016, METHODS ECOL EVOL, V7, P104, DOI 10.1111/2041-210X.12443; Lieberman D, 1996, J ECOL, V84, P137, DOI 10.2307/2261350; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Lohmus, 2018, FOLIA CRYPTOGAM EST, V55, P79, DOI [10.12697/ fce.2018.55.08, DOI 10.12697/FCE.2018.55.08]; Lohmus A., 2006, YB ESTONIAN NATURALI, V84, P207; Lohmus A, 2018, BIOL CONSERV, V219, P147, DOI 10.1016/j.biocon.2018.01.023; Lohmus A, 2017, FOREST ECOL MANAG, V404, P75, DOI 10.1016/j.foreco.2017.08.035; Lohmus A, 2015, BIOSCIENCE, V65, P1066, DOI 10.1093/biosci/biv136; Lohmus A, 2015, BIODIVERS CONSERV, V24, P3151, DOI 10.1007/s10531-015-1000-y; Lohmus A, 2013, FUNGAL ECOL, V6, P449, DOI 10.1016/j.funeco.2013.05.002; Lohmus A, 2011, SILVA FENN, V45, P1015, DOI 10.14214/sf.84; Lohmus A, 2011, CAN J FOREST RES, V41, P1352, DOI [10.1139/X11-047, 10.1139/x11-047]; Lohmus A, 2010, FOREST ECOL MANAG, V260, P155, DOI 10.1016/j.foreco.2010.04.018; Lohmus A, 2009, BIOL CONSERV, V142, P2792, DOI 10.1016/j.biocon.2009.05.022; Lohmus P., 2003, Folia Cryptogamica Estonica, P19; Lohmus P, 2018, J VEG SCI, V29, P200, DOI 10.1111/jvs.12600; Lohmus P, 2012, NOVA HEDWIGIA, V95, P493, DOI 10.1127/0029-5035/2012/0064; Lohmus P, 2010, FOREST ECOL MANAG, V260, P1754, DOI 10.1016/j.foreco.2010.07.056; Lohmus P, 2009, LICHENOLOGIST, V41, P61, DOI 10.1017/S002428290900807X; Lonsdale D, 2008, EUR J FOREST RES, V127, P1, DOI 10.1007/s10342-007-0182-6; Maes J, 2016, ECOSYST SERV, V17, P14, DOI 10.1016/j.ecoser.2015.10.023; Marsh DM, 2008, CONSERV BIOL, V22, P647, DOI 10.1111/j.1523-1739.2008.00927.x; McCune B, 1997, BRYOLOGIST, V100, P40; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Mcmullin RT, 2013, CONSERV BIOL, V27, P1020, DOI 10.1111/cobi.12094; Mcrae L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169156; Milberg P, 2008, J VEG SCI, V19, P633, DOI 10.3170/2008-8-18423; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Morrison LW, 2016, J PLANT ECOL, V9, P367, DOI 10.1093/jpe/rtv077; MUELLER GM, 2004, BIODIVERSITY FUNGI I; Nascimento HEM, 2002, FOREST ECOL MANAG, V168, P311, DOI 10.1016/S0378-1127(01)00749-6; Nelson GC, 2006, ECOL SOC, V11; Newmaster SG, 2005, DIVERS DISTRIB, V11, P57, DOI 10.1111/j.1366-9516.2005.00123.x; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Parmasto E, 2004, JARVSELJA PRIMEVAL F, P60; Parmasto E., 2004, DISTRIBUTION MAPS ES; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P21, DOI 10.1016/S0378-1127(97)00192-8; Ranius T, 2004, CAN J FOREST RES, V34, P1025, DOI [10.1139/x03-271, 10.1139/X03-271]; Remm L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063086; Renvall Pertti, 1999, Karstenia, V39, P33; Robinson OJ, 2018, DIVERS DISTRIB, V24, P460, DOI 10.1111/ddi.12698; Rombke J, 2016, APPL SOIL ECOL, V97, P125, DOI 10.1016/j.apsoil.2015.07.003; Rosenvald R, 2011, FOREST ECOL MANAG, V262, P1541, DOI 10.1016/j.foreco.2011.07.002; Runnel K, 2017, FUNGAL ECOL, V27, P155, DOI 10.1016/j.funeco.2016.09.006; Runnel K, 2016, NOVA HEDWIGIA, V103, P339, DOI 10.1127/nova_hedwigia/2016/0354; Runnel K, 2015, FUNGAL ECOL, V18, P93, DOI 10.1016/j.funeco.2015.08.008; Runnel K, 2014, FUNGAL ECOL, V9, P27, DOI 10.1016/j.funeco.2014.02.006; Saar I., 2007, Forestry Studies / Metsanduslikud Uurimused, V47, P71; San-Miguel-Ayanz J., 2011, STATE EUROPES FOREST, P65; Scherer-Lorenzen M, 2005, ECOL STUD-ANAL SYNTH, V176, P347; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Stork NE, 2017, CONSERV BIOL, V31, P924, DOI 10.1111/cobi.12883; Suija A., 2007, Forestry Studies / Metsanduslikud Uurimused, V47, P99; Suija A, 2016, HERZOGIA, V29, P355, DOI 10.13158/heia.29.2.2016.355; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; Thompson W., 2013, SAMPLING RARE ELUSIV; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tullus T, 2018, FOREST ECOL MANAG, V411, P67, DOI 10.1016/j.foreco.2018.01.008; Visconti P, 2016, CONSERV LETT, V9, P5, DOI 10.1111/conl.12159; Zenner EK, 2009, FOREST ECOL MANAG, V257, P311, DOI 10.1016/j.foreco.2008.09.006	108	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208535	10.1371/journal.pone.0208535	http://dx.doi.org/10.1371/journal.pone.0208535			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540799	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600077
J	Anderson, EATB; Ho, RK				Anderson, Erin A. T. Boyle; Ho, Robert K.			A transcriptomics analysis of the Tbx5 paralogues in zebrafish	PLOS ONE			English	Article							BRACHYURY; SOX7; TISSUE; ROLES; CELLS	TBX5 is essential for limb and heart development. Mutations in TBX5 are associated with Holt-Oram syndrome in humans. Due to the teleost specific genome duplication, zebrafish have two copies of TBX5: tbx5a and tbx5b. Both of these genes are expressed in regions of the lateral plate mesoderm and retina. In this study, we perform comparative RNA sequencing analysis on zebrafish embryos during the stages of lateral plate mesoderm migration. This work shows that knockdown of the Tbx5 paralogues results in altered gene expression in many tissues outside of the lateral plate mesoderm, especially in the somitic mesoderm and the intermediate mesoderm. Specifically, knockdown of tbx5b results in changes in somite size, in the differentiation of vasculature progenitors and in later patterning of trunk blood vessels.	[Anderson, Erin A. T. Boyle] Univ Chicago, Comm Dev Regenerat & Stem Cell Biol, Chicago, IL 60637 USA; [Ho, Robert K.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ho, RK (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	rkh@uchicago.edu			NIH [T32 GM007197]; National Institutes of Health [R01 HD072598]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR000430]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EATBA was supported by NIH T32 GM007197. This work was supported by National Institutes of Health grant R01 HD072598 awarded to RKH. This work was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1 TR000430. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; Albalat R, 2010, GENE EXPR PATTERNS, V10, P24, DOI 10.1016/j.gep.2009.11.003; Begemann G, 2000, MECH DEVELOP, V90, P299, DOI 10.1016/S0925-4773(99)00246-4; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Briscoe SD, 2018, CURR BIOL, V28, P686, DOI 10.1016/j.cub.2018.01.036; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Dai Zhiyin, 2014, F1000Res, V3, P95, DOI 10.12688/f1000research.3928.2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischer S, 2003, DEVELOPMENT, V130, P3515, DOI 10.1242/dev.00537; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Goldfarb CA, 2014, J HAND SURG-AM, V39, P1646, DOI 10.1016/j.jhsa.2014.02.015; Hasson P, 2010, DEV CELL, V18, P148, DOI 10.1016/j.devcel.2009.11.013; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hermkens DMA, 2015, DEVELOPMENT, V142, P1695, DOI 10.1242/dev.117275; HURST JA, 1991, J MED GENET, V28, P406, DOI 10.1136/jmg.28.6.406; Jackson VC, 2011, J CELL BIOCHEM, V112, P1857, DOI 10.1002/jcb.23104; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Lang SA, 2007, MOL CANCER THER, V6, P1123, DOI 10.1158/1535-7163.MCT-06-0628; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liao W, 2000, DEVELOPMENT, V127, P4303; Mao QY, 2015, DEVELOPMENT, V142, P4329, DOI 10.1242/dev.124750; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Parrie LE, 2013, DEV DYNAM, V242, P485, DOI 10.1002/dvdy.23953; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; PFLUGFELDER GO, 1992, BIOCHEM BIOPH RES CO, V186, P918, DOI 10.1016/0006-291X(92)90833-7; Pi-Roig A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140014; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Westerfield M, 2007, ZEBRAFISH BOOK	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208766	10.1371/journal.pone.0208766	http://dx.doi.org/10.1371/journal.pone.0208766			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532148	Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700050
J	Antti, H; Sellstedt, M				Antti, Henrik; Sellstedt, Magnus			Metabolic effects of an aspartate aminotransferase-inhibitor on two T-cell lines	PLOS ONE			English	Article								An emerging method to help elucidate the mode of action of experimental drugs is to use untargeted metabolomics of cell-systems. The interpretations of such screens are however complex and more examples with inhibitors of known targets are needed. Here two T-cell lines were treated with an inhibitor of aspartate aminotransferase and analyzed with untargeted GC-MS. The interpretation of the data was enhanced by the use of two different cell-lines and supports aspartate aminotransferase as a target. In addition, the data suggest an unexpected off-target effect on glutamate decarboxylase. The results exemplify the potency of metabolomics to provide insight into both mode of action and off-target effects of drug candidates.	[Antti, Henrik; Sellstedt, Magnus] Umea Univ, Dept Chem, Umea, Sweden	Umea University	Sellstedt, M (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	magnus.sellstedt@outlook.com		Sellstedt, Magnus/0000-0001-8839-286X	Swedish Research Council [350-2012-6611, 2014-04495]; Swedish Cancer Society [CAN 2016/741]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This study was funded by The Swedish Research Council, grant 350-2012-6611 (M.S.), and grant 2014-04495 (H.A), the Swedish Cancer Society, grant CAN 2016/741 (H.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canuto GAB, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1193-z; Caldwell GW, 2017, CURR TOP MED CHEM, V17, P2716, DOI 10.2174/1568026617666170707130032; Catalan U, 2017, GENOM PROTEOM BIOINF, V15, P236, DOI 10.1016/j.gpb.2016.12.007; dos Santos BS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01466; Gao D, 2016, J CHROMATOGR B, V1014, P17, DOI 10.1016/j.jchromb.2016.01.003; Hoerr V, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0696-5; Hollywood KA, 2015, MOL BIOSYST, V11, P2198, DOI 10.1039/c4mb00739e; Kim DH, 2014, MOL BIOSYST, V10, P398, DOI 10.1039/c3mb70423h; Li XN, 2017, ONCOTARGET, V8, P65022, DOI 10.18632/oncotarget.17531; Prosser GA, 2016, ANTIMICROB AGENTS CH, V60, P6091, DOI 10.1128/AAC.01249-16; SCAMAN CH, 1991, J BIOL CHEM, V266, P5525; Schelli K, 2017, MICROB BIOTECHNOL, V10, P1764, DOI 10.1111/1751-7915.12839; Spyrelli ED, 2017, MOL BIOSYST, V13, P841, DOI 10.1039/c6mb00830e; Stoessel D, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1062-1; Thornburg JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2154; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Tulloch LB, 2018, IUBMB LIFE, V70, P9, DOI 10.1002/iub.1697; Vincent IM, 2016, ANTIMICROB AGENTS CH, V60, P2281, DOI 10.1128/AAC.02109-15; YAMADA RH, 1987, BIOCHIM BIOPHYS ACTA, V911, P372, DOI 10.1016/0167-4838(87)90080-X; Zampieri M, 2017, CELL REP, V19, P1214, DOI 10.1016/j.celrep.2017.04.002; Zheng Z, 2017, ONCOTARGET, V8, P47619, DOI 10.18632/oncotarget.17411	21	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208025	10.1371/journal.pone.0208025	http://dx.doi.org/10.1371/journal.pone.0208025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532126	Green Submitted, Green Published, gold			2022-12-26	WOS:000452640900007
J	Mbemya, GT; Cadenas, J; de Sa, NAR; Guerreiro, DD; Donfack, NJ; Vieira, LA; de Sousa, FGC; Alves, BG; Lobo, CH; Santos, FW; Pinto, FDL; Pessoa, ODL; Smitz, J; Comizzoli, P; Figueiredo, JR; Rodrigues, APR				Mbemya, Gildas Tetaping; Cadenas, Jesus; Ribeiro de Sa, Naiza Arcangela; Guerreiro, Denise Damasceno; Donfack, Nathalie Jiatsa; Vieira, Luis Alberto; Canafistula de Sousa, Francisca Geovania; Alves, Benner Geraldo; Lobo, Carlos Henrique; Santos, Francielli Weber; Lima Pinto, Francisco das Chagas; Loiola Pessoa, Otilia Deusdenia; Smitz, Johan; Comizzoli, Pierre; Figueiredo, Jose Ricardo; Ribeiro Rodrigues, Ana Paula			Supplementation of in vitro culture medium with FSH to grow follicles and mature oocytes can be replaced by extracts of Justicia insularis	PLOS ONE			English	Article							AQUEOUS EXTRACT; ALOE-BUETTNERI; DICLIPTERA-VERTICILLATA; HIBISCUS-MACRANTHUS; SECONDARY FOLLICLES; ISOLATED CAPRINE; GENE-EXPRESSION; LEAF MIXTURE; KIT-LIGAND; CELL-CYCLE	The present study evaluated the effect of supplementing in vitro culture medium with J. insularis compared to FSH on isolated secondary follicles and in vitro maturation of oocytes from those follicles. Secondary follicles were isolated from sheep ovaries and individually cultured for 18 days in alpha-MEM+ (Control), alpha-MEM+ supplemented with 100 ng/mL recombinant bovine follicle stimulating hormone (FSH) or with 0.3, 1.25, or 2.5 mg/mL of J. insularis extract (JI0.3, JI1.25, and JI2.5, respectively). Culture medium collected every 2 days was used to measure ROS levels. At the end of the culture period, cumulus oocytes complex (COCs) were collected and matured in vitro. Follicular walls were used for mRNA quantitation. JI0.3 led to a higher (P < 0.05) percentages of intact follicles than other groups after 18 days of culture. While follicular diameter remained unchanged from Day 6 onwards with JI0.3 and FSH, percentages of antral cavity formation were higher (P < 0.05) with JI0.3 at Day 6 than in all other treatments. No differences were observed between controls and treatment groups regarding ROS levels and mRNA expression of genes. Viability of resulting oocytes was higher (P < 0.05) in JI0.3 compared to FSH. Interestingly, in control experiment, supplementation of maturation medium with JI0.3 led to higher (P < 0.05) percentages of metaphase II compared to controls. Although more validations will be needed, it seems that this natural extract could be used as a cheap and easily available alternative to commercial FSH.	[Mbemya, Gildas Tetaping; Cadenas, Jesus; Ribeiro de Sa, Naiza Arcangela; Guerreiro, Denise Damasceno; Donfack, Nathalie Jiatsa; Vieira, Luis Alberto; Canafistula de Sousa, Francisca Geovania; Figueiredo, Jose Ricardo; Ribeiro Rodrigues, Ana Paula] Univ Estadual Ceara, Fac Vet FAVET, Lab Manipulat Oocyte & Ovarian Preantral Follicle, Fortaleza, Ceara, Brazil; [Alves, Benner Geraldo] Univ Fed Uberlandia, Lab Biol Reprod, Uberlandia, MG, Brazil; [Lobo, Carlos Henrique] Univ Fed Ceara, Dept Anim Sci, Lab Anim Physiol, Fortaleza, Ceara, Brazil; [Santos, Francielli Weber] State Univ Pampa, Lab Reprod Biotechnol Biotech, Uruguaiana, Brazil; [Lima Pinto, Francisco das Chagas; Loiola Pessoa, Otilia Deusdenia] Univ Fed Ceara, Lab Phytochem Anal Med Plants LAFIPLAN, Fortaleza, Ceara, Brazil; [Smitz, Johan] UZ Brussel, Ctr Reprod Med, Follicle Biol Lab, Brussels, Belgium; [Comizzoli, Pierre] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA	Universidade Estadual do Ceara; Universidade Federal de Uberlandia; Universidade Federal do Ceara; Universidade Federal do Ceara; University Hospital Brussels; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Rodrigues, APR (corresponding author), Univ Estadual Ceara, Fac Vet FAVET, Lab Manipulat Oocyte & Ovarian Preantral Follicle, Fortaleza, Ceara, Brazil.	aprrodriguespapers@gmail.com	Pinto, Francisco das Chagas Lima/J-9641-2017; Cadenas, Jesus/AAD-4652-2022; Cibin, Francielli/AAW-3973-2020; Rodrigues, Ana/GYQ-6273-2022; Pessoa, Otilia DL/L-8863-2016; Vieira, Luis Alberto/S-7635-2017; GUERREIRO, DENISE/AAN-4518-2020; Alves, Benner/D-3599-2014	Pinto, Francisco das Chagas Lima/0000-0003-1481-7970; Cadenas, Jesus/0000-0001-8164-3697; Cibin, Francielli/0000-0003-2178-1857; Pessoa, Otilia DL/0000-0002-1617-7586; Vieira, Luis Alberto/0000-0002-2419-1329; Guerreiro, Denise/0000-0001-9581-8523; Smitz, Johan/0000-0002-5857-6542; Figueiredo, Jose Ricardo/0000-0002-5139-0964; Alves, Benner/0000-0001-9465-8054	National Council for Scientific and Technological Development (CNPq Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEC-PG/CAPES, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.030.433/2013-01]; CNPq Brazil [473968/2013-4, 457226/2013-7]	National Council for Scientific and Technological Development (CNPq Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEC-PG/CAPES, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from the National Council for Scientific and Technological Development (CNPq Brazil) for financial support. Gildas Tetaping Mbemya is the recipient of a doctoral scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEC-PG/CAPES, Brazil). Johan Smitz is Especial Visitor Researcher from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES: 88881.030.433/2013-01) and Ana Paula Ribeiro Rodrigues is recipient of a grant from CNPq Brazil through the projects 473968/2013-4 and 457226/2013-7.	Abu-Reidah IM, 2017, FOOD RES INT, V93, P87, DOI 10.1016/j.foodres.2017.01.014; AGARWAL A, 2014, REPROD BIOL ENDOCRIN, V12; Anguita B, 2008, ANIM REPROD SCI, V103, P290, DOI 10.1016/j.anireprosci.2006.12.018; Apolloni LB, THERIOGENOLOGY; Araujo VR, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-78; Arunakumari G, 2010, THERIOGENOLOGY, V74, P884, DOI 10.1016/j.theriogenology.2010.04.013; Bakuradze T, 2010, MOL NUTR FOOD RES, V54, P1734, DOI 10.1002/mnfr.201000147; Barberino RS, 2016, ZYGOTE, V24, P277, DOI 10.1017/S0967199415000179; Barros VRP, 2013, REPROD DOMEST ANIM, V48, P1025, DOI 10.1111/rda.12209; Cadenas J, 2017, THERIOGENOLOGY, V87, P321, DOI 10.1016/j.theriogenology.2016.09.008; Chahdoura H, 2014, FOOD FUNCT, V5, P2129, DOI [10.1039/C4FO00456F, 10.1039/c4fo00456f]; Choi EM, 2011, FOOD CHEM TOXICOL, V49, P1800, DOI 10.1016/j.fct.2011.04.031; Correa GM, 2012, REV BRAS FARMACOGN, V22, P220, DOI 10.1590/S0102-695X2011005000196; Costa RAP, 2011, J BIOENERG BIOMEMBR, V43, P25, DOI 10.1007/s10863-011-9329-8; Costa SHF, 2010, ZYGOTE, V18, P89, DOI 10.1017/S0967199409990104; Da Silva NLA, 2010, SCI PLENA, V6, P1; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; dela Pena EC, 2002, REPRODUCTION, V123, P593, DOI 10.1530/reprod/123.4.593; Erickson GF, 2003, REPROD BIOL ENDOCRIN, V1, P1, DOI [10.1186/1477-7827-1-9, DOI 10.1186/1477-7827-1-9)]; Farag MA, 2015, J PHARMACEUT BIOMED, V115, P383, DOI 10.1016/j.jpba.2015.08.003; Ferreira ACA, 2016, ANIM REPROD SCI, V165, P1, DOI 10.1016/j.anireprosci.2015.10.010; Goka CMS., 2016, PHARMACOLOGIA, V7, P328; Gouveia BB, 2016, THERIOGENOLOGY, V86, P1275, DOI 10.1016/j.theriogenology.2016.04.068; Heinzmann J, 2015, MOL HUM REPROD, V21, P770, DOI 10.1093/molehr/gav040; Higuchi CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143114; INDERJIT, 1991, J CHEM ECOL, V17, P1585, DOI 10.1007/BF00984690; Joyce IM, 1999, DEV BIOL, V214, P342, DOI 10.1006/dbio.1999.9437; Kuroda T, 2004, BIOL REPROD, V70, P154, DOI 10.1095/biolreprod.103.021519; Ledda S, 2001, BIOL REPROD, V65, P247, DOI 10.1095/biolreprod65.1.247; Leiva-Revilla J, 2017, SEMIN-CIENC AGRAR, V38, P1361, DOI 10.5433/1679-0359.2017v38n3p1361; Lima LF, 2017, MICROSC RES TECHNIQ, V80, P406, DOI 10.1002/jemt.22810; Lins TLBG, 2017, THERIOGENOLOGY, V89, P263, DOI 10.1016/j.theriogenology.2016.11.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loetchutinat C, 2005, RADIAT PHYS CHEM, V72, P323, DOI 10.1016/j.radphyschem.2004.06.011; Lunardi FO, 2015, CELL TISSUE RES, V362, P241, DOI 10.1007/s00441-015-2181-0; Luz VB, 2013, SMALL RUMINANT RES, V115, P99, DOI 10.1016/j.smallrumres.2013.09.003; Luz VB, 2012, REPROD SCI, V19, P1219, DOI 10.1177/1933719112446072; Magalhaes DM, 2011, REPROD DOMEST ANIM, V46, P134, DOI 10.1111/j.1439-0531.2010.01607.x; Magalhaes-Padilha DM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106096; Mbemya GT, 2017, J PHARM PHARM, V5, P668, DOI 10.17265/2328-2150/2017.09.009; McNatty K P, 2007, Soc Reprod Fertil Suppl, V64, P55; Mihm M, 2008, REPRODUCTION, V135, P253, DOI 10.1530/REP-06-0193; Mishra A, 2017, ANIM BIOTECHNOL, V28, P18, DOI 10.1080/10495398.2016.1193743; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Palama TL, 2010, BMC PLANT BIOL, V10, P1, DOI 10.1186/1471-2229-10-82; Pessoa AFC, 2014, THERIOGENOLOGY, V82, P312, DOI 10.1016/j.theriogenology.2014.04.008; Ribeiro RP, 2015, ZYGOTE, V23, P537, DOI 10.1017/S0967199414000173; Richards JS, 2002, RECENT PROG HORM RES, V57, P195, DOI 10.1210/rp.57.1.195; Robert C, 2002, BIOL REPROD, V67, P1456, DOI 10.1095/biolreprod.102.002147; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Rossetto R, 2013, SMALL RUMINANT RES, V113, P167, DOI 10.1016/j.smallrumres.2013.03.004; Rossetto R, 2013, ZYGOTE, V21, P125, DOI 10.1017/S0967199412000044; Ruijters EJB, 2013, EUR J PHARMACOL, V715, P147, DOI 10.1016/j.ejphar.2013.05.029; Sa NAR, 2017, THERIOGENOLOGY, V89, P226, DOI 10.1016/j.theriogenology.2015.12.014; Sadeghipour M, 2005, TOXICOL IN VITRO, V19, P155, DOI 10.1016/j.tiv.2004.06.009; Saraiva MVA, 2010, REPROD SCI, V17, P1135, DOI 10.1177/1933719110379269; Sherman J, 1991, HDB THIN LAYER CHROM; Silva-Santos KC, 2014, REPROD DOMEST ANIM, V49, P228, DOI 10.1111/rda.12255; Suarez S, 2003, S BRASILEIRO OLEOS E, V2, P78; Taieb F, 1997, MOL REPROD DEV, V48, P397, DOI 10.1002/(SICI)1098-2795(199711)48:3&lt;397::AID-MRD14&gt;3.0.CO;2-T; Tatsimo Simplice Joel Ndendoung, 2012, BMC Res Notes, V5, P158, DOI 10.1186/1756-0500-5-158; Taylor CT, 2001, ENVIRON TOXICOL PHAR, V10, P189, DOI 10.1016/S1382-6689(01)00099-0; Telefo PB, 2004, J ETHNOPHARMACOL, V91, P225, DOI 10.1016/j.jep.2003.12.024; Telefo PB, 2002, FITOTERAPIA, V73, P472, DOI 10.1016/S0367-326X(02)00177-6; Telefo PB, 1998, J ETHNOPHARMACOL, V63, P193, DOI 10.1016/S0378-8741(98)00062-2; Telefo PB, 2012, AFR J TRADIT COMPLEM, V9, P197, DOI 10.4314/ajtcam.v9i2.3; Turpaev KT, 2002, BIOCHEMISTRY-MOSCOW+, V67, P281, DOI 10.1023/A:1014819832003; Zhao G, 2016, MOL CELL, V62, P546, DOI 10.1016/j.molcel.2016.04.026; Zhou J, 2012, CURR MED CHEM, V19, P3523, DOI 10.2174/092986712801323171	70	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208760	10.1371/journal.pone.0208760	http://dx.doi.org/10.1371/journal.pone.0208760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532263	Green Published, gold, Green Submitted			2022-12-26	WOS:000452640900041
J	Bouacida, L; Suin, V; Hutse, V; Boudewijns, M; Cartuyvels, R; Debaisieux, L; De Laere, E; Hallin, M; Hougardy, N; Lagrou, K; Oris, E; Padalko, E; Reynders, M; Roussel, G; Senterre, JM; Stalpaert, M; Ursi, D; Vael, C; Vaira, D; Van Acker, J; Verstrepen, W; Van Gucht, S; Kabamba, B; Quoilin, S; Muyldermans, G				Bouacida, Lobna; Suin, Vanessa; Hutse, Veronik; Boudewijns, Michael; Cartuyvels, Reinoud; Debaisieux, Laurent; De Laere, Emmanuel; Hallin, Marie; Hougardy, Nicolas; Lagrou, Katrien; Oris, Els; Padalko, Elizaveta; Reynders, Marijke; Roussel, Gatien; Senterre, Jean-Marc; Stalpaert, Michel; Ursi, Dominique; Vael, Carl; Vaira, Dolores; Van Acker, Jos; Verstrepen, Walter; Van Gucht, Steven; Kabamba, Benoit; Quoilin, Sophie; Muyldermans, Gaetan			Distribution of HCV genotypes in Belgium from 2008 to 2015	PLOS ONE			English	Article							HEPATITIS-C VIRUS; EPIDEMIOLOGY; INFECTION; SOFOSBUVIR	Background The knowledge of circulating HCV genotypes and subtypes in a country is crucial to guide antiviral therapy and to understand local epidemiology. Studies investigating circulating HCV genotypes and their trends have been conducted in Belgium. However they are outdated, lack nationwide representativeness or were not conducted in the general population. Methods In order to determine the distribution of different circulating HCV genotypes in Belgium, we conducted a multicentre study with all the 19 Belgian laboratories performing reimbursed HCV genotyping assays. Available genotype and subtype data were collected for the period from 2008 till 2015. Furthermore, a limited number of other variables were collected: some demographic characteristics from the patients and the laboratory technique used for the determination of the HCV genotype. Results For the study period, 11,033 unique records collected by the participating laboratories were used for further investigation. HCV genotype 1 was the most prevalent (53.6%) genotype in Belgium, with G1a and G1b representing 19.7% and 31.6%, respectively. Genotype 3 was the next most prevalent (22.0%). Further, genotype 4, 2, and 5 were responsible for respectively 16.1%, 6.2%, and 1.9% of HCV infections. Genotype 6 and 7 comprise the remaining <1%. Throughout the years, a stable distribution was observed for most genotypes. Only for genotype 5, a decrease as a function of the year of analysis was observed, with respectively 3.6% for 2008, 2.3% for 2009 and 1.6% for the remaining years. The overall M:F ratio was 1.59 and was mainly driven by the high M:F ratio of 3.03 for patients infected with genotype 3. Patients infected with genotype 3 are also younger (mean age 41.7 years) than patients infected with other genotypes (mean age above 50 years for all genotypes). The patients for whom a genotyping assay was performed in 2008 were younger than those from 2015. Geographical distribution demonstrates that an important number of genotyped HCV patients live outside the Belgian metropolitan cities. Conclusion This national monitoring study allowed a clear and objective view of the circulating HCV genotypes in Belgium and will help health authorities in the establishment of cost effectiveness determinations before implementation of new treatment strategies. This baseline characterization of the circulating genotypes is indispensable for a continuous surveillance, especially for the investigation of the possible impact of migration from endemic regions and prior to the increasing use of highly potent direct-acting antiviral (DAA) agents.	[Bouacida, Lobna] Sciensano, Lab Med Microbiol, Brussels, Belgium; [Suin, Vanessa; Hutse, Veronik; Van Gucht, Steven] Sciensano, Viral dis, Brussels, Belgium; [Suin, Vanessa; Hutse, Veronik; Van Gucht, Steven; Kabamba, Benoit] Natl Reference Ctr Hepatitis Viruses, Brussels, Belgium; [Boudewijns, Michael] AZ Groeninge, Campus Kennedylaan Lab, Kortrijk, Belgium; [Cartuyvels, Reinoud] Jessa Ziekenhuis, Klin Lab, Hasselt, Belgium; [Debaisieux, Laurent] CUB Hop Erasme, LHUB ULB Site Anderlecht, Brussels, Belgium; [De Laere, Emmanuel] AZ Delta, Roeselare, Belgium; [Hallin, Marie] LHUB ULB, Brussels, Belgium; [Hougardy, Nicolas] Clin Sud Luxembourg, Site St Joseph Labo Anal Med, Arlon, Belgium; [Lagrou, Katrien] UZ Leuven, Clin Dept Lab Med, Leuven, Belgium; [Lagrou, Katrien] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Oris, Els] Ziekenhuis Oost Limburg, Labo Klin Biol, Genk, Belgium; [Padalko, Elizaveta] UZ Ghent, Clin Biol Med Microbiol Lab, Ghent, Belgium; [Reynders, Marijke] AZ Sint Jan Brugge Oostende AV, Lab Med, Brugge, Belgium; [Roussel, Gatien] Clin St Pierre, Lab Biol Clin, Ottignies, Belgium; [Senterre, Jean-Marc] Ch Reg Citadelle, Liege, Belgium; [Stalpaert, Michel] Algemeen Med Lab, Antwerp, Belgium; [Ursi, Dominique] Univ Hosp Antwerp, Lab Mol Diagnost Microbiol, Antwerp, Belgium; [Vael, Carl] AZ KLINA, Clin Lab, Brasschaat, Belgium; [Vaira, Dolores] CHU Liege, Lab Reference SIDA ULg, Liege, Belgium; [Van Acker, Jos] AZ Sint Lucas, Ghent, Belgium; [Verstrepen, Walter] ZNA, Klin Lab, Campus Middelheim, Antwerp, Belgium; [Kabamba, Benoit] Clin Univ St Luc, Lab Biol Clin Ria, Brussels, Belgium; [Quoilin, Sophie; Muyldermans, Gaetan] Sciensano, Epidemiol Infect Dis, Brussels, Belgium	Sciensano; Sciensano; Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven; KU Leuven; East Limburg Hospital; Ghent University; Ghent University Hospital; University of Antwerp; University of Liege; ZNA Stuivenberg; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Sciensano	Muyldermans, G (corresponding author), Sciensano, Epidemiol Infect Dis, Brussels, Belgium.	gaetan.muyldermans@sciensano.be	Muyldermans, Gaetan/AAE-7235-2020	Hallin, Marie/0000-0003-4544-0635				Alberti A, 2016, J MED VIROL, V88, P2157, DOI 10.1002/jmv.24573; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; BUKH J, 1992, P NATL ACAD SCI USA, V89, P187, DOI 10.1073/pnas.89.1.187; De Cock L, 2003, INFECTION, V31, P92, DOI 10.1007/s15010-002-3001-5; De Ryck I, 2011, ACTA CLIN BELG, V66, P46, DOI 10.1179/ACB.66.1.2062513; Delwaide J, 2006, EUR J GASTROEN HEPAT, V18, P707, DOI 10.1097/01.meg.0000219103.40435.8d; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; European Centre for Disease Prevention and Control (ECDC), 2016, EP ASS HEP B C PREV; Faustini A, 2005, INFECT CONT HOSP EP, V26, P762, DOI 10.1086/502614; Gerard C, 2005, J MED VIROL, V76, P503, DOI 10.1002/jmv.20390; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Institute of public health, 2016, YEARL HCV REP; Katsoulidou A, 1999, NEPHROL DIAL TRANSPL, V14, P1188, DOI 10.1093/ndt/14.5.1188; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Loly JP, 2011, ACTA GASTROENTEROLOG, V74, P2011; Mathei C, 2005, EUR J CLIN MICROBIOL, V24, P514, DOI 10.1007/s10096-005-1376-9; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Micalessi MI, 2008, J MED VIROL, V80, P640, DOI 10.1002/jmv.21145; Murphy DG, 2015, J CLIN MICROBIOL, V53, P967, DOI 10.1128/JCM.02831-14; Muyldermans G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160429; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Schreiber J, 2016, HEPATOLOGY, V64, P983, DOI 10.1002/hep.28636; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Verbeeck J, 2010, EUR J CLIN MICROBIOL, V29, P1427, DOI 10.1007/s10096-010-1021-0; WHO, DRAFT GLOB HLTH SECT; World Health Organization, 2017, ACT PLAN HLTH SECT R; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207584	10.1371/journal.pone.0207584	http://dx.doi.org/10.1371/journal.pone.0207584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517127	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400047
J	Galloway-Pena, J; DebRoy, S; Brumlow, C; Li, XQ; Tran, TT; Horstmann, N; Yao, H; Chen, K; Wang, F; Pan, BF; Hawke, DH; Thompson, EJ; Arias, CA; Fowler, VG; Bhatti, MM; Kalia, A; Flores, AR; Shelburne, SA				Galloway-Pena, Jessica; DebRoy, Sruti; Brumlow, Chelcy; Li, Xiqi; Tran, Truc T.; Horstmann, Nicola; Yao, Hui; Chen, Ken; Wang, Fang; Pan, Bih-Fang; Hawke, David H.; Thompson, Erika J.; Arias, Cesar A.; Fowler, Vance G., Jr.; Bhatti, Micah M.; Kalia, Awdhesh; Flores, Anthony R.; Shelburne, Samuel A.			Hypervirulent group A Streptococcus emergence in an acaspular background is associated with marked remodeling of the bacterial cell surface	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; VIRULENCE FACTOR EXPRESSION; HYALURONIC-ACID CAPSULE; RESPONSE REGULATOR; MGA REGULON; PYOGENES; PROTEIN; COVS; PHOSPHORYLATION; MUTATIONS	Inactivating mutations in the control of virulence two-component regulatory system (covRS) often account for the hypervirulent phenotype in severe, invasive group A streptococcal (GAS) infections. As CovR represses production of the anti-phagocytic hyaluronic acid capsule, high level capsule production is generally considered critical to the hypervirulent phenotype induced by CovRS inactivation. There have recently been large outbreaks of GAS strains lacking capsule, but there are currently no data on the virulence of covRS-mutated, acapsular strains in vivo. We investigated the impact of CovRS inactivation in acapsular serotype M4 strains using a wild-type (M4-SC-1) and a naturally-occurring CovS-inactivated strain (M4-LC-1) that contains an 11bp covS insertion. M4-LC-1 was significantly more virulent in a mouse bacteremia model but caused smaller lesions in a subcutaneous mouse model. Over 10% of the genome showed significantly different transcript levels in M4-LC-1 vs. M4-SC-1 strain. Notably, the Mga regulon and multiple cell surface protein-encoding genes were strongly upregulated-a finding not observed for CovS-inactivated, encapsulated M1 or M3 GAS strains. Consistent with the transcriptomic data, transmission electron microscopy revealed markedly altered cell surface morphology of M4-LC-1 compared to M4-SC-1. Insertional inactivation of covS in M4-SC-1 recapitulated the transcriptome and cell surface morphology. Analysis of the cell surface following CovS-inactivation revealed that the upregulated proteins were part of the Mga regulon. Inactivation of mga in M4-LC-1 reduced transcript levels of multiple cell surface proteins and reversed the cell surface alterations consistent with the effect of CovS inactivation on cell surface composition being mediated by Mga. CovRS-inactivating mutations were detected in 20% of current invasive serotype M4 strains in the United States. Thus, we discovered that hypervirulent M4 GAS strains with covRS mutations can arise in an acapsular background and that such hypervirulence is associated with profound alteration of the cell surface.	[Galloway-Pena, Jessica; DebRoy, Sruti; Brumlow, Chelcy; Li, Xiqi; Horstmann, Nicola; Shelburne, Samuel A.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA; [Galloway-Pena, Jessica; Shelburne, Samuel A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Tran, Truc T.; Arias, Cesar A.; Flores, Anthony R.] UTHlth McGovern Med Sch, Ctr Antimicrobial Resistance & Microbial Genom, Houston, TX USA; [Tran, Truc T.; Arias, Cesar A.; Flores, Anthony R.] UTHlth McGovern Med Sch, Div Infect Dis, Houston, TX USA; [Yao, Hui; Chen, Ken; Wang, Fang] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Pan, Bih-Fang; Hawke, David H.; Shelburne, Samuel A.] Univ Texas MD Anderson Canc Ctr, Prote & Metabol Facil, Houston, TX 77030 USA; [Thompson, Erika J.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Arias, Cesar A.] UTHlth Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA; [Arias, Cesar A.] Univ El Bosque, Mol Genet & Antimicrobial Resistance Unit, Int Ctr Microbial Genom, Bogota, Colombia; [Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC USA; [Bhatti, Micah M.] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA; [Kalia, Awdhesh] Univ Texas MD Anderson Canc Ctr, Grad Program Diagnost Genet, Sch Hlth Profess, Houston, TX 77030 USA; [Flores, Anthony R.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Universidad El Bosque; Duke University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Shelburne, SA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA.; Shelburne, SA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.; Shelburne, SA (corresponding author), Univ Texas MD Anderson Canc Ctr, Prote & Metabol Facil, Houston, TX 77030 USA.	sshelburne@mdanderson.org	Chen, Ken/AAU-1432-2021; Flores, Anthony/W-3797-2017; Galloway-Pena, Jessica/J-5496-2019; Fowler, Vance/AAW-2017-2021	Chen, Ken/0000-0003-4013-5279; Flores, Anthony/0000-0002-6402-4269; Galloway-Pena, Jessica/0000-0003-1081-254X; Kalia, Awdhesh/0000-0001-5365-1702; Li, Xiqi/0000-0003-0875-8337; Horstmann, Nicola/0000-0002-3620-5169	National Institutes of Allergy and Infectious Diseases [R01AI125292, R21AI132920]; National Cancer Institute [P30-CA016672]; Cancer Prevention Research Institute of Texas (CPRIT) [RP130397]; NIH [K24 AI121296, 1S10OD012304-01]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI121296, R21AI132920, R01AI134637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115774] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research Institute of Texas (CPRIT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this study was provided by the National Institutes of Allergy and Infectious Diseases (R01AI125292 and R21AI132920 to SAS), the National Cancer Institute (P30-CA016672 via the Bioinformatics Shared Resource), the Cancer Prevention Research Institute of Texas (CPRIT) grant number RP130397, and the NIH grant number 1S10OD012304-01 (core facility grants). CAA is supported by an NIH grant (K24 AI121296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LEC, 2010, J MOL MED, V88, P371, DOI 10.1007/s00109-009-0566-9; Almengor AC, 2004, J BACTERIOL, V186, P7847, DOI 10.1128/JB.186.23.7847-7857.2004; Bensi G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015693; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Calfee G, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00792-17; Cao TN, 2014, INFECT IMMUN, V82, P1744, DOI 10.1128/IAI.01639-13; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chochua S, 2017, MBIO, V8, DOI [10.1128/mBio.01422-17, 10.1128/mbio.01422-17]; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Creti R, 2012, EUR J CLIN MICROBIOL, V31, P233, DOI 10.1007/s10096-011-1298-7; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; Danecek P, 2017, BIOINFORMATICS, V33, P2037, DOI 10.1093/bioinformatics/btx100; Dochez AR, 1919, J EXP MED, V30, P179, DOI 10.1084/jem.30.3.179; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Fabich AJ, 2011, INFECT IMMUN, V79, P2430, DOI 10.1128/IAI.01199-10; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Flores AR, 2019, J PEDIAT INF DIS SOC, V8, P244, DOI 10.1093/jpids/piy053; Flores AR, 2015, P NATL ACAD SCI USA, V112, P6431, DOI 10.1073/pnas.1504725112; Flores AR, 2014, INFECT IMMUN, V82, P3958, DOI 10.1128/IAI.01788-14; Flores AR, 2014, J INFECT DIS, V209, P1520, DOI 10.1093/infdis/jit674; Flores AR, 2012, MBIO, V3, DOI 10.1128/mBio.00413-12; FORSBERG CM, 1972, J CLIN PATHOL, V25, P65, DOI 10.1136/jcp.25.1.65; Friaes A, 2015, MBIO, V6, DOI 10.1128/mBio.01780-15; Friaes A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12057; Galloway-Pena J, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw042; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Hanage WP, 2006, J CLIN MICROBIOL, V44, P743, DOI 10.1128/JCM.44.3.743-749.2006; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Henningham A, 2014, J BIOL CHEM, V289, P32303, DOI 10.1074/jbc.M114.602847; Horstmann N, 2015, INFECT IMMUN, V83, P1068, DOI 10.1128/IAI.02659-14; Horstmann N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004088; Horstmann N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002311; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Jacob Kristin M, 2016, Genome Announc, V4, DOI 10.1128/genomeA.00127-16; Kansal RG, 2010, J INFECT DIS, V201, P1778, DOI 10.1086/652703; KAYSNER CA, 1990, DIAGN MICR INFEC DIS, V13, P285, DOI 10.1016/0732-8893(90)90018-Q; Koskiniemi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070147; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2002, MICROBIOL-SGM, V148, P1501, DOI 10.1099/00221287-148-5-1501; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu GH, 2015, INFECT IMMUN, V83, P4293, DOI 10.1128/IAI.00857-15; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marks LR, 2013, MBIO, V4, DOI 10.1128/mBio.00438-13; Marzel A, 2016, CLIN INFECT DIS, V62, P879, DOI 10.1093/cid/civ1221; Mastroeni P, 2011, INFECT IMMUN, V79, P636, DOI 10.1128/IAI.00954-10; Masuno K, 2014, J MED MICROBIOL, V63, P504, DOI 10.1099/jmm.0.070300-0; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Reddinger RM, 2016, MBIO, V7, DOI 10.1128/mBio.01235-16; Ribardo DA, 2006, MOL MICROBIOL, V62, P491, DOI 10.1111/j.1365-2958.2006.05381.x; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Sanson M, 2015, INFECT IMMUN, V83, P2382, DOI 10.1128/IAI.03023-14; Shopsin B, 2010, J INFECT DIS, V202, P1593, DOI 10.1086/656915; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; SWANSON J, 1969, J EXP MED, V130, P1063, DOI 10.1084/jem.130.5.1063; Thern A, 1998, J IMMUNOL, V160, P860; Trevino J, 2013, INFECT IMMUN, V81, P364, DOI 10.1128/IAI.00703-12; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Turner Claire E, 2015, mBio, V6, pe00622, DOI 10.1128/mBio.00622-15; Vega LA, 2016, STREPTOCOCCUS PYOGEN; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zhu LC, 2015, MBIO, V6, DOI 10.1128/mBio.01378-15	73	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207897	10.1371/journal.pone.0207897	http://dx.doi.org/10.1371/journal.pone.0207897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517150	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400072
J	Lindstrom, AK; Hermansson, RS; Gustaysson, I; Lindberg, JH; Gyllensten, U; Olovsson, M				Lindstrom, Annika Kristina; Hermansson, Ruth Sanchez; Gustaysson, Inger; Lindberg, Julia Hedlund; Gyllensten, Ulf; Olovsson, Matts			Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing	PLOS ONE			English	Article							FOLLOW-UP; CANCER	Background About 30% of the cervical cancer cases in Sweden occur in women older than 60. The primary aim was to evaluate the acceptability of repeated self-sampling at home for HPV-testing in elderly women. The prevalence of HPV and HPV related dysplasia as well as the sensitivity of cytology was evaluated. Methods Repeated self-sampling at home for HPV testing was offered 375 women in each of the four age groups 60, 65, 70 and 75 years. Women with two consecutive positive HPV tests were examined with sampling for histology and cytology. Findings A self-sample was provided by 59.5% (893/1500) of the invited women. The overall prevalence of HPV was 4.4% (95% CI 3.2-6.0, n = 39) in the first test, and 2.5% were persistent positive in the second test (95% C 1.6-3.8, n = 22) collected on average 5.5 months later. Dysplasia, was found in 1.8% (16/893) (95% CI 1.1-3.0) and CIN 2+ in 1.0% (9/893) (95% CI 0.5-2.0) of the women. Of the 16 women with dysplasia in histology, 13 (81.2%) had a normal cytology. Interpretation Repeated self-sampling at home combined with HPV testing was well accepted among elderly women. A high prevalence of CIN was diagnosed by histology. Cytology showed extremely low sensitivity and should not be recommended for this age group.	[Lindstrom, Annika Kristina; Hermansson, Ruth Sanchez; Olovsson, Matts] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Lindstrom, Annika Kristina] Uppsala Univ, Ctr Clin Res, Uppsala, Sweden; [Lindstrom, Annika Kristina] Orebro Univ, Clin Res Ctr, Fac Med & Hlth, Orebro, Sweden; [Hermansson, Ruth Sanchez] Orebro Univ, Fac Med & Hlth, Dept Oncol, Orebro, Sweden; [Gustaysson, Inger; Lindberg, Julia Hedlund; Gyllensten, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; Uppsala University; Orebro University; Orebro University; Uppsala University	Lindstrom, AK (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Lindstrom, AK (corresponding author), Uppsala Univ, Ctr Clin Res, Uppsala, Sweden.; Lindstrom, AK (corresponding author), Orebro Univ, Clin Res Ctr, Fac Med & Hlth, Orebro, Sweden.	annika.lindstrom@itdalarna.se	Lindstrom, Annika K./ABB-7829-2020	Lindstrom, Annika K./0000-0002-7407-9642; Hermansson, Ruth/0000-0002-6549-9311	Uppsala-Orebro Regional Research Council [RFR - 383351, RFR - 561251]	Uppsala-Orebro Regional Research Council	This work was supported by Uppsala-Orebro Regional Research Council, RFR - 383351; Uppsala-Orebro Regional Research Council, RFR - 561251. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Beckman N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a279; Bekos C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24882-2; Bergengren L, 2018, INT J GYNECOL OBSTET, V142, P359, DOI 10.1002/ijgo.12538; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Carpenter AB, 1999, CANCER CYTOPATHOL, V87, P105, DOI 10.1002/(SICI)1097-0142(19990625)87:3<105::AID-CNCR2>3.0.CO;2-Z; Commission E, 2015, HLTH GLANC EUR 2014; Darlin L, 2014, ANTICANCER RES, V34, P5147; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gilani SM, 2013, ACTA CYTOL, V57, P575, DOI 10.1159/000353769; Gustavsson I, 2018, BRIT J CANCER, V118, P896, DOI 10.1038/bjc.2017.485; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Gustavsson I, 2009, J CLIN VIROL, V45, P85, DOI 10.1016/j.jcv.2009.04.012; Gyllensten U, 2011, BRIT J CANCER, V105, P694, DOI 10.1038/bjc.2011.277; Hammer A, 2018, J LOW GENIT TRACT DI, V22, P1, DOI 10.1097/LGT.0000000000000351; Hermansson RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189300; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P105, DOI 10.1016/j.ajog.2004.01.043; Kjaer SK, 2014, CANCER CAUSE CONTROL, V25, P179, DOI 10.1007/s10552-013-0320-z; Lam JUH, 2018, BRIT J CANCER, V118, P138, DOI 10.1038/bjc.2017.371; Lamin H, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014788; Landy R, 2016, BRIT J CANCER, V115, P1140, DOI 10.1038/bjc.2016.290; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Socialstyrelsen, NON TRADITIONAL REF; Socialstyrelsen, 2015, STAND INF PREV REPR, P1; The Board of Health and Welfare CfE, CANC INC SWED 2014; The Board of Health and Welfare CfE, CAUS DEATH 2013, P277; Tranbaloc P, 2008, GYNECOL OBSTET FERTI, V36, P650, DOI 10.1016/j.gyobfe.2008.03.016; Wang JR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002414	29	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207714	10.1371/journal.pone.0207714	http://dx.doi.org/10.1371/journal.pone.0207714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517176	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400061
J	Claeys, S; Denecker, G; Durinck, K; Decaesteker, B; Mus, LM; Loontiens, S; Vanhauwaert, S; Althoff, K; Wigerup, C; Bexell, D; Dolman, E; Henrich, KO; Wehrmann, L; Westerhout, EM; Demoulin, JB; Kumps, C; Van Maerken, T; Laureys, G; Van Neste, C; De Wilde, B; De Wever, O; Westermann, F; Versteeg, R; Molenaar, JJ; Pahlman, S; Schulte, JH; De Preter, K; Speleman, F				Claeys, Shana; Denecker, Geertrui; Durinck, Kaat; Decaesteker, Bieke; Mus, Liselot M.; Loontiens, Siebe; Vanhauwaert, Suzanne; Althoff, Kristina; Wigerup, Caroline; Bexell, Daniel; Dolman, Emmy; Henrich, Kai-Oliver; Wehrmann, Lea; Westerhout, Ellen M.; Demoulin, Jean-Baptiste; Kumps, Candy; Van Maerken, Tom; Laureys, Genevieve; Van Neste, Christophe; De Wilde, Bram; De Wever, Olivier; Westermann, Frank; Versteeg, Rogier; Molenaar, Jan J.; Pahlman, Sven; Schulte, Johannes H.; De Preter, Katleen; Speleman, Frank			ALK positively regulates MYCN activity through repression of HBP1 expression	ONCOGENE			English	Article							LARGE-CELL LYMPHOMA; TRANSCRIPTIONAL REPRESSOR; NEURONAL DIFFERENTIATION; ACTIVATING MUTATIONS; BET INHIBITORS; TARGET GENES; CANCER CELLS; NEUROBLASTOMA; KINASE; RESISTANCE	ALK mutations occur in 10% of primary neuroblastomas and represent a major target for precision treatment. In combination with MYCN amplification, ALK mutations infer an ultra-high-risk phenotype resulting in very poor patient prognosis. To open up opportunities for future precision drugging, a deeper understanding of the molecular consequences of constitutive ALK signaling and its relationship to MYCN activity in this aggressive pediatric tumor entity will be essential. We show that mutant ALK downregulates the 'HMG-box transcription factor 1' (HBP1) through the PI3K-AKT-FOXO3a signaling axis. HBP1 inhibits both the transcriptional activating and repressing activity of MYCN, the latter being mediated through PRC2 activity. HBP1 itself is under negative control of MYCN through miR-17 similar to 92. Combined targeting of HBP1 by PI3K antagonists and MYCN signaling by BET- or HDAC-inhibitors blocks MYCN activity and significantly reduces tumor growth, suggesting a novel targeted therapy option for high-risk neuroblastoma.	[Claeys, Shana; Denecker, Geertrui; Durinck, Kaat; Decaesteker, Bieke; Mus, Liselot M.; Loontiens, Siebe; Vanhauwaert, Suzanne; Kumps, Candy; Van Maerken, Tom; Van Neste, Christophe; De Wilde, Bram; De Preter, Katleen; Speleman, Frank] Univ Ghent, CMGG, Ghent, Belgium; [Claeys, Shana; Denecker, Geertrui; Durinck, Kaat; Decaesteker, Bieke; Mus, Liselot M.; Loontiens, Siebe; Vanhauwaert, Suzanne; Van Maerken, Tom; Laureys, Genevieve; Van Neste, Christophe; De Wilde, Bram; De Wever, Olivier; De Preter, Katleen; Speleman, Frank] Univ Ghent, CRIG, Ghent, Belgium; [Althoff, Kristina] Univ Childrens Hosp Essen, Dept Pediat Oncol & Hematol, Essen, Germany; [Wigerup, Caroline; Bexell, Daniel; Pahlman, Sven] Lund Univ, Translat Canc Res, Canc Ctr Medicon Village, Lund, Sweden; [Dolman, Emmy; Molenaar, Jan J.] Princess Maxima Ctr Pediat Canc, Utrecht, Netherlands; [Henrich, Kai-Oliver; Wehrmann, Lea; Westermann, Frank] German Canc Res Ctr, Neuroblastoma Genom B087, Heidelberg, Germany; [Westerhout, Ellen M.; Versteeg, Rogier] Acad Med Ctr, Dept Oncogen, Amsterdam, Netherlands; [Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, Brussels, Belgium; [Kumps, Candy] Ghent Univ Hosp, Dept Urogynaecol, Ghent, Belgium; [Laureys, Genevieve; De Wilde, Bram] Ghent Univ Hosp, Dept Pediat Oncol & Hematol, Ghent, Belgium; [De Wever, Olivier] Univ Ghent, LECR, Ghent, Belgium; [Schulte, Johannes H.] Charite, Dept Pediat Oncol Hematol, Berlin, Germany; [Schulte, Johannes H.] BIH, Berlin, Germany; [Schulte, Johannes H.] German Translat Canc Res Consortium DKTK, Berlin, Germany; [Schulte, Johannes H.] German Translat Canc Res Consortium DKFZ, Heidelberg, Germany	Ghent University; Ghent University; University of Duisburg Essen; Lund University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Amsterdam; Academic Medical Center Amsterdam; Universite Catholique Louvain; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health	Speleman, F (corresponding author), Univ Ghent, CMGG, Ghent, Belgium.; Speleman, F (corresponding author), Univ Ghent, CRIG, Ghent, Belgium.	franki.speleman@ugent.be	speleman, frank/AAR-5184-2020; Durinck, Kaat/AFN-5192-2022; de wever, olivier/J-3094-2013; Versteeg, Rogier/AAQ-1765-2020; Mus, Liselot/FCB-1557-2022; Van Neste, Christophe/AAE-5505-2020; laureys, genevieve/AAG-2390-2021; Westermann, Frank/F-7509-2013	speleman, frank/0000-0002-6628-8559; de wever, olivier/0000-0002-5453-760X; Mus, Liselot/0000-0001-5738-0639; Vanhauwaert, Suzanne/0000-0002-7768-4549; Schulte, Johannes Hubertus/0000-0003-0671-1201; De Wilde, Bram/0000-0003-0213-1322; Dolman, Emmy/0000-0002-0567-5918; Loontiens, Siebe/0000-0002-4602-4580; Decaesteker, Bieke/0000-0003-2264-781X; Durinck, Kaat/0000-0003-1762-5739; Bexell, Daniel/0000-0001-9426-9550	Research Foundation-Flanders (FWO) [11J8313N, 18B1716N, 12N6917N, 1803115 N]; Emmanuel van der Schueren grant ('Kom op tegen Kanker'); VLK (Flemish League against cancer); FWO Research Foundation-Flanders (FWO); Ghent University (BOF) [BOF16/PDO/043]; Belgian Foundation against Cancer [2014-175]; Ghent University [BOF10/GOA/019, BOF16/GOA/23]; Belgian Program of Interuniversity Poles of Attraction (IUAP) [VII-P7/03]; fund for Scientific Research Flanders [G053012N, G050712N, G051516N]; Stichting Villa Joep	Research Foundation-Flanders (FWO)(FWO); Emmanuel van der Schueren grant ('Kom op tegen Kanker'); VLK (Flemish League against cancer); FWO Research Foundation-Flanders (FWO)(FWO); Ghent University (BOF)(Ghent University); Belgian Foundation against Cancer; Ghent University(Ghent University); Belgian Program of Interuniversity Poles of Attraction (IUAP); fund for Scientific Research Flanders(FWO); Stichting Villa Joep	S.C. is supported by a pre-doctoral fellowship of the Research Foundation-Flanders (FWO; 11J8313N) and an Emmanuel van der Schueren grant ('Kom op tegen Kanker'). S.V. is funded by the VLK (Flemish League against cancer) and 'Stichting Villa Joep'. B.D. and S.L. are supported by a pre-doctoral fellowship of the FWO Research Foundation-Flanders (FWO). K.D. is supported by Ghent University (BOF; BOF16/PDO/043). C.V., B.D.W. and T.V.M. are senior clinical investigators of the Research Foundation-Flanders (FWO; 18B1716N (B.D.W.), 12N6917N (C.V.), 1803115 N (T.V.M.)). We would further like to thank the following funding agencies: the Belgian Foundation against Cancer (project 2014-175) to F.S., Ghent University (BOF10/GOA/019, BOF16/GOA/23) to F.S., the Belgian Program of Interuniversity Poles of Attraction (IUAP Phase VII-P7/03) to F.S., the fund for Scientific Research Flanders (Research projects G053012N, G050712N, G051516N to F.S) and 'Stichting Villa Joep' to F.S.	Althoff K, 2015, ONCOGENE, V34, P3357, DOI 10.1038/onc.2014.269; Amin AD, 2016, ONCOTARGET, V7, P23715, DOI 10.18632/oncotarget.8173; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Bollaert E, 2018, CELL SIGNAL, V44, P158, DOI 10.1016/j.cellsig.2018.01.014; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Braekeveldt N, 2015, INT J CANCER, V136, pE252, DOI 10.1002/ijc.29217; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Cage TA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00111; Carpenter EL, 2012, NAT REV CLIN ONCOL, V9, P391, DOI 10.1038/nrclinonc.2012.72; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Cortes C, 2015, CELL ONCOL, V38, P341, DOI 10.1007/s13402-015-0233-9; Corvetta D, 2013, J BIOL CHEM, V288, P8332, DOI 10.1074/jbc.M113.454280; de Brachene AC, 2014, BIOCHEM J, V460, P25, DOI 10.1042/BJ20131467; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Debruyne DN, 2016, ONCOGENE, V35, P3681, DOI 10.1038/onc.2015.434; Ferreira ACD, 2016, J LEUKOCYTE BIOL, V99, P569, DOI 10.1189/jlb.2A0415-162R; Duffy DJ, 2014, MOL CANCER THER, V13, P454, DOI 10.1158/1535-7163.MCT-13-0560-T; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Escamilla-Powers JR, 2010, J BIOL CHEM, V285, P4847, DOI 10.1074/jbc.M109.074856; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Frumm SM, 2013, CHEM BIOL, V20, P713, DOI 10.1016/j.chembiol.2013.03.020; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gu TL, 2004, BLOOD, V103, P4622, DOI 10.1182/blood-2003-03-0820; Guan J, 2016, DIS MODEL MECH, V9, P941, DOI 10.1242/dmm.024448; Hasan MK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03450; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henrich KO, 2016, CANCER RES, V76, P5523, DOI 10.1158/0008-5472.CAN-15-2507; Heuckmann JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648; Heukamp LC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003967; Isozaki H, 2016, CANCER RES, V76, P1506, DOI 10.1158/0008-5472.CAN-15-1010; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Lambertz I, 2015, CLIN CANCER RES, V21, P3327, DOI 10.1158/1078-0432.CCR-14-2024; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li YL, 2014, CANCER CELL, V26, P262, DOI 10.1016/j.ccr.2014.06.014; Louis CU, 2015, ANNU REV MED, V66, P49, DOI 10.1146/annurev-med-011514-023121; Lovly CM, 2014, CLIN CANCER RES, V20, P2249, DOI 10.1158/1078-0432.CCR-13-1610; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Moore NF, 2014, ONCOTARGET, V5, P8737, DOI 10.18632/oncotarget.2372; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Pall G, 2015, CURR OPIN ONCOL, V27, P118, DOI 10.1097/CCO.0000000000000165; Passoni L, 2009, CANCER RES, V69, P7338, DOI 10.1158/0008-5472.CAN-08-4419; Pei YX, 2016, CANCER CELL, V29, P311, DOI 10.1016/j.ccell.2016.02.011; Persson CU, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09662-8; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Santo EE, 2013, CANCER RES, V73, P2189, DOI 10.1158/0008-5472.CAN-12-3767; Schonerr C, 2012, ONCOGENE, V31, P5193, DOI 10.1038/onc.2012.12; Schubbert S, 2014, CANCER RES, V74, P7048, DOI 10.1158/0008-5472.CAN-14-1470; Stratikopoulos EE, 2016, CLIN CANCER RES, V22, P2605, DOI 10.1158/1078-0432.CCR-15-2389; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Toyokawa G, 2015, ONCOL RES TREAT, V38, P291, DOI 10.1159/000430852; Umapathy G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005470; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Vaughan L, 2016, ONCOTARGET, V7, P57525, DOI 10.18632/oncotarget.10544; Watanabe N, 2015, DEVELOPMENT, V142, P2278, DOI 10.1242/dev.120477; Yan Xiaocai, 2011, Genes Cancer, V2, P538, DOI 10.1177/1947601911416003; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Zeller K, 2003, GENOME BIOL, V4, P1; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	73	8	9	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2690	2705		10.1038/s41388-018-0595-3	http://dx.doi.org/10.1038/s41388-018-0595-3			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30538293				2022-12-26	WOS:000464121600002
J	Paroni, G; Bolis, M; Zanetti, A; Ubezio, P; Helin, K; Staller, P; Gerlach, LO; Fratelli, M; Neve, RM; Terao, M; Garattini, E				Paroni, Gabriela; Bolis, Marco; Zanetti, Adriana; Ubezio, Paolo; Helin, Kristian; Staller, Peter; Gerlach, Lars Ole; Fratelli, Maddalena; Neve, Richard M.; Terao, Mineko; Garattini, Enrico			HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases	ONCOGENE			English	Article							HISTONE DEMETHYLASE RBP2; EMERGING ROLE; RESISTANCE; PROLIFERATION; MECHANISMS; LAPATINIB; SURVIVAL; LANGUAGE	Targeting of histone methylation has therapeutic potential in oncology. Here, we provide proof-of-principle that pharmacological inhibition of KDM5 histone-demethylases is a new strategy for the personalized treatment of HER2(+) breast cancer. The anti-proliferative effects of the prototype of a new class of selective KDM5-inhibitors (KDM5-inhl) are evaluated in 40 cell lines, recapitulating the heterogeneity of breast cancer. This analysis demonstrates that HER2(+) cells are particularly sensitive to KDM5 inhibition. The results are confirmed in an appropriate in vivo model with a close structural analog (KDM5-inhlA). RNA-seq data obtained in HER2(+) BT-474 cells exposed to KDM5-Inhl indicate that the compound alters expression of numerous genes downstream of the ERBB2 gene-product, HER2. In selected HER2-positive breast-cancer cells, we demonstrate synergistic interactions between KDM5-inhl and HER2-targeting agents (trastuzumab and lapatinib). In addition, HER2(+) cell lines with innate and acquired resistance to trastuzumab show sensitivity to KDM5-inhl. The levels of KDM5A/B/C proteins, which are selectively targeted by the agent, have no significant association with KDM5-inhl responsiveness across our panel of breast-cancer cell lines, suggesting the existence of other determinants of sensitivity. Using RNA-seq data of the breast-cancer cell lines we generate a gene-expression model that is a robust predictor of KDM5-inhl sensitivity. In a test set of breast cancers, this model predicts sensitivity to the compound in a large fraction of HER2(+) tumors. In conclusion, KDM5 inhibition has potential in the treatment of HER2(+) breast cancer and our gene-expression model can be developed into a diagnostic tool for the selection of patients.	[Paroni, Gabriela; Bolis, Marco; Zanetti, Adriana; Fratelli, Maddalena; Terao, Mineko; Garattini, Enrico] Ist Ric Farmacol Mario Negri IRCCS, Mol Biol Lab, Via La Masa 19, I-20157 Milan, Italy; [Ubezio, Paolo] Ist Ric Farmacol Mario Negri IRCCS, Dept Oncol, Via La Masa 19, I-20157 Milan, Italy; [Helin, Kristian] Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Novo Nordisk Fdn Stem Cell Biol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark; [Staller, Peter] Bayer AG, Drug Discovery, Mullerstr 178, D-13353 Berlin, Germany; [Gerlach, Lars Ole] Global Drug Discovery, CV Res, Novo Nordisk, Denmark; [Neve, Richard M.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Copenhagen; University of Copenhagen; Bayer AG; Gilead Sciences	Garattini, E (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Mol Biol Lab, Via La Masa 19, I-20157 Milan, Italy.	enrico.garattini@marionegri.it	adriana, zanetti/ABA-1189-2020; Helin, Kristian/HDM-8306-2022; Paroni, Gabriela/J-4848-2018; Ubezio, Paolo/AAA-6455-2020; Bolis, Marco/AAC-2379-2019; Garattini, Enrico/AAI-1998-2019; terao, mineko/AAU-8089-2020; Fratelli, Maddalena/AAA-6446-2020; Terao, Mineko/AAA-6415-2020; ubezio, paolo/AAA-6704-2020	adriana, zanetti/0000-0002-5825-9707; Helin, Kristian/0000-0003-1975-6097; Paroni, Gabriela/0000-0003-0132-0869; Ubezio, Paolo/0000-0003-0412-9891; Bolis, Marco/0000-0003-4377-5079; Fratelli, Maddalena/0000-0002-1769-3427; Terao, Mineko/0000-0002-9976-9869; Garattini, Enrico/0000-0001-8983-886X	Associazione Italiana per la Ricerca contro il Cancro (AIRC); Fondazione Italo Monzino	Associazione Italiana per la Ricerca contro il Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italo Monzino	Grants from the Associazione Italiana per la Ricerca contro il Cancro (AIRC) and the Fondazione Italo Monzino to Enrico Garattini were fundamental for the completion of this work. We would like to acknowledge the help of Mr. Alessandro Soave for the artwork and Laura Pasetto for the densitometric analyses.	Akimoto C, 2008, GENES CELLS, V13, P623, DOI 10.1111/j.1365-2443.2008.01193.x; Araki K, 2018, BREAST CANCER-TOKYO, V25, P392, DOI 10.1007/s12282-017-0812-x; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Basse C, 2015, INT J CANCER, V137, P2785, DOI 10.1002/ijc.29347; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bolis M, 2017, ANN ONCOL, V28, P611, DOI 10.1093/annonc/mdw660; Brustel J, 2011, TRENDS CELL BIOL, V21, P452, DOI 10.1016/j.tcb.2011.04.006; Calabrich A, 2008, ONCOLOGY-NY, V22, p[1263, 1259]; Calabrich A, 2008, ONCOLOGY-NY, V22, p[1259, 1263]; Calabrich A, 2008, ONCOLOGY-NY, V22, P1250; Cao J, 2014, CELL REP, V6, P868, DOI 10.1016/j.celrep.2014.02.004; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Cejalvo JM, 2017, CANCER RES, V77, P2213, DOI 10.1158/0008-5472.CAN-16-2717; Centritto F, 2015, EMBO MOL MED, V7, P950, DOI 10.15252/emmm.201404670; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Fabi A, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0380-5; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI 10.1586/ERA.10.226; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Guo XQ, 2017, J KIDNEY CANCER VHL, V4, P1, DOI 10.15586/jkcvhl.2017.56; Hou JL, 2012, AM J TRANSL RES, V4, P247; Kennedy JM, 2014, J EXP MED, V211, P2519, DOI 10.1084/jem.20140455; Kute T, 2004, CYTOM PART A, V57A, P86, DOI 10.1002/cyto.a.10095; Labbe RM, 2014, AM J TRANSL RES, V6, P1; Li N, 2016, CANCER RES, V76, P831, DOI 10.1158/0008-5472.CAN-15-0906; Moldovan L, 2013, J Med Life, V6, P14; Paroni G, 2012, ONCOGENE, V31, P3431, DOI 10.1038/onc.2011.506; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Perou CM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003293; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4; Rodrigues Loreta M, 2012, BMC Res Notes, V5, P250, DOI 10.1186/1756-0500-5-250; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Sahlberg KK, 2013, MOL ONCOL, V7, P392, DOI 10.1016/j.molonc.2012.10.012; Sarter K, 2016, J EXP MED, V213, P177, DOI 10.1084/jem.20150435; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taylor-Papadimitriou J, 2017, EXPERT OPIN THER TAR, V21, P5, DOI 10.1080/14728222.2017.1263616; Teng YC, 2013, CANCER RES, V73, P4711, DOI 10.1158/0008-5472.CAN-12-3165; Tumber A, 2017, CELL CHEM BIOL, V24, P371, DOI 10.1016/j.chembiol.2017.02.006; Valabrega G, 2011, BREAST CANCER RES TR, V130, P29, DOI 10.1007/s10549-010-1281-5; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang Q, 2015, BIOCHEM BIOPH RES CO, V464, P659, DOI 10.1016/j.bbrc.2015.07.049; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004	46	12	12	5	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2675	2689		10.1038/s41388-018-0620-6	http://dx.doi.org/10.1038/s41388-018-0620-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30538297				2022-12-26	WOS:000464121600001
J	Kolb, R; Kluz, P; Tan, ZW; Borcherding, N; Bormann, N; Vishwakarma, A; Balcziak, L; Zhu, PC; Davies, BSJ; Gourronc, F; Liu, LZ; Ge, X; Jiang, BH; Gibson-Corley, K; Klingelhutz, A; Tan, NS; Zhu, YW; Sutterwala, FS; Shen, X; Zhang, Wz				Kolb, Ryan; Kluz, Paige; Tan, Zhen Wei; Borcherding, Nicholas; Bormann, Nicholas; Vishwakarma, Ajaykumar; Balcziak, Louis; Zhu, Pengcheng; Davies, Brandon S. J.; Gourronc, Francoise; Liu, Ling-Zhi; Ge, Xin; Jiang, Bing-Hua; Gibson-Corley, Katherine; Klingelhutz, Aloysius; Tan, Nguan Soon; Zhu, Yuwen; Sutterwala, Fayyaz S.; Shen, Xian; Zhang, Weizhou			Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4	ONCOGENE			English	Article							CELL-LINE; ANGPTL4; METASTASIS; BEVACIZUMAB; PROGRESSION; MIGRATION; BETA-1; TUMORS; VEGF	Obesity is a risk factor for breast cancer and also predicts poor clinical outcomes regardless of menopausal status. Contributing to the poor clinical outcomes is the suboptimal efficacy of standard therapies due to dose limiting toxicities and obesity-related complications, highlighting the need to develop novel therapeutic approaches for treating obese patients. We recently found that obesity leads to an increase in tumor-infiltrating macrophages with activated NLRC4 inflammasome and increased interleukin (IL)-1 beta production. IL-1 beta, in turn, leads to increased angiogenesis and cancer progression. Using Next Generation RNA sequencing, we identified an NLRC4/IL-1 beta-dependent upregulation of angiopoietin-like 4 (ANGPTL4), a known angiogenic factor in cancer, in tumors from obese mice. ANGPTL4-deficiency by genetic knockout or treatment with a neutralizing antibody led to a significant reduction in obesity-induced angiogenesis and tumor growth. At a mechanistic level, ANGPTL4 expression is induced by IL-1 beta from primary adipocytes in a manner dependent on NF-kappa B- and MAP kinase-activation, which is further enhanced by hypoxia. This report shows that adipocyte-derived ANGPTL4 drives disease progression under obese conditions and is a potential therapeutic target for treating obese breast cancer patients.	[Kolb, Ryan; Kluz, Paige; Borcherding, Nicholas; Vishwakarma, Ajaykumar; Liu, Ling-Zhi; Ge, Xin; Jiang, Bing-Hua; Gibson-Corley, Katherine; Zhang, Weizhou] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Kolb, Ryan; Zhang, Weizhou] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Kluz, Paige; Zhang, Weizhou] Univ Iowa, Free Rad & Radiat Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Tan, Zhen Wei; Zhu, Pengcheng; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Borcherding, Nicholas; Zhang, Weizhou] Univ Iowa, Med Scientist Training Program, Carver Coll Med, Iowa City, IA 52242 USA; [Borcherding, Nicholas; Vishwakarma, Ajaykumar; Zhang, Weizhou] Univ Iowa, Canc Biol Grad Program, Carver Coll Med, Iowa City, IA 52242 USA; [Bormann, Nicholas] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Balcziak, Louis] Univ Iowa, Interdisciplinary Neurosci Grad Program, Carver Coll Med, Iowa City, IA 52242 USA; [Davies, Brandon S. J.] Univ Iowa, Dept Biochem, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Davies, Brandon S. J.] Univ Iowa, Obes Res & Educ Initiat, Iowa City, IA 52242 USA; [Gourronc, Francoise; Klingelhutz, Aloysius] Univ Iowa, Dept Microbiol & Immunol, Carver Coll Med, Iowa City, IA 52242 USA; [Tan, Nguan Soon] Nanyang Technol Univ, Lee Kong Chian Sch Med, 50 Nanyang Dr, Singapore 639798, Singapore; [Tan, Nguan Soon] Agcy Sci Technol & Res, Inst Mol Cell Biol, Proteos, 61 Biopolis Dr, Singapore 138673, Singapore; [Tan, Nguan Soon] KK Womens & Children Hosp, KK Res Ctr, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Zhu, Yuwen] Univ Colorado, Dept Surg, Denver Anschutz Med Campus, Aurora, CO 80045 USA; [Sutterwala, Fayyaz S.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Shen, Xian] Wenzhou Med Univ, Div Gastrointestinal Surg, Affiliated Hosp 2, Wenzhou 325035, Zhejiang, Peoples R China	University of Iowa; State University System of Florida; University of Florida; University of Iowa; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); KK Women's & Children's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Cedars Sinai Medical Center; Wenzhou Medical University	Kolb, R; Zhang, Wz (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA.; Kolb, R; Zhang, Wz (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.; Zhang, Wz (corresponding author), Univ Iowa, Free Rad & Radiat Biol, Carver Coll Med, Iowa City, IA 52242 USA.; Zhang, Wz (corresponding author), Univ Iowa, Med Scientist Training Program, Carver Coll Med, Iowa City, IA 52242 USA.; Zhang, Wz (corresponding author), Univ Iowa, Canc Biol Grad Program, Carver Coll Med, Iowa City, IA 52242 USA.; Shen, X (corresponding author), Wenzhou Med Univ, Div Gastrointestinal Surg, Affiliated Hosp 2, Wenzhou 325035, Zhejiang, Peoples R China.	ryankolb@ufl.edu; shenxian1120@126.com; zhangw@ufl.edu	Bormann, Nicholas/AAF-7338-2022; Tan, Nguan Soon/A-2220-2011; Sutterwala, Fayyaz/AAH-5859-2021; Bormann, Nicholas/AFK-0303-2022; Kluz, Paige/AAT-4892-2021; Cassel, Suzanne/AAI-3947-2021; Klingelhutz, Aloysius/L-9081-2018	Tan, Nguan Soon/0000-0003-0136-7341; Cassel, Suzanne/0000-0003-2492-1923; Gibson-Corley, Katherine/0000-0002-1846-1580; Kolb, Ryan/0000-0001-6305-2885; Klingelhutz, Aloysius/0000-0003-4258-5046; Hartl, Carla/0000-0001-9769-7462; Bormann, Nicholas/0000-0001-8847-8727; Liu, Ling-Zhi/0000-0001-9234-457X; Borcherding, Nicholas/0000-0003-1427-6342; Jiang, Bing-Hua/0000-0003-4526-2031; Davies, Brandon/0000-0002-7168-8522	NIH [CA200673, CA203834, T32 AI007260, F30 CA206255, R01HL130146, R01 AI118719]; Oberley Award (National Cancer Institute Award) from Holden Comprehensive Cancer Center at the University of Iowa [P30CA086862]; Department of Microbiology, University of Iowa; Ministry of Education, Singapore [MOE2014-T2-1-012]; NATIONAL CANCER INSTITUTE [F30CA206255, R01CA193511, P30CA086862, R01CA203834, R01CA200673] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118719, R01AI104706, T32AI007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oberley Award (National Cancer Institute Award) from Holden Comprehensive Cancer Center at the University of Iowa; Department of Microbiology, University of Iowa; Ministry of Education, Singapore(Ministry of Education, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RK: NIH T32 AI007260; WZ: NIH R01 grants CA200673 and CA203834, Oberley Award (National Cancer Institute Award P30CA086862) from Holden Comprehensive Cancer Center at the University of Iowa; NB: NIH F30 CA206255; AK: Mark Stinski Developmental Grant from the Department of Microbiology, University of Iowa; BD: NIH R01HL130146; NST: grant from Ministry of Education, Singapore (MOE2014-T2-1-012); FSS: NIH R01 AI118719.	Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Bai L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17717; Biswas T, 2014, CANCER LETT, V346, P129, DOI 10.1016/j.canlet.2013.12.018; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Choi J, 2018, PROG LIPID RES, V69, P11, DOI 10.1016/j.plipres.2017.11.002; DeCicco-Skinner KL, 2014, JOVE-J VIS EXP, DOI 10.3791/51312; Fukumura D, 2016, MICROCIRCULATION, V23, P191, DOI 10.1111/micc.12270; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Gu JW, 2011, CANCER BIOL THER, V11, P910, DOI 10.4161/cbt.11.10.15473; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hata S, 2017, ONCOL REP, V38, P120, DOI 10.3892/or.2017.5669; Hu K, 2016, ONCOTARGET, V7, P7816, DOI 10.18632/oncotarget.6868; Huang ZQ, 2016, ARCH ORAL BIOL, V71, P144, DOI 10.1016/j.archoralbio.2016.07.011; Incio J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aag0945; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Kim SH, 2011, CANCER RES, V71, P7010, DOI 10.1158/0008-5472.CAN-11-1262; Kolb R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13007; Kolb R, 2016, CURR OPIN PHARMACOL, V29, P77, DOI 10.1016/j.coph.2016.07.005; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Li L, 2015, CELL REP, V10, P654, DOI 10.1016/j.celrep.2015.01.011; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Lohmann AE, 2012, CURR TREAT OPTION ON, V13, P249, DOI 10.1007/s11864-012-0181-9; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; SUGIURA K, 1952, CANCER, V5, P382, DOI 10.1002/1097-0142(195203)5:2<382::AID-CNCR2820050229>3.0.CO;2-3; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tolaney SM, 2015, P NATL ACAD SCI USA, V112, P14325, DOI 10.1073/pnas.1518808112; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vu BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077988; Zhu PC, 2012, BIOSCIENCE REP, V32, P211, DOI 10.1042/BSR20110102; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	42	59	60	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2351	2363		10.1038/s41388-018-0592-6	http://dx.doi.org/10.1038/s41388-018-0592-6			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30518876	Green Accepted			2022-12-26	WOS:000462588000009
J	Malecki, JM; Willemen, HLDM; Pinto, R; Ho, AYY; Moen, A; Kjonstad, IF; Burgering, BMT; Zwartkruis, F; Eijkelkamp, N; Falnes, PO				Malecki, Jedrzej M.; Willemen, Hanneke L. D. M.; Pinto, Rita; Ho, Angela Y. Y.; Moen, Anders; Kjonstad, Ingrid F.; Burgering, Boudewijn M. T.; Zwartkruis, Fried; Eijkelkamp, Niels; Falnes, Pal O.			Lysine methylation by the mitochondrial methyltransferase FAM173B optimizes the function of mitochondrial ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; post-translational modification (PTM); metabolic regulation; mitochondrial respiratory chain complex; mitochondria; protein methylation; ATP synthase c-subunit; FAM173B; methyltransferase; oxidative phosphorylation; protein lysine methylation; KMT; ATPSc-KMT	ELONGATION-FACTOR 1A; SEQUENCE-ANALYSIS; ROTOR RING; SUBUNIT-C; PROTEIN; TRANSLATION; IDENTIFICATION; RESIDUES; METTL21B; SET	Lysine methylation is an important post-translational modification that is also present on mitochondrial proteins, but the mitochondrial lysine-specific methyltransferases (KMTs) responsible for modification are in most cases unknown. Here, we set out to determine the function of human family with sequence similarity 173 member B (FAM173B), a mitochondrial methyltransferase (MTase) reported to promote chronic pain. Using bioinformatics analyses and biochemical assays, we found that FAM173B contains an atypical, noncleavable mitochondrial targeting sequence responsible for its localization to mitochondria. Interestingly, CRISPR/Cas9-mediated KO of FAM173B in mammalian cells abrogated trimethylation of Lys-43 in ATP synthase c-subunit (ATPSc), a modification previously reported as ubiquitous among metazoans. ATPSc methylation was restored by complementing the KO cells with enzymatically active human FAM173B or with a putative FAM173B orthologue from the nematode Caenorhabditis elegans. Interestingly, lack of Lys-43 methylation caused aberrant incorporation of ATPSc into the ATP synthase complex and resulted in decreased ATP-generating ability of the complex, as well as decreased mitochondrial respiration. In summary, we have identified FAM173B as the long-sought KMT responsible for methylation of ATPSc, a key protein in cellular ATP production, and have demonstrated functional significance of ATPSc methylation. We suggest renaming FAM173B to ATPSc-KMT (gene name ATPSCKMT).	[Malecki, Jedrzej M.; Pinto, Rita; Ho, Angela Y. Y.; Moen, Anders; Kjonstad, Ingrid F.; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Willemen, Hanneke L. D. M.; Eijkelkamp, Niels] Univ Utrecht, Univ Med Ctr Utrecht, Oncode Inst, Ctr Mol Med,LTI, NL-3584 EA Utrecht, Netherlands; [Burgering, Boudewijn M. T.; Zwartkruis, Fried] Univ Utrecht, Univ Med Ctr Utrecht, Oncode Inst, Ctr Mol Med,Mol Canc Res, NL-3584 EA Utrecht, Netherlands; [Kjonstad, Ingrid F.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Immunol, N-0310 Oslo, Norway	University of Oslo; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Oslo	Malecki, JM; Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	j.m.malecki@ibv.uio.no; pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Falnes, Pal/0000-0001-8114-6025; Burgering, Boudewijn/0000-0002-4044-9596; Malecki, Jedrzej/0000-0003-0825-7962; Fadum Kjonstad, Ingrid/0000-0001-5306-3492	Research Council of Norway [FRIMEDBIO-240009]; Norwegian Cancer Society [107744-PR-2007-0132]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by Research Council of Norway Grant FRIMEDBIO-240009 and Norwegian Cancer Society Grant 107744-PR-2007-0132. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Chu YD, 2012, J BACTERIOL, V194, P6917, DOI 10.1128/JB.01535-12; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; Dzialo MC, 2014, BIOCHEM BIOPH RES CO, V455, P382, DOI 10.1016/j.bbrc.2014.11.022; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Fujikawa M, 2015, FEBS LETT, V589, P2707, DOI 10.1016/j.febslet.2015.08.006; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamey JJ, 2017, MOL CELL PROTEOMICS, V16, P2229, DOI 10.1074/mcp.M116.066308; Hamey JJ, 2016, MOL CELL PROTEOMICS, V15, P164, DOI 10.1074/mcp.M115.052449; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jakobsson ME, 2017, NUCLEIC ACIDS RES, V45, P8239, DOI 10.1093/nar/gkx432; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; KATZ ML, 1994, J BIOL CHEM, V269, P9906; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Malecki J, 2017, J BIOL CHEM, V292, P17950, DOI 10.1074/jbc.M117.808451; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Malecki J, 2016, J BIOL CHEM, V291, P9581, DOI 10.1074/jbc.M115.709261; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Niu YL, 2013, J BIOL CHEM, V288, P13728, DOI 10.1074/jbc.M113.452979; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rhein VF, 2017, FEBS LETT, V591, P1641, DOI 10.1002/1873-3468.12649; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Van Bergen NJ, 2014, MITOCHONDRION, V15, P24, DOI 10.1016/j.mito.2014.03.003; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Walpole TB, 2015, MOL CELL PROTEOMICS, V14, P828, DOI 10.1074/mcp.M114.047456; Wang XH, 2017, ELIFE, V6, DOI 10.7554/eLife.23908; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Willemen HLDM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003452; Xu T, 2015, MICROB CELL, V2, P105, DOI 10.15698/mic2015.04.197; YAN WL, 1994, GENOMICS, V24, P375, DOI 10.1006/geno.1994.1631	55	11	13	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1128	1141		10.1074/jbc.RA118.005473	http://dx.doi.org/10.1074/jbc.RA118.005473			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30530489	Green Published, hybrid			2022-12-26	WOS:000457879500006
J	Zysnarski, CJ; Lahiri, S; Javed, FT; Martinez-Marquez, JY; Trowbridge, JW; Duncan, MC				Zysnarski, Christopher J.; Lahiri, Sagar; Javed, Fatima T.; Martinez-Marquez, Jorge Y.; Trowbridge, Justin W.; Duncan, Mara C.			Adaptor protein complex-1 (AP-1) is recruited by the HEATR5 protein Laa1 and its co-factor Laa2 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						clathrin; protein trafficking (Golgi); endosome; membrane trafficking; adaptor protein; gamma-ear; CLBA; HEAT repeat-containing 5; HEATR5; lysosome	CLATHRIN ADAPTER; GAMMA-ADAPTIN; STRUCTURAL BASIS; BUDDING YEAST; GOLGI; BINDING; LOCALIZATION; VERSATILE; SELECTION; DELETION	Cellular membrane trafficking mediated by the clathrin adaptor protein complex-1 (AP-1) is important for the proper composition and function of organelles of the endolysosomal system. Normal AP-1 function requires proteins of the HEAT repeat-containing 5 (HEATR5) family. Although HEATR5 proteins were first identified based on their ability to interact with AP-1, the functional significance of this interaction was unknown. We used bioinformatics-based phenotypic profiling and information from genome-wide fluorescence microscopy studies in the budding yeast Saccharomyces cerevisiae to identify a protein, Laa2, that mediates the interaction between AP-1 and the yeast HEATR5 protein Laa1. Further characterization of Laa2 revealed that it binds to both Laa1 and AP-1. Laa2 contains a motif similar to the characterized gamma-ear-binding sites found in other AP-1-binding proteins. This motif in Laa2 is essential for the Laa1-AP-1 interaction. Moreover, mutation of this motif disrupted AP-1 localization and function and caused effects similar to mutations that remove the gamma-ear of AP-1. These results indicate that Laa2 mediates the interaction between Laa1 and AP-1 and reveal that this interaction promotes the stable association of AP-1 with membranes in yeast.	[Zysnarski, Christopher J.; Javed, Fatima T.; Martinez-Marquez, Jorge Y.; Trowbridge, Justin W.; Duncan, Mara C.] Univ Michigan, Cell & Dev Biol Dept, Ann Arbor, MI 48109 USA; [Lahiri, Sagar] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Duncan, MC (corresponding author), Univ Michigan, Cell & Dev Biol Dept, Ann Arbor, MI 48109 USA.	mcduncan@umich.edu	Duncan, Mara/Z-6236-2019	Duncan, Mara/0000-0002-2383-0109; Zysnarski, Christopher/0000-0002-1474-9499; Javed, Fatima/0000-0002-5939-8039; Martinez-Marquez, Jorge/0000-0003-1485-4800	National Institutes of Health [R01 GM092741, F31-GM112470]; Michigan Protein Folding Disease Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Protein Folding Disease Initiative	This work was supported by National Institutes of Health Grants R01 GM092741 (to M. C. D.) and F31-GM112470 (J. Y. M.-M) and by funds from the Michigan Protein Folding Disease Initiative (to M. C. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoh QL, 2011, MOL BIOL CELL, V22, P3671, DOI 10.1091/mbc.E11-04-0309; Aravamudhan P, 2014, CURR BIOL, V24, P1437, DOI 10.1016/j.cub.2014.05.014; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Day KJ, 2018, DEV CELL, V44, P56, DOI 10.1016/j.devcel.2017.12.014; Duncan MC, 2003, TRENDS CELL BIOL, V13, P211, DOI 10.1016/S0962-8924(03)00076-X; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Fernandez GE, 2006, MOL BIOL CELL, V17, P3304, DOI 10.1091/mbc.E06-02-0096; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gillard G, 2015, DEVELOPMENT, V142, P1684, DOI 10.1242/dev.118216; Hirst J, 2005, MOL BIOL CELL, V16, P2554, DOI 10.1091/mbc.E04-12-1077; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hung CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30305-z; Hung CW, 2016, MOL BIOL CELL, V27, P1143, DOI 10.1091/mbc.E15-08-0588; Hung CW, 2012, J BIOL CHEM, V287, P17398, DOI 10.1074/jbc.M112.349035; James P, 1996, GENETICS, V144, P1425; Karathia H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016015; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Le Bras S, 2012, J CELL SCI, V125, P4886, DOI 10.1242/jcs.110171; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Lui-Roberts WWY, 2008, MOL BIOL CELL, V19, P5072, DOI 10.1091/mbc.E08-03-0301; Lund FW, 2014, TRAFFIC, V15, P1406, DOI 10.1111/tra.12228; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Noguchi Chiaki, 2008, Biotechnology Journal, V3, P1280, DOI 10.1002/biot.200800140; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Paczkowski JE, 2015, TRENDS CELL BIOL, V25, P408, DOI 10.1016/j.tcb.2015.02.005; RAD MR, 1995, J CELL SCI, V108, P1605; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Renard HF, 2010, TRAFFIC, V11, P931, DOI 10.1111/j.1600-0854.2010.01070.x; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; ROBINSON MS, 1993, J CELL BIOL, V123, P67, DOI 10.1083/jcb.123.1.67; STEPP JD, 1995, MOL BIOL CELL, V6, P41, DOI 10.1091/mbc.6.1.41; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Whitfield ST, 2016, MOL BIOL CELL, V27, P588, DOI 10.1091/mbc.E15-09-0621; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914; Yoshimura SH, 2016, J CELL SCI, V129, P3963, DOI 10.1242/jcs.185710; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068488; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045324	51	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1410	1419		10.1074/jbc.RA118.005253	http://dx.doi.org/10.1074/jbc.RA118.005253			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30523155	hybrid, Green Published			2022-12-26	WOS:000457879500029
J	Cardon, JH; Eide, ER; Phillips, KL; Showalter, MH				Cardon, James H.; Eide, Eric R.; Phillips, Kerk L.; Showalter, Mark H.			Interacting circadian and homeostatic processes with opportunity cost: A mathematical model of sleep with application to two mammalian species	PLOS ONE			English	Article								This paper introduces a new model of sleep for mammals. It extends the classic 'two-process' model of sleep to account for differences in external circumstances. We apply this model to previously-collected data on elephants and sloths, comparing sleep patterns in the wild with sleep patterns in captivity. We find that the model does very well in explaining sleeping patterns for both types of animals, in both the captive state and in the wild state.	[Cardon, James H.; Eide, Eric R.; Phillips, Kerk L.; Showalter, Mark H.] Brigham Young Univ, Dept Econ, Provo, UT 84602 USA; [Phillips, Kerk L.] US Congress Budget Off, Washington, DC USA	Brigham Young University; Congressional Budget Office	Cardon, JH (corresponding author), Brigham Young Univ, Dept Econ, Provo, UT 84602 USA.	cardon@byu.edu	Phillips, Kerk/H-2732-2012	Phillips, Kerk/0000-0002-4895-4167; Cardon, James/0000-0002-6405-3684; Showalter, Mark/0000-0002-8154-2703				Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Cardon JH, 2018, J ECON DYN CONTROL, V95, P19, DOI 10.1016/j.jedc.2018.08.003; Carskadon M.A., 2011, PRINCIPLES PRACTICE, V5th edition, P16, DOI DOI 10.1016/B978-1-4160-6645-3.00002-5; DEMOURA AG, 1983, COMP BIOCHEM PHYS A, V76, P345, DOI 10.1016/0300-9629(83)90336-5; Gravett N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171903; HEDIGER H, 1969, P ROY SOC MED, V62, P153, DOI 10.1177/003591576906200213; Phillips AJK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000826; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; Siegel JM, 2008, TRENDS NEUROSCI, V31, P208, DOI 10.1016/j.tins.2008.02.001; Skeldon AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103877; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; Voirin B, 2014, SLEEP, V37, P753, DOI 10.5665/sleep.3584; Walker M, 2017, WHY WE SLEEP UNLOCKI	16	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208043	10.1371/journal.pone.0208043	http://dx.doi.org/10.1371/journal.pone.0208043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540805	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600052
J	Hirshberg, MJ; Goldberg, SB; Schaefer, SM; Flook, L; Findley, D; Davidson, RJ				Hirshberg, Matthew J.; Goldberg, Simon B.; Schaefer, Stacey M.; Flook, Lisa; Findley, David; Davidson, Richard J.			Divergent effects of brief contemplative practices in response to an acute stressor: A randomized controlled trial of brief breath awareness, loving-kindness, gratitude or an attention control practice	PLOS ONE			English	Article							MINDFULNESS MEDITATION; NEGATIVE AFFECT; ACTIVATION	Mindfulness practices are increasingly being utilized as a method for cultivating well-being. The term mindfulness is often used as an umbrella for a variety of different practices and many mindfulness-based interventions (MBIs) contain multiple styles of practice. Despite the diversity of practices within MBIs, few studies have investigated whether constituent practices produce specific effects. We randomized 156 undergraduates to one of four brief practices: breath awareness, loving-kindness, gratitude, or to an attention control condition. We assessed practice effects on affect following brief training, and effects on affect and behavior after provocation with a stressor (i.e., Cold pressor test). Results indicate that gratitude training significantly improved positive affect compared to breath awareness (d=0.58) and loving-kindness led to significantly greater reductions in implicit negative affect compared to the control condition (d= 0.59) immediately after brief practice. In spite of gains in positive affect, the gratitude group demonstrated increased reactivity to the stressor, reporting the CPT as significantly more aversive than the control condition (d=0.46) and showing significantly greater increases in negative affect compared to the breath awareness, loving-kindness, and control groups (ds =0.55, 0.60, 0.65, respectively). Greater gains in implicit positive affect following gratitude training predicted decreased post-stressor likability ratings of novel neutral faces compared to breath awareness, loving-kindness, and control groups (ds =- 0.39,-0.40,-0.33, respectively) as well. Moreover, the gratitude group was significantly less likely to donate time than the loving-kindness group in an ecologically valid opportunity to provide unrewarded support. These data suggest that different styles of contemplative practice may produce different effects in the context of brief, introductory practice and these differences may be heightened by stress. Implications for the study of contemplative practices are discussed.	[Hirshberg, Matthew J.; Goldberg, Simon B.; Schaefer, Stacey M.; Flook, Lisa; Findley, David; Davidson, Richard J.] Univ Wisconsin, Ctr Hlth Minds, Madison, WI 53706 USA; [Hirshberg, Matthew J.] Univ Wisconsin, Dept Educ Psychol, Madison, WI 53706 USA; [Goldberg, Simon B.] Univ Wisconsin, Dept Counseling Psychol, Madison, WI USA; [Goldberg, Simon B.] VA Puget Sound Hlth Care Syst, Seattle Div, Seattle, WA USA; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Wisconsin System; University of Wisconsin Madison	Hirshberg, MJ (corresponding author), Univ Wisconsin, Ctr Hlth Minds, Madison, WI 53706 USA.; Hirshberg, MJ (corresponding author), Univ Wisconsin, Dept Educ Psychol, Madison, WI 53706 USA.	Hirshberg@wisc.edu	Hirshberg, Matthew/AAM-7317-2021; Goldberg, Simon/AAQ-5173-2021	Hirshberg, Matthew/0000-0001-9070-1270; Goldberg, Simon/0000-0002-6888-0126; Davidson, Richard/0000-0002-8506-4964	National Center for Complementary and Alternative Medicine (NCCAM) [P01AT004952]; Institute of Educational Sciences (IES) [R305A140479]; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Institute of Educational Sciences (IES); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Center for Complementary and Alternative Medicine (NCCAM) P01AT004952 to RJD (https://projectreporter.nih.gov/reporter_searchresults.cfm) and by generous donations from individuals to the Center for Investigating Healthy Minds. MJH was supported by an Institute of Educational Sciences (IES) grant R305A140479 to LF and RJD (https://ies.ed.gov/funding/grantsearch/details.asp? ID=1530). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaupre M.G., 2000, MONTREAL SET FACIAL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14846-3; Chiesa A, 2013, CLIN PSYCHOL REV, V33, P82, DOI 10.1016/j.cpr.2012.10.006; Condon P, 2013, PSYCHOL SCI, V24, P2125, DOI 10.1177/0956797613485603; Creswell JD, 2017, ANNU REV PSYCHOL, V68, P491, DOI 10.1146/annurev-psych-042716-051139; Dahl CJ, 2015, TRENDS COGN SCI, V19, P515, DOI 10.1016/j.tics.2015.07.001; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; Engert V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700495; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Forgas JP, 2011, J EXP SOC PSYCHOL, V47, P425, DOI 10.1016/j.jesp.2010.11.005; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Goldberg SB, 2018, CLIN PSYCHOL REV, V59, P52, DOI 10.1016/j.cpr.2017.10.011; Goldberg SB, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01367; Grupe DW, 2018, SOC COGN AFFECT NEUR, V13, P310, DOI 10.1093/scan/nsy011; Hofmann SG, 2011, CLIN PSYCHOL REV, V31, P1126, DOI 10.1016/j.cpr.2011.07.003; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lapate RC, 2014, PSYCHOL SCI, V25, P349, DOI 10.1177/0956797613503175; Law RW, 2011, ANALOGUE STUDY LOVIN; LOVALLO W, 1975, PSYCHOPHYSIOLOGY, V12, P268, DOI 10.1111/j.1469-8986.1975.tb01289.x; Lumma AL, 2015, INT J PSYCHOPHYSIOL, V97, P38, DOI 10.1016/j.ijpsycho.2015.04.017; Lutz A, 2013, NEUROIMAGE, V64, P538, DOI 10.1016/j.neuroimage.2012.09.030; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; Messer K., 1999, P 2 INT C AUD VID BA, V964, P965; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Przyrembel M, 2018, CONSCIOUS COGN, V62, P82, DOI 10.1016/j.concog.2018.04.004; Quirin M, 2009, J PERS SOC PSYCHOL, V97, P500, DOI 10.1037/a0016063; R Studio Team, 2016, RSTUDIO INT DEV ENV; Raio CM, 2013, P NATL ACAD SCI USA, V110, P15139, DOI 10.1073/pnas.1305706110; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Salzberg S., 2009, GUIDED MEDITATIONS L; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Stahl B., 2019, MINDFULNESS BASED ST; Steinbeis N, 2015, PSYCHONEUROENDOCRINO, V62, P138, DOI 10.1016/j.psyneuen.2015.08.003; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; Wallace BA, 2002, THE SPECTRUM OF BUDD, P34; Watkins PC, 2003, SOC BEHAV PERSONAL, V31, P431, DOI 10.2224/sbp.2003.31.5.431; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wood AM, 2008, J RES PERS, V42, P854, DOI 10.1016/j.jrp.2007.11.003; Wood AM, 2010, CLIN PSYCHOL REV, V30, P890, DOI 10.1016/j.cpr.2010.03.005; Zeidan F, 2010, J ALTERN COMPLEM MED, V16, P867, DOI 10.1089/acm.2009.0321	46	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207765	10.1371/journal.pone.0207765	http://dx.doi.org/10.1371/journal.pone.0207765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540772	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600033
J	Jain, P; Sudhanthirakodi, S; Chowdhury, G; Joshi, S; Anandan, S; Ray, U; Mukhopadhyay, A; Dutta, S				Jain, Priyanka; Sudhanthirakodi, Sudhanthiramani; Chowdhury, Goutam; Joshi, Sangeeta; Anandan, Shalini; Ray, Ujjwayni; Mukhopadhyay, Asish; Dutta, Shanta			Antimicrobial resistance, plasmid, virulence, multilocus sequence typing and pulsed-field gel electrophoresis profiles of Salmonella enterica serovar Typhimurium clinical and environmental isolates from India	PLOS ONE			English	Article							CLASS 1 INTEGRONS; MOLECULAR CHARACTERIZATION; QUINOLONE RESISTANCE; ANIMAL SOURCES; UNITED-STATES; GENES; OUTBREAK; REGION; FOOD; HUMANS	Salmonella enterica serovar Typhimurium (S. Typhimurium) is a common serovar associated with non-typhoidal salmonellosis globally. However, there is insufficient data on molecular characterization of S. Typhimurium isolates from India. This study was undertaken to determine the antimicrobial resistance (AMR), plasmid, virulence profiles and molecular subtypes of S. Typhimurium Indian isolates (n = 70) of clinical and environmental origin isolated during 2010-2017. Antimicrobial susceptibility and minimum inhibitory concentrations were determined by disc diffusion and E-test methods respectively. Plasmid extraction was done following standard protocol. AMR genes, virulence genes and plasmid incompatibility types were detected by PCR; Pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST) were used for molecular subtyping. Majority (57%) of the study isolates was pan susceptible; five AMR profiles were observed among the resistant (43%) isolates. AMR was significantly (p = 0.004) associated with extra-intestinal isolates than intestinal isolates.The class 1 integron and plasmid-mediated quinolone resistance genes (qnrI31, qnrS1) in the resistant isolates were transferable by conjugation. Plasmids (>= 1) ranging from 1.9 to 254kb size and of IncFlIS and/or FIB type were found in most isolates. A total of 39 pulsotypes by PFGE and four sequence types by MLST like ST36 (55.7%), ST19 (32.9%), ST313 (10%) and ST213 (1.4%) were observed. ST36 and ST19 were found circulating in both clinical and environmental host, while ST313 isolates had an exclusive clinical origin. All ST19 isolates (100%) were drug-resistant, while isolates belonging to ST313 (100%), ST213 (100%) and ST36 (82%) were pan susceptible. The virulence plasmid (VP) genes (spvB- spvC) were present in all genotypes except ST36. The VP was significantly (p<0.001) associated with extra-intestinal than intestinal isolates. Some environmental and clinical isolates were clonal indicating their zoonotic transmission. Knowledge on the molecular subtypes and AMR profiles of locally prevalent Salmonella serotypes is important for effective control of spread of resistant organisms. The MLST of S. Typhimurium isolates and its association with AMR, virulence profiles was not reported earlier from India.	[Jain, Priyanka; Chowdhury, Goutam; Mukhopadhyay, Asish; Dutta, Shanta] Indian Council Med Res, Nat Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, W Bengal, India; [Sudhanthirakodi, Sudhanthiramani] All India Inst Hyg & Publ Hlth, Dept Microbiol, Kolkata, W Bengal, India; [Joshi, Sangeeta] Manipal Hosp, Hosp Infect Control, Bangalore, Karnataka, India; [Anandan, Shalini] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India; [Ray, Ujjwayni] Apollo Gleneagles Hosp, Dept Microbiol, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Christian Medical College & Hospital (CMCH) Vellore	Dutta, S (corresponding author), Indian Council Med Res, Nat Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, W Bengal, India.	shanta1232001@yahoo.co.in	Mukhopadhyay, Asish/ABE-7697-2020; SOUNDRARAJAN, JOYSON/I-1779-2019	Dutta, Shanta/0000-0002-6897-7390; CHOWDHURY, GOUTAM/0000-0003-1830-1920	Indian Council of Medical Research (ICMR), New-Delhi intramural fund	Indian Council of Medical Research (ICMR), New-Delhi intramural fund	This study was funded by the Indian Council of Medical Research (ICMR), New-Delhi intramural fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HA, 2016, FOODBORNE PATHOG DIS, V13, P281, DOI 10.1089/fpd.2015.2097; Angelo KM, 2016, J INFECT DIS, V214, P1565, DOI 10.1093/infdis/jiw415; Anil M, 2009, INDIAN J PEDIATR, V76, P629, DOI 10.1007/s12098-009-0083-4; Antunes P, 2007, ANTIMICROB AGENTS CH, V51, P1545, DOI 10.1128/AAC.01275-06; Bugarel M., 2011, BMC MICROBIOL, V11; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; CDC (Centers for Disease Control),, 2013, STANDARD OPERATING P; Centers for Disease Control and Prevention. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), 2016, HUM IS SURV REP 2014; Chuanchuen Rungtip, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P419; Clinical and Laboratory Standards Institute, 2017, PERFORMANCE STANDARD; Cruchaga S, 2001, J ANTIMICROB CHEMOTH, V47, P315, DOI 10.1093/jac/47.3.315; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Ethelberg S, 2004, CLIN MICROBIOL INFEC, V10, P904, DOI 10.1111/j.1469-0691.2004.00990.x; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Garcia P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089635; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Graziani C, 2008, VET MICROBIOL, V128, P414, DOI 10.1016/j.vetmic.2007.10.017; Guerra B, 2001, ANTIMICROB AGENTS CH, V45, P1305, DOI 10.1128/AAC.45.4.1305-1308.2001; Heithoff DM, 2008, APPL ENVIRON MICROB, V74, P1757, DOI 10.1128/AEM.02740-07; Izumiya H, 2005, J CLIN MICROBIOL, V43, P5074, DOI 10.1128/JCM.43.10.5074-5079.2005; Jackson BR, 2013, EMERG INFECT DIS, V19, P1239, DOI 10.3201/eid1908.121511; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Kshirsagar DP, 2014, ISR J VET MED, V69, P228; Kumar Y, 2009, T ROY SOC TROP MED H, V103, P390, DOI 10.1016/j.trstmh.2008.09.009; Lunn AD, 2010, INT MICROBIOL, V13, P15, DOI 10.2436/20.1501.01.107; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Menezes GA, 2010, J MED MICROBIOL, V59, P1477, DOI 10.1099/jmm.0.022319-0; MOHAN VP, 1995, COMP IMMUNOL MICROB, V18, P283, DOI 10.1016/0147-9571(95)00010-6; Murugkar H, 2005, INDIAN J MED RES, V122, P237; Murugkar HV, 2003, INDIAN J MED RES, V117, P66; Ngoi ST, 2013, JPN J INFECT DIS, V66, P180, DOI 10.7883/yoken.66.180; Noda T, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-38; Rahman H, 2002, INDIAN J MED RES, V115, P108; Rotger R, 1999, Int Microbiol, V2, P177; Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004; Saha MR, 2001, J HEALTH POPUL NUTR, V19, P301; Sethuvel DPM, 2015, J INFECT DEV COUNTR, V9, P1294, DOI 10.3855/jidc.6965; Sjolund-Karlsson M, 2009, ANTIMICROB AGENTS CH, V53, P2142, DOI 10.1128/AAC.01288-08; Smith AM, 2014, J CLIN MICROBIOL, V52, P627, DOI 10.1128/JCM.02422-13; Soto SM, 2006, J MED MICROBIOL, V55, P365, DOI 10.1099/jmm.0.46257-0; Sudhanthirakodi S., 2016, J MICROBIOL INFECT D, V6, P113, DOI [10.5799/jmid.vi.328974, DOI 10.5799/JMID.VI.328974]; Sun JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113145; Taneja N, 2014, J MED MICROBIOL, V63, P66, DOI 10.1099/jmm.0.061416-0; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Threlfall EJ, 2002, FEMS MICROBIOL REV, V26, P141, DOI 10.1016/S0168-6445(02)00092-X; van Asten AJAM, 2005, FEMS IMMUNOL MED MIC, V44, P251, DOI 10.1016/j.femsim.2005.02.002; Vo ATT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009440; WATTAL C, 1994, INDIAN J MED RES, V100, P266; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Weill, 2007, WHO COLLABORATING CT, V9, P1, DOI DOI 10.1038/NATURE12153; WHO, 2010, LAB PROT BIOCH ID SA; Wiesner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-131	54	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207954	10.1371/journal.pone.0207954	http://dx.doi.org/10.1371/journal.pone.0207954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540810	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600047
J	Li, JL; Narayanan, C; Bian, J; Sambo, D; Brickler, T; Zhang, WC; Chetty, S				Li, Jingling; Narayanan, Cyndhavi; Bian, Jing; Sambo, Danielle; Brickler, Thomas; Zhang, Wancong; Chetty, Sundari			A transient DMSO treatment increases the differentiation potential of human pluripotent stem cells through the Rb family	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; SELF-RENEWAL; HUMAN ES; CYCLE; E2F; PRB; EXPRESSION; GENE; G1; PHOSPHORYLATION	The propensity for differentiation varies substantially across human pluripotent stem cell (hPSC) lines, greatly restricting the use of hPSCs for cell replacement therapy or disease modeling. Here, we investigate the underlying mechanisms and demonstrate that activation of the retinoblastoma (Rb) pathway in a transient manner is important for differentiation. In prior work, we demonstrated that pre-treating hPSCs with dimethylsulfoxide (DMSO) before directed differentiation enhanced differentiation potential across all three germ layers. Here, we show that exposure to DMSO improves the efficiency of hPSC differentiation through Rb and by repressing downstream E2F-target genes. While transient inactivation of the Rb family members (including Rb, p107, and p130) suppresses DMSO's capacity to enhance differentiation across all germ layers, transient expression of a constitutively active (non-phosphorylatable) form of Rb increases the differentiation efficiency similar to DMSO. Inhibition of downstream targets of Rb, such as E2F signaling, also promotes differentiation of hPSCs. More generally, we demonstrate that the duration of Rb activation plays an important role in regulating differentiation capacity.	[Li, Jingling; Narayanan, Cyndhavi; Bian, Jing; Sambo, Danielle; Brickler, Thomas; Zhang, Wancong; Chetty, Sundari] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Chetty, Sundari] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Chetty, S (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Chetty, S (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.	chettys@stanford.edu			Stanford University School of Medicine, a Siebel Fellowship; US National Institutes of Health	Stanford University School of Medicine, a Siebel Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Stanford University School of Medicine, a Siebel Fellowship awarded to S.C., and the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; BREMNER R, 1995, MOL CELL BIOL, V15, P3256; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chetty S, 2015, J EXP MED, V212, DOI [10.1084/jem.21211OIA91, DOI 10.1084/JEM.21211OIA91]; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; Choi SC, 2015, J CELL PHYSIOL, V230, P1807, DOI 10.1002/jcp.24892; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; Conklin JF, 2009, J CELL BIOCHEM, V108, P1023, DOI 10.1002/jcb.22342; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Czysz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117689; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Gage BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082076; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Herwig S, 1997, EUR J BIOCHEM, V246, P581, DOI 10.1111/j.1432-1033.1997.t01-2-00581.x; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Li VC, 2014, P NATL ACAD SCI USA, V111, P9503, DOI 10.1073/pnas.1408638111; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Ma YH, 2008, CANCER RES, V68, P6292, DOI 10.1158/0008-5472.CAN-08-0121; Manzar GS, 2015, THESIS; MUMMERY CL, 1987, CELL DIFFER DEV, V20, P153, DOI 10.1016/0045-6039(87)90429-5; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Nishizawa M, 2016, CELL STEM CELL, V19, P341, DOI 10.1016/j.stem.2016.06.019; Ogaki S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17297; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pal R, 2012, ARCH TOXICOL, V86, P651, DOI 10.1007/s00204-011-0782-2; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pauklin S, 2016, GENE DEV, V30, P421, DOI 10.1101/gad.271452.115; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Qiu ZF, 2015, STEM CELL RES, V15, P141, DOI 10.1016/j.scr.2015.05.010; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Savatier P, 1996, ONCOGENE, V12, P309; Sela Y, 2012, STEM CELLS, V30, P1097, DOI 10.1002/stem.1078; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Slack RS, 1996, DEV GENET, V18, P81, DOI 10.1002/(SICI)1520-6408(1996)18:1<81::AID-DVG9>3.0.CO;2-Y; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Stratigopoulos G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198637; Swartz EW, 2016, STEM CELL TRANSL MED, V5, P1461, DOI 10.5966/sctm.2015-0340; Task KD, 2014, THESIS; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Usui M, 2016, GENES CELLS, V21, P302, DOI 10.1111/gtc.12340; van den Berg CW, 2016, METHODS MOL BIOL, V1353, P163, DOI 10.1007/7651_2014_178; Vanhove J, 2016, STEM CELL REP, V7, P192, DOI 10.1016/j.stemcr.2016.06.013; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; YU ZW, 1994, BIOSCIENCE REP, V14, P259, DOI 10.1007/BF01199051	57	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208110	10.1371/journal.pone.0208110	http://dx.doi.org/10.1371/journal.pone.0208110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540809	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600058
J	Lian, SL; Sun, XJ; Zhou, ZK; Fan, CY; Niu, GF; Liu, QQ				Lian, Shuai-lei; Sun, Xiao-jun; Zhou, Zong-kui; Fan, Cui-ying; Niu, Geng-feng; Liu, Qing-qi			Social networking site addiction and undergraduate students' irrational procrastination: The mediating role of social networking site fatigue and the moderating role of effortful control	PLOS ONE			English	Article							DEVIANT PEER AFFILIATION; FACEBOOK ADDICTION; SLEEP QUALITY; SELF-ESTEEM; ACADEMIC-ACHIEVEMENT; TECHNOLOGY OVERLOAD; CHINESE ADOLESCENTS; LIFE SATISFACTION; COLLEGE-STUDENTS; SCHOOL CLIMATE	With the popularity of social networking sites (SNSs), the problems of SNS addiction have been increasing. Research has revealed the association between SNS addiction and irrational procrastination. However, the mechanism underlying this relation is still unclear. The present study aimed to examine the mediating role of social networking site fatigue and the moderating role of effortful control in this link among Chinese undergraduate students. The Social Networking Site Addiction Scale, Social Networking Service Fatigue Scale, Effortful Control Scale and Irrational Procrastination Scale were completed by 1,085 Chinese undergraduate students. Results indicated that SNS addiction, SNS fatigue and irrational procrastination were positively correlated with each other, and negatively correlated with effortful control. Further analyses revealed that, SNS addiction has a direct effect on irrational procrastination. SNS fatigue mediated the relationship between SNS addiction and irrational procrastination. Both direct and indirect effects of SNS addiction on irrational procrastination were moderated by effortful control. Specifically, this effect was stronger for people with lower effortful control. These findings help clarify the mechanism underlying the association between SNS addiction and irrational procrastination, which have potential implications for intervention.	[Lian, Shuai-lei; Sun, Xiao-jun; Zhou, Zong-kui; Fan, Cui-ying; Niu, Geng-feng; Liu, Qing-qi] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Hubei, Peoples R China; [Lian, Shuai-lei; Sun, Xiao-jun; Zhou, Zong-kui; Fan, Cui-ying; Liu, Qing-qi] Cent China Normal Univ, Sch Psychol, Wuhan, Hubei, Peoples R China; [Niu, Geng-feng] Xi An Jiao Tong Univ, Sch Humanities & Social Sci, Inst Social Psychol, Xian, Shaanxi, Peoples R China	Central China Normal University; Xi'an Jiaotong University	Zhou, ZK (corresponding author), Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Hubei, Peoples R China.; Zhou, ZK (corresponding author), Cent China Normal Univ, Sch Psychol, Wuhan, Hubei, Peoples R China.	zhouzk@mail.ccnu.edu.cn	Niu, Gengfeng/HCH-9546-2022	Liu, Qingqi/0000-0001-5169-8689	Major Program of National Social Science Foundation of China [11ZD151]; National Natural Science Foundation of China [31400887, 31872781]; Humanities and Social Sciences Research Funds from the Ministry of Education of China [15YJA190001]; Fundamental Research Funds of Central China Normal University [CCNU14Z02004]	Major Program of National Social Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and Social Sciences Research Funds from the Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds of Central China Normal University	This work was supported by Major Program of National Social Science Foundation of China [Project No. 11&ZD151], The National Natural Science Foundation of China (Project Nos. 31400887 and 31872781), Humanities and Social Sciences Research Funds from the Ministry of Education of China [Project No. 15YJA190001], and Fundamental Research Funds of Central China Normal University [Project No. CCNU14Z02004]. No competing financial interests existed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway TP, 2013, COMPUT EDUC, V63, P10, DOI 10.1016/j.compedu.2012.10.030; Andreassen C. S., 2015, CURR ADDICT REP, V2, P175, DOI [DOI 10.1007/S40429-015-0056-9, 10.1007/s40429-015-0056-9]; Andreassen CS, 2012, PSYCHOL REP, V110, P501, DOI 10.2466/02.09.18.PR0.110.2.501-517; Appel H, 2015, J SOC CLIN PSYCHOL, V34, P277, DOI 10.1521/jscp.2015.34.4.277; Balci S., 2014, IISES INT I SOC EC S, P120; Bao ZZ, 2015, J ABNORM CHILD PSYCH, V43, P81, DOI 10.1007/s10802-014-9903-8; Bayer JB, 2016, HUM COMMUN RES, V42, P71, DOI 10.1111/hcre.12067; Beutel M. E., 2016, PLOS ONE, V11; Blachnio A, 2015, EUR PSYCHIAT, V30, P681, DOI 10.1016/j.eurpsy.2015.04.002; Blachnio A, 2016, COMPUT HUM BEHAV, V55, P701, DOI 10.1016/j.chb.2015.10.026; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Brailovskaia J, 2018, COMPUT HUM BEHAV, V86, P199, DOI 10.1016/j.chb.2018.04.045; Brailovskaia J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189719; Bright LF, 2015, COMPUT HUM BEHAV, V44, P148, DOI 10.1016/j.chb.2014.11.048; Brown FC, 2016, CLIN NEUROPSYCHOL, V30, P753; Cao XF, 2018, COMPUT HUM BEHAV, V81, P10, DOI 10.1016/j.chb.2017.11.035; Chen LY, 2014, COMPUT HUM BEHAV, V35, P431, DOI 10.1016/j.chb.2014.03.025; Chen W, 2016, COMPUT HUM BEHAV, V64, P507, DOI 10.1016/j.chb.2016.04.038; Cho J, 2011, J APPL COMMUN RES, V39, P38, DOI 10.1080/00909882.2010.536847; Choi SB, 2016, COMPUT HUM BEHAV, V61, P245, DOI 10.1016/j.chb.2016.03.032; Constantin K., 2017, J RATION-EMOT COGN-B, P1, DOI DOI 10.1007/S10942-017-0271-5; Cramer EM, 2016, COMPUT HUM BEHAV, V64, P739, DOI 10.1016/j.chb.2016.07.049; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; DeArmond S, 2014, INT J STRESS MANAGE, V21, P137, DOI 10.1037/a0034893; Di Fabio A, 2006, INT J EDUC VOCAT GUI, V6, P109, DOI 10.1007/s10775-006-9000-9; Dogan U, 2016, J ED TRAINING STUDIE, V4, P176, DOI DOI 10.11114/JETS.V4I6.1420; Eisenberg N, 2005, CHILD DEV, V76, P1055, DOI 10.1111/j.1467-8624.2005.00897.x; Eisenberg N, 2004, CHILD DEV, V75, P25, DOI 10.1111/j.1467-8624.2004.00652.x; Eisenberg N, 2001, CHILD DEV, V72, P1112, DOI 10.1111/1467-8624.00337; Eisenberg N, 2009, DEV PSYCHOPATHOL, V21, P455, DOI 10.1017/S095457940900025X; Fairchild AJ, 2009, PREV SCI, V10, P87, DOI 10.1007/s11121-008-0109-6; Fardouly J, 2015, BODY IMAGE, V12, P82, DOI 10.1016/j.bodyim.2014.10.004; Fernie BA, 2016, J RATION-EMOT COGN-B, V34, P1, DOI 10.1007/s10942-015-0222-y; Ferrari JR, 2009, J SOC PSYCHOL, V149, P402, DOI 10.3200/SOCP.149.3.402-408; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fosco GM, 2012, J FAM PSYCHOL, V26, P565, DOI 10.1037/a0028873; Frison E, 2016, SOC SCI COMPUT REV, V34, P153, DOI 10.1177/0894439314567449; Griffiths MD, 2012, PSYCHOL REP, V110, P518, DOI 10.2466/01.07.18.PR0.110.2.518-520; Guo W. W., 2015, PLOS ONE, V10; Hanprathet Nitt, 2015, Journal of the Medical Association of Thailand, V98, pS81; Hayes AF, 2013, REGRESSION BASED APP; Hinsch C, 2013, J CONSUM BEHAV, V12, P496, DOI 10.1002/cb.1453; Inzlicht M, 2014, CURR DIR PSYCHOL SCI, V23, P302, DOI 10.1177/0963721414534256; Koc M, 2013, CYBERPSYCH BEH SOC N, V16, P279, DOI 10.1089/cyber.2012.0249; Lee AR, 2016, COMPUT HUM BEHAV, V55, P51, DOI 10.1016/j.chb.2015.08.011; Lengua LJ, 2008, DEV PSYCHOPATHOL, V20, P509, DOI 10.1017/S0954579408000254; Li DH, 2010, COMMUN ASSOC INF SYS, V26, P85; Li DP, 2016, COMPUT HUM BEHAV, V60, P54, DOI 10.1016/j.chb.2016.02.015; [梁宗保 Liang Zongbao], 2013, [心理学报, Acta Psychologica Sinica], V45, P556; Liu QQ, 2017, COMPUT HUM BEHAV, V72, P108, DOI 10.1016/j.chb.2017.02.042; Luthar S. S., 2015, HDB CHILD PSYCHOL DE, VIII, P247, DOI DOI 10.1002/9781118963418.CHILDPSY307; Maier C., 2012, ECIS 2012 P; Majstorovic J., 2015, THESIS; Marino C, 2018, J AFFECT DISORDERS, V226, P274, DOI 10.1016/j.jad.2017.10.007; Meier A, 2016, COMPUT HUM BEHAV, V64, P65, DOI 10.1016/j.chb.2016.06.011; Nesi J, 2015, J ABNORM CHILD PSYCH, V43, P1427, DOI 10.1007/s10802-015-0020-0; Nyadzayo MW, 2016, J RETAIL CONSUM SERV, V30, P262, DOI 10.1016/j.jretconser.2016.02.002; Oh HJ, 2014, COMPUT HUM BEHAV, V30, P69, DOI 10.1016/j.chb.2013.07.053; Pychyl TA, 2000, J SOC BEHAV PERS, V15, P239; Pychyl TA, 2012, J RATION-EMOT COGN-B, V30, P203, DOI 10.1007/s10942-012-0149-5; Rebetez MML, 2016, PERS INDIV DIFFER, V101, P435, DOI 10.1016/j.paid.2016.06.049; Rebetez MML, 2015, PERS INDIV DIFFER, V76, P1, DOI 10.1016/j.paid.2014.11.044; Reinecke L, 2014, COMPUT HUM BEHAV, V30, P95, DOI 10.1016/j.chb.2013.07.030; Rozental Alexander, 2014, BMC Psychol, V2, P54, DOI 10.1186/s40359-014-0054-z; Ryan T, 2014, J BEHAV ADDICT, V3, P133, DOI 10.1556/JBA.3.2014.016; Steel P, 2007, PSYCHOL BULL, V133, P65, DOI 10.1037/0033-2909.133.1.65; Steel P, 2010, PERS INDIV DIFFER, V48, P926, DOI 10.1016/j.paid.2010.02.025; Svartdal F., 2015, SCAND J EDUC RES, V61, P5; Tandoc EC, 2015, COMPUT HUM BEHAV, V43, P139, DOI 10.1016/j.chb.2014.10.053; TOOTHMAKER LE, 1994, J OPER RES SOC, V45, P119; Valiente C, 2007, MERRILL PALMER QUART, V53, P1; Valiente C, 2011, EARLY EDUC DEV, V22, P411, DOI 10.1080/10409289.2010.505259; Van Yperen NW, 2003, ACAD MANAGE J, V46, P339, DOI 10.2307/30040627; Wolniczak I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059087; Xanidis N, 2016, COMPUT HUM BEHAV, V55, P121, DOI 10.1016/j.chb.2015.09.004; Zhou Q, 2010, J EDUC PSYCHOL, V102, P180, DOI 10.1037/a0015908; Zhou ZK, 2017, PERS INDIV DIFFER, V104, P137, DOI 10.1016/j.paid.2016.07.040	77	23	24	18	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208162	10.1371/journal.pone.0208162	http://dx.doi.org/10.1371/journal.pone.0208162			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD8CS	30533013	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500013
J	Wang, CY; Schultzhaus, JN; Taitt, CR; Leary, DH; Shriver-Lake, LC; Snellings, D; Sturiale, S; North, SH; Orihuela, B; Rittschof, D; Wahl, KJ; Spillmann, CM				Wang, Chenyue; Schultzhaus, Janna N.; Taitt, Chris R.; Leary, Dagmar H.; Shriver-Lake, Lisa C.; Snellings, Daniel; Sturiale, Samantha; North, Stella H.; Orihuela, Beatriz; Rittschof, Daniel; Wahl, Kathryn J.; Spillmann, Christopher M.			Characterization of longitudinal canal tissue in the acorn barnacle Amphibalanus amphitrite	PLOS ONE			English	Article							BALANUS BALANOIDES; SEXUAL SYSTEMS; CIRRIPEDIA; SETTLEMENT; ADHESION; METAMORPHOSIS; PURIFICATION	The morphology and composition of tissue located within parietal shell canals of the barnacle Amphibalanus amphitrite are described. Longitudinal canal tissue nearly spans the length of side shell plates, terminating near the leading edge of the specimen basis in proximity to female reproductive tissue located throughout the peripheral sub-mantle region, i.e. mantle parenchyma. Microscopic examination of stained longitudinal canal sections reveal the presence of cell nuclei as well as an abundance of micron-sized spheroids staining positive for basic residues and lipids. Spheroids with the same staining profile are present extensively in ovarioles, particularly within oocytes which are readily identifiable at various developmental stages. Mass spectrometry analysis of longitudinal canal tissue compared to tissue collected from the mantle parenchyma reveals a nearly 50% overlap of the protein profile with the greatest number of sequence matches to vitellogenin, a glycolipoprotein playing a key role in vitellogenesis-yolk formation in developing oocytes. The morphological similarity and proximity to female reproductive tissue, combined with mass spectrometry of the two tissues, provides compelling evidence that one of several possible functions of longitudinal canal tissue is supporting the female reproductive system of A. amphitrite, thus expanding the understanding of the growth and development of this sessile marine organism.	[Wang, Chenyue; Schultzhaus, Janna N.] Natl Res Council Res Associateship Program, Washington, DC USA; [Taitt, Chris R.; Leary, Dagmar H.; Shriver-Lake, Lisa C.; North, Stella H.; Spillmann, Christopher M.] Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Snellings, Daniel; Sturiale, Samantha] Naval Res Enterprise Internship Program, Washington, DC USA; [Orihuela, Beatriz; Rittschof, Daniel] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Wahl, Kathryn J.] Naval Res Lab, Chem Div, Washington, DC 20375 USA; [Snellings, Daniel] Duke Univ, Mol Genet & Microbiol, Durham, NC USA; [Sturiale, Samantha] Univ Virginia, Charlottesville, VA USA; [North, Stella H.] Lantham & Watkins LLP, Washington, DC USA	National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; Duke University; United States Department of Defense; United States Navy; Naval Research Laboratory; Duke University; University of Virginia	Spillmann, CM (corresponding author), Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.	christopher.spillmann@nrl.navy.mil	Wahl, Kathryn J/A-6494-2012	Sturiale, Samantha/0000-0002-6825-4133; Schultzhaus, Janna/0000-0003-2007-1546; Taitt, Chris/0000-0002-0125-9239; Snellings, Daniel/0000-0003-0615-9111	internal basic research program at NRL; National Research Council Post-Doctoral Associateships; Office of Naval Research [N00014-16-1-3112]	internal basic research program at NRL; National Research Council Post-Doctoral Associateships; Office of Naval Research(Office of Naval Research)	Work under C.S. and K.W. was funded through an internal basic research program at NRL. C.W. and J.N.S. were both supported through National Research Council Post-Doctoral Associateships. Work at Duke University Marine Laboratory under D.R. was performed under the Office of Naval Research Grant N00014-16-1-3112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha M., 2018, HERPETOL REV, V49, P25; Anderson D.T., 1994, BARNACLES STRUCTURE; Brickner I, 2010, J EXP MAR BIOL ECOL, V392, P115, DOI 10.1016/j.jembe.2010.04.015; Brown GD, 2018, NAT REV IMMUNOL, V18, P374, DOI 10.1038/s41577-018-0004-8; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Clare AS, 2000, BIOFOULING, V15, P57, DOI 10.1080/08927010009386298; CLARE AS, 1989, NATURE, V338, P627, DOI 10.1038/338627b0; COSTLOW JOHN D., 1956, J MORPH, V99, P359, DOI 10.1002/jmor.1050990206; CRISP DJ, 1985, J COLLOID INTERF SCI, V104, P40, DOI 10.1016/0021-9797(85)90007-4; Darwin C., 1851, MONOGRAPH SUBCLASS C; Darwin C., 1854, MONOGRAPH SUBCLASS C; Davidson I, 2016, BIOFOULING, V32, P411, DOI 10.1080/08927014.2016.1149572; DAWSON RMC, 1966, J MAR BIOL ASSOC UK, V46, P249, DOI 10.1017/S0025315400027120; DEDONDER R, 1952, B SOC CHIM BIOL, V34, P144; DITTMER JC, 1964, J LIPID RES, V5, P126; Dreyer N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191963; Engelmann F., 1979, Advances in Insect Physiology, V14, P49, DOI 10.1016/S0065-2806(08)60051-X; Essock-Burns T, 2017, J EXP BIOL, V220, P194, DOI 10.1242/jeb.145094; Fears KP, 2018, ADV SCI, V5, DOI 10.1002/advs.201700762; Ferrier GA, 2016, INTEGR COMP BIOL, V56, P901, DOI 10.1093/icb/icw076; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOSTER BA, 1970, PHILOS T ROY SOC B, V256, P377, DOI 10.1098/rstb.1970.0001; FYHN UEH, 1977, BIOL BULL-US, V152, P351, DOI 10.2307/1540423; FYHN UEH, 1975, BIOL BULL, V149, P316, DOI 10.2307/1540529; Gale AS, 2015, J SYST PALAEONTOL, V13, P753, DOI 10.1080/14772019.2014.954409; Gohad NV, 2009, J EXP MAR BIOL ECOL, V380, P88, DOI 10.1016/j.jembe.2009.09.008; Gohad NV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5414; Guo TN, 2015, NAT MED, V21, P407, DOI 10.1038/nm.3807; Hayward A, 2010, FEBS LETT, V584, P1273, DOI 10.1016/j.febslet.2010.02.056; Holland D.L., 1987, Crustacean Issues, V5, P227; Holm ER, 2006, BIOFOULING, V22, P233, DOI 10.1080/08927010600826129; Holm ER, 2012, INTEGR COMP BIOL, V52, P348, DOI 10.1093/icb/ics042; Janecki DJ, 2005, RAPID COMMUN MASS SP, V19, P1268, DOI 10.1002/rcm.1924; Kelly MW, 2010, J EXP MAR BIOL ECOL, V392, P37, DOI 10.1016/j.jembe.2010.04.009; KLEPAL W, 1975, J EXP MAR BIOL ECOL, V20, P183, DOI 10.1016/0022-0981(75)90023-4; KNIGHTJONES EW, 1950, J MAR BIOL ASSOC UK, V29, P281, DOI 10.1017/S0025315400055375; LACOMBE D, 1970, BIOL BULL, V139, P164, DOI 10.2307/1540134; Lewis AC, 2014, JOM-US, V66, P143, DOI 10.1007/s11837-013-0793-y; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; Merck Ag E., 1974, DYEING REAGENTS THIN; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Newman W.A., 1976, Memoirs of the San Diego Society of Natural History, VNo. 9, P1; Olszowy PP, 2013, ANAL BIOCHEM, V438, P67, DOI 10.1016/j.ab.2013.03.023; Pitombo FB, 2004, ZOOL SCR, V33, P261, DOI 10.1111/j.0300-3256.2004.00145.x; Pochai A, 2017, ZOOSYST EVOL, V93, P13, DOI 10.3897/zse.93.10769; Raman S, 2013, INT J ADHES ADHES, V41, P140, DOI 10.1016/j.ijadhadh.2012.11.003; Rees DJ, 2014, CURR BIOL, V24, P1429, DOI 10.1016/j.cub.2014.05.030; Rittschof D, 2008, BIOFOULING, V24, P1, DOI 10.1080/08927010701784920; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Schultz MP, 2011, BIOFOULING, V27, P87, DOI 10.1080/08927014.2010.542809; So CR, 2017, ACS APPL MATER INTER, V9, P11493, DOI 10.1021/acsami.7b01185; So CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36219; SPIVEY HR, 1988, J ZOOL, V216, P265, DOI 10.1111/j.1469-7998.1988.tb02430.x; WALKER D, 1967, CHEM REV, V67, P153, DOI 10.1021/cr60246a002; WALKER G, 1971, MAR BIOL, V9, P205, DOI 10.1007/BF00351380; Walker G., 1992, MICROSCOPICAL ANATOM, V9; WALLEY LJ, 1969, PHILOS T ROY SOC B, V256, P237, DOI 10.1098/rstb.1969.0042; Wang Z, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2076-1; Wendt DE, 2006, BIOFOULING, V22, P1, DOI 10.1080/08927010500499563; Yamaguchi S, 2012, INTEGR COMP BIOL, V52, P356, DOI 10.1093/icb/ics046; Yusa Y, 2001, J MAR BIOL ASSOC UK, V81, P781, DOI 10.1017/S0025315401004593; Yusa Y, 2013, INTEGR COMP BIOL, V53, P701, DOI 10.1093/icb/ict016; Yusa Y, 2010, BIOL BULL-US, V218, P259, DOI 10.1086/BBLv218n3p259; Zhang G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133866	64	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208352	10.1371/journal.pone.0208352	http://dx.doi.org/10.1371/journal.pone.0208352			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532169	gold, Green Published			2022-12-26	WOS:000452644700021
J	Dreiseitl, A; Zavrelova, M				Dreiseitl, Antonin; Zavrelova, Marta			Identification of barley powdery mildew resistances in gene bank accessions and the use of gene diversity for verifying seed purity and authenticity	PLOS ONE			English	Article							HORDEUM-SPONTANEUM; CORE COLLECTION; VARIETIES; POPULATIONS; CULTIVARS; LINES; CZECH	Human activities including those in crop gene banks are subject to errors, especially during seed multiplication and maintenance of seed germination. Therefore, the most serious problem of gene banks is authenticity of the accessions and their genotypic purity. There are many methods for determining the identity of varieties, but comparisons between current data and past records are not easy since the latter are often missing. Breeding barley resistant to powdery mildew caused by Blumeria graminis f. sp. hordei (Bgh) was traditionally based on incorporating major genes into new varieties and the results have been published. Our goal was to identify resistance genes to powdery mildew in accessions of the Czech spring barley core collection and compare these data with earlier information to establish the authenticity of the accessions. Two hundred and twenty-three accessions of the collection including 665 single plant progenies were tested. Sixty-four selected reference isolates of Bgh representing the world diversity of the pathogen were used for resistance tests. Twenty-two known resistance genes were postulated either separately or in combinations. In the collection, 151 homogeneous accessions were found, but the resistances of nine of them were inconsistent with published data and in 12 accessions their authenticity is doubtful. The remaining 72 accessions were heterogeneous and comprised 176 resistance genotypes, 54 of which were probably mechanical admixtures of other varieties. There are several pathogens of cereals, e.g. rusts and mildews, against which many resistance genes in host crops have also been exploited. Knowledge of these resistances can assist in maintaining pure and genuine stocks in gene banks. Seed purity and the authenticity of accessions can subsequently be checked with more advanced methods.	[Dreiseitl, Antonin] Agrotest Fyto Ltd, Dept Integrated Plant Protect, Kromeriz, Czech Republic; [Zavrelova, Marta] Agrotest Fyto Ltd, Dept Plant Genet & Breeding, Kromeriz, Czech Republic	Agricultural Research Institute Kromeriz, Ltd; Agrotest Fyto; Agricultural Research Institute Kromeriz, Ltd; Agrotest Fyto	Dreiseitl, A (corresponding author), Agrotest Fyto Ltd, Dept Integrated Plant Protect, Kromeriz, Czech Republic.	dreiseitl@vukrom.cz	Dreiseitl, Antonin/AAB-8710-2022		Ministry of Agriculture of the Czech Republic [RO1117]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The article was prepared within project no. RO1117 supported by the Ministry of Agriculture of the Czech Republic. The funder (Agrotest Fyto Ltd.) provided support in the form of salaries for both authors [AD and MZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anonymous, 1998, BESCHREIBENDE SORTEN, P82; Bradova J, 2001, ROST VYROBA, V47, P167; BROWN AHD, 1978, HEREDITY, V41, P49, DOI 10.1038/hdy.1978.63; BROWN JKM, 1991, INTEGRATED CONTROL OF CEREAL MILDEWS : VIRULENCE PATTERNS AND THEIR CHANGE, P263; Bruckner F., 1975, Ochrana Rostlin, V11, P253; Bruckner F., 1964, ROSTL VYROB, V10, P395; CHEN FQ, 1994, THEOR APPL GENET, V88, P215, DOI 10.1007/BF00225900; Dreiseitl A, 2007, PLANT BREEDING, V126, P268, DOI 10.1111/j.1439-0523.2007.01348.x; Dreiseitl A, 2000, PLANT BREEDING, V119, P203, DOI 10.1046/j.1439-0523.2000.00473.x; Dreiseitl A, 2016, J AGR SCI-CAMBRIDGE, V154, P1082, DOI 10.1017/S0021859615001069; Dreiseitl A, 2014, ANN APPL BIOL, V165, P364, DOI 10.1111/aab.12141; Dreiseitl A, 2004, GENET RESOUR CROP EV, V51, P251, DOI 10.1023/B:GRES.0000024010.12369.b3; Dreiseitl A, 2004, EUPHYTICA, V135, P325, DOI 10.1023/B:EUPH.0000013372.65004.15; Dreiseitl A, 2011, ANN APPL BIOL, V159, P49, DOI 10.1111/j.1744-7348.2011.00474.x; Dreiseitl A, 2007, GENET RESOUR CROP EV, V54, P259, DOI 10.1007/s10722-005-3810-3; Dreiseitl A, 2017, PLANT BREEDING, V136, P351, DOI 10.1111/pbr.12471; Dreiseitl A, 2017, CROP PASTURE SCI, V68, P134, DOI [10.1071/CP16221, 10.1071/cp16221]; Dreiseitl A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00202; Dreiseitl A, 2014, EUR J PLANT PATHOL, V138, P561, DOI 10.1007/s10658-013-0266-8; Dreiseitl A, 2013, PLANT BREEDING, V132, P558, DOI 10.1111/pbr.12108; Dreiseitl A, 2013, EUPHYTICA, V191, P183, DOI 10.1007/s10681-012-0741-x; Dreiseitl A, 2012, CROP PASTURE SCI, V63, P997, DOI 10.1071/CP12165; FISCHBECK G, 1976, Z PFLANZENZUCHT, V76, P163; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; HIURA U., 1955, Berichte des Ohara Instituts fur Landwirtschaftliche Biologie, Okayama Universitat, V10, P135; Hovmoller MS, 2000, AGRONOMIE, V20, P729, DOI 10.1051/agro:2000172; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Jorgensen J. H., 1983, Barley Genetics Newsletter, V13, P51; JORGENSEN JH, 1994, CRIT REV PLANT SCI, V13, P97, DOI 10.1080/713608055; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kolmer JA, 1996, ANNU REV PHYTOPATHOL, V34, P435, DOI 10.1146/annurev.phyto.34.1.435; KOLSTER P, 1986, CROP SCI, V26, P903, DOI 10.2135/cropsci1986.0011183X002600050014x; Kominkova E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167099; Liu F, 2000, GENET RESOUR CROP EV, V47, P571, DOI 10.1023/A:1026532215990; Mago R, 2011, THEOR APPL GENET, V123, P615, DOI 10.1007/s00122-011-1611-y; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; Mitchell AG, 1990, ANN REPORT 1990, P26; MOSEMAN JG, 1981, CROP SCI, V21, P229, DOI 10.2135/cropsci1981.0011183X002100020006x; Nover I., 1972, Archiv fur Pflanzenschutz, V8, P439; Nover I, 1972, KULTURPFLANZE, V19, P298, DOI [10.1007/BF02103162, DOI 10.1007/BF02103162]; Ottosson F, 2002, HEREDITAS, V137, P7, DOI 10.1034/j.1601-5223.2002.1370102.x; Park RF, 2008, PLANT PATHOL, V57, P591, DOI 10.1111/j.1365-3059.2008.01836.x; SCHWARZBACH E, 1981, Z PFLANZENZUCHT, V87, P309; Stanford EH, 1940, J AGRIC RES, V61, P0231; Takahagi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33199; TORP J, 1978, ARSSKR/KGL VET LAND, P75; van Hintum TJL, 2000, GENET RESOUR CROP EV, V47, P507, DOI 10.1023/A:1008703031415; van Treuren R, 2014, PLANT GENET RESOUR-C, V12, P298, DOI 10.1017/S1479262114000082; VANHINTUM TJL, 1994, THEOR APPL GENET, V88, P70, DOI 10.1007/BF00222396; WIBERG A, 1974, HEREDITAS, V78, P1, DOI 10.1111/j.1601-5223.1974.tb01426.x; Xue YC, 2015, J I BREWING, V121, P496, DOI 10.1002/jib.253	51	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208719	10.1371/journal.pone.0208719	http://dx.doi.org/10.1371/journal.pone.0208719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532221	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900035
J	Manninger, M; Ebner, J; Zweiker, D; Sieghartsleitner, R; Mastnak, B; Bisping, E; Lercher, P; Riedlbauer, R; Rotman, B; Brussee, H; Scherr, D				Manninger, Martin; Ebner, Jakob; Zweiker, David; Sieghartsleitner, Raphael; Mastnak, Bernadette; Bisping, Egbert; Lercher, Peter; Riedlbauer, Rita; Rotman, Brigitte; Brussee, Helmut; Scherr, Daniel			Is there a difference in rhythm outcome between patients undergoing first line versus second line paroxysmal atrial fibrillation ablation?	PLOS ONE			English	Article							ANTIARRHYTHMIC-DRUG THERAPY; PULMONARY VEIN ISOLATION; CATHETER ABLATION; RADIOFREQUENCY ABLATION; 1ST-LINE TREATMENT; MULTICENTER; TIME	Background Catheter ablation of atrial fibrillation (AF) is an established second line therapy for patients with symptomatic paroxysmal AF (PAF) and may be considered as a first line therapy in selected patients who are highly symptomatic, considering patient choice, benefit, and risk, according to recent guidelines. Our study investigated whether a first line vs. second line ablation approach may result in improved sinus rhythm maintenance after ablation. Methods A total of 153 patients undergoing pulmonary vein isolation for PAF were included in the study (age 55 +/- 12 years, 29% female). Seventy-nine patients underwent first line AF ablation and 74 patients underwent second line AF ablation after failed antiarrhythmic drug therapy. There was no significant difference in baseline characteristics such as age, history of AF, left atrial size or LVEF between groups. Success was defined as atrial tachyar-rhythmia free survival during a 12-month follow-up by means of serial ECG Holter monitoring. Results There was no significant difference in cumulative arrhythmia-free survival between those patients who received AF ablation as a first or second line therapy. Single procedure success was 78% in the first line group vs. 81% in the second line group; multiple procedure success was 90 vs. 91%, (n.s.). Complication rate was 1.3% vs. 1.4% (n.s.). Conclusion Success of AF ablation did not differ between patients who receive ablation as first vs. second line therapy. Based on these data, a trial of AAD therapy before AF ablation may be justified in most patients with symptomatic PAF eligible for rhythm control.	[Manninger, Martin; Ebner, Jakob; Zweiker, David; Sieghartsleitner, Raphael; Mastnak, Bernadette; Bisping, Egbert; Lercher, Peter; Riedlbauer, Rita; Rotman, Brigitte; Brussee, Helmut; Scherr, Daniel] Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria; [Scherr, Daniel] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Cardiol, Med Ctr, Limburg, Netherlands	Medical University of Graz; Maastricht University	Manninger, M (corresponding author), Med Univ Graz, Dept Internal Med, Div Cardiol, Graz, Austria.	martin.manninger-wuenscher@medunigraz.at	Scherr, Daniel/D-4098-2019; Zweiker, David/W-3375-2019	Scherr, Daniel/0000-0001-5868-5493; Zweiker, David/0000-0002-7479-7767				Andrade JG, 2014, HEART RHYTHM, V11, P1919, DOI 10.1016/j.hrthm.2014.07.033; Bunch TJ, 2013, HEART RHYTHM, V10, P1257, DOI 10.1016/j.hrthm.2013.05.013; Calkins H, 2017, HEART RHYTHM; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Darkner S, 2014, EUR HEART J, V35, P3356, DOI 10.1093/eurheartj/ehu354; De Greef Y, 2018, EUROPACE, V20, P589, DOI 10.1093/europace/euw426; Ganesan AN, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004549; Hakalahti A, 2015, EUROPACE, V17, P370, DOI 10.1093/europace/euu376; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Kaitani K, 2016, EUR HEART J, V37, P610, DOI 10.1093/eurheartj/ehv501; Khan AR, 2014, CIRC-ARRHYTHMIA ELEC, V7, P853, DOI 10.1161/CIRCEP.114.001853; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lafuente-Lafuente C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub4; Lafuente-Lafuente C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub3; Marijon E, 2014, J CARDIOVASC ELECTR, V25, P130, DOI 10.1111/jce.12303; Mont L, 2014, EUR HEART J, V35, P501, DOI 10.1093/eurheartj/eht457; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Nabauer M, 2009, EUROPACE, V11, P423, DOI 10.1093/europace/eun369; Natale A, 2014, J AM COLL CARDIOL, V64, P647, DOI 10.1016/j.jacc.2014.04.072; Nielsen JC, 2017, HEART, V103, P370, DOI 10.1136/heartjnl-2016-309781; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208994	10.1371/journal.pone.0208994	http://dx.doi.org/10.1371/journal.pone.0208994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532216	Green Published, gold, Green Submitted			2022-12-26	WOS:000452640900056
J	Bacosa, HP; Kamalanathan, M; Chiu, MH; Tsai, SM; Sun, L; Labonte, JM; Schwehr, KA; Hala, D; Santschi, PH; Chin, WC; Quigg, A				Bacosa, Hernando P.; Kamalanathan, Manoj; Chiu, Meng-Hsuen; Tsai, Shih-Ming; Sun, Luni; Labonte, Jessica M.; Schwehr, Kathleen A.; Hala, David; Santschi, Peter H.; Chin, Wei-Chun; Quigg, Antonietta			Extracellular polymeric substances (EPS) producing and oil degrading bacteria isolated from the northern Gulf of Mexico	PLOS ONE			English	Article							PREFERENTIAL DEGRADATION; AROMATIC-HYDROCARBONS; CHEMICAL-COMPOSITION; MICROBIAL CONSORTIA; CRUDE-OIL; SP NOV.; DEEP; WATER; SURFACE; BIODEGRADATION	Sinking marine oil snow was found to be a major mechanism in the transport of spilled oil from the surface to the deep sea following the Deepwater Horizon (DwH) oil spill. Marine snow formation is primarily facilitated by extracellular polymeric substances (EPS), which are mainly composed of proteins and carbohydrates secreted by microorganisms. While numerous bacteria have been identified to degrade oil, there is a paucity of knowledge on bacteria that produce EPS in response to oil and Corexit exposure in the northern Gulf of Mexico (nGoM). In this study, we isolated bacteria from surface water of the nGoM that grow on oil or Corexit dispersant. Among the 100 strains isolated, nine were identified to produce remarkable amounts of EPS. 16S rRNA gene analysis revealed that six isolates (strains C1, C5, W10, W11, W14, W20) belong to the genus Alteromonas; the others were related to Thalassospira (C8), Aestuariibacter (C12), and Escherichia (W13a). The isolates preferably degraded alkanes (17-77%), over polycyclic aromatic hydrocarbons (0.90-23%). The EPS production was determined in the presence of a water accommodated fraction (WAF) of oil, a chemical enhanced WAF (CEWAF), Corexit, and control. The highest production of visible aggregates was found in Corexit followed by CEWAF, WAF, and control; indicating that Corexit generally enhanced EPS production. The addition of WAF and Corexit did not affect the carbohydrate content, but significantly increased the protein content of the EPS. On the average, WAF and CEWAF treatments had nine to ten times more proteins, and Corexit had five times higher than the control. Our results reveal that Alteromonas and Thalassospira, among the commonly reported bacteria following the DwH spill, produce protein rich EPS that could have crucial roles in oil degradation and marine snow formation. This study highlights the link between EPS production and bacterial oil-degrading capacity that should not be overlooked during spilled oil clearance.	[Bacosa, Hernando P.; Kamalanathan, Manoj; Labonte, Jessica M.; Hala, David; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Chiu, Meng-Hsuen; Tsai, Shih-Ming; Chin, Wei-Chun] Univ Calif Merced, Bioengn Program, Sch Engn, Merced, CA USA; [Sun, Luni; Schwehr, Kathleen A.; Santschi, Peter H.] Texas A&M Univ, Dept Marine Sci, Galveston, TX 77553 USA; [Santschi, Peter H.; Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Texas A&M University System; University of California System; University of California Merced; Texas A&M University System; Texas A&M University System; Texas A&M University College Station	Bacosa, HP (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	hpbacosa@tamug.edu	Santschi, Peter H/D-5712-2012; Labonte, Jessica/AHC-5426-2022; Bacosa, Hernando/AAE-4321-2019; Schwehr, Kathy/AAF-2713-2021	Santschi, Peter H/0000-0001-8188-7691; Labonte, Jessica/0000-0003-0236-7634; Kamalanathan, Manoj/0000-0001-9617-1362; Bacosa, Hernando/0000-0002-4100-8274	Gulf of Mexico Research Initiative (GoMRI)	Gulf of Mexico Research Initiative (GoMRI)	This research was made possible by a grant from The Gulf of Mexico Research Initiative (GoMRI) to the research consortium on Aggregation and Degradation of Dispersants and Oil by Microbial Exopolymers (ADDOMEx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnosti C, 2016, DEEP-SEA RES PT II, V129, P179, DOI 10.1016/j.dsr2.2014.12.008; Bacosa H.P., 2018, OIL SPILL ENV FORENS, P617, DOI 10.1016/B978-0-12-804434-6.00028-8; Bacosa H, 2010, INT BIODETER BIODEGR, V64, P702, DOI 10.1016/j.ibiod.2010.03.008; Bacosa HP, 2016, MAR POLLUT BULL, V109, P236, DOI 10.1016/j.marpolbul.2016.05.076; Bacosa HP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01325; Bacosa HP, 2015, MAR POLLUT BULL, V95, P265, DOI 10.1016/j.marpolbul.2015.04.005; Bacosa HP, 2013, J ENVIRON SCI HEAL A, V48, P835, DOI 10.1080/10934529.2013.761476; Bacosa HP, 2012, INT BIODETER BIODEGR, V74, P109, DOI 10.1016/j.ibiod.2012.04.022; Bacosa HP, 2011, WORLD J MICROB BIOT, V27, P1109, DOI 10.1007/s11274-010-0557-6; Bhaskar PV, 2005, CURR SCI INDIA, V88, P45; Chen EYT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016198; Chiu MH, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-2397-x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Colombo V, 2004, BRAZ J MICROBIOL, V35, P110, DOI 10.1590/S1517-83822004000100018; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Daly KL, 2016, ANTHROPOCENE, V13, P18, DOI 10.1016/j.ancene.2016.01.006; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Melo EB, 2006, TETRAHEDRON, V62, P10277, DOI 10.1016/j.tet.2006.08.055; Decho AW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00922; Dickinson E, 2003, FOOD HYDROCOLLOID, V17, P25, DOI 10.1016/S0268-005X(01)00120-5; Dombrowski N, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.57, 10.1038/nmicrobiol.2016.57]; Doyle SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00689; Dubinsky EA, 2013, ENVIRON SCI TECHNOL, V47, P10860, DOI 10.1021/es401676y; Fang HHP, 2002, WATER RES, V36, P4709, DOI 10.1016/S0043-1354(02)00207-5; Greenwood PF, 2008, ORG GEOCHEM, V39, P1336, DOI 10.1016/j.orggeochem.2008.05.005; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067717; Gutierrez T, 2013, ISME J, V7, P2091, DOI 10.1038/ismej.2013.98; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Jia XS, 1996, ENVIRON TECHNOL, V17, P283, DOI 10.1080/09593331708616386; Jin HM, 2015, INT J SYST EVOL MICR, V65, P4208, DOI 10.1099/ijsem.0.000563; Kamalanathan M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00798; Kang YS, 2010, J BIOSCI BIOENG, V109, P118, DOI 10.1016/j.jbiosc.2009.08.001; Kappell AD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00205; Kleindienst S, 2015, P NATL ACAD SCI USA, V112, P14900, DOI 10.1073/pnas.1507380112; Kodama Y, 2008, INT J SYST EVOL MICR, V58, P711, DOI 10.1099/ijs.0.65476-0; Leriche V, 2000, APPL ENVIRON MICROB, V66, P1851, DOI 10.1128/AEM.66.5.1851-1856.2000; Liao BQ, 2002, J COLLOID INTERF SCI, V249, P372, DOI 10.1006/jcis.2002.8305; Liao BQ, 2001, WATER RES, V35, P339, DOI 10.1016/S0043-1354(00)00277-3; Liu JQ, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02131; Liu ZF, 2013, MICROBIOLOGYOPEN, V2, P492, DOI 10.1002/mbo3.89; More TT, 2014, J ENVIRON MANAGE, V144, P1, DOI 10.1016/j.jenvman.2014.05.010; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Passow U, 2016, DEEP-SEA RES PT II, V129, P232, DOI 10.1016/j.dsr2.2014.10.001; Pasumarthi R, 2013, MAR POLLUT BULL, V76, P276, DOI 10.1016/j.marpolbul.2013.08.026; Poli A, 2010, MAR DRUGS, V8, P1779, DOI 10.3390/md8061779; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quigg A, 2016, LIMNOL OCEANOGR LETT, V1, P3, DOI 10.1002/lol2.10030; Redmond MC, 2012, P NATL ACAD SCI USA, V109, P20292, DOI 10.1073/pnas.1108756108; Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001; Sun LN, 2017, CHEMOSPHERE, V181, P675, DOI 10.1016/j.chemosphere.2017.04.099; Sutherland IW, 1990, BIOTECHNOLOGY MICROB, P1; The Federal Integracy Solutions Group (TFISG), 2010, OIL BUDGET CALCULATO; Torralba MG, 2017, MICROB ECOL, V73, P91, DOI 10.1007/s00248-016-0857-y; Tsai SM, 2017, J NANOPART RES, V19, DOI 10.1007/s11051-017-3957-9; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; Verdugo P, 2010, DEEP-SEA RES PT II, V57, P1486, DOI 10.1016/j.dsr2.2010.03.002; Wade TL, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00419; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xu C, 2018, EXPERIMENT; Xu C, 2011, MAR CHEM, V126, P27, DOI 10.1016/j.marchem.2011.03.004; Xu C, 2009, BIORESOURCE TECHNOL, V100, P6010, DOI 10.1016/j.biortech.2009.06.008; Yamada N, 2010, J OCEANOGR, V66, P233, DOI 10.1007/s10872-010-0021-0; Zhang SJ, 2012, ENVIRON SCI TECHNOL, V46, P8764, DOI 10.1021/es301000m; Zhang SJ, 2008, MAR CHEM, V112, P81, DOI 10.1016/j.marchem.2008.05.009	69	33	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208406	10.1371/journal.pone.0208406	http://dx.doi.org/10.1371/journal.pone.0208406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521589	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600058
J	Grimby-Ekman, A; Aberg, M; Toren, K; Brisman, J; Hagberg, M; Kim, JL				Grimby-Ekman, Anna; Aberg, Maria; Toren, Kjell; Brisman, Jonas; Hagberg, Mats; Kim, Jeong-Lim			Pain could negatively affect school grades - Swedish middle school students with low school grades most affected	PLOS ONE			English	Article							ACADEMIC-PERFORMANCE; SOCIOECONOMIC-STATUS; ADOLESCENTS; CHILDREN; PREVALENCE; HEADACHE; SCHOOLCHILDREN; AGE; ACHIEVEMENT; SYMPTOMS	Recurrent headache, abdominal and musculoskeletal pain are common in adolescents and it is therefore important to understand their impact on the transitional period from childhood to adulthood. However, studies of the prevalence over time and implications on educational outcomes are still limited, especially regarding multiple pain symptoms. The present study material consists of questionnaire surveys, completed in 2000 and 2008, including two study populations of 9th grade adolescents aged 15 living in West Sweden (n = 20 877). Pain symptoms and demographic variables were based on self-reports from the questionnaires, and school grades were obtained from Statistics Sweden after the student had finished their 9th grade. Between 2000 and 2008, the prevalence of abdominal pain increased among Swedish adolescents (largest increase in girls); the prevalence of headache increased only in girls; the prevalence of pain in upper body decreased only in boys. School grades were significantly lower among those with headache or abdominal pain. Among students with low school grades (10th percentile) the estimated difference between those having any of the symptoms or none were -27 school grade units (95% confidence interval for girls (-27.8; -26.0), for boys (-27.6; -25.5). Both symptoms being present pronounced the association. Low parental education increased the negative effect of symptoms on school grades, most pronounced in the group with the lowest grades. In conclusion, identification of pain symptoms may improve academic achievements, especially in students with multiple symptoms and with parents having low education. Further intervention studies are need.	[Grimby-Ekman, Anna] Univ Gothenburg, Sahlgrenska Acad, Hlth Metr, Publ Hlth & Community Med, Gothenburg, Sweden; [Grimby-Ekman, Anna; Toren, Kjell; Brisman, Jonas; Hagberg, Mats; Kim, Jeong-Lim] Univ Gothenburg, Sahlgrenska Acad, Publ Hlth & Community Med, Occupat & Eironm Med, Gothenburg, Sweden; [Aberg, Maria] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Publ Hlth & Community Med Primary Hlth Care, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Grimby-Ekman, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Hlth Metr, Publ Hlth & Community Med, Gothenburg, Sweden.; Grimby-Ekman, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Publ Hlth & Community Med, Occupat & Eironm Med, Gothenburg, Sweden.	anna.ekman@gu.se	Aberg, Maria/R-4001-2016	Hagberg, Mats/0000-0002-1182-8239; Aberg, Maria/0000-0002-0323-1061	Swedish Society of Medicine, the Department of Public Health at the Vastra Gotaland Region	Swedish Society of Medicine, the Department of Public Health at the Vastra Gotaland Region	This work received support from the Swedish Society of Medicine, the Department of Public Health at the Vastra Gotaland Region, to Anna Grimby-Ekman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MA, 2009, ACTA PAEDIATR, V98, P555, DOI 10.1111/j.1651-2227.2008.01103.x; Albers L, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0477-0; Altman DG, 2000, STAT CONFIDENCE BMJ; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Boey CCM, 2003, J PAEDIATR CHILD H, V39, P352, DOI 10.1046/j.1440-1754.2003.00173.x; Bottai M, 2010, STAT MED, V29, P309, DOI 10.1002/sim.3781; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Breuner CC, 2004, HEADACHE, V44, P217, DOI 10.1111/j.1526-4610.2004.04050.x; Casucci G, 2014, NEUROL SCI, V35, pS31, DOI 10.1007/s10072-014-1738-0; DEUBNER DC, 1977, HEADACHE, V17, P173, DOI 10.1111/j.1526-4610.1977.hed1704173.x; Dick BD, 2010, PAIN RES MANAG, V15, P238, DOI 10.1155/2010/354812; Donner A, 2012, STAT METHODS MED RES, V21, P347, DOI 10.1177/0962280210383082; Guddal MH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116685543; Hjern A, 2008, ACTA PAEDIATR, V97, P112, DOI 10.1111/j.1651-2227.2007.00585.x; Kelly Colette, 2010, Int J Adolesc Med Health, V22, P229, DOI 10.1515/IJAMH.2010.22.2.229; Kim JL, 2010, ACTA PAEDIATR, V99, P72, DOI 10.1111/j.1651-2227.2009.01545.x; Kim JL, 2014, RESP MED, V108, P701, DOI 10.1016/j.rmed.2014.02.011; KING NJ, 1990, J PAEDIATR CHILD H, V26, P50, DOI 10.1111/j.1440-1754.1990.tb02379.x; King S, 2011, PAIN, V152, P2729, DOI 10.1016/j.pain.2011.07.016; Kosola S, 2017, PAIN, V158, P1825, DOI 10.1097/j.pain.0000000000000984; Landry BW, 2015, PM&R, V7, pS295, DOI 10.1016/j.pmrj.2015.09.006; Leino-Arjas P, 2018, PAIN, V159, P67, DOI 10.1097/j.pain.0000000000001065; Lima Alaine Souza, 2014, Rev. paul. pediatr., V32, P256, DOI 10.1590/0103-0582201432212113; Meziat N, 2017, J BACK MUSCULOSKELET, V30, P467, DOI 10.3233/BMR-150339; Moore DJ, 2013, PAIN, V154, P1840, DOI 10.1016/j.pain.2013.06.006; Oosterman JM, 2013, EUR J PAIN, V17, P735, DOI 10.1002/j.1532-2149.2012.00235.x; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Petersen S, 2006, PAIN, V121, P145, DOI 10.1016/j.pain.2005.12.017; Rocha PAS, 2014, HEADACHE, V54, P1194, DOI 10.1111/head.12394; Roth-Isigkeit A, 2005, PEDIATRICS, V115, pE152, DOI 10.1542/peds.2004-0682; Saps M, 2009, J PEDIATR-US, V154, P322, DOI 10.1016/j.jpeds.2008.09.047; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Sillanpaa M, 1996, HEADACHE, V36, P466, DOI 10.1046/j.1526-4610.1996.3608466.x; SILLANPAA M, 1991, CEPHALALGIA, V11, P239, DOI 10.1046/j.1468-2982.1991.1105239.x; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sundberg R, 2007, J ADOLESCENT HEALTH, V40, P581, DOI 10.1016/j.jadohealth.2007.01.003; Sundblad GMB, 2007, EUR J PAIN, V11, P171, DOI 10.1016/j.ejpain.2006.02.006; Swain MS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-447; Szumski G, 2012, RES DEV DISABIL, V33, P1615, DOI 10.1016/j.ridd.2012.03.030; Wager J, 2018, EUROPEAN PAIN MANAGE	42	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208435	10.1371/journal.pone.0208435	http://dx.doi.org/10.1371/journal.pone.0208435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521591	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600066
J	Hoffmann, C; Stevens, J; Zong, SH; van Kruining, D; Saxena, A; Kucukali, CI; Tuzun, E; Yalcinkaya, N; De Hert, M; Gonzalez-Vioque, E; Arango, C; Lindstrom, J; De Beets, MH; Rutter, BPF; van Os, J; Molenaar, P; Losen, M; Martinez-Martinez, P				Hoffmann, Carolin; Stevens, Jo; Zong, Shenghua; van Kruining, Daan; Saxena, Abhishek; Kucukali, Cem Ismail; Tuzun, Erdem; Yalcinkaya, Nazli; De Hert, Marc; Gonzalez-Vioque, Emiliano; Arango, Celso; Lindstrom, Jon; De Beets, Marc H.; Rutter, Bail P. F.; van Os, Jim; Molenaar, Peter; Losen, Mario; Martinez-Martinez, Pilar			Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder	PLOS ONE			English	Article							NICOTINIC RECEPTOR; MYASTHENIA-GRAVIS; ANTIBODY; SUBUNIT; RELEVANCE; SYSTEM; CORTEX; BRAIN	The alpha 7 acetylcholine receptor (AChR) has been linked with the onset of psychotic symptoms and we hypothesized therefore that it might also be an autoimmune target. Here, we describe a new radioimmunoassay (RIA) using iodine 125-labelled alpha-bungarotoxin and membrane extract from transfected HEK293 cells expressing human alpha 7 AChR. This RIA was used to analyze sera pertaining to a cohort of 711 subjects, comprising 368 patients diagnosed with schizophrenia spectrum disorders, 140 with bipolar disorder, 58 individuals diagnosed of other mental disorders, and 118 healthy comparison subjects. We identified one patient whose serum tested positive although with very low levels (0.2 nM) for alpha 7 AChR-specific antibodies by RIA. Three out of 711 sera contained antibodies against iodine 125-labelled alpha-bungarotoxin, because they precipitated with it in the absence of alpha 7 AChR. This first evidence suggests that autoantibodies against alpha 7 AChR are absent or very rare in these clinical groups.	[Hoffmann, Carolin; Stevens, Jo; Zong, Shenghua; van Kruining, Daan; Saxena, Abhishek; De Beets, Marc H.; Rutter, Bail P. F.; van Os, Jim; Molenaar, Peter; Losen, Mario; Martinez-Martinez, Pilar] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Kucukali, Cem Ismail; Tuzun, Erdem; Yalcinkaya, Nazli] Istanbul Univ, Inst Expt Med Res DETAE, Dept Neurosci, Istanbul, Turkey; [De Hert, Marc] Katholieke Univ Leuven, Univ Psychiat Ctr, Campus Kortenberg, Kortenberg, Belgium; [De Hert, Marc] Katholieke Univ Leuven, Dept Neurosci, Leuven, Belgium; [Gonzalez-Vioque, Emiliano; Arango, Celso] Univ Complutense, Child & Adolescent Psychiat Dept, Sch Med, IiSGM,CIBERSAM,Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Lindstrom, Jon] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stevens, Jo] Roche Diagnost, Centralized & Point Care Solut, Antibody Dev, Penzberg, Germany; [Saxena, Abhishek] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Lab Antibody Engn, Shanghai, Peoples R China; [van Os, Jim] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, Utrecht, Netherlands	Maastricht University; Istanbul University; KU Leuven; KU Leuven; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Complutense University of Madrid; General University Gregorio Maranon Hospital; University of Pennsylvania; Pennsylvania Medicine; Roche Holding; ShanghaiTech University; Utrecht University; Utrecht University Medical Center	Losen, M; Martinez-Martinez, P (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands.	m.losen@maastrichtuniversity.nl; p.martinez@maastrichtuniversity.nl	Arango, Celso/AAZ-8314-2021; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Saxena, Abhishek/AGE-1658-2022; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Tuzun, Erdem/AAH-9212-2019; küçükali, cem ismail/AAC-2739-2020; De Hert, Marc/AAH-6090-2021	Arango, Celso/0000-0003-3382-4754; van Os, Jim/0000-0002-7245-1586; küçükali, cem ismail/0000-0001-9851-8577; Hoffmann, Carolin/0000-0002-2528-7541; Stevens, Jo/0000-0001-5737-7325; Losen, Mario/0000-0002-9761-0002; De Hert, Marc/0000-0003-4255-5920; Rutten, Bart/0000-0002-9834-6346; Saxena, Abhishek/0000-0003-0345-4887; Gonzalez Vioque, Emiliano/0000-0001-7279-4311; van Kruining, Daan/0000-0001-9329-7744	University of Istanbul [23979]; Netherlands Organization for Scientific Research (NWO) "Graduate School of Translational Neuroscience Program" [022005019]; Brain Foundation of the Netherlands [FS2008(1)-28, KS2012(1)-157]; ZonMW NWO Program Translationeel onderzoek [40-41200-98-9257]; Veni Fellowship of the NWO [916.10.148]; Prinses Beatrix Fonds [WAR08-12]	University of Istanbul(Istanbul University); Netherlands Organization for Scientific Research (NWO) "Graduate School of Translational Neuroscience Program"; Brain Foundation of the Netherlands; ZonMW NWO Program Translationeel onderzoek; Veni Fellowship of the NWO; Prinses Beatrix Fonds	This work was supported by the Research Fund of the University of Istanbul (ET, 23979, http://bap.istanbul.edu.tr/en/). The authors thank the Netherlands Organization for Scientific Research (NWO) (https://www.nwo.nl/en) "Graduate School of Translational Neuroscience Program" (BR and JvO, 022005019), the Brain Foundation of the Netherlands (www.hersenstichting.nl) (ML, KS2012(1)-157) and the ZonMW NWO Program Translationeel onderzoek (PM, 40-41200-98-9257); as well as the Veni Fellowship of the NWO (PM, 916.10.148), a fellowship of the Brain Foundation of the Netherlands (PM, FS2008(1)-28), and the Prinses Beatrix Fonds (www.prinsesbeatrixspierfonds.nl) (PM, WAR08-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apiwattanakul M, 2010, MUSCLE NERVE, V41, P702, DOI 10.1002/mus.21653; Chandley MJ, 2009, SCHIZOPHR RES, V109, P98, DOI 10.1016/j.schres.2009.01.023; Court JA, 2000, J CHEM NEUROANAT, V20, P281, DOI 10.1016/S0891-0618(00)00110-1; De Luca V, 2006, ACTA PSYCHIAT SCAND, V114, P211, DOI 10.1111/j.1600-0447.2006.00785.x; de Witte LD, 2015, JAMA PSYCHIAT, V72, P731, DOI 10.1001/jamapsychiatry.2015.0526; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Gass N, 2016, EUR NEUROPSYCHOPHARM, V26, P1150, DOI 10.1016/j.euroneuro.2016.03.013; Gibbons A, 2016, CURR PHARM DESIGN, V22, P2124, DOI 10.2174/1381612822666160127114010; Gomez AM, 2011, J IMMUNOL, V186, P2503, DOI 10.4049/jimmunol.1002539; Gotti C, 1997, PROG NEUROBIOL, V53, P199, DOI 10.1016/S0301-0082(97)00034-8; Gresa-Arribas N, 2014, LANCET NEUROL, V13, P167, DOI 10.1016/S1474-4422(13)70282-5; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Hoffmann C, 2016, ANTIBODIES, V5, DOI 10.3390/antib5020009; HOWARD FM, 1987, ANN NY ACAD SCI, V505, P526, DOI 10.1111/j.1749-6632.1987.tb51321.x; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Kalkman HO, 2016, CELL MOL LIFE SCI, V73, P2511, DOI 10.1007/s00018-016-2175-4; Koval L, 2011, J ALZHEIMERS DIS, V25, P747, DOI 10.3233/JAD-2011-101845; Kuryatov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062246; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; Liu X, 2013, PSYCHIAT RES, V209, P431, DOI 10.1016/j.psychres.2013.03.027; Lykhmus O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122706; McKeon A, 2011, NEUROLOGY, V76, P1108, DOI 10.1212/WNL.0b013e318211c379; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pina-Camacho L, 2014, REV PSIQUIATR SALUD, V7, P166, DOI 10.1016/j.rpsm.2014.05.004; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; SOMNIER FE, 1993, J NEUROL NEUROSUR PS, V56, P496, DOI 10.1136/jnnp.56.5.496; Sundar K, 2017, J NEUROIMMUNOL, V311, P68, DOI 10.1016/j.jneuroim.2017.08.004; van Winkel R, 2008, J CLIN PSYCHIAT, V69, P1319, DOI 10.4088/JCP.v69n0817; Vasic N, 2012, EUR ARCH PSY CLIN N, V262, P375, DOI 10.1007/s00406-011-0280-9; Vernino S, 2000, NEW ENGL J MED, V343, P847, DOI 10.1056/NEJM200009213431204; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Winston N, 2010, CURR OPIN NEUROL, V23, P514, DOI 10.1097/WCO.0b013e32833d4c7f	33	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208412	10.1371/journal.pone.0208412	http://dx.doi.org/10.1371/journal.pone.0208412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521579	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600059
J	Graham, SP; Kline, R; Steen, DA; Kelehear, C				Graham, Sean P.; Kline, Richard; Steen, David A.; Kelehear, Crystal			Description of an extant salamander from the Gulf Coastal Plain of North America: The Reticulated Siren, Siren reticulata	PLOS ONE			English	Article							POPULATION	The salamander family Sirenidae is represented by four extant species that are restricted to North America. Sirens are abundant throughout the southern United States and are among the world's largest amphibians, yet the biology, ecology, and phylogeography of this group is poorly-known. In this study we use morphological and genetic evidence to describe a previously unrecognized species from southern Alabama and the Florida panhandle. We name this species the Reticulated Siren, Siren reticulata. Future studies will enable more precise phylogenetic information about S. reticulata and will almost surely reveal additional undescribed species within the family.	[Graham, Sean P.; Kelehear, Crystal] Sul Ross State Univ, Dept Biol Geol & Phys Sci, Alpine, TX 79830 USA; [Kline, Richard] Univ Texas Rio Grande Valley, Sch Earth Environm & Marine Sci, Brownsville, TX USA; [Steen, David A.] Jekyll Isl Author, Georgia Sea Turtle Ctr, Jekyll Isl, GA USA; [Kelehear, Crystal] Smithsonian Trop Res Inst, Ancon, Panama, Panama	Texas State University System; University of Texas System; University of Texas Rio Grande Valley; Smithsonian Institution; Smithsonian Tropical Research Institute	Graham, SP (corresponding author), Sul Ross State Univ, Dept Biol Geol & Phys Sci, Alpine, TX 79830 USA.	sean.graham@sulross.edu		Kline, Richard/0000-0002-4116-2060; Steen, David/0000-0002-3031-7557				[Anonymous], 2010, SALAMANDERS US CANAD; Blaustein RJ, 2008, BIOSCIENCE, V58, P784, DOI 10.1641/B580904; Bonett RM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0200; Chippindale PT, 2004, EVOLUTION, V58, P2809; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans SE, 1996, PALAEONTOLOGY, V39, P77; Graham Sean P., 2015, Bulletin Alabama Museum of Natural History, V32, P1; Guyer C, 2007, HERPETOFAUNAL RESPON; Hanlin H.G., 1978, Journal of the Alabama Academy of Science, V49, P31; LaFortune TC., 2015, THESIS; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Liu FGR, 2006, MOL PHYLOGENET EVOL, V39, P149, DOI 10.1016/j.ympev.2005.09.015; Mount R.H, 1975, REPTILES AMPHIBIANS; Noss R.F., 1988, ENDANGER SPEC UPDATE, V5, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sorensen K, 2004, SOUTHEAST NAT, V3, P249, DOI 10.1656/1528-7092(2004)003[0249:PCOSLA]2.0.CO;2; Steen David A., 2012, Florida Field Naturalist, V40, P47; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207460	10.1371/journal.pone.0207460	http://dx.doi.org/10.1371/journal.pone.0207460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517124	gold, Green Submitted, Green Published			2022-12-26	WOS:000452212400036
J	Serebryakova, A; Aires, T; Viard, F; Serrao, EA; Engelen, AH				Serebryakova, Alexandra; Aires, Tania; Viard, Frederique; Serrao, Ester A.; Engelen, Aschwin H.			Summer shifts of bacterial communities associated with the invasive brown seaweed Sargassum muticum are location and tissue dependent	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MICROBIAL DIVERSITY; OCEAN ACIDIFICATION; MARINE MACROALGAE; CHEMICAL DEFENSE; VARIABILITY; DISEASE; MORPHOGENESIS; DYNAMICS; GROWTH	Seaweed-associated microbiota experience spatial and temporal shifts in response to changing environmental conditions and seaweed physiology. These shifts may result in structural, functional and behavioral changes in the host with potential consequences for its fitness. They, thus, may help the host to adapt to changing environmental conditions. The current knowledge of seasonal variation of seaweed-associated microbiota is however still limited. In this study, we explored temporal and spatial variation of microbial communities associated with the invasive brown seaweed S. muticum. We sampled in northern and southern Portugal, in September, March and July-August (summer). In addition, as (pseudo-)perennial seaweeds display seasonal reproductive phenology, we sampled various parts of the individuals to disentangle the effect of temporal changes from those due to structural development variations. The diversity and structure of associated microbial communities were determined using next generation sequencing of the variable regions V5-7 of the 16S rDNA. We expected to find differentiation in associated microbial communities between regions and sampling months, but with differences depending on the seaweed structure examined. As expected, the study revealed substantial temporal shifts in S. muticum microbiome, for instance with large abundance of Rhodobacteraceae and Loktanella in September-March but prevalence of Pirellulales during the summer months. Variations between regions and tissues were also observed: in northern Portugal and on basal structures, bacterial diversity was higher as compared to the South and apical parts. All exam ined seaweed structures showed temporal differences in associated microbial community structure over time, except for holdfasts between September and March. Bacteria contributing to these changes varied spatially. Conversely to all other structures, the holdfast also did not show differences in associated community structure between southern and northern regions. Our study highlights the importance of structural microscale differentiations within seaweeds hosts with regard to their associated microbial communities and their importance across temporal and spatial dimensions.	[Serebryakova, Alexandra; Aires, Tania; Serrao, Ester A.; Engelen, Aschwin H.] FCT Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal; [Serebryakova, Alexandra; Viard, Frederique] Sorbonne Univ, UPMC Univ Paris, Stn Biol Roscoff, CNRS,UMR AD2M 7144, Roscoff, France	Universidade do Algarve; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Engelen, AH (corresponding author), FCT Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal.	aengelen@ualg.pt	Viard, Frédérique/O-4360-2018; Engelen, Aschwin H/M-3432-2013; Serrao, Ester A/C-6686-2012; Aires, Tania/M-8306-2013	Viard, Frédérique/0000-0001-5603-9527; Engelen, Aschwin H/0000-0002-9579-9606; Serrao, Ester A/0000-0003-1316-658X; Aires, Tania/0000-0002-1964-6819	Erasmus Mundus Doctoral Programme MARES on Marine Ecosystem Health Conservation [MARES_13_08]; FCT (Portugal) [SFRH/BPD/63703/2009, SFRH/BPD/107878/2015, SFRH/BPD/116774/2016]; project EU SEAS-ERA INVASIVES [SEAS-ERA/0001/2012]; project MARFOR [FCT-BIODIVERSA/004/2015];  [CCMAR/Multi/04326/2013]; Fundação para a Ciência e a Tecnologia [SEAS-ERA/0001/2012] Funding Source: FCT	Erasmus Mundus Doctoral Programme MARES on Marine Ecosystem Health Conservation; FCT (Portugal)(Portuguese Foundation for Science and Technology); project EU SEAS-ERA INVASIVES; project MARFOR; ; Fundação para a Ciência e a Tecnologia	This study was made possible by the Erasmus Mundus Doctoral Programme MARES on Marine Ecosystem Health & Conservation (MARES_13_08: Acclimation and adaptation of invasive seaweeds) for AS, by FCT (Portugal) fellowships SFRH/BPD/63703/2009 and SFRH/BPD/107878/2015 to AHE and SFRH/BPD/116774/2016 to TA and projects EU SEAS-ERA INVASIVES (SEAS-ERA/0001/2012), MARFOR (FCT-BIODIVERSA/004/2015), CCMAR/Multi/04326/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires T, 2018, PEERJ, V6, DOI 10.7717/peerj.4377; Ballestriero F, 2010, APPL ENVIRON MICROB, V76, P5710, DOI 10.1128/AEM.00695-10; Bengtsson MM, 2012, ISME J, V6, P2188, DOI 10.1038/ismej.2012.67; Bengtsson MM, 2011, AQUAT MICROB ECOL, V62, P191, DOI 10.3354/ame01477; Bengtsson MM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-261; Bengtsson MM, 2010, AQUAT MICROB ECOL, V60, P71, DOI 10.3354/ame01409; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bondoso J, 2014, FEMS MICROBIOL ECOL, V88, P445, DOI 10.1111/1574-6941.12258; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Campbell AH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00230; Campbell AH, 2011, GLOBAL CHANGE BIOL, V17, P2958, DOI 10.1111/j.1365-2486.2011.02456.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Clarke K.R., CHANGE MARINE COMMUN, V2nd; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; de Oliveira LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-487; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egan S, 2008, CURR OPIN MICROBIOL, V11, P219, DOI 10.1016/j.mib.2008.04.001; Egan S, 2013, FEMS MICROBIOL REV, V37, P462, DOI 10.1111/1574-6976.12011; Engelen AH, 2015, OCEANOGR MAR BIOL, V53, P81; Ettinger CL, 2017, PEERJ, V5, DOI 10.7717/peerj.3246; Fernandes N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050854; Fuerst J. A., 2013, PLANCTOMYCETES CELL; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Gorley C.K., 2006, GETTING STARTED PRIM; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hollants J, 2013, FEMS MICROBIOL ECOL, V83, P1, DOI 10.1111/j.1574-6941.2012.01446.x; Jiang YF, 2015, ECOTOXICOLOGY, V24, P1548, DOI 10.1007/s10646-015-1511-z; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kubanek J, 2003, P NATL ACAD SCI USA, V100, P6916, DOI 10.1073/pnas.1131855100; Lachnit T, 2013, FEMS MICROBIOL ECOL, V84, P411, DOI 10.1111/1574-6941.12071; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lage OM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00267; Lane D.J., 1991, NUCL ACID TECHNIQUES, P125; LEMOS ML, 1985, MICROBIAL ECOL, V11, P149, DOI 10.1007/BF02010487; Li J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07320; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Liu JW, 2010, AQUAT MICROB ECOL, V61, P291, DOI 10.3354/ame01446; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; Mancuso FP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00476; Marshall K, 2006, MICROB ECOL, V52, P302, DOI 10.1007/s00248-006-9060-x; Martin M, 2014, APPL MICROBIOL BIOT, V98, P2917, DOI 10.1007/s00253-014-5557-2; Marzinelli EM, 2015, ENVIRON MICROBIOL, V17, P4078, DOI 10.1111/1462-2920.12972; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mensch B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00434; Michelou VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067480; Miranda LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058269; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; O'Brien PA, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00047; Palacios R, 2005, GENOMES GENOMICS NIT; Paul NA, 2006, MAR ECOL PROG SER, V306, P87, DOI 10.3354/meps306087; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Singh RP, 2014, FEMS MICROBIOL ECOL, V88, P213, DOI 10.1111/1574-6941.12297; Singh RP, 2011, AQUAT BIOL, V12, P13, DOI 10.3354/ab00312; Spoerner M, 2012, J PHYCOL, V48, P1433, DOI 10.1111/j.1529-8817.2012.01231.x; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Stratil SB, 2013, MICROBIOLOGYOPEN, V2, P338, DOI 10.1002/mbo3.79; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Tujula NA, 2010, ISME J, V4, P301, DOI 10.1038/ismej.2009.107; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; Wang G, 2008, J APPL PHYCOL, V20, P403, DOI 10.1007/s10811-007-9274-4; Wegner CE, 2013, MAR GENOM, V9, P51, DOI 10.1016/j.margen.2012.12.001; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wiese J, 2009, MAR BIOTECHNOL, V11, P287, DOI 10.1007/s10126-008-9143-4; Zozaya-Valdes E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00146	71	32	32	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206734	10.1371/journal.pone.0206734	http://dx.doi.org/10.1371/journal.pone.0206734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517113	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400017
J	Siddarth, P; Burggren, AC; Merrill, DA; Ercoli, LM; Mahmood, Z; Barrio, JR; Small, GW				Siddarth, Prabha; Burggren, Alison C.; Merrill, David A.; Ercoli, Linda M.; Mahmood, Zanjbeel; Barrio, Jorge R.; Small, Gary W.			Longer TOM M40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding	PLOS ONE			English	Article							IMPLICATES REGIONAL ENHANCERS; ALZHEIMERS-DISEASE; FUNCTIONAL-ANALYSIS; COGNITIVE DECLINE; RISK-FACTORS; BRAIN; APOE; PREDICTS; LENGTH; VOLUME	Background The translocase of outer mitochondrial membrane 40 (TOMM40), which lies in linkage disequilibrium with the apolipoprotein E (APOE) gene, has been implicated in Alzheimer's disease (AD). TOMM40 influences AD pathology through mitochondrial neurotoxicity, and the medial temporal lobe (MTL) is the most likely brain region for identifying early manifestations of AD-related morphology changes. While early reports indicated that the longer length poly-T allele of TOMM40 increases risk for AD, these findings have not been consistently replicated in further studies. We examined the effect of TOMM40 and APOE on regional brain positron emission tomography (PET) 2-(1-{6-[(2 [F18]fluoroethyl) (methyl) amino]-2- naphthyllethylidene)malononitrile (FDDNP) binding values in MTL. Methods A total of 73 non-demented older adults (42 females; mean age: 62.9(10.9) completed geno-typing for both APOE and TOMM40 and received FDDNP-PET scans. For TOMM40, the lengths of the poly-T sequence were classified as short (14-20 repeats; S), long (21-29 repeats, L) or very long (>29 repeats, VL). Using general linear models, we examined medial temporal lobe FDDNP binding and cognitive functioning between TOMM40 and APOE-4 groups, with age, sex, and education as covariates. Results Data from 30 individuals with APOE-4 and L TOMM40 poly-T length, 11 non E4 TOMM40 S/S, 14 non E4 TOMM40 SNL and 13 non E4 TOMM40 VL/VL were analyzed. Medial temporal FDDNP binding differed significantly between TOMM40/APOE groups (F(3,62) = 3.3, p = .03). Participants with TOMM40 S/S exhibited significantly lower binding compared to TOMM40 SNL and APOE-4 carriers. We did not find a significant relationship between TOMM40 poly-T lengths/APOE risk groups and cognitive functioning. Conclusions This is the first report to demonstrate a significant association between longer TOMM40 poly-T lengths and higher medial temporal plaque and tangle burden in non-demented older adults. Identifying biomarkers that are risk factors for AD will enhance our ability to identify subjects likely to benefit from novel AD treatments.	[Siddarth, Prabha; Merrill, David A.; Ercoli, Linda M.; Small, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Burggren, Alison C.] Univ Calif Los Angeles, Ctr Cognit Neurosci, Los Angeles, CA USA; [Burggren, Alison C.] Univ Oregon, Lewis Ctr Neuroimaging, Eugene, OR 97403 USA; [Mahmood, Zanjbeel] San Diego State Univ, Univ Calif San Diego, Joint Doctoral Program Clin Psychol, San Diego, CA 92182 USA; [Barrio, Jorge R.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Oregon; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Siddarth, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	psiddarth@mednet.ucla.edu			Zegar Family Foundation Research Fund; Ahmanson Foundation; McComb Foundation; McMahan Foundation; Bob and Marion Wilson, Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research, Plott Professorship; Parlow-Solomon Professorship; National Institutes of Health [P01-AG025831, AG13308, P50 AG 16570, MH/AG58156, MH52453, AG10123, M01RR00865]; U.S. Department of Energy [DE-FC03-87-ER60615]; General Clinical Research Centers Program; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA034728] Funding Source: NIH RePORTER	Zegar Family Foundation Research Fund; Ahmanson Foundation; McComb Foundation; McMahan Foundation; Bob and Marion Wilson, Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research, Plott Professorship; Parlow-Solomon Professorship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the Zegar Family Foundation Research Fund, Ahmanson Foundation, McComb Foundation, McMahan Foundation, Bob and Marion Wilson, Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research, Plott Professorship (JRB), and the Parlow-Solomon Professorship (GWS), as well as grants P01-AG025831, AG13308, P50 AG 16570, MH/AG58156, MH52453, AG10123, and M01RR00865 from the National Institutes of Health; contract DE-FC03-87-ER60615 from the U.S. Department of Energy; and the General Clinical Research Centers Program. The authors thank John Williams, University of California, Los Angeles, Nuclear Medicine Clinic, for assistance in performing the PET scans; and Vladimir Kepe, Cleveland Clinic, for developing the FDDNP PET analysis procedures for proteinopathies in patients with neurodegenerative diseases. The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled "Methods for Labeling beta-Amyloid Plaques and Neurofibrillary Tangles", which has been licensed to TauMark, LLC. Drs. Small and Barrio are among the inventors and have financial interest in TauMark, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpawong TE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182448; Ashford JW, 2002, J ALZHEIMERS DIS, V4, P169, DOI 10.3233/JAD-2002-4307; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bekris LM, 2012, J HUM GENET, V57, P18, DOI 10.1038/jhg.2011.123; Bertram L, 2005, NEURODEGENER DIS, P575, DOI [10.1017/CBO9780511544873.031, DOI 10.1017/CBO9780511544873.031]; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Burggren AC, 2017, ALZHEIMERS DEMENT, V13, P739, DOI 10.1016/j.jalz.2016.12.009; Carrasquillo MM, 2012, J HUM GENET, V57, P3, DOI 10.1038/jhg.2011.135; Caselli RJ, 2012, ALZHEIMERS DEMENT, V8, P490, DOI 10.1016/j.jalz.2011.11.006; Chu SH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.016; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; de Bruijn RFAG, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0130-5; Desikan RS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002258; Gottschalk William K, 2014, J Parkinsons Dis Alzheimers Dis, V1; Hersi M, 2017, NEUROTOXICOLOGY, V61, P143, DOI 10.1016/j.neuro.2017.03.006; Jack CR, 2013, ACTA NEUROPATHOL, V126, P643, DOI 10.1007/s00401-013-1185-7; Jiang T, 2013, CURR ALZHEIMER RES, V10, P852; Johnson KA, 2006, CURR NEUROL NEUROSCI, V6, P496, DOI 10.1007/s11910-006-0052-5; Johnson SC, 2011, ALZHEIMERS DEMENT, V7, P456, DOI 10.1016/j.jalz.2010.11.012; Jun G, 2012, ARCH NEUROL-CHICAGO, V69, P1270, DOI 10.1001/archneurol.2012.2052; Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103; Liu J, 2007, MOL IMAGING BIOL, V9, P6, DOI 10.1007/s11307-006-0061-4; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lutz MW, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0643-8; Lutz MW, 2011, J ALZHEIMERS DIS, V24, P247, DOI 10.3233/JAD-2010-101765; Macbeth G., 2011, CLIFFS DELTA CALCULA; Maruszak A, 2012, J ALZHEIMERS DIS, V28, P309, DOI 10.3233/JAD-2011-110743; O'Brien JT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0218-y; Price J. L, 1999, ANN NEUROL, DOI [10.1002/1531-8249(199903):45:3<358::AID-3.0.CO;2-X, DOI 10.1002/1531-8249(199903):453<ANA12>3.0.CO;2-X]; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Roses AD, 2010, ARCH NEUROL-CHICAGO, V67, P536, DOI 10.1001/archneurol.2010.88; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Shen LX, 2016, NEUROSCI BULL, V32, P183, DOI 10.1007/s12264-016-0011-3; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Small GW, 2012, ARCH NEUROL-CHICAGO, V69, P215, DOI 10.1001/archneurol.2011.559; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; SMALL GW, 1992, PSYCHIAT RES-NEUROIM, V45, P177, DOI 10.1016/0925-4927(92)90025-Y; Smid LM, 2013, J ALZHEIMERS DIS, V36, P261, DOI 10.3233/JAD-122434; Stocker H, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0221-8; Talairach J, 1988, NEUROPSYCHOLOGIA, V39, DOI [10.1111/mono.12083, DOI 10.1111/MONO.12083]; Tilley L, 1998, J CLIN PATHOL-MOL PA, V51, P293, DOI 10.1136/mp.51.6.293; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; Villemagne VL, 2018, NAT REV NEUROL, V14, P225, DOI 10.1038/nrneurol.2018.9; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wenham P. R, 1991, APOLIPOPROTEIN E GEN	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208358	10.1371/journal.pone.0208358	http://dx.doi.org/10.1371/journal.pone.0208358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517207	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400091
J	Yang, JF; Ding, XF; Zhu, WD				Yang, Jianfeng; Ding, Xiaofan; Zhu, Weidong			Improving the calling of non-invasive prenatal testing on 13-/18-/21-trisomy by support vector machine discrimination	PLOS ONE			English	Article							TRISOMIES 21; FETAL DNA; DIAGNOSIS; 1ST-TRIMESTER; ANEUPLOIDIES; FRACTION; SOCIETY; PLASMA	With the advance of next-generation sequencing (NGS) technologies, non-invasive prenatal testing (NIPT) has been developed and employed in fetal aneuploidy screening on 13-/18-/21-trisomies through detecting cell-free fetal DNA (cffDNA) in maternal blood. Although Z-test is widely used in NIPT NGS data analysis, there is still necessity to improve its accuracy for reducing a) false negatives and false positives, and b) the ratio of unclassified data, so as to lower the potential harm to patients as well as the induced cost of retests. Combining the multiple Z-tests with indexes of clinical signs and quality control, features were collected from the known samples and scaled for model training using support vector machine (SVM). We trained SVM models from the qualified NIPT NGS data that Z-test can discriminate and tested the performance on the data that Z-test+ cannot discriminate. On screenings of 13-/18-/21-trisomies, the trained SVM models achieved 100% accuracies in both internal validations and unknown sample predictions. It is shown that other machine learning (ML) models can also achieve similar high accuracy, and SVM model is most robust in this study. Moreover, four false positives and four false negatives caused by Z-test were corrected by using the SVM models. To our knowledge, this is one of the earliest studies to employ SVM in NIPT NGS data analysis. It is expected to replace Z-test in clinical practice.	[Yang, Jianfeng; Zhu, Weidong] Guangzhou DaAn Clin Lab Ctr, YunKang Grp, Guangzhou, Guangdong, Peoples R China; [Ding, Xiaofan] Hong Kong Univ Sci & Technol, Appl Genom Ctr, Saikung, Hong Kong, Peoples R China; [Yang, Jianfeng] Sun Yat Sen Univ, Zhongshan Med Sch, Guangzhou, Guangdong, Peoples R China; [Ding, Xiaofan] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Sun Yat Sen University; Chinese University of Hong Kong	Yang, JF (corresponding author), Guangzhou DaAn Clin Lab Ctr, YunKang Grp, Guangzhou, Guangdong, Peoples R China.; Yang, JF (corresponding author), Sun Yat Sen Univ, Zhongshan Med Sch, Guangzhou, Guangdong, Peoples R China.	yangjianfeng@yunkanghealth.com	DING, Xiaofan/GLS-2274-2022	DING, Xiaofan/0000-0003-2565-7757	Guangzhou Science Technology and Innovation Commission [201604016136]; Guangzhou DaAn Clinical Laboratory Center of YunKang Group	Guangzhou Science Technology and Innovation Commission; Guangzhou DaAn Clinical Laboratory Center of YunKang Group	Our study is supported by a grant from Guangzhou Science Technology and Innovation Commission (Grant No. 201604016136 to JY). Besides, Guangzhou DaAn Clinical Laboratory Center of YunKang Group also funds both Mr. Weidong Zhu and me in form of salary. I myself currently have been working at Zhongshan Medical School of Sun Yat-sen University since June 2017 and hence I am no longer funded by Guangzhou DaAn Clinical Laboratory Center in form of salary. Dr. Xiaofan Ding is from the Applied Genomic Center of the Hong Kong University of Science and Technology, and currently working at the Chinese University of Hong Kong. No funder has any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baten AKMA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S15; Bayindir B, 2015, EUR J HUM GENET, V23, P1286, DOI 10.1038/ejhg.2014.282; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Devers PL, 2013, J GENET COUNS, V22, P291, DOI 10.1007/s10897-012-9564-0; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Jiang FM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-57; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Kim SK, 2015, PRENATAL DIAG, V35, P810, DOI 10.1002/pd.4615; Kuhn M, 2009, J STAT SOFTWARE, V28; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Lee Y, 2003, BIOINFORMATICS, V19, P1132, DOI 10.1093/bioinformatics/btg102; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao C, 2014, P NATL ACAD SCI USA, V111, P7415, DOI 10.1073/pnas.1321997111; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Mccullough RM, 2014, NONINVASIVE PRENATAL, V9; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; O'Fallon BD, 2013, BIOINFORMATICS, V29, P1361, DOI 10.1093/bioinformatics/btt172; Poon LC, 2016, ULTRASOUND OBST GYN, V47, P184, DOI 10.1002/uog.15749; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; TABOR A, 1986, LANCET, V1, P1287; Taneja PA, 2016, PRENATAL DIAG, V36, P237, DOI 10.1002/pd.4766; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701; Wang JC, 2015, OBSTET GYNECOL SURV, V70, P434, DOI 10.1097/01.ogx.0000469203.83102.db; Wataganara T, 2016, BJOG-INT J OBSTET GY, V123, P31, DOI 10.1111/1471-0528.14197; Yang H, 2015, PUBLIC HEALTH, V129, P1304, DOI 10.1016/j.puhe.2015.07.027; Yu SC, 2016, CLIN CHEM; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792; 2012, OBSTET GYNECOL, V120, P1532	33	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207840	10.1371/journal.pone.0207840	http://dx.doi.org/10.1371/journal.pone.0207840			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517156	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400068
J	Yusefzadeh, H; Didarloo, A; Nabilou, B				Yusefzadeh, Hasan; Didarloo, Alireza; Nabilou, Bahram			Provider knowledge and performance in medication injection safety in anesthesia: A mixed method prospective crosses sectional study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; HEPATITIS-B; NEEDLESTICK INJURIES; PRECAUTIONS; EXPOSURE	Objectives Injection safety during anesthesia is a challenging health care issue in Iranian hospitals. Anesthesia is one of the most medication-intensive procedures in healthcare and injecting patients are an integral part of that care. The present study aimed to assess the status of medication injection safety practice in a teaching center. Design, setting, participants A prospective cross-sectional study was done in 2014-2015 at a 500-bed secondary level teaching hospital affiliated with Urmia University of Medical Sciences, Iran. The study population included providers of anesthesia in two groups of operating rooms (ORs) with different types of surgeries at the center. Data were collected using valid and reliable observation and a questionnaire instruments in two consecutive phases. Mann-Whitney U, Kruskal-Wallis, and Spearman correlation tests were used for data analyses. Results A total of 345 injections were observed and recorded during the study period, 53% in group A ORs, and 47% in group B ORs. Eighty-two questionnaires were completed (96.5% response rate) to determine hospital injection practices and personal knowledge of injection safety. Adherence to safety requirements was observed in 58.5% of injections. Fifty five percent of respondents knew that hepatitis B, C, and HIV are blood borne diseases. Observed compliance with injection safety requirements was determined significant by OR groups (P = 0.00). Correlation was significant between observed injection safety practices by age and work experience (P = 0.00). The Kruskal-Wallis test showed a significant difference (P = 0.000) in observed safe injection practices among four job groups but not in reported adherence. Knowledge of respondents was significant by job groups about blood borne diseases and receiving three doses of hepatitis B vaccine. Conclusions The study revealed that some of safe injection procedures were well carried out in our ORs, but that others were not. The reported adherence of staff was acceptable but their actual practices were unsafe. It is suggested to implement audits, provide safer supplies, and complete Hepatitis B vaccination of injection providers.	[Yusefzadeh, Hasan] Urmia Univ Med Sci, Sch Publ Hlth, Dept Publ Hlth, Orumiyeh, Iran; [Didarloo, Alireza] Urmia Univ Med Sci, Social Determinants Hlth Res Ctr, Sch Publ Hlth, Dept Publ Hlth, Orumiyeh, Iran; [Nabilou, Bahram] Urmia Univ Med Sci, Patient Safety Res Ctr, Sch Publ Hlth, Dept Publ Hlth, Orumiyeh, Iran	Urmia University of Medical Sciences; Urmia University of Medical Sciences; Urmia University of Medical Sciences	Nabilou, B (corresponding author), Urmia Univ Med Sci, Patient Safety Res Ctr, Sch Publ Hlth, Dept Publ Hlth, Orumiyeh, Iran.	bnabil@umsu.ac.ir	Didarloo, Alireza/G-7434-2017; yusefzadeh, hasan/F-9850-2017; Didarloo, Alireza/AAF-9651-2021; nabilou, bahram/ABI-4723-2020; nabilou, bahram/G-7659-2017	Didarloo, Alireza/0000-0002-4541-6654; yusefzadeh, hasan/0000-0001-9919-0235; nabilou, bahram/0000-0001-7188-9992; nabilou, bahram/0000-0001-7188-9992				Abdi MH, 2009, JAHROM MED J, V7, P30, DOI DOI 10.29252/JMJ.7.3.30; Abkar MAA, 2013, J INFECT PUBLIC HEAL, V6, P252, DOI 10.1016/j.jiph.2013.01.003; Adejumo P. O., 2013, INT J INFECT CONTROL, V9, P1, DOI DOI 10.3396/ijic.v9i1.004.13; Adib-Hajbaghery M, 2013, TRAUMA MON, V18, P75, DOI 10.5812/traumamon.12779; Amosu A. M., 2011, Current Research Journal of Biological Sciences, V3, P586; [Anonymous], 2000, ERR IS HUMAN BUILDIN; Azami M, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.37781; Azami-Aghdash Saber, 2015, Med J Islam Repub Iran, V29, P251; Batra V, 2015, ANN GASTROENTEROL, V28, P276; Bobby Paul, 2011, Turk Silahli Kuvvetleri,  Koruyucu Hekimlik Bulteni, V10, P681; Brown L. B, 2014, AANA J, V82; Ford K, 2013, AANA J, V81; Frandzel S, 2012, ANESTHESIOL NEWS, V38; Gholami A., 2013, INT J HOSP RES, V2, P31; Giard M, 2016, AM J INFECT CONTROL, V44, P8, DOI 10.1016/j.ajic.2015.07.034; Gounder P, 2013, J CLIN ANESTH, V25, P521, DOI 10.1016/j.jclinane.2013.04.013; Hanafi M. I., 2011, Eastern Mediterranean Health Journal, V17, P26; Hashemi SH, 2012, HAMADAN U MED SCI, V18, P41; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; Joint Commission, 2014, Sentinel Event Alert, P1; Kaphle H. P., 2014, International Journal of Medical and Health Sciences, V3, P301; Kesieme E. B., 2011, HEPATITIS RES TREATM, V2011; MEMON A.R, 2007, IFECT DIS J, V16, P105; Merali R, 2008, HEALTHCARE Q, V11; Moghri J, 2013, J CLIN RES GOVERNANC, V2, P47; Mohammadi N, 2011, HEPAT MON, V11, P186; Motamed N., 2006, Eastern Mediterranean Health Journal, V12, P653; Mwachofi A, 2011, INT J HEALTH CARE Q, V24, P274, DOI 10.1108/09526861111125589; Nabilou B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135610; Ogoina Dimie, 2015, J Infect Prev, V16, P16, DOI 10.1177/1757177414558957; Olatosi J O, 2016, J West Afr Coll Surg, V6, P88; Omorogbe V. E., 2012, ANN AFRICAN MED, V11; Shah S, 2007, PAK J MED SCI, V23, P538; Shiva F., 2008, Pejouhesh dar Pezeshki, V32, pPe247; Shrestha Sanjaya Kumar, 2006, J Coll Physicians Surg Pak, V16, P108; Talaat M, 2003, AM J INFECT CONTROL, V31, P469, DOI 10.1016/j.ajic.2003.03.003; Taylor DL, 2006, AORN J, V83, P833, DOI DOI 10.1016/S0001-2092(06)60004-5; Vaziri Siavash, 2008, Indian J Med Sci, V62, P292; Vong S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-56; World Health Organization, 2008, REV INJ SAF ASS TOOL	40	0	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207572	10.1371/journal.pone.0207572	http://dx.doi.org/10.1371/journal.pone.0207572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517128	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400044
J	Gwon, Y; Kim, SH; Kim, HT; Kam, TI; Park, J; Lim, B; Cha, H; Chang, HJ; Hong, YR; Jung, YK				Gwon, Youngdae; Kim, Seo-Hyun; Kim, Hyun Tae; Kam, Tae-In; Park, Jisu; Lim, Bitna; Cha, Hyunju; Chang, Ho-Jin; Hong, Yong Rae; Jung, Yong-Keun			Amelioration of amyloid -FcRIIb neurotoxicity and tau pathologies by targeting LYN	FASEB JOURNAL			English	Article						Alzheimer's disease; A; cocrystallization; memory impairment	SRC-FAMILY KINASES; PRION PROTEIN; A-BETA; FYN; TYROSINE; PHOSPHORYLATION; ENVIRONMENT; ACTIVATION; INHIBITION; IMPAIRMENT	SRC-family kinases (SFKs) have been implicated in Alzheimer's disease (AD), but their mode of action was scarcely understood. Here, we show that LYN plays an essential role in amyloid (A)-triggered neurotoxicity and tau hyperphosphorylation by phosphorylating Fc receptor IIb2 (FcRIIb2). We found that enzyme activity of LYN was increased in the brain of AD patients and was promoted in neuronal cells exposed to A 1-42 (A(1-42)). Knockdown of LYN expression inhibited A(1-42)-induced neuronal cell death. Of note, LYN interacted with FcRIIb2 upon exposure to A(1-42) and phosphorylated FcRIIb2 at Tyr273 within immunoreceptor tyrosine-based inhibitory motif in neuronal cells. With the use of the structure-based drug design, we isolated KICG2576, an ATP-competitive inhibitor of LYN. Determination of cocrystal structure illustrated that KICG2576 bound to the cleft in the LYN kinase domain and inhibited LYN with a half-maximal inhibitory concentration value of 0.15 M. KICG2576 inhibited A- or FcRIIb2-induced cell death, and this effect was better than pyrazolopyrimidine 1, a widely used inhibitor of SFK. Upon exposure to A, KICG2576 blocked the phosphorylation of FcRIIb2 and translocation of phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2, a binding protein to the phosphorylated FcRIIb2, to the plasma membrane, resulting in the inhibition of tau hyperphosphorylation, the downstream event of A(1-42)-FcRIIb2 binding. Furthermore, intracerebroventricular injection of KICG2576 into mice ameliorated A-induced memory impairment. These results suggest that LYN plays a crucial role in A(1-42)-mediated neurotoxicity and tau pathology, providing a therapeutic potential of LYN in AD.Gwon, Y., Kim, S.-H., Kim, H. T., Kam, T.-I., Park, J., Lim, B., Cha, H., Chang, H.-J., Hong, Y. R., Jung, Y.-K. Amelioration of amyloid -FcRIIb neurotoxicity and tau pathologies by targeting LYN.	[Gwon, Youngdae; Kim, Seo-Hyun; Kam, Tae-In; Park, Jisu; Lim, Bitna; Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 08826, South Korea; [Kim, Hyun Tae; Cha, Hyunju; Chang, Ho-Jin; Hong, Yong Rae] Crystalgenomics Inc, Gyeonggi Do, South Korea	Seoul National University (SNU)	Jung, YK (corresponding author), Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 08826, South Korea.	ykjung@snu.ac.kr	Gwon, Youngdae/AAK-1621-2021	Kam, Tae-In/0000-0002-7241-4902; Gwon, Youngdae/0000-0002-5618-9370	Creative Research Initiative (CRI) Grant [NRF-2016R1A2A1A05005304]; Bio and Medical Technology Development Program of the National Research Foundation - Ministry of Education, Science, and Technology (South Korea) [NRF-2017M3A9G7073521]	Creative Research Initiative (CRI) Grant; Bio and Medical Technology Development Program of the National Research Foundation - Ministry of Education, Science, and Technology (South Korea)	The authors thank Dr. D. Selkoe (Harvard Medical School, Boston, MA, USA) for CHO and 7PA2 cells, Harvard Brain Tissue Center of McLean Hospital for human brain tissues, and Jeong Eun Na (Crystalgenomics Inc.) for technical assistance. This work was also supported by a Creative Research Initiative (CRI) Grant (NRF-2016R1A2A1A05005304), and by the Bio and Medical Technology Development Program of the National Research Foundation Grant (NRF-2017M3A9G7073521), funded by the Ministry of Education, Science, and Technology (South Korea). The authors declare no conflicts of interest.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dallari S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14830; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freedman TS, 2015, ELIFE, V4, DOI 10.7554/eLife.09183; George C, 2017, BRAIN, V140, P2012, DOI 10.1093/brain/awx132; Gwon Y, 2018, J NEUROSCI, V38, P9001, DOI 10.1523/JNEUROSCI.1996-17.2018; Hernandez-Rapp J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04881; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Kam TI, 2016, ELIFE, V5, DOI 10.7554/eLife.18691; Kam TI, 2014, CELL MOL LIFE SCI, V71, P4803, DOI 10.1007/s00018-014-1706-0; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Ku M, 2015, LEUKEMIA LYMPHOMA, V56, P577, DOI 10.3109/10428194.2014.907897; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Li CJ, 2008, CELL SIGNAL, V20, P1960, DOI 10.1016/j.cellsig.2008.07.004; Loberto N, 2005, J NEUROCHEM, V95, P771, DOI 10.1111/j.1471-4159.2005.03397.x; Lonskaya I, 2013, EMBO MOL MED, V5, P1247, DOI 10.1002/emmm.201302771; Manocha GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132604; Martinez-Garay I, 2016, DEVELOPMENT, V143, P2121, DOI 10.1242/dev.132456; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084746; Nygaard HB, 2018, BIOL PSYCHIAT, V83, P369, DOI 10.1016/j.biopsych.2017.06.004; Ochs K, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00063; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Oh Y, 2012, CELL DEATH DIFFER, V19, P1196, DOI 10.1038/cdd.2011.209; Ohnishi H, 2011, TRENDS NEUROSCI, V34, P629, DOI 10.1016/j.tins.2011.09.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2012, HUM MOL GENET, V21, P2725, DOI 10.1093/hmg/dds100; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; Socodato R, 2017, SCI REP-UK, V7, DOI 10.1038/srep40912; Song SM, 2008, J CELL BIOL, V182, P675, DOI 10.1083/jcb.200711066; Stepanek O, 2013, J IMMUNOL, V190, P1807, DOI 10.4049/jimmunol.1202401; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Summy JM, 2005, MOL CANCER THER, V4, P1900, DOI 10.1158/1535-7163.MCT-05-0171; Ul Amin F, 2017, SCI REP-UK, V7, DOI 10.1038/srep40753; Um JW, 2013, NEURON, V80, P531, DOI 10.1016/j.neuron.2013.10.001; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Umemori H, 2003, NEUROSCIENCE, V118, P709, DOI 10.1016/S0306-4522(03)00025-3; van der Vlist M, 2016, NAT REV RHEUMATOL, V12, P593, DOI 10.1038/nrrheum.2016.131; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zhuang SG, 2012, J CELL PHYSIOL, V227, P2138, DOI 10.1002/jcp.22946	50	6	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4300	4313		10.1096/fj.201800926R	http://dx.doi.org/10.1096/fj.201800926R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30540497	Bronze			2022-12-26	WOS:000459794800096
J	Kuusk, S; Kont, R; Kuusk, P; Heering, A; Sorlie, M; Bissaro, B; Eijsink, VGH; Valjamae, P				Kuusk, Silja; Kont, Riin; Kuusk, Piret; Heering, Agnes; Sorlie, Morten; Bissaro, Bastien; Eijsink, Vincent G. H.; Valjamae, Priit			Kinetic insights into the role of the reductant in H2O2-driven degradation of chitin by a bacterial lytic polysaccharide monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; copper monooxygenase; polysaccharide; enzyme kinetics; Serratia marcescens; chitin; enzyme inactivation; CBP21; lytic polysaccharide monooxygenase; oxidative degradation; reductant; SmLPMO10A; binding; oxidative degradation	CHELATE CATALYZED OXIDATION; MOLECULAR-OXYGEN; METAL-ION; SERRATIA-MARCESCENS; ACTIVITY ASSAY; ASCORBIC-ACID; BINDING; HYDROLYSIS; CELLULOSE; CELLULASES	Lytic polysaccharide monooxygenases (LPMOs) are monocopper enzymes that catalyze oxidative cleavage of glycosidic bonds in polysaccharides in the presence of an external electron donor (reductant). In the classical O-2-driven monooxygenase reaction, the reductant is needed in stoichiometric amounts. In a recently discovered, more efficient H2O2-driven reaction, the reductant would be needed only for the initial reduction (priming) of the LPMO to its catalytically active Cu(I) form. However, the influence of the reductant on reducing the LPMO or on H2O2 production in the reaction remains undefined. Here, we conducted a detailed kinetic characterization to investigate how the reductant affects H2O2-driven degradation of C-14-labeled chitin by a bacterial LPMO, SmLPMO10A (formerly CBP21). Sensitive detection of C-14-labeled products and careful experimental set-ups enabled discrimination between the effects of the reductant on LPMO priming and other effects, in particular enzyme-independent production of H2O2 through reactions with O-2. When supplied with H2O2, SmLPMO10A catalyzed 18 oxidative cleavages per molecule of ascorbic acid, suggesting a "priming reduction" reaction. The dependence of initial rates of chitin degradation on reductant concentration followed hyperbolic saturation kinetics, and differences between the reductants were manifested in large variations in their half-saturating concentrations (KmRapp). Theoretical analyses revealed that KmRapp decreases with a decreasing rate of polysaccharide-independent LPMO reoxidation (by either O-2 or H2O2). We conclude that the efficiency of LPMO priming depends on the relative contributions of reductant reactivity, on the LPMO's polysaccharide monooxygenase/peroxygenase and reductant oxidase/peroxidase activities, and on reaction conditions, such as O-2, H2O2, and polysaccharide concentrations.	[Kuusk, Silja; Kont, Riin; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Kuusk, Piret] Univ Tartu, Inst Phys, EE-51010 Tartu, Estonia; [Heering, Agnes] Univ Tartu, Inst Chem, EE-51010 Tartu, Estonia; [Sorlie, Morten; Bissaro, Bastien; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, N-1433 As, Norway	University of Tartu; University of Tartu; University of Tartu Institute of Physics; University of Tartu; Norwegian University of Life Sciences	Valjamae, P (corresponding author), Riia 23b-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018; BISSARO, Bastien/AAL-7130-2021; Bissaro, Bastien/AAI-6814-2020; Heering, Agnes/N-1760-2017	Väljamäe, Priit/0000-0002-1035-9493; Heering, Agnes/0000-0002-0893-8015; Bissaro, Bastien/0000-0001-8354-3892; Eijsink, Vincent/0000-0002-9220-8743; Sorlie, Morten/0000-0001-7259-6710	Estonian Research Council [PUT1024]; Research Council of Norway [262853, 269408]	Estonian Research Council(Estonian Research Council); Research Council of Norway(Research Council of Norway)	This work was supported by Estonian Research Council Grant PUT1024 and Research Council of Norway Grants 262853 and 269408. The authors declare that they have no conflicts of interest with the contents of this article.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Arteaga JF, 2012, MOLECULES, V17, P5126, DOI 10.3390/molecules17055126; Bertini L, 2018, INORG CHEM, V57, P86, DOI 10.1021/acs.inorgchem.7b02005; Bissaro B, 2016, BIORXIV, P1, DOI [10.1101/097022, DOI 10.1101/097022]; Bissaro B, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00029-18; Bissaro B, 2018, BIOCHEMISTRY-US, V57, P1893, DOI 10.1021/acs.biochem.8b00138; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Bissaro B, 2016, GREEN CHEM, V18, P5357, DOI [10.1039/C6GC01666A, 10.1039/c6gc01666a]; Boatright WL, 2016, FOOD CHEM, V196, P1361, DOI 10.1016/j.foodchem.2015.07.141; Bradshaw MP, 2011, CRIT REV FOOD SCI, V51, P479, DOI 10.1080/10408391003690559; Brenelli L, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-017-0985-8; Breslmayr E, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1063-6; Bulakhov AG, 2016, BIOCHEMISTRY-MOSCOW+, V81, P530, DOI 10.1134/S0006297916050102; Camci-Unal G, 2010, J CHEM ENG DATA, V55, P1117, DOI 10.1021/je900552w; Chaplin AK, 2016, J BIOL CHEM, V291, P12838, DOI 10.1074/jbc.M116.722447; Forsberg Z, 2018, J BIOL CHEM, V293, P1397, DOI 10.1074/jbc.M117.817130; Franzle S, 2015, ANN BOT-COENOL PLANT, V5, P79, DOI 10.4462/annbotrm-13065; Frommhagen M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01080; Frommhagen M, 2018, APPL MICROBIOL BIOT, V102, P1281, DOI 10.1007/s00253-017-8541-9; Frommhagen M, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0810-4; Frommhagen M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0594-y; Hangasky JA, 2018, P NATL ACAD SCI USA, V115, P4915, DOI 10.1073/pnas.1801153115; Hangasky JA, 2018, BIOCHEMISTRY-US, V57, P3191, DOI 10.1021/acs.biochem.8b00129; Hansberg W, 2012, ARCH BIOCHEM BIOPHYS, V525, P170, DOI 10.1016/j.abb.2012.05.014; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hedegard ED, 2018, CHEM SCI, V9, P3866, DOI 10.1039/c8sc00426a; Holtmann D, 2016, CHEMBIOCHEM, V17, P1391, DOI 10.1002/cbic.201600176; Hu JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21016-6; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; ILAN YA, 1976, BIOCHIM BIOPHYS ACTA, V430, P209, DOI 10.1016/0005-2728(76)90080-3; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Karlsen V, 2010, THERMOCHIM ACTA, V501, P119, DOI 10.1016/j.tca.2010.01.007; KHAN MMT, 1967, J AM CHEM SOC, V89, P7104, DOI 10.1021/ja01002a046; KHAN MMT, 1967, J AM CHEM SOC, V89, P4176, DOI 10.1021/ja00992a036; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kracher D, 2018, J BIOL CHEM, V293, P1676, DOI 10.1074/jbc.RA117.000109; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Kruer-Zerhusen N, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0925-7; Kuusk S, 2018, J BIOL CHEM, V293, P523, DOI 10.1074/jbc.M117.817593; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Loose JSM, 2018, BIOCHEMISTRY-US, V57, P4114, DOI 10.1021/acs.biochem.8b00484; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Meier KK, 2018, CHEM REV, V118, P2593, DOI 10.1021/acs.chemrev.7b00421; Modenbach AA, 2012, BIOTECHNOL BIOENG, V109, P1430, DOI 10.1002/bit.24464; Mollers KB, 2017, CARBOHYD RES, V448, P182, DOI 10.1016/j.carres.2017.03.013; Muller G, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1199-4; Muraleedharan MN, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1294-6; Peciulyte A, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1159-z; Qi F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-238; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rodriguez-Zuniga UF, 2015, GREEN CHEM, V17, P2896, DOI [10.1039/c4gc02179g, 10.1039/C4GC02179G]; Sabbadin F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03142-x; SCARPA M, 1983, J BIOL CHEM, V258, P6695; Scott BR, 2016, BIOTECHNOL LETT, V38, P425, DOI 10.1007/s10529-015-1989-8; Sun CL, 2011, BIOSENS BIOELECTRON, V26, P3450, DOI 10.1016/j.bios.2011.01.023; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Wang BJ, 2018, ACS CATAL, V8, P1346, DOI 10.1021/acscatal.7b03888; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561	65	38	41	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1516	1528		10.1074/jbc.RA118.006196	http://dx.doi.org/10.1074/jbc.RA118.006196			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30514757	Green Published, hybrid			2022-12-26	WOS:000457879200008
J	Liu, KH; Zhong, PS; Zheng, Y; Yang, KG; Liu, M				Liu, Kunhua; Zhong, Peisi; Zheng, Yi; Yang, Kaige; Liu, Mei			P_VggNet: A convolutional neural network (CNN) with pixel-based attention map	PLOS ONE			English	Article							RECOGNITION	Attention maps have been fused in the VggNet structure (EAC-Net) [1] and have shown significant improvement compared to that of the VggNet structure. However, in [1], E-Net was designed based on the facial action unit (AU) center and for facial AU detection only. Thus, for the use of attention maps in every image type, this paper proposed a new convolutional neural network (CNN) structure, P_VggNet, comprising the following parts: P_Net and VggNet with 16 layers (VggNet-16). The generation approach of P_Net was designed, and the P_VggNet structure was proposed. To prove the efficiency of P_VggNet, we designed two experiments, which indicated that P_VggNet could more efficiently extract image features than VggNet-16.	[Liu, Kunhua; Zhong, Peisi; Zheng, Yi; Yang, Kaige; Liu, Mei] Shandong Univ Sci & Technol, Adv Mfg Technol Ctr, Qingdao, Shandong, Peoples R China	Shandong University of Science & Technology	Zhong, PS (corresponding author), Shandong Univ Sci & Technol, Adv Mfg Technol Ctr, Qingdao, Shandong, Peoples R China.	pszhong@163.com	yi, zheng/AAC-8835-2020		National Natural Science Foundation of China [51375282]; Key Research and Development Plan of Shandong Province [2018GGX106001]; Scientific and Technological Innovation Projects of Shandong Science and Technology School [SDKDYC180329, SDKDYC180334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Plan of Shandong Province; Scientific and Technological Innovation Projects of Shandong Science and Technology School	This work was supported by the National Natural Science Foundation of China (No. 51375282), the Key Research and Development Plan of Shandong Province (2018GGX106001), and Scientific and Technological Innovation Projects of Shandong Science and Technology School (Nos. SDKDYC180329 and SDKDYC180334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Ciresan D.C., 2011, PROC 22 INT JOINT C, P1237; Gehring J, 2013, INT CONF ACOUST SPEE, P3377, DOI 10.1109/ICASSP.2013.6638284; Glorot X., 2011, P 14 INT C ART INT S, P315; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang G.B, 2008, TECHNICAL REPORT; Jain V., 2010, TECH REP; Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59; Krizhevsky A, 2009, THESIS U TORONTO TOR; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Li W, 2017, IEEE INT CONF AUTOMA, P103, DOI 10.1109/FG.2017.136; Llorca DF, 2013, IEEE INT C INTELL TR, P2229, DOI 10.1109/ITSC.2013.6728559; Luo Y, 2013, OPTIK, V124, P2767, DOI 10.1016/j.ijleo.2012.08.040; Masci J, 2011, LECT NOTES COMPUT SC, V6791, P52, DOI 10.1007/978-3-642-21735-7_7; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Oquab M, 2014, PROC CVPR IEEE, P1717, DOI 10.1109/CVPR.2014.222; Pang YW, 2011, SIGNAL PROCESS, V91, P773, DOI 10.1016/j.sigpro.2010.08.010; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sainath TN, 2013, INT CONF ACOUST SPEE, P8614, DOI 10.1109/ICASSP.2013.6639347; Sun R, 2009, LECT NOTES COMPUT SC, V5821, P318; Sun Y, 2013, PROC CVPR IEEE, P3476, DOI 10.1109/CVPR.2013.446; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; YANG S, 2016, PROC CVPR IEEE, P5525, DOI DOI 10.1109/CVPR.2016.596; Yang ZC, 2016, PROC CVPR IEEE, P21, DOI 10.1109/CVPR.2016.10; Zhang Y, 2016, IEEE T IMAGE PROCESS, V25, DOI 10.1109/TIP.2016.2549360; Zhao R, 2015, PROC CVPR IEEE, P1265, DOI 10.1109/CVPR.2015.7298731	28	4	5	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208497	10.1371/journal.pone.0208497	http://dx.doi.org/10.1371/journal.pone.0208497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540804	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600074
J	Schnabl-Feichter, E; Tichy, A; Gumpenberger, M; Bockstahler, B				Schnabl-Feichter, Eva; Tichy, Alexander; Gumpenberger, Michaels; Bockstahler, Barbara			Comparison of ground reaction force measurements in a population of Domestic Shorthair and Maine Coon cats	PLOS ONE			English	Article							DEGENERATIVE JOINT DISEASE; HIP-DYSPLASIA; GAIT ANALYSIS; PRESSURE; WALKING; ONYCHECTOMY; INDEXES; DOGS	Current research on gait analysis mostly involves horses and dogs. Feline kinetics and kinematics are being investigated and receiving more clinical interest at present. Ground reaction forces measured on pressure-sensitive mattresses have been established in healthy Domestic Shorthair cats (DSH). Currently, no further information exists on either breed-specific measured gait reaction forces or comparisons among breeds. Because Maine Coon (MC) cats appear to be over-represented with orthopaedic diseases of the hind limb (hip dysplasia, patellar luxation), we evaluated ground reaction force GRF measurements in MC cats and compared them with those of DSH cats. Pre-evaluation radiological and clinical exams determined that the cats were not lame. The parameters evaluated were peak vertical force (PFz), vertical impulse (lFz), time to PFz (TPFz), step length (SL), paw contact area (PCA), stance phase duration (SPD) and symmetry index (SI) for the fore- and hind limbs. In both breeds, PFz and IFz were greater in forelimbs than in hind limbs. The PFz and IFz in Newtons were higher in the MC cats compared to the DSH cats, but not after normalisation for total force (%TF) and body mass (%BM). Furthermore, due to their body conformation, MC cats have a longer SL, larger PCA, and higher body weight than DSH cats. No other parameters differed significantly, except that the TPFz displayed an earlier value in the MC hind limbs. Measured symmetry indices were similar to those reported in dogs and did not differ between breeds. This is the first study to report GRF values and temporospatial parameters in a healthy MC cat population. However, our results could not confirm differences between normalized PFz and IFz and temporospatial parameters between the breeds. The authors therefore conclude that genetic or other causes may be involved in orthopaedic hind limb pathogenesis seen in MC cats more often than in other breeds.	[Schnabl-Feichter, Eva] Univ Vet Med, Univ Clin Small Animals, Dept Compan Animals & Horses, Small Anim Surg, Veterinarpl, Vienna, Austria; [Tichy, Alexander] Univ Vet Med, Dept Biomed Sci, Platform Bioinformat & Biostat, Veterinarpl, Vienna, Austria; [Gumpenberger, Michaels] Univ Vet Med, Univ Clin Radiol, Dept Compan Animals & Horses, Veterinarpl, Vienna, Austria; [Bockstahler, Barbara] Univ Vet Med, Univ Clin Small Animals, Sect Phys Therapy, Dept Compan Animals & Horses,Small Anim Surg, Veterinarpl, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Schnabl-Feichter, E (corresponding author), Univ Vet Med, Univ Clin Small Animals, Dept Compan Animals & Horses, Small Anim Surg, Veterinarpl, Vienna, Austria.	eva.schnabl-feichter@vetmeduni.ac.at	Bockstahler, Barbara/P-3152-2019; Schnabl-Feichter, Eva/AAM-1050-2020	Bockstahler, Barbara/0000-0002-1499-5753; Schnabl-Feichter, Eva/0000-0003-1058-6511; Gumpenberger, Michaela/0000-0003-2412-0501				Agostinho FS, 2011, VET COMP ORTHOPAED, V24, P185, DOI 10.3415/VCOT-10-03-0039; Bertram JEA, 2000, AM J VET RES, V61, P832, DOI 10.2460/ajvr.2000.61.832; Borak D, 2017, J FELINE MED SURG, V19, P13, DOI [10.1177/1098612x15598551, 10.1177/1098612X15598551]; BUDSBERG SC, 1993, AM J VET RES, V54, P1569; Colborne GR, 2008, VET COMP ORTHOPAED, V21, P294; Corbee RJ, 2014, VET J, V202, P116, DOI 10.1016/j.tvjl.2014.07.001; Harting J, 1996, THESIS; Keller GG, 1999, VET RADIOL ULTRASOUN, V40, P460, DOI 10.1111/j.1740-8261.1999.tb00375.x; Kim J, 2011, AM J VET RES, V72, P1171, DOI 10.2460/ajvr.72.9.1171; Langenbach A, 1998, J AM VET MED ASSOC, V213, P1439; Lascelles BDX, 2007, VET REC, V160, P512, DOI 10.1136/vr.160.15.512; Lascelles BDX, 2010, VET SURG, V39, P535, DOI 10.1111/j.1532-950X.2010.00708.x; Lascelles BDX, 2006, AM J VET RES, V67, P277, DOI 10.2460/ajvr.67.2.277; McLaughlin RM, 2001, VET CLIN N AM-SMALL, V31, P193, DOI 10.1016/S0195-5616(01)50045-5; Molsa SH, 2010, VET SURG, V39, P701, DOI 10.1111/j.1532-950X.2010.00651.x; Oosterlinck M, 2011, AM J VET RES, V72, P820, DOI 10.2460/ajvr.72.6.820; Polzin IA, 2003, THESIS; Robinson DA, 2007, JAVMA-J AM VET MED A, V230, P353, DOI 10.2460/javma.230.3.353; Romans CW, 2005, JAVMA-J AM VET MED A, V227, P89, DOI 10.2460/javma.2005.227.89; Romans CW, 2004, AM J VET RES, V65, P1276, DOI 10.2460/ajvr.2004.65.1276; Schnabl E, 2015, VET J, V206, P83, DOI 10.1016/j.tvjl.2015.05.017; Schnabl-Feichter E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171946; Slingerland LI, 2011, VET J, V187, P304, DOI 10.1016/j.tvjl.2009.12.014; Smith GK, 1999, J AM VET MED ASSOC, V215, P40; Souza ANA, 2013, VET COMP ORTHOPAED, V26, P6, DOI 10.3415/VCOT-11-07-0100; Stadig S, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0248-x; Stadig SM, 2015, J FELINE MED SURG, V17, P523, DOI 10.1177/1098612X14551588; Verdugo MR, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-129; Voss K, 2010, VET SURG, V39, P863, DOI 10.1111/j.1532-950X.2010.00729.x	29	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208085	10.1371/journal.pone.0208085	http://dx.doi.org/10.1371/journal.pone.0208085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540817	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600056
J	Diederichs, C; Jordan, S; Domanska, O; Neuhauser, H				Diederichs, Claudia; Jordan, Susanne; Domanska, Olga; Neuhauser, Hannelore			Health literacy in men and women with cardiovascular diseases and its association with the use of health care services-Results from the population-based GEDA2014/2015-EHIS survey in Germany	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; LIFE-STYLE; HIGH-RISK; OUTCOMES; INTERVENTION; PREVENTION; SECONDARY; BENEFITS; ADULTS; SKILLS	Background Health literacy (HL), defined as the ability to access, understand, appraise and apply health information, offers a promising approach to reduce the development of cardiovascular diseases (CVD) and to improve the management of CVD in populations. Design We used data from nationwide cross-sectional German Health Update (GEDA2014/2015-EHIS) survey. 13,577 adults >= 40 years completed a comprehensive standardized paper or online questionnaire including the short form of the European Health Literacy Survey Questionnaire (HLS-EU-Q16). Methods We compared participants with and without CVD with regard to their HL. We also analyzed the association between HL level and health care outcomes among individuals with CVD, i.e. frequency of general practitioner or specialist consultations, hospitalization and treatment delay. Results The percentage of "problematic" or "inadequate" HL, defined as "not sufficient" HL, was significantly higher in individuals with CVD compared to without CVD (men 41.8% vs. 33.6%, women 46.7% vs. 33.4%). Having CVD was independently associated with "not sufficient" HL after adjusting for age, education, income, health consciousness and social support (adjusted OR: men 1.36, women 1.64). Among participants with CVD, individuals with "inadequate" HL were more likely to have more than 6 general practitioner consultations (49.3% vs. 28.7%), hospitalization (46.6% vs. 36.0%) in the last 12 months and to experience delay in getting health care because of long waiting lists for an appointment (30.7% vs. 18.5%) compared to participants with "sufficient" HL. Conclusion "Problematic" or "inadequate" HL is independently associated with CVD and health care use. This is a challenge and an opportunity for both CVD prevention and treatment.	[Diederichs, Claudia; Jordan, Susanne; Domanska, Olga; Neuhauser, Hannelore] Robert Koch Inst Berlin, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Diederichs, Claudia; Neuhauser, Hannelore] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany	Robert Koch Institute; German Centre for Cardiovascular Research	Diederichs, C (corresponding author), Robert Koch Inst Berlin, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.; Diederichs, C (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany.	Diederichs@rki.de		Neuhauser, Hannelore K./0000-0002-6605-6221; Jordan, Susanne/0000-0003-0721-1604	German Ministry of Health; DZHK (German Centre for Cardiovascular Research) [MDC2016Z4]	German Ministry of Health; DZHK (German Centre for Cardiovascular Research)	The GEDA2014/2015-EHIS Survey is primarily financed by the German Ministry of Health. The work was supported by the DZHK (German Centre for Cardiovascular Research), grant number MDC2016Z4.	Alm-Roijer Carin, 2004, Eur J Cardiovasc Nurs, V3, P321; Alsabbagh MHDW, 2014, VALUE HEALTH, V17, P288, DOI 10.1016/j.jval.2013.11.011; Altin SV, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1207; Baker DW, 1997, AM J PUBLIC HEALTH, V87, P1027, DOI 10.2105/AJPH.87.6.1027; Barber MN, 2009, HEALTH PROMOT INT, V24, P252, DOI 10.1093/heapro/dap022; Berens EM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3810-6; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Blanson-Henkeman OA, 2014, METHOD INFORM MED, V47, P82; Bosworth HB, 2005, PATIENT EDUC COUNS, V57, P5, DOI 10.1016/j.pec.2004.03.011; Cajita MI, 2016, J CARDIOVASC NURS, V31, P121, DOI 10.1097/JCN.0000000000000229; CARR W, 1976, INT J HEALTH SERV, V6, P417, DOI 10.2190/MCG0-UH8D-0AG8-VFNU; Castro-Sanchez E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022132; Cooney MT, 2009, EUR J CARDIOV PREV R, V16, P541, DOI 10.1097/HJR.0b013e32832b38a1; Dalmer NK, 2017, J MED LIBR ASSOC, V105, P61, DOI 10.5195/jmla.2017.108; Della Pelle C, 2018, J CLIN NURS, V27, P859, DOI 10.1111/jocn.14137; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Eurostat, 2018, HLTH VAR EU SILC 201; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gazmararian JA, 2003, PATIENT EDUC COUNS, V51, P267, DOI 10.1016/S0738-3991(02)00239-2; Gerich J, 2018, HEALTH COMMUN, V33, P254, DOI 10.1080/10410236.2016.1255846; GOULD SJ, 1990, AM J PREV MED, V6, P228, DOI 10.1016/S0749-3797(18)31009-2; Halbach SM, 2016, PATIENT EDUC COUNS, V99, P1511, DOI 10.1016/j.pec.2016.06.028; Haun JN, 2014, J HEALTH COMMUN, V19, P302, DOI 10.1080/10810730.2014.936571; Ishikawa H, 2008, HEALTH PROMOT INT, V23, P269, DOI 10.1093/heapro/dan017; Ishikawa H, 2008, DIABETES CARE, V31, P874, DOI 10.2337/dc07-1932; Jayasinghe UW, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0471-1; Jessup RL, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1973-6; Jordan JE, 2011, J CLIN EPIDEMIOL, V64, P366, DOI 10.1016/j.jclinepi.2010.04.005; Jordan S, 2017, HLTH LITERACY FORSCH; Jordan S, 2015, BUNDESGESUNDHEITSBLA, V58, P942, DOI 10.1007/s00103-015-2200-z; Kiechle ES, 2015, J GEN INTERN MED, V30, P1538, DOI 10.1007/s11606-015-3288-4; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P2007, DOI 10.1177/2047487316667784; Kurth BM, 2009, BUNDESGESUNDHEITSBLA, V52, P557, DOI 10.1007/s00103-009-0843-3; Lange C, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0208-6; Levy H, 2016, J HEALTH COMMUN, V21, P43, DOI 10.1080/10810730.2015.1131776; Liu K, 2012, CIRCULATION, V125, P996, DOI 10.1161/CIRCULATIONAHA.111.060681; Lloyd LLJ, 2006, HEALTH PROMOT PRACT, V7, P331, DOI 10.1177/1524839906289378; Mazor KM, 2012, PATIENT EDUC COUNS, V89, P69, DOI 10.1016/j.pec.2012.06.018; McLeod S, 2017, GERIATR NURS, P1; McNaughton CD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001799; Miller TA, 2016, PATIENT EDUC COUNS, V99, P1079, DOI 10.1016/j.pec.2016.01.020; Mitchell SE, 2012, J HEALTH COMMUN, V17, P325, DOI 10.1080/10810730.2012.715233; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2018, HEALTH PROMOT INT, V33, P901, DOI 10.1093/heapro/dax015; O'Neill B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109110; OECD, HLTH GLANC EUR 2016; Organization WH, 2009, GLOB HLTH RISKS MORT; Pelikan F., 2013, GESUNDHEITSKOMPETENZ; Pelikan JM, 2012, GANAHL K BEHALF EURO; Pelikan JM., 2014, 2 INT C HLTH LIT HLT; Peters RJG, 2017, NETH HEART J, V25, P407, DOI 10.1007/s12471-017-1001-4; Peterson PN, 2011, JAMA-J AM MED ASSOC, V305, P1695, DOI 10.1001/jama.2011.512; Quenzel G, 2015, BUNDESGESUNDHEITSBLA, V58, P951, DOI 10.1007/s00103-015-2201-y; Reading SR, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005128; Safeer RS, 2006, VASC HEALTH RISK MAN, V2, P457, DOI 10.2147/vhrm.2006.2.4.457; Sass AC, 2017, J HLTH MONITORING, V2; Schaeffer D, 2017, DTSCH ARZTEBL INT, V114, P53, DOI 10.3238/arztebl.2017.0053; Simonds SK, 1974, HLTH ED MONOGR, V2, P2; Song LX, 2012, CANCER-AM CANCER SOC, V118, P3842, DOI 10.1002/cncr.26713; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; TAGGART J, 2012, BMC FAM PRACT, V13; Tiller D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2210-7; van Schaik TM, 2017, NETH HEART J, V25, P446, DOI 10.1007/s12471-017-0963-6; Wang CL, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-153; Wangdahl J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1030; Weiss BD, 2004, J AM BOARD FAM PRACT, V17, P44, DOI 10.3122/jabfm.17.1.44; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Zok, 2014, WIDO MONITOR, V11, P1	69	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208303	10.1371/journal.pone.0208303	http://dx.doi.org/10.1371/journal.pone.0208303			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521588	Green Submitted, gold, Green Published			2022-12-26	WOS:000452307600044
J	Zanotto, T; Mercer, TH; van der Linden, ML; Traynor, JP; Petrie, CJ; Doyle, A; Chalmers, K; Allan, N; Price, J; Oun, H; Shilliday, I; Koufaki, P				Zanotto, Tobia; Mercer, Thomas H.; van der Linden, Marietta L.; Traynor, Jamie P.; Petrie, Colin J.; Doyle, Arthur; Chalmers, Karen; Allan, Nicola; Price, Jonathan; Oun, Hadi; Shilliday, Ilona; Koufaki, Pelagia			Baroreflex function, haemodynamic responses to an orthostatic challenge, and falls in haemodialysis patients	PLOS ONE			English	Article							BLOOD-PRESSURE; EFFECTIVENESS INDEX; RISK-FACTORS; MORTALITY; SENSITIVITY; ASSOCIATION; PREVENTION; DIAGNOSIS; ACCURACY; INJURIES	Background Stage 5 chronic kidney disease patients on haemodialysis (HD) often present with dizziness and pre-syncopal events as a result of the combined effect of HD therapy and cardiovascular disease. The dysregulation of blood pressure (BP) during orthostasis may be implicated in the aetiology of falls in these patients. Therefore, we explored the relationship between baroreflex function, the haemodynamic responses to a passive orthostatic challenge, and falls in HD patients. Methods Seventy-six HD patients were enrolled in this cross-sectional study. Participants were classified as "fallers" and "non-fallers" and completed a passive head up tilting to 60 degrees (HUT-60 degrees) test on an automated tilt table. ECG signals, continuous and oscillometric BP measurements and impedance cardiography were recorded. The following variables were derived from these measurements: heart rate (HR) stroke volume (SV), cardiac output (CO), total peripheral resistance (TPR), number of baroreceptor events, and baroreceptor effectiveness index (BEI). Results The forty-four participants who were classified as fallers (57.9%) had a lower number of baroreceptor events (6.5 +/- 8.5 vs 14 +/- 16.7, p = .027) and BEI (20.8 +/- 24.2% vs 33.4 +/- 23.3%, p = .025). In addition, fallers experienced a significantly larger drop in systolic (-6.4 +/- 10.9 vs -0.4 +/- 7.7 mmHg, p = .011) and diastolic (-2.7 +/- 7.3 vs 1.8 +/- 6 mmHg, p = .027) oscillometric BP from supine to HUT-60 degrees compared with non-fallers. None of the variables taken for the analysis were significantly associated with falls in multivariate logistic regression analysis. Conclusions This cross-sectional comparison indicates that, at rest, HD patients with a positive history of falls present with a lower count of baroreceptor sequences and BEI. Short-term BP regulation warrants further investigation as BP drops during a passive orthostatic challenge may be implicated in the aetiology of falls in HD.	[Zanotto, Tobia; Mercer, Thomas H.; van der Linden, Marietta L.; Koufaki, Pelagia] Queen Margaret Univ, Ctr Hlth Act & Rehabil Res, Edinburgh, Midlothian, Scotland; [Traynor, Jamie P.] Queen Elizabeth Univ Hosp, Renal & Transplant Unit, Glasgow, Lanark, Scotland; [Petrie, Colin J.] Monklands Hosp, Dept Cardiol, Airdrie, Scotland; [Doyle, Arthur; Chalmers, Karen; Allan, Nicola] Victoria Hosp, Renal Unit, Kirkcaldy, Scotland; [Price, Jonathan; Oun, Hadi; Shilliday, Ilona] Monklands Hosp, Renal Unit, Airdrie, Scotland	Queen Margaret University; Queen Elizabeth University Hospital (QEUH); Monklands Hospital; Monklands Hospital	Zanotto, T (corresponding author), Queen Margaret Univ, Ctr Hlth Act & Rehabil Res, Edinburgh, Midlothian, Scotland.	TZanotto@qmu.ac.uk		Zanotto, Tobia/0000-0002-6571-4763	British Kidney Patient Association - British Renal Society joint grant (BKPA-BRS) [16-003]	British Kidney Patient Association - British Renal Society joint grant (BKPA-BRS)	This work was supported by a British Kidney Patient Association - British Renal Society joint grant (BKPA-BRS grant number 16-003). PK, TZ, KC, and NA received funding from this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman EM, 2011, NEPHRON CLIN PRACT, V118, pC278, DOI 10.1159/000322275; Angelousi A, 2014, J HYPERTENS, V32, P1562, DOI 10.1097/HJH.0000000000000235; Brignole M, 2004, EUR HEART J, V25, P2054, DOI 10.1016/j.ehj.2004.09.004; Brittain JM, 2018, CLIN PHYSIOL FUNCT I, V38, P384, DOI 10.1111/cpf.12425; Cook WL, 2006, CLIN J AM SOC NEPHRO, V1, P1197, DOI 10.2215/CJN.01650506; Cooke J, 2009, QJM-INT J MED, V102, P335, DOI 10.1093/qjmed/hcp020; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Desmet C, 2005, AM J KIDNEY DIS, V45, P148, DOI 10.1053/j.ajkd.2004.09.027; Di Rienzo M, 2001, AM J PHYSIOL-REG I, V280, pR744, DOI 10.1152/ajpregu.2001.280.3.R744; Fisher VL, 2017, DIABET METAB SYND OB, V10, P419, DOI 10.2147/DMSO.S129797; Ganz DA, 2005, J AM GERIATR SOC, V53, P2190, DOI 10.1111/j.1532-5415.2005.00509.x; Gratze G, 1998, COMPUT BIOL MED, V28, P121, DOI 10.1016/S0010-4825(98)00005-5; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Hildreth CM, 2012, FRONT PHYSIOL, V2, P1, DOI DOI 10.3389/fphys.2011.00121; Hinghofer-Szalkay H, 2011, EUR J APPL PHYSIOL, V111, P163, DOI 10.1007/s00421-010-1646-9; Ilies C, 2012, BRIT J ANAESTH, V108, P202, DOI 10.1093/bja/aer394; Jeleazcov C, 2010, BRIT J ANAESTH, V105, P264, DOI 10.1093/bja/aeq143; Lopez-Soto PJ, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0173-7; Johansson M, 2007, J HYPERTENS, V25, P163, DOI 10.1097/01.hjh.0000254377.18983.eb; Khurana RK, 1996, CLIN AUTON RES, V6, P335, DOI 10.1007/BF02556304; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Li M, 2008, NEPHROL DIAL TRANSPL, V23, P1396, DOI 10.1093/ndt/gfm778; Mattace-Raso FUS, 2007, J HYPERTENS, V25, P1421, DOI 10.1097/HJH.0b013e32811d6a07; McAdams-DeMarco MA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-224; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Pasma JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106808; Penaz J, 1976, Z Gesamte Inn Med, V31, P1030; Pinna GD, 2000, EUR HEART J, V21, P1522, DOI 10.1053/euhj.1999.1948; Pitzalis M, 2003, J AM COLL CARDIOL, V41, P1167, DOI 10.1016/S0735-1097(03)00050-0; Polinder-Bos HA, 2014, NETH J MED, V72, P509; Roberts R, 2007, INT UROL NEPHROL, V39, P275, DOI 10.1007/s11255-006-9088-3; Roberts Russell G., 2003, International Urology and Nephrology, V35, P415, DOI 10.1023/B:UROL.0000022866.07751.4a; Schwartz CE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00461; Shaw BH, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0168-z; Tang ZH, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-8; Tinetti ME, 2014, JAMA INTERN MED, V174, P588, DOI 10.1001/jamainternmed.2013.14764; UK RENAL REGISTRY. UKRR, 2016, UK REN REG REP 19 AN; Wong AKW, 2014, J AM GERIATR SOC, V62, P1534, DOI 10.1111/jgs.12931; World Health Organization, 2008, GLOBAL REPORT FALLS	39	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208127	10.1371/journal.pone.0208127	http://dx.doi.org/10.1371/journal.pone.0208127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521545	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600027
J	Pel, J; Leung, A; Choi, WWY; Despotovic, M; Ung, WL; Shibahara, G; Gelinas, L; Marziali, A				Pel, Joel; Leung, Amy; Choi, Wendy W. Y.; Despotovic, Milenko; Ung, W. Lloyd; Shibahara, Gosuke; Gelinas, Laura; Marziali, Andre			Rapid and highly-specific generation of targeted DNA sequencing libraries enabled by linking capture probes with universal primers	PLOS ONE			English	Article							PCR; ENRICHMENT; MULTIPLEX; SELECTION	Targeted Next Generation Sequencing (NGS) is being adopted increasingly broadly in many research, commercial and clinical settings. Currently used target capture methods, however, typically require complex and lengthy (sometimes multi-day) workflows that complicates their use in certain applications. In addition, small panels for high sequencing depth applications such as liquid biopsy typically have low on-target rates, resulting in unnecessarily high sequencing cost. We have developed a novel targeted sequencing library preparation method, named Linked Target Capture (LTC), which replaces typical multi-day target capture workflows with a single-day, combined 'target-capture-PCR' workflow. This approach uses physically linked capture probes and PCR primers and is expected to work with panel sizes from 100 bp to >10 Mbp. It reduces the time and complexity of the capture workflow, eliminates long hybridization and wash steps and enables rapid library construction and target capture. High on-target read fractions are achievable due to repeated sequence selection in the target-capture-PCR step, thus lowering sequencing cost. We have demonstrated this technology on sample types including cell-free DNA (cfDNA) and formalin-fixed, paraffin-embedded (FFPE) derived DNA, capturing a 35 -gene pan-cancer panel, and therein detecting single nucleotide variants, copy number variants, insertions, deletions and gene fusions. With the integration of unique molecular identifiers (UMIs), variants as low as 0.25% abundance were detected, limited by input mass and sequencing depth. Additionally, sequencing libraries were prepared in less than eight hours from extracted DNA to loaded sequencer, demonstrating that LTC holds promise as a broadly applicable tool for rapid, cost-effective and high performance targeted sequencing.	[Pel, Joel; Leung, Amy; Choi, Wendy W. Y.; Despotovic, Milenko; Ung, W. Lloyd; Shibahara, Gosuke; Gelinas, Laura; Marziali, Andre] Boreal Genom Inc, Vancouver, BC, Canada; [Marziali, Andre] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada	University of British Columbia	Marziali, A (corresponding author), Boreal Genom Inc, Vancouver, BC, Canada.; Marziali, A (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada.	andre@phas.ubc.ca						Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; ALCAIDE M, 2017, SCI REP UK, V7; Alvarez-Cubero MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27819-x; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caruccio N, 2011, METHODS MOL BIOL, V733, P241, DOI 10.1007/978-1-61779-089-8_17; DAHL F, 2005, NUCLEIC ACIDS RES, V33; Dapprich J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2836-6; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Garcia-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20948; Gentalen E, 1999, NUCLEIC ACIDS RES, V27, P1485, DOI 10.1093/nar/27.6.1485; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; HOPMANS ES, 2014, NUCLEIC ACIDS RES, V42; Lee C, 2017, J MOL DIAGN, V19, P651, DOI 10.1016/j.jmoldx.2017.06.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mamanova L, 2011, NAT PROTOC, V6, P1736, DOI 10.1038/nprot.2011.399; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Satterfield BC, 2014, J MOL DIAGN, V16, P163, DOI 10.1016/j.jmoldx.2013.10.004; Schenk D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181062; Schmitt MW, 2015, NAT METHODS, V12, P423, DOI [10.1038/nmeth.3351, 10.1038/NMETH.3351]; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Stahlberg A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw224; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Underhill HR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006162; Wang Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03448-8; Ware JS, 2013, J CARDIOVASC TRANSL, V6, P94, DOI 10.1007/s12265-012-9401-8; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729	33	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208283	10.1371/journal.pone.0208283	http://dx.doi.org/10.1371/journal.pone.0208283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517195	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400087
J	Taniai, K; Arakawa, T; Maeda, T				Taniai, Kiyoko; Arakawa, Toru; Maeda, Taro			Traumatic insemination is not the case in three Orius species (Heteroptera: Anthocoridae)	PLOS ONE			English	Article							FEMALE COUNTER-ADAPTATION; SAUTERI POPPIUS; THYSANOPTERA; BUG; THRIPIDAE; CONFLICT	Traumatic insemination (TI) is an extraordinary style of mating behavior wherein the female integument is pierced by the male extragenital structure to transfer the spermatozoa into the female's body through wounding. Flower bugs of the genus Onus belong to the family Anthocoridae (Heteroptera), which is referred to as the "TI family". Males possess sharp shaped extragenitalia, and females receive the extragenitalia using the copulatory tubes, which are specialized extragenital structures in Onus species. Since TI is not well studied in insects possessing the copulatory tube, we examined the genital structures and copulatory processes of three species, Onus strigicollis, O. sauteri, and O. minutus. Scanning electron microscopic observations revealed the positions of male extragenital structures during copulation. A needle-like flagellum was deeply inserted into the female intersegment between the abdominal VII and VIII segments, while the curved part of a sickle-like cone forced the intersegment to expand. No scars were detected around the copulation region after copulation. The copulatory tube adhered to the interior of segment VII, and the interior integument around the copulatory tube remained intact after copulation. On the basis of these results, TI does not occur in these Orius species. A pair of seminal conceptacles, which exists in typical TI insects, was found at the base of the oviducts in O. strigicollis. The distal end of the copulatory tube connected to a closed bag with a double-membrane, termed the sperm pouch. The sperm pouch was filled with filamentous structures after copulation and structures with equivalent forms were observed in adult male testis. These structures, considered to be spermatozoa, persisted in the pouch for at least two weeks after copulation, suggesting that the pouch is a long-term spermatozoa storage organ.	[Taniai, Kiyoko; Arakawa, Toru; Maeda, Taro] Natl Agr & Food Res Org NARO, Div Insect Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan	Taniai, K (corresponding author), Natl Agr & Food Res Org NARO, Div Insect Sci, Tsukuba, Ibaraki, Japan.	taniai@affrc.go.jp		Taniai, Kiyoko/0000-0002-3460-2478; MAEDA, Taro/0000-0002-3558-8460				Backhouse A, 2012, BIOL LETTERS, V8, P706, DOI 10.1098/rsbl.2012.0091; Carayon J., 1966, MONOGRAPH CIMICIDAE, P81, DOI DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Cassis G., 1995, ZOOLOGICAL CATALOGUE, V27; Grimaldi David, 2005, pi; Hinomoto N, 2009, JARQ-JPN AGR RES Q, V43, P281, DOI 10.6090/jarq.43.281; HORTON D. R., 2008, ENCY ENTOMOLOGY, P2402, DOI DOI 10.1007/978-1-4020-6359-6_4633; Jung S, 2010, MOL PHYLOGENET EVOL, V57, P1173, DOI 10.1016/j.ympev.2010.09.013; Kamimura Y, 2007, BIOL LETTERS, V3, P401, DOI 10.1098/rsbl.2007.0192; Ke YL, 2007, EUR J ENTOMOL, V104, P89, DOI 10.14411/eje.2007.014; Kohno K, 1998, APPL ENTOMOL ZOOL, V33, P227, DOI 10.1303/aez.33.227; Lange R, 2013, BIOL REV, V88, P585, DOI 10.1111/brv.12018; Lattin JD, 1999, ANNU REV ENTOMOL, V44, P207, DOI 10.1146/annurev.ento.44.1.207; LESTON D, 1954, NATURE, V174, P91, DOI 10.1038/174091b0; Matsuda R., 1976, MORPHOLOGY EVOLUTION, P300; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Nagai K, 2000, APPL ENTOMOL ZOOL, V35, P565, DOI 10.1303/aez.2000.565; Ohno K, 1997, APPL ENTOMOL ZOOL, V32, P27, DOI 10.1303/aez.32.27; Peinert M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25052; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Reinhardt K, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017582; SCHUH RT, 1991, J NEW YORK ENTOMOL S, V99, P298; Sekine K, 2015, DEV BIOL, V399, P154, DOI 10.1016/j.ydbio.2014.12.027; Shapiro JP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.18901; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tatarnic NJ, 2010, J EVOLUTION BIOL, V23, P1321, DOI 10.1111/j.1420-9101.2010.01991.x; Tatarnic NJ, 2014, ANNU REV ENTOMOL, V59, P245, DOI 10.1146/annurev-ento-011613-162111	27	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206225	10.1371/journal.pone.0206225	http://dx.doi.org/10.1371/journal.pone.0206225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517107	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400010
J	Aloor, JJ; Azzam, KM; Guardiola, JJ; Gowdy, KM; Madenspacher, JH; Gabor, KA; Mueller, GA; Lin, WC; Lowe, JM; Gruzdev, A; Henderson, MW; Draper, DW; Merrick, BA; Fessler, MB				Aloor, Jim J.; Azzam, Kathleen M.; Guardiola, John J.; Gowdy, Kymberly M.; Madenspacher, Jennifer H.; Gabor, Kristin A.; Mueller, Geoffrey A.; Lin, Wan-Chi; Lowe, Julie M.; Gruzdev, Artiom; Henderson, Michael W.; Draper, David W.; Merrick, B. Alex; Fessler, Michael B.			Leucine-rich repeats and calponin homology containing 4 (Lrch4) regulates the innate immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; macrophage; lipid raft; toll-like receptor (TLR); lipopolysaccharide (LPS); leucine-rich repeat	TOLL-LIKE RECEPTORS; FREE-CHOLESTEROL; CD14 EXPRESSION; GENE-EXPRESSION; LIPID RAFTS; RECOGNITION; INFLAMMATION; BINDING; ACCUMULATION; MACROPHAGES	Toll-like receptors (TLRs) are pathogen-recognition receptors that trigger the innate immune response. Recent reports have identified accessory proteins that provide essential support to TLR function through ligand delivery and receptor trafficking. Herein, we introduce leucine-rich repeats (LRRs) and calponin homology containing 4 (Lrch4) as a novel TLR accessory protein. Lrch4 is a membrane protein with nine LRRs in its predicted ectodomain. It is widely expressed across murine tissues and has two expression variants that are both regulated by lipopolysaccharide (LPS). Predictive modeling indicates that Lrch4 LRRs conform to the horseshoe-shaped structure typical of LRRs in pathogen-recognition receptors and that the best structural match in the protein database is to the variable lymphocyte receptor of the jawless vertebrate hagfish. Silencing Lrch4 attenuates cytokine induction by LPS and multiple other TLR ligands and dampens the in vivo innate immune response. Lrch4 promotes proper docking of LPS in lipid raft membrane microdomains. We provide evidence that this is through regulation of lipid rafts as Lrch4 silencing reduces cell surface gangliosides, a metric of raft abundance, as well as expression and surface display of CD14, a raft-resident LPS co-receptor. Taken together, we identify Lrch4 as a broad-spanning regulator of the innate immune response and a potential molecular target in inflammatory disease.	[Aloor, Jim J.; Azzam, Kathleen M.; Guardiola, John J.; Gowdy, Kymberly M.; Madenspacher, Jennifer H.; Gabor, Kristin A.; Lin, Wan-Chi; Lowe, Julie M.; Henderson, Michael W.; Draper, David W.; Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Mueller, Geoffrey A.] NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Gruzdev, Artiom] NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Merrick, B. Alex] NIEHS, Natl Toxicol Program, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Aloor, Jim J.] East Carolina Univ, East Carolina Diabet & Obes Inst, Dept Physiol, Greenville, NC 27834 USA; [Gowdy, Kymberly M.] East Carolina Univ, Dept Pharmacol & Toxicol, Greenville, NC 27834 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Fessler, MB (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,POB 12233,MD D2-01, Res Triangle Pk, NC 27709 USA.	fesslerm@niehs.nih.gov	Mueller, Geoffrey A/I-2909-2017; Fessler, Michael B/C-6323-2019	Mueller, Geoffrey A/0000-0001-8361-5323; Fessler, Michael B/0000-0002-8262-8613; Henderson, Michael/0000-0001-9098-3853; Gowdy, Kymberly/0000-0002-7227-0697; Guardiola, John/0000-0002-4934-8628	Intramural Research Program of the NIEHS, National Institutes of Health [Z01 ES102005]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102005, ZICES102425] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant Z01 ES102005 from the Intramural Research Program of the NIEHS, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Blumenthal A, 2009, CELL HOST MICROBE, V5, P35, DOI 10.1016/j.chom.2008.12.002; Carpenter S, 2009, J IMMUNOL, V183, P3989, DOI 10.4049/jimmunol.0901518; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Di Gioia M, 2015, MOL IMMUNOL, V63, P143, DOI 10.1016/j.molimm.2014.05.008; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Foussard H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012257; Gale SC, 2014, J ALLERGY CLIN IMMUN, V134, P127, DOI 10.1016/j.jaci.2014.01.032; Gokhale NA, 2013, BIOCHEM J, V453, P413, DOI 10.1042/BJ20121528; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; Jha SS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-100; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Liu SB, 2000, GENE, V250, P137, DOI 10.1016/S0378-1119(00)00179-7; Liu SB, 2000, J LEUKOCYTE BIOL, V67, P894, DOI 10.1002/jlb.67.6.894; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Madenspacher JH, 2013, J EXP MED, V210, P891, DOI 10.1084/jem.20121674; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Rahimi AAR, 2005, J IMMUNOL, V174, P7823, DOI 10.4049/jimmunol.174.12.7823; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Sjoblom B, 2008, CURR OPIN STRUC BIOL, V18, P702, DOI 10.1016/j.sbi.2008.10.003; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Triantafilou M, 2002, J CELL SCI, V115, P2603; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	52	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1997	2008		10.1074/jbc.RA118.004300	http://dx.doi.org/10.1074/jbc.RA118.004300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30523158	hybrid, Green Published			2022-12-26	WOS:000459711400019
J	Duzel, S; Buchmann, N; Drewelies, J; Gerstort, D; Lindenberger, U; Steinhagen-Thiessen, E; Norman, K; Demuth, I				Duezel, Sandra; Buchmann, Nikolaus; Drewelies, Johanna; Gerstort, Denis; Lindenberger, Ulman; Steinhagen-Thiessen, Elisabeth; Norman, Kristina; Demuth, Ilja			Validation of a single factor representing the indicators of metabolic syndrome as a continuous measure of metabolic load and its association with health and cognitive function	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; NUTRITION EXAMINATION SURVEY; HAND GRIP STRENGTH; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; LUNG-FUNCTION; FIT INDEXES; RISK; ADOLESCENTS	The metabolic syndrome (MetS) is a cluster of risk factors for cardiovascular disease associated with reduced physical fitness, higher disease burden, and impaired cognitive functions. Little is known about the operation of these risk factors in older adults when considered comprehensively without relying on the cut-off values of the single MetS components. The three main aims of the current study were to: (i) establish a latent metabolic load factor (MetL), using confirmatory factor analysis (CFA), and representing a continuous measure of MetL, defined by indicators that are commonly used to separate MetS groups from healthy individuals; (ii) examine the associations of this MetL factor with objective health, and cognitive function in men and women; (iii) compare the magnitude of these associations to those observed for the individual indicators used to define the MetL factor as well to the classical categorized MetS vs. non-MetS groups. The current analysis is based on cross-sectional data from 1,609 participants of the Berlin Aging Study II (mean age = 68.5 years, SD (3.7); 50.1% female). We applied structural equation modeling (SEM) to establish a latent MetL factor defined by the five indicators commonly used to diagnose MetS. The latent MetL factor was associated with physician-assessed morbidity and kidney function (estimated glomerular filtration rate, eGFR) in both men and women, but not with hand grip strength and lung function (Forced Expiratory Volume in 1 Second (FEV1)). In addition, we found a negative association between MetL and fluid intelligence among men. A continuous latent variable approach representing the common variance of MetS indicators is well suited to foster our understanding of human aging as a systemic phenomenon in which risk factors are operating on either side of the normal versus pathological divide.	[Duezel, Sandra; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Buchmann, Nikolaus; Steinhagen-Thiessen, Elisabeth; Norman, Kristina; Demuth, Ilja] Charite Univ Med Berlin, Berlin, Germany; [Buchmann, Nikolaus; Steinhagen-Thiessen, Elisabeth; Norman, Kristina; Demuth, Ilja] Free Univ Berlin, Berlin, Germany; [Buchmann, Nikolaus; Drewelies, Johanna; Gerstort, Denis; Steinhagen-Thiessen, Elisabeth; Norman, Kristina; Demuth, Ilja] Humboldt Univ, Berlin, Germany; [Buchmann, Nikolaus; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Lipid Clin Interdisciplinary Metab Ctr, Berlin Inst Hlth, Berlin, Germany; [Norman, Kristina] Berlin Inst Hlth, Res Grp Geriatr, Berlin, Germany; [Norman, Kristina] German Inst Nutr Potsdam Rehbrucke, Dept Nutr & Gerontol, Nuthetal, Germany; [Demuth, Ilja] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Med BCRT, Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Demuth, I (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Demuth, I (corresponding author), Free Univ Berlin, Berlin, Germany.; Demuth, I (corresponding author), Humboldt Univ, Berlin, Germany.; Demuth, I (corresponding author), Lipid Clin Interdisciplinary Metab Ctr, Berlin Inst Hlth, Berlin, Germany.; Demuth, I (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Med BCRT, Berlin, Germany.	ilja.demuth@charite.de	Demuth, Ilja/ABD-5352-2021	Demuth, Ilja/0000-0002-4340-2523; Buchmann, Nikolaus/0000-0002-4345-3515; Duezel, Sandra/0000-0001-7179-2664; Gerstorf, Denis/0000-0002-2133-9498; Norman, Kristina/0000-0003-2029-9102; Drewelies, Johanna/0000-0002-3774-2169	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [16SV5536K, 16SV5537, 16SV5538, 16SV5837, 01UW0808, 01GL1716A, 01GL1716B]; Max Planck Institute for Human Development, Berlin, Germany	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Institute for Human Development, Berlin, Germany	The BASE-II research project (Co-PIs are Lars Bertram, Ilja Demuth, Denis Gerstorf, Ulman Lindenberger, Graham Pawelec, Elisabeth Steinhagen-Thiessen, and Gert G. Wagner) is supported by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) under grant numbers #16SV5536K, #16SV5537, #16SV5538, #16SV5837, #01UW0808, 01GL1716A and 01GL1716B. Another source of funding is the Max Planck Institute for Human Development, Berlin, Germany. Additional contributions (e.g., equipment, logistics, personnel) are made from each of the other participating sites. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2016, DIABETES RES CLIN PR, V120, P156, DOI 10.1016/j.diabres.2016.07.024; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KG, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; Bertram L, 2014, INT J EPIDEMIOL, V43, P703, DOI 10.1093/ije/dyt018; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Buchmann N, STEINHAGEN THIESSEN; Buchmann N, 2016, J GERONTOL A-BIOL, V71, P265, DOI 10.1093/gerona/glv089; Cassis LA, 2008, CURR HYPERTENS REP, V10, P93, DOI 10.1007/s11906-008-0019-9; Cavalier M, 2010, DIABETES CARE, V33, P2489, DOI 10.2337/dc10-0851; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Dik MG, 2007, DIABETES CARE, V30, P2655, DOI 10.2337/dc06-1190; Dodd JW, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0116-3; Eckardt R., 2015, Z GERONTOL GERIATR, P1; Eckstein N, 2016, GERONTOLOGY, V62, P337, DOI 10.1159/000434678; Esler M, 2002, AM J PHYSIOL-REG I, V282, pR909, DOI 10.1152/ajpregu.00335.2001; Fitzpatrick SL, 2013, DIABETES CARE, V36, P436, DOI 10.2337/dc12-0828; Ford ES, 2014, J DIABETES, V6, P603, DOI 10.1111/1753-0407.12136; Gerstorf D, 2016, GERONTOLOGY, V62, P311, DOI 10.1159/000441495; Haley AP, 2010, METAB BRAIN DIS, V25, P397, DOI 10.1007/s11011-010-9221-y; Hanley AJG, 2002, DIABETES, V51, P2642, DOI 10.2337/diabetes.51.8.2642; Hassenstab JJ, 2010, DEMENT GERIATR COGN, V29, P356, DOI 10.1159/000296071; Hill K, 2010, CAN MED ASSOC J, V182, P673, DOI 10.1503/cmaj.091784; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Infurna FJ, 2013, PSYCHOL AGING, V28, P1147, DOI 10.1037/a0033327; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Li CY, 2007, DIABETES CARE, V30, P1556, DOI 10.2337/dc06-2481; Little TD, 1999, PSYCHOL METHODS, V4, P192, DOI 10.1037/1082-989X.4.2.192; Llabre MM, 2015, ANN EPIDEMIOL, V25, P480, DOI 10.1016/j.annepidem.2015.02.010; Magnussen C, 2017, INT J CARDIOL, V234, P64, DOI 10.1016/j.ijcard.2017.02.012; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Meyer A, 2016, AM J CLIN NUTR, V103, P178, DOI 10.3945/ajcn.115.116806; Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Pottel H, 2016, NEPHROL DIAL TRANSPL, V31, P798, DOI 10.1093/ndt/gfv454; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Sayer AA, 2007, QJM-INT J MED, V100, P707, DOI 10.1093/qjmed/hcm095; Schermelleh-Engel K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00181; Schuur M, 2010, EUR J EPIDEMIOL, V25, P561, DOI 10.1007/s10654-010-9476-y; Shen BJ, 2003, AM J EPIDEMIOL, V157, P701, DOI 10.1093/aje/kwg045; Song H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113450; Strange RC, 2015, WORLD J DIABETES, V6, P896, DOI 10.4239/wjd.v6.i7.896; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Taylor VH, 2007, OBES REV, V8, P409, DOI 10.1111/j.1467-789X.2007.00401.x; Tournoy J, 2010, DIABETES-METAB RES, V26, P668, DOI 10.1002/dmrr.1144; Vasconcellos F, 2014, SPORTS MED, V44, P1139, DOI 10.1007/s40279-014-0193-7; Viitasalo A, 2014, DIABETOLOGIA, V57, P940, DOI 10.1007/s00125-014-3172-5; World Health Organization, 2003, WHO INT DIAB FED M G; Yaffe K, 2007, ALZ DIS ASSOC DIS, V21, P167, DOI 10.1097/WAD.0b013e318065bfd6; Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759; Yoon HE, 2014, KOREAN J INTERN MED, V29, P291, DOI 10.3904/kjim.2014.29.3.291	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208231	10.1371/journal.pone.0208231	http://dx.doi.org/10.1371/journal.pone.0208231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540802	gold, Green Published			2022-12-26	WOS:000452898600065
J	Mosconi, L; Rahman, A; Diaz, I; Wu, X; Scheyer, O; Hristov, HW; Vallabhajosula, S; Isaacson, RS; de Leon, MJ; Brinton, RD				Mosconi, Lisa; Rahman, Aneela; Diaz, Ivan; Wu, Xian; Scheyer, Olivia; Hristov, Hollie Webb; Vallabhajosula, Shankar; Isaacson, Richard S.; de Leon, Mony J.; Brinton, Roberta Diaz			Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study	PLOS ONE			English	Article							APOLIPOPROTEIN-E; HYPOTHETICAL MODEL; SEX-DIFFERENCES; DISEASE; ESTROGEN; GENDER; PERIMENOPAUSE; ESTRADIOL; THERAPY; DECLINE	Two thirds of all persons with late-onset Alzheimer's disease (AD) are women. Identification of sex-based molecular mechanisms underpinning the female-based prevalence of AD would advance development of therapeutic targets during the prodromal AD phase when prevention or delay in progression is most likely to be effective. This 3-year brain imaging study examines the impact of the menopausal transition on Alzheimer's disease (AD) biomarker changes [brain beta-amyloid load via C-11-PiB PET, and neurodegeneration via F-18-FDG PET and structural MRI] and cognitive performance in midlife. Fifty-nine 40-60 year old cognitively normal participants with clinical, neuropsychological, and brain imaging exams at least 2 years apart were examined. These included 41 women [15 premenopausal controls (PRE), 14 perimenopausal (PERI), and 12 postmenopausal women (MENO)] and 18 men. We used targeted minimum loss-based estimation to evaluate AD biomarker and cognitive changes. Older age was associated with baseline A beta and neurodegeneration markers, but not with rates of change in these biomarkers. APOE4 status influenced change in A beta load, but not neurodegenerative changes. Longitudinally, MENO and PERI groups showed declines in estrogen-dependent memory tests as compared to men (p<.04). Adjusting for age, APOE4 status, and vascular risk confounds, the MENO and PERI groups exhibited higher rates of CMRgIc decline as compared to males (p <=.015). The MENO group exhibited the highest rate of hippocampal volume loss (p's <=.001), and higher rates of A beta deposition than males (p<.01). CMRgIc decline exceeded AP and atrophy changes in all female groups vs. men. These findings indicate emergence and progression of a female specific hypometabolic AD-endophenotype during the menopausal transition. These findings suggest that the optimal window of opportunity for therapeutic intervention to prevent or delay progression of AD endophenotype in women is early in the endocrine aging process.	[Mosconi, Lisa; Rahman, Aneela; Scheyer, Olivia; Hristov, Hollie Webb; Isaacson, Richard S.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Mosconi, Lisa; de Leon, Mony J.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Diaz, Ivan; Wu, Xian] Weill Cornell Med, Dept Healthcare Policy & Res, Div Biostat & Epidemiol, New York, NY USA; [Vallabhajosula, Shankar] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Brinton, Roberta Diaz] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Brinton, Roberta Diaz] Univ Arizona, Coll Med, Dept Neurol, Tucson, AZ USA	Cornell University; New York University; Cornell University; Cornell University; University of Arizona; University of Arizona	Mosconi, L (corresponding author), Weill Cornell Med Coll, Dept Neurol, New York, NY USA.; Mosconi, L (corresponding author), NYU, Sch Med, Dept Psychiat, New York, NY USA.	lim2035@med.cornell.edu	Díaz, Iván/ABG-1090-2021; de Leon, Mony/AAP-7890-2021	Díaz, Iván/0000-0001-9056-2047; Brinton, Roberta/0000-0001-8450-772X; de Leon, Mony/0000-0003-2245-4380	National Institutes of Health/National Institute on Aging (NIH/NIA) [AG035137, 2P01AG026572, AG057931]; Cure Alzheimer's Fund; NATIONAL INSTITUTE ON AGING [P01AG026572, R01AG057931] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cure Alzheimer's Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health/National Institute on Aging (NIH/NIA) grants AG035137 to LM, 2P01AG026572 to RDB, AG057931 to LM/RDB; Cure Alzheimer's Fund grant to LM; and philanthropic support to the Alzheimer's Prevention Clinic, Weill Cornell Memory Disorders program. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Espeland MA, 2015, NEUROLOGY, V85, P1131, DOI 10.1212/WNL.0000000000001816; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Ferretti MT, 2018, NATURE REV NEUROLOGY, V1, DOI [10.1038/nrneurol.2017.163, DOI 10.1038/NRNEUROL.2017.163]; Fleisher A, 2005, ARCH NEUROL-CHICAGO, V62, P953, DOI 10.1001/archneur.62.6.953; Greendale GA, 2011, OBSTET GYN CLIN N AM, V38, P519, DOI 10.1016/j.ogc.2011.05.007; Harlow SD, 2012, MENOPAUSE, V19, P387, DOI 10.1097/gme.0b013e31824d8f40; Hodis HN, 2015, MENOPAUSE, V22, P391, DOI [10.1097/GME.0000000000000343, 10.1097/gme.0000000000000343]; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kivipelto M, 2018, NATURE REV NEUROLOGY, V1, DOI [10.1038/nrneurol.2017.163, DOI 10.1038/NRNEUROL.2017.163]; Maki PM, 2016, MENOPAUSE, V23, P803, DOI 10.1097/GME.0000000000000681; Maki PM, 2000, NEUROBIOL AGING, V21, P373, DOI 10.1016/S0197-4580(00)00123-8; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mosconi L, 2010, P NATL ACAD SCI USA; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185926; Mosconi L, 2017, NEUROLOGY, V89, P1382, DOI 10.1212/WNL.0000000000004425; Mosconi L, 2014, NEUROLOGY, V82, P752, DOI 10.1212/WNL.0000000000000181; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Rasgon NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089095; Rasgon NL, 2011, NEUROBIOL AGING, V32, P1942, DOI 10.1016/j.neurobiolaging.2009.12.005; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Rentz DM, 2017, MENOPAUSE, V24, P400, DOI 10.1097/GME.0000000000000771; Rettberg JR, 2016, NEUROBIOL AGING, V40, P155, DOI 10.1016/j.neurobiolaging.2016.01.011; Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Santoro N, 2011, OBSTET GYN CLIN N AM, V38, pXVII, DOI 10.1016/j.ogc.2011.07.002; Sherwin BB, 1996, OBSTET GYNECOL, V87, pS20, DOI 10.1016/0029-7844(95)00431-9; Silverman DHS, 2011, PSYCHONEUROENDOCRINO, V36, P502, DOI 10.1016/j.psyneuen.2010.08.002; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ungar L, 2014, BRAIN IMAGING BEHAV, V8, P262, DOI 10.1007/s11682-013-9272-x; van der Laan M. J., 2012, INT J BIOSTAT, V8; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Vlassenko AG, 2011, ANN NEUROL, V70, P857, DOI 10.1002/ana.22608; Yao J, 2012, NEUROBIOL AGING, V33, P1507, DOI 10.1016/j.neurobiolaging.2011.03.001; Yin F, 2015, NEUROBIOL AGING, V36, P2282, DOI 10.1016/j.neurobiolaging.2015.03.013	46	61	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207885	10.1371/journal.pone.0207885	http://dx.doi.org/10.1371/journal.pone.0207885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540774	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600042
J	Shi, MS; Ellingsen, O; Bathen, TF; Hoydal, MA; Koch, LG; Britton, SL; Wisloff, U; Stolen, TO; Esmaeili, M				Shi, Mingshu; Ellingsen, Oyvind; Bathen, Tone Frost; Hoydal, Morten A.; Koch, Lauren G.; Britton, Steven L.; Wisloff, Ulrik; Stolen, Tomas O.; Esmaeili, Morteza			Skeletal muscle metabolism in rats with low and high intrinsic aerobic capacity: Effect of aging and exercise training	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; ARTIFICIAL SELECTION; CALORIE RESTRICTION; PROLONGED EXERCISE; INSULIN-SECRETION; RUNNING CAPACITY; HEART-FAILURE; AMINO-ACID; AGE; INTENSITY	Purpose Exercise training increases aerobic capacity and is beneficial for health, whereas low aerobic exercise capacity is a strong independent predictor of cardiovascular disease and premature death. The purpose of the present study was to determine the metabolic profiles in a rat model of inborn low versus high capacity runners (LCR/HCR) and to determine the effect of inborn aerobic capacity, aging, and exercise training on skeletal muscle metabolic profile. Methods LCR/HCR rats were randomized to high intensity low volume interval treadmill training twice a week or sedentary control for 3 or 11 months before they were sacrificed, at 9 and 18 months of age, respectively. Magnetic resonance spectra were acquired from soleus muscle extracts, and partial least square discriminative analysis was used to determine the differences in metabolic profile. Results Sedentary HCR rats had 54% and 30% higher VO2max compared to sedentary LCR rats at 9 months and 18 months, respectively. In HCR, exercise increased running speed significantly, and VO2max was higher at age of 9 months, compared to sedentary counterparts. In LCR, changes were small and did not reach the level of significance. The metabolic profile was significantly different in the LCR sedentary group compared to the HCR sedentary group at the age of 9 and 18 months, with higher glutamine and glutamate levels (9 months) and lower lactate level (18 months) in HCR. Irrespective of fitness level, aging was associated with increased soleus muscle concentrations of glycerophosphocholine and glucose. Interval training did not influence metabolic profiles in LCR or HCR rats at any age. Conclusion Differences in inborn aerobic capacity gave the most marked contrasts in metabolic profile, there were also some changes with ageing. Low volume high intensity interval training twice a week had no detectable effect on metabolic profile.	[Shi, Mingshu; Ellingsen, Oyvind; Bathen, Tone Frost; Hoydal, Morten A.; Wisloff, Ulrik; Stolen, Tomas O.; Esmaeili, Morteza] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Ellingsen, Oyvind; Hoydal, Morten A.; Stolen, Tomas O.] St Olays Hosp, Clin Cardiol, Trondheim, Norway; [Hoydal, Morten A.; Stolen, Tomas O.] St Olays Hosp, Clin Cardiothorac Surg, Trondheim, Norway; [Koch, Lauren G.] Univ Toledo, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Britton, Steven L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wisloff, Ulrik] Univ Queensland, Sch Human Movement & Nutr Sci, St Lucia, Qld, Australia	Norwegian University of Science & Technology (NTNU); University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Queensland	Ellingsen, O (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway.; Ellingsen, O (corresponding author), St Olays Hosp, Clin Cardiol, Trondheim, Norway.	oyvind.ellingsen@ntnu.no	Høydal, Morten A/K-2806-2012	Høydal, Morten A/0000-0003-1804-2578; Stolen, Tomas/0000-0002-2190-9948; Esmaeili, Morteza/0000-0003-0686-3571	UNIKARD [10396700]; Liaison Committee [46056808]; Norwegian Health Association [47091600]; Office of Research Infrastructure Programs/OD [ROD012098A]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD021331] Funding Source: NIH RePORTER	UNIKARD; Liaison Committee; Norwegian Health Association; Office of Research Infrastructure Programs/OD; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by UNIKARD, 10396700 http://unikard.org/(UW, TOS) the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology, 46056808 https://helse-midt.no/samarbeidsorganet (TFB); Norwegian Health Association, 47091600, http://nasjonalforeningen.no/(TOS, emptysetE); the Office of Research Infrastructure Programs/OD, ROD012098A, https://orip.nih.gov/(LGK, SLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva-Andany M, 2014, MITOCHONDRION, V17, P76, DOI 10.1016/j.mito.2014.05.007; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Basu R, 2006, DIABETES, V55, P2001, DOI 10.2337/db05-1692; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Cairns SP, 2006, SPORTS MED, V36, P279, DOI 10.2165/00007256-200636040-00001; Chapleau MW, 2014, EXP PHYSIOL, V99, P607, DOI 10.1113/expphysiol.2013.074294; Cochran AJR, 2014, EXP PHYSIOL, V99, P782, DOI 10.1113/expphysiol.2013.077453; DELPRATO S, 1993, J CLIN INVEST, V91, P484, DOI 10.1172/JCI116226; Fang ZY, 2005, DIABETES CARE, V28, P1643, DOI 10.2337/diacare.28.7.1643; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Garvey SM, 2014, BIOGERONTOLOGY, V15, P217, DOI 10.1007/s10522-014-9492-5; Gheller BJF, 2016, ANNU REV NUTR, V36, P129, DOI 10.1146/annurev-nutr-071715-050901; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; GOLAY A, 1988, DIABETOLOGIA, V31, P585, DOI 10.1007/BF00264764; Gosselin R, 2010, CHEMOMETR INTELL LAB, V100, P12, DOI 10.1016/j.chemolab.2009.09.005; HANSEN C, 1984, ALCOHOL CLIN EXP RES, V8, P477, DOI 10.1111/j.1530-0277.1984.tb05706.x; HENRIKSSON J, 1991, J EXP BIOL, V160, P149; Johannsen DL, 2012, J CLIN ENDOCR METAB, V97, P242, DOI 10.1210/jc.2011-1798; Karaman Ibrahim, 2017, Adv Exp Med Biol, V965, P145, DOI 10.1007/978-3-319-47656-8_6; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; Kivela R, 2010, FASEB J, V24, P4565, DOI 10.1096/fj.10-157313; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; LEMON PWR, 1980, J APPL PHYSIOL, V48, P624, DOI 10.1152/jappl.1980.48.4.624; Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8; MACLEAN DA, 1991, J APPL PHYSIOL, V70, P2095, DOI 10.1152/jappl.1991.70.5.2095; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; Mourtzakis M, 2006, J APPL PHYSIOL, V100, P1822, DOI 10.1152/japplphysiol.00571.2005; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nielsen JJ, 2004, J PHYSIOL-LONDON, V554, P857, DOI 10.1113/jphysiol.2003.050658; Nilsen LH, 2014, J CEREBR BLOOD F MET, V34, P906, DOI 10.1038/jcbfm.2014.37; Palpant NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006117; Pan H, 2019, EXP CLIN ENDOCR DIAB, V127, P557, DOI 10.1055/a-0672-0908; Park S, 2006, EXP GERONTOL, V41, P837, DOI 10.1016/j.exger.2006.06.055; Pastoris O, 2000, EXP GERONTOL, V35, P95, DOI 10.1016/S0531-5565(99)00077-7; Petersen KF, 2015, P NATL ACAD SCI USA, V112, P11330, DOI 10.1073/pnas.1514844112; Phielix E, 2008, PHYSIOL BEHAV, V94, P252, DOI 10.1016/j.physbeh.2008.01.020; Ramos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131766; Rivas DA, 2011, AM J PHYSIOL-REG I, V300, pR835, DOI 10.1152/ajpregu.00659.2010; Rodriguez DA, 2014, RESP MED, V108, P745, DOI 10.1016/j.rmed.2014.02.004; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; Sato T, 2015, J AGR FOOD CHEM, V63, P8192, DOI 10.1021/acs.jafc.5b03811; Sato T, 2013, J NUTR SCI VITAMINOL, V59, P412, DOI 10.3177/jnsv.59.412; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Suarez J, 2018, J BIOL CHEM, V293, P8182, DOI 10.1074/jbc.RA118.002066; Svedenkrans J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161314; Swank AM, 2012, CIRC-HEART FAIL, V5, P579, DOI 10.1161/CIRCHEARTFAILURE.111.965186; Szendroedi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021846; Tomasi G, 2011, J CHROMATOGR A, V1218, P7832, DOI 10.1016/j.chroma.2011.08.086; Valkovic L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20087; Wang HY, 2016, J GERONTOL A-BIOL, V71, P323, DOI 10.1093/gerona/glv142; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wisloff U, 2006, EUR J CARDIOV PREV R, V13, P798, DOI 10.1097/01.hjr.0000216548.84560.ac; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Woo JS, 2006, J AM COLL CARDIOL, V47, P1049, DOI 10.1016/j.jacc.2005.09.066	59	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208703	10.1371/journal.pone.0208703	http://dx.doi.org/10.1371/journal.pone.0208703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533031	Green Submitted, gold, Green Published			2022-12-26	WOS:000452782500029
J	Coccurello, R; Nazio, F; Rossi, C; De Angelis, F; Vacca, V; Giacovazzo, G; Procacci, P; Magnaghi, V; Ciavardelli, D; Marinelli, S				Coccurello, Roberto; Nazio, Francesca; Rossi, Claudia; De Angelis, Federica; Vacca, Valentina; Giacovazzo, Giacomo; Procacci, Patrizia; Magnaghi, Valerio; Ciavardelli, Domenico; Marinelli, Sara			Effects of caloric restriction on neuropathic pain, peripheral nerve degeneration and inflammation in normometabolic and autophagy defective prediabetic Ambra1 mice	PLOS ONE			English	Article							SCHWANN-CELL AUTOPHAGY; INSULIN-RESISTANCE; ACYLCARNITINE PROFILES; PLASMA ACYLCARNITINES; ACTIVATION; EXPRESSION; OBESITY; STRESS; LIFE; RAT	There is a growing interest on the role of autophagy in diabetes pathophysiology, where development of neuropathy is one of the most frequent comorbidities. We have previously demonstrated that neuropathic pain after nerve damage is exacerbated in autophagy-defective heterozygous Ambra1 mice. Here, we show the existence of a prediabetic state in Ambra1 mice, characterized by hyperglycemia, intolerance to glucose and insulin resistance. Thus, we further investigate the hypothesis that prediabetes may account for the exacerbation of allodynia and chronic pain and that counteracting the autophagy deficit may relieve the neuropathic condition. We took advantage from caloric restriction (CR) able to exert a double action: a powerful increase of autophagy and a control on the metabolic status. We found that CR ameliorates neuropathy throughout anti-inflammatory and metabolic mechanisms both in Ambra1 and in WT animals subjected to nerve injury. Moreover, we discovered that nerve lesion represents, per se, a metabolic stressor and CR reinstates glucose homeostasis, insulin resistance, incomplete fatty acid oxidation and energy metabolism. As autophagy inducer, CR promotes and anticipates Schwann cell autophagy via AMP-activated protein kinase (AMPK) that facilitates remyelination in peripheral nerve. In summary, we provide new evidence for the role of autophagy in glucose metabolism and identify in energy depletion by dietary restriction a therapeutic approach in the fight against neuropathic pain.	[Coccurello, Roberto; Vacca, Valentina; Giacovazzo, Giacomo; Marinelli, Sara] CNR, Natl Res Council, Inst Cell Biol & Neurobiol, Rome, Italy; [Coccurello, Roberto; Nazio, Francesca; De Angelis, Federica; Vacca, Valentina; Giacovazzo, Giacomo; Marinelli, Sara] IRCCS S Lucia Fdn, Rome, Italy; [Rossi, Claudia] G dAnnunzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Rossi, Claudia; Ciavardelli, Domenico] Ctr Sci Invecchiamento & Med Traslaz CeSI MeT, Chieti, Italy; [Procacci, Patrizia] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Magnaghi, Valerio] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Ciavardelli, Domenico] Kore Univ Enna, Sch Human & Social Sci, Enna, Italy; [Nazio, Francesca] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol & Oncol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara; University of Milan; University of Milan; Universita Kore di ENNA; IRCCS Bambino Gesu	Marinelli, S (corresponding author), CNR, Natl Res Council, Inst Cell Biol & Neurobiol, Rome, Italy.	sara.marinelli@cnr.it	Marinelli, Sara/L-7738-2019; de angelis, federica/AAG-3425-2020; Coccurello, Roberto/F-8460-2015; Nazio, Francesca/K-5272-2014; De Angelis, Federica/P-6426-2018; Vacca, Valentina/J-6643-2018	Marinelli, Sara/0000-0001-5393-4796; Nazio, Francesca/0000-0002-3039-4448; Giacovazzo, Giacomo/0000-0001-7430-2835; De Angelis, Federica/0000-0001-5773-3414; Vacca, Valentina/0000-0003-2657-0450	Italian Ministry of Health - Young Researchers grant [GR-2011-02346912]	Italian Ministry of Health - Young Researchers grant	This work was supported by Italian Ministry of Health - Young Researchers grant GR-2011-02346912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Bonomini M, 2013, AM J KIDNEY DIS, V62, P929, DOI 10.1053/j.ajkd.2013.04.007; Coccurello R, 2017, EUR J NUTR, V56, P1; Delaney CL, 2001, J NEUROPATH EXP NEUR, V60, P147, DOI 10.1093/jnen/60.2.147; Di Liberato L, 2014, J NEPHROL, V27, P699, DOI 10.1007/s40620-014-0076-x; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Dubovy P, 2011, ANN ANAT, V193, P267, DOI 10.1016/j.aanat.2011.02.011; Eldin WS, 2008, INT J CLIN PRACT, V62, P642, DOI 10.1111/j.1742-1241.2008.01705.x; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Giacovazzo G, 2018, PURINERG SIGNAL, V14, P299, DOI 10.1007/s11302-018-9610-y; Giesbertz P, 2016, CURR OPIN CLIN NUTR, V19, P48, DOI 10.1097/MCO.0000000000000235; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Hao W, 2015, J BIOL CHEM, V290, P17106, DOI 10.1074/jbc.M114.631291; Heimburger DC, 2006, HDB CLIN NUTR, V17, P371; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kidd GJ, 2013, HAND CLINIC, V115, P55, DOI 10.1016/B978-0-444-52902-2.00005-9; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kobayakawa K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009430; LECLERCQMEYER V, 1985, ENDOCRINOLOGY, V116, P1168, DOI 10.1210/endo-116-3-1168; Luvisetto S, 2007, NEUROSCIENCE, V145, P1, DOI 10.1016/j.neuroscience.2006.12.004; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946; Marinelli S, 2014, PAIN, V155, P93, DOI 10.1016/j.pain.2013.09.013; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Parkitna JR, 2006, J PHYSIOL PHARMACOL, V57, P401; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sandhir R, 2011, NEUROCHEM RES, V36, P856, DOI 10.1007/s11064-011-0414-5; Sirolli V, 2012, BLOOD TRANSFUS-ITALY, V10, pS78, DOI 10.2450/2012.012S; Stino AM, 2017, J DIABETES INVEST, V8, P646, DOI 10.1111/jdi.12650; Stockli J, 2017, J BIOL CHEM, V292, P19135, DOI 10.1074/jbc.M117.818351; Stohr R, 2014, ATHEROSCLEROSIS, V235, P438, DOI 10.1016/j.atherosclerosis.2014.05.946; Su XD, 2015, NAT IMMUNOL, V16, P838, DOI 10.1038/ni.3205; Sun L, 2016, DIABETES CARE, V39, P1563, DOI 10.2337/dc16-0232; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Veroni C, 2010, MOL CELL NEUROSCI, V45, P234, DOI 10.1016/j.mcn.2010.06.014; Wu J, 2013, ENDOCRINE, V44, P87, DOI 10.1007/s12020-012-9826-5; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yagihashi S, 2016, INT REV NEUROBIOL, V127, P121, DOI 10.1016/bs.irn.2016.03.006; Zhang XY, 2014, DIABETES RES CLIN PR, V104, P376, DOI 10.1016/j.diabres.2014.04.013; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	53	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208569	10.1371/journal.pone.0208596	http://dx.doi.org/10.1371/journal.pone.0208596			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532260	gold, Green Submitted, Green Published			2022-12-26	WOS:000452644700034
J	Ouedraogo, AM; Crighton, EJ; Sawada, M; To, T; Brand, K; Lavigne, E				Ouedraogo, Alexandra M.; Crighton, Eric J.; Sawada, Michael; To, Teresa; Brand, Kevin; Lavigne, Eric			Exploration of the spatial patterns and determinants of asthma prevalence and health services use in Ontario using a Bayesian approach	PLOS ONE			English	Article							AMBIENT POLLEN CONCENTRATIONS; EMERGENCY-DEPARTMENT VISITS; AIR-POLLUTION; RISK-FACTORS; ASSOCIATION; EXPOSURE; MODELS; ADULTS; HOSPITALIZATIONS; MORTALITY	The purpose of this study was to examine the spatial variability of asthma outcomes in Ontario, Canada and broad environmental factors that contribute to this variability. Age-/sex-standardized asthma prevalence and health services use rates (2003-2013) were obtained from a provincial cohort of asthma patients. Employing an ecological-level study design, descriptive and Bayesian spatial regression analyses were used to examine patterns of asthma outcomes and their relationship to physical environment, socioeconomic environment and healthcare factors. Significant spatial variation in asthma outcomes was found between southern urban/suburban areas and northern/rural areas. Rurality was found to have a substantial effect on all asthma outcomes, except hospitalizations. For example, the most rural areas were associated with lower asthma prevalence and physician visits [RR = 0.708, 95% credible interval (CI): 0.636-0.795 and RR = 0.630, 95% CI: 0.504-0.758, respectively], and with higher ED visits (RR = 1.818, 95% CI: 1.194-2.858), when compared to urban areas. Strong associations were also found between material deprivation and ED visits (RR = 1.559, 95% CI: 1.358-1.737) and hospitalizations (RR = 1.259, 95% CI: 1.143-1.374). Associations between asthma outcomes and environmental variables such as air pollution and temperature were also found. Findings can be expected to inform the development of improved public health strategies, which take into account local environmental, socioeconomic and healthcare characteristics.	[Ouedraogo, Alexandra M.; Crighton, Eric J.; To, Teresa] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Crighton, Eric J.; Sawada, Michael] Univ Ottawa, Dept Geog Environm & Geomat, Ottawa, ON, Canada; [To, Teresa] Hosp Sick Children, Toronto, ON, Canada; [To, Teresa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Brand, Kevin] Univ Ottawa, Telfer Sch Management, Ottawa, ON, Canada; [Lavigne, Eric] Hlth Canada, Air Hlth Sci Div, Ottawa, ON, Canada; [Lavigne, Eric] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada	University of Toronto; University of Ottawa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Ottawa; Health Canada; University of Ottawa	Ouedraogo, AM (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	alexandra.ouedraogo@ices.on.ca	Sawada, Michael/O-8457-2019; Lavigne, Eric/E-2948-2013	Sawada, Michael/0000-0001-5180-5325; Lavigne, Eric/0000-0001-6146-9839	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	The authors would like to acknowledge the analyst, Jinquin Zhu, for providing the calculation of asthma rates. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this article are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	[Anonymous], 2013, EQUITY ACCESS COMMUN; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Ayres-Sampaio D, 2014, APPL GEOGR, V47, P10, DOI 10.1016/j.apgeog.2013.11.011; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa; Boulieri A, 2016, SPAT SPATIO-TEMPORAL, V19, P28, DOI 10.1016/j.sste.2016.05.004; Canada Statistics, 2016, POP YEAR PROV TERR; Chen Y, 2006, CHEST, V130, P890, DOI 10.1378/chest.130.3.890; Choo L., J R STAT SOC A, V171, P395; Clark NM, 2013, AM J PUBLIC HEALTH, V103, P1124, DOI 10.2105/AJPH.2012.300983; Crighton EJ, 2012, CAN J PUBLIC HEALTH, V103, pE384, DOI 10.1007/BF03404447; Crighton EJ, 2010, INT J CIRCUMPOL HEAL, V69, P138, DOI 10.3402/ijch.v69i2.17435; Crouse DL, 2015, ENVIRON HEALTH PERSP, V123, P1180, DOI 10.1289/ehp.1409276; Darrow LA, 2012, J ALLERGY CLIN IMMUN, V130, P630, DOI 10.1016/j.jaci.2012.06.020; Delamater PL, 2013, HEALTH PLACE, V24, P30, DOI 10.1016/j.healthplace.2013.07.012; DellaValle CT, 2012, EPIDEMIOLOGY, V23, P55, DOI 10.1097/EDE.0b013e31823b66b8; Elliot P, 2000, SPATIAL EPIDEMIOLOGY; Ernst P, 2000, AM J RESP CRIT CARE, V161, P1563, DOI 10.1164/ajrccm.161.5.9908119; EVANS RG, 1990, SOC SCI MED, V31, P1347, DOI 10.1016/0277-9536(90)90074-3; Gershon A, 2007, HEALTHC Q, V10, P22; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Global Asthma Network, 2014, GLOB ASTHM REP; Gupta RS, 2008, J ALLERGY CLIN IMMUN, V121, P639, DOI 10.1016/j.jaci.2007.11.036; Guttmann A., 2010, PEDIATRICS; Gwynn RC, 2004, J ASTHMA, V41, P91, DOI 10.1081/JAS-120026066; Hedlund U, 2006, EUR RESPIR J, V28, P303, DOI 10.1183/09031936.06.00108105; Huss K, 2001, J ALLERGY CLIN IMMUN, V107, P48, DOI 10.1067/mai.2001.111146; Hystad P, 2011, ENVIRON HEALTH PERSP, V119, P1123, DOI 10.1289/ehp.1002976; Kralj B., 2009, MEASURING RURALITY R; Lajoie Pierre, 2004, Can Respir J, V11, P427; Lavigne E, 2012, CAN J PUBLIC HEALTH, V103, P4, DOI 10.1007/BF03404060; Lawson JA, 2011, ANN ALLERG ASTHMA IM, V107, P220, DOI 10.1016/j.anai.2011.06.014; Lee D, 2013, J STAT SOFTW, V55, P1; Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001; Leroux BG, 2000, STAT MODELS EPIDEMIO, P179, DOI [10.1007/978-1-4612-1284-3_4, DOI 10.1007/978-1-4612-1284-3]; Li JL, 2009, TRANSPORT RES D-TR E, V14, P317, DOI 10.1016/j.trd.2009.03.004; Liu TB, 2009, GENET MED, V11, P323, DOI 10.1097/GIM.0b013e31819d3015; Lougheed AD, 2006, CHEST, V129, P909, DOI 10.1378/chest.129.4.909; Matheson F., 2011, ONTARIO MARGINALIZAT; Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823; Matisziw TC, 2008, COMPUT ENVIRON URBAN, V32, P81, DOI 10.1016/j.compenvurbsys.2007.06.002; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Ministry of Health and Long-term Care, 2017, STAGE 1 REPORT; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Nandram B, 2000, J AM STAT ASSOC, V95, P1110; Openshaw S., 1984, MODIFIABLE AREAL UNI; Portengen L, 2002, CLIN EXP ALLERGY, V32, P247, DOI 10.1046/j.1365-2222.2002.01310.x; Project AdaptWest, 2015, GRIDD CURR PROJ CLIM; Tepper JD, 2006, PHYS SERVICES RURAL; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; Tolbert PE, 2000, AM J EPIDEMIOL, V151, P798, DOI 10.1093/oxfordjournals.aje.a010280; Torabi M, 2014, J APPL STAT, V41, P612, DOI 10.1080/02664763.2013.847066; Ungar WJ, 2011, ANN ALLERG ASTHMA IM, V106, P17, DOI 10.1016/j.anai.2010.10.006; Villeneuve PJ, 2006, ALLERGY, V61, P750, DOI 10.1111/j.1398-9995.2006.01070.x; Wakefield J, 1999, STAT MED, V18, P2377, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2377::AID-SIM263>3.3.CO;2-7; Zhu L, 2003, ENVIRONMETRICS, V14, P537, DOI 10.1002/env.614	56	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208205	10.1371/journal.pone.0208205	http://dx.doi.org/10.1371/journal.pone.0208205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6JR	30532203	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700014
J	Yang, YJ; Park, GM; Han, SB; Kim, YG; Suh, J; Park, HW; Won, KB; Ann, SH; Kim, SJ; Kim, DW; Park, MW; Hee, SH; Lee, SG				Yang, Yujin; Park, Gyung-Min; Han, Seungbong; Kim, Yong-Giun; Suh, Jon; Park, Hyun Woo; Won, Ki-Bum; Ann, Soe Hee; Kim, Shin-Jae; Kim, Dae-Won; Park, Mahn-Won; Hee, Sung Ho; Lee, Sang-Gon			Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study	PLOS ONE			English	Article							ARTERY-DISEASE; RISK STRATIFICATION; SHORT-TERM; MORTALITY; OUTCOMES; TRENDS; REVASCULARIZATION; CLOPIDOGREL; MECHANISMS; PREVENTION	Objectives Despite an obvious improvement in the treatment of coronary artery disease (CAD) and survival rate of patients with CAD during recent decades, diabetes mellitus (DM) is still considered a risk factor of adverse clinical outcomes in these patients. Therefore, we sought to evaluate the clinical implications of DM in patients with CAD who underwent contemporary percutaneous coronary intervention (PCI). Methods Based on the National Health Insurance claims data in South Korea, patients aged 18 years or older who had undergone PCI for the diagnosis of CAD between 2011 and 2015 were analyzed. Patients were classified into the DM (n = 26,872) and non-DM (n = 54,243) groups. The primary endpoint was all-cause mortality, and it was compared between the two groups via a propensity score matching analysis. Results The study population was categorized as patients with angina (n = 49,228) or acute myocardial infarction (AMI, n = 31,887). The study population had a median follow-up of 2.1 years (interquartile range, 1.1-3.2). After the propensity score matching analysis, 8,157 and 4,266 pairs of patients with angina and AMI were identified, respectively. In the matched angina group, the incidence of all-cause death was significantly higher in patients with DM (adjusted hazard ratio [aHR]: 1.30; 95% confidence interval [CI]: 1.16-1.47; p<0.001) than in those without DM. Moreover, in the matched AMI group, the incidence of all-cause death was significantly higher in patients with DM (aHR: 1.35; 95% CI: 1.19-1.53; p<0.001) than in those without DM. Conclusions In patients undergoing contemporary PCI in Korea, the presence of DM was associated with poorer clinical outcomes.	[Yang, Yujin; Park, Gyung-Min; Kim, Yong-Giun; Won, Ki-Bum; Ann, Soe Hee; Kim, Shin-Jae; Lee, Sang-Gon] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan, South Korea; [Han, Seungbong] Gachon Univ, Dept Appl Stat, Seongnam, South Korea; [Suh, Jon; Park, Hyun Woo] Soon Chun Hyang Univ Hosp Bucheon, Dept Cardiol, Bucheon, South Korea; [Kim, Dae-Won; Park, Mahn-Won; Hee, Sung Ho] Catholic Univ Korea, Dept Cardiol, Daejeon St Marys Hosp, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; Gachon University; Catholic University of Korea	Park, GM (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan, South Korea.; Han, SB (corresponding author), Gachon Univ, Dept Appl Stat, Seongnam, South Korea.	min8684@hanmail.net; hanseungbong@gmail.com	Kim, Shin-Jae/CAE-9456-2022		Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2018R1D1A3B07043344]; Ministry of Science, ICT & Future Planning [2017R1C1B1006717]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	`This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2018R1D1A3B07043344 to G.M.P.) and the Ministry of Science, ICT & Future Planning (2017R1C1B1006717 to S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, EUR HEART J, DOI [DOI 10.1093/eurheartj/ehy394, DOI 10.1093/EURHEARTJ/EHY394]; Aronson D, 1997, ANN INTERN MED, V126, P296, DOI 10.7326/0003-4819-126-4-199702150-00006; Bangalore S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002626; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Colwell JA, 2003, DIABETES CARE, V26, P2181, DOI 10.2337/diacare.26.7.2181; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI DOI 10.1056/NEJM0A0805796; Garg S, 2010, CIRC-CARDIOVASC INTE, V3, P317, DOI 10.1161/CIRCINTERVENTIONS.109.914051; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goyal A, 2007, ANN THORAC SURG, V83, P993, DOI 10.1016/j.athoracsur.2006.10.046; Iqbal J, 2015, CIRCULATION, V131, P1269, DOI 10.1161/CIRCULATIONAHA.114.013042; Kang SH, 2016, JACC-CARDIOVASC IMAG, V9, P1292, DOI 10.1016/j.jcmg.2016.01.040; Kappetein AP, 2013, EUR J CARDIO-THORAC, V43, P1006, DOI 10.1093/ejcts/ezt017; Koskinas KC, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003255; Mak KH, 1997, J AM COLL CARDIOL, V30, P171, DOI 10.1016/S0735-1097(97)00118-6; Mehran R, 2004, J AM COLL CARDIOL, V43, P1348, DOI 10.1016/j.jacc.2003.04.004; MICK MJ, 1994, J AM COLL CARDIOL, V24, P74, DOI 10.1016/0735-1097(94)90544-4; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Norhammar A, 2007, HEART, V93, P1577, DOI 10.1136/hrt.2006.097956; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Park GM, 2016, J NUCL MED, V57, P1364, DOI 10.2967/jnumed.115.169318; Park GM, 2014, CIRC-CARDIOVASC QUAL, V7, P944, DOI 10.1161/CIRCOUTCOMES.114.001305; Park GM, 2014, AM J CARDIOL, V113, P765, DOI 10.1016/j.amjcard.2013.11.028; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Sedlis SP, 2015, NEW ENGL J MED, V373, P1937, DOI 10.1056/NEJMoa1505532; Sianos Georgios, 2005, EuroIntervention, V1, P219; STEIN B, 1995, CIRCULATION, V91, P979, DOI 10.1161/01.CIR.91.4.979; Wackers FJT, 2007, DIABETES CARE, V30, P2892, DOI 10.2337/dc07-1250; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Youn JC, 2017, KOREAN CIRC J, V47, P316, DOI 10.4070/kcj.2017.0075	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208746	10.1371/journal.pone.0208746	http://dx.doi.org/10.1371/journal.pone.0208746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532214	Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700048
J	Hong, S; Choi, YM; Ihm, SH; Kim, D; Choi, MG; Yu, JM; Hong, EG				Hong, Sangmo; Choi, Yun Mi; Ihm, Sung-Hee; Kim, Dooman; Choi, Moon-Gi; Yu, Jae Myung; Hong, Eun-Gyoung			Association between metabolic parameters and glomerular hyperfiltration in a representative Korean population without chronic kidney disease	PLOS ONE			English	Article							RENAL HYPERFILTRATION; DYSFUNCTION; PROGRESSION; GLUCOSE; RISK	Aims To investigate associations of glomerular hyperfiltration with other metabolic factors in a nationally representative dataset. Methods We analyzed cross-sectional data from 15,918 subjects with estimated glomerular filtration rate (eGFR) >60 ml/min/1.73 m(2) and urine albumin creation ratio (ACR) <30 mg/g, who participated in the 5th and 6th Korea National Health and Nutrition Examination Surveys. Hyperfiltration was defined as eGFR (CKD-EPI equation) exceeding the age- and sex-specific 95th percentile for healthy control subjects. Results Prevalence of hyperfiltration was 5.2% and that among normal, prediabetic, and diabetic subjects was 4.9%, 5.6%, and 7.3%, respectively, after adjusting for age, sex, and body weight (p for trend = 0.008). In a multiple logistic regression analysis, hyperfiltration was associated with a body mass index >= 30 kg/m(2) [odds ratio (OR) = 3.461, p<0.001], waist circumference 85 cm (men) or 80 cm (women) (OR = 1.425, p = 0.015), systolic blood pressure 120-129 mmHg (OR = 1.644, p = 0.022), fasting plasma glucose 140 mg/dL (OR = 1.695, p = 0.033) and t serum triglyceride level 500 mg/dL (OR = 2.988, p = 0.001), and was independently associated with the ACR (B = 0.053, p<0.001). Conclusions In a general Korean population, both hyperfiltration and ACR were associated with similar metabolic parameters, and hyperfiltration correlated independently with a high ACR. Longitudinal studies are needed to further explore risks of hyperfiltration and microalbuminuria.	[Hong, Sangmo; Choi, Yun Mi; Hong, Eun-Gyoung] Hallym Univ, Dept Internal Med, Div Endocrinol & Metab, Dongtan Sacred Heart Hosp, Hwaseong, South Korea; [Ihm, Sung-Hee] Hallym Univ, Coll Med, Div Endocrinol & Metab, Sacred Heart Hosp, Gyeonggi Do, South Korea; [Kim, Dooman] Hallym Univ, Coll Med, Dept Endocrinol & Metab, Kangdong Sacred Heart Hosp,Div Internal Med, Seoul, South Korea; [Choi, Moon-Gi] Hallym Univ, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Chunchon, South Korea; [Yu, Jae Myung] Hallym Univ, Div Endocrinol Metab & Geriatr Med, Dept Internal Med, Coll Med,Kangnam Sacred Heart Hosp, Seoul, South Korea	Hallym University; Hallym University; Hallym University; Hallym University; Hallym University	Hong, EG (corresponding author), Hallym Univ, Dept Internal Med, Div Endocrinol & Metab, Dongtan Sacred Heart Hosp, Hwaseong, South Korea.	hegietter@hanmail.net	Hong, Sangmo/ABF-6388-2021; Hong, Sangmo/C-9515-2018	Hong, Sangmo/0000-0002-8535-0565; Choi, Yun Mi/0000-0001-8209-874X	Hallym University Medical Center Research Fund [01-2007-17]	Hallym University Medical Center Research Fund	This study was supported by a grant from Hallym University Medical Center Research Fund (01-2007-17 (tel:01-2007-17)).	Aviv A, 2004, KIDNEY INT, V65, P361, DOI 10.1111/j.1523-1755.2004.00389.x; Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; BERGSTROM J, 1985, ACTA MED SCAND, V217, P189; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Caramori MLA, 1999, DIABETES CARE, V22, P1512, DOI 10.2337/diacare.22.9.1512; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hoy Wendy E, 2003, Kidney Int Suppl, pS31; Kazancioglu R, 2013, KIDNEY INT SUPPL, V3, P368, DOI 10.1038/kisup.2013.79; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee AM, 2017, NEPHROL DIAL TRANSPL, V32, P1517, DOI 10.1093/ndt/gfw231; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Okada R, 2012, RENAL FAILURE, V34, P1084, DOI 10.3109/0886022X.2012.717516; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Oterdoom LH, 2007, NEPHROL DIAL TRANSPL, V22, P1587, DOI 10.1093/ndt/gfm037; Palatini P, 2006, KIDNEY INT, V70, P578, DOI 10.1038/sj.ki.5001603; Palatini P, 2012, NEPHROL DIAL TRANSPL, V27, P1708, DOI 10.1093/ndt/gfs037; Pecly IMD, 2006, INT J CLIN PRACT, V60, P1198, DOI 10.1111/j.1742-1241.2006.01037.x; Quaschning T, 2001, J AM SOC NEPHROL, V12, P2280, DOI 10.1681/ASN.V12112280; Samuelsson O, 1998, J AM SOC NEPHROL, V9, P1482; Schmieder RE, 1997, J AM SOC NEPHROL, V8, P893; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tolonen N, 2009, DIABETOLOGIA, V52, P2522, DOI 10.1007/s00125-009-1541-2; Tuttle KR, 2017, DIABETES, V66, P14, DOI 10.2337/dbi16-0056; Vallon V, 1999, J AM SOC NEPHROL, V10, P2569	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207843	10.1371/journal.pone.0207843	http://dx.doi.org/10.1371/journal.pone.0207843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521539	gold, Green Published, Green Submitted			2022-12-26	WOS:000452307600022
J	Lee, YM; Kim, SA; Choi, GS; Park, SY; Jeon, SW; Lee, HS; Lee, SJ; Heo, S; Lee, DH				Lee, Yu-Mi; Kim, Se-A; Choi, Gyu-Seog; Park, Soo-Yeun; Jeon, Seong Woo; Lee, Hyun Seok; Lee, Su-Jin; Heo, Somi; Lee, Duk-Hee			Association of colorectal polyps and cancer with low-dose persistent organic pollutants: A case-control study	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; ORGANOCHLORINE PESTICIDES; CHEMICAL-MIXTURES; WEIGHT-LOSS; MORTALITY; EXPOSURE; RISK; SERUM	Background Low-dose persistent organic pollutants (POPs) have recently been linked to immunosenescence, a key mechanism in carcinogenesis, as well as many aging-related chronic diseases. Since feces are the main excretion route of POPs, the large intestine is a potential target organ for these pollutants. We performed a case-control study to evaluate whether exposure to low-dose POPs is related to the risk of colorectal polyps and cancer. Methods A total of 277 participants were recruited from one hospital: 99 cancer patients, 102 polyp patients, and 76 control subjects. As typical examples of POPs, we measured the serum concentrations of organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCBs). Results Across the tertiles of the summary measure of POPs, the adjusted odds ratios (ORs) of colorectal polyps and cancer were 2.8 (1.2-6.8) (P-trend = 0.01) and 3.0 (1.0-8.8) (P-trend = 0.02), respectively, for subjects in the highest tertile. When OCPs and PCBs were analyzed separately, OCPs were linked to an increased risk of both polyps and cancer; the adjusted ORs were 2.3 (0.9-5.7) (P-trend = 0.05) for polyps and 3.6 (1.1-11.8) (P-trend< 0.01) for cancer. However, PCBs were only significantly associated with a high risk of polyps but not cancer; the adjusted OR was 2.8 (1.2-6.6) (P-trend = 0.01). Conclusion Chronic exposure to low-dose POPs may be associated with an increased risk of colorectal polyps and cancer. Our findings suggest the carcinogenic potential of strong lipophilic chemical mixtures such as POPs which are accumulated in adipose tissue, released to circulation, and eliminated through feces.	[Lee, Yu-Mi; Heo, Somi; Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Daegu, South Korea; [Kim, Se-A] Kyungpook Natl Univ, Grad Sch, Dept Biomed Sci, Daegu, South Korea; [Kim, Se-A; Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Daegu, South Korea; [Choi, Gyu-Seog; Park, Soo-Yeun] Kyungpook Natl Univ, Sch Med, Dept Surg, Daegu, South Korea; [Jeon, Seong Woo; Lee, Hyun Seok] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Lee, Su-Jin] Kyungpook Natl Univ, Grad Sch, Dept Publ Hlth, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University	Lee, DH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Daegu, South Korea.; Lee, DH (corresponding author), Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Daegu, South Korea.	lee_dh@knu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MEST) [2013R1A2A2A01068254]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (Grant No: 2013R1A2A2A01068254, Recipient: DHL, URL: www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquavella JF, 1996, ENVIRON HEALTH PERSP, V104, P728, DOI 10.2307/3433218; Atashgahi S, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00888; BERTAZZI PA, 1987, AM J IND MED, V11, P165, DOI 10.1002/ajim.4700110206; BIRNBAUM LS, 1985, ENVIRON HEALTH PERSP, V61, P11, DOI 10.2307/3430058; BROWN DP, 1987, ARCH ENVIRON HEALTH, V42, P333, DOI 10.1080/00039896.1987.9934355; Cantor KP, 1999, AM J IND MED, V36, P239, DOI 10.1002/(SICI)1097-0274(199908)36:2&lt;239::AID-AJIM3&gt;3.0.CO;2-V; Cottet V, 2012, GUT, V61, P1180, DOI 10.1136/gutjnl-2011-300295; Goerke H, 2004, MAR POLLUT BULL, V48, P295, DOI 10.1016/j.marpolbul.2003.08.004; Golden R, 2009, CRIT REV TOXICOL, V39, P299, DOI 10.1080/10408440802291521; Goodson WH, 2015, CARCINOGENESIS, V36, pS254, DOI 10.1093/carcin/bgv039; Grandjean P, 2008, ENVIRON SCI TECHNOL, V42, P6991, DOI 10.1021/es800778q; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KEA, 2019, CHEMOSPHERE, V214, P534, DOI 10.1016/j.chemosphere.2018.09.126; Howsam M, 2004, ENVIRON HEALTH PERSP, V112, P1460, DOI 10.1289/ehp.7143; IARC, 2017, AG CLASS IARC MON, V1-123; IPAQ, IPAQ SCOR PROT; Jansen A, 2017, J TOXICOL ENV HEAL B, V20, P22, DOI 10.1080/10937404.2016.1246391; KCDC, KOR NAT HLTH NUTR EX; Khalid U, 2007, SUPPORT CARE CANCER, V15, P39, DOI 10.1007/s00520-006-0091-0; Kim KS, 2015, ENVIRON INT, V75, P87, DOI 10.1016/j.envint.2014.11.003; Lauby-Secretan B, 2013, LANCET ONCOL, V14, P287, DOI 10.1016/S1470-2045(13)70104-9; Lee DH, 2017, ENVIRON INT, V108, P170, DOI 10.1016/j.envint.2017.08.015; Lee DH, 2016, ENVIRON INT, V89-90, P179, DOI 10.1016/j.envint.2016.02.001; Lee DH, 2015, REV ENDOCR METAB DIS, V16, P289, DOI 10.1007/s11154-016-9340-9; Lee DH, 2014, ENDOCR REV, V35, P557, DOI 10.1210/er.2013-1084; Lee HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027773; Leet T, 1996, AM J IND MED, V30, P300, DOI 10.1002/(SICI)1097-0274(199609)30:3<300::AID-AJIM8>3.0.CO;2-1; MACDONALD TL, 1983, CRC CR REV TOXICOL, V11, P85, DOI 10.3109/10408448309089849; Moser GA, 2001, CHEMOSPHERE, V45, P201, DOI 10.1016/S0045-6535(00)00551-8; Persoon C, 2010, ENVIRON SCI TECHNOL, V44, P2797, DOI 10.1021/es901691s; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Porta M, 2012, PREV MED, V55, P560, DOI 10.1016/j.ypmed.2012.09.020; Ryu DH, 2018, CANCER EPIDEM BIOMAR, V27, P1159, DOI [10.1158/1055-9965.EPI-17-0799, 10.1158/1055-9965.epi-17-0799]; Shrubsole MJ, 2008, AM J EPIDEMIOL, V167, P1050, DOI 10.1093/aje/kwm400; Soliman AS, 1997, ARCH ENVIRON HEALTH, V52, P409, DOI 10.1080/00039899709602219; Song L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112700; Song L, 2014, TOXICOL LETT, V229, P284, DOI 10.1016/j.toxlet.2014.06.003; Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004; Wang Y, 2002, ARCH ENVIRON HEALTH, V57, P561, DOI 10.1080/00039890209602089; Wilkinson P, 1997, OCCUP ENVIRON MED, V54, P101, DOI 10.1136/oem.54.2.101; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	42	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208546	10.1371/journal.pone.0208546	http://dx.doi.org/10.1371/journal.pone.0208546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521631	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600088
J	Leungtongkam, U; Thummeepak, R; Tasanapak, K; Sitthisak, S				Leungtongkam, Udomluk; Thummeepak, Rapee; Tasanapak, Kannipa; Sitthisak, Sutthirat			Acquisition and transfer of antibiotic resistance genes in association with conjugative plasmid or class 1 integrons of Acinetobacter baumannii	PLOS ONE			English	Article							CARBAPENEM RESISTANCE; HIGH PREVALENCE; MULTIPLEX PCR; BLA(NDM-1); BLA(OXA-23); EVOLUTION	Conjugation is a type of horizontal gene transfer (HGT) that serves as the primary mechanism responsible for accelerating the spread of antibiotic resistance genes in Gram-negative bacteria. The present study aimed to elucidate the mechanisms underlying the conjugation-mediated gene transfer from the extensively drug-resistant Acinetobacter baumannii (XDR-AB) and New Delhi Metallo-beta-lactamase-1-producing Acinetobacter baumannii (NDM-AB) to environmental isolates of Acinetobacter spp. Conjugation experiments demonstrated that resistance to ticarcillin and kanamycin could be transferred from four donors to two sodium azide-resistant A. baumannii strains, namely, NU013R and NU015R. No transconjugants were detected on Mueller-Hinton Agar (MHA) plates containing tetracycline. Plasmids obtained from donors as well as successful transconjugants were characterized by PCR-based replicon typing and S1-nuclease pulsed-field gel electrophoresis (S1-PFGE). Detection of antibiotic resistance genes and integrase genes (int) was performed using PCR. Results revealed that the donor AB364 strain can transfer the b/a(OXA-23) and b/a(PER-1) genes to both recipients in association with int1. A 240-kb plasmid was successfully transferred from the donor AB364 to recipients. In addition, the aphA6 and b/a(PER-1) genes were co-transferred with the int1 gene from the donor strains AB352 and AB405. The transfer of a 220-kb plasmid from the donors to recipient was detected. The GR6 plasmid containing the kanamycin resistance gene (aphA6) was successfully transferred from the donor strain AB140 to both recipient strains. However, the b/a(NDM-1) and tet(B) genes were not detected in all transconjugants. Our study is the first to demonstrate successful in vitro conjugation, which indicated that XDR-AB contained combination mechanisms of the co-transfer of anti-microbial resistance elements with integron cassettes or with the plasmid group GR6. Thus, conjugation could be responsible for the emergence of new types of antibiotic-resistant strains.	[Leungtongkam, Udomluk; Thummeepak, Rapee; Tasanapak, Kannipa; Sitthisak, Sutthirat] Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand; [Sitthisak, Sutthirat] Naresuan Univ, Ctr Excellence Med Biotechnol, Phitsanulok, Thailand	Naresuan University; Naresuan University	Sitthisak, S (corresponding author), Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand.; Sitthisak, S (corresponding author), Naresuan Univ, Ctr Excellence Med Biotechnol, Phitsanulok, Thailand.	sutthirats@nu.ac.th	Sitthisak, Sutthirat/AAF-9383-2020; Sitthisak, Sutthirat/ABF-4922-2021	Sitthisak, Sutthirat/0000-0003-4992-7635	Thailand Research Fund [RSA5780015]; Royal Golden Jubilee Ph.D. Program [PHD/0031/2558, PHD/0227/2560]	Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This study was funded by Thailand Research Fund (RSA5780015). RT and UL were supported by The Royal Golden Jubilee Ph.D. Program (PHD/0031/2558 and PHD/0227/2560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliakbarzade K, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.11924; Aly MM, 2016, EUR J CLIN MICROBIOL, V35, P1759, DOI 10.1007/s10096-016-2723-8; Aminov RI, 2002, APPL ENVIRON MICROB, V68, P1786, DOI 10.1128/AEM.68.4.1786-1793.2002; Bertini A, 2010, ANTIMICROB AGENTS CH, V54, P4168, DOI 10.1128/AAC.00542-10; Charfi-Kessis K, 2014, MICROB PATHOGENESIS, V74, P20, DOI 10.1016/j.micpath.2014.07.003; Chatterjee S, 2017, J ANTIMICROB CHEMOTH, V72, P2201, DOI 10.1093/jac/dkx131; CLSI, 2017, PERFORMANCE STANDARD; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Da Silva GJ, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4030029; Fu Y, 2012, J ANTIMICROB CHEMOTH, V67, P2114, DOI 10.1093/jac/dks192; Gillings MR, 2017, ANN NY ACAD SCI, V1388, P92, DOI 10.1111/nyas.13268; Giovanetti E, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00746; Hamidian M, 2016, PLASMID, V87-88, P43, DOI 10.1016/j.plasmid.2016.09.001; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P955, DOI 10.1093/jac/dkt454; Huang C., 2015, New Microbes and New Infections, V8, P103, DOI 10.1016/j.nmni.2015.09.015; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Karah N, 2011, MICROB DRUG RESIST, V17, P545, DOI 10.1089/mdr.2011.0089; Koeleman JGM, 2001, J CLIN MICROBIOL, V39, P8, DOI 10.1128/JCM.39.1.8-13.2001; Krahn T, 2016, ANTIMICROB AGENTS CH, V60, P3032, DOI 10.1128/AAC.00124-16; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Leungtongkam U, 2018, MICROB DRUG RESIST, V24, P55, DOI 10.1089/mdr.2016.0248; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; Misbah S., 2005, SMJ Singapore Medical Journal, V46, P461; Pagano M, 2016, BRAZ J MICROBIOL, V47, P785, DOI 10.1016/j.bjm.2016.06.005; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Ploy MC, 2000, ANTIMICROB AGENTS CH, V44, P2684, DOI 10.1128/AAC.44.10.2684-2688.2000; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Ramoul A, 2016, J GLOB ANTIMICROB RE, V6, P136, DOI 10.1016/j.jgar.2016.05.003; Randall CP, 2013, J ANTIMICROB CHEMOTH, V68, P131, DOI 10.1093/jac/dks372; Shousha A, 2015, APPL ENVIRON MICROB, V81, P4600, DOI 10.1128/AEM.00872-15; Talreja D, 2014, CURR EYE RES, V39, P695, DOI 10.3109/02713683.2013.873055; Thummeepak R, 2015, J INFECT PUBLIC HEAL, V8, P274, DOI 10.1016/j.jiph.2014.11.002; Towner KJ, 2011, ANTIMICROB AGENTS CH, V55, P2154, DOI 10.1128/AAC.01661-10; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Yang YS, 2015, INFECT GENET EVOL, V31, P305, DOI 10.1016/j.meegid.2015.02.017; Zarrilli R, 2008, ANTIMICROB AGENTS CH, V52, P4115, DOI 10.1128/AAC.00366-08	38	40	40	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208468	10.1371/journal.pone.0208468	http://dx.doi.org/10.1371/journal.pone.0208468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521623	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600074
J	Ponnusamy, L; Willcox, AC; Roe, RM; Davidson, SA; Linsuwanon, P; Schuster, AL; Richards, AL; Meshnick, SR; Apperson, CS				Ponnusamy, Loganathan; Willcox, Alexandra C.; Roe, R. Michael; Davidson, Silas A.; Linsuwanon, Piyada; Schuster, Anthony L.; Richards, Allen L.; Meshnick, Steven R.; Apperson, Charles S.			Bacterial microbiome of the chigger mite Leptotrombidium imphalum varies by life stage and infection with the scrub typhus pathogen Orientia tsutsugamushi	PLOS ONE			English	Article							TRANSOVARIAL TRANSMISSION; RICKETTSIA-TSUTSUGAMUSHI; VERTICAL TRANSMISSION; ACARI; TICK; COMMUNITIES; GREENGENES; SYMBIONTS; PHYLOGENY; IXODIDAE	Scrub typhus is a mites-borne rickettsiosis caused by the obligate intracellular Gram-negative bacterium Orientia tsutsugamushi. The disease is potentially life threatening and is prevalent in tropical Asia, islands of the western Pacific Ocean and northern Australia where an estimated one million cases occur annually. Orientia tsutsugamushi is transmitted by the bite of larval mites in the genus Leptotrombidium. In the present study, the composition of the microbiome in larvae, deutonymphs and adult males and females from laboratory colonies of L. imphalum that were infected as well as uninfected with O. tsutsugamushi were investigated by high-throughput sequencing of the bacterial 16S rRNA gene. Notably, the bacterial microbiomes of infected adult females were dominated by sequences of O. tsutsugamushi and an unidentified species of Amoebophilaceae, which together comprised 98.2% of bacterial sequences. To improve the taxonomic resolution of the Amoebophilaceae OTU a nearly full length sequence of the 16S rRNA gene was amplified, cloned, and Sanger sequenced. Infected female mites had 89 to 92% nucleotide identity with the Amoebophilaceae family, indicating that the bacterium was likely to be a species of a novel genus. The species composition of bacterial communities varied between mite life stages regardless of their infection status. Uninfected adults exhibited greater species diversity than adults infected with O. tsutsugamushi. In the infected colony, the rate of filial infection with Orientia was less than 100%. Larval and male mites that were PCR-negative for Orientia contained low numbers of sequences of Amoebophilaceae (0.01 and 0.06%, respectively) in their taxonomic profiles, suggesting that a mutualistic relationship exists between the novel species of Amoebophilaceae and O. tsutsugamushi. Our study findings provide the basis for further research to determine the influence of the novel Amoebophilaceae species on the bacterial microbiome and on vector susceptibility to and transovarial transmission of O. tsutsugamushi.	[Ponnusamy, Loganathan; Roe, R. Michael; Apperson, Charles S.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Ponnusamy, Loganathan; Apperson, Charles S.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Willcox, Alexandra C.; Meshnick, Steven R.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Davidson, Silas A.; Linsuwanon, Piyada; Schuster, Anthony L.] Armed Forces Res Inst Med Sci, US Army Med Component, Dept Entomol, Bangkok, Thailand; [Richards, Allen L.] Naval Med Res Ctr, Viral & Rickettsia Dis Dept, Silver Spring, MD USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Naval Medical Research Center (NMRC)	Ponnusamy, L; Apperson, CS (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; Ponnusamy, L; Apperson, CS (corresponding author), North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.	loganathan_ponnusamy@ncsu.edu; charles_apperson@ncsu.edu	Core, UNC Microbiome/AAB-3304-2022; Linsuwanon, Piyada/AAS-7642-2020	Willcox, Alexandra/0000-0001-6037-6841; Ponnusamy, Loganathan/0000-0002-0700-4472; Roe, Richard/0000-0002-6386-0994	North Carolina State University Comparative Medicine Institute	North Carolina State University Comparative Medicine Institute	Our research was supported in part by the North Carolina State University Comparative Medicine Institute to Charles S. Apperson, https://research.ncsu.edu/cmi/.	Abdul-Ghani R, 2012, ACTA TROP, V121, P71, DOI 10.1016/j.actatropica.2011.11.001; Abraham NM, 2017, P NATL ACAD SCI USA; Ahantarig A, 2013, FOLIA MICROBIOL, V58, P419, DOI 10.1007/s12223-013-0222-1; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00191-16; Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401; Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Bonnet SI, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00236; BREITSCHWERDT EB, 1988, AM J VET RES, V49, P70; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112; Chaisiri K, 2015, PARASITOLOGY, V142, P1152, DOI 10.1017/S0031182015000530; Charlat S, 2007, CURR BIOL, V17, P273, DOI 10.1016/j.cub.2006.11.068; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duron O, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-45; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferrari J, 2011, PHILOS T R SOC B, V366, P1389, DOI 10.1098/rstb.2010.0226; Frances SP, 2001, J MED ENTOMOL, V38, P17, DOI 10.1603/0022-2585-38.1.17; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hammer O, 2006, MORPHOMETRICS PALEON, P78; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Horn M, 2001, ENVIRON MICROBIOL, V3, P440, DOI 10.1046/j.1462-2920.2001.00210.x; Hubert J, 2017, MICROB ECOL, P1; Hubert J, 2016, J ECON ENTOMOL, V109, P1887, DOI 10.1093/jee/tow089; Jensenius M, 2004, INT J INFECT DIS, V8, P139, DOI 10.1016/j.ijid.2003.06.004; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LIPOVSKY LJ, 1951, J PARASITOL, V37, P324, DOI 10.2307/3273223; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lurchachaiwong W, 2012, EXP APPL ACAROL, V58, P23, DOI 10.1007/s10493-012-9563-8; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Phasomkusolsil S, 2012, J MED ENTOMOL, V49, P1270, DOI 10.1603/ME12100; Phasomkusolsil S, 2009, J MED ENTOMOL, V46, P1442, DOI 10.1603/033.046.0628; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Ponnusamy L, 2014, APPL ENVIRON MICROB, V80, P354, DOI 10.1128/AEM.02987-13; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; ROBERTS LW, 1977, J MED ENTOMOL, V14, P89, DOI 10.1093/jmedent/14.1.89; ROBERTS LW, 1977, J MED ENTOMOL, V13, P493, DOI 10.1093/jmedent/13.4-5.493; Rodkvamtook W, 2013, EMERG INFECT DIS, V19, P774, DOI 10.3201/eid1905.121445; Salje J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006657; Shin EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088453; Shropshire JD, 2016, MBIO, V7, DOI 10.1128/mBio.01785-15; Steiner FE, 2008, J MED ENTOMOL, V45, P289, DOI 10.1603/0022-2585(2008)45[289:IACROA]2.0.CO;2; Takahashi M, 1997, EUR J EPIDEMIOL, V13, P79, DOI 10.1023/A:1007341721795; Takhampunya R, 2016, VECTOR-BORNE ZOONOT, V16, P33, DOI 10.1089/vbz.2014.1753; TAMURA A, 1995, INT J SYST BACTERIOL, V45, P589, DOI 10.1099/00207713-45-3-589; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor AJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003971; TRAUB R, 1974, J MED ENTOMOL, V11, P237, DOI 10.1093/jmedent/11.3.237; URAKAMI H, 1994, AM J TROP MED HYG, V50, P219, DOI 10.4269/ajtmh.1994.50.219; Van Treuren W, 2015, APPL ENVIRON MICROB, V81, P6200, DOI 10.1128/AEM.01562-15; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Walter DE, 1999, MITES ECOLOGY EVOLUT; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Zhang YK, 2016, SYST APPL ACAROL-UK, V21, P978, DOI 10.11158/saa.21.7.11	67	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208327	10.1371/journal.pone.0208327	http://dx.doi.org/10.1371/journal.pone.0208327			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521561	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600049
J	Rajamoorthy, Y; Radam, A; Taib, NM; Ab Rahim, K; Wagner, AL; Mudatsir, M; Munusamy, S; Harapan, H				Rajamoorthy, Yogambigai; Radam, Alias; Taib, Niazlin Mohd; Ab Rahim, Khalid; Wagner, Abram Luther; Mudatsir, Mudatsir; Munusamy, Subramaniam; Harapan, Harapan			The relationship between perceptions and self-paid hepatitis B vaccination: A structural equation modeling approach	PLOS ONE			English	Article							HEALTH BELIEF MODEL; WILLINGNESS-TO-PAY; CANCER; PLS; ACCEPTANCE; BEHAVIOR; DECADE	Background Malaysia has a comprehensive, publicly-funded immunization program for hepatitis B (HepB) among infants, but adults must pay for the vaccine. The number of HepB carriers among adults is expected to increase in the future; therefore, we examined the impact of five constructs (cues to action, perceived barriers, perceived benefit, perceived severity, and perceived susceptibility) on adults' willingness to pay (WTP) for HepB vaccine; secondarily, we examined the association between perceived barriers and perceived benefits. Methods Adults were selected through a stratified, two-stage cluster community sample in Selangor, Malaysia. The reliability, convergent validity, and discriminant validity of the measurement model were assessed before implementing a partial least squares structural equation model (PLS-SEM) to evaluate the significance of the structural paths. Results A total of 728 participants were enrolled. The five constructs all showed adequate internal reliability, convergent validity, and discriminant validity. There was a significant, positive relationship to WTP from constructs (perceived barriers [Path coefficient (beta) = 0.082, P= 0.036], perceived susceptibility [beta = 0.214, P<0.001], and cues to action [beta = 0.166, P<0.001]), and the model all together accounted for 8.8% of the variation in WTP. There was a significant, negative relationship between perceived barriers and perceived benefit [beta = -0.261, P<0.001], which accounted for 6.8% of variation in perceived benefit. Conclusions Policy and programs should be targeted that can modify individuals' thoughts about disease risk, their obstacles in obtaining the preventive action, and their readiness to obtain a vaccine. Such programs include educational materials about disease risk and clinic visits that can pair HepB screening and vaccination.	[Rajamoorthy, Yogambigai] Univ Tunku Abdul Rahman, Fac Accountancy & Management, Dept Econ, Kajang, Selangor, Malaysia; [Rajamoorthy, Yogambigai; Radam, Alias; Ab Rahim, Khalid; Munusamy, Subramaniam] Univ Putra Malaysia, Fac Econ & Management, Dept Econ, Serdang, Selangor, Malaysia; [Taib, Niazlin Mohd] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Serdang, Selangor, Malaysia; [Wagner, Abram Luther] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Mudatsir, Mudatsir; Harapan, Harapan] Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh, Indonesia; [Mudatsir, Mudatsir] Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia; [Munusamy, Subramaniam] Manipal Int Univ, Sch Management & Business, Nilai, Negeri Sembilan, Malaysia; [Harapan, Harapan] Syiah Kuala Univ, Trop Dis Ctr, Sch Med, Banda Aceh, Indonesia; [Harapan, Harapan] Univ Western Australia, Sch Biomed Sci, Nedlands, WA, Australia	Universiti Tunku Abdul Rahman (UTAR); Universiti Putra Malaysia; Universiti Putra Malaysia; University of Michigan System; University of Michigan; Universitas Syiah Kuala; Universitas Syiah Kuala; Universitas Syiah Kuala; University of Western Australia	Rajamoorthy, Y (corresponding author), Univ Tunku Abdul Rahman, Fac Accountancy & Management, Dept Econ, Kajang, Selangor, Malaysia.; Rajamoorthy, Y (corresponding author), Univ Putra Malaysia, Fac Econ & Management, Dept Econ, Serdang, Selangor, Malaysia.; Mudatsir, M; Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh, Indonesia.; Mudatsir, M (corresponding author), Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia.; Harapan, H (corresponding author), Syiah Kuala Univ, Trop Dis Ctr, Sch Med, Banda Aceh, Indonesia.; Harapan, H (corresponding author), Univ Western Australia, Sch Biomed Sci, Nedlands, WA, Australia.	yogambigai@utar.edu.my; mudatsir@unsyiah.ac.id; harapan@unsyiah.ac.id	Harapan, Harapan/I-8741-2016; Wagner, Abram/X-6379-2019; Mudatsir, Mudatsir/Q-4999-2017; Mudatsir, Mudatsir/AAC-1633-2021	Harapan, Harapan/0000-0001-7630-8413; Wagner, Abram/0000-0003-4691-7802; Mudatsir, Mudatsir/0000-0002-5643-9384; Mudatsir, Mudatsir/0000-0002-5643-9384; Mohd Taib, Niazlin/0000-0002-9910-9393; Rajamoorthy, Yogambigai/0000-0002-3222-4346	Putra Grant - Putra Graduate Initiative (IPS) [GP-IPS/2013-939220]; PhRMA Foundation; Australia Awards Scholarship (AAS) from the Department of Foreign Affairs and Trade; Scholarship for International Research Fees (SIRF) from The University of Western Australia; NHMRC Centre of Research Excellence in Emerging Infectious Diseases (CREID) Scholarship	Putra Grant - Putra Graduate Initiative (IPS); PhRMA Foundation; Australia Awards Scholarship (AAS) from the Department of Foreign Affairs and Trade; Scholarship for International Research Fees (SIRF) from The University of Western Australia; NHMRC Centre of Research Excellence in Emerging Infectious Diseases (CREID) Scholarship(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Putra Grant - Putra Graduate Initiative (IPS), grant number GP-IPS/2013-939220. ALW's salary was funded through a fellowship from the PhRMA Foundation. HH is a recipient of an Australia Awards Scholarship (AAS) from the Department of Foreign Affairs and Trade, Scholarship for International Research Fees (SIRF) from The University of Western Australia and NHMRC Centre of Research Excellence in Emerging Infectious Diseases (CREID) Scholarship.	Bagozzi R, J ACAD MARK SCI, V16, P74; BECKER MH, 1978, PUBLIC HEALTH REP, V93, P268; BODENHEIMER HC, 1986, AM J PUBLIC HEALTH, V76, P252, DOI 10.2105/AJPH.76.3.252; Bosompra K, 2001, HEALTH EDUC RES, V16, P157, DOI 10.1093/her/16.2.157; CHALIKI H, 1995, AM J PUBLIC HEALTH, V85, P1133, DOI 10.2105/AJPH.85.8_Pt_1.1133; CHEN MS, 1986, SOC PSYCHOL QUART, V49, P45, DOI 10.2307/2786856; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; FULTON JP, 1991, PUBLIC HEALTH REP, V106, P410; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Henseler J, 2014, ORGAN RES METHODS, V17, P182, DOI 10.1177/1094428114526928; Hesham R, 2005, Med J Malaysia, V60, P407; Hochbaum G., 1952, HLTH BELIEF MODEL; Hulland J, 1999, STRATEGIC MANAGE J, V20, P195, DOI 10.1002/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.3.CO;2-Z; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Juraskova I, 2011, WOMEN HEALTH ISS, V21, P71, DOI 10.1016/j.whi.2010.08.004; Khairullah NS, 2004, J GASTROEN HEPATOL, V19, pS13, DOI 10.1111/j.1440-1746.2003.03393.x; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Ma Grace X, 2007, J Immigr Minor Health, V9, P213, DOI 10.1007/s10903-006-9028-4; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Ministry of Health Malaysia, 2011, HLTH FACTS 2010; Ministry of Health Malaysia, 2014, HLTH FACTS 2014; Mohamed R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-601; Nunnallyn J., 1978, PSYCHOMETRIC THEORY; Pinto Sharrel L, 2006, Res Social Adm Pharm, V2, P38, DOI 10.1016/j.sapharm.2005.11.001; Raihan Ruksana, 2017, Euroasian J Hepatogastroenterol, V7, P65, DOI 10.5005/jp-journals-10018-1214; Raihan Ruksana, 2016, Euroasian J Hepatogastroenterol, V6, P52, DOI 10.5005/jp-journals-10018-1167; Rajamoorthy Y, 2018, BMC PUBLIC HLTH; Rajamoorthy Y., 2016, MALAYS J PUBLIC HLTH, V16, P113; RAZAK I A, 1991, Clinical Preventive Dentistry, V13, P22; Rhodes SD, 2003, J COMMUN HEALTH, V28, P347, DOI 10.1023/A:1025444629753; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Salmon Daniel A, 2009, WMJ, V108, P17; Simsekoglu O, 2008, TRANSPORT RES F-TRAF, V11, P181, DOI 10.1016/j.trf.2007.10.001; Smith PJ, 2011, PUBLIC HEALTH REP, V126, P135, DOI 10.1177/00333549111260S215; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wong RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-677; World Health Organization, 2016, COMB HEP B C REACH E; YAACOB HB, 1989, J ORAL PATHOL MED, V18, P236, DOI 10.1111/j.1600-0714.1989.tb00770.x; Yogambigai R, 2017, PERTANIKA J SOC SCI, V25, P635	40	24	24	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208402	10.1371/journal.pone.0208402	http://dx.doi.org/10.1371/journal.pone.0208402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521602	Green Published, gold			2022-12-26	WOS:000452307600056
J	Kim, Y; Radoias, V				Kim, Younoh; Radoias, Vlad			Screening, diagnosis, and long-term health outcomes in developing countries-The case of hypertension	PLOS ONE			English	Article							EDUCATION; HEIGHT	Hypertension is a rapidly growing problem in developing countries. At the same time, due to its asymptomatic nature, the afflicted population is largely unaware of being hypertensive. Due to a lack of resources, routine medical exams are very rare in developing countries and many sick individuals remain undiagnosed. Using a large sample of hypertensive individuals from Indonesia, we show the importance of being diagnosed. Diagnosed individuals exhibit lower systolic and diastolic blood pressure, and overall lower probability of remaining hypertensive than undiagnosed individuals. We also show the main channels through which this is achieved: taking medication, routinely monitoring one's blood pressure, and engaging in moderate physical activities. We also point to channels through which additional benefits could be realized, but that are currently ineffective: dietary changes and maintaining a healthy body weight. Combined, these results point to the importance of directing public policy towards addressing the under-diagnosis problem and educating the public of the benefits of adopting a healthy life-style.	[Kim, Younoh; Radoias, Vlad] Sam Houston State Univ, Dept Econ & Int Business, Huntsville, TX 77340 USA	Texas State University System; Sam Houston State University	Radoias, V (corresponding author), Sam Houston State Univ, Dept Econ & Int Business, Huntsville, TX 77340 USA.	radoias@shsu.edu						Ahsan MN, 2018, SOUTH ECON J, V85, P121, DOI 10.1002/soej.12298; Anker D, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0101-z; BOUND J, 1994, J LABOR ECON, V12, P345, DOI 10.1086/298348; Burris JL, 2015, CANCER EPIDEM BIOMAR, V24, P1450, DOI 10.1158/1055-9965.EPI-15-0257; Bustamante AV, 2018, SOC SCI MED, V216, P107, DOI 10.1016/j.socscimed.2018.09.025; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Kessler CS, 2010, AM FAM PHYSICIAN, V81, P470; Kim Y, 2016, SOC SCI MED, V150, P15, DOI 10.1016/j.socscimed.2015.11.051; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Si S, 2014, BRIT J GEN PRACT, V64, pE47, DOI 10.3399/bjgp14X676456; Sohn K, 2018, GLOB HEART, V13, P285, DOI 10.1016/j.gheart.2018.01.004; Sohn K, 2017, ECON HUM BIOL, V27, P74, DOI 10.1016/j.ehb.2017.04.007; Sohn K, 2015, ECON HUM BIOL, V16, P1, DOI 10.1016/j.ehb.2013.12.011; Strauss J, 2010, J POPUL AGEING, V3, P111, DOI 10.1007/s12062-011-9033-9; Witoelar F., 2012, AGING ASIA FINDINGS	16	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208466	10.1371/journal.pone.0208466	http://dx.doi.org/10.1371/journal.pone.0208466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517184	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400097
J	Hald, OH; Olsen, L; Gallo-Oller, G; Elfman, LHM; Lokke, C; Kogner, P; Sveinbjornsson, B; Flaegstad, T; Johnsen, JI; Einvik, C				Hald, Oyvind H.; Olsen, Lotte; Gallo-Oller, Gabriel; Elfman, Lotta Helena Maria; Lokke, Cecilie; Kogner, Per; Sveinbjornsson, Baldur; Flaegstad, Trond; Johnsen, John Inge; Einvik, Christer			Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma	ONCOGENE			English	Article							RNA-POLYMERASE I; N-MYC; THERAPEUTIC STRATEGY; G-QUADRUPLEXES; EXPRESSION; CANCER; P53; CX-5461; TARGET; PATHWAYS	Abnormal increases in nucleolar size and number caused by dysregulation of ribosome biogenesis has emerged as a hallmark in the majority of spontaneous cancers. The observed ribosome hyperactivity can be directly induced by the MYC transcription factors controlling the expression of RNA and protein components of the ribosome. Neuroblastoma, a highly malignant childhood tumor of the sympathetic nervous system, is frequently characterized by MYCN gene amplification and high expression of MYCN and c-MYC signature genes. Here, we show a strong correlation between high-risk disease, MYCN expression, poor survival, and ribosome biogenesis in neuroblastoma patients. Treatment of neuroblastoma cells with quarfloxin or CX-5461, two small molecule inhibitors of RNA polymerase I, suppressed MycN expression, induced DNA damage, and activated p53 followed by cell cycle arrest or apoptosis. CX-5461 repressed the growth of established MYCN-amplified neuroblastoma xenograft tumors in nude mice. These findings suggest that inhibition of ribosome biogenesis represent new therapeutic opportunities for children with high-risk neuroblastomas expressing high levels of Myc.	[Hald, Oyvind H.; Flaegstad, Trond; Einvik, Christer] UNN Univ Hosp North Norway, Dept Pediat, Div Child & Adolescent Hlth, NO-9038 Tromso, Norway; [Olsen, Lotte; Lokke, Cecilie; Flaegstad, Trond; Einvik, Christer] Arctic Univ Norway UiT, Pediat Res Grp, Dept Clin Med, Fac Hlth Sci, NO-9037 Tromso, Norway; [Gallo-Oller, Gabriel; Elfman, Lotta Helena Maria; Kogner, Per; Sveinbjornsson, Baldur; Johnsen, John Inge] Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Sveinbjornsson, Baldur] Arctic Univ Norway UiT, Mol Inflammat Res Grp, Dept Med Biol, Fac Hlth Sci, NO-9037 Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; Karolinska Institutet; UiT The Arctic University of Tromso	Einvik, C (corresponding author), UNN Univ Hosp North Norway, Dept Pediat, Div Child & Adolescent Hlth, NO-9038 Tromso, Norway.; Einvik, C (corresponding author), Arctic Univ Norway UiT, Pediat Res Grp, Dept Clin Med, Fac Hlth Sci, NO-9037 Tromso, Norway.	christer.einvik@uit.no	; Gallo-Oller, Gabriel/D-6825-2019	Johnsen, John Inge/0000-0003-1277-812X; Gallo-Oller, Gabriel/0000-0002-3864-1941	Norwegian Childhood Cancer Society (Barnekreftforeningen); Northern-Norwegian Health Authorities (Helse Nord); Simon Fougner Hartmanns Familiefond; Swedish Childhood Cancer Foundation; Swedish Cancer Foundation; Swedish Foundation for Strategic Research; Cancer Research Foundations of Radiumhemmet	Norwegian Childhood Cancer Society (Barnekreftforeningen); Northern-Norwegian Health Authorities (Helse Nord); Simon Fougner Hartmanns Familiefond; Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Cancer Research Foundations of Radiumhemmet	This work was supported by the Norwegian Childhood Cancer Society (Barnekreftforeningen), The Northern-Norwegian Health Authorities (Helse Nord), the Simon Fougner Hartmanns Familiefond, the Swedish Childhood Cancer Foundation, the Swedish Cancer Foundation, the Swedish Foundation for Strategic Research (www.nnbcr.se) and The Cancer Research Foundations of Radiumhemmet. We wish to thank Dr. Emma Bell for kindly providing the siMYCN IMR-32 microarray data.	Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Bykov VJN, 2018, NAT REV CANCER, V18, P89, DOI 10.1038/nrc.2017.109; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Cole KA, 2012, CLIN CANCER RES, V18, P2423, DOI 10.1158/1078-0432.CCR-11-1409; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; EGAN M, 1988, J CLIN PATHOL, V41, P527, DOI 10.1136/jcp.41.5.527; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Goldschneider D, 2006, NUCLEIC ACIDS RES, V34, P5603, DOI 10.1093/nar/gkl619; Gonin-Laurent N, 2006, CARCINOGENESIS, V27, P1266, DOI 10.1093/carcin/bgi356; Hein N, 2013, TRENDS MOL MED, V19, P643, DOI 10.1016/j.molmed.2013.07.005; Henriksen JR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-1; Johnsen JI, 2018, PHARMACOL RES, V131, P164, DOI 10.1016/j.phrs.2018.02.023; Karahan G, 2015, ONCOL REP, V33, P3131, DOI 10.3892/or.2015.3940; Keshelava N, 2001, CANCER RES, V61, P6185; Kitade S, 2016, CANCER SCI, V107, P1399, DOI 10.1111/cas.13026; Kobayashi C, 2005, CANCER-AM CANCER SOC, V103, P174, DOI 10.1002/cncr.20717; Lee HC, 2017, BRIT J HAEMATOL, V177, P80, DOI 10.1111/bjh.14525; Li LM, 2016, ONCOTARGETS THER, V9, P5985, DOI 10.2147/OTT.S104513; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Negi SS, 2015, ONCOTARGET, V6, P18094, DOI 10.18632/oncotarget.4093; Niemas-Teshiba Risa, 2018, Oncotarget, V9, P6416, DOI 10.18632/oncotarget.23740; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Popov A, 2013, NUCLEUS-AUSTIN, V4, P134, DOI 10.4161/nucl.23985; Quin J, 2016, ONCOTARGET, V7, P49800, DOI 10.18632/oncotarget.10452; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Roth Sarah Andrea, 2018, Oncotarget, V9, P18160, DOI 10.18632/oncotarget.24793; Ruiz-Perez MV, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040113; Scaife JE, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.7_suppl.94; Schroeder U, 2003, BLOOD, V102, P246, DOI 10.1182/blood-2002-07-2268; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Singhal J, 2011, CANCER PREV RES, V4, P879, DOI 10.1158/1940-6207.CAPR-11-0025; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Suenaga Y, 2009, BIOCHEM BIOPH RES CO, V390, P21, DOI 10.1016/j.bbrc.2009.09.044; Trajkovski M, 2012, J AM CHEM SOC, V134, P4132, DOI 10.1021/ja208483v; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang LL, 2013, CANCER-AM CANCER SOC, V119, P3718, DOI 10.1002/cncr.28251; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Xu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14432; Xue C, 2007, CANCER RES, V67, P10351, DOI 10.1158/0008-5472.CAN-06-4345; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846	44	28	30	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2800	2813		10.1038/s41388-018-0611-7	http://dx.doi.org/10.1038/s41388-018-0611-7			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30542116	hybrid, Green Published			2022-12-26	WOS:000464121600010
J	Liu, SM; Yin, P; Kujawa, SA; Coon, JS; Okeigwe, I; Bulun, SE				Liu, Shimeng; Yin, Ping; Kujawa, Stacy A.; Coon, John S.; Okeigwe, Ijeoma; Bulun, Serdar E.			Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma	ONCOGENE			English	Article							OSTEOCLAST DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; MEDIATOR; LIGAND; GENE; MUTATIONS; PATHWAY; CANCER	Progesterone and its receptor, PR, are essential for uterine leiomyoma (LM, a.k.a., fibroid) tumorigenesis, but the underlying cellular and molecular mechanisms remain unclear. The receptor activator of NF-kappa B (RANKL) was recently identified as a novel progesterone/PR-responsive gene that plays an important role in promoting LM growth. Here, we used RANKL as a representative gene to investigate how steroid hormone, genetic, and epigenetic signals are integrated to regulate LM stem cell (LSC) function. We demonstrated that RANKL specifically upregulates LSC proliferation through activation of Cyclin D1. RANKL gene transcription was robustly induced by the progesterone agonist R5020, leading to a dramatically higher RANKL expression in LM compared to adjacent myometrial (MM) tissue. MethylCap-Seq revealed a differentially methylated region (DMR) adjacent to the distal PR-binding site (PRBS) 87 kb upstream of the RANKL transcription start site. Hypermethylation of the DMR inhibited recruitment of PR to the adjacent PRBS. Luciferase assays indicated that the DMR and distal PRBS constitute a novel RANKL distal regulatory element that actively regulates RANKL expression. Furthermore, MED12 physically interacts with PR in LM tissue. The interaction between MED12 and PR, binding of PR and MED12 to PRBS, and RANKL gene expression are significantly higher in LM containing a distinct MED12 mutation (G44D) than in LM with wild-type MED12. In summary, our findings suggest that DNA methylation and MED12 mutation together constitute a complex regulatory network that affects progesterone/PR-mediated RANKL gene expression, with an important role in activating stem cell proliferation and fibroid tumor development.	[Liu, Shimeng; Yin, Ping; Kujawa, Stacy A.; Coon, John S.; Okeigwe, Ijeoma; Bulun, Serdar E.] Northwestern Univ, Div Reprod Sci Med, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Bulun, SE (corresponding author), Northwestern Univ, Div Reprod Sci Med, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA.	s-bulun@northwestern.edu			NIH [P01 HD057877]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057877] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH grant P01 HD057877 to SB.	Acevedo ML, 2003, MOL CELL BIOL, V23, P335, DOI 10.1128/MCB.23.1.335-348.2003; Aranda-Orgilles B, 2016, CELL STEM CELL, V19, P784, DOI 10.1016/j.stem.2016.08.004; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Banaganapalli B, 2016, J CELL BIOCHEM, V117, P2023, DOI 10.1002/jcb.25499; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonifacino Juan S, 2016, CURR PROTOC CELL BIO, V71; Borahay MA, 2015, MOL MED, V21, P242, DOI 10.2119/molmed.2014.00053; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Catherino WH, 2011, FERTIL STERIL, V95, P9, DOI 10.1016/j.fertnstert.2010.08.049; Chen W, 2007, NUCLEIC ACIDS RES, V35, P6161, DOI 10.1093/nar/gkm661; Delgado-Calle J, 2012, EPIGENETICS-US, V7, P83, DOI 10.4161/epi.7.1.18753; Flaque MCD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3587; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Fan X, 2004, J CELL BIOCHEM, V93, P807, DOI 10.1002/jcb.20217; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsu PY, 2016, ONCOGENE, V35, P2379, DOI 10.1038/onc.2015.298; Hu H, 2014, BREAST CANCER RES TR, V146, P515, DOI 10.1007/s10549-014-3049-9; Hu Y, 2008, BIOCHEM BIOPH RES CO, V370, P440, DOI 10.1016/j.bbrc.2008.03.106; Ikhena DE, 2018, J CLIN ENDOCR METAB, V103, P1842, DOI 10.1210/jc.2017-01585; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kiesel L, 2016, MATURITAS, V86, P10, DOI 10.1016/j.maturitas.2016.01.001; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Klug M., 2014, EPIGENETICS, V1, P127, DOI DOI 10.4161/EPI.1.3.3327; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Li Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1412-9; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik M, 2012, MATRIX BIOL, V31, P389, DOI 10.1016/j.matbio.2012.09.005; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mittal P, 2015, J CLIN INVEST, V125, P3280, DOI 10.1172/JCI81534; Navarro A, 2014, J CLIN ENDOCR METAB, V99, pE2437, DOI 10.1210/jc.2014-2264; Navarro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033284; Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774; Nolan E, 2016, NAT MED, V22, P933, DOI 10.1038/nm.4118; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Ono M, 2013, P NATL ACAD SCI USA, V110, P17053, DOI 10.1073/pnas.1313650110; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Renema N, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160150; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Tanos T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005654; Turunen M, 2014, CELL REP, V7, P654, DOI 10.1016/j.celrep.2014.03.047; Yin P, 2015, J CLIN ENDOCR METAB, V100, pE601, DOI 10.1210/jc.2014-2134; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021	50	21	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2722	2735		10.1038/s41388-018-0612-6	http://dx.doi.org/10.1038/s41388-018-0612-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30538295	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000464121600004
J	Flood, B; Manils, J; Nulty, C; Flis, E; Kenealy, S; Barber, G; Fay, J; Mills, KHG; Kay, EW; Creagh, EM				Flood, Brian; Manils, Joan; Nulty, Ciara; Flis, Ewelina; Kenealy, Sinead; Barber, Gillian; Fay, Joanna; Mills, Kingston H. G.; Kay, Elaine W.; Creagh, Emma M.			Caspase-11 regulates the tumour suppressor function of STAT1 in a murine model of colitis-associated carcinogenesis	ONCOGENE			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; CELL-PROLIFERATION; INTERFERON-ALPHA; COLON; ANGIOGENESIS; EXPRESSION; LIPOPOLYSACCHARIDE; TUMORIGENESIS; PYROPTOSIS; INNATE	Murine inflammatory caspase-11 has an important role in intestinal epithelial inflammation and barrier function. Activation of the non-canonical inflammasome, mediated by caspase-11, serves as a regulatory pathway for the production of the proinflammatory cytokines IL-1 beta and IL-18, and has a key role in pyroptotic cell death. We have previously demonstrated a protective role for caspase-11 during dextran sulphate sodium (DSS)-induced colitis, however the importance of caspase-11 during colorectal tumour development remains unclear. Here, we show that Casp11(-1-) mice are highly susceptible to the azoxymethane (AOM)-DSS model of colitis-associated cancer (CAC), compared to their wild type (WT) littermates. We show that deficient IL-18 production occurs at initial inflammation stages of disease, and that IL-1 beta production is more significantly impaired in Casp11(-1-) colons during established CAC. We identify defective STAT1 activation in Casp11(-)(1-) colons during disease progression, and show that IL-1 beta signalling induces caspase-11 expression and STAT1 activation in primary murine macrophages and intestinal epithelial cells. These findings uncover an anti-tumour role for the caspase-11 and the non-canonical inflammasome during CAC, and suggest a critical role for caspase-11, linking IL-1 beta and STAT1 signalling pathways.	[Flood, Brian; Manils, Joan; Nulty, Ciara; Flis, Ewelina; Kenealy, Sinead; Barber, Gillian; Mills, Kingston H. G.; Creagh, Emma M.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Fay, Joanna; Kay, Elaine W.] Royal Coll Surgeons Ireland, Dublin 9, Ireland; [Fay, Joanna; Kay, Elaine W.] Beaumont Hosp, Dublin 9, Ireland	Trinity College Dublin; Royal College of Surgeons - Ireland	Creagh, EM (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	ecreagh@tcd.ie	Manils, Joan/ABC-7884-2021; Manils, Joan/I-1258-2015; Mills, Kingston H/F-5684-2013; Creagh, Emma/AAX-1064-2021	Manils, Joan/0000-0001-8429-1295; Manils, Joan/0000-0001-8429-1295; Mills, Kingston H/0000-0003-3646-8222; Creagh, Emma/0000-0001-7631-4370; Barber, Gillian/0000-0002-6909-6042	Enterprise Ireland [CF-2015-0061P]; Government of Ireland PRTLI PhD programme [201921, 12259]; EU [721906]; SFI Investigator programme [12/IP/1400]	Enterprise Ireland; Government of Ireland PRTLI PhD programme; EU(European Commission); SFI Investigator programme(Science Foundation Ireland)	We thank the J. Yuan laboratory (Harvard Medical School) for the provision of Caspase-11<SUP>-/-</SUP> mice; and the technical staff of the Comparative Medicine Unit, TCD for their assistance in the backcrossing and breeding of these mice. This study was supported by Enterprise Ireland (CF-2015-0061P). B.F. was supported by a Government of Ireland PRTLI PhD programme (scheme #201921, award #12259). E.F. is an Early Stage Researcher of the EU Horizon 2020 Research and Innovation Programme, TRACT (Marie Sklodowska-Curie grant agreement No 721906). S.K. is funded by an SFI Investigator programme grant (12/IP/1400).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bhattacharyya S, 2011, P NATL ACAD SCI USA, V108, P9554, DOI 10.1073/pnas.1017296108; BIASCO G, 1990, CANCER RES, V50, P1156; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Broz P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003144; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Creagh EM, 2014, TRENDS IMMUNOL, V35, P631, DOI 10.1016/j.it.2014.10.004; Crncec I, 2018, MOL ONCOL, V12, P514, DOI 10.1002/1878-0261.12178; Demon D, 2014, MUCOSAL IMMUNOL, V7, P1504, DOI 10.1038/mi.2014.83; Dempoya J, 2012, J VIROL, V86, P12760, DOI 10.1128/JVI.01881-12; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Flood B, 2015, CLIN EXP IMMUNOL, V181, P39, DOI 10.1111/cei.12617; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fung KYC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120425; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gkouskou KK, 2016, ONCOGENE, V35, P2496, DOI 10.1038/onc.2015.307; Gurung P, 2012, J BIOL CHEM, V287, P16955; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hou J, 2014, CANCER CELL, V25, P49, DOI 10.1016/j.ccr.2013.11.011; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Hur J, 2001, FEBS LETT, V507, P157, DOI 10.1016/S0014-5793(01)02975-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalerl P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00088; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lopez-Pastrana J, 2015, J BIOL CHEM, V290, P17485, DOI 10.1074/jbc.M115.641191; Ma YH, 2016, ONCOTARGET, V7, P73003, DOI 10.18632/oncotarget.12193; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mattarollo SR, 2011, CANCER RES, V71, P4809, DOI 10.1158/0008-5472.CAN-11-0753; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nivarthi H, 2016, ONCOTARGET, V7, P51096, DOI 10.18632/oncotarget.9315; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Oficjalska K, 2015, J IMMUNOL, V194, P1252, DOI 10.4049/jimmunol.1400501; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Peterson JE, 2012, ANGIOGENESIS, V15, P265, DOI 10.1007/s10456-012-9259-z; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; Simpson JAD, 2010, GUT, V59, P926, DOI 10.1136/gut.2009.194472; Tattoli I, 2016, CELL REP, V14, P2576, DOI 10.1016/j.celrep.2016.02.065; Williams TM, 2015, J IMMUNOL, V194, P3369, DOI 10.4049/jimmunol.1402098; Williams TM, 2015, AM J PHYSIOL-GASTR L, V308, pG139, DOI 10.1152/ajpgi.00234.2014; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Wu XL, 2014, WORLD J GASTROENTERO, V20, P10440, DOI 10.3748/wjg.v20.i30.10440; Yuasa K, 2016, GENES CELLS, V21, P25, DOI 10.1111/gtc.12316; Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046	62	18	20	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2658	2674		10.1038/s41388-018-0613-5	http://dx.doi.org/10.1038/s41388-018-0613-5			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30538296	Green Published, hybrid			2022-12-26	WOS:000463335200015
J	Pearson, SJ; Sarkar, TR; McQueen, CM; Elswood, J; Schmitt, EE; Wall, SW; Scribner, KC; Wyatt, G; Barhoumi, R; Behbod, F; Rijnkels, M; Porter, WW				Pearson, Scott J.; Sarkar, Tapasree Roy; McQueen, Cole M.; Elswood, Jessica; Schmitt, Emily E.; Wall, Steven W.; Scribner, Kelly C.; Wyatt, Garhett; Barhoumi, Rola; Behbod, Fariba; Rijnkels, Monique; Porter, Weston W.			ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition	ONCOGENE			English	Article							CARCINOMA IN-SITU; SURGICAL ADJUVANT BREAST; DNA-DAMAGE; GENOMIC INSTABILITY; LOCAL RECURRENCE; CELL-CYCLE; C-MET; CANCER; REPAIR; BRCA1	There is increasing evidence that genomic instability is a prerequisite for cancer progression. Here we show that SIM2s, a member of the bHLH/PAS family of transcription factors, regulates DNA damage repair through enhancement of homologous recombination (HR), and prevents epithelial-mesenchymal transitions (EMT) in an Ataxia-telangiectasia mutated (ATM)-dependent manner. Mechanistically, we found that SIM2s interacts with ATM and is stabilized through ATM-dependent phosphorylation in response to IR. Once stabilized, SIM2s interacts with BRCA1 and supports RAD51 recruitment to the site of DNA damage. Loss of SIM2s through the introduction of shSIM2 or the mutation of SIM2s at one of the predicted ATM phosphorylation sites (S115) reduces HR efficiency through disruption of RAD51 recruitment, resulting in genomic instability and induction of EMT. The EMT induced by the mutation of S115 is characterized by a decrease in E-cadherin and an induction of the basal marker, K14, resulting in increased invasion and metastasis. Together, these results identify a novel player in the DNA damage repair pathway and provides a link in ductal carcinoma in situ progression to invasive ductal carcinoma through loss of SIM2s, increased genomic instability, EMT, and metastasis.	[Pearson, Scott J.; Sarkar, Tapasree Roy; McQueen, Cole M.; Elswood, Jessica; Schmitt, Emily E.; Wall, Steven W.; Scribner, Kelly C.; Wyatt, Garhett; Barhoumi, Rola; Rijnkels, Monique; Porter, Weston W.] Texas A&M Univ, Coll Vet Med, Dept Integrat Biosci, College Stn, TX 77843 USA; [Behbod, Fariba] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Porter, Weston W.] Texas A&M Univ, Vet Integrat Biosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University of Kansas; University of Kansas Medical Center; Texas A&M University System; Texas A&M University College Station	Porter, WW (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Integrat Biosci, College Stn, TX 77843 USA.; Porter, WW (corresponding author), Texas A&M Univ, Vet Integrat Biosci, College Stn, TX 77843 USA.	wporter@cvm.tamu.edu	Schmitt, Emily/GOP-0896-2022	Wall, Steven/0000-0002-4813-9920; Epps (Elswood), Jessica/0000-0003-1966-1557; Wyatt, Garhett/0000-0001-7402-6404	National Cancer Institute [R21CA190941, R01HD083952, R21CA185460]; Department of Defense (DOD-CDMRP) [W81XWH-11-1-0158]; American Association for Cancer Research (AACR)-2014 Breast Cancer Research Foundation-Translational Breast Cancer research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083952] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA190941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES026568] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense (DOD-CDMRP)(United States Department of Defense); American Association for Cancer Research (AACR)-2014 Breast Cancer Research Foundation-Translational Breast Cancer research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Cancer Institute R21CA190941 (WP); R01HD083952 (CO-PI WP, MR); R21CA185460 (FB) Department of Defense (DOD-CDMRP) W81XWH-11-1-0158 (KCS) American Association for Cancer Research (AACR)-2014 Breast Cancer Research Foundation-Translational Breast Cancer research (FB)	Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; [Anonymous], 2018, SOC AC CANC FACTS FI; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Burgess M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00019; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; Cowell CF, 2013, MOL ONCOL; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Du Y, 2016, NAT MED, V22, P194, DOI 10.1038/nm.4032; Elsarraj HS, 2017, CANCER RES, V77, P3802, DOI 10.1158/0008-5472.CAN-16-2794; Epstein DJ, 2000, DEVELOPMENT, V127, P4701; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gustafson TL, 2009, ONCOGENE, V28, P1561, DOI 10.1038/onc.2008.497; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Kim TM, 2012, MOL CELL BIOL, V32, P3663, DOI 10.1128/MCB.00406-12; Kumar Gaurav, 2005, Mo Med, V102, P138; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Laffin B, 2008, MOL CELL BIOL, V28, P1936, DOI 10.1128/MCB.01701-07; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Loeb LA, 2001, CANCER RES, V61, P3230; Lorkovic ZJ, 2017, NUCLEUS-PHILA, V8, P583, DOI 10.1080/19491034.2017.1384893; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Metz RP, 2006, J BIOL CHEM, V281, P10839, DOI 10.1074/jbc.M508858200; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Okui M, 2005, EXP CELL RES, V309, P220, DOI 10.1016/j.yexcr.2005.05.018; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rudloff U, 2010, J CLIN ONCOL, V28, P3762, DOI 10.1200/JCO.2009.26.8847; Rugo HS, 2016, NEW ENGL J MED, V375, P23, DOI 10.1056/NEJMoa1513749; Ryu T, 2015, NAT CELL BIOL, V17, P1401, DOI 10.1038/ncb3258; Sanders ME, 2005, CANCER, V103, P2481, DOI 10.1002/cncr.21069; Savage KI, 2014, MOL CELL, V54, P445, DOI 10.1016/j.molcel.2014.03.021; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scribner KC, 2013, ONCOGENE, V32, P2631, DOI 10.1038/onc.2012.286; Scribner KC, 2011, MOL ENDOCRINOL, V25, P635, DOI 10.1210/me.2010-0423; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Tirkkonen M, 1997, CANCER RES, V57, P1222; Trenz K, 2005, MUTAGENESIS, V20, P131, DOI 10.1093/mutage/gei018; Tsouroula K, 2016, MOL CELL, V63, P293, DOI 10.1016/j.molcel.2016.06.002; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Valdez KE, 2011, J PATHOL, V225, P565, DOI 10.1002/path.2969; Van Cleef A, 2014, FACTS VIEWS VIS OBGY, V6, P210; Wang Haibo, 2014, Jacobs J Radiat Oncol, V1; Wang JH, 2016, ONCOTARGET, V7, P7701, DOI 10.18632/oncotarget.6715; Wellberg E, 2010, DEVELOPMENT, V137, P945, DOI 10.1242/dev.041657; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; Yang RL, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0698-3; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Zamborszky J, 2017, ONCOGENE, V36, P746, DOI 10.1038/onc.2016.243; Zhou CY, 2003, ONCOGENE, V22, P2396, DOI 10.1038/sj.onc.1206319	78	10	10	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2611	2626		10.1038/s41388-018-0622-4	http://dx.doi.org/10.1038/s41388-018-0622-4			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30531838	Green Accepted			2022-12-26	WOS:000463335200012
J	Calatayud, M; Dezutter, O; Hernandez-Sanabria, E; Hidalgo-Martinez, S; Meysman, FJR; Van de Wiele, T				Calatayud, Marta; Dezutter, Olivier; Hernandez-Sanabria, Emma; Hidalgo-Martinez, Silvia; Meysman, Filip J. R.; Van de Wiele, Tom			Development of a host-microbiome model of the small intestine	FASEB JOURNAL			English	Article						in vitro microbiome; inflammation; Caco-2; HT29-MTX; THP-1	IN-VITRO; EPITHELIAL-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; PARACELLULAR PERMEABILITY; CHEMOKINE CXCL16; BARRIER FUNCTION; COCULTURE MODEL; GUT; CACO-2	The intestinal epithelium plays an essential role in the balance between tolerant and protective immune responses to infectious agents. In vitro models do not typically consider the innate immune response and gut microbiome in detail, so these models do not fully mimic the physiologic aspects of the small intestine. We developed and characterized a long-term in vitro model containing enterocyte, goblet, and immune-like cells exposed to a synthetic microbial community representative of commensal inhabitants of the small intestine. This model showed differential responses toward a synthetic microbial community of commensal bacterial inhabitants of the small intestine in the absence or presence of LPS from Escherichia coli O111:B4. Simultaneous exposure to LPS and microbiota induced impaired epithelial barrier function; increased production of IL-8, IL-6, TNF-, and C-X-C motif chemokine ligand 16; and augmented differentiation and adhesion of macrophage-like cells and the overexpression of dual oxidase 2 and TLR-2 and -4 mRNA. In addition, the model demonstrated the ability to assess the adhesion of specific bacterial strains from the synthetic microbial communitymore specifically, Veillonella parvulato the simulated epithelium. This novel in vitro model may assist in overcoming sampling and retrieval difficulties when studying host-microbiome interactions in the small intestine.Calatayud, M., Dezutter, O., Hernandez-Sanabria, E., Hidalgo-Martinez, S., Meysman, F. J. R., Van de Wiele, T. Development of a host-microbiome model of the small intestine.	[Calatayud, Marta; Dezutter, Olivier; Hernandez-Sanabria, Emma; Van de Wiele, Tom] Univ Ghent, CMET, Ghent, Belgium; [Hidalgo-Martinez, Silvia; Meysman, Filip J. R.] Univ Antwerp, Dept Biol, Ecosyst Management Res Grp ECOBE, Antwerp, Belgium; [Meysman, Filip J. R.] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Ghent University; University of Antwerp; Delft University of Technology	Calatayud, M; Van de Wiele, T (corresponding author), Univ Ghent, CMET UGent, Coupure Links 653, B-9000 Ghent, Belgium.	marta.calatayudarroyo@ugent.be; tom.vandewiele@ugent.be	CALATAYUD, MARTA/AAB-7099-2019; Van de Wiele, Tom/C-8638-2011; Meysman, Filip JR/C-9585-2009; Calatayud, Marta/B-6850-2019	Van de Wiele, Tom/0000-0001-6854-5689; Meysman, Filip JR/0000-0001-5334-7655; Calatayud, Marta/0000-0003-3592-3377; Hernandez Sanabria, Emma/0000-0002-5845-9821	Research Foundation Flanders (FWO) [12R2717N]; Ghent University [BOF-GOA-2017]; Flemish Agency for Innovation and Entrepreneurship; FWO Grant [G031416N]; Vici grant from Netherlands Organisation for Scientific Research [016.VICI.170.072]	Research Foundation Flanders (FWO)(FWO); Ghent University(Ghent University); Flemish Agency for Innovation and Entrepreneurship; FWO Grant(FWO); Vici grant from Netherlands Organisation for Scientific Research	The authors thank Charlotte de Rudder, Annelore Beterams, Rachael Hage, Brecht Hoflack, and Evelien Heiremans [all from the Center for Microbial Ecology and Technology (CMET), Ghent University] for their assistance in the cell laboratory. Special thanks are given to Geert Meesens (Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University) for his technical assistance during confocal imaging. This work was supported by a postdoctoral fellowship from Research Foundation Flanders (FWO) (12R2717N, to M.C.), and a Ghent University Concerted Research Action Grant (BOF-GOA-2017). O.D. was supported by Ghent University as a M.Sc. student. E.H.-S. is a postdoctoral fellow supported by the Flemish Agency for Innovation and Entrepreneurship (Agentschap Innoveren en Ondernemen). S.H.M. and F.J.R.M. were supported by FWO Grant G031416N, and a Vici grant from the Netherlands Organisation for Scientific Research (016.VICI.170.072). The authors declare no conflicts of interest.	Abreu M. T., 2001, GASTROENTEROLOGY, V120, P1609; Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Al-Ghadban S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29783; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Andersen SJ, 2014, ENVIRON SCI TECHNOL, V48, P7135, DOI 10.1021/es500483w; [Anonymous], CURR PROTOC IMMUNOL; Antunes F, 2013, EUR J PHARM BIOPHARM, V83, P427, DOI 10.1016/j.ejpb.2012.10.003; Arroyo MC, 2018, JOVE-J VIS EXP, DOI 10.3791/57699; ARTURSSON P, 1993, PHARMACEUT RES, V10, P1123, DOI 10.1023/A:1018903931777; Barrila J, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0011-2; Bein A, 2017, J CELL PHYSIOL, V232, P381, DOI 10.1002/jcp.25435; Beloqui A, 2017, NAT PROTOC, V12, P1387, DOI 10.1038/nprot.2017.041; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; Bowdish D., 2011, MAINTENANCE CULTURE; Calatayud M, 2013, TOXICOL LETT, V218, P70, DOI 10.1016/j.toxlet.2013.01.013; Calatayud M, 2012, CHEM RES TOXICOL, V25, P2654, DOI 10.1021/tx300295n; Calatayud M, 2012, CHEM RES TOXICOL, V25, P446, DOI 10.1021/tx200491f; Calatayud M, 2010, CHEM RES TOXICOL, V23, P547, DOI 10.1021/tx900279e; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Costello CM, 2014, BIOTECHNOL BIOENG, V111, P1222, DOI 10.1002/bit.25180; Didierlaurent A, 2002, CELL MICROBIOL, V4, P61, DOI 10.1046/j.1462-5822.2002.00177.x; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; El Aidy S, 2015, CURR OPIN BIOTECH, V32, P14, DOI 10.1016/j.copbio.2014.09.005; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Fischer Elizabeth R, 2012, Curr Protoc Microbiol, VChapter 2, DOI 10.1002/9780471729259.mc02b02s25; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Grasberger H, 2015, GASTROENTEROLOGY, V149, P1849, DOI 10.1053/j.gastro.2015.07.062; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hernandez-Sanabria E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00235; Hernandez-Sanabria E, 2010, APPL ENVIRON MICROB, V76, P6338, DOI 10.1128/AEM.01052-10; Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; Kampfer AAM, 2017, TOXICOL IN VITRO, V45, P31, DOI 10.1016/j.tiv.2017.08.011; Kanzato H, 2001, BIOSCI BIOTECH BIOCH, V65, P449, DOI 10.1271/bbb.65.449; Kubow KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9026; Kvietys PR, 2010, ANN NY ACAD SCI, V1207, pE29, DOI 10.1111/j.1749-6632.2010.05709.x; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Ma T. Y., 2005, GASTROENTEROLOGY, V128, pG422; Mani V., 2012, THESIS; McClure R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00386; Moyes SM, 2010, J ANAT, V217, P740, DOI 10.1111/j.1469-7580.2010.01304.x; Nicoletti C, 2009, MUCOSAL IMMUNOL, V2, P462, DOI 10.1038/mi.2009.92; Noel G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45270; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Props R, 2016, METHODS ECOL EVOL, V7, P1376, DOI 10.1111/2041-210X.12607; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sjoberg A, 2013, EUR J PHARM SCI, V48, P166, DOI 10.1016/j.ejps.2012.10.007; Sommer F, 2015, MUCOSAL IMMUNOL, V8, P372, DOI 10.1038/mi.2014.74; Song JC, 2001, AM J PHYSIOL-CELL PH, V281, pC649, DOI 10.1152/ajpcell.2001.281.2.C649; STENSON WF, 1993, AM J PHYSIOL, V265, pG955, DOI 10.1152/ajpgi.1993.265.5.G955; Sundin OH, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1059-6; van den Bogert B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01013-13; van den Bogert B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114277; von Martels JZH, 2017, ANAEROBE, V44, P3, DOI 10.1016/j.anaerobe.2017.01.001; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012	61	14	17	5	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3985	3996		10.1096/fj.201801414R	http://dx.doi.org/10.1096/fj.201801414R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521380				2022-12-26	WOS:000459794800070
J	Li, J; Kolberg, K; Schlecht, U; St Onge, RP; Aparicio, AM; Horecka, J; Davis, RW; Hillenmeyer, ME; Harvey, CJB				Li, Jian; Kolberg, Kristen; Schlecht, Ulrich; St Onge, Robert P.; Aparicio, Ana Maria; Horecka, Joe; Davis, Ronald W.; Hillenmeyer, Maureen E.; Harvey, Colin J. B.			A biosensor-based approach reveals links between efflux pump expression and cell cycle regulation in pleiotropic drug resistance of yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosensor; drug resistance; gene regulation; multidrug transporter; microarray	BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE; SPINDLE CHECKPOINT; WALL INTEGRITY; MECHANISMS; ANEUPLOIDY; PATHWAYS; PROTEINS; CANCER; GENES	Multidrug resistance is highly conserved in mammalian, fungal, and bacterial cells, is characterized by resistance to several unrelated xenobiotics, and poses significant challenges to managing infections and many cancers. Eukaryotes use a highly conserved set of drug efflux transporters that confer pleiotropic drug resistance (PDR). To interrogate the regulation of this critical process, here we developed a small molecule-responsive biosensor that couples transcriptional induction of PDR genes to growth rate in the yeast Saccharomyces cerevisiae. Using diverse PDR inducers and the homozygous diploid deletion collection, we applied this biosensor system to genome-wide screens for potential PDR regulators. In addition to recapitulating the activity of previously known factors, these screens identified a series of genes involved in a variety of cellular processes with significant but previously uncharacterized roles in the modulation of yeast PDR. Genes identified as down-regulators of the PDR included those encoding the MAD family of proteins involved in the mitotic spindle assembly checkpoint (SAC) complex. Of note, we demonstrated that genetic disruptions of the mitotic spindle assembly checkpoint elevate expression of PDR-mediating efflux pumps in response to exposure to a variety of compounds that themselves have no known influence on the cell cycle. These results not only establish our biosensor system as a viable tool for investigating PDR in a high-throughput fashion, but also uncover critical control mechanisms governing the PDR response and a previously uncharacterized link between PDR and cell cycle regulation in yeast.	[Li, Jian; Kolberg, Kristen; Schlecht, Ulrich; St Onge, Robert P.; Aparicio, Ana Maria; Horecka, Joe; Davis, Ronald W.; Hillenmeyer, Maureen E.; Harvey, Colin J. B.] Stanford Univ, Sch Med, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Hillenmeyer, Maureen E.] Hexagon Bio, Menlo Pk, CA 94025 USA	Stanford University	Harvey, CJB (corresponding author), Hexagon Bio, Menlo Pk, CA 94025 USA.	colinjbharvey@gmail.com		Harvey, Colin/0000-0002-4719-7627	National Institutes of Health [U01 GM110706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant U01 GM110706. U.S., C. J. B. H., and M. E. H. own shares in Hexagon Bio. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Calkins GN, 1914, SCIENCE, V40, P857, DOI DOI 10.1126/SCIENCE.40.1041.857; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cui ZF, 1999, BIOSCI BIOTECH BIOCH, V63, P162, DOI 10.1271/bbb.63.162; da Rosa JL, 2012, BBA-GENE REGUL MECH, V1819, P349, DOI 10.1016/j.bbagrm.2011.08.007; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dubey R, 2016, CANCER RES, V76, P5810, DOI 10.1158/0008-5472.CAN-16-0716; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Hallstrom TC, 1998, J BIOL CHEM, V273, P2098, DOI 10.1074/jbc.273.4.2098; James P, 1996, GENETICS, V144, P1425; Kathawala RJ, 2015, DRUG RESIST UPDATE, V18, P1, DOI 10.1016/j.drup.2014.11.002; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049, DOI 10.1074/jbc.271.38.23049; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Le Crom S, 2002, MOL CELL BIOL, V22, P2642, DOI 10.1128/MCB.22.8.2642-2649.2002; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nishida N, 2014, CURR GENET, V60, P149, DOI 10.1007/s00294-013-0419-5; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Piecuch A, 2014, CELL MOL BIOL LETT, V19, P1, DOI 10.2478/s11658-013-0111-2; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Salmela AL, 2013, CHROMOSOMA, V122, P431, DOI 10.1007/s00412-013-0419-8; Schlecht U, 2012, P NATL ACAD SCI USA, V109, P9213, DOI 10.1073/pnas.1204952109; Shekhar-Guturja T, 2016, NAT CHEM BIOL, V12, P867, DOI [10.1038/nchembio.2165, 10.1038/NCHEMBIO.2165]; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Vasudevan S, 2015, CARCINOGENESIS, V36, P883, DOI 10.1093/carcin/bgv072; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319; Yibmantasiri P, 2014, MOL BIOSYST, V10, P128, DOI 10.1039/c3mb70351g; Zhang XT, 2001, J BIOL CHEM, V276, P8812, DOI 10.1074/jbc.M010686200	43	1	1	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1257	1266		10.1074/jbc.RA118.003904	http://dx.doi.org/10.1074/jbc.RA118.003904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30514758	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000457879500017
J	De Pascalis, F; Collins, PM; Green, JA				De Pascalis, Federico; Collins, Philip M.; Green, Jonathan A.			Utility of time-lapse photography in studies of seabird ecology	PLOS ONE			English	Article							BLACK-LEGGED KITTIWAKES; RISSA-TRIDACTYLA; NORTH-SEA; FORAGING STRATEGIES; BREEDING SEABIRDS; INDICATORS; BEHAVIOR; FOOD; ALLOCATION; CONSEQUENCES	Marine ecosystems are heavily influenced by a wide range of human-related impacts, and thus monitoring is essential to preserve and manage these sensitive habitats. Seabirds are considered important bioindicators of the oceans, but accessing breeding populations can be difficult, expensive and time consuming. New technologies have been employed to facilitate data collection on seabirds that can reduce costs and minimize disturbance. Among these, the use of time-lapse photography is a potentially effective way to reduce researcher effort, while collecting valuable information on key ecological parameters. However, the feasibility of this approach remains uncertain. Here, we assessed the use of time-lapse photography as a tool for estimating foraging behaviour from breeding seabirds, and evaluate ways forward for this method. We deployed cameras in front of active nests at a colony of black legged kittiwakes (Rissa tridactyla) during two breeding seasons, 5 nests in 2013 and 5 in 2014, taking pictures every 4 minutes. A subsample of monitored individuals were also equipped with accelerometers. Approximately 100,000 frames, covering incubation and chick-rearing periods, were analysed. Estimates of foraging trip duration from images were positively correlated with accelerometry estimates (R-2 = 0.967). Equal partitioning of effort between pairs, predation events, nest attendance patterns and variation in trip metrics with breeding stage were also identified. Our results suggest that time-lapse photography is potentially a useful tool for assessing foraging trip duration and other fine-scale nesting ecology parameters as well as for assessing the effect of bio-logging devices on seabird foraging behaviour. Nevertheless, the time investment to manually extract data from images was high, and the process to set up cameras was not straightforward. To encourage wide use of time-lapse photography in seabird ecology, we thus provide guidelines for camera deployment and we suggest a need for further development of automated approaches to allow data extraction.	[De Pascalis, Federico] Univ Trieste, Dept Life Sci, Trieste, Italy; [De Pascalis, Federico; Green, Jonathan A.] Univ Liverpool, Sch Environm Sci, Liverpool, Merseyside, England; [Collins, Philip M.] Univ Roehampton, Sch Life Sci, London, England	University of Trieste; University of Liverpool; Roehampton University	Green, JA (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool, Merseyside, England.	Jonathan.Green@liverpool.ac.uk	Green, Jonathan A/B-8799-2011	Green, Jonathan A/0000-0001-8692-0163; De Pascalis, Federico/0000-0002-1414-7770	University of Trieste [2015/2016-88]; University of Roehampton	University of Trieste; University of Roehampton	FDP was founded by an Erasmus+ Traineeship grant from the University of Trieste (Agreement N. 2015/2016-88, https://ec.europa.eu/programmes/erasmus-plus/opportunities/traineeships-students_en). PMC was supported by a studentship from the .University of Roehampton (https://www.roehampton.ac.uk/graduate-school/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benvenuti S, 2001, IBIS, V143, P402, DOI 10.1111/j.1474-919X.2001.tb04941.x; BirdLife International, 2017, RISS TRID IUCN RED L, DOI [10.2305/IUCN.UK.2017-3.RLTS.T22694497A118366481.en, DOI 10.2305/IUCN.UK.2017-3.RLTS.T22694497A118366481.EN]; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Bodey TW, 2018, METHODS ECOL EVOL, V9, P946, DOI 10.1111/2041-210X.12934; Bolton M, 2007, J FIELD ORNITHOL, V78, P213, DOI 10.1111/j.1557-9263.2007.00104.x; Brisson-Curadeau E, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00357; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Casazza Gianna, 2002, Journal of Coastal Conservation, V8, P147, DOI 10.1652/1400-0350(2002)008[0147:TUOBFQ]2.0.CO;2; Chivers LS, 2016, CONDOR, V118, P159, DOI 10.1650/CONDOR-15-66.1; Chivers LS, 2012, MAR ECOL PROG SER, V456, P269, DOI 10.3354/meps09691; Collins PM, 2016, J ZOOL, V300, P153, DOI 10.1111/jzo.12370; Collins PM, 2015, ECOL EVOL, V5, P4642, DOI 10.1002/ece3.1660; Collins PM, 2014, WILSON J ORNITHOL, V126, P158, DOI 10.1676/13-141.1; Coulson J.C., 2011, THE KITTIWAKE; COULSON JC, 1993, IBIS, V135, P372, DOI 10.1111/j.1474-919X.1993.tb02108.x; COULSON JC, 1984, ANIM BEHAV, V32, P1204, DOI 10.1016/S0003-3472(84)80238-9; Daunt F, 2002, MAR ECOL PROG SER, V245, P239, DOI 10.3354/meps245239; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Frederiksen M, 2007, MAR ECOL PROG SER, V352, P205, DOI 10.3354/meps07071; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Gaston Anthony J., 2007, Marine Ornithology, V35, P119; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HAMER KC, 1993, IBIS, V135, P255, DOI 10.1111/j.1474-919X.1993.tb02842.x; Heggoy O, 2015, MAR ECOL PROG SER, V521, P237, DOI 10.3354/meps11140; Huffeldt NP, 2013, WATERBIRDS, V36, P330, DOI 10.1675/063.036.0310; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; JNCC, BLACK LEGGED KITTIWA; Kitaysky AS, 2000, MAR ECOL PROG SER, V206, P283, DOI 10.3354/meps206283; Kotzerka J, 2010, J ORNITHOL, V151, P459, DOI 10.1007/s10336-009-0479-y; Kullenberg C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147152; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Lorentzen E, 2012, J ORNITHOL, V152, pS477, DOI 10.1007/s10336-011-0723-0; Lynch TP, 2015, METHODS ECOL EVOL, V6, P491, DOI 10.1111/2041-210X.12339; MONAGHAN P, 1994, IBIS, V136, P214, DOI 10.1111/j.1474-919X.1994.tb01087.x; O'Brien TG, 2008, BIRD CONSERV INT, V18, pS144, DOI 10.1017/S0959270908000348; Orians G.H., 1979, P155; Paredes R, 2005, ANIM BEHAV, V69, P197, DOI 10.1016/j.anbehav.2003.12.029; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Pinheiro J, 2020, R PACKAGE VERSION 31; Puffin Island Seabird Research, MON; R Core Team, 2021, R LANGUAGE ENV STAT; Redfern CPF, 2001, BTO RINGERS MANUAL; Regehr HM, 1997, MAR ECOL PROG SER, V155, P249, DOI 10.3354/meps155249; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Southwell C, 2015, J NAT CONSERV, V23, P1, DOI 10.1016/j.jnc.2014.11.002; Suryan RM, 2000, CONDOR, V102, P374, DOI 10.1650/0010-5422(2000)102[0374:PSAVFS]2.0.CO;2; Tack JLP, 2016, ECOL INFORM, V36, P145, DOI 10.1016/j.ecoinf.2016.11.003; Venables WN., 2002, MODERN APPL STAT S, V4; Wanless S, 2007, PROG OCEANOGR, V72, P30, DOI 10.1016/j.pocean.2006.07.007; White CR, 2013, J EXP BIOL, V216, P537, DOI 10.1242/jeb.076554; Zooniverse.org, SEAB	56	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208995	10.1371/journal.pone.0208995	http://dx.doi.org/10.1371/journal.pone.0208995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540854	Green Submitted, gold, Green Published			2022-12-26	WOS:000452898600104
J	Eida, AA; Ziegler, M; Lafi, FF; Michell, CT; Voolstra, CR; Hirt, H; Saad, MM				Eida, Abdul Aziz; Ziegler, Maren; Lafi, Feras F.; Michell, Craig T.; Voolstra, Christian R.; Hirt, Heribert; Saad, Maged M.			Desert plant bacteria reveal host influence and beneficial plant growth properties	PLOS ONE			English	Article							PROMOTING RHIZOBACTERIA; MYCORRHIZAL FUNGI; ABIOTIC STRESS; RHIZOSPHERE; MICROBIOME; SOIL; PRODUCTIVITY; EVOLUTIONARY; METABOLISM; TOLERANCE	Deserts, such as those found in Saudi Arabia, are one of the most hostile places for plant growth. However, desert plants are able to impact their surrounding microbial community and select beneficial microbes that promote their growth under these extreme conditions. In this study, we examined the soil, rhizosphere and endosphere bacterial communities of four native desert plants Tribulus terrestris, Zygophyllum simplex, Panicum turgidum and Euphorbia granulata from the Southwest (Jizan region), two of which were also found in the Midwest (Al Wahbah area) of Saudi Arabia. While the rhizosphere bacterial community mostly resembled that of the highly different surrounding soils, the endosphere composition was strongly correlated with its host plant phylogeny. In order to assess whether any of the native bacterial endophytes might have a role in plant growth under extreme conditions, we analyzed the properties of 116 cultured bacterial isolates that represent members of the phyla Proteobacteria, Bacteroidetes, Actinobacteria and Firmicutes. Our analysis shows that different strains have highly different biochemical properties with respect to nutrient acquisition, hormone production and growth under stress conditions. More importantly, eleven of the isolated strains could confer salinity stress tolerance to the experimental model plant Arabidopsis thaliana suggesting some of these plant-associated bacteria might be useful for improving crop desert agriculture.	[Eida, Abdul Aziz; Lafi, Feras F.; Hirt, Heribert; Saad, Maged M.] KAUST, Biol & Environm Sci & Engn Div BESE, Desert Agr Initiat, Thuwal, Saudi Arabia; [Ziegler, Maren; Michell, Craig T.; Voolstra, Christian R.] KAUST, Biol & Environm Sci & Engn Div BESE, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Lafi, Feras F.] Zayed Univ, Coll Nat & Hlth Sci, Abu Dhabi Campus, Dubai, U Arab Emirates; [Michell, Craig T.] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Zayed University; University of Eastern Finland	Hirt, H (corresponding author), KAUST, Biol & Environm Sci & Engn Div BESE, Desert Agr Initiat, Thuwal, Saudi Arabia.	heribert.hirt@kaust.edu.sa	Voolstra, Christian R/H-7158-2014; Saad, Maged M./B-5546-2018; Eida, Abdul Aziz/AAN-8678-2020; Lafi, Feras/P-4776-2016	Voolstra, Christian R/0000-0003-4555-3795; Saad, Maged M./0000-0002-5655-8674; Eida, Abdul Aziz/0000-0002-1718-3750; Ziegler, Maren/0000-0003-2237-9261; Hirt, Heribert/0000-0003-3119-9633; Lafi, Feras/0000-0001-6468-4104; Michell, Craig/0000-0003-4706-7256	KAUST baseline research projects [BAS/1/1062-01-01]	KAUST baseline research projects	The work was funded by KAUST baseline BAS/1/1062-01-01 research projects of HH and CRV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work presented in this study is part of the DARWIN21 project (http://www.darwin21.org/), with the objective to improve sustainable agriculture on arid lands by exploiting microbes isolated from pioneer desert plants that are able to survive in extreme environmental conditions. The authors would thank all members of Hirt lab, CDA management team and the greenhouse core lab facility in KAUST for the technical assistance and for their help in many aspects of this work. The work was funded by KAUST baseline research projects of H.H. and C.R.V. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andres-Barrao C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02023; [Anonymous], 2017, WORLD POP PROSP 2017; Bapiri A, 2013, J APPL SCI ENV MANAG, V16; Belnap J., 2003, BIOL SOIL CRUSTS STR, P167, DOI [10.1007/978-3-642-56475-8_14, 10.1007/978-3-642-56475-8, DOI 10.1007/978-3-642-56475-8]; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRAY E, 2000, BIOCH MOL BIOL PLANT; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Bulgarelli D, 2015, CELL HOST MICROBE, V17, P392, DOI 10.1016/j.chom.2015.01.011; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cerri CEP, 2007, SCI AGR, V64, P83, DOI 10.1590/S0103-90162007000100013; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Daur I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00477; de Zelicourt A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007273; de Zelicourt A, 2013, MOL PLANT, V6, P242, DOI 10.1093/mp/sst028; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; Elbeltagy A, 2000, SOIL SCI PLANT NUTR, V46, P617, DOI 10.1080/00380768.2000.10409127; Ezcurra E., 2006, GLOBAL DESERTS OUTLO; Friesen ML, 2011, ANNU REV ECOL EVOL S, V42, P23, DOI 10.1146/annurev-ecolsys-102710-145039; Glick BR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/963401; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gorley C.K., 2006, GETTING STARTED PRIM; Hanin M, 2016, FRONT PLANT SCI, P7; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hartwell J, 2005, BIOCHEM SOC T, V33, P945, DOI 10.1042/BST20050945; Hernandez M, 2015, APPL ENVIRON MICROB, V81, P2244, DOI 10.1128/AEM.03209-14; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jha B, 2012, PLANT SOIL, V356, P265, DOI 10.1007/s11104-011-0877-9; Kaplan D, 2013, AM J BOT, V100, P1713, DOI 10.3732/ajb.1200615; Kieft T. L., 1991, Semiarid lands and deserts: soil resource and reclamation., P209; Kim WI, 2011, J MICROBIOL BIOTECHN, V21, P777, DOI 10.4014/jmb.1101.01031; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; KLOEPPER JW, 1981, PHYTOPATHOLOGY, V71, P642, DOI 10.1094/Phyto-71-642; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lafi FF, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01707-16, 10.1128/genomea.01707-16]; Lafi FF, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomea.01708-16, 10.1128/genomeA.01708-16]; Lafi FF, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01437-16, 10.1128/genomea.01437-16]; Lafi FF, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01214-16; Lafi FF, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01520-16; Lafi FF, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01431-16; Lafi FF, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00678-16; Ledger T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01838; Liu XM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00774; Louden BC, 2011, J MICROBIOL BIOL EDU, V12, P51, DOI 10.1128/jmbe.v12i1.249; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mahmood S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00876; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mengual C, 2014, J ENVIRON MANAGE, V134, P1, DOI 10.1016/j.jenvman.2014.01.008; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Morgan JAW, 2005, J EXP BOT, V56, P1729, DOI 10.1093/jxb/eri205; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadeem SM, 2014, BIOTECHNOL ADV, V32, P429, DOI 10.1016/j.biotechadv.2013.12.005; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Ortiz N, 2015, J PLANT PHYSIOL, V174, P87, DOI 10.1016/j.jplph.2014.08.019; Osman JR, 2016, OPEN C P J; OSMOND CB, 1978, ANNU REV PLANT PHYS, V29, P379, DOI 10.1146/annurev.pp.29.060178.002115; Pandey P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00537; Persello-Cartieaux F, 2003, PLANT CELL ENVIRON, V26, P189, DOI 10.1046/j.1365-3040.2003.00956.x; Pikovskaya R.I., 1948, MIKROBIOLOGIYA, V17, pe370; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rewald B, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P196, DOI 10.1079/9781845938147.0196; Rolli E, 2015, ENVIRON MICROBIOL, V17, P316, DOI 10.1111/1462-2920.12439; Rothig T, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00259; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Schlaeppi K, 2015, MOL PLANT MICROBE IN, V28, P212, DOI 10.1094/MPMI-10-14-0334-FI; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmid M, 2009, RES MICROBIOL, V160, P608, DOI 10.1016/j.resmic.2009.08.013; Selvakumar G, 2008, WORLD J MICROB BIOT, V24, P955, DOI 10.1007/s11274-007-9558-5; Singh R, 2013, IND CROP PROD, V45, P335, DOI 10.1016/j.indcrop.2013.01.003; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Yamori W, 2014, PHOTOSYNTH RES, V119, P101, DOI 10.1007/s11120-013-9874-6; Yeoh YK, 2017, NATURE COMMUNICATION, P8; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14	78	45	46	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208223	10.1371/journal.pone.0208223	http://dx.doi.org/10.1371/journal.pone.0208223			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540793	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600064
J	Hickl, J; Argyropoulou, A; Sakavitsi, ME; Halabalaki, M; Al-Ahmad, A; Hellwig, E; Aligiannis, N; Skaltsounis, AL; Wittmer, A; Vach, K; Karygianni, L				Hickl, Joachim; Argyropoulou, Aikaterini; Sakavitsi, Maria Eleni; Halabalaki, Maria; Al-Ahmad, Ali; Hellwig, Elmer; Aligiannis, Nektarios; Skaltsounis, Alexios Leandros; Wittmer, Annette; Vach, Kirstin; Karygianni, Lamprini			Mediterranean herb extracts inhibit microbial growth of representative oral microorganisms and biofilm formation of Streptococcus mutans	PLOS ONE			English	Article							LABDANE-TYPE DITERPENES; ESSENTIAL OILS; ROSMARINUS-OFFICINALIS; ANTIMICROBIAL ACTIVITY; ANTIBACTERIAL ACTIVITIES; HYDROALCOHOLIC EXTRACT; CHEMICAL-COMPOSITION; SUBSP ERIOCEPHALUS; PHENOLIC-COMPOUNDS; MASS-SPECTROMETRY	In light of the growing antibiotic resistance, the usage of plant-derived antimicrobial agents could serve as an effective alternative treatment against oral infections. The aim of this study was to investigate the antimicrobial and antibiofilm activity of Mediterranean herb extracts against representative oral microorganisms. The extraction procedures and the analysis of the obtained extracts were performed under established experimental conditions. The minimum inhibitory (MIC) and bactericidal (MBC) concentrations of the methanol extracts of Cistus creticus ssp. creticus, Cistus monspeliensis, Origanum vulgare, Rosmarinus officinalis, Salvia sclarea and Thymus longicaulis against eight typical oral bacteria and the fungus Candida albicans were determined. The antibiofilm activity against Streptococcus mutans was also quantified using the microtiter plate test. Overall, all tested extracts inhibited effectively the screened obligate anaerobic microorganisms and in concentrations >= 0.3 mg ml(-1) had moderate to high antibiofilm activity comparable to that of chlorhexidine (CHX) against S. mutans. In particular, R. officinalis (MIC: 0.08-5.00 mg ml(-1)) and S. sclarea (MIC: 0.08-2.50 mg ml(-1)) showed the highest antibacterial activity, while Cistusspp., R. officinalis and S. sclarea significantly inhibited S. mutans biofilm formation at 0.60, 1.25 and 2.50 mg ml(-1), respectively. Porphyromonas gingivalis and Parvimonas micra were high susceptible to O. vulgare (MIC = 0.30 mg ml(-1)), whereas T. longicaulis eradicated all oral bacteria (MBC: 0.15-2.50 mg ml(-1)). Nevertheless, C. albicans showed no sensitivity to the tested extracts. In conclusion, the tested plant extracts could serve as alternative natural antibacterial and antibiofilm components against oral infections.	[Hickl, Joachim; Al-Ahmad, Ali; Hellwig, Elmer; Karygianni, Lamprini] Univ Freiburg, Med Ctr, Dept Operat Dent & Periodontol, Fac Med, Freiburg, Germany; [Argyropoulou, Aikaterini; Sakavitsi, Maria Eleni; Halabalaki, Maria; Aligiannis, Nektarios; Skaltsounis, Alexios Leandros] Natl & Kapodistrian Univ Athens, Dept Pharmacognosy & Nat Prod Chem, Fac Pharm, Athens, Greece; [Wittmer, Annette] Univ Freiburg, Inst Med Microbiol & Hyg, Fac Med, Freiburg, Germany; [Vach, Kirstin] Univ Freiburg, Inst Med Biometry & Stat, Fac Med, Freiburg, Germany; [Vach, Kirstin] Univ Freiburg, Med Ctr, Freiburg, Germany; [Karygianni, Lamprini] Univ Zurich, Clin Prevent Dent Periodontol & Cariol, Ctr Dent Med, Zurich, Switzerland	University of Freiburg; National & Kapodistrian University of Athens; University of Freiburg; University of Freiburg; University of Freiburg; University of Zurich	Karygianni, L (corresponding author), Univ Freiburg, Med Ctr, Dept Operat Dent & Periodontol, Fac Med, Freiburg, Germany.; Karygianni, L (corresponding author), Univ Zurich, Clin Prevent Dent Periodontol & Cariol, Ctr Dent Med, Zurich, Switzerland.	lamprini.karygianni@zzm.uzh.ch	Vach, Kirstin/AAI-4643-2020; skaltsounis, alexios leandros/AAE-9617-2019; Vach, Kirstin/GQP-0449-2022; Sakavitsi, Maria Eleni/AAH-1514-2020; Halabalaki, Maria/AAD-2127-2020	Vach, Kirstin/0000-0001-9278-2203; Vach, Kirstin/0000-0001-9278-2203; Sakavitsi, Maria Eleni/0000-0002-7849-638X; ALIGIANNIS, NEKTARIOS/0000-0002-3335-8135	German Research Foundation (DFG) [AL 1179/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported in part by the German Research Foundation (DFG, AL 1179/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Achour M, 2018, PHYTOCHEM ANALYSIS, V29, P87, DOI 10.1002/pca.2717; Agrawal Vineet, 2017, Journal of Dietary Supplements, V14, P229, DOI 10.1080/19390211.2016.1207004; Al-Ahmad A, 2008, ARCH ORAL BIOL, V53, P765, DOI 10.1016/j.archoralbio.2008.02.014; Anastasaki T, 1999, PLANTA MED, V65, P735, DOI 10.1055/s-1999-14095; Bardaji DKR, 2016, NAT PROD RES, V30, P1178, DOI 10.1080/14786419.2015.1043630; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; Bouamama H, 2006, J ETHNOPHARMACOL, V104, P104, DOI 10.1016/j.jep.2005.08.062; Breen S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00900; Chang SY, 2016, BIOCHEM BIOPH RES CO, V471, P282, DOI 10.1016/j.bbrc.2016.01.123; CHINOU I, 1994, PLANTA MED, V60, P34, DOI 10.1055/s-2006-959403; Chinsembu KC, 2016, ACTA TROP, V154, P6, DOI 10.1016/j.actatropica.2015.10.019; Chorianopoulos N, 2004, J AGR FOOD CHEM, V52, P8261, DOI 10.1021/jf049113i; CLSI, 2012, METHODS DILUTION ANT; CLSI, 2012, METH ANT SUSC TEST A, V32; Coccimiglio J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1404505; Cui JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150595; De Martino L, 2009, MOLECULES, V14, P4614, DOI 10.3390/molecules14114614; Demetzos C, 1997, PLANTA MED, V63, P477, DOI 10.1055/s-2006-957742; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Didry N, 1994, Pharm Acta Helv, V69, P25, DOI 10.1016/0031-6865(94)90027-2; Fernandez-Arroyo S, 2010, PHYTOCHEM ANALYSIS, V21, P307, DOI 10.1002/pca.1200; Fernandez-Ochoa A, 2017, J FUNCT FOODS, V33, P202, DOI 10.1016/j.jff.2017.03.046; Firuzi O, 2013, IRAN J PHARM RES, V12, P801; Freires IA, 2016, PHARM RES-DORDR, V33, P1311, DOI 10.1007/s11095-016-1905-5; Freires IA, 2015, MOLECULES, V20, P7329, DOI 10.3390/molecules20047329; German Institute for Standardization, 2007, 2077612006 ISO; Gortzi O, 2006, J FOOD PROTECT, V69, P2998, DOI 10.4315/0362-028X-69.12.2998; Gyawali R, 2014, FOOD CONTROL, V46, P412, DOI 10.1016/j.foodcont.2014.05.047; Hammer KA, 1999, J APPL MICROBIOL, V86, P985, DOI 10.1046/j.1365-2672.1999.00780.x; Hannig C, 2009, J DENT, V37, P560, DOI 10.1016/j.jdent.2009.03.017; Hernandez-Hernandez Elvia, 2014, ScientificWorldJournal, V2014, P641814, DOI 10.1155/2014/641814; Horner C, 2012, J ANTIMICROB CHEMOTH, V67, P2547, DOI 10.1093/jac/dks284; Hotwani Kavita, 2014, J Complement Integr Med, V11, P233, DOI 10.1515/jcim-2013-0015; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Jones D, 1991, MAINTENANCE MICROORG, P45; Justesen U, 2000, J CHROMATOGR A, V902, P369, DOI 10.1016/S0021-9673(00)00861-X; Karygianni L, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01529; Karygianni L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/839019; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kontogianni VG, 2013, FOOD CHEM, V136, P120, DOI 10.1016/j.foodchem.2012.07.091; Kuzma L, 2007, PHYTOMEDICINE, V14, P31, DOI 10.1016/j.phymed.2005.10.008; Lemstrova R, 2016, CANCER CHEMOTH PHARM, V78, P1101, DOI 10.1007/s00280-016-3058-y; Maggi F, 2016, BIOCHEM SYST ECOL, V66, P50, DOI 10.1016/j.bse.2016.02.030; Mahyari S, 2016, COMPLEMENT THER CLIN, V22, P93, DOI 10.1016/j.ctcp.2015.12.001; Martins N, 2015, FOOD CHEM, V170, P378, DOI 10.1016/j.foodchem.2014.08.096; Martins N, 2015, FOOD CHEM, V167, P131, DOI 10.1016/j.foodchem.2014.06.094; Martins N, 2014, FOOD CHEM, V158, P73, DOI 10.1016/j.foodchem.2014.02.099; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Mikaili P, 2013, ANC SCI LIFE, V33, P131, DOI 10.4103/0257-7941.139059; Munita JM, 2015, CLIN INFECT DIS, V61, pS48, DOI 10.1093/cid/civ523; Nassiri-Asl M, 2009, PHYTOTHER RES, V23, P1197, DOI 10.1002/ptr.2761; Nawrocki KL, 2014, ANTIBIOTICS-BASEL, V3, P461, DOI 10.3390/antibiotics3040461; Oluwatuyi M, 2004, PHYTOCHEMISTRY, V65, P3249, DOI 10.1016/j.phytochem.2004.10.009; Page Malcolm G P, 2012, Handb Exp Pharmacol, P67, DOI 10.1007/978-3-642-28951-4_5; Pages JM, 2009, BBA-PROTEINS PROTEOM, V1794, P826, DOI 10.1016/j.bbapap.2008.12.011; Petiwala SM, 2015, CANCER LETT, V367, P93, DOI 10.1016/j.canlet.2015.07.005; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Sassi AB, 2008, PHARM BIOL, V45, P421; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Sharifzadeh A, 2016, AVICENNA J PHYTOMEDI, V6, P215; Stagos D, 2012, FOOD CHEM TOXICOL, V50, P4115, DOI 10.1016/j.fct.2012.08.033; Sulniute V, 2017, FOOD CHEM, V224, P37, DOI 10.1016/j.foodchem.2016.12.047; Taamalli A, 2015, PHYTOCHEM ANALYSIS, V26, P320, DOI 10.1002/pca.2566; Thakur R, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.00618, 10.3389/fmicb.2015.00429]; Tiwari V, 2017, MICROB PATHOGENESIS, V110, P345, DOI 10.1016/j.micpath.2017.07.013; Tsai PJ, 2007, FOOD CHEM, V105, P311, DOI 10.1016/j.foodchem.2006.11.051; Tsimogiannis D, 2007, MOLECULES, V12, P593, DOI 10.3390/12030593; Walencka E, 2007, PLANTA MED, V73, P545, DOI 10.1055/s-2007-967179; Welin-Neilands J, 2007, APPL ENVIRON MICROB, V73, P5633, DOI 10.1128/AEM.01049-07; Wolf P, 2016, BRIT J DERMATOL, V174, P11, DOI 10.1111/bjd.14341	71	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207574	10.1371/journal.pone.0207574	http://dx.doi.org/10.1371/journal.pone.0207574			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540782	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600023
J	Tai, AS; Peng, CH; Peng, SC; Hsieh, WP				Tai, An-Shun; Peng, Chien-Hua; Peng, Shih-Chi; Hsieh, Wen-Ping			Decomposing the subclonal structure of tumors with two-way mixture models on copy number aberrations	PLOS ONE			English	Article							CLONAL EVOLUTION; CELL; CANCER; HEAD; OVEREXPRESSION; HETEROGENEITY; AMPLIFICATION; METASTASIS; GENOME; 11Q13	Multistage tumorigenesis is a dynamic process characterized by the accumulation of mutations. Thus, a tumor mass is composed of genetically divergent cell subclones. With the advancement of next-generation sequencing (NGS), mathematical models have been recently developed to decompose tumor subclonal architecture from a collective genome sequencing data. Most of the methods focused on single-nucleotide variants (SNVs). However, somatic copy number aberrations (CNAs) also play critical roles in carcinogenesis. Therefore, further modeling subclonal CNAs composition would hold the promise to improve the analysis of tumor heterogeneity and cancer evolution. To address this issue, we developed a two-way mixture Poisson model, named CloneDeMix for the deconvolution of read depth information. It can infer the subclonal copy number, mutational cellular prevalence (MCP), subclone composition, and the order in which mutations occurred in the evolutionary hierarchy. The performance of CloneDeMix was systematically assessed in simulations. As a result, the accuracy of CNA inference was nearly 93% and the MCP was also accurately restored. Furthermore, we also demonstrated its applicability using head and neck cancer samples from TCGA. Our results inform about the extent of subclonal CNA diversity, and a group of candidate genes that probably initiate lymph node metastasis during tumor evolution was also discovered. Most importantly, these driver genes are located at 11q13.3 which is highly susceptible to copy number change in head and neck cancer genomes. This study successfully estimates subclonal CNAs and exhibit the evolutionary relationships of mutation events. By doing so, we can track tumor heterogeneity and identify crucial mutations during evolution process. Hence, it facilitates not only understanding the cancer development but finding potential therapeutic targets. Briefly, this framework has implications for improved modeling of tumor evolution and the importance of inclusion of subclonal CNAs.	[Tai, An-Shun; Peng, Chien-Hua; Peng, Shih-Chi; Hsieh, Wen-Ping] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan	National Tsing Hua University	Peng, CH; Hsieh, WP (corresponding author), Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan.	ariel0207@gmail.com; wphsieh@stat.nthu.edu.tw	Tai, An-Shun/AAA-7181-2021	Tai, An-Shun/0000-0002-2583-0188	Ministry of Science and Technology in Taiwan [MOST 106-2118-M-007-004]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the Ministry of Science and Technology in Taiwan [MOST 106-2118-M-007-004]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Ding L, 2013, CANCER LETT, V340, P212, DOI 10.1016/j.canlet.2012.12.028; El-Kebir M, 2015, BIOINFORMATICS, V31, P62, DOI 10.1093/bioinformatics/btv261; Fagiani E, 2011, CANCER RES, V71, P5717, DOI 10.1158/0008-5472.CAN-10-4635; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Hao JJ, 2016, NAT GENET, V48, P1500, DOI 10.1038/ng.3683; Hao JJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-367; Holopainen T, 2009, CANCER RES, V69, P4656, DOI 10.1158/0008-5472.CAN-08-4654; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hu XX, 2016, INT J MED SCI, V13, P868, DOI 10.7150/ijms.16845; Jiao W, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-35; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Krijgsman O, 2014, BBA-MOL CELL RES, V1843, P2698, DOI 10.1016/j.bbamcr.2014.08.001; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li P, 2015, INT J CLIN EXP PATHO, V8, P12101; Li TT, 2012, CANCER MICROENVIRON, V5, P249, DOI 10.1007/s12307-012-0119-6; Li Y, 2014, BIOINFORMATICS; Li Y, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S1; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Malikic S, 2015, BIOINFORMATICS, V31, P1349, DOI 10.1093/bioinformatics/btv003; Mangiola S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33918; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Miller CA, 2014, SCICLONE INFERRING C, DOI [10.1371/journal.pcbi.1003665, DOI 10.1371/JOURNAL.PCBI.1003665]; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Mroz EA, 2013, CANCER-AM CANCER SOC, V119, P3034, DOI 10.1002/cncr.28150; MULLER D, 1994, ORAL ONCOL, V30B, P113; Nomura Tsutomu, 2007, Journal of Nippon Medical School, V74, P163, DOI 10.1272/jnms.74.163; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oesper L, 2014, BIOINFORMATICS, V30, P3532, DOI 10.1093/bioinformatics/btu651; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Petty RD, 2017, J CLIN ONCOL, V35, P2279, DOI 10.1200/JCO.2016.70.3934; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Qi L, 2016, ONCOTARGET, V7, DOI [10.18632/oncotarget.6589, DOI 10.18632/ONCOTARGET.6589]; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sugahara K, 2011, INT J ONCOL, V39, P761, DOI 10.3892/ijo.2011.1094; Valsesia Armand, 2013, Frontiers in Genetics, V4, P92, DOI 10.3389/fgene.2013.00092; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yang PW, 2013, ANN SURG ONCOL, V20, P562, DOI 10.1245/s10434-012-2622-x; Yu ZH, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1174-7; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang ZW, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0458-0	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0206579	10.1371/journal.pone.0206579	http://dx.doi.org/10.1371/journal.pone.0206579			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540749	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600004
J	German-Cecilia, C; Reyes, SMG; Silva, AP; Munoz, CS; Ortiz-Ruiz, AJ				German-Cecilia, Concepcion; Gallego Reyes, Sandra Maria; Perez Silva, Amparo; Serna Munoz, Clara; Jose Ortiz-Ruiz, Antonio			Microleakage of conventional light-cure resin-based fissure sealant and resin-modified glass ionomer sealant after application of a fluoride varnish on demineralized enamel	PLOS ONE			English	Article							AMERICAN-DENTAL-ASSOCIATION; CARIES; PIT; EFFICACY; ADHESION	Background International guidelines on the prevention of caries recommend sealing of the pits and fissures of the permanent molars. There is no evidence on which type of material is most effective on demineralized enamel. Aim To evaluate the microleakage of a conventional light-cured, resin-based fissure sealant (LCRBS), GrandiO Seal, and a resin-modified glass ionomer sealant (RMGIS), Vitremer, after application of a fluoride varnish, Bifluorid 12, on demineralized enamel. Design 80 human third molars were divided into eight groups. The groups combined the three study factors (1) type of enamel (intact or demineralized); (2) enamel non-varnished or varnished with Biflourid12; and (3) type of sealant (GrandiO Seal or Vitremer). The percentage of microleakage after thermocycling was measured using imaging analysis software. The Kruskal-Wallis plus Dunn tests were used to compare differences in microleakage in the different groups. Results The lowest microleakage was in the unvarnished groups, and was the same for GrandiO Seal and Vitremer. When varnish was applied, microleakage was greater in demineralized enamel than in intact enamel for both LCRBS and RMGIS. Conclusion The application of fluoride varnish on demineralized enamel increases the microleakage of both GrandiO Seal and Vitremer.	[German-Cecilia, Concepcion; Gallego Reyes, Sandra Maria; Perez Silva, Amparo; Serna Munoz, Clara; Jose Ortiz-Ruiz, Antonio] Univ Murcia, Fac Med & Dent, Dept Integral Paediat Dent, Murcia, Spain	University of Murcia	German-Cecilia, C (corresponding author), Univ Murcia, Fac Med & Dent, Dept Integral Paediat Dent, Murcia, Spain.	concgermam@yahoo.es	Ortiz-Ruiz, Antonio J/M-2458-2018	Ortiz-Ruiz, Antonio J/0000-0001-9113-8416				Ahovuo-Saloranta A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001830.pub5; Ahovuo-Saloranta A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003067.pub4; Ak AT, 2010, EUR J PAEDIATR DENT, V11, P93; Alirezaei M, 2018, J AM DENT ASSOC, V149, P640, DOI 10.1016/j.adaj.2018.02.001; Alves LS, 2014, J DENT RES, V93, P114, DOI 10.1177/0022034514537646; Baseggio W, 2010, ORAL HLTH PREV DENT, V8, P261; Beauchamp J, 2008, J AM DENT ASSOC, V139, P257, DOI 10.14219/jada.archive.2008.0155; Bernardo PC, 2000, PESQUI ODONTOL BRAS, V14, P53; Beun S, 2012, DENT MATER, V28, P349, DOI 10.1016/j.dental.2011.11.001; Bonetti D, 2016, CARIES RES, V50, P45, DOI 10.1159/000444268; Bravo M, 2005, J DENT RES, V84, P1138, DOI 10.1177/154405910508401209; Carvalho JC, 2014, CARIES RES, V48, P339, DOI 10.1159/000356307; Alvarenga FAD, 2012, J ADHES DENT, V14, P335, DOI 10.3290/j.jad.a22713; Fleming Eleanor, 2018, NCHS Data Brief, P1; Fracasso Marina de Lourdes Calvo, 2005, J. Appl. Oral Sci., V13, P269, DOI 10.1590/S1678-77572005000300013; Frencken JE, 2010, J DENT, V38, P59, DOI 10.1016/j.jdent.2009.09.004; Ganesh Mahadevan, 2007, J Contemp Dent Pract, V8, P10; Gunjal Shilpa, 2012, Indian J Dent Res, V23, P320, DOI 10.4103/0970-9290.102214; Ismail AI, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-S1-S9; Kantovitz KR, 2013, J DENT, V41, P42, DOI 10.1016/j.jdent.2012.09.015; Kassebaum NJ, 2017, J DENT RES, V96, P380, DOI 10.1177/0022034517693566; Kervanto-Seppala S, 2008, INT J PAEDIATR DENT, V18, P56, DOI 10.1111/j.1365-263X.2007.00855.x; Markovic D, 2012, VOJNOSANIT PREGL, V69, P320, DOI 10.2298/VSP1204320M; Mickenautsch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077103; Nicholson JW, 2016, INT J ADHES ADHES, V69, P33, DOI 10.1016/j.ijadhadh.2016.03.012; Pardi Vanessa, 2006, Braz. Dent. J., V17, P49, DOI 10.1590/S0103-64402006000100011; Patil Namrata, 2013, J Conserv Dent, V16, P116, DOI 10.4103/0972-0707.108185; Rirattanapong Praphasri, 2013, Southeast Asian J Trop Med Public Health, V44, P931; Salz U, 2010, J ADHES DENT, V12, P343, DOI 10.3290/j.jad.a19741; Sidhu SK, 2016, J FUNCT BIOMATER, V7, DOI 10.3390/jfb7030016; Singla Anshu, 2011, Indian J Dent Res, V22, P205, DOI 10.4103/0970-9290.84286; Vicente A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176389; Welbury R, 2004, Eur J Paediatr Dent, V5, P179; Wright JT, 2016, J AM DENT ASSOC, V147, P672, DOI 10.1016/j.adaj.2016.06.001	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208856	10.1371/journal.pone.0208856	http://dx.doi.org/10.1371/journal.pone.0208856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533062	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500044
J	Marquez-Florez, K; Shefelbine, S; Ramirez-Martinez, A; Garzon-Alvarado, D				Marquez-Florez, Kalenia; Shefelbine, Sandra; Ramirez-Martinez, Angelica; Garzon-Alvarado, Diego			Computational model for the patella onset	PLOS ONE			English	Article							HUMAN PROXIMAL FEMUR; TOPOLOGY OPTIMIZATION; TRABECULAR ARCHITECTURE; WOLFFS LAW; BONE; MECHANOBIOLOGY; ADAPTATION; EXPRESSION; FRACTURE; TENDONS	The patella is a sesamoid bone embedded within the quadriceps tendon and the patellar tendon that articulates with the femur. However, how is it formed is still unknown. Therefore, here we have evaluated, computationally, how three theories explain, independently, the patella onset. The first theory was proposed recently, in 2015. This theory suggested that the patella is initially formed as a bone eminence, attached to the anterodistal surface of the femur, while the quadriceps tendon is forming. Thereafter, a joint develops between the eminence and the femur, regulated by mechanical load. We evaluated this theory by simulating the biochemical environment that surrounds the tendon development. As a result, we obtained a patella-like structure embedded within the tendon, especially for larger flexion angles. The second and third theories are the most accepted until now. They state that the patella develops within tendons in response to the mechanical environment provided by the attaching muscles. The second theory analyzed the mechanical conditions (high hydrostatic stress) that (according to previous Carter theories) lead to the differentiation from tendon to fibrocartilage, and then, to bone. The last theory was evaluated using the self-optimizing capability of biological tissue. It was considered that the development of the patella, due to tissue topological optimization of the developing quadriceps tendon, is a feasible explanation of the patella appearance. For both theories, a patella onset was obtained as a structure embedded within the tendon. This model provided information about the relationship between the flexion angle and the patella size and shape. In conclusion, the computational models used to evaluate and analyze the selected theories allow determining that the patella onset may be the result of a combination of biochemical and mechanical factors that surround the patellar tendon development.	[Marquez-Florez, Kalenia; Garzon-Alvarado, Diego] Univ Nacl Colombia, Inst Biotecnol, Biomimet Lab, Bogota, Colombia; [Marquez-Florez, Kalenia; Garzon-Alvarado, Diego] Univ Nacl Colombia, Numer Methods & Modeling Res Grp GNUM, Bogota, Colombia; [Shefelbine, Sandra] Northeastern Univ, Dept Mech Engn, Boston, MA 02115 USA; [Ramirez-Martinez, Angelica] Univ Cent, Dept Mech Engn, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Northeastern University	Garzon-Alvarado, D (corresponding author), Univ Nacl Colombia, Inst Biotecnol, Biomimet Lab, Bogota, Colombia.; Garzon-Alvarado, D (corresponding author), Univ Nacl Colombia, Numer Methods & Modeling Res Grp GNUM, Bogota, Colombia.	dagarzona@unal.edu.co	Garzon-Alvarado, Diego/AAD-6607-2019	Garzon-Alvarado, Diego A./0000-0003-0072-3738; Marquez-Florez, Kalenia/0000-0001-6388-3208; Ramirez-Martinez, Angelica Maria/0000-0002-9186-5848				Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Blitz E, 2013, DEVELOPMENT, V140, P2680, DOI 10.1242/dev.093906; Boyle C, 2011, J BIOMECH, V44, P935, DOI 10.1016/j.jbiomech.2010.11.029; Bruce J, 1942, JBJS, V24; Cai K, 2015, SPRINGER P MATH STAT, V95, P263, DOI 10.1007/978-3-319-08377-3_26; CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Chang CL, 2012, MED ENG PHYS, V34, P999, DOI 10.1016/j.medengphy.2012.06.004; Coelho PG, 2009, J BIOMECH, V42, P830, DOI 10.1016/j.jbiomech.2009.01.020; DRACHMAN DB, 1966, DEV BIOL, V14, P401, DOI 10.1016/0012-1606(66)90022-4; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Eyal S, 2015, DEVELOPMENT, P1, DOI [10.1242/dev.119727, DOI 10.1242/DEV.119727]; Fraldi M, 2010, BIOMECH MODEL MECHAN, V9, P389, DOI 10.1007/s10237-009-0183-0; Geris L, 2009, PHILOS T R SOC A, V367, P2031, DOI 10.1098/rsta.2008.0293; GIORI NJ, 1993, J ORTHOP RES, V11, P581, DOI 10.1002/jor.1100110413; Guevara JM, 2015, COMPUT METH PROG BIO, V118, P59, DOI 10.1016/j.cmpb.2014.10.007; Howalle D. S., 2013, INT J SCI RES PUBLIC, V3, P1; Jang IG, 2008, J BIOMECH, V41, P2353, DOI 10.1016/j.jbiomech.2008.05.037; Jang IG, 2010, FINITE ELEM ANAL DES, V46, P311, DOI 10.1016/j.finel.2009.11.003; Kang H, 2010, STRUCT MULTIDISCIP O, V42, P633, DOI 10.1007/s00158-010-0508-8; Kavanagh E, 2006, DEV DYNAM, V235, P826, DOI 10.1002/dvdy.20679; MACAUSLAND WR, 1946, AM J SURG, V72, P510, DOI 10.1016/0002-9610(46)90385-6; Mottershead S., 1988, CLIN ANAT, V1, P59, DOI [10.1002/ca.980010110, DOI 10.1002/CA.980010110]; Piszczatowski S, 2011, ACTA BIOENG BIOMECH, V13, P3; Sarin VK, 2000, J ORTHOP RES, V18, P706, DOI 10.1002/jor.1100180505; Schindler OS, 2011, ACTA ORTHOP BELG, V77, P421; Schlegel W, 2009, J CELL MOL MED, V13, P3398, DOI 10.1111/j.1582-4934.2009.00953.x; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Sigmund O, 2001, STRUCT MULTIDISCIP O, V21, P120, DOI 10.1007/s001580050176; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Sutradhar A, 2016, MED BIOL ENG COMPUT, V54, P1123, DOI 10.1007/s11517-015-1418-0; Sutradhar A, 2010, P NATL ACAD SCI USA, V107, P13222, DOI 10.1073/pnas.1001208107; SUTTON FS, 1976, J BONE JOINT SURG AM, V58, P537, DOI 10.2106/00004623-197658040-00017; WILKINSON J, 1977, J BONE JOINT SURG BR, V59, P352, DOI 10.1302/0301-620X.59B3.893514; Wren TAL, 2000, J REHABIL RES DEV, V37, P135	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0207770	10.1371/journal.pone.0207770	http://dx.doi.org/10.1371/journal.pone.0207770			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533045	gold, Green Submitted, Green Published			2022-12-26	WOS:000452782500010
J	Embaby, AM; Hussein, MN; Hussein, A				Embaby, Amira M.; Hussein, Mohamed N.; Hussein, Ahmed			Monascus orange and red pigments production by Monascus purpureus ATCC16436 through co-solid state fermentation of corn cob and glycerol: An eco-friendly environmental low cost approach	PLOS ONE			English	Article							CITRININ PRODUCTION; GROWTH; BIOSYNTHESIS; OPTIMIZATION; COLOR	The present study underlines a statistically optimized, low cost, effective approach for efficient co-valorization of two non-efficiently utilized, highly accumulated, raw agro-industrial wastes: corn cob and glycerol for co-production of natural biopigments: monascus orange and red pigments by the aid of Monascus purpureus strain ATCC 16436. A three step sequential, statistical modeling approach: one variable at a time (OVAT), Plackett-Burman design (PBD), and central composite design (CCD) was employed to optimize the production of monascus pigments using co-solid state fermentation of the two raw agro-industrial wastes. Corn cob among other carbon sources (e.g., rice grains, sugarcane bagasse, and potato peel) was the most appropriate substrate triggering co-production of orange and red monascus pigments; deduced from OVAT. Glycerol and inoculum size proved to impose significant consequences (P<0.05) on the production of monascus pigments as inferred from PBD. The optimal levels of inoculum size (12 x 10(11) spores/mL) and glycerol (2.17 M) did achieve a maximal color value of 133.77 and 108.02 color value units/mL of orange and red pigments, respectively at 30 degrees C after 10 days; concluded from CCD with an agitation speed of 150 rpm. Present data would underpin the large scale production of monascus pigments using the present approach for efficient exploitation of such biopigments in food, pharmaceutical and textile industries.	[Embaby, Amira M.; Hussein, Mohamed N.; Hussein, Ahmed] Alexandria Univ, Inst Grad Studies & Res, Biotechnol Dept, Alexandria, Egypt; [Hussein, Ahmed] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	Egyptian Knowledge Bank (EKB); Alexandria University; Texas Tech University System; Texas Tech University	Embaby, AM (corresponding author), Alexandria Univ, Inst Grad Studies & Res, Biotechnol Dept, Alexandria, Egypt.	Amira.Embaby@alexu.eg	Embaby, Amira M./AAD-5080-2021	Hussein, Ahmed/0000-0002-6887-2927; Embaby, Amira/0000-0001-8068-4200				Ahmad M, 2014, SONGKLA J SCI TECHNO, V36, P439; Anan A, 2018, J BASIC MICROB, V58, P120, DOI 10.1002/jobm.201700497; Babitha S., 2009, BIOTECHNOLOGY AGROIN, P147, DOI [10.1007/978-1-4020-9942-7_8, DOI 10.1007/978-1-4020-9942-7_8]; Babitha S, 2007, J BASIC MICROB, V47, P118, DOI 10.1002/jobm.200610261; Babitha S, 2007, BIORESOURCE TECHNOL, V98, P1554, DOI 10.1016/j.biortech.2006.06.005; Buhler RMK, 2012, CIENC TECNOLOGY A S1, V33, P9; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Daroit DJ, 2007, PROCESS BIOCHEM, V42, P904, DOI 10.1016/j.procbio.2007.01.012; Dasari MA, 2005, APPL CATAL A-GEN, V281, P225, DOI 10.1016/j.apcata.2004.11.033; de Carvalho JC, 2005, BRAZ ARCH BIOL TECHN, V48, P885, DOI 10.1590/S1516-89132005000800004; Dikshit R., 2013, International Food Research Journal, V20, P1235; Dikshit R., 2011, J MICROB BIOTEC FOOD, V1, P164; Dufosse L., 2009, MICROBIOLOGY, V4, P457; Embaby AM, 2018, PROCESS BIOCHEM, V64, P16, DOI 10.1016/j.procbio.2017.09.030; Fan X., 2010, OPEN FUELS ENERGY SC, V3, P17, DOI [DOI 10.2174/1876973X01003010017., 10.2174/1876973X01003010017]; Orozco SFB, 2008, WORLD J MICROB BIOT, V24, P263, DOI 10.1007/s11274-007-9465-9; Hamdi M, 1996, PROCESS BIOCHEM, V31, P543, DOI 10.1016/S0032-9592(96)00010-6; Hamdiyati Y, 2016, AIP CONF PROC, V1708, DOI 10.1063/1.4941147; Heer K, 2017, INT J PHARM SCI RES, V8, P1913, DOI 10.13040/IJPSR.0975-8232.8(5).1913-22; Huang T, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0382-5; Jirasatid S, 2013, J MICROBIOL BIOTECHN, V23, P364, DOI 10.4014/jmb.1206.06068; Kantifedaki A, 2018, J CLEAN PROD, V185, P882, DOI 10.1016/j.jclepro.2018.03.032; Kim D, 2018, MOLECULES, V23, DOI 10.3390/molecules23010098; Lin CH, 2017, FOOD FUNCT, V8, P2102, DOI 10.1039/c7fo00406k; Meinicke RM, 2012, BIOCATAL AGRIC BIOTE, V1, P238, DOI 10.1016/j.bcab.2012.03.001; Murray PR, 1995, AM SOC MICROBIOLOGY; Myers R.H., 1976, RESPONSE SURFACE MET; Neera DK, 2017, INT J CURRENT RES BI, V4, P71, DOI DOI 10.20546/IJCRBP.2017.403.008; PANDEY A, 1992, PROCESS BIOCHEM, V27, P109, DOI 10.1016/0032-9592(92)80017-W; Pereira L, ENV PROTECTION STRAT; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Ratana S, 1987, WORLD J MICROB BIOT, V6, P347; Rezende CA, 2011, BIOTECHNOL BIOFUELS, V4, P1, DOI 10.1186/1754-6834-4-54; Sepelev I, 2015, RES RURAL DEV, P130; Sinha S., 2013, INT J INNOV RES SCI, V2, P7031; Srivastav P, 2015, NUTRAFOODS, V14; Tachibana S, 2007, BIOSCI BIOTECH BIOCH, V71, P2573, DOI 10.1271/bbb.70285; Tallapragada P., 2013, International Food Research Journal, V20, P3265; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Velmurugan P, 2011, J BIOSCI BIOENG, V112, P590, DOI 10.1016/j.jbiosc.2011.08.009; Vendruscolo F, 2016, APPL BIOCHEM BIOTECH, V178, P211, DOI 10.1007/s12010-015-1880-z; Wang YZ, 2005, FOOD MICROBIOL, V22, P145, DOI 10.1016/j.fm.2004.01.006; Zhou ZX, 2014, BIOTECHNOL APPL BIOC, V61, P716, DOI 10.1002/bab.1225	43	26	27	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0207755	10.1371/journal.pone.0207755	http://dx.doi.org/10.1371/journal.pone.0207755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532218	gold, Green Submitted, Green Published			2022-12-26	WOS:000452644700010
J	Khasin, M; Cahoon, RR; Nickerson, KW; Riekhof, WR				Khasin, Maya; Cahoon, Rebecca R.; Nickerson, Kenneth W.; Riekhof, Wayne R.			Molecular machinery of auxin synthesis, secretion, and perception in the unicellular chlorophyte alga Chlorella sorokiniana UTEX 1230	PLOS ONE			English	Article							ARABIDOPSIS; BIOSYNTHESIS; TRYPTOPHAN; GROWTH; TRANSPORTER; PATHWAY; COMPLEX; GENE; ROOT	Indole-3-acetic acid is a ubiquitous small molecule found in all domains of life. It is the predominant and most active auxin in seed plants, where it coordinates a variety of complex growth and development processes. The potential origin of auxin signaling in algae remains a matter of some controversy. In order to clarify the evolutionary context of algal auxin signaling, we undertook a genomic survey to assess whether auxin acts as a signaling molecule in the emerging model chlorophyte Chlorella sorokiniana UTEX 1230. C. sorokiniana produces the auxin indole-3-acetic acid (IAA), which was present in both the cell pellet and in the supernatant at a concentration of similar to 1 nM, and its genome encodes orthologs of genes related to auxin synthesis, transport, and signaling in higher plants. Candidate orthologs for the canonical AUX/IAA signaling pathway were not found; however, auxin-binding protein 1 (ABP1), an alternate auxin receptor, is present and highly conserved at essential auxin binding and zinc coordinating residues. Additionally, candidate orthologs for PIN proteins, responsible for intercellular, vectorial auxin transport in higher plants, were not found, but PILs (PIN-Like) proteins, a recently discovered family that mediates intracellular auxin transport, were identified. The distribution of auxin related gene in this unicellular chlorophyte demonstrates that a core suite of auxin signaling components was present early in the evolution of plants. Understanding the simplified auxin signaling pathways in chlorophytes will aid in understanding phytohormone signaling and crosstalk in seed plants, and in understanding the diversification and integration of developmental signals during the evolution of multicellular plants.	[Khasin, Maya; Nickerson, Kenneth W.; Riekhof, Wayne R.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Cahoon, Rebecca R.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Riekhof, WR (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	wriekhof2@unl.edu	Nickerson, Kenneth/V-9979-2019		National Science Foundation [EPS-1004094]; Nebraska Center for Energy Sciences Research; University of Nebraska - Lincoln College of Arts and Sciences and School of Biological Sciences	National Science Foundation(National Science Foundation (NSF)); Nebraska Center for Energy Sciences Research; University of Nebraska - Lincoln College of Arts and Sciences and School of Biological Sciences	This work was supported by National Science Foundation award number EPS-1004094 (to W.R.R.), a seed grant from the Nebraska Center for Energy Sciences Research (to W.R.R.) and by laboratory startup funding from the University of Nebraska - Lincoln College of Arts and Sciences and School of Biological Sciences (to W.R.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Barbez E, 2012, NATURE, V485, P119, DOI 10.1038/nature11001; Berner F, 2015, J APPL PHYCOL, V27, P1793, DOI 10.1007/s10811-014-0489-x; Blanken W, 2014, BIOTECHNOL BIOENG, V111, P2436, DOI 10.1002/bit.25301; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Cerutti T, 2013, PLANT SCI, V198, P91, DOI 10.1016/j.plantsci.2012.10.007; Chen LS, 2001, PLANT PHYSIOL, V125, P1813, DOI 10.1104/pp.125.4.1813; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; DOHRMANN U, 1978, PLANTA, V140, P97, DOI 10.1007/BF00384907; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; HESSE T, 1989, EMBO J, V8, P2453, DOI 10.1002/j.1460-2075.1989.tb08380.x; Kriechbaumer V, 2017, J EXP BOT, V68, P4195, DOI 10.1093/jxb/erw195; Kubes M, 2012, PLANT J, V69, P640, DOI 10.1111/j.1365-313X.2011.04818.x; Lau S, 2009, TRENDS PLANT SCI, V14, P182, DOI 10.1016/j.tplants.2009.01.004; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; Lu YD, 2015, TRENDS PLANT SCI, V20, P273, DOI 10.1016/j.tplants.2015.01.006; Mano Y, 2010, J EXP BOT, V61, P25, DOI 10.1093/jxb/erp292; Moat A.G., 2002, MICROB PHYSIOL, P412, DOI DOI 10.1002/0471223867.CH11; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turnaev II, 2015, TRENDS PLANT SCI, V20, P463, DOI 10.1016/j.tplants.2015.06.004; Wang B, 2015, P NATL ACAD SCI USA, V112, P4821, DOI 10.1073/pnas.1503998112; Wang RH, 2014, CURR OPIN PLANT BIOL, V21, P51, DOI 10.1016/j.pbi.2014.06.006; Wang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110092; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Xu TD, 2014, SCIENCE, V343, P1025, DOI 10.1126/science.1245125; Yang HB, 2009, PLANT J, V59, P179, DOI 10.1111/j.1365-313X.2009.03856.x; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Yue JP, 2014, TRENDS PLANT SCI, V19, P764, DOI 10.1016/j.tplants.2014.07.004; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104	35	8	8	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0205227	10.1371/journal.pone.0205227	http://dx.doi.org/10.1371/journal.pone.0205227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532131	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700004
J	Hettiarachchige, C; von Cavallar, S; Lynar, T; Hickson, RI; Gambhir, M				Hettiarachchige, Chathurika; von Cavallar, Stefan; Lynar, Timothy; Hickson, Roslyn, I; Gambhir, Manoj			Risk prediction system for dengue transmission based on high resolution weather data	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; GLOBAL DISTRIBUTION; FEVER; CLIMATE; POPULATION; CULICIDAE; TEMPERATURE; VARIABLES; DYNAMICS; VIETNAM	Background Dengue is the fastest spreading vector-borne viral disease, resulting in an estimated 390 million infections annually. Precise prediction of many attributes related to dengue is still a challenge due to the complex dynamics of the disease. Important attributes to predict include: the risk of and risk factors for an infection; infection severity; and the timing and magnitude of outbreaks. In this work, we build a model for predicting the risk of dengue transmission using high-resolution weather data. The level of dengue transmission risk depends on the vector density, hence we predict risk via vector prediction. Methods and findings We make use of surveillance data on Aedes aegypti larvae collected by the Taiwan Centers for Disease Control as part of the national routine entomological surveillance of dengue, and weather data simulated using the IBM's Containerized Forecasting Workflow, a high spatial- and temporal-resolution forecasting system. We propose a two stage risk prediction system for assessing dengue transmission via Aedes aegypti mosquitoes. In stage one, we perform a logistic regression to determine whether larvae are present or absent at the locations of interest using weather attributes as the explanatory variables. The results are then aggregated to an administrative division, with presence in the division determined by a threshold percentage of larvae positive locations resulting from a bootstrap approach. In stage two, larvae counts are estimated for the predicted larvae positive divisions from stage one, using a zero-inflated negative binomial model. This model identifies the larvae positive locations with 71% accuracy and predicts the larvae numbers producing a coverage probability of 98% over 95% nominal prediction intervals. This two-stage model improves the overall accuracy of identifying larvae positive locations by 29%, and the mean squared error of predicted larvae numbers by 9.6%, against a single-stage approach which uses a zero-inflated binomial regression approach. Conclusions We demonstrate a risk prediction system using high resolution weather data can provide valuable insight to the distribution of risk over a geographical region. The work also shows that a two-stage approach is beneficial in predicting risk in non-homogeneous regions, where the risk is localised.	[Hettiarachchige, Chathurika; von Cavallar, Stefan; Lynar, Timothy; Hickson, Roslyn, I; Gambhir, Manoj] IBM Res Australia, Southgate, Vic, Australia; [Hettiarachchige, Chathurika; Hickson, Roslyn, I] Univ Melbourne, Sch Math & Stat, Parkville, Vic, Australia	University of Melbourne	Hettiarachchige, C (corresponding author), IBM Res Australia, Southgate, Vic, Australia.; Hettiarachchige, C (corresponding author), Univ Melbourne, Sch Math & Stat, Parkville, Vic, Australia.	chathu.het@gmail.com	; Hickson, Roslyn/B-3847-2011	Lynar, Timothy/0000-0001-7934-5658; Hettiarachchige, Chathurika/0000-0002-8605-9083; Hickson, Roslyn/0000-0001-6453-7745; Gambhir, Manoj/0000-0002-4831-6261				Agresti A, 2006, LOGISTIC REGRESSION, p99?136, DOI [10.1002/9780470114759.ch4, DOI 10.1002/9780470114759.CH4, 10.1002/9780470114759.CH4]; [Anonymous], 2016, DENG VACC WHO POS PA; Arboleda S, 2012, J VECTOR ECOL, V37, P37, DOI 10.1111/j.1948-7134.2012.00198.x; Bambrick HJ, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2059; Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Bergmeir C, 2018, COMPUT STAT DATA AN, V120, P70, DOI 10.1016/j.csda.2017.11.003; Bhardwaj A, 2012, INT J GEOINFORMATICS, V8; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Campbell KM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003957; Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321; Chadee DD, 2009, ACTA TROP, V112, P174, DOI 10.1016/j.actatropica.2009.07.017; Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012; Chou M.-D., 1999, SOLAR RAD PARAMETERI; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503; Dans AL, 2018, J CLIN EPIDEMIOL, V95, P142, DOI 10.1016/j.jclinepi.2017.12.025; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008; Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560; Lim KSS, 2010, MON WEATHER REV, V138, P1587, DOI 10.1175/2009MWR2968.1; Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395; Menard S, 2011, SOC FORCES, V89, P1409, DOI 10.1093/sf/89.4.1409; Mlawer EJ, 1997, J GEOPHYS RES-ATMOS, V102, P16663, DOI 10.1029/97JD00237; Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167; Phung D, 2016, TROP MED INT HEALTH, V21, P1324, DOI 10.1111/tmi.12754; Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279; Ramadona AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152688; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Romero-Vivas CME, 2005, J AM MOSQUITO CONTR, V21, P15, DOI 10.2987/8756-971X(2005)21[15:IORBAA]2.0.CO;2; Rubio-Palis Y, 2011, B MALARIOL SALUD AMB, V51, P145; Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775; Shu PY, 2005, EMERG INFECT DIS, V11, P460, DOI 10.3201/eid1103.040420; Tsai CT, 2012, STOCH ENV RES RISK A, V26, P671, DOI 10.1007/s00477-011-0527-z; Tsai PJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2002-4; Vu Ha Hai, 2014, Trop Med Health, V42, P25, DOI 10.2149/tmh.2013-24; World Health Organization, 2009, DENGUE GUIDELINES DI; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034; Yang CF, 2014, ACTA TROP, V130, P17, DOI 10.1016/j.actatropica.2013.10.013; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040; Yang HM, 2011, BIOSYSTEMS, V103, P360, DOI 10.1016/j.biosystems.2010.11.002; Zhang YT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004473	53	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208203	10.1371/journal.pone.0208203	http://dx.doi.org/10.1371/journal.pone.0208203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521550	Green Published, Green Accepted, gold			2022-12-26	WOS:000452307600032
J	Wurster, JI; Bispo, PJM; Van Tyne, D; Cadorette, JJ; Boody, R; Gilmore, MS				Wurster, Jenna, I; Bispo, Paulo J. M.; Van Tyne, Daria; Cadorette, James J.; Boody, Rick; Gilmore, Michael S.			Staphylococcus aureus from ocular and otolaryngology infections are frequently resistant to clinically important antibiotics and are associated with lineages of community and hospital origins	PLOS ONE			English	Article							UNITED-STATES; NASAL CARRIAGE; EPIDEMIOLOGY; COMBINATION; GENOMICS; UPDATE; TRIAL	Staphylococcus aureus is an important human pathogen that causes serious antibiotic-resistant infections. Its population structure is marked by the appearance and dissemination of successful lineages across different settings. To begin understanding the population structure of S. aureus causing ocular and otolaryngology infections, we characterized 262 isolates by antimicrobial sensitivity testing and multilocus sequence typing (MLST). Methicillin-resistant S. aureus were subjected to SCCmec typing and Panton-Valentine leukocidin (PVL) screening. Although we detected a high level of genetic diversity among methicillin-sensitive (MSSA) isolates, (63 sequence types-STs), the population was dominated by five lineages: ST30, ST5, ST8, ST15 and ST97. Resistance to penicillin, erythromycin and clindamycin was common among the major MSSA lineages, with fluctuations markedly impacted by genetic background. Isolates belonging to the predominant lineage, ST30, displayed high rates of resistance to penicillin (100%), erythromycin (71%), and clindamycin (63%). Overall, 21% of the isolates were methicillin-resistant (MRSA), with an apparent enrichment among otitis and orbital cellulitis isolates (>40%). MRSA isolates belonged to 14 STs grouped in 5 clonal complexes (CC), however, CC5 (56.1%) and CC8 (38.6%) dominated the population. Most CC5 strains were SCCmec type II, and resembled the hospital-adapted USA100 clone. CC8 strains were SCCmec type IV, and 86% were positive for the PVL toxin, common features of the community-acquired clone USA300. CC5 strains harboring a SCCmec type IV, typical for the USA800 clone, comprised 15.5% of the population. USA100 strains were highly resistant to clindamycin, erythromycin and levofloxacin (100%), while USA300 strains were frequently resistant to erythromycin (89%) but displayed lower rates of resistance to levofloxacin (39%) and clindamycin (17%). Our data demonstrate that the ocular and otolaryngology S. aureus populations are composed of strains that are commonly resistant to clinically relevant antibiotics, and are associated with the major epidemic clonal complexes of both community and hospital origins.	[Wurster, Jenna, I; Bispo, Paulo J. M.; Van Tyne, Daria; Gilmore, Michael S.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Infect Dis Inst, Boston, MA 02115 USA; [Van Tyne, Daria; Gilmore, Michael S.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Cadorette, James J.; Boody, Rick] Massachusetts Eye & Ear Infirm, Henry Whittier Porter Bacteriol Lab, Boston, MA 02114 USA; [Wurster, Jenna, I] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Van Tyne, Daria] Univ Pittsburgh, Div Infect Dis, Dept Med, Philadelphia, PA USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bispo, PJM; Gilmore, MS (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Infect Dis Inst, Boston, MA 02115 USA.; Gilmore, MS (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	paulo_bispo@meei.harvard.edu; michael_gilmore@meei_harvard.edu	Van Tyne, Daria/K-1251-2019	Van Tyne, Daria/0000-0001-7284-0103; Bispo, Paulo/0000-0002-2867-1450; Wurster, Jenna/0000-0002-3452-2531	NIH [EY024285, AI109855]; Molecular Basis for Ocular Surface Tropism in Conjunctivitis; Harvard-wide Program on Antibiotic Resistance [AI083214]; Coordenacao de Aperfeicoamentio de Pessoal de Nivel Superior, Brazil (CAPES) [9775-13-7]; NATIONAL EYE INSTITUTE [R00EY028222, R01EY024285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI109855, P01AI083214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Basis for Ocular Surface Tropism in Conjunctivitis; Harvard-wide Program on Antibiotic Resistance; Coordenacao de Aperfeicoamentio de Pessoal de Nivel Superior, Brazil (CAPES); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this project were supported by NIH grants EY024285, Molecular Basis for Ocular Surface Tropism in Conjunctivitis, and AI083214, which funds the Harvard-wide Program on Antibiotic Resistance. P.B. was supported by a grant from the Coordenacao de Aperfeicoamentio de Pessoal de Nivel Superior, Brazil (CAPES #9775-13-7), and D.V.T. was supported by NIH grant AI109855. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aanensen DM, 2016, MBIO, V7, DOI 10.1128/mBio.00444-16; Asbell PA, 2008, J CATARACT REFR SURG, V34, P814, DOI 10.1016/j.jcrs.2008.01.016; Asbell PA, 2015, JAMA OPHTHALMOL, V133, P1445, DOI 10.1001/jamaophthalmol.2015.3888; Bispo PJM, 2014, J CLIN MICROBIOL, V52, P1412, DOI 10.1128/JCM.03098-13; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Brook I, 2012, EXPERT REV ANTI-INFE, V10, P1367, DOI [10.1586/ERI.12.133, 10.1586/eri.12.133]; Cavuoto K, 2008, OPHTHALMOLOGY, V115, P51, DOI 10.1016/j.ophtha.2007.03.076; CDC, 2013, ANTIBIOTIC RESISTANC; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; CLSI, 2015, PERFORMANCE STANDARD, V3rd ed.; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; David M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024778; Davis SL, 2007, J CLIN MICROBIOL, V45, P1705, DOI 10.1128/JCM.02311-06; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Fusco NM, 2015, ANN PHARMACOTHER, V49, P458, DOI 10.1177/1060028014567526; Henry DC, 2003, ANTIMICROB AGENTS CH, V47, P2770, DOI 10.1128/AAC.47.9.2770-2774.2003; Ho PL, 2012, J INFECTION, V64, P500, DOI 10.1016/j.jinf.2012.02.018; Hudson LO, 2013, J CLIN MICROBIOL, V51, P3788, DOI 10.1128/JCM.01708-13; Hudson LO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062117; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Katayama Y, 2005, J CLIN MICROBIOL, V43, P2380, DOI 10.1128/JCM.43.5.2380-2383.2005; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Lawes T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006596; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Ma XX, 2005, EMERG INFECT DIS, V11, P973; Major JC, 2010, AM J OPHTHALMOL, V149, P278, DOI 10.1016/j.ajo.2009.08.023; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mendes RE, 2012, J CLIN MICROBIOL, V50, P3694, DOI 10.1128/JCM.02024-12; Mendes RE, 2010, J CLIN MICROBIOL, V48, P568, DOI 10.1128/JCM.01384-09; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Miller D, 2013, J OCUL PHARMACOL TH, V29, P339, DOI 10.1089/jop.2012.0081; Ophthalmology AAO, 2013, CORN EXT DIS PAN PRE; Park KH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179003; Qureishi A, 2014, INFECT DRUG RESIST, V7, P15, DOI 10.2147/IDR.S39637; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Sadaka A, 2015, OCULAR IMMUNOLOGY IN, P1; Sakoulas G, 2016, ANTIMICROB AGENTS CH, V60, P6609, DOI 10.1128/AAC.01192-16; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Tavares A, 2014, EUR J CLIN MICROBIOL, V33, P423, DOI 10.1007/s10096-013-1972-z; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; Thanathanee Onsiri, 2011, Curr Infect Dis Rep, V13, P141, DOI 10.1007/s11908-011-0167-y; Velargo PA, 2010, ENT-EAR NOSE THROAT, V89, P459; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Williamson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062020	46	11	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208518	10.1371/journal.pone.0208518	http://dx.doi.org/10.1371/journal.pone.0208518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521630	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600082
J	Wang, C; Wang, G; Feng, X; Shepherd, P; Zhang, J; Tang, MF; Chen, Z; Srivastava, M; McLaughlin, ME; Navone, NM; Hart, GT; Chen, JJ				Wang, Chao; Wang, Gang; Feng, Xu; Shepherd, Peter; Zhang, Jie; Tang, Mengfan; Chen, Zhen; Srivastava, Mrinal; McLaughlin, Megan E.; Navone, Nora M.; Hart, Glen Traver; Chen, Junjie			Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition	ONCOGENE			English	Article							AICARDI-GOUTIERES-SYNDROME; CANCER-CELLS; REPLICATION STRESS; PROTEIN-KINASE; DNA-DAMAGE; H2; MUTATIONS; SENSITIVITY; PATHWAY; LEADS	Ataxia telangiectasia mutated and RAD3 related (ATR) protein kinase plays critical roles in ensuring DNA replication, DNA repair, and cell cycle control in response to replication stress, making ATR inhibition a promising therapeutic strategy for cancer treatment. To identify genes whose loss makes tumor cells hypersensitive to ATR inhibition, we performed CRISPR/ Cas9-based whole-genome screens in 3 independent cell lines treated with a highly selective ATR inhibitor, AZD6738. These screens uncovered a comprehensive genome-wide profile of ATR inhibitor sensitivity. From the candidate genes, we demonstrated that RNASEH2 deficiency is synthetic lethal with ATR inhibition both in vitro and in vivo. RNASEH2-deficient cells exhibited elevated levels of DNA damage and, when treated with AZD6738, underwent apoptosis (short-time treated) or senescence (long-time treated). Notably, RNASEH2 deficiency is frequently found in prostate adenocarcinoma; we found decreased RNASEH2B protein levels in prostate adenocarcinoma patient-derived xenograft (PDX) samples. Our findings suggest that ATR inhibition may be beneficial for cancer patients with reduced levels of RNASEH2 and that RNASEH2 merits further exploration as a potential biomarker for ATR inhibitor-based therapy.	[Wang, Chao; Feng, Xu; Zhang, Jie; Tang, Mengfan; Chen, Zhen; Srivastava, Mrinal; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Wang, Gang; McLaughlin, Megan E.; Hart, Glen Traver] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Shepherd, Peter; Navone, Nora M.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org	Srivastava, Mrinal/AAM-5013-2020	Wang, Andy/0000-0001-6798-1032; Wang, Chao/0000-0001-6191-5261; Feng, Xu/0000-0003-1603-7070	CPRIT [RP160667]; NIH [CA157448, CA193124, CA210929, CA216911, CA216437]; MD Anderson's NIH Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P01CA160032, R01CA216911, R01CA216437, R01CA157448, R01CA210929, P30CA016672, P01CA193124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM130119] Funding Source: NIH RePORTER	CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson's NIH Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of Dr. Junjie Chen's lab for their kind help and Dr. Lei Li for his suggestions regarding the experimental design. We also thank Amy Ninetto from the Department of Scientific Publications at MD Anderson for editing the manuscript. This work was supported in part by CPRIT (RP160667) and NIH grants (CA157448, CA193124, CA210929, CA216911, and CA216437) to JC and MD Anderson's NIH Cancer Center Support Grant (CA016672).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Brown EJ, 2000, GENE DEV, V14, P397; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Checkley S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13545; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Fokas E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.181; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guichard SM, 2013, CANCER RES, V73, DOI 10.1158/1538-7445.AM2013-3343; Hall AB, 2014, ONCOTARGET, V5, P5674, DOI 10.18632/oncotarget.2158; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Hart T, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1015-8; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; He T, 2017, EPIGENOMICS-UK, V9, P849, DOI 10.2217/epi-2017-0019; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Keszthelyi A, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120134; Kim H, 2017, CLIN CANCER RES, V23, P3097, DOI 10.1158/1078-0432.CCR-16-2273; Kim H, 2016, CLIN CANCER RES, V22, DOI 10.1158/1557-3265.OVCA15-A08; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Kwok M, 2016, BLOOD, V127, P582, DOI 10.1182/blood-2015-05-644872; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Mackenzie KJ, 2016, EMBO J, V35, P831, DOI 10.15252/embj.201593339; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Mohni KN, 2014, CANCER RES, V74, P2835, DOI 10.1158/0008-5472.CAN-13-3229; Mu YH, 2016, EMBO REP, V17, P94, DOI 10.15252/embr.201540964; Pendergraft WF, 2015, J CLIN INVEST, V125, P102, DOI 10.1172/JCI78533; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Pizzi S, 2015, HUM MOL GENET, V24, P649, DOI 10.1093/hmg/ddu485; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Prevo R, 2012, CANCER BIOL THER, V13, P1072, DOI 10.4161/cbt.21093; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice GI, 2013, HUM MUTAT, V34, P1066, DOI 10.1002/humu.22336; Robinson D, 2015, CELL, V162, P454, DOI 10.1016/j.cell.2015.06.053; Ruiz S, 2016, MOL CELL, V62, P307, DOI 10.1016/j.molcel.2016.03.006; Rundle S, 2017, CANCERS, V9, DOI 10.3390/cancers9050041; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Techer H, 2017, NAT REV GENET, V18, P535, DOI 10.1038/nrg.2017.46; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Williams JS, 2017, DNA REPAIR, V53, P52, DOI 10.1016/j.dnarep.2017.02.016; Williamson CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13837; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhu SY, 2017, METHODS MOL BIOL, V1656, P175, DOI 10.1007/978-1-4939-7237-1_11; Zimmermann M, 2018, NATURE, V559, P285, DOI 10.1038/s41586-018-0291-z	54	64	64	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2451	2463		10.1038/s41388-018-0606-4	http://dx.doi.org/10.1038/s41388-018-0606-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30532030	Green Accepted			2022-12-26	WOS:000463335200002
J	Tatavosian, R; Kent, S; Brown, K; Yao, TT; Huy, ND; Huynh, TN; Zhen, CY; Ma, B; Wang, HB; Ren, XJ				Tatavosian, Roubina; Kent, Samantha; Brown, Kyle; Yao, Tingting; Huy Nguyen Duc; Thao Ngoc Huynh; Zhen, Chao Yu; Ma, Brian; Wang, Haobin; Ren, Xiaojun			Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Polycomb; epigenetics; heterochromatin; chromatin; gene regulation; histone methylation; histone; chromatin modification; chromatin structure; chromatin regulation; CBX2; liquid-liquid phase separation; PcG; phase separation; PRC1	HISTONE METHYLTRANSFERASE ACTIVITY; REPRESSIVE COMPLEX; FACULTATIVE HETEROCHROMATIN; PRC1 COMPLEX; SAM DOMAIN; CHROMATIN; H3; H2A; METHYLATION; TRANSITION	Polycomb group (PcG) proteins repress master regulators of development and differentiation through organization of chromatin structure. Mutation and dysregulation of PcG genes cause developmental defects and cancer. PcG proteins form condensates in the cell nucleus, and these condensates are the physical sites of PcG-targeted gene silencing via formation of facultative heterochromatin. However, the physiochemical principles underlying the formation of PcG condensates remain unknown, and their determination could shed light on how these condensates compact chromatin. Using fluorescence live-cell imaging, we observed that the Polycomb repressive complex 1 (PRC1) protein chromobox 2 (CBX2), a member of the CBX protein family, undergoes phase separation to form condensates and that the CBX2 condensates exhibit liquid-like properties. Using site-directed mutagenesis, we demonstrated that the conserved residues of CBX2 within the intrinsically disordered region (IDR), which is the region for compaction of chromatin in vitro, promote the condensate formation both in vitro and in vivo. We showed that the CBX2 condensates concentrate DNA and nucleosomes. Using genetic engineering, we report that trimethylation of Lys-27 at histone H3 (H3K27me3), a marker of heterochromatin formation produced by PRC2, had minimal effects on the CBX2 condensate formation. We further demonstrated that the CBX2 condensate formation does not require CBX2-PRC1 subunits; however, the condensate formation of CBX2-PRC1 subunits depends on CBX2, suggesting a mechanism underlying the assembly of CBX2-PRC1 condensates. In summary, our results reveal that PcG condensates assemble through liquid-liquid phase separation (LLPS) and suggest that phase-separated condensates can organize PcG-bound chromatin.	[Tatavosian, Roubina; Kent, Samantha; Brown, Kyle; Huy Nguyen Duc; Thao Ngoc Huynh; Zhen, Chao Yu; Ma, Brian; Wang, Haobin; Ren, Xiaojun] Univ Colorado, Dept Chem, Denver, CO 80217 USA; [Yao, Tingting] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Denver; Colorado State University	Ren, XJ (corresponding author), Univ Colorado, Dept Chem, Denver, CO 80217 USA.	xiaojun.ren@ucdenver.edu	WANG, Haobin/S-1187-2019	Brown, Kyle/0000-0001-9640-6520; Wang, Haobin/0000-0002-3532-7770; Ren, Xiaojun/0000-0002-3931-7625	NCI, National Institutes of Health [R03CA191443]; National Science Foundation [CHE-1500285]; NIGMS, National Institutes of Health [R01GM098401]; Office of Research Services (ORS) at the University of Colorado Denver; NATIONAL CANCER INSTITUTE [R03CA191443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098401] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Research Services (ORS) at the University of Colorado Denver; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health Grant R03CA191443 (to X. R.), National Science Foundation Grant CHE-1500285 (to H. W.), NIGMS, National Institutes of Health Grant R01GM098401 (to T. Y.), and the Office of Research Services (ORS) at the University of Colorado Denver. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Allshire RC, 2018, NAT REV MOL CELL BIO, V19, P229, DOI 10.1038/nrm.2017.119; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Boehning M, 2018, NAT STRUCT MOL BIOL, V25, P833, DOI 10.1038/s41594-018-0112-y; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; BROWN SW, 1966, SCIENCE, V151, P417, DOI 10.1126/science.151.3709.417; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Gunster MJ, 1997, MOL CELL BIOL, V17, P2326, DOI 10.1128/MCB.17.4.2326; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Hemenway CS, 1998, ONCOGENE, V16, P2541, DOI 10.1038/sj.onc.1202042; Duc HN, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2526; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kawaguchi T, 2017, J BIOCHEM, V162, P343, DOI 10.1093/jb/mvx040; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Kundu S, 2017, MOL CELL, V65, P432, DOI 10.1016/j.molcel.2017.01.009; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Larson AG, 2018, BIOCHEMISTRY-US, V57, P2540, DOI 10.1021/acs.biochem.8b00401; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lau MS, 2017, SCIENCE, V355, DOI 10.1126/science.aah5403; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Meldi L, 2011, TRENDS CELL BIOL, V21, P701, DOI 10.1016/j.tcb.2011.08.001; Mitrea DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03255-3; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Piovesan D, 2018, NUCLEIC ACIDS RES, V46, pD471, DOI 10.1093/nar/gkx1071; Pirrotta V, 2012, CURR OPIN GENET DEV, V22, P101, DOI 10.1016/j.gde.2011.11.004; Reinberg D, 2018, SCIENCE, V361, P33, DOI 10.1126/science.aat7871; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h; Senthilkumar R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-549; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Tardat M, 2015, MOL CELL, V58, P157, DOI 10.1016/j.molcel.2015.02.013; Tatavosian R, 2015, J BIOL CHEM, V290, P28038, DOI 10.1074/jbc.M115.671115; Huynh TN, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2333; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang RJ, 2008, BIOCHEMISTRY-US, V47, P8007, DOI 10.1021/bi800857f; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Wani AH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10291; Woodruff JB, 2018, TRENDS BIOCHEM SCI, V43, P81, DOI 10.1016/j.tibs.2017.11.005; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Zhen CY, 2016, ELIFE, V5, DOI 10.7554/eLife.17667; Zhen CY, 2014, MOL BIOL CELL, V25, P3726, DOI 10.1091/mbc.E14-06-1109	82	159	161	6	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1451	1463		10.1074/jbc.RA118.006620	http://dx.doi.org/10.1074/jbc.RA118.006620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30514760	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000457879200002
J	Li, Y; Wang, YM; Shen, CJ; Huang, JL; Kang, JL; Huang, BX; Guo, FS; Edwards, J				Li, Yin; Wang, Youming; Shen, Chaojian; Huang, Jianlong; Kang, Jingli; Huang, Baoxu; Guo, Fusheng; Edwards, John			Closure of live bird markets leads to the spread of H7N9 influenza in China	PLOS ONE			English	Article							POULTRY MARKET; A(H7N9) VIRUS; HUMAN INFECTION; RISK; EPIDEMIOLOGY	Following the emergence of H7N9 influenza in March 2013, local animal and public health authorities in China have been closing live bird markets as a measure to try to control the H7N9 influenza epidemic. The role of live bird market (LBM) closure on the spread of N7N9 influenza following the closure of LBMs during March to May 2013 (the first wave) and October 2013 to March 2014 (the second wave) is described in this paper. Different provinces implemented closure actions at different times, and intensive media reports on H7N9 in different provinces started at different times. Local broiler prices dropped dramatically in places with outbreaks and more live chickens were transported to other LBMs in neighboring areas without human cases from infected areas when live bird markets were being closed. There were six clusters of human infection from March to May 2013 and October 2013 to March 2014 and there may have been intensive poultry transportation among cluster areas. These findings provide evidence that the closure of LBMs in early waves of H7N9 influenza had resulted in expansion of H7N9 infection to uninfected areas. This suggests that provincial authorities in inland provinces should be alert to the risks of sudden changes in movement patterns for live birds after LBM closure or increased publicity about LBM closure.	[Li, Yin; Wang, Youming; Shen, Chaojian; Kang, Jingli; Huang, Baoxu; Edwards, John] China Anim Hlth & Epidemiol Ctr, Epidemiol Survey Div, Qingdao, Shandong, Peoples R China; [Li, Yin; Edwards, John] Murdoch Univ, Perth, WA, Australia; [Huang, Jianlong] Hunan Prov Ctr Anim Dis Control, Changsha, Hunan, Peoples R China; [Guo, Fusheng] FAO ECTAD China Off, Beijing, Peoples R China	China Animal Health & Epidemiology Center; Murdoch University	Edwards, J (corresponding author), China Anim Hlth & Epidemiol Ctr, Epidemiol Survey Div, Qingdao, Shandong, Peoples R China.; Edwards, J (corresponding author), Murdoch Univ, Perth, WA, Australia.	John.Edwards@murdoch.edu.au	Li, Yin/AAE-6546-2022	Li, Yin/0000-0001-5720-5267	National Key R&D Program of China [2017YFC1200500]	National Key R&D Program of China	This study was funded by the National Key R&D Program of China (2017YFC1200500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NEWS QQ; Chen JD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10605-6; China NHaFPCotPsRo, 2014, EP PREV CONTR SCHEM; Cui B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4364-y; FluTrackers. com. Inc, 2016, CHIN H7N9 OUTB TRACK; He Y, 2014, EMERG INFECT DIS, V20, P1565, DOI 10.3201/eid2009.131243; Huang XH, 2016, MITOCHONDRIAL DNA A, V27, P1311, DOI 10.3109/19401736.2014.945571; Huo X, 2017, EUROSURVEILLANCE B E, V22, DOI [10.2807/1560-7917.ES.2017.22.13.30496, DOI 10.2807/1560-7917.ES.2017.22.13.30496]; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Ke CW, 2017, EMERG INFECT DIS, V23, P1332, DOI 10.3201/eid2308.170600; Liao QY, 2016, J PUBLIC HEALTH-UK, V38, P34, DOI 10.1093/pubmed/fdv020; Lin X, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4374-9; PRC NHaFPCot, 2016, NAT NOT DIS SIT; Qiu J, 2014, PREV VET MED, V115, P229, DOI 10.1016/j.prevetmed.2014.03.030; Shen YZ, 2017, BIOSCI TRENDS, V11, P120, DOI 10.5582/bst.2017.01040; Song PP, 2013, BIOSCI TRENDS, V7, P168, DOI 10.5582/bst.2013.v7.4.168; Veterinary Bureau MoAoP, H7N9 SURV 2016; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Wang X, 2014, CLIN INFECT DIS OFFI, V59, P27; Wang XL, 2017, LANCET INFECT DIS, V17, P822, DOI [10.1016/s1473-3099(17)30323-7, 10.1016/S1473-3099(17)30323-7]; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yuan J, 2015, EMERG INFECT DIS, V21, P1784, DOI 10.3201/eid2110.150623; Zhou L, 2017, EMERG INFECT DIS, V23, P1355, DOI 10.3201/eid2308.170640; Zhou L, 2017, WEST PAC SURVEILL RE, V8, DOI [10.5365/wpsar.2017.8.1.001, 10.5365/WPSAR.2017.8.1.001]	24	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208884	10.1371/journal.pone.0208884	http://dx.doi.org/10.1371/journal.pone.0208884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540847	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600094
J	Pietri, JE; Tiffany, C; Liang, DS				Pietri, Jose E.; Tiffany, Connor; Liang, Dangsheng			Disruption of the microbiota affects physiological and evolutionary aspects of insecticide resistance in the German cockroach, an important urban pest	PLOS ONE			English	Article							PERIPLANETA-AMERICANA; SYMBIOTIC BACTERIA; CROSS-RESISTANCE; DIAMONDBACK MOTH; GUT MICROBIOTA; EXPOSURE; INDOXACARB; ALLERGEN; BLATTELLIDAE; POPULATIONS	The German cockroach, Blatella germanica, is a common pest in urban environments and is among the most resilient insects in the world. The remarkable ability of the German cockroach to develop resistance when exposed to toxic insecticides is a prime example of adaptive evolution and makes control of this insect an ongoing struggle. Like many other organisms, the German cockroach is host to a diverse community of symbiotic microbes that play important roles in its physiology. In some insect species, there is a strong correlation between the commensal microbial community and insecticide resistance. In particular, several bacteria have been implicated in the detoxification of xenobiotics, including synthetic insecticides. While multiple mechanisms that mediate insecticide resistance in cockroaches have been discovered, significant knowledge gaps still exist in this area of research. Here, we examine the effects of altering the microbiota on resistance to a common insecticide using antibiotic treatments. We describe an indoxacarb-resistant laboratory strain in which treatment with antibiotic increases susceptibility to orally administered insecticide. We further reveal that this strains harbors a gut microbial community that differs significantly from that of susceptible cockroaches in which insecticide resistance is unaffected by antibiotic. More importantly, we demonstrate that transfer of gut microbes from the resistant to the susceptible strain via fecal transplant increases its resistance. Lastly, our data show that antibiotic treatment adversely affects several reproductive life-history traits that may contribute to the dynamics of resistance at the population level. Together these results suggest that the microbiota contributes to both physiological and evolutionary aspects of insecticide resistance and that targeting this community may be an effective strategy to control the German cockroach.	[Pietri, Jose E.; Liang, Dangsheng] Apex Bait Technol Inc, Santa Clara, CA 95054 USA; [Tiffany, Connor] Univ Calif Davis, Davis Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Pietri, JE (corresponding author), Apex Bait Technol Inc, Santa Clara, CA 95054 USA.	Jose.Pietri@usd.edu			Apex Bait Technologies, Inc., a commercial company	Apex Bait Technologies, Inc., a commercial company	This work was internally funded at Apex Bait Technologies, Inc., a commercial company. The funder supported salaries for authors JEP and DL and costs for materials and reagents, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ayayee PA, 2018, PEERJ, V6, DOI 10.7717/peerj.4717; Ayayee PA, 2016, PEERJ, V4, DOI 10.7717/peerj.2046; BANDI C, 1994, P ROY SOC B-BIOL SCI, V257, P43, DOI 10.1098/rspb.1994.0092; Bandi C, 1955, P BIOL SCI, V259, P293; Berlanga M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152400; Bertino-Grimaldi D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-609; BRACKE JW, 1978, ANTIMICROB AGENTS CH, V13, P115, DOI 10.1128/AAC.13.1.115; BROOKS MA, 1955, BIOL BULL, V109, P22, DOI 10.2307/1538656; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carrasco P, 2014, INT MICROBIOL, V17, P99, DOI 10.2436/20.1501.01.212; Cheng DF, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0236-z; Cohn RD, 2006, ENVIRON HEALTH PERSP, V114, P522, DOI 10.1289/ehp.8561; Do DC, 2016, ALLERGY, V71, P463, DOI 10.1111/all.12827; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Perez-Cobas AE, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv022; FOTEDAR R, 1993, J HOSP INFECT, V23, P55, DOI 10.1016/0195-6701(93)90131-I; Garcia F, 2012, J MED ENTOMOL, V49, P1481, DOI 10.1603/ME12007; Gondhalekar AD, 2016, PESTIC BIOCHEM PHYS, V134, P14, DOI 10.1016/j.pestbp.2016.05.003; Gontang EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177189; Jensen K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28731; Kakumanu ML, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01037-18; KANE MD, 1991, APPL ENVIRON MICROB, V57, P2628, DOI 10.1128/AEM.57.9.2628-2634.1991; Kayya GP, 1987, INT J TROP INSECT SC, V8, P271; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; KOPANIC RJ, 1994, J FOOD PROTECT, V57, P125, DOI 10.4315/0362-028X-57.2.125; Liang DS, 2017, J ECON ENTOMOL, V110, P1713, DOI 10.1093/jee/tox144; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Menasria T, 2014, PATHOG GLOB HEALTH, V108, P141, DOI 10.1179/2047773214Y.0000000136; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Pai HH, 2005, ACTA TROP, V93, P259, DOI 10.1016/j.actatropica.2004.11.006; Pietri JE, 2018, ANN ENTOMOL SOC AM, V111, P92, DOI 10.1093/aesa/say009; R Core Team, 2020, R LANG ENV STAT COMP; Ramya SL, 2016, BRAZ J MICROBIOL, V47, P327, DOI 10.1016/j.bjm.2016.01.012; Rosas T, 2018, FEMS MICROBIOL ECOL, P94; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; SACCHI L, 1985, J INVERTEBR PATHOL, V46, P139, DOI 10.1016/0022-2011(85)90142-9; Sangare AK, 2016, INT J ANTIMICROB AG, V47, P217, DOI 10.1016/j.ijantimicag.2016.01.001; SCHLEIN Y, 1977, EXPERIENTIA, V33, P450, DOI 10.1007/BF01922204; SILVERMAN J, 1994, ENVIRON ENTOMOL, V23, P425, DOI 10.1093/ee/23.2.425; Soltani A, 2017, PATHOG GLOB HEALTH, V111, P289, DOI 10.1080/20477724.2017.1356052; SRIVASTAVA PN, 1976, CAN J ZOOL, V54, P1025, DOI 10.1139/z76-115; Tegtmeier D, 2016, APPL ENVIRON MICROB, V82, P1080, DOI 10.1128/AEM.03130-15; Vaishampayan PA, 2007, MOL PHYLOGENET EVOL, V44, P1346, DOI 10.1016/j.ympev.2007.01.003; Vicente CSL, 2016, MICROBES ENVIRON, V31, P314, DOI 10.1264/jsme2.ME16088; Wada-Katsumata A, 2015, P NATL ACAD SCI USA, V112, P15678, DOI 10.1073/pnas.1504031112; Zhang F, 2018, PEST MANAG SCI, V74, P438, DOI 10.1002/ps.4726; Zhang JH, 2016, COMP BIOCHEM PHYS D, V20, P151, DOI 10.1016/j.cbd.2016.10.001; Zhang SZ, 2017, PESTIC BIOCHEM PHYS, V140, P85, DOI 10.1016/j.pestbp.2017.06.011	51	30	31	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207985	10.1371/journal.pone.0207985	http://dx.doi.org/10.1371/journal.pone.0207985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540788	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600048
J	Reed, JM; Olson, S; Brees, DF; Griffin, CE; Grove, RA; Davis, PJ; Kachman, SD; Adamec, J; Somerville, GA				Reed, Joseph M.; Olson, Sean; Brees, Danielle F.; Griffin, Caitlin E.; Grove, Ryan A.; Davis, Paul J.; Kachman, Stephen D.; Adamec, Jiri; Somerville, Greg A.			Coordinated regulation of transcription by CcpA and the Staphylococcus aureus two-component system HptRS	PLOS ONE			English	Article							PHOSPHATE-TRANSPORT-SYSTEM; ANAEROBIC GENE-EXPRESSION; ESCHERICHIA-COLI; NASAL CARRIAGE; METABOLISM; DETERMINANT; FOSFOMYCIN; DATABASE; GROWTH; IRON	The success of Staphylococcus aureus as a pathogen is due in part to its ability to adapt to changing environmental conditions using signal transduction pathways, such as metabolite responsive regulators and two-component systems. S. aureus has a two-component system encoded by the gene pair sav0224 (hptS) and sav0223 (hptR) that regulate the hexose phosphate transport (uhpT) system in response to extracellular glucose-6-phosphate. Glycolytic intermediates such as glucose-6-phosphate are important carbon sources that also modulate the activity of the global metabolite-responsive transcriptional regulator CcpA. Because uhpT has a putative CcpA binding site in its promoter and it is regulated by HptR, it was hypothesized the regulons of CcpA and HptR might intersect. To determine if the regulatory domains of CcpA and HptRS overlap, ccpA was deleted in strains SA564 and SA564-Delta hptRS and growth, metabolic, proteomic, and transcriptional differences were assessed. As expected, CcpA represses hptS and hptR in a glucose dependent manner; however, upon CcpA derepression, the HptRS system functions as a transcriptional activator of metabolic genes within the CcpA regulon. Importantly, inactivation of ccpA and hptRS altered sensitivity to fosfomycin and ampicillin in the absence of exogenous glucose-6-phosphate, indicating that both CcpA and HptRS modulate antibiotic susceptibility.	[Reed, Joseph M.; Brees, Danielle F.; Griffin, Caitlin E.; Somerville, Greg A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Olson, Sean; Kachman, Stephen D.] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Grove, Ryan A.; Adamec, Jiri] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Griffin, Caitlin E.] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Somerville, GA (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	gsomerville3@unl.edu	Somerville, Greg/B-1326-2013	Somerville, Greg/0000-0002-0991-8737; Kachman, Stephen/0000-0003-0506-513X				[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Balasubramanian D, 2013, RNA BIOL, V10, P337, DOI 10.4161/rna.23696; Bizzini A, 2007, J ANTIMICROB CHEMOTH, V59, P607, DOI 10.1093/jac/dkm021; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; DETTE GA, 1983, J ANTIMICROB CHEMOTH, V11, P517, DOI 10.1093/jac/11.6.517; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Fann MC, 1998, J BIOL CHEM, V273, P33735, DOI 10.1074/jbc.273.50.33735; FORSGREN A, 1983, J ANTIMICROB CHEMOTH, V11, P467, DOI 10.1093/jac/11.5.467; Foster TJ, 1998, METHOD MICROBIOL, V27, P433; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; GRIMM H, 1979, INFECTION, V7, P256, DOI 10.1007/BF01648937; Guldimann C, 2016, APPL ENVIRON MICROB, V82, P4456, DOI 10.1128/AEM.00714-16; Halsey CR, 2017, MBIO, V8, DOI 10.1128/mBio.01434-16; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; ISLAND MD, 1992, J BACTERIOL, V174, P2754, DOI 10.1128/JB.174.9.2754-2762.1992; KADNER RJ, 1973, J BACTERIOL, V116, P764, DOI 10.1128/JB.116.2.764-770.1973; KASATIYA SS, 1967, CAN J MICROBIOL, V13, P1079, DOI 10.1139/m67-144; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Ledala N, 2014, J BACTERIOL, V196, P2178, DOI 10.1128/JB.01475-14; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; MASON PW, 1981, J BIOL CHEM, V256, P1861; Mijakovic I, 2002, P NATL ACAD SCI USA, V99, P13442, DOI 10.1073/pnas.212410399; Morrissey JA, 2004, INFECT IMMUN, V72, P972, DOI 10.1128/IAI.72.2.972-979.2004; Nakano MM, 1998, J BACTERIOL, V180, P3304, DOI 10.1128/JB.180.13.3304-3311.1998; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Nuxoll AS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003033; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Park JY, 2015, INFECT IMMUN, V83, P1620, DOI 10.1128/IAI.03109-14; Price-Whelan A, 2013, MBIO, V4, DOI 10.1128/mBio.00407-13; Richardson AR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0004-2014; Sadykov MR, 2011, MICROBIOL-SGM, V157, P3458, DOI 10.1099/mic.0.051243-0; Schramke H, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.438; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Weinstein M.P., 2012, M07 A METHODS DILUTI, V32, P1; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; WINKLER HH, 1973, J BACTERIOL, V116, P1079, DOI 10.1128/JB.116.2.1079-1081.1973; Xu S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00914; Xue T, 2011, INFECT IMMUN, V79, P2154, DOI 10.1128/IAI.01180-10; Yang YF, 2016, MED MICROBIOL IMMUN, V205, P241, DOI 10.1007/s00430-015-0446-6	61	8	10	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207161	10.1371/journal.pone.0207161	http://dx.doi.org/10.1371/journal.pone.0207161			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540769	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600008
J	Chen, TK; Cong, Q; Jin, JF; Choy, KL				Chen, Tingkun; Cong, Qian; Jin, Jingfu; Choy, Kwang-Leong			Experimental study on frost-formation characteristics on cold surface of arched copper sample	PLOS ONE			English	Article							DEFROSTING PERFORMANCE; SUPERHYDROPHOBIC SURFACES; THERMAL-CONDUCTIVITY; HEAT; CYCLE	The present work investigates the process of frosting formation on arched copper samples with different surface temperatures, calculated the thickness of the frost layer by using the scale method, and analyzed frost lodging, melting, and other phenomena that appeared during the frost-formation process. The results showed that the frosting process on an arched surface can be divided into ice-film formation, rapid growth of the frost layer, and stable growth of the frost layer. Meanwhile, the phenomena of frost-branch breakage, lodging, and melting were observed. The surface temperature had a large effect on the frost formation and thickness of the frost layer, e.g., the formation time of the ice film on a surface at-5 degrees C was the longest (similar to 135 s), the frost layer formed on a surface at-20 degrees C was the thickest (similar to 660 mu m). When microscopic observation of the frosting process was accompanied by calculation of the frost-layer thickness, it could be seen that the appearance of the frost branches was affected by the different thermal conductivities of the frost layers, undulating surface of the ice film, and temperature difference between the layers. The changes in the frost branches and the soft surface of the frost layer also affected the growth of the frost layer. The findings of this study are expected to provide guidelines for optimization of conventional defrosting methods.	[Chen, Tingkun; Cong, Qian] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Jilin, Peoples R China; [Cong, Qian] Jilin Univ, State Key Lab Automot Simulat & Control, Changchun, Jilin, Peoples R China; [Jin, Jingfu] Jilin Univ, Coll Biol & Agr Engn, Changchun, Jilin, Peoples R China; [Choy, Kwang-Leong] UCL, Inst Mat Discovery, London, England	Jilin University; Jilin University; Jilin University; University of London; University College London	Jin, JF (corresponding author), Jilin Univ, Coll Biol & Agr Engn, Changchun, Jilin, Peoples R China.	jinjingfu@jlu.edu.cn		Choy, Kwang-Leong/0000-0002-5596-4427	Royal Society; NSFC [51711530236]	Royal Society(Royal Society of London); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the international exchanges scheme between the Royal Society and the NSFC [Grant No. 51711530236] to QC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Breque F, 2017, INT J REFRIG, V75, P129, DOI 10.1016/j.ijrefrig.2016.12.012; Cao LL, 2009, LANGMUIR, V25, P12444, DOI 10.1021/la902882b; Gin B, 2010, ENERG CONVERS MANAGE, V51, P2698, DOI 10.1016/j.enconman.2010.06.005; Gong JY, 2017, INT COMMUN HEAT MASS, V82, P139, DOI 10.1016/j.icheatmasstransfer.2017.02.013; He M, 2011, SOFT MATTER, V7, P3993, DOI 10.1039/c0sm01504k; He M, 2010, SOFT MATTER, V6, P2396, DOI 10.1039/c0sm00024h; Hermes CJL, 2018, INT J REFRIG, V87, P164, DOI 10.1016/j.ijrefrig.2017.09.022; Hewitt N, 2008, INT J REFRIG, V31, P444, DOI 10.1016/j.ijrefrig.2007.07.010; Huang LY, 2009, EXP THERM FLUID SCI, V33, P1049, DOI 10.1016/j.expthermflusci.2009.06.002; Ji KP, 2015, COMPUT STRUCT, V157, P153, DOI 10.1016/j.compstruc.2015.05.014; Jung S, 2011, LANGMUIR, V27, P3059, DOI 10.1021/la104762g; Karmouch R, 2010, J PHYS CHEM C, V114, P4063, DOI 10.1021/jp911211m; Kim MH, 2017, ENERG CONVERS MANAGE, V138, P1, DOI [10.1016/j.encoriman.2017.01.067, 10.1016/j.enconman.2017.01.067]; Kulinich SA, 2011, LANGMUIR, V27, P25, DOI 10.1021/la104277q; Li ZQ, 2017, INT J REFRIG, V77, P136, DOI 10.1016/j.ijrefrig.2017.03.003; Liu ZB, 2017, APPL THERM ENG, V118, P256, DOI 10.1016/j.applthermaleng.2017.02.077; Lv JY, 2014, ACS NANO, V8, P3152, DOI 10.1021/nn406522n; Morales-Fuentes A, 2017, INT J REFRIG, V75, P26, DOI 10.1016/j.ijrefrig.2017.01.016; Na B, 2003, INT J HEAT MASS TRAN, V46, P3797, DOI 10.1016/S0017-9310(03)00194-7; Negrelli S, 2016, EXP THERM FLUID SCI, V78, P301, DOI 10.1016/j.expthermflusci.2016.06.019; Negrelli S, 2015, INT J REFRIG, V58, P243, DOI 10.1016/j.ijrefrig.2015.05.021; Piucco RO, 2008, EXP THERM FLUID SCI, V32, P1710, DOI 10.1016/j.expthermflusci.2008.06.004; Schmiesing NC, 2017, SCI TECHNOL BUILT EN, V23, P946, DOI 10.1080/23744731.2017.1333876; Sheikholeslami M, 2015, RENEW SUST ENERG REV, V49, P444, DOI 10.1016/j.rser.2015.04.113; Sommers AD, 2018, INT J HEAT MASS TRAN, V122, P78, DOI 10.1016/j.ijheatmasstransfer.2018.01.074; Sommers AD, 2016, EXP THERM FLUID SCI, V75, P25, DOI 10.1016/j.expthermflusci.2016.01.008; Song MJ, 2016, APPL ENERG, V165, P371, DOI 10.1016/j.apenergy.2015.12.107; Varanasi KK, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524513; Wexler JS, 2015, SOFT MATTER, V11, P5023, DOI 10.1039/c5sm00611b; Yue XF, 2016, SURF COAT TECH, V307, P278, DOI 10.1016/j.surfcoat.2016.09.004; Zheng HK, 2017, PROG CHEM, V29, P102, DOI 10.7536/PC161015	32	3	3	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208721	10.1371/journal.pone.0208721	http://dx.doi.org/10.1371/journal.pone.0208721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533064	Green Submitted, Green Published, gold			2022-12-26	WOS:000452782500032
J	Gupta, C; Tan, R; Mishra, C; Khandelwal, N; Raman, R; Kim, R; Agrawal, R; Sen, P				Gupta, Chanda; Tan, Roy; Mishra, Chitaranjan; Khandelwal, Neha; Raman, Rajiv; Kim, Ramasamy; Agrawal, Rupesh; Sen, Parveen			Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema-A novel OCT based imaging biomarker	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VASCULARITY INDEX; THICKNESS; CHORIOCAPILLARIS; CHOROIDOPATHY; VASCULATURE; SEVERITY	Purpose To evaluate structural changes in the choroid among patients with diabetic macular edema (DME), with varying grades of diabetic retinopathy (DR), using enhance depth imaging spectral domain optical coherence tomography (EDI SD-OCT) scans. Methods A cross-sectional study was conducted on 82 eyes with DR and DME and 86 healthy control eyes. Eyes with DME were classified according to the severity of DR as per the international DR severity scale. Sub foveal choroidal thickness (SFCT) was obtained using EDI SD-OCT scans. These scans were binarized into luminal and stromal areas, to derive the choroidal vascularity index (CVI). CVI and SFCT were analyzed between the study and control group using paired-T test. Tukey's test was used to correlate the differences in CVI and SFCT between different grades of DR. Further analysis was done to look for the effect of DR severity and type of DME on CVI as well as SFCT using correlation coefficient and linear regression analysis. Results SFCT was significantly increased in eyes with DME as compared to the controls (334.47 +/- 51.81 mu m vs 284.53 +/- 56.45 mu m, p< 0.001), and showed an ascending trend with worsening of DR, though this difference was not statistically significant [ mild non-proliferative diabetic retinopathy (NPDR) = 304.33 +/- 40.39 mu m, moderate NPDR = 327.81 +/- 47.39 mu m, severe NPDR = 357.72 +/- 62.65 mu m, proliferative DR (PDR) = 334.59 +/- 47.4 mu m, p-0.09]. CVI was significantly decreased in DME with DR eyes as compared to controls (63.89 +/- 1.89 vs 67.51 +/- 2.86, p< 0.001). CVI was also significantly decreased with worsening DR (mild NPDR = 66.38 +/- 0.3, moderate NPDR = 65.28 +/- 0.37, severe NPDR = 63.50 +/- 0.47, PDR = 61.27 +/- 0.9, p<0.001). Conclusion SFCT and CVI are dynamic parameters that are affected by DME. Unlike CVI, SFCT is also affected by ocular and systemic factors like edema and hypertension. CVI may be a more accurate surrogate marker for DME and DR and can potentially be used to monitor the progression of DR.	[Gupta, Chanda; Raman, Rajiv; Sen, Parveen] Sankara Nethralaya, Med Res Fdn, Madras, Tamil Nadu, India; [Tan, Roy; Khandelwal, Neha; Agrawal, Rupesh] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore; [Mishra, Chitaranjan; Kim, Ramasamy] Aravind Eye Hosp, Madurai, Tamil Nadu, India; [Agrawal, Rupesh] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore	Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Sen, P (corresponding author), Sankara Nethralaya, Med Res Fdn, Madras, Tamil Nadu, India.; Agrawal, R (corresponding author), Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore, Singapore.; Agrawal, R (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.	Rupesh_agrawal@ttsh.com.sg; parveensen@gmail.com	Raman, Rajiv/A-7234-2009; Sen, Parveen/W-4707-2019	Raman, Rajiv/0000-0001-5842-0233; Mishra, Chitaranjan/0000-0002-4874-563X				Agrawal R, 2016, PLOS ONE, V11, P1; Agrawal R, 2017, ACTA OPHTHALMOL, V95, pe770, DOI 10.1111/aos.13442; Agrawal R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21090; Cao JT, 1998, ARCH OPHTHALMOL-CHIC, V116, P589, DOI 10.1001/archopht.116.5.589; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Esmaeelpour M, 2010, INVEST OPHTH VIS SCI, V51, P5260, DOI 10.1167/iovs.10-5196; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; FRYCZKOWSKI AW, 1989, INT OPHTHALMOL, V13, P269, DOI 10.1007/BF02280087; Galgauskas S, 2016, EUR J OPHTHALMOL, V26, P163, DOI 10.5301/ejo.5000677; Gerendas BS, 2014, AM J OPHTHALMOL, V158, P1039, DOI 10.1016/j.ajo.2014.08.001; HIDAYAT AA, 1985, OPHTHALMOLOGY, V92, P512; Kim JT, 2013, INVEST OPHTH VIS SCI, V54, P3378, DOI 10.1167/iovs.12-11503; Kim M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18511-7; Lains I, 2017, RETINA, V38, P173; Lee Hyo Kyung, 2013, Korean J Ophthalmol, V27, P433, DOI 10.3341/kjo.2013.27.6.433; Melancia D, 2016, GRAEF ARCH CLIN EXP, V254, P1453, DOI 10.1007/s00417-016-3360-8; Nagaoka T, 2004, BRIT J OPHTHALMOL, V88, P1060, DOI 10.1136/bjo.2003.035345; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Otani T, 1999, AM J OPHTHALMOL, V127, P688, DOI 10.1016/S0002-9394(99)00033-1; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P6017, DOI 10.1167/iovs.12-9692; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Rewbury R, 2016, EYE, V30, P1568, DOI 10.1038/eye.2016.187; Schocket Lisa S., 2004, International Ophthalmology, V25, P89, DOI 10.1023/B:INTE.0000031744.93778.60; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Sudhalkar A, 2015, INDIAN J OPHTHALMOL, V63, P912, DOI 10.4103/0301-4738.176024; Tan KA, 2016, ACTA OPHTHALMOL, V94, pE612, DOI 10.1111/aos.13044; Vujosevic S, 2012, RETINA-J RET VIT DIS, V32, P1781, DOI 10.1097/IAE.0b013e31825db73d; Wei X, 2017, RETINA-J RET VIT DIS, V37, P1120, DOI 10.1097/IAE.0000000000001312; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009	31	28	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0207435	10.1371/journal.pone.0207435	http://dx.doi.org/10.1371/journal.pone.0207435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533048	Green Published, gold			2022-12-26	WOS:000452782500006
J	Kowallick, A; Fischer, CV; Hoerauf, H				Kowallick, Antonia; Fischer, Charlotte Viola; Hoerauf, Hans			Optical coherence tomography findings in patients prior to cataract surgery regarded as unremarkable with ophthalmoscopy	PLOS ONE			English	Article							EPIRETINAL MEMBRANES; MACULAR DEGENERATION; EYES; PREVALENCE; DRUSEN; RISK	Purpose To investigate the feasibility and diagnostic benefit of routinely performed preoperative macular spectral-domain (SD-) optical coherence tomography (OCT) for the detection of macular pathology in patients with normal biomicroscopic funduscopy prior to cataract surgery. Methods Prospective, single center study. A total of 162 eyes of 123 consecutive patients referred for cataract surgery with a visual acuity better than 20/100, absence of macular symptoms such as metamorphopsia, no history of previous intravitreal procedures and a normal funduscopic appearance on biomicroscopy underwent an additional SD-OCT-examination prior to cataract surgery. OCT-scans were classified in three categories: normal, degenerative vitreous changes without impact on visual outcome or pathological with potential impact on visual outcome. Results 80 eyes (49.38%) showed normal OCT-scans. 69 eyes (42.59%) were classified as degenerative vitreous changes without impact on visual outcome and 20 eyes (12.35%) as pathological with potential impact on visual outcome. The indication of cataract surgery or the therapeutic strategy remained unchanged in all patients. In patients with pathological alterations further follow-up examinations were recommended. Conclusions Routine SD-OCT-imaging of the macular region in patients prior to cataract surgery was feasible to detect macular pathologies in a considerable number of patients, which remained undiagnosed on biomicroscopic funduscopy. Although OCT-findings did not impact therapeutic strategy in this study, preoperative judgement of the expected visual outcome and patient's informed consent can improve.	[Kowallick, Antonia; Fischer, Charlotte Viola; Hoerauf, Hans] Univ Med Ctr Goettingen, Dept Ophthalmol, Gottingen, Germany	University of Gottingen	Fischer, CV (corresponding author), Univ Med Ctr Goettingen, Dept Ophthalmol, Gottingen, Germany.	c.fischer@med.uni-goettingen.de						Contreras I., 2008, Arch Soc Esp Oftalmol, V83, P89; Creese K, 2012, CLIN EXP OPHTHALMOL, V40, pE118, DOI 10.1111/j.1442-9071.2011.02623.x; Hirnschall N, 2016, J CATARACT REFR SURG, V42, P530, DOI 10.1016/j.jcrs.2016.02.029; Hoerster R, 2011, BRIT J OPHTHALMOL, V95, P1424, DOI 10.1136/bjo.2010.201129; Ivastinovic D, 2012, AM J OPHTHALMOL, V153, P705, DOI 10.1016/j.ajo.2011.09.009; Jahn CE, 1999, KLIN MONATSBL AUGENH, V215, P252, DOI 10.1055/s-2008-1034709; Jain N, 2010, INVEST OPHTH VIS SCI, V51, P4875, DOI 10.1167/iovs.09-4962; Klein BR, 2016, J CATARACT REFR SURG, V42, P537, DOI 10.1016/j.jcrs.2016.01.036; Klein R, 1994, Trans Am Ophthalmol Soc, V92, P403; Klein R, 1994, T AM OPHTHAL SOC, V92, P425; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Milani P, 2012, RETINA-J RET VIT DIS, V32, P897, DOI 10.1097/IAE.0b013e31822a8fec; Mitchell P, 1997, OPHTHALMOLOGY, V104, P1033, DOI 10.1016/S0161-6420(97)30190-0; Neto CAM, 2015, ARQ BRAS OFTALMOL, V78, P241, DOI 10.5935/0004-2749.20150062; Nessmann A, 2016, OPHTHALMOLOGE, V113, P507, DOI 10.1007/s00347-015-0113-8; PEARLSTONE AD, 1985, ANN OPHTHALMOL, V17, P378; Recchia FM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1587; Schaub F, 2018, GRAEF ARCH CLIN EXP, V256, P909, DOI 10.1007/s00417-018-3954-4; Sebag J, 2004, GRAEF ARCH CLIN EXP, V242, P690, DOI 10.1007/s00417-004-0980-1; Sigler EJ, 2013, RETINA-J RET VIT DIS, V33, P1158, DOI 10.1097/IAE.0b013e318276e104; Wang JJ, 2012, OPHTHALMOLOGY, V119, P2298, DOI 10.1016/j.ophtha.2012.07.003; Wang JJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P658, DOI 10.1001/archopht.121.5.658; Zafar S, 2017, J CATARACT REFR SURG, V43, P324, DOI 10.1016/j.jcrs.2016.12.022	23	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208980	10.1371/journal.pone.0208980	http://dx.doi.org/10.1371/journal.pone.0208980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533037	gold, Green Published, Green Submitted			2022-12-26	WOS:000452782500057
J	Madrova, L; Krijt, M; Baresova, V; Vaclavik, J; Friedecky, D; Dobesova, D; Souckova, O; Skopova, V; Adam, T; Zikanova, M				Madrova, Lucie; Krijt, Matyas; Baresova, Veronika; Vaclavik, Jan; Friedecky, David; Dobesova, Dana; Souckova, Olga; Skopova, Vaclava; Adam, Tomas; Zikanova, Marie			Mass spectrometric analysis of purine de novo biosynthesis intermediates	PLOS ONE			English	Article							AICA-RIBOSIDURIA; ADSL; DEFICIENCY; PHOSPHORIBOSYLAMINE; ACCUMULATION; NUCLEOTIDES; FIBROBLASTS; MUTATIONS; COMPLEXES; MECHANISM	Purines are essential molecules for all forms of life. In addition to constituting a backbone of DNA and RNA, purines play roles in many metabolic pathways, such as energy utilization, regulation of enzyme activity, and cell signaling. The supply of purines is provided by two pathways: the salvage pathway and de novo synthesis. Although purine de novo synthesis (PDNS) activity varies during the cell cycle, this pathway represents an important source of purines, especially for rapidly dividing cells. A method for the detailed study of PDNS is lacking for analytical reasons (sensitivity) and because of the commercial unavailability of the compounds. The aim was to fully describe the mass spectrometric fragmentation behavior of newly synthesized PDNS-related metabolites and develop an analytical method. Except for four initial ribotide PDNS intermediates that preferentially lost water or phosphate or cleaved the forming base of the purine ring, all the other metabolites studied cleaved the glycosidic bond in the first fragmentation stage. Fragmentation was possible in the third to sixth stages. A liquid chromatography-high-resolution mass spectrometric method was developed and applied in the analysis of CRISPR-Cas9 genome-edited HeLa cells deficient in the individual enzymatic steps of PDNS and the salvage pathway. The identities of the newly synthesized intermediates of PDNS were confirmed by comparing the fragmentation patterns of the synthesized metabolites with those produced by cells (formed under pathological conditions of known and theoretically possible defects of PDNS). The use of stable isotope incorporation allowed the confirmation of fragmentation mechanisms and provided data for future fluxomic experiments. This method may find uses in the diagnosis of PDNS disorders, the investigation of purinosome formation, cancer research, enzyme inhibition studies, and other applications.	[Madrova, Lucie; Vaclavik, Jan; Friedecky, David; Dobesova, Dana; Adam, Tomas] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic; [Madrova, Lucie; Vaclavik, Jan; Friedecky, David; Dobesova, Dana; Adam, Tomas] Univ Hosp Olomouc, Olomouc, Czech Republic; [Madrova, Lucie; Vaclavik, Jan; Friedecky, David; Adam, Tomas] Univ Hosp Olomouc, Dept Clin Biochem, Olomouc, Czech Republic; [Krijt, Matyas; Baresova, Veronika; Souckova, Olga; Skopova, Vaclava; Zikanova, Marie] Charles Univ Prague, Res Unit Rare Dis, Dept Pediat & Adolescent Med, Fac Med 1, Prague, Czech Republic; [Krijt, Matyas; Baresova, Veronika; Souckova, Olga; Skopova, Vaclava; Zikanova, Marie] Gen Univ Hosp Prague, Prague, Czech Republic; [Friedecky, David; Adam, Tomas] Univ Hosp Olomouc, Dept Clin Chem, Lab Inherited Metab Disorders, Olomouc, Czech Republic	Palacky University Olomouc; University Hospital Olomouc; University Hospital Olomouc; Charles University Prague; General University Hospital Prague; University Hospital Olomouc	Zikanova, M (corresponding author), Charles Univ Prague, Res Unit Rare Dis, Dept Pediat & Adolescent Med, Fac Med 1, Prague, Czech Republic.; Zikanova, M (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	marie.zikanova@lf1.cuni.cz	Škopová, Václava/F-4992-2017; Krijt, Matyáš/AAX-5175-2021; FRIEDECKÝ, David/AAR-5649-2021; Zikanova, Marie/D-1325-2010	Škopová, Václava/0000-0002-6560-4177; Krijt, Matyáš/0000-0001-5930-5595; Friedecky, David/0000-0002-3448-9073; Zikanova, Marie/0000-0002-9375-800X; Dobesova, Dana/0000-0001-9357-414X	Ministry of Health of the Czech Republic [AZV 15-28979A]; Charles University Grant Agency [GAUK 818416, GAUK 1102217]; Czech Science Foundation [GACR 18-12204S]; Charles University [PRIMUS/17/MED/6, PROGRES Q26/LF1, UNCE 204064, SVV 260367/2017]; Ministry of Education, Youth and Sports of CR [LO1304, LQ1604]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Charles University Grant Agency; Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; Ministry of Education, Youth and Sports of CR(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Ministry of Health of the Czech Republic [grant AZV 15-28979A, http://www.azvcr.cz, recipient MZ], by The Charles University Grant Agency [grant GAUK 818416, recipient MK and GAUK 1102217, recipient OS, https://www.cuni.cz/UK-33.html] and by The Czech Science Foundation [grant GACR 18-12204S, recipient TA, https://gacr.cz/en/]. Institutional support was provided by Charles University [programmes PRIMUS/17/MED/6, recipient MZ, PROGRES Q26/LF1, UNCE 204064 and SVV 260367/2017 http://www.cuni.cz] and by the Ministry of Education, Youth and Sports of CR [LO1304 National Sustainability Programme I and LQ1604 National Sustainability Programme II, http://www.msmt.cz/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Baresova V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201432; Baresova V, 2016, MOL GENET METAB, V119, P270, DOI 10.1016/j.ymgme.2016.08.004; Baresova V, 2012, HUM MOL GENET, V21, P1534, DOI 10.1093/hmg/ddr591; BECKER MA, 1987, J BIOL CHEM, V262, P14531; Bulock KG, 2002, J BIOL CHEM, V277, P22168, DOI 10.1074/jbc.M111964200; Chakravarthi BVSK, 2017, PROSTATE, V77, P10, DOI 10.1002/pros.23243; Curto R, 1998, MATH BIOSCI, V151, P1, DOI 10.1016/S0025-5564(98)10001-9; Duval N, 2013, MOL GENET METAB, V108, P178, DOI 10.1016/j.ymgme.2013.01.002; Goswami MT, 2015, ONCOTARGET, V6, P23445, DOI 10.18632/oncotarget.4352; HARTMAN SC, 1958, J BIOL CHEM, V233, P451; HOMMES FA, 1991, TECHNIQUES DIAGNOSTI; Hornik P, 2006, J CHROMATOGR B, V843, P15, DOI 10.1016/j.jchromb.2006.05.020; Huang WY, 2017, PROTEIN CELL, V8, P284, DOI 10.1007/s13238-016-0350-x; JAEKEN J, 1984, LANCET, V2, P1058; JINNAH HA, 1993, J NEUROCHEM, V60, P2036, DOI 10.1111/j.1471-4159.1993.tb03488.x; Jurecka A, 2015, J INHERIT METAB DIS, V38, P231, DOI 10.1007/s10545-014-9755-y; Kasper PT, 2012, RAPID COMMUN MASS SP, V26, P2275, DOI 10.1002/rcm.6340; Kmoch S, 2000, HUM MOL GENET, V9, P1501, DOI 10.1093/hmg/9.10.1501; Lopez JM, 2008, MED HYPOTHESES, V71, P657, DOI 10.1016/j.mehy.2008.06.033; LUKENS L, 1963, METHOD ENZYMOL, V6, P671, DOI 10.1016/0076-6879(63)06236-4; Marie S, 2004, AM J HUM GENET, V74, P1276, DOI 10.1086/421475; NEWCOMBE DS, 1970, PEDIATRICS, V46, P508; Neychev VK, 2004, MED HYPOTHESES, V63, P131, DOI 10.1016/j.mehy.2004.01.019; Ridder L, 2012, RAPID COMMUN MASS SP, V26, P2461, DOI 10.1002/rcm.6364; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; SANT ME, 1989, ANAL BIOCHEM, V182, P121, DOI 10.1016/0003-2697(89)90728-8; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; Sheldon MT, 2009, J AM SOC MASS SPECTR, V20, P370, DOI 10.1016/j.jasms.2008.10.017; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; STONE TW, 1991, PURINES BASIC CLIN A; Thomas A, 2013, ANAL BIOANAL CHEM, V405, P9703, DOI 10.1007/s00216-013-7162-0; Tschirner SK, 2016, LIFE SCI, V156, P68, DOI 10.1016/j.lfs.2016.05.031; Wojtowicz P, 2012, COMPREHENSIVE 2 DIME; Zhao H, 2015, J BIOL CHEM, V290, P6705, DOI 10.1074/jbc.M114.628701; Zidkova L, 2010, MOL GENET METAB, V101, P286, DOI 10.1016/j.ymgme.2010.06.014; Zikanova M, 2005, J INHERIT METAB DIS, V28, P493, DOI 10.1007/s10545-005-0493-z; Zikanova M, 2015, CLIN BIOCHEM, V48, P2, DOI 10.1016/j.clinbiochem.2014.10.004; Zikanova M, 2010, HUM MUTAT, V31, P445, DOI 10.1002/humu.21212	39	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208947	10.1371/journal.pone.0208947	http://dx.doi.org/10.1371/journal.pone.0208947			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532129	Green Published, gold			2022-12-26	WOS:000452644700059
J	McCaskey, A; Dumitrescu, E; Chen, MS; Lyakh, D; Humble, T				McCaskey, Alexander; Dumitrescu, Eugene; Chen, Mengsu; Lyakh, Dmitry; Humble, Travis			Validating quantum-classical programming models with tensor network simulations	PLOS ONE			English	Article							MATRIX PRODUCT STATES; RENORMALIZATION-GROUP; ALGORITHMS	The exploration of hybrid quantum-classical algorithms and programming models on noisy near-term quantum hardware has begun. As hybrid programs scale towards classical intractability, validation and benchmarking are critical to understanding the utility of the hybrid computational model. In this paper, we demonstrate a newly developed quantum circuit simulator based on tensor network theory that enables intermediate-scale verification and validation of hybrid quantum-classical computing frameworks and programming models. We present our tensor-network quantum virtual machine (TNQVM) simulator which stores a multi-qubit wavefunction in a compressed (factorized) form as a matrix product state, thus enabling single-node simulations of larger qubit registers, as compared to brute-force state-vector simulators. Our simulator is designed to be extensible in both the tensor network form and the classical hardware used to run the simulation (multicore, GPU, distributed). The extensibility of the TNQVM simulator with respect to the simulation hardware type is achieved via a pluggable interface for different numerical backends (e.g., ITensor and Exa-TENSOR numerical libraries). We demonstrate the utility of our TNQVM quantum circuit simulator through the verification of randomized quantum circuits and the variational quantum eigensolver algorithm, both expressed within the eXtreme-scale ACCelerator (XACC) programming model.	[McCaskey, Alexander; Dumitrescu, Eugene; Lyakh, Dmitry; Humble, Travis] Oak Ridge Natl Lab, Quantum Comp Inst, Oak Ridge, TN 37831 USA; [McCaskey, Alexander] Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN 37831 USA; [Dumitrescu, Eugene; Humble, Travis] Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN 37831 USA; [Chen, Mengsu] Virginia Tech, Dept Phys, Blacksburg, VA 24060 USA; [Lyakh, Dmitry] Oak Ridge Natl Lab, Natl Ctr Computat Sci, Oak Ridge, TN 37831 USA; [Humble, Travis] Univ Tennessee, Bredesen Ctr Interdisciplinary Res, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	McCaskey, A (corresponding author), Oak Ridge Natl Lab, Quantum Comp Inst, Oak Ridge, TN 37831 USA.; McCaskey, A (corresponding author), Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN 37831 USA.	mccaskeyaj@ornl.gov	Humble, Travis/AAC-6694-2019; Scarola, Vito/G-5412-2012	Lyakh, Dmitry/0000-0002-1851-2974; Scarola, Vito/0000-0002-8653-2723	U.S. Department of Energy ASCR Quantum Algorithms Team [ERKJ332]; U.S. Department of Energy ASCR Quantum Testbed Pathfinder [ERKJ335]; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory [8297]; U.S. Department of Energy Early Career Award; U.S. Department of Energy [DE-AC0500OR22725, DE-AC05-00OR22725, DE-AC05-00OR22750]; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; US Department of Energy (DOE) Office of Science Advanced Scientific Computing Research (ASCR) Early Career Research Award; DOE Office of Science ASCR quantum algorithms and testbed programs [ERKJ332, ERKJ335]; ORNL Undergraduate Research Participation Program - ORNL	U.S. Department of Energy ASCR Quantum Algorithms Team; U.S. Department of Energy ASCR Quantum Testbed Pathfinder; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; U.S. Department of Energy Early Career Award(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; US Department of Energy (DOE) Office of Science Advanced Scientific Computing Research (ASCR) Early Career Research Award; DOE Office of Science ASCR quantum algorithms and testbed programs; ORNL Undergraduate Research Participation Program - ORNL	This work was supported by U.S. Department of Energy ASCR Quantum Algorithms Team (ERKJ332, Mr. Alexander McCaskey), U.S. Department of Energy ASCR Quantum Testbed Pathfinder (ERKJ335, Mr. Alexander McCaskey), Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ID 8297, Mr. Alexander McCaskey), and U.S. Department of Energy Early Career Award (Dr. Travis Humble). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript has been authored by UT-Battelle, LLC, under Contract No. DE-AC0500OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a non-exclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for the United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan. This work has been supported by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory, the US Department of Energy (DOE) Office of Science Advanced Scientific Computing Research (ASCR) Early Career Research Award, and the DOE Office of Science ASCR quantum algorithms and testbed programs, under field work proposal numbers ERKJ332 and ERKJ335. This work was also supported by the ORNL Undergraduate Research Participation Program, which is sponsored by ORNL and administered jointly by ORNL and the Oak Ridge Institute for Science and Education (ORISE). ORNL is managed by UT-Battelle, LLC, for the US Department of Energy under contract no. DE-AC05-00OR22725. ORISE is managed by Oak Ridge Associated Universities for the US Department of Energy under contract no. DE-AC05-00OR22750.	Aaronson S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052328; Boixo S, 2018, NAT PHYS, V14, P595, DOI 10.1038/s41567-018-0124-x; Britt KA, 2017, ACM J EMERG TECH COM, V13, DOI 10.1145/3007651; Childs AM, 2010, REV MOD PHYS, V82, P1, DOI 10.1103/RevModPhys.82.1; Cross A. W., 2017, ARXIV E PRINTS; Dang A, 2017, OPTIMISING MATRIX PR; Dumitrescu EF, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.210501; Dumitrescu E, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.062322; Evenbly G, 2009, PHYS REV B, V79, P1; Fried E. S, 2017, ARXIV170903636; Friis N, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021012; Gamma E., 1994, DESIGN PATTERNS ELEM; Green AS, 2013, ACM SIGPLAN NOTICES, V48, P333, DOI 10.1145/2499370.2462177; Haner T, 2017, ARXIV E PRINTS; Humble T. S., 2014, Computational Science and Discovery, V7, DOI 10.1088/1749-4680/7/1/015006; Humble TS, 2016, IEEE HIGH PERF EXTR; JavadiAbhari A., 2014, P 11 ACM C COMPUTING, P1; Kandala A, 2017, NATURE, V549, P242, DOI 10.1038/nature23879; Kolda TG, 2015, MATH PROGRAM, V151, P225, DOI 10.1007/s10107-015-0895-0; Linke N. M., 2017, P NATL ACAD SCI USA; Liu S., 2017, ARXIV171009500; Marti KH, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103008; McCaskey A, 2017, TNQVM TENSOR NETWORK; McCaskey A, 2018, ARXIV E PRINTS; McCaskey AJ, 2018, LANGUAGE HARDWARE IN; Montanaro A, 2016, NPJ QUANTUM INFORM, V2, DOI 10.1038/npjqi.2015.23; Murg V, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205105; Nakatani N, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4798639; Orus R, 2014, ANN PHYS-NEW YORK, V349, P117, DOI 10.1016/j.aop.2014.06.013; Pakin S., 2018, THEOR PRACT LOG PROG, P1; Pednault E., 2017, BREAKING 49 QUBIT BA; Peruzzo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5213; Preskill J., 2018, ARXIV180100862; Schollwock U, 2011, ANN PHYS-NEW YORK, V326, P96, DOI 10.1016/j.aop.2010.09.012; Schuyler Hong S., 2017, ARXIV171205771QUANTP; Smith R S, 2016, PRACTICAL QUANTUM IN; Smith R. S., 2016, PRACTICAL QUANTUM IN; Steiger DS, 2016, ARXIV E PRINTS; Svore K.M., 2014, ARXIV14024467; Svore K, 2018, RWDSL2018: PROCEEDINGS OF THE REAL WORLD DOMAIN SPECIFIC LANGUAGES WORKSHOP 2018, DOI 10.1145/3183895.3183901; Vidal G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.110501; Ye K, 2018, ARXIV E PRINTS	48	17	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0206704	10.1371/journal.pone.0206704	http://dx.doi.org/10.1371/journal.pone.0206704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532151	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700006
J	Cagno, V; Tintori, C; Civra, A; Cavalli, R; Tiberi, M; Botta, L; Brai, A; Poli, G; Tapparel, C; Lembo, D; Botta, M				Cagno, Valeria; Tintori, Cristina; Civra, Andrea; Cavalli, Roberta; Tiberi, Marika; Botta, Lorenzo; Brai, Annalaura; Poli, Giulio; Tapparel, Caroline; Lembo, David; Botta, Maurizio			Novel broad spectrum virucidal molecules against enveloped viruses	PLOS ONE			English	Article							HEPATITIS-B; MECHANISMS; INFECTION; AGENTS; HIV	Viral infections are an important cause of death worldwide. Unfortunately, there is still a lack of antiviral drugs or vaccines for a large number of viruses, and this represents a remarkable challenge particularly for emerging and re-emerging viruses. For this reason, the identification of broad spectrum antiviral compounds provides a valuable opportunity for developing efficient antiviral therapies. Here we report on a class of rhodanine and thiobarbituric derivatives displaying a broad spectrum antiviral activity against seven different enveloped viruses including an HSV-2 acyclovir resistant strain with favorable selectivity indexes. Due to their selective action on enveloped viruses and to their lipid oxidation ability, we hypothesize a mechanism on the viral envelope that affects the fluidity of the lipid bilayer, thus compromising the efficiency of virus-cell fusion and preventing viral entry.	[Cagno, Valeria; Civra, Andrea; Lembo, David] Univ Torino, Dept Clin & Biol Sci, Lab Mol Virol & Antiviral Res, Turin, Italy; [Cagno, Valeria; Tapparel, Caroline] Univ Geneva, Dept Mol Microbiol, Geneva, Switzerland; [Tintori, Cristina; Tiberi, Marika; Botta, Lorenzo; Brai, Annalaura; Poli, Giulio; Botta, Maurizio] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy; [Cavalli, Roberta] Univ Torino, Dept Drug Sci & Technol, Turin, Italy; [Brai, Annalaura; Botta, Maurizio] Lead Discovery Siena Srl, Siena, Italy; [Botta, Maurizio] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Botta, Lorenzo] Univ Roma Tor Vergata, Fac Pharm, Dept Biol, Rome, Italy	University of Turin; University of Geneva; University of Siena; University of Turin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Rome Tor Vergata	Botta, M (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy.	botta.maurizio@gmail.com	Cagno, Valeria/AAE-7612-2020; BRAI, Annalaura/AAV-3656-2020	BRAI, Annalaura/0000-0001-6395-9348; Cagno, Valeria/0000-0002-5597-334X; Tapparel Vu, Caroline/0000-0002-0411-6567; POLI, GIULIO/0000-0002-8061-5632	European Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance [734548]; Lead Discovery Siena srl	European Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance; Lead Discovery Siena srl	This work was supported by the European Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance Grant Agreement no. 734548 to MB. https://cordis.europa.eu/project/rcn/207455_it.html. Lead Discovery Siena srl provided support in the form of research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13; Bay BH, 1999, NEUROSCI LETT, V277, P127, DOI 10.1016/S0304-3940(99)00872-1; Botta L, 2017, BIOORG MED CHEM LETT, V27, P2502, DOI 10.1016/j.bmcl.2017.03.097; Brai A, 2016, P NATL ACAD SCI USA, V113, P5388, DOI 10.1073/pnas.1522987113; Cagno V, 2015, ANTIMICROB AGENTS CH, V59, P5250, DOI 10.1128/AAC.00443-15; Cagno V, 2014, ANTIMICROB AGENTS CH, V58, P4782, DOI 10.1128/AAC.02594-14; Carlotti ME, 2008, J INCL PHENOM MACRO, V61, P279, DOI 10.1007/s10847-008-9420-x; Civra A, 2015, J BIOL CHEM, V290, P12403, DOI 10.1074/jbc.M114.620500; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Donalisio M, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-266; Guillen-Sans R, 1998, CRIT REV FOOD SCI, V38, P315, DOI 10.1080/10408699891274228; Mackenzie JS, 2013, CURR OPIN VIROL, V3, P170, DOI 10.1016/j.coviro.2013.02.002; Pollock S, 2010, P NATL ACAD SCI USA, V107, P17176, DOI 10.1073/pnas.1009445107; Rinaldi M, 2011, CHEMMEDCHEM, V6, P343, DOI 10.1002/cmdc.201000510; Sample CJ, 2013, PEPTIDES, V48, P96, DOI 10.1016/j.peptides.2013.07.014; Speerstra S, 2018, ANTIVIR RES, V149, P164, DOI 10.1016/j.antiviral.2017.11.018; Tang LSY, 2018, JAMA-J AM MED ASSOC, V319, P1802, DOI 10.1001/jama.2018.3795; Tiberi M, 2014, ANTIMICROB AGENTS CH, V58, P3043, DOI 10.1128/AAC.02739-13; Tintori C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198478; WHO, DENG SEV DENG; Wisskirchen K, 2014, TRENDS PHARMACOL SCI, V35, P470, DOI 10.1016/j.tips.2014.06.004; World Health Organization, TOP 10 CAUS DEATH	22	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208333	10.1371/journal.pone.0208333	http://dx.doi.org/10.1371/journal.pone.0208333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532192	Green Published, gold, Green Submitted			2022-12-26	WOS:000452640900011
J	Li, N; Lu, YL; Liao, H; He, QY; Li, JY; Long, X				Li, Nan; Lu, Yilei; Liao, Hong; He, Qingyang; Li, Jingyi; Long, Xin			WRF-Chem modeling of particulate matter in the Yangtze River Delta region: Source apportionment and its sensitivity to emission changes	PLOS ONE			English	Article							SUMMERTIME OZONE FORMATION; NORTH CHINA PLAIN; MEXICO-CITY; AIR-QUALITY; POLLUTION EPISODES; GUANZHONG BASIN; PM2.5; HAZE; IMPACTS; URBAN	China has been troubled by high concentrations of fine particulate matter (PM2.5) for many years. Up to now, the pollutant sources are not yet fully understood and the control approach still remains highly uncertain. In this study, four month-long (January, April, July and October in 2015) WRF-Chem simulations with different sensitivity experiments were conducted in the Yangtze River Delta (YRD) region of eastern China. The simulated results were compared with abundant meteorological and air quality observations at 138 stations in 26 YRD cities. Our model well captured magnitudes and variations of the observed PM2.5, with the normal mean biases (NMB) less than +/- 20% for 19 out of the 26 YRD cities. A series of sensitivity simulations were conducted to quantify the contributions from individual source sectors and from different regions to the PM2.5 in the YRD region. The calculated results show that YRD local source contributed 64% of the regional PM2.5 concentration, while outside transport contributed the rest 36%. Among the local sources, industry activity was the most significant sector in spring (25%), summer (36%) and fall (33%), while residential source was more important in winter (38%). We further conducted scenario simulations to explore the potential impacts of varying degrees of emission controls on PM2.5 reduction. The result demonstrated that regional cooperative control could effectively reduce the PM2.5 level. The proportionate emission controls of 10%, 20%, 30%, 40% and 50% could reduce the regional mean PM2.5 concentrations by 10%, 19%, 28%, 37% and 46%, respectively, and for places with higher ambient concentrations, the mitigation efficiency was more significant. Our study on source apportionment and emission controls can provide useful information on further mitigation actions.	[Li, Nan; Liao, Hong; Li, Jingyi] Nanjing Univ Informat Sci & Technol, Jiangsu Collaborat Innovat Ctr Atmospher Environm, Sch Environm Sci & Engn, Jiangsu Key Lab Atmospher Environm Monitoring & P, Nanjing, Jiangsu, Peoples R China; [Lu, Yilei] Nanjing Gaochun Dist Meteorol Bur, Nanjing, Jiangsu, Peoples R China; [He, Qingyang] Nanjing Star Jelly Environm Consultants Co Ltd, Nanjing, Jiangsu, Peoples R China; [Long, Xin] Chinese Acad Sci, Inst Earth Environm, Key Lab Aerosol Chem & Phys, Xian, Shaanxi, Peoples R China	Nanjing University of Information Science & Technology; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Li, N (corresponding author), Nanjing Univ Informat Sci & Technol, Jiangsu Collaborat Innovat Ctr Atmospher Environm, Sch Environm Sci & Engn, Jiangsu Key Lab Atmospher Environm Monitoring & P, Nanjing, Jiangsu, Peoples R China.	linan@nuist.edu.cn	Liao, Hong/T-7963-2017	Liao, Hong/0000-0002-9315-4839; Li, Nan/0000-0003-3052-4414; Long, Xin/0000-0002-6272-4712	National Natural Science Foundation of China [41705128]; Nanjing University of Information Science and Technology [2016r063]; Opening Project of Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3) [FDLAP17003]; Nanjing Star-jelly Environmental Consultants Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing University of Information Science and Technology(Nanjing University of Information Science & Technology); Opening Project of Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3); Nanjing Star-jelly Environmental Consultants Co., Ltd.	This work was supported by the National Natural Science Foundation of China (41705128), Nanjing University of Information Science and Technology (2016r063), and Opening Project of Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3) (FDLAP17003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. QYH was supported by Nanjing Star-jelly Environmental Consultants Co., Ltd. The funder provided support in the form of salaries for author [QYH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Binkowski FS, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001409; Cao JJ, 2012, ATMOS ENVIRON, V59, P559, DOI 10.1016/j.atmosenv.2012.05.036; Chang D, 2009, ATMOS RES, V94, P161, DOI 10.1016/j.atmosres.2009.05.006; Chen DS, 2018, SCI TOTAL ENVIRON, V610, P1476, DOI 10.1016/j.scitotenv.2017.07.255; Cheng YF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601530; Cheng Z, 2013, ENVIRON POLLUT, V182, P101, DOI 10.1016/j.envpol.2013.06.043; Ding AJ, 2013, ATMOS CHEM PHYS, V13, P5813, DOI 10.5194/acp-13-5813-2013; Emmons LK, 2010, GEOSCI MODEL DEV, V3, P43, DOI 10.5194/gmd-3-43-2010; Feng T, 2016, ATMOS CHEM PHYS, V16, P4323, DOI 10.5194/acp-16-4323-2016; Gao LN, 2014, AEROSOL AIR QUAL RES, V14, P311, DOI 10.4209/aaqr.2013.02.0054; Grell GA, 2005, ATMOS ENVIRON, V39, P6957, DOI 10.1016/j.atmosenv.2005.04.027; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Guo S, 2014, P NATL ACAD SCI USA, V111, P17373, DOI 10.1073/pnas.1419604111; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Hu JL, 2016, ATMOS CHEM PHYS, V16, P10333, DOI 10.5194/acp-16-10333-2016; Hu JL, 2014, ATMOS ENVIRON, V95, P598, DOI 10.1016/j.atmosenv.2014.07.019; Li G, 2011, ATMOS CHEM PHYS, V11, P5169, DOI 10.5194/acp-11-5169-2011; Li G, 2011, ATMOS CHEM PHYS, V11, P3789, DOI 10.5194/acp-11-3789-2011; Li G, 2010, ATMOS CHEM PHYS, V10, P6551, DOI 10.5194/acp-10-6551-2010; Li GH, 2017, ATMOS CHEM PHYS, V17, P3301, DOI 10.5194/acp-17-3301-2017; Li M, 2017, ATMOS CHEM PHYS, V17, P935, DOI 10.5194/acp-17-935-2017; Li N, 2018, ATMOS CHEM PHYS, V18, P7489, DOI 10.5194/acp-18-7489-2018; Li N, 2016, ENVIRON POLLUT, V214, P86, DOI 10.1016/j.envpol.2016.03.046; Li X, 2015, ATMOS ENVIRON, V123, P229, DOI 10.1016/j.atmosenv.2015.10.048; Liu YM, 2017, SCI TOTAL ENVIRON, V596, P194, DOI 10.1016/j.scitotenv.2017.03.255; Liu ZR, 2018, ATMOS CHEM PHYS, V18, P8849, DOI 10.5194/acp-18-8849-2018; Long SC, 2016, J ENVIRON SCI-CHINA, V41, P69, DOI 10.1016/j.jes.2015.05.019; Long X, 2016, ATMOS CHEM PHYS, V16, P9675, DOI 10.5194/acp-16-9675-2016; Lyu BL, 2017, ATMOSPHERE-BASEL, V8, DOI 10.3390/atmos8080147; Ma XY, 2018, ATMOS ENVIRON, V195, P125, DOI 10.1016/j.atmosenv.2018.09.058; Mai JH, 2016, ADV METEOROL, V2016, DOI 10.1155/2016/5836070; Menon S, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/024004; Ni ZZ, 2018, ENVIRON POLLUT, V236, P550, DOI 10.1016/j.envpol.2018.01.069; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Poschl U, 2005, ANGEW CHEM INT EDIT, V44, P7520, DOI 10.1002/anie.200501122; Pui DYH, 2014, PARTICUOLOGY, V13, P1, DOI 10.1016/j.partic.2013.11.001; Qin SS, 2014, ATMOS ENVIRON, V98, P665, DOI 10.1016/j.atmosenv.2014.09.046; Skamarock W.C., 2008, DESCRIPTION ADV RES; Sun J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4130-1; Sun J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040402; Tai APK, 2010, ATMOS ENVIRON, V44, P3976, DOI 10.1016/j.atmosenv.2010.06.060; Tian Y, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019104; U.S. EPA, 2009, INT SCI ASS ISA PART; Wang GH, 2016, P NATL ACAD SCI USA, V113, P13630, DOI 10.1073/pnas.1616540113; Wang LT, 2014, ATMOS CHEM PHYS, V14, P3151, DOI 10.5194/acp-14-3151-2014; Wang Q, 2013, PLOS ONE, V8, P10, DOI [10.1002/2016jd025136, DOI 10.1002/2016JD025136]; Wang TJ, 2012, ATMOS ENVIRON, V58, P70, DOI 10.1016/j.atmosenv.2012.01.014; Wiedinmyer C, 2011, GEOSCI MODEL DEV, V4, P625, DOI 10.5194/gmd-4-625-2011; Wiedinmyer C, 2006, ATMOS ENVIRON, V40, P3419, DOI 10.1016/j.atmosenv.2006.02.010; Xu JM, 2016, SCI TOTAL ENVIRON, V572, P1138, DOI 10.1016/j.scitotenv.2016.08.024; Yang Y, 2016, J GEOPHYS RES-ATMOS, V121, P13050, DOI 10.1002/2016JD025136; Zhang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12558; Zhao PS, 2011, ATMOS RES, V101, P711, DOI 10.1016/j.atmosres.2011.04.019; Zheng B, 2015, ATMOS CHEM PHYS, V15, P2031, DOI 10.5194/acp-15-2031-2015; Zhou TC, 2017, ATMOSPHERE-BASEL, V8, DOI 10.3390/atmos8080137; Zhu YH, 2018, ENVIRON INT, V115, P343, DOI 10.1016/j.envint.2018.03.037	56	13	15	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208944	10.1371/journal.pone.0208944	http://dx.doi.org/10.1371/journal.pone.0208944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532166	Green Submitted, gold, Green Published			2022-12-26	WOS:000452640900055
J	Stotzer, US; Pisani, GFD; Canevazzi, GHR; Shiguemoto, GE; Duarte, ACGD; Perez, SED; Selistre-de-Araujo, HS				Stotzer, Uliana Sbeguen; Deriggi Pisani, Graziele Fernanda; Rigo Canevazzi, Gustavo Henrique; Shiguemoto, Gilberto Eiji; de Oliveira Duarte, Ana Claudia Garcia; de Andrade Perez, Sergio Eduardo; Selistre-de-Araujo, Heloisa Sobreiro			Benefits of resistance training on body composition and glucose clearance are inhibited by long-term low carbohydrate diet in rats	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; INSULIN-RESISTANCE; KETOGENIC DIET; VISCERAL OBESITY; ADIPOSE-TISSUE; WEIGHT-LOSS; FREE MASS; EXERCISE; LIVER; MUSCLE	Background/Objectives Regular exercise training is effective to altering many markers of metabolic syndrome and its effects are strongly influenced by the type of consumed diet. Nowadays, resistance training (RT) has been frequently associated with low-carbohydrate high-fat diet (LCD). After long term these diets causes body weight (BW) regain with deleterious effects on body composition and metabolic risk factors. The effects of RT associated with long-term LCD on these parameters remain unexplored. We aimed to investigate the effects of RT when associated with long-term LCD on BW, feed efficiency, body composition, glucose homeostasis, liver parameters and serum biochemical parameters during BW regain period in rats. Subjects/Methods Male Sprague-Dawley rats were fed with LCD (LC groups) or standard diet (STD) (ST groups). After 10 weeks-diet animals were separated into sedentary (Sed-LC and Sed-ST) and resistance-trained (RT-LC and RT-ST) groups (N = 8/group). RT groups performed an 11-week climbing program on a ladder with progressive load. Dual x-ray absorptiometry, glucose tolerance tests and insulin tolerance tests were performed at weeks 10 and 20. Liver and serum were collected at week 21. Results RT reduced feed efficiency, BW gain, liver fat and total and LDL cholesterol, and improved body composition and glucose clearance in animals fed on STD. In those fed with LCD, RT reduced caloric intake, BW regain, liver fat and serum triglycerides levels. However, improvement in body composition was inhibited and bone mineral density and glucose clearance was further impaired in this association. Conclusions The LCD nullifies the beneficial effects of RT on body composition, glucose homeostasis and impairs some health parameters. Our results do not support the association of RT with LCD in a long term period.	[Stotzer, Uliana Sbeguen; Deriggi Pisani, Graziele Fernanda; Rigo Canevazzi, Gustavo Henrique; Shiguemoto, Gilberto Eiji; de Andrade Perez, Sergio Eduardo; Selistre-de-Araujo, Heloisa Sobreiro] Univ Fed Sao Carlos, Dept Physiol Sci, Sao Carlos, SP, Brazil; [de Oliveira Duarte, Ana Claudia Garcia] Univ Fed Sao Carlos, Dept Phys Educ & Human Motr, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos	Stotzer, US (corresponding author), Univ Fed Sao Carlos, Dept Physiol Sci, Sao Carlos, SP, Brazil.	ulianass@hotmail.com	Stotzer, Uliana S/H-3413-2018	Stotzer, Uliana S/0000-0003-3325-5539; Duarte, Ana Claudia/0000-0002-7667-9481	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [13/00798-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [403144/2014-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (13/00798-2 - USS; HSSA), by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (403144/2014-0 - USS) and by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (001 - USS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandraki I, 2015, SOUTH MED J, V108, P401, DOI 10.14423/SMJ.0000000000000308; Aoi W, 2012, PHYSIOL RES, V61, P81, DOI 10.33549/physiolres.932239; Asrih M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126364; Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Axen KV, 2010, OBESITY, V18, P1538, DOI 10.1038/oby.2009.466; Bidinotto P.M., 1997, Boletim Tecnico do CEPTA, V10, P53; Bielohuby M, 2013, AM J PHYSIOL-ENDOC M, V305, pE1059, DOI 10.1152/ajpendo.00208.2013; Brazil Ministrio da Cincia Tecnologia e Inovao Conselho Nacional de Controle de Experimentao Animal, 2016, GUIA BRAS PROD MAN U; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Caton SJ, 2012, PHYSIOL BEHAV, V106, P185, DOI 10.1016/j.physbeh.2012.02.003; Cleasby ME, 2016, J ENDOCRINOL, V229, pR67, DOI 10.1530/JOE-15-0533; Rodrigues MFC, 2013, CLINICS, V68, P1247, DOI 10.6061/clinics/2013(09)12; Domingos MM, 2012, EUR J APPL PHYSIOL, V112, P1437, DOI 10.1007/s00421-011-2098-6; Duffy PH, 2002, J NUTR, V132, P101, DOI 10.1093/jn/132.1.101; Dulloo AG, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12250; Dulloo AG, 2015, OBES REV, V16, P25, DOI 10.1111/obr.12253; Ellenbroek JH, 2014, AM J PHYSIOL-ENDOC M, V306, pE552, DOI 10.1152/ajpendo.00453.2013; Erlanson-Albertsson C, 2005, INT J OBESITY, V29, pS26, DOI 10.1038/sj.ijo.0803086; Handa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104948; Holland AM, 2016, AM J PHYSIOL-REG I, V311, pR337, DOI 10.1152/ajpregu.00156.2016; Honors MA, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-46; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Hunter GR, 2010, OBESITY, V18, P690, DOI 10.1038/oby.2009.316; Jabekk PT, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-17; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Leite RD, 2009, APPL PHYSIOL NUTR ME, V34, P1079, DOI 10.1139/H09-116; Mann S, 2014, SPORTS MED, V44, P211, DOI 10.1007/s40279-013-0110-5; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; Prestes J, 2012, INT J SPORTS MED, V33, P550, DOI 10.1055/s-0032-1304646; Roberts MD, 2016, J APPL PHYSIOL, V120, P1173, DOI 10.1152/japplphysiol.00837.2015; Rodriguez-Huguet M, 2017, AM J PHYS MED REHAB, V00, P1; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schwingshackl L, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-130; Sene-Fiorese M, 2008, OBESITY, V16, P2217, DOI 10.1038/oby.2008.339; Shiroma EJ, 2017, MED SCI SPORT EXER, V49, P40, DOI 10.1249/MSS.0000000000001063; Sitnick M, 2009, J PHYSIOL-LONDON, V587, P5753, DOI 10.1113/jphysiol.2009.180174; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Stotzer US, 2015, INT J SPORTS MED, V36, P226, DOI 10.1055/s-0034-1390494; Strasser B, 2012, OBES REV, V13, P578, DOI 10.1111/j.1467-789X.2012.00988.x; Suk MinHwa, 2015, J Exerc Nutrition Biochem, V19, P289, DOI 10.5717/jenb.2015.15122303; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tinsley GM, 2016, INT J SPORT NUTR EXE, V26, P78, DOI 10.1123/ijsnem.2015-0070; Tirapegui J, 2012, NUTRIENTS, V4, P1328, DOI 10.3390/nu4091328; Tobias DK, 2015, LANCET DIABETES ENDO, V3, P968, DOI 10.1016/S2213-8587(15)00367-8; Verheggen RJHM, 2016, OBES REV, V17, P664, DOI 10.1111/obr.12406; Vina J, 2012, BRIT J PHARMACOL, V167, P1, DOI 10.1111/j.1476-5381.2012.01970.x; Warner SO, 2010, J CLIN HYPERTENS, V12, P64, DOI 10.1111/j.1751-7176.2009.00209.x; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Wood RJ, 2012, METAB SYNDR RELAT D, V10, P167, DOI 10.1089/met.2011.0104; Xiao J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147062; Zengin A, 2016, EUR J NUTR, V55, P2307, DOI 10.1007/s00394-015-1040-9	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0207951	10.1371/journal.pone.0207951	http://dx.doi.org/10.1371/journal.pone.0207951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532163	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900006
J	Polychronidou, G; Kotoula, V; Manousou, K; Kostopoulos, I; Karayannopoulou, G; Vrettou, E; Bobos, M; Raptou, G; Efstratiou, I; Dionysopoulos, D; Chatzopoulos, K; Lakis, S; Chrisafi, S; Tsolakidis, D; Papanikolaou, A; Dombros, N; Fountzilas, G				Polychronidou, Genovefa; Kotoula, Vassiliki; Manousou, Kyriaki; Kostopoulos, Ioannis; Karayannopoulou, Georgia; Vrettou, Eleni; Bobos, Mattheos; Raptou, Georgia; Efstratiou, Ioannis; Dionysopoulos, Dimitrios; Chatzopoulos, Kyriakos; Lakis, Sotirios; Chrisafi, Sofia; Tsolakidis, Dimitrios; Papanikolaou, Alexios; Dombros, Nikolaos; Fountzilas, George			Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer	PLOS ONE			English	Article							SIGNALING PATHWAY; MICROSATELLITE INSTABILITY; ADJUVANT THERAPY; SOLID TUMORS; STAGE-II; EXPRESSION; CARCINOMA; ADENOCARCINOMA; RECEPTOR; PTCH	The aim of this study was to investigate the prognostic value of the Hedgehog (Gli, Patched1, Shh, Smo) and Notch (Jag1, Notch2, Notch3) pathway members, in comparison to a panel of proteins (ER, PgR, HER2/neu, Ki67, p53, p16, PTEN and MMR) previously suggested to be involved in the pathogenesis of endometrial cancer, in association with clinical outcome and standard clinicopathological characteristics. A total of 204 patients with histological diagnosis of endometrial cancer treated from 2004 to 2013 were included. The evaluation of protein expression was assessed by immunohistochemistry. Univariate analysis showed that higher Ki67 labeling, expression of PTEN, p16, Notch2 and Notch3 proteins, as well as MMR proficiency were associated with increased relapse and mortality rate. Additionally, Patched-1 protein expression was associated with worse DFS, while p53 overexpression was associated with worse OS. In multivariate analyses, patients with MMR proficient tumors had more than double risk for death than patients with MMR deficient (MMRd) tumors (adjusted HR = 2.19, 95% CI 1.05-4.58, p = 0.036). Jag1 positivity conferred reduced mortality risk (HR = 0.48, 95% CI 0.23-0.97, p = 0.042). However, as shown by hierarchical clustering, patients fared better when their tumors expressed high Jag1 protein in the absence of Notch2 and Notch3, while they fared worse when all three proteins were highly expressed. Patched-1 positivity conferred higher risk for relapse (HR = 2.04, 95% CI 1.05-3.96, p = 0.036). Aberrant expression of key components of the Notch and Hedgehog signaling pathways, as well as MMRd may serve as independent prognostic factors for recurrence and survival in patients with endometrial cancer.	[Polychronidou, Genovefa; Dionysopoulos, Dimitrios] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Sch Hlth Sci, Dept Med Oncol,Fac Med, Thessaloniki, Greece; [Kotoula, Vassiliki; Kostopoulos, Ioannis; Karayannopoulou, Georgia; Vrettou, Eleni; Raptou, Georgia] Aristotle Univ Thessaloniki, Fac Med, Sch Hlth Sci, Dept Pathol, Thessaloniki, Greece; [Kotoula, Vassiliki; Bobos, Mattheos; Chatzopoulos, Kyriakos; Lakis, Sotirios; Chrisafi, Sofia; Fountzilas, George] Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece; [Manousou, Kyriaki] Hellen Cooperat Oncol Grp, Data Off, Sect Biostat, Athens, Greece; [Efstratiou, Ioannis] Papageorgiou Hosp, Dept Pathol, Thessaloniki, Greece; [Tsolakidis, Dimitrios; Papanikolaou, Alexios] Aristotle Univ Thessaloniki, Papageorgiou Gen Hosp, Dept Obstet & Gynaecol 1, Thessaloniki, Greece; [Dombros, Nikolaos; Fountzilas, George] Aristotle Univ Thessaloniki, Thessaloniki, Greece	Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Hellenic Cooperative Oncology Group; Papageorgiou Hospital; Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki	Polychronidou, G (corresponding author), Aristotle Univ Thessaloniki, Papageorgiou Hosp, Sch Hlth Sci, Dept Med Oncol,Fac Med, Thessaloniki, Greece.; Kotoula, V (corresponding author), Aristotle Univ Thessaloniki, Fac Med, Sch Hlth Sci, Dept Pathol, Thessaloniki, Greece.; Kotoula, V (corresponding author), Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece.	vefap@yahoo.gr; vkotoula@auth.gr	Chatzopoulos, Kyriakos/AAW-3788-2020; Fountzilas, George/ABF-2139-2020; Chrisafi, Sofia/AAH-2823-2020; Chatzopoulos, Kyriakos/AAL-2470-2020	Chatzopoulos, Kyriakos/0000-0001-6769-6952; Fountzilas, George/0000-0001-8045-2186; Tsolakidis, Dimitrios/0000-0002-6608-509X; Bobos, Mattheos/0000-0001-5662-9201	internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_E); Hellenic Society for Medical Oncology (HeSMO) grant	internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_E); Hellenic Society for Medical Oncology (HeSMO) grant	This study was supported by an internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_E) and by a Hellenic Society for Medical Oncology (HeSMO) grant. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aditya Suruchi, 2013, Indian Dermatol Online J, V4, P365, DOI 10.4103/2229-5178.120685; Alkushi A, 2007, MODERN PATHOL, V20, P1156, DOI 10.1038/modpathol.3800950; Backes FJ, 2016, GYNECOL ONCOL, V141, P312, DOI 10.1016/j.ygyno.2016.03.006; Berger AC, 2018, CANCER CELL, V33, P690, DOI 10.1016/j.ccell.2018.03.014; Bilbao C, 2010, INT J RADIAT ONCOL, V76, P9, DOI 10.1016/j.ijrobp.2009.09.035; Bilbao-Sieyro C, 2014, ONCOTARGET, V5, P6206, DOI 10.18632/oncotarget.2187; Black D, 2006, J CLIN ONCOL, V24, P1745, DOI 10.1200/JCO.2005.04.1574; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bonneterre J, 2015, GYNECOL ONCOL, V138, P663, DOI 10.1016/j.ygyno.2015.06.037; Chen X, 2008, WORLD J GASTROENTERO, V14, P3249, DOI 10.3748/wjg.14.3249; Cohn DE, 2006, OBSTET GYNECOL, V108, P1208, DOI 10.1097/01.AOG.0000239097.42987.0c; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Devor EJ, 2017, GYNECOL ONCOL, V147, P648, DOI 10.1016/j.ygyno.2017.09.025; Diaz-Padilla I, 2013, CRIT REV ONCOL HEMAT, V88, P154, DOI 10.1016/j.critrevonc.2013.03.002; Feng YZ, 2007, CLIN CANCER RES, V13, P1389, DOI 10.1158/1078-0432.CCR-06-1407; Fu XH, 2008, EXP MOL PATHOL, V84, P195, DOI 10.1016/j.yexmp.2008.04.002; Garg K, 2012, INT J GYNECOL PATHOL, V31, P48, DOI 10.1097/PGP.0b013e3182230d00; Garg K, 2010, MODERN PATHOL, V23, P80, DOI 10.1038/modpathol.2009.153; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Inoue K, 2016, ANTICANCER RES, V36, P149; Ishiyama A, 2006, ANTICANCER RES, V26, P195; Jonusiene V, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0438-y; Kato M, 2015, J GYNECOL ONCOL, V26, P40, DOI 10.3802/jgo.2015.26.1.40; Khatra H, 2017, CURR MED CHEM, V24, P2033, DOI 10.2174/0929867324666170316115500; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00254; Liao XY, 2009, MODERN PATHOL, V22, P839, DOI 10.1038/modpathol.2009.45; Locatelli M, 2017, CURR OPIN ONCOL, V29, P411, DOI 10.1097/CCO.0000000000000406; Ma CC, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-54; Mackay HJ, 2010, EUR J CANCER, V46, P1365, DOI 10.1016/j.ejca.2010.02.031; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; MORROW CP, 1991, GYNECOL ONCOL, V40, P55, DOI 10.1016/0090-8258(91)90086-K; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Patel SA, 2018, ONCOLOGIST, V23, P1395, DOI 10.1634/theoncologist.2018-0108; Pectasides D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1406-7; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Resnick KE, 2010, GYNECOL ONCOL, V117, P234, DOI 10.1016/j.ygyno.2009.12.028; Ruiz I, 2014, GYNECOL ONCOL, V134, P20, DOI 10.1016/j.ygyno.2014.04.053; Sasnauskiene A, 2014, MED LITH, V50, P14, DOI 10.1016/j.medici.2014.05.002; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Shikama A, 2016, GYNECOL ONCOL, V140, P226, DOI 10.1016/j.ygyno.2015.11.032; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Srijaipracharoen S, 2010, ASIAN PAC J CANCER P, V11, P215; Steg AD, 2011, CLIN CANCER RES, V17, P5674, DOI 10.1158/1078-0432.CCR-11-0432; Stoian SC, 2011, ROM J MORPHOL EMBRYO, V52, P631; Strati TM, 2017, ANTICANCER RES, V37, P2323, DOI 10.21873/anticanres.11570; Takebe N, 2014, PHARMACOL THERAPEUT, V141, P140, DOI 10.1016/j.pharmthera.2013.09.005; Talhouk A, 2016, Gynecol Oncol Res Pract, V3, P14, DOI 10.1186/s40661-016-0035-4; Terada KY, 2013, GYNECOL ONCOL, V129, P188, DOI 10.1016/j.ygyno.2013.01.028; Wolf I, 2007, BREAST CANCER RES TR, V105, P139, DOI 10.1007/s10549-006-9440-4; Xuan YH, 2006, MODERN PATHOL, V19, P1139, DOI 10.1038/modpathol.3800600; Xue SL, 2017, ARCH MED RES, V48, P169, DOI 10.1016/j.arcmed.2017.03.014; Yemelyanova A, 2009, AM J SURG PATHOL, V33, P1504, DOI 10.1097/PAS.0b013e3181ac35f5; You SH, 2010, UPSALA J MED SCI, V115, P169, DOI 10.3109/03009731003668316	57	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208221	10.1371/journal.pone.0208221	http://dx.doi.org/10.1371/journal.pone.0208221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521558	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600035
J	Humphries, C; Jaganathan, S; Panniyammakal, J; Singh, S; Goenka, S; Dorairaj, P; Gill, P; Greenfield, S; Lilford, R; Manaseki-Holland, S				Humphries, Claire; Jaganathan, Suganthi; Panniyammakal, Jeemon; Singh, Sanjeev; Goenka, Shifalika; Dorairaj, Prabhakaran; Gill, Paramjit; Greenfield, Sheila; Lilford, Richard; Manaseki-Holland, Semira			Investigating clinical handover and healthcare communication for outpatients with chronic disease in India: A mixed-methods study	PLOS ONE			English	Article							TRANSITIONAL CARE; INCOME COUNTRIES; QUALITY; RECORDS	Objectives Research concentrating on continuity of care for chronic, non-communicable disease (NCD) patients in resource-constrained settings is currently limited and focusses on inpatients. Outpatient care requires attention as this is where NCD patients often seek treatment and optimal handover of information is essential. We investigated handover, healthcare communication and barriers to continuity of care for chronic NCD outpatients in India. We also explored potential interventions for improving storage and exchange of healthcare information. Methods A mixed-methods design was used across five healthcare facilities in Kerala and Himachal Pradesh states. Questionnaires from 513 outpatients with cardiovascular disease, chronic respiratory disease, or diabetes covered the form and comprehensiveness of information exchange between healthcare professionals (HCPs) and between HCPs and patients. Semi-structured interviews with outpatients and HCPs explored handover, healthcare communication and intervention ideas. Barriers to continuity of care were identified through triangulation of all data sources. Results Almost half (46%) of patients self-referred to hospital outpatient clinics (OPCs). Patient-held healthcare information was often poorly recorded on unstructured sheets of paper; 24% of OPC documents contained the following: diagnosis, medication, long-term care and follow-up information. Just 55% of patients recalled receiving verbal follow-up and medication instructions during OPC appointments. Qualitative themes included patient preference for hospital visits, system factors, inconsistent doctor-patient communication and attitudes towards medical documents. Barriers were hospital time constraints, inconsistent referral practices and absences of OPC medical record-keeping, structured patient-held medical documents and clinical handover training. Patients and HCPs were in favour of the introduction of patient-held booklets for storing and transporting medical documents. Conclusions Deficiencies in communicative practices are compromising the continuity of chronic NCD outpatient care. Targeted systems-based interventions are urgently required to improve information provision and exchange. Our findings indicate that well-designed patient -held booklets are likely to be an acceptable, affordable and effective part of the solution.	[Humphries, Claire; Greenfield, Sheila; Manaseki-Holland, Semira] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Jaganathan, Suganthi; Panniyammakal, Jeemon; Goenka, Shifalika; Dorairaj, Prabhakaran] Publ Hlth Fdn India, Delhi, India; [Jaganathan, Suganthi; Panniyammakal, Jeemon; Goenka, Shifalika; Dorairaj, Prabhakaran] Ctr Chron Dis Control, Delhi, India; [Panniyammakal, Jeemon] Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum, Kerala, India; [Singh, Sanjeev] Amrita Inst Med Sci, Hosp Adm, Kochi, Kerala, India; [Gill, Paramjit] Univ Warwick, Acad Unit Primary Care, Coventry, W Midlands, England; [Lilford, Richard] Univ Warwick, Ctr Appl Hlth Res & Delivery, Coventry, W Midlands, England	University of Birmingham; Public Health Foundation of India; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; University of Warwick; University of Warwick	Manaseki-Holland, S (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	S.ManasekiHolland@bham.ac.uk	JAGANATHAN, SUGANTHI/AAU-7807-2020; Manaseki-Holland, Semira/I-7303-2017; Manaseki-Holland, Semira/AFX-1728-2022	JAGANATHAN, SUGANTHI/0000-0001-6422-1329; Manaseki-Holland, Semira/0000-0001-5827-8855; Manaseki-Holland, Semira/0000-0001-5827-8855; Goenka, Shifalika/0000-0001-6993-2883; Jeemon, Panniyammakal/0000-0003-4172-4307; Lilford, Richard/0000-0002-0634-984X; Humphries, Claire/0000-0001-9784-5218	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands (NIHR CLAHRC WM); Department For International Development [MR/M00287X/1]; Economic and Social Research Council; Medical Research Council; Wellcome Trust; MRC [MR/M00287X/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands (NIHR CLAHRC WM)(National Institute for Health Research (NIHR)); Department For International Development; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands (NIHR CLAHRC WM). This research was supported by a joint-funded grant (Ref No: MR/M00287X/1) from the following funders: The Department For International Development, The Economic and Social Research Council, The Medical Research Council, and the Wellcome Trust. The funders had no role in study design, data collection, analysis, decision to publish, or reporting of this manuscript.	Aarons GA, 2011, ADM POLICY MENT HLTH, V38, P4, DOI 10.1007/s10488-010-0327-7; Alberti H, 2006, PUBLIC HEALTH, V120, P650, DOI 10.1016/j.puhe.2005.05.011; Australian Commission on Safety and Quality in Healthcare, 2005, NON TRADITIONAL REF, P10; Bradley S, 2014, J CLIN NURS, V23, P1927, DOI 10.1111/jocn.12403; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; British Medical Association, 2004, NON TRADITIONAL REF, V7; Campanella P, 2016, EUR J PUBLIC HEALTH, V26, P60, DOI 10.1093/eurpub/ckv122; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Creswell W. C., 2011, DESIGNING CONDUCTING; Das J, 2014, ANNU REV ECON, V6, P525, DOI 10.1146/annurev-economics-080213-041350; Davies M, 2001, GUIDELINES PRACTICE, V4; Government of Kerala, EHEALTH KER; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Gulliford Martin, 2006, J Health Serv Res Policy, V11, P248, DOI 10.1258/135581906778476490; Gyedu A, 2015, INT J SURG, V15, P74, DOI 10.1016/j.ijsu.2015.01.033; Hekmatpou D, 2010, INT J NURS PRACT, V16, P389, DOI 10.1111/j.1440-172X.2010.01856.x; Hesselink G, 2012, ANN INTERN MED, V157, P417, DOI 10.7326/0003-4819-157-6-201209180-00006; Ibiyemi O, 2012, ACTA ODONTOL SCAND, V70, P165, DOI 10.3109/00016357.2011.600712; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kumar P, 2015, INT J RES FDN, V3, P33; Labbadia LL, 2004, ACTA PAUL ENFERM, V17, P55; LILFORD RJ, 1992, BMJ-BRIT MED J, V305, P1181, DOI 10.1136/bmj.305.6863.1181; Majothi S, 2014, NON TRADITIONAL REF, DOI [10.15124/CRD42014009309, DOI 10.15124/CRD42014009309]; Merten H, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4328; Mudany MA, 2015, J TROP PEDIATRICS, V61, P442, DOI 10.1093/tropej/fmv055; Naidu DVN, 2008, INT J EMERG MED, V1, P321, DOI 10.1007/s12245-008-0077-4; Nakamura Y, 2010, JPN MED ASS J, V53, P259; Osaki K, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20429; Palys T., 2008, SAGE ENCY QUALITATIV, P697, DOI DOI 10.4135/9781412963909.N349; Perez R.C., 2016, GLOB PEDIAT HLTH, V3, P1; Philibert I, 2012, BMJ QUAL SAF, V21, P1, DOI 10.1136/bmjqs-2012-001598; Pichitpornchai W, 1999, INT J NURS STUD, V36, P355, DOI 10.1016/S0020-7489(99)00043-7; Piette JD, 2012, B WORLD HEALTH ORGAN, V90, P365, DOI 10.2471/BLT.11.099069; Ramanayake R P J C, 2013, J Family Med Prim Care, V2, P145, DOI 10.4103/2249-4863.117404; SHAH PM, 1993, B WORLD HEALTH ORGAN, V71, P535; Strauss A., 1998, BASICS QUALITATIVE R; Turner Kathleen E, 2011, Online J Public Health Inform, V3, DOI 10.5210/ojphi.v3i2.3631; University of Birmingham, HAND IND WORK INT PR; van Walraven C, 2002, J GEN INTERN MED, V17, P186, DOI 10.1046/j.1525-1497.2002.10741.x; van Walraven C, 1999, AM J MED QUAL, V14, P160, DOI 10.1177/106286069901400403; Walton S, 2006, BRIT MED J, V332, P269, DOI 10.1136/bmj.332.7536.269; WHO, 2014, NON TRADITIONAL REF; Williams Faustine, 2008, Inform Prim Care, V16, P139; World Health Organisation, 1978, NON TRADITIONAL REF; World Health Organization, WHO RES POL, DOI [10.1016/j.respol.2016.03.011, DOI 10.1016/J.RESPOL.2016.03.011]; World Health Organization, 2007, PROM SAF MED CHILDR, P1	46	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207511	10.1371/journal.pone.0207511	http://dx.doi.org/10.1371/journal.pone.0207511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517130	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400038
J	Kessler, BE; Mishall, KM; Kellett, MD; Clark, EG; Pugazhenthi, U; Pozdeyev, N; Kim, J; Tan, AC; Schweppe, RE				Kessler, Brittelle E.; Mishall, Katie M.; Kellett, Meghan D.; Clark, Erin G.; Pugazhenthi, Umarani; Pozdeyev, Nikita; Kim, Jihye; Tan, Aik Choon; Schweppe, Rebecca E.			Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis	ONCOGENE			English	Article							FOCAL-ADHESION-KINASE; TARGETED THERAPIES; THYROID-CARCINOMA; GROWTH-FACTOR; PHASE-II; CANCER; FAK; DASATINIB; MIGRATION; SURVIVAL	Few therapy options exist for patients with advanced papillary and anaplastic thyroid cancer. We and others have previously identified c-Src as a key mediator of thyroid cancer pro-tumorigenic processes and a promising therapeutic target for thyroid cancer. To increase the efficacy of targeting Src in the clinic, we sought to define mechanisms of resistance to the Src inhibitor, dasatinib, to identify key pathways to target in combination. Using a panel of thyroid cancer cell lines expressing clinically relevant mutations in BRAF or RAS, which were previously developed to be resistant to dasatinib, we identified a switch to a more invasive phenotype in the BRAF-mutant cells as a potential therapy escape mechanism. This phenotype switch is driven by FAK kinase activity, and signaling through the p130Cas>c-Jun signaling axis. We have further shown this more invasive phenotype is accompanied by alterations in the secretome through the increased expression of pro-inflammatory cytokines, including IL-1 beta, and the pro-invasive metalloprotease, MMP-9. Furthermore, IL-1 beta signals via a feedforward autocrine loop to promote invasion through a FAK>p130Cas>c-Jun>MMP-9 signaling axis. We further demonstrate that upfront combined inhibition of FAK and Src synergistically inhibits growth and invasion, and induces apoptosis in a panel of BRAF- and RAS-mutant thyroid cancer cell lines. Together our data demonstrate that acquired resistance to single-agent Src inhibition promotes a more invasive phenotype through an IL-1 beta>FAK>p130Cas>c-Jun >MMP signaling axis, and that combined inhibition of FAK and Src has the potential to block this inhibitor-induced phenotype switch.	[Kessler, Brittelle E.; Mishall, Katie M.; Kellett, Meghan D.; Clark, Erin G.; Pugazhenthi, Umarani; Pozdeyev, Nikita; Schweppe, Rebecca E.] Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Dept Med, Aurora, CO 80045 USA; [Kim, Jihye; Tan, Aik Choon] Univ Colorado, Sch Med, Canc Ctr, Aurora, CO 80045 USA; [Kim, Jihye; Tan, Aik Choon; Schweppe, Rebecca E.] Univ Colorado, Sch Med, Dept Med, Div Med Oncol, Aurora, CO 80045 USA; [Pozdeyev, Nikita] Div Bioinformat & Personalized Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Schweppe, RE (corresponding author), Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Dept Med, Aurora, CO 80045 USA.; Schweppe, RE (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Med Oncol, Aurora, CO 80045 USA.	Rebecca.Schweppe@ucdenver.edu	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369; Kim, Jihye/0000-0002-0338-2329; Schweppe, Rebecca/0000-0001-7502-0151	NIH/NCI [1RO1CA164193, 1R01CA222299]; American Cancer Society [RSG-13-060-01-TBE]; Cancer League of Colorado; Front Range Cancer Challenge Fellowship; NCI Cancer Center support grant [P30CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA164193, R01CA222299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Cancer League of Colorado; Front Range Cancer Challenge Fellowship; NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Christopher Korch, UCCC, and Randall Wong at the B. Davis Center BioResources Core Facility for STR profiling of the cell lines. We thank Dr. Rytis Prekeris for assistance with the zymography assays. This work was supported by NIH/NCI grant 1RO1CA164193 (RES), 1R01CA222299 (RES), American Cancer Society RSG-13-060-01-TBE (RES), the Cancer League of Colorado (RES), and the Front Range Cancer Challenge Fellowship (KMM). The UCCC DNA Sequencing, Flow Cytometry, and Protein Production/Mab/Tissue Culture Shared Resources are supported by NCI Cancer Center support grant, P30CA046934.	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Antonelli A, 2011, CURR GENOMICS, V12, P626, DOI 10.2174/138920211798120808; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Barderas R, 2013, MOL CELL PROTEOMICS, V12, P1602, DOI 10.1074/mcp.M112.022848; Beadnell TC, 2016, MOL CANCER THER, V15, P1952, DOI 10.1158/1535-7163.MCT-15-0702; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Carneiro RM, 2015, CANCER TREAT REV, V41, P690, DOI 10.1016/j.ctrv.2015.06.002; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Chan D, 2012, ONCOL LETT, V3, P807, DOI 10.3892/ol.2012.579; Chen GM, 2018, MOL CANCER THER, V17, P806, DOI 10.1158/1535-7163.MCT-17-0561; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Chen YF, 2011, ACTA PHARM SIN B, V1, P197, DOI 10.1016/j.apsb.2011.10.007; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Chow AKM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078675; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Fallahi-Sichani M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20166796; Fallahi-Sichani M, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145877; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Gelfo V, 2016, ONCOTARGET, V7, P72167, DOI 10.18632/oncotarget.12354; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Golubovskaya VM, 2003, MOL CANCER RES, V1, P755; Hauck CR, 2000, J BIOL CHEM, V275, P41092, DOI 10.1074/jbc.M005450200; Hayes DN, 2012, CLIN CANCER RES, V18, P2056, DOI 10.1158/1078-0432.CCR-11-0563; Hirata E, 2015, CANCER CELL, V27, P574, DOI 10.1016/j.ccell.2015.03.008; Ilic D, 1998, J CELL BIOL, V143, P547; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Kessler BEBE, 2016, MOL CANCER RES, P14869; Kim WG, 2012, CLIN CANCER RES, V18, P1281, DOI 10.1158/1078-0432.CCR-11-2892; Lee BY, 2015, PHARMACOL THERAPEUT, V146, P132, DOI 10.1016/j.pharmthera.2014.10.001; Lee CR, 2016, FEBS LETT, V590, P358, DOI 10.1002/1873-3468.12057; Leight JL, 2015, P NATL ACAD SCI USA, V112, P5366, DOI 10.1073/pnas.1505662112; Lu HB, 2013, MOL CANCER THER, V12, P2864, DOI 10.1158/1535-7163.MCT-13-0233; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; Michailidi C, 2010, PATHOL ONCOL RES, V16, P497, DOI 10.1007/s12253-010-9269-3; Mishall KM, 2017, ONCOTARGET IMPACT J, V8; Mon NN, 2017, ONCOL LETT, V13, P955, DOI 10.3892/ol.2016.5521; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Ng M, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.2584; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Paraiso KHT, 2015, CANCER DISCOV, V5, P264, DOI 10.1158/2159-8290.CD-14-0293; Qiao YC, 2016, J BIOL CHEM, V291, P5068, DOI 10.1074/jbc.M115.702571; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sandri S, 2016, PHARMACOL RES, V111, P523, DOI 10.1016/j.phrs.2016.07.017; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Schweppe RE, 2009, J CLIN ENDOCR METAB, V94, P2199, DOI 10.1210/jc.2008-2511; Segarra M, 2005, FASEB J, V19, P1875, DOI 10.1096/fj.04-3574fje; Shah MH, 2017, J CLIN ONCOL, V32, P6022; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sipos Jennifer A, 2010, Ther Adv Med Oncol, V2, P3, DOI 10.1177/1758834009352667; Stanam A, 2016, ONCOTARGET, V7, P76087, DOI 10.18632/oncotarget.12590; Taylor KN, 2018, MOL CANCER THER, V17, P719, DOI 10.1158/1535-7163.MCT-17-1177; Titz B, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.28; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wilson C, 2014, ONCOTARGET, V5, P7328, DOI 10.18632/oncotarget.2397; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zhang P, 2015, EUR J ORAL SCI, V123, P249, DOI 10.1111/eos.12191; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867; Zubrilov I, 2015, CANCER LETT, V361, P86, DOI 10.1016/j.canlet.2015.02.041	65	10	11	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2565	2579		10.1038/s41388-018-0617-1	http://dx.doi.org/10.1038/s41388-018-0617-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30531837	Green Accepted			2022-12-26	WOS:000463335200009
J	Khurana, S; Coffey, MJ; John, A; Uboldi, AD; Huynh, MH; Stewart, RJ; Carruthers, VB; Tonkin, CJ; Goddard-Borger, ED; Scott, NE				Khurana, Sachin; Coffey, Michael J.; John, Alan; Uboldi, Alessandro D.; Huynh, My-Hang; Stewart, Rebecca J.; Carruthers, Vern B.; Tonkin, Christopher J.; Goddard-Borger, Ethan D.; Scott, Nichollas E.			Protein O-fucosyltransferase 2-mediated O-glycosylation of the adhesin MIC2 is dispensable for Toxoplasma gondii tachyzoite infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; Toxoplasma gondii; fucosyltransferase; proteomics; MS	PETERS PLUS SYNDROME; HOST-CELLS; GLIDING MOTILITY; INVASION; IDENTIFICATION; MUTATIONS; SECRETION; EGRESS	Toxoplasma gondii is a ubiquitous, obligate intracellular eukaryotic parasite that causes congenital birth defects, disease in immunocompromised individuals, and blindness. Protein glycosylation plays an important role in the infectivity and evasion of immune responses of many eukaryotic parasites and is also of great relevance to vaccine design. Here we demonstrate that micronemal protein 2 (MIC2), a motility-associated adhesin of T. gondii, has highly glycosylated thrombospondin repeat (TSR) domains. Using affinity-purified MIC2 and MS/MS analysis along with enzymatic digestion assays, we observed that at least seven C-linked and three O-linked glycosylation sites exist within MIC2, with >95% occupancy at these O-glycosylation sites. We found that addition of O-glycans to MIC2 is mediated by a protein O-fucosyltransferase 2 homolog (TgPOFUT2) encoded by the TGGT1_273550 gene. Even though POFUT2 homologs are important for stabilizing motility-associated adhesins and for host infection in other apicomplexan parasites, loss of TgPOFUT2 in T. gondii had only a modest impact on MIC2 levels and the wider parasite proteome. Consistent with this, both plaque formation and tachyzoite invasion were broadly similar in the presence or absence of TgPOFUT2. These findings indicate that TgPOFUT2 O-glycosylates MIC2 and that this glycan, in contrast to previous findings in another study, is dispensable in T. gondii tachyzoites and for T. gondii infectivity.	[Khurana, Sachin; Coffey, Michael J.; John, Alan; Uboldi, Alessandro D.; Stewart, Rebecca J.; Tonkin, Christopher J.; Goddard-Borger, Ethan D.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3025, Australia; [Khurana, Sachin; Coffey, Michael J.; John, Alan; Uboldi, Alessandro D.; Stewart, Rebecca J.; Tonkin, Christopher J.; Goddard-Borger, Ethan D.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Huynh, My-Hang; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Scott, Nichollas E.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Michigan System; University of Michigan; University of Melbourne	Goddard-Borger, ED (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3025, Australia.; Goddard-Borger, ED (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	tonkin@wehi.edu.au; goddard-borger.e@wehi.edu.au; nichollas.scott@unimelb.edu.au	John, Alan/AAX-1829-2020; Tonkin, Christopher/K-6534-2019	John, Alan/0000-0002-6855-5470; Tonkin, Christopher/0000-0002-7036-6222; Goddard-Borger, Ethan/0000-0002-8181-9733; Scott, Nichollas/0000-0003-2556-8316; Coffey, Michael/0000-0002-8025-4558	National Health and Medical Research Council of Australia (NHMRC) [APP1100164]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1100164 (to N. E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Bandini G, 2019, J BIOL CHEM, V294, P1967, DOI 10.1074/jbc.RA118.005179; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Boucher LE, 2015, J STRUCT BIOL, V190, P93, DOI 10.1016/j.jsb.2015.02.008; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Chen CI, 2012, EMBO J, V31, P3183, DOI 10.1038/emboj.2012.143; Coffey MJ, 2018, MBIO, V9, DOI [10.1128/mBio.01796-18, 10.1128/mbio.01796-18]; Cowman AF, 2017, CELL HOST MICROBE, V22, P232, DOI 10.1016/j.chom.2017.07.003; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Frenal K, 2017, NAT REV MICROBIOL, V15, P645, DOI 10.1038/nrmicro.2017.86; Frese CK, 2012, ANAL CHEM, V84, P9668, DOI 10.1021/ac3025366; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Goddard-Borger ED, 2018, FUTURE MICROBIOL, V13, P609, DOI 10.2217/fmb-2017-0284; Gras Simon, 2017, Wellcome Open Res, V2, P32, DOI [10.12688/wellcomeopenres.11594.2, 10.12688/wellcomeopenres.11594.1]; Hartmann S, 2000, J BIOL CHEM, V275, P28569, DOI 10.1074/jbc.M001732200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hoppe CM, 2018, GLYCOBIOLOGY, V28, P333, DOI 10.1093/glycob/cwy013; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Huynh MH, 2004, CELL MICROBIOL, V6, P771, DOI 10.1111/j.1462-5822.2004.00403.x; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Huynh MH, 2015, J BIOL CHEM, V290, P1432, DOI 10.1074/jbc.M114.613646; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kang D., 2002, B KOREAN CHEM SOC, V23, P2; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Long SJ, 2016, INFECT IMMUN, V84, P1262, DOI 10.1128/IAI.01173-15; Lopaticki S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00571-y; Marino ND, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006828; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Niwa Y, 2015, FEBS LETT, V589, P3287, DOI 10.1016/j.febslet.2015.09.012; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Pinger J, 2018, NAT MICROBIOL, V3, P932, DOI 10.1038/s41564-018-0187-6; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Swearingen KE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005791; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; Whitelaw JA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0343-5; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22	62	9	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1541	1553		10.1074/jbc.RA118.005357	http://dx.doi.org/10.1074/jbc.RA118.005357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30514763	Green Published, hybrid			2022-12-26	WOS:000457879200010
J	Buurman, DJ; Blokzijl, T; Festen, EAM; Pham, BT; Faber, KN; Brouwer, E; Dijkstra, G				Buurman, D. J.; Blokzijl, T.; Festen, E. A. M.; Pham, B. T.; Faber, K. N.; Brouwer, E.; Dijkstra, G.			Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-alpha biologicals and an Infliximab-biosimilar	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; CLINICAL-RESPONSE; ANTIBODIES; MAINTENANCE; ADALIMUMAB; REMISSION; TERM	Introduction TNF-alpha-neutralizing antibodies, such as infliximab (IFX) and adalimumab (ADA), are effective in the treatment of inflammatory bowel diseases (IBD), but they are expensive and become ineffective when patients develop anti-IFX or anti-ADA antibodies (ATI and ATA, respectively). Second-generation anti-TNF-alpha antibodies, such as Golimumab, Etanercept, Certolizumab-pegol and IFX biosimilars, may solve these issues. Aim To determine the neutralizing capacity of first- and second generation anti-TNF-alpha antibodies and to determine whether ATI show cross-reactivity with the IFX biosimilar CT-P13 (Inflectra). Methods TNF-alpha neutralization was measured using a quantitative TNF-alpha sensor assay consisting of HeLa 8D8 cells that express the Green Fluorescence Protein (GFP) under control of a NF kappa B response element. All available anti-TNF-alpha drugs and the IFX biosimilar CT-P13 (Inflectra) were tested for their TNF-alpha-neutralizing capacity. In addition, patient sera with ATI were tested for their potential to block the activity of IFX, IFX (F)ab(2)-fragment, biosimilar CT-P13 (Inflectra) and ADA. Results TNF-alpha strongly induced GFP expression in Hela 8D8 cells. Higher concentrations of firstgeneration anti-TNF-alpha drugs were required to neutralize TNF-alpha compared to the secondgeneration anti-TNF-alpha drugs. Serum of IBD patients with proven ATI blocked TNF-alpha-neutralizing properties of IFX biosimilar CT-P13 (Inflectra), whereas such sera did not block the effect of ADA. Conclusion The second-generation anti-TNF-alpha drugs show increased TNF-alpha-neutralizing potential compared to first-generation variants. ATI show cross-reactivity toward IFX biosimilar CT-P13 (Inflectra), consequently patients with ATI are unlikely to benefit from treatment with this IFX biosimilar.	[Buurman, D. J.; Blokzijl, T.; Festen, E. A. M.; Pham, B. T.; Faber, K. N.; Dijkstra, G.] Univ Groningen, Dept Gastroenterol & Hepatol, Univ Med Ctr Groningen, Groningen, Netherlands; [Blokzijl, T.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Brouwer, E.] Univ Groningen, Dept Rheumatol & Clin Immunol, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Buurman, DJ (corresponding author), Univ Groningen, Dept Gastroenterol & Hepatol, Univ Med Ctr Groningen, Groningen, Netherlands.	d.buurman@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423; /0000-0003-4563-7462				Ainsworth MA, 2008, AM J GASTROENTEROL, V103, P944, DOI 10.1111/j.1572-0241.2007.01638.x; Beck A, 2013, MABS-AUSTIN, V5, P621, DOI 10.4161/mabs.25864; Ben-Horin S, 2016, GUT, V65, P1132, DOI 10.1136/gutjnl-2015-309290; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Ebbers HC, 2012, NAT BIOTECHNOL, V30, P1186, DOI 10.1038/nbt.2438; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hong J, 2016, MABS, V1-19, P49, DOI [10.1136/gut.2009.183095, DOI 10.1136/GUT.2009.183095]; Jorgensen KK, 2017, LANCET, V389, P2304, DOI 10.1016/S0140-6736(17)30068-5; Karmiris K, 2009, GASTROENTEROLOGY, V137, P1628, DOI 10.1053/j.gastro.2009.07.062; Kronthaler U, 2018, EXPERT OPIN BIOL TH, V18, P921, DOI 10.1080/14712598.2018.1495193; Maser EA, 2006, CLIN GASTROENTEROL H, V4, P1248, DOI 10.1016/j.cgh.2006.06.025; Patil SA, 2013, DIGEST DIS SCI, V58, P209, DOI 10.1007/s10620-012-2323-0; Qiu Y, 2017, J GASTROENTEROL, V52, P535, DOI 10.1007/s00535-017-1324-3; Rinaudo-Gaujous M, 2013, ALIMENT PHARM THER, V38, P914, DOI 10.1111/apt.12477; Rispens T, 2012, J IMMUNOL METHODS, V375, P93, DOI 10.1016/j.jim.2011.09.011; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Rutgeerts P, 2012, GASTROENTEROLOGY, V142, P1102, DOI 10.1053/j.gastro.2012.01.035; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P96, DOI 10.1053/j.gastro.2013.06.010; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Schnitzler F, 2009, GUT, V58, P492, DOI 10.1136/gut.2008.155812; Seow CH, 2010, GUT, V59, P49, DOI 10.1136/gut.2009.183095; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Van Assche G, 2010, J CROHNS COLITIS, V4, P63, DOI 10.1016/j.crohns.2009.09.009; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208922	10.1371/journal.pone.0208922	http://dx.doi.org/10.1371/journal.pone.0208922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533022	Green Submitted, Green Published, gold			2022-12-26	WOS:000452782500049
J	Haskell, KJ; Schriever, SR; Fonoimoana, KD; Haws, B; Hair, BB; Wienclaw, TM; Holmstead, JG; Barboza, AB; Berges, ET; Heaton, MJ; Berges, BK				Haskell, Kyler J.; Schriever, Samuel R.; Fonoimoana, Kenisi D.; Haws, Benjamin; Hair, Bryan B.; Wienclaw, Trevor M.; Holmstead, Joseph G.; Barboza, Andrew B.; Berges, Erik T.; Heaton, Matthew J.; Berges, Bradford K.			Antibiotic resistance is lower in Staphylococcus aureus isolated from antibiotic-free raw meat as compared to conventional raw meat	PLOS ONE			English	Article							ANTIMICROBIAL USE; STRAINS; PREVALENCE; CONSEQUENCES; EPIDEMIOLOGY; TRANSMISSION; VIRULENCE; MRSA	The frequent use of antibiotics contributes to antibiotic resistance in bacteria, resulting in an increase in infections that are difficult to treat. Livestock are commonly administered antibiotics in their feed, but there is current interest in raising animals that are only administered antibiotics during active infections. Staphylococcus aureus (SA) is a common pathogen of both humans and livestock raised for human consumption. SA has achieved high levels of antibiotic resistance, but the origins and locations of resistance selection are poorly understood. We determined the prevalence of SA and MRSA in conventional and antibiotic-free (AF) meat products, and also measured rates of antibiotic resistance in these isolates. We isolated SA from raw conventional turkey, chicken, beef, and pork samples and also from AF chicken and turkey samples. We found that SA contamination was common, with an overall prevalence of 22.6% (range of 2.8-30.8%) in conventional meats and 13.0% (range of 12.5-13.2%) in AF poultry meats. MRSA was isolated from 15.7% of conventional raw meats (range of 2.8-20.4%) but not from AF-free meats. The degree of antibiotic resistance in conventional poultry products was significantly higher vs AF poultry products for a number of different antibiotics, and while multi-drug resistant strains were relatively common in conventional meats none were detected in AF meats. The use of antibiotics in livestock contributes to high levels of antibiotic resistance in SA found in meat products. Our results support the use of AF conditions for livestock in order to prevent antibiotic resistance development in SA.	[Haskell, Kyler J.; Schriever, Samuel R.; Fonoimoana, Kenisi D.; Haws, Benjamin; Hair, Bryan B.; Wienclaw, Trevor M.; Holmstead, Joseph G.; Barboza, Andrew B.; Berges, Erik T.; Berges, Bradford K.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Heaton, Matthew J.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Berges, BK (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	brad.erges@gmail.com		Schriever, Samuel/0000-0002-5482-1731	Brigham Young University Mentoring Environment Grant; Brigham Young University Office of Research and Creative Activities Grant; Turkey Research Grant	Brigham Young University Mentoring Environment Grant; Brigham Young University Office of Research and Creative Activities Grant; Turkey Research Grant	This research was supported by a Brigham Young University Mentoring Environment Grant and a Turkey Research Grant to BKB, and a Brigham Young University Office of Research and Creative Activities Grant to BBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalrahman LS, 2015, INT J ENV RES PUB HE, V12, P6148, DOI 10.3390/ijerph120606148; [Anonymous], 2015, 2014 SUMM REP ANT SO; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Barza M, 2002, CLIN INFECT DIS, V34, pS71, DOI 10.1086/340241; Bien J, 2011, J PATHOG, V2011, DOI 10.4061/2011/601905; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; CLSI, 2013, M11S23 CLSI S, DOI [10.1128/JCM.03166-12, DOI 10.1128/JCM.03166-12]; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Hegde NV, 2016, VET ANIM SCI, V1-2, P9, DOI 10.1016/j.vas.2016.07.001; Hughes C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006354.pub4; Jackson CR, 2013, J CLIN MICROBIOL, V51, P1199, DOI 10.1128/JCM.03166-12; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Krishnasamy V, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0050-y; Lee JH, 2003, APPL ENVIRON MICROB, V69, P6489, DOI 10.1128/AEM.69.11.6489-6494.2003; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lindsay JA, 2014, INT J MED MICROBIOL, V304, P103, DOI 10.1016/j.ijmm.2013.11.010; Maes N, 2002, J CLIN MICROBIOL, V40, P1514, DOI 10.1128/JCM.40.4.1514-1517.2002; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; Osterberg J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157049; Prevention CfDCa, 2012, ACT BACT COR SURV RE; Pu SH, 2009, APPL ENVIRON MICROB, V75, P265, DOI 10.1128/AEM.01110-08; Sapkota AR, 2011, ENVIRON HEALTH PERSP, V119, P1622, DOI 10.1289/ehp.1003350; Thapaliya D, 2017, FOOD MICROBIOL, V65, P122, DOI 10.1016/j.fm.2017.01.015; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Rijen MML, 2009, J HOSP INFECT, V72, P299, DOI 10.1016/j.jhin.2009.05.006; Ventola C Lee, 2015, P T, V40, P277; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2010, CAN VET J, V51, P749	36	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0206712	10.1371/journal.pone.0206712	http://dx.doi.org/10.1371/journal.pone.0206712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532208	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700007
J	Hatsukawa, Y; Hayakawa, T; Tsukada, K; Hashimoto, K; Sato, T; Asai, M; Toyoshima, A; Tanimori, T; Sonoda, S; Kabuki, S; Kimura, H; Takada, A; Mizumoto, T; Takaki, S				Hatsukawa, Yuichi; Hayakawa, Takehito; Tsukada, Kazuaki; Hashimoto, Kazuyuki; Sato, Tetsuya; Asai, Masato; Toyoshima, Atsushi; Tanimori, Toru; Sonoda, Shinya; Kabuki, Shigeto; Kimura, Hiroyuki; Takada, Atsushi; Mizumoto, Tetsuya; Takaki, Seiya			Electron-tracking Compton camera imaging of technetium-95m	PLOS ONE			English	Article							GAMMA-RAYS; PROTON-BEAMS; TC-99M; DESIGN; TELESCOPE; MEDICINE; THERAPY; SYSTEM	Imaging was conducted using an electron tracking-Compton camera (ETCC), which measures y-rays with energies in the range of 200-900 keV from Tc-95m. Tc-95m was produced by the Mo-95 (p, n) Tc-95m reaction on a Mo-95-enriched target. A method for recycling( 95)Mo-enriched molybdenum trioxide was employed, and the recycled yield of Mo-95 was 70%-90%. Images were obtained with the gate of three energies. The results showed that the spatial resolution increases with increasing y-ray energy, and suggested that the ETCC with high-energy y-ray emitters such as Tc-95m is useful for the medical imaging of deep tissue and organs in the human body.	[Hatsukawa, Yuichi; Hayakawa, Takehito; Hashimoto, Kazuyuki] Natl Inst Quantum & Radiol Sci & Technol QST, Tokai, Ibaraki, Japan; [Tsukada, Kazuaki; Sato, Tetsuya; Asai, Masato; Toyoshima, Atsushi; Takaki, Seiya] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan; [Tanimori, Toru; Sonoda, Shinya; Takada, Atsushi; Mizumoto, Tetsuya] Kyoto Univ, Kyoto, Japan; [Kabuki, Shigeto] Tokai Univ, Kanagawa, Japan; [Kimura, Hiroyuki] Kyoto Pharmaceut Univ, Kyoto, Japan	National Institutes for Quantum Science & Technology; Japan Atomic Energy Agency; Kyoto University; Tokai University; Kyoto Pharmaceutical University	Hatsukawa, Y (corresponding author), Natl Inst Quantum & Radiol Sci & Technol QST, Tokai, Ibaraki, Japan.	Hatsukawa.yuichi@qst.go.jp	Hayakawa, Takehito T/K-8478-2015; Sato, Tetsuya K/T-9755-2018	Sato, Tetsuya K/0000-0002-5490-9178; Hatsukawa, Yuichi/0000-0001-6516-2033; TAKADA, ATSUSHI/0000-0002-2515-5573	Japan Society for the Promotion of Science [Kakenhi-JPK1605025]; JSPS KAKENHI [JP16K05025]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by Japan Society for the Promotion of Science Kakenhi-JPK1605025 to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by JSPS KAKENHI Grant Number JP16K05025. We thank the operating crew of the JAEA tandem accelerator facility for providing the proton beam used in the experiment.	Aldawood S, 2017, RADIAT PHYS CHEM, V140, P190, DOI 10.1016/j.radphyschem.2017.01.024; An SH, 2007, NUCL INSTRUM METH A, V571, P251, DOI 10.1016/j.nima.2006.10.075; Atwood WB, 2007, ASTROPART PHYS, V28, P422, DOI 10.1016/j.astropartphys.2007.08.010; Banerjee S, 2001, SEMIN NUCL MED, V31, P260, DOI 10.1053/snuc.2001.26205; BETHE HA, 1953, PHYS REV, V89, P1256, DOI 10.1103/PhysRev.89.1256; Caucci L, 2010, IEEE NUCL SCI CONF R, P2643, DOI 10.1109/NSSMIC.2010.5874269; DAVIS L, 1976, HEALTH PHYS, V31, P521; Eckelman WC, 2009, JACC-CARDIOVASC IMAG, V2, P364, DOI 10.1016/j.jcmg.2008.12.013; Frandes M, 2010, IEEE T NUCL SCI, V57, P144, DOI 10.1109/TNS.2009.2031679; Gagnon K, 2012, APPL RADIAT ISOTOPES, V70, P1685, DOI 10.1016/j.apradiso.2012.04.016; Hatsukawa Y, 2015, J RADIOANAL NUCL CH, V303, P1283, DOI 10.1007/s10967-014-3508-0; Hayakawa T, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2017.e00497; HERZO D, 1975, NUCL INSTRUM METHODS, V123, P583, DOI 10.1016/0029-554X(75)90215-3; Hueso-Gonzalez F, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/05/P05002; IZUMO M, 1991, APPL RADIAT ISOTOPES, V42, P297, DOI 10.1016/0883-2889(91)90092-F; Kabuki S, 2010, NUCL INSTRUM METH A, V623, P606, DOI 10.1016/j.nima.2010.03.085; Kormoll T, 2011, NUCL INSTRUM METH A, V626, P114, DOI 10.1016/j.nima.2010.10.031; LeBlanc JW, 1999, NUCL INSTRUM METH A, V422, P735, DOI 10.1016/S0168-9002(98)01027-4; Llosa G, 2013, NUCL INSTRUM METH A, V718, P130, DOI 10.1016/j.nima.2012.08.074; Mizumoto T, 2015, NUCL INSTRUM METH A, V800, P40, DOI 10.1016/j.nima.2015.08.004; Munoz E, 2017, PHYS MED BIOL, V62, P7321, DOI 10.1088/1361-6560/aa8070; Ortega PG, 2015, PHYS MED BIOL, V60, P1845, DOI 10.1088/0031-9155/60/5/1845; Peterson SW, 2010, PHYS MED BIOL, V55, P6841, DOI 10.1088/0031-9155/55/22/015; PHILLIPS GW, 1995, NUCL INSTRUM METH B, V99, P674, DOI 10.1016/0168-583X(95)80085-9; Polf JC, 2015, PHYS MED BIOL, V60, P7085, DOI 10.1088/0031-9155/60/18/7085; Richard MH, 2011, IEEE T NUCL SCI, V58, P87, DOI 10.1109/TNS.2010.2076303; SCHONFELDER V, 1993, ASTROPHYS J SUPPL S, V86, P657, DOI 10.1086/191794; SINGH M, 1983, MED PHYS, V10, P421, DOI 10.1118/1.595313; Takada A, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/13; Tanimori T, 2015, ASTROPHYS J, V810, DOI 10.1088/0004-637X/810/1/28; Tanimori T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41511; Tawara Y, 1998, P SOC PHOTO-OPT INS, V3444, P569, DOI 10.1117/12.331278; Tkac P, 2016, J RADIOANAL NUCL CH, V308, P205, DOI 10.1007/s10967-015-4357-1; Tomono D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41972; Wilderman SJ, 1998, IEEE T NUCL SCI, V45, P957, DOI 10.1109/23.682685; Zoglauer A, 2013, P SPIE XRAY GAMMA RA, V4851, P1302	36	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208909	10.1371/journal.pone.0208909	http://dx.doi.org/10.1371/journal.pone.0208909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532248	gold, Green Submitted, Green Published			2022-12-26	WOS:000452644700057
J	Gerrick, KY; Gerrick, ER; Gupta, A; Wheelan, SJ; Yegnasubramanian, S; Jaffee, EM				Gerrick, Kimberline Y.; Gerrick, Elias R.; Gupta, Anuj; Wheelan, Sarah J.; Yegnasubramanian, Srinivasan; Jaffee, Elizabeth M.			Transcriptional profiling identifies novel regulators of macrophage polarization	PLOS ONE			English	Article							HISTONE DEACETYLASE; DNA METHYLATION; GENE-EXPRESSION; EPIGENETIC THERAPY; HUMAN MONOCYTES; DENDRITIC CELLS; IL-10; CHOLESTEROL; GENOME; METABOLISM	Macrophages are key inflammatory immune cells that display dynamic phenotypes and functions in response to their local microenvironment. Major advances have occurred in understanding the transcriptional, epigenetic, and functional differences in various macrophage subsets by in vitro modeling and gene expression and epigenetic profiling for biomarker discovery. However, there is still no standardized protocol for macrophage polarization largely due to the lack of thorough validation of macrophage phenotypes following polarization. In addition, transcriptional regulation is recognized as a major mechanism governing differential macrophage polarization programs and as such, many genes have been identified to be associated with each macrophage subset. However, the functional role of many of these genes in macrophage polarization is still unknown. Moreover, the role of other regulatory mechanisms, such as DNA methylation, in macrophage polarization remains poorly understood. Here, we employed an optimized model of human M1 and M2 macrophage polarization which we used for large-scale transcriptional and DNA methylation profiling. We were unable to demonstrate a role for DNA methylation in macrophage polarization, as no significant changes were identified. However, we observed significant changes in the transcriptomes of M1 and M2 macrophages. Additionally, we identified numerous novel differentially regulated genes involved in macrophage polarization, including CYBB and DHCR7 which we show as important regulators of M1 and M2 macrophage polarization, respectively. Taken together, our improved in vitro human M1 and M2 macrophage model provides new understandings of the regulation of macrophage polarization and candidate macrophage biomarkers.	[Gerrick, Kimberline Y.; Gupta, Anuj; Wheelan, Sarah J.; Yegnasubramanian, Srinivasan; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Gerrick, Kimberline Y.; Gupta, Anuj; Wheelan, Sarah J.; Yegnasubramanian, Srinivasan; Jaffee, Elizabeth M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA; [Gerrick, Kimberline Y.; Jaffee, Elizabeth M.] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Sch Med, Baltimore, MD 21218 USA; [Gerrick, Kimberline Y.; Jaffee, Elizabeth M.] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Skip Viragh Ctr Pancreas Canc Clin Res & Patient, Baltimore, MD 21218 USA; [Gerrick, Elias R.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Jaffee, EM (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.; Jaffee, EM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA.; Jaffee, EM (corresponding author), Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Sch Med, Baltimore, MD 21218 USA.; Jaffee, EM (corresponding author), Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Skip Viragh Ctr Pancreas Canc Clin Res & Patient, Baltimore, MD 21218 USA.	ejaffee@jhmi.edu		Jaffee, Elizabeth/0000-0003-3841-6549	National Institute of Health/National Cancer Institute [RO1CA184926, P50CA062924]; National Institute of Health [T32 GM008752]; National Science Foundation [DGE1144152]; NIH/NCI [P30CA006973]; Commonwealth Foundation; NATIONAL CANCER INSTITUTE [P50CA062924, R01CA184926, P30CA006973] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health/National Cancer Institute grants RO1CA184926 and P50CA062924 to E.M.J. K.Y.G. is supported by the National Institute of Health Training Grant T32 GM008752. E.R.G. is supported by the National Science Foundation Fellowship DGE1144152. A.G, S.J.W., and S.Y. are supported by the NIH/NCI grant P30CA006973 and the Commonwealth Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aberg KA, 2012, EPIGENOMICS-UK, V4, P605, DOI [10.2217/EPI.12.59, 10.2217/epi.12.59]; ABRAMSON SL, 1990, J IMMUNOL, V144, P625; Araldi E, 2017, CELL REP, V19, P2743, DOI 10.1016/j.celrep.2017.05.093; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Bellosta S, 1998, ARTERIOSCL THROM VAS, V18, P1671, DOI 10.1161/01.ATV.18.11.1671; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Blake Gavin J, 2000, Curr Control Trials Cardiovasc Med, V1, P161, DOI 10.1186/CVM-1-3-161; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Brogdon JL, 2007, BLOOD, V109, P1123, DOI 10.1182/blood-2006-04-019711; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Cheng X, 2014, COLD SPRING HARB PER, V6; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; CHEUNG DL, 1992, BLOOD, V79, P1972; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; ERICKSONMILLER CL, 1990, INT J CELL CLONING, V8, P346, DOI 10.1002/stem.5530080503; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gnyszka A, 2013, ANTICANCER RES, V33, P2989; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Ikeda U, 1999, LANCET, V353, P2070, DOI 10.1016/S0140-6736(05)77885-5; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; JOHNSON WD, 1977, J EXP MED, V146, P1613, DOI 10.1084/jem.146.6.1613; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kapellos TS, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6591703; Kittan NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078045; Kobayashi T, 2012, J IMMUNOL, V189, P1792, DOI 10.4049/jimmunol.1200042; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Lan X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022226; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luu W, 2015, J LIPID RES, V56, P888, DOI 10.1194/jlr.M056986; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Padgett LE, 2015, DIABETES, V64, P937, DOI 10.2337/db14-0929; Prabhu AV, 2016, PROG LIPID RES, V64, P138, DOI 10.1016/j.plipres.2016.09.003; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Shrivastava S, 2008, BIOCHEMISTRY-US, V47, P5668, DOI 10.1021/bi8001677; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Spiller KL, 2016, EXP CELL RES, V347, P1, DOI 10.1016/j.yexcr.2015.10.017; Stone ML, 2017, P NATL ACAD SCI USA, V114, pE10981, DOI 10.1073/pnas.1712514114; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Terranova-Barberio M, 2016, IMMUNOTHERAPY-UK, V8, P705, DOI 10.2217/imt-2016-0014; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; Troegeler A, 2014, IMMUNOL CELL BIOL, V92, P699, DOI 10.1038/icb.2014.39; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang XJ, 2010, TRENDS PHARMACOL SCI, V31, P536, DOI 10.1016/j.tips.2010.08.001; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293; Yi L, 2012, AM J PATHOL, V180, P1049, DOI 10.1016/j.ajpath.2011.11.019; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257; ZUCKERMAN SH, 1979, IMMUNOLOGY, V38, P401	83	49	51	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208602	10.1371/journal.pone.0208602	http://dx.doi.org/10.1371/journal.pone.0208602			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532146	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900026
J	Shi, R; Lewis, RS; Panthee, DR				Shi, Rui; Lewis, Ramsey S.; Panthee, Dilip R.			Filter paper-based spin column method for cost-efficient DNA or RNA purification	PLOS ONE			English	Article							RT-PCR; EXTRACTION; REGENERATION; CELLULOSE; MATRIX	We describe herein a method of recharging used commercial spin columns or assembling homemade spin columns using filter paper as binding material for cost-effective, low throughput nucleic acid purification. The efficiency of filter paper-based spin columns was evaluated for purification of nucleic acids from various sources. Following protocols of commercial kits, we found filter paper to be a useful binding material for purification of nucleic acids, including plant genomic DNA, plant total RNA, PCR products, and DNA from agarose gels. However, filter paper has a weak binding affinity to plasmid DNA in tested miniprep protocols. Protocols for the use of filter paper recharged spin columns or homemade spin columns for low throughput purification of plant genomic DNA and total RNA with unused commercial kit buffers or less expensive homemade buffers are presented.	[Shi, Rui; Panthee, Dilip R.] North Carolina State Univ, Dept Hort Sci, Mt Hort Crops Res & Extens Ctr, Mills River, NC 28759 USA; [Shi, Rui; Lewis, Ramsey S.] North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Panthee, DR (corresponding author), North Carolina State Univ, Dept Hort Sci, Mt Hort Crops Res & Extens Ctr, Mills River, NC 28759 USA.	dilip_panthee@ncsu.edu	Rui, Shi/B-3306-2008; Panthee, Dilip/AFM-0574-2022; Panthee, Dilip/CAF-8991-2022; Panthee, Dilip/AAH-2974-2022	Panthee, Dilip/0000-0002-8736-512X; Panthee, Dilip/0000-0002-8736-512X	North Carolina State University; NC Tomato Growers Association	North Carolina State University; NC Tomato Growers Association	The work was partially supported by North Carolina State University in the form of enhancing funding to Prof. Ramsey S. Lewis, North Carolina State University in the form of enhancing funding and NC Tomato Growers Association to Prof. Dilip R. Panthee, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Borodina TA, 2003, ANAL BIOCHEM, V321, P135, DOI 10.1016/S0003-2697(03)00403-2; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Drake K, 2013, CROP SCI, V53, P1366, DOI 10.2135/cropsci2012.10.0605; Esser KH, 2005, BIOTECHNIQUES, V39, P270, DOI 10.2144/05392AF01; Glowacka K, 2016, PLANT CELL ENVIRON, V39, P908, DOI 10.1111/pce.12693; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Lemke L, 2011, VITIS, V50, P7; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li XF, 2014, ANAL BIOCHEM, V451, P18, DOI 10.1016/j.ab.2014.01.016; MCCORMICK RM, 1989, ANAL BIOCHEM, V181, P66, DOI 10.1016/0003-2697(89)90394-1; Moeller JR, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400048; Rimola A, 2013, CHEM REV, V113, P4216, DOI 10.1021/cr3003054; Shi R, 2017, PLANTA, V246, P579, DOI 10.1007/s00425-017-2743-3; Shi Rui, 2012, Methods Mol Biol, V822, P53, DOI 10.1007/978-1-61779-427-8_4; Su X, 1999, ANAL BIOCHEM, V267, P415, DOI 10.1006/abio.1998.2987; Tagliavia M, 2009, ANAL BIOCHEM, V385, P182, DOI 10.1016/j.ab.2008.10.021; Takakura KI, 2012, J PLANT RES, V125, P805, DOI 10.1007/s10265-012-0502-x; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; Thatcher SA, 2015, CLIN CHEM, V61, P89, DOI 10.1373/clinchem.2014.221374; VANHUYNH N, 1993, ANAL BIOCHEM, V211, P61, DOI 10.1006/abio.1993.1233; Yaffe Hila, 2012, BMC Res Notes, V5, P45, DOI 10.1186/1756-0500-5-45; Yang F, 2017, J VIROL METHODS, V247, P61, DOI 10.1016/j.jviromet.2017.05.020; Zou YP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003916	25	19	21	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0203011	10.1371/journal.pone.0203011	http://dx.doi.org/10.1371/journal.pone.0203011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532193	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900001
J	Alexander, J; Edwards, RA; Brodsky, M; Manca, L; Grugni, R; Savoldelli, A; Bonfanti, G; Emir, B; Whalen, E; Watt, S; Parsons, B				Alexander, Joe, Jr.; Edwards, Roger A.; Brodsky, Marina; Manca, Luigi; Grugni, Roberto; Savoldelli, Alberto; Bonfanti, Gianluca; Emir, Birol; Whalen, Ed; Watt, Steve; Parsons, Bruce			Using time series analysis approaches for improved prediction of pain outcomes in subgroups of patients with painful diabetic peripheral neuropathy	PLOS ONE			English	Article							DOUBLE-BLIND; PREGABALIN; EFFICACY; MANAGEMENT; SEVERITY; SYMPTOMS; TRIALS; RELIEF; SAFETY	Prior work applied hierarchical clustering, coarsened exact matching (CEM), time series regressions with lagged variables as inputs, and microsimulation to data from three randomized clinical trials (RCTs) and a large German observational study (OS) to predict pregabalin pain reduction outcomes for patients with painful diabetic peripheral neuropathy. Here, data were added from six RCTs to reduce covariate bias of the same OS and improve accuracy and/or increase the variety of patients for pain response prediction. Using hierarchical cluster analysis and CEM, a matched dataset was created from the OS (N= 2642) and nine total RCTs (N= 1320). Using a maximum likelihood method, we estimated weekly pain scores for pregabalin-treated patients for each cluster (matched dataset); the models were validated with RCT data that did not match with OS data. We predicted novel 'virtual' patient pain scores over time using simulations including instance-based machine learning techniques to assign novel patients to a cluster, then applying cluster-specific regressions to predict pain response trajectories. Six clusters were identified according to baseline variables (gender, age, insulin use, body mass index, depression history, pregabalin monotherapy, prior gabapentin, pain score, and pain-related sleep interference score). CEM yielded 1766 patients (matched dataset) having lower covariate imbalances. Regression models for pain performed well (adjusted R-squared 0.90-0.93; root mean square errors 0.41-0.48). Simulations showed positive predictive values for achieving >50% and >30% change-from-baseline pain score improvements (range 68.6-83.8% and 86.5-93.9%, respectively). Using more RCTs (nine vs. the earlier three) enabled matching of 46.7% more patients in the OS dataset, with substantially reduced global imbalance vs. not matching. This larger RCT pool covered 66.8% of possible patient characteristic combinations (vs. 25.0% with three original RCTs) and made prediction possible for a broader spectrum of patients.	[Alexander, Joe, Jr.; Emir, Birol; Whalen, Ed; Watt, Steve; Parsons, Bruce] Pfizer Inc, New York, NY 10017 USA; [Edwards, Roger A.] Hlth Serv Consulting Corp, Boxboro, MA USA; [Brodsky, Marina] Pfizer Inc, Groton, CT 06340 USA; [Manca, Luigi; Grugni, Roberto; Savoldelli, Alberto; Bonfanti, Gianluca] Fair Dynam Consulting, Milan, Italy	Pfizer; Pfizer	Alexander, J (corresponding author), Pfizer Inc, New York, NY 10017 USA.	joe.alexander.jr@pfizer.com			Pfizer	Pfizer(Pfizer)	These analyses were funded by Pfizer. Pfizer medical directors, statisticians, and publications specialists play a role in the study design, data collection, and analysis, and they review the paper for scientific accuracy, data verification, and adherence to ICJME authorship and reporting guidelines. However, Pfizer leaves the final decisions on the clinical interpretation of the data and the content of the paper to the expert judgement of the authors. The specific roles of these authors are articulated in the 'Author Contributions' section"of the manuscript.; Editorial support in the form of copyediting and formatting was provided by Ray Beck, Jr, PhD of Engage Scientific Solutions and was funded by Pfizer.	Alexander J, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0389-2; Alpaydin E., 2010, INTRO MACHINE LEARNI; [Anonymous], 2016, LYRICA PREGABALIN SU; Arezzo JC, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-33; Baron R, 2012, LANCET NEUROL, V11, P999, DOI 10.1016/S1474-4422(12)70189-8; Bouhassira D, 2014, PAIN, V155, P2171, DOI 10.1016/j.pain.2014.08.020; Choi B.S., 1992, ARMA MODEL IDENTIFIC; Coble J., 2009, ANN C PHM SOC, V1; Coble J.B., 2010, MERGING DATA SOURCES; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Emir B, 2017, CLIN THER, V39, P98, DOI 10.1016/j.clinthera.2016.11.015; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Freeman R, 2008, DIABETES CARE, V31, P1448, DOI 10.2337/dc07-2105; Freeman R, 2014, PAIN, V155, P367, DOI 10.1016/j.pain.2013.10.023; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Freynhagen R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3002; Gobl CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141524; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Gunes F., 2018, PENALIZED REGRESSION; Hannan EL, 2008, JACC-CARDIOVASC INTE, V1, P211, DOI 10.1016/j.jcin.2008.01.008; Hebert HL, 2017, PAIN, V158, P560, DOI 10.1097/j.pain.0000000000000785; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hoffman DL, 2010, PAIN, V149, P194, DOI 10.1016/j.pain.2009.09.017; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Lesser H, 2004, NEUROLOGY, V63, P2104, DOI 10.1212/01.WNL.0000145767.36287.A1; Markman JD, 2017, PAIN PRACT, V17, P718, DOI 10.1111/papr.12516; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; North M.J., 2007, MANAGING BUSINESS CO; Parsons B, 2016, CURR MED RES OPIN, V32, P929, DOI 10.1185/03007995.2016.1151776; Parsons B, 2015, J PAIN RES, V8, P303, DOI 10.2147/JPR.S82806; Perez C, 2017, PAIN PRACT, V17, P470, DOI 10.1111/papr.12469; Pfizer Inc, 2013, LYR PREG US PRESCR I; Raskin P, 2014, CLIN J PAIN, V30, P379, DOI 10.1097/AJP.0b013e31829ea1a1; Richter RW, 2005, J PAIN, V6, P253, DOI 10.1016/j.jpain.2004.12.007; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Satoh J, 2011, DIABETIC MED, V28, P109, DOI 10.1111/j.1464-5491.2010.03152.x; Semel D, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-85; Stanos S, 2016, POSTGRAD MED, V128, P502, DOI 10.1080/00325481.2016.1188319; Tesfaye S, 2011, J DIABETES INVEST, V2, P33, DOI 10.1111/j.2040-1124.2010.00083.x; Tolle T, 2008, EUR J PAIN, V12, P203, DOI 10.1016/j.ejpain.2007.05.003; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Vinik A, 2014, PAIN MED, V15, P661, DOI 10.1111/pme.12310	43	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207120	10.1371/journal.pone.0207120	http://dx.doi.org/10.1371/journal.pone.0207120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521533	gold, Green Published, Green Submitted			2022-12-26	WOS:000452307600007
J	Araneda, P; Sielfeld, W; Bonacic, C; Ibarra, JT				Araneda, Paola; Sielfeld, Walter; Bonacic, Cristian; Tomas Ibarra, Jose			Bird diversity along elevational gradients in the Dry Tropical Andes of northern Chile: The potential role of Aymara indigenous traditional agriculture	PLOS ONE			English	Article							SPECIES RICHNESS; BIODIVERSITY CONSERVATION; TERRESTRIAL ECOSYSTEMS; HABITAT ASSOCIATIONS; VEGETATION STRUCTURE; BETA-DIVERSITY; ATACAMA DESERT; SMALL MAMMALS; LAND-USE; AREA	Understanding diversity patterns along environmental gradients lies at the heart of community ecology and conservation. Previous studies have found variation in bird diversity and density along "natural" elevational gradients in the Tropical Andes Hotspot. However, there is still a lack of knowledge about how bird communities respond to traditional land-use patterns, in association with other multiple drivers, along elevations. In the present study, we investigated biotic, abiotic and anthropogenic sources of variation associated with bird species diversity, density and turnover along a 3000-m elevational gradient, in southern limit of the Tropical Andes Hotspot, northern Chile. Over four seasons, we conducted 472 bird point count surveys and established 118 plots distributed across the Desert, Pre-Puna, Puna and High-Andean belts, where biotic, abiotic and anthropogenic factors were measured. We used mixed-effects models to estimate alpha diversity and multinomial Poisson mixture models to estimate species density, accounting for detectability. Species diversity and density increased until 3300 masl and then declined. This type of elevational pattern is characteristic of dry-based mountains, where environmental conditions are suitable at mid-elevations. Habitats shaped by traditional Aymara indigenous agriculture, associated with relatively high vegetation heterogeneity, hosted the highest values of bird diversity and density. Species turnover was structured by habitat type, while elevational ranges of most species were restricted to three relatively discrete assemblages that replaced each other along the gradient. Our study revealed a hump-shaped relationship between elevation and bird diversity and density in the Dry Tropical Andes Biodiversity Hotspot, supporting a diversity pattern characteristic of dry-based mountains of the world. Traditional Aymara agriculture may have constructed ecological niches for biodiversity at mid-elevations, enhancing	[Araneda, Paola; Bonacic, Cristian] Pontificia Univ Catolica Chile, Sch Agr & Forest Sci, Dept Ecosyst & Environm, Fauna Australis Wildlife Lab, Santiago, Chile; [Araneda, Paola; Sielfeld, Walter] Univ Arturo Prat, Ctr Invest Medio Ambiente CENIMA, Iquique, Region De Tarap, Chile; [Araneda, Paola; Tomas Ibarra, Jose] Pontificia Univ Catolica Chile, Ctr Local Dev Educ & Intercultural CEDEL, ECOS Ecol Complex Soc Lab, Villarr Campus, Villarrica, Region De La Ar, Chile; [Bonacic, Cristian; Tomas Ibarra, Jose] Pontificia Univ Catolica Chile, Fac Social Sci, CIIR, Santiago, Chile; [Tomas Ibarra, Jose] Pontificia Univ Catolica Chile, Millennium Nucleus Ctr Socioecon Impact Environm, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad Arturo Prat; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Araneda, P (corresponding author), Pontificia Univ Catolica Chile, Sch Agr & Forest Sci, Dept Ecosyst & Environm, Fauna Australis Wildlife Lab, Santiago, Chile.; Araneda, P (corresponding author), Univ Arturo Prat, Ctr Invest Medio Ambiente CENIMA, Iquique, Region De Tarap, Chile.; Araneda, P (corresponding author), Pontificia Univ Catolica Chile, Ctr Local Dev Educ & Intercultural CEDEL, ECOS Ecol Complex Soc Lab, Villarr Campus, Villarrica, Region De La Ar, Chile.	araneda.paola@gmail.com	Bonacic, Cristian/O-2558-2014	Bonacic, Cristian/0000-0003-2175-076X; Ibarra, Jose Tomas/0000-0002-7705-3974	CONICYT/Fondecyt Iniciacion [11160932]; Centre for Intercultural and Indigenous Research (CIIR) [CONICYT/FONDAP/15110006]; Centro de Investigacion en Medio Ambiente (CENIMA) of the Universidad Arturo Prat	CONICYT/Fondecyt Iniciacion(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centre for Intercultural and Indigenous Research (CIIR); Centro de Investigacion en Medio Ambiente (CENIMA) of the Universidad Arturo Prat	This work has been supported by CONICYT/Fondecyt Iniciacion 11160932, the Centro de Investigacion en Medio Ambiente (CENIMA) of the Universidad Arturo Prat, and the Centre for Intercultural and Indigenous Research (CIIR) (GRANT: CONICYT/FONDAP/15110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Albuquerque UP, 2018, PERSPECT ECOL CONSER, V16, P1, DOI 10.1016/j.pecon.2017.08.006; Albuquerque UP, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-72; ALDUNATE C, 1983, ECON BOT, V37, P120, DOI 10.1007/BF02859312; Alwang J, 2013, FUTURE MOUNTAIN AGR, P21, DOI DOI 10.1007/978-3-642-33584-6_3; Anderson A, 2015, PLOS ONE, V10, P1; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bengoa J., 2004, MEMORIA OLVIDADA HIS; Bruun M, 2003, BIOL CONSERV, V114, P179, DOI 10.1016/S0006-3207(03)00021-1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Castro M, 2017, DERECHO CONSUETUDINA; Cayot Linda J., 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22719323A94622165.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22722406A94765253.EN, 10.2305/IUCN.UK.2016-1.RLTS.T9017A65487433.EN, DOI 10.2305/IUCN.UK.2016-1.RLTS.T9017A65487433.EN]; Caziani SM, 2001, WATERBIRDS, V24, P103, DOI 10.2307/1522249; Chandler R, 2014, DISTANCE SAMPLING AN, P1; Chappell MJ, 2011, AGR HUM VALUES, V28, P3, DOI 10.1007/s10460-009-9251-4; CODY ML, 1970, ECOLOGY, V51, P455, DOI 10.2307/1935380; Cofre H.L., 2007, BOL CHIL ORNITOL, V13, P56; Cueto VR, 1999, J BIOGEOGR, V26, P487, DOI 10.1046/j.1365-2699.1999.00299.x; Dainese M, 2012, LANDSCAPE ECOL, V27, P417, DOI 10.1007/s10980-011-9687-y; del Hoyo J., 1992, P1; DGA, 2013, AN REC HIDR QUEBR AR; Duelli P, 2003, BASIC APPL ECOL, V4, P129, DOI 10.1078/1439-1791-00140; Duran AP, 2013, BIOL CONSERV, V160, P272, DOI 10.1016/j.biocon.2013.02.003; Eisenberg A, 2013, AYMARA INDIAN PERSPE; Elewa AMT, 2005, MIGRATION ORGANISMS; ERICKSON CL, 1992, POPUL ENVIRON, V13, P285, DOI 10.1007/BF01271028; Estades CF, 1996, WILSON BULL, V108, P268; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fjeldsa J., 1985, Ornithological Monographs, P85; Fjeldsa J, 2007, BIODIVERS CONSERV, V16, P2739, DOI 10.1007/s10531-007-9204-4; Fjeldsa J, 2012, ANNU REV ECOL EVOL S, V43, P249, DOI 10.1146/annurev-ecolsys-102710-145113; Fu CZ, 2007, BIODIVERS CONSERV, V16, P707, DOI 10.1007/s10531-005-4382-4; Fuentes-Allende N, 2016, J ARID ENVIRON, V135, P115, DOI 10.1016/j.jaridenv.2016.08.018; Gantz A, 2009, GAYANA, V73, P172; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gibbs KE, 2009, DIVERS DISTRIB, V15, P242, DOI 10.1111/j.1472-4642.2008.00543.x; Gilroy JJ, 2010, IBIS, V152, P90, DOI 10.1111/j.1474-919X.2009.00988.x; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Grotzbach S, 1997, MOUNTAINS WORLD GLOB, P17; Hagen M, 2010, BIOL CONSERV, V143, P1654, DOI 10.1016/j.biocon.2010.03.036; HAINSWORTH FR, 1977, CONDOR, V79, P69, DOI 10.2307/1367532; Hanspach J, 2016, DIVERS DISTRIB, V22, P853, DOI 10.1111/ddi.12449; Herrnstadt Z, 2016, RENEW AGR FOOD SYST, V31, P516, DOI 10.1017/S1742170515000447; Herzog SK, 2003, WILSON BULL, V115, P438, DOI 10.1676/03-048; Heynen I, 2018, HDB BIRDS WORLD ALIV; Hofer U, 1999, ECOLOGY, V80, P976, DOI 10.2307/177031; Jacquemyn H, 2007, BIOL CONSERV, V136, P388, DOI 10.1016/j.biocon.2006.12.008; Jankowski JE, 2013, ECOGRAPHY, V36; Jankowski JE, 2013, J BIOGEOGR, V40, P950, DOI 10.1111/jbi.12041; Jankowski JE, 2009, J ANIM ECOL, V78, P315, DOI 10.1111/j.1365-2656.2008.01487.x; Jaramillan R, 2005, AVES CHILE INCLUYE P; Jodha N. S., 2005, Global change and mountain regions: an overview of current knowledge, P583; Kajtoch L, 2017, ACTA OECOL, V78, P53, DOI 10.1016/j.actao.2016.12.010; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Katuwal HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158362; Kendal J, 2011, PHILOS T R SOC B, V366, P785, DOI 10.1098/rstb.2010.0306; Kent R, 2013, PLOS ONE, V8; Kessler Michael, 2001, Diversity and Distributions, V7, P61, DOI 10.1046/j.1472-4642.2001.00097.x; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Kohler T, 2011, MOUNTAINS CLIMATE CH; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Korner C, 2016, ALP BOT, V127; Labree W, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0123672, 10.1371/journal.pone.0138822]; Lavercombe B, 1972, B ORNITOL, V4, P1; Legendre P., 2003, NUMERICAL ECOLOGY, VSecond; Liu JG, 2001, ECOL MODEL, V140, P1, DOI 10.1016/S0304-3800(01)00265-4; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Luebert F., 2017, SINOPSIS BIOCLIMATIC; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Marin M, 2004, ANNOTATED CHECKLIST; MARIN-A M, 1989, Bulletin of the British Ornithologists' Club, V109, P66; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Marquet PA, 1998, REV CHIL HIST NAT, V71, P593; Martinez G, 1987, CHUNGARA, V18, P163; Martinez-Tilleria K, 2017, BIODIVERS CONSERV, V26, P2857, DOI 10.1007/s10531-017-1393-x; Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Messerli B., 1997, MOUNTAINS WORLD GLOB; Meynard CN, 2008, ECOLOGY, V89, P981, DOI 10.1890/07-0350.1; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Mittermeier RA, 2015, CHELONIAN CONSERV BI, V14, P2, DOI 10.2744/ccab-14-01-2-10.1; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Molyneux M, 2011, HIST LANGUAGE ANDES; Montano-Centellas FA, 2015, ACTA OECOL, V65-66, P51, DOI 10.1016/j.actao.2015.05.003; Munaz AE, 2006, GAYANA BOT, V63, P75; Nor SM, 2001, GLOBAL ECOL BIOGEOGR, V10, P41, DOI 10.1046/j.1466-822x.2001.00231.x; Norfolk O, 2015, J ARID ENVIRON, V114, P110, DOI 10.1016/j.jaridenv.2014.12.004; Norris K, 2008, CONSERV LETT, V1, P2, DOI 10.1111/j.1755-263X.2008.00007.x; Oyarzun J, 2011, SUSTAIN DEV, V19, P263, DOI 10.1002/sd.441; Pan XY, 2016, PEERJ, V4, DOI 10.7717/peerj.2636; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Paudel PK, 2014, GLOB ECOL CONSERV, V2, P338, DOI 10.1016/j.gecco.2014.10.012; Piksa Krzysztof, 2013, PLoS ONE, V8, P1; Placzek C, 2009, ANN MO BOT GARD, V96, P386, DOI 10.3417/2008019; Pliscoff P, 2011, ENVIRON CONSERV, V38, P303, DOI 10.1017/S0376892911000208; Quintero I, 2018, NATURE, V555, P246, DOI 10.1038/nature25794; R Core Team, 2021, R LANGUAGE ENV STAT; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; RAMAKRISHNAN PS, 2005, ADV GLOB CHANGE RES, V23, P551; Rau JR, 1998, REV CHIL HIST NAT, V71, P527; Rodriguez-Estrella R, 2007, DIVERS DISTRIB, V13, P877, DOI 10.1111/j.1472-4642.2007.00387.x; Rottmann J, 1970, B ORNITOL, V2, P1; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Salinas Letty, 2007, Rev. peru biol., V14, P129; Sallaberry Michel, 1992, Noticiario Mensual Museo Nacional de Historia Natural (Santiago), V321, P3; Sarmiento FO, 2017, ANN AM ASSOC GEOGR, V4452, P1; SCHULENBERG TS, 1987, CONDOR, V89, P654, DOI 10.2307/1368654; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Sielfeld Walter, 1996, Boletin Chileno de Ornitologia, V3, P17; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TERBORGH J, 1971, Ecology (Washington D C), V52, P23, DOI 10.2307/1934735; Ibarra JT, 2015, BIOL CONSERV, V192, P418, DOI 10.1016/j.biocon.2015.11.008; Ibarra JT, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00207.1; Torres-Mura Juan C., 1998, Boletin Chileno de Ornitologia, V5, P24; Trivelli MG, 2009, ALCANCES FLORA VEGET; Victoriano Pedro F, 2006, Gayana (Concepc.), V70, P140; Vilina Y, 2008, BIODIVERS CHILE, P246; Villagran C., 2004, CIENCIA INDIGENA AND; Visco DM, 2015, BIOL CONSERV, V191, P117, DOI 10.1016/j.biocon.2015.05.018; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; VUILLEUMIER F, 1993, REV CHIL HIST NAT, V66, P11; Vuilleumier F, 1985, ORNITHOL MONO, V36, P255, DOI [10.2307/40168287, DOI 10.2307/40168287]; WIENS JA, 1981, ECOL MONOGR, V51, P21, DOI 10.2307/2937305; Williams SE, 2002, ECOLOGY, V83, P1317, DOI 10.1890/0012-9658(2002)083[1317:SSSDAH]2.0.CO;2; Wilson JD, 2005, IBIS, V147, P453, DOI 10.1111/j.1474-919x.2005.00440.x; Young B, 2015, ECOSYSTEM PROFILE TR; Zuchner T, 2018, HDB BIRDS WORLD ALIV; Zuur A, 2009, MIXED EFFECTS MODELS	134	4	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207544	10.1371/journal.pone.0207544	http://dx.doi.org/10.1371/journal.pone.0207544			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517135	Green Submitted, gold, Green Published			2022-12-26	WOS:000452212400043
J	Widge, AS; Boggess, M; Rockhill, AP; Mullen, A; Sheopory, S; Loonis, R; Freeman, DK; Miller, EK				Widge, Alik S.; Boggess, Matthew; Rockhill, Alexander P.; Mullen, Andrew; Sheopory, Shivani; Loonis, Roman; Freeman, Daniel K.; Miller, Earl K.			Altering alpha-frequency brain oscillations with rapid analog feedback-driven neurostimulation	PLOS ONE			English	Article							ALTERNATING-CURRENT STIMULATION; NEURAL OSCILLATIONS; FRONTAL THETA; ENTRAINMENT; GAMMA; POWER; DYNAMICS; NEUROMODULATION; MECHANISM; SYSTEMS	Oscillations of the brain's local field potential (LFP) may coordinate neural ensembles and brain networks. It has been difficult to causally test this model or to translate its implications into treatments, because there are few reliable ways to alter LFP oscillations. We developed a closed-loop analog circuit to enhance brain oscillations by feeding them back into cortex through phase-locked transcranial electrical stimulation. We tested the system in a rhesus macaque with chronically implanted electrode arrays, targeting 8-15 Hz (alpha) oscillations. Ten seconds of stimulation increased alpha oscillatory power for up to 1 second after stimulation offset. In contrast, open-loop stimulation decreased alpha power. There was no effect in the neighboring 15-30 Hz (beta) LFP rhythm or on a neighboring array that did not participate in closed-loop feedback. Analog closed-loop neurostimulation might thus be a useful strategy for altering brain oscillations, both for basic research and the treatment of neuropsychiatric disease.	[Widge, Alik S.; Boggess, Matthew; Rockhill, Alexander P.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Widge, Alik S.; Boggess, Matthew; Rockhill, Alexander P.] Harvard Med Sch, Boston, MA 02115 USA; [Widge, Alik S.; Mullen, Andrew; Sheopory, Shivani; Loonis, Roman; Miller, Earl K.] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sheopory, Shivani] Boston Univ, Coll Engn, Boston, MA 02215 USA; [Freeman, Daniel K.] Charles Stark Draper Lab Inc, Cambridge, MA USA; [Widge, Alik S.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Northwell Health; Boston University; The Charles Stark Draper Laboratory, Inc.; University of Minnesota System; University of Minnesota Twin Cities	Widge, AS (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.; Widge, AS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Widge, AS (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Widge, AS (corresponding author), Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA.	awidge@umn.edu	Widge, Alik/M-9064-2017; Miller, Earl K./AAE-8187-2019	Widge, Alik/0000-0001-8510-341X; Miller, Earl K./0000-0002-0582-6958; Rockhill, Alexander/0000-0003-3868-7453; Mullen, Andrew/0000-0002-0627-9749	MIT-MGH Strategic Initiative; MIT Undergraduate Research Opportunities program; Brain & Behavior Research Foundation; National Institute of Mental Health [MH109722-01]; Bipolar Fund at Harvard University; MIT Picower Innovation Fund; MIT Bose Fellowship; Paul E. Gray Fellowship	MIT-MGH Strategic Initiative; MIT Undergraduate Research Opportunities program; Brain & Behavior Research Foundation(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bipolar Fund at Harvard University; MIT Picower Innovation Fund; MIT Bose Fellowship; Paul E. Gray Fellowship	The research was supported by a grant from the MIT-MGH Strategic Initiative to ASW and EKM. AM was further supported by the MIT Undergraduate Research Opportunities program and Paul E. Gray Fellowship. ASW acknowledges further support from the Brain & Behavior Research Foundation, National Institute of Mental Health (MH109722-01), and the Bipolar Fund at Harvard University supported by Kent & Liz Dauten. EKM acknowledges support from the MIT Picower Innovation Fund and MIT Bose Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou CA, 2015, CURR OPIN NEUROBIOL, V31, P95, DOI 10.1016/j.conb.2014.09.002; Antal A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00317; Bachinger M, 2017, J NEUROSCI, P1756; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackwood E, 2018, P 2018 IEEE ENG MED; Boyle MR, 2013, I IEEE EMBS C NEUR E, P140, DOI 10.1109/NER.2013.6695891; Braun V, 2017, BRAIN STIMUL, V10, P910, DOI 10.1016/j.brs.2017.04.129; Broadway JM, 2012, NEUROPSYCHOPHARMACOL, V37, P1764, DOI 10.1038/npp.2012.23; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Coffey RJ, 2009, ARTIF ORGANS, V33, P208, DOI 10.1111/j.1525-1594.2008.00620.x; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Compton RJ, 2011, PSYCHOPHYSIOLOGY, V48, P583, DOI 10.1111/j.1469-8986.2010.01124.x; de Hemptinne C, 2015, NAT NEUROSCI, V18, P779, DOI 10.1038/nn.3997; Dotson NM, 2014, J NEUROSCI, V34, P13600, DOI 10.1523/JNEUROSCI.1961-14.2014; Frohlich F, 2015, PROG BRAIN RES, V222, P41, DOI 10.1016/bs.pbr.2015.07.025; Frohlich F, 2015, EXPERT REV NEUROTHER, V15, P145, DOI 10.1586/14737175.2015.992782; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Hanslmayr S, 2005, APPL PSYCHOPHYS BIOF, V30, P1, DOI 10.1007/s10484-005-2169-8; Hanslmayr S, 2014, CURR BIOL, V24, P904, DOI 10.1016/j.cub.2014.03.007; Headley DB, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00170; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Lo MC, 2017, INT REV PSYCHIATR, V29, P191, DOI 10.1080/09540261.2017.1282438; Lundqvist M, 2016, NEURON, V90, P152, DOI 10.1016/j.neuron.2016.02.028; Lustenberger C, 2016, CURR BIOL, V26, P2127, DOI 10.1016/j.cub.2016.06.044; Manza P, 2014, J NEUROSCI, V34, P5998, DOI 10.1523/JNEUROSCI.4641-13.2014; Martinez-Rubio C, 2018, J NEUROSCI, V38, P1942, DOI 10.1523/JNEUROSCI.2021-17.2017; Mathalon DH, 2015, JAMA PSYCHIAT, V72, P840, DOI 10.1001/jamapsychiatry.2015.0483; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Neuling T, 2013, CLIN NEUROPHYSIOL, V124, pe69, DOI [10.1523/JNEUROSCI.2021-17.2017, DOI 10.1523/JNEUROSCI.2021-17.2017]; Noury N, 2016, NEUROIMAGE, V140, P99, DOI 10.1016/j.neuroimage.2016.03.065; Patel YA, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005430; Philip NS, 2017, AM J PSYCHIAT, V174, P628, DOI 10.1176/appi.ajp.2017.16090996; Quinn EJ, 2015, MOVEMENT DISORD, V30, P1750, DOI 10.1002/mds.26376; Schalk G, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00352; Schmidt SL, 2014, BRAIN STIMUL, V7, P878, DOI 10.1016/j.brs.2014.07.033; Siegle JH, 2014, ELIFE, V3, DOI 10.7554/eLife.03061; Smart OL, 2015, BIOL PSYCHIAT, V77, P1061, DOI 10.1016/j.biopsych.2015.01.002; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Struber D, 2015, FRONT CELL NEUROSCI, P9, DOI DOI 10.3389/FNCEL.2015.00311/ABSTRACT; Thut G, 2017, CLIN NEUROPHYSIOL, V128, P843, DOI 10.1016/j.clinph.2017.01.003; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Voytek B, 2015, NAT NEUROSCI, V18, P1318, DOI 10.1038/nn.4071; Wade Elizabeth C, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P411, DOI 10.1016/j.bpsc.2016.06.002; Widge AS, 2017, EXP NEUROL, V287, P461, DOI 10.1016/j.expneurol.2016.07.021; Widge AS, 2016, BIOL PSYCHIAT, V80, pE59, DOI 10.1016/j.biopsych.2015.10.029; Widge AS, 2016, BIOL PSYCHIAT, V79, pE9, DOI 10.1016/j.biopsych.2015.06.005; Widge AS, 2015, CURR BEHAV NEUROSCI, V2, P187, DOI DOI 10.1007/S40473-015-0049-Y; Widge AS, 2015, EMERGING TRENDS SOCI, DOI DOI 10.1002/9781118900772.ETRDS0103/ABSTRACT; Wutz A, 2018, NEURON, V97, P716, DOI 10.1016/j.neuron.2018.01.009; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	62	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207781	10.1371/journal.pone.0207781	http://dx.doi.org/10.1371/journal.pone.0207781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517149	gold, Green Submitted, Green Published			2022-12-26	WOS:000452212400066
J	Tillander, V; Miniami, A; Alves-Bezerra, M; Coleman, RA; Cohen, DE				Tillander, Veronika; Miniami, Akihiro; Alves-Bezerra, Michele; Coleman, Rosalind A.; Cohen, David E.			Thioesterase superfamily member 2 promotes hepatic insulin resistance in the setting of glycerol-3-phosphate acyltransferase 1-induced steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diacylglycerol; fatty acid; fatty acid metabolism; insulin resistance; liver; triacylglycerol	FATTY-ACID OXIDATION; PROTEIN-KINASE-C; TRIACYLGLYCEROL SYNTHESIS; LIVER; OVEREXPRESSION; PHOSPHORYLATION; THERMOGENESIS; HEPATOCYTES; RATS	Hepatic insulin resistance in the setting of steatosis is attributable at least in part to the accumulation of bioactive lipids that suppress insulin signaling. The mitochondria-associated glycerol-3-phosphate acyltransferase 1 (GPAT1) catalyzes the first committed step in glycerolipid synthesis, and its activity diverts fatty acids from mitochondrial -oxidation. GPAT1 overexpression in mouse liver leads to hepatic steatosis even in the absence of overnutrition. The mice develop insulin resistance owing to the generation of saturated diacylglycerol and phosphatidic acid molecular species that reduce insulin signaling by activating PKCE and by suppressing mTORC2, respectively. Them2, a mitochondria-associated acyl-CoA thioesterase, also participates in the trafficking of fatty acids into oxidative versus glycerolipid biosynthetic pathways. Them2(-/-) mice are protected against diet-induced hepatic steatosis and insulin resistance. To determine whether Them2 contributes to hepatic insulin resistance due to hepatic overexpression of GPAT1, recombinant adenovirus was used to overexpress GPAT1 in livers of chow-fed Them2(+/+) and Them2(-/-) mice. Hepatic GPAT1 overexpression led to steatosis in both genotypes. In the setting of GPAT1 overexpression, glucose tolerance was reduced in Them2(+/+) but not Them2(-/-) mice, without influencing whole-body insulin sensitivity or basal hepatic glucose production. Improved glucose tolerance in Them2(-/-) mice was associated with reduced PKCE translocation. Preserved insulin receptor activity was supported by Thr-308 phosphorylation of Akt following GPAT1 overexpression in Them2(-/-) hepatocytes. These findings suggest a pathogenic role of Them2 in the biosynthesis of glycerolipid metabolites that promote hepatic insulin resistance.	[Tillander, Veronika; Miniami, Akihiro; Alves-Bezerra, Michele; Cohen, David E.] Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA; [Tillander, Veronika] Karolinska Inst, Dept Lab Med, Div Clin Chem, S-14152 Huddinge, Sweden; [Miniami, Akihiro] Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan; [Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA	Cornell University; Karolinska Institutet; Kobe University; University of North Carolina; University of North Carolina Chapel Hill	Cohen, DE (corresponding author), Belfer Res Bldg,413 E 69th St,Rm 630, New York, NY 10021 USA.	dcohen@med.cornell.edu	Alves-Bezerra, Michele/B-4662-2014; Alves-Bezerra, Michele/AAJ-8017-2021	Alves-Bezerra, Michele/0000-0003-4430-6434; Alves-Bezerra, Michele/0000-0003-4430-6434; Coleman, Rosalind/0000-0003-4379-3824	NIDDK, National Institutes of Health [R37 DK048873, R01 DK056626, R01 DK56598]; Swedish Society for Medical Research (SSMF) Postdoctoral Research Fellowship [201525]; American Heart Association Postdoctoral Fellowship [18POST33990445]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598, R37DK048873, R01DK056626] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Society for Medical Research (SSMF) Postdoctoral Research Fellowship; American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants R37 DK048873 and R01 DK056626 (to D.E.C.) and R01 DK56598 (to R.A.C.), the Swedish Society for Medical Research (SSMF) Postdoctoral Research Fellowship 201525 (to V.T.), and American Heart Association Postdoctoral Fellowship 18POST33990445 (to M.A.-B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng ZJ, 2006, BIOCHEM BIOPH RES CO, V349, P172, DOI 10.1016/j.bbrc.2006.08.025; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cooper DE, 2015, J BIOL CHEM, V290, P20023, DOI 10.1074/jbc.R115.663260; Ersoy BA, 2018, J CLIN INVEST, V128, P141, DOI 10.1172/JCI93123; Ersoy BA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004111; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Han SX, 2012, J LIPID RES, V53, P2620, DOI 10.1194/jlr.M029538; Hutchins PM, 2008, J LIPID RES, V49, P804, DOI 10.1194/jlr.M700521-JLR200; Kang HW, 2013, J BIOL CHEM, V288, P33376, DOI 10.1074/jbc.M113.481408; Kang HW, 2012, FASEB J, V26, P2209, DOI 10.1096/fj.11-202853; Kawano Y, 2014, MOL CELL BIOL, V34, P2396, DOI 10.1128/MCB.01601-13; Leiker TJ, 2011, INT J MASS SPECTROM, V305, P103, DOI 10.1016/j.ijms.2010.09.008; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Linden D, 2004, J LIPID RES, V45, P1279, DOI 10.1194/jlr.M400010-JLR200; Linden D, 2006, FASEB J, V20, P434, DOI 10.1096/fj.05-4568com; MONROY G, 1972, J BIOL CHEM, V247, P6884; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Okada K, 2016, MOL METAB, V5, P340, DOI 10.1016/j.molmet.2016.02.002; Petersen MC, 2017, TRENDS PHARMACOL SCI, V38, P649, DOI 10.1016/j.tips.2017.04.004; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHLOSSMAN DM, 1976, J BIOL CHEM, V251, P5738; ter Horst KW, 2017, CELL REP, V19, P1997, DOI 10.1016/j.celrep.2017.05.035; Tillander V, 2017, TRENDS ENDOCRIN MET, V28, P473, DOI 10.1016/j.tem.2017.03.001; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang CB, 2015, J BIOL CHEM, V290, P3519, DOI 10.1074/jbc.M114.602789; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	34	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2009	2020		10.1074/jbc.RA118.005184	http://dx.doi.org/10.1074/jbc.RA118.005184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30523156	Green Published, hybrid			2022-12-26	WOS:000459711400020
J	Homke, P; Holler, J; Levinson, SC				Homke, Paul; Holler, Judith; Levinson, Stephen C.			Eye blinks are perceived as communicative signals in human face-to-face interaction	PLOS ONE			English	Article							TURN-TAKING; ADDRESSEES; RESPONSES; FEEDBACK; SPEAKING; ORIGINS; MINDS	In face-to-face communication, recurring intervals of mutual gaze allow listeners to provide speakers with visual feedback (e.g. nodding). Here, we investigate the potential feedback function of one of the subtlest of human movements eye blinking. While blinking tends to be subliminal, the significance of mutual gaze in human interaction raises the question whether the interruption of mutual gaze through blinking may also be communicative. To answer this question, we developed a novel, virtual reality-based experimental paradigm, which enabled us to selectively manipulate blinking in a virtual listener, creating small differences in blink duration resulting in 'short' (208 ms) and 'long' (607 ms) blinks. We found that speakers unconsciously took into account the subtle differences in listeners' blink duration, producing substantially shorter answers in response to long listener blinks. Our findings suggest that, in addition to physiological, perceptual and cognitive functions, listener blinks are also perceived as communicative signals, directly influencing speakers' communicative behavior in face-to-face communication. More generally, these findings may be interpreted as shedding new light on the evolutionary origins of mental-state signaling, which is a crucial ingredient for achieving mutual understanding in everyday social interaction.	[Homke, Paul; Holler, Judith; Levinson, Stephen C.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands; [Holler, Judith; Levinson, Stephen C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Levinson, Stephen C.] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen	Homke, P (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands.	paul.hoemke@mpi.nl			European Research Council [269484 INTERACT]; Max Planck Gesellschaft	European Research Council(European Research Council (ERC)European Commission); Max Planck Gesellschaft(Max Planck Society)	This research was funded by the European Research Council (Advanced Grant #269484 INTERACT awarded to Prof. Levinson) and the Max Planck Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PERSPECTIVES SOCIALL; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bavelas J., 2014, OXFORD HDB LANGUAGE, P111; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; Brennan SE, 2010, PSYCHOL LEARN MOTIV, V53, P301, DOI 10.1016/S0079-7421(10)53008-1; Clark H.H., 1996, USING LANGUAGE; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; CLARK HH, 1989, COGNITIVE SCI, V13, P259, DOI 10.1207/s15516709cog1302_7; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; DOANE MG, 1980, AM J OPHTHALMOL, V89, P507, DOI 10.1016/0002-9394(80)90058-6; Doughty MJ, 2001, OPTOMETRY VISION SCI, V78, P712, DOI 10.1097/00006324-200110000-00011; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Frohlich M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25887; Gobel MS, 2015, COGNITION, V136, P359, DOI 10.1016/j.cognition.2014.11.040; Grice H.P., 1975, SYNTAX SEMANTICS; GRICE HP, 1957, PHILOS REV, V66, P377, DOI 10.2307/2182440; Heerey EA, 2015, CURR DIR PSYCHOL SCI, V24, P285, DOI 10.1177/0963721415570731; Holler J, 2017, PSYCHONOMIC B REV; Homke P, 2017, RES LANG SOC INTERAC, V50, P54, DOI 10.1080/08351813.2017.1262143; Kaneko K, 1999, PERCEPT MOTOR SKILL, V88, P1037, DOI 10.2466/pms.1999.88.3.1037; Kendrick KH, 2017, RES LANG SOC INTERAC, V50, P1, DOI 10.1080/08351813.2017.1267911; Kuhlen AK, 2010, DISCOURSE PROCESS, V47, P567, DOI 10.1080/01638530903441339; Lakoff G., 1999, PHILOS FLESH; Lee DH, 2014, PSYCHOL SCI, V25, P745, DOI 10.1177/0956797613514451; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Levelt WJM, 1989, SPEAKING INTENTION A; Levinson S. C., 2000, PRESUMPTIVE MEANINGS; Levinson SC, 2004, COMP FEEDBACK CULTUR; Levinson SC, 2016, TRENDS COGN SCI, V20, P6, DOI 10.1016/j.tics.2015.10.010; Levinson SC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0302; Mandel A, 2015, EUR J NEUROSCI, V42, P2508, DOI 10.1111/ejn.13011; Mandel A, 2014, EUR J NEUROSCI, V40, P2576, DOI 10.1111/ejn.12611; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; Perniss P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0300; Peshori KR, 2001, EXP BRAIN RES, V136, P351, DOI 10.1007/s002210000585; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; PONDER ERIC, 1927, QUART JOUR EXP PHYSIOL, V18, P89; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Rossano F., 2012, THESIS RADBOUD U; ROSSANO F., 2013, HDB CONVERSATION ANA, P308; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Schegloff EA, 2007, LANG CULT COGN, P123; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Siegle GJ, 2008, PSYCHOPHYSIOLOGY, V45, P679, DOI 10.1111/j.1469-8986.2008.00681.x; Tada H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066018; Team RC, 2014, R LANG ENV STAT COMP; Tomasello M., 2007, GESTURAL COMMUNICATI; Wittenburg P., 2006, P 5 INT C LANG RES E, V2006, P5; Yngve V.H., 1970, 6 REG M CHIC LING SO, P567; ZAMETKIN AJ, 1979, ANN NEUROL, V5, P453, DOI 10.1002/ana.410050509	55	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208030	10.1371/journal.pone.0208030	http://dx.doi.org/10.1371/journal.pone.0208030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540819	gold, Green Published			2022-12-26	WOS:000452898600051
J	Pohl, K; Nichols, DP; Taylor-Cousar, JL; Saavedra, MT; Strand, MJ; Nick, JA; Bratcher, PE				Pohl, Kerstin; Nichols, David P.; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Strand, Matthew J.; Nick, Jerry A.; Bratcher, Preston E.			Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RECEPTORS CXCR1; IN-VITRO; EXPRESSION; INTERLEUKIN-8; IVACAFTOR; LIPOPOLYSACCHARIDE; IDENTIFICATION; MANAGEMENT; CHILDREN	Cystic fibrosis (CF) is the most common life-shortening genetic disease and is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Several current therapies aim at improving availability and/or function of the mutant CFTR proteins. The combination therapeutic lumacaftor/ivacaftor (Orkambi, luma/iva) partially corrects folding and potentiates CFTR function impaired by the F508del mutation. Despite the potential for clinical benefit, a substantial number of patients discontinue treatment due to intolerable adverse effects. The aim of the present study is to identify differences between individuals who continued treatment and those who discontinued due to adverse respiratory effects to potentially inform treatment decisions. Clinical data from the year prior to treatment initiation were analyzed from 82 patients homozygous for the F508del mutation treated at the Colorado Adult CF Program. Blood samples were collected from 30 of these subjects before initiation of treatment to examine expression of circulating leukocyte surface antigens and cytokines. Clinical and demographic characteristics were analyzed along with inflammatory markers to determine biomarkers of drug discontinuation. The use of oral prednisone and/or nasal budesonide in the year prior to luma/iva initiation was more prevalent in CF subjects who did not tolerate luma/iva (82% vs. 43%). Increased age, but not gender or initial lung function, was associated with higher probability of discontinuing treatment due to side effects overall. Worse lung function (lower ppFEV(1), PPFEF25-75 <= 60%) was associated with higher incidence of discontinuing treatment due to pulmonary adverse effects. In a nested cohort of patients, increased surface levels of CXCR2 on CD14+CD16- monocytes were associated with discontinuation. Overall, the patients who tolerated luma/iva were distinguishable from those who did not tolerate the drug based on clinical and cellular markers obtained prior to treatment initiation.	[Pohl, Kerstin; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Nichols, David P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Taylor-Cousar, Jennifer L.; Bratcher, Preston E.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Nick, Jerry A.] Univ Colorado, Sch Med, Aurora, CO USA; [Strand, Matthew J.] Natl Jewish Hlth, Biostat & Bioinformat, Denver, CO USA	National Jewish Health; University of Washington; University of Washington Seattle; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Bratcher, PE (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	bratcherp@njhealth.org	Strand, Matt/AAU-3762-2021	Strand, Matt/0000-0002-9083-5989; , Kerstin/0000-0002-0787-8620; Nichols, David/0000-0001-8611-7960	Cystic Fibrosis Foundation [POHL16F0, NICK15R0, BRATCH16I0, BRATCH18A0-I]; NIH/NCRR Colorado CTSA Grant [UL1 RR025780]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH/NCRR Colorado CTSA Grant	KP, JAN and PEB received funding from the Cystic Fibrosis Foundation (https://www.cff.org/Research/Researcher-Resources/Awards-and-Grants/Training-Awards/Postdoctoral-Research-Fellowship-Award/, POHL16F0, NICK15R0, BRATCH16I0, BRATCH18A0-I) and KP received funding a NIH/NCRR Colorado CTSA Grant (http://www.ucdenver.edu/research/CCTSI/funding/Pages/default.aspx, UL1 RR025780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration USFaD, 2015, OR TABL, DOI [10.1056/NEJMc1510466, DOI 10.1056/NEJMC1510466]; [Anonymous], 2016, ORKAMBI R LUMACAFTOR; Aziz M, 2012, J IMMUNOL, V189, P393, DOI 10.4049/jimmunol.1200262; Balfour-Lynn IM, 1999, THORAX, V54, P657; Bonecchi R, 2000, J IMMUNOL, V164, P3862, DOI 10.4049/jimmunol.164.7.3862; Bratcher PE, 2016, J CYST FIBROS, V15, P67, DOI 10.1016/j.jcf.2015.02.010; Chaaban MR, 2013, AM J RHINOL ALLERGY, V27, P387, DOI 10.2500/ajra.2013.27.3919; Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; Chishti AD, 2001, J THORAC CARDIOV SUR, V122, P1162, DOI 10.1067/mtc.2001.116559; De Boeck K, 2014, J CYST FIBROS, V13, P674, DOI 10.1016/j.jcf.2014.09.005; DEAN TP, 1993, PEDIATR RES, V34, P159, DOI 10.1203/00006450-199308000-00010; del Campo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029577; deWerra I, 1997, CRIT CARE MED, V25, P607, DOI 10.1097/00003246-199704000-00009; Dyugovskaya L, 2011, AM J RESP CELL MOL, V45, P154, DOI 10.1165/rcmb.2010-0025OC; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Hosokawa K, 2017, BRIT J HAEMATOL, V177, P136, DOI 10.1111/bjh.14502; Hu N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3534; Janusonis S, 2009, J NEUROSCI METH, V179, P173, DOI 10.1016/j.jneumeth.2009.01.017; Jennings MT, 2017, OBSERVATIONAL STUDY, DOI [10.1513/AnnalsATS.201701-058OC, DOI 10.1513/ANNALSATS.201701-058OC]; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Khandaker MH, 1999, BLOOD, V93, P2173, DOI 10.1182/blood.V93.7.2173.407a06_2173_2185; Konstan M, 2016, PEDIATR PULM, V51, P260; Kormann MSD, 2012, EUR RESPIR J, V39, P1385, DOI 10.1183/09031936.00130011; Lei ZB, 2002, CARDIOVASC RES, V53, P524, DOI 10.1016/S0008-6363(01)00491-6; Leonard DA, 2011, CORONARY ARTERY DIS, V22, P491, DOI 10.1097/MCA.0b013e32834b67e2; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; Marseglia GL, 2007, ALLERGY ASTHMA PROC, V28, P74, DOI 10.2500/aap.2007.28.2920; Meddows-Taylor S, 2001, CLIN DIAGN LAB IMMUN, V8, P21, DOI 10.1128/CDLI.8.1.21-30.2001; Mogayzel PJ, 2013, AM J RESP CRIT CARE, V187, P680, DOI 10.1164/rccm.201207-1160OE; Moss RB, 2013, J CYST FIBROS, V12, P241, DOI 10.1016/j.jcf.2012.08.016; MROUEH S, 1994, CHEST, V105, P32, DOI 10.1378/chest.105.1.32; NIESSEN HWM, 1992, CELL SIGNAL, V4, P501, DOI 10.1016/0898-6568(92)90019-5; O'Callaghan L, 2017, PEDIATR PULM, V52, pS225; Pharmaceuticals Vertex, 2017, VERT ANN POS PHAS 1; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; RAYNER RJ, 1991, RESP MED, V85, P139, DOI 10.1016/S0954-6111(06)80292-1; Rehman A, 2015, NEW ENGL J MED, V373, P1783, DOI 10.1056/NEJMc1510466; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Taylor-Cousar JL, 2017, J CYSTIC FIBROSIS OF, DOI [10.1016/j.jcf.2017.09, DOI 10.1016/J.JCF.2017.09]; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Virgin FW, 2012, AM J RHINOL ALLERGY, V26, P70, DOI 10.2500/ajra.2012.26.3705; WILMOTT RW, 1994, PEDIATR PULM, V18, P21, DOI 10.1002/ppul.1950180107; Xu RN, 2016, SCI REP-UK, V6, DOI 10.1038/srep38714	50	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0209026	10.1371/journal.pone.0209026	http://dx.doi.org/10.1371/journal.pone.0209026			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540818	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600108
J	Sanchez-Amaro, A; Duguid, S; Call, J; Tomasello, M				Sanchez-Amaro, Alejandro; Duguid, Shona; Call, Josep; Tomasello, Michael			Chimpanzees' understanding of social leverage	PLOS ONE			English	Article							PAN-TROGLODYTES; BIOLOGICAL MARKETS; CAPUCHIN MONKEYS; DEMAND DETERMINE; GAME; RISK; INDIVIDUALS; COOPERATION; PREFERENCES; COORDINATE	Social primates can influence others through the control of resources. For instance, dominant male chimpanzees might allow subordinates access to mate with females in exchange for social support. However, little is known about how chimpanzees strategically use a position of leverage to maximize their own benefits. We address this question by presenting dyads of captive chimpanzee (N= 6) with a task resulting in an unequal reward distribution. To gain the higher reward each individual should wait for their partner to act. In addition, one participant had leverage: access to an alternative secure reward. By varying the presence and value of the leverage we tested whether individuals used it strategically (e.g. by waiting longer for partners to act when they had leverage in the form of alternatives). Additionally, non-social controls served to show if chimpanzees understood the social dilemma. We measured the likelihood to choose the leverage and their latencies to act. The final decision made by the chimpanzees did not differ as a function of condition (test versus non-social control) or the value of the leverage, but they did wait longer to act when the leverage was smaller particularly in test (versus non-social control) trials suggesting that they understood the conflict of interest involved. The chimpanzees thus recognized the existence of social leverage, but did not use it strategically to maximize their rewards.	[Sanchez-Amaro, Alejandro] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Sanchez-Amaro, Alejandro; Duguid, Shona; Call, Josep; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Duguid, Shona] Univ Warwick, Warwick Business Sch, Warwick, England; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Tomasello, Michael] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	University of California System; University of California San Diego; Max Planck Society; University of Warwick; University of St Andrews; Duke University	Sanchez-Amaro, A (corresponding author), Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA.; Sanchez-Amaro, A (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	a5sanchezamaro@ucsd.edu	Amaro, Alejandro Sanchez/AAM-1710-2020	Call Balaguer, Josep/0000-0002-8597-8336; Duguid, Shona/0000-0003-4844-0673				Barclay P, 2013, EVOL HUM BEHAV, V34, P164, DOI 10.1016/j.evolhumbehav.2013.02.002; Beran MJ, 2006, BEHAV PROCESS, V73, P315, DOI 10.1016/j.beproc.2006.07.005; Beran MJ, 2016, BEHAV PROCESS, V129, P68, DOI 10.1016/j.beproc.2016.06.007; Binmore K, 1989, DO PEOPLE EXPLOIT TH; Brosnan SF, 2017, J ECON BEHAV ORGAN, V142, P293, DOI 10.1016/j.jebo.2017.07.037; Bullinger AF, 2013, ANIM BEHAV, V85, P51, DOI 10.1016/j.anbehav.2012.10.006; Camerer C.F., 2011, BEHAV GAME THEORY EX; Cooper R., 1994, PROBLEMS COORDINATIO, P129; COOPER RW, 1990, AM ECON REV, V80, P218; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Gilby IC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1771, DOI 10.1007/s00265-007-0410-6; Gilby IC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0005; HAND JL, 1986, Q REV BIOL, V61, P201, DOI 10.1086/414899; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; Haun DBM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028801; Heilbronner SR, 2008, BIOL LETTERS, V4, P246, DOI 10.1098/rsbl.2008.0081; Hillemann F, 2014, ANIM BEHAV, V90, P1, DOI 10.1016/j.anbehav.2014.01.007; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; KNEZ MJ, 1995, GAME ECON BEHAV, V10, P65, DOI 10.1006/game.1995.1025; Koomen R, 2018, AM J PRIMATOL, V80, DOI 10.1002/ajp.22734; Krupenye C, 2018, CURRENT BIOL; Krupenye C, 2016, SCIENCE, V354, P110, DOI 10.1126/science.aaf8110; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; Melis AP, 2009, EVOL HUM BEHAV, V30, P381, DOI 10.1016/j.evolhumbehav.2009.05.003; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Proctor D, 2013, P NATL ACAD SCI USA, V110, P2070, DOI 10.1073/pnas.1220806110; Rapoport A., 1965, PRISONERS DILEMMA ST; Rosati AG, 2012, ANIM BEHAV, V84, P869, DOI 10.1016/j.anbehav.2012.07.010; Sanchez-Amaro A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0259; Sanchez-Amaro A, 2016, ANIM BEHAV, V116, P61, DOI 10.1016/j.anbehav.2016.03.030; Schmelz M, 2017, P NATL ACAD SCI USA, V114, P7462, DOI 10.1073/pnas.1700351114; Schmitt PM, 2004, EXP ECON, V7, P49, DOI 10.1023/A:1026210021955; Sugden R, 1986, EC RIGHTS COOPERATIO; Talbot CF, 2018, J COMP PSYCHOL, V132, P75, DOI 10.1037/com0000088	38	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207868	10.1371/journal.pone.0207868	http://dx.doi.org/10.1371/journal.pone.0207868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540763	gold, Green Published			2022-12-26	WOS:000452898600039
J	Weigmann, S; Kaschner, CJ; Thiel, R				Weigmann, Simon; Kaschner, Carina Julia; Thiel, Ralf			A new microendemic species of the deep-water catshark genus Bythaelurus (Carcharhiniformes, Pentanchidae) from the northwestern Indian Ocean, with investigations of its feeding ecology, generic review and identification key	PLOS ONE			English	Review							N. SP.; CHIMERAS CHONDRICHTHYES; ANNOTATED CHECKLIST; LIVING SHARKS; SCYLIORHINIDAE; SEAMOUNTS; DIVERSITY; ENDEMISM; BIOLOGY; BATOIDS	A new deep-water catshark, Bythaelurus stewarti, is described based on 121 examined specimens caught on the Error Seamount (Mount Error Guyot) in the northwestern Indian Ocean. The new species differs from all congeners in the restricted distribution, a higher spiral valve turn count and in the morphology of the dermal denticles. It is distinguished from its morphologically and geographically closest congener, B. hispidus (Alcock), by the larger size (maximum size 44 vs. 39 cm TL, maturity size of males 35-39 vs. 21-28 cm TL), darker fresh coloration and dark grayish-brown mottling of the ventral head (vs. ventral head typically uniformly yellowish or whitish). Furthermore, it has a strongly different morphology of dermal denticles, in particular smaller and less elongate branchial, trunk and lateral caudal denticles that are set much less densely and have a surface that is very strongly and fully structured by reticulations (vs. structured by reticulations only in basal fourth). In addition, the new species differs from B. hispidus in having more slender claspers that are gradually narrowing to the bluntly pointed tip without knob-like apex (vs. claspers broader and with distinct knob-like apex), more spiral valve turns (11-12 vs. 8-10) and numerous statistical differences in morphometrics. A review of and a key to the species of Bythaelurus are given.	[Weigmann, Simon] Elasmobranch Res Lab, Elasmolab, Hamburg, Germany; [Weigmann, Simon; Thiel, Ralf] Univ Hamburg, Ctr Nat Hist, Hamburg, Germany; [Kaschner, Carina Julia] Fed Off Agr & Food, Fisheries, Dept 522, Hamburg, Germany	University of Hamburg	Weigmann, S (corresponding author), Elasmobranch Res Lab, Elasmolab, Hamburg, Germany.; Weigmann, S (corresponding author), Univ Hamburg, Ctr Nat Hist, Hamburg, Germany.	simon.weigmann@elasmo-lab.de		Kaschner, Carina/0000-0002-9809-3027				Acuna E, 2010, REV BIOL MAR OCEANOG, V45, P737, DOI 10.4067/S0718-19572010000400016; Akhilesh KV, 2013, J FISH BIOL, V82, P1582, DOI 10.1111/jfb.12087; al Sakaff H., 1999, Naga, V22, P43; Alcock A.W., 1899, DESCRIPTIVE CATALOGU; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; [Anonymous], CSIRO MARINE ATMOSPH; [Anonymous], 1979, NOAA TECHNICAL REPOR, DOI DOI 10.5962/BHL.TITLE.63029; Appukuttan K.K., 1988, P173; Bass A.J., 1975, Investigational Rep oceanogr Res Inst Durban, VNo. 37, P1; Bruce Niel L., 1994, Invertebrate Taxonomy, V8, P583, DOI 10.1071/IT9940583; Chu Y., 1982, Oceanologia et Limnologia Sinica, V13, P301; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Compagno L.J.V., 2005, FIELD GUIDE SHARKS W; Compagno L.J.V., 1988, SHARKS ORDER CARCHAR; Compagno Leonard J.V., 2005, P503; Compagno Leonard J.V., 1999, P471; COMPAGNO LJV, 1990, S AFR J MARINE SCI, V9, P201; Compagno LJV., 1984, FAO FISH SYNOP, P20; Concha F, 2010, J FISH BIOL, V77, P963, DOI 10.1111/j.1095-8649.2010.02736.x; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Ebert DA., 2013, SHARKS WORLD; Ebert David A., 2015, Journal of the Ocean Science Foundation, V15, P53; Francis MP, 2006, ENVIRON BIOL FISH, V75, P295, DOI 10.1007/s10641-006-0026-0; Garman S., 1913, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge, V36; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Kaschner CJ, 2015, ZOOTAXA, V4013, P120, DOI 10.11646/zootaxa.4013.1.9; Koslow J.A., 2007, SILENT DEEP DISCOVER; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Lopez S, 2013, J APPL ICHTHYOL, V29, P751, DOI 10.1111/jai.12151; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McCosker JE, 2012, ZOOTAXA, P48; Melendez R, 1989, CHILE INVEST MAR VAL, V17, P3; Moravec F, 2000, J NAT HIST, V34, P1, DOI 10.1080/002229300299660; NAIR R V, 1973, Senckenbergiana Biologica, V54, P71; Nair R.V., 1973, Indian Journal of Fisheries, V20, P575; Nakaya Kazuhiro, 2008, CSIRO Marine and Atmospheric Research Paper, V022, P49; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; Pitcher T.J., 1982, FISHERIES ECOLOGY; Rago PJ, 1998, FISH RES, V39, P165, DOI 10.1016/S0165-7836(98)00181-7; Raje SG., 2002, CMFRI SPECIAL PUBLIC, V71, P1; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Sabaj M.H., 2016, STANDARD SYMBOLIC CO; Seret B., 1987, SMITH I ICHTHYOLOGY, V44, P1; Sosebee Katherine A., 2005, Journal of Northwest Atlantic Fishery Science, V35, P115; SPRINGER S, 1971, Records of the Dominion Museum (Wellington), V7, P235; Springer S., 1972, Investigational Rep Oceanogr Res Inst Durban, VNo. 29, P1; SPRINGER VICTOR G., 1964, PROC U S NAT MUS, V116, P73; Stehmann MFW, 2002, ARCH FISH MAR RES, V50, P23; Stocks Karen I., 2007, Fish and Aquatic Resources Series, V12, P255; Tizard TH, 1885, NARRATIVE, V1, P511; Valenzuela A, 2008, SCI MAR, V72, P231; Weigmann S, 2017, J FISH BIOL, V90, P1176, DOI 10.1111/jfb.13234; Weigmann S, 2016, J FISH BIOL, V88, P837, DOI 10.1111/jfb.12874; Weigmann S, 2017, ZOOTAXA, V4263, P97, DOI 10.11646/zootaxa.4263.1.4; Weigmann S, 2016, ZOOTAXA, V4208, P401, DOI 10.11646/zootaxa.4208.5.1; Weigmann S, 2015, DEEP-SEA RES PT II, V115, P18, DOI 10.1016/j.dsr2.2013.09.005; Weigmann S, 2013, ZOOTAXA, V3609, P163, DOI 10.11646/zootaxa.3609.2.3; White WT, 2013, ZOOTAXA, V 3752, P228, DOI 10.11646/zootaxa.3752.1.14; Wood-Mason J., 1891, ANN MAGAZINE NATUR 6, V8, P353, DOI DOI 10.1080/00222939109460385	60	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207887	10.1371/journal.pone.0207887	http://dx.doi.org/10.1371/journal.pone.0207887			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540765	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600043
J	Kamikawa, N; Hamada, H; Sekikawa, K; Yamamoto, H; Fujika, Y; Kajiwara, T; Aizawa, F; Otoyama, I				Kamikawa, Norimichi; Hamada, Hironobu; Sekikawa, Kiyokazu; Yamamoto, Hikaru; Fujika, Yoshiya; Kajiwara, Teruki; Aizawa, Fumiya; Otoyama, Ippo			Posture and firmness changes in a pressure-relieving air mattress affect cough strength in elderly people with dysphagia	PLOS ONE			English	Article							RESPIRATORY MUSCLE STRENGTH; ASPIRATION PNEUMONIA; CAPACITY; FLOW	Dysphagia is the major pathophysiologic mechanism leading to aspiration pneumonia in the elderly. Elderly people with dysphagia who show low levels of the cough peak flow (CPF) are at greater risk for aspiration pneumonia. It has been reported that CPF values were significantly lower in the "soft" versus "hard" mode of a pressure-relieving air mattress in healthy volunteers in a supine position. Parameters such as spinal curvature, however, were not evaluated in detail. In this study, we clarified whether the changes in posture associated with two different firmness levels of a pressure-relieving air mattress were associated with cough production and related factors in the elderly with dysphagia. The body sinking distance, pelvic tilt angle, and immersion of the lumbar spine were measured to evaluate changes in posture. Forty subjects met the study criteria for dysphagia. The "soft" mode showed significantly lower CPF values than the "hard" mode (soft 274.9 +/- 107.2 L/min vs. hard 325.0 +/- 99.5 L/min, MD 50.0 95% CI 33.1-66.9 P < 0.001). Values of forced vital capacity (FVC) and maximal inspiratory pressure (PImax) were significantly lower in the "soft" mode than in the "hard" mode (MD 0.10 95% CI 0.04-0.17, P = 0.002, MD 3.2 95% CI 0.9-5.5, P = 0.007, respectively). Although there was no significant difference between the two firmness levels, maximal expiratory pressure (PEmax) values also tended to be lower in the "soft" than in the "hard" mode, (MD 2.9 95% CI -0.6-6.3 P = 0.1). At both firmness levels, CPF values were significantly correlated with FVC, PImax, and PEmax. The difference in sinking distance in the anterior superior iliac spine was significantly larger than that in the lesser tubercle of the humerus and patella. Additionally, in the soft mode, the pelvic tilt angle and contact area around the lumbar spine were significantly larger than those observed in the "hard" mode. Parameters associated with the production of cough, including inspiratory muscle strength, lung volume, and ultimately CPF, may be affected by immersion of the lumbar spine and curvature of the spine that results from the "soft" mode in elderly patients with dysphagia.	[Kamikawa, Norimichi; Hamada, Hironobu; Sekikawa, Kiyokazu; Yamamoto, Hikaru; Fujika, Yoshiya; Kajiwara, Teruki; Aizawa, Fumiya; Otoyama, Ippo] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan; [Kamikawa, Norimichi] Hiroshima Cosmopolitan Univ, Fac Hlth Sci, Dept Rehabil, Hiroshima, Japan	Hiroshima University	Hamada, H (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phys Anal & Therapeut Sci, Hiroshima, Japan.	hirohamada@hiroshima-u.ac.jp	Hamada, Hironobu/A-6489-2018; kiyokazu, sekikawa/AAC-1498-2020	Hamada, Hironobu/0000-0002-7979-0708; Aizawa, Fumiya/0000-0003-2239-5771	Fundamental Budget for Education and Research	Fundamental Budget for Education and Research	This work was supported by Fundamental Budget for Education and Research.	Badr C, 2002, AUST J PHYSIOTHER, V48, P95, DOI 10.1016/S0004-9514(14)60203-8; Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919, DOI 10.1177/000348940811701210; Bianchi C, 2012, AM J PHYS MED REHAB, V91, P783, DOI 10.1097/PHM.0b013e3182556701; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; CULHAM EG, 1994, SPINE, V19, P1250, DOI 10.1097/00007632-199405310-00010; DAY JW, 1984, PHYS THER, V64, P510, DOI 10.1093/ptj/64.4.510; Hegland KW, 2014, LUNG, V192, P601, DOI 10.1007/s00408-014-9584-7; HICKLING KG, 1988, INTENS CARE MED, V14, P617; Kamikawa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146714; Kang SW, 2006, YONSEI MED J, V47, P184, DOI 10.3349/ymj.2006.47.2.184; Kang SW, 2000, CHEST, V118, P61, DOI 10.1378/chest.118.1.61; Kera T, 2001, J PHYS THER SCI, V13, P153; Levine D, 1996, J ORTHOP SPORT PHYS, V24, P130, DOI 10.2519/jospt.1996.24.3.130; Lin F, 2006, ARCH PHYS MED REHAB, V87, P504, DOI 10.1016/j.apmr.2005.11.031; Manabe T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140060; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moysidis T, 2011, INT WOUND J, V8, P578, DOI 10.1111/j.1742-481X.2011.00814.x; Normand Martin C, 2005, J Can Chiropr Assoc, V49, P96; Park JH, 2010, YONSEI MED J, V51, P392, DOI 10.3349/ymj.2010.51.3.392; Polkey MI, 1998, AM J RESP CRIT CARE, V158, P734, DOI 10.1164/ajrccm.158.3.9710072; Srour N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056676; SZEINBERG A, 1988, CHEST, V94, P1232, DOI 10.1378/chest.94.6.1232; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Yamamoto Y, 2011, J JPN WOUND OSTOMY C, V15, P239	25	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208895	10.1371/journal.pone.0208895	http://dx.doi.org/10.1371/journal.pone.0208895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533019	gold, Green Published, Green Submitted			2022-12-26	WOS:000452782500045
J	Song, YM				Song, Yongming			Deriving the priority weights from probabilistic linguistic preference relation with unknown probabilities	PLOS ONE			English	Article							GROUP DECISION-MAKING; TERM SETS; CONSISTENCY MEASURES; INFORMATION FUSION; MODEL; DETERMINANTS; MIGRATION	Generally, the probabilistic linguistic term set (PLTS) provides more accurate descriptive properties than the hesitant fuzzy linguistic term set does. The probabilistic linguistic preference relation (PLPR), which is applied to deal with complex decision-making problems, can be constructed for PLTSs. However, it is difficult for decision makers to provide the probabilities of occurrence for PLPR. To deal with this problem, we propose a definition of expected consistency for PLPR and establish a probability computing model to derive probabilities of occurrence in PLPR with priority weights for alternatives. A consistency-improving iterative algorithm is presented to examine whether or not the PLPR is at an acceptable consistency. Moreover, the consistency-improving iterative algorithm should obtain the satisfaction consistency level for the unacceptable consistency PLPR. Finally, a real-world employment-city selection is used to demonstrate the effectiveness of the proposed method of deriving priority weights from PLPR.	[Song, Yongming] Shandong Technol & Business Univ, Sch Business Adm, Yantai, Peoples R China	Shandong Technology & Business University	Song, YM (corresponding author), Shandong Technol & Business Univ, Sch Business Adm, Yantai, Peoples R China.	xinshiji7819@163.com		Song, Yongming/0000-0002-4413-2107	Doctoral Scientific Research Foundation of Shandong Technology and Business University [BS201805]; Shandong Provincial Natural Science Foundation [ZR2016GQ07, ZR2017BG017]; Humanities and Social Sciences Foundation of the Ministry of Education in China [17YJC630238]	Doctoral Scientific Research Foundation of Shandong Technology and Business University; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Humanities and Social Sciences Foundation of the Ministry of Education in China	This work is supported by the Doctoral Scientific Research Foundation of Shandong Technology and Business University (No. BS201805), Shandong Provincial Natural Science Foundation (Nos. ZR2016GQ07 and ZR2017BG017), and Humanities and Social Sciences Foundation of the Ministry of Education in China (No. 17YJC630238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2009, INT J INTELL SYST, V24, P201, DOI 10.1002/int.20332; Bai CZ, 2017, KNOWL-BASED SYST, V119, P284, DOI 10.1016/j.knosys.2016.12.020; Chiang Y., 2012, INT J CHINESE ED, V1, P106; [丁金宏 Ding Jinhong], 2005, [地理学报, Acta Geographica Sinica], V60, P106; Dong YC, 2008, EUR J OPER RES, V189, P430, DOI 10.1016/j.ejor.2007.06.013; Dong YC, 2015, INFORM SCIENCES, V297, P95, DOI 10.1016/j.ins.2014.11.011; Gou XJ, 2016, INFORM SCIENCES, V372, P407, DOI 10.1016/j.ins.2016.08.034; Herrera F, 2000, IEEE T FUZZY SYST, V8, P746, DOI 10.1109/91.890332; Herrera-Viedma E, 2005, IEEE T FUZZY SYST, V13, P644, DOI 10.1109/TFUZZ.2005.856561; Lamonica GR, 2013, DEMOGR RES, V29, P407, DOI 10.4054/DemRes.2013.29.16; Liang DC, 2018, INT J FUZZY SYST, V20, P2234, DOI 10.1007/s40815-017-0374-2; Liao HC, 2017, INFORM SCIENCES, V415, P341, DOI 10.1016/j.ins.2017.06.035; Liao HC, 2014, INFORM SCIENCES, V271, P125, DOI 10.1016/j.ins.2014.02.125; Liu JQ, 2011, POPULATION RES, V35, P73; Liu PD, 2018, APPL SOFT COMPUT, V68, P396, DOI 10.1016/j.asoc.2018.03.027; Liu SQ, 2014, J RURAL STUD, V33, P71, DOI 10.1016/j.jrurstud.2013.11.001; Ma SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173700; Ma ZZ, 2020, IEEE T SYST MAN CY-S, V50, P2421, DOI 10.1109/TSMC.2018.2815716; Pang Q, 2016, INFORM SCIENCES, V369, P128, DOI 10.1016/j.ins.2016.06.021; Pei LD, 2017, INT J SYST SCI, V48, P2779, DOI 10.1080/00207721.2017.1343405; Rodriguez RM, 2016, INFORM FUSION, V29, P89, DOI 10.1016/j.inffus.2015.11.004; Rodriguez RM, 2012, IEEE T FUZZY SYST, V20, P109, DOI 10.1109/TFUZZ.2011.2170076; Song YM, 2019, J OPER RES SOC, V70, P827, DOI 10.1080/01605682.2018.1458017; Song Y, 2017, APPL SOFT COMPUT, V59, P174, DOI 10.1016/j.asoc.2017.05.056; TANINO T, 1984, FUZZY SET SYST, V12, P117, DOI 10.1016/0165-0114(84)90032-0; Garcia JMT, 2012, EXPERT SYST APPL, V39, P10022, DOI 10.1016/j.eswa.2012.02.008; Torra V, 2010, INT J INTELL SYST, V25, P529, DOI 10.1002/int.20418; Willmore L, 2012, POPUL ENVIRON, V33, P161, DOI 10.1007/s11111-011-0135-3; Wu XL, 2019, EUR J OPER RES, V272, P1017, DOI 10.1016/j.ejor.2018.07.044; Wu XL, 2018, IEEE T FUZZY SYST, V26, P3688, DOI 10.1109/TFUZZ.2018.2843330; Wu XL, 2018, INFORM FUSION, V43, P13, DOI 10.1016/j.inffus.2017.11.008; Wu ZB, 2016, IEEE T CYBERNETICS, V46, P694, DOI 10.1109/TCYB.2015.2413894; Xu DD, 2015, J MT SCI-ENGL, V12, P1562, DOI 10.1007/s11629-014-3371-z; Xu ZS, 2019, INT J MACH LEARN CYB, V10, P1513, DOI 10.1007/s13042-018-0830-9; Xu ZS, 2017, INFORM FUSION, V34, P43, DOI 10.1016/j.inffus.2016.06.002; Xu ZS, 2005, INT J INF TECH DECIS, V4, P197, DOI 10.1142/S0219622005001465; Xu ZS, 2004, INT J UNCERTAIN FUZZ, V12, P791, DOI 10.1142/S0218488504003211; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90046-8; ZHANG XL, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9071231; Zhang YX, 2017, INFORM SCIENCES, V414, P260, DOI 10.1016/j.ins.2017.06.006; Zhang YX, 2016, APPL SOFT COMPUT, V49, P817, DOI 10.1016/j.asoc.2016.08.045; Zhang ZM, 2014, KNOWL-BASED SYST, V72, P13, DOI 10.1016/j.knosys.2014.08.026; Zhu B, 2014, IEEE T FUZZY SYST, V22, P35, DOI 10.1109/TFUZZ.2013.2245136; Zhu N, 2010, AGR ECON-BLACKWELL, V41, P191, DOI 10.1111/j.1574-0862.2009.00434.x	44	9	9	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208855	10.1371/journal.pone.0208855	http://dx.doi.org/10.1371/journal.pone.0208855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532157	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700055
J	Peng, CA; Gaertner, AAE; Henriquez, SA; Fang, D; Colon-Reyes, RJ; Brumaghim, JL; Kozubowski, L				Peng, Congyue Annie; Gaertner, Andrea A. E.; Henriquez, Sarah Ana; Fang, Diana; Colon-Reyes, Rodney J.; Brumaghim, Julia L.; Kozubowski, Lukasz			Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; CHROMOSOMAL INSTABILITY; CANDIDA-ALBICANS; METALLOTHIONEIN; RESISTANCE; BINDING; ANTIOXIDANT; INDUCTION; VIRULENCE; GLABRATA	Pathogenic basidiomycetous yeast, Cryptococcus neoformans, causes fatal meningitis in immunocompromised individuals. Fluconazole (FLC) is a fungistatic drug commonly administered to treat cryptococcosis. Unfortunately, FLC-resistant strains characterized by various degree of chromosomal instability were isolated from clinical patients. Importantly, the underlying mechanisms that lead to chromosomal instability in FLC-treated C. neoformans remain elusive. Previous studies in fungal and mammalian cells link chromosomal instability to the reactive oxygen species (ROS). This study provides the evidence that exposure of C. neoformans to FLC induces accumulation of intracellular ROS, which correlates with plasma membrane damage. FLC caused transcription changes of oxidative stress related genes encoding superoxide dismutase (SOD1), catalase (CAT3), and thioredoxin reductase (TRR1). Strikingly, FLC contributed to an increase of the DNA damage in vitro, when complexed with iron or copper in the presence of hydrogen peroxide. Strains with isogenic deletion of copper response protein metallothionein were more susceptible to FLC. Addition of ascorbic acid (AA), an anti-oxidant at 10 mM, reduced the inhibitory effects of FLC. Consistent with potential effects of FLC on DNA integrity and chromosomal segregation, FLC treatment led to elevated transcription of RAD54 and repression of cohesin-encoding gene SCC1. We propose that FLC forms complexes with metals and contributes to elevated ROS, which may lead to chromosomal instability in C. neoformans.	[Peng, Congyue Annie; Henriquez, Sarah Ana; Fang, Diana; Colon-Reyes, Rodney J.; Kozubowski, Lukasz] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA; [Gaertner, Andrea A. E.; Brumaghim, Julia L.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA; [Henriquez, Sarah Ana] Univ Dallas, Irving, TX USA; [Fang, Diana] Med Univ South Carolina, Charleston, SC 29425 USA	Clemson University; Clemson University; Medical University of South Carolina	Kozubowski, L (corresponding author), Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA.	lkozubo@clemson.edu	Peng, Congyue/AAK-3850-2020	Brumaghim, Julia/0000-0002-9274-014X; Fang, Diana/0000-0001-7644-0377; Peng, Congyue/0000-0002-9992-5737; Gaertner, Andrea A. E./0000-0002-5910-2541; Henriquez, Sarah/0000-0001-8574-2748	NIH AREA [1R15 AI119801-01]; NIH [1P20GM109094-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109094] Funding Source: NIH RePORTER	NIH AREA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the NIH AREA grant #1R15 AI119801-01 to LK. LK and CAP are also supported by the NIH grant #1P20GM109094-01A1.; The authors would like to thank Dr. Dennis J. Thiele for kindly providing cmt1 Delta, cmt2 Delta, and cmt1/2 Delta deletion mutants; Dr. Andrew Alspaugh and Dr. Aaron Smith for helpful discussions, and technical supports from Dr. Stephen Nowak, Sophie Altamirano, Piotr Stempinski, Jessica Zielinski and Michelle Rock. The authors also thank Oly Ahmed and Rodrigo Catalan-Hurtado for statistic analysis, Dr. Mariusz Dylag, Dr. Steve Osmani, Dr. Ron Wek, and Jessica Zielinski for help with editing the text. This work was partially supported by the NIH AREA grant #1R15 AI119801-01. LK and CAP are also supported by the NIH grant #1P20GM109094-01A1.	Altamirano S, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00203; Altamirano S, 2017, MSPHERE, V2, DOI [10.1128/msphere.00205-17, 10.1128/mSphere.00205-17]; Angele-Martinez C, 2014, METALLOMICS, V6, P1358, DOI 10.1039/c4mt00057a; Arana DM, 2010, J ANTIMICROB CHEMOTH, V65, P54, DOI 10.1093/jac/dkp407; Assing K, 2003, CLIN MICROBIOL INFEC, V9, P441, DOI 10.1046/j.1469-0691.2003.00571.x; Bard A. J., 2004, ELECTROCHEMICAL METH, P286; Bard AJ, 2004, ELECTROCHEMICAL METH, P804; Betanzos-Lara S, 2015, DALTON T, V44, P3673, DOI 10.1039/c4dt02883j; Blazquez J, 2012, CURR OPIN MICROBIOL, V15, P561, DOI 10.1016/j.mib.2012.07.007; Bristow RG, 2007, RADIOTHER ONCOL, V83, P220, DOI 10.1016/j.radonc.2007.04.016; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Castro-Ramirez R, 2018, DALTON T, V47, P7551, DOI 10.1039/c8dt00716k; Chaturvedi S, 2001, GENE, V268, P41, DOI 10.1016/S0378-1119(01)00408-5; Chen Y, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0243-0; Cowen LE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019752; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; da Silva CR, 2013, ANTIMICROB AGENTS CH, V57, P1691, DOI 10.1128/AAC.00966-12; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Degtyareva NP, 2008, MOL CELL BIOL, V28, P5432, DOI 10.1128/MCB.00307-08; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Ding C, 2011, MOL MICROBIOL, V81, P1560, DOI 10.1111/j.1365-2958.2011.07794.x; Dzoyem JP, 2012, AFR HEALTH SCI, V12, P129, DOI 10.4314/ahs.v12i2.8; Espart A, 2015, MOL MICROBIOL, V98, P977, DOI 10.1111/mmi.13171; FOULDS G, 1988, J CLIN PHARMACOL, V28, P363, DOI 10.1002/j.1552-4604.1988.tb03159.x; Gast CE, 2013, ANTIMICROB AGENTS CH, V57, P5478, DOI 10.1128/AAC.02287-12; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; GOA KL, 1995, DRUGS, V50, P658, DOI 10.2165/00003495-199550040-00007; Harrison BD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001815; HERTZBERG RP, 1982, J AM CHEM SOC, V104, P313, DOI 10.1021/ja00365a069; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Jessberger R, 2012, EMBO REP, V13, P539, DOI 10.1038/embor.2012.54; Jung KW, 2016, MBIO, V7, DOI [10.1128/mBio.01483-16, 10.1128/mbio.01483-16]; Lee KT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12766; Limoli CL, 2003, NEOPLASIA, V5, P339, DOI 10.1016/S1476-5586(03)80027-1; Mahl CD, 2015, DIAGN MICR INFEC DIS, V82, P203, DOI 10.1016/j.diagmicrobio.2015.03.019; May RC, 2016, NAT REV MICROBIOL, V14, P106, DOI 10.1038/nrmicro.2015.6; McAleenan A, 2013, NATURE, V493, P250, DOI 10.1038/nature11630; Missall TA, 2005, EUKARYOT CELL, V4, P487, DOI 10.1128/EC.4.2.487-489.2005; Nagaj J, 2012, J INORG BIOCHEM, V106, P23, DOI 10.1016/j.jinorgbio.2011.09.014; Ngamskulrungroj P, 2012, PLOS ONE, V7, P1; Ngamskulrungroj P, 2012, FEMS YEAST RES, V12, P748, DOI 10.1111/j.1567-1364.2012.00824.x; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PASKO MT, 1990, DICP ANN PHARMAC, V24, P860, DOI 10.1177/106002809002400914; Perron NR, 2008, INORG CHEM, V47, P6153, DOI 10.1021/ic7022727; Perron NR, 2011, J INORG BIOCHEM, V105, P745, DOI 10.1016/j.jinorgbio.2011.02.009; Pierre JL, 1999, BIOMETALS, V12, P195, DOI 10.1023/A:1009252919854; Posteraro B, 2003, MOL MICROBIOL, V47, P357, DOI 10.1046/j.1365-2958.2003.03281.x; Revankar SG, 2004, BIOCHEM BIOPH RES CO, V324, P719, DOI 10.1016/j.bbrc.2004.09.112; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Samaranayake YH, 2013, J MED MICROBIOL, V62, P303, DOI 10.1099/jmm.0.044123-0; Shapiro RS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004678; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sionov E, 2009, ANTIMICROB AGENTS CH, V53, P2804, DOI 10.1128/AAC.00295-09; Smith KD, 2015, ANTIMICROB AGENTS CH, V59, P7197, DOI 10.1128/AAC.01299-15; Takahashi Y, 2004, J HEALTH SCI, V50, P154; Tosato V, 2015, MICROB CELL, V2, P363, DOI 10.15698/mic2015.10.230; Tosato V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060926; Upadhya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055110; Uthman A, 2002, BIOCHEM BIOPH RES CO, V299, P688, DOI 10.1016/S0006-291X(02)02724-9; Van Hauwenhuyse F, 2014, EUKARYOT CELL, V13, P1278, DOI 10.1128/EC.00096-14; Vanden B. H., 1985, CURR TOP MED MYCOL, V1, P313, DOI DOI 10.1007/978-1-4613-9547-8_; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Wang Y, 2009, CLIN EXP PHARMACOL P, V36, pe40, DOI 10.1111/j.1440-1681.2009.05187.x; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wu MJ, 2011, FEMS YEAST RES, V11, P379, DOI 10.1111/j.1567-1364.2011.00726.x; Yang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7129; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zyracka E, 2005, J BIOTECHNOL, V115, P271, DOI 10.1016/j.jbiotec.2004.09.003	70	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208471	10.1371/journal.pone.0208471	http://dx.doi.org/10.1371/journal.pone.0208471			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532246	Green Submitted, Green Published, gold			2022-12-26	WOS:000452640900018
J	Danilo, B; Perrot, L; Botton, E; Nogue, F; Mazier, M				Danilo, Benoit; Perrot, Laura; Botton, Emmanuel; Nogue, Fabien; Mazier, Marianne			The DFR locus: A smart landing pad for targeted transgene insertion in tomato	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; GENOME; ARABIDOPSIS; ANTHOCYANIN; MUTAGENESIS; RNA; TRANSFORMATION; GENERATION; SEQUENCES; NICKASES	Targeted insertion of transgenes in plants is still challenging and requires further technical innovation. In the present study, we chose the tomato DFR gene involved in anthocyanin biosynthesis as a landing pad for targeted transgene insertion using CRISPR-Cas9 in a two-step strategy. First, a 1013 bp was deleted in the endogenous DFR gene. Hypocotyls and callus of in vitro regenerated plantlets homozygous for the deletion were green instead of the usual anthocyanin produced purple colour. Next, standard Agrobacterium-mediated transformation was used to target transgene insertion at the DFR landing pad in the dfr deletion line. The single binary vector carried two sgRNAs, a donor template containing two homology arms of 400 bp, the previously deleted DFR sequence, and a Nptll expression cassette. Regenerating plantlets were screened for a purple-colour phenotype indicating that DFR function had been restored. Targeted insertions were identified in 1.29% of the transformed explants. Thus, we established an efficient method for selecting HDR-mediated transgene insertion using the CRISPR-Cas9 system in tomato. The visual screen used here facilitates selection of these rare gene targeting events, does not necessitate the systematic PCR screening of all the regenerating material and can be potentially applied to other crops.	[Danilo, Benoit; Perrot, Laura; Botton, Emmanuel; Mazier, Marianne] INRA PACA, GAFL Unit Genet & Ameliorat Fruits & Legumes, UR 1052, Avignon, France; [Nogue, Fabien] Univ Paris Saclay, CNRS, AgroParisTech, Inst Jean Pierre Bourgin,INRA, Versailles, France	INRAE; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Mazier, M (corresponding author), INRA PACA, GAFL Unit Genet & Ameliorat Fruits & Legumes, UR 1052, Avignon, France.	marianne.mazier@inra.fr		Danilo, Benoit/0000-0002-0360-282X; PERROT, Laura/0000-0003-1149-4504	Investissement d'Avenir program of the French National Agency of Research [ANR-11-BTBR-0001_GENIUS]; LabEx Saclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]	Investissement d'Avenir program of the French National Agency of Research(French National Research Agency (ANR)); LabEx Saclay Plant Sciences-SPS	This work was funded by the Investissement d'Avenir program of the French National Agency of Research for the project GENIUS (ANR-11-BTBR-0001_GENIUS). The IJPB benefits from the support of the LabEx Saclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Investissement d'Avenir program of the French National Agency of Research for the project GENIUS (ANR-11-BTBR-0001_GENIUS). The IJPB benefits from the support of the LabEx Saclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS). The authors thank Peter Rogowsky and Wyatt Paul for their efficient management of the GENIUS project and Holger Puchta and the Botanish Institute for the pDe-Cas9 BASTA resistance plasmid. The authors thank Marie-Noelle Core for her help measuring anthocyanins by chromatography liquid.	Begemann MB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11760-6; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Dahan-Meir T, 2018, PLANT J, V95, P5, DOI 10.1111/tpj.13932; Deng L, 2018, J GENET GENOMICS, V45, P51, DOI 10.1016/j.jgg.2017.10.002; Endo M, 2016, PLANT PHYSIOL, V170, P667, DOI 10.1104/pp.15.01663; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GOLDSBROUGH A, 1994, PLANT PHYSIOL, V105, P491, DOI 10.1104/pp.105.2.491; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hahn F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00424; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hummel AW, 2018, PLANT BIOTECHNOL J, V16, P1275, DOI 10.1111/pbi.12868; Ito Y, 2017, NAT PLANTS, V3, P866, DOI 10.1038/s41477-017-0041-5; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Klap C, 2017, PLANT BIOTECHNOL J, V15, P634, DOI 10.1111/pbi.12662; Klimek-Chodacka M, 2018, PLANT CELL REP, V37, P575, DOI 10.1007/s00299-018-2252-2; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li R, 2018, PLANT J, V94, P513, DOI 10.1111/tpj.13872; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; MARSHALLSAY C, 1990, NUCLEIC ACIDS RES, V18, P3459, DOI 10.1093/nar/18.12.3459; Mazier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029595; MCCORMICK S, 1986, PLANT CELL REP, V5, P81, DOI 10.1007/BF00269239; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; Nonaka S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06400-y; Qin XQ, 2018, PLANT J, V93, P417, DOI 10.1111/tpj.13796; Ran YD, 2017, SCI CHINA LIFE SCI, V60, P490, DOI 10.1007/s11427-017-9022-1; Rodriguez-Leal D, 2017, CELL, V171, P470, DOI 10.1016/j.cell.2017.08.030; Roldan MVG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04556-1; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Rui Li, 2018, Plant Biotechnology Journal, V16, P415, DOI 10.1111/pbi.12781; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Siebert R, 2002, PLANT CELL, V14, P1121, DOI 10.1105/tpc.001727; Soyk S, 2017, CELL, V169, P1142, DOI 10.1016/j.cell.2017.04.032; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Steinert J, 2016, PLANT CELL REP, V35, P1429, DOI 10.1007/s00299-016-1981-3; Ueta R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00501-4; WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451; Wang L, 2017, J AGR FOOD CHEM, V65, P8674, DOI 10.1021/acs.jafc.7b02745; WATANABE K, 2017, SCI REP UK, V7; Xu C, 2015, NAT GENET, V47, P784, DOI 10.1038/ng.3309; Yang YF, 2017, PLANT PHYSIOL, V175, P1690, DOI 10.1104/pp.17.01265; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107; YODER JI, 1994, EUPHYTICA, V79, P163, DOI 10.1007/BF00022514; Yu QY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10960-4; Zaidi S. S.-e-A., 2017, FRONT PLANT SCI, V8, P2012; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890	53	9	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208395	10.1371/journal.pone.0208395	http://dx.doi.org/10.1371/journal.pone.0208395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521567	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600054
J	Ho, KH; Chang, CJ; Huang, TW; Shih, CM; Liu, AJ; Chen, PH; Chen, KT; Chen, KC				Ho, Kuo-Hao; Chang, Chih-Ju; Huang, Tzu-Wen; Shih, Chwen-Ming; Liu, Ann-Jeng; Chen, Peng-Hsu; Chen, Kur-Ta; Chen, Ku-Chung			Gene landscape and correlation between B- cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set	PLOS ONE			English	Article							ANTI-PD-L1 ANTIBODY; PD-L1; IMMUNOSURVEILLANCE; LYMPHOCYTES; APOPTOSIS; PROSTATE; RECEPTOR; ALPHA	Tumor-infiltrating lymphocytes are related to positive clinical prognoses in numerous cancer types. Programmed death ligand 1 (PD-L1), a mediator of the PD-1 receptor, plays an inhibitory role in cancer immune responses. PD-L1 upregulation can impede infiltrating T-cell functions in lung adenocarcinoma (LUAD), a lung cancer subtype. However, associations between the expression of PD-L1 and infiltration of B cells (a major immunoregulatory cell) remain unknown. Therefore, we investigated the role of infiltrating B cells in LUAD progression and its correlation with PD-L1 expression. The Cancer Genome Atlas (TCGA) LUAD data set was used to explore associations among B-cell infiltration, PD-L1 expression, clinical outcome, and gene landscape. Gene set enrichment analysis was used to explore putative signaling pathways and candidate genes. The drug enrichment analysis was used to identify candidate genes and the related drugs. We found that high B-cell infiltration was correlated with better prognoses; however, PD-L1 may interfere with the survival advantage in patients with high B-cell infiltration. The gene landscape was characterized comprehensively, with distinct PD-L1 levels in cell populations with high B-cell infiltration. We obtained five upregulated signaling pathways from the gene landscape: apoptosis, tumor necrosis factor (TNF)-alpha signaling via nuclear factor (NF)-kappa B, apical surface, interferon-alpha response, and KRAS signaling. Moreover, four candidate genes and their related target drugs were also identified, namely interleukin-2 beta receptor (IL2RB), IL-2 gamma receptor (IL2RG), Toll-like receptor 8 (TLR8), and TNF. These findings suggest that tumor-infiltrating B cells could act as a clinical factor in anti-PD-L1 immunotherapy for LUAD.	[Ho, Kuo-Hao; Huang, Tzu-Wen; Shih, Chwen-Ming; Chen, Peng-Hsu; Chen, Kur-Ta; Chen, Ku-Chung] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Ho, Kuo-Hao; Shih, Chwen-Ming; Chen, Peng-Hsu; Chen, Kur-Ta; Chen, Ku-Chung] Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol, Taipei, Taiwan; [Chang, Chih-Ju] Cathay Gen Hosp, Dept Neurosurg, Taipei, Taiwan; [Chang, Chih-Ju] Fu Jen Catholic Univ, Sch Med, Dept Med, New Taipei, Taiwan; [Chang, Chih-Ju] Natl Cent Univ, Dept Mech Engn, Taoyuan, Taoyuan County, Taiwan; [Huang, Tzu-Wen] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan; [Liu, Ann-Jeng] Taipei City Hosp, Dept Neurosurg, Ren Ai Branch, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Cathay General Hospital; Fu Jen Catholic University; National Central University; Taipei Medical University; Taipei City Hospital	Chen, KT; Chen, KC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Chen, KT; Chen, KC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol, Taipei, Taiwan.	ktbot@tmu.edu.tw; kuchung@tmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 106-2320-B-038-051-MY3]; Taipei City Government Contract, Taiwan [105XDAA00013, 106XDAA00014]; Taipei City Hospital Ren-Ai Branch, Taiwan [TPCH-106-020, TPCH-107-020]; Cathay General Hospital, Taiwan [106CGH-TMU-06]; Taipei Medical University [106-1200-008-110]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Government Contract, Taiwan; Taipei City Hospital Ren-Ai Branch, Taiwan; Cathay General Hospital, Taiwan; Taipei Medical University	This work was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 106-2320-B-038-051-MY3), Taipei City Government Contract, Taiwan (105XDAA00013 and 106XDAA00014), Taipei City Hospital Ren-Ai Branch, Taiwan (intramural grant no. TPCH-106-020 and TPCH-107-020), Cathay General Hospital, Taiwan (intramural grant no. 106CGH-TMU-06), and Taipei Medical University contract grant no.: 106-1200-008-110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Balar AV, 2017, CANCER IMMUNOL IMMUN, V66, P551, DOI 10.1007/s00262-017-1954-6; Brahmer JR, 2013, CANCER IMMUNOL RES, V1, P85, DOI 10.1158/2326-6066.CIR-13-0078; Bruno TC, 2017, CANCER IMMUNOL RES, V5, P898, DOI 10.1158/2326-6066.CIR-17-0075; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Jia MH, 2015, J THORAC DIS, V7, P455, DOI 10.3978/j.issn.2072-1439.2015.02.06; Jing W, 2016, ONCOTARGETS THER, V9, P489, DOI 10.2147/OTT.S94993; Kamata T, 2016, CANCER IMMUNOL IMMUN, V65, P1477, DOI 10.1007/s00262-016-1901-y; Kerr KM, 2016, ARCH PATHOL LAB MED, V140, P249, DOI 10.5858/arpa.2015-0303-SA; Linnebacher M, 2012, ONCOIMMUNOLOGY, V1, P1186, DOI 10.4161/onci.20641; Linnebacher M, 2013, WORLD J GASTROENTERO, V19, P8, DOI 10.3748/wjg.v19.i1.8; Mackus WJM, 2002, INT IMMUNOL, V14, P973, DOI 10.1093/intimm/dxf065; Mizukami M, 2006, ANTICANCER RES, V26, P1827; Mori M, 2000, TOHOKU J EXP MED, V191, P113, DOI 10.1620/tjem.191.113; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; O'Callaghan DS, 2015, EUR RESPIR J, V46, P1762, DOI 10.1183/13993003.00176-2014; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Ritchie DS, 2004, SCAND J IMMUNOL, V60, P543, DOI 10.1111/j.0300-9475.2004.01517.x; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Shao YK, 2015, INT J CLIN EXP MED, V8, P20742; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sumimoto H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166626; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Tsou PL, 2016, CANCER RES, V76, P5597, DOI 10.1158/0008-5472.CAN-16-0431; Wang X, 2017, IMMUNOL LETT, V184, P7, DOI 10.1016/j.imlet.2017.02.006; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958	39	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208459	10.1371/journal.pone.0208459	http://dx.doi.org/10.1371/journal.pone.0208459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521597	gold, Green Submitted, Green Published			2022-12-26	WOS:000452307600072
J	Pretorius, TR; Charest, C; Kimpe, LE; Blais, JM				Pretorius, Travers R.; Charest, Christiane; Kimpe, Linda E.; Blais, Jules M.			The accumulation of metals, PAHs and alkyl PAHs in the roots of Echinacea purpurea	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; ARBUSCULAR MYCORRHIZAL FUNGUS; PHYTOREMEDIATION; RHIZOSPHERE; SOILS; PHENANTHRENE; DISSIPATION; BIOREMEDIATION; INOCULATION; DEGRADATION	We examined the accumulation of polycyclic aromatic hydrocarbons (PAHs), alkyl PAHs, and toxic metals in soils by the roots of Echinacea purpurea (L.) Moench, in a 20-week greenhouse study and a 2-year field study. In the greenhouse study, inoculation by arbuscular mycorrhizal fungus (AMF), Rhizoglomus intraradices (N.C. Schenck & G.S. Sm.). increased the first order accumulation rates (k(1)) for PAHs by 10-fold, though had no effect on the bioaccumulation rates of toxic metals. In the greenhouse study, PAHs concentrations in soil increased over time with AMF inoculation, suggesting AMF promote 'solvent depletion' in soils by enhancing absorption of minerals and carbon by roots, concentrating the more hydrophobic PAHs in the residual soil. Under field conditions, contaminant concentrations in soils remained unchanged over the 2-year duration of the study. Despite this, all contaminants in E. purpurea roots increased significantly, as a result of a long term extraction of contaminants by plants from soil and a reduction in soil volume as a result of plant growth. First order accumulation rates by roots were inversely correlated to log K-ow for the PAHs and alkyl PAHs, indicating that accumulation is inversely related to the compound's hydrophobicity. This study is the first to our knowledge to assess the accumulation of alkyl PAHs by roots, with implications for soil bioremediation by plants because alkyl PAHs are a major source of petrogenic contamination in soils.	[Pretorius, Travers R.; Charest, Christiane; Kimpe, Linda E.; Blais, Jules M.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	University of Ottawa	Blais, JM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	Jules.Blais@uottawa.ca	Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598	National Capital commission	National Capital commission	Funding was provided by the National Capital commission: http://ncc-ccn.gc.ca/.	Alford ER, 2010, PLANT SOIL, V337, P33, DOI 10.1007/s11104-010-0482-3; Allen MF, 2001, MYCORRHIZA, V10, P255, DOI 10.1007/s005720000081; Araim G, 2009, J AGR FOOD CHEM, V57, P2255, DOI 10.1021/jf803173x; Audet P, 2010, J BOT, V2010, P1, DOI [10.1155/2010/718013, DOI 10.1155/2010/718013]; Audet P, 2013, ARCH AGRON SOIL SCI, V59, P533, DOI 10.1080/03650340.2011.653683; Banks MK, 1999, J ENVIRON QUAL, V28, P294, DOI 10.2134/jeq1999.00472425002800010036x; Barrett B, 2003, PHYTOMEDICINE, V10, P66, DOI 10.1078/094471103321648692; Bell TH, 2014, TRENDS BIOTECHNOL, V32, P271, DOI 10.1016/j.tibtech.2014.02.008; Binet P, 2000, SOIL BIOL BIOCHEM, V32, P2011, DOI 10.1016/S0038-0717(00)00100-0; Cerniglia Carl E., 1993, Current Opinion in Biotechnology, V4, P331, DOI [10.1016/0958-1669(93)90104-5, 10.1007/BF00129093]; Chen M, 2015, BIOTECHNOL ADV, V33, P745, DOI 10.1016/j.biotechadv.2015.05.003; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Dalpe Y, 1993, SOIL SAMPLING METHOD, P287; Davies FT, 2001, J PLANT PHYSIOL, V158, P777, DOI 10.1078/0176-1617-00311; Debiane D, 2009, PHYTOCHEMISTRY, V70, P1421, DOI 10.1016/j.phytochem.2009.07.002; Fester T, 1999, MYCORRHIZA, V8, P241, DOI 10.1007/s005720050240; FREEMAN DJ, 1990, ENVIRON SCI TECHNOL, V24, P1581, DOI 10.1021/es00080a019; Gao YZ, 2006, BIOL FERT SOILS, V42, P387, DOI 10.1007/s00374-006-0081-x; Gao YZ, 2011, J HAZARD MATER, V185, P703, DOI 10.1016/j.jhazmat.2010.09.076; Gao YZ, 2005, J ENVIRON SCI-CHINA, V17, P14; Gobas FAPC, 2000, HANDBOOK OF PROPERTY ESTIMATION METHODS FOR CHEMICALS, P189; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; HEITKAMP MA, 1987, ENVIRON TOXICOL CHEM, V6, P535, DOI 10.1002/etc.5620060706; Hewitt E.J., 1975, PLANT MINERAL NUTR; Huang HL, 2006, J AGR FOOD CHEM, V54, P9377, DOI 10.1021/jf061699g; Jeffries, 2003, CONTR ARB MYC FUNG S; Johnsen AR, 2005, ENVIRON POLLUT, V133, P71, DOI 10.1016/j.envpol.2004.04.015; Joner EJ, 2001, BIOL FERT SOILS, V33, P351, DOI 10.1007/s003740000331; Joner EJ, 2001, ENVIRON SCI TECHNOL, V35, P2773, DOI 10.1021/es000288s; Juwarkar AA, 2008, BIORESOURCE TECHNOL, V99, P4732, DOI 10.1016/j.biortech.2007.09.060; Kuppusamy S, 2017, CHEMOSPHERE, V168, P944, DOI 10.1016/j.chemosphere.2016.10.115; Leung HM, 2006, ENVIRON POLLUT, V139, P1, DOI 10.1016/j.envpol.2005.05.009; Ling WT, 2010, J SOIL SEDIMENT, V10, P799, DOI 10.1007/s11368-010-0187-5; Liu R, 2012, ENVIRON ENG SCI, V29, P494, DOI 10.1089/ees.2010.0490; MacDonald R, 2002, ENVIRON SCI TECHNOL, V36, p456A, DOI 10.1021/es022470u; Maier W, 1999, PLANTA, V207, P620, DOI 10.1007/s004250050526; Matthias A, 2008, FITOTERAPIA, V79, P53, DOI 10.1016/j.fitote.2007.07.012; Meier S, 2012, CRIT REV ENV SCI TEC, V42, P741, DOI 10.1080/10643389.2010.528518; Mistrikova I, 2007, BIOLOGIA, V62, P2, DOI 10.2478/s11756-007-0006-7; Muntean L., 1991, Buletinul Institutului Agronomic Cluj-Napoca. Seria Agricultura si Horticultura, V45, P41; Muntean L, 1990, B I AGR CLUJ NAPOCA, V44, P23; Pilon-Smits E, 2002, CRIT REV PLANT SCI, V21, P439, DOI 10.1080/0735-260291044313; Pinedo-Rivilla C, 2009, CURR ORG CHEM, V13, P1194, DOI 10.2174/138527209788921774; Rayu S, 2012, BIODEGRADATION, V23, P917, DOI 10.1007/s10532-012-9576-3; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Sarwar N, 2017, CHEMOSPHERE, V171, P710, DOI 10.1016/j.chemosphere.2016.12.116; Singh A, 2009, SOIL BIOL, V17, P1, DOI 10.1007/978-3-540-89621-0_1; Sung KJ, 2001, J ENVIRON QUAL, V30, P2081, DOI 10.2134/jeq2001.2081; Suresh B, 2004, CRIT REV BIOTECHNOL, V24, P97, DOI 10.1080/07388550490493627; Thomas JC, 2013, INT J PHYTOREMEDIAT, V15, P5, DOI 10.1080/15226514.2012.669800; Toussaint JP, 2007, MYCORRHIZA, V17, P291, DOI 10.1007/s00572-006-0104-3; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Willis A, 2013, CRIT REV PLANT SCI, V32, P1, DOI 10.1080/07352689.2012.683375	56	10	10	10	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208325	10.1371/journal.pone.0208325	http://dx.doi.org/10.1371/journal.pone.0208325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521573	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600048
J	Wu, K; Shirk, PD; Taylor, CE; Furlong, RB; Shirk, BD; Pinheiro, DH; Siegfried, BD				Wu, Ke; Shirk, Paul D.; Taylor, Caitlin E.; Furlong, Richard B.; Shirk, Bryce D.; Pinheiro, Daniele H.; Siegfried, Blair D.			CRISPR/Cas9 mediated knockout of the abdominal-A homeotic gene in fall armyworm moth (Spodoptera frugiperda)	PLOS ONE			English	Article							FIELD-EVOLVED RESISTANCE; ABD-A; INSECTICIDE RESISTANCE; LEPIDOPTERA-NOCTUIDAE; BITHORAX-COMPLEX; RNA INTERFERENCE; DROSOPHILA; REQUIRES; MUTAGENESIS; SILKWORM	The fall armyworm (FAW), Spodoptera frugiperda (J.E. Smith), is an important pest of maize in the Americas and has recently been introduced into Africa. Fall armyworm populations have developed resistance to control strategies that depend on insecticides and transgenic plants expressing Bacillus thuringiensis toxins. The study of various resistance mechanisms at the molecular level and the development novel control strategies have been hampered by a lack of functional genomic tools such as gene editing in this pest. In the current study, we explored the possibility of using the CRISPR/Cas9 system to modify the genome of FAW. We first identified and characterized the abdominal-A (Sfabd-A) gene of FAW. Sfabd-A single guide RNA (sgRNA) and Cas9 protein were then injected into 244 embryos of FAW. Sixty-two embryos injected with Sfabd-A sgRNA hatched. Of these hatched embryos, twelve developed into larvae that displayed typical aba-A mutant phenotypes such as fused segments. Of the twelve mutant larvae, three and five eventually developed into female and male moths, respectively. Most mutant moths were sterile, and one female produced a few unviable eggs when it was outcrossed to a wild-type male. Genotyping of 20 unhatched Sfabd-A sgRNA-injected embryos and 42 moths that developed from Sfabd-A sgRNA-injected embryos showed that 100% of the unhatched embryos and 50% of the moths contained indel mutations at the Sfabd-A genomic locus near the guide RNA target site. These results suggest that the CRISPR/Cas9 system is highly efficient in editing FAW genome. Importantly, this gene editing technology can be used to validate gene function to facilitate an understanding of the resistance mechanism and lead to the development of novel pest management approaches.	[Wu, Ke; Taylor, Caitlin E.; Pinheiro, Daniele H.; Siegfried, Blair D.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Shirk, Paul D.; Furlong, Richard B.; Shirk, Bryce D.] USDA ARS, CMAVE IBBRU, Gainesville, FL USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Wu, K (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	kewu@ufl.edu		Wu, Ke/0000-0002-4438-1517				Banerjee R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09866-y; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bi HL, 2016, INSECT SCI, V23, P469, DOI 10.1111/1744-7917.12341; BUSTURIA A, 1989, DEVELOPMENT, V107, P575; Chandrasena DI, 2018, PEST MANAG SCI, V74, P746, DOI 10.1002/ps.4776; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CUMBERLEDGE S, 1992, DEVELOPMENT, V115, P395; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Flagel L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25491-9; Foronda D, 2006, DEVELOPMENT, V133, P117, DOI 10.1242/dev.02173; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Huang YP, 2016, INSECT BIOCHEM MOLEC, V75, P98, DOI 10.1016/j.ibmb.2016.06.004; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Khan SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40025; Li GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154492; Li XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9212; Lovato TL, 2002, DEVELOPMENT, V129, P5019; Marchetti M, 2003, DEVELOPMENT, V130, P3683, DOI 10.1242/dev.00587; MATHIES LD, 1994, DEVELOPMENT, V120, P2799; MICHELSON AM, 1994, DEVELOPMENT, V120, P755; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Pan MH, 2009, INSECT MOL BIOL, V18, P155, DOI 10.1111/j.1365-2583.2009.00862.x; Perera OP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197567; Perrin L, 2004, DEV BIOL, V272, P419, DOI 10.1016/j.ydbio.2004.04.036; Ponzielli R, 2002, DEVELOPMENT, V129, P4509; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Prasanna BM., 2018, FALL ARMYWORM AFRICA, P120; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rezsohazy R, 2015, DEVELOPMENT, V142, P1212, DOI 10.1242/dev.109785; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Suzuki T, 2010, PESTIC BIOCHEM PHYS, V97, P199, DOI 10.1016/j.pestbp.2010.01.005; Suzuki T, 2009, J INSECT PHYSIOL, V55, P250, DOI 10.1016/j.jinsphys.2008.11.014; Taning CNT, 2017, J INSECT PHYSIOL, V98, P245, DOI 10.1016/j.jinsphys.2017.01.007; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu K, 2012, J INVERTEBR PATHOL, V109, P20, DOI 10.1016/j.jip.2011.09.005; Xue WH, 2018, INSECT BIOCHEM MOLEC, V93, P19, DOI 10.1016/j.ibmb.2017.12.003; Yoon JS, 2017, INSECT BIOCHEM MOLEC, V90, P53, DOI 10.1016/j.ibmb.2017.09.011; Yu SJ, 2003, PESTIC BIOCHEM PHYS, V77, P1, DOI 10.1016/S0048-3575(03)00079-8; YU SJ, 1991, PESTIC BIOCHEM PHYS, V39, P84, DOI 10.1016/0048-3575(91)90216-9	54	17	19	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208647	10.1371/journal.pone.0208647	http://dx.doi.org/10.1371/journal.pone.0208647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521608	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600101
J	Yanagisawa, D; Hamezah, HS; Durani, LW; Taguchi, H; Tooyama, I				Yanagisawa, Daijiro; Hamezah, Hamizah Shahirah; Durani, Lina Wati; Taguchi, Hiroyasu; Tooyama, Ikuo			Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5	PLOS ONE			English	Article							MOUSE MODEL; AMYLOID-BETA; IN-VIVO; DYSFUNCTION; MEDICINE; FIBRILS; DISEASE; PLAQUES	Intracellular inclusions of aggregated tau appear in neurons and glial cells in a range of neurodegenerative diseases known as tauopathies. Inhibition of pathological changes in tau is a therapeutic target for tauopathy. We recently synthesized a novel curcumin derivative, named Shiga-Y5, and showed that Shiga-Y5 inhibited cognitive impairment and amyloid deposition in a mouse model of Alzheimer's disease. Here we investigated whether Shiga-Y5 inhibited cognitive impairment and tau accumulation in a mouse model of tauopathy, rTg4510. The rTg4510 mouse is a bitransgenic mouse model that uses a system of responder and activator transgenes to express human four-repeat tau with the P301 L mutation. This strain is obtained by crossing tetO-MAPT*P301L mouse line (on a FVB/NJ background) with CaMKII-tTA mouse line (on a C57BL/6J background). Male rTg4510 mice and wild-type mice were fed with a standard chow diet with or without Shiga-Y5 (500 ppm) for 4 months. Behavioral tests were conducted from 5.5 months of age, and the mice were sacrificed at 6 months of age. There were no significant changes in behavioral performance in rTg4510 mice fed with SY5-containing chow diet compared with rTg4510 mice fed with control chow diet. Histological and biochemical analyses also showed no significant alterations in tau accumulation by the treatment with SY5. One of noticeable finding in this study was that rTg4510 mice on a F1 female FVB/NJ x male C57BL/6J background showed more severe tau accumulation than rTg4510 mice on a F1 female C57BL/6J x male FVB/NJ background. Further studies to clarify the mechanisms underlying tau aggregation may help to develop therapeutic approaches aimed at preventing this pathological feature.	[Yanagisawa, Daijiro; Hamezah, Hamizah Shahirah; Durani, Lina Wati; Taguchi, Hiroyasu; Tooyama, Ikuo] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga, Japan	Shiga University of Medical Science	Tooyama, I (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga, Japan.	kinchan@belle.shiga-med.ac.jp	Hamezah, Hamizah Shahirah/AAG-3286-2021; Hamezah, Hamizah Shahirah/AAL-2092-2020	Hamezah, Hamizah Shahirah/0000-0003-2169-5000; Durani, Lina Wati/0000-0002-7677-4382; Tooyama, Ikuo/0000-0001-8054-9666	JSPS KAKENHI from Japan Society for the Promotion of Science [JP17H03560, JP17K01355]; Translational Research program; Strategic PRomotion for practical application of INnovative medical Technology (TR-SPRINT) from Japan Agency for Medical Research and Development [A85]	JSPS KAKENHI from Japan Society for the Promotion of Science; Translational Research program; Strategic PRomotion for practical application of INnovative medical Technology (TR-SPRINT) from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by JSPS KAKENHI Grant Number JP17H03560 (I.T.) and JP17K01355 (D.Y.) from Japan Society for the Promotion of Science and The Translational Research program; Strategic PRomotion for practical application of INnovative medical Technology (TR-SPRINT) from Japan Agency for Medical Research and Development Grant Number A85 (D.Y.).	Bailey RM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-8; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Blackmore T, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0306-2; Cook C, 2014, NEUROBIOL AGING, V35, P1769, DOI 10.1016/j.neurobiolaging.2013.12.023; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Han HJ, 2012, J NEUROSCI, V32, P10574, DOI 10.1523/JNEUROSCI.0893-12.2012; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Ma QL, 2013, J BIOL CHEM, V288, P4056, DOI 10.1074/jbc.M112.393751; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Miyasaka T, 2016, NEUROBIOL AGING, V39, P69, DOI 10.1016/j.neurobiolaging.2015.11.004; Mohorko N, 2010, J NEUROPATH EXP NEUR, V69, P405, DOI 10.1097/NEN.0b013e3181d709eb; Okuda M, 2017, J ALZHEIMERS DIS, V59, P313, DOI 10.3233/JAD-161017; Okuda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117511; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Sankaranarayanan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125614; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Soeda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10216; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Spires-Jones TL, 2014, NEUROSCI LETT, V562, P63, DOI 10.1016/j.neulet.2014.01.013; Umeda T, 2016, BRAIN, V139, P1568, DOI 10.1093/brain/aww042; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wes PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106050; Yanagisawa D, 2011, NEUROSCIENCE, V184, P120, DOI 10.1016/j.neuroscience.2011.03.071; Yanagisawa D, 2018, J NEUROSCI RES, V96, P841, DOI 10.1002/jnr.24188; Yanagisawa D, 2015, NEUROBIOL AGING, V36, P201, DOI 10.1016/j.neurobiolaging.2014.07.041; Yanagisawa D, 2010, BIOMATERIALS, V31, P4179, DOI 10.1016/j.biomaterials.2010.01.142; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yue M, 2011, NEUROBIOL AGING, V32, P590, DOI 10.1016/j.neurobiolaging.2009.04.006	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208440	10.1371/journal.pone.0208440	http://dx.doi.org/10.1371/journal.pone.0208440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521594	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600070
J	Zhou, P; Ye, F; Du, L				Zhou, Peng; Ye, Fan; Du, Liang			Spectral clustering with distinction and consensus learning on multiple views data	PLOS ONE			English	Article								Since multi-view data are available in many real-world clustering problems, multi-view clustering has received considerable attention in recent years. Most existing multi-view clustering methods learn consensus clustering results but do not make full use of the distinct knowledge in each view so that they cannot well guarantee the complementarity across different views. In this paper, we propose a Distinction based Consensus Spectral Clustering (DCSC), which not only learns a consensus result of clustering, but also explicitly captures the distinct variance of each view. It is by using the distinct variance of each view that DCSC can learn a clearer consensus clustering result. In order to optimize the introduced optimization problem effectively, we develop a block coordinate descent algorithm which is theoretically guaranteed to converge. Experimental results on real-world data sets demonstrate the effectiveness of our method.	[Zhou, Peng; Ye, Fan] Anhui Univ, Sch Comp Sci Technol, Hefei, Anhui, Peoples R China; [Du, Liang] Shanxi Univ, Sch Comp & Informat Technol, Taiyuan, Shanxi, Peoples R China	Anhui University; Shanxi University	Ye, F (corresponding author), Anhui Univ, Sch Comp Sci Technol, Hefei, Anhui, Peoples R China.	yfan@ahu.edu.cn	Zhou, Peng/AAX-5482-2020	Zhou, Peng/0000-0002-3675-4985; Du, Liang/0000-0002-3294-5071	Key Natural Science Project of Anhui Provincial Education Department [KJ2018A0010]; National Natural Science Foundation of China [61502289]	Key Natural Science Project of Anhui Provincial Education Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by the Key Natural Science Project of Anhui Provincial Education Department KJ2018A0010, and National Natural Science Foundation of China grant 61502289.	[Anonymous], 2011, P 28 INT C INT C MAC; [Anonymous], P SIAM INT C DAT MIN; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Cai X., 2013, IJCAI, P2598, DOI DOI 10.5555/2540128.2540503; Cao X., 2015, DIVERSITY INDUCED MU; French J.C., 2003, P INT WORKSH MULT IN; Goldfarb D, 2009, SIAM J IMAGING SCI, V2, P84, DOI 10.1137/080726926; Gretton A, 2005, LECT NOTES ARTIF INT, V3734, P63; Gunnemann S., 2012, P 18 ACM SIGKDD INT, P132, DOI DOI 10.1145/2339530.2339553; JI S., 2009, P 26 ANN INT C MACH, P457; Kumar A., 2011, ADV NEURAL INFORM PR, P1413; Kushmerick N., 1999, Proceedings of the Third International Conference on Autonomous Agents, P175, DOI 10.1145/301136.301186; Li S.-Y., 2014, AAAI; Liu J, 2015, IEEE T NEUR NET LEAR, V26, P1233, DOI 10.1109/TNNLS.2014.2335234; Ng AY, 2002, ADV NEUR IN, V14, P849; Nie F, 2016, INT JOINT C ART INT; Nie FP, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2564; Nilsback M.-E., 2008, P IND C COMP VIS GRA; Niu D., 2010, PROC 27 INT C MACH L, P831; Petersen K.B., 2008, THE MATRIX COOKBOOK, V7, P15; Ren PZ, 2018, PROCEEDINGS OF THE TWENTY-SEVENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2644; Scholkopf B., 2002, LEARNING KERNELS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Tang C, 2018, KNOWL-BASED SYST, V160, P49, DOI 10.1016/j.knosys.2018.06.016; Tang Jiliang, 2013, IJCAI, P2712; Vese LA, 2003, SIAM J NUMER ANAL, V40, P2085; Wang W, 2007, LECT NOTES ARTIF INT, V4701, P454; Wen ZW, 2013, MATH PROGRAM, V142, P397, DOI 10.1007/s10107-012-0584-1; Xia RK, 2014, AAAI CONF ARTIF INTE, P2149; Xu C., 2013, ARXIV; Yu SX, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P313, DOI 10.1109/iccv.2003.1238361; Zhang ZY, 2017, IEEE T PATTERN ANAL, V39, P1675, DOI 10.1109/TPAMI.2016.2601608; Zhao J, 2017, INFORM FUSION, V38, P43, DOI 10.1016/j.inffus.2017.02.007	35	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208494	10.1371/journal.pone.0208494	http://dx.doi.org/10.1371/journal.pone.0208494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521611	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600078
J	Agrawal, S; Ganley, ARD				Agrawal, Saumya; Ganley, Austen R. D.			The conservation landscape of the human ribosomal RNA gene repeats	PLOS ONE			English	Article							REPLICATION INITIATION SITES; POLYMERASE-I; DNA-REPLICATION; COPY NUMBER; SACCHAROMYCES-CEREVISIAE; GENOMIC ARCHITECTURE; CELLULAR SENESCENCE; SEQUENCE VARIATION; PROMOTER ELEMENTS; ORGANIZER REGIONS	Ribosomal RNA gene repeats (rDNA) encode ribosomal RNA, a major component of ribo- somes. Ribosome biogenesis is central to cellular metabolic regulation, and several diseases are associated with rDNA dysfunction, notably cancer, However, its highly repetitive nature has severely limited characterization of the elements responsible for rDNA function. Here we make use of phylogenetic footprinting to provide a comprehensive list of novel, potentially functional elements in the human rDNA. Complete rDNA sequences for six non-human primate species were constructed using de novo whole genome assemblies. These new sequences were used to determine the conservation profile of the human rDNA, revealing 49 conserved regions in the rDNA intergenic spacer (IGS). To provide insights into the potential roles of these conserved regions, the conservation profile was integrated with functional genomics datasets. We find two major zones that contain conserved elements characterised by enrichment of transcription-associated chromatin factors, and transcription. Conservation of some IGS transcripts in the apes underpins the potential functional significance of these transcripts and the elements controlling their expression. Our results characterize the conservation landscape of the human IGS and suggest that noncoding transcription and chromatin elements are conserved and important features of this unique genomic region.	[Agrawal, Saumya; Ganley, Austen R. D.] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [Ganley, Austen R. D.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Agrawal, Saumya] RIKEN, Ctr Integrat Med Sci, Lab Appl Computat Genom, Yokohama, Kanagawa, Japan	Massey University; University of Auckland; RIKEN	Ganley, ARD (corresponding author), Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand.; Ganley, ARD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	a.ganley@auckland.ac.nz			Auckland Medical Research Foundation [4108008]; New Zealand Marsden Fund [14-MAU-053]; Institute of Natural and Mathematical Sciences, Massey University	Auckland Medical Research Foundation; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Institute of Natural and Mathematical Sciences, Massey University	This work was supported by grants from the Auckland Medical Research Foundation (4108008) and the New Zealand Marsden Fund (14-MAU-053) to ARDG, and a PhD scholarship from the Institute of Natural and Mathematical Sciences, Massey University to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2016, METHODS MOL BIOL, V1455, P161, DOI 10.1007/978-1-4939-3792-9_13; Akamatsu Y, 2015, MOL CELL BIOL, V35, P1871, DOI 10.1128/MCB.01521-14; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; BREWER BJ, 1991, BIOESSAYS, V13, P317, DOI 10.1002/bies.950130702; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Brombin A, 2015, CURR OPIN GENET DEV, V34, P61, DOI 10.1016/j.gde.2015.07.006; Burkhalter MD, 2004, MOL CELL, V15, P409, DOI 10.1016/j.molcel.2004.06.024; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Challice J, 1989, J BIOL CHEM, V264, P20060; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Cheutin T, 2002, J CELL SCI, V115, P3297; COFFMAN FD, 1993, EXP CELL RES, V209, P123, DOI 10.1006/excr.1993.1292; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Dellino GI, 2013, GENOME RES, V23, P1, DOI 10.1101/gr.142331.112; Derenzini M, 2005, J CELL PHYSIOL, V202, P483, DOI 10.1002/jcp.20144; Dimitrova DS, 2011, J CELL SCI, V124, P2743, DOI 10.1242/jcs.082230; DIXIT A, 1987, J BIOL CHEM, V262, P11616; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Floutsakou I, 2013, GENOME RES, V23, P2003, DOI 10.1101/gr.157941.113; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Ganley AR, 2008, COMP GENOMICS, P367; Ganley ARD, 2005, P NATL ACAD SCI USA, V102, P11787, DOI 10.1073/pnas.0504905102; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Ganley ARD, 2014, FEMS YEAST RES, V14, P49, DOI 10.1111/1567-1364.12133; Gencheva M, 1996, J BIOL CHEM, V271, P2608, DOI 10.1074/jbc.271.5.2608; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Gibbons JG, 2015, P NATL ACAD SCI USA, V112, P2485, DOI 10.1073/pnas.1416878112; Gibbons JG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5850; Gogel E, 1996, CHROMOSOMA, V104, P511, DOI 10.1007/BF00352115; GONZALEZ IL, 1993, GENOMICS, V18, P29, DOI 10.1006/geno.1993.1423; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; GONZALEZ IL, 1990, MOL BIOL EVOL, V7, P203; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; GRAY MW, 1990, RIBOSOME, P589; GRIMALDI G, 1988, P NATL ACAD SCI USA, V85, P5502, DOI 10.1073/pnas.85.15.5502; Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0; HALTINER MM, 1986, MOL CELL BIOL, V6, P227, DOI 10.1128/MCB.6.1.227; Hamperl S, 2013, BBA-GENE REGUL MECH, V1829, P405, DOI 10.1016/j.bbagrm.2012.12.007; Hannan KM, 1998, PROTEINS, V4; Hayashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098586; HENDERSON AS, 1976, CHROMOSOMA, V59, P147, DOI 10.1007/BF00328483; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; HIGUCHI R, 1981, GENE, V15, P177, DOI 10.1016/0378-1119(81)90127-X; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Huang KM, 2013, J BIOL CHEM, V288, P26067, DOI 10.1074/jbc.M113.486175; Hubisz MJ, 2014, CURR OPIN GENET DEV, V29, P15, DOI 10.1016/j.gde.2014.07.005; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Iglesias AR, 2004, GENE, V341, P149, DOI 10.1016/j.gene.2004.06.035; Jacob MD, 2012, NUCLEUS-PHILA, V3, P315, DOI 10.4161/nucl.20585; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kim JH, 2018, NUCLEIC ACIDS RES, V46, P6712, DOI 10.1093/nar/gky442; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kobayashi T, 2001, MOL CELL BIOL, V21, P136, DOI 10.1128/MCB.21.1.136-147.2001; KOBAYASHI T, 1992, MOL GEN GENET, V233, P355, DOI 10.1007/BF00265431; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; KUHN A, 1990, P NATL ACAD SCI USA, V87, P7527, DOI 10.1073/pnas.87.19.7527; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; LITTLE RD, 1993, MOL CELL BIOL, V13, P6600, DOI 10.1128/MCB.13.10.6600; Ma HH, 2008, TRENDS CELL BIOL, V18, P575, DOI 10.1016/j.tcb.2008.09.003; Marques-Bonet T, 2009, ANNU REV GENOM HUM G, V10, P355, DOI 10.1146/annurev.genom.9.081307.164420; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; McStay B, 2016, GENE DEV, V30, P1598, DOI 10.1101/gad.283838.116; Meloni R, 1998, HUM MOL GENET, V7, P423, DOI 10.1093/hmg/7.3.423; Millau JF, 2011, BIOCHEM CELL BIOL, V89, P505, DOI [10.1139/o11-052, 10.1139/O11-052]; MILLER CA, 1993, MOL CELL BIOL, V13, P5360, DOI 10.1128/MCB.13.9.5360; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Muller M, 2000, MOL CELL, V5, P767, DOI 10.1016/S1097-2765(00)80317-2; Nakhoul H, 2014, CLIN MED INSIGHTS-BL, V7, P7, DOI 10.4137/CMBD.S16952; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Nielsen MM, 2014, RNA, V20, P236, DOI 10.1261/rna.038927.113; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Nomura M, 2004, MOL BIOL INTELL UNIT, P128; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Oakes ML, 2006, MOL CELL BIOL, V26, P6223, DOI 10.1128/MCB.02324-05; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; PAPE LK, 1989, MOL CELL BIOL, V9, P5093, DOI 10.1128/MCB.9.11.5093; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Parks MM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao0665; Peng XX, 2015, NUCLEIC ACIDS RES, V43, pD737, DOI 10.1093/nar/gku1110; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; PFLEIDERER C, 1990, NUCLEIC ACIDS RES, V18, P4727, DOI 10.1093/nar/18.16.4727; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; PIKAARD CS, 1990, MOL CELL BIOL, V10, P4816, DOI 10.1128/MCB.10.9.4816; Pontvianne F, 2013, GENE DEV, V27, P1545, DOI 10.1101/gad.221648.113; Poortinga G, 2015, ONCOGENE, V34, P403, DOI 10.1038/onc.2014.13; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; SAFRANY G, 1989, GENE, V79, P299, DOI 10.1016/0378-1119(89)90212-6; Saka K, 2013, CURR BIOL, V23, P1794, DOI 10.1016/j.cub.2013.07.048; SCHMICKEL RD, 1973, PEDIATR RES, V7, P5, DOI 10.1203/00006450-197301000-00002; Shiue CN, 2009, ONCOGENE, V28, P1833, DOI 10.1038/onc.2009.21; Shiue CN, 2014, NUCLEIC ACIDS RES, V42, P5505, DOI 10.1093/nar/gku183; Shyian M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006414; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; TANTRAVAHI R, 1976, CHROMOSOMA, V56, P15, DOI 10.1007/BF00293725; Tchurikov NA, 2015, J MOL CELL BIOL, V7, P366, DOI 10.1093/jmcb/mju038; Tran DA, 2010, DNA CELL BIOL, V29, P499, DOI 10.1089/dna.2009.0994; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; VANTHOF J, 1987, PLANT MOL BIOL, V9, P87, DOI 10.1007/BF00015641; VELDMAN GM, 1980, NUCLEIC ACIDS RES, V8, P5179, DOI 10.1093/nar/8.22.5179; VOELKELMEIMAN K, 1987, CELL, V48, P1071, DOI 10.1016/0092-8674(87)90714-8; Wai HH, 2000, NUCLEIC ACIDS RES, V28, P3524, DOI 10.1093/nar/28.18.3524; WARBURTON D, 1975, CHROMOSOMA, V51, P35, DOI 10.1007/BF00285805; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Woolnough JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157276; Xu BS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006771; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; YOON Y, 1995, MOL CELL BIOL, V15, P2482; Yu F, 2015, SCI REPORTS, V5; Yu SK, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007258; Zaidi SK, 2016, J CELLULAR PHYSL; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	154	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207531	10.1371/journal.pone.0207531	http://dx.doi.org/10.1371/journal.pone.0207531			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517151	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400041
J	Eissner, F; Haymerle, G; Brunner, M				Eissner, Friederike; Haymerle, Georg; Brunner, Markus			Risk factors for acute unplanned tracheostomy during panendoscopy in HNSCC patients	PLOS ONE			English	Article							MAJOR HEAD; TRACHEOTOMY; CANCER; COMPLICATIONS; EMERGENCY; SYSTEM	Background Despite of careful pre-operative risk evaluation some patients require an acute unplanned tracheostomy during panendoscopy. Methods Risk factors of patients requiring an unplanned tracheostomy during panendoscopy (n = 32) were compared to a control group with panendoscopy without tracheostomy (n = 180). Results 2131 panendoscopies for Head and Neck squamous cell carcinoma were performed at our Department between 2000 and 2014. Unplanned tracheostomies were necessary in 1.6% of all panendoscopies. Patients with laryngeal cancer (p = 0.001) or abnormal activated partial thromboplastin time (aPTT) (p = 0.03) had a statistically significant higher risk of unplanned tracheostomy. Regression analysis showed that patients with advanced laryngeal cancer had an almost 6 times higher risk for tracheostomy than patients with early stage oropharyngeal cancer. Conclusions We identified abnormal aPTT and laryngeal carcinoma as significant predictors for unplanned tracheostomy during panendoscopy. The results of our study could improve preoperative risk evaluation in HNSCC patients.	[Eissner, Friederike; Haymerle, Georg; Brunner, Markus] Med Univ Vienna, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria	Medical University of Vienna	Haymerle, G (corresponding author), Med Univ Vienna, Dept Otorhinolaryngol Head & Neck Surg, Vienna, Austria.	georg.haymerle@meduniwien.ac.at						Altman KW, 2005, LARYNGOSCOPE, V115, P2101, DOI 10.1097/01.mlg.0000180176.66968.0f; ATKINS JP, 1984, ARCH OTOLARYNGOL, V110, P533; Cameron M, 2009, INT J ORAL MAX SURG, V38, P846, DOI 10.1016/j.ijom.2009.03.713; Cheung NH, 2014, RESP CARE, V59, P895, DOI 10.4187/respcare.02971; CHEW JY, 1972, ARCHIV OTOLARYNGOL, V96, P538; Cordes SR, 2015, LARYNGOSCOPE, V125, P105, DOI 10.1002/lary.24793; Darrat I, 2008, LARYNGOSCOPE, V118, P2125, DOI 10.1097/MLG.0b013e3181847a78; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P412, DOI 10.1016/j.ejcts.2007.05.018; Durbin Charles G Jr, 2005, Respir Care, V50, P511; ELSOLH AA, 2007, CRIT CARE, V11; Fang CH, 2015, LARYNGOSCOPE, V125, P2476, DOI 10.1002/lary.25348; Gillespie MB, 1999, LARYNGOSCOPE, V109, P1766, DOI 10.1097/00005537-199911000-00008; GILYOMA JM, 2011, WORLD J EMERG SURG, V6; Goldenberg D, 2000, OTOLARYNG HEAD NECK, V123, P495, DOI 10.1067/mhn.2000.105714; Guardiola Emmanuel, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P85; Kim YH, 2014, J KOR ASSOC ORAL MAX, V40, P211, DOI 10.5125/jkaoms.2014.40.5.211; Koo K, 2015, J LARYNGOL OTOL, V129, pS27, DOI 10.1017/S0022215114002989; Kroll Tobias, 2015, Laryngorhinootologie, V94, P434, DOI 10.1055/s-0035-1555632; Kruse-Losler B, 2005, ACTA ANAESTH SCAND, V49, P654, DOI 10.1111/j.1399-6576.2005.00655.x; Kumar D, 2012, BMJ CASE REP, V2012; Lee Ho-Jin, 2015, Maxillofac Plast Reconstr Surg, V37, P19, DOI 10.1186/s40902-015-0021-5; LEIPZIG B, 1985, ARCH OTOLARYNGOL, V111, P589; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rodriguez-Bruno K, 2011, HEAD NECK-J SCI SPEC, V33, P949, DOI 10.1002/hed.21561; Silvester W, 2006, CRIT CARE MED, V34, P2145, DOI 10.1097/01.CCM.0000229882.09677.FD; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; URIBE AA, 2015, FRONT MED, V2; WALDRON J, 1990, ANN ROY COLL SURG, V72, P218; Yuen HW, 2007, OTOLARYNG HEAD NECK, V136, P838, DOI 10.1016/j.otohns.2006.12.012	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207171	10.1371/journal.pone.0207171	http://dx.doi.org/10.1371/journal.pone.0207171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517141	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400028
J	Everson, F; Genis, A; Ogundipe, T; De Boever, P; Goswami, N; Lochner, A; Blackhurst, D; Strijdom, H				Everson, Frans; Genis, Amanda; Ogundipe, Temitope; De Boever, Patrick; Goswami, Nandu; Lochner, Amanda; Blackhurst, Dee; Strijdom, Hans			Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA-REPERFUSION; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PERSONS; OXIDATIVE STRESS; CARDIOVASCULAR RISK; METABOLIC ABNORMALITIES; HIGH-FAT; INSULIN; GLUCOSE; DISEASE	HIV-infection, certain antiretroviral drug classes, especially protease inhibitors (PI), and obesity are associated with increased ischaemic heart disease (IHD) risk. However, the effect of PI-free fixed dose combination (FDC) antiretroviral therapy (ART) on hearts exposed to ischaemia-reperfusion injury (I/R) is unknown, particularly in obesity. This is becoming relevant as World Health Organisation guidelines recommend a FDC ART containing (non-) nucleoside reverse transcriptase inhibitors (tenofovir (TDF), emtricitabine (FTC) and efavirenz (EFV)) as first-line HIV treatment. Additionally, obesity rates are rising in HIV-infected populations, not only in ART-experienced individuals, but also at the time of ART initiation, which may further increase the risk of IHD. Therefore, we investigated the effects of PI-free FDC ART in myocardial I/R-exposed hearts from obese rats. Obesity was induced in male wistar rats via a 16-week high calorie diet. At week 10, treatment with a FDC ART drug containing TDF/FTC/EFV was initiated. Biometric and metabolic parameters, as well as myocardial functional recovery and infract size (IS), and myocardial signalling proteins following I/R were assessed after 16 weeks. Obese rats presented with increased body and intraperitoneal fat mass, elevated triglyceride and TBARS levels, whilst the hearts responded to I/R with impaired functional performance and increased IS. The FDC ART treatment did not alter biometric and metabolic parameters in obese rats. In a novel finding, ART protected obese hearts against I/R as shown by improved functional performance and smaller IS vs. untreated obese hearts. Cardioprotection was underscored by increased myocardial phosphorylated endothelial nitric oxide synthase (eNOS) and reduced AMP-kinase levels. In conclusion, these results demonstrate for the first time, that 6-weeks treatment of obese rats with a FDC ART drug specifically containing TDF/FTC/EFV conferred cardioprotection against I/R. The FDC ART-induced cardioprotection was seemingly unrelated to metabolic changes, but rather due to direct cardiac mechanisms including the up-regulation of myocardial eNOS.	[Everson, Frans; Genis, Amanda; Ogundipe, Temitope; Lochner, Amanda; Strijdom, Hans] Stellenbosch Univ, Div Med Physiol, Fac Med & Hlth Sci, Cape Town, South Africa; [De Boever, Patrick] Flemish Inst Technol Res VITO, Environm Risk & Hlth, Mol, Belgium; [De Boever, Patrick] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium; [Goswami, Nandu] Med Univ Graz, Otto Loewi Res Ctr, Dept Physiol, Graz, Austria; [Blackhurst, Dee] Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa	Stellenbosch University; VITO; Hasselt University; Medical University of Graz; University of Cape Town	Everson, F (corresponding author), Stellenbosch Univ, Div Med Physiol, Fac Med & Hlth Sci, Cape Town, South Africa.	franseverson@gmail.com	De Boever, Patrick/AAA-8387-2019	De Boever, Patrick/0000-0002-5197-8215; Strijdom, Hans/0000-0003-3726-9153	South African National Research Foundation [CSUR13082330472, TTK13061118934]; Harry Crossley Foundation; South African Department of Science and Technology [DST/CON 0077/2014]	South African National Research Foundation(National Research Foundation - South Africa); Harry Crossley Foundation; South African Department of Science and Technology	This study was funded by the South African National Research Foundation (Acquisition: HS and AG; http://www.nrf.ac.za/; grant numbers: CSUR13082330472 and TTK13061118934), Harry Crossley Foundation (Acquisition: AG; https://educationinnovations.org/funder/harry-crossley-foundation) and the South African Department of Science and Technology (Acquisition: HS; www.dst.gov.za; Grant number: DST/CON 0077/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; Axelsen LN, 2010, AM J PHYSIOL-REG I, V298, pR1560, DOI 10.1152/ajpregu.00392.2009; Barbaro G, 2011, INDIAN J MED RES, V134, P898, DOI 10.4103/0971-5916.92634; Beltowski J, 2000, J PHYSIOL PHARMACOL, V51, P883; Beraldo Rebeca Antunes, 2017, Rev. bras. epidemiol., V20, P526, DOI 10.1590/1980-5497201700030014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvo M, 2014, CURR OPIN HIV AIDS, V9, P332, DOI 10.1097/COH.0000000000000075; Carroll JF, 2006, HYPERTENSION, V48, P65, DOI 10.1161/01.HYP.0000224147.01024.77; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Crum-Cianflone N, 2008, AIDS PATIENT CARE ST, V22, P925, DOI 10.1089/apc.2008.0082; Crum-Cianflone N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010106; D'Ascenzo F, 2012, EUR HEART J, V33, P875, DOI 10.1093/eurheartj/ehr456; Donner D, 2013, DIS MODEL MECH, V6, P457, DOI 10.1242/dmm.010959; Ekali LG, 2013, DIABETES METAB, V39, P71, DOI 10.1016/j.diabet.2012.08.012; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; Estrada V, 2014, J INT AIDS SOC, V17, P38, DOI [10.7448/IAS.17.4.19544, 10.7448/IAS.17.4.19721]; Estrada V, 2011, AIDS REV, V13, P49; Fedele F, 2011, AIDS REV, V13, P119; Floris-Moore M, 2006, HIV MED, V7, P421, DOI 10.1111/j.1468-1293.2006.00401.x; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2008, CURR OPIN HIV AIDS, V3, P220, DOI 10.1097/COH.0b013e3282fb7bcf; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; GIDEZ LI, 1982, J LIPID RES, V23, P1206; Giralt M, 2011, BEST PRACT RES CL EN, V25, P487, DOI 10.1016/j.beem.2010.12.001; Haugaard SB, 2005, DIABETES, V54, P3474, DOI 10.2337/diabetes.54.12.3474; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Huisamen B, 2012, MOL CELL BIOCHEM, V368, P37, DOI 10.1007/s11010-012-1340-9; Huisamen B, 2011, CARDIOVASC DRUG THER, V25, P13, DOI 10.1007/s10557-010-6271-7; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Jones R, 2005, HIV MED, V6, P396, DOI 10.1111/j.1468-1293.2005.00325.x; KANNENGIESSER GJ, 1979, J MOL CELL CARDIOL, V11, P197, DOI 10.1016/0022-2828(79)90464-4; Keithley JK, 2009, J ASSOC NURSE AIDS C, V20, P260, DOI 10.1016/j.jana.2009.02.006; Lafeuillade A, 2003, JAIDS-J ACQ IMM DEF, V33, P544, DOI 10.1097/00126334-200308010-00018; Lakey W, 2013, AIDS RES HUM RETROV, V29, P435, DOI [10.1089/aid.2012.0234, 10.1089/AID.2012.0234]; Liu J, 2013, NUTR RES, V33, P311, DOI 10.1016/j.nutres.2013.02.005; Lopaschuk GD, 2008, INT J OBESITY, V32, pS29, DOI 10.1038/ijo.2008.120; Maarman G, 2012, CARDIOVASC DRUG THER, V26, P205, DOI 10.1007/s10557-012-6377-1; Leite LHM, 2010, NUTR HOSP, V25, P635, DOI 10.3305/nh.2010.25.4.4481; Leite LHM, 2008, REV NUTR, V21, P277, DOI 10.1590/S1415-52732008000300002; Mak IT, 2017, FREE RADICAL BIO MED, V112, P117, DOI 10.1016/j.freeradbiomed.2017.10.175; Margolis AM, 2014, J MED TOXICOL, V10, P26, DOI 10.1007/s13181-013-0325-8; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Masia M, 2007, CLIN THER, V29, P1448, DOI 10.1016/j.clinthera.2007.07.025; Mavroudis CA, 2013, INT J CARDIOL, V167, P1147, DOI 10.1016/j.ijcard.2012.09.043; Mondy KE, 2011, CLIN INFECT DIS, V52, P378, DOI 10.1093/cid/ciq066; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nduhirabandi F, 2014, J PINEAL RES, V57, P317, DOI 10.1111/jpi.12171; Nduhirabandi F, 2011, J PINEAL RES, V50, P171, DOI 10.1111/j.1600-079X.2010.00826.x; Nix LM, 2014, CURR HIV-AIDS REP, V11, P271, DOI 10.1007/s11904-014-0219-7; Panagia M, 2005, AM J PHYSIOL-HEART C, V288, pH2677, DOI 10.1152/ajpheart.00200.2004; Papparella I, 2007, CARDIOVASC RES, V73, P432, DOI 10.1016/j.cardiores.2006.10.010; Paula AA, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-32; PRYOR WA, 1984, METHOD ENZYMOL, V105, P293; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Rodriguez-Rodriguez P, 2017, PLOS ONE, V12, P1; Salie R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0109-8; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Sharma B, 2014, CURR HIV RES, V12, P13, DOI 10.2174/1570162X12666140402100959; Smit SE, 2018, PLANTA MED, V84, P75, DOI 10.1055/s-0043-117415; Thakker GD, 2008, OBESITY, V16, P2593, DOI 10.1038/oby.2008.414; Tripathi A, 2014, DIABETIC MED, V31, P1185, DOI 10.1111/dme.12455; Turko IV, 2002, PHARMACOL REV, V54, P619, DOI 10.1124/pr.54.4.619; Warden CH, 2011, CELL METAB, V4, P121; Westcott C, 2017, SAHEART, V14, P22, DOI DOI 10.24170/14-1-1865; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Zannou DM, 2009, ANTIVIR THER, V14, P371	68	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208537	10.1371/journal.pone.0208537	http://dx.doi.org/10.1371/journal.pone.0208537			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517206	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400105
J	Ravindranathan, A; Cimini, B; Diolaiti, ME; Stohr, BA				Ravindranathan, Ajay; Cimini, Beth; Diolaiti, Morgan E.; Stohr, Bradley A.			Preliminary development of an assay for detection of TERT expression, telomere length, and telomere elongation in single cells	PLOS ONE			English	Article							CATALYTIC SUBUNIT GENE; SPLICING PATTERNS; DNA METHYLATION; RNA; HTERT; LINES; POT1; FIBROBLASTS; REGULATOR; DELIVERY	The telomerase enzyme enables unlimited proliferation of most human cancer cells by elongating telomeres and preventing replicative senescence. Despite the critical importance of telomerase in cancer biology, challenges detecting telomerase activity and expression in individual cells have hindered the ability to study patterns of telomerase expression and function across heterogeneous cell populations. While sensitive assays to ascertain telomerase expression and function exist, these approaches have proven difficult to implement at the single cell level. Here, we validate in situ RNAscope detection of the telomerase TERT mRNA and couple this assay with our recently described TSQ1 method for in situ detection of telomere elongation. This approach enables detection of TERT expression, telomere length, and telomere elongation within individual cells of the population. Using this assay, we show that the heterogeneous telomere elongation observed across a HeLa cell population is in part driven by variable expression of the TERT gene. Furthermore, we show that the absence of detectable telomere elongation in some TERT-positive cells is the result of inhibition by the telomeric shelterin complex. This combined assay provides a new approach for understanding the integrated expression, function, and regulation of telomerase at the single cell level.	[Ravindranathan, Ajay; Diolaiti, Morgan E.; Stohr, Bradley A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Cimini, Beth] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stohr, BA (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	bradley.stohr@ucsf.edu	Cimini, Beth/ABA-9337-2021	Cimini, Beth/0000-0001-9640-9318	American Cancer Society [RSG-14-183-01]	American Cancer Society(American Cancer Society)	This study was funded by American Cancer Society grant RSG-14-183-01 to Bradley A. Stohr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedalthagafi MS, 2015, CANCER GENET-NY, V208, P345, DOI 10.1016/j.cancergen.2015.03.005; Armstrong CA, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160338; Avilion AA, 1996, CANCER RES, V56, P645; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Casillas MA, 2003, GENE, V316, P57, DOI 10.1016/S0378-1119(03)00739-X; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Diolaiti ME, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt689; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gordon K, 2014, NUCLEIC ACIDS RES, V42, P3529, DOI 10.1093/nar/gkt1351; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Kendellen MF, 2009, MOL CELL BIOL, V29, P5611, DOI 10.1128/MCB.00286-09; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, CELL, V117, P279, DOI 10.1016/S0092-8674(04)00409-X; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Ludlow AT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku439; Mavrogiannou E, 2007, CLIN CHEM, V53, P53, DOI 10.1373/clinchem.2006.073015; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Ohyashiki Kazuma, 2002, Methods Mol Biol, V191, P159; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Stohr BA, 2008, CANCER RES, V68, P5309, DOI 10.1158/0008-5472.CAN-08-0504; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wills QF, 2015, HUM MOL GENET, V24, pR74, DOI 10.1093/hmg/ddv235; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206525	10.1371/journal.pone.0206525	http://dx.doi.org/10.1371/journal.pone.0206525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517099	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400015
J	Nie, E; Miao, F; Jin, X; Wu, WN; Zhou, X; Zeng, AL; Yu, TF; Zhi, TL; Shi, ZM; Wang, YY; Zhang, JX; Liu, N; You, YP				Nie, Er; Miao, Faan; Jin, Xin; Wu, Weining; Zhou, Xu; Zeng, Ailiang; Yu, Tianfu; Zhi, Tongle; Shi, Zhumei; Wang, Yingyi; Zhang, Junxia; Liu, Ning; You, Yongping			Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma	ONCOGENE			English	Article							FOLLISTATIN-LIKE 1; GENE O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; HISTONE DEACETYLATION; PROMOTER METHYLATION; BINDING-PROTEIN; EXPRESSION; MGMT; REPAIR; FSTL1; HDAC2	Temozolomide was recognized as the first-line therapy for glioblastoma to prolong the survival of patients noticeably, while recent clinical studies found that some patients were not sensitive to temozolomide treatment. The possible mechanisms seemed to be methylguanine-DNA-methyltransferase (MGMT), mismatch repair, PARP, etc. And the abnormal expression of MGMT might be the most direct factor. In this study, we provide evidence that Fstl1 plays a vital role in temozolomide resistance by sequentially regulating DIP2A protein distribution, H3K9 acetylation (H3K9Ac), and MGMT transcription. As a multifunctional protein widely distributed in cells, DIP2A cooperates with the HDAC2-DMAP1 complex to enhance H3K9Ac deacetylation, prevent MGMT transcription, and increase temozolomide sensitivity. Fstl1, a glycoprotein highly expressed in glioblastoma, competitively binds DIP2A to block DIP2A nuclear translocation, so as to hinder DIP2A from binding the HDAC2-DMAP1 complex. The overexpression of Fstl1 promoted the expression of MGMT in association with increased promoter H3K9Ac. Upregulation of Fstl1 enhanced temozolomide resistance, whereas Fstl1 silencing obviously sensitized GBM cells to temozolomide both in vivo and in vitro. Moreover, DIP2A depletion abolished the effects of Fstl1 on MGMT expression and temozolomide resistance. These findings highlight an important role of Fstl1 in the regulation of temozolomide resistance by modulation of DIP2A/MGMT signaling.	[Nie, Er; Miao, Faan; Jin, Xin; Wu, Weining; Zhou, Xu; Zeng, Ailiang; Yu, Tianfu; Zhi, Tongle; Shi, Zhumei; Wang, Yingyi; Zhang, Junxia; Liu, Ning; You, Yongping] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Shi, Zhumei] Nanjing Med Univ, State Key Lab Reprod Med, Collaborat Innovat Ctr Canc Personalized Med, Dept Pathol,Canc Ctr, Nanjing 210029, Jiangsu, Peoples R China; [Liu, Ning; You, Yongping] CGCG, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Liu, N; You, YP (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.; Liu, N; You, YP (corresponding author), CGCG, Nanjing 210029, Jiangsu, Peoples R China.	liuning0853@126.com; yypl9@njmu.edu.cn	zeng, ailiang/AAF-4498-2020	Zeng, Ailiang/0000-0003-2869-9899	Research Special Fund for Public Welfare Industry of Health [201402008]; National Key Research and Development Plan [2016YFC0902500]; National Natural Science Foundation of China [81672501, 81472362, 81372709]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Research Special Fund for Public Welfare Industry of Health; National Key Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the Research Special Fund for Public Welfare Industry of Health (201402008), the National Key Research and Development Plan (2016YFC0902500), National Natural Science Foundation of China (81672501, 81472362, and 81372709), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Bae K, 2016, ONCOTARGET, V7, P18076, DOI 10.18632/oncotarget.6729; Bhakat KK, 2000, J BIOL CHEM, V275, P34197, DOI 10.1074/jbc.M005447200; Boldogh I, 1998, CANCER RES, V58, P3950; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Chan QKY, 2009, CARCINOGENESIS, V30, P114, DOI 10.1093/carcin/bgn215; Choi YB, 2004, J BIOL CHEM, V279, P50930, DOI 10.1074/jbc.M406831200; COSTELLO JF, 1994, MOL CELL BIOL, V14, P6515, DOI 10.1128/MCB.14.10.6515; Danam RP, 2005, MOL CANCER THER, V4, P61; Esteller M, 1999, CANCER RES, V59, P793; Fiskus W, 2014, MOL CANCER THER, V13, P1142, DOI 10.1158/1535-7163.MCT-13-0770; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Gerace E, 2015, METHOD ENZYMOL, V559, P99, DOI 10.1016/bs.mie.2014.11.010; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Kim HJ, 2016, CELL SIGNAL, V28, P1137, DOI 10.1016/j.cellsig.2016.05.018; Kitange GJ, 2016, CELL REP, V14, P2587, DOI 10.1016/j.celrep.2016.02.045; Kitange GJ, 2012, CLIN CANCER RES, V18, P4070, DOI 10.1158/1078-0432.CCR-12-0560; Kramer OH, 2009, TRENDS PHARMACOL SCI, V30, P647, DOI 10.1016/j.tips.2009.09.007; Kudo-Saito C, 2013, CANCER RES, V73, P6185, DOI 10.1158/0008-5472.CAN-13-1364; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lavon I, 2007, CANCER RES, V67, P8952, DOI 10.1158/0008-5472.CAN-06-3820; Liu S, 2006, EXP MOL PATHOL, V80, P132, DOI 10.1016/j.yexmp.2005.07.005; Liu S, 2010, AM J PHYSIOL-ENDOC M, V299, pE351, DOI 10.1152/ajpendo.00005.2010; Luo H, 2015, BRAIN, V138, P3654, DOI 10.1093/brain/awv287; Ma XY, 2009, J CLIN NEUROSCI, V16, P1595, DOI 10.1016/j.jocn.2009.02.036; Mukhopadhyay M, 2002, GENE, V293, P59, DOI 10.1016/S0378-1119(02)00694-7; Murakami K, 2012, FEBS LETT, V586, P319, DOI 10.1016/j.febslet.2012.01.010; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; Nie E, 2017, J NEURO-ONCOL, V133, P59, DOI 10.1007/s11060-017-2425-9; Nie E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39743; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2010, J BIOL CHEM, V285, P7127, DOI 10.1074/jbc.M109.069468; Park HG, 2014, INT J NEUROPSYCHOPH, V17, P1487, DOI 10.1017/S1461145714000248; Pistollato F, 2010, STEM CELLS, V28, P851, DOI 10.1002/stem.415; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sundaram GM, 2013, NATURE, V495, P103, DOI 10.1038/nature11890; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Turtoi A, 2012, J PROTEOME RES, V11, P5011, DOI 10.1021/pr3005698; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Wilting RH, 2012, DRUG RESIST UPDATE, V15, P21, DOI 10.1016/j.drup.2012.01.008; Yang JH, 2016, ONCOL REP, V35, P3566, DOI 10.3892/or.2016.4757	58	23	23	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2706	2721		10.1038/s41388-018-0596-2	http://dx.doi.org/10.1038/s41388-018-0596-2			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30542120	Green Published, hybrid			2022-12-26	WOS:000464121600003
J	Guo, W; Li, D; You, Y; Li, WZ; Hu, B; Zhang, SL; Miao, L; Xian, M; Zhu, YZ; Shen, XY				Guo, Wei; Li, Dong; You, Yan; Li, Wanzhen; Hu, Bin; Zhang, Sulin; Miao, Lei; Xian, Ming; Zhu, Yizhun; Shen, Xiaoyan			Cystathionine -lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis	FASEB JOURNAL			English	Article						hydrogen sulfide; hyperglycemia; hepatic insulin resistance; glucose homeostasis	TRANSCRIPTION FACTOR FOXO1; ACTIVATED PROTEIN-KINASE; HYDROGEN-SULFIDE; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; IN-VIVO; GLUCOSE; LIVER; METABOLISM; FKHR	Hepatic gluconeogenesis makes a significant contribution to the pathogenesis of obesity and its related insulin resistance. Cystathionine -lyase (CSE; also cystathionase), a principal hydrogen sulfide (H2S)-synthesizing enzyme in the liver, is involved in glucose and lipid metabolism disorders. However, the roles and precise mechanisms of CSE/H2S in obesity and its related insulin resistance remain obscure. Here we show that CSE knockout exacerbated high-fat diet-induced mouse obesity as well as its related insulin resistance. Further study elucidated that the inhibition of insulin and AMPK signaling pathways by CSE deficiency resulted in nuclear accumulation of Forkhead box protein O1 and subsequently promoted hepatic gluconeogenesis. These phenomena can be reversed by NaHS supplementation. However, in wild-type mice, NaHS treatment ameliorates high fat diet-induced obesity and metabolism disorders, indicating that maintaining an appropriate level of H2S is critical for its mutual change of positive and negative effects of obesity-associated insulin resistance. Our study reveals a double-edged sword effect and a novel mechanism for CSE/H2S in obesity associated with insulin resistance and provides evidence for CSE/H2S as a promising therapeutic potential target for obesity-related insulin resistance.Guo, W., Li, D., You, Y., Li, W., Hu, B., Zhang, S., Miao, L., Xian, M., Zhu, Y., Shen, X. Cystathionine -lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis.	[Guo, Wei; Li, Dong; You, Yan; Li, Wanzhen; Hu, Bin; Zhang, Sulin; Miao, Lei; Zhu, Yizhun; Shen, Xiaoyan] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Xian, Ming] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Zhu, Yizhun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Macau, Peoples R China	Fudan University; Washington State University; Macau University of Science & Technology	Zhu, YZ (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.; Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Ave Wai Long, Taipa, Macau, Peoples R China.; Shen, XY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Pudong New Area, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	yzzhu@must.edu.mo; shxiaoy@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041; , Xiaoyan/0000-0003-4828-3268	National Natural Science Foundation of China [81573441, 81371923, 81173056, 81872864]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81573441, 81371923, 81173056, and 81872864. The authors declare no conflicts of interest.	Balbis A, 2000, ENDOCRINOLOGY, V141, P4041, DOI 10.1210/en.141.11.4041; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cheng ZY, 2012, NAT MED, V18, P351, DOI 10.1038/nm.2694; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Du XL, 2017, J CELL PHYSIOL, V232, P3296, DOI 10.1002/jcp.25773; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Ghoshal K, 2015, WORLD J DIABETES, V6, P151, DOI 10.4239/wjd.v6.i1.151; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gogiashvili M, 2017, ANAL BIOANAL CHEM, V409, P1591, DOI 10.1007/s00216-016-0100-1; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kaushik VK, 2001, AM J PHYSIOL-ENDOC M, V281, pE335, DOI 10.1152/ajpendo.2001.281.2.E335; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.119; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; Kundu S, 2014, BBA-MOL CELL RES, V1843, P2816, DOI 10.1016/j.bbamcr.2014.08.005; Li D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050635; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Majumder A, 2018, AM J PHYSIOL-CELL PH, V315, pC609, DOI 10.1152/ajpcell.00147.2018; Mani S, 2013, CIRCULATION, V127, P2523, DOI 10.1161/CIRCULATIONAHA.113.002208; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Miao L, 2016, ANTIOXID REDOX SIGN, V25, P268, DOI 10.1089/ars.2015.6577; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Song YX, 2016, J DAIRY SCI, V99, P9184, DOI 10.3168/jds.2016-11219; Sun XD, 2017, CELL PHYSIOL BIOCHEM, V42, P1109, DOI 10.1159/000478765; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; ter Horst KW, 2016, METABOLISM, V65, P757, DOI 10.1016/j.metabol.2016.02.010; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Untereiner AA, 2016, ANTIOXID REDOX SIGN, V24, P129, DOI 10.1089/ars.2015.6369; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Velmurugan GV, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac7135; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Xue R, 2013, ANTIOXID REDOX SIGN, V19, P5, DOI 10.1089/ars.2012.5024; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Yazdi FT, 2015, PEERJ, V3, DOI 10.7717/peerj.856; Zhang L, 2013, ENDOCRINOLOGY, V154, P114, DOI 10.1210/en.2012-1658	56	19	22	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4212	4224		10.1096/fj.201801894R	http://dx.doi.org/10.1096/fj.201801894R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526049				2022-12-26	WOS:000459794800089
J	Lee, BS; Kalia, NP; Jin, XEF; Hasenoehrl, EJ; Berney, M; Pethe, K				Lee, Bei Shi; Kalia, Nitin P.; Jin, Xin Er F.; Hasenoehrl, Erik J.; Berney, Michael; Pethe, Kevin			Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; ATP; tuberculosis; antibiotics; Mycobacterium tuberculosis; antagonism; Bedaquiline; oxidative phosphorylation; Q203; Telacebec	DRUG-RESISTANT TUBERCULOSIS; BACTERICIDAL ACTIVITY; MULTIDRUG-RESISTANT; DISCOVERY; BEDAQUILINE; EMERGENCE; PHASE	Energy metabolism has recently gained interest as a target space for antibiotic drug development in mycobacteria. Of particular importance is bedaquiline (Sirturo), which kills mycobacteria by inhibiting the F1F0 ATP synthase. Other components of the electron transport chain such as the NADH dehydrogenases (NDH-2 and NdhA) and the terminal respiratory oxidase bc(1):aa(3) are also susceptible to chemical inhibition. Because antituberculosis drugs are prescribed as part of combination therapies, the interaction between novel drugs targeting energy metabolism and classical first and second line antibiotics must be considered to maximize treatment efficiency. Here, we show that subinhibitory concentration of drugs targeting the F1F0 ATP synthase and the cytochrome bc(1):aa(3), as well as energy uncouplers, interfere with the bactericidal potency of isoniazid and moxifloxacin. Isoniazid- and moxifloxacin-induced mycobacterial death correlated with a transient increase in intracellular ATP that was dissipated by co-incubation with energy metabolism inhibitors. Although oxidative phosphorylation is a promising target space for drug development, a better understanding of the link between energy metabolism and antibiotic-induced mycobacterial death is essential to develop potent drug combinations for the treatment of tuberculosis.	[Lee, Bei Shi; Pethe, Kevin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Kalia, Nitin P.; Jin, Xin Er F.; Pethe, Kevin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore; [Hasenoehrl, Erik J.; Berney, Michael] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Yeshiva University; Albert Einstein College of Medicine	Pethe, K (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore.	kevin.pethe@ntu.edu.sg	Pethe, Kevin/F-9495-2015; Berney, Michael/GQZ-2111-2022; Kalia, Nitin Pal/AAE-5959-2019	Berney, Michael/0000-0002-4833-0573; Pethe, Kevin/0000-0003-0916-8873; Kalia, Nitin Pal/0000-0003-4346-6567; Lee, Bei Shi/0000-0003-1104-9486	Singapore Ministry of Education under Academic Research Fund Tier 1 [2016-T1-001-034]; Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant; Nanyang President's Graduate Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	Singapore Ministry of Education under Academic Research Fund Tier 1(Ministry of Education, Singapore); Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant(Nanyang Technological University); Nanyang President's Graduate Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Singapore Ministry of Education under Academic Research Fund Tier 1 Grant 2016-T1-001-034 (to K.P.), by a Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant (to K.P.), and by a Nanyang President's Graduate Scholarship (to B.S.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; [Anonymous], 2012, PRINCIPLES PHARM PAT; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Chahine EB, 2014, ANN PHARMACOTHER, V48, P107, DOI 10.1177/1060028013504087; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Debnath J, 2012, J MED CHEM, V55, P3739, DOI 10.1021/jm201608g; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; Dunn EA, 2014, BIOORGAN MED CHEM, V22, P5320, DOI 10.1016/j.bmc.2014.07.050; Gagneux S, 2018, NAT REV MICROBIOL, V16, P202, DOI 10.1038/nrmicro.2018.8; Guglielmetti L, 2015, CLIN INFECT DIS, V60, P188, DOI 10.1093/cid/ciu786; Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Kalia NP, 2017, P NATL ACAD SCI USA, V114, P7426, DOI 10.1073/pnas.1706139114; Khan SR, 2013, INT J ANTIMICROB AG, V41, P41, DOI 10.1016/j.ijantimicag.2012.09.012; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Lobritz MA, 2015, P NATL ACAD SCI USA, V112, P8173, DOI 10.1073/pnas.1509743112; Lu XQ, 2012, CHEMBIOCHEM, V13, P129, DOI 10.1002/cbic.201100585; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Moraski GC, 2013, ACS MED CHEM LETT, V4, P110, DOI 10.1021/ml400088y; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Prasad R, 2017, INDIAN J MED RES, V145, P271, DOI 10.4103/ijmr.IJMR_177_16; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rybniker J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8659; Shin HJ, 2015, TUBERC RESPIR DIS, V78, P161, DOI 10.4046/trd.2015.78.3.161; Sulochana S, 2009, J CHEMOTHERAPY, V21, P127, DOI 10.1179/joc.2009.21.2.127; Veziris N, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01719-2016; Warman AJ, 2013, J ANTIMICROB CHEMOTH, V68, P869, DOI 10.1093/jac/dks483; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2017, TREATMENT TUBERCULOS; Zheng J, 2013, J BIOL CHEM, V288, P23447, DOI 10.1074/jbc.M113.475798	33	28	28	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1936	1943		10.1074/jbc.RA118.005732	http://dx.doi.org/10.1074/jbc.RA118.005732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30530783	Green Published, hybrid			2022-12-26	WOS:000459711400014
J	Turowec, JP; Lau, EWT; Wang, XW; Brown, KR; Fellouse, FA; Jawanda, KK; Pan, J; Moffat, J; Sidhu, SS				Turowec, Jacob P.; Lau, Esther W. T.; Wang, Xiaowei; Brown, Kevin R.; Fellouse, Frederic A.; Jawanda, Kamaldeep K.; Pan, James; Moffat, Jason; Sidhu, Sachdev S.			Functional genomic characterization of a synthetic anti-HER3 antibody reveals a role for ubiquitination by RNF41 in the anti-proliferative response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; antibody engineering; ubiquitylation (ubiquitination); functional genomics; E3 ubiquitin ligase; cell signaling; short hairpin RNA (shRNA); cancer; protein engineering; HER3; RNF41	EPIDERMAL-GROWTH-FACTOR; HER3 MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; PHOSPHATIDYLINOSITOL 3-KINASE; PREDICTIVE BIOMARKER; EXTRACELLULAR DOMAIN; MEK INHIBITION; EGF RECEPTOR; ERBB3; CANCER	Dysregulation of the ErbB family of receptor tyrosine kinases is involved in the progression of many cancers. Antibodies targeting the dimerization domains of family members EGFR and HER2 are approved cancer therapeutics, but efficacy is restricted to a subset of tumors and resistance often develops in response to treatment. A third family member, HER3, heterodimerizes with both EGFR and HER2 and has also been implicated in cancer. Consequently, there is strong interest in developing antibodies that target HER3, but to date, no therapeutics have been approved. To aid the development of anti-HER3 antibodies as cancer therapeutics, we combined antibody engineering and functional genomics screens to identify putative mechanisms of resistance or synthetic lethality with antibody-mediated anti-proliferative effects. We developed a synthetic antibody called IgG 95, which binds to HER3 and promotes ubiquitination, internalization, and receptor down-regulation. Using an shRNA library targeting enzymes in the ubiquitin proteasome system, we screened for genes that effect response to IgG 95 and uncovered the E3 ubiquitin ligase RNF41 as a driver of IgG 95 anti-proliferative activity. RNF41 has been shown previously to regulate HER3 levels under normal conditions and we now show that it is also responsible for down-regulation of HER3 upon treatment with IgG 95. Moreover, our findings suggest that down-regulation of RNF41 itself may be a mechanism for acquired resistance to treatment with IgG 95 and perhaps other anti-HER3 antibodies. Our work deepens our understanding of HER3 signaling by uncovering the mechanistic basis for the anti-proliferative effects of potential anti-HER3 antibody therapeutics.	[Turowec, Jacob P.; Lau, Esther W. T.; Wang, Xiaowei; Brown, Kevin R.; Fellouse, Frederic A.; Jawanda, Kamaldeep K.; Pan, James; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Turowec, Jacob P.; Lau, Esther W. T.; Wang, Xiaowei; Brown, Kevin R.; Fellouse, Frederic A.; Jawanda, Kamaldeep K.; Pan, James; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Med Genet, Toronto, ON M5S 3E1, Canada; [Turowec, Jacob P.; Lau, Esther W. T.; Wang, Xiaowei; Brown, Kevin R.; Fellouse, Frederic A.; Jawanda, Kamaldeep K.; Pan, James; Moffat, Jason; Sidhu, Sachdev S.] Banting & Best Inst, Ctr Commercializat Antibodies & Biol, 100 Coll St, Toronto, ON M5G 1L5, Canada	University of Toronto; University of Toronto; University of Toronto	Moffat, J; Sidhu, SS (corresponding author), 160 Coll St, Toronto, ON M5S 3E1, Canada.	j.moffat@utoronto.ca; sachdev.sidhu@utoronto.ca	Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586; Brown, Kevin/0000-0002-5514-2538	Canadian Institutes of Health Research (CIHR) [MOP-136944]; CIHR post-doctoral fellowship; Mitacs Elevate fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR post-doctoral fellowship(Canadian Institutes of Health Research (CIHR)); Mitacs Elevate fellowship	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-136944 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a CIHR post-doctoral fellowship and a Mitacs Elevate fellowship.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Blakely K, 2011, METHODS MOL BIOL, V781, P161, DOI 10.1007/978-1-61779-276-2_9; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Gaborit N, 2016, HUM VACC IMMUNOTHER, V12, P576, DOI 10.1080/21645515.2015.1102809; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Huang Z, 2015, ONCOGENE, V34, P1105, DOI 10.1038/onc.2014.56; HYNES NE, 1989, J CELL BIOCHEM, V39, P167, DOI 10.1002/jcb.240390208; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Lazrek Y, 2013, NEOPLASIA, V15, P335, DOI 10.1593/neo.121960; Le Clorennec C, 2017, MOL CANCER THER, V16, P1312, DOI 10.1158/1535-7163.MCT-16-0886; Le Clorennec C, 2016, ONCOTARGET, V7, P37013, DOI 10.18632/oncotarget.9455; Lee S, 2015, P NATL ACAD SCI USA, V112, P13225, DOI 10.1073/pnas.1518361112; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Liu JF, 2016, J CLIN ONCOL, V34, P4345, DOI 10.1200/JCO.2016.67.1891; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu H, 2014, TUMOR BIOL, V35, P8639, DOI 10.1007/s13277-014-2132-5; Malm M, 2016, MABS-AUSTIN, V8, P1195, DOI 10.1080/19420862.2016.1212147; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Meetze K, 2015, CLIN CANCER RES, V21, P1106, DOI 10.1158/1078-0432.CCR-14-2407; Mendell J, 2015, EBIOMEDICINE, V2, P264, DOI 10.1016/j.ebiom.2015.02.005; Meulendijks D, 2016, CLIN CANCER RES, V22, P877, DOI 10.1158/1078-0432.CCR-15-1683; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Parakh S, 2017, CANCER TREAT REV, V59, P1, DOI 10.1016/j.ctrv.2017.06.005; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Rajan S, 2012, METHOD ENZYMOL, V502, P3, DOI 10.1016/B978-0-12-416039-2.00001-X; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Schulze Waltraud X, 2005, Mol Syst Biol, V1; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Steinkamp MP, 2014, MOL CELL BIOL, V34, P965, DOI 10.1128/MCB.01605-13; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Xiao Z, 2016, MOL CANCER THER, V15, P689, DOI 10.1158/1535-7163.MCT-15-0555; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319; Yonesaka K, 2017, LUNG CANCER, V105, P1, DOI 10.1016/j.lungcan.2016.12.018; Zhang NY, 2016, ACTA BIOCH BIOPH SIN, V48, P39, DOI 10.1093/abbs/gmv103	72	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1396	1409		10.1074/jbc.RA118.004420	http://dx.doi.org/10.1074/jbc.RA118.004420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30523157	Green Published, hybrid			2022-12-26	WOS:000457879500028
J	Arias-Real, R; Menendez, M; Abril, M; Oliva, F; Munoz, I				Arias-Real, Rebeca; Menendez, Margarita; Abril, Meritxell; Oliva, Francesc; Munoz, Isabel			Quality and quantity of leaf litter: Both are important for feeding preferences and growth of an aquatic shredder	PLOS ONE			English	Article							FRESH-WATER ECOSYSTEMS; FUNGAL DIVERSITY; MEDITERRANEAN STREAM; SPECIES-DIVERSITY; FATTY-ACIDS; DECOMPOSITION; FOOD; COLONIZATION; PALATABILITY; DEGRADATION	The study of leaf litter as a resource for shredders has emerged as a key topic in trophic links in ecology. However, thus far, most studies have emphasized the leaf quality as one of the main determinants of shredder behaviour and growth without simultaneously considering the leaf quantity availability. Nevertheless, the combined effects of leaf quantity and quality on shredder behaviour and growth is particularly crucial to further understand how ecosystem functioning may respond to the increasing flow intermittency due to climate change. In this study, we explore how changes in the leaf litter quality and quantity influence the feeding preferences and growth of an invertebrate shredder (Potamophylax latipennis). To do so, we used black poplar leaves conditioned in two streams with different flow regimens as a food resource. Afterwards, using a microcosm approach, we offered leaf discs that varied in terms of leaf quantity and quality to P. latipennis. Our results showed that flow intermittency had a negative effect on the quality of the food resource, and a lower quality had a negative effect on the consumption and growth rates of P. latipennis. Furthermore, we found that P. latipennis fed selectively on higher quality leaves even though the availability (quantity) of this resource was lower. In the context of climate change, with higher aridity/drier conditions/scenarios, our findings suggest that a decrease in the availability (quantity) of high-quality resources could potentially threaten links in global fluvial food webs and thus threaten ecosystem functioning.	[Arias-Real, Rebeca; Menendez, Margarita; Munoz, Isabel] Univ Barcelona, Fac Biol, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain; [Abril, Meritxell] Cent Univ Catalonia, Univ Vic, BETA Technol Ctr, Vic, Spain; [Oliva, Francesc] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Barcelona, Spain	University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Barcelona	Arias-Real, R (corresponding author), Univ Barcelona, Fac Biol, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain.	rebeca.arias.real@ub.edu	Oliva, Francesc/M-1173-2014; Menendez, Margarita/AAD-2043-2020; Muñoz, Isabel/L-9414-2014	Oliva, Francesc/0000-0002-8989-9117; Menendez, Margarita/0000-0002-6590-7960; Muñoz, Isabel/0000-0001-8110-9435; Abril, Meritxell/0000-0002-5103-5567; Arias del Real, Rebeca/0000-0002-9504-9418	Ministry of Economy, Industry and Competitiveness of Spain [CGL2014-58760-C3-1-R, CGL2017-88640-C2-2-R, BES-2015-073961]	Ministry of Economy, Industry and Competitiveness of Spain	This work was funded by the Ministry of Economy, Industry and Competitiveness of Spain via the projects CGL2014-58760-C3-1-R and CGL2017-88640-C2-2-R. RAR held a predoctoral grant (BES-2015-073961, FPI) from the Ministry of Economy, Industry and Competitiveness of Spain. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril M, 2016, SCI TOTAL ENVIRON, V553, P330, DOI 10.1016/j.scitotenv.2016.02.082; ARSUFFI T L, 1986, Journal of the North American Benthological Society, V5, P297, DOI 10.2307/1467482; ARSUFFI TL, 1984, OIKOS, V42, P144, DOI 10.2307/3544786; Auer SK, 2015, FUNCT ECOL, V29, P479, DOI 10.1111/1365-2435.12396; Barlocher F, 2016, FUNGAL ECOL, V19, P14, DOI 10.1016/j.funeco.2015.05.005; BARLOCHER F, 1985, BOT J LINN SOC, V91, P83, DOI 10.1111/j.1095-8339.1985.tb01137.x; BARLOCHER F, 1975, OIKOS, V26, P55, DOI 10.2307/3543277; Cargill A.S. II, 1985, FRESHWATER INVERTEBRATE BIOLOGY, V4, P64; CARGILL AS, 1985, FRESHWATER BIOL, V15, P455, DOI 10.1111/j.1365-2427.1985.tb00215.x; CHAMIER AC, 1982, OECOLOGIA, V52, P109, DOI 10.1007/BF00349018; Chauvet E, 2016, FUNGAL ECOL, V19, P112, DOI 10.1016/j.funeco.2015.05.014; Chung N, 2009, HYDROBIOLOGIA, V630, P257, DOI 10.1007/s10750-009-9820-y; Costantini ML, 2010, FRESHWATER BIOL, V55, P2281, DOI 10.1111/j.1365-2427.2010.02433.x; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Cruz-Rivera AE, 2008, ECOLOGY, V81, P201; Dang CK, 2005, ECOL LETT, V8, P1129, DOI 10.1111/j.1461-0248.2005.00815.x; Danger M, 2013, FUNGAL ECOL, V6, P453, DOI 10.1016/j.funeco.2013.05.007; Datry T, 2014, BIOSCIENCE, V64, P229, DOI 10.1093/biosci/bit027; Dieter D, 2013, FRESHWATER BIOL, V58, P1918, DOI 10.1111/fwb.12180; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Flores L, 2014, FRESHW SCI, V33, P134, DOI 10.1086/674578; Frost PC, 2006, ECOL LETT, V9, P774, DOI 10.1111/j.1461-0248.2006.00919.x; Frost PC, 2005, OIKOS, V109, P18, DOI 10.1111/j.0030-1299.2005.14049.x; Geraldes P, 2012, FUNGAL ECOL, V5, P734, DOI 10.1016/j.funeco.2012.05.007; Gessner Mark O., 2005, P189, DOI 10.1007/1-4020-3466-0_25; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; GESSNER MO, 1993, APPL ENVIRON MICROB, V59, P502, DOI 10.1128/AEM.59.2.502-507.1993; Goncalves AL, 2016, INT REV HYDROBIOL, V101, P78, DOI 10.1002/iroh.201501817; Goncalves AL, 2014, FRESHWATER BIOL, V59, P2172, DOI 10.1111/fwb.12420; Gonczol J, 2001, ARCH HYDROBIOL, V150, P677; GRACA MAS, 1993, OECOLOGIA, V93, P139, DOI 10.1007/BF00321203; Graca MAS, 2001, INT REV HYDROBIOL, V86, P383, DOI 10.1002/1522-2632(200107)86:4/5<383::AID-IROH383>3.0.CO;2-D; Grimmett IJ, 2013, FUNGAL ECOL, V6, P493, DOI 10.1016/j.funeco.2013.08.002; Kaspari M, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00136.1; Kuehn KA, 2016, FUNGAL ECOL, V19, P135, DOI 10.1016/j.funeco.2015.09.009; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Leberfinger K, 2010, AQUAT ECOL, V44, P195, DOI 10.1007/s10452-009-9268-1; Leigh C, 2016, FRESHWATER BIOL, V61, P1181, DOI 10.1111/fwb.12646; Marcarelli AM, 2011, ECOLOGY, V92, P1215, DOI 10.1890/10-2240.1; Martinez A, 2015, SCI TOTAL ENVIRON, V503, P251, DOI 10.1016/j.scitotenv.2014.06.018; Mas-Marti E, 2017, AQUAT SCI, V79, P719, DOI 10.1007/s00027-017-0531-6; Mas-Marti E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118520; Menendez M, 2013, HYDROBIOLOGIA, V716, P5, DOI 10.1007/s10750-013-1539-0; Menendez M, 2012, HYDROBIOLOGIA, V691, P135, DOI 10.1007/s10750-012-1064-6; Menendez M, 2011, HYDROBIOLOGIA, V669, P143, DOI 10.1007/s10750-011-0657-9; Mora-Gomez J, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw121; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Pascoal C, 2010, MICROB ECOL, V59, P84, DOI 10.1007/s00248-009-9567-z; R Development Core Team, 2011, R FDN STAT COMP, V1, P409; Richardson JS, 2010, RIVER RES APPL, V26, P55, DOI 10.1002/rra.1283; Rong Q, 1995, HYDROBIOLOGIA, V316, P173, DOI 10.1007/BF00017435; Sanpera-Calbet I, 2017, LIMNETICA, V36, P29, DOI 10.23818/limn.36.03; Sterner R. W., 2002, NEW PHYTOL, V186, P593, DOI [10.1111/j.1469-8137.2010.03214.x, DOI 10.1111/J.1469-8137.2010.03214.X]; SUBERKROPP K, 1984, MYCOLOGIA, V76, P398, DOI 10.2307/3793320; SUBERKROPP K, 1983, APPL ENVIRON MICROB, V46, P237, DOI 10.1128/AEM.46.1.237-244.1983; Torres-Ruiz M, 2007, J N AM BENTHOL SOC, V26, P509, DOI 10.1899/06-070.1; Torres-Ruiz M, 2010, HYDROBIOLOGIA, V651, P265, DOI 10.1007/s10750-010-0305-9; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warkentin M, 2007, APPL ENVIRON MICROB, V73, P6722, DOI 10.1128/AEM.00405-07; Woodward G, 2009, FRESHWATER BIOL, V54, P2171, DOI 10.1111/j.1365-2427.2008.02081.x; ZOLLNER N., 1962, ZEIT GES EXPTL MED, V135, P545, DOI 10.1007/BF02045455; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	62	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208272	10.1371/journal.pone.0208272	http://dx.doi.org/10.1371/journal.pone.0208272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540796	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600067
J	Dash, M; Yordanov, YS; Georgieva, T; Wei, HR; Busov, V				Dash, Madhumita; Yordanov, Yordan S.; Georgieva, Tatyana; Wei, Hairong; Busov, Victor			Gene network analysis of poplar root transcriptome in response to drought stress identifies a PtaJAZ3PtaRAP2.6-centered hierarchical network	PLOS ONE			English	Article							ARCHITECTURAL TRAITS; REGULATORY NETWORKS; JASMONATE; GROWTH; ARABIDOPSIS; ACTIVATION; GENOTYPES; ACID; IMPROVEMENT; ACCLIMATION	Using time-series transcriptomic data from poplar roots undergoing polyethylene glycol (PEG)-induced drought stress, we built a genetic network model of the involved putative molecular responses. We found that the network resembled a hierarchical structure. The highest hierarchical level in this structure is occupied by 9 genes, which we called superhubs because they were primarily connected to 18 hub genes, which are then connected to 2,934 terminal genes. We were only able to regenerate transgenic plants overexpressing two of the superhubs, suggesting that the majority of the superhubs might interfere with the regeneration process and did not allow recovery of transgenic plants. The two superhubs encode proteins with closest homology to JAZ3 and RAP2.6 genes of Arabidopsis and were consequently named PtaJAZ3 and PtaRAP2.6. PtaJAZ3 and PtaRAP2.6 overexpressing trans genic lines showed a significant increase in both root elongation and lateral root proliferation and these responses were specific for the drought stress conditions and were highly correlated with the levels of overexpression of the transgenes. Several lines of evidence suggest of regulatory interactions between the two superhubs. Both superhubs were significantly induced by methyl jasmonate (MeJA). Because jasmonate signaling involves ubiquitin-mediated proteasome degradation, treatment with proteasome inhibitor abolished the MeJA induction for both genes. PtaRAP2.6 was upregulated in PtaJAZ3 transgenics but PtaJAZ3 expression was not affected in the PtaRAP2.6 overexpressors. The discovery of the two genes and further future insights into the associated mechanisms can lead to improved understanding and novel approaches to regulate root architecture in relation to drought stress.	[Dash, Madhumita; Yordanov, Yordan S.; Georgieva, Tatyana; Wei, Hairong; Busov, Victor] Michigan Technol Univ, Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Dash, Madhumita] SquadRun, A-29,Sect 3, Noida, India; [Yordanov, Yordan S.] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA	Michigan Technological University; Eastern Illinois University	Busov, V (corresponding author), Michigan Technol Univ, Forest Resources & Environm Sci, Houghton, MI 49931 USA.	vbusov@mtu.edu	wei, hairong/GNM-7061-2022	wei, hairong/0000-0002-3551-4998; Dash, Madhumita/0000-0002-0571-3152	Plant Feedstock Genomics for Bioenergy: A Joint Research Program of USDA; DOE [2009-65504-05767, DE-SC0008462]; USDA McIntire Stennis Fund [1001498]	Plant Feedstock Genomics for Bioenergy: A Joint Research Program of USDA; DOE(United States Department of Energy (DOE)); USDA McIntire Stennis Fund(United States Department of Agriculture (USDA))	This research was supported, by grants from the Plant Feedstock Genomics for Bioenergy: A Joint Research Program of USDA and DOE (2009-65504-05767 and DE-SC0008462) and USDA McIntire Stennis Fund (Grant 1001498).	Albacete AA, 2014, BIOTECHNOL ADV, V32, P12, DOI 10.1016/j.biotechadv.2013.10.005; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Barchet GLH, 2014, TREE PHYSIOL, V34, P1203, DOI 10.1093/treephys/tpt080; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boter M, 2015, PLANT CELL, V27, P3160, DOI 10.1105/tpc.15.00220; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Busov VB, 2003, PLANT PHYSIOL, V132, P1283, DOI 10.1104/pp.103.020354; Cao X, 2014, PHYSIOL PLANTARUM, V151, P480, DOI 10.1111/ppl.12138; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Comas LH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00442; Dash M, 2017, PLANT J, V89, P692, DOI 10.1111/tpj.13413; Dash M, 2015, PLANT J, V84, P335, DOI 10.1111/tpj.13002; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elias AA, 2012, GREEN REVOLUTION TRE; Famiglietti JS, 2013, SCIENCE, V340, P1300, DOI 10.1126/science.1236460; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gitter A, 2013, GENOME RES, V23, P365, DOI 10.1101/gr.138628.112; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hamanishi ET, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1535-z; Han KH, 2000, PLANT CELL REP, V19, P315, DOI 10.1007/s002990050019; Hao ZF, 2010, EUPHYTICA, V174, P165, DOI 10.1007/s10681-009-0091-5; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; He P, 2004, PLANT J, V37, P589, DOI 10.1111/j.1365-313X.2003.01986.x; Henry A, 2011, FIELD CROP RES, V120, P205, DOI 10.1016/j.fcr.2010.10.003; Huang BR, 2000, CROP SCI, V40, P196, DOI 10.2135/cropsci2000.401196x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jia JB, 2016, PHYSIOL PLANTARUM, V157, P38, DOI 10.1111/ppl.12400; Kashiwagi J, 2005, EUPHYTICA, V146, P213, DOI 10.1007/s10681-005-9007-1; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Kim YS, 2007, BIOTECHNOL LETT, V29, P1789, DOI 10.1007/s10529-007-9442-2; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Lavenus J, 2015, PLANT CELL, V27, P1368, DOI 10.1105/tpc.114.132993; Lorenz WW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-264; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Ren CM, 2009, PLANT PHYSIOL, V151, P1412, DOI 10.1104/pp.109.140202; Riemann M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01077; Schulz MH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-104; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Stolf-Moreira R, 2011, PLANT MOL BIOL REP, V29, P19, DOI 10.1007/s11105-010-0203-3; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Uga Y, 2011, J EXP BOT, V62, P2485, DOI 10.1093/jxb/erq429; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Valenzuela CE, 2016, J EXP BOT, V67, P4209, DOI 10.1093/jxb/erw202; Wei HR, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.27211; Wei HR, 2013, NEW PHYTOL, V200, P483, DOI 10.1111/nph.12375; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Ye X, 2011, CRIT REV PLANT SCI, V30, P415, DOI 10.1080/07352689.2011.605737; Yordanov YS, 2010, PLANT CELL, V22, P3662, DOI 10.1105/tpc.110.078634; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zhu Q, 2010, GENE, V457, P1, DOI 10.1016/j.gene.2010.02.011; Zou Y, 2016, J INTEGR PLANT BIOL, V58, P600, DOI 10.1111/jipb.12427	64	8	8	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208560	10.1371/journal.pone.0208560	http://dx.doi.org/10.1371/journal.pone.0208560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540849	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600079
J	Diaz-Lara, A; Klaassen, V; Stevens, K; Sudarshana, MR; Rowhani, A; Maree, HJ; Chooi, KM; Blouin, AG; Habili, N; Song, YS; Aram, K; Arnold, K; Cooper, ML; Wunderlich, L; Battany, MC; Bettiga, LJ; Smith, RJ; Bester, R; Xiao, HG; Menh, B; Preece, JE; Golino, D; Al Rwahnih, M				Diaz-Lara, Alfredo; Klaassen, Vicki; Stevens, Kristian; Sudarshana, Mysore R.; Rowhani, Adib; Maree, Hans J.; Chooi, Kar Mun; Blouin, Arnaud G.; Habili, Nuredin; Song, Yashu; Aram, Kamyar; Arnold, Kari; Cooper, Monica L.; Wunderlich, Lynn; Battany, Mark C.; Bettiga, Larry J.; Smith, Rhonda J.; Bester, Rachelle; Xiao, Huogen; Menh, Baozhong; Preece, John E.; Golino, Deborah; Al Rwahnih, Maher			Characterization of grapevine leafroll-associated virus 3 genetic variants and application towards RT-qPCR assay design	PLOS ONE			English	Article							TRANSMISSION; DIVERSITY	Grapevine leafroll-associated virus 3 (GLRaV-3) is the most widely prevalent and economically important of the complex of RNA viruses associated with grapevine leafroll disease (GLD). Phylogenetic studies have grouped GLRaV-3 isolates into nine different monophyletic groups and four supergroups, making GLRaV-3 a genetically highly diverse virus species. In addition, new divergent variants have been discovered recently around the world. Accurate identification of the virus is an essential component in the management and control of GLRaV-3; however, the diversity of GLRaV-3, coupled with the limited sequence information, have complicated the development of a reliable detection assay. In this study, GLRaV-3 sequence data available in GenBank and those generated at Foundation Plant Services, University of California-Davis, was used to develop a new RT-qPCR assay with the capacity to detect all known GLRaV-3 variants. The new assay, referred to as FPST, was challenged against samples that included plants infected with different GLRaV-3 variants and originating from 46 countries. The FPST assay detected all known GLRaV-3 variants, including the highly divergent variants, by amplifying a small highly conserved region in the 3' untranslated terminal region (UTR) of the virus genome. The reliability of the new RT-qPCR assay was confirmed by an enzyme linked immunosorbent assay (ELISA) that can detect all known GLRaV-3 variants characterized to date. Additionally, three new GLRaV-3 divergent variants, represented by four isolates, were identified using a hierarchical testing process involving the FPST assay, GLRaV-3 variant-specific assays and high-throughput sequencing analysis. These variants were distantly related to groups I, II, III, V, VI, VII and IX, but much similar to GLRaV-3 variants with no assigned group; thus, they may represent new clades. Finally, based on the phylogenetic analysis, a new GLRaV-3 subclade is proposed and named as group X.	[Diaz-Lara, Alfredo; Rowhani, Adib; Aram, Kamyar; Golino, Deborah; Al Rwahnih, Maher] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Klaassen, Vicki] Univ Calif Davis, Fdn Plant Serv, Davis, CA 95616 USA; [Stevens, Kristian] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Sudarshana, Mysore R.] Univ Calif Davis, USDA, ARS, Davis, CA 95616 USA; [Maree, Hans J.; Bester, Rachelle] Stellenbosch Univ, Dept Genet, Stellenbosch, South Africa; [Chooi, Kar Mun; Blouin, Arnaud G.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Habili, Nuredin] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Song, Yashu; Xiao, Huogen; Menh, Baozhong] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Arnold, Kari] Univ Calif Modesto, Cooperat Extens Stanislaus Cty, Modesto, CA USA; [Cooper, Monica L.] Univ Calif Napa, Cooperat Extens Napa Cty, Napa, CA USA; [Wunderlich, Lynn] Univ Calif Placerville, Cooperat Extens Cent Sierra, Placerville, CA USA; [Battany, Mark C.] Univ Calif San Luis Obispo, Cooperat Extens San Luis Obispo Cty, San Luis Obispo, CA USA; [Bettiga, Larry J.] Univ Calif Monterey, Cooperat Extens Monterey Cty, Monterey, CA USA; [Smith, Rhonda J.] Univ Calif Sonoma, Cooperat Extens Sonoma Cty, Sonoma, CA USA; [Preece, John E.] ARS, Natl Clonal Germplasm Repository, USDA, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Davis; Stellenbosch University; New Zealand Institute for Plant & Food Research Ltd; University of Adelaide; University of Guelph; United States Department of Agriculture (USDA)	Al Rwahnih, M (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	malrwahnih@ucdavis.edu	Diaz-Lara, Alfredo/AFJ-8316-2022; Bester, Rachelle/AAY-2621-2020; Diaz-Lara, Alfredo/AAF-5150-2022; Bester, Rachelle/AAZ-2127-2020	Diaz-Lara, Alfredo/0000-0002-4736-8019; Bester, Rachelle/0000-0002-2226-0968; Al Rwahnih, Maher/0000-0003-1589-9234; Maree, Hano/0000-0001-9639-4558	Pierce's Disease and Glassy-winged sharpshooter Research Board, California Department of Food and Agriculture [17-0430-000-5A]; New Zealand Ministry of Business, Innovation & Employment Strategic Science Investment Fund; Gryphon's LAAIR project of OMAFRA-UoG Partnerships program [LAAIR2017-5293]	Pierce's Disease and Glassy-winged sharpshooter Research Board, California Department of Food and Agriculture; New Zealand Ministry of Business, Innovation & Employment Strategic Science Investment Fund; Gryphon's LAAIR project of OMAFRA-UoG Partnerships program	This project was supported by funding from the Pierce's Disease and Glassy-winged sharpshooter Research Board, which is part of the California Department of Food and Agriculture (agreement no. 17-0430-000-5A), funds awarded to MAR and DG. The New Zealand section of the work is part of The New Zealand Institute for Plant and Food Research Limited's Wine Research programme, funded by the New Zealand Ministry of Business, Innovation & Employment Strategic Science Investment Fund, such funds were awarded to KMC and AGB. The part of the work related to Canadian samples was funded by a Gryphon's LAAIR project of OMAFRA-UoG Partnerships program (project LAAIR2017-5293) awarded to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2017, PHYTOPATHOLOGY, V107, P141; Al Rwahnih M, 2018, PLANT DIS, V102, P1419, DOI 10.1094/PDIS-12-17-1988-RE; Al Rwahnih M, 2013, PHYTOPATHOLOGY, V103, P1069, DOI 10.1094/PHYTO-10-12-0253-R; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bester R, 2014, J VIROL METHODS, V210, P67, DOI 10.1016/j.jviromet.2014.09.022; Bruisson S, 2017, J VIROL METHODS, V240, P73, DOI 10.1016/j.jviromet.2016.12.003; Burger J.T., 2017, GRAPEVINE VIRUSES MO, P167; Chooi KM, 2013, ARCH VIROL, V158, P1597, DOI 10.1007/s00705-013-1631-9; Chooi KM, 2013, J VIROL METHODS, V189, P20, DOI 10.1016/j.jviromet.2012.12.018; Cohen D, 2018, P 19 C ICVG SAN CHIL, P1076, DOI [10.1094/PHYTO-10-12-0253-R, DOI 10.1094/PHYTO-10-12-0253-R]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farooq AU, 2013, VIRUS RES, V171, P15, DOI 10.1016/j.virusres.2012.10.014; Fuchs M, 2009, PLANT DIS, V93, P395, DOI 10.1094/PDIS-93-4-0395; Fuller KB, 2015, AM J ENOL VITICULT, V66, P112, DOI 10.5344/ajev.2014.14055; Gouveia P, 2012, VIRUS GENES, V45, P333, DOI 10.1007/s11262-012-0772-3; Gouveia P, 2011, ARCH VIROL, V156, P413, DOI 10.1007/s00705-010-0878-7; Jooste AEC, 2015, EUR J PLANT PATHOL, V142, P363, DOI 10.1007/s10658-015-0620-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Le Maguet J, 2012, PHYTOPATHOLOGY, V102, P717, DOI 10.1094/PHYTO-10-11-0289; Maree HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126819; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; Puckett J., 2018, P 19 C ICVG SANT, P184; Rast H.E., 2012, P 17 C INT COUNCIL S, P61; ROWHANI A, 1992, AM J ENOL VITICULT, V43, P38; Sharma AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026227; Thompson BD, 2019, PLANT DIS, V103, P509, DOI [10.1094/PDIS-08-18-1303-RE, 10.1094/pdis-08-18-1303-re]; Tsai CW, 2010, PHYTOPATHOLOGY, V100, P830, DOI 10.1094/PHYTO-100-8-0830; Wang JB, 2011, PHYTOPATHOLOGY, V101, P445, DOI 10.1094/PHYTO-07-10-0173; Xiao HG, 2019, PLANT DIS, V103, P1275, DOI 10.1094/PDIS-09-18-1503-RE; Xiao HG, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1036-1	30	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208862	10.1371/journal.pone.0208862	http://dx.doi.org/10.1371/journal.pone.0208862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540844	Green Published, gold			2022-12-26	WOS:000452898600093
J	Ren, JP; Ling, F; Sun, JM; Gong, ZY; Liu, Y; Shi, XG; Zhang, R; Zhai, YJ; Chen, EF; Chen, ZP				Ren, Jiangping; Ling, Feng; Sun, Jimin; Gong, Zhenyu; Liu, Ying; Shi, Xuguang; Zhang, Rong; Zhai, Yujia; Chen, Enfu; Chen, Zhiping			Epidemiological profile of dengue in Zhejiang Province, southeast China	PLOS ONE			English	Article							RISK-FACTORS; OUTBREAK; FEVER; TEMPERATURE; INFECTION; BURDEN; BRAZIL	Background Dengue is one of the most important vector-bore infectious diseases in China because of its drastic increase in incidence, geographic extension and profound influence on China's economy. This study aims to retrospectively uncover the epidemiological profile of dengue in Zhejiang, one of the most developed provinces in China, and to find the problem existing in dengue control and prevention. Methodology Descriptive analyses on the dengue incidence and associated factors were performed. We also identified potential space-time cluster and generated the risk map of dengue. Principal findings A total of 529 cases were reported in Zhejiang Province from 2005 to 2016, and 44.4% were imported. 67.7% of cases were 25-60 years old and the overall male-to-female sex ratio was 1.09:1. Dengue was reported all year round and 70.7% of cases occurred between August and October. Indigenous cases were only reported in the period between July to November and more than half occurred in September. Geographically, dengue was most distributed in Jinghua (3.62 per million), Shaoxing (1.00 per million) and Taizhou (0.81 per million) prefecture level cities. Outbreaks were confirmed in Yiwu, Keqiao and Huangyan counties in 2009, 2015, and 2016, respectively. 73.9% cases would seek medical advice within two days after onset and be confirmed within 9 days after onset. 75.6% would be recognized as dengue within 8 days after their first visit. The time intervals between onset and confirmation (median 7 vs 6 days; Wilcoxon rank sum test Z=-2.40, P= 0.016), first visit and confirmation (median 7 vs 6 days; Wilcoxon rank sum test Z=-2.59, P =0.009) of indigenous cases were significantly longer than those of imported ones. However, the time intervals between onset and first visit for indigenous cases was shorter (median 0 vs 1 days; Wilcoxon rank sum test Z= -2.10, P= 0.036). Fever (99.1%), fatigue (81.9), rash (63.7%), headache (67.2%) and myalgia (52.60%) were the most frequently mentioned symptoms. Conclusions Zhejiang has recently witnessed an increase in incidence and geographic extension of dengue. Timely diagnosis is important to stop local transmission and outbreak.	[Ren, Jiangping; Ling, Feng; Sun, Jimin; Gong, Zhenyu; Liu, Ying; Shi, Xuguang; Zhang, Rong; Zhai, Yujia; Chen, Enfu; Chen, Zhiping] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Ren, Jiangping; Ling, Feng; Sun, Jimin; Gong, Zhenyu; Chen, Enfu] Key Lab Vaccine Prevent & Control Infect Dis Zhej, Hangzhou, Zhejiang, Peoples R China; [Ren, Jiangping] Field Epidemiol Training Program Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Chen, EF; Chen, ZP (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Chen, EF (corresponding author), Key Lab Vaccine Prevent & Control Infect Dis Zhej, Hangzhou, Zhejiang, Peoples R China.	sullyrjp@sina.com; 394856670@qq.com			Medical Research Program of Zhejiang Province [2015RCA005]; Zhejiang Provincal Medical Science and Technology Platform Project [2017RC018]	Medical Research Program of Zhejiang Province; Zhejiang Provincal Medical Science and Technology Platform Project	This work was supported by the Medical Research Program of Zhejiang Province (2015RCA005) to JR and Zhejiang Provincal Medical Science and Technology Platform Project (no. 2017RC018) to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, DENG GUID DIAGN TREA, pe1760, DOI [10.1371/journal.pntd.0001760, DOI 10.1371/JOURNAL.PNTD.0001760]; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Brunkard JM, 2008, SALUD PUBLICA MEXICO, V50, P227; Burattini MN, 2016, CLINICS, V71, P455, DOI 10.6061/clinics/2016(08)08; Campos KB, 2015, TROP MED INT HEALTH, V20, P211, DOI 10.1111/tmi.12425; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Guo RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085596; Guo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112975; Haryanto S, 2016, PATHOG GLOB HEALTH, V110, P119, DOI 10.1080/20477724.2016.1184864; Huang XY, 2014, BIOMED ENVIRON SCI, V27, P894, DOI 10.3967/bes2014.125; Je S, 2016, J KOREAN MED SCI, V31, P1863, DOI 10.3346/jkms.2016.31.12.1863; Karunakaran A, 2014, J INFECT PUBLIC HEAL, V7, P114, DOI 10.1016/j.jiph.2013.09.006; Khalil Muhammad Abdul Mabood, 2014, BMC Res Notes, V7, P473, DOI 10.1186/1756-0500-7-473; Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1; Li ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-132; Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Pooja C, 2014, ASIAN PAC J TROP MED, V7, P169, DOI 10.1016/S1995-7645(14)60016-X; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Sun JM, 2017, INT J INFECT DIS, V57, P86, DOI 10.1016/j.ijid.2017.02.007; Wang Cheng-Gang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P1064; Wang JZ, 2017, SCI CHINA LIFE SCI, V60, P72, DOI 10.1007/s11427-016-0021-y; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wilson ME, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0457-2; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182; Yacoub Sophie, 2016, F1000Res, V5, DOI 10.12688/f1000research.6233.1; Yin XR, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658090, 10.1590/s1678-9946201658090]; Zhang H., 2014, BIOMED RES INT	31	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208810	10.1371/journal.pone.0208810	http://dx.doi.org/10.1371/journal.pone.0208810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533054	Green Published, gold, Green Submitted			2022-12-26	WOS:000452782500039
J	Acton, WJF; Jud, W; Ghirardo, A; Wohlfahrt, G; Hewitt, CN; Taylor, JE; Hansel, A				Acton, W. J. F.; Jud, W.; Ghirardo, A.; Wohlfahrt, G.; Hewitt, C. N.; Taylor, J. E.; Hansel, A.			The effect of ozone fumigation on the biogenic volatile organic compounds (BVOCs) emitted from Brassica napus above- and below-ground	PLOS ONE			English	Article							REACTION-MASS-SPECTROMETRY; INDUCED PLANT VOLATILES; ION FLOW TUBE; TROPOSPHERIC OZONE; PTR-MS; ATMOSPHERIC SESQUITERPENES; EMISSIONS; SERIES; SIFT; H3O+	The emissions of BVOCs from oilseed rape (Brassica napus), both when the plant is exposed to clean air and when it is fumigated with ozone at environmentally-relevant mixing ratios (ca. 135 ppbv), were measured under controlled laboratory conditions. Emissions of BVOCs were recorded from combined leaf and root chambers using a recently developed Selective Reagent Ionisation-Time of Flight-Mass Spectrometer (SRI-ToF-MS) enabling BVOC detection with high time and mass resolution, together with the ability to identify certain molecular functionality. Emissions of BVOCs from below-ground were found to be dominated by sulfur compounds including methanethiol, dimethyl disulfide and dimethyl sulfide, and these emissions did not change following fumigation of the plant with ozone. Emissions from above-ground plant organs exposed to clean air were dominated by methanol, monoterpenes, 4-oxopentanal and methanethiol. Ozone fumigation of the plants caused a rapid decrease in monoterpene and sesquiterpene concentrations in the leaf chamber and increased concentrations of ca. 20 oxygenated species, almost doubling the total carbon lost by the plant leaves as volatiles. The drop in sesquiterpenes concentrations was attributed to ozonolysis occurring to a major extent on the leaf surface. The drop in monoterpene concentrations was attributed to gas phase reactions with OH radicals deriving from ozonolysis reactions. As plant-emitted terpenoids have been shown to play a role in plant-plant and plant-insect signalling, the rapid loss of these species in the air surrounding the plants during photochemical pollution episodes may have a significant impact on plant-plant and plant-insect communications.	[Acton, W. J. F.; Hewitt, C. N.; Taylor, J. E.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Jud, W.; Hansel, A.] Univ Innsbruck, Inst Ion & Appl Phys, Innsbruck, Austria; [Jud, W.; Ghirardo, A.] Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Res Unit Environm Simulat EUS, Neuherberg, Germany; [Wohlfahrt, G.] Univ Innsbruck, Inst Ecol, Innsbruck, Austria	Lancaster University; University of Innsbruck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Innsbruck	Acton, WJF (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	w.acton@lancaster.ac.uk	Ghirardo, Andrea/P-1764-2019; Wohlfahrt, Georg/D-2409-2009; Hewitt, Charles Nicholas/ABF-9429-2020; Hansel, Armin/F-3915-2010	Ghirardo, Andrea/0000-0003-1973-4007; Wohlfahrt, Georg/0000-0003-3080-6702; Hewitt, Charles Nicholas/0000-0001-7973-2666; Hansel, Armin/0000-0002-1062-2394; Acton, William/0000-0001-5328-3399; Taylor, Jane Elizabeth/0000-0002-1467-7149; Jud, Werner/0000-0003-4267-0435	Biotechnology and Biological Sciences Research Council; Ionicon Analytik GmbH Industrial CASE studentship [1095375, BB/I015442/1]; BBSRC/Ionicon Analytik GmbH Industrial CASE studentship	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ionicon Analytik GmbH Industrial CASE studentship; BBSRC/Ionicon Analytik GmbH Industrial CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council and Ionicon Analytik GmbH Industrial CASE studentship [awards 1095375 and BB/I015442/1]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; W.J.F. Acton was in receipt of a BBSRC/Ionicon Analytik GmbH Industrial CASE studentship.	Acton WJF, 2016, ATMOS CHEM PHYS, V16, P7149, DOI 10.5194/acp-16-7149-2016; Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; Atkinson R, 2003, ATMOS ENVIRON, V37, pS197, DOI 10.1016/S1352-2310(03)00391-1; Atkinson R, INT J CHEM KINETICS; Behnke K, 2009, TREE PHYSIOL, V29, P725, DOI 10.1093/treephys/tpp009; Calfapietra C, 2007, PLANT CELL ENVIRON, V30, P654, DOI 10.1111/j.1365-3040.2007.01646.x; CRIEGEE R, 1975, ANGEW CHEM INT EDIT, V14, P745, DOI 10.1002/anie.197507451; Danner H, 2012, J CHEM ECOL, V38, P785, DOI 10.1007/s10886-012-0129-3; de Gouw J, 2007, MASS SPECTROM REV, V26, P223, DOI 10.1002/mas.20119; Degenhardt J, 2009, P NATL ACAD SCI USA, V106, P13213, DOI 10.1073/pnas.0906365106; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Diskin AM, 2002, INT J MASS SPECTROM, V218, P87, DOI 10.1016/S1387-3806(02)00662-0; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Fall R, 1999, J GEOPHYS RES-ATMOS, V104, P15963, DOI 10.1029/1999JD900144; Fares S, 2006, PHYSIOL PLANTARUM, V128, P456, DOI 10.1111/j.1399-3054.2006.00750.x; Fares S, 2010, PHOTOSYNTH RES, V104, P61, DOI 10.1007/s11120-010-9549-5; Farre-Armengol G, 2016, NEW PHYTOL, V209, P152, DOI 10.1111/nph.13620; Fischer T, 2014, ACIAR MONOGR SER, V158, P1; Fruekilde P, 1998, ATMOS ENVIRON, V32, P1893, DOI 10.1016/S1352-2310(97)00485-8; Fu Y, 2015, ATMOS CHEM PHYS, V15, P10093, DOI 10.5194/acp-15-10093-2015; Ghalaieny M, 2012, PHYS CHEM CHEM PHYS, V14, P6596, DOI 10.1039/c2cp23988d; Ghirardo A, 2016, ATMOS CHEM PHYS, V16, P2901, DOI 10.5194/acp-16-2901-2016; Ghirardo A, 2012, PLANT CELL ENVIRON, V35, P2192, DOI 10.1111/j.1365-3040.2012.02545.x; Gonzalez FR, 1999, J CHROMATOGR A, V842, P29, DOI 10.1016/S0021-9673(99)00158-2; Gosset V, 2009, J EXP BOT, V60, P1231, DOI 10.1093/jxb/erp015; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; Guenther AB, 2012, GEOSCI MODEL DEV, V5, P1471, DOI 10.5194/gmd-5-1471-2012; HANSEL A, 1995, INT J MASS SPECTROM, V149, P609, DOI 10.1016/0168-1176(95)04294-U; Heiden AC, 1999, ECOL APPL, V9, P1160, DOI 10.1890/1051-0761(1999)009[1160:EOVOCF]2.0.CO;2; Hewitt CN, 2003, J ENVIRON MONITOR, V5, P1, DOI 10.1039/b204712h; HEWITT N, 1992, ENVIRON SCI TECHNOL, V26, P1890, DOI 10.1021/es00034a004; HGCA, 2012, HGCA DESCR LIST SPRI; Hiltpold I, 2011, PLANT CELL ENVIRON, V34, P1267, DOI 10.1111/j.1365-3040.2011.02327.x; Himanen SJ, 2009, NEW PHYTOL, V181, P174, DOI 10.1111/j.1469-8137.2008.02646.x; HOLLOWAY PJ, 1977, CHEM PHYS LIPIDS, V19, P114, DOI 10.1016/0009-3084(77)90092-5; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; Ibrahim MA, 2008, PLANT BIOLOGY, V10, P97, DOI 10.1111/j.1438-8677.2007.00013.x; Insam H, 2010, BIOL FERT SOILS, V46, P199, DOI 10.1007/s00374-010-0442-3; Jordan A, 2009, INT J MASS SPECTROM, V286, P122, DOI 10.1016/j.ijms.2009.07.005; Jordan A, 2009, INT J MASS SPECTROM, V286, P32, DOI 10.1016/j.ijms.2009.06.006; Jud W, 2016, ATMOS CHEM PHYS, V16, P277, DOI 10.5194/acp-16-277-2016; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Karl T, 2005, ATMOS CHEM PHYS, V5, P3015, DOI 10.5194/acp-5-3015-2005; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kim S, 2009, ATMOS MEAS TECH, V2, P99, DOI 10.5194/amt-2-99-2009; Kreuzwieser J, 2014, J EXP BOT, V65, P755, DOI 10.1093/jxb/ert455; Kroll JH, 2001, J PHYS CHEM A, V105, P4446, DOI 10.1021/jp004136v; Laothawornkitkul J, 2008, ENVIRON SCI TECHNOL, V42, P8433, DOI 10.1021/es801738s; Laothawornkitkul J, 2009, NEW PHYTOL, V183, P27, DOI 10.1111/j.1469-8137.2009.02859.x; Lee A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007050; Lee JH, 2006, J AIR WASTE MANAGE, V56, P1503, DOI 10.1080/10473289.2006.10464560; Lin C, 2007, SOIL BIOL BIOCHEM, V39, P951, DOI 10.1016/j.soilbio.2006.11.007; Lindinger W, 1998, INT J MASS SPECTROM, V173, P191, DOI 10.1016/S0168-1176(97)00281-4; LOGAN JA, 1985, J GEOPHYS RES-ATMOS, V90, P10463, DOI 10.1029/JD090iD06p10463; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Maffei ME, 2010, S AFR J BOT, V76, P612, DOI 10.1016/j.sajb.2010.03.003; Mayrhofer S, 2006, ENVIRON MICROBIOL, V8, P1960, DOI 10.1111/j.1462-2920.2006.01076.x; McEwan M, 1998, CLIN EXP ALLERGY, V28, P332; Muller M, 2013, CHEMOMETR INTELL LAB, V127, P158, DOI 10.1016/j.chemolab.2013.06.011; Niinemets U, 2014, PLANT CELL ENVIRON, V37, P1790, DOI 10.1111/pce.12322; Oltmans SJ, 2013, ATMOS ENVIRON, V67, P331, DOI 10.1016/j.atmosenv.2012.10.057; Pinto DM, 2007, J CHEM ECOL, V33, P683, DOI 10.1007/s10886-007-9255-8; Pinto DM, 2010, J CHEM ECOL, V36, P22, DOI 10.1007/s10886-009-9732-3; Pollmann J, 2005, ENVIRON SCI TECHNOL, V39, P9620, DOI 10.1021/es050440w; R Core Team, 2012, R LANG ENV STAT COMP; Ryan A, 2009, PLANT CELL ENVIRON, V32, P31, DOI 10.1111/j.1365-3040.2008.01897.x; SALTER L, 1992, PHYTOCHEMISTRY, V31, P4045, DOI 10.1016/0031-9422(92)80411-7; SHU YG, 1994, INT J CHEM KINET, V26, P1193, DOI 10.1002/kin.550261207; Spanel P, 1997, INT J MASS SPECTROM, V165, P25, DOI 10.1016/S0168-1176(97)00166-3; Spanel P, 1997, INT J MASS SPECTROM, V167, P375, DOI 10.1016/S0168-1176(97)00085-2; Taipale R, 2008, ATMOS CHEM PHYS, V8, P6681, DOI 10.5194/acp-8-6681-2008; Tani A, 2004, INT J MASS SPECTROM, V239, P161, DOI 10.1016/j.ijms.2004.07.020; The Royal Society report, 2008, 1508 ROYAL SOC, P133; van Dam NM, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls021; Vickers CE, 2009, PLANT CELL ENVIRON, V32, P520, DOI 10.1111/j.1365-3040.2009.01946.x; Vuorinen T, 2004, ENVIRON POLLUT, V131, P305, DOI 10.1016/j.envpol.2004.02.027; W. H. Organization, 2003, HLTH ASP AIR POLL PA; Wang TS, 2003, INT J MASS SPECTROM, V228, P117, DOI 10.1016/S1387-3806(03)00271-9; Weikl F, 2016, SCI REP-UK, V6, DOI 10.1038/srep22152; Wildt J, 2003, J ATMOS CHEM, V45, P173, DOI 10.1023/A:1024030821349; Winterhalter R, 2009, PHYS CHEM CHEM PHYS, V11, P4152, DOI 10.1039/b817824k; Wisthaler A, 2010, P NATL ACAD SCI USA, V107, P6568, DOI 10.1073/pnas.0904498106	83	17	17	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208825	10.1371/journal.pone.0208825	http://dx.doi.org/10.1371/journal.pone.0208825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532234	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700053
J	Walker, AK; Chang, A; Ziegler, AI; Dhillon, HM; Vardy, JL; Sloan, EK				Walker, Adam K.; Chang, Aeson; Ziegler, Alexandra, I; Dhillon, Haryana M.; Vardy, Janette L.; Sloan, Erica K.			Low dose aspirin blocks breast cancer-induced cognitive impairment in mice	PLOS ONE			English	Article							DEPRESSIVE-LIKE BEHAVIOR; COLORECTAL-CANCER; CHEMOTHERAPY; MODEL; NEUROINFLAMMATION; METASTASIS; IMPACT; TUMORS; ASSOCIATION; PREVENTION	Cancer patients with non-central nervous system tumors often suffer from cognitive impairment. While chemotherapy has long been attributed as the cause of these memory, learning and concentration difficulties, we recently observed cognitive impairment in cancer patients prior to treatment. This suggests the cancer alone may be sufficient to induce cognitive impairment, however the mechanisms are unknown. Here, we show that we can experimentally replicate the clinical phenomenon of cancer-associated cognitive impairment and we identify inflammation as a causal mechanism. We demonstrate that a peripheral tumor is sufficient to induce memory loss. Using an othotopic mouse model of breast cancer, we found that mice with 4T1 .2 or EO771 mammary tumors had significantly poorer memory than mice without tumors. Memory impairment was independent of cancer-induced sickness behavior, which was only observed during the later stage of cancer progression in mice with high metastatic burden. Tumor-secreted factors were sufficient to induce memory impairment and pro-inflammatory cytokines were elevated in the plasma of tumor-bearing mice. Oral treatment with low-dose aspirin completely blocked tumor-induced memory impairment without affecting tumor-induced sickness or tumor growth, demonstrating a causal role for inflammation in cognitive impairment. These findings suggest that anti-inflam-matories may be a safe and readily translatable strategy that could be used to prevent cancer-associated cognitive impairment in patients.	[Walker, Adam K.; Chang, Aeson; Ziegler, Alexandra, I; Sloan, Erica K.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic, Australia; [Walker, Adam K.] Neurosci Res Australia, Randwick, NSW, Australia; [Walker, Adam K.] Univ New South Wales, Sch Psychiat, Randwick, NSW, Australia; [Walker, Adam K.; Sloan, Erica K.] Peter MacCallum Canc Ctr, Div Canc Surg, East Melbourne, Vic, Australia; [Dhillon, Haryana M.] Univ Sydney, Fac Sci, Ctr Med Psychol & Evidence Based Decis Making, Sch Psychol, Camperdown, NSW, Australia; [Vardy, Janette L.] Univ Sydney, Concord Clin Sch, Sydney Med Sch, Camperdown, NSW, Australia; [Vardy, Janette L.] Concord Repatriat Gen Hosp, Concord Canc Ctr, Concord, NSW, Australia; [Sloan, Erica K.] Univ Calif Los Angeles, Cousins Ctr PNI, UCLA Semel Inst, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA; [Sloan, Erica K.] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA USA	Monash University; Neuroscience Research Australia; University of New South Wales Sydney; Peter Maccallum Cancer Center; University of Sydney; University of Sydney; Concord Repatriation General Hospital; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Walker, AK (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic, Australia.; Walker, AK (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.; Walker, AK (corresponding author), Univ New South Wales, Sch Psychiat, Randwick, NSW, Australia.; Walker, AK (corresponding author), Peter MacCallum Canc Ctr, Div Canc Surg, East Melbourne, Vic, Australia.	a.walker@neura.edu.au		Sloan, Erica/0000-0002-2355-1433; Ziegler, Alexandra/0000-0001-7364-1317; Chang, Aeson/0000-0003-0769-516X	National Breast Cancer Foundation Australia [PF-15-014]; Monash Institute of Pharmaceutical Sciences Faculty Seed Grant; Monash Interdisciplinary Research Program Grant; David and Lorelle Skewes Foundation; Peter Mac Foundation; National Cancer Institute [CA160890]	National Breast Cancer Foundation Australia; Monash Institute of Pharmaceutical Sciences Faculty Seed Grant; Monash Interdisciplinary Research Program Grant; David and Lorelle Skewes Foundation; Peter Mac Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Breast Cancer Foundation Australia postdoctoral fellowship (PF-15-014) to AKW, and a National Breast Cancer Foundation Australia practitioner fellowship to JLV; a Monash Institute of Pharmaceutical Sciences Faculty Seed Grant and Monash Interdisciplinary Research Program Grant; the David and Lorelle Skewes Foundation, the Peter Mac Foundation, and the National Cancer Institute (CA160890).	Ahles TA, 2008, BREAST CANCER RES TR, V110, P143, DOI 10.1007/s10549-007-9686-5; Arora NK, 2003, SOC SCI MED, V57, P791, DOI 10.1016/S0277-9536(02)00449-5; Bains SJ, 2016, J CLIN ONCOL, V34, P2501, DOI 10.1200/JCO.2015.65.3519; Beeken RJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011646; Bever SR, 2017, NEUROIMMUNOMODULATIO; Bray VJ, 2017, J CLIN ONCOL, V35, P217, DOI 10.1200/JCO.2016.67.8201; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Cao Y, 2016, JAMA ONCOL, V2, P762, DOI 10.1001/jamaoncol.2015.6396; Cao Y, 2014, CANCER RES, V74, P5091, DOI 10.1158/0008-5472.CAN-13-3171; Chen CH, 2017, PALLIATIVE MED, V31, P406, DOI 10.1177/0269216316663976; Cheung YT, 2015, ANN ONCOL, V26, P1446, DOI 10.1093/annonc/mdv206; Chow E, 2001, CLIN ONCOL-UK, V13, P204, DOI 10.1053/clon.2001.9255; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Denoyer D, 2011, J NUCL MED, V52, P115, DOI 10.2967/jnumed.110.078154; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Flahavan EM, 2014, ANN ONCOL, V25, P154, DOI 10.1093/annonc/mdt428; Formica MK, 2017, PATIENT EDUC COUNS, V100, P812, DOI 10.1016/j.pec.2016.11.019; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Hermelink K, 2007, CANCER, V109, P1905, DOI 10.1002/cncr.22610; Johnstone CN, 2015, DIS MODEL MECH, V8, P237, DOI 10.1242/dmm.017830; Kaminskas LM, 2013, J CONTROL RELEASE, V168, P200, DOI 10.1016/j.jconrel.2013.03.006; Kim-Fuchs C, 2014, BRAIN BEHAV IMMUN, V40, P40, DOI 10.1016/j.bbi.2014.02.019; Kinnavane L, 2016, HIPPOCAMPUS, V26, P1393, DOI 10.1002/hipo.22615; Koppelmans V, 2012, J CLIN ONCOL, V30, P1080, DOI 10.1200/JCO.2011.37.0189; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Lyon DE, 2016, J NEUROIMMUNOL, V301, P74, DOI 10.1016/j.jneuroim.2016.11.002; Nicolai J, 2016, PATIENT EDUC COUNS, V99, P739, DOI 10.1016/j.pec.2015.11.019; Norden DM, 2015, LIFE SCI, V143, P65, DOI 10.1016/j.lfs.2015.10.020; Norden DM, 2015, PHYSIOL BEHAV, V140, P230, DOI 10.1016/j.physbeh.2014.12.045; Norden DM, 2015, BRAIN BEHAV IMMUN, V43, P76, DOI 10.1016/j.bbi.2014.07.013; Olin JJ, 2001, ONCOLOGY-NY, V15, P613; Olin JJ, 2001, ONCOLOGY HUNTINGT, V15, P21; Olin JJ, 2001, ONCOLOGY HUNTINGT, V15, P8; Patel S. K., 2015, J NATL CANC I, V107; Podetz-Pedersen KM, 2014, HUM GENE THER, V25, P955, DOI 10.1089/hum.2014.048; Pomykala KL, 2013, BRAIN IMAGING BEHAV, V7, P511, DOI 10.1007/s11682-013-9243-2; Pyter LM, 2017, BEHAV BRAIN RES, V330, P108, DOI 10.1016/j.bbr.2017.05.011; Pyter LM, 2010, BRAIN BEHAV IMMUN, V24, P903, DOI 10.1016/j.bbi.2010.02.004; Pyter LM, 2009, P NATL ACAD SCI USA, V106, P9069, DOI 10.1073/pnas.0811949106; Rohwer N, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-5244; Sceneay J, 2012, CANCER RES, V72, P3906, DOI 10.1158/0008-5472.CAN-11-3873; Singhal G, 2014, FRONTIERS NEUROSCIEN, V8; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79; Vardy JL, 2015, J CLIN ONCOL, V33, P4085, DOI 10.1200/JCO.2015.63.0905; VARDY JL, 2009, J CLIN ONCOL S, V27; Vichaya EG, 2016, BEHAV BRAIN RES, V297, P241, DOI 10.1016/j.bbr.2015.10.024; Walker AK, 2014, PHARMACOL REV, V66, P80, DOI 10.1124/pr.113.008144; Walker AK, 2013, NEUROPSYCHOPHARMACOL, V38, P1609, DOI 10.1038/npp.2013.71; Winocur G, 2018, NEUROSCIENCE, V369, P51, DOI 10.1016/j.neuroscience.2017.10.048; Yang M, 2014, BRAIN BEHAV IMMUN, V36, P147, DOI 10.1016/j.bbi.2013.10.022	53	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208593	10.1371/journal.pone.0208593	http://dx.doi.org/10.1371/journal.pone.0208593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532184	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700033
J	Dittfeld, C; Reimann, G; Mieting, A; Buttner, P; Jannasch, A; Plotze, K; Steiner, G; Tugtekin, SM; Matschke, K				Dittfeld, Claudia; Reimann, Gabriel; Mieting, Alice; Buettner, Petra; Jannasch, Anett; Ploetze, Katrin; Steiner, Gerald; Tugtekin, Sems Malte; Matschke, Klaus			Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells	PLOS ONE			English	Article							CATENIN SIGNALING PATHWAY; AORTIC-VALVE CALCIFICATION; DISEASE; HEART; MECHANISMS; PROMOTES; DIFFERENTIATION; ACTIVATION; SOX9	The development of a substance or inhibitor-based treatment strategy for the prevention of aortic valve stenosis is a challenge and a main focus of medical research in this area. One strategy may be to use the tankyrase inhibitor XAV-939, which leads to Axin stabilisation and subsequent destruction of the beta-catenin complex and dephosphorylation of beta-catenin. The dephosphorylated active form of beta-catenin (non-phospho-beta-catenin) then promotes nuclear transcription that leads to osteogenesis. The aims of the present study were to develop an experimental system for inducing in vitro calcification of human aortic valvular interstitial cells (VICs) to investigate the potential anti-calcific effect of XAV-939 and to analyse expression of the Wnt signalling proteins and Sox9, a chondrogenesis regulator, in this model. Calcification of human VIC cultures was induced by cultivation in an osteogenic medium and the effect of co-incubation with 1 mu M XAV-939 was monitored. Calcification was quantified when mineral deposits were visible in culture and was histologically verified by von Kossa or Alizarin red staining and by IR-spectroscopy. Protein expression of alkaline phosphatase, Axin, beta-catenin and Sox9 were quantified by western blotting. In 58% of the VIC preparations, calcification was induced in an osteogenic culture medium and was accompanied by upregulation of alkaline phosphatase. The calcification induction was prevented by the XAV-939 co-treatment and the alkaline phosphatase upregulation was suppressed. As expected, Axin was upregulated, but the levels of active non-phospho-beta-catenin were also enhanced. Sox9 was induced during XAV-939 treatment but apparently not as a result of downregulation of beta-catenin signalling. XAV-939 was therefore able to prevent calcification of human VIC cultures, and XAV-939 treatment was accompanied by upregulation of active non-phospho-beta-catenin. Although XAV-939 does not downregulate active beta-catenin, treatment with XAV-939 results in Sox9 upregulation that may prevent the calcification process.	[Dittfeld, Claudia; Reimann, Gabriel; Mieting, Alice; Buettner, Petra; Jannasch, Anett; Ploetze, Katrin; Tugtekin, Sems Malte; Matschke, Klaus] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Cardiac Surg, Herzzentrum Dresden, Dresden, Germany; [Steiner, Gerald] Tech Univ Dresden, Fac Med Carl Gustav Carus Clin Sensoring & Monito, Dresden, Germany; [Buettner, Petra] Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Heart Center Leipzig GMBH	Dittfeld, C (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Cardiac Surg, Herzzentrum Dresden, Dresden, Germany.	claudia.dittfeld1@tu-dresden.de	Dittfeld, Claudia/AAE-5084-2022; Büttner, Petra/ADR-1721-2022	Buttner, Petra/0000-0003-0799-4725				Acharya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027743; Bowler MA, 2015, CARDIOVASC PATHOL, V24, P1, DOI 10.1016/j.carpath.2014.08.003; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750; Cloyd KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048154; Coffey S, 2016, HEART, V102, P75, DOI 10.1136/heartjnl-2014-307020; Dritsa V, 2014, IN VIVO, V28, P91; Fang M, 2014, ARTERIOSCL THROM VAS, V34, P2601, DOI 10.1161/ATVBAHA.114.304579; Gao X, 2015, J HEART VALVE DIS, V24, P190; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Gu GJ, 2014, J HUAZHONG U SCI-MED, V34, P33, DOI 10.1007/s11596-014-1228-x; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huk DJ, 2016, ARTERIOSCL THROM VAS, V36, P328, DOI 10.1161/ATVBAHA.115.306091; Hulin A, 2017, CARDIOVASC RES, V113, P40, DOI 10.1093/cvr/cvw229; Hutcheson JD, 2014, NAT REV CARDIOL, V11, P218, DOI 10.1038/nrcardio.2014.1; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; James RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050457; Jastrzebska M, 2006, GEN PHYSIOL BIOPHYS, V25, P231; Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt328; Latif N, 2015, EUR HEART J, V36, P1335, DOI 10.1093/eurheartj/eht547; Lefebvre V, 2017, CONNECT TISSUE RES, V58, P2, DOI 10.1080/03008207.2016.1183667; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Leopold JA, 2012, CIRC-CARDIOVASC INTE, V5, P605, DOI 10.1161/CIRCINTERVENTIONS.112.971028; Li JM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2470351; Lindman BR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.6; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Liu XH, 2016, PROG BIOPHYS MOL BIO, V122, P156, DOI 10.1016/j.pbiomolbio.2016.02.002; Louvet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115342; Mallinger A, 2015, J MED CHEM, V58, P1717, DOI 10.1021/jm501436m; Mangialardo S, 2012, APPL SPECTROSC, V66, P1121, DOI 10.1366/12-06606; Mathieu P, 2014, CAN J CARDIOL, V30, P982, DOI 10.1016/j.cjca.2014.03.029; Pal SN, 2011, J ATHEROSCLER THROMB, V18, P551; Peacock JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026769; Peacock JD, 2010, CIRC RES, V106, P712, DOI 10.1161/CIRCRESAHA.109.213702; Pilgrim T., 2010, CARDIOVASCULAR MED, V13, P197; Rajamannan NM, 2019, J CELL BIOCHEM, V120, P3362, DOI 10.1002/jcb.27606; Rajamannan NM, 2018, CARDIOLOGY, V139, P175, DOI 10.1159/000485074; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rajamannan NM, 2011, J CELL BIOCHEM, V112, P2987, DOI 10.1002/jcb.23221; Rajamannan NM, 2005, CIRCULATION, V112, pI229, DOI 10.1161/01.CIRCULATIONAHA.104.524306; Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142; Shroff RC, 2007, SEMIN DIALYSIS, V20, P103, DOI 10.1111/j.1525-139X.2007.00255.x; Teo KK, 2011, CAN J CARDIOL, V27, P800, DOI 10.1016/j.cjca.2011.03.012; Tortelote GG, 2017, CELL SIGNAL, V40, P30, DOI 10.1016/j.cellsig.2017.08.008; Wang Q, 2018, CHIN MED-UK, V13, DOI 10.1186/s13020-018-0175-z; Wirrig EE, 2014, ARTERIOSCL THROM VAS, V34, P737, DOI 10.1161/ATVBAHA.113.302071; Witt W, 2014, J MOL CELL CARDIOL, V74, P127, DOI 10.1016/j.yjmcc.2014.05.008; Xie CH, 2016, AGING CLIN EXP RES, V28, P181, DOI 10.1007/s40520-015-0408-2; Zhang XQ, 2015, AM J CANCER RES, V5, P2344	51	8	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208774	10.1371/journal.pone.0208774	http://dx.doi.org/10.1371/journal.pone.0208774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532256	gold, Green Published, Green Submitted			2022-12-26	WOS:000452640900045
J	Lanszki, J; Hayward, MW; Nagyapati, N				Lanszki, Jozsef; Hayward, Matthew W.; Nagyapati, Nikolett			Feeding responses of the golden jackal after reduction of anthropogenic food subsidies	PLOS ONE			English	Article							CANIS-AUREUS L.; FOX VULPES-VULPES; DIET COMPOSITION; RED FOX; PREFERENCES; POPULATIONS; HABITS; WINTER; AREA; BIODIVERSITY	Little is known of the resources that limit or promote the rapidly expanding golden jackal (Canis aureus) population in Europe. We hypothesised that in an area of intensive big game hunting, a reduction of the main food resource (human subsidised big game viscera) would result in dietary switching. We used multivariate analyses to test whether the dietary composition of 200 jackal stomachs varied between two 2-yearly survey occasions, the first without big game viscera removal (availability of 68 kg viscera/year/km(2)) followed by a period with viscera removal (minimum of 50 kg of viscera/year/km(2) removed). The proportion of empty stomachs and the stomach wet content weight did not differ between the two periods. Even after the reduction of food subsidies, the primary food of jackals was viscera and carrion from wild ungulates (frequency of occurrence: 45% vs. 30%; wet weight: 55% vs. 29%, respectively), and scavenging was not affected by season or sex. Log-linear analysis of frequency data revealed no significant differences between survey occasions in consumption of either food type. MANCOVA of wet weight data revealed that in the first period with food subsidies jackals consumed a higher proportion of adult wild boar (11.6% vs. 1.3%; from predation or scavenging), while juvenile wild boar (0 vs. 11.8%; from predation or scavenging), domestic animals (0.8% vs. 6.2%; mostly from scavenging) and invertebrates (2.6% vs. 4.1%) increased in the second period. The stomachs in the second survey occasion contained more varied food items, but the trophic niche was not significantly wider. The feeding responses of this mesopredator to the reduction of food subsidies were less pronounced than expected. Because in high big game density areas, wild ungulate carrion from different mortality causes are available in high quantities throughout the year, predator populations can be maintained despite the high amount of viscera removal.	[Lanszki, Jozsef; Nagyapati, Nikolett] Kaposvar Univ, Carnivore Ecol Res Grp, Kaposvar, Hungary; [Hayward, Matthew W.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia	Hungarian University of Agriculture & Life Sciences; Kaposvar University; University of Newcastle	Lanszki, J (corresponding author), Kaposvar Univ, Carnivore Ecol Res Grp, Kaposvar, Hungary.	lanszkij@gmail.com	Lanszki, Jozsef/AAN-1013-2020; Hayward, Matt W./F-3569-2010	Hayward, Matt W./0000-0002-5574-1653; Lanszki, Jozsef/0000-0002-2067-6601; Nagyapati, Nikolett/0000-0001-6811-6737	 [EFOP-3.6.1-16-2016-00007]		This publication was supported by the EFOP-3.6.1-16-2016-00007 project.	[Anonymous], 1993, WHITEHEAD ENCY DEER; Atkinson RPD, 2002, J ZOOL, V257, P129, DOI 10.1017/S0952836902000729; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Barton KA, 2007, GLOBAL ECOL BIOGEOGR, V16, P281, DOI 10.1111/j.1466-8238.2007.00299.x; Bekoff M, 2003, WILD MAMMALS N AM BI, P467; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Bino G, 2010, J APPL ECOL, V47, P1262, DOI 10.1111/j.1365-2664.2010.01882.x; Borkowski J, 2011, ANN ZOOL FENN, V48, P108, DOI 10.5735/086.048.0203; Boskovic Ivica, 2013, Agriculturae Conspectus Scientificus, V78, P245; Cagnacci F, 2003, ITAL J ZOOL, V70, P31, DOI 10.1080/11250000309356493; Cirovic D, 2016, BIOL CONSERV, V199, P51, DOI 10.1016/j.biocon.2016.04.027; Cirovic D, 2014, MAMM BIOL, V79, P132, DOI 10.1016/j.mambio.2013.11.003; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Courchamp F, 2003, SCIENCE, V302, P1532, DOI 10.1126/science.1089492; Cozzi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121471; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Csanyi S, 2016, HUNGARIAN GAME MANAG; DEMETER A., 1993, HDB SAUGETIERE EUROP, P107; Farago S, 2014, HUNGARIAN GAME PERIS; Forsyth DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097937; Gehring TM, 2003, BIOL CONSERV, V109, P283, DOI 10.1016/S0006-3207(02)00156-8; Gehrt SD, 2009, J MAMMAL, V90, P1045, DOI 10.1644/08-MAMM-A-277.1; Giannatos G, 2005, BELG J ZOOL, V135, P145; Giannatos G, 2010, MAMM BIOL, V75, P227, DOI 10.1016/j.mambio.2009.03.003; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Hayward MW, 2017, MAMM BIOL, V85, P70, DOI 10.1016/j.mambio.2017.02.005; Imperio S, 2010, WILDLIFE BIOL, V16, P205, DOI 10.2981/08-051; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Kamler JF, 2010, AFR J ECOL, V48, P847, DOI 10.1111/j.1365-2028.2009.01173.x; Kapota D, 2016, SCI REP-UK, V6, DOI 10.1038/srep24021; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; KOLB HH, 1980, J APPL ECOL, V17, P7, DOI 10.2307/2402959; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Krofel M, 2017, HYSTRIX, V28, P9, DOI 10.4404/hystrix-28.1-11819; Lanszki J, 2006, CAN J ZOOL, V84, P1647, DOI 10.1139/Z06-147; Lanszki J, 2010, MAMMALIA, V74, P267, DOI 10.1515/MAMM.2010.005; Lanszki J, 2018, MAMM BIOL, V88, P81, DOI 10.1016/j.mambio.2017.11.011; Lanszki J, 2015, ANN ZOOL FENN, V52, P243, DOI 10.5735/086.052.0403; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; MACDONALD DW, 1979, BEHAV ECOL SOCIOBIOL, V5, P17, DOI 10.1007/BF00302692; Markov G, 2012, ACTA ZOOL BULGAR, P67; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; MOEHLMAN PD, 1987, AM SCI, V75, P366; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Newsome TM, 2014, OECOLOGIA, V175, P139, DOI 10.1007/s00442-014-2889-7; Newsome TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063931; POULLE ML, 1995, CAN J ZOOL, V73, P1625, DOI 10.1139/z95-193; Prerna S., 2015, Journal of Threatened Taxa, V7, P7416; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Raichev EG, 2013, MAMM STUDY, V38, P19, DOI 10.3106/041.038.0102; Randa LA, 2009, J MAMMAL, V90, P594, DOI 10.1644/08-MAMM-A-092R1.1; Reinken G, 1987, DAMTIERHALTUNG; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; Rotem G, 2011, J WILDLIFE MANAGE, V75, P132, DOI 10.1002/jwmg.9; Rutkowski R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141236; Soe E, 2017, MAMMAL REV, V47, P198, DOI 10.1111/mam.12092; Stoyanov S., 2012, INT S HUNT MOD ASP S, V1, P48; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trouwborst A, 2015, BIODIVERS CONSERV, V24, P1567, DOI 10.1007/s10531-015-0894-8; Yom-Tov Y, 2003, FUNCT ECOL, V17, P323, DOI 10.1046/j.1365-2435.2003.00735.x; Yom-Tov Y., 1995, ISR BIOL CONS, V73, P19, DOI DOI 10.1016/0006-3207(95)90051-9	62	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208727	10.1371/journal.pone.0208727	http://dx.doi.org/10.1371/journal.pone.0208727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532165	gold, Green Submitted, Green Published			2022-12-26	WOS:000452640900037
J	Liu, C; Lin, TT; Zhou, ZL				Liu, Chao; Lin, Tingting; Zhou, Zhenlei			Dexmedetomidine combined with etomidate or emulsified isoflurane for induction reduced cardiopulmonary response in dogs	PLOS ONE			English	Article							MINIMUM ALVEOLAR CONCENTRATION; ANESTHETIC INDUCTION; OXYGEN-CONSUMPTION; INHALED ISOFLURANE; PRETREATMENT; SEVOFLURANE; PROPOFOL; MYOCLONUS; MIDAZOLAM; ECG	To investigate the effects of etomidate, emulsified isoflurane, and their combination with dexmedetomidine on physiological parameters, electrocardiogram (ECG) results, and the quality of induction and recovery during isoflurane maintenance anaesthesia. 5 mixed-breed dogs received each of four treatments: etomidate (E group); emulsified isoflurane (El group); both dexmedetomidine and etomidate (DE group); or both dexmedetomidine and emulsified isoflurane (DEI group). All drugs were IV injection administered for induction, followed by 1.5 MAC (minimal alveolar concentration) of isoflurane to maintain anaesthesia. Rectal temperature (RT), respiratory rate (RR), heart rate (HR), mean arterial pressure (MAP), and ECG were measured at baseline, 0, 5, 10, 20, 40, and 60 minutes after intubation. The quality of induction and recovery was evaluated for all dogs. All the anaesthetic procedures provided good conditions for induction of anaesthesia. The quality of induction and recovery in the E group was worse than other groups. The decrease of RR in the E and DE groups was stronger than that in the El and DEI groups. The dogs in the E group had the most significant prolongation of the Q-T interval and changes in the S-T segment. Deviation and extension of the S-T segment were noted in the El group. The dogs in the DE and DEI groups had fewer changes in the ECG results than those in the E and El groups. The addition of dexmedetomidine caused less effect on cardiopulmonary parameters and the ECG results than either etomidate or emulsified isoflurane alone. Thus, etomidate or emulsified isoflurane in combination with dexmedetomidine may be useful clinically for the induction of anaesthesia.	[Liu, Chao; Lin, Tingting; Zhou, Zhenlei] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, ZL (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	zhouzl@njau.edu.cn	Zhou, Zhenlei/AFS-6215-2022		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Amengual M, 2013, VET ANAESTH ANALG, V40, P115, DOI 10.1111/j.1467-2995.2012.00747.x; [Anonymous], 2010, VET ANAESTH ANALG, V35, P488; Bhana N, 2000, DRUGS, V59, P263, DOI 10.2165/00003495-200059020-00012; Bisth DS, 2017, STUDIES PHYSL HAEMAT; Cesarovic N, 2010, LAB ANIM-UK, V44, P329, DOI 10.1258/la.2010.009085; Chai YF, 2008, BRIT J ANAESTH, V100, P109, DOI 10.1093/bja/aem298; Chen CY, 2012, PAK VET J, V32, P635; Diao HX, 2016, VET ANAESTH ANALG, V43, P145, DOI 10.1111/vaa.12287; Doenicke AW, 1999, ANESTHESIOLOGY, V90, P113, DOI 10.1097/00000542-199901000-00017; EGER RP, 1995, CAN J ANAESTH, V42, P173, DOI 10.1007/BF03028273; Gargiulo S, 2012, ILAR J, V53, pE70, DOI 10.1093/ilar.53.1.70; GAUTHIER J, 1962, ANESTH ANALG, V41, P466, DOI 10.1213/00000539-196241040-00015; GIESE JL, 1983, PHARMACOTHERAPY, V3, P251; Groeben H, 2004, ANESTHESIOLOGY, V100, P359, DOI 10.1097/00000542-200402000-00026; Gurm HS, 2005, HEART, V91, P851, DOI 10.1136/hrt.2004.047258; Hueter L, 2003, ACTA ANAESTH SCAND, V47, P482, DOI 10.1034/j.1399-6576.2003.00081.x; KAPUR PA, 1984, ANESTHESIOLOGY, V61, P156, DOI 10.1097/00000542-198408000-00008; Lervik A, 2012, VET ANAESTH ANALG, V39, P414, DOI 10.1111/j.1467-2995.2012.00713.x; Lozano AJ, 2009, VET ANAESTH ANALG, V36, P220, DOI 10.1111/j.1467-2995.2009.00451.x; Lucchinetti E, 2008, ANESTH ANALG, V106, P1346, DOI 10.1213/ane.0b013e31816d1661; Lv X, 2011, INT J MED SCI, V8, P353, DOI 10.7150/ijms.8.353; Martin M., 2007, SMALL ANIMAL ECGS IN; Rodriguez JM, 2012, VET ANAESTH ANALG, V39, P357, DOI 10.1111/j.1467-2995.2011.00695.x; Muir WW, 2003, AM J VET RES, V64, P1155, DOI 10.2460/ajvr.2003.64.1155; Mutoh T, 2001, J VET MED A, V48, P223, DOI 10.1046/j.1439-0442.2001.00350.x; Pagel PS, 1998, CAN J ANAESTH, V45, P809, DOI 10.1007/BF03012155; Pascoe PJ, 2015, VET ANAESTH ANALG, V42, P360, DOI 10.1111/vaa.12220; REDDY RV, 1993, ANESTH ANALG, V77, P1008; Ruth WJ, 2001, ACAD EMERG MED, V8, P13, DOI 10.1111/j.1553-2712.2001.tb00539.x; Sams L, 2008, VET ANAESTH ANALG, V35, P488, DOI 10.1111/j.1467-2995.2008.00417.x; Schwarzkopf KRG, 2003, ANAESTH INTENS CARE, V31, P18, DOI 10.1177/0310057X0303100103; Sinclair MD, 2002, VET ANAESTH ANALG, V29, P1, DOI 10.1046/j.1467-2987.2001.00056.x; SPRUNG J, 1995, ANESTHESIOLOGY, V83, P628, DOI 10.1097/00000542-199509000-00026; STOCKHAM RJ, 1988, ANAESTH INTENS CARE, V16, P171, DOI 10.1177/0310057X8801600207; Taittonen MT, 1997, BRIT J ANAESTH, V78, P400, DOI 10.1093/bja/78.4.400; TATEKAWA S, 1987, ANESTH ANALG, V66, P1073; Yang XL, 2006, ANESTHESIOLOGY, V104, P482, DOI 10.1097/00000542-200603000-00015; Zhou JX, 2006, ANESTH ANALG, V102, P129, DOI 10.1213/01.ane.0000189612.24147.07	38	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208625	10.1371/journal.pone.0208625	http://dx.doi.org/10.1371/journal.pone.0208625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532170	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900027
J	Segal, L; Nguyen, H; Gent, D; Hampton, C; Boffa, J				Segal, Leonie; Nguyen, Ha; Gent, Debra; Hampton, Catherine; Boffa, John			Child protection outcomes of the Australian Nurse Family Partnership Program for Aboriginal infants and their mothers in Central Australia	PLOS ONE			English	Article							HOME-VISITING PROGRAMS	Background The Nurse Family Partnership Program developed in the USA, designed to improve mother and infant/child outcomes, has reported lower rates of child protection system involvement. The study tested the hypothesis that an adapted Nurse Family Partnership Program implemented in an Aboriginal community in Central Australia (the FPP) would improve Child Protection outcomes. Methods This was a retrospective and prospective cohort study drawing on linked administrative data, including birth registry, primary health care client information system, FPP program data, and child protection data. Participants were children of women eligible for the FPP program (an exposed and a control group of women, eligible but not referred) live-born between 1/3/2009 (program commencement) and 31/12/2015. Child protection data covered all reports, investigations, substantiations and out-of-home care placements from the time of the child's birth to 31/12/2016. Generalised linear modelling was used to estimate the relative risk (RR) of involvement with child protection and type of involvement (report, investigation, substantiation, out-of-home-care placement) among FPP and control children. Results FPP mothers (n = 291) were on average younger, were more likely to be first-time mothers and experiencing housing instability than control mothers (n = 563). Among younger mothers <= 20 years, FPP children had statistically significantly lower rates of involvement with child protection (ARR(report) = 0.49, 95% CI: 0.29 to 0.82; ARR(investigation )= 0.34, 95% CI: 0.19 to 0.64; ARR(substantiation )= 0.45, 95% CI: 0.21 to 0.96) and experience fewer days in care (ARR = 0.10, 95% CI: 0.02 to 0.48). Among children of first-time mothers, FPP children also had statistically significantly lower rates of involvement with child protection (ARR(report )= 0.50, 95% CI: 0.30 to 0.83; ARR(investigation) = 0.36, 95% CI: 0.19 to 0.67; ARR(substantiation) 0.38, 95% CI: 0.18 to 0.80) and fewer days in care (ARR = 0.06, 95% CI: 0.01 to 0.27). Conclusion Study results suggest a modified Nurse Family Partnership delivered by an Indigenous community-controlled organisation may have reduced child protection system involvement in a highly vulnerable First Nations population, especially in younger or first-time mothers. Testing these results with an RCT design is desirable.	[Segal, Leonie; Nguyen, Ha] Univ South Australia, Sch Hlth Sci, Hlth Econ & Social Policy Grp, Adelaide, SA, Australia; [Gent, Debra; Hampton, Catherine; Boffa, John] Cent Australian Aboriginal Congress Aboriginal Co, Alice Springs, NT, Australia; [Nguyen, Ha] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [Nguyen, Ha] George Inst Global Hlth, Sydney, NSW, Australia	University of South Australia; University of Sydney; George Institute for Global Health; University of Sydney	Segal, L (corresponding author), Univ South Australia, Sch Hlth Sci, Hlth Econ & Social Policy Grp, Adelaide, SA, Australia.	leonie.segal@unisa.edu.au	Nguyen, Ha/O-1586-2019; Segal, Leonie/B-2357-2009	Nguyen, Ha/0000-0001-8327-5488; Segal, Leonie/0000-0002-6391-6791	Australian National Health and Medical Research Council (NHMRC) [631947]; Central Australian Aboriginal Congress Aboriginal Corporation (CAAC)	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Central Australian Aboriginal Congress Aboriginal Corporation (CAAC)	Funds were contributed to the study from The Australian National Health and Medical Research Council (NHMRC) Program grant (No. 631947) [https://www.nhmrc.gov.au/] and a grant from Central Australian Aboriginal Congress Aboriginal Corporation (CAAC) [https://www.caac.org.au/]. JB, DG and CH are employed by Central Australian Aboriginal Congress Aboriginal Corporation. There was no commercial or sponsored funding. The NHMRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A Project Steering Committee was established for the project that included persons from CAAC. Three persons from CAAC are identified as authors (JB, DG, CH). As such, CAAC contributed to the study design and analysis. However, all final decisions about the analysis plan, manuscript content and finalization and decision to publish were made by the senior author LS, an independent academic.	ABS, 2013, CENS POP HOUS SOC IN; Australian Institute of Health and Welfare, 2017, CHILD WELF SER, V66; Department of Social Services, 2009, NAT FRAM PROT AUSTR; Department of Social Services, 2015, FOOTPR TIM LONG STUD; Drake B, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14090971; Gomby DS, 2007, CHILD ABUSE NEGLECT, V31, P793, DOI 10.1016/j.chiabu.2007.07.001; Nguyen H, 2018, PREV SCI, V19, P966, DOI 10.1007/s11121-018-0930-5; Kitzman HJ, 2007, ENCY EARLY CHILDHOOD; Mejdoubi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120182; Olds David L, 2008, J Scand Stud Criminol Crime Prev, V9, P2, DOI 10.1080/14043850802450096; OLDS DL, 1986, PEDIATRICS, V78, P65; Peacock S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-17; Segal L, 2012, MILBANK Q, V90, P47, DOI 10.1111/j.1468-0009.2011.00655.x; Steering Committee for the Review of Government Service Provision, 2017, REP GOV SERV 2016; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Tilbury C, 2012, INTENSIVE FAMILY BAS	16	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208764	10.1371/journal.pone.0208764	http://dx.doi.org/10.1371/journal.pone.0208764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6IO	30532276	gold, Green Published, Green Submitted			2022-12-26	WOS:000452640900043
J	Watts, AS; Mortby, ME; Burns, JM				Watts, Amber S.; Mortby, Moyra E.; Burns, Jeffrey M.			Depressive symptoms as a barrier to engagement in physical activity in older adults with and without Alzheimer's disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; EXERCISE; DEMENTIA; PEOPLE; ASSOCIATION; EXPERIENCES; BEHAVIORS; DIAGNOSIS; DECLINE; APATHY	Objectives Physical activity shows promise for reduced risk of Alzheimer's disease (AD) and protection against cognitive decline among individuals with and without AD. Older adults face many barriers to adoption of physically active lifestyles and people with AD face even further challenges. Physical activity is a promising non-pharmacological approach to improve depressive symptoms, but little is known about the impact of depressive symptoms as a potential barrier to engagement in physical activity. The present study aimed to investigate depressive symptoms as a potential barrier for participation in physical activity across a range of dementia severity. Method We used longitudinal structural equation modelling to investigate the bi-directional relationship between depressive symptoms and physical activity in 594 older adults with and without AD over a 2 year longitudinal follow up. Participants ranged from no cognitive impairment to moderately severe AD. Results We found that depressive symptoms predicted reduced engagement in subsequent physical activity, but physical activity did not predict subsequent reductions in depressive symptoms. Conclusion We conclude that depressive symptoms may be an important barrier to engagement in physical activity that may be addressed in clinical practice and intervention research.	[Watts, Amber S.; Burns, Jeffrey M.] Univ Kansas, Alzheimers Dis Ctr, Fairway, KS 66205 USA; [Mortby, Moyra E.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Mortby, Moyra E.] Neurosci Res Australia NeuRA, Sydney, NSW, Australia	University of Kansas; University of New South Wales Sydney; Neuroscience Research Australia	Watts, AS (corresponding author), Univ Kansas, Alzheimers Dis Ctr, Fairway, KS 66205 USA.	amberwatts@ku.edu	Watts, Amber/AAL-5754-2020; Mortby, Moyra/AAY-6075-2020	Watts, Amber/0000-0002-8385-1091; Mortby, Moyra/0000-0002-9568-6628; Burns, Jeffrey/0000-0001-7609-8954	University of Kansas Alzheimer's Disease Center; National Institute on Aging [P30AG035982, R01AG033673]; Australian National Health and Medical Research Council (NHMRC); Australian Research Council (ARC) Dementia Research Development Fellowship [1102028]; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	University of Kansas Alzheimer's Disease Center; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Dementia Research Development Fellowship(Australian Research Council); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ASW and JMB are supported by University of Kansas Alzheimer's Disease Center, supported by the National Institute on Aging (P30AG035982; R01AG033673). MEM is supported by the Australian National Health and Medical Research Council (NHMRC) and Australian Research Council (ARC) Dementia Research Development Fellowship #1102028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Barreto PD, 2015, AGEING RES REV, V24, P274, DOI 10.1016/j.arr.2015.09.001; BARSKY AJ, 1988, PSYCHOSOM MED, V50, P510, DOI 10.1097/00006842-198809000-00007; Bennett S, 2014, MATURITAS, V79, P184, DOI 10.1016/j.maturitas.2014.05.009; Blazer DG, 2003, J GERONTOL A-BIOL, V58, P249; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Buchman AS, 2011, EXPERT REV NEUROTHER, V11, P665, DOI [10.1586/ern.11.57, 10.1586/ERN.11.57]; Burns JM, 2010, ARCH NEUROL-CHICAGO, V67, P428, DOI 10.1001/archneurol.2010.38; Cedervall Y, 2015, AGING MENT HEALTH, V19, P679, DOI 10.1080/13607863.2014.962004; Clair A.A., 2008, THERAPEUTIC USES MUS; Farina N, 2019, J AGING PHYS ACTIV, V27, P413, DOI 10.1123/japa.2018-0031; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Garcia-Cordero I, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0006; Graves RS, 2015, J REGISTRY MANAGEMEN, V42, P111; Harvey JA, 2013, INT J ENV RES PUB HE, V10, P6645, DOI 10.3390/ijerph10126645; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Lanza G, 2018, COMPLEMENT THER MED, V38, P74, DOI 10.1016/j.ctim.2018.04.013; Lees FD, 2005, J AGING PHYS ACTIV, V13, P23, DOI 10.1123/japa.13.1.23; Malthouse R, 2014, PHYSIOTHERAPY, V100, P169, DOI 10.1016/j.physio.2013.10.002; Mathews AE, 2010, J AGING PHYS ACTIV, V18, P119, DOI 10.1123/japa.18.2.119; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McPhillips JB, 1989, AM J PREV MED; Morris JC, 1993, NEUROLOGY; Nyman SR, 2017, BR J HLTH PSYCHOL; Pacher P, 2004, CURR PHARM DESIGN, V10, P2463, DOI 10.2174/1381612043383872; Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720; Rhyner KT, 2016, J AGING PHYS ACTIV, V24, P234, DOI 10.1123/japa.2015-0146; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Sexton H, 2001, SOC PSYCH PSYCH EPID, V36, P348, DOI 10.1007/s001270170040; Snowden MB, 2015, AM J GERIAT PSYCHIAT, V23, P897, DOI 10.1016/j.jagp.2014.09.002; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Souter MA, 2007, ANTHROZOOS, V20, P167, DOI 10.2752/175303707X207954; Topolski TD, 2006, PREV CHRONIC DIS, V3; Varma VR, 2017, J ALZHEIMERS DIS, V55, P659, DOI 10.3233/JAD-160582; Verkaik R, 2005, INT J GERIATR PSYCH, V20, P301, DOI 10.1002/gps.1279; Vikstrom S., 2008, DEMENTIA, V7, P251, DOI [DOI 10.1177/1471301208091164, 10.1177/1471301208091164]; Watts Amber, 2015, Gerontol Geriatr Med, V1; Watts AS, 2013, CLIN GERONTOLOGIST, V36, P356, DOI 10.1080/07317115.2013.788116; Wherton JP, 2010, INTERACT COMPUT, V22, P253, DOI 10.1016/j.intcom.2010.03.004; Yeager CA, 2008, PSYCHOL REP, V102, P718, DOI 10.2466/PR0.102.3.718-722; Yesavage J.A., 1986, CLIN GERONTOL J AGIN; Yu F, 2012, AM J ALZHEIMERS DIS, V27, P397, DOI 10.1177/1533317512453492; Zimmermann U, 2003, J PSYCHIATR RES, V37, P193, DOI 10.1016/S0022-3956(03)00018-9	44	18	18	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208581	10.1371/journal.pone.0208581	http://dx.doi.org/10.1371/journal.pone.0208581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6IO	30532212	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900024
J	Bonifay, T; Prince, C; Neyra, C; Demar, M; Rousset, D; Kallel, H; Nacher, M; Djossou, F; Epelboin, L				Bonifay, Timothee; Prince, Christelle; Neyra, Clarisse; Demar, Magalie; Rousset, Dominique; Kallel, Hatem; Nacher, Mathieu; Djossou, Felix; Epelboin, Loic		Char Chik Working Grp	Atypical and severe manifestations of chikungunya virus infection in French Guiana: A hospital-based study	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; REUNION ISLAND; OUTBREAK; FEVER; DENGUE	Background French Guiana (FG) was the first country in South America to declare chikungunya virus infection (CHIKV). The outbreak affected about 16,000 persons between February 2014 and October 2015, with several atypical cases, but only two fatal cases. We aimed to describe the clinical presentation of patients hospitalized for CHIKV infection, to estimate and identify risk factors of unusual and severe forms in adult patients. Materials and methods A monocentric retrospective study was conducted in Cayenne hospital, the main city and the main hospital in FG, from March 1st 2014 to August 31st 2015. All patients admitted for at least one night with a biological diagnosis of CHIKV infection during the 2014/2015 outbreak were included, except pregnant women and children under 15 years. Results During the study period, 285 patients with a diagnosis of CHIKV infection were hospitalized in Cayenne hospital, among whom 96 nonpregnant adults were studied. Five were classified as severe forms (5.2%) and 23 as unusual forms (23.9%). The most frequent atypical and/or severe form was neurological (n = 20), followed by cardio-respiratory failure (acute respiratory failure n = 4, acute heart failure n = 2), digestive and hepatic disorders (acute hepatitis n = 3, acute pancreatitis n = 2), renal disorders (acute renal failure n = 5) and muscular impairment (rhabdomyolysis n = 3). Conclusion During the outbreak, hospitalizations were frequent, particularly for common forms, driven by algic clinical presentations and concerns due to the novelty of this infection. Despite atypical neurological and liver forms of CHIKV infection, case-fatality was low in French Guiana. No specific risk factor of atypical and/or severe forms was found in our study.	[Bonifay, Timothee; Prince, Christelle; Neyra, Clarisse; Demar, Magalie; Djossou, Felix; Epelboin, Loic] Ctr Hosp Andree Rosemon, Trop & Infect Dis Dept, Cayenne, French Guiana; [Bonifay, Timothee] Univ French West Indies, Dept Gen Med, Pointe a Pitre, Guadeloupe, France; [Bonifay, Timothee; Nacher, Mathieu] INSERM, CIC 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana; [Demar, Magalie] Ctr Hosp Andree Rosemon, Lab Hosp Univ Immunol, Cayenne, French Guiana; [Demar, Magalie; Nacher, Mathieu; Djossou, Felix; Epelboin, Loic] Univ Guyane, Equipe EA 3593, Ecosyst Amazoniens Pathol Trop, Cayenne, French Guiana; [Rousset, Dominique] Inst Pasteur, Natl Reference Ctr Arboviruses, Cayenne, French Guiana; [Kallel, Hatem] Ctr Hosp Andree Rosemon, Intens Care Unit, Cayenne, French Guiana	Institut National de la Sante et de la Recherche Medicale (Inserm)	Bonifay, T (corresponding author), Ctr Hosp Andree Rosemon, Trop & Infect Dis Dept, Cayenne, French Guiana.; Bonifay, T (corresponding author), Univ French West Indies, Dept Gen Med, Pointe a Pitre, Guadeloupe, France.; Bonifay, T (corresponding author), INSERM, CIC 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana.	timothee.bonifay@gmail.com	Rousset, Dominique/S-5400-2019; Djossou, Felix/AAM-8640-2020; Demar, Magalie Pierre/AAM-6913-2020; amsalu, ribka/G-8780-2019; nacher, mathieu/AAH-4796-2021; Epelboin, LoÃc/AAP-6477-2020; Bonifay, Timothee/AAO-5230-2021	Rousset, Dominique/0000-0002-1473-3147; Demar, Magalie Pierre/0000-0003-3414-0821; nacher, mathieu/0000-0001-9397-3204; Epelboin, LoÃc/0000-0002-3481-5991; Bonifay, Timothee/0000-0003-3321-6011				Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753; Boisson V, 2012, MED TROP REV CORPS S, V72; Bonifay T, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx247; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Cerny T, 2017, NEUROCRIT CARE, V27, P447, DOI 10.1007/s12028-017-0413-8; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Couillaud A., 2017, RECENSEMENT POPULATI; Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010; de la Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI 10.1016/j.jcv.2015.05.021; Djossou F, 2016, T ROY SOC TROP MED H, V110, P705, DOI 10.1093/trstmh/trx004; Djossou F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150828; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; Epelboin L, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax028; Flamand C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172267; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Godaert L, 2017, J AM GERIATR SOC, V65, P2510, DOI 10.1111/jgs.15004; InVS, 2015, 022015 ARS INVS; InVS, 2015, SURV CHIK B PER SEM; Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2; Paixao ES, 2018, T ROY SOC TROP MED H, V112, P301, DOI 10.1093/trstmh/try063; Ramon-Pardo, 2015, WKLY EPIDEMIOL REC, V33, P410; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449; Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588; Seyler T, 2010, T ROY SOC TROP MED H, V104, P133, DOI 10.1016/j.trstmh.2009.07.014; Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004; Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009; Thomas L, 2014, AM J TROP MED HYG, V91, P138, DOI 10.4269/ajtmh.13-0595; Torres JR, 2015, IDCases, V2, P6, DOI 10.1016/j.idcr.2014.12.002	33	33	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207406	10.1371/journal.pone.0207406	http://dx.doi.org/10.1371/journal.pone.0207406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521555	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600012
J	Mell, M; Monroy, F				Mell, Michael; Monroy, Francisco			A gradient-based, GPU-accelerated, high-precision contour-segmentation algorithm with application to cell membrane fluctuation spectroscopy	PLOS ONE			English	Article							PHASE-CONTRAST; BENDING ELASTICITY; DIFFRACTION PHASE; MICROSCOPY; MECHANICS	We present a novel intensity-gradient based algorithm specifically designed for nanometer-segmentation of cell membrane contours obtained with high-resolution optical microscopy combined with high-velocity digital imaging. The algorithm relies on the image oversampling performance and computational power of graphical processing units (GPUs). Both, synthetic and experimental data are used to quantify the sub-pixel precision of the algorithm, whose analytic performance results comparatively higher than in previous methods. Results from the synthetic data indicate that the spatial precision of the presented algorithm is only limited by the signal-to-noise ratio (SNR) of the contour image. We emphasize on the application of the new algorithm to membrane fluctuations (flickering) in eukaryotic cells, bacteria and giant vesicle models. The method shows promising applicability in several fields of cellular biology and medical imaging for nanometer-precise boundary-determination and mechanical fingerprinting of cellular membranes in optical microscopy images. Our implementation of this high-precision flicker spectroscopy contour tracking algorithm (HiPFSTA) is provided as open-source at www.github.com/michaelmell/hipfsta.	[Mell, Michael; Monroy, Francisco] Univ Complutense, Dept Quim Fis 1, Mech Biol Membranes & Biorheol, Madrid, Spain; [Monroy, Francisco] Hosp Doce Octubre i 12, Inst Invest Biomed, Translat Biophys, Madrid, Spain	Complutense University of Madrid	Mell, M; Monroy, F (corresponding author), Univ Complutense, Dept Quim Fis 1, Mech Biol Membranes & Biorheol, Madrid, Spain.; Monroy, F (corresponding author), Hosp Doce Octubre i 12, Inst Invest Biomed, Translat Biophys, Madrid, Spain.	michael.mell@gmx.net; monroy@ucm.es	Monroy, Francisco/N-2763-2013	Monroy, Francisco/0000-0001-6455-3083	Ministry of Economy and Competitiveness (MINECO), Spain [FIS2015-70339-C2-1-R]; Comunidad de Madrid, Spain [S2013/MIT-2807]; FPU program (MEC); Ministerio de Economia y Competitividad (MINECO, Spain) [FIS2015-70339-C2-1-R]; Comunidad de Madrid [S2013/MIT-2807]	Ministry of Economy and Competitiveness (MINECO), Spain; Comunidad de Madrid, Spain(Comunidad de Madrid); FPU program (MEC)(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia); Ministerio de Economia y Competitividad (MINECO, Spain); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Ministry of Economy and Competitiveness (MINECO), Spain (Grant No. FIS2015-70339-C2-1-R) and Comunidad de Madrid, Spain (Grant No. S2013/MIT-2807). MM thanks the FPU program (MEC) for financial support.; The authors wish to thank Jose A. Rodrigo (Department of Optics, UCM) for fruitful discussions on the noise structure factor. We also thank Julia Gala and Victor G. Almendro-Vedia for providing us with microscopy images of lymphocyte and E. coli cells. The work was supported in part by Ministerio de Economia y Competitividad (MINECO, Spain) under grant FIS2015-70339-C2-1-R and by Comunidad de Madrid under grant S2013/MIT-2807. MM thanks the FPU program (MEC) for financial support.	Ben-Isaac E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238103; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; Boal D., 2012, MECH CELL; Carpenter AE, 2007, NAT METHODS, V4, P120, DOI 10.1038/nmeth0207-120; Dobereiner HG, 1997, PHYS REV E, V55, P4458, DOI 10.1103/PhysRevE.55.4458; DUWE HP, 1990, J PHYS-PARIS, V51, P945, DOI 10.1051/jphys:019900051010094500; ENGELHARDT H, 1985, J PHYS LETT-PARIS, V46, pL395, DOI 10.1051/jphyslet:01985004608039500; Evans JJ, 2008, COMPUT BIOL MED, V38, P545, DOI 10.1016/j.compbiomed.2008.01.013; FAUCON JF, 1989, J PHYS-PARIS, V50, P2389, DOI 10.1051/jphys:0198900500170238900; Fowler B, 2010, PROC SPIE, V7536, DOI 10.1117/12.846975; Guillemin E. A., 2013, THEORY LINEAR PHYS S; Hackl W, 1997, J PHYS II, V7, P1141, DOI 10.1051/jp2:1997177; Kandel ME, 2018, BIOMED OPT EXPRESS, V9, P623, DOI 10.1364/BOE.9.000623; Meleard P, 1997, BIOPHYS J, V72, P2616, DOI 10.1016/S0006-3495(97)78905-7; Monzel C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9162; Nguyen TH, 2016, OPT EXPRESS, V24, P1683, DOI 10.1364/OE.24.011683; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Park YK, 2006, OPT EXPRESS, V14, P8263, DOI 10.1364/OE.14.008263; Park Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051925; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Pecreaux J, 2004, EUR PHYS J E, V13, P277, DOI 10.1140/epje/i2004-10001-9; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Rodriguez-Garcia R, 2015, BIOPHYS J, V108, P2794, DOI 10.1016/j.bpj.2015.05.005; Smith AS, 2016, NAT PHYS, V12, P378, DOI 10.1038/nphys3703; Smith J. O., 2010, LINEAR INTERPOLATION; Spring K. R., 1997, VIDEOMICROSCOPY FUND; STREY H, 1995, BIOPHYS J, V69, P478, DOI 10.1016/S0006-3495(95)79921-0; Turlier H, 2016, NAT PHYS, V12, P513, DOI [10.1038/nphys3621, 10.1038/NPHYS3621]; Usenik P, 2011, MED BIOL ENG COMPUT, V49, P957, DOI 10.1007/s11517-011-0789-0; Waters J., 2014, METHODS CELL BIOL SE, V123; WILSON T, 1981, OPTIK, V59, P19; Yoon YZ, 2009, BIOPHYS J, V97, P1606, DOI 10.1016/j.bpj.2009.06.028; Zernike F, 1942, PHYSICA, V9, P686, DOI 10.1016/S0031-8914(42)80035-X; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207376	10.1371/journal.pone.0207376	http://dx.doi.org/10.1371/journal.pone.0207376			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521560	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600010
J	Nikzad, Z; Iravani, M; Abedi, P; Shahbazian, N; Saki, A				Nikzad, Zahra; Iravani, Mina; Abedi, Parvin; Shahbazian, Nahid; Saki, Amal			The relationship between iron deficiency anemia and sexual function and satisfaction among reproductive-aged Iranian women	PLOS ONE			English	Article							QUALITY-OF-LIFE; GENERAL HEALTH; DYSFUNCTION; PREVALENCE; IMPACT; MEN	Iron deficiency anemia (IDA) is a common micronutrient deficiency worldwide, and an important health problem especially in women of reproductive age. This study aimed to determine the relationship between IDA and sexual satisfaction and function among reproductive-aged Iranian women. In this study, 129 women (52 with IDA and 77 non-IDA) with age 18-45 in Mahshahr, Iran were recruited. Data was gathered by a demographic questionnaire, Female Sexual Function Index (FSFI) and Larson Sexual Satisfaction Questionnaire. Data were analyzed using an independent t-test, Mann-Whitney test, Chi-square, and correlation coefficient test. The results of this study showed that the means of hemoglobin (Hb), hematocrit (HCT), serum iron and ferritin were significantly lower in the IDA group than those in the non-IDA group (p<0.01). All dimensions of sexual function and satisfaction were significantly lower in women with IDA compared to the healthy women (p<0.001). Also, all blood indices for IDA had a significant relationship with all sexual function components and sexual satisfaction (p = 0.01) except for pain with Hb and ferritin. Health care providers should provide screening, education, and counseling about anemia and sexual function in reproductive age women.	[Nikzad, Zahra] Ahvaz Jundishapur Univ Med Sci, Reprod Hlth Promot Res Ctr, Midwifery Dept, Ahvaz, Iran; [Iravani, Mina; Abedi, Parvin] Ahvaz Jundishapur Univ Med Sci, Menopause Andropause Res Ctr, Midwifery Dept, Ahvaz, Iran; [Shahbazian, Nahid] Ahvaz Jundishapour Univ Med Sci, Fertil Infertil & Perinatol Res Ctr, Dept Obstet & Gynecol, Ahvaz, Iran; [Saki, Amal] Ahvaz Jundishapur Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Ahvaz, Iran	Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS)	Iravani, M (corresponding author), Ahvaz Jundishapur Univ Med Sci, Menopause Andropause Res Ctr, Midwifery Dept, Ahvaz, Iran.	minairavani2004@yahoo.com	Shahbazian, Nahid/AAE-2741-2019		Ahvaz Jundishapur University of Medical Sciences	Ahvaz Jundishapur University of Medical Sciences	This study was funded and supported by the Ahvaz Jundishapur University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Asadifard F., 2013, SEXUAL FUNCTION WOME; Bahrami N, 2016, J KERMAN U MED SCI, V23, P344; Bateni j, 2006, Q J ZANJAN U MED SCI, V14, P39; Bhatia V, 2006, DIABETES CARE, V29, P2289, DOI 10.2337/dc06-0637; Bradford A, 2006, BEHAV RES THER, V44, P1067, DOI 10.1016/j.brat.2005.08.006; deBenoist B, 2008, WORLDWIDE PREVALENCE; Diehl A, 2013, CLINICS, V68, P205, DOI [10.6061/clinics/2013(02)OA14, 10.6061/CLINICS/2013(02)OA14]; Dunn KM, 1999, J EPIDEMIOL COMMUN H, V53, P144, DOI 10.1136/jech.53.3.144; Ekart R, 2014, ARTIF ORGANS, V38, P598, DOI 10.1111/aor.12218; Esposito K, 2005, INT J IMPOT RES, V17, P224, DOI 10.1038/sj.ijir.3901310; Fakhri A, 2012, J SEX MED, V9, P514, DOI 10.1111/j.1743-6109.2011.02553.x; Fontaine O, 2007, FOOD NUTR BULL, V28, pS621; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Gebremedhin S, 2011, ETHIOP J HEALTH DEV, V25, P22; Gulmez H, 2014, J SEX MED, V11, P1042, DOI 10.1111/jsm.12454; Guo W, 2014, J GERONTOL A-BIOL, V69, P505, DOI 10.1093/gerona/glt127; Larson JH, 1998, J SEX MARITAL THER, V24, P193, DOI 10.1080/00926239808404933; LAUMANN E., 2000, JAMA-J AM MED ASSOC, V281, P537; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Li SX, 2016, J NUTR SCI VITAMINOL, V62, P397, DOI 10.3177/jnsv.62.397; Maldonado-Araque C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24352-9; Mawani M., 2016, REPROD SYST SEX DISO, V5, P1, DOI [10.4172/2161-038X.1000187, DOI 10.4172/2161-038X.1000187]; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Naeinian MR, 2011, UROL J, V8, P127; Nowrousian MR, 2008, RECOMBINANT HUMAN ER; Palmer BF, 2003, ADV RENAL REPLACE TH, V10, P48, DOI 10.1053/jarr.2003.50003; Pasquali D, 2013, J ENDOCRINOL INVEST, V36, P729, DOI 10.3275/8933; Patterson AJ, 2000, QUAL LIFE RES, V9, P491, DOI 10.1023/A:1008978114650; Peuranpaa P, 2014, ACTA OBSTET GYN SCAN, V93, P654, DOI 10.1111/aogs.12394; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Safarinejad MR, 2006, INT J IMPOT RES, V18, P382, DOI 10.1038/sj.ijir.3901440; Salehzadeh M., 2011, EFFECTIVENESS COGNIT; Salonia A, 2004, EUR UROL, V45, P642, DOI 10.1016/j.eururo.2003.11.023; Saydam BK, 2017, PAK J MED SCI, V33, P433, DOI 10.12669/pjms.332.11771; Sheikholeslam R, 2001, TEB VA TAZKIYEH, V47, P37; TANG XY, 2013, PLOS ONE, V8; Teuwafeu DG, 2016, NEPHROL DIAL TRANSPL, V31, P295	38	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208485	10.1371/journal.pone.0208485	http://dx.doi.org/10.1371/journal.pone.0208485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521614	gold, Green Published, Green Submitted			2022-12-26	WOS:000452307600076
J	Arnulf, JK; Larsen, KR; Martinsen, OL				Arnulf, Jan Ketil; Larsen, Kai Rune; Martinsen, Oyvind Lund			Semantic algorithms can detect how media language shapes survey responses in organizational behaviour	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; CHARISMATIC LEADERSHIP; SOCIAL CONSTRUCTION; WORK MOTIVATION; PERFORMANCE; INFORMATION; SENSEMAKING; EXCHANGE; COMMITMENT; DIMENSIONS	Research on sensemaking in organisations and on linguistic relativity suggests that speakers of the same language may use this language in different ways to construct social realities at work. We apply a semantic theory of survey response (STSR) to explore such differences in quantitative survey research. Using text analysis algorithms, we have studied how language from three media domains-the business press, PR Newswire and general newspapers-has differential explanatory value for analysing survey responses in leadership research. We projected well-known surveys measuring leadership, motivation and outcomes into large text samples from these three media domains significantly different impacts on survey responses. Business press language was best in explaining leadership-related items, PR language best at explaining organizational results and "ordinary" newspaper language seemed to explain the relationship among motivation items. These findings shed light on how different public arenas construct organizational realities in different ways, and how these differences have consequences on methodology in research on leadership.	[Arnulf, Jan Ketil; Martinsen, Oyvind Lund] BI Norwegian Business Sch, Dept Org Management & Leadership, Oslo, Norway; [Larsen, Kai Rune] Univ Colorado, Leeds Business Sch, Boulder, CO 80309 USA	BI Norwegian Business School; University of Colorado System; University of Colorado Boulder	Arnulf, JK (corresponding author), BI Norwegian Business Sch, Dept Org Management & Leadership, Oslo, Norway.	jan.k.arnulf@bi.no	Arnulf, Jan Ketil/K-7654-2013	Arnulf, Jan Ketil/0000-0002-3798-1477; Martinsen, Oyvind Lund/0000-0002-7968-4497	U.S. National Science Foundation [NSF 0965338]; National Institutes of Health through Colorado Clinical & Translational Sciences Institute [NIH/CTSI 5 UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); National Institutes of Health through Colorado Clinical & Translational Sciences Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	KL received funding from the following sources: 1) The U.S. National Science Foundation for research support under grant NSF 0965338 and 2) The National Institutes of Health through Colorado Clinical & Translational Sciences Institute for research support under NIH/CTSI 5 UL1 RR025780.	Alvesson M, 2003, LEADERSHIP QUART, V14, P359, DOI 10.1016/S1048-9843(03)00031-6; Alvesson M, 2008, SCAND J MANAG, V24, P1, DOI 10.1016/j.scaman.2007.10.001; Andrich D, 1996, BRIT J MATH STAT PSY, V49, P347, DOI 10.1111/j.2044-8317.1996.tb01093.x; [Anonymous], MYSTICISM LOGIC; [Anonymous], 2012, LEADERSHIP ORG; [Anonymous], INTRO LATENT SEMANTI; [Anonymous], 1944, ETC REV GEN SEMANT; [Anonymous], STUFF LANGUAGE WINDO; Arnulf JK, 2018, BEHAV RES METHODS, V50, P2345, DOI 10.3758/s13428-017-0999-y; Arnulf JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106361; Arnulf JK, 2015, SCANDINAVIAN PSYCHOL, V2; Arnulf JK, 2012, J INVESTIGATIVE PSYC; ASTLEY WG, 1992, ORGAN SCI, V3, P443, DOI 10.1287/orsc.3.4.443; Avolio B., 1995, MLQ MULTIFACTOR LEAD; Bagozzi RP, 2011, MIS QUART, V35, P261; Bargh JA., 2010, HDB SOCIAL PSYCHOL, V5, P268; BARNES B, 1983, SOCIOLOGY, V17, P524, DOI 10.1177/0038038583017004004; Beckstead JW, 2012, MULTIVAR BEHAV RES, V47, P224, DOI 10.1080/00273171.2012.658331; Bedeian AG, 2006, LEADERSHIP QUART, V17, P190, DOI 10.1016/j.leaqua.2005.12.006; Berger P., 1967, SOCIAL CONSTRUCTION; Bernerth JB, 2007, J ORGAN BEHAV, V28, P979, DOI 10.1002/job.443; Berry MW, 1995, COMPUT HUMANITIES, V29, P413, DOI 10.1007/BF01829874; Berry MW, 1995, SIAM REV, V37, P573, DOI 10.1137/1037127; Bligh MC, 2004, J APPL PSYCHOL, V89, P562, DOI 10.1037/0021-9010.89.3.562; Bligh MC, 2012, Z PSYCHOL, V220, P205, DOI 10.1027/2151-2604/a000122; Bonet E, 2010, J ORGAN CHANGE MANAG, V23, P120, DOI 10.1108/09534811011031283; Bono JE, 2003, ACAD MANAGE J, V46, P554, DOI 10.2307/30040649; Boroditsky L, 2011, SCI AM, P43; Borsboom D, 2008, MEAS-INTERDISCIP RES, V6, P25, DOI 10.1080/15366360802035497; BRUNER J, 1991, CRIT INQUIRY, V18, P1, DOI 10.1086/448619; Cammann C., 1979, MICHIGAN ORG ASSESSM; Cascio WF, 2012, INT J HUM RESOUR MAN, V23, P2532, DOI 10.1080/09585192.2011.561242; Cavalli-Sforza LL, 1986, AFRICAN PYGMIES; Cha SE, 2006, LEADERSHIP QUART, V17, P57, DOI 10.1016/j.leaqua.2005.10.006; CHEN CC, 1991, ADMIN SCI QUART, V36, P521, DOI 10.2307/2393273; Chomsky N, 2008, PHILOS LANGUAGE; Conger JA, 1991, ACADEMV MANAGEMENT E, V5; COOMBS CH, 1960, PSYCHOMETRIKA, V25, P219, DOI 10.1007/BF02289726; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Den Hartog DN, 1997, LEADERSHIP QUART, V8, P355, DOI 10.1016/S1048-9843(97)90020-5; Dennis S., 2003, 25 ANN M COGN SCI SO; Drath W.H., 1994, MAKING COMMON SENSE; Dubois D, 1988, FUZZY SETS SYSTEMS; DUMAIS ST, 1991, BEHAV RES METH INS C, V23, P229, DOI 10.3758/BF03203370; Dumdum UR, 2013, MONOGR LEAD MANAGE, V2, P39, DOI 10.1108/S1479-3571(2013)0000005008; Dysvik A, 2008, INT J TRAIN DEV, V12, P138, DOI 10.1111/j.1468-2419.2008.00301.x; Epitropaki O, 2005, J APPL PSYCHOL, V90, P659, DOI 10.1037/0021-9010.90.4.659; Fairhurst GT, 2010, MANAGE COMMUN Q, V24, P171, DOI 10.1177/0893318909359697; Fausey CM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00162; Favero N, 2016, PUBLIC PERFORM MANAG, V40, P145, DOI 10.1080/15309576.2016.1180997; Fellbaum C, 2010, THEORY AND APPLICATIONS OF ONTOLOGY: COMPUTER APPLICATIONS, P231, DOI 10.1007/978-90-481-8847-5_10; Fleenor JW, 2010, LEADERSHIP QUART, V21, P1005, DOI 10.1016/j.leaqua.2010.10.006; FOUCAULT M, 1979, IC, P5; Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322; Gefen D, 2017, J ASSOC INF SYST, V18, P727, DOI 10.17705/1jais.00469; Gefen D, 2017, COMMUN ASSOC INF SYS, V41, P450, DOI 10.17705/1CAIS.04121; Gumperz John J., 1996, RETHINKING LINGUISTI, P374; Habing B, 2005, APPL PSYCH MEAS, V29, P457, DOI 10.1177/0146621604279550; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Hamann PM, 2013, ORGAN RES METHODS, V16, P67, DOI 10.1177/1094428112470007; Hansen MT, 2013, HARVARD BUS REV, V91, P81; Hayward MLA, 2004, STRATEGIC MANAGE J, V25, P637, DOI 10.1002/smj.405; Holt R, 2010, INT SMALL BUS J, V28, P20, DOI 10.1177/0266242609350822; Howell JM, 2005, ACAD MANAGE REV, V30, P96, DOI [10.2307/20159097, 10.5465/AMR.2005.15281435]; Jacob MC, 2014, 1 KNOWLEDGE EC HUMAN, P1750; Kay J., 1993, FDN CORPORATE SUCCES; Kay P, 1996, RETHINKING LINGUISTI, P97; Khurana R, 2007, FROM HIGHER AIMS TO HIRED HANDS: THE SOCIAL TRANSFORMATION OF AMERICAN BUSINESS SCHOOLS AND THE UNFULFILLED PROMISE OF MANAGEMENT AS A PROFESSION, P1; Khurana R, 2002, HARVARD BUS REV, V80, P60; Kuvaas B, 2006, J ORGAN BEHAV, V27, P365, DOI 10.1002/job.377; Kuvaas B, 2006, INT J HUM RESOUR MAN, V17, P504, DOI 10.1080/09585190500521581; Lamiell JT, 2013, NEW IDEAS PSYCHOL, V31, P65, DOI 10.1016/j.newideapsych.2011.02.009; Landauer T. K., 2007, HDB LATENT SEMANTIC, P3; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Landauer TK, 1990, FULLY AUTOMATIC CROS, P31; Larsen KR, 2016, MIS QUART, V40, P529, DOI 10.25300/MISQ/2016/40.3.01; Larsen KR, 2004, SOCIOL METHODOL, V34, P349, DOI 10.1111/j.0081-1750.2004.00156.x; Larsen KR, 2013, LEEDS SCH WORKING PA, P1; Larsen KR, 2008, EXPLORING SEMANTIC V, P1; Lauring J, 2011, PERS REV, V40, P324, DOI 10.1108/00483481111118649; Leacock C, 1998, COMPUT LINGUIST, V24, P147; Li YH, 2006, IEEE T KNOWL DATA EN, V18, P1138, DOI 10.1109/TKDE.2006.130; LIEBERSON S, 1972, AM SOCIOL REV, V37, P117, DOI 10.2307/2094020; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Littman ML, 1998, KLUW S INF, V2, P51; Lovasz N, 2013, NEW IDEAS PSYCHOL, V31, P22, DOI 10.1016/j.newideapsych.2011.02.005; Lucier C, 2006, CEO SUCCESSION 2005; Lucy John A., 1996, RETHINKING LINGUISTI, P37; Maclean M, 2012, HUM RELAT, V65, P17, DOI 10.1177/0018726711425616; March JG, 1997, ORGAN SCI, V8, P698, DOI 10.1287/orsc.8.6.698; March JG, 1994, PRIMER DECISION MAKI; Maul A, 2017, MEAS-INTERDISCIP RES, V15, P51, DOI 10.1080/15366367.2017.1348108; MEYER JP, 1993, J APPL PSYCHOL, V78, P538, DOI 10.1037/0021-9010.78.4.538; MICHELL J, 1994, J MATH PSYCHOL, V38, P244, DOI 10.1006/jmps.1994.1016; Micklethwait John, 2003, CO SHORT HIST REVOLU; Mihalcea R., 2006, AAAI, P775; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mohler M., 2009, TEXT TO TEXT SEMANTI, P567; Nakov P, 2001, WEIGHT FUNCTIONS IMP, P187; Neuman Y., 2014, PSYCHOL TODAY; Neuman Y, 2012, INTEGR PSYCHOL BEHAV, V46, P129, DOI 10.1007/s12124-011-9165-8; Nimon K., 2015, J HAPPINESS STUD, P1; Nimon K, 2016, J HAPPINESS STUD, V17, P1149, DOI 10.1007/s10902-015-9636-6; Nimon KF, 2013, ORGAN RES METHODS, V16, P650, DOI 10.1177/1094428113493929; Nunnally K, 2010, PSYCHOMETRIC THEORY, V3rd; Pinker Steven, 1994, LANGUAGE INSTINCT; Podolny JM, 2005, RES ORGAN BEHAV, V26, P1, DOI 10.1016/S0191-3085(04)26001-4; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Raelin JA, 2007, ACAD MANAG LEARN EDU, V6, P495, DOI 10.5465/AMLE.2007.27694950; RENFREW C, 1987, ARCHAEOLOGY LANGUAGE; Rhemtulla M, 2017, MEAS-INTERDISCIP RES, V15, P95, DOI 10.1080/15366367.2017.1369785; Richards I.A, 1989, MEANING MEANING; Rindova VP, 2006, ACAD MANAGE REV, V31, P50; Russell Bertrand, 1922, TRACTATUS LOGICOPHIL; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schedlitzki D, 2017, EUR MANAG REV, V14, P19, DOI 10.1111/emre.12087; Scherbaum CA, 2006, LEADERSHIP QUART, V17, P366, DOI 10.1016/j.leaqua.2006.04.005; Shamir B., 1994, LEADERSHIP QUART, V5, P25, DOI [10.1016/1048-9843(94)90004-3, DOI 10.1016/1048-9843(94)90004-3]; Shore LM, 2006, J APPL SOC PSYCHOL, V36, P837, DOI 10.1111/j.0021-9029.2006.00046.x; Sidnell J, 2012, CURR ANTHROPOL, V53, P302, DOI 10.1086/665697; Sirota D., 2005, ENTHUSIASTIC EMPLOYE; Slaney K., 2017, VALIDATING PSYCHOL C; Slaney KL, 2013, NEW IDEAS PSYCHOL, V31, P4, DOI 10.1016/j.newideapsych.2011.02.003; Slobin D., 1996, RETHINKING LINGUISTI, P70, DOI DOI 10.1016/S0378-2166(97)83851-9; Steyaert C, 2011, J WORLD BUS, V46, P270, DOI 10.1016/j.jwb.2010.07.003; Stogdill R. M., 1963, MANUAL LEADER BEHAV; Taylor J.R., 2000, EMERGENT ORG COMMUNI; Van Berkum JJA, 2007, BRAIN RES, V1146, P158, DOI 10.1016/j.brainres.2006.06.091; Van Dyne L, 1998, ACAD MANAGE J, V41, P108, DOI 10.2307/256902; Van Knippenberg D, 2013, ACAD MANAG ANN, V7, P1, DOI 10.1080/19416520.2013.759433; Wade JB, 2006, ACAD MANAGE J, V49, P643, DOI 10.2307/20159790; Weick K.E., 1995, SENSEMAKING ORG; Weick KE, 2011, J CHANG MANAG, V11, P7, DOI 10.1080/14697017.2011.548937; Weick KE, 2012, HUM RELAT, V65, P141, DOI 10.1177/0018726711424235; Weick KE, 2005, ORGAN SCI, V16, P409, DOI 10.1287/orsc.1050.0133; Weick KE, 2000, BREAKING THE CODE OF CHANGE, P223; Whorf B.L., 2012, LANGUAGE THOUGHT REA; Yukl G, 2012, ACAD MANAGE PERSPECT, V26, P66, DOI 10.5465/amp.2012.0088	141	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207643	10.1371/journal.pone.0207643	http://dx.doi.org/10.1371/journal.pone.0207643			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517132	gold, Green Submitted, Green Published			2022-12-26	WOS:000452212400054
J	Bazzano, AN; Potts, KS; Mulugeta, A				Bazzano, Alessandra N.; Potts, Kaitlin Storck; Mulugeta, Afework			How do pregnant and lactating women, and young children, experience religious food restriction at the community level ? A qualitative study of fasting traditions and feeding behaviors in four regions of Ethiopia	PLOS ONE			English	Article							ANIMAL-SOURCE FOODS; DIETARY DIVERSITY; HEALTH; MILK; GLUCOSE; RAMADAN; MECHANISMS	Maternal and child feeding behaviors are often rooted in family and sociocultural context,. making these an important point of inquiry for improving nutrition and health over the life course. The present study explored the practice of fasting during religious periods in relation to eating patterns of pregnant and lactating women and young children in four regions of Ethiopia, a nation which has experienced rapid economic growth and marked improvement in health and nutrition outcomes over the last two decades. Qualitative data collection and analysis at community level illustrated conflicting areas of understanding and practice related to diets of children and pregnant and lactating women during fasting times, potentially leading to gaps in nutrition. Community participants described different understandings of fasting requirements for these vulnerable populations and associated social norms and doxa, not always in accordance with religious texts or published guidance. Useful behavior change strategies may be developed through these results to address the potential barriers to appropriate feeding patterns for pregnant and lactating women and young children in Ethiopia. This will include continuing to work with communities and religious leaders to clarify that religious doctrine promotes improved nutrition outcomes.	[Bazzano, Alessandra N.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA; [Bazzano, Alessandra N.] Tulane Univ, Taylor Ctr Social Innovat & Design Thinking, New Orleans, LA 70118 USA; [Potts, Kaitlin Storck] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Mulugeta, Afework] Mekelle Univ, Coll Hlth Sci, Dept Nutr & Dietet, Mekelle, Ethiopia	Tulane University; Tulane University; Tulane University; Mekelle University	Bazzano, AN (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA.; Bazzano, AN (corresponding author), Tulane Univ, Taylor Ctr Social Innovat & Design Thinking, New Orleans, LA 70118 USA.	abazzano@tulane.edu	Bazzano, Alessandra N./U-7703-2019	Bazzano, Alessandra N./0000-0002-8299-2626; Mulugeta, Afework/0000-0003-0707-4363	UNICEF [43228122]; DfID	UNICEF; DfID	ANB's institution received funding from UNICEF (www.unicef.org) for this award through contract 43228122, sponsored in part through DfID (www.dfid.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adawi M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01144; Aliasghari F, 2017, J AM COLL NUTR, V36, P640, DOI 10.1080/07315724.2017.1339644; [Anonymous], 1992, MOD LANG J, DOI [DOI 10.2307/330063, 10.2307/330063]; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Baianonie M, RULES FASTING RAMADA; Bekele KS, 2016, PATRIARCH ETHIOPIA O; Bener A, 2001, NUTR RES, V21, P859, DOI 10.1016/S0271-5317(01)00303-7; Bernard HR, 2006, RES METHODS ANTHR QU, Vxvi; Central Intelligence Agency, WORLD FACTB COUNTR P; Chia JL, 2018, APPETITE, V127, P44, DOI 10.1016/j.appet.2018.04.017; Daelmans B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4029; Daelmans B, 2013, MATERN CHILD NUTR, V9, P116, DOI 10.1111/mcn.12083; Delbiso TD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02271-5; Disha A., 2015, PLOS ONE, DOI DOI 10.1371/journal.pone.0208408; Dror DK, 2011, FOOD NUTR BULL, V32, P227, DOI 10.1177/156482651103200307; Ethiopia CSA (CSA) [Ethiopia], 2017, ETH DEM HLTH SURV 20; Gebru M., 2018, FOOD SYSTEMS HLTH DI; Ghandour LA, 2013, PSYCHOL ADDICT BEHAV, V27, P279, DOI 10.1037/a0030172; Guest G, 2008, HDB TEAM BASED QUALI, Vviii; Institute of Medicine, 1991, NUTR LACT; Ji C, 2018, J PSYCHOL CHRISTIANI, V2011, P3; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Karras SN, 2017, EUR J CLIN NUTR, V71, P743, DOI 10.1038/ejcn.2017.26; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; KNUTSSON KE, 1970, AM J CLIN NUTR, V23, P956; Koufakis T, 2018, EUR J CLIN NUTR, V72, P474, DOI 10.1038/s41430-018-0113-2; Koufakis T, 2017, EUR J NUTR, V56, P2439, DOI 10.1007/s00394-017-1534-8; Kumera G, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0248-0; Lazarou C, 2010, INT J FOOD SCI NUTR, V61, P739, DOI 10.3109/09637481003769782; Lessan N, 2018, AM J CLIN NUTR, V107, P54, DOI 10.1093/ajcn/nqx016; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, DOI DOI 10.1016/0147-1767(85)90062-8; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Lynda Clarke WW-F, 2018, OXFORD ISLAMIC STUDI; Makedou Kali G, 2018, Open Access Maced J Med Sci, V6, P284, DOI 10.3889/oamjms.2018.095; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; Mohammad MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE879, DOI 10.1152/ajpendo.00364.2009; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; NEVILLE MC, 1993, J ENDOCRINOL, V139, P165, DOI 10.1677/joe.0.1390165; NWEMA, 2017, NW ETH MET AG; Padela AI, 2018, SOC SCI MED, V204, P92, DOI 10.1016/j.socscimed.2018.03.023; PRENTICE AM, 1984, CLIN SCI, V66, P291, DOI 10.1042/cs0660291; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sarri KO, 2005, BRIT J NUTR, V94, P198, DOI 10.1079/BJN20051472; Shao Y, 2018, DIABETES RES CLIN PR, V142, P85, DOI 10.1016/j.diabres.2018.05.022; Steckler RA, 2018, J SCI STUD RELIG, V57, P585, DOI 10.1111/jssr.12533; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trabelsi K, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-23; Trepanowski JF, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-57; Venegas-Borsellino Carla, 2018, Curr Nutr Rep, DOI 10.1007/s13668-018-0233-2; World Bank United Nations, 2011, NAT HAZ UNNATURAL DI; Zhang ZY, 2016, FOOD NUTR BULL, V37, P303, DOI 10.1177/0379572116647823; Zimmerman DR, 2009, J HUM LACT, V25, P194, DOI 10.1177/0890334409331505	53	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208408	10.1371/journal.pone.0208408	http://dx.doi.org/10.1371/journal.pone.0208408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517203	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400093
J	Yousuf, M; Shaikh, NN; Ul-Haq, Z; Choudhary, MI				Yousuf, Maria; Shaikh, Nimra Naveed; Ul-Haq, Zaheer; Choudhary, M. Iqbal			Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent beta-Glucuronidase inhibitors	PLOS ONE			English	Article							TOXICITY; LIGAND	Identification of hotspot drug-receptor interactions through in-silico prediction methods (Pharmacophore mapping virtual screening 3DQSAR, etc), is considered as a key approach in drug designing and development process. In the current design study advanced in-silico based computational techniques were used for the identification of lead-like molecules against the targeted receptor beta-glucuronidase. The binding pattern of a potent inhibitor in the ligand-receptor X-ray co-crystallize complex was used to identify and extract the structure-base Pharmacophore features. Based on these observations five structure-based pharmacophore models were derived to conduct the virtual screening of ICCBS in-house data-base. Top-ranked identified Hits (3 compounds) were selected to subject for in-vitro biological activity evaluation against beta-glucuronidase enzyme out of them twenty compounds (61% of screened compounds) evaluated as actives however eleven compounds were found to have significantly higher inhibitory activity including compounds 1, 5-8, 10, 12-13, and 17-19 with IC50 values ranging from 1.2 mu M to 34.9 mu M. Out of the eleven potent inhibitors seven compounds 1, 5, 6, 7, 8, 13, and 19 were found new and evaluated first time for the beta-glucuronidase inhibitory activity. Compounds 1, 5, and 19 exhibited a highly potent inhibition in mu M of beta-glucuronidase enzyme with non-cytotoxic behavior against the mouse fibroblast (3T3) cell line. Our combined in-silico and in-vitro results revealed that the binding pattern analysis of the eleven potent inhibitors showed almost similar non-covalent interactions as observed in case of our validated pharmaco-phore model. The obtained results thus demonstrated that the virtual screening minimizes false positives and provide a template for the identification and development of new and more potent beta-glucuronidase inhibitors with non-toxic effects.	[Yousuf, Maria; Ul-Haq, Zaheer] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan; [Shaikh, Nimra Naveed] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Pakistan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia	University of Karachi; University of Karachi; King Abdulaziz University	Yousuf, M (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan.	drmariayousuf@hotmail.com	Ul-Haq, Zaheer/E-3061-2010	Ul-Haq, Zaheer/0000-0002-8530-8711	Higher Education Commission, Pakistan [106-2333-PS6-138]	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	The research underlying this study was partially funded by Higher Education Commission, Pakistan (grant no. 106-2333-PS6-138 to Dr. Maria Yousuf). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, CURR CHEM GENOM, V5, P13; Ahmad S, 2012, J BIOMOL SCREEN, V17, P957, DOI 10.1177/1087057112444927; Bender A, 2005, J CHEM INF MODEL, V45, P1369, DOI 10.1021/ci0500177; Collins RA, 1997, BIOCHEM MOL BIOL INT, V42, P1163; Gao QZ, 2010, CURR COMPUT-AID DRUG, V6, P37, DOI 10.2174/157340910790980151; Gerhard W, AUTOMATED STRUCTURE; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Khan KM, 2014, BIOORGAN MED CHEM, V22, P3449, DOI 10.1016/j.bmc.2014.04.039; Khan KM, 2011, BIOORGAN MED CHEM, V19, P4286, DOI 10.1016/j.bmc.2011.05.052; KIM DH, 1994, BIOL PHARM BULL, V17, P443, DOI 10.1248/bpb.17.443; Liao CZ, 2011, FUTURE MED CHEM, V3, P1057, DOI [10.4155/FMC.11.63, 10.4155/fmc.11.63]; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Matthew R, 2012, U.S. Patents, Patent No. [2012/0322797, 20120322797]; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Molecular Operating Environment (MOE), 2013, NON TRADITIONAL REF; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oleson L, 2008, J PHARM PHARMACOL, V60, P1175, DOI 10.1211/jpp.60.9.0009; Ooms F, 2000, CURR MED CHEM, V7, P141, DOI 10.2174/0929867003375317; Perola E, 2004, J MED CHEM, V47, P2499, DOI 10.1021/jm030563w; Sanders MPA, 2012, MEDCHEMCOMM, V3, P28, DOI 10.1039/c1md00210d; Swets JA, 1996, SCI PSYCH S; Taha M, 2018, BIOORG CHEM, V77, P47, DOI [10.1016/j.bioorg.2018.01.002, 10.1016/j.bioorg.2018.02.028]; Taha M, 2018, EUR J MED CHEM, V143, P1757, DOI 10.1016/j.ejmech.2017.10.071; Taha M, 2017, BIOORG CHEM, V71, P86, DOI 10.1016/j.bioorg.2017.01.015; Thangapandian S, 2011, EUR J MED CHEM, V46, P2469, DOI 10.1016/j.ejmech.2011.03.035; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; Walaszek Z, 1997, CANCER DETECT PREV, V21, P178; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Walters WP, 1998, DRUG DISCOV TODAY, V3, P160, DOI 10.1016/S1359-6446(97)01163-X; Wermuth G, 1998, PURE APPL CHEM, V70, P1129, DOI 10.1351/pac199870051129; Wong AW, 1998, J BIOL CHEM, V273, P34057, DOI 10.1074/jbc.273.51.34057	31	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0200502	10.1371/jourmal.pone.0200502	http://dx.doi.org/10.1371/jourmal.pone.0200502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517092				2022-12-26	WOS:000452212400001
J	Lin, TH; Pajarinen, J; Kohno, Y; Huang, JF; Maruyama, M; Romero-Lopez, M; Nathan, K; Yao, ZY; Goodman, SB				Lin, Tzuhua; Pajarinen, Jukka; Kohno, Yusuke; Huang, Jhih-Fong; Maruyama, Masahiro; Romero-Lopez, Monica; Nathan, Karthik; Yao, Zhenyu; Goodman, Stuart B.			Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation	FASEB JOURNAL			English	Article						trained immunity; immunomodulation; T lymphocyte	STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; REINFECTION; PROTECTION; TISSUE	Mesenchymal stem cell (MSC)-mediated immunomodulation affects both innate and adaptive immune systems. These responses to environmental cues, such as pathogen-associated molecular patterns, damage-associated molecular patterns, or proinflammatory cytokines, are crucial for resolution of inflammation, as well as successful tissue healing and regeneration. We observed that intermittent, repeated exposure of MSCs to LPS induced stronger NF-B activation than singular stimulation. A similar phenomenon, named innate immune memory or trained immunity, has been reported with macrophages. However, the potential regulation of immune memory in nonclassic immune cells, such as MSCs, has not been reported. In the current study, we chose IFN- plus TNF- restimulation-induced iNOS expression as a model of MSC activation, because IFN- and TNF- play crucial roles in MSC-mediated immunomodulation. The iNOS expression was enhanced in LPS-trained MSCs, 3 d after a washout period following primary stimulation. LPS-trained MSCs enhanced the anti-inflammatory (arginase 1 and CD206) marker expression, but decreased the proinflammatory marker (TNF-, IL-1, iNOS, and IL-6) expression using an MSC-macrophage coculture model. In contrast, LPS-trained MSCs demonstrated a defective regulation on CD4 T-cell proliferation. Mechanistic studies suggested that histone methylation and the JNK pathway are involved in LPS-trained immunomodulation in MSCs. Our results demonstrate differential immunomodulatory effects of trained MSCs on macrophages and T cells. These immunomodulatory consequences are critical, because they will have a major impact on current MSC-based cell therapies.Lin, T., Pajarinen, J., Kohno, Y., Huang, J.-F., Maruyama, M., Romero-Lopez, M., Nathan, K., Yao, Z., Goodman, S. B. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation.	[Lin, Tzuhua; Pajarinen, Jukka; Kohno, Yusuke; Huang, Jhih-Fong; Maruyama, Masahiro; Romero-Lopez, Monica; Nathan, Karthik; Yao, Zhenyu; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Goodman, Stuart B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodman, SB (corresponding author), Stanford Univ, Sch Med, Dept Orthopaed Surg, 450 Broadway St, Redwood City, CA 94063 USA.	goodbone@stanford.edu	Maruyama, Masahiro/AED-5275-2022; Kohno, Yusuke/AAO-9850-2021; Goodman, Stuart/AAZ-7499-2020	Maruyama, Masahiro/0000-0002-1339-0023; Kohno, Yusuke/0000-0003-1821-4560; Goodman, Stuart/0000-0002-1919-3717; Romero-Lopez, Monica/0000-0003-0148-6033	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [1R01AR063717]; Ellenburg Chair in Surgery at Stanford University; Jane and Aatos Erkko Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063717, R01AR073145] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; Ellenburg Chair in Surgery at Stanford University; Jane and Aatos Erkko Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Katie Hsu, Sai-Wen Tang, and Magdiel Perez Cruz (all from Stanford University) for consulting on the T-cell proliferation assay. The authors also thank Piera Smeriglio (Stanford University) for consulting on the mechanistic study of epigenetic regulation. This work was supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant 1R01AR063717 (to S.B.G.) and the Ellenburg Chair in Surgery at Stanford University. J.P. was supported by a grant from the Jane and Aatos Erkko Foundation. The authors declare no conflicts of interest.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Davies LC, 2017, STEM CELLS, V35, P766, DOI 10.1002/stem.2509; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Engela AU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00126; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Lin TH, 2015, TISSUE ENG PT A, V21, P875, DOI [10.1089/ten.tea.2014.0144, 10.1089/ten.TEA.2014.0144]; Lin TH, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0730-z; Lin T, 2017, CYTOTHERAPY, V19, P1025, DOI 10.1016/j.jcyt.2017.06.008; Ling WF, 2014, CANCER RES, V74, P1576, DOI 10.1158/0008-5472.CAN-13-1656; Lundin JI, 2009, ENVIRON HEALTH PERSP, V117, P1344, DOI 10.1289/ehp.0800439; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Redondo-Castro E, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0531-4; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Saparov A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3924858; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	27	16	17	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4203	4211		10.1096/fj.201801845R	http://dx.doi.org/10.1096/fj.201801845R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521384	Green Published, Bronze			2022-12-26	WOS:000459794800088
J	McCarthy, EL; Rankin, AN; Dill, ZR; Booker, SJ				McCarthy, Erin L.; Rankin, Ananda N.; Dill, Zerick R.; Booker, Squire J.			The A-type domain in Escherichia coli NfuA is required for regenerating the auxiliary [4Fe-4S] cluster in Escherichia coli lipoyl synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron-sulfur protein; S-adenosylmethionine (SAM); radical; sulfur; enzyme mechanism; metalloenzyme; Fe-S cluster carrier; lipoic acid; NfuA; radical SAM enzyme	IRON-SULFUR CLUSTER; FUNCTIONAL-CHARACTERIZATION; RADICAL MECHANISMS; BIOSYNTHESIS; INTERMEDIATE; PROTEIN; ACID; COMPETENT; SUBSTRATE; CATALYSIS	The lipoyl cofactor plays an integral role in several essential biological processes. The last step in its de novo biosynthetic pathway, the attachment of two sulfur atoms at C6 and C8 of an n-octanoyllysyl chain, is catalyzed by lipoyl synthase (LipA), a member of the radical SAM superfamily. In addition to the [4Fe-4S] cluster common to all radical SAM enzymes, LipA contains a second [4Fe-4S] auxiliary cluster, which is sacrificed during catalysis to supply the requisite sulfur atoms, rendering the protein inactive for further turnovers. Recently, it was shown that the Fe-S cluster carrier protein NfuA from Escherichia coli can regenerate the auxiliary cluster of E. coli LipA after each turnover, but the molecular mechanism is incompletely understood. Herein, using protein-protein interaction and kinetic assays as well as site-directed mutagenesis, we provide further insight into the mechanism of NfuA-mediated cluster regeneration. In particular, we show that the N-terminal A-type domain of E. coli NfuA is essential for its tight interaction with LipA. Further, we demonstrate that NfuA from Mycobacterium tuberculosis can also regenerate the auxiliary cluster of E. coli LipA. However, an Nfu protein from Staphylococcus aureus, which lacks the A-type domain, was severely diminished in facilitating cluster regeneration. Of note, addition of the N-terminal domain of E. coli NfuA to S. aureus Nfu, fully restored cluster-regenerating activity. These results expand our understanding of the newly discovered mechanism by which the auxiliary cluster of LipA is restored after each turnover.	[McCarthy, Erin L.; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Rankin, Ananda N.; Dill, Zerick R.; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Booker, Squire J.] Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), 302 Chem Bldg, University Pk, PA 16802 USA.	squire@psu.edu			National Institutes of Health [GM-122595]; National Science Foundation [MCB-1716686, CHE-1659679]; Howard Hughes Medical Institute EXROP program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute EXROP program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-122595 and National Science Foundation Grants MCB-1716686 and CHE-1659679. This work was also supported by the Howard Hughes Medical Institute EXROP program (to Z. R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Beinert H, 1978, Methods Enzymol, V54, P435; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; Douglas P, 2006, ANGEW CHEM INT EDIT, V45, P5197, DOI 10.1002/anie.200601910; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; HAYDEN MA, 1993, BIOCHEMISTRY-US, V32, P3778, DOI 10.1021/bi00065a033; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P15109, DOI 10.1021/bi972001i; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Lanz ND, 2015, J AM CHEM SOC, V137, P13216, DOI 10.1021/jacs.5b04387; Lanz ND, 2015, BBA-MOL CELL RES, V1853, P1316, DOI 10.1016/j.bbamcr.2015.01.002; Lanz ND, 2014, BIOCHEMISTRY-US, V53, P4557, DOI 10.1021/bi500432r; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Mashruwala AA, 2015, MOL MICROBIOL, V95, P383, DOI 10.1111/mmi.12860; McCarthy EL, 2018, METHOD ENZYMOL, V606, P217, DOI 10.1016/bs.mie.2018.06.006; McCarthy EL, 2017, SCIENCE, V358, P373, DOI 10.1126/science.aan4574; McLaughlin MI, 2016, P NATL ACAD SCI USA, V113, P9446, DOI 10.1073/pnas.1602486113; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Subramanian S, 2015, J AM CHEM SOC, V137, P4567, DOI 10.1021/jacs.5b01869; WHITE RH, 1980, J AM CHEM SOC, V102, P6605, DOI 10.1021/ja00541a059	29	13	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1609	1617		10.1074/jbc.RA118.006171	http://dx.doi.org/10.1074/jbc.RA118.006171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30538130	Green Published, hybrid			2022-12-26	WOS:000457879200016
J	Palacios, V; Roldan, A; Jimenez-Cantizano, A; Amores-Arrocha, A				Palacios, Victor; Roldan, Ana; Jimenez-Cantizano, Ana; Amores-Arrocha, Antonio			Physicochemical and microbiological characterization of the sensory deviation responsible for the origin of the special sherry wines "palo cortado" type	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SCHIZOSACCHAROMYCES-POMBE MUTANT; GLUCONIC ACID; FLOR YEASTS; MALOLACTIC FERMENTATION; FINO SHERRY; AROMA; EVOLUTION; LYSOZYME	The aim of this study was to characterize the biochemical changes and microbiological processes involved in the sensory deviation of "sobretablas" wines during biological aging, which leads to the origin of special or rare "palo cortado" wines. Industrial trials of biological aging of "sobretablas" wines with the potential for the development of lactic acid bacteria (LAB) were performed to study this phenomenon. The results showed that sensory deviation was due to the development of malolactic fermentation (MLF) together with an attenuated aerobic metabolism of "flor" yeast. Malolactic fermentation (MLF) was promoted by the presence of malic acid concentrations that were higher than 1 g/L and the coexistence of LAB and "flor" velum yeast. Ethyl lactate, acetoin and 2,3-butanediol are some of the volatile compounds that are responsible for this sensory deviation. Wines with high levels of gluconic and malic acids (> 1 g/L) can cause, with very low probability, the sensory deviation of "palo cortado". A lysozyme dose of 12 g/hL is an effective treatment to avoid malolactic fermentation (MFL) and sensory deviation. Understanding the biochemical and microbiological changes involved in sensory deviation can be useful to wineries as markers to identify the origin of the special sherry wines "palo cortado" type.	[Palacios, Victor; Roldan, Ana; Jimenez-Cantizano, Ana; Amores-Arrocha, Antonio] Univ Cadiz, Fac Sci, Dept Chem Engn & Food Technol, Cadiz, Spain; [Palacios, Victor; Roldan, Ana; Jimenez-Cantizano, Ana; Amores-Arrocha, Antonio] IVAGRO, Agrifood Campus Int Excellence ceiA3, Cadiz, Spain	Universidad de Cadiz	Palacios, V (corresponding author), Univ Cadiz, Fac Sci, Dept Chem Engn & Food Technol, Cadiz, Spain.; Palacios, V (corresponding author), IVAGRO, Agrifood Campus Int Excellence ceiA3, Cadiz, Spain.	victor.palacios@uca.es	Gómez, Ana M Roldán/AAN-4440-2020; CANTIZANO, ANA C JIMÉNEZ/G-8756-2018; Arrocha, Antonio Amores/AAC-1261-2019; Palacios, Víctor/D-3128-2012	Gómez, Ana M Roldán/0000-0003-4550-8089; CANTIZANO, ANA C JIMÉNEZ/0000-0002-3779-3214; Arrocha, Antonio Amores/0000-0001-9690-591X; Palacios, Víctor/0000-0002-6225-0975				Alexandre H, 2013, INT J FOOD MICROBIOL, V167, P269, DOI 10.1016/j.ijfoodmicro.2013.08.021; Pozo-Bayon MA, 2011, ADV FOOD NUTR RES, V63, P17, DOI 10.1016/B978-0-12-384927-4.00002-6; BARTOWSKY E, 2002, AUST NZ GRAPEGROW WI, V461, P10; Benito A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151102; Benito A, 2015, MOLECULES, V20, P9510, DOI 10.3390/molecules20069510; Bobadilla GF, 1952, CONTRIBUCION ESTUDIO; Cappello MS, 2017, INT J FOOD MICROBIOL, V243, P16, DOI 10.1016/j.ijfoodmicro.2016.11.025; Carr JG, IDENTIFICATION METHO, P333; Carrete R, 2002, FEMS MICROBIOL LETT, V211, P155, DOI 10.1016/S0378-1097(02)00687-0; Charpentier C., 2002, REV FR OENOL, V195, P33; DAVIS CR, 1988, AM J ENOL VITICULT, V39, P137; DELAOSSA EM, 1987, AM J ENOL VITICULT, V38, P321; DELAOSSA EM, 1987, AM J ENOL VITICULT, V38, P293; Delaquis P, 2000, AM J ENOL VITICULT, V51, P42; Domecq B., 2011, JEREZ SUS MISTERIOS; Elmaci SB, 2015, ANTON LEEUW INT J G, V107, P675, DOI 10.1007/s10482-014-0362-6; Guillamon JM, LAR WINE MICROBIOLOG, P227; Ibeas JI, 1997, AM J ENOL VITICULT, V48, P71; John P, 1977, AUSTR GRAPEGROWER WI, V160, P44; Lasanta C, 2010, FOOD CONTROL, V21, P1442, DOI 10.1016/j.foodcont.2010.03.013; Leal B., MICROBIOLOGIA ENOLOG; Liu SQ, 2002, J APPL MICROBIOL, V92, P589, DOI 10.1046/j.1365-2672.2002.01589.x; Maicas S, 1999, FOOD RES INT, V32, P491, DOI 10.1016/S0963-9969(99)00122-2; MARTINEZ P, 1995, YEAST, V11, P1399, DOI 10.1002/yea.320111408; Martinez P, 1997, AM J ENOL VITICULT, V48, P160; Martinez P, 1998, AM J ENOL VITICULT, V49, P240; MAURICIO JC, 1993, MICROBIOS, V75, P95; Mesa JJ, 1999, FOOD SCI TECHNOL-LEB, V32, P114; Moreno JA, 2005, FOOD CONTROL, V16, P333, DOI 10.1016/j.foodcont.2004.03.013; Moreno-Arribas MV, 2008, FOOD MICROBIOL, V25, P875, DOI 10.1016/j.fm.2008.05.004; Moyano L, 2010, J AGR FOOD CHEM, V58, P6900, DOI 10.1021/jf100410n; Peinado RA, 2004, J AGR FOOD CHEM, V52, P493, DOI 10.1021/jf035030a; Peinado RA, 2007, FOOD CHEM, V104, P457, DOI 10.1016/j.foodchem.2006.11.070; Peinado RA, 2009, J AGR FOOD CHEM, V57, P2368, DOI 10.1021/jf803479r; PEREZ L, 1991, AM J ENOL VITICULT, V42, P58; Perez L., 2005, BIG BOOK SHERRY WINE, P67; Puertas B., 1989, ESTUDIO POTENCIAL VI; Roldan AM, 2017, FOOD CONTROL, V71, P42, DOI 10.1016/j.foodcont.2016.06.016; Roldan A, 2012, FOOD MICROBIOL, V30, P245, DOI 10.1016/j.fm.2011.10.010; Romano P, 1996, APPL ENVIRON MICROB, V62, P309, DOI 10.1128/AEM.62.2.309-315.1996; SUAREZ JA, 1993, Z LEBENSM UNTERS FOR, V196, P152, DOI 10.1007/BF01185576; WEBB AD, 1976, BIOTECHNOL BIOENG, V18, P939, DOI 10.1002/bit.260180707; Zea L, 2013, INT J FOOD PROP, V16, P1534, DOI 10.1080/10942912.2011.599093; Zea L, 2001, FOOD CHEM, V75, P79, DOI 10.1016/S0308-8146(01)00190-X; Zea L, 2015, COMPR REV FOOD SCI F, V14, P681, DOI 10.1111/1541-4337.12159; Zea L, 2010, INT J FOOD SCI TECH, V45, P2425, DOI 10.1111/j.1365-2621.2010.02422.x; [No title captured]	47	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208330	10.1371/journal.pone.0208330	http://dx.doi.org/10.1371/journal.pone.0208330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540795	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600069
J	Cavallero, S; Martini, A; Migliara, G; De Vito, C; Iavicoli, S; D'Amelio, S				Cavallero, Serena; Martini, Agnese; Migliara, Giuseppe; De Vito, Corrado; Iavicoli, Sergio; D'Amelio, Stefano			Anisakiasis in Italy: Analysis of hospital discharge records in the years 2005-2015	PLOS ONE			English	Article							A-SIMPLEX S.S.; MOLECULAR EPIDEMIOLOGY; ENGRAULIS-ENCRASICOLUS; SPP. LARVAE; INFECTION; ANISAKIDOSIS; CEPHALOPODS; RISK	Background Anisakiasis is a fish-borne zoonosis caused by the ingestion of marine food infected with Anisakis third-stage larvae, widespread marine parasitic nematodes. Gastrointestinal and/ or allergic clinical signs and symptoms are not specific. While frequently reported in countries with large raw fish consumption as Japan, the global prevalence of anisakiasis may be severely underestimated due to limitations of available diagnostic tools and to diverse clinical manifestations. Recently, infective larvae were found in the same localization with gastrointestinal tumors. The occurrence of allergic exacerbation upon secondary exposure and the possible occupational exposure, highlight the need to increase scientific evidences on anisakiasis. Methods We performed a retrospective descriptive study using analysis of Hospital Discharge Records (HDRs) from 2005 to 2015 in Italy, with particular attention to allergic manifestations. Descriptive statistics and multivariate analyses were performed using backward step-wise logistic regression models to assess spatial distribution and temporal trend as well as the variables independently associated with the allergic clinical signs and symptoms in Italian cases of anisakiasis. Results HDRs reporting the ICD-9 code for anisakiasis were retrieved (370), with a higher number of cases reported from central and southern regions, with particular regard to populations inhabiting the coastal territories. Around 40% of patients presented allergic manifestations and half of them showed serious allergic reactions. The multivariate analyses showed an independent association between allergic manifestations and features as living in southern regions and female gender, while anaphylactic episodes was independently associated only with female gender. Conclusion The present study is the first attempt to a better understanding of the epidemiological picture of anisakiasis in Italy, mining official data. A common strategy on data collection, monitoring and reporting would favor a more accurate epidemiological scenario in Italy, since the report of the diseases is not mandatory.	[Cavallero, Serena; Martini, Agnese; Migliara, Giuseppe; De Vito, Corrado; D'Amelio, Stefano] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Martini, Agnese; Iavicoli, Sergio] Italian Workers Compensat Author, Dept Occupat & Environm Med, Epidemiol & Hyg, Rome, Italy	Sapienza University Rome	Cavallero, S (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.	serena.cavallero@uniroma1.it	CAVALLERO, Serena/AAF-3218-2020; Migliara, Giuseppe/AAN-2138-2021	CAVALLERO, Serena/0000-0002-2245-9694; DE VITO, CORRADO/0000-0002-7846-672X; Migliara, Giuseppe/0000-0002-4573-6025; D'Amelio, Stefano/0000-0002-1871-9553				Abollo E, 2001, PARASITOL RES, V87, P492, DOI 10.1007/s004360100389; AKASAKA Y, 1979, ENDOSCOPY, V11, P158, DOI 10.1055/s-0028-1098343; Anderson R.C, 1992, NEMATODE PARASITES V, P253; Audicana MT, 2008, CLIN MICROBIOL REV, V21, P360, DOI 10.1128/CMR.00012-07; Audicana MT, 2002, TRENDS PARASITOL, V18, P20, DOI 10.1016/S1471-4922(01)02152-3; Baird FJ, 2014, MOL CELL PROBE, V28, P167, DOI 10.1016/j.mcp.2014.02.003; Bao M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43699; Brunet J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2493-7; Carballeda-Sangiao N, 2014, ACTA TROP, V138, P1, DOI 10.1016/j.actatropica.2014.05.020; Cavallero S, 2016, PARASITOL INT, V65, P488, DOI 10.1016/j.parint.2016.07.003; Cipriani P, 2018, FISH RES, V202, P79, DOI 10.1016/j.fishres.2017.07.010; Cipriani P, 2018, FISH RES, V202, P59, DOI 10.1016/j.fishres.2017.03.020; Cost A, 2016, PARASITOL INT, V65, P696, DOI 10.1016/j.parint.2016.08.004; D'Amelio S., 1999, Parassitologia (Rome), V41, P591; Daschner A, 2012, TRENDS PARASITOL, V28, P9, DOI 10.1016/j.pt.2011.10.001; delPozo MD, 1996, J ALLERGY CLIN IMMUN, V97, P977, DOI 10.1016/S0091-6749(96)80073-X; EFSA, 2010, EFSA J, V8, P9; Garcia-Perez JC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001699; Gazzonis AL, 2017, FOOD CONTROL, V80, P366, DOI 10.1016/j.foodcont.2017.05.004; Gomez-Mateos M, 2016, INT J FOOD MICROBIOL, V232, P111, DOI 10.1016/j.ijfoodmicro.2016.05.026; Guardone L, 2018, INT J FOOD MICROBIOL, V268, P10, DOI 10.1016/j.ijfoodmicro.2017.12.030; Guardone L, 2018, PARASITE, V25, DOI 10.1051/parasite/2018034; Heffler E, 2011, ALLERGY, V66, P1563, DOI 10.1111/j.1398-9995.2011.02691.x; Herrador Z, 2019, CLIN INFECT DIS, V69, P69, DOI 10.1093/cid/ciy853; Mattiucci S, 2014, HELMINTH INFECT THEI; Mattiucci S, 2018, ADV PARASIT, V99, P93, DOI 10.1016/bs.apar.2017.12.001; Mattiucci S, 2013, EMERG INFECT DIS, V19, P496, DOI 10.3201/eid1903.121017; Mattiucci S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-82; McCleary N, 2018, J ALLERGY CLIN IMMUN, V141, P1510, DOI 10.1016/j.jaci.2017.11.034; Mineta Sho, 2006, J Nippon Med Sch, V73, P169; Mladineo I, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1401-x; Pico-Duran G, 2016, VET PARASITOL, V220, P47, DOI 10.1016/j.vetpar.2016.02.020; Piscaglia AC, 2014, EUR REV MED PHARMACO, V18, P3916; Sonoda H, 2015, SURG TODAY, V45, P1321, DOI 10.1007/s00595-014-1012-3; Takabayashi T, 2014, AM J EMERG MED, V32, P1485, DOI 10.1016/j.ajem.2014.09.010; Torres P, 2007, J PARASITOL, V93, P440, DOI 10.1645/GE-946R.1; van THIEL P, 1960, Trop Geogr Med, V12, P97; Yera H, 2018, PARASITE, V25, DOI 10.1051/parasite/2018016	38	16	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208772	10.1371/journal.pone.0208772	http://dx.doi.org/10.1371/journal.pone.0208772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533066	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500035
J	Tsuruta, T; Sakai, K; Watanabe, J; Katagiri, W; Hibi, H				Tsuruta, Takeshi; Sakai, Kiyoshi; Watanabe, Junna; Katagiri, Wataru; Hibi, Hideharu			Dental pulp-derived stem cell conditioned medium to regenerate peripheral nerves in a novel animal model of dysphagia	PLOS ONE			English	Article							SUPERIOR LARYNGEAL NERVE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; IG-LIKE LECTIN-9; RAT SPINAL-CORD; GROWTH-FACTOR; SECRETED ECTODOMAIN; SCHWANN-CELL; MACROPHAGES; TISSUE; TRANSPLANTATION	In nerve regeneration studies, various animal models are used to assess nerve regeneration. However, because of the difficulties in functional nerve assessment, a visceral nerve injury model is yet to be established. The superior laryngeal nerve (SLN) plays an essential role in swallowing. Although a treatment for SLN injury following trauma and surgery is desirable, no such treatment is reported in the literature. We recently reported that stem cells derived from human exfoliated deciduous teeth (SHED) have a therapeutic effect on various tissues via macrophage polarization. Here, we established a novel animal model of SLN injury. Our model was characterized as having weight loss and drinking behavior changes. In addition, the SLN lesion caused a delay in the onset of the swallowing reflex and gain of laryngeal residue in the pharynx. Systemic administration of SHED-conditioned media (SHED-CM) promoted functional recovery of the SLN and significantly promoted axonal regeneration by converting of macrophages to the anti-inflammatory M2 phenotype. In addition, SHED-CM enhanced new blood vessel formation at the injury site. Our data suggest that the administration of SHED-CM may provide therapeutic benefits for SLN injury.	[Tsuruta, Takeshi; Sakai, Kiyoshi; Watanabe, Junna; Hibi, Hideharu] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi, Japan; [Katagiri, Wataru] Niigata Univ, Grad Sch Med & Dent Sci, Div Reconstruct Surg Oral & Maxillofacial Reg, Niigata, Japan	Nagoya University; Niigata University	Sakai, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi, Japan.	www-kiyo@med.nagoya-u.ac.jp	sakai, kiyoshi/AAB-8971-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [7116K20569]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grant number 7116K20569 to KS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012; Carvalho TC, 2004, PHYSIOL BEHAV, V82, P331, DOI 10.1016/j.physbeh.2004.04.003; Cattin AL, 2015, CELL, V162, P1127, DOI 10.1016/j.cell.2015.07.021; Chalisserry EP, 2017, J TISSUE ENG, V8, DOI 10.1177/2041731417702531; Ding P, 2015, DYSPHAGIA, V30, P47, DOI 10.1007/s00455-014-9572-3; Ding P, 2013, LARYNGOSCOPE, V123, P1942, DOI 10.1002/lary.24051; Gharaei MA, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0815-3; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Hishida N, 1997, J VET MED SCI, V59, P499, DOI 10.1292/jvms.59.499; Ito T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44043; Jafari S, 2003, J PHYSIOL-LONDON, V550, P287, DOI 10.1113/jphysiol.2003.039966; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Kano F, 2017, STEM CELLS, V35, P641, DOI 10.1002/stem.2534; Kitagawa JI, 2002, AM J PHYSIOL-REG I, V282, pR1342, DOI 10.1152/ajpregu.00556.2001; Kitagawa Junichi, 2009, J Oral Sci, V51, P167; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Lever TE, 2015, DYSPHAGIA, V30, P328, DOI 10.1007/s00455-015-9604-7; Lever TE, 2009, DYSPHAGIA, V24, P180, DOI 10.1007/s00455-008-9190-z; Matsubara K, 2015, J NEUROSCI, V35, P2452, DOI 10.1523/JNEUROSCI.4088-14.2015; Mead B, 2017, STEM CELLS, V35, P61, DOI 10.1002/stem.2398; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050; Onofri SMM, 2014, DYSPHAGIA, V29, P256, DOI 10.1007/s00455-013-9504-7; Navarro X, 2016, EUR J NEUROSCI, V43, P271, DOI 10.1111/ejn.13033; Omi M, 2016, J DIABETES INVEST, V7, P485, DOI 10.1111/jdi.12452; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Pauloski BR, 2009, DYSPHAGIA, V24, P196, DOI 10.1007/s00455-008-9192-x; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; Pisciotta A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00547; Poras JR, 2015, J IMMUNOL METHODS, V420, P38, DOI 10.1016/j.jim.2015.03.013; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Sanen K, 2017, J TISSUE ENG REGEN M, V11, P3362, DOI 10.1002/term.2249; Shen ZL, 2000, MICROSURG, V20, P255, DOI 10.1002/1098-2752(2000)20:5<255::AID-MICR6>3.0.CO;2-A; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Spina A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00354; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Sugimura-Wakayama Y, 2015, STEM CELLS DEV, V24, P2687, DOI 10.1089/scd.2015.0104; Sugiyama N, 2014, DYSPHAGIA, V29, P61, DOI 10.1007/s00455-013-9481-x; Sulica L, 2004, OTOLARYNG CLIN N AM, V37, P183, DOI 10.1016/S0030-6665(03)00175-0; Sulica L, 2002, ANN OTO RHINOL LARYN, V111, P291, DOI 10.1177/000348940211100402; Takemura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044592; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Tsuji K, 2015, BRAIN RES BULL, V111, P53, DOI 10.1016/j.brainresbull.2014.12.008; Ullah I, 2017, STEM CELLS DEV, V26, P1247, DOI 10.1089/scd.2017.0068; Wanigasekara Y, 2005, EUR J NEUROSCI, V22, P595, DOI 10.1111/j.1460-9568.2005.04260.x; Xiao N, 2016, ARCH IMMUNOL THER EX, V64, P89, DOI 10.1007/s00005-015-0376-4; Yamagata M, 2013, STROKE, V44, P551, DOI 10.1161/STROKEAHA.112.676759; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhan C, 2015, BIOCHEM BIOPH RES CO, V468, P343, DOI 10.1016/j.bbrc.2015.10.097	51	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208938	10.1371/journal.pone.0208938	http://dx.doi.org/10.1371/journal.pone.0208938			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533035	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500052
J	Maggio, V; Chierici, M; Jurman, G; Furlanello, C				Maggio, Valerio; Chierici, Marco; Jurman, Giuseppe; Furlanello, Cesare			Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma	PLOS ONE			English	Article							EXPRESSION-BASED CLASSIFICATION; RNA-SEQ; N-MYC; PREDICTS; STRATIFICATION; VALIDATION; SIGNATURE; ACCURACY	We introduce the CDRP (Concatenated Diagnostic-Relapse Prognostic) architecture for multi-task deep learning that incorporates a clinical algorithm, e.g., a risk stratification schema to improve prognostic profiling. We present the first application to survival prediction in High-Risk (HR) Neuroblastoma from transcriptomics data, a task that studies from the MAQC consortium have shown to remain the hardest among multiple diagnostic and prognostic endpoints predictable from the same dataset. To obtain a more accurate risk stratification needed for appropriate treatment strategies, CDRP combines a first component (CDRP-A) synthesizing a diagnostic task and a second component (CDRP-N) dedicated to one or more prognostic tasks. The approach leverages the advent of semi-supervised deep learning structures that can flexibly integrate multimodal data or internally create multiple processing paths. CDRP-A is an autoencoder trained on gene expression on the HR/non-HR risk stratification by the Children's Oncology Group, obtaining a 64-node representation in the bottleneck layer. CDRP-N is a multi-task classifier for two prognostic endpoints, i.e., Event-Free Survival (EFS) and Overall Survival (OS). CDRP-A provides the HR embedding input to the CDRP-N shared layer, from which two branches depart to model EFS and OS, respectively. To control for selection bias, CDRP is trained and evaluated using a Data Analysis Protocol (DAP) developed within the MAQC initiative. CDRP was applied on Illumina RNA-Seq of 498 Neuroblastoma patients (HR: 176) from the SEQC study (12,464 Entrez genes) and on Affymetrix Human Exon Array expression profiles (17,450 genes) of 247 primary diagnostic Neuroblastoma of the TARGET NBL cohort. On the SEQC HR patients, CDRP achieves Matthews Correlation Coefficient (MCC) 0.38 for EFS and MCC = 0.19 for OS in external validation, improving over published SEQC models. We show that a CDRP-N embedding is indeed parametrically associated to increasing severity and the embedding can be used to better stratify patients' survival.	[Maggio, Valerio; Chierici, Marco; Jurman, Giuseppe; Furlanello, Cesare] Fdn Bruno Kessler, Trento, Italy	Fondazione Bruno Kessler	Jurman, G (corresponding author), Fdn Bruno Kessler, Trento, Italy.	jurman@fbk.eu	Chierici, Marco/P-9949-2019; Jurman, Giuseppe/GRS-8221-2022; ARSLAN, Okan/AAA-3232-2020	Chierici, Marco/0000-0001-9791-9301; Furlanello, Cesare/0000-0002-5384-3605; Maggio, Valerio/0000-0003-4824-893X; Jurman, Giuseppe/0000-0002-2705-5728	Azure Research grant "Deep Learning for Precision Medicine"	Azure Research grant "Deep Learning for Precision Medicine"	The Microsoft Azure platform used for all computations was funded by the Azure Research grant "Deep Learning for Precision Medicine", assigned to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Microsoft Azure platform used for all computations was funded by the Azure Research grant "Deep Learning for Precision Medicine", assigned to CF. The authors thank Sagar Malhotra for the linguistic revision of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berthold F, 2007, NB2004 HIGH RISK TRI; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Cangelosi D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1194-3; Children's Oncology Group, GEN EXPR PRED OUTC S, DOI 10.1186/s12859-016-1194-3; Children's Oncology Group, STUD GEN EXPR SAMPL; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; De Preter K, 2010, CLIN CANCER RES, V16, P1532, DOI 10.1158/1078-0432.CCR-09-2607; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; Formicola D, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0896-7; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Jurman G., 2012, PLOS ONE, V7; Kantelhardt EJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-140; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; Maas AL, 2014, ICML WORKSH DEEP LEA, P1; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; MD Anderson Cancer Center, 2018, CANCER SCREENING ALG; Mohlin S, 2013, NEOPLASIA, V15, P328, DOI 10.1593/neo.121706; Nair V., 2010, P 27 INT C INT C MAC, P807; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Oberthuer A, 2015, CLIN CANCER RES, V21, P1904, DOI 10.1158/1078-0432.CCR-14-0817; Oberthuer A, 2010, J CLIN ONCOL, V28, P3506, DOI 10.1200/JCO.2009.27.3367; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrov I, 2017, ONCOTARGET, V8, P83768, DOI 10.18632/oncotarget.19662; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rozmus J, 2012, J PEDIAT HEMATOL ONC, V34, P151, DOI 10.1097/MPH.0b013e318221ca82; Ruder S., 2016, ARXIV; Salazar BM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010037; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shohet JM, 2012, P NATL ACAD SCI USA, V109, P19041, DOI 10.1073/pnas.1217598109; Sholler G., 2012, J CANC THER, V3, P602, DOI [DOI 10.4236/JCT.2012.35077, 10.4236/jct.2012.35077]; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stricker TP, 2014, MOL ONCOL, V8, P669, DOI 10.1016/j.molonc.2014.01.010; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Zeiler Matthew D, 2012, ARXIV12125701; Zhang WW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0581-9	48	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208924	10.1371/journal.pone.0208924	http://dx.doi.org/10.1371/journal.pone.0208924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532223	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900053
J	Fernando, MR; Jiang, C; Krzyzanowski, GD; Somer-Shely, T; Ryan, WL				Fernando, M. Rohan; Jiang, Chao; Krzyzanowski, Gary D.; Somer-Shely, Tifany; Ryan, Wayne L.			A novel approach to stabilize fetal cell-free DNA fraction in maternal blood samples for extended period of time	PLOS ONE			English	Article							PLASMA; COLLECTION; ANEUPLOIDY; DIAGNOSIS; STORAGE	This study was undertaken to evaluate a novel method for stabilizing and preserving the original proportion of cell-free fetal DNA (cffDNA) in maternal blood for extended periods of time without using crosslinking agents, such as formaldehyde, which compromise DNA integrity and extraction efficiency. Blood was drawn from pregnant donors into K(3)EDTA and Blood Exo DNA ProTeck (R) (ProTeck) tubes. Blood drawn into both tubes were aliquoted and stored at three different temperatures. At indicated times sample aliquots were processed for cell-free DNA (cfDNA) extraction. Plasma cfDNA and cffDNA quantified by droplet digital PCR (ddPCR) assay which amplify RASSF1A gene promoter region. ProTeck reagent is formaldehyde free and inhibits blood cell metabolism in blood samples during storage. Cell-free DNA concentration increased over time in blood plasma stored in K(3)EDTA tubes at 4, 22 and 30 degrees C. Blood stored in ProTeck tubes, cfDNA concentration was stable at 4, 22 and 30 degrees C for 21, 28 and 7 days, respectively. In K(3)EDTA tubes cffDNA proportion decreases steadily over time whereas in ProTeck tubes cffDNA proportion remained stable. This novel technology stabilizes cffDNA proportion in maternal blood samples at 4, 22 and 30 degrees C for 21, 28 and 7 days, respectively.	[Fernando, M. Rohan; Jiang, Chao; Krzyzanowski, Gary D.] Univ Nebraska, Med Ctr, Dept Obstet & Gynecol, 600 S 42nd St, Omaha, NE 68198 USA; [Fernando, M. Rohan; Krzyzanowski, Gary D.; Ryan, Wayne L.] CFGenome, Dept Res & Dev, Omaha, NE 68130 USA; [Somer-Shely, Tifany] Methodist Physicians Clin Womens Ctr, Elkhorn, NE USA	University of Nebraska System; University of Nebraska Medical Center	Fernando, MR (corresponding author), Univ Nebraska, Med Ctr, Dept Obstet & Gynecol, 600 S 42nd St, Omaha, NE 68198 USA.; Fernando, MR (corresponding author), CFGenome, Dept Res & Dev, Omaha, NE 68130 USA.	mrohan.fernando@unmc.edu			University of Nebraska Foundation, Obstetrics and Gynecology Research Fund [1712]	University of Nebraska Foundation, Obstetrics and Gynecology Research Fund	Funding for this research was provided by University of Nebraska Foundation, Obstetrics and Gynecology Research Fund #1712.	Allyse M, 2015, INT J WOMENS HEALTH, V7, P113, DOI 10.2147/IJWH.S67124; Angert RM, 2003, CLIN CHEM, V49, P195, DOI 10.1373/49.1.195; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P26, DOI 10.1002/uog.12331; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; Diaz IM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166354; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Fernando MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183915; Fernando MR, 2017, Patent No. [WO2017/214310 A1, 2017214310]; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Hidestrand M, 2012, FETAL DIAGN THER, V31, P122, DOI 10.1159/000335020; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120086; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Wong D, 2013, CLIN BIOCHEM, V46, P1099, DOI 10.1016/j.clinbiochem.2013.04.023; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Zhang Y, 2008, CLIN CHIM ACTA, V397, P60, DOI 10.1016/j.cca.2008.07.017	26	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208508	10.1371/journal.pone.0208508	http://dx.doi.org/10.1371/journal.pone.0208508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521613	Green Submitted, gold, Green Published			2022-12-26	WOS:000452307600080
J	Serrano, NC; Quintero-Lesmes, DC; Becerra-Bayona, S; Guio, E; Beltran, M; Paez, MC; Ortiz, R; Saldarriaga, W; Diaz, LA; Monterrosa, A; Miranda, J; Mesa, CM; Sanin, JE; Monsalve, G; Dudbridge, F; Hingorani, AD; Casas, JP				Serrano, Norma C.; Cristina Quintero-Lesmes, Doris; Becerra-Bayona, Silvia; Guio, Elizabeth; Beltran, Monica; Paez, Maria C.; Ortiz, Ricardo; Saldarriaga, Wilmar; Diaz, Luis A.; Monterrosa, Alvaro; Miranda, Jezid; Mesa, Clara M.; Sanin, Jose E.; Monsalve, German; Dudbridge, Frank; Hingorani, Aroon D.; Casas, Juan P.			Association of pre-eclampsia risk with maternal levels of folate, homocysteine and vitamin B12 in Colombia: A case-control study	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; PERICONCEPTIONAL MULTIVITAMIN USE; GESTATIONAL HYPERTENSION; EARLY-PREGNANCY; DIETARY-FOLATE; WOMEN	Background Maternal serum concentrations of folate, homocysteine, and vitamin B12 have been associated with pre-eclampsia. Nevertheless, reported studies involve limited number of cases to reliably assess the nature of these associations. Our aim was to examine the relation of these three biomarkers with pre-eclampsia risk in a large Colombian population. Materials and methods Design: A case-control study. Setting: Cases of pre-eclampsia and healthy pregnant controls were recruited at the time of delivery from eight different Colombian cities between 2000 and 2012. Population or Sample: 2978 cases and 4096 controls were studied. Maternal serum concentrations of folate, homocysteine, and vitamin B12 were determined in 1148 (43.6%) cases and 1300 (31.7%) controls. Also, self-reported folic acid supplementation was recorded for 2563 (84%) cases and 3155 (84%) controls. Analysis: Adjusted odds ratios (OR) for pre-eclampsia were estimated for one standard deviation (1SD) increase in log-transformed biomarkers. Furthermore, we conducted analyses to compare women that reported taking folic acid supplementation for different periods during pregnancy. Main Outcomes Measures: Odds ratio for pre-eclampsia. Results After adjusting for potential confounders in logistic regression models, the OR for preeclampsia was 0.80 (95% CI: 0.72, 0.90) for 1SD increase in log-folate, 1.16 (95%CI: 1.05, 1.27) for 1SD increase in log-homocysteine, and 1.10 (95%CI: 0.99, 1.22) for 1SD increase in log-vitamin B12. No interactions among the biomarkers were identified. Women who self-reported consumption of folic acid (1 mg/day) throughout their pregnancy had an adjusted OR for pre-eclampsia of 0.86 (95%CI: 0.67, 1.09) compared to women that reported no consumption of folic acid at any point during pregnancy. Conclusions Maternal serum concentrations of folate were associated as a protective factor for pre-eclampsia while concentrations of homocysteine were associated as a risk factor. No association between maternal vitamin B12 concentrations and preeclampsia was found.	[Serrano, Norma C.; Cristina Quintero-Lesmes, Doris; Guio, Elizabeth] Fdn Cardiovasc Colombia, Floridablanca, Colombia; [Serrano, Norma C.; Cristina Quintero-Lesmes, Doris] Hosp Int Colombia, Piedecuesta, Colombia; [Serrano, Norma C.; Becerra-Bayona, Silvia; Beltran, Monica; Paez, Maria C.; Ortiz, Ricardo] Univ Autonoma Bucaramanga, Bucaramanga, Colombia; [Beltran, Monica; Diaz, Luis A.] Univ Ind Santander, Bucaramanga, Colombia; [Saldarriaga, Wilmar] Univ Valle, Fac Salud, Dept Ginecol & Obstet, Dept Morfol, Cali, Colombia; [Monterrosa, Alvaro; Miranda, Jezid] Univ Cartagena, Cartagena, Colombia; [Mesa, Clara M.] Univ CES, Medellin, Colombia; [Sanin, Jose E.; Monsalve, German] Univ Pontificia Bolivariana, Bucaramanga, Colombia; [Dudbridge, Frank] Univ Leicester, Ctr Med, Dept Hlth Sci, Leicester, Leics, England; [Hingorani, Aroon D.; Casas, Juan P.] UCL, Farr Inst Hlth Informat, London, England	Universidad Industrial de Santander; Universidad del Valle; Universidad de Cartagena; Universidad Pontificia Bolivariana; University of Leicester; University of London; University College London	Serrano, NC (corresponding author), Fdn Cardiovasc Colombia, Floridablanca, Colombia.; Serrano, NC (corresponding author), Hosp Int Colombia, Piedecuesta, Colombia.; Serrano, NC (corresponding author), Univ Autonoma Bucaramanga, Bucaramanga, Colombia.	normaserrano@fcv.org	Miranda, Jezid/AAG-4747-2021; Quintero-Lesmes, Doris Cristina/AGP-5258-2022; Martinez, Luis Alfonso Diaz/J-8069-2017	Miranda, Jezid/0000-0003-4198-6534; Quintero-Lesmes, Doris Cristina/0000-0001-8875-0110; Martinez, Luis Alfonso Diaz/0000-0002-4498-6639; Serrano Diaz, Norma Cecilia/0000-0003-3532-2002; Hingorani, Aroon/0000-0001-8365-0081; Becerra-Bayona, Silvia Milena/0000-0002-4499-5885; Miranda, Jezid/0000-0003-0372-8374; Saldarriaga, Wilmar/0000-0001-7815-4390	COLCIENCIAS - Colombia [295-2007]	COLCIENCIAS - Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This project was funded by COLCIENCIAS - Colombia (grant code No. 295-2007).	Agrawal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119120; Almeida LC, 2010, CAD SAUDE PUBLICA, V26, P2011, DOI 10.1590/S0102-311X2010001100003; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Atkinson KR, 2009, J LIPID RES, V50, P71, DOI 10.1194/jlr.M800296-JLR200; Bergen NE, 2012, BJOG-INT J OBSTET GY, V119, P739, DOI 10.1111/j.1471-0528.2012.03321.x; Bodnar LM, 2006, AM J EPIDEMIOL, V164, P470, DOI 10.1093/aje/kwj218; Calonge N, 2009, ANN INTERN MED, V150, P626, DOI 10.7326/0003-4819-150-9-200905050-00009; Catov JM, 2009, AM J EPIDEMIOL, V169, P1304, DOI 10.1093/aje/kwp052; Clarke R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001177; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; De Stavola BL, 2006, AM J EPIDEMIOL, V163, P84, DOI 10.1093/aje/kwj003; Di Simone N, 2004, MOL HUM REPROD, V10, P665, DOI 10.1093/molehr/gah091; Di Simone N, 2003, BIOL REPROD, V69, P1129, DOI 10.1095/biolreprod.103.015800; Eddib A, 2009, CLIN MED WOMENS HLTH, V2, pS2385; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Guo YanFang, 2012, Fetal and Maternal Medicine Review, V23, P131, DOI 10.1017/S096553951200006X; Hernandez-Diaz S, 2002, AM J EPIDEMIOL, V156, P806, DOI 10.1093/aje/kwf129; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Kamudhamas A, 2004, AM J OBSTET GYNECOL, V191, P563, DOI 10.1016/j.ajog.2004.01.037; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kim MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097273; Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009; Leanos-Miranda A, 2015, J RHEUMATOL, V42, P1141, DOI 10.3899/jrheum.141571; Li ZW, 2013, HYPERTENSION, V61, P873, DOI 10.1161/HYPERTENSIONAHA.111.00230; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Manizheh SM, 2009, SAUDI MED J, V30, P88; Mignini LE, 2005, OBSTET GYNECOL, V105, P411, DOI 10.1097/01.AOG.0000151117.52952.b6; Neyman J, 1928, BIOMETRIKA, V20A, P175, DOI 10.2307/2331945; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Salehi-Pourmehr Hanieh, 2012, Iran J Nurs Midwifery Res, V17, P461; Serrano NC, 2018, PREGNANCY HYPERTENS; Serrano NC, 2018, ATHEROSCLEROSIS, V276, P189, DOI 10.1016/j.atherosclerosis.2018.05.051; Shenoy V, 2010, TRENDS ENDOCRIN MET, V21, P529, DOI 10.1016/j.tem.2010.05.002; Singh MD, 2015, NUTR REV, V73, P694, DOI 10.1093/nutrit/nuv028; Steegers-Theunissen RPM, 2000, BRIT J OBSTET GYNAEC, V107, P1513, DOI 10.1111/j.1471-0528.2000.tb11677.x; Thangaratinam S, 2011, BEST PRACT RES CL OB, V25, P419, DOI 10.1016/j.bpobgyn.2011.02.008; Theriault S, 2013, OBSTET GYNECOL, V122, P345, DOI 10.1097/AOG.0b013e31829b2f7c; Timmermans S, 2011, NUTR METAB CARDIOVAS, V21, P54, DOI 10.1016/j.numecd.2009.07.002; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59; Wang Y, 2015, EUR J CLIN NUTR, V69, P1145, DOI 10.1038/ejcn.2014.295; Wei SQ, 2012, BJOG-INT J OBSTET GY, V119, P832, DOI 10.1111/j.1471-0528.2012.03307.x; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067	43	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208137	10.1371/journal.pone.0208137	http://dx.doi.org/10.1371/journal.pone.0208137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521542	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600028
J	Thorpe, M; Fu, ZR; Albat, E; Akula, S; de Garavilla, L; Kervinen, J; Hellman, L				Thorpe, Michael; Fu, Zhirong; Albat, Emanuelle; Akula, Srinivas; de Garavilla, Lawrence; Kervinen, Jukka; Hellman, Lars			Extended cleavage specificities of mast cell proteases 1 and 2 from golden hamster: Classical chymase and an elastolytic protease comparable to rat and mouse MCP-5	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; GRANULE PROTEASES; SERINE PROTEASES; ALPHA; SIMILARITIES; REVEALS; CLONING; MMCP-1	Serine proteases constitute the major protein content of mast cell secretory granules. Here we present the extended cleavage specificity of two such proteases from the golden hamster, Mesocricetus auratus. Analysis by phage display technique showed that one of them (HAM1) is a classical chymase with a specificity similar to the human mast cell chymase. However, in contrast to the human chymase, it does not seem to have a particular preference for any of the three aromatic amino acids, Phe, Tyr and Trp, in the P1 position of substrates. HAM1 also efficiently cleaved after Leu similarly to human and many other mast cell chymases. We observed only a 3-fold lower cleavage activity on Leu compared to substrates with P1 aromatic amino acids. Chymotryptic enzymes seem to be characteristic for connective tissue mast cells in mammalian species from opossums to humans, which indicates a very central role of these enzymes in mast cell biology. HAM1 also seems to have the strongest preference for negatively charged amino acids in the P2 position of all mast cell chymases so far characterized. The second hamster chymase, HAM2, is an elastolytic in its activity, similarly to the alpha-chymases in rats and mice (rMCP-5 and mMCP-5, respectively). The presence of an alpha-chymase that developed elastase activity thereby seems to be a relatively early modification of the alpha-chymase within the rodent branch of the mammalian evolutionary tree.	[Thorpe, Michael; Fu, Zhirong; Albat, Emanuelle; Akula, Srinivas; Hellman, Lars] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [de Garavilla, Lawrence] GDL Pharmaceut Consulting & Contracting, Downingtown, PA USA; [Kervinen, Jukka] Tosoh Biosci LLC, Separat Business Unit, King Of Prussia, PA USA	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	lars.hellman@icm.uu.se	Akula, Srinivas/GYJ-1463-2022	Hellman, Lars/0000-0003-1459-3815	Swedish Research Council-VR-NT [621-2011-5007]; Swedish National Research Council (VR-NT)	Swedish Research Council-VR-NT(Swedish Research Council); Swedish National Research Council (VR-NT)	This work was supported by the Swedish Research Council-VR-NT (621-2011-5007) to LH. JK is employed by Tosoh Bioscience LLC. LG is employed by GDL Pharmaceutical Consulting and Contracting. Tosoh Bioscience LLC and GDL Pharmaceutical Consulting and Contracting provided support in the form of salaries for authors JK and LG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was supported by grants from the Swedish National Research Council (VR-NT).	Akula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143091; Andersson MK, 2008, MOL IMMUNOL, V45, P2548, DOI 10.1016/j.molimm.2008.01.012; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Chahal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129511; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fu ZR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131720; Galli SJ, 2016, ALLERGOL INT, V65, P3, DOI 10.1016/j.alit.2015.09.002; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Hellman LT, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01749; HUANG RY, 1991, EUR J IMMUNOL, V21, P1611, DOI 10.1002/eji.1830210706; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kervinen J, 2008, J BIOL CHEM, V283, P427, DOI 10.1074/jbc.M707157200; Kervinen J, 2010, BIOCHEM PHARMACOL, V80, P1033, DOI 10.1016/j.bcp.2010.06.014; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P3730, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3730::AID-IMMU3730&gt;3.0.CO;2-0; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P1022, DOI 10.1002/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Reimer JM, 2010, IMMUNOGENETICS, V62, P369, DOI 10.1007/s00251-010-0443-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Thorpe M, 2016, DEV COMP IMMUNOL, V63, P84, DOI 10.1016/j.dci.2016.05.013; Thorpe M, 2012, INT IMMUNOL, V24, P771, DOI 10.1093/intimm/dxs081; Trivedi NN, 2007, J IMMUNOL, V179, P6072, DOI 10.4049/jimmunol.179.9.6072; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207826	10.1371/journal.pone.0207826	http://dx.doi.org/10.1371/journal.pone.0207826			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521603	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600021
J	Cohen, SA; Greaney, ML; Sabik, NJ				Cohen, Steven A.; Greaney, Mary L.; Sabik, Natalie J.			Assessment of dietary patterns, physical activity and obesity from a national survey: Rural-urban health disparities in older adults	PLOS ONE			English	Article							QUALITY-OF-LIFE; UNITED-STATES; BABY BOOMERS; ALL-CAUSE; OVERWEIGHT; DETERMINANTS; PREVALENCE; MORTALITY; ASSOCIATION; NUTRITION	Background Obesity is a critical public health issue, affecting over one-third of all Americans, and is an underlying cause of numerous health issues across the lifespan. For older adults, obesity is linked to premature declines in physical and mental health and cognitive functioning. The occurrence of obesity and related health behaviors and chronic diseases are higher in rural areas than in urban areas. Furthermore, rural areas of the United States have a higher proportion of older adults than urban areas. Few studies, to date, have explored rural-urban differences in the relationships between dietary patterns and obesity among older adults. Therefore, the purpose of this study is to assess rural-urban differences in obesity rates in older adults, and the potential for the associations between obesity and physical activity and dietary patterns to vary by rural-urban status. Methods Data were abstracted from respondents aged 65 and above from the 2012 Behavioral Risk Factor Surveillance System (BRFSS) database linked to Census-based county-level information on rural-urban status and socioeconomic status. Generalized linear models were utilized to assess rural-urban disparities in obesity, and the potential for associations between obesity and known risk factors (fruit consumption, green vegetable consumption and physical activity) to vary by rural-urban status, accounting for complex sampling and confounders. Results Obesity rates were highest and fruit consumption was lowest in the most rural areas. However, for older adults in the most urban areas, there was a significant negative association between obesity and fruit and green vegetable consumption. This association was not observed in more rural older adults. Conclusion These findings underscore the need to take into account place-based factors such as rural-urban status, when designing and implementing policies and interventions designed to reduce obesity through risk factor mitigation in older adults. To reduce rural-urban disparities in older adults, all policies, programs, and interventions should address the unique barriers and needs specific to rural and urban older adults.	[Cohen, Steven A.; Greaney, Mary L.; Sabik, Natalie J.] Univ Rhode Isl, Hlth Studies Program, Dept Kinesiol, Kingston, RI 02881 USA	University of Rhode Island	Cohen, SA (corresponding author), Univ Rhode Isl, Hlth Studies Program, Dept Kinesiol, Kingston, RI 02881 USA.	steven_cohen@uri.edu			American Public Health Association	American Public Health Association	The American Public Health Association awarded a previous version of this manuscript with the "Rural and Environmental Research Award" in aging and health, and the authors received a modest ($200) stipend as a result. The American Public Health Association was not involved in any other capacity other than providing the award stipend, and did not bias the results or interpretation of the manuscript in any manner. Likewise, the American Public Health Association has not published or managed any version of this manuscript. No other sources of funding were utilized in the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration on Aging, PROF OLD AM 2016; [Anonymous], 2013, STAT AG HLTH AM 2013; [Anonymous], 2006, ANN M AM AGR EC ASS; [Anonymous], 1999, RURAL DEV PERSPECTIV; Badley EM, 2015, MILBANK Q, V93, P40, DOI 10.1111/1468-0009.12105; Baernholdt M, 2012, J RURAL HEALTH, V28, P339, DOI 10.1111/j.1748-0361.2011.00403.x; Befort CA, 2012, J RURAL HEALTH, V28, P392, DOI 10.1111/j.1748-0361.2012.00411.x; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; Caschili S, 2015, COMPUT ENVIRON URBAN, V49, P98, DOI 10.1016/j.compenvurbsys.2014.05.005; Centers for Disease Control and Prevention, 2013, BEH RISK FACT SURV S; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Chale Angela, 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P1, DOI 10.1080/21551197.2011.623924; Cohen DA, 2006, SOC SCI MED, V62, P769, DOI 10.1016/j.socscimed.2005.06.033; Cohen SA, 2017, J RURAL HEALTH, V33, P167, DOI 10.1111/jrh.12207; David CN, 2017, J NUTR HEALTH AGING, V21, P597, DOI 10.1007/s12603-016-0812-0; Eberhardt MS, 2004, AM J PUBLIC HEALTH, V94, P1682, DOI 10.2105/AJPH.94.10.1682; Eberhardt MS, 2001, URBAN RURAL HLTH CHA; Estabrooks PA, 2003, ANN BEHAV MED, V25, P100, DOI 10.1207/S15324796ABM2502_05; Fakhouri Tala H I, 2012, NCHS Data Brief, P1; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Frost SS, 2010, AM J HEALTH PROMOT, V24, P267, DOI 10.4278/ajhp.08040532; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; Hart LG, 2005, AM J PUBLIC HEALTH, V95, P1149, DOI 10.2105/AJPH.2004.042432; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; Hill JO, 1999, MED SCI SPORT EXER, V31, pS515, DOI 10.1097/00005768-199911001-00005; Hosler AS, 2008, PREVENTING CHRONIC D, V5; Hugo G, 2008, OBES RES CLIN PRACT, V2, P203, DOI 10.1016/j.orcp.2008.05.001; King DE, 2013, JAMA INTERN MED, V173, P385, DOI 10.1001/jamainternmed.2013.2006; Lamerz A, 2005, INT J OBESITY, V29, P373, DOI 10.1038/sj.ijo.0802914; MANN GV, 1974, NEW ENGL J MED, V291, P178, DOI 10.1056/NEJM197407252910405; Martinez-Gonzalez MA, 1999, INT J OBESITY RELATE, V23; Masters RK, 2013, AM J PUBLIC HEALTH, V103, P1895, DOI 10.2105/AJPH.2013.301379; Michimi A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-49; Nejat EJ, 2010, MATURITAS, V65, P106, DOI 10.1016/j.maturitas.2009.09.006; Newman A., 2009, ONLINE J ISSUES NURS, V14, DOI [10.3912/OJIN.Vol14No1Man03, DOI 10.3912/OJIN.VOL14NO1MAN03]; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Patterson PD, 2004, J RURAL HEALTH, V20, P151, DOI 10.1111/j.1748-0361.2004.tb00022.x; Pearce J, 2007, AM J PREV MED, V32, P375, DOI 10.1016/j.amepre.2007.01.009; Pearson T, 2005, APPETITE, V45, P195, DOI 10.1016/j.appet.2005.04.003; Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008; Reidpath DD, 2002, HEALTH PLACE, V8, P141, DOI 10.1016/S1353-8292(01)00028-4; Shaikh Raees A, 2015, Int J MCH AIDS, V4, P22; Smoyer-Tomic KE, 2008, HEALTH PLACE, V14, P740, DOI 10.1016/j.healthplace.2007.12.001; Srikanthan P, 2009, ANN EPIDEMIOL, V19, P724, DOI 10.1016/j.annepidem.2009.05.003; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Villareal DT, 2006, AM J CLIN NUTR, V84, P1317, DOI 10.1093/ajcn/84.6.1317; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013; Wallace AE, 2006, PSYCHIAT SERV, V57, P851, DOI 10.1176/appi.ps.57.6.851; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Weinstock RS, 1998, ARCH INTERN MED, V158, P2477, DOI 10.1001/archinte.158.22.2477; Wilcox S, 2000, J EPIDEMIOL COMMUN H, V54, P667, DOI 10.1136/jech.54.9.667; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010; Woods LM, 2005, BRIT J CANCER, V92, P1279, DOI 10.1038/sj.bjc.6602506; Woolf SH, 2008, AM J PREV MED, V34, P263, DOI 10.1016/j.amepre.2007.12.002; Woolf SH, 2011, HEALTH AFFAIR, V30, P1852, DOI 10.1377/hlthaff.2011.0685; Yen IH, 1998, AM J PUBLIC HEALTH, V88, P1709, DOI 10.2105/AJPH.88.11.1709	60	27	28	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208268	10.1371/journal.pone.0208268	http://dx.doi.org/10.1371/journal.pone.0208268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517166	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400086
J	de Lima, LS; Merry, F; Soares, B; Rodrigues, HO; Damaceno, CD; Bauch, MA				de Lima, Leticia Santos; Merry, Frank; Soares-Filho, Britaldo; Rodrigues, Hermann Oliveira; Damaceno, Christiane dos Santos; Bauch, Marcos A.			Illegal logging as a disincentive to the establishment of a sustainable forest sector in the Amazon	PLOS ONE			English	Article							LAND-USE CHANGE; BRAZILIAN AMAZON; CARBON-DENSITY; DEFORESTATION; IMPACT; BIOMASS; POLICY; TIMBER; CONCESSIONS; GOVERNANCE	Brazil recently began granting timber concessions in public forests to promote sustainable forest use. The effectiveness of this strategy hinges on the design and implementation of the concessions themselves as well as their competitive position within the logging sector as a whole. There is, however, a lack of information on the competitive interaction between legal and illegal logging and its effects on concessions profits. We address this knowledge gap by using a spatially explicit simulation model of the Amazon timber industry to examine the potential impact of illegal logging on timber concessions allocation and profits in a 30-year harvest cycle. In a scenario in which illegal logging takes place outside concessions, including private and public "undesignated" lands, concession harvested area would decrease by 59% due to competition with illegal logging. Moreover, 29 out of 39 National Forests (approximate to 74%) would experience a decrease in harvested area. This "leakage" effect could reduce concession net rents by up to USD 1.3 Billion after 30 years. Federal and State "undesignated" lands, if not adequately protected, could have 40% of their total volume illegally harvested in 30 years. Our results reinforce the need to invest in tackling illegal logging, if the government wants the forest concessions program to be successful.	[de Lima, Leticia Santos] Univ Fed Minas Gerais, Dept Engn Hidraul & Recursos Hidr, Belo Horizonte, MG, Brazil; [de Lima, Leticia Santos] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, Berlin, Germany; [Merry, Frank] Conservat Strategy Fund, Washington, DC USA; [Soares-Filho, Britaldo; Rodrigues, Hermann Oliveira; Damaceno, Christiane dos Santos] Univ Fed Minas Gerais, Ctr Sensoriamento Remoto, Belo Horizonte, MG, Brazil; [Bauch, Marcos A.] Minist Meio Ambiente, Governo Brasil, Serv Florestal Brasileiro, Brasilia, DF, Brazil	Universidade Federal de Minas Gerais; Humboldt University of Berlin; Universidade Federal de Minas Gerais	de Lima, LS (corresponding author), Univ Fed Minas Gerais, Dept Engn Hidraul & Recursos Hidr, Belo Horizonte, MG, Brazil.; de Lima, LS (corresponding author), Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, Berlin, Germany.	leticia.stlima@gmail.com	Lima, Letícia Santos de/F-3694-2014	Lima, Letícia Santos de/0000-0002-0268-2055	Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico - CNPq [202203/2014-0, 471272/2012-4]; Alexander von Humboldt Foundation [2332333]	Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Leticia Santos de Lima and Britaldo Soares-Filho receive support from Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico - CNPq (grant numbers 202203/2014-0 and 471272/2012-4, respectively). The Alexander von Humboldt Foundation also supports Britaldo Soares-Filho (grant number 2332333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher GS, 2012, J ENVIRON ECON MANAG, V63, P92, DOI 10.1016/j.jeem.2011.05.007; [Anonymous], 2018, IM TREES REAL DESTR; [Anonymous], 2014, GUARDIAN; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Asner GP, 2009, GEOPHYS MONOGR SER, V186, P25, DOI 10.1029/2008GM000723; Azevedo-Ramos C, 2018, LAND USE POLICY, V73, P125, DOI 10.1016/j.landusepol.2018.01.005; Azevedo-Ramos C, 2015, ELEMENTA-SCI ANTHROP, V3, DOI 10.12952/journal.elementa.000048; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Bank World, 2004, SUST FOR DEV STRAT; BARROS AC, 1995, FOREST ECOL MANAG, V77, P87, DOI 10.1016/0378-1127(95)03574-T; Bisschop L, 2012, GLOB CRIME, V13, P191, DOI 10.1080/17440572.2012.701836; Borner J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121544, 10.1371/journal.pone.0116846]; Brazilian Forest Service, 2016, RES EC CONC FLOR; Brazilian Forest Service, 2013, CAD NAC FLOR PUBL; Brazilian Forest Service Environmental Ministry of Brazil, 2014, PLAN AN OUT FLOR 201; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Carmelio E C., 2012, LEVANTAMENTO CARGA T; Ribeiro SMC, 2018, ECOSYST SERV, V31, P517, DOI 10.1016/j.ecoser.2018.03.016; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Gan JB, 2007, ECOL ECON, V64, P423, DOI 10.1016/j.ecolecon.2007.02.032; Gerwing JJ, 2002, FOREST ECOL MANAG, V157, P131, DOI 10.1016/S0378-1127(00)00644-7; Giudice R, 2012, ECOL ECON, V77, P158, DOI 10.1016/j.ecolecon.2012.02.024; Goetz Scott J, 2009, Carbon Balance Manag, V4, P2, DOI 10.1186/1750-0680-4-2; Gutierrez-Velez VH, 2008, FOREST POLICY ECON, V10, P248, DOI 10.1016/j.forpol.2007.10.007; Hoare A., 2015, TACKLING ILLEGAL LOG; Holmes TP, 2002, FOREST ECOL MANAG, V163, P93, DOI 10.1016/S0378-1127(01)00530-8; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Hummel A. C., 2010, ATIVIDADE MADEIREIRA; INPE, 2008, MON COB FLOR AM SAT; Instituto do Homem e Meio Ambiente da Amazonia, 2009, AC PREC MED MAD TOR; Instituto Nacional de Pesquisas Espaciais, 2014, PRODES AM MON SYST S; Karsenty A, 2008, FOREST ECOL MANAG, V256, P1498, DOI 10.1016/j.foreco.2008.07.001; Kauffmann-Zeh A, 1999, NATURE, V398, pA20, DOI 10.1038/18795; Lambin EF, 2018, NAT CLIM CHANGE, V8, P109, DOI 10.1038/s41558-017-0061-1; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lentini M., 2005, FATOS FLORESTAIS AMA; Lima E, 2006, ENVIRONMENT, V48, P26, DOI 10.3200/ENVT.48.1.26-38; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Merry FD, 2003, SCIENCE, V299, P1843, DOI 10.1126/science.299.5614.1843b; Merry Frank, 2006, International Journal of Sustainable Development, V9, P277, DOI 10.1504/IJSD.2006.012849; Merry F, 2009, ENVIRON MANAGE, V44, P395, DOI 10.1007/s00267-009-9337-1; Ministerio das Minas e Energia, 1974, PROJETO RADAMBRASIL; Ministerio dos Transportes, 2010, PLAN NAC LOG TRANSP; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Monteiro A, 2014, TRANSPARENCIA MANEJO, P1; Monteiro A, 2012, TRANSPARENCY FOREST, P14; Moutinho P, 2016, ELEMENTA-SCI ANTHROP, V4, DOI 10.12952/journal.elementa.000125; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Oliveira AS, 2018, GEOGR J; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PEREIRA D., 2010, FATOS FLORESTAIS AMA, V1; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Ravenel R. M., 2004, Journal of Sustainable Forestry, V19, P351, DOI 10.1300/J091v19n01_16; Reboredo F, 2013, INT FOREST REV, V15, P218, DOI 10.1505/146554813806948512; Rochedo PRR, 2018, NAT CLIM CHANGE, V8, P695, DOI 10.1038/s41558-018-0213-y; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Scholz I, 2001, OVEREXPLOITATION SUS; Schulze M., 2008, Journal of Sustainable Forestry, V26, P61, DOI 10.1300/J091v26n01_03; SFB, 2018, CONC FLOR FED; Silgueiro V, 2015, TRANSPARENCIA FLORES; Sistema de protecao da Amazonia, 2009, HIDR BIF ESP RED DER; Smith W, 2002, TROPICAL FOREST UPDA, V12, P3; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2013, ENVIRON MODELL SOFTW, V43, P80, DOI 10.1016/j.envsoft.2013.01.010; Spracklen DV, 2015, GEOPHYS RES LETT, V42, P9546, DOI 10.1002/2015GL066063; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; Stone SW, 1998, ECOL ECON, V27, P43, DOI 10.1016/S0921-8009(97)00130-4; Vegetal e da Silvicultura, 2014, PROD EXTR VEG SILV V; Verissimo A, 2003, SCIENCE, V299, P1843; Verissimo A, 2002, SCIENCE, V297, P1478, DOI 10.1126/science.1072807; Walker R, 2013, ECOL APPL, V23, P239, DOI 10.1890/11-1800.1; World Bank, 2004, SUST FOR DEV STRAT; World Bank, 2006, LAW 11428 2006 ATL F	80	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207855	10.1371/journal.pone.0207855	http://dx.doi.org/10.1371/journal.pone.0207855			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517153	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400069
J	Hussain, S; Saxena, S; Shrivastava, S; Mohanty, AK; Kumar, S; Singh, RJ; Kumar, A; Wani, SA; Gandham, RK; Kumar, N; Sharma, AK; Tiwari, AK; Singh, RK				Hussain, Shahid; Saxena, Sonal; Shrivastava, Sameer; Mohanty, Ashok Kumar; Kumar, Sudarshan; Singh, Rajkumar James; Kumar, Abhinav; Wani, Sajad Ahmad; Gandham, Ravi Kumar; Kumar, Naveen; Sharma, Anil Kumar; Tiwari, Ashok Kumar; Singh, Raj Kumar			Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ENDOTHELIAL GROWTH-FACTOR; NONMUSCLE MYOSIN IIA; ANNEXIN-II; LIPOCALIN 2; CELL-CYCLE; MATRIX METALLOPROTEINASES; PANCREATIC-CARCINOMA; PROTEIN-2 SFRP2; DISTINCT ROLES	Spontaneously occurring canine mammary tumours (CMTs) are the most common neoplasms of unspayed female dogs leading to thrice higher mortality rates than human breast cancer. These are also attractive models for human breast cancer studies owing to clinical and molecular similarities. Thus, they are important candidates for biomarker studies and understanding cancer pathobiology. The study was designed to explore underlying molecular networks and pathways in CMTs for deciphering new prognostic factors and therapeutic targets. To gain an insight into various pathways and networks associated with the development and pathogenesis of CMTs, comparative cDNA microarray expression profiling was performed using CMT tissues and healthy mammary gland tissues. Upon analysis, 1700 and 1287 differentially expressed genes (DEGs, P <= 0.05) were identified in malignant and benign tissues, respectively. DEGs identified from microarray analysis were further annotated using the Ingenuity Systems Pathway Analysis (IPA) tool for detection of deregulated canonical pathways, upstream regulators, and networks associated with malignant, as well as, benign disease. Top scoring key networks in benign and malignant mammary tumours were having central nodes of VEGF and BUB1B, respectively. Cyclins & cell cycle regulation and TREM1 signalling were amongst the top activated canonical pathways in CMTs. Other cancer related significant pathways like apoptosis signalling, dendritic cell maturation, DNA recombination and repair, Wnt/beta-catenin signalling, etc. were also found to be altered. Furthermore, seven proteins (ANXA2, APOCII, CDK6, GATC, GDI2, GNAQ and MYH9) highly up-regulated in malignant tissues were identified by two-dimensional gel electrophoresis (2DE) and MALDI-TOF PMF studies which were in concordance with microarray data. Thus, the study has uncovered ample number of candidate genes associated with CMTs which need to be further validated as therapeutic targets and prognostic markers.	[Hussain, Shahid; Saxena, Sonal; Shrivastava, Sameer; Singh, Rajkumar James; Tiwari, Ashok Kumar; Singh, Raj Kumar] Deemed Univ, ICAR Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India; [Mohanty, Ashok Kumar; Kumar, Sudarshan] Deemed Univ, ICAR Natl Dairy Res Inst, Anim Biotechnol Div, Karnal, Haryana, India; [Kumar, Abhinav] IIT BHU, Dept Comp Sci & Engn, Varanasi, Uttar Pradesh, India; [Wani, Sajad Ahmad] Ohio State Univ, Columbus, OH 43210 USA; [Gandham, Ravi Kumar] Natl Inst Anim Biotechnol, Hyderabad, Telangana, India; [Kumar, Naveen] Deemed Univ, ICAR Indian Vet Res Inst, Div Vet Surg, Bareilly, Uttar Pradesh, India; [Sharma, Anil Kumar] Deemed Univ, ICAR Indian Vet Res Inst, Div Vet Pathol, Bareilly, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT BHU) - Varanasi; University System of Ohio; Ohio State University; Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Saxena, S; Shrivastava, S; Singh, RK (corresponding author), Deemed Univ, ICAR Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India.	sonalvet@gmail.com; sameer_vet@rediffmail.com; rks_virology@rediffmail.com	Kumar, Abhinav/ABD-7598-2021; Sharma, Anil K./AAP-1909-2020	Kumar, Abhinav/0000-0001-9741-4020; Sharma, Anil K./0000-0002-9768-1644; WANI, SAJAD/0000-0002-7593-1825; Hussain, Shahid/0000-0002-5874-6732; Singh, Rajkumar/0000-0003-4649-2015	ICAR-IVRI [IVRI/BIOTECH/15-18/010]; Department of Biotechnology (DBT), Govt. of India [BT/ADV/CANINE HEALTH/GADVASU]	ICAR-IVRI; Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	This study was supported by the grants received from ICAR-IVRI (Project code IVRI/BIOTECH/15-18/010), By Dr Sonal, Department of Biotechnology (DBT), Govt. of India (Project code BT/ADV/CANINE HEALTH/GADVASU) by Dr Sonal, ICAR-Niche Area of Excellence Programme on Biosensors by Dr Sameer.	Agarwal P, 2013, J CELL BIOCHEM, V114, P1355, DOI 10.1002/jcb.24476; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Aresu L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-33; Azenshtein E, 2005, CANCER LETT, V217, P73, DOI 10.1016/j.canlet.2004.05.024; Beaver CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089834; Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Brachelente C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06281-1; BROADUS AE, 1988, NEW ENGL J MED, V319, P556; Broekaert SMC, 2010, PIGM CELL MELANOMA R, V23, P763, DOI 10.1111/j.1755-148X.2010.00778.x; Cantile M, 2013, TUMORI J, V99, P245; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen CL, 2013, J PROTEOMICS, V85, P28, DOI 10.1016/j.jprot.2013.04.024; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Choi YK, 2018, BIOMOL THER, V26, P19, DOI 10.4062/biomolther.2017.178; Chung IH, 2016, ONCOTARGET, V7, P11113, DOI 10.18632/oncotarget.7096; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Cress WD, 2017, INT J BIOCHEM CELL B, V91, P98, DOI 10.1016/j.biocel.2017.05.013; Derycke L, 2011, INT J DEV BIOL, V55, P835, DOI 10.1387/ijdb.113336ld; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Ding GX, 2015, PROSTATE, V75, P957, DOI 10.1002/pros.22978; DORN CR, 1968, JNCI-J NATL CANCER I, V40, P307; Dugimont T, 1995, BIOL CELL, V85, P117, DOI 10.1016/0248-4900(96)85272-5; Eckstein N, 2008, J BIOL CHEM, V283, P739, DOI 10.1074/jbc.M706287200; Egenvall A, 2005, PREV VET MED, V69, P109, DOI 10.1016/j.prevetmed.2005.01.014; Fan C, 2015, BRIT J CANCER, V113, P1735, DOI 10.1038/bjc.2015.378; Fischer H, 2001, CARCINOGENESIS, V22, P875, DOI 10.1093/carcin/22.6.875; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Ganapathi MK, 2016, INT J CANCER, V138, P679, DOI 10.1002/ijc.29815; Gao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091771; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Gruvberger S, 2001, CANCER RES, V61, P5979; Guo XZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-233; Hagan CR, 2013, NUCLEIC ACIDS RES, V41, P8926, DOI 10.1093/nar/gkt706; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Halsted KC, 2008, MODERN PATHOL, V21, P1246, DOI 10.1038/modpathol.2008.129; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Ishikawa N, 2005, CANCER RES, V65, P9176, DOI 10.1158/0008-5472.CAN-05-1556; Jensen-Jarolim E, 2016, ALLERGY, V71, P286, DOI 10.1111/all.12797; Jiang JH, 2011, BIOCHEM BIOPH RES CO, V415, P325, DOI 10.1016/j.bbrc.2011.10.055; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kariagina Anastasia, 2010, Hormones & Cancer, V1, P229, DOI 10.1007/s12672-010-0048-0; Kig C, 2013, J BIOL CHEM, V288, P24200, DOI 10.1074/jbc.M113.471433; Kim KE, 2007, ONCOGENE, V26, P1468, DOI 10.1038/sj.onc.1209926; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Klopfleisch R, 2011, VET PATHOL, V48, P98, DOI 10.1177/0300985810390826; Klopfleisch R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-618; Kolbl AC, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00219; Kollmann K, 2013, CANCER CELL, V24, P167, DOI 10.1016/j.ccr.2013.07.012; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; Lee JL, 2006, BREAST CANCER RES TR, V100, P49, DOI 10.1007/s10549-006-9233-9; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Li JR, 2011, J CLIN INVEST, V121, P4655, DOI 10.1172/JCI46134; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Liao Wen-Ting, 2011, Chin J Cancer, V30, P627, DOI 10.5732/cjc.010.10599; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031251; Liu DN, 2012, INT J MOL SCI, V13, P15291, DOI 10.3390/ijms131115291; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Ma XL, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.427; MACEWEN EG, 1996, SMALL ANIMAL CLIN ON, P356; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Maruo T, 2013, NEUROPATHOLOGY, V33, P264, DOI 10.1111/j.1440-1789.2012.01361.x; McBryan J, 2008, J MAMMARY GLAND BIOL, V13, P159, DOI 10.1007/s10911-008-9075-7; McDonald J Tyson, 2018, Oncotarget, V9, P22693, DOI 10.18632/oncotarget.25209; Mersch J, 2015, CANCER-AM CANCER SOC, V121, P269, DOI 10.1002/cncr.29041; Ming ZJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0201-0; Mo ML, 2010, USE SERUM CIRCULATIN; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Moulay M, 2013, ANTICANCER RES, V33, P5421; Nakano I, 2009, METHODS ANAL BRAIN T; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Owen JL, 2003, J IMMUNOL, V171, P4340, DOI 10.4049/jimmunol.171.8.4340; Padala C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184448; Park SH, 2007, CLIN CANCER RES, V13, P858, DOI 10.1158/1078-0432.CCR-06-1461; Pawlowski KM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-119; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Queiroga FL, 2011, IN VIVO, V25, P455; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Restucci B, 2002, VET PATHOL, V39, P488, DOI 10.1354/vp.39-4-488; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saad ES, 2017, J COMP PATHOL, V156, P352, DOI 10.1016/j.jcpa.2017.03.005; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Schoeffner DJ, 2005, LAB INVEST, V85, P608, DOI 10.1038/labinvest.3700258; Schwarzenbach H, 2016, EBIOMEDICINE, V13, P9, DOI 10.1016/j.ebiom.2016.11.001; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Shigeishi H, 2006, ONCOL REP, V16, P1071; Shiozawa Y, 2008, J CELL BIOCHEM, V105, P370, DOI 10.1002/jcb.21835; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stav D, 2007, INT J BIOL MARKER, V22, P108, DOI 10.1177/172460080702200204; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Sun ZL, 2007, BBA-PROTEINS PROTEOM, V1774, P764, DOI 10.1016/j.bbapap.2007.04.001; Takahashi Y, 2012, MOL CANCER RES, V10, P1135, DOI 10.1158/1541-7786.MCR-12-0098-T; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Tomonaga T, 2003, CANCER RES, V63, P3511; Tooley J, 2011, CHROMOSOME RES, V19, P377, DOI 10.1007/s10577-010-9180-5; Torring N, 1998, PROSTATE CANCER P D, V1, P262, DOI 10.1038/sj.pcan.4500250; Totoki Y, 2014, GENOME RES, V24, P1411, DOI 10.1101/gr.160598.113; Tu M, 2014, MOL MED REP, V10, P663, DOI 10.3892/mmr.2014.2317; Vincent KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep42719; VISHWANATHA JK, 1993, CARCINOGENESIS, V14, P2575, DOI 10.1093/carcin/14.12.2575; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953; Wu YH, 2014, ONCOGENE, V33, P3432, DOI 10.1038/onc.2013.307; Xia ZK, 2012, DIS ESOPHAGUS, V25, P427, DOI 10.1111/j.1442-2050.2011.01261.x; Xiong D, 2012, ONCOL REP, V28, P1625, DOI 10.3892/or.2012.1965; Xu QX, 2016, TRENDS CANCER, V2, P111, DOI 10.1016/j.trecan.2016.02.002; Xue X, 2013, ONCOGENE, V32, P1724, DOI 10.1038/onc.2012.177; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yusuf N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00224	120	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208656	10.1371/journal.pone.0208656	http://dx.doi.org/10.1371/journal.pone.0208656			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517191	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400108
J	Redshaw, M; Henderson, J				Redshaw, Maggie; Henderson, Jane			Mothers' experience of maternity and neonatal care when babies die: A quantitative study	PLOS ONE			English	Article							FAMILY-CENTERED CARE; PARENTS; STILLBIRTH; RECALL; IMPACT	Background The death of a newborn baby is devastating. While clinical issues may be a primary concern, interpersonal aspects can impact significantly. Mothers in this situation are not easy to access for research and little quantitative evidence is available. In this study we aimed to describe their experience of care, emphasising associations with infant gestational age. Methods Secondary analysis of population-based survey data collected through the Office for National Statistics following neonatal death in England in 2012-13. Women were asked about clinical events and care during pregnancy, labour and birth, when the baby died, postnatally and in the neonatal unit. Results 249 mothers returned completed questionnaires (30% response rate), 50% of births were at 28 weeks' gestation or less and 66% had babies admitted for neonatal care. 24% of women were left alone and worried during labour and 18% after birth. Only 49% felt sufficiently involved in decision-making at this time. Postnatally only 53% were cared for away from other mothers and babies, 47% could not have their partner stay with them, and 55% were not located close to their baby. Mothers of term babies were significantly less likely to report confidence in staff, feeling listened to and having concerns taken seriously during labour, and postnatally many felt insufficiently informed about their baby's condition, and that neonatal staff were not always aware of parental needs. However, most mothers (84%) were satisfied with neonatal care. Conclusions There is room for improvement if women whose babies die in the neonatal period are to receive the care and support they need. Women who have a baby admitted to a neonatal unit should be cared for nearby, with room for their partner and with greater involvement in decision-making, particularly where withdrawal of life support is considered.	[Redshaw, Maggie; Henderson, Jane] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England	University of Oxford	Redshaw, M (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Policy Res Unit Maternal Hlth & Care, Oxford, England.	maggie.redshaw@npeu.ox.ac.uk			Policy Research Programme, Department of Health, UK	Policy Research Programme, Department of Health, UK	The funder was the Policy Research Programme, Department of Health, UK. The award was to the National Perinatal Epidemiology Unit, University of Oxford, lead investigator, NPEU director Professor Jenny Kurinczuk. Maggie Redshaw was a co-investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002487; Bat-Erdene U, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S3; Bennett SM, 2008, J LOSS TRAUMA, V13, P485, DOI 10.1080/15325020802171268; Bennett SM, 2005, PROF PSYCHOL-RES PR, V36, P180, DOI 10.1037/0735-7028.36.2.180; Bliss, 2009, BLISS BAB CHART STAN; Bliss, 2017, FAM KEPT AP BARR PAR; Burden C, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0800-8; Department for Communities and Local Government, 2010, ENGL IND DEPR; Draper ES., 2017, PERINATAL CONFIDENTI; Flenady V, 2014, BJOG-INT J OBSTET GY, V121, P137, DOI 10.1111/1471-0528.13009; Flenady V, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000452.pub2; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Henderson J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016351; Henderson J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178475; Hennegan JM, 2018, J REPROD INFANT PSYC, V36, P120, DOI 10.1080/02646838.2018.1424325; Lundqvist A, 2002, BIRTH-ISS PERINAT C, V29, P192, DOI 10.1046/j.1523-536X.2002.00187.x; Lundqvist Anita, 2002, Pediatr Nurs, V28, P621; National Institute for Health and Clinical Excellence ( NICE), 2012, SPEC NEON CAR QUAL S; National Neonatal Audit Programme, 2017, ANN REP 2016 DAT; NHS, 2009, TOOLK HIGH QUAL NEON; Quigley MA, 2007, BJOG-INT J OBSTET GY, V114, P195, DOI 10.1111/j.1471-0528.2006.01203.x; Redshaw M., 2010, DELIVERED CARE NATL; Redshaw M., 2015, SAFELY DELIVERED NAT; Redshaw M., 1996, DELIVERING NEONATAL; Redshaw M, 2014, LISTENING PARENTS ST; Redshaw ME, 2010, ARCH DIS CHILD-FETAL, V95, pF365, DOI 10.1136/adc.2009.163717; Redshaw M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-70; Rowlands IJ, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-138; Russell G, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-230; Staniszewska S, 2012, WORLDV EVID-BASED NU, V9, P243, DOI 10.1111/j.1741-6787.2012.00253.x; Sullivan J, 2014, ARCH DIS CHILD, V99, P216, DOI 10.1136/archdischild-2013-304249; Turton P, 2009, ARCH WOMEN MENT HLTH, V12, P35, DOI 10.1007/s00737-008-0040-7; Yoxall CW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008494	34	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208134	10.1371/journal.pone.0208134	http://dx.doi.org/10.1371/journal.pone.0208134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517175	Green Submitted, gold, Green Published			2022-12-26	WOS:000452212400081
J	Riedlinger, T; Liefke, R; Meier-Soelch, J; Jurida, L; Nist, A; Stiewe, T; Kracht, M; Schmitz, ML				Riedlinger, Tabea; Liefke, Robert; Meier-Soelch, Johanna; Jurida, Liane; Nist, Andrea; Stiewe, Thorsten; Kracht, Michael; Schmitz, M. Lienhard			NF-B p65 dimerization and DNA-binding is important for inflammatory gene expression	FASEB JOURNAL			English	Article						inflammation; chromatin; transcription	FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; CHROMATIN ACCESSIBILITY; SUBUNIT STOICHIOMETRY; RECEPTOR; ALPHA; DEGRADATION; SITES; TNF; NF-KAPPA-B1	Increasing evidence shows that many transcription factors execute important biologic functions independent from their DNA-binding capacity. The NF-B p65 (RELA) subunit is a central regulator of innate immunity. Here, we investigated the relative functional contribution of p65 DNA-binding and dimerization in p65-deficient human and murine cells reconstituted with single amino acid mutants preventing either DNA-binding (p65 E/I) or dimerization (p65 FL/DD). DNA-binding of p65 was required for RelB-dependent stabilization of the NF-B p100 protein. The antiapoptotic function of p65 and expression of the majority of TNF--induced genes were dependent on p65's ability to bind DNA and to dimerize. Chromatin immunoprecipitation with massively parallel DNA sequencing experiments revealed that impaired DNA-binding and dimerization strongly diminish the chromatin association of p65. However, there were also p65-independent TNF--inducible genes and a subgroup of p65 binding sites still allowed some residual chromatin association of the mutants. These sites were enriched in activator protein 1 (AP-1) binding motifs and showed increased chromatin accessibility and basal transcription. This suggests a mechanism of assisted p65 chromatin association that can be in part facilitated by chromatin priming and cooperativity with other transcription factors such as AP-1.Riedlinger, T., Liefke, R., Meier-Soelch, J., Jurida, L., Nist, A., Stiewe, T., Kracht, M., Schmitz, M. L. NF-B p65 dimerization and DNA-binding is important for inflammatory gene expression.	[Riedlinger, Tabea; Liefke, Robert; Schmitz, M. Lienhard] Justus Liebig Univ, Inst Biochem, German Ctr Lung Res, Friedrichstr 24, D-35392 Giessen, Germany; [Meier-Soelch, Johanna; Jurida, Liane; Kracht, Michael] Justus Liebig Univ, Rudolf Buchheim Inst Pharmacol, German Ctr Lung Res, Giessen, Germany; [Liefke, Robert] Philipps Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany; [Nist, Andrea; Stiewe, Thorsten] Philipps Univ Marburg, Inst Mol Oncol, Genom Core Facil, Marburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Philipps University Marburg; Philipps University Marburg	Schmitz, ML (corresponding author), Justus Liebig Univ, Inst Biochem, German Ctr Lung Res, Friedrichstr 24, D-35392 Giessen, Germany.	lienhard.schmitz@biochemie.med.uni-giessen.de	Schmitz, M. Lienhard/D-9328-2017; Liefke, Robert/AAF-6842-2021	Schmitz, M. Lienhard/0000-0002-6984-7192; Liefke, Robert/0000-0002-8549-637X; Stiewe, Thorsten/0000-0003-0134-7826	Deutsche Forschungsgemeinschaft [SCHM 1417/8-3, LI 2057/2-1, Kr1143/7-3, KR1143/9-1, KLIFO309, TRR81/2, SFB1213, SFB1021]; Deutsche Krebshilfe [111447]; International Max Planck Research Schools Program of the Max-Planck Society; Excellence Cluster Cardio-Pulmonary System;  [SFB/TRR81]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); International Max Planck Research Schools Program of the Max-Planck Society; Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); 	The authors thank Dr. Feng Zhang (Massachusetts Institute of Technology, Boston, MA USA) for pX459. This work was supported by grants from the Deutsche Forschungsgemeinschaft (SCHM 1417/8-3), SFB/TRR81, SFB1021, SFB1213, the Deutsche Krebshilfe (111447), and the International Max Planck Research Schools Program of the Max-Planck Society (to M.L.S.). The work of R.L. was supported by the Deutsche Forschungsgemeinschaft (LI 2057/2-1). The work of M.K. is supported by Deutsche Forschungsgemeinschaft Kr1143/7-3, KR1143/9-1 (KLIFO309), TRR81/2 (B02), SFB1213 (B03), and SFB1021 (C02). Work from the M.L.S. and M.K. laboratories was further supported by the Excellence Cluster Cardio-Pulmonary System. The authors declare no conflicts of interest.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bell LA, 2006, ONCOGENE, V25, P5656, DOI 10.1038/sj.onc.1209580; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Dennis G, 2003, GENOME BIOL, V4; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fusco AJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad9413; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Huang DB, 1997, STRUCTURE, V5, P1427, DOI 10.1016/S0969-2126(97)00293-1; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jurida L., 2015, CELL REP; Kao YS, 2008, CELL SIGNAL, V20, P771, DOI 10.1016/j.cellsig.2007.12.012; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kolovos P, 2016, GENOME RES, V26, P1478, DOI 10.1101/gr.210005.116; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanucara F, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160055; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Liu N, 2009, DEVELOPMENT, V136, P933, DOI 10.1242/dev.034025; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu YF, 2012, J INFRARED MILLIM W, V31, P1; MATTHEWS JR, 1995, INT J BIOCHEM CELL B, V27, P865, DOI 10.1016/1357-2725(95)00071-V; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Milanovic M, 2014, BIOCHEM J, V457, P401, DOI 10.1042/BJ20130780; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Mueller S, 2015, MOL BIOL CELL, V26, P2596, DOI 10.1091/mbc.E15-03-0168; Na SY, 1999, J BIOL CHEM, V274, P7674, DOI 10.1074/jbc.274.12.7674; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; O'Neil J, 2001, ONCOGENE, V20, P3897, DOI 10.1038/sj.onc.1204519; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Porcher C, 1999, DEVELOPMENT, V126, P4603; Reintjes A, 2016, P NATL ACAD SCI USA, V113, P4326, DOI 10.1073/pnas.1522372113; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Riedlinger T, 2017, BBA-MOL CELL RES, V1864, P1785, DOI 10.1016/j.bbamcr.2017.07.005; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Stellzig J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.42; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wissink S, 1997, J BIOL CHEM, V272, P22278, DOI 10.1074/jbc.272.35.22278; Wolter S, 2008, MOL CELL BIOL, V28, P4407, DOI 10.1128/MCB.00535-07; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Yilmaz ZB, 2014, CELL REP, V9, P1756, DOI 10.1016/j.celrep.2014.11.014; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang LQ, 2010, J MOL BIOL, V396, P528, DOI 10.1016/j.jmb.2010.01.008; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037; Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916	64	20	21	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4188	4202		10.1096/fj.201801638R	http://dx.doi.org/10.1096/fj.201801638R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526044	hybrid, Green Published			2022-12-26	WOS:000459794800087
J	Stomberski, CT; Zhou, HL; Wang, LW; van den Akker, F; Stamler, JS				Stomberski, Colin T.; Zhou, Hua-Lin; Wang, Liwen; van den Akker, Focco; Stamler, Jonathan S.			Molecular recognition of S-nitrosothiol substrate by its cognate protein denitrosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						S-nitrosylation; coenzyme A (CoA); enzyme kinetics; mutagenesis; nitric oxide; denitrosylase; denitrosylation; SCoR; SNO-CoA	ALDEHYDE REDUCTASE; NITRIC-OXIDE; NITROSYLATION; PURIFICATION; SUPERFAMILY; INTERPLAY; GENOMICS	Protein S-nitrosylation mediates a large part of nitric oxide's influence on cellular function by providing a fundamental mechanism to control protein function across different species and cell types. At steady state, cellular S-nitrosylation reflects dynamic equilibria between S-nitrosothiols (SNOs) in proteins and small molecules (low-molecular-weight SNOs) whose levels are regulated by dedicated S-nitrosylases and denitrosylases. S-Nitroso-CoA (SNO-CoA) and its cognate denitrosylases, SNO-CoA reductases (SCoRs), are newly identified determinants of protein S-nitrosylation in both yeast and mammals. Because SNO-CoA is a minority species among potentially thousands of cellular SNOs, SCoRs must preferentially recognize this SNO substrate. However, little is known about the molecular mechanism by which cellular SNOs are recognized by their cognate enzymes. Using mammalian cells, molecular modeling, substrate-capture assays, and mutagenic analyses, we identified a single conserved surface Lys (Lys-127) residue as well as active-site interactions of the SNO group that mediate recognition of SNO-CoA by SCoR. Comparing SCoRK127A versus SCoRWT HEK293 cells, we identified a SNO-CoA-dependent nitrosoproteome, including numerous metabolic protein substrates. Finally, we discovered that the SNO-CoA/SCoR system has a role in mitochondrial metabolism. Collectively, our findings provide molecular insights into the basis of specificity in SNO-CoA-mediated metabolic signaling and suggest a role for SCoR-regulated S-nitrosylation in multiple metabolic processes.	[Stomberski, Colin T.; Zhou, Hua-Lin; Stamler, Jonathan S.] Case Western Reserve Univ, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Stomberski, Colin T.; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Wang, Liwen] Case Western Reserve Univ, Ctr Prote & Bioinformat, Dept Nutr, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Univ Hosp Cleveland Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Stamler, JS (corresponding author), Harrington Discovery Inst, 10900 Euclid Ave,LC 7294, Cleveland, OH 44106 USA.; Stamler, JS (corresponding author), Inst Transformat Mol Med, 10900 Euclid Ave,LC 7294, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Stamler, Jonathan/0000-0002-6866-1572; Stomberski, Colin/0000-0002-3362-9345	National Institutes of Health [R01DK119506, R01HL126900, P01HL075443, P01HL128192]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126900, P01HL128192, P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK119506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DK119506 (to J. S. S.), R01HL126900 (to J. S. S.), P01HL075443 (to J. S. S.), and P01HL128192 (to J. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abunimer A, 2014, GENES-BASEL, V5, P254, DOI 10.3390/genes5020254; AMVA Panel on Euthanasia, 2013, AVMA GUIDELINES EUTH; Anand P, 2014, P NATL ACAD SCI USA, V111, P18572, DOI 10.1073/pnas.1417816112; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Barski OA, 1996, BIOCHEMISTRY-US, V35, P14276, DOI 10.1021/bi9619740; BARSKI OA, 1995, BIOCHEMISTRY-US, V34, P11264, DOI 10.1021/bi00035a036; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Benhar M, 2015, BBA-GEN SUBJECTS, V1850, P2476, DOI 10.1016/j.bbagen.2015.09.010; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; BRANLANT G, 1980, EUR J BIOCHEM, V105, P611, DOI 10.1111/j.1432-1033.1980.tb04539.x; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, DOI [10.17226/12910, DOI 10.17226/12910]; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mindnich Rebekka D., 2009, Human Genomics, V3, P362; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Seth D, 2018, MOL CELL, V69, P451, DOI 10.1016/j.molcel.2017.12.025; Stomberski CT, 2019, ANTIOXID REDOX SIGN, V30, P1331, DOI 10.1089/ars.2017.7403; Talipov MR, 2013, J PHYS CHEM B, V117, P1827, DOI 10.1021/jp310664z; Timerghazin QK, 2007, ORG LETT, V9, P3049, DOI 10.1021/ol0711016; WERMUTH B, 1977, J BIOL CHEM, V252, P3821; Zhou HL, 2019, NATURE, V565, P96, DOI 10.1038/s41586-018-0749-z	27	17	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1568	1578		10.1074/jbc.RA118.004947	http://dx.doi.org/10.1074/jbc.RA118.004947			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30538128	Green Published, hybrid			2022-12-26	WOS:000457879200012
J	Aguirrebengoa, M; Garcia-Planas, M; Muller, C; Gonzalez-Megias, A				Aguirrebengoa, Martin; Garcia-Planas, Maite; Mueller, Caroline; Gonzalez-Megias, Adela			Transgenerational effects of ungulates and pre-dispersal seed predators on offspring success and resistance to herbivory	PLOS ONE			English	Article							INSECT HERBIVORES; PLANT-RESPONSES; CONSEQUENCES; MECHANISMS; DEFENSE; TOLERANCE; SELECTION; ECOLOGY; DETRITIVORES; PERFORMANCE	Herbivorous mammals and insect pre-dispersal seed predators are two types of herbivores that, despite their functional and morphological differences, tend to severely impact many plant species, highly decreasing their seed production and even imperiling the performance of their offspring through transgenerational effects. However, how they influence offspring resistance to herbivory remains largely unknown. In this study we experimentally examined the effects of ungulates and pre-dispersal seed predators on seed quality as well as on the emergence, survival and resistance to herbivory of the seedlings of a semiarid herb. We found that ungulates reduced seedling recruitment but increased seedling resistance to leaf miners. These effects were probably a consequence of insufficient carbon provisioning in seeds that reduced seed viability and provoked carbon limitation in seedlings. Pre-dispersal seed predators did not influence seedling recruitment, but seedlings from mothers damaged by ungulates and by pre-dispersal seed predators suffered less herbivory by grasshoppers. Remarkably, intra-individual differences in damage by pre-dispersal seed predators affected the rate of damage underwent by seedlings. That is, seedlings derived from fruits attacked by seed predators were more resistant to herbivores than siblings derived from un-attacked fruits in plant populations exposed to ungulates. To our knowledge, this is the first study reporting variation in transgenerational-induced resistance of seedlings from the same maternal plant. This study is a valuable contribution to the understanding of transgenerational effects of multiple herbivores and their implications for a deeper comprehension of the natural systems in which they co-occur.	[Aguirrebengoa, Martin; Garcia-Planas, Maite; Gonzalez-Megias, Adela] Univ Granada, Dept Zool, Granada, Spain; [Mueller, Caroline] Bielefeld Univ, Dept Chem Ecol, Bielefeld, Germany	University of Granada; University of Bielefeld	Aguirrebengoa, M (corresponding author), Univ Granada, Dept Zool, Granada, Spain.	martinab@ugr.es	Megias, Adela Gonzalez/P-8974-2016; Muller, Caroline/G-5073-2011	Megias, Adela Gonzalez/0000-0002-2292-9334; Muller, Caroline/0000-0002-8447-534X; Aguirrebengoa, Martin/0000-0002-2019-790X	Fundacion BBVA [PR17-ECO-0021]; Ministry of Economy and Competitivity of the Spanish Government (MICINN, Ministerio de Economia y Competitividad, Gobierno de Espana) [CGL2011-24840, CGL2015-71634-P];  [BES-2012-059576]	Fundacion BBVA(BBVA Foundation); Ministry of Economy and Competitivity of the Spanish Government (MICINN, Ministerio de Economia y Competitividad, Gobierno de Espana); 	AGM was funded by the grant PR17-ECO-0021 from the Fundacion BBVA, and by grants CGL2011-24840 and CGL2015-71634-P from the Ministry of Economy and Competitivity of the Spanish Government (MICINN, Ministerio de Economia y Competitividad, Gobierno de Espana); https://sede.micinn.gob.es/stfls/eSede/Ficheros/2011/Anexo_ayudas_concedidas_segunda_resolucion_parcial_definitiva.pdf; http://www.ciencia.gob.es/stfls/eSede/Ficheros/2016/Anexo_I_concedidos_Proyectos_ID_2015_Excelencia.pdf.MA was supported by a fellowship (BES-2012-059576) linked to CGL2011-24840 grant; https://sede.micinn.gob.es/stfls/eSede/Ficheros/2012/2012_resolucion% 20concesion_fpi_firmada. pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Agrawal AA, 2002, ECOLOGY, V83, P3408, DOI 10.1890/0012-9658(2002)083[3408:HAMEMA]2.0.CO;2; Alonso C, 2018, ANN BOT-LONDON, V121, P153, DOI 10.1093/aob/mcx140; Ballhorn DJ, 2016, CHEMOECOLOGY, V26, P1, DOI 10.1007/s00049-015-0201-x; Barton KE, 2008, OIKOS, V117, P917, DOI 10.1111/j.0030-1299.2008.16324.x; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckers GJ, 2007, CURR OPIN PLANT BIOL, V10, P425, DOI 10.1016/j.pbi.2007.06.002; Boege K, 2007, ECOL LETT, V10, P177, DOI 10.1111/j.1461-0248.2006.01012.x; Colicchio J, 2017, J EVOLUTION BIOL, V30, P664, DOI 10.1111/jeb.13042; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; CRAWLEY MJ, 1989, ANNU REV ENTOMOL, V34, P531, DOI 10.1146/annurev.en.34.010189.002531; Crawley MJ, 2009, PLANT ECOL, P401; De Bruyn L, 2002, OECOLOGIA, V130, P594, DOI 10.1007/s00442-001-0840-1; De Menezes LCCR, 2010, BASIC APPL ECOL, V11, P126, DOI 10.1016/j.baae.2009.11.004; DeSoto L, 2016, OECOLOGIA, V180, P91, DOI 10.1007/s00442-015-3446-8; du Toit JT, 2014, OECOLOGIA, V174, P1075, DOI 10.1007/s00442-013-2864-8; Ehrlen J, 2003, AM NAT, V162, P796, DOI 10.1086/379350; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fulkerson WJ, 2001, AUST J EXP AGR, V41, P261, DOI 10.1071/EA00062; Giron D, 2016, J INSECT PHYSIOL, V84, P70, DOI 10.1016/j.jinsphys.2015.12.009; Gish M, 2017, OECOLOGIA, V183, P347, DOI 10.1007/s00442-016-3775-2; Gomez JM, 1996, J ARID ENVIRON, V33, P425, DOI 10.1006/jare.1996.0078; Gomez JM, 2003, AM NAT, V162, P242, DOI 10.1086/376574; Gomez JM, 2002, ECOLOGY, V83, P203, DOI 10.1890/0012-9658(2002)083[0203:AIBUAP]2.0.CO;2; Gomez JM, 2008, EVOLUTION, V62, P668, DOI 10.1111/j.1558-5646.2007.00312.x; Gomez Jose M., 2007, P104, DOI 10.1017/CBO9780511542701.006; Gomez JM, 2007, ECOL ENTOMOL, V32, P229; Megias AG, 2010, J ANIM ECOL, V79, P923, DOI 10.1111/j.1365-2656.2010.01681.x; Gonzalez-Megias A, 2016, J ANIM ECOL, V85, P283, DOI 10.1111/1365-2656.12453; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Han P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04455; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Herrera C.M., 2009, MULTIPLICITY UNITY P; Herrera CM, 2017, WEB ECOL, V17, P51, DOI 10.5194/we-17-51-2017; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; HUNTLY N, 1991, ANNU REV ECOL SYST, V22, P477, DOI 10.1146/annurev.ecolsys.22.1.477; Inbar M, 2001, OIKOS, V94, P228, DOI 10.1034/j.1600-0706.2001.940203.x; Irwin RE, 2006, AM NAT, V167, P315, DOI 10.1086/499377; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Karasov TL, 2017, PLANT CELL, V29, P666, DOI 10.1105/tpc.16.00931; KARBAN R, 1997, INDUCED RESPONSES HE; Kellenberger RT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21880-2; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kitajima Kaoru, 2008, P172; Kolb A, 2007, PERSPECT PLANT ECOL, V9, P79, DOI 10.1016/j.ppees.2007.09.001; Latzel V, 2014, OIKOS, V123, P41, DOI 10.1111/j.1600-0706.2013.00537.x; Lecomte X, 2017, BASIC APPL ECOL, V21, P45, DOI 10.1016/j.baae.2017.03.005; Lecomte X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158139; Li HH, 2012, ZOOTAXA, P1; Maron JL, 1998, ECOLOGY, V79, P1281, DOI 10.1890/0012-9658(1998)079[1281:IHAABI]2.0.CO;2; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Meldau S, 2012, ANN BOT-LONDON, V110, P1503, DOI 10.1093/aob/mcs212; Moles Angela T., 2008, P217; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; OBESO JR, 1993, FUNCT ECOL, V7, P150, DOI 10.2307/2389881; Osuna D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01023; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Sakata Y, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00401.1; Sanchez-Pinero F., 2007, BIODIVERSIDAD CONSER; Steets JA, 2010, INT J PLANT SCI, V171, P509, DOI 10.1086/651944; Suwa T, 2008, AM J BOT, V95, P434, DOI 10.3732/ajb.95.4.434; Tadey M, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0400-z; Takagi S, 2014, POPUL ECOL, V56, P435, DOI 10.1007/s10144-014-0441-6; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; van Dam NM, 2009, PHYTOCHEM REV, V8, P171, DOI 10.1007/s11101-008-9101-9; Zas R, 2013, HEREDITY, V111, P248, DOI 10.1038/hdy.2013.44	79	3	3	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207553	10.1371/journal.pone.0207553	http://dx.doi.org/10.1371/journal.pone.0207553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540778	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600022
J	Gomez, JP; Nekorchuk, DM; Mao, L; Ryan, SJ; Ponciano, JM; Blackburn, JK				Gomez, Juan Pablo; Nekorchuk, Dawn M.; Mao, Liang; Ryan, Sadie J.; Ponciano, Jose Miguel; Blackburn, Jason K.			Decoupling environmental effects and host population dynamics for anthrax, a classic reservoir-driven disease	PLOS ONE			English	Article							BISON-BISON-BISON; FREE-ROAMING BISON; BACILLUS-ANTHRACIS; PATHOGEN TRANSMISSION; BIOLOGY; SEASONALITY; PERSISTENCE; EXPOSURE; IMMUNITY; CANADA	Quantitative models describing environmentally-mediated disease transmission rarely focus on the independent contribution of recruitment and the environment on the force of infection driving outbreaks. In this study we attempt to investigate the interaction between external factors and host's population dynamics in determining the outbreaks of some indirectly transmitted diseases. We first built deterministic and stochastic compartmental models based on anthrax which were parameterized using information from literature and complemented with field observations. Our force of infection function was derived modeling the number of successful transmission encounters as a pure birth process that depends on the pathogen's dispersion effort. After accounting for individual heterogeneity in pathogen's dispersion effort, we allowed the force of infection to vary seasonally according to external factors recreating a scenario in which disease transmission increases in response to an environmental variable. Using simulations we demonstrate that anthrax disease dynamics in mid-latitude grasslands is decoupled from hosts population dynamics. When seasonal forcing was ignored, outbreaks matched hosts reproductive events, a scenario that is not realistic in nature. Instead, when allowing the force of infection to vary seasonally, outbreaks were only present in years were environmental variables were appropriate for the outbreaks to develop. We used the stochastic formulation of the force of infection to derive R-0 under scenarios with different assumptions. The derivation of R-0 allowed us to conclude that during epizootic years, pathogen contribution to disease persistence is nearly independent of dispersion. In endemic years, only pathogens with high dispersion significantly prevent disease extinction. Finally, we used our model in a maximum likelihood framework to estimate the parameters that determined a significant anthrax outbreak in Montana in 2008. Our study highlights the importance of the environment in determining anthrax outbreak intensity and could be useful to predict future events that could result in significant wildlife and domestic livestock losses.	[Gomez, Juan Pablo; Nekorchuk, Dawn M.; Blackburn, Jason K.] Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA; [Gomez, Juan Pablo; Nekorchuk, Dawn M.; Mao, Liang; Ryan, Sadie J.; Blackburn, Jason K.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Gomez, Juan Pablo; Ponciano, Jose Miguel] Univ Florida, Dept Biol, Gainesville, FL USA; [Nekorchuk, Dawn M.] South Dakota State Univ, Geospatial Sci Ctr Excellence, Brookings, SD USA; [Ryan, Sadie J.] Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat Lab, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; South Dakota State University; State University System of Florida; University of Florida	Blackburn, JK (corresponding author), Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA.; Blackburn, JK (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.	jkblackburn@ufl.edu	Blackburn, Jason/AAV-9445-2020; Ryan, Sadie Jane/H-7488-2019; Ponciano, Jose/AAQ-1038-2020	Blackburn, Jason/0000-0003-0928-4831; Ryan, Sadie Jane/0000-0002-4308-6321; Ponciano, Jose/0000-0001-8457-7840; Nekorchuk, Dawn M/0000-0001-8200-2146; Gomez, Juan Pablo/0000-0002-4128-8739	NIH [1R01GM117617]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117617] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH 1R01GM117617 to JKB and JMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L. J., 2008, MATH EPIDEMIOLOGY, V1945; Allen LJS, 2008, LECT NOTES MATH, V1945, P81, DOI 10.1007/978-3-540-78911-6_3; Allen LJ., 2010, INTRO STOCHASTIC PRO; Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Altizer S, 2004, J ANIM ECOL, V73, P309, DOI 10.1111/j.0021-8790.2004.00807.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Aune K, 2012, J WILDLIFE MANAGE, V76, P253, DOI 10.1002/jwmg.274; Bagamian KH, 2013, J WILDLIFE DIS, V49, P786, DOI 10.7589/2013-05-126; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Blackburn JK, 2014, VECTOR-BORNE ZOONOT, V14, P576, DOI 10.1089/vbz.2013.1538; Blackburn JK, 2014, J WILDLIFE DIS, V50, P393, DOI 10.7589/2013-08-204; Blackburn JK, 2013, J WILDLIFE DIS, V49, P699, DOI 10.7589/2012-10-253; Britton T, 2010, MATH BIOSCI, V225, P24, DOI 10.1016/j.mbs.2010.01.006; BROUGHTON E, 1992, CAN VET J, V33, P134; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Caraco T, 2018, J THEOR BIOL, V436, P51, DOI 10.1016/j.jtbi.2017.09.029; Cizauskas CA, 2014, J ANIM ECOL, V83, P1078, DOI 10.1111/1365-2656.12207; Cushing JM, 2016, J THEOR BIOL, V404, P295, DOI 10.1016/j.jtbi.2016.06.017; Dennis B., 1989, Natural Resource Modeling, V3, P481; Dougherty ER, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0110-4; DRAGON DC, 1995, CAN VET J, V36, P295; Dragon DC, 1999, J APPL MICROBIOL, V87, P208, DOI 10.1046/j.1365-2672.1999.00872.x; Fasanella A, 2010, VET MICROBIOL, V140, P318, DOI 10.1016/j.vetmic.2009.08.016; Friedman A, 2013, MATH BIOSCI, V241, P137, DOI 10.1016/j.mbs.2012.10.004; Fuller JA, 2007, J WILDLIFE MANAGE, V71, P2365, DOI 10.2193/2006-201; FURNISS PR, 1981, APPL MATH MODEL, V5, P130, DOI 10.1016/0307-904X(81)90034-2; Ganz HH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002903; GATES CC, 1995, CAN J VET RES, V59, P256; Getz WM, 1996, ECOLOGY, V77, P2014, DOI 10.2307/2265697; HAHN BD, 1983, ECOL MODEL, V20, P233, DOI 10.1016/0304-3800(83)90009-1; Hosseini PR, 2004, P ROY SOC B-BIOL SCI, V271, P2569, DOI 10.1098/rspb.2004.2938; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kirkpatrick JF, 1996, CAN J ZOOL, V74, P8, DOI 10.1139/z96-002; Kirpich A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004153; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Marston CK, 2005, APPL ENVIRON MICROB, V71, P7778, DOI 10.1128/AEM.71.12.7778-7780.2005; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; Morris LR, 2016, J WILDLIFE MANAGE, V80, P235, DOI 10.1002/jwmg.1016; Mushayabasa S, 2015, DISCRETE DYN NAT SOC, V2015, DOI 10.1155/2015/573146; Nekorchuk D., 2017, MODELING INDIRECT TR; Nishi JS, 2007, CAN VET J, V48, P37; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Pascual M, 2002, MICROBES INFECT, V14, P576; Ponciano JM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001079; Proffitt KM, 2011, J APPL ECOL, V48, P471, DOI 10.1111/j.1365-2664.2010.01928.x; Rijks J., 1999, SEROLOGICAL STUDY BI; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; Salb A, 2014, J WILDLIFE DIS, V50, P459, DOI 10.7589/2013-04-095; SHAW JH, 1989, J WILDLIFE MANAGE, V53, P896, DOI 10.2307/3809584; Shury TK, 2009, CAN VET J, V50, P152; Tien JH, 2010, B MATH BIOL, V72, P1506, DOI 10.1007/s11538-010-9507-6; TURNBULL PCB, 1992, EPIDEMIOL INFECT, V108, P299, DOI 10.1017/S0950268800049773; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; Turner AJ, 1999, J APPL MICROBIOL, V87, P196, DOI 10.1046/j.1365-2672.1999.00869.x; Turner WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27311; Turner WC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1785	63	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208621	10.1371/journal.pone.0208621	http://dx.doi.org/10.1371/journal.pone.0208621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540815	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600082
J	Sprygin, A; Babin, Y; Pestova, Y; Kononova, S; Wallace, DB; Van Schalkwyk, A; Byadovskaya, O; Diev, V; Lozovoy, D; Kononov, A				Sprygin, Alexander; Babin, Yurii; Pestova, Yana; Kononova, Svetlana; Wallace, David B.; Van Schalkwyk, Antoinette; Byadovskaya, Olga; Diev, Vyacheslav; Lozovoy, Dmitry; Kononov, Alexander			Analysis and insights into recombination signals in lumpy skin disease virus recovered in the field	PLOS ONE			English	Article							LIVE-ATTENUATED VACCINE; REAL-TIME PCR; DIFFERENTIATION; SEQUENCES; GENOMES	Wide spread incidences of vaccine-like strains of lumpy skin disease virus (LSDV) have recently been reported in a Russian region with a neighboring country that actively vaccinate with a live attenuated LSD vaccine. The use of live-attenuated viruses (LAVs) as vaccines during an active outbreak, creates potential ground for coinfection of hosts and emergence of a strain combining genetic fragments of both parental vaccine and field strains. In this study, we analyse the vaccine-like strain LSDV RUSSIA/Saratov/2017 detected in Saratovskaya oblast, a region sharing border with Kazakhstan. To gain insight into possible recombination signals, a full-genome next-generation sequencing of the viral genome was performed using the Illumina platform. The genome contains the backbone of a live-attenuated vaccine with a patchwork of wild-type field virus DNA fragments located throughout. A total of 27 recombination events were identified. The average distance between the recombination sites was 3400 base pairs (bp). The impact of the recombination events on the virulence and transmission capacity of the identified virus remains to be clarified. These findings provide evidence for the first time of genetic exchanges between closely related strains of capripoxviruses in the field and a vaccine strain, and prompt a revisiting of the vaccination issue for a safe and efficacious prevention and control strategy of LSD.	[Sprygin, Alexander; Pestova, Yana; Kononova, Svetlana; Byadovskaya, Olga; Diev, Vyacheslav; Lozovoy, Dmitry; Kononov, Alexander] Fed Ctr Anim Hlth, Vladimir, Russia; [Babin, Yurii] Fed Budget Inst Sci, Cent Res Inst Epidemiol, Moscow, Russia; [Wallace, David B.; Van Schalkwyk, Antoinette] ARC Onderstepoort Vet Res Inst, Onderstepoort, South Africa; [Wallace, David B.] Univ Pretoria, Dept Vet Trop Dis, Fac Vet Sci, Onderstepoort, South Africa	Federal Centre for Animal Health; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria	Sprygin, A (corresponding author), Fed Ctr Anim Hlth, Vladimir, Russia.	sporiginav@mail.ru	Babin, Yuriy/S-2099-2019; Cihan, Sadullah/X-1527-2019; Lozovoy, Dmitry/AAA-5170-2019; Sprygin, Alexander/L-2752-2019	Babin, Yuriy/0000-0002-7524-5921; Lozovoy, Dmitry/0000-0002-5983-7062; Sprygin, Alexander/0000-0001-5982-3675; VAN SCHALKWYK, ANTOINETTE/0000-0003-4761-8767				Agianniotaki EI, 2017, J VIROL METHODS, V249, P48, DOI 10.1016/j.jviromet.2017.08.011; ALEXANDER R. A., 1957, Bulletin of epizootic diseases of Africa, V5, P489; Bedekovic T, 2018, TRANSBOUND EMERG DIS, V65, P491, DOI 10.1111/tbed.12730; Bull JJ, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev005; Camus-Bouclainville C, 2011, EMERG INFECT DIS, V17, P633, DOI 10.3201/eid1704.101146; DAVIES FG, 1982, J HYG-CAMBRIDGE, V88, P95, DOI 10.1017/S002217240006993X; De Boom HPA, 1948, S AFRICAN SCI B, V1, P44; Fenner F., 1959, VIRUSES, V3, P225; GERSHON PD, 1989, J GEN VIROL, V70, P485, DOI 10.1099/0022-1317-70-2-485; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gundlach BR, 2000, J VIROL, V74, P3537, DOI 10.1128/JVI.74.8.3537-3542.2000; Han GZ, 2008, J VIROL, V82, P6782, DOI 10.1128/JVI.00370-08; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hunter P, 2001, J S AFR VET ASSOC, V72, P68; Katsoulos PD, 2018, TRANSBOUND EMERG DIS, V65, P174, DOI 10.1111/tbed.12646; Kerr PJ, 2017, P NATL ACAD SCI USA, V114, P9397, DOI 10.1073/pnas.1710336114; Kolcov A., 2018, P 12 ANN M EPIZONE; Lamien CE, 2011, VET MICROBIOL, V149, P30, DOI 10.1016/j.vetmic.2010.09.038; Le Goff C, 2009, J GEN VIROL, V90, P1967, DOI 10.1099/vir.0.010686-0; Lin YCJ, 2010, J VIROL, V84, P2432, DOI 10.1128/JVI.01998-09; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MacDonald R.A.S., 1931, ANN REPORT 1930, P20; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mathijs E, GENOME ANNOUNCEMENTS, V4, P1; Menasherow S, 2016, J VIROL METHODS, V232, P12, DOI 10.1016/j.jviromet.2016.02.008; Nei M, 2000, MOL EVOLUTION PHYLOG; OIE, 2015, 4 OIE; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Paszkowski P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005824; Perez-Losada M, 2015, INFECT GENET EVOL, V30, P296, DOI 10.1016/j.meegid.2014.12.022; Pestova Ya E., 2018, Sel'skokhozyaistvennaya Biologiya, V53, P422, DOI [10.15389/agrobiology.2018.2.422eng, 10.15389/agrobiology.2018.2.422rus]; Pliaka V, 2012, EXPERT REV VACCINES, V11, P609, DOI [10.1586/ERV.12.28, 10.1586/erv.12.28]; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Qin L, 2011, J VIROL, V85, P13049, DOI 10.1128/JVI.05779-11; Sevik M, 2017, TRANSBOUND EMERG DIS, V64, P1268, DOI 10.1111/tbed.12501; SMITH JM, 1992, J MOL EVOL, V34, P126; Sprygin A, 2018, TRANSBOUND EMERG DIS, V65, P1514, DOI 10.1111/tbed.12889; Sprygin A, SELSKOKHOZYAISTVENNA; Sprygin A, 2018, TRANSBOUNDARY EMERGI; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Tulman ER, 2001, J VIROL, V75, P7122, DOI 10.1128/JVI.75.15.7122-7130.2001; van Rooyen P J, 1969, Onderstepoort J Vet Res, V36, P165; Vidanovic D, 2016, ACTA VET-BEOGRAD, V66, P444, DOI 10.1515/acve-2016-0038; Von Backstrom U., 1945, J S AFR VET ASSOC, V16, P29	45	53	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207480	10.1371/journal.pone.0207480	http://dx.doi.org/10.1371/journal.pone.0207480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540759	Green Submitted, gold, Green Published			2022-12-26	WOS:000452898600021
J	Zahradnik, E; Janssen-Weets, B; Sander, I; Kendzia, B; Mitlehner, W; May, C; Rauf, M				Zahradnik, Eva; Janssen-Weets, Bente; Sander, Ingrid; Kendzia, Benjamin; Mitlehner, Wolfgang; May, Caroline; Rauf, Monika			Lower allergen levels in hypoallergenic Curly Horses? A comparison among breeds by measurements of horse allergens in hair and air samples	PLOS ONE			English	Article							CLINICAL-RELEVANCE; FUNGAL DNA; SENSITIZATION; LIPOCALIN; CAT; DOG; IGE; ADULTS; DIAGNOSIS; ALBUMINS	Background Exposure to horses can cause severe allergic reactions in sensitized individuals. The breed, American Bashkir Curly Horse is categorized as hypoallergenic, primarily due to reports of allergic patients experiencing fewer symptoms while handling this special breed. The possible reasons for this phenomenon could be lower allergen production and/or reduced allergen release into the air because of increased sebum content in their skin and hair compared to other breeds. Therefore, the aim of the current study was to compare different horse breeds in relation to allergen content in hair and airborne dust samples. Methods In total, 224 hair samples from 32 different horse breeds were investigated. Personal nasal filters were used to collect airborne dust during the grooming of 20 Curly Horses and 20 Quarter Horses. Quantitative analysis of all samples was performed using two newly developed immunoassays for the detection of horse dander (HD) antigens and the major allergen Equ c 1 and the commercial assay for Equ c 4. Results were analyzed using multiple linear regression models for hair samples and the Mann Whitney U test for airborne samples. Results Horse antigen and allergen levels differed up to four orders of magnitude between individual animals. Despite enormous variability, levels of HD antigen, Equ c 1 and Equ c 4 in hair were significantly related to the breed and gender combined with the castration status of male animals. Curly Horses had significantly higher concentrations of all three tested parameters compared to the majority of the investigated breeds (medians: 11800 mu g/g for HD antigen, 2400 mu g/g for Equ c 1, and 258 kU/g for Equ c 4). Tinker Horses, Icelandic Horses and Shetland Ponies were associated with approximately 7-fold reduced levels of HD antigen and Equ c 1, and up to 25-fold reduced levels of Equ c 4 compared to Curly Horses. Compared to mares, stallions displayed increased concentrations of HD antigens, Equ c 1 and Equ c 4 by a factor 2.2, 3.5 and 6.7, respectively. No difference was observed between mares and geldings. No differences in airborne allergen concentrations collected with personal nasal filters during grooming were found between Curly and Quarter Horses. Conclusion Breed and castration status had a significant influence on the antigen and allergen levels of horse hair. However, these differences were smaller than the wide variability observed among individual horses. Compared to other breeds, Curly Horses were not associated with lower allergen levels in hair and in air samples collected during grooming. Our approach provides no molecular explanation why Curly Horses are considered to be hypoallergenic.	[Zahradnik, Eva; Janssen-Weets, Bente; Sander, Ingrid; Kendzia, Benjamin; Rauf, Monika] Inst Ruh Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Janssen-Weets, Bente] Luxemburg Inst Hlth, Esch Sur Alzette, Luxembourg; [May, Caroline] Ruhr Univ Bochum, MPC, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Zahradnik, E (corresponding author), Inst Ruh Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany.	zahradnik@ipa-dguv.de	Sander, Ingrid/R-8940-2017	Sander, Ingrid/0000-0002-5014-4112; Janssen-Weets, Bente/0000-0003-3379-7792; Kendzia, Benjamin/0000-0002-8662-795X				Arseneau CAM, 2012, MIL MED, V177, P877, DOI 10.7205/MILMED-D-12-00038; Bienboire-Frosini C, 2012, VET J, V193, P162, DOI 10.1016/j.tvjl.2011.09.031; Bjerg A, 2016, CLIN EXP ALLERGY, V46, P1328, DOI 10.1111/cea.12757; Bjerg A, 2015, PEDIAT ALLERG IMM-UK, V26, P557, DOI 10.1111/pai.12422; Botros HG, 1996, IMMUNOLOGY, V88, P340, DOI 10.1046/j.1365-2567.1996.d01-669.x; Botros HG, 2001, EUR J BIOCHEM, V268, P3126, DOI 10.1046/j.1432-1327.2001.02217.x; Bulone V, 1998, EUR J BIOCHEM, V253, P202, DOI 10.1046/j.1432-1327.1998.2530202.x; Cai GH, 2011, J ENVIRON MONITOR, V13, P2018, DOI 10.1039/c0em00553c; Felix K, 1996, J ALLERGY CLIN IMMUN, V98, P169, DOI 10.1016/S0091-6749(96)70239-7; Fu X, 2013, ENVIRON SCI-PROC IMP, V15, P1228, DOI 10.1039/c3em30928b; Gregoire C, 1996, J BIOL CHEM, V271, P32951, DOI 10.1074/jbc.271.51.32951; Haftenberger M, 2013, BUNDESGESUNDHEITSBLA, V56, P687, DOI 10.1007/s00103-012-1658-1; Jakob T, 2013, ALLERGY, V68, P690, DOI 10.1111/all.12107; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Liccardi G, 2011, INT ARCH ALLERGY IMM, V155, P412, DOI 10.1159/000321414; Liccardi G, 2012, CURR ALLERGY ASTHM R, V12, P429, DOI 10.1007/s11882-012-0280-5; LORUSSO JR, 1986, J ALLERGY CLIN IMMUN, V78, P928, DOI 10.1016/0091-6749(86)90242-3; Merritt Anne-Sophie, 2011, ISRN Allergy, V2011, P574258, DOI 10.5402/2011/574258; Mitlehner W, 2017, PNEUMOLOGIE, V71, P480, DOI 10.1055/s-0043-108137; Mitlehner W, 2015, PNEUMOLOGIE, V69, P711, DOI 10.1055/s-0034-1393396; Nicholas CE, 2011, AM J RHINOL ALLERGY, V25, P252, DOI 10.2500/ajra.2011.25.3606; Nilsson OB, 2012, ALLERGY, V67, P751, DOI 10.1111/j.1398-9995.2012.02826.x; Nilsson OB, 2014, METHODS, V66, P86, DOI 10.1016/j.ymeth.2013.09.002; Pallasaho P, 2006, CLIN EXP ALLERGY, V36, P503, DOI 10.1111/j.1365-2222.2006.02460.x; Plum S, 2013, J PROTEOMICS, V94, P202, DOI 10.1016/j.jprot.2013.07.015; Ramadour M, 2005, ALLERGY, V60, P1060, DOI 10.1111/j.1398-9995.2005.00824.x; Raulf M, 2014, ALLERGY, V69, P1280, DOI 10.1111/all.12456; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Smith W, 2011, INT ARCH ALLERGY IMM, V156, P159, DOI 10.1159/000322879; Spitzauer S, 1995, J ALLERGY CLIN IMMUN, V96, P951, DOI 10.1016/S0091-6749(95)70233-4; Tillander H, 2014, J ALLERGY CLIN IMMUN, V133, P580, DOI 10.1016/j.jaci.2013.09.009; Uriarte SA, 2016, ALLERGY, V71, P1066, DOI 10.1111/all.12917; VANDOREN G, 1983, EUR J BIOCHEM, V134, P175, DOI 10.1111/j.1432-1033.1983.tb07548.x; Vredegoor DW, 2012, J ALLERGY CLIN IMMUN, V130, P904, DOI 10.1016/j.jaci.2012.05.013; WENTZ PE, 1990, J ALLERGY CLIN IMMUN, V85, P94, DOI 10.1016/0091-6749(90)90228-V; Zahradnik E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00076; Zahradnik E, 2011, INT ARCH ALLERGY IMM, V155, P225, DOI 10.1159/000319839; ZIELONKA TM, 1994, CLIN EXP ALLERGY, V24, P1169, DOI 10.1111/j.1365-2222.1994.tb03324.x	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207871	10.1371/journal.pone.0207871	http://dx.doi.org/10.1371/journal.pone.0207871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540798	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600040
J	Zeng, X; Kirkpatrick, R; Hofmann, G; Grillot, D; Linhart, V; Viviani, F; Marino, J; Boyer, J; Graham, TL; Lu, Q; Wu, ZN; Benowitz, A; Cousins, R				Zeng, Xin; Kirkpatrick, Robert; Hofmann, Glenn; Grillot, Didier; Linhart, Valerie; Viviani, Fabrice; Marino, Joseph, Jr.; Boyer, Joseph; Graham, Taylor L.; Lu, Quinn; Wu, Zining; Benowitz, Andrew; Cousins, Rick			Screen for modulators of atonal homolog 1 gene expression using notch pathway-relevant gene transcription based cellular assays	PLOS ONE			English	Article							FALSE POSITIVES; HAIR-CELLS; INHIBITORS; GENERATION; LINES; DIFFERENTIATION; IDENTIFICATION; REGULATORS; HEARING; MATH1	Atonal homolog 1 (Atoh1) is a basic helix-loop-helix 9 (bHLH) transcription factor acting downstream of Notch and is required for the differentiation of sensory hair cells in the inner ear and the specification of secretory cells during the intestinal crypt cell regeneration. Motivated by the observations that the upregulation of Atoh1 gene expression, through genetic manipulation or pharmacological inhibition of Notch signaling (e.g. gamma-secretase inhibitors, GSIs), induces ectopic hair cell growth in the cochlea of the inner ear and partially restores hearing after injuries in experimental models, we decided to identify small molecule modulators of the Notch-Atoh1 pathway, which could potentially regenerate hair cells. However, the lack of cellular models of the inner ear has precluded the screening and characterization of such modulators. Here we report using a colon cancer cell line LS-174T, which displays Notch inhibition-dependent Atoh1 expression as a surrogate cellular model to screen for inducers of Atoh1 expression. We designed an Atoh1 promoter-driven luciferase assay to screen a target-annotated library of-6000 compounds. We further developed a medium throughput, real-time quantitative RT-PCR assay measuring the endogenous Atoh1 gene expression to confirm the hits and eliminate false positives from the reporter-based screen. This strategy allowed us to successfully recover GSIs of known chemotypes. This LS-174T cell-based assay directly measures Atoh1 gene expression induced through Notch-Hest inhibition, and therefore offers an opportunity to identify novel cellular modulators along the Notch-Atoh1 pathway.	[Zeng, Xin; Graham, Taylor L.; Lu, Quinn] GlaxoSmithKline, R&D Target Sci, Collegeville, PA 19426 USA; [Kirkpatrick, Robert; Marino, Joseph, Jr.; Benowitz, Andrew] GlaxoSmithKline, R&D Alternat Discovery & Dev, Collegeville, PA USA; [Hofmann, Glenn; Wu, Zining] GlaxoSmithKline, R&D Platform Technol Sci Drug Design & Select, Collegeville, PA USA; [Grillot, Didier; Linhart, Valerie; Viviani, Fabrice] R&D Flexible Discovery Unit, Paris, France; [Boyer, Joseph] GlaxoSmithKline, R&D Stat Sci, Collegeville, PA USA; [Cousins, Rick] GlaxoSmithKline, R&D Alternat Discovery & Dev, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Zeng, X (corresponding author), GlaxoSmithKline, R&D Target Sci, Collegeville, PA 19426 USA.; Cousins, R (corresponding author), GlaxoSmithKline, R&D Alternat Discovery & Dev, Stevenage, Herts, England.	Xin.X.Zeng@gsk.com; rck.pc.cousins@gsk.com		Kirkpatrick, Robert/0000-0002-8671-2361; Benowitz, Andrew/0000-0002-9913-605X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The funder (GlaxoSmithKline) provided support in the form of salaries for the authors [X.Z., R.K., G.H., D.G., V.L., F.V., J.M., J.B., T.G., Q.L., Z.W., A.B., R.C.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'uthor contributions' section.	Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Atkinson PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102077; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Costa A, 2015, DEVELOPMENT, V142, P1948, DOI 10.1242/dev.119149; Crisman TJ, 2007, J CHEM INF MODEL, V47, P1319, DOI 10.1021/ci6005504; Fauq AH, 2007, BIOORG MED CHEM LETT, V17, P6392, DOI 10.1016/j.bmcl.2007.07.062; Germiller JA, 2004, DEV DYNAM, V231, P815, DOI 10.1002/dvdy.20186; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hackett L, 2002, EXP CELL RES, V278, P19, DOI 10.1006/excr.2002.5574; Heitman LH, 2008, J MED CHEM, V51, P4724, DOI 10.1021/jm8004509; Helms AW, 2000, DEVELOPMENT, V127, P1185; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Lawoko-Kerali G, 2004, DEV DYNAM, V231, P801, DOI 10.1002/dvdy.20187; Liu Y, 2014, MOL BIOSYST, V10, P251, DOI 10.1039/c3mb70413k; Martone RL, 2009, J PHARMACOL EXP THER, V331, P598, DOI 10.1124/jpet.109.152975; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Nakhi A, 2012, BIOORG MED CHEM LETT, V22, P6433, DOI 10.1016/j.bmcl.2012.08.056; Ni WL, 2016, J NEUROSCI, V36, P8734, DOI 10.1523/JNEUROSCI.0060-16.2016; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Ott GR, 2008, BIOORG MED CHEM LETT, V18, P1577, DOI 10.1016/j.bmcl.2008.01.075; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Rivolta MN, 2002, GENOME RES, V12, P1091, DOI 10.1101/gr.225602; Rivolta MN, 2002, J NEUROBIOL, V53, P306, DOI 10.1002/neu.10111; Shi FX, 2010, J BIOL CHEM, V285, P392, DOI 10.1074/jbc.M109.059055; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; van Tetering G, 2011, CURR MOL MED, V11, P255, DOI 10.2174/156652411795677972; Weir J, 2000, AM J OTOL, V21, P130, DOI 10.1016/S0196-0709(00)80087-3; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xie WR, 2017, J NEUROSCI, V37, P8583, DOI 10.1523/JNEUROSCI.0295-17.2017; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Zeng X, 2016, J BIOMOL SCREEN, V21, P260, DOI 10.1177/1087057115620169; Zheng X, 2011, INFLAMM BOWEL DIS, V17, P2251, DOI 10.1002/ibd.21611	36	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207140	10.1371/journal.pone.0207140	http://dx.doi.org/10.1371/journal.pone.0207140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540745	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600007
J	Ter-Karapetyan, A; Triphan, SMF; Jobst, BJ; Anjorin, AF; Ley-Zaporozhan, J; Ley, S; Sedlaczek, O; Biederer, J; Kauczor, HU; Jakob, PM; Wielputz, MO				Ter-Karapetyan, Alvard; Triphan, Simon M. F.; Jobst, Bertram J.; Anjorin, Angela F.; Ley-Zaporozhan, Julia; Ley, Sebastian; Sedlaczek, Oliver; Biederer, Juergen; Kauczor, Hans-Ulrich; Jakob, Peter M.; Wielpuetz, Mark O.			Towards quantitative perfusion MRI of the lung in COPD: The problem of short-term repeatability	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FOURIER DECOMPOSITION; HEALTHY-VOLUNTEERS; VENTILATION; FLOW	Purpose 4D perfusion magnetic resonance imaging (MRI) with intravenous injection of contrast agent allows for a radiation-free assessment of regional lung function. It is therefore a valuable method to monitor response to treatment in patients with chronic obstructive pulmonary disease (COPD). This study was designed to evaluate its potential for monitoring short-term response to hyperoxia in COPD patients. Materials and methods 19 prospectively enrolled COPD patients (median age 66y) underwent paired dynamic contrast-enhanced 4D perfusion MRI within 35min, first breathing 100% oxygen (injection 1, O-2) and then room air (injection 2, RA), which was repeated on two consecutive days (day 1 and 2). Post-processing software was employed to calculate mean transit time (MTT), pulmonary blood volume (PBV) and pulmonary blood flow (PBF), based on the indicator dilution theory, for the automatically segmented whole lung and 12 regions of equal volume. Results Comparing O-2 with RA conditions, PBF and PBV were found to be significantly lower at O-2, consistently on both days (p<10-8). Comparing day 2 to day 1, MTT was shorter by 0.59 +/- 0.63 s (p<10-8), PBF was higher by 22 +/- 80 ml/min/100ml (p<3.10-4), and PBV tended to be lower by 0.2 +/- 7.2 ml/100ml (p = 0.159) at both, RA and O-2, conditions. Conclusion The second injection (RA) yielded higher PBF and PBV, which apparently contradicts the established hypothesis that hyperoxia increases lung perfusion. Quantification of 4D perfusion MRI by current software approaches may thus be limited by residual circulating contrast agent in the short-term and even the next day.	[Ter-Karapetyan, Alvard; Triphan, Simon M. F.; Jobst, Bertram J.; Anjorin, Angela F.; Ley-Zaporozhan, Julia; Ley, Sebastian; Sedlaczek, Oliver; Biederer, Juergen; Kauczor, Hans-Ulrich; Wielpuetz, Mark O.] Univ Hosp Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Ter-Karapetyan, Alvard; Triphan, Simon M. F.; Jobst, Bertram J.; Anjorin, Angela F.; Ley-Zaporozhan, Julia; Ley, Sebastian; Sedlaczek, Oliver; Biederer, Juergen; Kauczor, Hans-Ulrich; Wielpuetz, Mark O.] German Lung Res Ctr DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Ter-Karapetyan, Alvard; Jobst, Bertram J.; Anjorin, Angela F.; Sedlaczek, Oliver; Kauczor, Hans-Ulrich; Wielpuetz, Mark O.] Heidelberg Univ, Dept Diagnost & Intervent Radiol Nucl Med, Thoraxklin, Heidelberg, Germany; [Triphan, Simon M. F.; Jakob, Peter M.] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [Ley-Zaporozhan, Julia; Ley, Sebastian] Ludwig Maximilians Univ Hosp Munich, Inst Clin Radiol, Munich, Germany; [Ley, Sebastian] Chirurg Klinikum Munchen Sud, Diagnost & Intervent Radiol, Munich, Germany; [Biederer, Juergen] Cty Hosp Gross Gerau, Dept Radiol, Radiol Darmstadt, Gross Gerau, Germany; [Jakob, Peter M.] Julius Maximilians Univ, Dept Expt Phys, Wurzburg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg; University of Munich; University of Wurzburg	Triphan, SMF (corresponding author), Univ Hosp Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.; Triphan, SMF (corresponding author), German Lung Res Ctr DZL, Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany.; Triphan, SMF (corresponding author), Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany.	Simon.Triphan@uni-heidelberg.de	Wielpuetz, Mark/ABE-1790-2020; Kauczor, HU/AAX-6033-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Kauczor, Hans-Ulrich/AAU-5955-2021; Ley, Sebastian/I-3426-2013	Wielpuetz, Mark/0000-0001-6962-037X; Wielpütz, Mark Oliver/0000-0001-6962-037X; Ley, Sebastian/0000-0001-9269-2670	Bundesministerium fur Bildung und Forschung (BMBF) [82DZL00401, 82DZL004A1]; Competence Network on Asthma/COPD (ASCONET) through the Bundesministerium fur Bildung und Forschung (BMBF) of the federal government of Germany [01GI0870]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Competence Network on Asthma/COPD (ASCONET) through the Bundesministerium fur Bildung und Forschung (BMBF) of the federal government of Germany(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from the Bundesministerium fur Bildung und Forschung (BMBF) to the German Center for Lung Research (DZL) (82DZL00401 and 82DZL004A1). It was also supported by the Competence Network on Asthma/COPD (ASCONET) through a grant from the Bundesministerium fur Bildung und Forschung (BMBF) of the federal government of Germany 01GI0870, www.bmbf.de/en).The funders had no role in study design, data collection analysis, or manuscript preparation.	[Anonymous], 2014, MAGNEVIST PRESCRIBIN; ASHUTOSH K, 1983, AM REV RESPIR DIS, V127, P399, DOI 10.1164/arrd.1983.127.4.399; AUBIER M, 1980, AM REV RESPIR DIS, V122, P747, DOI 10.1164/arrd.1980.122.5.747; Bauman G, 2013, MAGN RESON MED, V69, P229, DOI 10.1002/mrm.24236; Bauman G, 2009, MAGN RESON MED, V62, P656, DOI 10.1002/mrm.22031; Bell LC, 2015, INVEST RADIOL, V50, P174, DOI 10.1097/RLI.0000000000000122; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Eichinger M, 2012, EUR J RADIOL, V81, P1321, DOI 10.1016/j.ejrad.2011.02.045; Hopkins SR, 2007, J APPL PHYSIOL, V103, P240, DOI 10.1152/japplphysiol.01289.2006; Hopkins SR, 2012, J APPL PHYSIOL, V113, P328, DOI 10.1152/japplphysiol.00320.2012; Incalzi RA, 2010, CHEST, V137, P831, DOI 10.1378/chest.09-1710; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137282; Jobst BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121520; Jones E., 2001, SCIPY OPEN SOURCE SC; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Kohlmann P, 2011, FULLY AUTOMATIC DETE; Kohlmann P, 2015, INT J COMPUT ASS RAD, V10, P403, DOI 10.1007/s11548-014-1090-0; Lavelle LP, 2017, DIAGN INTERV RADIOL, V23, P106, DOI 10.5152/dir.2016.15331; Ley S, 2007, INVEST RADIOL, V42, P283, DOI 10.1097/01.rli.0000258655.58753.5d; Ley-Zaporozhan J, 2011, J THORAC IMAG, V26, P230, DOI 10.1097/RTI.0b013e3181e48c36; Lynch DA, 2015, RADIOLOGY; Nikolaou K, 2004, INVEST RADIOL, V39, P537, DOI 10.1097/01.rli.0000133813.22873.47; Puderbach M, 2008, EUR RADIOL, V18, P2102, DOI 10.1007/s00330-008-0974-1; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Risse F, 2009, EUR RADIOL, V19, P2569, DOI 10.1007/s00330-009-1464-9; Roberts TPL, 1997, J MAGN RESON IMAGING, V7, P82, DOI 10.1002/jmri.1880070112; Smit HJ, 2003, CHEST, V123, P1803, DOI 10.1378/chest.123.6.1803; Stahl M, 2017, AM J RESP CRIT CARE, V195, P349, DOI 10.1164/rccm.201604-0893OC; Wielputz MO, 2016, ROFO-FORTSCHR RONTG, V188, P834, DOI 10.1055/s-0042-104936; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0; Wielputz MO, 2014, AM J RESP CRIT CARE, V189, P956, DOI 10.1164/rccm.201309-1659OC; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208587	10.1371/journal.pone.0208587	http://dx.doi.org/10.1371/journal.pone.0208587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532179	gold, Green Published			2022-12-26	WOS:000452644700032
J	Zhu, WH; Jin, X; Ni, JY; Wei, BG; Lu, ZG				Zhu, Wenhao; Jin, Xin; Ni, Jianyue; Wei, Baogang; Lu, Zhiguo			Improve word embedding using both writing and pronunciation	PLOS ONE			English	Article								Text representation can map text into a vector space for subsequent use in numerical calculations and processing tasks. Word embedding is an important component of text representation. Most existing word embedding models focus on writing and utilize context, weight, dependency, morphology, etc., to optimize the training. However, from the linguistic point of view, spoken language is a more direct expression of semantics; writing has meaning only as a recording of spoken language. Therefore, this paper proposes the concept of a pronunciation-enhanced word embedding model (PWE) that integrates speech information into training to fully apply the roles of both speech and writing to meaning. This paper uses the Chinese language, English language and Spanish language as examples and presents several models that integrate word pronunciation characteristics into word embedding. Word similarity and text classification experiments show that the PWE outperforms the baseline model that does not include speech information. Language is a storehouse of sound-images; therefore, the PWE can be applied to most languages.	[Zhu, Wenhao; Jin, Xin; Ni, Jianyue] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China; [Wei, Baogang] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Lu, Zhiguo] Shanghai Univ, Lib Shanghai Univ, Shanghai, Peoples R China	Shanghai University; Zhejiang University; Shanghai University	Lu, ZG (corresponding author), Shanghai Univ, Lib Shanghai Univ, Shanghai, Peoples R China.	luzg@staff.shu.edu.cn		lu, zhiguo/0000-0002-9044-2819	National Natural Science Foundation of China [61572434, 91630206]; Shanghai Science and Technology Committee [16DZ2293600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work is supported by National Natural Science Foundation of China (No. 61572434 and No. 91630206) and Shanghai Science and Technology Committee (No. 16DZ2293600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre Eneko, 2009, P HUMAN LANGUAGE TEC, P19; Bengio S, 2014, IEEE INT C AC SPEECH; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bloomfield L., 1933, LANGUAGE; Botha JA, 2014, PR MACH LEARN RES, V32, P1899; Bruni E, 2014, J ARTIF INTELL RES, V49, P1, DOI 10.1613/jair.4135; Camacho-Collados J, 2015, P 53 ANN M ASS COMP; Chen J, 2016, LECT NOTES ARTIF INT, V9983, P123, DOI 10.1007/978-3-319-47650-6_10; Chen XX, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P1236; Collobert R., 2008, P 25 ICML, V25, P160, DOI DOI 10.1145/1390156.1390177; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Guy Halawi, 2012, KDD; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hassan S., 2009, P C EMP METH NAT LAN; He W., 2016, ARXIV161104496; Jin P, 2013, JOINT C LEX COMP SEM, P374; Kamper H, 2016, INT CONF ACOUST SPEE, P4950, DOI 10.1109/ICASSP.2016.7472619; Le Q., 2014, 31 INT C MACH LEARN, P1188; Levin K, 2015, INT CONF ACOUST SPEE, P5828, DOI 10.1109/ICASSP.2015.7179089; Levy O, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P302, DOI 10.3115/v1/p14-2050; Martinez-Camara E., 2017, TASS 2017 WORKSH SEN; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov T, 2011, INT CONF ACOUST SPEE, P5528; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mnih A, 2008, ADV NEURAL INFORM PR, V21, P1081; Qiu L, 2014, AAAI CONF ARTIF INTE, P1572; Ryu S, 2017, PATTERN RECOGN LETT, V88, P26, DOI 10.1016/j.patrec.2017.01.008; Santos Cicero Dos, 2014, P COLING 2014 25 INT, P69; Sapir Edward, 1921, LANGUAGE INTRO STUDY; Saussure Ferdinand de, 1915, COURSE GEN LINGUISTI; Xu J., 2016, P 2016 C N AM CHAPTE, P1041; Xu Y, 2017, ARXIV170102481; Zhang JJ, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P111	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208785	10.1371/journal.pone.0208785	http://dx.doi.org/10.1371/journal.pone.0208785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532197	gold, Green Submitted, Green Published			2022-12-26	WOS:000452644700051
J	Alcantara, JA; Bernarde, PS; Sachett, J; da Silva, AM; Valente, SF; Peixote, HM; Lacerda, M; Oliveire, MR; Saraiva, I; Sampaio, VD; Monteiro, WM				Alcantara, Joao Arthur; Bernarde, Paulo Sergio; Sachett, Jacqueline; da Silva, Ageane Mota; Valente, Samara Freire; Peixote, Henry Maia; Lacerda, Marcus; Oliveire, Maria Regina; Saraiva, Ivan; Sampaio, Vanderson de Souza; Monteiro, Wuelton Marcelo			Stepping into a dangerous quagmire: Macroecological determinants of Bothrops envenomings, Brazilian Amazon	PLOS ONE			English	Article							SNAKE ASSEMBLAGE; CLINICAL-TRIAL; 2 ANTIVENOMS; ATROX; PITVIPERS; DIVERSITY; STATE	Despite significant and successful efforts in Brazil regarding snakebites in the areas of research, antivenom manufacture and quality control, training of health professionals in the diagnosis and clinical management of bites, little is known about determinants of snakebites incidence in order to further plan interventions to reduce the impact of this medical condition. Understanding the complexity of ecological interactions in a geographical region is important for prediction, prevention and control measures of snakebites. This investigation aims to describe spatial distribution and identify environmental determinants of human envenoming by lancehead pit vipers (Bothrops genus), in the Brazilian Amazon. Aggregated data by the municipality was used to analyze the spatial distribution of Bothrops bites cases and its relationship with geographic and environmental factors. Eight geo-environmental factors were included in the analysis as independent variables: (1) tree canopy loss increase; (2) area with vegetation cover; (3) area covered by water bodies; (4) altitude; (5) precipitation; (6) air relative humidity; (7) soil moisture; and (8) air temperature. Human envenoming by lancehead pit vipers (Bothrops genus) in the Amazon region is more incident in lowlands [Adjusted regression coefficient [ARC] -0.0007 (IC95%: -0.001; -0.0006), p<0.0001], with high preserved original vegetation cover [ARC 0.0065 (IC95%: 0.0071; 0.0060), p<0.0001], with heaviest rainfall [ARC 0.0001 (IC95%: 0.00009; 0.0001), p<0.0001] and higher air relative humidity [ARC 0.0082 (IC95%: 0.0108; 0.0056), p<0.0001]. This association is interpreted as the result of the higher prey availability and further abundance of pit vipers in such landscapes.	[Alcantara, Joao Arthur; Sachett, Jacqueline; Lacerda, Marcus; Sampaio, Vanderson de Souza; Monteiro, Wuelton Marcelo] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil; [Alcantara, Joao Arthur; Lacerda, Marcus; Sampaio, Vanderson de Souza; Monteiro, Wuelton Marcelo] Fundacao Med Trop Dr Heitor Vieira Dourado, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil; [Bernarde, Paulo Sergio] Univ Fed Acre, Ctr Multidisciplinar, Lab Herpetol, Campus Floresta, Cruzeiro Do Sul, AC, Brazil; [Sachett, Jacqueline] Fundacao Alfredo da Matta, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil; [da Silva, Ageane Mota] Inst Fed Acre, Campus Cruzeiro do Sul, Cruzeiro Do Sul, Acre, Brazil; [Valente, Samara Freire; Peixote, Henry Maia; Oliveire, Maria Regina] Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil; [Saraiva, Ivan] Minist Def, Ctr Gestor & Operac Sistema Protecao Amazonia, Manaus, Amazonas, Brazil; [Sampaio, Vanderson de Souza] Fundacao Vigilancia Saude Amazonas, Sala Anal Situacao Saude, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Instituto Federal do Acre (IFAC); Universidade de Brasilia	Monteiro, WM (corresponding author), Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil.; Monteiro, WM (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil.	wueltonmm@gmail.com	Bernarde, Paulo Sérgio/J-2267-2014; Sampaio, Vanderson/AAQ-1418-2020; Peixoto, Henry Maia/B-7997-2013; Sachett, Jacqueline/I-5642-2017; Sampaio, Vanderson/M-4337-2015	Sampaio, Vanderson/0000-0001-7307-8851; Peixoto, Henry Maia/0000-0001-5982-8855; Sachett, Jacqueline/0000-0001-5723-9977; Sampaio, Vanderson/0000-0001-7307-8851; Sergio Bernarde, Paulo/0000-0002-2191-7817	Capes, Procad	Capes, Procad(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Capes, Procad, to Dr. Wuelton Marcelo Monteiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernarde P.S., 2014, SERPENTES PECONHENTA; Bernarde Paulo Sergio, 2006, South American Journal of Herpetology, V1, P102, DOI 10.2994/1808-9798(2006)1[102:ASCAED]2.0.CO;2; Bernarde Paulo Sérgio, 2012, Acta Amaz., V42, P65, DOI 10.1590/S0044-59672012000100008; Borges C. C., 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P637, DOI 10.1590/S0037-86821999000600005; Butantan-British Bothrops Systematics Project, 1999, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V8, P135; Butantan-British Bothrops Systematics Project, 1999, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V8, P127; Calvete JJ, 2011, J PROTEOMICS, V74, P510, DOI 10.1016/j.jprot.2011.01.003; Campbell J.A., 1989, VENOMOUS REPTILES LA; Chen MY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009132; Chettri B, 2010, ACTA OECOL, V36, P16, DOI 10.1016/j.actao.2009.09.004; Cunha O., 1982, B MUS PAR EMILIO GOE, V112, P1; Cunha O.R., 1975, B MUS E GOELDI NOVA, V83, P1; Cunha OR, 1978, MUS EMILIO GOELDI, V83, P1; da Cunha DB, 2018, TOXICON, V146, P1, DOI 10.1016/j.toxicon.2018.03.007; de Carvalho M A, 1998, Cad Saude Publica, V14, P753, DOI 10.1590/S0102-311X1998000400017; De Fraga R, 2013, COPEIA, P684, DOI 10.1643/CE-11-098; de Fraga R, 2011, HERPETOL J, V21, P51; Dos Reis AT, 2012, RECIIS, V6, P1; Duellman WE, 1978, BIOL EQUATORIAL HERP; Egler Silvia G., 1996, Herpetological Review, V27, P22; Fan H. W, 2015, PLOS NEGLECT TROP D, V9, DOI DOI 10.1371/JOURNAL.PNTD; Fan HW, 2018, TOXICON, V151, P15, DOI 10.1016/j.toxicon.2018.06.070; Feitosa EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132237; Feitosa ES, 2015, REV SOC BRAS MED TRO, V48, P34, DOI 10.1590/0037-8682-0105-2013; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Fu CZ, 2007, BIODIVERS CONSERV, V16, P707, DOI 10.1007/s10531-005-4382-4; HEESTERBEEK JAP, 1993, J MATH BIOL, V31, P529, DOI 10.1007/BF00173891; Henderson RW, 1979, MILW PUBL MUS CONTRI, V17, P1; HOGE A R, 1978, Memorias do Instituto Butantan (Sao Paulo), V42-43, P373; HOGE A R, 1972, Memorias do Instituto Butantan (Sao Paulo), V36, P109; Hoge A.R., 1981, MEM I BUTANTAN, V42/43, P179; IBGE, 2018, CAR GER POP RES AM; IBGE, 2013, ATL CENS DEM 2010; Instituto Nacional de Pesquisas Espaciais, 2013, PROJ PRODES MET CALC; Jacob-Ferreira AL, 2016, TOXICON, V109, P18, DOI 10.1016/j.toxicon.2015.11.002; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kjoss VA, 2001, BIOL CONSERV, V98, P285, DOI 10.1016/S0006-3207(00)00167-1; Levins R, 1999, INT J HEALTH SERV, V29, P261, DOI 10.2190/WLVK-D0RR-KVBV-A1DH; LEVINS R, 1995, TRENDS ECOL EVOL, V10, P304, DOI 10.1016/0169-5347(95)90043-8; Lopez-Lozano JL, 2002, TOXICON, V40, P997, DOI 10.1016/S0041-0101(02)00096-X; Macedo-Bernarde L. C., 2005, DIET HERPETOL REV, V36, P456; Marques Otavio A. M., 1996, Amphibia-Reptilia, V17, P277, DOI 10.1163/156853896X00441; Martins M, 2001, J ZOOL, V254, P529, DOI 10.1017/S0952836901001030; Martins M., 1993, DIET HERPETOL REV, V24, P2; Martins M., 1999, HERPETOLOGICAL NATUR, V2, P78; Martins Marcio, 2002, P307; Nascimento Pablo Fachin, 2008, Herpetological Review, V39, P353; Nascimento S P, 2000, Cad Saude Publica, V16, P271, DOI 10.1590/S0102-311X2000000100031; Oliveira M. E., 2003, PREY HERPETOL REV, V34, P61; Oliveira M. Ermelinda, 2001, Herpetological Natural History, V8, P101; Otero R, 1996, T ROY SOC TROP MED H, V90, P696, DOI 10.1016/S0035-9203(96)90442-3; Pardal PPD, 2004, T ROY SOC TROP MED H, V98, P28, DOI 10.1016/S0035-9203(03)00005-1; Parkinson CL, 1999, COPEIA, P576, DOI 10.2307/1447591; RAO VB, 1990, THEOR APPL CLIMATOL, V42, P81, DOI 10.1007/BF00868215; Sachett JAG, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005745; Salomao MDG, 1997, DNA EVOLUTION S AM P; SAZIMA I, 1988, Memorias do Instituto Butantan (Sao Paulo), V50, P83; SAZIMA I, 1995, ECOLOGIA PRESERVACAO, P78; Sazima Ivan, 1992, P199; STRUSSMANN C, 1993, STUD NEOTROP FAUNA E, V28, P157, DOI 10.1080/01650529309360900; Turci Luiz Carlos Batista, 2009, Biota Neotrop., V9, P197, DOI 10.1590/S1676-06032009000300020; WHO, 2006, COMM DIS SURV RESP S	62	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208532	10.1371/journal.pone.0208532	http://dx.doi.org/10.1371/journal.pone.0208532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521617	gold, Green Published, Green Submitted			2022-12-26	WOS:000452307600087
J	Pamenter, ME; Lau, GY; Richards, JG				Pamenter, Matthew E.; Lau, Gigi Y.; Richards, Jeffrey G.			Effects of cold on murine brain mitochondrial function	PLOS ONE			English	Article							HYPOTHERMIA; HYPOXIA; ANOXIA; INJURY; SUPPRESSION; TOLERANCE; RESISTANT; RESPONSES; MICE	Therapeutic hypothermia is a strategy that reduces metabolic rate and brain damage during clinically-relevant hypoxic events. Mitochondrial respiration is compromised by hypoxia, with deleterious consequences for the mammalian brain; however, little is known about the effects of reduced temperature on mitochondrial metabolism. Therefore, we examined how mitochondrial function is impacted by temperature using high resolution respirometry to assess electron transport system (ETS) function in saponin-permeabilized mouse brain at 28 and 37 degrees C. Respirometric analysis revealed that, at the colder temperature, ETS respiratory flux was similar to 40-75% lower relative to the physiological temperature in all respiratory states and for all fuel substrates tested. In whole brain tissue, the enzyme maximum respiratory rates for complexes I-V were similarly reduced by between 37-88%. Complexes II and V were particularly temperature-sensitive; a temperature-mediated decrease in complex II activity may support a switch to complex I mediated ATP-production, which is considerably more oxygen-efficient. Finally, the mitochondrial H+-gradient was more tightly coupled, indicating that mitochondrial respiration is more efficient at the colder temperature. Taken together, our results suggest that improvements in mitochondrial function with colder temperatures may contribute to energy conservation and enhance cellular viability in hypoxic brain.	[Pamenter, Matthew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Pamenter, Matthew E.] Ottawa Brain & Mind Res Inst, Ottawa, ON, Canada; [Lau, Gigi Y.; Richards, Jeffrey G.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of Ottawa; University of British Columbia	Pamenter, ME (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.; Pamenter, ME (corresponding author), Ottawa Brain & Mind Res Inst, Ottawa, ON, Canada.	mpamenter@uottawa.ca	Pamenter, Matt/R-9216-2019	Pamenter, Matt/0000-0003-4035-9555	NSERC Discovery grant; NSERC CGS; Parker B Francis PDF	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parker B Francis PDF	This work was supported by a NSERC Discovery grant to JGR, a Parker B Francis PDF to MEP, and an NSERC CGS to GYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036801; Barksdale KA, 2010, FASEB J, V24, P3590, DOI 10.1096/fj.09-152108; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Bogdanov NN, 1999, B EXP BIOL MED+, V128, P1100, DOI 10.1007/BF02433410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buck LT, 2006, RESP PHYSIOL NEUROBI, V154, P226, DOI 10.1016/j.resp.2006.03.004; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chretien D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003992; Cramer NP, 2015, PHYSIOL BEHAV, V143, P158, DOI 10.1016/j.physbeh.2015.01.036; Galli GLJ, 2013, J EXP BIOL, V216, P3283, DOI 10.1242/jeb.087155; Ghosh S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15002-7; Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Hogg DW, 2015, J PHYSIOL-LONDON, V593, P2311, DOI 10.1113/JP270474; Ilacqua AN, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0545; Koo E, 2017, PEDIATR RES, V82, P518, DOI 10.1038/pr.2017.75; Kuter N, 2018, NEONATOLOGY, V113, P360, DOI 10.1159/000487221; Larson J, 2014, J EXP BIOL, V217, P1024, DOI 10.1242/jeb.085381; Liu BJ, 2017, BRAIN RES, V1672, P18, DOI 10.1016/j.brainres.2017.07.008; Marcinkeviciute  A, 2000, BIOCHEM J, V349, P519, DOI 10.1042/0264-6021:3490519; McFarlane SV, 2017, AM J PHYSIOL-REG I, V312, pR434, DOI 10.1152/ajpregu.00316.2016; Muleme HM, 2006, PHYSIOL BIOCHEM ZOOL, V79, P474, DOI 10.1086/501053; Nakayama S, 2017, NEUROCRIT CARE; Pamenter ME, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.171397; Pamenter ME, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0797; Pamenter ME, 2014, CAN J ZOOL, V92, P569, DOI 10.1139/cjz-2013-0247; Pamenter ME, 2012, BRAIN RES, V1452, P165, DOI 10.1016/j.brainres.2012.03.004; Pamenter ME, 2007, FASEB J, V21, pA594; Pamenter ME, 2007, J COMP PHYSIOL B, V177, P473, DOI 10.1007/s00360-007-0145-8; Pamenter ME, 2012, J CEREBR BLOOD F MET, V32, P2033, DOI 10.1038/jcbfm.2012.103; Peterson BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031568; ROTTENBERG H, 1984, J MEMBRANE BIOL, V81, P127, DOI 10.1007/BF01868977; St-Pierre J, 2000, P NATL ACAD SCI USA, V97, P8670, DOI 10.1073/pnas.140093597; Tong G, 2017, NEUROSCIENCE, V358, P201, DOI 10.1016/j.neuroscience.2017.06.055; West JB, 2006, INTEGR COMP BIOL, V46, P25, DOI 10.1093/icb/icj005	36	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208453	10.1371/journal.pone.0208453	http://dx.doi.org/10.1371/journal.pone.0208453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521596	gold, Green Published, Green Submitted			2022-12-26	WOS:000452307600071
J	Nayeri, UA; Buhimschi, CS; Zhao, GM; Buhimschi, IA; Bhandari, V				Nayeri, Unzila Ali; Buhimschi, Catalin S.; Zhao, Guomao; Buhimschi, Irina A.; Bhandari, Vineet			Components of the antepartum, intrapartum, and postpartum exposome impact on distinct short-term adverse neonatal outcomes of premature infants: A prospective cohort study	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; PRETERM BIRTH; AMNIOTIC-FLUID; CEREBRAL-PALSY; RISK-FACTORS; NEURODEVELOPMENTAL OUTCOMES; NECROTIZING ENTEROCOLITIS; INTRAUTERINE INFLAMMATION; OXYGEN-SATURATION; NATIONAL COHORT	We aimed to test the hypothesis that determinants of the perinatal clinical exposome related to the underlying etiology of premature birth (PTB) impact differently on select neonatal outcomes. We conducted a prospective longitudinal study of 377 singleton preterm neonates [gestational age (GA) at birth: 23-34 weeks] separated into three distinct contemporaneous newborn cohorts: i) spontaneous PTB in the setting of intra-amniotic infection/inflammation (yes-IAI, n = 116); ii) spontaneous PTB in the absence of IAI (no-IAI, n = 130), and iii) iatrogenic PTB for preeclampsia (iPTB-PE, n = 131). Newborns (n = 372) were followed until death or discharge. Amniotic fluid defensins 1&2 and calgranulins A&C were used as biomarkers of IAI. An algorithm considering cord blood interleukin-6 (IL-6) and haptoglobin (Hp switch-on) was used to assess fetal exposure to IAI. lntraventricular hemorrhage (IVH), penventricular leukomalacia (PVL), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), early-onset neonatal (EONS) and late-onset (LOS) sepsis, death. Independent risk factors for adverse outcomes were: i) IVH (n = 53): histologic chorioamnionitis, GA, fetal growth restriction, male sex, Hp switch-on; ii) PVL (n = 11): cord blood IL-6; iii) NEC (n = 25), GA; iv) BPD (n = 53): ventilator support, need for surfactant, GA; v) ROP (n = 79): ventilator support, Hp switch-on, GA; vi) fetal and neonatal death (n = 31): GA, amniotic fluid IL-6; vii) suspect EONS (n = 92): GA, Hp switch-on; viii) LOS (n = 81): GA. Our findings are applicable to pregnancies delivered between 23 and 34 weeks' gestation in the setting of IAI and PE, and suggest that GA and inflammatory intrauterine environment play key roles in occurrence of IVH, PVL, ROP, death, EONS and LOS. Postnatal determinants seem to play major role in NEC and BPD.	[Nayeri, Unzila Ali; Buhimschi, Catalin S.; Zhao, Guomao; Buhimschi, Irina A.; Bhandari, Vineet] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Nayeri, Unzila Ali] Univ Miami Hlth Syst, Dept Obstet & Gynecol, Div Maternal Fetal Med, Miami, FL USA; [Buhimschi, Catalin S.; Buhimschi, Irina A.] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Buhimschi, Catalin S.; Zhao, Guomao; Buhimschi, Irina A.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Perinatal Res, Columbus, OH 43210 USA; [Buhimschi, Catalin S.; Zhao, Guomao; Buhimschi, Irina A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Bhandari, Vineet] Drexel Univ, Coll Med, Dept Pediat, Philadelphia, PA 19104 USA	Yale University; Yale University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Drexel University	Buhimschi, CS (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.; Buhimschi, CS (corresponding author), Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA.; Buhimschi, CS (corresponding author), Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Perinatal Res, Columbus, OH 43210 USA.; Buhimschi, CS (corresponding author), Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA.	catalin.buhimschi@nationwidechildrens.org	Bhandari, Vineet/AAS-3365-2020; Buhimschi, Irina/AAY-6619-2021	Buhimschi, Irina/0000-0002-1701-1326	National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD062007, R01HD047321]	National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (https://www.nichd.nih.gov/) R01HD062007 (CSB&IAB) and R01HD047321 (IAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang AA, 2017, TRANSL STROKE RES, V8, P461, DOI 10.1007/s12975-017-0539-1; Allendorf A, 2018, J PEDIATR SURG, V53, P1573, DOI 10.1016/j.jpedsurg.2018.01.006; American College of Obstetricians and Gynecologists Committee on Practice BulletinsObstetrics, 2016, Obstet Gynecol, V128, pe165, DOI 10.1097/AOG.0000000000001712; [Anonymous], 2014, Obstet Gynecol, V124, P863, DOI 10.1097/01.AOG.0000454932.15177.be; Aranda JV, 2017, PEDIATR CLIN N AM, V64, P1327, DOI 10.1016/j.pcl.2017.08.009; Archabald KL, 2017, FETAL DIAGN THER, V42, P99, DOI 10.1159/000450997; Babnik J, 2006, BIOL NEONATE, V90, P113, DOI 10.1159/000092070; Bastek JA, 2010, AM J PERINAT, V27, P163, DOI 10.1055/s-0029-1234036; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; Bizzarro MJ, 2006, PEDIATRICS, V118, P1858, DOI 10.1542/peds.2006-1088; Bizzarro MJ, 2011, J PEDIATR-US, V158, P234, DOI 10.1016/j.jpeds.2010.07.060; Buhimschi C, 2015, AM J OBSTET GYNECOL, V212, pS86, DOI 10.1016/j.ajog.2014.10.185; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026111; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Buhimschi IA, 2012, SEMIN FETAL NEONAT M, V17, P36, DOI 10.1016/j.siny.2011.10.002; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Committee on Practice Bulletins-Obstetrics, 2012, AM COLL OBST GYN PRA, V120, P964; Costantine MM, 2007, AM J OBSTET GYNECOL, V196, pE6, DOI 10.1016/j.ajog.2007.01.009; Cuna A, 2017, SEMIN PERINATOL, V41, P61, DOI 10.1053/j.semperi.2016.09.019; Dulay AT, 2015, CYTOKINE, V76, P236, DOI 10.1016/j.cyto.2015.04.014; Farstad T, 2011, ACTA PAEDIATR, V100, P53, DOI 10.1111/j.1651-2227.2010.01959.x; Ghidini A, 2000, OBSTET GYNECOL, V96, P201, DOI 10.1016/S0029-7844(00)00908-X; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Good M, 2012, P NATL ACAD SCI USA, V109, P11330, DOI 10.1073/pnas.1200856109; Hackam D, 2018, SEMIN PEDIATR SURG, V27, P11, DOI 10.1053/j.sempedsurg.2017.11.003; Hellstrom A, 2018, ACTA PAEDIATR, V107, P811, DOI 10.1111/apa.14206; Higgins RD, 2016, OBSTET GYNECOL, V127, P426, DOI 10.1097/AOG.0000000000001246; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Karna Padmani, 2005, BMC Pediatr, V5, P18, DOI 10.1186/1471-2431-5-18; Keogh JM, 2006, CURR OPIN NEUROL, V19, P129, DOI 10.1097/01.wco.0000218227.35560.0d; Kim T, 2004, PAEDIATR PERINAT EP, V18, P130, DOI 10.1111/j.1365-3016.2003.00545.x; Klebanoff M, 2016, PAEDIATR PERINAT EP, V30, P134, DOI 10.1111/ppe.12267; Klinger G, 2010, PEDIATRICS, V125, pE736, DOI 10.1542/peds.2009-2017; Lavoie PM, 2008, PEDIATRICS, V122, P479, DOI 10.1542/peds.2007-2313; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee J, 2012, SEMIN FETAL NEONAT M, V17, P26, DOI 10.1016/j.siny.2011.08.007; LEVITON A, 1993, DEV MED CHILD NEUROL, V35, P553; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luu TM, 2009, PEDIATRICS, V123, P1037, DOI 10.1542/peds.2008-1162; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Mackay DF, 2013, BJOG-INT J OBSTET GY, V120, P297, DOI 10.1111/1471-0528.12071; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Majnemer A, 2000, DEV MED CHILD NEUROL, V42, P53; Manuck TA, 2016, AM J OBSTET GYNECOL, V215, DOI [10.1016/j.ajog.2016.01.004, DOI 10.1016/J.AJ0G.2016.01.004]; Marchant EA, 2015, PEDIATR RES, V78, P492, DOI 10.1038/pr.2015.132; Marins L. R., 2017, J MATERN-FETAL NEO M, V20, P1, DOI [10.1080/14767058.2017.1401996, DOI 10.1080/14767058.2017.1401996]; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Ment LR, 2014, PEDIATR RES, V75, P241, DOI 10.1038/pr.2013.195; Ment LR, 2002, NEUROLOGY, V58, P1726, DOI 10.1212/WNL.58.12.1726; Moscuzza F, 2011, GYNECOL ENDOCRINOL, V27, P319, DOI 10.3109/09513590.2010.487619; Msall ME, 2004, JAMA-J AM MED ASSOC, V292, P2399, DOI 10.1001/jama.292.19.2399; Mukerji A, 2015, PEDIATRICS, V136, P1132, DOI 10.1542/peds.2015-0944; O'Shea TM, 2008, PEDIATRICS, V122, pE662, DOI 10.1542/peds.2008-0594; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; PATZ A, 1984, PEDIATRICS, V74, P160; Ratanasopa K, 2013, ANTIOXID REDOX SIGN, V18, P2364, DOI 10.1089/ars.2012.4878; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Rodriguez-Trujillo A, 2016, ACTA OBSTET GYN SCAN, V95, P926, DOI 10.1111/aogs.12905; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Shah VA, 2005, ANN ACAD MED SINGAP, V34, P169; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Stafford IA, 2018, EUR J OBSTET GYN R B, V223, P93, DOI 10.1016/j.ejogrb.2018.02.024; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Thekkeveedu RK, 2017, RESP MED, V132, P170, DOI 10.1016/j.rmed.2017.10.014; Thome UH, 2018, NEONATOLOGY, V113, P221, DOI 10.1159/000485828; Tseng CF, 2004, PROTEOMICS, V4, P2221, DOI 10.1002/pmic.200300787; Vadlapatla RK, 2013, CURR DRUG TARGETS, V14, P919, DOI 10.2174/13894501113149990015; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]; Zhao XR, 2011, ACTA NEUROCHIR SUPPL, V111, P107, DOI 10.1007/978-3-7091-0693-8_17	77	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207298	10.1371/journal.pone.0207298	http://dx.doi.org/10.1371/journal.pone.0207298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517142	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400030
J	Pan, WW; Moroishi, T; Koo, JH; Guan, KL				Pan, Wei-Wei; Moroishi, Toshiro; Koo, Ja Hyun; Guan, Kun-Liang			Cell type-dependent function of LATS1/2 in cancer cell growth	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PATHWAY; ORGAN SIZE CONTROL; HIPPO PATHWAY; TEAD/TEF FAMILY; YAP; GENE; INACTIVATION; INHIBITION; YAP/TAZ; ROLES	The Hippo pathway controls organ size and tissue homeostasis, and its dysregulation often contributes to tumorigenesis. Extensive studies have shown that the Hippo pathway inhibits cell proliferation, and survival in a cell-autonomous manner. We examined the function of the Hippo pathway kinases LATS1/2 (large tumor suppressor 1 and 2) in cancer cells. As expected, loss of LATS1/2 promotes cancer cell growth in most cell lines. Surprisingly, however, LATS1/2 deletion inhibits the growth of murine MC38 colon cancer cells, especially under detachment conditions. This growth inhibitory effect caused by LATS1/2 deletion is due to uncontrolled activation of Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ), the key downstream transcriptional coactivators inhibited by LATS1/2. We identified Wnt inducible signaling pathway protein 2 (Wisp2) and coiled-coil domain containing 80 (Ccdc80) as direct targets of YAP/TAZ. Their expression is selectively induced by LATS1/2 deletion in MC38 cells. Furthermore, deletion of WISP2 and CCDC80 prevents the growth inhibitory effect of LATS1/2 loss in MC38 cells. Our study demonstrates that the function of LATS1/2 in cell growth is cell context dependent, suggesting that LATS1/2 inhibition can be a therapeutic approach for some cancer types.	[Pan, Wei-Wei; Moroishi, Toshiro; Koo, Ja Hyun; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Pan, Wei-Wei; Moroishi, Toshiro; Koo, Ja Hyun; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Pan, Wei-Wei] Jiaxing Univ, Sch Med, Jiaxing 314001, Peoples R China; [Moroishi, Toshiro] Kumamoto Univ, Fac Life Sci, Dept Mol Enzymol, Kumamoto 8608556, Japan; [Moroishi, Toshiro] Kumamoto Univ, Fac Life Sci, Ctr Metab Regulat Hlth Aging, Kumamoto 8608556, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Jiaxing University; Kumamoto University; Kumamoto University	Pan, WW; Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Pan, WW; Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.; Pan, WW (corresponding author), Jiaxing Univ, Sch Med, Jiaxing 314001, Peoples R China.	aidspan@163.com; kuguan@ucsd.edu	Koo, Ja Hyun/GQP-5440-2022; Guan, Kun-Liang/ADK-7088-2022	Koo, Ja Hyun/0000-0001-5738-1105; Moroishi, Toshiro/0000-0001-6419-3882	National Institutes of Health [CA196878, CA217642, GM51586]; National Natural Science Foundation of China [31871402, 81402162]; Natural Science Foundation of Zhejiang Province [LY17H160060]; NATIONAL CANCER INSTITUTE [R01CA217642, R35CA196878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Zhipeng Meng, Rui Chen, Shenghong Ma, Zhengming Wu, Kimberly C, Lin and Min Luo for technical assistance; JiaYu Chen and Xiangdong Fu for help in bioinformatics analysis. This work was supported by grants from the National Institutes of Health (CA196878, CA217642, and GM51586) to K.L.G. This study was supported by grants from National Natural Science Foundation of China (31871402, 81402162), and the Natural Science Foundation of Zhejiang Province (LY17H160060) to W.W.P.	Baia GS, 2012, MOL CANCER RES, V10, P904, DOI 10.1158/1541-7786.MCR-12-0116; Barreto SC, 2016, J BUON, V21, P1359; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bommer GT, 2005, J BIOL CHEM, V280, P7962, DOI 10.1074/jbc.M412593200; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; Dhar G, 2008, CANCER RES, V68, P4580, DOI 10.1158/0008-5472.CAN-08-0316; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ferraro A, 2013, J CLIN ENDOCR METAB, V98, P2834, DOI 10.1210/jc.2012-2926; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Herbst A, 2011, ONCOL LETT, V2, P981, DOI 10.3892/ol.2011.356; Huang HY, 2017, CANCER RES, V77, P5769, DOI 10.1158/0008-5472.CAN-17-0449; Ji JF, 2015, BRIT J CANCER, V113, P921, DOI 10.1038/bjc.2015.285; Jiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14058; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Oh JE, 2015, J NEUROPATH EXP NEUR, V74, P952, DOI 10.1097/NEN.0000000000000238; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Wang Z, 2017, CANCER RES, V77, P2413, DOI 10.1158/0008-5472.CAN-16-3229; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	39	20	22	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2595	2610		10.1038/s41388-018-0610-8	http://dx.doi.org/10.1038/s41388-018-0610-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30531839	Green Accepted, Green Submitted			2022-12-26	WOS:000463335200011
J	Chen, L; Liu, QH; Tang, Q; Kuang, JY; Li, H; Pu, SY; Wu, T; Yang, XP; Li, R; Zhang, JH; Zhang, ZJ; Huang, Y; Li, YP; Zou, M; Jiang, W; Li, T; Gong, M; Zhang, L; Wang, H; Qu, AJ; Xie, W; He, JH				Chen, Lei; Liu, Qinhui; Tang, Qin; Kuang, Jiangying; Li, Hong; Pu, Shiyun; Wu, Tong; Yang, Xuping; Li, Rui; Zhang, Jinhang; Zhang, Zijing; Huang, Ya; Li, Yanping; Zou, Min; Jiang, Wei; Li, Tao; Gong, Meng; Zhang, Lu; Wang, Hua; Qu, Aijuan; Xie, Wen; He, Jinhan			Hepatocyte-specific Sirt6 deficiency impairs ketogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; liver; liver metabolism; lipogenesis; lipid metabolism; lipid droplet; lipid; metabolic disease; transcription regulation	ACTIVATED RECEPTOR-ALPHA; FATTY-ACID OXIDATION; ELEMENT-BINDING PROTEIN; TRANSCRIPTION FACTOR; HEPATIC STEATOSIS; KETONE-BODIES; CREBH; LIPOLYSIS; FSP27; INFLAMMATION	Sirt6 is an NADH (NAD(+))-dependent deacetylase with a critical role in hepatic lipid metabolism. Ketogenesis is controlled by a signaling network of hepatic lipid metabolism. However, how Sirt6 functions in ketogenesis remains unclear. Here, we demonstrated that Sirt6 functions as a mediator of ketogenesis in response to a fasting and ketogenic diet (KD). The KD-fed hepatocyte-specific Sirt6 deficiency (HKO) mice exhibited impaired ketogenesis, which was due to enhanced Fsp27 (fat-specific induction of protein 27), a protein known to regulate lipid metabolism. In contrast, overexpression of Sirt6 in mouse primary hepatocytes promoted ketogenesis. Mechanistically, Sirt6 repressed Fsp27 beta expression by interacting with Crebh (cAMP response element-binding protein H) and preventing its recruitment to the Fsp27 beta gene promoter. The KD-fed HKO mice also showed exacerbated hepatic steatosis and inflammation. Finally, Fsp27 silencing rescued hypoketonemia and other metabolic phenotypes in KD-fed HKO mice. Our data suggest that the Sirt6-Crebh-Fsp27 axis is pivotal for hepatic lipid metabolism and inflammation. Sirt6 may be a pharmacological target to remedy metabolic diseases.	[Chen, Lei; Tang, Qin; Kuang, Jiangying; Li, Hong; Pu, Shiyun; Wu, Tong; Yang, Xuping; Li, Rui; Zhang, Jinhang; Zhang, Zijing; Huang, Ya; Li, Yanping; Zou, Min; He, Jinhan] Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Sichuan, Peoples R China; [Chen, Lei; Liu, Qinhui; Tang, Qin; Kuang, Jiangying; Li, Hong; Pu, Shiyun; Wu, Tong; Yang, Xuping; Li, Rui; Zhang, Jinhang; Zhang, Zijing; Huang, Ya; Li, Yanping; He, Jinhan] Sichuan Univ, West China Hosp, Lab Clin Pharm & Adverse Drug React, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Jiang, Wei] Sichuan Univ, West China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao; Gong, Meng; Zhang, Lu] Sichuan Univ, West China Hosp, West China Washington Mitochondria & Metab Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao; Gong, Meng; Zhang, Lu] Sichuan Univ, West China Hosp, Lab Anesthesiol, Chengdu 610041, Sichuan, Peoples R China; [Wang, Hua] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei 230022, Anhui, Peoples R China; [Qu, Aijuan] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100069, Peoples R China; [Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA; [Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Anhui Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA.; Xie, W (corresponding author), Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA.; He, JH (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.; He, JH (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China.; He, JH (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.	wex6@pitt.edu; jinhanhe@scu.edu.cn	Gong, Meng/AAQ-9126-2021; li, yan/GTI-4638-2022; Li, Tao/ADA-1377-2022; Xie, Wen/M-1768-2016	Gong, Meng/0000-0002-1203-5820; 	National Natural Science Foundation of China [81471068, 81603035]; Young Scientist Fellowship of Sichuan University [2017SCU11026]; Postdoctoral Fellowship of Sichuan University [2017SCU12036]; China Postdoctoral Fellowship [2017M612981]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scientist Fellowship of Sichuan University; Postdoctoral Fellowship of Sichuan University; China Postdoctoral Fellowship	This work was supported by National Natural Science Foundation of China Grants 81471068 and 81603035, China Postdoctoral Fellowship 2017M612981, Young Scientist Fellowship of Sichuan University 2017SCU11026, and Postdoctoral Fellowship of Sichuan University 2017SCU12036. The authors declare that they have no conflicts of interest with the contents of this article.	Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Cheng SH, 2017, AM J PATHOL, V187, P808, DOI 10.1016/j.ajpath.2016.12.013; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; d'Avignon DA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99762; Elhanati S, 2013, CELL REP, V4, P905, DOI 10.1016/j.celrep.2013.08.006; Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukao T, 2014, J INHERIT METAB DIS, V37, P541, DOI 10.1007/s10545-014-9704-9; Grabacka M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122093; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; He JH, 2015, METABOLISM, V64, P826, DOI 10.1016/j.metabol.2015.02.005; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Ka SO, 2017, FASEB J, V31, P3999, DOI 10.1096/fj.201700098RR; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim H, 2015, MOL CELL BIOL, V35, P4121, DOI 10.1128/MCB.00665-15; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Kuang JY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00135; Kuang JY, 2017, DIABETES, V66, P1159, DOI 10.2337/db16-1225; Langhi C, 2015, HEPATOLOGY, V61, P1227, DOI 10.1002/hep.27607; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Meex RCR, 2009, AM J PHYSIOL-REG I, V297, pR913, DOI 10.1152/ajpregu.91053.2008; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Puri V, 2008, J CLIN INVEST, V118, P2693, DOI 10.1172/JCI36554; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiao Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869186; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Wang M, 2016, MOL MED REP, V13, P1455, DOI 10.3892/mmr.2015.4749; Wang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072315; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4617; Xiao CY, 2012, J BIOL CHEM, V287, P41903, DOI 10.1074/jbc.M112.415182; Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Yoo H, 2004, J LIPID RES, V45, P1324, DOI 10.1194/jlr.M400031-JLR200; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zheng Z, 2011, METHOD ENZYMOL, V489, P329, DOI 10.1016/B978-0-12-385116-1.00019-4	51	12	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1579	1589		10.1074/jbc.RA118.005309	http://dx.doi.org/10.1074/jbc.RA118.005309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30530497	Green Published, hybrid			2022-12-26	WOS:000457879200013
J	Wasserman, SS; Shteiman-Kotler, A; Harris, K; Iliadi, KG; Persaud, A; Zhong, Y; Zhang, Y; Fang, XD; Boulianne, GL; Stewart, B; Rotin, D				Wasserman, Samantha S.; Shteiman-Kotler, Alina; Harris, Kathryn; Iliadi, Konstantin G.; Persaud, Avinash; Zhong, Yvonne; Zhang, Yi; Fang, Xuedong; Boulianne, Gabrielle L.; Stewart, Bryan; Rotin, Daniela			Regulation of SH3PX1 by dNedd4-long at the Drosophila neuromuscular junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; sorting nexin (SNX); synapse; ubiquitin; protein degradation	SORTING NEXIN; AXONAL GUIDANCE; C2 DOMAIN; NEDD4; ENDOCYTOSIS; SUBSTRATE; PROTEINS; DSH3PX1; FAMILY	Drosophila Nedd4 (dNedd4) is a HECT E3 ubiquitin ligase present in two major isoforms: short (dNedd4S) and long (dNedd4Lo), with the latter containing two unique regions (N terminus and Middle). Although dNedd4S promotes neuromuscular synaptogenesis (NMS), dNedd4Lo inhibits it and impairs larval locomotion. To explain how dNedd4Lo inhibits NMS, MS analysis was performed to find its binding partners and identified SH3PX1, which binds dNedd4Lo unique Middle region. SH3PX1 contains SH3, PX, and BAR domains and is present at neuromuscular junctions, where it regulates active zone ultrastructure and presynaptic neurotransmitter release. Here, we demonstrate direct binding of SH3PX1 to the dNedd4Lo Middle region (which contains a Pro-rich sequence) in vitro and in cells, via the SH3PX1-SH3 domain. In Drosophila S2 cells, dNedd4Lo overexpression reduces SH3PX1 levels at the cell periphery. In vivo overexpression of dNedd4Lo post-synaptically, but not pre-synaptically, reduces SH3PX1 levels at the subsynaptic reticulum and impairs neurotransmitter release. Unexpectedly, larvae that overexpress dNedd4Lo post-synaptically and are heterozygous for a null mutation in SH3PX1 display increased neurotransmission compared with dNedd4Lo or SH3PX1 mutant larvae alone, suggesting a compensatory effect from the remaining SH3PX1 allele. These results suggest a post-synaptic-specific regulation of SH3PX1 by dNedd4Lo.	[Wasserman, Samantha S.; Shteiman-Kotler, Alina; Iliadi, Konstantin G.; Persaud, Avinash; Zhong, Yvonne; Boulianne, Gabrielle L.; Rotin, Daniela] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Wasserman, Samantha S.; Shteiman-Kotler, Alina; Iliadi, Konstantin G.; Persaud, Avinash; Zhong, Yvonne; Boulianne, Gabrielle L.; Rotin, Daniela] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Wasserman, Samantha S.; Shteiman-Kotler, Alina; Zhong, Yvonne; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada; [Harris, Kathryn; Stewart, Bryan] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5G 0A4, Canada; [Boulianne, Gabrielle L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada; [Zhang, Yi; Fang, Xuedong] Jilin Univ, Dept Gastrointestinal Surg, Changchun 130033, Jilin, Peoples R China	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Jilin University	Rotin, D (corresponding author), Hosp Sick Children, PGCRL 19-9715,686 Bay St, Toronto, ON M5G 0A4, Canada.	drotin@sickkids.ca		Harris, Kathryn/0000-0003-1769-2587; Zhong, Yunan/0000-0001-9008-5893; Boulianne, Gabrielle/0000-0002-2964-2344; Stewart, Bryan/0000-0003-2520-3632	Ontario Graduate Scholarship; NSERC [RGPIN-201706475, RGPIN 250078-12, RGPIN05229, RGPAS462171]; RESTRA-COMP studentship	Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); RESTRA-COMP studentship	This work was supported by a Ontario Graduate Scholarship and RESTRA-COMP studentship (to S. W.), and NSERC Discovery Grants RGPIN-201706475 (to D. R.), RGPIN 250078-12 (to B. S.), and RGPIN05229 and RGPAS462171 (to G. L. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Baumann C, 2010, FEBS J, V277, P2803, DOI 10.1111/j.1742-4658.2010.07698.x; Brent Jonathan R, 2009, J Vis Exp, DOI 10.3791/1107; BROADIE KS, 1993, J NEUROSCI, V13, P144; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Frank CA, 2014, NEUROPHARMACOLOGY, V78, P63, DOI 10.1016/j.neuropharm.2013.06.015; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hicks L, 2015, BIOL OPEN, V4, P1448, DOI 10.1242/bio.013755; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Safi F, 2016, MOL BIOL CELL, V27, P907, DOI 10.1091/mbc.E15-06-0420; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Shin N, 2007, J BIOL CHEM, V282, P28939, DOI 10.1074/jbc.M700283200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Ukken FP, 2016, J CELL SCI, V129, P166, DOI 10.1242/jcs.178699; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Worby CA, 2002, J BIOL CHEM, V277, P9422, DOI 10.1074/jbc.M110172200; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhong YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027007	33	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1739	1752		10.1074/jbc.RA118.005161	http://dx.doi.org/10.1074/jbc.RA118.005161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30518551	Green Published, hybrid			2022-12-26	WOS:000457879200034
J	Ghosh, DK; Kokane, SB; Kokane, AD; Warghane, AJ; Motghare, MR; Bhose, S; Sharma, AK; Reddy, MK				Ghosh, Dilip Kumar; Kokane, Sunil B.; Kokane, Amol D.; Warghane, Ashish J.; Motghare, Manali R.; Bhose, Sumit; Sharma, Ashwani Kumar; Reddy, M. Krishna			Development of a recombinase polymerase based isothermal amplification combined with lateral flow assay (HLB-RPA-LFA) for rapid detection of "Candidatus Liberibacter asiaticus"	PLOS ONE			English	Article							CITRUS GREENING DISEASE; REAL-TIME PCR; ORGANISM; IDENTIFICATION; DIAGNOSIS; PLANTS	Huanglongbing (HLB) or citrus greening is highly destructive disease that is affecting the citrus industry worldwide and it has killed millions of citrus plants globally. HLB is caused by the phloem limited, Gram negative, non-culturable, alpha-proteobacterium, 'Candidatus Liberibacter asiaticus'. Currently, polymerase chain reaction (PCR) and real time PCR have been the gold standard techniques used for detection of 'Ca. L. asiaticus'. These diagnostic methods are expensive, require well equipped laboratories, not user-friendly and not suitable for on -site detection of the pathogen. In this study, a sensitive, reliable, quick and low cost recombinase polymerase based isothermal amplification combined with lateral flow assay (HLB-RPA-LFA) technique has been developed as a diagnostic tool for detection of 'Ca. L. asiaticus'. The assay was standardized by designing the specific primer pair and probe based on the conserved 16S rRNA gene of 'Ca. L. asiaticus'. The assay was optimized for temperature and reaction time by using purified DNA and crude plant extracts and the best HLB-RPA-LFA was achieved at the isothermal temperature of 38 degrees C for 20 to 30 min. The efficacy and sensitivity of the assay was carried out by using field grown, HLB-infected, HLB-doubtful and healthy citrus cultivars including mandarin, sweet orange cv. mosambi, and acid lime. The HLB-RPA-LFA did not show cross-reactivity with other citrus pathogens and is simple, cost-effective, rapid, user-friendly and sensitive. Thus, the HLB-RPA-LFA method has great potential to provide an improved diagnostic tool for detection of `Ca. L. asiaticus' for the farmers, nurserymen, disease surveyors, mobile plant pathology laboratories, bud-wood certification and quarantine programs.	[Ghosh, Dilip Kumar; Kokane, Sunil B.; Kokane, Amol D.; Warghane, Ashish J.; Motghare, Manali R.; Bhose, Sumit] ICAR Cent Citrus Res Inst, Plant Virol Lab, Nagpur, Maharashtra, India; [Sharma, Ashwani Kumar] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee, Uttarakhand, India; [Reddy, M. Krishna] ICAR Indian Inst Hort, Plant Virol Lab, Bengaluru, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Citrus Research Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Ghosh, DK (corresponding author), ICAR Cent Citrus Res Inst, Plant Virol Lab, Nagpur, Maharashtra, India.	ghoshdk@hotmail.com	kokane, sunil/W-2379-2019; Bhose, Sumit/AAR-2231-2021; Warghane, Ashish/AAY-9078-2020; Kokane, Amol Dattu/ABB-1016-2020; Ghosh, Dilip/W-7874-2019; Warghane, Ashish/GRJ-7718-2022	kokane, sunil/0000-0001-6904-3672; Warghane, Ashish/0000-0002-9778-2998; Ghosh, Dilip/0000-0001-6237-7610; Warghane, Ashish/0000-0002-9778-2998; BHOSE, SUMIT/0000-0003-0858-308X	ICAR-Consortia Research Platform (CRP) on Vaccines and Diagnostics, ICAR, Government of India, New Delhi [16-11/PP/ICAR-CRP/17-18/06]	ICAR-Consortia Research Platform (CRP) on Vaccines and Diagnostics, ICAR, Government of India, New Delhi	This research was funded by ICAR-Consortia Research Platform (CRP) on Vaccines and Diagnostics, ICAR, Government of India, New Delhi, F. No. 16-11/PP/ICAR-CRP/17-18/06.	Abukhalid N, 2017, J MED MICROB DIAGN, V6, P1, DOI [10.4172/2161-0703.1000250, DOI 10.4172/2161-0703.1000250]; Ahlawat Y.S., 2012, VIRUS DIS CITRUS MAN; Ashish Warghane, 2017, Indian Phytopathology, V70, P359; Bassanezi R. B, 2007, PLANT HLTH PROGR, V8, P1, DOI DOI 10.1094/PHP-2007-0906-01-RV; Batool A, 2007, HORTIC SCI, V34, P159, DOI 10.17221/1897-HORTSCI; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Bove JM, 2006, J PLANT PATHOL, V88, P7; Boyle DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103091; Chandu D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3145921; da Graca JV, 2016, J INTEGR PLANT BIOL, V58, P373, DOI 10.1111/jipb.12437; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; Daher RK, 2016, CLIN CHEM, V62, P947, DOI 10.1373/clinchem.2015.245829; GARNIER M, 1987, ANN INST PASTEUR MIC, V138, P639, DOI 10.1016/0769-2609(87)90142-6; Ghosh D, 2013, PHYTOPARASITICA, V41, P295, DOI 10.1007/s12600-013-0290-4; Ghosh DK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204702; Ghosh DK, 2016, J PLANT BIOCHEM BIOT, V25, P219, DOI 10.1007/s13562-015-0332-8; Ghosh DK, 2015, PHYTOPATHOLOGY, V105, P1043, DOI 10.1094/PHYTO-09-14-0253-R; Hocquellet A, 1999, MOL CELL PROBE, V13, P373, DOI 10.1006/mcpr.1999.0263; Hou PL, 2018, MOL CELL PROBE, V38, P31, DOI 10.1016/j.mcp.2017.12.003; Hu H, 2013, PLANT DIS, V97, P1158, DOI 10.1094/PDIS-09-12-0880-RE; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Kapoor R, 2017, ARCH VIROL, V162, P2791, DOI 10.1007/s00705-017-3399-9; Kumar PV, 2018, ACTA VIROL, V62, P104, DOI 10.4149/av_2018_113; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Lillis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108189; Londono MA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0504-8; Miles TD, 2015, PHYTOPATHOLOGY, V105, P265, DOI 10.1094/PHYTO-05-14-0134-R; Morgan JK, 2012, MOL CELL PROBE, V26, P90, DOI 10.1016/j.mcp.2011.12.001; Okuda M, 2005, PLANT DIS, V89, P705, DOI 10.1094/PD-89-0705; Pagliaccia D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02041; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Qian WJ, 2018, J AGR FOOD CHEM, V66, P5473, DOI 10.1021/acs.jafc.8b01015; Rosser A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1055-3; Silva G, 2018, ANAL BIOCHEM, V546, P17, DOI 10.1016/j.ab.2018.01.019; Sumit Bhose, 2015, Indian Phytopathology, V68, P334; VILLECHANOUX S, 1992, CURR MICROBIOL, V24, P89, DOI 10.1007/BF01570903; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Wang Z, 2006, PLANT PATHOL, V55, P630, DOI 10.1111/j.1365-3059.2006.01438.x; Yasir Iftikhar, 2016, Journal of the Saudi Society of Agricultural Sciences, V15, P1, DOI 10.1016/j.jssas.2014.04.006; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zaghloul H, 2014, WORLD J HEPATOL, V6, P916, DOI 10.4254/wjh.v6.i12.916	43	36	38	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208530	10.1371/journal.pone.0208530	http://dx.doi.org/10.1371/journal.pone.0208530			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540789	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600076
J	Gupta, A; Mallick, P; Sharma, O; Gupta, R; Duggal, R				Gupta, Anubha; Mallick, Pramit; Sharma, Ojaswa; Gupta, Ritu; Duggal, Rahul			PCSeg: Color model driven probabilistic multiphase level set based tool for plasma cell segmentation in multiple myeloma	PLOS ONE			English	Article							IMAGE SEGMENTATION; ACTIVE CONTOURS; CT; FRAMEWORK; ATLAS	Plasma cell segmentation is the first stage of a computer assisted automated diagnostic tool for multiple myeloma (MM). Owing to large variability in biological cell types, a method for one cell type cannot be applied directly on the other cell types. In this paper, we present PCSeg Tool for plasma cell segmentation from microscopic medical images. These images were captured from bone marrow aspirate slides of patients with MM. PCSeg has a robust pipeline consisting of a pre-processing step, the proposed modified multiphase level set method followed by post-processing steps including the watershed and circular Hough transform to segment clusters of cells of interest and to remove unwanted cells. Our modified level set method utilizes prior information about the probability densities of regions of interest (ROIs) in the color spaces and provides a solution to the minimal-partition problem to segment ROls in one of the level sets of a two-phase level set formulation. PCSeg tool is tested on a number of microscopic images and provides good segmentation results on single cells as well as efficient segmentation of plasma cell clusters.	[Gupta, Anubha; Duggal, Rahul] Indraprastha Inst Informat Technol Delhi IIIT Del, Dept ECE, SBILab, New Delhi, India; [Mallick, Pramit] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA; [Sharma, Ojaswa] Indraprastha Inst Informat Technol Delhi IIIT Del, Dept CSE, New Delhi, India; [Gupta, Ritu] AIIMS, Dr BRA IRCH, Lab Oncol Unit, New Delhi, India	Indraprastha Institute of Information Technology Delhi; New York University; Indraprastha Institute of Information Technology Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital	Gupta, A (corresponding author), Indraprastha Inst Informat Technol Delhi IIIT Del, Dept ECE, SBILab, New Delhi, India.	anubha@iiitd.ac.in	Gupta, Ritu/ABC-3310-2020	Gupta, Anubha/0000-0002-7752-1926; Sharma, Ojaswa/0000-0002-9902-1367	Department of Science and Technology [EMR/2016/006183]; Ministry of Communication and IT [1(7)/2014-ME]	Department of Science and Technology(Department of Science & Technology (India)); Ministry of Communication and IT	The work was funded by Department of Science and Technology, Govt. of India. Grant Number: EMR/2016/006183 and the Ministry of Communication and IT, Govt. of India. Grant Number: 1(7)/2014-ME&HI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram SU, 2016, LECT NOTES COMPUT SC, V10008, P21, DOI 10.1007/978-3-319-46976-8_3; Anoraganingrum D, 1999, CELL SEGMENTATION AD, P27; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Bilkova Z, 2016, LECT NOTES COMPUT SC, V9730, P183, DOI 10.1007/978-3-319-41501-7_21; Chan TE, 2000, J VIS COMMUN IMAGE R, V11, P130, DOI 10.1006/jvci.1999.0442; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chen YT, 2017, MAGN RESON IMAGING, V39, P175, DOI 10.1016/j.mri.2017.02.008; Dorini LB, 2007, SIBGRAPI, P294, DOI 10.1109/SIBGRAPI.2007.33; Duggal R, 2016, TENTH INDIAN CONFERENCE ON COMPUTER VISION, GRAPHICS AND IMAGE PROCESSING (ICVGIP 2016), DOI 10.1145/3009977.3010043; Gupta A., MIMM SBILAB DATASET, DOI [10.7910/DVN/XCX7ST, DOI 10.7910/DVN/XCX7ST]; Gupta R, 2017, CL LYMPH MYELOM LEUK, V17, pE99, DOI 10.1016/j.clml.2017.03.178; Hatipoglu N, 2017, MED BIOL ENG COMPUT, V55, P1829, DOI 10.1007/s11517-017-1630-1; Kass M., 1987, Proceedings of the First International Conference on Computer Vision (Cat. No.87CH2465-3), P259, DOI 10.1007/BF00133570; Lu Z, 2013, LECT NOTES COMPUT SC, V8149, P452, DOI 10.1007/978-3-642-40811-3_57; Man Yan, 2012, 2012 5th International Conference on BioMedical Engineering and Informatics (BMEI), P295, DOI 10.1109/BMEI.2012.6513157; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; Mohapatra S., 2010, 2010 International Conference on Systems in Medicine and Biology (ICSMB), P49, DOI 10.1109/ICSMB.2010.5735344; Orozco-Monteagudo M, 2012, COMPUT SIST, V16, P133; Patel A, 2017, MED IMAGE ANAL, V36, P216, DOI 10.1016/j.media.2016.12.002; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Sadeghian F, 2009, BIOL PROCED ONLINE, V11, P196, DOI 10.1007/s12575-009-9011-2; Saeedizadeh Z, 2016, J MICROSC-OXFORD, V261, P46, DOI 10.1111/jmi.12314; Sharif J. M., 2012, 2012 INT C BIOM ENG, P2; Shi CF, 2017, MED IMAGE ANAL, V38, P30, DOI 10.1016/j.media.2017.02.008; Song YY, 2017, IEEE T MED IMAGING, V36, P288, DOI 10.1109/TMI.2016.2606380; Stoklasa R, 2015, I S BIOMED IMAGING, P1447, DOI 10.1109/ISBI.2015.7164149; Swierczynski P, 2018, COMPUT MED IMAG GRAP, V65, P58, DOI 10.1016/j.compmedimag.2017.06.003; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Wang JK, 2016, INT J COMPUT ASS RAD, V11, P817, DOI 10.1007/s11548-015-1332-9; Wei Gao, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P2609; Xing FY, 2016, IEEE T MED IMAGING, V35, P550, DOI 10.1109/TMI.2015.2481436; Yang L, 2005, IEEE T INF TECHNOL B, V9, P475, DOI 10.1109/TITB.2005.847515; Yin ZZ, 2010, I S BIOMED IMAGING, P125, DOI 10.1109/ISBI.2010.5490399; Yu WM, 2008, LECT NOTES COMPUT SC, V5358, P540; Zamani F, 2006, INT CONF SIGN PROCES, P1519; Zhang L, 2017, I S BIOMED IMAGING, P406, DOI 10.1109/ISBI.2017.7950548; Zhang PY, 2017, I S BIOMED IMAGING, P718, DOI 10.1109/ISBI.2017.7950620	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207908	10.1371/journal.pone.0207908	http://dx.doi.org/10.1371/journal.pone.0207908			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540767	gold, Green Submitted, Green Published			2022-12-26	WOS:000452898600045
J	Szabo, B; Marosi, EK; Vargova, K; Nyolczas, N				Szabo, Barna; Marosi, Eszter Krisztina; Vargova, Katarina; Nyolczas, Noerni			Cardiac Index by Transthoracic Echocardiography (CITE) study	PLOS ONE			English	Article							HEART-FAILURE; AMBULATORY PATIENTS; DIAGNOSIS; THERAPY	Aims Left ventricular ejection fraction (LVEF) is the most frequently used parameter in the assessment of heart failure (HF). Cardiac index (CI) is considered a potential alternative to LVEF despite limited evidence. We aimed to assess and compare the predictive accuracy of LVEF and echocardiographically-assessed CI in HF patients. Methods and results A single-centre, retrospective cohort study was conducted in patients hospitalized for acute HF from 2010-2016. Cox proportional hazard models including either LVEF or CI were created to predict all cause death, cardiovascular (CV) death, or first HF-readmission. Of 334 patients included in the analysis, 58.7% exhibited HF with reduced LVEF (HFrEF). Left ventricular ejection fraction did not show correlation with any endpoint, while CI was predictive of HF-readmission in the entire cohort. Both the LVEF-based and Cl-based models demonstrated moderate discriminative accuracy when predicting all-cause death, CV death, or HFreadmission. Left ventricular ejection fraction proved to be an independent predictor of CV mortality in HFrEF-patients, while CI was predictive of HF-readmission in the non-HFrEF group. Conclusions Left ventricular ejection fraction seemed to be associated more closely with disease severity in HFrEF, and CI in the non-HFrEF group, in this real-life cohort of elderly HF patients. The LVEF-based and Cl-based predictive models have clinically similar predictive accuracy for mortality and HF-readmission, thus CI may be a potential alternative to LVEF in the assessment of left ventricular function. Cardiac index may be an important new tool in the assessment of HF patients with midrange or preserved LVEF.	[Szabo, Barna; Marosi, Eszter Krisztina; Vargova, Katarina] Orebro Univ Hosp, Heart Lung Physiol Clin, Orebro, Sweden; [Nyolczas, Noerni] Mil Hosp, State Hlth Ctr, Cardiol, Budapest, Hungary	Orebro University	Szabo, B (corresponding author), Orebro Univ Hosp, Heart Lung Physiol Clin, Orebro, Sweden.	barna.szabo@regionorebrolan.se		Szabo, Barna/0000-0002-6072-8306				Abraham Jacob, 2009, Heart Fail Clin, V5, P191, DOI 10.1016/j.hfc.2008.11.002; Aimo A, 2018, INT J CARDIOL, V273, P136, DOI 10.1016/j.ijcard.2018.07.117; Amara N, 2018, EUROPACE, V20, P65, DOI 10.1093/europace/euw379; Blondheim DS, 2010, J AM SOC ECHOCARDIOG, V23, P258, DOI 10.1016/j.echo.2009.12.020; Farmakis D, 2016, INT J CARDIOL, V203, P279, DOI 10.1016/j.ijcard.2015.10.172; Florea VG, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003123; Fornwalt BK, 2010, CIRCULATION, V121, P1985, DOI 10.1161/CIRCULATIONAHA.109.910778; FRANCIOSA JA, 1987, CIRCULATION, V75, P20; Gilewski W, 2018, HEART VESSELS, V33, P180, DOI 10.1007/s00380-017-1044-x; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Grodin JL, 2015, EUR J HEART FAIL, V17, P689, DOI 10.1002/ejhf.268; Habash-Bseiso DE, 2005, CLIN MED RES, V3, P75, DOI 10.3121/cmr.3.2.75; Kato TS, 2013, J HEART LUNG TRANSPL, V32, P333, DOI 10.1016/j.healun.2012.11.026; Mercado P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1737-7; PARAMESHWAR J, 1992, AM HEART J, V123, P421, DOI 10.1016/0002-8703(92)90656-G; Pfister R, 2008, EUR J HEART FAIL, V10, P315, DOI 10.1016/j.ejheart.2008.01.009; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Zakeri R, 2018, HEART, V104, P377, DOI 10.1136/heartjnl-2016-310790; Zhang Q, 2015, CURR OPIN CARDIOL, V30, P40, DOI 10.1097/HCO.0000000000000140	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207269	10.1371/journal.pone.0207269	http://dx.doi.org/10.1371/journal.pone.0207269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540751	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600013
J	Da Ros, S; Aresu, L; Ferraresso, S; Zorzan, E; Gaudio, E; Bertoi, F; Dacasto, M; Giantin, M				Da Ros, Silvia; Aresu, Luca; Ferraresso, Serena; Zorzan, Eleonora; Gaudio, Eugenio; Bertoi, Francesco; Dacasto, Mauro; Giantin, Mery			Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; PROMOTER HYPERMETHYLATION; HDAC INHIBITORS; CPG ISLAND; PCR ASSAY; CANCER; PROTEIN; DOGS	Despite canine B-cell Lymphoma (BCL) representing the most common haematological tumour, epigenetic events driving development and progression are scarcely known. Recently, canine Diffuse Large BCL (DLBCL) DNA methylome by genome-wide CpG micro-array has identified genes and pathways associated to pathogenesis. To validate data previously obtained by array analysis, the CLBL-1 cell line was used and the HOXD10, FGFR2, ITIH5 and RASAL3 genes were selected. CLBL-1 cells were treated with two hypomethylating drugs (HDs; IC50, 50% inhibitory concentration), i.e. azacytidine and decitabine (DEC), either alone or in combination with three histone deacetylase inhibitors (HDACis; IC20), i.e. valproic acid, trichostatin and vorinostat. Following the incubation with both HDs, an overall decrease of promoter methylation was highlighted, thus confirming target genes hyper-methylation. The highest mRNA restoration was observed following the exposure to HDs combined with HDACis, and mostly with valproic acid. Contrasting results were only obtained for RASAL3. An in vivo confirmation was finally attempted treating Nod-Scid mice engrafted with CLBL-1 cells with DEC. Although DEC did not arrest tumour growth, target genes promoter methylation was significantly reduced in DEC-treated mice vs controls. Overall, this work demonstrates that CLBL-1 cell line represents a reliable in vitro model to validate the methylation-dependent silencing of key genes for BCL; moreover, it may be useful for xenograft models in mice, despite its aggressive behaviour. In future, functional studies will be performed to deepen the role of selected genes on BCL pathogenesis and progression, and their methylation-dependent mechanism of regulation.	[Da Ros, Silvia; Ferraresso, Serena; Zorzan, Eleonora; Dacasto, Mauro; Giantin, Mery] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Aresu, Luca] Univ Turin, Dept Vet Sci, Turin, Italy; [Gaudio, Eugenio; Bertoi, Francesco] Univ Svizzera Italiana, Inst Oncol Res, Bellinzona, Switzerland; [Bertoi, Francesco] Oncol Inst Southern Switzerland, Bellinzona, Switzerland	University of Padua; University of Turin; Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Institute of Oncology Research (IOR)	Giantin, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy.	mery.giantin@unipd.it	Giantin, Mery/AAX-3235-2020; Aresu, Luca/J-9788-2018; Bertoni, Francesco/G-6922-2014	Ferraresso, Serena/0000-0001-5928-9361; Aresu, Luca/0000-0002-7893-1740; Bertoni, Francesco/0000-0001-5637-8983; GIANTIN, Mery/0000-0003-0015-3800	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [RBSI14EDX9]	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This project was funded by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) to LA, MG (RBSI14EDX9: An Integrative Analysis of Methylome and Transcriptome in Canine Diffuse Large B-cell Lymphoma).	Aresu L, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00077; Aresu L, 2014, VET J, V200, P318, DOI 10.1016/j.tvjl.2014.03.006; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Capobianco E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095596; CHABOT GG, 1983, CANCER RES, V43, P592; Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fan H, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/371087; Ferraresso S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11724-w; Ferraresso S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092707; Flesner BK, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0290-8; Fujiwara-Igarashi A, 2014, RES VET SCI, V97, P60, DOI 10.1016/j.rvsc.2014.04.008; Fulkerson CM, 2017, VET COMP ONCOL, V15, P226, DOI 10.1111/vco.12159; Gianti M, 2013, RES VET SCI, V94, P90, DOI 10.1016/j.rvsc.2012.07.035; Giantin M, 2013, VET IMMUNOL IMMUNOP, V154, P153, DOI 10.1016/j.vetimm.2013.05.014; Giantin M, 2016, VET J, V212, P36, DOI 10.1016/j.tvjl.2016.03.024; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Hahn NM, 2012, J UROLOGY, V187, P302, DOI 10.1016/j.juro.2011.09.010; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hernandez HG, 2013, BIOTECHNIQUES, V55, P181, DOI 10.2144/000114087; Hopp L, 2015, GENES-BASEL, V6, P812, DOI 10.3390/genes6030812; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kalac M, 2011, BLOOD, V118, P5506, DOI 10.1182/blood-2011-02-336891; Kerr JS, 2010, INT J TOXICOL, V29, P3, DOI 10.1177/1091581809352111; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; Kloten V, 2014, EPIGENETICS-US, V9, P1290, DOI 10.4161/epi.32089; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malspeis L, 1983, Invest New Drugs, V1, P47; Marchi E, 2015, BRIT J HAEMATOL, V171, P215, DOI 10.1111/bjh.13566; Marconato L, 2011, VET J, V188, P34, DOI 10.1016/j.tvjl.2010.04.027; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; MOMPARLER RL, 1989, TOXICOLOGY, V57, P329, DOI 10.1016/0300-483X(89)90120-0; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Oing C, 2011, CLIN EPIGENETICS, V2, P419, DOI 10.1007/s13148-011-0043-5; Park S, 2007, BIOCHEM BIOPH RES CO, V357, P1011, DOI 10.1016/j.bbrc.2007.04.051; Pera B, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0245-y; Piekarz RL, 2009, CLIN CANCER RES, V15, P3918, DOI 10.1158/1078-0432.CCR-08-2788; Richards KL, 2013, CANCER RES, V73, P5029, DOI 10.1158/0008-5472.CAN-12-3546; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Saito S, 2015, EUR J IMMUNOL, V45, P1512, DOI 10.1002/eji.201444977; Samuel S, 2015, EUR J CANCER, V41, P2428, DOI [10.1007/s13148-011-0043-5, DOI 10.1007/S13148-011-0043-5]; Sandhu Punam, 2007, Drug Metab Lett, V1, P153, DOI 10.2174/187231207780363642; Sato M, 2014, VET IMMUNOL IMMUNOP, V161, P222, DOI 10.1016/j.vetimm.2014.08.011; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Song SH, 2011, DRUGS, V71, P2391, DOI 10.2165/11596690-000000000-00000; Stirzaker C, 2014, TRENDS GENET, V30, P75, DOI 10.1016/j.tig.2013.11.004; Tomiyasu H, 2014, VET J, V199, P103, DOI 10.1016/j.tvjl.2013.10.022; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Wang LJ, 2012, MOL MED, V18, P389, DOI 10.2119/molmed.2011.00172; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wittenburg LA, 2010, CLIN CANCER RES, V16, P4832, DOI 10.1158/1078-0432.CCR-10-1238; Wittenburg LA, 2011, CANCER CHEMOTH PHARM, V67, P83, DOI 10.1007/s00280-010-1287-z; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P121, DOI [10.1056/NEJMra072067, DOI 10.1056/NEJMRA072067]; Zandvliet M, 2016, VET QUART, V36, P76, DOI 10.1080/01652176.2016.1152633; Zeschnigk M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh122; Zhu X, 2007, AM J PATHOL, V170, P1618, DOI 10.2353/ajpath.2007.061111	59	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208709	10.1371/journal.pone.0208709	http://dx.doi.org/10.1371/journal.pone.0208709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533020	gold, Green Published, Green Submitted			2022-12-26	WOS:000452782500030
J	Mills, KL; Gomes, AM; Standlee, CR; Rojo, MD; Carmeliet, P; Lin, Z; Machado, HL				Mills, Kylie L.; Gomes, Angelica M.; Standlee, Courtney R.; Rojo, Michelle D.; Carmeliet, Peter; Lin, Zhen; Machado, Heather L.			Gas6 is dispensable for pubertal mammary gland development	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; ARREST-SPECIFIC GENE; GROWTH ARREST; AXL; PROLIFERATION; MORPHOGENESIS; EXPRESSION; APOPTOSIS; PRODUCT; CASCADE	Mammary gland development is a complex and dynamic process that occurs mainly postnatally. Ductal elongation and branching morphogenesis are regulated by a plethora of factors, including cytokines, hormones, growth factors and the extracellular matrix. Gas6 is a secreted gamma-carboxylated protein that binds to a family of receptors tyrosine kinase receptors known as the TAMR family (Tyro3, Axl, Mer). Gas6 function in developmental processes has been shown in nervous, reproductive and immune systems. In this study, we found that Gas6 is highly expressed in virgin adult mammary glands but declines during pregnancy and lactation. Specifically, Gas6 is highly expressed in luminal and basal mammary epithelial cells during puberty and adulthood, while TAMR expression is low. Mammary whole mount analysis revealed that Gas6 germline deletion does not impact ductal elongation, branching morphogenesis or terminal end bud formation. Masson's trichrome staining showed that collagen deposition is similar in Gas6(-/-) mice as compared to wildtype mice. Gas6(-/-) mammary glands presented an organized luminal and myoepithelial bilayer of cells, and the proportion of mammary stem cells was unchanged in Gas6(-/-) mammary glands as compared to wildtype. Finally, proliferation of epithelial cells and macrophage number were similar in both groups. These studies suggest that Gas6 is not essential for pubertal mammary gland development in nulliparous mice.	[Mills, Kylie L.; Gomes, Angelica M.; Standlee, Courtney R.; Rojo, Michelle D.; Machado, Heather L.] Tulane Sch Med, Tulane Canc Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Carmeliet, Peter] VIB KU Leuven Ctr Canc Biol, Lab Angiogenesis & Vasc Metab, Leuven, Belgium; [Carmeliet, Peter] Sun Yat Sen Univ, Zhongsan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Vasc Metab, Leuven, Belgium; [Carmeliet, Peter] Katholieke Univ Leuven, Leuven Canc Inst LKI, Leuven, Belgium; [Lin, Zhen] Tulane Sch Med, Tulane Canc Ctr, Dept Pathol, New Orleans, LA USA	Tulane University; Flanders Institute for Biotechnology (VIB); Sun Yat Sen University; KU Leuven; KU Leuven; Tulane University	Machado, HL (corresponding author), Tulane Sch Med, Tulane Canc Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	hmachado@tulane.edu	Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821; Machado, Heather/0000-0001-6889-6139	NIH COBRE [P20 GM121288]; Tulane School of Medicine Faculty Research Pilot grant; Flemish Government; Research Foundation Flanders (FWO-Vlanderen); Foundation against Cancer [2012-175, 2016-078]; Flemish cancer society; Advanced European Research Council [EU-ERC743074]; Susan G. Komen [CCR16377665]; National Cancer Institute (NIH) [R01 CA212518]; NATIONAL CANCER INSTITUTE [R01CA212518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121288, P30GM114732] Funding Source: NIH RePORTER	NIH COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane School of Medicine Faculty Research Pilot grant; Flemish Government(European Commission); Research Foundation Flanders (FWO-Vlanderen); Foundation against Cancer; Flemish cancer society; Advanced European Research Council(European Research Council (ERC)); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH COBRE P20 GM121288 (Z.L.), a Tulane School of Medicine Faculty Research Pilot grant (Z.L.), long-term structural Methusalem funding by the Flemish Government (P.C.), the Research Foundation Flanders (FWO-Vlanderen) (P.C.), the Foundation against Cancer 2012-175 and 2016-078 (P.C.), Kom op tegen Kanker (Stand up to Cancer) by the Flemish cancer society (P.C.), Advanced European Research Council EU-ERC743074 (P.C.), Susan G. Komen CCR16377665 (H.L.M) and National Cancer Institute (NIH) R01 CA212518 (H.L.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Brown JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036800; Buehler M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/238284; Burstyn-Cohen T, 2017, INT J DEV BIOL, V61, P215, DOI 10.1387/ijdb.160285tb; Carron EC, 2017, ONCOTARGET, V8, P50731, DOI 10.18632/oncotarget.14913; Chodosh LA, 2000, DEV BIOL, V219, P259, DOI 10.1006/dbio.2000.9614; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Goyette MA, 2018, CELL REP, V23, P1476, DOI 10.1016/j.celrep.2018.04.019; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Jokela TA, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00041; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Mc Cormack O, 2008, BRIT J CANCER, V98, P1141, DOI 10.1038/sj.bjc.6604260; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Pal B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01560-x; Pond AC, 2013, STEM CELLS, V31, P178, DOI 10.1002/stem.1266; Sadahiro H, 2018, CANCER RES, V78, P3002, DOI 10.1158/0008-5472.CAN-17-2433; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Williams MM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0893-7; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200	35	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208550	10.1371/journal.pone.0208550	http://dx.doi.org/10.1371/journal.pone.0208550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533018	Green Published, gold, Green Submitted			2022-12-26	WOS:000452782500025
J	Adu, MD; Malabu, UH; Malau-Aduli, AEO; Malau-Aduli, BS				Adu, Mary D.; Malabu, Usman H.; Malau-Aduli, Aduli E. O.; Malau-Aduli, Bunmi S.			Users' preferences and design recommendations to promote engagements with mobile apps for diabetes self-management: Multi-national perspectives	PLOS ONE			English	Article							HEALTH; INTERVENTION; PERCEPTIONS; TYPE-1	Background Mobile phone applications (apps) offer motivation and support for self-management of diabetes mellitus (DM), but their use is limited by high attrition due to insufficient consideration of end-users perspectives and usability requirements. This study aimed to examine app usage and feature preferences among people with DM, and explore their recommendations for future inclusions to foster engagement with diabetes apps. Methods The study was conducted internationally on adults with type 1 or type 2 DM using online questionnaire (quantitative) to investigate usage and preferences for app features that support diabetes self-management and semi structured telephone interview (qualitative) to explore suggestions on fostering engagement and specific educational information for inclusion into diabetes apps. Survey and interview data were analysed using descriptive/inferential statistics and inductive thematic analysis respectively. Results A total of 217 respondents with type 1 DM (38.25%) or type 2 DM (61.8%), from 4 continents (Australia, Europe, Asia and America) participated in the survey. About half of the respondents (48%) use apps, mainly with features for tracking blood glucose (56.6%), blood pressure (51.9%) and food calories (48.1%). Preferred features in future apps include nutrient values of foods (56.7%), blood glucose (54.8%), physical exercise tracker (47%), health data analytics (42.9%) and education on diabetes self-management (40.6%). Irrespective of the type of DM, participants proposed future apps that are user friendly, support healthy eating, provide actionable reminders and consolidate data across peripheral health devices. Participants with type 1 DM recommended customised features with news update on developments in the field of diabetes. Nominated specific educational topics included tips on problem solving, use of insulin pump therapy, signs of diabetes complication and transitioning from paediatric into adult care. Conclusions The study has highlighted patients' perspectives on essential components for inclusion in diabetes apps to promote engagement and foster better health outcomes.	[Adu, Mary D.; Malabu, Usman H.; Malau-Aduli, Bunmi S.] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Malau-Aduli, Aduli E. O.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia	James Cook University; James Cook University	Adu, MD (corresponding author), James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia.	mary.adu@my.jcu.edu.au	Malau-Aduli, Aduli Enoch Othniel/C-2419-2014; Malau-Aduli, Bunmi/J-9388-2014	Malau-Aduli, Aduli Enoch Othniel/0000-0002-3660-7862; Adu, Damilola Mary/0000-0003-0046-9215; Malau-Aduli, Bunmi/0000-0001-6054-8498	Australian Government International Training Program Scholarship	Australian Government International Training Program Scholarship(Australian Government)	The first author (MDA) of this study is supported by the Australian Government International Training Program Scholarship. The funding body had no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Adu MD, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10115; Ancker JS, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4209; Arnhold M, 2014, J MED INTERNET RES, V16, P34, DOI 10.2196/jmir.2968; Arsand E, 2008, INFORM HEALTH SOC CA, V33, P158, DOI 10.1080/17538150802457562; Bender MS, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3710; Bickmore T, 2010, APPL ARTIF INTELL, V24, P648, DOI 10.1080/08839514.2010.492259; Boyle L, 2017, JMIR MHEALTH UHEALTH, V5; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chiauzzi E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0319-2; Cho J, 2014, J MED INTERNET RES, V16, P206, DOI 10.2196/jmir.3283; Chomutare T, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1874; Conway N, 2016, HEALTH INFORM J, V22, P1111, DOI 10.1177/1460458215616265; Crane D, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00039; Creswell JW, 2003, HDB MIXED METHODS SO, P223; Demidowich AP, 2012, J TELEMED TELECARE, V18, P235, DOI 10.1258/jtt.2012.111002; Dennison L, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2583; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Dobson Rosie, 2017, JMIR Diabetes, V2, pe4, DOI 10.2196/diabetes.7221; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Franz MJ, 2010, J AM DIET ASSOC, V110, P1852, DOI 10.1016/j.jada.2010.09.014; Gagnon MP, 2016, J AM MED INFORM ASSN, V23, P212, DOI 10.1093/jamia/ocv052; Garabedian LF, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0680-8; Giroux D, 2014, TELEMED E-HEALTH, V20, P923, DOI 10.1089/tmj.2013.0222; Glasgow RE, 2007, DIABETES CARE, V30, P33, DOI 10.2337/dc06-1390; Goyal S, 2013, QJM-INT J MED, V106, P1067, DOI 10.1093/qjmed/hct203; Guertler D, J MED INTERNET RES; Heisler M, 2007, DIABETES SPECTR, V20, P214, DOI [10.2337/diaspect.20.4.214, DOI 10.2337/DIASPECT.20.4.214]; Hill-Briggs F, 2003, ANN BEHAV MED, V25, P182, DOI 10.1207/S15324796ABM2503_04; Hill-Briggs F, 2001, DIABETES CARE, V24, P959, DOI 10.2337/diacare.24.5.959; Holmen H, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7045; Holmen H, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3882; Holtz B, 2012, TELEMED E-HEALTH, V18, P175, DOI 10.1089/tmj.2011.0119; Istepanian RS, 2009, J TELEMED TELECARE; Izahar S, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00318; Juarascio AS, 2015, INT J MED INFORM, V84, P808, DOI 10.1016/j.ijmedinf.2015.06.004; Kayyali R, 2017, PHARMACY-BASEL, V5, DOI 10.3390/pharmacy5020033; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; Kim YJ, 2015, DIABETES METAB J, V39, P207, DOI 10.4093/dmj.2015.39.3.207; Klein MCA, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061436; Kontos E., 2014, J MED INTERNET RES, V16; Lalmas M., 2014, SYNTHESIS LECT INFOR, V6, P1, DOI [DOI 10.2200/S00605ED1V01Y201410ICR038, 10.2200/S00605ED1V01Y201410ICR038]; Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x; Lithgow Kirstie, 2017, JMIR Diabetes, V2, pe2, DOI 10.2196/diabetes.6643; Lustria MLA, 2011, HEALTH INFORM J, V17, P224, DOI 10.1177/1460458211414843; Mallenius S., 2007, 6 ANN GLOBAL MOBILIT, V31, P12; McCurdie Tara, 2012, Biomed Instrum Technol, VSuppl, P49, DOI 10.2345/0899-8205-46.s2.49; Mulcahy K, 2003, DIABETES EDUCATOR, V29, P768, DOI 10.1177/014572170302900509; O'Brien HL, 2008, J AM SOC INF SCI TEC, V59, P938, DOI 10.1002/asi.20801; Payne KFB, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-121; Plain Language Action and Information Network [PLAIN], WHAT IS PLAIN LANG; Qenam B, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.8536; Quinn CC, 2011, DIABETES CARE; Rao Anoop, 2010, J Diabetes Sci Technol, V4, P949; Scheibe M, 2015, MED 2 0, V4; Shibuta T, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000322; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Smith A, 2018, AM FAM PHYSICIAN, V98, P154; Stableford S, 2007, J PUBLIC HEALTH POL, V28, P71, DOI 10.1057/palgrave.jphp.3200102; Taki S, 2017, JMIR MHEALTH UHEALTH, V5; Tatara N, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2432; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torous J, 2018, EVID-BASED MENT HEAL, V21, P116, DOI 10.1136/eb-2018-102891; Tran J., 2012, CLIN DIABETES, V30, P173, DOI 10.2337/diaclin.30.4.173; Wallace S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001099; Winters-Miner LA, TECHNOLOGY HLTH COMM; Woldaregay AZ, 2018, STUD HEALTH TECHNOL, V249, P151, DOI 10.3233/978-1-61499-868-6-151; Ye Qing, 2018, J Diabetes Sci Technol, V12, P808, DOI 10.1177/1932296818754907	67	28	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208942	10.1371/journal.pone.0208942	http://dx.doi.org/10.1371/journal.pone.0208942			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6JR	30532235	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700058
J	Fried, ES; Sawaya, NPD; Cao, YD; Kivlichan, ID; Romero, J; Aspuru-Guzik, A				Fried, E. Schuyler; Sawaya, Nicolas P. D.; Cao, Yudong; Kivlichan, Ian D.; Romero, Jhonathan; Aspuru-Guzik, Alan			qTorch: The quantum tensor contraction handler	PLOS ONE			English	Article							CLASSICAL SIMULATION; CIRCUITS; COMPUTATION; NOISE	Classical simulation of quantum computation is necessary for studying the numerical behavior of quantum algorithms, as there does not yet exist a large viable quantum computer on which to perform numerical tests. Tensor network (TN) contraction is an algorithmic method that can efficiently simulate some quantum circuits, often greatly reducing the computational cost over methods that simulate the full Hilbert space. In this study we implement a tensor network contraction program for simulating quantum circuits using multi-core compute nodes. We show simulation results for the Max-Cut problem on 3-through 7-regular graphs using the quantum approximate optimization algorithm (QAOA), successfully simulating up to 100 qubits. We test two different methods for generating the ordering of tensor index contractions: one is based on the tree decomposition of the line graph, while the other generates ordering using a straight-forward stochastic scheme. Through studying instances of QAOA circuits, we show the expected result that as the treewidth of the quantum circuit's line graph decreases, TN contraction becomes significantly more efficient than simulating the whole Hilbert space. The results in this work suggest that tensor contraction methods are superior only when simulating Max-Cut/QAOA with graphs of regularities approximately five and below. Insight into this point of equal computational cost helps one determine which simulation method will be more efficient for a given quantum circuit. The stochastic contraction method outperforms the line graph based method only when the time to calculate a reasonable tree decomposition is prohibitively expensive. Finally, we release our software package, qTorch (Quantum TensOR Contraction Handler), intended for general quantum circuit simulation. For a nontrivial subset of these quantum circuits, 50 to 100 qubits can easily be simulated on a single compute node.	[Fried, E. Schuyler; Sawaya, Nicolas P. D.; Cao, Yudong; Kivlichan, Ian D.; Romero, Jhonathan; Aspuru-Guzik, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Sawaya, Nicolas P. D.] Intel Corp, Intel Labs, Santa Clara, CA USA; [Aspuru-Guzik, Alan] Canadian Inst Adv Res, Toronto, ON, Canada	Harvard University; Intel Corporation; Canadian Institute for Advanced Research (CIFAR)	Aspuru-Guzik, A (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Aspuru-Guzik, A (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.	alan@aspuru.com		Kivlichan, Ian/0000-0003-2719-2500; Romero Fontalvo, Jhonathan/0000-0002-9973-9491	National Energy Research Scientific Computing Center, a DOE Office of Science User Facility - Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Office of Naval Research [N00014-16-1-2008]; NSF [CHE-1655187]; Intel Corporation	National Energy Research Scientific Computing Center, a DOE Office of Science User Facility - Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Intel Corporation(Intel Corporation)	N.S. acknowledges the use of resources of the National Energy Research Scientific Computing Center, a DOE Office of Science User Facility supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231 (http://www.nersc.gov).A.A.-G.and E.F. were supported by the Office of Naval Research under grant N00014-16-1-2008 (Vannevar Bush Faculty Fellowship) (https://www.onr.navy.mil). A.A.-G. and Y.C. were supported by NSF grant CHE-1655187 (https://www.nsf.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Intel Corporation provided support in the form of salary for N.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aaronson S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052328; Amir E, 2010, ALGORITHMICA, V56, P448, DOI 10.1007/s00453-008-9180-4; [Anonymous], 2016, ARXIV160107195; ARNBORG S, 1987, SIAM J ALGEBRA DISCR, V8, P277, DOI 10.1137/0608024; Bodlaender HL, 2011, INFORM COMPUT, V209, P1103, DOI 10.1016/j.ic.2011.04.003; Bodlaender HL, 2010, INFORM COMPUT, V208, P259, DOI 10.1016/j.ic.2009.03.008; Boixo S., 2017, ARXIV171205384; Boixo S, 2018, NAT PHYS, V14, P595, DOI 10.1038/s41567-018-0124-x; Bouland A., 2018, ARXIV180304402; Chen J., 2018, ARXIV180501450QUANTP; Chen Z.-Y., 2018, ARXIV180206952; Childs A. M., 2017, ARXIV171110980; Farhi E., 2016, ARXIV160207674; Farhi E., 2014, ARXIV14126062; Garcia HJ, 2013, 2013 IEEE 31ST INTERNATIONAL CONFERENCE ON COMPUTER DESIGN (ICCD), P404, DOI 10.1109/ICCD.2013.6657072; Garcia HJ, 2017, IEEE T COMPUTERS, V64; Geller MR, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.012314; Gogate V., 2004, P 20 ANN C UNC ART I, P201; Gottesman D., 1998, ARXIVQUANTPH9807006; Haner T., 2017, ARXIV170401127; Johnson S.G., NLOPT NONLINEAR OPTI; Kraus K., 1983, STATES EFFECTS OPERA; Lin Yen-Yu, 2016, ARXIV160101744; Markov IL, 2008, SIAM J COMPUT, V38, P963, DOI 10.1137/050644756; McCaskey AJ, 2016, TENSOR NETWORK QUANT; McClean J.R., 2017, ARXIV171007629; McClean JR, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/2/023023; Merkel D, 2014, LINUX J, V2014; Miszczak JA, 2011, B POL ACAD SCI-TECH, V59, P305, DOI 10.2478/v10175-011-0039-5; Nielsen M. A., 2011, QUANTUM COMPUTATION, DOI DOI 10.1017/CBO9780511976667; Orus R, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50502-9; Orus R, 2014, ANN PHYS-NEW YORK, V349, P117, DOI 10.1016/j.aop.2014.06.013; Pednault Edwin, 2017, J ENV SCI CHINA; Peruzzo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5213; Preskill J, 2013, QUANTUM INF COMPUT, V13, P181; Ran SJ, 2017, ARXIV170809213; ROBERTSON N, 1991, J COMB THEORY B, V52, P153, DOI 10.1016/0095-8956(91)90061-N; Rudiak-Gould B., 2006, ARXIVQUANTPH0607151; Sawaya NPD, 2016, J CHEM THEORY COMPUT, V12, P3097, DOI 10.1021/acs.jctc.6b00220; Silva M, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012347; Steiger Damian S, 2016, ARXIV161208091; Svore K.M., 2014, ARXIV14024467; Tabakin F, 2011, COMPUT PHYS COMMUN, V182, P1693, DOI 10.1016/j.cpc.2011.04.010; Tabakin F, 2009, COMPUT PHYS COMMUN, V180, P948, DOI 10.1016/j.cpc.2008.11.021; Terhal BM, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.032325; Tomita Y, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.062320; Valiant L. G., 2001, P 33 ANN ACM S THEOR, P114, DOI [10.1145/380752.380785, DOI 10.1145/380752.380785]; Viamontes GF, 2005, QUANTUM INF COMPUT, V5, P113; Wecker D, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.022309; Wecker D, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.042303; Whitfield JD, 2011, MOL PHYS, V109, P735, DOI 10.1080/00268976.2011.552441	59	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208510	10.1371/journal.pone.0208510	http://dx.doi.org/10.1371/journal.pone.0208510			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532242	Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700026
J	Majkowski, M; Laszkiewicz, A; Sniezewski, L; Grzmil, P; Pawlicka, B; Tomczyk, I; Michniewicz, M; Kapusniak, V; Janik, S; Chodaczek, G; Cebrat, M				Majkowski, Michel; Laszkiewicz, Agnieszka; Sniezewski, Lukasz; Grzmil, Pawel; Pawlicka, Bernadette; Tomczyk, Igor; Michniewicz, Martyna; Kapusniak, Violetta; Janik, Sylwia; Chodaczek, Grzegorz; Cebrat, Malgorzata			Lack of NWC protein (c11 orf74 homolog) in murine spermatogenesis results in reduced sperm competitiveness and impaired ability to fertilize egg cells in vitro	PLOS ONE			English	Article							RAG LOCUS; GENE; PROMOTER	NWC is an uncharacterised protein containing three strongly conserved domains not found in any other known protein. Previously, we reported that the NWC protein is detected in cells in the germinal layer in murine testes (strain: C57BL/6), and its knockout results in no obvious phenotype. We determined the NWC expression pattern during spermatogenesis, and found this protein in spermatocytes and round spermatids, but not in epididymal sperm. Although NWC knockout males are fertile, we further characterised their reproductive potential employing non-standard mating that better simulates the natural conditions by including sperm competition. Such an approach revealed that the sperm of knockout males fail to successfully compete with control sperm. After analysing selected characteristics of the male reproductive system, we found that NWC knockout sperm had a reduced ability to fertilize cumulus-intact eggs during IVF. This is the first report describing a subtle phenotype of NWC knockout mice that could be detected under non-standard mating conditions. Our results indicate that NWC plays an important role in spermatogenesis and its deficiency results in the production of functionally impaired sperm.	[Majkowski, Michel; Laszkiewicz, Agnieszka; Sniezewski, Lukasz; Janik, Sylwia; Cebrat, Malgorzata] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Lab Mol & Cellular Immunol, Wroclaw, Poland; [Grzmil, Pawel; Pawlicka, Bernadette; Tomczyk, Igor] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Genet & Evolut, Krakow, Poland; [Michniewicz, Martyna] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Vivarium, Wroclaw, Poland; [Kapusniak, Violetta] Wroclaw Univ Environm & Life Sci, Dept Histol & Embryol, Chair Biostruct & Physiol, Wroclaw, Poland; [Majkowski, Michel; Chodaczek, Grzegorz] PORT Polish Ctr Technol Dev, Lab Confocal Microscopy, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Jagiellonian University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw University of Environmental & Life Sciences	Cebrat, M (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Lab Mol & Cellular Immunol, Wroclaw, Poland.	cebrat@iitd.pan.wroc.pl	Chodaczek, Grzegorz/AAH-1681-2022; Chodaczek, Grzegorz/G-4073-2014; Chodaczek, Grzegorz/AFL-9576-2022	Laszkiewicz, Agnieszka/0000-0002-0317-4255; Grzmil, Pawel/0000-0001-9780-2007; Cebrat, Malgorzata/0000-0003-4544-3289	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	The work was supported and publication costs were covered by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018 (MM, AL, MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brukman NG, 2016, MOL HUM REPROD, V22, P240, DOI 10.1093/molehr/gaw005; Cebrat M, 2005, EUR J IMMUNOL, V35, P2230, DOI 10.1002/eji.200526225; Cebrat M, 2008, MOL IMMUNOL, V45, P2297, DOI 10.1016/j.molimm.2007.11.009; Damario MA, 2014, METHODS MOL BIOL, V1154, P3, DOI 10.1007/978-1-4939-0659-8_1; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Garratt M, 2013, REPRODUCTION, V146, P297, DOI 10.1530/REP-13-0229; Gomendio M, 2006, P NATL ACAD SCI USA, V103, P15113, DOI 10.1073/pnas.0605795103; Grzmil P, 2008, BIOL REPROD, V78, P958, DOI 10.1095/biolreprod.107.065706; Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kasztura M, 2016, ARCH IMMUNOL THER EX, V64, P311, DOI 10.1007/s00005-015-0379-1; Kierszenbaum AL, 2011, DEV DYNAM, V240, P723, DOI 10.1002/dvdy.22563; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Laszkiewicz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106927; Laszkiewicz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044807; Laszkiewicz A, 2011, IMMUNOGENETICS, V63, P183, DOI 10.1007/s00251-011-0511-2; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Meistrich Marvin L, 2013, Methods Mol Biol, V927, P299; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Nagy A., 2003, MANIPULATING MOUSE E; Pasek RC, 2016, DEV BIOL, V412, P208, DOI 10.1016/j.ydbio.2016.01.042; Rathi R, 2001, BIOL REPROD, V65, P462, DOI 10.1095/biolreprod65.2.462; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Sniezewski L, 2018, DEV COMP IMMUNOL, V81, P105, DOI 10.1016/j.dci.2017.11.013; Sutton KA, 2008, P NATL ACAD SCI USA, V105, P8661, DOI 10.1073/pnas.0800603105	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208649	10.1371/journal.pone.0208649	http://dx.doi.org/10.1371/journal.pone.0208649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521625	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600102
J	Persyn, E; Redon, R; Bellanger, L; Dina, C				Persyn, Elodie; Redon, Richard; Bellanger, Lise; Dina, Christian			The impact of a fine-scale population stratification on rare variant association test results	PLOS ONE			English	Article							PRINCIPAL-COMPONENTS; COMMON DISEASES; SEQUENCING DATA; ADJUSTMENT; RISK	Population stratification is a well-known confounding factor in both common and rare variant association analyses. Rare variants tend to be more geographically clustered than common variants, because of their more recent origin. However, it is not yet clear if population stratification at a very fine scale (neighboring administrative regions within a country) would lead to statistical bias in rare variant analyses. As the inclusion of convenience controls from external studies is indeed a common procedure, in order to increase the power to detect genetic associations, this problem is important. We studied through simulation the impact of a fine scale population structure on different rare variant association strategies, assessing type I error and power. We showed that principal component analysis (PCA) based methods of adjustment for population stratification adequately corrected type I error inflation at the largest geographical scales, but not at finest scales. We also showed in our simulations that adding controls obviously increased power, but at a considerably lower level when controls were drawn from another population.	[Persyn, Elodie; Redon, Richard; Dina, Christian] UNIV Nantes, Inst Thorax, CNRS, INSERM, Nantes, France; [Persyn, Elodie] Kings Coll London, Dept Med & Mol Genet, London 2, England; [Redon, Richard] CHU Nantes, Inst Thorax, Nantes, France; [Bellanger, Lise] Lab Math Jean Leray, Nantes, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Dina, C (corresponding author), UNIV Nantes, Inst Thorax, CNRS, INSERM, Nantes, France.; Bellanger, L (corresponding author), Lab Math Jean Leray, Nantes, France.	lise.bellanger@univ-nantes.fr; christian.dina@univ-nantes.fr	Redon, Richard/F-3303-2014; Dina, Christian R/D-3535-2015	Redon, Richard/0000-0001-7751-2280; Dina, Christian R/0000-0002-7722-7348; Persyn, Elodie/0000-0001-9104-1972; Bellanger, Lise/0000-0001-6369-6744	The French Regional Council of Pays de la Loire (RFI VaCaRMe: Recherche, Formation et Innovation, Vaincre les maladies Cardiovaculaires, Respiratoires et Metaboliques); Agence Nationale de la Recherche [ANR-15-CE17-0008-01]; French Regional Council of Pays-de-la-Loire (VaCaRMe program)	The French Regional Council of Pays de la Loire (RFI VaCaRMe: Recherche, Formation et Innovation, Vaincre les maladies Cardiovaculaires, Respiratoires et Metaboliques); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Regional Council of Pays-de-la-Loire (VaCaRMe program)	This work was supported by a grant from The French Regional Council of Pays de la Loire (RFI VaCaRMe: Recherche, Formation et Innovation, Vaincre les maladies Cardiovaculaires, Respiratoires et Metaboliques) (CD, LB, and RR and funded Dr. Elodie Persyn). The website for this project is available at the following URL address http://www.vacarme-project.org/. Agence Nationale de la Recherche (ANR-15-CE17-0008-01 to RR): Grant Recipient was Richard Redon and funded scientist was Dr Elodie Persyn.; The authors would like to thank the Genomics and Bioinformatics Core Facility of Nantes (GenoBiRD, Biogenouest). This work was supported by the French Regional Council of Pays-de-la-Loire (VaCaRMe program to C. D., L.B. and R.R.), and the Agence Nationale de la Recherche (ANR-15-CE17-0008-01 to R.R.).	Babron MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046519; Bodenhofer U., 2015, PODKAT R PACKAGE ASS; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Che RL, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-9; Chen YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003224; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Davies RB, 1980, APPLIED STATISTICS, V29, P323, DOI DOI 10.2307/2346911; Epstein MP, 2012, AM J HUM GENET, V91, P215, DOI 10.1016/j.ajhg.2012.06.004; Fier H, 2012, BIOINFORMATICS, V28, P3027, DOI 10.1093/bioinformatics/bts568; Genin E, 2016, PRESENTED AT THE 69T; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Ionita-Laza I, 2012, AM J HUM GENET, V90, P1002, DOI 10.1016/j.ajhg.2012.04.010; Jiang YX, 2013, HUM HERED, V76, P28, DOI 10.1159/000353270; Karakachoff M, 2015, EUR J HUM GENET, V23, P831, DOI 10.1038/ejhg.2014.175; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094337; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu QY, 2013, GENET EPIDEMIOL, V37, P286, DOI 10.1002/gepi.21714; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; O'Connor TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065834; Pan W, 2011, GENET EPIDEMIOL, V35, P381, DOI 10.1002/gepi.20586; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Persyn E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179364; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schaid DJ, 2013, HUM GENET, V132, P1301, DOI 10.1007/s00439-013-1335-y; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Silverman B.W., 1986, DENSITY ESTIMATION S; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tintle N, 2011, GENET EPIDEMIOL, V35, pS56, DOI 10.1002/gepi.20650; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zawistowski M, 2014, EUR J HUM GENET, V22, P1137, DOI 10.1038/ejhg.2013.297; Zhang YW, 2013, GENET EPIDEMIOL, V37, P99, DOI 10.1002/gepi.21691	45	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207677	10.1371/journal.pone.0207677	http://dx.doi.org/10.1371/journal.pone.0207677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521541	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600016
J	Wu, KJ; Pan, HT; Li, C; Zhao, QB; Wang, L; Xia, JL				Wu, Kejian; Pan, Haitao; Li, Chen; Zhao, Qingbo; Wang, Ling; Xia, Jielai			An evaluation roadmap for critical quality attributes from tier 1 in analytical similarity assessment	PLOS ONE			English	Article							SAMPLE-SIZE; EQUIVALENCE ASSESSMENT	Analytical similarity assessment of critical quality attributes (CQAs) serves as a foundation for the development of biosimilar products and facilitates an abbreviated subsequent clinical evaluation. In this study, we establish a statistical evaluation roadmap with statistical approaches for some selected CQAs from Tier 1, because they are most relevant to clinical outcomes and require the most rigorous statistical methods. In the roadmap, we incorporate 3 methods-ranking and tier assignment of quality attributes, the equivalence test, and the Mann-Whitney test for equivalence-that are important to determine analytical similarity between the reference and biosimilar products. For the equivalence test, we develop a power calculation formula based on the two one-sided tests procedure. Exact sample sizes can be numerically calculated. Then, we propose a flexible idea for selecting the number of reference lots (n(R)) and the number of biosimilar lots (n(T)) to adjust for serious unbalanced sample sizes. From results of extensive simulations under various parameter settings, we obtain a workable strategy to determine the optimum sample size combination (n(T), n(R)) for the equivalence test of CQAs from Tier 1. R codes are provided to facilitate implementation of the roadmap and corresponding methods in practice.	[Wu, Kejian; Li, Chen; Wang, Ling; Xia, Jielai] Fourth Mil Med Univ, Dept Hlth Stat, Xian, Shaanxi, Peoples R China; [Wu, Kejian; Zhao, Qingbo] Fourth Mil Med Univ, Dept Math & Phys, Xian, Shaanxi, Peoples R China; [Pan, Haitao] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA	Air Force Military Medical University; Air Force Military Medical University; St Jude Children's Research Hospital	Wang, L; Xia, JL (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Xian, Shaanxi, Peoples R China.	wl.medstat@gmail.com; jielaixia@yahoo.com			National major scientific and technological special project for significant new drugs development of China [2015ZX09501008-004]; National Natural Science Foundation of China [81773553]; American Lebanese and Syrian Associated Charities	National major scientific and technological special project for significant new drugs development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This research was supported by the National major scientific and technological special project for significant new drugs development of China (2015ZX09501008-004) to JX, and the National Natural Science Foundation of China (81773553) to LW. Pan's research was supported by the American Lebanese and Syrian Associated Charities.	Alt N, 2016, BIOLOGICALS, V44, P291, DOI 10.1016/j.biologicals.2016.06.005; [Anonymous], 2015, GUIDELINE ON SIMILAR; [Anonymous], 2015, QUALITY CONSIDERATIO; [Anonymous], 2015, SCIENTIFIC CONSIDERA; Burdick R, 2017, AAPS J, V19, P4, DOI 10.1208/s12248-016-9968-0; Chen YM, 2017, J BIOPHARM STAT, V27, P308, DOI 10.1080/10543406.2016.1265542; China Food and Drug Administration, 2015, DRAFT GUIDELINE ON D; Chow S.-C., 2015, BIOSIMILARS, V5, P33, DOI [10.2147/BS.S84141, DOI 10.2147/BS.S84141]; Chow SC, 2017, J BIOPHARM STAT, V27, P233, DOI 10.1080/10543406.2016.1265545; Chow SC, 2016, AAPS J, V18, P670, DOI 10.1208/s12248-016-9882-5; Chung Chow S, 2014, DRUG DESIGNING OPEN, V03, DOI DOI 10.4172/2169-0138.1000E124; Dong XY, 2017, J BIOPHARM STAT, V27, P220, DOI 10.1080/10543406.2016.1265544; Dong XY, 2017, J BIOPHARM STAT, V27, P317, DOI [10.1080/10543406.2016.1265546, 10.1080/10543406.2014.972512]; Generics and Biosimilars Initiative (GaBi), FDA APPROVES EPOETIN; Liao JJZ, 2013, STAT MED, V32, P462, DOI 10.1002/sim.5564; Liu J, 2016, BIODRUGS, V30, P321, DOI 10.1007/s40259-016-0184-3; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Seo N, 2018, MABS-AUSTIN, V10, P678, DOI 10.1080/19420862.2018.1452580; Shen MY, 2017, J BIOPHARM STAT, V27, P213, DOI 10.1080/10543406.2016.1265541; Shen MY, 2015, PHARM STAT, V14, P95, DOI 10.1002/pst.1666; Stevenson JG, 2017, ANN PHARMACOTHER, V51, P590, DOI 10.1177/1060028017690743; Tsong Y, 2017, J BIOPHARM STAT, V27, P197, DOI 10.1080/10543406.2016.1272606; Udpa N, 2016, NAT REV DRUG DISCOV, V15, P13, DOI 10.1038/nrd.2015.12; Vandekerckhove K, 2018, AAPS J, V20, DOI 10.1208/s12248-018-0230-9; Wang TR, 2017, J BIOPHARM STAT, V27, P206, DOI 10.1080/10543406.2016.1265539; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wellek S, 1996, BIOMETRICAL J, V38, P695, DOI 10.1002/bimj.4710380608; World Health Organization, 2009, GUIDELINES ON EVALUA; [吴克坚 Wu Kejian], 2018, [中国卫生统计, Chinese Journal of Health Statistics], V35, P343	30	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208354	10.1371/journal.pone.0208354	http://dx.doi.org/10.1371/journal.pone.0208354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521581	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600051
J	Martin, CW; Swenson, EM				Martin, Charles W.; Swenson, Erick M.			Herbivory of oil-exposed submerged aquatic vegetation Ruppia maritima	PLOS ONE			English	Article							WATER-HORIZON OIL; TURTLEGRASS THALASSIA-TESTUDINUM; SEASONAL GROWTH; SALT MARSHES; TROPHIC ROLE; ESTUARINE; LOUISIANA; SPILL; RESPONSES; RECOVERY	Oil spills, such as the Deepwater Horizon spill in the Gulf of Mexico, have the potential to dramatically alter coastal food webs through a variety of mechanisms. While oil can have direct impacts on primary producers through toxicity and shading, it is also possible that more subtle, indirect changes to the interactions among organisms could alter energy flow through the ecosystem. Here, we present the results of a series of manipulative experiments to determine the impacts of oil exposure on herbivory of Ruppia maritima, one of the most common species of submerged vegetation found in the region impacted by the 2010 Deep-water Horizon oil spill. In previous experiments, R. maritima was grown in a range of manipulated sediment oil concentrations. Using plant tissue from this experiment, we analyzed the effects of oil on plant chemical composition and found that plant carbon:nitrogen ratio (C:N) was reduced by as much as 21% in plants exposed to higher concentrations of oil. Given that nitrogen plays a key role in herbivore preference patterns, we performed herbivory assays and found oil-contaminated plants were preferred by herbivores in choice trials, although subsequent no-choice experiments indicated herbivores consumed less oil-contaminated tissue. We hypothesize the reason for this is that more tissue of higher C:N content is needed to meet similar metabolic demands while avoiding the potentially negative impacts of feeding on contaminated tissues. These results indicate that substantial food web alterations may occur via enhanced consumption of oil-exposed plants and provides vital information necessary to assess the large-scale impact of oil on submerged macrophytes.	[Martin, Charles W.] Univ Florida, Inst Food & Agr Sci, Nat Coast Biol Stn, Cedar Key, FL 32625 USA; [Swenson, Erick M.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	State University System of Florida; University of Florida; Louisiana State University System; Louisiana State University	Martin, CW (corresponding author), Univ Florida, Inst Food & Agr Sci, Nat Coast Biol Stn, Cedar Key, FL 32625 USA.	martin.charles.w@gmail.com		Martin, Charles/0000-0001-9240-3824	Gulf of Mexico Research Initiative; Gulf of Mexico Research Initiative Information & Data Cooperative (GRIIDC)	Gulf of Mexico Research Initiative; Gulf of Mexico Research Initiative Information & Data Cooperative (GRIIDC)	This research was made possible by a grant from The Gulf of Mexico Research Initiative.; This research was made possible by a grant from The Gulf of Mexico Research Initiative. Data are publicly available through the Gulf of Mexico Research Initiative Information & Data Cooperative (GRIIDC) at https://data.gulfresearchinitiative.org (doi:R4.x264.000:0080). We thank R.E. Turner, M. Polito, T. Mauney, J. Valentine, A. McDonald, C. Milan, J. Lee, and L. Hollis for their assistance that contributed toward the completion of this project and the constructive comments from the PLoS Editorial Staff and anonymous reviewers.	Able KW, 2011, ESTUAR COAST, V38, P1385; [Anonymous], MARINE ECOLOGICAL PR; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Cho H.J., 2009, HDB ENV QUALITY, P1; Cho HJ, 2005, AQUAT BOT, V81, P37, DOI 10.1016/j.aquabot.2004.10.002; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; Deis DR, 2017, PEERJ, V5, DOI 10.7717/peerj.3680; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P201, DOI 10.3354/meps067201; Duffy JE, 2003, ECOL LETT, V6, P881, DOI 10.1046/j.1461-0248.2003.00503.x; Fleeger JW, 2018, J EXP MAR BIOL ECOL, V502, P182, DOI 10.1016/j.jembe.2017.03.001; Fodrie FJ, 2014, BIOSCIENCE, V64, P778, DOI 10.1093/biosci/biu123; Frederick P, 2016, J SHELLFISH RES, V35, P359, DOI 10.2983/035.035.0210; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Haney JC, 2014, MAR ECOL PROG SER, V513, P225, DOI 10.3354/meps10991; HAY ME, 1984, ECOLOGY, V65, P446, DOI 10.2307/1941407; Hay ME, 1997, CORAL REEFS, V16, pS67, DOI 10.1007/s003380050243; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Herman RW, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3142-9; Hillmann E. R., 2016, J SE ASS FISH WILDL, V3, P25; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kanouse S, 2006, MAR ECOL PROG SER, V327, P61, DOI 10.3354/meps327061; Kauffman TC, 2018, MAR ECOL PROG SER, V592, P97, DOI 10.3354/meps12517; Kenworthy WJ, 2017, MAR ECOL PROG SER, V576, P145, DOI 10.3354/meps11983; Kirsch KD, 2002, MAR ECOL PROG SER, V227, P71, DOI 10.3354/meps227071; KLUMPP DW, 1993, AQUAT BOT, V45, P205, DOI 10.1016/0304-3770(93)90022-O; KRAFT SK, 1982, OECOLOGIA, V52, P156, DOI 10.1007/BF00363829; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Lilly G.R., 1975, THESIS; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; Martin CW, 2017, MAR ECOL PROG SER, V576, P125, DOI 10.3354/meps12084; Martin CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138797; Martin CW, 2012, MAR ECOL PROG SER, V449, P109, DOI 10.3354/meps09515; Martin CW, 2011, ESTUAR COAST, V34, P364, DOI 10.1007/s12237-010-9274-5; Martin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014395; McCall DD, 2007, ECOLOGY, V88, P618, DOI 10.1890/06-0375; McCann MJ, 2017, FRONT ECOL ENVIRON, V15, P142, DOI 10.1002/fee.1474; MCGLATHERY KJ, 1995, MAR ECOL PROG SER, V122, P239, DOI 10.3354/meps122239; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; ORTH RJ, 1988, AQUAT BOT, V32, P291, DOI 10.1016/0304-3770(88)90122-2; Osland MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183431; Pennings SC, 2014, BIOSCIENCE, V64, P789, DOI 10.1093/biosci/biu118; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; Pezeshki SR, 2015, ENVIRONMENTS, V2, P586, DOI 10.3390/environments2040586; Poirrier MA, 2002, SEAGRASS STATUS TREN, P62; Polito MJ, 2017, AGU FALL M; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; Rozas LP, 2013, MAR ECOL PROG SER, V492, P9, DOI 10.3354/meps10486; SCHROEDER LA, 1986, ECOLOGY, V67, P1628, DOI 10.2307/1939094; Scyphers SB, 2015, CONSERV LETT, V8, P242, DOI 10.1111/conl.12127; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Steele L, 2015, MAR ECOL PROG SER, V524, P83, DOI 10.3354/meps11127; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; Turner RE, 2014, MAR POLLUT BULL, V87, P57, DOI 10.1016/j.marpolbul.2014.08.011; Tweel AW, 2014, LANDSCAPE ECOL, V29, P1083, DOI 10.1007/s10980-014-0047-6; VALENTINE JF, 1991, J EXP MAR BIOL ECOL, V154, P215, DOI 10.1016/0022-0981(91)90165-S; Valentine JF, 2001, J EXP MAR BIOL ECOL, V258, P65, DOI 10.1016/S0022-0981(00)00342-7; Valentine JF, 1999, MAR ECOL PROG SER, V176, P291, DOI 10.3354/meps176291; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; Valinoti CE, 2011, J EXP MAR BIOL ECOL, V409, P42, DOI 10.1016/j.jembe.2011.08.001; Vastano AR, 2017, ENVIRON BIOL FISH, V100, P1315, DOI 10.1007/s10641-017-0645-7; Wallace BP, 2017, ENDANGER SPECIES RES, V33, P1, DOI 10.3354/esr00789; WILLIAMS SL, 1988, MAR BIOL, V98, P447, DOI 10.1007/BF00391121; ZIEMAN JC, 1984, B MAR SCI, V35, P380; ZIMMERMAN MS, 1976, MAR BIOL, V34, P297, DOI 10.1007/BF00398123	70	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208463	10.1371/journal.pone.0208463	http://dx.doi.org/10.1371/journal.pone.0208463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517177	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400096
J	Rahmel, T; Nowak, H; Rump, K; Siffert, W; Peters, J; Adamzik, M				Rahmel, Tim; Nowak, Hartmuth; Rump, Katharina; Siffert, Winfried; Peters, Juergen; Adamzik, Michael			The aquaporin 5-1364A/C promoter polymorphism impacts on resolution of acute kidney injury in pneumonia evoked ARDS	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; MECHANICAL VENTILATION; RENAL-FUNCTION; ALDOSTERONE; DYSFUNCTION; EXPRESSION; FAILURE; SYSTEM; RENIN	Background Aquaporin 5 (AQP5) expression impacts on cellular water transport, renal function but also on key mechanisms of inflammation and immune cell migration that prevail in sepsis and ARDS. Thus, the functionally relevant AQP5-1364A/C promoter single nucleotide polymorphism could impact on the development and resolution of acute kidney injury (AKI). Accordingly, we tested the hypothesis that the AQP5promoter-1364A/C polymorphism is associated with AKI in patients suffering from pneumonia evoked ARDS. Methods This prospective study included 136 adult patients of Caucasian ethnicity with bacterially evoked pneumonia resulting in ARDS. Blood sampling was performed within 24 hours of ICU admission and patients were genotyped for the AQP5promoter-1364A/C single nucleotide polymorphism. The development of an AKI and the cumulative net fluid balance was described over a 30-day observation period and compared between the AA and AC/CC genotypes, and between survivors and non-survivors. Results Incidence of an AKI upon admission did not differ in AA (58%) and AC/CC genotype carriers (60%; p = 0.791). However, on day 30, homozygous AA genotypes (57%) showed an increased prevalence of AKI compared to AC/CC genotypes (24%; p = 0.001). Furthermore, the AA genotype proved to be a strong, independent risk factor for predicting AKI persistence (odds-ratio: 3.35; 95%-CI: 1.2-9.0; p = 0.017). While a negative cumulative fluid balance was associated with increased survival (p = 0.001) the AQP5 promoter polymorphism had no impact on net fluid balance (p = 0.96). Conclusions In pneumonia evoked ARDS, the AA genotype of the AQP5promoter polymorphism is associated with a decreased recovery rate from AKI and this is independent of fluid balance. Consequently, the role of AQP5 in influencing AKI likely rests in factors other than fluid balance.	[Rahmel, Tim; Nowak, Hartmuth; Rump, Katharina; Adamzik, Michael] Univ Klinikum Knappschaftskrankenhaus Bochum, Klin Anasthesiol Intens Med & Schmerztherapie, Bochum, Germany; [Siffert, Winfried] Univ Duisburg Essen, Inst Pharmakogenet, Essen, Germany; [Siffert, Winfried; Peters, Juergen; Adamzik, Michael] Univ Klinikum Essen, Essen, Germany; [Peters, Juergen; Adamzik, Michael] Univ Duisburg Essen, Lin Anasthesiol & Intens Med, Essen, Germany	Ruhr University Bochum; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Rahmel, T (corresponding author), Univ Klinikum Knappschaftskrankenhaus Bochum, Klin Anasthesiol Intens Med & Schmerztherapie, Bochum, Germany.	Tim.Rahmel@ruhr-uni-bochum.de	Rump, Katharina/AAJ-9090-2020; Adamzik, Michael/HGE-9286-2022; Rahmel, Tim/AAI-1566-2020	Rump, Katharina/0000-0003-2220-519X; Rahmel, Tim/0000-0002-7039-6288	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum, just for financial support for publication costs. This had no impact on our design or study, collection, analysis and interpretation of data.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Adamzik M, 2008, BASIC RES CARDIOL, V103, P598, DOI 10.1007/s00395-008-0750-z; Adamzik M, 2011, ANESTHESIOLOGY, V114, P912, DOI 10.1097/ALN.0b013e31820ca911; ANNAT G, 1983, ANESTHESIOLOGY, V58, P136, DOI 10.1097/00000542-198302000-00006; Basu RK, 2011, PULM MED, V2011, DOI 10.1155/2011/414253; Bellomo R, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0260-y; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Campanholle G, 2010, INFLAMM RES, V59, P861, DOI 10.1007/s00011-010-0198-0; Chen YC, 2011, ANN THORAC SURG, V91, P137, DOI 10.1016/j.athoracsur.2010.08.063; Cooke CR, 2008, CRIT CARE MED, V36, P1412, DOI 10.1097/CCM.0b013e318170a375; Darmon M, 2014, CLIN J AM SOC NEPHRO, V9, P1347, DOI 10.2215/CJN.08300813; Federspiel CK, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0374-x; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Grigoryev DN, 2008, J AM SOC NEPHROL, V19, P547, DOI 10.1681/ASN.2007040469; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kuiper JW, 2005, CRIT CARE MED, V33, P1408, DOI 10.1097/01.CCM.0000165808.30416.EF; Paladino JD, 2009, MICROVASC RES, V77, P8, DOI 10.1016/j.mvr.2008.09.001; Pannu N, 2013, CLIN J AM SOC NEPHRO, V8, P194, DOI 10.2215/CJN.06480612; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Procino G, 2011, CELL PHYSIOL BIOCHEM, V28, P683, DOI 10.1159/000335762; Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x; Rabb H, 2001, CONTRIB NEPHROL, V132, P41; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Rosenberg Andrew L, 2009, J Intensive Care Med, V24, P35, DOI 10.1177/0885066608329850; Rump K, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1079-2; Rump K, 2013, SHOCK, V40, P430, DOI 10.1097/SHK.0000000000000035; Song YL, 2000, J PHYSIOL-LONDON, V525, P771, DOI 10.1111/j.1469-7793.2000.00771.x; Verkman AS, 2007, RESP PHYSIOL NEUROBI, V159, P324, DOI 10.1016/j.resp.2007.02.012; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208582	10.1371/journal.pone.0208582	http://dx.doi.org/10.1371/journal.pone.0208582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517197	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400107
J	Ma, AH; Tang, M; Zhang, L; Wang, BS; Yang, ZJ; Liu, Y; Xu, GQ; Wu, L; Jing, TT; Xu, XL; Yang, SL; Liu, YZ				Ma, Aihui; Tang, Ming; Zhang, Li; Wang, Boshi; Yang, Zhaojuan; Liu, Yun; Xu, Guiqin; Wu, Lin; Jing, Tiantian; Xu, Xiaoli; Yang, Shengli; Liu, Yongzhong			USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis	ONCOGENE			English	Article							MULTIPLE-MYELOMA; STEM-CELLS; EXPRESSION; DEUBIQUITINATION; CARCINOMAS; SURVIVAL; RNA	Metastatic progression is the main cause of mortality in breast cancer, necessitating the determination of the molecular events driving this process for the development of new therapeutic approaches. Here, we demonstrate that hyperactivation of the deubiquitinase USP1 contributes to breast cancer metastasis. Upregulated USP1 expression in primary breast cancer specimens correlates with metastatic progression and poor prognosis in breast cancer patients. USP1 enhances the expression of a number of pro-metastatic genes in breast cancer cells, promotes cell migration and invasion in vitro, and facilitates lung metastasis of breast cancer cells. Moreover, USP1-mediated deubiquitination and stabilization of KPNA2 are revealed as the downstream events crucial for USP1-pro-metastatic function. Most importantly, pharmacological intervention of USP1 function by pimozide or ML323 significantly represses breast cancer metastasis in mice, suggesting a rationale for using USP1 inhibitors for treatment of patients with breast cancer. Taken together, our results establish USP1 as a promoter of breast cancer metastasis and provide evidence for the potential practice of USP1 targeting in the treatment of breast cancer.	[Ma, Aihui; Tang, Ming; Zhang, Li; Wang, Boshi; Yang, Zhaojuan; Liu, Yun; Xu, Guiqin; Wu, Lin; Jing, Tiantian; Xu, Xiaoli; Yang, Shengli; Liu, Yongzhong] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University	Liu, YZ (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China.	liuyzg@shsci.org		Liu, Yongzhong/0000-0002-1477-116X	National Natural Science Foundation of China [81572293, 31770976, 81672359]; Natural Science Foundation of Shanghai [18ZR1436800]; State Key Laboratory of Oncogenes and Related Genes [91-1705, 91-17-11]; Shanghai Cancer Institute [SB18-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); State Key Laboratory of Oncogenes and Related Genes; Shanghai Cancer Institute	This work was supported by the National Natural Science Foundation of China (81572293, 31770976, and 81672359), Natural Science Foundation of Shanghai (18ZR1436800), the State Key Laboratory of Oncogenes and Related Genes (91-1705, 91-17-11), and Shanghai Cancer Institute (SB18-07).	Altan B, 2013, CARCINOGENESIS, V34, P2314, DOI 10.1093/carcin/bgt214; Auslander D, 2018, NAT METHODS, V15, P57, DOI [10.1038/NMETH.4505, 10.1038/nmeth.4505]; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brown D, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15759, 10.1038/ncomms14944]; Chen JJ, 2011, CHEM BIOL, V18, P1390, DOI 10.1016/j.chembiol.2011.08.014; Christiansen A, 2013, CANCER LETT, V331, P18, DOI 10.1016/j.canlet.2012.12.013; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Dankof A, 2007, VIRCHOWS ARCH, V451, P877, DOI 10.1007/s00428-007-0513-5; Das DS, 2017, CLIN CANCER RES, V23, P4280, DOI 10.1158/1078-0432.CCR-16-2692; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fujiwara T, 1998, GENOMICS, V54, P155, DOI 10.1006/geno.1998.5554; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Jensen JB, 2011, EUR UROL, V59, P841, DOI 10.1016/j.eururo.2011.01.048; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Lee JK, 2016, NEURO-ONCOLOGY, V18, P37, DOI 10.1093/neuonc/nov091; Liang Q, 2014, NAT CHEM BIOL, V10, P298, DOI [10.1038/NCHEMBIO.1455, 10.1038/nchembio.1455]; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Mothi M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001949.pub3; Ni IBP, 2010, PATHOL RES PRACT, V206, P223, DOI 10.1016/j.prp.2009.11.006; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Ogrunc M, 2016, CELL REP, V15, P1401, DOI 10.1016/j.celrep.2016.04.033; Rahme GJ, 2016, CANCER RES, V76, P2964, DOI 10.1158/0008-5472.CAN-15-2157; Raimondi M, 2016, CELL CYCLE, V15, P106, DOI 10.1080/15384101.2015.1121325; Ree AH, 1997, CLIN CANCER RES, V3, P1623; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudland PS, 2000, CANCER RES, V60, P1595; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Siegel MB, 2018, J CLIN INVEST, V128, P1371, DOI 10.1172/JCI96153; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TUETH MJ, 1993, SOUTH MED J, V86, P344, DOI 10.1097/00007611-199303000-00019; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wu YD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14228; Xiao ZN, 2016, CANCER METAST REV, V35, P589, DOI 10.1007/s10555-016-9640-2; Yu ZX, 2017, J EXP MED, V214, P3553, DOI 10.1084/jem.20170180; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522	50	49	53	5	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2405	2419		10.1038/s41388-018-0590-8	http://dx.doi.org/10.1038/s41388-018-0590-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30531833				2022-12-26	WOS:000462588000013
J	Traxel, S; Schadt, L; Eyer, T; Mordasini, V; Gysin, C; Munthe, LA; Niggli, F; Nadal, D; Burgler, S				Traxel, Sabrina; Schadt, Linda; Eyer, Tatjana; Mordasini, Vanessa; Gysin, Claudine; Munthe, Ludvig A.; Niggli, Felix; Nadal, David; Burgler, Simone			Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CHILDHOOD LEUKEMIA; MULTIPLE-MYELOMA; GENE-EXPRESSION; IFN-GAMMA; TRANSCRIPTION FACTOR; CYTOKINE PRODUCTION; LYMPHOMA-CELLS; IN-VITRO; PRE-B	Precursor B cell acute lymphoblastic leukemia (BCP-ALL) constitutes the leading cause of cancer-related death in children. While chromosomal alterations contribute to BCP-ALL pathogenesis, they are insufficient for leukemia development. Epidemiological data and evidence from a mouse model suggest that immune responses to infections may trigger the emergence of leukemia, but the mechanisms remain unclear. Here, we show that T helper (Th) cells from bone marrow of pediatric BCP-ALL patients can be attracted and activated by autologous BCP-ALL cells. Bone-marrow Th cells supportively interacted with BCP-ALL cells, inducing upregulation of important surface molecules and BCP-ALL cell proliferation. These Th cells displayed a Th1-like phenotype and produced high levels of IFN-gamma. IFN-gamma was responsible for the upregulation of CD38 in BCP-ALL cells, a molecule which we found to be associated with early relapse, and accountable for the production of IP-10, a chemokine involved in BCP-ALL migration and drug resistance. Thus, our data provide mechanistic support for an involvement of Th cell immune responses in the propagation of BCP-ALL and suggest that BCP-ALL cell-supportive Th cells may serve as therapeutic target.	[Traxel, Sabrina; Schadt, Linda; Eyer, Tatjana; Mordasini, Vanessa; Niggli, Felix; Nadal, David; Burgler, Simone] Univ Childrens Hosp Zurich, Expt Infect Dis & Canc Res, Childrens Res Ctr, Zurich, Switzerland; [Gysin, Claudine] Univ Childrens Hosp Zurich, Div Otolaryngol, Childrens Res Ctr, Zurich, Switzerland; [Munthe, Ludvig A.] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Inst Clin Med, Oslo, Norway	University Children's Hospital Zurich; University Children's Hospital Zurich; University of Oslo	Burgler, S (corresponding author), Univ Childrens Hosp Zurich, Expt Infect Dis & Canc Res, Childrens Res Ctr, Zurich, Switzerland.	simone.buergler@kispi.uzh.ch	Munthe, Ludvig/GRJ-3355-2022	Traxel, Sabrina/0000-0002-9193-5586; Munthe, Ludvig A/0000-0002-0344-3654	Forschungskredit of the University of Zurich; Children's Research Center (CRC) of the Children's Hospital Zurich; Stiftung fur Krebsbekampfung; Krebsliga Schweiz/Swiss Cancer League [KLS 3189-02-2013]; Charles Meyer Cancer Research Initiative	Forschungskredit of the University of Zurich; Children's Research Center (CRC) of the Children's Hospital Zurich; Stiftung fur Krebsbekampfung; Krebsliga Schweiz/Swiss Cancer League; Charles Meyer Cancer Research Initiative	We thank the pediatric patients and donors who provided the clinical samples. This work was supported by the Forschungskredit of the University of Zurich, The Children's Research Center (CRC) of the Children's Hospital Zurich, the Stiftung fur Krebsbekampfung and the Krebsliga Schweiz/Swiss Cancer League (grant number KLS 3189-02-2013), the Krebsliga Schweiz/Swiss Cancer League (grant number KLS 3189-02-2013) and the Charles Meyer Cancer Research Initiative.	Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Boyerinas B, 2013, BLOOD, V121, P4821, DOI 10.1182/blood-2012-12-475483; Burgler S, 2015, CRIT REV IMMUNOL, V35, P417, DOI 10.1615/CritRevImmunol.v35.i5.50; Burgler S, 2015, J IMMUNOL, V194, P827, DOI 10.4049/jimmunol.1401350; BUSCHLE M, 1993, J EXP MED, V177, P213, DOI 10.1084/jem.177.1.213; Buske C, 1997, EXP HEMATOL, V25, P329; Cardoso AA, 1996, BLOOD, V88, P41; Chen JJY, 2002, J LEUKOCYTE BIOL, V72, P271; Chillemi A, 2014, FRONT BIOSCI-LANDMRK, V19, P152, DOI 10.2741/4201; Deckert J, 2014, CLIN CANCER RES, V20, P4574, DOI 10.1158/1078-0432.CCR-14-0695; Dhodapkar MV, 2003, J EXP MED, V198, P1753, DOI 10.1084/jem.20031030; Duan CW, 2014, CANCER CELL, V25, P778, DOI 10.1016/j.ccr.2014.04.015; Einav U, 2005, ONCOGENE, V24, P6367, DOI 10.1038/sj.onc.1208797; Fei F, 2015, ONCOTARGET, V6, P11378, DOI 10.18632/oncotarget.3409; Feuerer M, 2001, NAT MED, V7, P452, DOI 10.1038/86523; FLUCKIGER AC, 1992, BLOOD, V80, P3173; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; Fortney JE, 2001, LEUKEMIA RES, V25, P901, DOI 10.1016/S0145-2126(01)00051-0; Ghia P, 2001, BLOOD, V98, P533, DOI 10.1182/blood.V98.3.533; Gomez AM, 2015, BLOOD CELL MOL DIS, V55, P220, DOI 10.1016/j.bcmd.2015.07.001; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves M, 2018, NAT REV CANCER, V18, P471, DOI 10.1038/s41568-018-0015-6; Herndler-Brandstetter D, 2011, J IMMUNOL, V186, P6965, DOI 10.4049/jimmunol.1100243; Hersher R, 2012, NAT MED, V18, P1446, DOI 10.1038/nm1012-1446a; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; JOHNSON PWM, 1993, BLOOD, V82, P1848, DOI 10.1182/blood.V82.6.1848.bloodjournal8261848; KINLEN L, 1988, LANCET, V2, P1323; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Kreis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170020; Lee Y, 2012, BLOOD, V119, P227, DOI 10.1182/blood-2011-06-357442; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; MacKenzie J, 2006, HAEMATOL-HEMATOL J, V91, P240; Martin-Lorenzo A, 2015, CANCER DISCOV, V5, P1328, DOI 10.1158/2159-8290.CD-15-0892; McHeyzer-Williams LJ, 2006, CURR TOP MICROBIOL, V311, P59; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Nakase K, 2007, LEUKEMIA, V21, P326, DOI 10.1038/sj.leu.2404497; Nijhof IS, 2015, CLIN CANCER RES, V21, P2802, DOI 10.1158/1078-0432.CCR-14-1813; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; Os A, 2013, CELL REP, V4, P566, DOI 10.1016/j.celrep.2013.07.011; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pangault C, 2010, LEUKEMIA, V24, P2080, DOI 10.1038/leu.2010.223; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Purizaca J, 2012, ARCH MED RES, V43, P89, DOI 10.1016/j.arcmed.2012.03.005; Raetz EA, 2012, HEMATOL-AM SOC HEMAT, P129, DOI 10.1182/asheducation-2012.1.129; Rakoff-Nahoum Seth, 2006, Yale J Biol Med, V79, P123; Reid GSD, 2003, LEUKEMIA RES, V27, P1135, DOI 10.1016/S0145-2126(03)00106-1; Renard N, 1996, BLOOD, V87, P5162, DOI 10.1182/blood.V87.12.5162.bloodjournal87125162; Richardson RB, 2011, LEUKEMIA RES, V35, P1425, DOI 10.1016/j.leukres.2011.07.023; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taylor GM, 2009, LEUKEMIA, V23, P863, DOI 10.1038/leu.2008.374; Thompson P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100480; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; UMETSU DT, 1990, J IMMUNOL, V144, P2550; Vaisitti T, 2015, LEUKEMIA, V29, P356, DOI 10.1038/leu.2014.207; van der Veer MS, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.42; Wang D, 2017, LEUKEMIA, V31, P2114, DOI 10.1038/leu.2017.69; Wu SL, 2005, CANCER-AM CANCER SOC, V103, P1054, DOI 10.1002/cncr.20869; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Zaki M, 2000, LEUKEMIA RES, V24, P611, DOI 10.1016/S0145-2126(00)00022-9; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	66	4	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2420	2431		10.1038/s41388-018-0594-4	http://dx.doi.org/10.1038/s41388-018-0594-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30532071				2022-12-26	WOS:000462588000014
J	Violante, S; Achetib, N; van Roermund, CWT; Hagen, J; Dodatko, T; Vaz, FM; Waterham, HR; Chen, HJ; Baes, M; Yu, CL; Argmann, CA; Houten, SM				Violante, Sara; Achetib, Nihad; van Roermund, Carlo W. T.; Hagen, Jacob; Dodatko, Tetyana; Vaz, Frederic M.; Waterham, Hans R.; Chen, Hongjie; Baes, Myriam; Yu, Chunli; Argmann, Carmen A.; Houten, Sander M.			Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4	FASEB JOURNAL			English	Article						fatty acid oxidation; mitochondria; organellar crosstalk; acylcarnitine; CPT2 deficiency	PALMITOYLTRANSFERASE-II DEFICIENCY; CARNITINE PALMITOYLTRANSFERASE; BETA-OXIDATION; MOUSE-LIVER; MOLECULAR-CLONING; PRISTANIC ACID; ACETYL MOIETY; PHYTANIC ACID; MALONYL-COA; MITOCHONDRIAL	Peroxisomes are essential organelles for the specialized oxidation of a wide variety of fatty acids, but they are also able to degrade fatty acids that are typically handled by mitochondria. Using a combination of pharmacological inhibition and clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 genome editing technology to simultaneously manipulate peroxisomal and mitochondrial fatty acid -oxidation (FAO) in HEK-293 cells, we identified essential players in the metabolic crosstalk between these organelles. Depletion of carnitine palmitoyltransferase (CPT)2 activity through pharmacological inhibition or knockout (KO) uncovered a significant residual peroxisomal oxidation of lauric and palmitic acid, leading to the production of peroxisomal acylcarnitine intermediates. Generation and analysis of additional single- and double-KO cell lines revealed that the D-bifunctional protein (HSD17B4) and the peroxisomal ABC transporter ABCD3 are essential in peroxisomal oxidation of lauric and palmitic acid. Our results indicate that peroxisomes not only accept acyl-CoAs but can also oxidize acylcarnitines in a similar biochemical pathway. By using an Hsd17b4 KO mouse model, we demonstrated that peroxisomes contribute to the plasma acylcarnitine profile after acute inhibition of CPT2, proving in vivo relevance of this pathway. We summarize that peroxisomal FAO is important when mitochondrial FAO is defective or overloaded.Violante, S., Achetib, N., van Roermund, C. W. T., Hagen, J., Dodatko, T., Vaz, F. M., Waterham, H. R., Chen, H., Baes, M., Yu, C., Argmann, C. A., Houten, S. M. Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.	[Violante, Sara; Achetib, Nihad; Hagen, Jacob; Dodatko, Tetyana; Chen, Hongjie; Yu, Chunli; Argmann, Carmen A.; Houten, Sander M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave,Box 1498, New York, NY 10029 USA; [Violante, Sara; Achetib, Nihad; Hagen, Jacob; Dodatko, Tetyana; Argmann, Carmen A.; Houten, Sander M.] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA; [Violante, Sara; Chen, Hongjie; Yu, Chunli] Mt Sinai Genom Inc, New York, NY USA; [van Roermund, Carlo W. T.; Vaz, Frederic M.; Waterham, Hans R.] Dept Clin Chem, Amsterdam, Netherlands; [van Roermund, Carlo W. T.; Vaz, Frederic M.; Waterham, Hans R.] Dept Pediat, Amsterdam, Netherlands; [van Roermund, Carlo W. T.; Vaz, Frederic M.; Waterham, Hans R.] Lab Genet Metab Dis, Amsterdam, Netherlands; [Baes, Myriam] Univ Leuven, KU Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Cell Metab, Leuven, Belgium	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; KU Leuven	Houten, SM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave,Box 1498, New York, NY 10029 USA.	sander.houten@mssm.edu	Houten, Sander/Y-3599-2019	Houten, Sander/0000-0002-6167-9147; Vaz, Frederic/0000-0002-9048-1041; Baes, Myriam/0000-0002-2525-2269	U.S. Natiional Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Award [R01DK113172]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113172] Funding Source: NIH RePORTER	U.S. Natiional Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Janet Koster (Academic Medical Center) for providing the ABCD3 plasmid, Ethellyn Panta and Tara Singh (Clinical Biochemical Genetics, Icahn School of Medicine at Mount Sinai) for assistance with the acylcarnitine measurements, Charles L. Hoppel (Case Western Reserve University, Cleveland, OH, USA) for quantification of the C14:1-carnitines, and Benny Das (University of Leuven) for technical assistance. Research reported in this publication was supported by U.S. Natiional Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Award R01DK113172. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Albers S, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e103; Anichini A, 2011, NEUROL RES, V33, P24, DOI 10.1179/016164110X12767786356390; Antonenkov VD, 2012, BBA-MOL BASIS DIS, V1822, P1374, DOI 10.1016/j.bbadis.2011.12.011; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Baker A, 2015, BIOCHEM SOC T, V43, P959, DOI 10.1042/BST20150127; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Carnitine Palmitoyltransferase II Deficiency, 1993, GENEREVIEWS; Chegary M, 2008, MOL GENET METAB, V93, P403, DOI 10.1016/j.ymgme.2007.11.001; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; CHOI SJ, 1995, BBA-GENE STRUCT EXPR, V1264, P215, DOI 10.1016/0167-4781(95)00146-8; Ding J, 2013, CELL REP, V5, P248, DOI 10.1016/j.celrep.2013.08.032; Ebberink MS, 2011, HUM MUTAT, V32, P59, DOI 10.1002/humu.21388; FARRELL SO, 1983, ARCH BIOCHEM BIOPHYS, V222, P123, DOI 10.1016/0003-9861(83)90509-X; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Ferdinandusse S, 2015, HUM MOL GENET, V24, P361, DOI 10.1093/hmg/ddu448; Fontaine M, 1998, CLIN CHIM ACTA, V273, P161, DOI 10.1016/S0009-8981(98)00041-2; Furihata T, 2003, ARCH BIOCHEM BIOPHYS, V416, P101, DOI 10.1016/S0003-9861(03)00286-8; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Houten SM, 2012, J LIPID RES, V53, P1296, DOI 10.1194/jlr.M024463; Hurvitz H, 2000, PEDIATR NEUROL, V22, P148, DOI 10.1016/S0887-8994(99)00125-3; JAKOBS BS, 1995, BIOCHEM BIOPH RES CO, V213, P1035, DOI 10.1006/bbrc.1995.2232; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; LAZAROW PB, 1977, SCIENCE, V197, P580, DOI 10.1126/science.195342; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; Minkler PE, 2015, MOL GENET METAB, V116, P231, DOI 10.1016/j.ymgme.2015.10.002; Minkler PE, 2015, ANAL CHEM, V87, P8994, DOI 10.1021/acs.analchem.5b02198; MIYAZAWA S, 1983, J BIOCHEM, V94, P529, DOI 10.1093/oxfordjournals.jbchem.a134384; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; Satoh T, 2006, CHEM-BIOL INTERACT, V162, P195, DOI 10.1016/j.cbi.2006.07.001; Schrader M, 2015, J INHERIT METAB DIS, V38, P681, DOI 10.1007/s10545-015-9819-7; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001; Ventura FV, 1999, CLIN CHIM ACTA, V281, P1, DOI 10.1016/S0009-8981(98)00188-0; Verhoeven NM, 1998, J LIPID RES, V39, P66; Verhoeven NM, 1998, J INHERIT METAB DIS, V21, P753, DOI 10.1023/A:1005449200468; Violante S, 2013, BBA-MOL CELL BIOL L, V1831, P1467, DOI 10.1016/j.bbalip.2013.06.007; Violante S, 2013, FASEB J, V27, P2039, DOI 10.1096/fj.12-216689; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Yamada K, 2017, MOL GENET METAB REP, V11, P59, DOI 10.1016/j.ymgmr.2017.04.008	51	40	41	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4355	4364		10.1096/fj.201801498R	http://dx.doi.org/10.1096/fj.201801498R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30540494	Green Published, Bronze			2022-12-26	WOS:000459794800100
J	Marrella, SA; Brown, KA; Mansouri-Noori, F; Porat, J; Wilson, DJ; Bayfield, MA				Marrella, Stefano A.; Brown, Kerene A.; Mansouri-Noori, Farnaz; Porat, Jennifer; Wilson, Derek J.; Bayfield, Mark A.			An interdomain bridge influences RNA binding of the human La protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; precursor tRNA (pre-tRNA); RNA processing; intracellular trafficking; protein domain; mass spectrometry (MS); RNA-protein interaction; La protein; Sjogren syndrome antigen B; SSB	STRUCTURAL-ANALYSIS; CHAPERONE ACTIVITY; MASS-SPECTROMETRY; POLIOVIRUS RNA; RECOGNITION; TRANSLATION; REVEALS; COMPLEXES; DOMAIN; PHOSPHORYLATION	La proteins are RNA chaperones that perform various functions depending on distinct RNA-binding modes and their subcellular localization. In the nucleus, they help process UUU-3 ' OH-tailed nascent RNA polymerase III transcripts, such as pre-tRNAs, whereas in the cytoplasm they contribute to translation of poly(A)-tailed mRNAs. La accumulation in the nucleus and cytoplasm is controlled by several trafficking elements, including a canonical nuclear localization signal in the extreme C terminus and a nuclear retention element (NRE) in the RNA recognition motif 2 (RRM2) domain. Previous findings indicate that cytoplasmic export of La due to mutation of the NRE can be suppressed by mutations in RRM1, but the mechanism by which the RRM1 and RRM2 domains functionally cooperate is poorly understood. In this work, we use electromobility shift assays (EMSA) to show that mutations in the NRE and RRM1 affect binding of human La to pre-tRNAs but not UUU-3 ' OH or poly(A) sequences, and we present compensatory mutagenesis data supporting a direct interaction between the RRM1 and RRM2 domains. Moreover, we use collision-induced unfolding and time-resolved hydrogen-deuterium exchange MS analyses to study the conformational dynamics that occur when this interaction is intact or disrupted. Our results suggest that the intracellular distribution of La may be linked to its RNA-binding modes and provide the first evidence for a direct protein-protein interdomain interaction in La proteins.	[Marrella, Stefano A.; Mansouri-Noori, Farnaz; Porat, Jennifer; Bayfield, Mark A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Brown, Kerene A.; Wilson, Derek J.] York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada; [Marrella, Stefano A.; Brown, Kerene A.; Mansouri-Noori, Farnaz; Porat, Jennifer; Wilson, Derek J.; Bayfield, Mark A.] York Univ, Ctr Res Biomol Interact, Toronto, ON M3J 1P3, Canada; [Brown, Kerene A.; Wilson, Derek J.] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada	Bayfield, MA (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada.; Wilson, DJ (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada.; Wilson, DJ; Bayfield, MA (corresponding author), York Univ, Ctr Res Biomol Interact, Toronto, ON M3J 1P3, Canada.; Wilson, DJ (corresponding author), York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada.	dkwilson@yorku.ca; bayfield@yorku.ca		Bayfield, Mark/0000-0002-8971-7598	Canadian Institutes of Health Research's Institute of Genetics; Natural Sciences and Engineering Council of Canada [DG-544760]; Collaborative Research and Development Program Grant [CRD-485321-15]	Canadian Institutes of Health Research's Institute of Genetics; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Collaborative Research and Development Program Grant	This work was supported by an open operating grant from the Canadian Institutes of Health Research's Institute of Genetics (to M. A. B.), Natural Sciences and Engineering Council of Canada Discovery Program Grant DG-544760, and Collaborative Research and Development Program Grant CRD-485321-15. The authors declare that they have no conflicts of interest with the contents of this article.	Alfano C, 2004, NAT STRUCT MOL BIOL, V11, P323, DOI 10.1038/nsmb747; Allison TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9551; Bayfield MA, 2007, MOL CELL BIOL, V27, P3303, DOI 10.1128/MCB.00026-07; Bayfield MA, 2009, NAT STRUCT MOL BIOL, V16, P430, DOI 10.1038/nsmb.1573; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Brown KA, 2017, ANALYST, V142, P2874, DOI 10.1039/c7an00662d; Brown KA, 2016, BIOCHEMISTRY-US, V55, P7141, DOI 10.1021/acs.biochem.6b00995; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; Fan H, 1998, MOL CELL BIOL, V18, P3201, DOI 10.1128/MCB.18.6.3201; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Goodier JL, 1997, MOL CELL BIOL, V17, P5823, DOI 10.1128/MCB.17.10.5823; Hopper JTS, 2009, J AM SOC MASS SPECTR, V20, P1851, DOI 10.1016/j.jasms.2009.06.010; Huang Y, 2006, NAT STRUCT MOL BIOL, V13, P611, DOI 10.1038/nsmb1110; Hussain RH, 2013, NUCLEIC ACIDS RES, V41, P8715, DOI 10.1093/nar/gkt649; Inada M, 2004, P NATL ACAD SCI USA, V101, P434, DOI 10.1073/pnas.0307425100; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Intine RV, 2002, MOL CELL, V9, P1113, DOI 10.1016/S1097-2765(02)00533-6; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Kuehnert J, 2015, NUCLEIC ACIDS RES, V43, P581, DOI 10.1093/nar/gku1309; Lento C, 2015, CAN J CHEM, V93, P7, DOI 10.1139/cjc-2014-0260; Liuni P, 2010, RAPID COMMUN MASS SP, V24, P315, DOI 10.1002/rcm.4391; Martino L, 2012, NUCLEIC ACIDS RES, V40, P1381, DOI 10.1093/nar/gkr890; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; Naeeni AR, 2012, J BIOL CHEM, V287, P5472, DOI 10.1074/jbc.M111.276071; Niu S, 2015, PROTEIN SCI, V24, P1272, DOI 10.1002/pro.2699; Niu S, 2013, CURR OPIN CHEM BIOL, V17, P809, DOI 10.1016/j.cbpa.2013.06.019; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Rey M, 2014, STRUCTURE, V22, P1538, DOI 10.1016/j.str.2014.08.013; SIMONS FHM, 1994, J CELL BIOL, V125, P981, DOI 10.1083/jcb.125.5.981; Singh M, 2013, RNA BIOL, V10, P353, DOI 10.4161/rna.23608; Singh M, 2012, MOL CELL, V47, P16, DOI 10.1016/j.molcel.2012.05.018; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; STEFANO JE, 1984, CELL, V36, P145, DOI 10.1016/0092-8674(84)90083-7; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Vakiloroayaei A, 2017, NUCLEIC ACIDS RES, V45, P11341, DOI 10.1093/nar/gkx764; van Duijn E, 2009, J AM CHEM SOC, V131, P1452, DOI 10.1021/ja8055134; Vinayak J, 2018, NUCLEIC ACIDS RES, V46, P4228, DOI 10.1093/nar/gky090; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015032	43	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1529	1540		10.1074/jbc.RA118.003995	http://dx.doi.org/10.1074/jbc.RA118.003995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30530494	Green Published, hybrid			2022-12-26	WOS:000457879200009
J	Spencer, C; Bensing, BA; Mishra, NN; Sullam, PM				Spencer, Cierra; Bensing, Barbara A.; Mishra, Nagendra N.; Sullam, Paul M.			Membrane trafficking of the bacterial adhesin GspB and the accessory Sec transport machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid-protein interaction; protein translocation; liposome; protein targeting; Streptococcus; adhesin; accessory Sec system; anionic lipids; electrostatic interactions; signal peptide; adhesion	SURFACE GLYCOPROTEIN GSPB; STREPTOCOCCUS-GORDONII; SIGNAL PEPTIDES; BINDING; EXPORT; GLYCOSYLATION; SYSTEM; GLYCOLIPIDS; COMPONENTS; SUBSTRATE	The serine-rich repeat (SRR) glycoproteins of Gram-positive bacteria are large, cell wall-anchored adhesins that mediate binding to many host cells and proteins and are associated with bacterial virulence. SRR glycoproteins are exported to the cell surface by the accessory Sec (aSec) system comprising SecA2, SecY2, and 3-5 additional proteins (Asp1 to Asp5) that are required for substrate export. These adhesins typically have a 90-amino acid-long signal peptide containing an elongated N-region and a hydrophobic core. Previous studies of GspB (the SRR adhesin of Streptococcus gordonii) have shown that a glycine-rich motif in its hydrophobic core is essential for selective, aSec-mediated transport. However, the role of this extended N-region in transport is poorly understood. Here, using protein-lipid co-flotation assays and site-directed mutagenesis, we report that the N-region of the GspB signal peptide interacts with anionic lipids through electrostatic forces and that this interaction is necessary for GspB preprotein trafficking to lipid membranes. Moreover, we observed that protein-lipid binding is required for engagement of GspB with SecA2 and for aSec-mediated transport. We further found that SecA2 and Asp1 to Asp3 also localize selectively to liposomes that contain anionic lipids. These findings suggest that the GspB signal peptide electrostatically binds anionic lipids at the cell membrane, where it encounters SecA2. After SecA2 engagement with the signal peptide, Asp1 to Asp3 promote SecA2 engagement with the mature domain, which activates GspB translocation.	[Spencer, Cierra; Bensing, Barbara A.; Sullam, Paul M.] San Francisco VA Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA; [Spencer, Cierra; Bensing, Barbara A.; Sullam, Paul M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Mishra, Nagendra N.] Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90502 USA; [Mishra, Nagendra N.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sullam, PM (corresponding author), Vet Affairs Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA.	paul.sullam@ucsf.edu		Spencer, Cierra/0000-0001-9723-0766	American Heart Association postdoctoral fellowship; NIAID, National Institutes of Health [5 T32 AI060537-13, R01AI41513]; LA Biomed-Harbor UCLA [31604-01]; Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041513, T32AI060537] Funding Source: NIH RePORTER	American Heart Association postdoctoral fellowship(American Heart Association); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); LA Biomed-Harbor UCLA; Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an American Heart Association postdoctoral fellowship (to C. S.); NIAID, National Institutes of Health, Postdoctoral Training Grant 5 T32 AI060537-13 (to C. S.) and Grant R01AI41513 (to P. M. S.); Merck (to N. N. M.); and LA Biomed-Harbor UCLA, Intramural Research Grant 31604-01 (to N. N. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams HM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02552-16; Ahn T, 2002, J BIOL CHEM, V277, P26157, DOI 10.1074/jbc.M203445200; Bandara M, 2016, J BIOL CHEM, V291, P21474, DOI 10.1074/jbc.M116.729806; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2007, J BACTERIOL, V189, P3846, DOI 10.1128/JB.00027-07; Bensing BA, 2016, GLYCOBIOLOGY, V26, P1222, DOI 10.1093/glycob/cww042; Bensing BA, 2012, J BIOL CHEM, V287, P24438, DOI 10.1074/jbc.M112.378059; Bensing BA, 2010, J BACTERIOL, V192, P4223, DOI 10.1128/JB.00373-10; Bensing BA, 2009, J BACTERIOL, V191, P3482, DOI 10.1128/JB.00365-09; BRUNDISH DE, 1966, BIOCHEM J, V99, P546; BRUNDISH DE, 1965, BIOCHEM J, V97, P158; BRUNDISH DE, 1965, BIOCHEM J, V97, pC37, DOI 10.1042/bj0970037C; Chen Q, 2006, FEMS MICROBIOL LETT, V264, P174, DOI 10.1111/j.1574-6968.2006.00455.x; Chen Y, 2016, P NATL ACAD SCI USA, V113, pE1190, DOI 10.1073/pnas.1600494113; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; FISCHER W, 1977, BIOCHIM BIOPHYS ACTA, V487, P89, DOI 10.1016/0005-2760(77)90046-7; FISCHER W, 1970, BIOCHEM BIOPH RES CO, V41, P731, DOI 10.1016/0006-291X(70)90074-4; HOYT DW, 1991, BIOCHEMISTRY-US, V30, P10155, DOI 10.1021/bi00106a012; Jiang YL, 2017, J BIOL CHEM, V292, P6213, DOI 10.1074/jbc.M116.770446; KELLER RCA, 1992, BIOCHEMISTRY-US, V31, P1672, DOI 10.1021/bi00121a014; KOMARATAT P, 1975, BIOCHIM BIOPHYS ACTA, V398, P464, DOI 10.1016/0005-2760(75)90197-6; MACRINA FL, 1983, GENE, V25, P145; MCKNIGHT CJ, 1989, J BIOL CHEM, V264, P17293; Meiers M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-12; Mishra NN, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02435-16; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Seepersaud R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006558; Seepersaud R, 2012, J BACTERIOL, V194, P5564, DOI 10.1128/JB.01000-12; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Seo HS, 2013, J BIOL CHEM, V288, P35982, DOI 10.1074/jbc.M113.513358; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; SHAW N, 1970, Bacteriological Reviews, V34, P365; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; UMEMOTO Y, 1978, AGR BIOL CHEM TOKYO, V42, P213, DOI 10.1080/00021369.1978.10862960; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Yen YT, 2013, J BACTERIOL, V195, P682, DOI 10.1128/JB.01742-12; Yen YT, 2011, J BACTERIOL, V193, P3165, DOI 10.1128/JB.00057-11; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Zhang J, 2018, J BIOL CHEM, V293, P4366, DOI 10.1074/jbc.M117.814327; Zhu F, 2016, J BIOL CHEM, V291, P27354, DOI 10.1074/jbc.M116.752998	48	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1502	1515		10.1074/jbc.RA118.005657	http://dx.doi.org/10.1074/jbc.RA118.005657			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30514759	Green Published, hybrid			2022-12-26	WOS:000457879200007
J	Ameli, R; Sinaii, N; Luna, MJ; Cheringal, J; Gril, B; Berger, A				Ameli, Rezvan; Sinaii, Ninet; Luna, Maria Jose; Cheringal, Julia; Gril, Brunilde; Berger, Ann			The National Institutes of Health measure of Healing Experience of All Life Stressors (NIH-HEALS): Factor analysis and validation	PLOS ONE			English	Article							POSTTRAUMATIC GROWTH; THREATENING ILLNESS; ADVANCED CANCER; SOCIAL SUPPORT; BREAST-CANCER; SPIRITUALITY; ADJUSTMENT; RELIGION; SENSE; RESILIENCE	Two hundred patients with severe and/or life-threatening disease were recruited form the NIH Clinical Center and participated in the validation of the NIH-HEALS, which included exploratory factor analysis, principal component analysis, reliability, convergent validity, and divergent validity analyses. Item-reducing principal components analysis and internal consistency and split-half reliability demonstrated excellent internal consistency and split-half reliability (Cronbach's alpha = 0.89, split-half reliability = 0.95). Exploratory factor analysis revealed a three-factor structure, namely Connection (including religious, spiritual, and interpersonal), Reflection & Introspection, and Trust & Acceptance. Seven items were not retained. Convergent and divergent validity of 35-item NI H-HEALS against other validated measures of healing and spirituality provided strong evidence for its validity. As predicted, the Healed factor of the Self-Integration Scale (SIS), and Meaning, Peace, and Faith factors of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being-12 Scale (FACIT-SP12) were all positively and significantly correlated with the NIH-HEALS and its three factors. Divergent validity was also confirmed by the significant negative correlation between the NIH-HEALS and the Codependent factor on the SIS. Confirmatory Factor Analyses revealed good model fit by GFI (0.96), adjusted GFI (0.95), SRMR (0.077), and RMSEA (0.065), supporting the use of the NIH-HEALS with 35 items.	[Ameli, Rezvan] NIMH, NIH, Bethesda, MD 20892 USA; [Sinaii, Ninet; Berger, Ann] NIH, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Luna, Maria Jose] Northwestern Univ, Chicago, IL 60611 USA; [Cheringal, Julia] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Gril, Brunilde] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Northwestern University; Walter Reed National Military Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ameli, R (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	Rezvan.Arneli@nih.gov		Sinaii, Ninet/0000-0003-4045-1386	NIH Clinical Center	NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the NIH Clinical Center.	Anderson Hair, 2006, MULTIVARIATE DATA AN; Andrykowski Michael A, 2008, Semin Oncol Nurs, V24, P193, DOI 10.1016/j.soncn.2008.05.007; [Anonymous], 2015, PSYCHOONCOLOGY; [Anonymous], 2012, HUMAN QUEST MEANING; Benor D, 2017, EXPLORE-NY, V13, P259, DOI 10.1016/j.explore.2017.04.007; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Canada AL, 2008, PSYCHO-ONCOL, V17, P908, DOI 10.1002/pon.1307; CERNY BA, 1977, MULTIVAR BEHAV RES, V12, P43, DOI 10.1207/s15327906mbr1201_3; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Denz-Penhey H, 2008, QUAL HEALTH RES, V18, P391, DOI 10.1177/1049732307313431; Egnew TR, 2005, ANN FAM MED, V3, P255, DOI 10.1370/afm.313; Evangelista CB, 2016, REV BRAS ENFERM, V69, P554, DOI 10.1590/0034-7167.2016690324i; Fife BL, 2005, SOC SCI MED, V61, P2132, DOI 10.1016/j.socscimed.2005.04.026; FIFE BL, 1995, SOC SCI MED, V40, P1021, DOI 10.1016/0277-9536(94)00174-R; Fischer J. L., 1991, ALCOHOL TREAT Q, V8, P86, DOI [10.1300/J020V08N0106, DOI 10.1300/J020V08N01-06, 10.1300/J020V08N01_06, DOI 10.1300/J020V08N01_06]; Folkman S, 2010, PSYCHO-ONCOLOGY, V19, P901, DOI 10.1002/pon.1836; Frankl V., 1992, MANS SEARCH MEANING; George LS, 2017, PSYCHOL RELIG SPIRIT, V9, P131, DOI 10.1037/rel0000103; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Heintzelman SJ, 2014, AM PSYCHOL, V69, P561, DOI 10.1037/a0035049; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; Hillen MA, 2011, PSYCHO-ONCOLOGY, V20, P227, DOI 10.1002/pon.1745; Hoffman MA, 2013, COUNS PSYCHOL, V41, P240, DOI 10.1177/0011000012461378; Holder GN, 2015, PALLIAT SUPPORT CARE, V13, P749, DOI 10.1017/S1478951514000583; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hooker SA, 2017, REV GEN PSYCHOL, DOI [10.1037/gpr0000105, DOI 10.1037/GPR0000105]; Ingram C, 2014, J PAIN SYMPTOM MANAG, V47, P198, DOI 10.1016/j.jpainsymman.2013.09.015; Jo Cox Commission on Loneliness, 2017, COMB LON ON CONV TIM; Kearney M., 2000, PLACE HEALING WORKIN; Knight SJ, 2007, J PALLIAT MED, V10, P1190, DOI 10.1089/jpm.2006.0068; Koenig HG, 2001, ANN PHARMACOTHER, V35, P352, DOI 10.1345/aph.10215; Koithan M, 2007, J ALTERN COMPLEM MED, V13, P659, DOI 10.1089/acm.2007.7090; Landmark BT, 2002, J ADV NURS, V40, P112, DOI 10.1046/j.1365-2648.2002.02346.x; Lichtenstein AH, 2017, ANN PALLIAT MED, V6, P248, DOI 10.21037/apm.2017.06.16; Martela F, 2016, J POSIT PSYCHOL, V11, P531, DOI 10.1080/17439760.2015.1137623; Meza JP, 2008, ANN FAM MED, V6, P355, DOI 10.1370/afm.869; Miller WL, 2003, ALTERN THER HEALTH M, V9, pA80; Moreira-Almeida A, 2006, REV BRAS PSIQUIATR, V28, P242, DOI 10.1590/S1516-44462006000300018; Moreno PI, 2013, CANCER J, V19, P421, DOI 10.1097/PPO.0b013e3182a5bbe7; Mount BM, 2007, J PAIN SYMPTOM MANAG, V33, P372, DOI 10.1016/j.jpainsymman.2006.09.014; Pargament K.I., 1997, PSYCHOL RELIG COPING; Pargament KI, 2004, J HEALTH PSYCHOL, V9, P713, DOI 10.1177/1359105304045366; Park CL, 2008, J CONSULT CLIN PSYCH, V76, P863, DOI 10.1037/a0013348; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; Parry S, 2019, FIT STAT COMMONLY RE; Patrick DL, 2011, VALUE HEALTH, V14, P967, DOI 10.1016/j.jval.2011.06.014; Peres JFP, 2007, J RELIG HEALTH, V46, P343, DOI 10.1007/s10943-006-9103-0; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Peterman AH, 2014, PSYCHOL ASSESSMENT, V26, P127, DOI 10.1037/a0034805; Richardson P, 2014, ANN PALLIAT MED, V3, P150, DOI 10.3978/j.issn.2224-5820.2014.07.05; Roepke AM, 2014, APPL RES QUAL LIFE, V9, P1055, DOI 10.1007/s11482-013-9288-9; Ruf M, 2009, HEAD NECK-J SCI SPEC, V31, P513, DOI 10.1002/hed.21000; Ryan CL, 2016, ED ATTAINMENT POPULA; Salkind N. J, 2010, ENCY RES DESIGN, V1, DOI 10.4135/9781412961288.n35.SAGEPublicationsInc; Saunders C, 1996, BRIT MED J, V313, P1599, DOI 10.1136/bmj.313.7072.1599; Shaw A, 2005, MENT HEALTH RELIG CU, V8, P1, DOI 10.1080/1367467032000157981; Skeath P, 2013, QUAL HEALTH RES, V23, P1155, DOI 10.1177/1049732313499074; Sloan DH, 2017, PATIENT-RELAT OUTCOM, V8, DOI 10.2147/PROM.S118696; Steger M.F., 2009, OXFORD HDB POSITIVE, P679, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0064; Sulmasy Daniel P, 2002, Gerontologist, V42 Spec No 3, P24; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tennant A., 2012, RASCH MEAS T, V25, P1348; Tomas-Sabado J, 2015, J PAIN SYMPTOM MANAG, V50, P861, DOI 10.1016/j.jpainsymman.2015.06.015; Truog RD, 2012, NEW ENGL J MED, V366, P581, DOI 10.1056/NEJMp1110848; Trzebinski J, 2013, J LOSS TRAUMA, V18, P195, DOI 10.1080/15325024.2012.687289; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Unger JM, 2013, J CLIN ONCOL, V31, P536, DOI 10.1200/JCO.2012.45.4553; Weathers F. W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Williams B, 2010, EMERG MED J, V27, P794, DOI 10.1136/emj.2010.091751; Willis G.B, 2004, COGNITIVE INTERVIEWI; Young WC, 2016, PALLIAT SUPPORT CARE, V14, P680, DOI 10.1017/S147895151600033X; Young WC, 2015, PALLIAT SUPPORT CARE, V13, P653, DOI 10.1017/S1478951514000340; Zieba M., 2010, STUD PSYCHOL, V49, P109, DOI DOI 10.1164/RCCM.200409-1295OC	79	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207820	10.1371/journal.pone.0207820	http://dx.doi.org/10.1371/journal.pone.0207820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540764	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600037
J	Keenan, SW; Emmons, AL; Taylor, LS; Phillips, G; Mason, AR; Mundorff, AZ; Bernardi, EC; Davoren, J; DeBruyn, JM				Keenan, Sarah W.; Emmons, Alexandra L.; Taylor, Lois S.; Phillips, Gary; Mason, Allison R.; Mundorff, Amy Z.; Bernardi, Ernest C.; Davoren, Jon; DeBruyn, Jennifer M.			Spatial impacts of a multi-individual grave on microbial and microfaunal communities and soil biogeochemistry	PLOS ONE			English	Article							NEMATODE COMMUNITIES; FAUNAL ANALYSIS; TESTATE AMEBAS; HUMAN CADAVERS; DECOMPOSITION; SUCCESSION; MANAGEMENT; NITROGEN; TIME; INDICATORS	Decomposing vertebrates, including humans, result in pronounced changes in surrounding soil biogeochemistry, particularly nitrogen (N) and carbon (C) availability, and alter soil micro- and macrofauna. However, the impacts of subsurface human decomposition, where oxygen becomes limited and microbial biomass is generally lower, are far less understood. The goals of this study were to evaluate the impact of human decomposition in a multi-individual, shallow (similar to 70 cm depth) grave on soil biogeochemistry and soil microbial and nematode communities. Three individuals were interred and allowed to decay for four years. Soils were collected from two depths (0-5 and 30-35 cm) along linear transects radiating from the grave as well as from within and below (85-90 cm depth) the grave during excavation to assess how decomposition affects soil properties. Along radiating surface transects, several extracellular enzymes rates and nematode richness increased with increasing distance from the grave, and likely reflect physical site disruption due to grave excavation and infill. There was no evidence of carcass-sourced C and N lateral migration from the grave, at least at 30-35 cm depth. Within the grave, soils exhibited significant N-enrichment (e.g., ammonium, dissolved organic N), elevated electrical conductivity, and elevated respiration rates with depth. Soil biogeochemistry within the grave, particularly in the middle (30-35 cm) and base (70-75 cm depth), was significantly altered by human decomposition. Mean microbial gene abundances changed with depth in the grave, demonstrating increased microbial presence in response to ongoing decomposition. Human-associated Bacteroides were only detected at the base of the grave where anoxic conditions prevailed. Nematode community abundance and richness were reduced at 70-75 cm and not detectable below 85-90 cm. Further, we identified certain Plectus spp. as potential indicators of enrichment due to decomposition. Here we demonstrate that human decomposition influences soil biogeochemistry, microbes, and microfauna up to four years after burial.	[Keenan, Sarah W.; Taylor, Lois S.; Mason, Allison R.; DeBruyn, Jennifer M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA; [Emmons, Alexandra L.; Mundorff, Amy Z.] Univ Tennessee, Dept Anthropol, Knoxville, TN 37996 USA; [Phillips, Gary; Bernardi, Ernest C.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Davoren, Jon] Bode Cellmark Forens, Lorton, VA USA; [Keenan, Sarah W.] South Dakota Sch Mines & Technol, Dept Geol & Geol Engn, Rapid City, SD 57701 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; South Dakota School Mines & Technology	Keenan, SW; DeBruyn, JM (corresponding author), Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA.; Keenan, SW (corresponding author), South Dakota Sch Mines & Technol, Dept Geol & Geol Engn, Rapid City, SD 57701 USA.	sarah.keenan@sdsmt.edu; jdebruyn@utk.edu	DeBruyn, Jennifer M./A-8813-2010	DeBruyn, Jennifer M./0000-0002-2993-4144; Taylor, Lois/0000-0002-2401-8382; Emmons, Alexandra/0000-0002-5637-105X; Keenan, Sarah W./0000-0002-2905-7823; Mundorff, Amy/0000-0003-4008-4969	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (DOJ) [2016-DN-BX-0178]; Forensic Anthropology Center at the University of Tennessee	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (DOJ); Forensic Anthropology Center at the University of Tennessee	This project was supported by Award No. 2016-DN-BX-0178, awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice (DOJ) to AZM, JMD, JD, and ALE. DOJ had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bode Cellmark Forensics provided support in the form of salary for JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The opinions, findings, and conclusions or recommendations expressed in this presentation are those of the authors and do not necessarily reflect those of the DOJ or Bode Cellmark Forensics.; Emily Grimes assisted with soil sample processing. Annette S. Engel provided access to IC equipment, and Audrey Paterson conducted grave water geochemical analyses. Thanks to DeBruyn and Mundorff Lab members and to graduate students in the Department of Anthropology for assisting with internment, excavation, and data collection. The authors would also like to thank the Forensic Anthropology Center at the University of Tennessee for their support and assistance facilitating this research.	Aitkenhead-Peterson JA, 2012, FORENSIC SCI INT, V216, P127, DOI 10.1016/j.forsciint.2011.09.007; ALLEN MW, 1968, P HELM SOC WASH, V35, P77; Althoff PS, 2009, APPL SOIL ECOL, V43, P122, DOI 10.1016/j.apsoil.2009.06.011; ANDRASSY I, 1985, ACTA ZOOL HUNG, V31, P1; [Anonymous], 2017, STANDARD METHODS EXA; Arieira GD, 2016, SEMIN-CIENC AGRAR, V37, P715, DOI 10.5433/1679-0359.2016v37n2p715; Bell CW, 2013, JOVE-J VIS EXP, DOI 10.3791/50961; BELSER LW, 1980, APPL ENVIRON MICROB, V39, P505, DOI 10.1128/AEM.39.3.505-510.1980; Benbow ME, 2013, J MED ENTOMOL, V50, P440, DOI 10.1603/ME12194; Blakely JK, 2002, APPL SOIL ECOL, V21, P71, DOI 10.1016/S0929-1393(02)00023-9; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bongers Tom, 1995, Russian Journal of Nematology, V3, P61; Braig HR, 2009, EXP APPL ACAROL, V49, P45, DOI 10.1007/s10493-009-9287-6; Briar S, 2009, J NEMATOL, V41, P313; Briar SS, 2012, J NEMATOL, V44, P245; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Bump JK, 2009, ECOSYSTEMS, V12, P996, DOI 10.1007/s10021-009-9274-0; Carter DO, 2008, APPL SOIL ECOL, V40, P129, DOI 10.1016/j.apsoil.2008.03.010; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Carter DO, 2010, FORENSIC SCI INT, V200, P60, DOI 10.1016/j.forsciint.2010.03.031; Carter DO, 2003, J FORENSIC SCI, V48, P168; Cobaugh KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130201; Corcoran KA, 2016, THESIS; Crotty FV, 2016, SOIL BIOL BIOCHEM, V103, P241, DOI 10.1016/j.soilbio.2016.08.018; Damann FE, 2015, J FORENSIC SCI, V60, P844, DOI 10.1111/1556-4029.12744; Damann FE, 2012, FORENSIC SCI INT, V222, P4, DOI 10.1016/j.forsciint.2012.04.028; Danell K, 2002, ARCTIC, V55, P389; DeBruyn JM, 2017, PEERJ, V5, DOI 10.7717/peerj.3437; Dent BB, 2004, ENVIRON GEOL, V45, P576, DOI 10.1007/s00254-003-0913-z; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Doyle A, 2004, SOIL SCI SOC AM J, V68, P669, DOI 10.2136/sssaj2004.0669; ETTEMA CH, 1993, BIOL FERT SOILS, V16, P79, DOI 10.1007/BF00369407; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Ferris H, 2003, APPL SOIL ECOL, V23, P93, DOI 10.1016/S0929-1393(03)00044-1; Ferris H, 2006, J NEMATOL, V38, P3; Fiedler S, 2003, NATURWISSENSCHAFTEN, V90, P291, DOI 10.1007/s00114-003-0437-0; Finley SJ, 2016, MICROB ECOL, V71, P524, DOI 10.1007/s00248-015-0725-1; Fiscus DA, 2002, ECOL APPL, V12, P565, DOI 10.1890/1051-0761(2002)012[0565:DSOFLS]2.0.CO;2; Fonseca G, 2011, AQUAT BIOL, V13, P27, DOI 10.3354/ab00347; Fox J., 2019, R COMPANION APPL REG, V.; Geraert E., 2008, TYLENCHIDAE WORLD; Gill-King H., FORENSIC TAPHONOMY P; Hart S. C., 1994, METHODS SOIL ANAL, P985, DOI DOI 10.2136/SSSAB00KSER5.2.C42; Hauther KA, 2015, J FORENSIC SCI, V60, P1234, DOI 10.1111/1556-4029.12828; Hoss S, 2011, SCI TOTAL ENVIRON, V409, P2674, DOI 10.1016/j.scitotenv.2011.03.041; Hopkins DW, 2000, APPL SOIL ECOL, V14, P283, DOI 10.1016/S0929-1393(00)00063-9; Janaway Robert C., 2009, P313, DOI 10.1007/978-1-59745-327-1_14; Jantz LM, 2008, FORENSIC ANTHR LAB, P7, DOI [10.1201/9781420004021.ch2, DOI 10.1201/9781420004021.CH2]; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Keenan SW, 2018, SOIL BIOL BIOCHEM, V121, P165, DOI 10.1016/j.soilbio.2018.03.005; Keeney D.R, 1982, AGRON MONOGR, P643; Lashley MA, 2018, ECOLOGY, V99, P491, DOI 10.1002/ecy.2027; Lauber CL, 2014, APPL ENVIRON MICROB, V80, P4920, DOI 10.1128/AEM.00957-14; Layton A, 2006, APPL ENVIRON MICROB, V72, P4214, DOI 10.1128/AEM.01036-05; Meng FX, 2006, PEDOSPHERE, V16, P169, DOI 10.1016/S1002-0160(06)60040-4; Metcalf JL, 2016, SCIENCE, V351, P158, DOI 10.1126/science.aad2646; Metcalf JL, 2013, ELIFE, V2, DOI 10.7554/eLife.01104; Nannipieri P, 2011, SOIL BIOL, V26, P215, DOI 10.1007/978-3-642-15271-9_9; Neher DA, 2001, J NEMATOL, V33, P161; Ortiz V, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0109-5; PAYNE JA, 1968, NATURE, V219, P1180, DOI 10.1038/2191180a0; Pechal JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079035; Porazinska DL, 1999, APPL SOIL ECOL, V13, P69, DOI 10.1016/S0929-1393(99)00018-9; Porazinska DL, 1998, J NEMATOL, V30, P170; Rhine ED, 1998, SOIL SCI SOC AM J, V62, P473, DOI 10.2136/sssaj1998.03615995006200020026x; Rich VI., 2015, ENVIRON MICROBIOL; RODRIGUEZ WC, 1985, J FORENSIC SCI, V30, P836; RODRIGUEZ WC, 1983, J FORENSIC SCI, V28, P423, DOI 10.1520/JFS11524J; Ruess L, 2003, NEMATOLOGY, V5, P179, DOI 10.1163/156854103767139662; Seppey CVW, 2016, INT J LEGAL MED, V130, P551, DOI 10.1007/s00414-015-1149-7; SIDDIQI MR, 2000, PARASITES PLANTS INS; Singh B, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02616; Smith CR, 2015, ANNU REV MAR SCI, V7, P571, DOI 10.1146/annurev-marine-010213-135144; Subalusky AL, 2017, P NATL ACAD SCI USA, V114, P7647, DOI 10.1073/pnas.1614778114; Szelecz I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18179-z; Szelecz I, 2016, SOIL BIOL BIOCHEM, V103, P405, DOI 10.1016/j.soilbio.2016.09.011; Szelecz I, 2014, FORENSIC SCI INT, V236, P90, DOI 10.1016/j.forsciint.2013.12.030; Team,R.C, 2018, R LANG ENV STAT COMP; Tibbett M, 2004, J FORENSIC SCI, V49, P560; Tomberlin JK, 2017, CURR OPIN INSECT SCI, V23, P7, DOI 10.1016/j.cois.2017.06.006; Towne EG, 2000, OECOLOGIA, V122, P232, DOI 10.1007/PL00008851; VASS AA, 1992, J FORENSIC SCI, V37, P1236; Wheeler TA, 2017, CAN J FOREST RES, V47, P1506, DOI 10.1139/cjfr-2017-0194; Wilson AS, 2007, FORENSIC SCI INT, V169, P6, DOI 10.1016/j.forsciint.2006.07.023; YEATES GW, 1993, J NEMATOL, V25, P315; Zell H, 1993, BEITRAG OKOLOGIE BIO, V11, P3; Zhao J, 2013, APPL SOIL ECOL, V64, P135, DOI 10.1016/j.apsoil.2012.11.008	89	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208845	10.1371/journal.pone.0208845	http://dx.doi.org/10.1371/journal.pone.0208845			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540836	Green Published, gold			2022-12-26	WOS:000452898600092
J	Wang, TS; Ito, A; Aoyama, T; Nakahara, R; Nakahata, A; Ji, X; Zhang, J; Kawai, H; Kuroki, H				Wang, Tianshu; Ito, Akira; Aoyama, Tomoki; Nakahara, Ryo; Nakahata, Akihiro; Ji, Xiang; Zhang, Jue; Kawai, Hideki; Kuroki, Hiroshi			Functional evaluation outcomes correlate with histomorphometric changes in the rat sciatic nerve crush injury model: A comparison between sciatic functional index and kinematic analysis	PLOS ONE			English	Article							FACTOR EXPRESSION; RECOVERY; REGENERATION; ULTRASOUND; MORPHOMETRY	Elucidating whether there is a correlation between biomechanical functions and histomorphometric data in the rat sciatic nerve crush injury model would contribute to an accurate evaluation of the regeneration state without sacrificing animals. The gold standard for functional evaluation is the sciatic functional index (SFI) despite there being intrinsic shortcomings. Kinematic analysis is considered a reliable and sensitive approach for functional evaluation, most commonly assessed as ankle angle at various phases of a gait cycle. Studies utilizing the toe angle for functional evaluation are scarce, and changes in the toe angle following surgery remain unknown. The present study assessed correlations of ankle angle, toe angle and SFI with histomorphometric data, aiming to determine which parameters most accurately reflect changes in histomorphometric data over time. Six Lewis rats were designated as the control group. 30 animals received surgery, six of them were randomly selected on the first, second, third, fourth, and sixth week after surgery for measurements of ankle and toe angles in the "toe-off" phase, and for evaluation of SFI. Histomorphometric analysis were also performed, to determine the number of myelinated nerve fibers, diameters of myelinated nerve fibers, axon diameters, and myelin sheath thicknesses. Furthermore, we investigated changes in ankle angle, toe angle, SFI, and histomorphometric data over time, as well as correlations between ankle angle, toe angle, and SFI with histomorphometric data. The results revealed that changes in SFI, ankle angle, and toe angle highly correlate with histomorphometric data in the rat sciatic nerve crush injury model. Toe angle reflected changes in histomorphometric data with time more precisely than ankle angle or SFI did, and ankle angle was a better prognostic parameter than SFI.	[Wang, Tianshu; Aoyama, Tomoki; Ji, Xiang] Kyoto Univ, Grad Sch Med, Dept Dev & Rehabil Motor Funct, Human Hlth Sci, Kyoto, Japan; [Ito, Akira; Nakahara, Ryo; Nakahata, Akihiro; Zhang, Jue; Kawai, Hideki; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto, Japan	Kyoto University; Kyoto University	Ito, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto, Japan.	ito.akira.4m@kyoto-u.ac.jp	Ito, Akira/AAA-4872-2021	Ito, Akira/0000-0002-9645-9777	Japan Society for the Promotion of Science (JSPS) KAKENHI [17K13052]; JSPS KAKENHI [26282154]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/index.html) KAKENHI Grant-in-Aid for Young Scientists (B) (number 17K13052) to AI and JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (number 26282154) to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Chen WZ, 2010, ULTRASOUND MED BIOL, V36, P1109, DOI 10.1016/j.ultrasmedbio.2010.04.014; Clin H., 2015, PERIPHERAL NERVE TRA, V29, P317; de Ruiter GC, 2007, J PERIPHER NERV SYST, V12, P216, DOI 10.1111/j.1529-8027.2007.00142.x; DELLON AL, 1989, ANN PLAS SURG, V23, P197, DOI 10.1097/00000637-198909000-00002; DELLON AL, 1989, MICROSURG, V10, P220, DOI 10.1002/micr.1920100316; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Di Scipio F, 2008, MICROSC RES TECHNIQ, V71, P497, DOI 10.1002/jemt.20577; Dijkstra JR, 2000, J NEUROSCI METH, V96, P89, DOI 10.1016/S0165-0270(99)00174-0; Jiang WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22773; Kakegawa A, 2015, ANAT SCI INT, V90, P97, DOI 10.1007/s12565-014-0236-z; Kanaya F, 1996, PLAST RECONSTR SURG, V98, P1264, DOI 10.1097/00006534-199612000-00023; Lee JY, 2013, PLAST RECONSTR SURG, V132, P1173, DOI 10.1097/PRS.0b013e3182a3bfeb; Monte-Raso VV, 2008, J NEUROSCI METH, V170, P255, DOI 10.1016/j.jneumeth.2008.01.022; Munro CA, 1998, MUSCLE NERVE, V21, P1095, DOI 10.1002/(SICI)1097-4598(199808)21:8<1095::AID-MUS20>3.0.CO;2-S; Ni XJ, 2017, ULTRASOUND MED BIOL, V43, P461, DOI 10.1016/j.ultrasmedbio.2016.09.017; Oliveira EF, 2001, J RECONSTR MICROSURG, V17, P69, DOI 10.1055/s-2001-12691; Rui J, 2014, ANN PLAS SURG, V73, P405, DOI 10.1097/SAP.0000000000000008; Rustemeyer J, 2009, MICROSURG, V29, P560, DOI 10.1002/micr.20658; Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037; Tajino J, 2015, BEHAV BRAIN RES, V287, P276, DOI 10.1016/j.bbr.2015.03.030; Takhtfooladi MA, 2015, LASER MED SCI, V30, P1047, DOI 10.1007/s10103-015-1709-6; WALKER JL, 1994, J NEUROSCI METH, V52, P47, DOI 10.1016/0165-0270(94)90054-X; WEBER RA, 1993, MICROSURG, V14, P323, DOI 10.1002/micr.1920140507; Xing HY, 2015, MUSCLE NERVE, V51, P400, DOI 10.1002/mus.24322; Yang CC, 2015, NEUROL RES, V37, P816, DOI 10.1179/1743132815Y.0000000060; Yu PR, 2001, MUSCLE NERVE, V24, P231, DOI 10.1002/1097-4598(200102)24:2<231::AID-MUS80>3.0.CO;2-5; Yurie H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171448	28	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208985	10.1371/journal.pone.0208985	http://dx.doi.org/10.1371/journal.pone.0208985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540822	Green Submitted, gold, Green Published			2022-12-26	WOS:000452898600103
J	Muszynski, S; Tomaszewska, E; Dobrowolski, P; Kwiecien, M; Wiacek, D; Swietlicka, I; Skibinska, M; Szymanska-Chargot, M; Orzel, J; Swietlicki, M; Arczewska, M; Szymanek, M; Zhyla, M; Hulas-Stasiak, M; Rudyk, H; Tomczyk-Warunek, A				Muszynski, Siemowit; Tomaszewska, Ewa; Dobrowolski, Piotr; Kwiecien, Matgorzata; Wiacek, Dariusz; Swietlicka, Izabela; Skibinska, Malgorzata; Szymanska-Chargot, Monika; Orzel, Jolanta; Swietlicki, Michal; Arczewska, Marta; Szymanek, Mariusz; Zhyla, Mykola; Hulas-Stasiak, Monika; Rudyk, Halyna; Tomczyk-Warunek, Agnieszka			Analysis of bone osteometry, mineralization, mechanical and histomorphometrical properties of tibiotarsus in broiler chickens demonstrates a influence of dietary chickpea seeds (Cicer arietinum L.) inclusion as a primary protein source	PLOS ONE			English	Article							REPLACING SOYBEAN-MEAL; 2-OXOGLUTARIC ACID; GEOMETRIC PARAMETERS; ARTICULAR-CARTILAGE; MATERNAL TREATMENT; NUTRITIONAL-VALUE; NUTRIENT DENSITY; GROWTH-PLATE; DEXAMETHASONE; STRENGTH	This study was focused on analyzing the effects of dietary inclusion of raw chickpea seed as a replacement of soybean meal as a primary protein source on bone structure in broiler chickens. Broiler chickens (n = 160) received in their diet either soybean meal (SBM) or raw chickpea seeds (CPS) as a primary protein source throughout the whole rearing period (n = 80 in each group). On the 42th day randomly selected chickens from each group (n = 8) were slaughtered. Collected tibiotarsus were subjected to examination of the biomechanical characteristics of bone mid-diaphysis, microstructure of the growth plate and articular cartilages; the analysis of mineral content and crystallinity of mineral phase, and the measurements of thermal stability of collagen in hyaline cartilage were also carried out. The inclusion of chickpea seeds resulted in increase of bone osteometric parameters (weight, length and mid-diaphysis cross-sectional area) and mechanical endurance (yield load, ultimate load, stiffness, Young modulus). However, when loads were adjusted to bone shape (yield and ultimate stress) both groups did not differ. Mineral density determined by means of densitometric measurements did not differ between groups, however the detailed analysis revealed the differences in the macro- and microelements composition. The results of FT-IR and XRD analyses showed no effect of diet type on mineral phase crystallinity and hydroxyapatite nanocrystallites size. In trabecular bone, the increase of real bone volume (BV/TV) and number of trabeculae was observed in the CPS group. Total thickness of articular cartilage was the same in both groups, save the transitional zone, which was thicker in the SBM group. The total thickness of the growth plate cartilage was significantly increased in the CPS group. The area of the most intense presence of proteoglycans was wider in the SBM group. The structural analysis of fibrous components of bone revealed the increase of fraction of thin, immature collagen content in articular cartilage, trabeculae and compact bone in the CPS group. The dietary inclusion of CPS affected the thermal stability of collagen, as decrease of net denaturation enthalpy was observed. This study showed a beneficial effect of CPS on the skeletal development, improving the overall bone development and the micro-architecture of cancellous bone. It suggests that CPS can be a promising replacement for SBM in broilers feeding in the aspect of animal welfare related to the development of the skeletal system.	[Muszynski, Siemowit; Swietlicka, Izabela; Arczewska, Marta] Univ Life Sci, Fac Prod Engn, Dept Phys, Lublin, Poland; [Tomaszewska, Ewa; Tomczyk-Warunek, Agnieszka] Univ Life Sci Lublin, Fac Vet Med, Dept Anim Physiol, Lublin, Poland; [Dobrowolski, Piotr; Hulas-Stasiak, Monika] Marie Curie Sklodowska Univ, Fac Biol & Biotechnol, Dept Comparat Anat & Anthropol, Lublin, Poland; [Kwiecien, Matgorzata] Univ Life Sci Lublin, Fac Biol Anim Sci & Bioecon, Inst Anim Nutr & Bromathol, Lublin, Poland; [Wiacek, Dariusz; Szymanska-Chargot, Monika] Polish Acad Sci, Bohdan Dobrzanski Inst Agrophys, Lublin, Poland; [Skibinska, Malgorzata] Marie Curie Sklodowska Univ, Fac Chem, Dept Crystallog, Lublin, Poland; [Orzel, Jolanta] Marie Curie Sklodowska Univ, Fac Chem, Dept Radiochem & Colloid Chem, Lublin, Poland; [Swietlicki, Michal] Lublin Univ Technol, Fac Mech Engn, Dept Appl Phys, Lublin, Poland; [Szymanek, Mariusz] Univ Life Sci Lublin, Fac Prod Engn, Dept Agr Hort & Forest Machinery, Lublin, Poland; [Zhyla, Mykola; Rudyk, Halyna] State Sci Res Control Inst Vet Med Prod & Feed Ad, Lab Clin Biol Res, Lvov, Ukraine	University of Life Sciences in Lublin; Maria Curie-Sklodowska University; University of Life Sciences in Lublin; Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; Maria Curie-Sklodowska University; Maria Curie-Sklodowska University; Lublin University of Technology; University of Life Sciences in Lublin; Institute of Veterinary Medicinal Products & Feed Additives	Muszynski, S (corresponding author), Univ Life Sci, Fac Prod Engn, Dept Phys, Lublin, Poland.; Tomaszewska, E (corresponding author), Univ Life Sci Lublin, Fac Vet Med, Dept Anim Physiol, Lublin, Poland.	siemowit.muszynski@up.lublin.pl; ewaRST@interia.pl	Świetlicki, Michał/B-6656-2017; Szymanek, Mariusz/U-9805-2018; Świetlicka, Izabela/T-7914-2019; Muszyński, Siemowit/U-4945-2018; Halyna, Rudyk/AAZ-7220-2020; Dobrowolski, Piotr Jerzy/R-7917-2019; Świetlicka, Izabela/E-3959-2018; Tomaszewska, Ewa/U-5490-2018	Świetlicki, Michał/0000-0003-3625-542X; Szymanek, Mariusz/0000-0002-3337-0337; Świetlicka, Izabela/0000-0003-1053-0948; Muszyński, Siemowit/0000-0002-4118-6302; Halyna, Rudyk/0000-0002-4152-560X; Dobrowolski, Piotr Jerzy/0000-0001-5873-9666; Świetlicka, Izabela/0000-0003-1053-0948; Kwiecien, Malgorzata/0000-0002-8047-8682; Hulas-Stasiak, Monika/0000-0002-5039-009X; Szymanska-Chargot, Monika/0000-0002-2251-4307; Wiacek, Dariusz/0000-0001-9043-6163; Zila, Mikola/0000-0003-1206-168X; Tomaszewska, Ewa/0000-0002-7574-2653				Algam T. A., 2012, International Journal of Poultry Science, V11, P294; Bampidis VA, 2011, ANIM FEED SCI TECH, V168, P1, DOI 10.1016/j.anifeedsci.2011.04.098; Blicharski T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179693; Bozzini C., 2012, Comparative Clinical Pathology, V21, P1159, DOI 10.1007/s00580-011-1253-0; Christodoulou V, 2006, ARCH GEFLUGELKD, V70, P112; Dirkes RK, 2018, CURR DEV NUTR, V2, DOI 10.1093/cdn/nzy010; Fried A, 2012, NUTRITION, V28, P331, DOI 10.1016/j.nut.2011.07.022; Friedman M, 1996, J AGR FOOD CHEM, V44, P6, DOI 10.1021/jf9400167; Ghadimi E, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-499; Hassan IAG, 2003, TROP ANIM HEALTH PRO, V35, P189, DOI 10.1023/A:1022833820757; Hossain MA, 2013, S AFR J ANIM SCI, V43, P208, DOI 10.4314/sajas.v43i2.11; HUANG SC, 2018, SCI REP UK, V8; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; Jimenez-Moreno E, 2009, ANIM FEED SCI TECH, V154, P93, DOI 10.1016/j.anifeedsci.2009.06.020; Khalaji S, 2016, POULTRY SCI, V95, P287, DOI 10.3382/ps/pev330; Li Z, 2016, POULTRY SCI, V95, P2889, DOI 10.3382/ps/pew182; Mignon-Grasteau Sandrine, 2016, Bone Rep, V5, P43, DOI 10.1016/j.bonr.2016.02.004; Muszynski S, 2018, POULTRY SCI, V97, P695, DOI 10.3382/ps/pex333; Muszynski S, 2018, BIOL TRACE ELEM RES, V182, P339, DOI 10.1007/s12011-017-1092-1; Muszynski S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191964; Muszynski S, 2017, POULTRY SCI, V96, P491, DOI 10.3382/ps/pew301; Naka M, 2019, P I MECH ENG H, V2005, P175; NRC, 1994, NUTR REQ POULTR; Olkowski AA, 2001, POULTRY SCI, V80, P621, DOI 10.1093/ps/80.5.621; Olkowski B, 2016, J ANIM PHYSIOL AN N, V100, P731, DOI 10.1111/jpn.12450; Palander S, 2006, ANIM FEED SCI TECH, V127, P89, DOI 10.1016/j.anifeedsci.2005.07.003; Poinern GJE, 2011, INT J NANOMED, V6, P2083, DOI 10.2147/IJN.S24790; Rajesh R, 2012, PHOSPHORUS SULFUR, V187, P914, DOI 10.1080/10426507.2011.650806; Rath NC, 2000, POULTRY SCI, V79, P1024, DOI 10.1093/ps/79.7.1024; Rath NC, 1999, POULTRY SCI, V78, P1232, DOI 10.1093/ps/78.8.1232; Rauch F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P194; Rey C, 2009, OSTEOPOROSIS INT, V20, P1013, DOI 10.1007/s00198-009-0860-y; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Rizzoli R, 2007, ELSEVIER INT C SERIE, P50; Ruppel ME, 2008, OSTEOPOROSIS INT, V19, P1251, DOI 10.1007/s00198-008-0579-1; Rutkowski A, 2016, ANN ANIM SCI, V16, P1059, DOI 10.1515/aoas-2016-0025; Saeed M, 2017, ANN ANIM SCI, V17, P849, DOI 10.1515/aoas-2016-0091; Scherrer P., 1918, GOTTINGER NACHRICHTE, V2, P98, DOI DOI 10.1007/978-3-662-33915-2_7; Shahnazari M, 2007, CALCIFIED TISSUE INT, V80, P160, DOI 10.1007/s00223-006-0176-2; Sliwa E, 2006, J MATERN-FETAL NEO M, V19, P489, DOI 10.1080/14767050600850381; Sliwa E, 2010, J ANIM PHYSIOL AN N, V94, pe86, DOI 10.1111/j.1439-0396.2009.00985.x; Tomaszewska E, 2018, ANIM PROD SCI, V58, P507, DOI 10.1071/AN16289; Tomaszewska E, 2018, J ANIM PHYSIOL AN N, V102, pE299, DOI 10.1111/jpn.12742; Tomaszewska E, 2017, BRIT POULTRY SCI, V58, P312, DOI 10.1080/00071668.2017.1280770; Tomaszewska E, 2017, BRAZ J POULTRY SCI, V19, P159, DOI 10.1590/1806-9061-2016-0285; Tomaszewska E, 2018, ANN ANIM SCI; Tomaszewska E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194969; Tomaszewska E, 2017, ANN ANIM SCI, V17, P1089, DOI 10.1515/aoas-2017-0022; Tomaszewska E, 2017, J TRACE ELEM MED BIO, V42, P103, DOI 10.1016/j.jtemb.2017.05.002; Tomaszewska E, 2017, BIOL TRACE ELEM RES, V178, P54, DOI 10.1007/s12011-016-0894-x; Tomaszewska E, 2016, ENVIRON TOXICOL PHAR, V46, P36, DOI 10.1016/j.etap.2016.06.027; Tomaszewska E, 2016, ANN ANIM SCI, V16, P507, DOI 10.1515/aoas-2015-0087; Tomaszewska E, 2015, B VET I PULAWY, V59, P563, DOI 10.1515/bvip-2015-0084; Tomaszewska E, 2015, CONNECT TISSUE RES, V56, P483, DOI 10.3109/03008207.2015.1069822; Tomaszewska E, 2012, LIVEST SCI, V146, P175, DOI 10.1016/j.livsci.2012.03.008; Tomaszewska E, 2012, NUTRITION, V28, P190, DOI 10.1016/j.nut.2011.05.010; Wang SJ, 2017, ANIM SCI J, V88, P1820, DOI 10.1111/asj.12837; Wang X, 2014, POULTRY SCI, V93, P1463, DOI 10.3382/ps.2013-03838; Wang X, 2015, J POULT SCI, V52, P197, DOI 10.2141/jpsa.0140152; Williams B, 2004, CALCIFIED TISSUE INT, V74, P236, DOI 10.1007/s00223-002-2124-0; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008	61	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208921	10.1371/journal.pone.0208921	http://dx.doi.org/10.1371/journal.pone.0208921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533027	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500048
J	Sunagar, R; Kumar, S; Namjoshi, P; Rosa, SJ; Hazlett, KRO; Gosselin, EJ				Sunagar, Raju; Kumar, Sudeep; Namjoshi, Prachi; Rosa, Sarah J.; Hazlett, Karsten R. O.; Gosselin, Edmund J.			Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing	PLOS ONE			English	Article							HISTOCOMPATIBILITY COMPLEX HAPLOTYPE; MYCOBACTERIUM-TUBERCULOSIS; AEROSOL CHALLENGE; BALB/C MICE; T-CELLS; PROTECTION; TULAREMIA; INFECTION; STRAINS; RESISTANCE	Francisella tularensis (Ft) is a biothreat agent for which there is no FDA-approved human vaccine. Currently, there are substantial efforts underway to develop both vaccines and the tools to assess these vaccines. Tularemia laboratory research has historically relied primarily upon a small number of inbred mouse strains, but the utility of such findings to outbred animals may be limited. Specifically, C57BL/6 mice are more susceptible than BALB/c mice to Ft infection and less easily protected against challenge with highly virulent type A Ft. Thus, depending on the inbred mouse strain used, one could be misled as to which immunogen( s)/vaccine will ultimately be effective in an outbred human population. Accordingly, we evaluated an outbred Swiss Webster (SW) mouse model in direct comparison to a wellestablished, inbred C57BL/6 mouse model. Mucosal vaccination with the live, attenuated Ft LVS superoxide dismutase (sodB) mutant demonstrated significantly higher protection in outbred SW mice compared to inbred C57BL/6 mice against Ft SchuS4 respiratory challenge. The protection observed in vaccinated outbred mice correlated with lower bacterial density, reduced tissue inflammation, and reduced levels of pro-inflammatory cytokine production. This protection was CD4(+) and CD8(+) T cell-dependent and characterized by lower titers of serum antibody (Ab) that qualitatively differed from vaccinated inbred mice. Enhanced protection of vaccinated outbred mice correlated with early and robust production of IFN-gamma and IL-17A. Neutralizing Ab administered at the time of challenge revealed that IFN-gamma was central to this protection, while IL-17A neutralization did not alter bacterial burden or survival. The present study demonstrates the utility of the outbred mouse as an alternative vaccination model for testing tularemia vaccines. Given the limited MHC repertoire in inbred mice, this outbred model is more analogous to the human in terms of immunological diversity.	[Sunagar, Raju; Kumar, Sudeep; Namjoshi, Prachi; Rosa, Sarah J.; Hazlett, Karsten R. O.; Gosselin, Edmund J.] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA; [Sunagar, Raju] Ella Fdn, Hyderabad, India	Albany Medical College	Gosselin, EJ (corresponding author), Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA.	gossele@mail.amc.edu		Kumar, Sudeep/0000-0003-0960-8162	National Institutes of Health [P01 AI056320, RO1 AI100138, RO1 AI123129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R01AI100138, R01AI123129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institutes of Health (P01 AI056320 to EJG, RO1 AI100138 to EJG, and RO1 AI123129 to KROH) funded these studies but had no role in study design, data collection or the decision to publish this study.	Abolins S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14811; Alibek K, 1999, ANN NY ACAD SCI, V894, P18, DOI 10.1111/j.1749-6632.1999.tb08038.x; Anderson RV, 2010, VACCINE, V28, P6562, DOI 10.1016/j.vaccine.2010.07.072; Aronova N V, 2001, Mol Gen Mikrobiol Virusol, P26; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Barbi J, 2008, J IMMUNOL, V181, P4613, DOI 10.4049/jimmunol.181.7.4613; Bitsaktsis C, 2009, J IMMUNOL, V182, P4899, DOI 10.4049/jimmunol.0803242; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; CORIELL LL, 1947, J IMMUNOL, V56, P245; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Eisen RJ, 2009, AM J TROP MED HYG, V80, P259, DOI 10.4269/ajtmh.2009.80.259; Fellows P, 2012, CLIN VACCINE IMMUNOL, V19, P468, DOI 10.1128/CVI.05591-11; Flick-Smith HC, 2005, MICROB PATHOGENESIS, V38, P33, DOI 10.1016/j.micpath.2004.10.007; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; Garcia-Pelayo MC, 2015, TUBERCULOSIS, V95, P48, DOI 10.1016/j.tube.2014.10.012; Gerdts V, 2015, ILAR J, V56, P53, DOI 10.1093/ilar/ilv009; Gough SCL, 2007, CURR GENOMICS, V8, P453, DOI 10.2174/138920207783591690; Harris S., 1992, ANN NY ACAD SCI, V666, P21; HOAG KA, 1995, AM J RESP CELL MOL, V13, P487, DOI 10.1165/ajrcmb.13.4.7546779; Hume EBH, 2005, IMMUNOL CELL BIOL, V83, P294, DOI 10.1111/j.1440-1711.2005.01326.x; Kamath AB, 2004, INFECT IMMUN, V72, P6790, DOI 10.1128/IAI.72.12.6790-6798.2004; Keller C, 2004, TUBERCULOSIS, V84, P144, DOI 10.1016/j.tube.2003.12.003; Kennedy RC, 1997, VACCINE, V15, P903, DOI 10.1016/S0264-410X(96)00277-0; Kumar S, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00677; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; McHugh KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082865; Medina E, 1998, IMMUNOLOGY, V93, P270, DOI 10.1046/j.1365-2567.1998.00419.x; Periasamy S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005517; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Roberts LM, 2016, J IMMUNOL, V197, P2738, DOI 10.4049/jimmunol.1600879; Roberts LM, 2014, VACCINE, V32, P3595, DOI 10.1016/j.vaccine.2014.05.013; Russell P, 1998, J ANTIMICROB CHEMOTH, V41, P461, DOI 10.1093/jac/41.4.461; Schneider-Hohendorf T, 2018, P NATL ACAD SCI USA, V115, P2168, DOI 10.1073/pnas.1716146115; Sebastian S, 2009, VACCINE, V27, P597, DOI 10.1016/j.vaccine.2008.10.079; Shearer MH, 1999, CLIN DIAGN LAB IMMUN, V6, P953, DOI 10.1128/CDLI.6.6.953-958.1999; Shen H, 2004, VACCINE, V22, P2116, DOI 10.1016/j.vaccine.2003.12.003; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Skyberg JA, 2013, INFECT IMMUN, V81, P3099, DOI 10.1128/IAI.00203-13; Sunagar R, 2016, VACCINE, V34, P3396, DOI 10.1016/j.vaccine.2016.04.054; Tam M, 1999, AM J RESP CELL MOL, V20, P710, DOI 10.1165/ajrcmb.20.4.3223; Viney M, 2015, PARASITE IMMUNOL, V37, P267, DOI 10.1111/pim.12150; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	46	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0207587	10.1371/journal.pone.0207587	http://dx.doi.org/10.1371/journal.pone.0207587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533047	gold, Green Published, Green Submitted			2022-12-26	WOS:000452782500008
J	He, ZY; Xiong, LP; Xie, F; Shen, MX; Han, S; Hu, JQ; Xu, WY				He, Zhongyi; Xiong, Liping; Xie, Feng; Shen, Mingxue; Han, Sheng; Hu, Jianqiang; Xu, Wenyuan			Tribological and antioxidation properties study of two N-containing borate ester derivatives as additive in rapeseed oil	PLOS ONE			English	Article							CONTAINING TRIAZINE DERIVATIVES; LUBRICANT ADDITIVES; HYDROLYTIC STABILITY; MECHANISM; PERFORMANCE; BEHAVIOR	Two kinds of phenol- and N- containing borate ester, BTEB and BMEB have good hydrolysis stability due to the B-N coordination bond. The P-B value improved by 60.7% and 67.6% respectively at 0.5wt% BTEB, BMEB in rapeseed oil. Their antiwear effect increases with the increase of adding content, and BMEB is better than BTEB. The friction-reducing effect of BTEB is better than BMEB. All additives formed a protective film which containing BOx, FeOx and other organic nitrogen compounds. The better capacities of BMEB may due to the complex boundary lubricating film which contain ferrous sulfate, ferrous sulfide. All additives possessed good antioxidation effect, and it increased the oxidation activation energy than rapeseed oil by 51.15% and 78.82% respectively at 0.25wt%.	[He, Zhongyi; Xiong, Liping; Shen, Mingxue; Xu, Wenyuan] East China Jiaotong Univ, Sch Mat Sci & Engn, Nanchang, Jiangxi, Peoples R China; [Xie, Feng; Hu, Jianqiang] Air Force Logist Coll, Dept Aviat Oil & Mat, Xuzhou, Jiangsu, Peoples R China; [Han, Sheng] Shanghai Appl Technol Univ, Shanghai, Peoples R China	East China Jiaotong University	He, ZY; Shen, MX (corresponding author), East China Jiaotong Univ, Sch Mat Sci & Engn, Nanchang, Jiangxi, Peoples R China.	hzy220567@163.com; shenmingxue@126.com			National Natural Science Foundation of China [21563012, 21363008]; Major academic and technological leaders of Jiangxi Province of China [20162BCB22020]; Jiangxi Natural Science Foundation of China [20143ACB20003, 20142BAB203015, 20171BCD40009, 20181BAB203010]; Jiangxi Provincial Education Department Foundation of China [GJJ170371]; Jiangsu Science Foundation of China [BK20151137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major academic and technological leaders of Jiangxi Province of China; Jiangxi Natural Science Foundation of China(Natural Science Foundation of Jiangxi Province); Jiangxi Provincial Education Department Foundation of China; Jiangsu Science Foundation of China	The authors acknowledge the financial support provided by the National Natural Science Foundation of China (21563012, 21363008) to ZH; Major academic and technological leaders of Jiangxi Province of China (20162BCB22020) to ZH; Jiangxi Natural Science Foundation of China (20143ACB20003, 20142BAB203015, 20171BCD40009, 20181BAB203010) to ZH; Jiangxi Provincial Education Department Foundation of China (GJJ170371) to LX; Jiangsu Science Foundation of China (BK20151137) to FX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MO, 2003, POLYMER, V44, P7353, DOI 10.1016/j.polymer.2003.09.019; Camenzind H, 2000, Patent No. [US 6150307 A, 6150307]; Farag AA, 2014, INT J, V3, P870; He ZY, 2014, LUBR SCI, V26, P81, DOI 10.1002/ls.1230; He ZY, 2011, MATER SCI FORUM, V694, P98, DOI 10.4028/www.scientific.net/MSF.694.98; Kamano H, 2014, Patent No. [WO 2014184362 A1, 2014184362]; Li JC, 2014, TRIBOL INT, V73, P101, DOI 10.1016/j.triboint.2014.01.006; Li JS, 2010, TRIBOL INT, V43, P1048, DOI 10.1016/j.triboint.2009.12.030; Liang P, 2010, P I MECH ENG J-J ENG, V224, P65, DOI 10.1243/13506501JET615; ONAK TP, 1963, J PHYS CHEM-US, V67, P1741, DOI 10.1021/j100802a517; Papay A G, 1981, Patent No. [US 4295983 A, 4295983]; Qiao D, 2014, LUBR SCI, V26, P1, DOI 10.1002/ls.1217; Small V.R., 1990, US Patent, Patent No. 4975211; Stevens JS, 2013, SURF INTERFACE ANAL, V45, P1238, DOI 10.1002/sia.5261; Wu YL, 2017, TRIBOL INT, V110, P113, DOI 10.1016/j.triboint.2017.02.020; Wu YG, 2017, TRIBOL INT, V109, P140, DOI 10.1016/j.triboint.2016.12.038; Xiong LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083501; Xiong LP, 2011, LUBR SCI, V23, P33, DOI 10.1002/ls.139; Yan JC, 2014, TRIBOL INT, V71, P149, DOI 10.1016/j.triboint.2013.10.009; Yang FW, 2016, IND LUBR TRIBOL, V68, P569, DOI 10.1108/ILT-06-2015-0074; Yang GB, 2017, RSC ADV, V7, P7944, DOI 10.1039/c6ra26896j; Yang GB, 2013, TRIBOL INT, V62, P163, DOI 10.1016/j.triboint.2013.02.024; Yang GB, 2011, J TRIBOL-T ASME, V133, DOI 10.1115/1.4003304; Yao JB, 2010, LUBR SCI, V14, P415; Yue W, 2014, MATER DESIGN, V64, P601, DOI 10.1016/j.matdes.2014.08.020; Zhang YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep14539; Zhang YX, 2003, LUBRICATION OIL, V18, P55; Zheng Z, 1998, WEAR, V222, P135, DOI 10.1016/S0043-1648(98)00323-8	28	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0207267	10.1371/journal.pone.0207267	http://dx.doi.org/10.1371/journal.pone.0207267			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532239	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700009
J	Hunter, S; Williams, N; McDougal, R; Scott, P; Garbelotto, M				Hunter, Shannon; Williams, Nari; McDougal, Rebecca; Scott, Peter; Garbelotto, Matteo			Evidence for rapid adaptive evolution of tolerance to chemical treatments in Phytophthora species and its practical implications	PLOS ONE			English	Article							OAK DEATH PATHOGEN; FUNGICIDE RESISTANCE; FOSETYL-AL; IN-VITRO; CINNAMOMI; PHOSPHITE; SENSITIVITY; INFESTANS; METALAXYL; SELECTION	Chemical treatments are used widely in agricultural and natural settings to protect plants from diseases; however, they may exert an important selection pressure on plant pathogens, promoting the development of tolerant isolates through adaptive evolution. Phosphite is used to manage diseases caused by Phytophthora species which include a large number of the most economically damaging plant pathogens worldwide. Phosphite controls the growth of Phytophthora species in planta without killing it; as a result, isolates can develop tolerance to phosphite after prolonged exposure. We investigated the inter- and intra-specific variability in phosphite tolerance of eleven Phytophthora species, including P. ramorum, an internationally important, highly regulated pathogen. Phytophthora ramorum is a good model system because it is comprised of multiple genetically homogeneous lineages. Seven species were found to be consistently sensitive to phosphite based on the low Effective Concentration (EC) 50 values of all isolates tested (amount of phosphite required to inhibit mycelial growth by 50% relative to growth in the absence of phosphite). However, P. ramorum, P. lateralis, P. crassamura and P. cambivora showed intraspecific variability in sensitivity to phosphite, with at least one isolate showing significantly higher tolerance than the other isolates. Within the three P. ramorum evolutionarily divergent lineages tested, NA1 was the most susceptible to phosphite, the NA1 and EU1 lineages showed intralineage variability and the NA2 lineage showed a decreased sensitivity to phosphite overall as all isolates were relatively tolerant. This finding is relevant because NA1 is dominant in the wild and can be controlled using phosphite, while the EU1 lineage has recently been identified in the wild and is phosphite-tolerant, making the treatment approach potentially less effective. Phytophthora ramorum, P. lateralis and P. crassamura are either selfing, homothallic species, or are known to reproduce exclusively clonally, indicating tolerance to phosphite can emerge even in the absence of sexual recombination.	[Hunter, Shannon] Univ Waikato, Sch Sci, Dept Biol, Hamilton, New Zealand; [Hunter, Shannon; Garbelotto, Matteo] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Williams, Nari; McDougal, Rebecca; Scott, Peter] Scion, Forest Protect, Rotorua, New Zealand; [Hunter, Shannon] Plant & Food Res, Auckland, New Zealand	University of Waikato; University of California System; University of California Berkeley; Scion; New Zealand Institute for Plant & Food Research Ltd	Garbelotto, M (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	matteog@berkeley.edu	McDougal, Rebecca/AAT-3224-2021	McDougal, Rebecca/0000-0003-2154-8668; Williams, Nari/0000-0003-0493-4954; Hunter, Shannon/0000-0002-5302-2655; Scott, Peter/0000-0002-5050-8553	University of California Cooperative Extension Support Funds [19977]; Strategic Science Investment Funds from the New Zealand Ministry of Business, Innovation and Employment	University of California Cooperative Extension Support Funds; Strategic Science Investment Funds from the New Zealand Ministry of Business, Innovation and Employment	Funding for this research was provided by Grant 19977, University of California Cooperative Extension Support Funds to MG which covered experimental costs. SH, NW, RM and PS were supported by Strategic Science Investment Funds from the New Zealand Ministry of Business, Innovation and Employment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWER LA, 1985, CAN J PLANT PATHOL, V7, P1; Chen WJ, 2007, APPL ENVIRON MICROB, V73, P5162, DOI 10.1128/AEM.00507-07; COFFEY MD, 1984, PHYTOPATHOLOGY, V74, P738, DOI 10.1094/Phyto-74-738; COHEN Y, 1986, ANNU REV PHYTOPATHOL, V24, P311, DOI 10.1146/annurev.py.24.090186.001523; Croucher PJP, 2013, BIOL INVASIONS, V15, P2281, DOI 10.1007/s10530-013-0453-8; Dobrowolski MP, 2008, PLANT PATHOL, V57, P928, DOI 10.1111/j.1365-3059.2008.01883.x; Dobrowolski MP, 2003, PHYTOPATHOLOGY, V93, P695, DOI 10.1094/PHYTO.2003.93.6.695; Duvenhage J. A., 1994, Yearbook - South African Avocado Growers' Association, V17, P35; FENN ME, 1984, PHYTOPATHOLOGY, V74, P606, DOI 10.1094/Phyto-74-606; Garbelotto M, 2009, PLANT PATHOL, V58, P111, DOI 10.1111/j.1365-3059.2008.01894.x; Garbelotto M, 2014, PLANT DIS, V98, P849, DOI 10.1094/PDIS-10-13-1043-PDN; Garbelotto M, 2018, CALIF AGR; Garbelotto M, 2009, CALIF AGR, V63, P10, DOI 10.3733/ca.v063n01p10; Gisi U, 1996, ANNU REV PHYTOPATHOL, V34, P549, DOI 10.1146/annurev.phyto.34.1.549; Grunwald NJ, 2012, TRENDS MICROBIOL, V20, P131, DOI 10.1016/j.tim.2011.12.006; Grunwald NJ, 2006, PHYTOPATHOLOGY, V96, P1397, DOI 10.1094/PHYTO-96-1397; Hardy GES, 2001, AUSTRALAS PLANT PATH, V30, P133, DOI 10.1071/AP01012; Hunter S., 2018, THESIS; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kasuga T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2717-z; McDonald BA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0026; McLeod A., 2014, S AFRICAN AVOCADO GR, V37; Pang ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24103; R Core Team, 2021, R LANGUAGE ENV STAT; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Sims L, 2019, PLANT PATHOL, V68, P196, DOI 10.1111/ppa.12933; Wilkinson CJ, 2001, PLANT PATHOL, V50, P83, DOI 10.1046/j.1365-3059.2001.00539.x	27	16	17	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208961	10.1371/journal.pone.0208961	http://dx.doi.org/10.1371/journal.pone.0208961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532144	gold, Green Submitted, Green Published			2022-12-26	WOS:000452644700061
J	Davis, EM; Baust, JJ; O'Donnell, BJ; Shah, FA; McDowell, A; Goo, L; O'Donnell, CP				Davis, Eric M.; Baust, Jeffrey J.; O'Donnell, Brett J.; Shah, Faraaz A.; McDowell, Angela; Goo, Lanping; O'Donnell, Christopher P.			A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEART-FAILURE; FACTOR-ALPHA; PRESSURE; ASSOCIATION; INHIBITION; STRESS; DEATH; ONSET; APNEA	The relationship between cardiovascular disease and abnormalities in sleep architecture is complex and bi-directional. Sleep disordered breathing (SDB) often confounds human studies examining sleep in the setting of heart failure, and the independent impact of isolated right or left heart failure on sleep is difficult to assess. We utilized an animal model of right heart failure using pulmonary artery banding (PAB) in mice to examine the causal effect of right heart failure on sleep architecture. Four weeks after PAB or sham (control) surgery, sleep was measured by polysomnography for 48 hours and right ventricular (RV) hypertrophy confirmed prior to sacrifice. PAB resulted in right ventricular hypertrophy based on a 30% increase in the Fulton Index (p < 0.01). After PAB, mice spent significantly more time in NREM sleep compared to the control group over a 24 hour period (53.5 +/- 1.5% vs. 46.6 +/- 1.4%; p <0.01) and exhibited an inability to both cycle into REM sleep and decrease delta density across the light/sleep period. Our results support a phenotype of impaired sleep cycling and increased 'sleepiness' in a mouse model of RV dysfunction.	[Davis, Eric M.; Baust, Jeffrey J.; O'Donnell, Brett J.; Shah, Faraaz A.; McDowell, Angela; Goo, Lanping; O'Donnell, Christopher P.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Davis, Eric M.] Univ Virginia, Dept Med, Div Pulm & Crit Care, Charlottesville, VA 22903 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia	Davis, EM (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.; Davis, EM (corresponding author), Univ Virginia, Dept Med, Div Pulm & Crit Care, Charlottesville, VA 22903 USA.	emd9b@virginia.edu		Shah, Faraaz/0000-0002-2847-7738; O'Donnell, Christopher/0000-0002-9120-6850	National Institutes of Health [T32 HL007563, R01 HL132877]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132877, P01HL103455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health, R01 HL132877 to CPOD and the National Institutes of Health, T32 HL007563 to EMD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzt M, 2006, ARCH INTERN MED, V166, P1716, DOI 10.1001/archinte.166.16.1716; BENINGTON JH, 1994, SLEEP, V17, P28, DOI 10.1093/sleep/17.1.28; Chervin RD, 1999, NEUROLOGY, V52, P125, DOI 10.1212/WNL.52.1.125; Francis J, 2004, AM J PHYSIOL-HEART C, V286, pH2264, DOI 10.1152/ajpheart.01072.2003; Frazziano G, 2014, AM J PHYSIOL-HEART C, V306, pH197, DOI 10.1152/ajpheart.00977.2012; Friess E, 2004, NEUROPSYCHOPHARMACOL, V29, P598, DOI 10.1038/sj.npp.1300362; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Hastings PC, 2006, EUR RESPIR J, V27, P748, DOI 10.1183/09031936.06.00063005; Hill MR, 2014, ANN BIOMED ENG, V42, P2451, DOI 10.1007/s10439-014-1096-3; Hjelm C, 2013, EUR J HEART FAIL, V15, P496, DOI 10.1093/eurjhf/hft014; Javaheri S, 1998, CIRCULATION, V97, P2154, DOI 10.1161/01.CIR.97.21.2154; Jennings JR, 2007, SLEEP, V30, P219, DOI 10.1093/sleep/30.2.219; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; KAPAS L, 1992, AM J PHYSIOL, V263, pR708, DOI 10.1152/ajpregu.1992.263.3.R708; Lanfranchi PA, 1999, CIRCULATION, V99, P1435, DOI 10.1161/01.CIR.99.11.1435; Lanfranchi PA, 2003, CIRCULATION, V107, P727, DOI 10.1161/01.CIR.0000049641.11675.EE; McDowell AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067435; Mehra R, 2017, J CLIN SLEEP MED, V13, P1411, DOI 10.5664/jcsm.6836; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Odeh M, 2006, EUR J HEART FAIL, V8, P141, DOI 10.1016/j.ejheart.2005.05.010; Patel SR, 2006, AM J EPIDEMIOL, V164, P947, DOI 10.1093/aje/kwj280; Pepperell JCT, 2003, AM J RESP CRIT CARE, V168, P1109, DOI 10.1164/rccm.200212-1476OC; Rubin AE, 2003, AM J RESP CRIT CARE, V168, P1520, DOI 10.1164/rccm.200304-462OC; SHOHAM S, 1987, AM J PHYSIOL, V253, pR142, DOI 10.1152/ajpregu.1987.253.1.R142; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Takahashi S, 1995, PFLUG ARCH EUR J PHY, V431, P155, DOI 10.1007/BF00410186; Takahashi S, 1997, AM J PHYSIOL-REG I, V273, pR677, DOI 10.1152/ajpregu.1997.273.2.R677; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Ulrich S, 2013, RESPIRATION, V86, P45, DOI 10.1159/000342351; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Veasey SC, 2004, SLEEP, V27, P388, DOI 10.1093/sleep/27.3.388; Verrier RL, 1996, CARDIOVASC RES, V31, P181, DOI 10.1016/0008-6363(95)00211-1; WILLICH SN, 1992, AM J CARDIOL, V70, P65, DOI 10.1016/0002-9149(92)91391-G; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208540	10.1371/journal.pone.0208540	http://dx.doi.org/10.1371/journal.pone.0208540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532231	Green Published, gold, Green Submitted			2022-12-26	WOS:000452640900021
J	Mori, T; Hamaya, Y; Uotani, T; Yamade, M; Iwaizumi, M; Furuta, T; Miyajima, H; Osawa, S; Sugimoto, K				Mori, Taiki; Hamaya, Yasushi; Uotani, Takahiro; Yamade, Mihoko; Iwaizumi, Moriya; Furuta, Takahisa; Miyajima, Hiroaki; Osawa, Satoshi; Sugimoto, Ken			Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; MISMATCH REPAIR; INSTABILITY; TOMOGRAPHY; DIAGNOSIS; MSH3	Pancreatic ductal adenocarcinoma (PDAC) prognosis remains poor even after complete resection owing to no valuable biomarkers for recurrence and chemosensitivity. Tumors not expressing MSH3 show elevated microsatellite alterations at selected tetranucleotide repeats (EMAST). EMAST reportedly occurs in several tumors. In colorectal cancer (CRC), EMAST was reportedly correlated with 5-fluorouracil (5-FU) sensitivity. However, EMAST prevalence in PDAC and its significance as a prognostic biomarker are unknown. This study aimed to investigate EMAST prevalence in PDAC and the associations between EMAST and pathological factors, EMAST and prognosis, and EMAST and MSH3 expression via immunohistochemistry (IHC). We assessed 40 PDAC patients undergoing surgery. Genomic DNA was extracted from tumors and normal tissues. EMAST and microsatellite instability-high (MSI-H) were analyzed using five polymorphic tetranucleotide markers and five mononucleotide markers, respectively. Tumor sections were stained for MSH3, and staining intensity was evaluated via the Histoscore (H-score). Eighteen of 40 (45%) PDAC patients were EMAST-positive; however, none were MSI-H-positive. Clinicopathological characteristics including overall survival (OS) and recurrence-free survival (RFS) were not significantly different between EMAST-positive and EMAST-negative patients (P = 0.45, 0.98 respectively). IHC was performed to evaluate MSH3 protein expression levels for the PDAC tissue specimens. H-scores of EMAST-positive patients ranged from 0 to 300 (median, 40) and those of EMAST-negative patients ranged from 0 to 300 (median, 170). MSH3 protein was not significantly downregulated in EMAST-positive patients (P = 0.07). This study is a preliminary study and the number of cases investigated was small, and thus, study of a larger cohort will reveal the clinical implication of EMAST.	[Mori, Taiki; Hamaya, Yasushi; Uotani, Takahiro; Yamade, Mihoko; Miyajima, Hiroaki; Sugimoto, Ken] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan; [Iwaizumi, Moriya] Hamamatsu Univ Sch Med, Lab Med, Hamamatsu, Shizuoka, Japan; [Furuta, Takahisa] Hamamatsu Univ Sch Med, Ctr Clin Res, Hamamatsu, Shizuoka, Japan; [Osawa, Satoshi] Dept Endoscop & Photodynam Med, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Hamaya, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan.	yhamaya@hama-med.ac.jp	Iwaizumi, Moriya/AAG-3173-2019; Hamaya, Yasushi/ABA-8280-2021	Iwaizumi, Moriya/0000-0002-2629-0830; Hamaya, Yasushi/0000-0002-1355-6687				Ahrendt SA, 2000, CANCER RES, V60, P2488; Aquilina G, 2001, J CELL PHYSIOL, V187, P145, DOI 10.1002/jcp.1067; Barrett MT, 2017, BRIT J CANCER, V117, P572, DOI 10.1038/bjc.2017.209; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Burger M, 2006, EUR UROL, V50, P770, DOI 10.1016/j.eururo.2006.04.010; Carethers JM, 2015, GENES-BASEL, V6, P185, DOI 10.3390/genes6020185; Choi YD, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-88; DeWitt J, 2004, ANN INTERN MED, V141, P753, DOI 10.7326/0003-4819-141-10-200411160-00006; Dietlein F, 2014, CANCER DISCOV, V4, P592, DOI 10.1158/2159-8290.CD-13-0907; Garcia M, 2012, GASTROENTEROLOGY, V143, P48, DOI 10.1053/j.gastro.2012.03.034; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Hamaya Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127591; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; HERREROSVILLANUEVA, 2016, ANN TRANSL MED, V4; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Hu ZSI, 2018, CLIN CANCER RES, V24, P1326, DOI 10.1158/1078-0432.CCR-17-3099; Humphris JL, 2017, GASTROENTEROLOGY, V152, P68, DOI 10.1053/j.gastro.2016.09.060; Kim HW, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005926; Koi M, 2016, GASTROENTEROLOGY, V150, P944, DOI 10.1053/j.gastro.2015.12.032; Kondelin J, 2017, CANCER RES, V77, P4078, DOI 10.1158/0008-5472.CAN-17-0682; Lee ES, 2014, WORLD J GASTROENTERO, V20, P7864, DOI 10.3748/wjg.v20.i24.7864; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Matsumoto I, 2013, CLIN GASTROENTEROL H, V11, P712, DOI 10.1016/j.cgh.2012.12.033; Ni HF, 2017, INT J MOL MED, V40, P673, DOI 10.3892/ijmm.2017.3044; Numata M, 2013, INT J ONCOL, V42, P403, DOI 10.3892/ijo.2012.1723; Plaschke J, 2004, CANCER RES, V64, P864, DOI 10.1158/0008-5472.CAN-03-2807; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tajima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028117; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Tseng-Rogenski SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050616; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; Watson MMC, 2014, BRIT J CANCER, V111, P823, DOI 10.1038/bjc.2014.167; Yamada K, 2010, ONCOL REP, V23, P551, DOI 10.3892/or_00000669	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208557	10.1371/journal.pone.0208557	http://dx.doi.org/10.1371/journal.pone.0208557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532127	Green Submitted, gold, Green Published			2022-12-26	WOS:000452640900022
J	Barreales, EG; Payero, TD; de Pedro, A; Aparicio, JF				Barreales, Eva G.; Payero, Tamara D.; de Pedro, Antonio; Aparicio, Jesus F.			Phosphate effect on filipin production and morphological differentiation in Streptomyces filipinensis and the role of the PhoP transcription factor	PLOS ONE			English	Article							ANTIBIOTIC BIOSYNTHESIS; SECONDARY METABOLISM; REGULATOR PHOP; COELICOLOR; GENOME; IDENTIFICATION; EXPRESSION; PROMOTERS; BINDING; SYSTEM	The biosynthesis of the antifungal filipin in Streptomyces filipinensis is very sensitive to phosphate regulation. Concentrations as low as 2.5 mM block filipin production. This effect is, at least in part, produced by repression of the transcription of most filipin biosynthetic genes. The role of the two-component PhoRP system in this process was investigated. The phoRP system of S. filipinensis was cloned and transcriptionally characterised. PhoP binds to two PHO boxes present in one of its two promoters. Filipin production was greatly increased in Delta phoP and Delta phoRP mutants, in agreement with a higher transcription of the fil genes, and the effect of phosphate repression on the antibiotic production of these strains was significantly reduced. No PhoP binding was observed by electrophoretic mobility gel shift assays (EMSAs) with the promoter regions of the fil gene cluster thus suggesting an indirect effect of mutations. Binding assays with cell-free extracts from the wild-type and mutant strains on fil genes promoters revealed retardation bands in the parental strain that were absent in the mutants, thus suggesting that binding of the putative transcriptional regulator or regulators controlled by PhoP was PhoP dependent. Noteworthy, PhoP or PhoRP deletion also produced a dramatic decrease in sporulation ability, thus indicating a clear relationship between the phosphate starvation response mediated by PhoP and the sporulation process in S. filipinensis. This effect was overcome upon gene complementation, but also by phosphate addition, thus suggesting that alternative pathways take control in the absence of PhoRP.	[Barreales, Eva G.; Payero, Tamara D.; de Pedro, Antonio; Aparicio, Jesus F.] Univ Leon, Dept Biol Mol, Area Microbiol, Leon, Spain	Universidad de Leon	Aparicio, JF (corresponding author), Univ Leon, Dept Biol Mol, Area Microbiol, Leon, Spain.	jesus.aparicio@unileon.es	Aparicio, Jesús F./K-8686-2014	Aparicio, Jesús F./0000-0003-4242-4701; Garcia Barreales, Eva/0000-0003-1913-1388	Spanish Ministerio de Economia, Industria y Competitividad [BIO2013-42983-P, PCIN-2016-190]; Ministerio de Educacion, Cultura y Deporte [FPU13/01537]	Spanish Ministerio de Economia, Industria y Competitividad; Ministerio de Educacion, Cultura y Deporte	This work was supported by the Spanish Ministerio de Economia, Industria y Competitividad (Grants BIO2013-42983-P and PCIN-2016-190 to JFA), and a F.P.U. contract of the Ministerio de Educacion, Cultura y Deporte (FPU13/01537 to AP. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Allenby NEE, 2012, NUCLEIC ACIDS RES, V40, P9543, DOI 10.1093/nar/gks766; AMMANN A, 1955, PHYTOPATHOLOGY, V45, P559; Aparicio JF, 2016, APPL MICROBIOL BIOT, V100, P61, DOI 10.1007/s00253-015-7077-0; ASTURIAS JA, 1990, GENE, V93, P79, DOI 10.1016/0378-1119(90)90139-I; Barreales EG, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00246-18; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; BOURN WR, 1995, NUCLEIC ACIDS RES, V23, P3696, DOI 10.1093/nar/23.18.3696; Chater KF, 1997, PRODUCTS SECONDARY M, P57, DOI [10.1002/9783527620890.ch2, DOI 10.1002/9783527620890.CH2]; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P57, DOI 10.1016/0005-2736(74)90332-0; Demain AL, 2009, MED RES REV, V29, P821, DOI 10.1002/med.20154; Enriquez LL, 2006, FEMS MICROBIOL LETT, V257, P312, DOI 10.1111/j.1574-6968.2006.00189.x; Fernandez-Martinez LT, 2012, MOL GENET GENOMICS, V287, P565, DOI 10.1007/s00438-012-0698-4; Gao H, 2014, RSC ADV, V4, P57267, DOI 10.1039/c4ra09875g; Ghorbel S, 2006, J BACTERIOL, V188, P677, DOI 10.1128/JB.188.2.677-686.2006; Ghorbel S, 2006, J BACTERIOL, V188, P6269, DOI 10.1128/JB.00202-06; Gimpl G, 2011, STEROIDS, V76, P216, DOI 10.1016/j.steroids.2010.11.001; Guerra SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031475; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HIGGENS CE, 1974, J ANTIBIOT, V27, P298, DOI 10.7164/antibiotics.27.298; Ikeda H, 2014, J IND MICROBIOL BIOT, V41, P233, DOI 10.1007/s10295-013-1327-x; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim JD, 2012, J BASIC MICROB, V52, P150, DOI 10.1002/jobm.201100134; KRUTH HS, 1986, J BIOL CHEM, V261, P6769; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Lounes A, 1996, APPL MICROBIOL BIOT, V45, P204, DOI 10.1007/s002530050671; MacFaddin J.F., 1985, MEDIA ISOLATION CULT, V1; Martin JF, 2017, J ANTIBIOT, V70, P534, DOI 10.1038/ja.2017.19; Martin JF, 2012, APPL MICROBIOL BIOT, V95, P61, DOI 10.1007/s00253-012-4129-6; Martin-Martin S, 2018, J ANTIBIOT, V71, P113, DOI 10.1038/ja.2017.130; McDowall KJ, 1999, J BACTERIOL, V181, P3025, DOI 10.1128/JB.181.10.3025-3032.1999; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Ordonez-Robles M, 2017, MICROBIOL RES, V205, P80, DOI 10.1016/j.micres.2017.08.010; Payero TD, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0307-4; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen R, 2000, RAPID CYCLE REAL TIM, P21; Recio E, 2006, MICROBIOL-SGM, V152, P3147, DOI 10.1099/mic.0.28953-0; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; ROMERO J, 1984, APPL MICROBIOL BIOT, V20, P318, DOI 10.1007/BF00270593; Santos-Beneit F, 2008, MICROBIOL-SGM, V154, P2356, DOI 10.1099/mic.0.2008/019539-0; Santos-Beneit F, 2009, MOL MICROBIOL, V72, P53, DOI 10.1111/j.1365-2958.2009.06624.x; Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; Sola-Landa A, 2008, NUCLEIC ACIDS RES, V36, P1358, DOI 10.1093/nar/gkm1150; Sola-Landa A, 2013, NUCLEIC ACIDS RES, V41, P1767, DOI 10.1093/nar/gks1203; Van Leeuwen MR, 2009, J APPL MICROBIOL, V106, P1908, DOI 10.1111/j.1365-2672.2009.04165.x; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Vicente CM, 2015, APPL MICROBIOL BIOT, V99, P5123, DOI 10.1007/s00253-015-6472-x; Vicente CM, 2014, APPL MICROBIOL BIOT, V98, P9311, DOI 10.1007/s00253-014-5998-7; Vicente CM, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-33; Welscher YMT, 2008, J BIOL CHEM, V283, P6393, DOI 10.1074/jbc.M707821200; Wu HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09532-3; Xu LH, 2010, J BIOL CHEM, V285, P16844, DOI 10.1074/jbc.M109.092460; Yang RJ, 2015, APPL MICROBIOL BIOT, V99, P10547, DOI 10.1007/s00253-015-6921-6; Yoo HG, 2011, BIOSCI BIOTECH BIOCH, V75, P1191, DOI 10.1271/bbb.110003; Zhu CH, 2007, APPL MICROBIOL BIOT, V73, P1031, DOI 10.1007/s00253-006-0572-6	61	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208278	10.1371/journal.pone.0208278	http://dx.doi.org/10.1371/journal.pone.0208278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521601	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600041
J	Awolola, TS; Adeogun, A; Olakiigbe, AK; Oyeniyi, T; Olukosi, YA; Okoh, H; Arowolo, T; Akila, J; Oduola, A; Amajoh, CN				Awolola, Taiwo Samson; Adeogun, Adedapo; Olakiigbe, Abiodun K.; Oyeniyi, Tolulope; Olukosi, Yetunde Adeola; Okoh, Hilary; Arowolo, Tolulope; Akila, Joel; Oduola, Adedayo; Amajoh, Chioma N.			Pyrethroids resistance intensity and resistance mechanisms in Anopheles gambiae from malaria vector surveillance sites in Nigeria	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; IDENTIFICATION; POPULATIONS; COMPLEX; S.S.; SS	Anopheles gambiae, An. coluzzii and An. arabiensis are the three major vectors of malaria in Nigeria. These mosquitoes have developed resistance to different insecticides. Insecticides resistance intensity assay was recently introduced to provide insight into the potential operational significance of insecticide resistance. Here, we present data on pyrethroids resistance intensity and resistance mechanisms from six vector surveillance sites (Lagos, Ogun, Edo, Anambra, Kwara and Niger) in Nigeria. Adult Anopheles reared from larval collections were tested using WHO insecticides susceptibility protocol with 1x concentration of permethrin and deltamethrin followed with intensity assays with 5x and 10x concentrations of both insecticides. Synergistic and biochemical assays were carried out and underlying resistance mechanisms determined following standard protocols. Anopheles gambiae constituted >50% samples tested in five sites. Permethrin and deltamethrin resistance was observed at all the sites. The Kdt50 varied from 15 minutes (CI = 13.6-17.2) in deltamethrin to 42.1 minutes (CI = 39.4-44.1) in permethrin. For both insecticides, Kdt95 was >30 minutes with 25% to 87% post exposure mortality at the different sites. The West Africa knock down resistance (kdr-w) mechanism was found at each site. Resistant An. gambiae from Lagos, Ogun and Niger synergized prior to permethrin or deltamethrin exposure showed significant mortality (89-100%) compared to unsynergized mosquitoes (Lagos, p = 0.031; Ogun, p = 0.025; Niger, p = 0.018). Biochemical analyses revealed significant increased levels of P450 enzymes in resistant Anopheles gambiae from Lagos (p = 0.038); Ogun (p = 0.042) and Niger (p = 0.028) in addition to GST in Lagos (p = 0.028) and Ogun (p = 0.033). Overall, the results revealed high pyrethroid resistance associated with increased activities of metabolic enzymes (P450 + GST) in An.gambiae and An.coluzzii from Lagos and Ogun. The presence of kdr + P450 conferred moderate resistance whereas low resistance was the case where kdr was the sole resistance mechanism. Findings thus suggests that elevated levels of cytochrome P450 enzymes together with GST were responsible for high or severe pyrethroid resistance.	[Awolola, Taiwo Samson; Adeogun, Adedapo; Olakiigbe, Abiodun K.; Oyeniyi, Tolulope; Olukosi, Yetunde Adeola] Nigerian Inst Med Res, 6 Edmund Crescent, Lagos, Nigeria; [Okoh, Hilary] Fed Univ Oye, Dept Biol Sci, Oye, Ekiti State, Nigeria; [Arowolo, Tolulope] WHO, Lagos, Nigeria; [Akila, Joel] Fed Minist Hlth, Natl Malaria Eliminat Program, Abuja, Nigeria; [Oduola, Adedayo] Univ Ilorin, Dept Zool, Ilorin, Kwara State, Nigeria; [Amajoh, Chioma N.] Community Vis Initiat, Abuja, Nigeria	World Health Organization; University of Ilorin	Awolola, TS (corresponding author), Nigerian Inst Med Res, 6 Edmund Crescent, Lagos, Nigeria.	awololas@hotmail.com			Vestergaard Frandsen (EA) Ltd [IRB/11/168]; World Health Organization Special Program for Research and Training in Tropical Diseases (TDR) [B20388]	Vestergaard Frandsen (EA) Ltd; World Health Organization Special Program for Research and Training in Tropical Diseases (TDR)	The study was partly supported by Vestergaard Frandsen (EA) Ltd through research grant No. IRB/11/168 and the World Health Organization Special Program for Research and Training in Tropical Diseases (TDR) through Grant Ref. No. B20388 to TSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alout H, 2017, TRENDS PARASITOL, V33, P610, DOI 10.1016/j.pt.2017.04.006; [Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Asogwa EU, 2009, AFR J AGR RES, V4, P675; Awolola ST, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-236; Awolola TS, 2009, T ROY SOC TROP MED H, V103, P1139, DOI 10.1016/j.trstmh.2008.08.021; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P181; Awolola TS, 2002, ANN TROP MED PARASIT, V96, P849, DOI 10.1179/000349802125002581; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Coetzee M, 2013, SAMJ S AFR MED J, V103, P770, DOI [10.7196/samj.7446, 10.7196/SAMJ.7446]; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Finney DJ, 1971, PROBIT ANAL, V63; Gillies MT, 1968, JOHANNESBURG PUBL S, V54; Gillies MT, 1987, PUBL S AFR I MED, V55; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kristan M, 2003, MED VET ENTOMOL, V17, P326, DOI 10.1046/j.1365-2915.2003.00449.x; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; MITTAL P K, 1991, Indian Journal of Malariology, V28, P167; Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4; Okorie PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028347; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Venter N, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2134-4; WHO, 2015, COR VECT CONTR METH; [WHO World Health Organization], 1998, REP WHO INF CONS 199; World Health Organization, 2006, PEST THEIR APPL CONT; World Health Organization, 2012, WHO GLOB MAL PROGR G	35	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0205230	10.1371/journal.pone.0205230	http://dx.doi.org/10.1371/journal.pone.0205230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517090	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400007
J	Greene, ML; Tan, JY; Weiser, SD; Christopoulos, K; Shiels, M; O'Hollaren, A; Mureithi, E; Meissner, L; Havlir, D; Gandhi, M				Greene, Meredith L.; Tan, Judy Y.; Weiser, Sheri D.; Christopoulos, Katerina; Shiels, Mary; O'Hollaren, Allison; Mureithi, Eva; Meissner, Loren; Havlir, Diane; Gandhi, Monica			Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in San Francisco	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CARDIOVASCULAR-DISEASE; OLDER-ADULTS; POLYPHARMACY; RISK	Objective People living with HIV (PLWH) are living longer and developing comorbidities and aging-related syndromes. New care models are needed to address the combined burden and complexity of HIV and its comorbidities in this group. The goal of this study is to describe qualitative data from patients and providers that informed the development of a comprehensive care model for older PLWH. Methods Patient and provider perspectives on the clinical care and service needs of patients living and aging with HIV were explored via surveys and focus groups at a safety net HIV clinic in San Francisco. We surveyed 77 patients and 26 providers and conducted separate focus groups of older patients living with HIV (n = 31) and staff (n = 20). Transcripts were analyzed using thematic analysis. Themes for a care program were additionally explored using findings from the literature on HIV and aging. Findings Themes from surveys and focus groups emphasized (a) the need for knowledge expertise in HIV and aging, (b) focus on medical conditions and determinants of health of particular import (e.g. marginal housing) among older PLWH, (c) co-locating specialty services (e.g. cardiology, geriatrics) with primary care, and (d) addressing social isolation. Findings informed the design of a comprehensive, multidisciplinary care model for PLWH called the Golden Compass program composed of four "points": Heart and Mind (North), Bones and Strength (East), Network and Navigation (South), and Dental, Hearing, and Vision (West). Conclusion Based on patient and clinic staff perspectives from surveys and focus groups, we designed a multidisciplinary program of integrated primary and specialty care, as well as housing and social support, to address the needs of older PLWH within a safety-net infrastructure. Golden Compass launched in 2017 for PLWH older than 50 years. Future research to evaluate the effectiveness of this care program in improving patient outcomes and satisfaction is ongoing.	[Greene, Meredith L.; Meissner, Loren] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA; [Tan, Judy Y.] Univ Calif San Francisco, Dept Med, Div Prevent Sci, San Francisco, CA USA; [Weiser, Sheri D.; Christopoulos, Katerina; Shiels, Mary; O'Hollaren, Allison; Mureithi, Eva; Havlir, Diane; Gandhi, Monica] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, ML (corresponding author), Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA.	Meredith.Greene@ucsf.edu			Tideswell at UCSF; National Institute on Aging (NIH/NIA) [P30 AG044281]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, T32MH019105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG044281, R03AG056341] Funding Source: NIH RePORTER	Tideswell at UCSF; National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	M. Greene received funding from Tideswell at UCSF, http://www.tideswellucsf.org/, and National Institute on Aging (NIH/NIA) P30 AG044281 to complete this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the patients living with HIV at Ward 86 and providers and staff who participated in the focus groups and surveys. We are grateful to AIDS Walk San Francisco for funding to help us launch the program and to Design Industries Foundation Fighting AIDS (DIFFA) for helping us maintain it. We thank former Supervisor Jeff Sheehy of San Francisco for his ongoing support of the program. Finally, we are eternally grateful to Mayor Ed Lee (1952-2017) of San Francisco for his never-ending support of HIV/AIDS efforts in the city, and conviction that San Francisco will be the first city "Getting to Zero" new infections, deaths from HIV, and stigma.	Aidala AA, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2015.302905; Allgaier R, 2010, ADDRESSING SERVICE N; Centers for Disease Control and Prevention, 2016, 4 CDCP; Crane HM, 2006, AIDS PATIENT CARE ST, V20, P161, DOI 10.1089/apc.2006.20.161; Crosby R, 2011, J PUBLIC HEALTH DENT, V71, pS7, DOI 10.1111/j.1752-7325.2011.00235.x; D'Abramo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149601; Department of Public Health Population Health Division HIV Epidemiology Section, 2017, SAN FRANC HIV EP ANN; Edelman EJ, 2013, DRUG AGING, V30, P613, DOI 10.1007/s40266-013-0093-9; Emlet CA, 2017, GERONTOLOGIST, V57, pS40, DOI 10.1093/geront/gnw171; Engels EA, 2017, CLIN INFECT DIS, V65, P636, DOI 10.1093/cid/cix392; Gallant J, 2017, J INFECT DIS, V216, P1525, DOI 10.1093/infdis/jix518; Greene M, 2017, AIDS BEHAV, V22, P1; Greene M, 2015, JAIDS-J ACQ IMM DEF, V69, P161, DOI 10.1097/QAI.0000000000000556; Greene M, 2014, AIDS, V28, P2711, DOI 10.1097/QAD.0000000000000507; Greene M, 2014, J AM GERIATR SOC, V62, P447, DOI 10.1111/jgs.12695; Greene M, 2013, JAMA-J AM MED ASSOC, V309, P1397, DOI 10.1001/jama.2013.2963; Guaraldi G, 2017, CLIN INFECT DIS, V65, P507, DOI 10.1093/cid/cix316; John MD, 2016, JAIDS-J ACQ IMM DEF, V72, P534, DOI 10.1097/QAI.0000000000001009; Langlois MA, 2010, HEALTH PROMOT PRACT, V11, P282, DOI 10.1177/1524839908317668; Losina E, 2017, CLIN INFECT DIS, V65, P1266, DOI 10.1093/cid/cix547; Martin-Iguacel R, 2015, CURR HIV-AIDS REP, V12, P375, DOI 10.1007/s11904-015-0284-6; McNicholl IR, 2017, PHARMACOTHERAPY, V37, P1498, DOI 10.1002/phar.2043; Ojikutu B, 2014, AIDS CARE, V26, P731, DOI 10.1080/09540121.2013.855299; Piggott DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054910; Singh HK, 2017, CLIN INFECT DIS, V65, P501, DOI 10.1093/cid/cix311; Solomon P, 2018, INT J STD AIDS, V29, P172, DOI 10.1177/0956462417721439; Solomon P, 2014, AIDS CARE, V26, P240, DOI 10.1080/09540121.2013.811209; Strauss A., 1998, BASICS QUALITATIVE R; Tassiopoulos K, 2017, AIDS, V31, P2287, DOI [10.1097/QAD.0000000000001613, 10.1097/qad.0000000000001613]; USAID, 2011, PERF MON EV TIPS CON; Van Epps P, 2017, INFECT DIS CLIN N AM, V31, P791, DOI 10.1016/j.idc.2017.07.007; Wing EJ, 2016, INT J INFECT DIS, V53, P61, DOI 10.1016/j.ijid.2016.10.004; Wong C, 2018, CLIN INFECT DIS, V66, P1230, DOI 10.1093/cid/cix998	33	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208486	10.1371/journal.pone.0208486	http://dx.doi.org/10.1371/journal.pone.0208486			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517193	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400102
J	Huang, W; Li, HM; Cheng, CH; Ren, CH; Chen, T; Jiang, X; Cheng, KM; Luo, P; Hu, CQ				Huang, Wen; Li, Hongmei; Cheng, Chuhang; Ren, Chunhua; Chen, Ting; Jiang, Xiao; Cheng, Kaimin; Luo, Peng; Hu, Chaoqun			Analysis of the transcriptome data in Litopenaeus vannamei reveals the immune basis and predicts the hub regulation-genes in response to high-pH stress	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CRUSTACEAN BRINE SHRIMP; JUVENILE WHITE SHRIMP; RNA-SEQ; MOLECULAR CHARACTERIZATION; SEAWATER ACIDIFICATION; VIBRIO-ALGINOLYTICUS; OCEAN ACIDIFICATION; HIGH-TEMPERATURE; SALINITY	Soil salinization. erodes the farmlands and poses a serious threat to human life, reuse of the saline-alkali lands as cultivated resources becomes increasingly prominent. Pacific white shrimp (Litopenaeus vannamei) is an important farmed aquatic species for the development and utilization of the saline-alkali areas. However, little is known about the adaptation mechanism of this species in terms of high-pH stress. In the present study, a transcriptome analysis on the gill tissues of L. vannamei in response to high-pH stress (pH 9.3 +/- 0.1) was conducted. After analyzing, the cyclic nucleotide gated channel-Ca2+ (CNGC-Ca2+) and patched 1 (Ptc1) were detected as the majority annotated components in the cAMP signaling pathway (KO04024), indicating that the CNGC-Ca2+ and Ptc1 might be the candidate components for transducing and maintaining the high-pH stress signals, respectively. The immunoglobulin superfamily (IgSF), heat shock protein (HSP), glutathione s-transferase (GST), prophenoloxidase/phenoloxidase (proPO/PO), superoxide dismutase (SOD), antilipopolysaccharide factor (ALF) and lipoprotein were discovered as the major transcribed immune factors in response to high-pH stress. To further detect hub regulation-genes, protein-protein interaction (PPI) networks were constructed; the genes/proteins "Polymerase (RNA) II (DNA directed) polypeptide A" (POLR2A), "Histone acetyltransferase p300" (EP300) and "Heat shock 70kDa protein 8 '' (HSPA8) were suggested as the top three hub regulation-genes in response to acute high-pH stress; the genes/proteins "Heat shock 70kDa protein 4 '' (HSPA4), "FBJ murine osteosarcoma viral oncogene homolog" (FOS) and "Nucleoporin 54kDa" (NUP54) were proposed as the top three hub regulation-genes involved in adapting endurance high-pH stress; the protein-interactions of "EP300-HSPA8" and "HSPA4-NUP54" were detected as the most important biological interactions in response to the high-pH stress; and the HSP70 family genes might play essential roles in the adaptation of the high-pH stress environment in L. vannamei. These findings provide the first insight into the molecular and immune basis of L. vannamei in terms of high-pH environments, and the construction of a PPI network might improve our understanding in revealing the hub regulation-genes in response to abiotic stress in shrimp species and might be beneficial for further studies.	[Huang, Wen; Li, Hongmei; Cheng, Chuhang; Ren, Chunhua; Chen, Ting; Jiang, Xiao; Luo, Peng; Hu, Chaoqun] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Guangdong, Peoples R China; [Huang, Wen; Ren, Chunhua; Chen, Ting; Jiang, Xiao; Hu, Chaoqun] South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Li, Hongmei; Cheng, Chuhang; Hu, Chaoqun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Cheng, Kaimin] Yuehai Feed Grp Co LTD, Zhanjiang, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Luo, P; Hu, CQ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Guangdong, Peoples R China.; Hu, CQ (corresponding author), South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China.; Hu, CQ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	luopengli@163.com; hucq@scsio.ac.cn	huang, wen/GXW-0661-2022	Chen, Ting/0000-0002-5777-909X	National Natural Science Foundation of China [31602135, 31402287]; Guangdong Province Program [2013B091300020, 2014B030301064, 2015B020231007, 2016A020210062, 2016A030310112, 2017B030314052]; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province [A201601A03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Program; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province	This research was supported by the National Natural Science Foundation of China (31602135, 31402287 to WH), the Guangdong Province Program (2013B091300020, 2014B030301064, 2015B020231007, 2016A020210062, 2016A030310112, 2017B030314052 to CH), and the Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province (A201601A03 to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2014, J INVEST DERMATOL, V134, P1981, DOI 10.1038/jid.2014.63; Al Hassan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160236; Aneja B, 2015, PHYSIOL MOL BIOL PLA, V21, P305, DOI 10.1007/s12298-015-0305-3; [Anonymous], 2018, SCI REP UK; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Cai YM, 2017, FISH SHELLFISH IMMUN, V64, P226, DOI 10.1016/j.fsi.2017.02.047; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang XJ, 2016, FISH SHELLFISH IMMUN, V58, P669, DOI 10.1016/j.fsi.2016.10.008; Chen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131503; Chen YY, 2015, FISH SHELLFISH IMMUN, V46, P192, DOI 10.1016/j.fsi.2015.05.055; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dangi SS, 2015, INT J BIOMETEOROL, V59, P1095, DOI 10.1007/s00484-014-0922-5; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Re AD, 2012, J THERM BIOL, V37, P413, DOI 10.1016/j.jtherbio.2012.04.004; Destoumieux D, 2000, J CELL SCI, V113, P461; deVries MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38637; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Duan YF, 2018, J EXP ZOOL PART A, V329, P43, DOI 10.1002/jez.2162; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Exil V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094753; FAO. Fisheries and Aquaculture Department, 2012, FISH AQ DEP STAT WOR, P37; Fehsenfeld S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-488; Fischer C, 2017, PLANT CELL PHYSIOL, V58, P1208, DOI 10.1093/pcp/pcx052; Funasaka T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00878; Gao WH, 2012, AQUACULTURE, V364, P186, DOI 10.1016/j.aquaculture.2012.08.024; Gao Y, 2018, DEV COMP IMMUNOL, V81, P342, DOI 10.1016/j.dci.2017.12.022; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Gilmour KM, 2009, J EXP BIOL, V212, P1647, DOI 10.1242/jeb.029181; Glisic B, 2015, AQUAT TOXICOL, V158, P50, DOI 10.1016/j.aquatox.2014.10.013; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo H, 2013, FISH SHELLFISH IMMUN, V35, P2008, DOI 10.1016/j.fsi.2013.09.019; Guo MX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185732; Hasanuzzaman M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/589341; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Huang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178604; Johnston CL, 2018, J MOL BIOL, V430, P4525, DOI 10.1016/j.jmb.2018.05.021; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karbalaei Reza, 2018, Gastroenterol Hepatol Bed Bench, V11, P27; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kim W, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S5; Kumlu M, 2010, J THERM BIOL, V35, P302, DOI 10.1016/j.jtherbio.2010.06.008; Kurihara H, 2008, J EXP MAR BIOL ECOL, V367, P41, DOI 10.1016/j.jembe.2008.08.016; Le Moullac G, 2000, AQUACULTURE, V191, P121, DOI 10.1016/S0044-8486(00)00422-1; Li CC, 2008, FISH SHELLFISH IMMUN, V25, P701, DOI 10.1016/j.fsi.2008.01.007; Li EC, 2007, AQUACULTURE, V265, P385, DOI 10.1016/j.aquaculture.2007.02.018; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Li JG, 2014, J GEOGR SCI, V24, P943, DOI 10.1007/s11442-014-1130-2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SJ, 2017, GENETICA, V145, P175, DOI 10.1007/s10709-017-9956-z; Liang L. Q., 2013, CHINESE FISHERIES EC, V31, P138, DOI DOI 10.3969/J.ISSN.1009-590X.2013.04.021; Liao ZW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01338-7; Liu Cun-qi, 2008, Yingyong Shengtai Xuebao, V19, P1337; Liu YX., 2016, STRAT STUD CAE, V18, P74, DOI [10.15302/J-SSCAE-2016.03.012, DOI 10.15302/J-SSCAE-2016.03.012]; Liu ZX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191552; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164396; [栾治华 Luan Zhihua], 2003, [海洋湖沼通报, Transactions of Oceanology and Limnology], V0, P71; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lv XJ, 2017, DEV COMP IMMUNOL, V70, P128, DOI 10.1016/j.dci.2017.01.010; Mendoza HL, 1999, DEV COMP IMMUNOL, V23, P359, DOI 10.1016/S0145-305X(99)00017-8; Morrison Deborah K, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a011254; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parnes S, 2004, AQUACULTURE, V236, P593, DOI 10.1016/j.aquaculture.2004.01.040; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Phuoc LH, 2016, J FISH DIS, V39, P555, DOI 10.1111/jfd.12388; Qi XF, 2018, SCIENCE, V362, P52, DOI 10.1126/science.aas8843; Raychaudhuri S, 2014, CELL, V156, P975, DOI 10.1016/j.cell.2014.01.055; Reinders MG, 2018, MOL GENET GENOM MED, V6, P409, DOI 10.1002/mgg3.380; Ren LP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-844; Robledo D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12459-4; Roggatz CC, 2016, GLOBAL CHANGE BIOL, V22, P3914, DOI 10.1111/gcb.13354; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salazar-Medina AJ, 2010, J BIOCHEM MOL TOXIC, V24, P218, DOI 10.1002/jbt.20326; Sau A, 2010, ARCH BIOCHEM BIOPHYS, V500, P116, DOI 10.1016/j.abb.2010.05.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singh M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0404-2; Skaggs HS, 2007, J BIOL CHEM, V282, P33902, DOI 10.1074/jbc.M704054200; Skoda AM, 2018, BOSNIAN J BASIC MED, V18, P8, DOI 10.17305/bjbms.2018.2756; Soderhall Kenneth, 1992, Annual Review of Fish Diseases, V2, P3, DOI 10.1016/0959-8030(92)90053-Z; Sookruksawong S, 2013, DEV COMP IMMUNOL, V41, P523, DOI 10.1016/j.dci.2013.07.020; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Taylor JRA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10608; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Urquhart W, 2011, J EXP BOT, V62, P3671, DOI 10.1093/jxb/err074; Valentim-Neto Pedro A., 2014, VirusDisease, V25, P437, DOI 10.1007/s13337-014-0236-6; Wang H, 2018, MOL MED REP, V18, P834, DOI 10.3892/mmr.2018.9029; [王佳丽 WANG Jiali], 2011, [地理学报, Acta Geographica Sinica], V66, P673; Wang L, 2012, ECOTOXICOLOGY, V21, P1585, DOI 10.1007/s10646-012-0942-z; Wang ST, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187536; Wang WN, 2009, COMP BIOCHEM PHYS C, V150, P428, DOI 10.1016/j.cbpc.2009.06.010; Wang XiaoDan, 2013, Journal of Aquaculture Research and Development, V4, P190; Wang XD, 2015, J SHELLFISH RES, V34, P1037, DOI 10.2983/035.034.0330; Wang YZ, 2018, MOL MED REP, V17, P8091, DOI 10.3892/mmr.2018.8895; Wu FL, 2017, MAR POLLUT BULL, V120, P99, DOI 10.1016/j.marpolbul.2017.04.053; Wu MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40896; Xue M, 2018, SHAANXI WATER RESOUR, V1, P88; Yang Y, 2016, FISH SHELLFISH IMMUN, V58, P89, DOI 10.1016/j.fsi.2016.09.014; Yang YS, 2018, CELL J, V20, P435, DOI 10.22074/cellj.2018.5213; Yepiz-Plascencia G, 2002, COMP BIOCHEM PHYS B, V132, P585, DOI 10.1016/S1096-4959(02)00074-X; Zang YQ, 2018, ONCOL LETT, V15, P9361, DOI 10.3892/ol.2018.8503; Zhang D, 2016, SHANXI HYDROTECHNICS, V4, P127, DOI [10.3969/j.issn.1006-8139.2016.04.041, DOI 10.3969/J.ISSN.1006-8139.2016.04.041]; Zhang F, 2016, CELL MOL LIFE SCI, V73, P4577, DOI 10.1007/s00018-016-2282-2; Zhang L, 2018, FISH SHELLFISH IMMUN, V75, P48, DOI 10.1016/j.fsi.2018.01.046; Zhang QL, 2007, DEV COMP IMMUNOL, V31, P429, DOI 10.1016/j.dci.2006.08.005; Zhang Y, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.131; Zhang YL, 2004, J EXP MAR BIOL ECOL, V301, P39, DOI 10.1016/j.jembe.2003.09.011; Zhao Q, 2016, FISH SHELLFISH IMMUN, V49, P396, DOI 10.1016/j.fsi.2015.12.045; Zhao Q, 2015, FISH SHELLFISH IMMUN, V42, P400, DOI 10.1016/j.fsi.2014.11.020; Zheng CQ, 2015, FISH SHELLFISH IMMUN, V43, P181, DOI 10.1016/j.fsi.2014.12.027; Zhou J, 2009, COMP BIOCHEM PHYS C, V150, P224, DOI 10.1016/j.cbpc.2009.04.012	127	13	14	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207771	10.1371/journal.pone.0207771	http://dx.doi.org/10.1371/journal.pone.0207771			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517152	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400065
J	Ahodantin, J; Bou-Nader, M; Cordier, C; Megret, J; Soussan, P; Desdouets, C; Kremsdorf, D				Ahodantin, James; Bou-Nader, Myriam; Cordier, Corinne; Megret, Jerome; Soussan, Patrick; Desdouets, Chantal; Kremsdorf, Dina			Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation	ONCOGENE			English	Article							HBX PROTEIN; CELL-DEATH; KINASE; REPLICATION; P38; EXPRESSION; INCREASES; REPAIR; HEPATOCYTES; INHIBITION	Hepatitis B virus X protein (HBx) contributes to Hepatitis B virus (HBV)-related liver cancer. However, its impact on hepatocyte proliferation and genomic stability remains elusive. We studied the role of HBx expression on the progression of cell cycle and liver polyploidization during proliferation and liver carcinogenesis. Full-length HBx transgenic mice (FL-HBx) were developed to investigate liver ploidy as well as hepatocyte proliferation, along normal liver maturation and during cancer initiation (chemical carcinogen treatment). Investigation of postnatal liver development in FL-HBx showed an aberrant G1/S and G2/M transitions, triggered (1) a delay of the formation of hepatocytes binucleation, (2) the early synthesis of polyploidy nuclei (>= 4n) and (3) DNA damage appearance. Moreover, HBV infection during hepatocytes proliferation in a humanized liver mouse model led, to modifications in polyploidy of hepatocytes. In initiation of hepatocellular carcinoma, FL-HBx protein decreased ChK1 phosphorylation, Mre11 and Rad51 expression, upregulated IL-6 expression and impaired apoptosis. This was related to DNA damage accumulation in FL-HBx mice. At day 75 after initiation of hepatocellular carcinoma, FL-HBx mice revealed significant cell cycle changes related to the increased amount of 4n nuclei and of markers of cancer progenitor cells. Finally, PLK1 upregulation and p38/ERK activation in FL-HBx mice were implicated in aberrant polyploidization favoring DNA damage propagation and hepatocyte transformation. In conclusion, our data indicate that FL-HBx protein increases DNA damage through the hijack of hepatocyte polyploidization. That leads to enhancement of hepatocellular carcinoma initiation in an inflammatory context.	[Ahodantin, James; Soussan, Patrick; Kremsdorf, Dina] Inserm U1135 CIMI Paris, Team Persistent Viral Infect, Paris, France; [Ahodantin, James; Soussan, Patrick; Kremsdorf, Dina] Univ Paris 06, Paris, France; [Ahodantin, James; Soussan, Patrick; Kremsdorf, Dina] CNRS, ERL 8255, Paris, France; [Bou-Nader, Myriam; Desdouets, Chantal] INSERM, Inst Cochin, U1016, Paris, France; [Bou-Nader, Myriam; Desdouets, Chantal] CNRS, UMR8104, Paris, France; [Bou-Nader, Myriam; Desdouets, Chantal] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Cordier, Corinne; Megret, Jerome] Inserm US24, CNRS UMS 3633, SFR Necker, Cytometry Core Facil, Paris, France; [Cordier, Corinne; Megret, Jerome] Paris Descartes, Fac Med, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kremsdorf, D (corresponding author), Inserm U1135 CIMI Paris, Team Persistent Viral Infect, Paris, France.; Kremsdorf, D (corresponding author), Univ Paris 06, Paris, France.; Kremsdorf, D (corresponding author), CNRS, ERL 8255, Paris, France.	dina.kremsdorf@inserm.fr	soussan, patrick/O-9801-2017; Cordier, Corinne/F-9966-2018; Ahodantin, James/AAB-7216-2022; Ahodantin, James/AAK-3326-2020	soussan, patrick/0000-0003-2706-7371; Cordier, Corinne/0000-0003-4799-6143; Ahodantin, James/0000-0003-4405-2593; Ahodantin, James/0000-0003-4405-2593	Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) [AO 2014-1 16032]; Ligue Contre le Cancer [RS16/75-7, 2017 RS17/75-23]; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Pierre et Marie Curie (UPMC); ANRS doctoral grant	Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie (UPMC); ANRS doctoral grant	This work was supported by grants from the Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) (AO 2014-1 16032), Ligue Contre le Cancer (2016, RS16/75-7 and 2017 RS17/75-23), Institut National de la Sante et de la Recherche Medicale (Inserm) and Universite Pierre et Marie Curie (UPMC). J.A. was supported by an ANRS doctoral grant.	Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200; Bandopadhyay M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0085-6; Bontron S, 2002, J BIOL CHEM, V277, P38847, DOI 10.1074/jbc.M205722200; Brezillon N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025096; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chaisaingmongkol J, 2017, CANCER CELL, V32, P57, DOI 10.1016/j.ccell.2017.05.009; Cheng B, 2010, LIVER INT, V30, P319, DOI 10.1111/j.1478-3231.2009.02167.x; Dan Yue, 2016, Sci Rep, V6, P24430, DOI 10.1038/srep24430; Desdouets C, 2015, ONCOTARGET, V6, P8430, DOI 10.18632/oncotarget.3809; Duncan AW, 2012, GASTROENTEROLOGY, V142, P25, DOI 10.1053/j.gastro.2011.10.029; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Gentric G, 2015, J CLIN INVEST, V125, P981, DOI 10.1172/JCI73957; Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; He ZL, 2009, WORLD J GASTROENTERO, V15, P4177, DOI 10.3748/wjg.15.4177; Kawai H, 2000, HEPATOLOGY, V31, P1246, DOI 10.1053/jhep.2000.7298; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; Kim S, 2015, J GEN VIROL, V96, P2242, DOI 10.1099/vir.0.000150; KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Na TY, 2016, ONCOGENE, V35, P5435, DOI 10.1038/onc.2016.82; Pandey V, 2012, J BIOL CHEM, V287, P20545, DOI 10.1074/jbc.M112.359760; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Parrilla A, 2016, CELL CYCLE, V15, P3177, DOI 10.1080/15384101.2016.1249544; Qadri I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-48; Qiao L, 2001, HEPATOLOGY, V34, P906, DOI 10.1053/jhep.2001.28886; Quetier I, 2015, J GEN VIROL, V96, P614, DOI 10.1099/vir.0.070680-0; Quetier I, 2013, J HEPATOL, V59, P285, DOI 10.1016/j.jhep.2013.03.021; Rakotomalala L, 2008, J BIOL CHEM, V283, P28729, DOI 10.1074/jbc.M802751200; Schmit TL, 2007, MOL CANCER THER, V6, P1920, DOI 10.1158/1535-7163.MCT-06-0781; Studach L, 2010, J BIOL CHEM, V285, P30282, DOI 10.1074/jbc.M109.093963; Studach LL, 2009, HEPATOLOGY, V50, P414, DOI 10.1002/hep.22996; Tarn C, 2002, J VIROL, V76, P9763, DOI 10.1128/JVI.76.19.9763-9772.2002; Tormos AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171738; Toyoda H, 2005, GUT, V54, P297, DOI 10.1136/gut.2004.043893; Wang C, 2012, HEPATOLOGY, V55, P108, DOI 10.1002/hep.24675; Wang SN, 2012, EUR J CLIN INVEST, V42, P1295, DOI 10.1111/eci.12003; Wang YL, 2016, ONCOTARGET, V7, P11284, DOI 10.18632/oncotarget.7022; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089; Yun C, 2004, MOL CANCER RES, V2, P159	45	21	25	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2645	2657		10.1038/s41388-018-0607-3	http://dx.doi.org/10.1038/s41388-018-0607-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30538294				2022-12-26	WOS:000463335200014
J	Nishimura, T; Nakata, A; Chen, XX; Nishi, K; Meguro-Horike, M; Sasaki, S; Kita, K; Horike, S; Saitoh, K; Kato, K; Igarashi, K; Murayama, T; Kohno, S; Takahashi, C; Mukaida, N; Yano, SJ; Soga, T; Tojo, A; Gotoh, N				Nishimura, Tatsunori; Nakata, Asuka; Chen, Xiaoxi; Nishi, Kurumi; Meguro-Horike, Makiko; Sasaki, Soichiro; Kita, Kenji; Horike, Shin-ichi; Saitoh, Kaori; Kato, Keiko; Igarashi, Kaori; Murayama, Takahiko; Kohno, Susumu; Takahashi, Chiaki; Mukaida, Naofumi; Yano, Seiji; Soga, Tomoyoshi; Tojo, Arinobu; Gotoh, Noriko			Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2	ONCOGENE			English	Article							CELL LUNG-CANCER; TUMOR-INITIATING CELLS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; ACQUIRED-RESISTANCE; GLYCINE; AMPK; GROWTH; SERINE; MAINTENANCE; MECHANISMS	Tumor recurrence is attributable to cancer stem-like cells (CSCs), the metabolic mechanisms of which currently remain obscure. Here, we uncovered the critical role of folate-mediated one-carbon (1C) metabolism involving mitochondrial methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) and its downstream purine synthesis pathway. MTHFD2 knockdown greatly reduced tumorigenesis and stem-like properties, which were associated with purine nucleotide deficiency, and caused marked accumulation of 5-aminoimidazole carboxamide ribonucleotide (AICAR)-the final intermediate of the purine synthesis pathway. Lung cancer cells with acquired resistance to the targeted drug gefitinib, caused by elevated expression of components of the beta-catenin pathway, exhibited increased stem-like properties and enhanced expression of MTHFD2. MTHFD2 knockdown or treatment with AICAR reduced the stem-like properties and restored gefitinib sensitivity in these gefitinib-resistant cancer cells. Moreover, overexpression of MTHFD2 in gefitinib-sensitive lung cancer cells conferred resistance to gefitinib. Thus, MTHFD2-mediated mitochondrial 1C metabolism appears critical for cancer stem-like properties and resistance to drugs including gefitinib through consumption of AICAR, leading to depletion of the intracellular pool of AICAR. Because CSCs are dependent on MTHFD2, therapies targeting MTHFD2 may eradicate tumors and prevent recurrence.	[Nishimura, Tatsunori; Nakata, Asuka; Chen, Xiaoxi; Nishi, Kurumi; Gotoh, Noriko] Kanazawa Univ, Canc Res Inst, Div Canc Cell Biol, Kanazawa, Ishikawa 9201192, Japan; [Meguro-Horike, Makiko; Horike, Shin-ichi] Kanazawa Univ, Adv Sci Res Ctr, Div Funct Genom, Kanazawa, Ishikawa 9201192, Japan; [Sasaki, Soichiro; Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa 9201192, Japan; [Kita, Kenji; Yano, Seiji] Kanazawa Univ, Canc Res Inst, Div Med Oncol, 13-1 Takaramachi, Kanazawa, Ishikawa 9200934, Japan; [Saitoh, Kaori; Kato, Keiko; Igarashi, Kaori; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, 246-2 Minakami, Tsuruoka, Yamagata 9970052, Japan; [Murayama, Takahiko; Tojo, Arinobu; Gotoh, Noriko] Univ Tokyo, Inst Med Sci, Div Mol Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Kohno, Susumu; Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Keio University; University of Tokyo; Kanazawa University	Gotoh, N (corresponding author), Kanazawa Univ, Canc Res Inst, Div Canc Cell Biol, Kanazawa, Ishikawa 9201192, Japan.; Gotoh, N (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ngotoh@staff.kanazawa-u.ac.jp	GOTOH, Noriko/D-8430-2015; KITA, Kenji/D-8437-2015; Mukaida, Naofumi/D-7623-2011	KITA, Kenji/0000-0002-4622-6633; Murayama, Takahiko/0000-0003-0764-8646; Mukaida, Naofumi/0000-0002-4193-1851	Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University; MEXT [22130009]; JSPS [15H04294, 17K19587, 17K15021]; AMED Project for Development of Innovative Research on Cancer Therapeutics	Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AMED Project for Development of Innovative Research on Cancer Therapeutics	We thank H. Miyoshi for his kind gift of pCMV-VSV-G-RSV-Rev and pCAG-HIVgp and J. Yokota and T. Kohno for their kind gift of lung cancer cell lines. We are grateful to K. Kitamura and Y. Tanabe for their technical assistance. This work was supported in part by an Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University, Hokkoku Gan-Kikin, a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (22130009), a Grant-in-Aid for Scientific Research (B) from JSPS (15H04294, 17K19587), and a research grant from AMED Project for Development of Innovative Research on Cancer Therapeutics to NG. This work was supported in part by a Grant-in-Aid for Scientific Research for Young Scientists (B) from JSPS (17K15021) to TN.	Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Chae HD, 2012, STEM CELLS, V30, P140, DOI 10.1002/stem.778; Christensen KE, 2005, J BIOL CHEM, V280, P34316, DOI 10.1074/jbc.M505210200; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; Gotoh N, 2011, CANC STEM CELLS THEO, P261; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hinohara K, 2012, P NATL ACAD SCI USA, V109, P6584, DOI 10.1073/pnas.1113271109; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hussein HA, 2015, NUCLEIC ACIDS RES, V43, pW436, DOI 10.1093/nar/gkv462; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Koufaris C, 2016, J PROTEOME RES, V15, P2618, DOI 10.1021/acs.jproteome.6b00188; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lehtinen L, 2013, ONCOTARGET, V4, P48, DOI 10.18632/oncotarget.756; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; Moran DM, 2014, MOL CANCER THER, V13, P1611, DOI 10.1158/1535-7163.MCT-13-0649; Murayama T, 2016, CANCER RES, V76, P974, DOI 10.1158/0008-5472.CAN-15-2135; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Nakata A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13076; Nakayama S, 2014, CANCER RES, V74, P5891, DOI 10.1158/0008-5472.CAN-14-0184; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pikman Y, 2016, J EXP MED, V213, P1285, DOI 10.1084/jem.20151574; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Russo A, 2015, ONCOTARGET, V6, P26814, DOI 10.18632/oncotarget.4254; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shen BW, 1999, PROTEIN SCI, V8, P1342, DOI 10.1110/ps.8.6.1342; Sheppard NG, 2015, SCI REP-UK, V5, DOI 10.1038/srep15029; SMITH GK, 1990, ARCH BIOCHEM BIOPHYS, V283, P367, DOI 10.1016/0003-9861(90)90656-J; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Stewart B. W., 2014, WORLD CANC REPORT 20, P630; Suski M, 2017, EUR J PHARM SCI, V104, P406, DOI 10.1016/j.ejps.2017.04.021; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tominaga K, 2017, ONCOGENE, V36, P1276, DOI 10.1038/onc.2016.293; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang XX, 2017, NAT NEUROSCI, V20, P661, DOI 10.1038/nn.4537; Yamauchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043923; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	65	41	44	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2464	2481		10.1038/s41388-018-0589-1	http://dx.doi.org/10.1038/s41388-018-0589-1			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30532069	Green Published, hybrid			2022-12-26	WOS:000463335200003
J	Yang, JW; Murray, B; Barbier-Torres, L; Liu, T; Liu, ZQ; Yang, HP; Fan, W; Wang, JH; Li, Y; Seki, E; Mato, JM; Lu, SC				Yang, Jin Won; Murray, Ben; Barbier-Torres, Lucia; Liu, Ting; Liu, Zhenqiu; Yang, Heping; Fan, Wei; Wang, Jiaohong; Li, Yuan; Seki, Ekihiro; Mato, Jose M.; Lu, Shelly C.			The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); NF-B; migration; invasion; hepatocellular carcinoma; interleukin-8; prohibitin 1	HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; EXPRESSION; FIBROSIS; NUCLEUS; PROTEIN; KINASE; INJURY; GENE; P53	Prohibitin 1 (PHB1) is a mitochondrial chaperone whose expression is dysregulated in cancer. In liver cancer, PHB1 acts as a tumor suppressor, but the mechanisms of tumor suppression are incompletely understood. Here we aimed to determine PHB1 target genes to better understand how PHB1 influences liver tumorigenesis. Using RNA-Seq analysis, we found interleukin-8 (IL-8) to be one of the most highly up-regulated genes following PHB1 silencing in HepG2 cells. Induction of IL-8 expression also occurred in multiple liver and nonliver cancer cell lines. We examined samples from 178 patients with hepatocellular carcinoma (HCC) and found that IL-8 mRNA levels were increased, whereas PHB1 mRNA levels were decreased, in the tumors compared with adjacent nontumorous tissues. Notably, HCC patients with high IL-8 expression have significantly reduced survival. An inverse correlation between PHB1 and IL-8 mRNA levels is found in HCCs with reduced PHB1 expression. To understand the molecular basis for these observations, we altered PHB1 levels in liver cancer cells. Overexpression of PHB1 resulted in lowered IL-8 expression and secretion. Silencing PHB1 increased c-Jun N-terminal kinase (JNK) and NF-B activity, induced nuclear accumulation of c-JUN and p65, and enhanced their binding to the IL-8 promoter containing AP-1 and NF-B elements. Conditioned medium from PHB1-silenced HepG2 cells increased migration and invasion of parental HepG2 and SK-hep-1 cells, and this was blocked by co-treatment with neutralizing IL-8 antibody. In summary, our findings show that reduced PHB1 expression induces IL-8 transcription by activating NF-B and AP-1, resulting in enhanced IL-8 expression and release to promote tumorigenesis.	[Yang, Jin Won; Murray, Ben; Barbier-Torres, Lucia; Yang, Heping; Fan, Wei; Wang, Jiaohong; Li, Yuan; Seki, Ekihiro; Lu, Shelly C.] Cedars Sinai Med Ctr, Div Digest & Liver Dis, Los Angeles, CA 90048 USA; [Yang, Jin Won] Woosuk Univ, Coll Pharm, Wonju, South Korea; [Liu, Ting; Li, Yuan] Cent S Univ, Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Liu, Zhenqiu] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Mato, Jose M.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC bioGUNE, Technol Pk Bizkaia, Derio 48160, Spain	Cedars Sinai Medical Center; Woosuk University; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Lu, SC (corresponding author), Cedars Sinai Med Ctr, Davis Bldg,Rm 2097,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	shelly.lu@cshs.org	MATO, JOSE/A-5187-2011; Seki, Ekihiro/K-2481-2016; Li, Yuan/GXV-1310-2022; Lu, Shelly/AAH-5937-2021	MATO, JOSE/0000-0003-1264-3153; Seki, Ekihiro/0000-0002-9472-6085; Lu, Shelly/0000-0003-2128-5407; FAN, WEI/0000-0001-6462-7425	National Institutes of Health [R01CA172086]; Plan Nacional of I + D [SAF2017-88041-R]; Innovative Medicines Initiative (IMI) Grant [777377-LITMUS-H2020-JTI-IMI2-2016-09]; Instituto de Salud Carlos III Grant CIBERehd MAT-3; Centers of Excellence Severo Ochoa Grant [SEV-2016-0644]; NATIONAL CANCER INSTITUTE [R01CA172086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional of I + D; Innovative Medicines Initiative (IMI) Grant; Instituto de Salud Carlos III Grant CIBERehd MAT-3; Centers of Excellence Severo Ochoa Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA172086 (to S.C.L., H.P.Y., and J.M.M.), Plan Nacional of I + D SAF2017-88041-R, Innovative Medicines Initiative (IMI) Grant 777377-LITMUS-H2020-JTI-IMI2-2016-09, Instituto de Salud Carlos III Grant CIBERehd MAT-3, and Centers of Excellence Severo Ochoa Grant SEV-2016-0644 (to J.M.M.). J.M.M. is a consultant for Abbott. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Anaya Jordan, 2015, PeerJ, V3, pe1499, DOI 10.7717/peerj.1499; Barbier-Torres L, 2015, HEPATOLOGY, V62, P1237, DOI 10.1002/hep.27959; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Chowdhury I, 2013, APOPTOSIS, V18, P1513, DOI 10.1007/s10495-013-0901-z; Eun JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110744; Fan W, 2017, HEPATOLOGY, V65, P1249, DOI 10.1002/hep.28964; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Gangwani MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135633; Guan XX, 2014, BIOCHEM BIOPH RES CO, V443, P1239, DOI 10.1016/j.bbrc.2013.12.124; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Jiang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.40; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; Kathiria AS, 2012, CANCER RES, V72, P5778, DOI 10.1158/0008-5472.CAN-12-0603; Ko KS, 2010, HEPATOLOGY, V52, P2096, DOI 10.1002/hep.23919; Koushyar S, 2015, CANCER LETT, V369, P316, DOI 10.1016/j.canlet.2015.09.012; Krause A, 1998, J BIOL CHEM, V273, P23681, DOI 10.1074/jbc.273.37.23681; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu T, 2018, GASTROENTEROLOGY, V155, P557, DOI 10.1053/j.gastro.2018.04.032; Liu YH, 2017, VIROLOGY, V506, P64, DOI 10.1016/j.virol.2017.03.009; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Omori E, 2012, P NATL ACAD SCI USA, V109, P3365, DOI 10.1073/pnas.1116188109; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ramani K, 2016, J BIOL CHEM, V291, P24148, DOI 10.1074/jbc.M116.744045; Ren Y, 2003, CLIN CANCER RES, V9, P5996; Sato S, 2011, CHEM BIOL, V18, P131, DOI 10.1016/j.chembiol.2010.10.017; Shi SL, 2009, J CELL BIOCHEM, V108, P926, DOI 10.1002/jcb.22324; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang HP, 2015, ANTIOXID REDOX SIGN, V22, P259, DOI 10.1089/ars.2014.6027	42	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1984	1996		10.1074/jbc.RA118.004863	http://dx.doi.org/10.1074/jbc.RA118.004863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30523154	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000459711400018
J	Zhang, Z; Parker, MP; Graw, S; Novikova, LV; Fedosyuk, H; Fontes, JD; Koestler, DC; Peterson, KR; Slawson, C				Zhang, Zhen; Parker, Matthew P.; Graw, Stefan; Novikova, Lesya V.; Fedosyuk, Halyna; Fontes, Joseph D.; Koestler, Devin C.; Peterson, Kenneth R.; Slawson, Chad			O-GlcNAc homeostasis contributes to cell fate decisions during hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); hematopoiesis; GATA transcription factor; gene regulation; differentiation; post-translational modification; transcription; erythropoiesis; myelopoiesis; G1E-ER4; FOG-1	IN-VITRO; ERYTHROID-DIFFERENTIATION; CHROMATIN OCCUPANCY; TRANSCRIPTION; GENE; PROTEIN; GLCNACYLATION; PHOSPHORYLATION; TRANSFERASE; EXPRESSION	The addition of a single beta-d-GlcNAc sugar (O-GlcNAc) by O-GlcNAc-transferase (OGT) and O-GlcNAc removal by O-GlcNAcase (OGA) maintain homeostatic O-GlcNAc levels on cellular proteins. Changes in protein O-GlcNAcylation regulate cellular differentiation and cell fate decisions, but how these changes affect erythropoiesis, an essential process in blood cell formation, remains unclear. Here, we investigated the role of O-GlcNAcylation in erythropoiesis by using G1E-ER4 cells, which carry the erythroid-specific transcription factor GATA-binding protein 1 (GATA-1) fused to the estrogen receptor (GATA-1-ER) and therefore undergo erythropoiesis after beta-estradiol (E-2) addition. We observed that during G1E-ER4 differentiation, overall O-GlcNAc levels decrease, and physical interactions of GATA-1 with both OGT and OGA increase. RNA-Seq-based transcriptome analysis of G1E-ER4 cells differentiated in the presence of the OGA inhibitor Thiamet-G (TMG) revealed changes in expression of 433 GATA-1 target genes. ChIP results indicated that the TMG treatment decreases the occupancy of GATA-1, OGT, and OGA at the GATA-binding site of the lysosomal protein transmembrane 5 (Laptm5) gene promoter. TMG also reduced the expression of genes involved in differentiation of NB4 and HL60 human myeloid leukemia cells, suggesting that O-GlcNAcylation is involved in the regulation of hematopoietic differentiation. Sustained treatment of G1E-ER4 cells with TMG before differentiation reduced hemoglobin-positive cells and increased stem/progenitor cell surface markers. Our results show that alterations in O-GlcNAcylation disrupt transcriptional programs controlling erythropoietic lineage commitment, suggesting a role for O-GlcNAcylation in regulating hematopoietic cell fate.	[Zhang, Zhen; Parker, Matthew P.; Novikova, Lesya V.; Fedosyuk, Halyna; Fontes, Joseph D.; Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Peterson, Kenneth R.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Graw, Stefan; Koestler, Devin C.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA; [Fontes, Joseph D.; Koestler, Devin C.; Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Canc Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Zhang, Zhen] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Epigenet Inst, Philadelphia, PA 19104 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Pennsylvania Medicine	Peterson, KR; Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.; Peterson, KR (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.; Peterson, KR; Slawson, C (corresponding author), Univ Kansas, Med Ctr, Canc Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	kpeterson@kumc.edu; cslawson@kumc.edu		Graw, Stefan/0000-0002-6386-8267; Fontes, Joseph/0000-0003-4796-343X	NIDDK, National Institutes of Health [R01DK100595, R01HL111264]; University of Kansas Medical Center (KUMC) Biomedical Research Training Program; NIGMS, National Institutes of Health [P20GM103549, P30GM118247, P20GM103418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118247, P20GM103418] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Kansas Medical Center (KUMC) Biomedical Research Training Program; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIDDK, National Institutes of Health Grants R01DK100595 (to C. S. and K. R. P.) and R01HL111264 (to K. R. P.) and a University of Kansas Medical Center (KUMC) Biomedical Research Training Program grant (to Z. Z.). Partial support was provided by NIGMS, National Institutes of Health Grants P20GM103549, P30GM118247, and P20GM103418. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Baines KJ, 2011, THORAX, V66, P942, DOI 10.1136/thx.2010.157719; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; DRACH J, 1993, CANCER RES, V53, P2100; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gambetta MC, 2015, CHROMOSOMA, V124, P429, DOI 10.1007/s00412-015-0513-1; Glowacka WK, 2012, J BIOL CHEM, V287, P27691, DOI 10.1074/jbc.M112.355917; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hastings NB, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0181-0; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kadri Z, 2015, GENE DEV, V29, P2603, DOI 10.1101/gad.267633.115; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Koyama T, 2015, EXP CELL RES, V338, P194, DOI 10.1016/j.yexcr.2015.08.009; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; Lewis BA, 2016, J BIOL CHEM, V291, P14056, DOI 10.1074/jbc.M115.684365; Li LQ, 2013, BLOOD, V121, P4575, DOI 10.1182/blood-2013-01-479451; Manavathi B, 2012, J BIOL CHEM, V287, P5600, DOI 10.1074/jbc.M111.289843; Maurya JJP, 2015, STEM CELL RES, V15, P182, DOI 10.1016/j.scr.2015.06.007; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ogawa M, 2012, BBA-GEN SUBJECTS, V1820, P24, DOI 10.1016/j.bbagen.2011.10.011; Olivier-Van Stichelen S, 2015, CURR OPIN CLIN NUTR, V18, P339, DOI 10.1097/MCO.0000000000000188; ORKIN SH, 1992, BLOOD, V80, P575; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Resto M, 2016, J BIOL CHEM, V291, P22703, DOI 10.1074/jbc.M116.751420; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sohn KC, 2014, J DERMATOL SCI, V75, P10, DOI 10.1016/j.jdermsci.2014.04.010; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Speakman CM, 2014, STEM CELLS, V32, P2605, DOI 10.1002/stem.1761; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan EP, 2017, J BIOL CHEM, V292, P14940, DOI 10.1074/jbc.M117.797944; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wang Z, 2011, AUTOPHAGY, V7, P401, DOI 10.4161/auto.7.4.14397; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yoon SG, 2013, CANCER RES TREAT, V45, P126, DOI 10.4143/crt.2013.45.2.126; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zhang Y, 2009, LEUKEMIA RES, V33, P166, DOI 10.1016/j.leukres.2008.05.021; Zhang Z, 2016, J BIOL CHEM, V291, P15628, DOI 10.1074/jbc.M116.721928	67	21	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1363	1379		10.1074/jbc.RA118.005993	http://dx.doi.org/10.1074/jbc.RA118.005993			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30523150	hybrid, Green Published			2022-12-26	WOS:000457879500026
J	Hjorthaug, HS; Gervin, K; Mowinckel, P; Munthe-Kaas, MC				Hjorthaug, Hanne Sagsveen; Gervin, Kristina; Mowinckel, Petter; Munthe-Kaas, Monica Cheng			Exploring the influence from whole blood DNA extraction methods on Infinium 450K DNA methylation	PLOS ONE			English	Article								Genome-wide DNA methylation studies are becoming increasingly important in unraveling the epigenetic basis of cell biology, aging and human conditions. The aim of the present study was to explore whether different methods for extracting DNA from whole blood can affect DNA methylation outcome, potentially confounding DNA methylation studies. DNA was isolated from healthy blood donors (n = 10) using three different extraction methods (i.e. two automatic extractions methods based on magnetic beads or isopropanol precipitation, and manual organic extraction). DNA methylation was analyzed using the Infinium HumanMethylation450 Bead Chip (Infinium 450K) (n = 30 samples in total), which is a frequently used method in genome-wide DNA methylation analyses. Overall, the different extraction methods did not have a significant impact on the global DNA methylation patterns. However, DNA methylation differences between organic extraction and each of the automated methods were in general larger than differences between the two automated extraction methods. No CpG sites or regions reached genome-wide significance when testing for differential methylation between extraction methods. Although this study is based on a small sample, these results suggest that extraction method is unlikely to confound Infinium 450K methylation analysis in whole blood.	[Hjorthaug, Hanne Sagsveen] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Hjorthaug, Hanne Sagsveen] Univ Oslo, Oslo, Norway; [Gervin, Kristina] Univ Oslo, Fac Math & Nat Sci, PharmaTox Strateg Res Initiat, Oslo, Norway; [Gervin, Kristina] Univ Oslo, Sch Pharm, Dept Pharm, Pharmacoepidemiol & Drug Safety Res Grp, Oslo, Norway; [Mowinckel, Petter] Oslo Univ Hosp, Dept Pediat & Adolescent Med, Oslo, Norway; [Munthe-Kaas, Monica Cheng] Oslo Univ Hosp, Dept Pediat Oncol & Hematol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Hjorthaug, HS (corresponding author), Oslo Univ Hosp, Dept Med Genet, Oslo, Norway.; Hjorthaug, HS (corresponding author), Univ Oslo, Oslo, Norway.	uxhjhb@ous-hf.no			functional genomics program (FUGE) in the Research Council of Norway	functional genomics program (FUGE) in the Research Council of Norway(Research Council of Norway)	The Infinium 450K array service was provided by the Norwegian Microarray Consortium at the national technology platform, and supported by the functional genomics program (FUGE) in the Research Council of Norway. We would like to thank the Blood Bank at Oslo University Hospital, Norway and for collecting blood samples and extracting DNA on the MagNA Pure extractor. We also appreciate advices on statistical analyses from Magnus D. Vigeland (Department of Medical Genetics, Oslo University Hospital, Oslo, Norway).	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; [Anonymous], 2014, R LANG ENV STAT COMP; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Benjamini Y, 2017, J ROYAL STAT SOC B, V57, P289; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Braun KVE, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-016-0304-4; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Farlik M, 2016, CELL STEM CELL, V19, P808, DOI 10.1016/j.stem.2016.10.019; Gutierrez-Arcelus M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004958; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jaffe A. E., 2018, FLOWSORTEDBLOOD450K; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Olsson AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004735; Owczarzy R, 2004, BIOCHEMISTRY-US, V43, P3537, DOI 10.1021/bi034621r; Rohrich M, 2016, ACTA NEUROPATHOL, V131, P877, DOI 10.1007/s00401-016-1540-6; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Shiwa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147519; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Yang IV, 2015, J ALLERGY CLIN IMMUN, V136, P69, DOI 10.1016/j.jaci.2015.01.025	22	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208699	10.1371/journal.pone.0208699	http://dx.doi.org/10.1371/journal.pone.0208699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540848	Green Submitted, gold, Green Published			2022-12-26	WOS:000452898600083
J	Hsu, CH; Otte, ML; Liu, CC; Chou, JY; Fang, WT				Hsu, Chia-Hsuan; Otte, Marinus L.; Liu, Chi-Chang; Chou, Jui-Yu; Fang, Wei-Ta			What are the sympatric mechanisms for three species of terrestrial hermit crab (Coenobita rugosus, C. brevimanus, and C. cavipes) in coastal forests?	PLOS ONE			English	Article							BEHAVIORAL ECOLOGY; SHELL UTILIZATION; PREDATION; COEXISTENCE; COMPETITION	Terrestrial hermit crabs play a significant role in coastal ecology. For example, as seed dis-persers and debris scavengers in coastal forests, they accelerate the decomposition of organic substances. In the Indo-Pacific Ocean, Coenobita rugosus, C. brevimanus, and C. cavipes are the three most common species of terrestrial hermit crab. Because the mechanisms that contribute to the sympatry of these three species of crab have not been identified, this study investigated the three most likely explanations: niche differences, competition, and predation. The results showed that the three species displayed niche differences in terms of seasonal activity, habitat, utilization of shells, and food preference, suggesting that competition for resources is avoided. The habitat of terrestrial hermit crabs in Taiwan is closely associated with that of humans. Our study helps improve our understanding of the ecology of terrestrial hermit crabs and their conservation.	[Hsu, Chia-Hsuan; Liu, Chi-Chang] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei, Taiwan; [Otte, Marinus L.] North Dakota State Univ, NDSU Dept 2715, Dept Biol Sci, Wet Ecosyst Res Grp, Fargo, ND USA; [Chou, Jui-Yu] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan; [Fang, Wei-Ta] Natl Taiwan Normal Univ, Grad Inst Environm Educ, Taipei, Taiwan	National Taiwan University; North Dakota State University Fargo; National Changhua University of Education; National Taiwan Normal University	Liu, CC (corresponding author), Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei, Taiwan.; Fang, WT (corresponding author), Natl Taiwan Normal Univ, Grad Inst Environm Educ, Taipei, Taiwan.	chichangliu@ntu.edu.tw; wtfang@ntnu.edu.tw		Fang, Wei-Ta/0000-0002-4460-0652; Hsu, Chia-Hsuan/0000-0002-5128-5902	Ministry of Science and Technology [MOST 106-2119-M-003 -003-]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The grant No. Ministry of Science and Technology MOST 106-2119-M-003 -003-to Wei-Ta Fang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander H.G.L., 1979, Philosophical Transactions of the Royal Society of London B Biological Sciences, V285, P241; BERTNESS MD, 1981, ECOLOGY, V62, P411, DOI 10.2307/1936715; Boersma M, 2002, ECOLOGY, V83, P2552, DOI 10.1890/0012-9658(2002)083[2552:LATEIF]2.0.CO;2; Burggren WW, 1988, BIOL LAND CRABS; CHILDRESS JR, 1972, ECOLOGY, V53, P960, DOI 10.2307/1934316; De Wilde P, 1973, ECOLOGY COENOBITA CL; DOWDS BM, 1983, BEHAVIOUR, V85, P1, DOI 10.1163/156853983X00011; FOTHERINGHAM N, 1976, ECOLOGY, V57, P570, DOI 10.2307/1936441; Fox S, 2000, HERMIT CRABS BARRON; GRANT WC, 1974, BIOL BULL-US, V146, P32, DOI 10.2307/1540395; HAZLETT B A, 1970, Zeitschrift fuer Tierpsychologie, V27, P369; HAZLETT BA, 1981, ANNU REV ECOL SYST, V12, P1, DOI 10.1146/annurev.es.12.110181.000245; Hsu C-H, 2015, TESTING MECH CAUSING; Hsu CH, 2016, NAT CONSERV-CRACOW, V96, P28; Hsu CH, 2017, CRUSTACEANA, V90, P111, DOI 10.1163/15685403-00003630; Hsu CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174319; Kessler C, 2005, CRUSTACEANA, V78, P761, DOI 10.1163/156854005774353485; Krieger J, 2016, ZOOL STUD, V55, DOI 10.6620/ZS.2016.55-06; KUHLMANN ML, 1992, J EXP MAR BIOL ECOL, V157, P143, DOI 10.1016/0022-0981(92)90159-8; Laidre ME, 2017, FRONT ECOL ENVIRON, V15, P527, DOI 10.1002/fee.1730; Lindquist ES, 2009, BIOL REV, V84, P203, DOI 10.1111/j.1469-185X.2008.00070.x; McLaughlin PA, 2007, CATALOG HERMIT CRABS; Molles M., 1999, ECOLOGY CONCEPTS APP; Morrison LW, 2002, ACTA OECOL, V23, P223, DOI 10.1016/S1146-609X(02)01136-0; Rahayu DL, 2016, NEW SPECIES LAND HER; REDDY T, 1993, CRUSTACEANA, V65, P13, DOI 10.1163/156854093X00324; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SMALL MP, 1994, J EXP MAR BIOL ECOL, V182, P169, DOI 10.1016/0022-0981(94)90049-3; Sokal R.R., 2012, BIOMETRY; Thacker RW, 1996, J EXP MAR BIOL ECOL, V199, P179, DOI 10.1016/0022-0981(95)00192-1; Tran MV, 2013, J CRUSTACEAN BIOL, V33, P512, DOI 10.1163/1937240X-00002154; VANCE RR, 1972, ECOLOGY, V53, P1062, DOI 10.2307/1935418; VANNINI M, 1975, Monitore Zoologico Italiano Supplemento, V6, P233	33	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207640	10.1371/journal.pone.0207640	http://dx.doi.org/10.1371/journal.pone.0207640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540770	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600027
J	Park, EJ; Kang, J; Hur, H; Min, BS; Baik, SH; Lee, KY; Kim, NK				Park, Eun Jung; Kang, Jeonghyun; Hur, Hyuk; Min, Byung Soh; Baik, Seung Hyuk; Lee, Kang Young; Kim, Nam Kyu			Different clinical features according to the anastomotic leakage subtypes after rectal cancer surgeries: contained vs. free leakages	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; LOW ANTERIOR RESECTION; RISK-FACTORS; CURATIVE RESECTION; PREOPERATIVE RADIOTHERAPY; DEFUNCTIONING STOMA; MULTICENTER; SURVIVAL; IMPACT; CHEMORADIOTHERAPY	Background Anastomotic leakage can be classified by free and contained leakage according to clinical manifestations. The risk factors and their comparison between these leakage subtypes are uncertain. This study aims to evaluate anastomotic leakage patterns and to compare clinical features between free and contained leakages after low anterior resection for rectal cancer. Materials and methods Between January 2005 and December 2012, a total of 2035 consecutive patients who underwent low anterior resection for primary rectal cancer were evaluated retrospectively at two-tertiary referral centers. The primary end points of this study were to assess detailed clinical features among leakage subtypes. The secondary end point was to compare risk factors between free and contained leakages. Results Patients were subdivided into a no leakage group (n = 1890), free leakage group (n = 73), and contained leakage group (n = 72). Free leakage occurred more frequently in laparoscopic and robotic surgeries than open surgery (p = 0.015). On the other hand, contained leakage was developed in a higher rate of patients who received preoperative chemoradiotherapy (p<0.001). The mean development time was 4.6 days in the free leakage group, and 23.6 days in the contained leakage group. Patients with free leakage had a lower rate of a defunctioning stoma than contained leakage (5.5% vs. 29.2%, p<0.001). Risk factors for free leakage were smoking, tumor location, and laparoscopic surgery. However, tumor location and preoperative chemoradiotherapy increased the risk for contained leakage. Conclusions Contained leakage in rectal cancer surgery showed different clinical manifestations and risk factors compared to free leakage. It is necessary to pay more attention to patients with particular risk factors for anastomotic leakage subtypes.	[Park, Eun Jung; Kang, Jeonghyun; Hur, Hyuk; Min, Byung Soh; Baik, Seung Hyuk; Lee, Kang Young; Kim, Nam Kyu] Yonsei Univ, Coll Med, Dept Surg, Div Colon & Rectal Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System	Baik, SH (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Div Colon & Rectal Surg, Seoul, South Korea.	whitenoja@yuhs.ac	Park, Eun Jung/W-1340-2019; Kang, Jeonghyun/K-7600-2019	Park, Eun Jung/0000-0002-4559-2690; Kang, Jeonghyun/0000-0001-7311-6053; Baik, Seung Hyuk/0000-0003-4183-2332; Kim, Nam-Kyu/0000-0003-0639-5632; Hur, Hyuk/0000-0002-9864-7229	Faculty Research Grant of Yonsei University College of Medicine [6-2011-0218]	Faculty Research Grant of Yonsei University College of Medicine	This study was supported by a Faculty Research Grant of Yonsei University College of Medicine for 2011 (6-2011-0218).	Baik SH, 2013, ANN SURG ONCOL, V20, P2625, DOI 10.1245/s10434-013-2895-8; Beck DE, 2011, ASCRS TEXTBOOK OF COLON AND RECTAL SURGERY, SECOND EDITION, P1, DOI 10.1007/978-1-4419-1584-9; Cancer AJCo, 2010, AJCC CANC STAGING MA; Chang JS, 2014, ANN SURG, V259, P516, DOI 10.1097/SLA.0b013e31829068c5; Cong ZJ, 2009, WORLD J SURG, V33, P1292, DOI 10.1007/s00268-009-0008-4; Damrauer SM, 2009, ARCH SURG-CHICAGO, V144, P333, DOI 10.1001/archsurg.2008.589; Floodeen H, 2013, COLORECTAL DIS, V15, P334, DOI 10.1111/j.1463-1318.2012.03195.x; Huser N, 2008, ANN SURG, V248, P52, DOI [10.1097/SLA.0b013e18176bf65, 10.1097/SLA.0b013e318176bf65]; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Jestin P, 2008, COLORECTAL DIS, V10, P715, DOI 10.1111/j.1463-1318.2007.01466.x; Kang J, 2013, ANN SURG, V257, P95, DOI 10.1097/SLA.0b013e3182686bbd; Kim CW, 2016, ANN SURG, V263, P130, DOI 10.1097/SLA.0000000000001157; Kim JS, 2009, J AM COLL SURGEONS, V209, P694, DOI 10.1016/j.jamcollsurg.2009.09.021; Krarup PM, 2014, ANN SURG, V259, P930, DOI 10.1097/SLA.0b013e3182a6f2fc; Kulu Y, 2015, ANN SURG ONCOL, V22, P2059, DOI 10.1245/s10434-014-4187-3; Lee WS, 2008, WORLD J SURG, V32, P1124, DOI 10.1007/s00268-007-9451-2; Marijnen CAM, 2002, J CLIN ONCOL, V20, P817, DOI 10.1200/JCO.20.3.817; Matthiessen P, 2007, ANN SURG, V246, P207, DOI 10.1097/SLA.0b013e3180603024; McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054; McDermott ED, 2015, BRIT J SURG, V102, P462, DOI 10.1002/bjs.9697; Park JS, 2013, ANN SURG, V257, P665, DOI 10.1097/SLA.0b013e31827b8ed9; Ptok H, 2007, BRIT J SURG, V94, P1548, DOI 10.1002/bjs.5707; Rahbari NN, 2010, SURGERY, V147, P339, DOI 10.1016/j.surg.2009.10.012; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Trencheva K, 2013, ANN SURG, V257, P108, DOI 10.1097/SLA.0b013e318262a6cd; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; Warschkow R, 2011, ANN SURG ONCOL, V18, P2772, DOI 10.1245/s10434-011-1696-1	27	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208572	10.1371/journal.pone.0208572	http://dx.doi.org/10.1371/journal.pone.0208572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540826	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600080
J	Poon, CM; Wong, NS; Kwan, TH; Wong, HTH; Chan, KCW; Lee, SS				Poon, Chin Man; Wong, Ngai Sze; Kwan, Tsz Ho; Wong, Horas Tze Hoo; Chan, Kenny Chi Wai; Lee, Shui Shan			Changes of sexual risk behaviors and sexual connections among HIV-positive men who have sex with men along their HIV care continuum	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY COVERAGE; TRANSMISSION RISK; ANAL INTERCOURSE; CONDOMLESS SEX; UNITED-STATES; VIRAL LOAD; YOUNG MEN; INFECTION; WOMEN; EPIDEMIOLOGY	Background While HIV incidence among men who have sex with men (MSM) is increasing in Hong Kong, unprotected sex apparently remains prevalent among those infected but virally non suppressed. Little is known about how sexual behaviours and sexual connections may change among MSM along their HIV care continuum. Methods In this retrospective cross-sectional study, HIV-positive MSM attending the largest HIV specialist clinic in Hong Kong between October and December 2014 were invited to complete a self-administrated structured questionnaire. Their behavioural profile and partner sourcing patterns during the one-year period respectively (a) before HIV diagnosis, (b) after HIV diagnosis, (c) after initiation of antiretroviral treatment and (d) preceding the survey were examined. Results Of 345 recruited MSM, 304 (88.1%) had treatment initiated and 272 (78.8%) had viral load suppressed. In the first year after HIV diagnosis, the proportion reporting inconsistent condom use dropped from 47.0% to 17.5% (p<0.05) and from 49.6% to 17.8% (p<0.01) for anal sex with main and casual partners respectively. Except for mobile applications, usage of most sex-networking venues decreased significantly after diagnosis. Inconsistent condom usage rate remained at around 20% after treatment initiation and viral load suppression, but the frequency of use of sex-networking venues further varied among virally suppressed MSM. Conclusions Most HIV-positive MSM had persistently low level of sexual risk behaviours along their care continuum and achieved viral load suppression, conferring a general reduction of secondary transmission risk in Hong Kong. To increase the effectiveness of Treatment as Prevention strategy, uptake of HIV testing for undiagnosed HIV-positive MSM shall be emphasised.	[Poon, Chin Man; Wong, Ngai Sze; Lee, Shui Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Peoples R China; [Kwan, Tsz Ho] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China; [Wong, Horas Tze Hoo] Univ New South Wales, Ctr Social Res Hlth, Sydney, NSW, Australia; [Chan, Kenny Chi Wai] Ctr Hlth Protect, Integrated Treatment Ctr, Dept Hlth, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of New South Wales Sydney	Lee, SS (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Wong, Ngai Sze/A-3145-2012; Lee, Shui Shan/B-9374-2008; Wong, Horas/AAP-5311-2020; Poon, Chin Man/B-8516-2014; Kwan, Tsz Ho/GSE-2729-2022; Kwan, Tsz Ho/GLS-0384-2022	Wong, Ngai Sze/0000-0003-3788-8114; Lee, Shui Shan/0000-0003-1448-765X; Poon, Chin Man/0000-0003-2089-2504; Kwan, Tsz Ho/0000-0002-2855-5038; Kwan, Tsz Ho/0000-0002-2855-5038; Wong, Tze/0000-0001-8473-1086	Council for the AIDS Trust Fund, the Government of Hong Kong Special Administrative Region [MSS 230 R, MSS 304R]	Council for the AIDS Trust Fund, the Government of Hong Kong Special Administrative Region	This study is supported by a grant approved by Council for the AIDS Trust Fund, the Government of Hong Kong Special Administrative Region (MSS 230 R). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by grants approved by Council for the AIDS Trust Fund, the Government of Hong Kong Special Administrative Region (MSS 230R and MSS 304R). The content of this article represents the opinion of our organisation only. It does not represent the position of the AIDS Trust Fund. AIDS Trust Fund is not responsible for any claims, demands or liabilities whatsoever arising from or in connection with the use of any information contained in this article or the participation of the sponsored project.	Ahn JY, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20965; Aidala AA, 2006, AIDS EDUC PREV, V18, P12, DOI 10.1521/aeap.2006.18.1.12; Amirkhanian YA, 2014, CURR HIV-AIDS REP, V11, P81, DOI 10.1007/s11904-013-0194-4; [Anonymous], 2016, HIV SURVEILLANCE REP; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bogart LM, 2006, AM J PUBLIC HEALTH, V96, P1078, DOI 10.2105/AJPH.2005.070771; Camoni L, 2011, ANN I SUPER SANITA, V47, P214, DOI 10.4415/ANN_11_02_14; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Das M, 2010, PLOS ONE, V5; Daskalopoulou M, 2017, SEX TRANSM INFECT, V93, P590, DOI 10.1136/sextrans-2016-053029; Dombrowski JC, 2013, SEX TRANSM DIS, V40, P41, DOI 10.1097/OLQ.0b013e3182753327; Eaton LA, 2009, J ASSOC NURSE AIDS C, V20, P39, DOI 10.1016/j.jana.2008.10.005; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gorbach PM, 2006, JAIDS-J ACQ IMM DEF, V42, P80, DOI 10.1097/01.qai.0000196665.78497.f1; Hall HI, 2013, AIDS BEHAV, V17, P1632, DOI 10.1007/s10461-013-0426-z; Khosropour CM, 2016, JAIDS-J ACQ IMM DEF, V73, P475, DOI 10.1097/QAI.0000000000001128; Lee Shui Shan, 2009, J Infect Public Health, V2, P177, DOI 10.1016/j.jiph.2009.09.002; Lee SS, 2009, AIDS, V23, P1753, DOI 10.1097/QAD.0b013e32832dc025; Lee SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031072; Leung KK, 2015, ARCH SEX BEHAV, V44, P2067, DOI 10.1007/s10508-014-0390-3; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Lin AWC, 2015, J FORMOS MED ASSOC, V114, P1154, DOI 10.1016/j.jfma.2015.08.008; Lin AWC, 2014, J INT AIDS SOC, V17, P113, DOI 10.7448/IAS.17.4.19663; Margolis AD, 2014, SEX TRANSM DIS, V41, P749, DOI 10.1097/OLQ.0000000000000206; McClelland RS, 2015, AIDS, V29, P2279, DOI 10.1097/QAD.0000000000000829; McFarland W, 2012, AIDS BEHAV, V16, P121, DOI 10.1007/s10461-011-9936-8; McFarland W, 2011, AIDS CARE, V23, P261, DOI 10.1080/09540121.2010.507748; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Poon CM, 2013, SEX TRANSM DIS, V40, P933, DOI 10.1097/OLQ.0000000000000052; Punyacharoensin N, 2015, AIDS, V29, P339, DOI 10.1097/QAD.0000000000000525; Rodger AJ, 2018, J ACQ IMMUN DEF SYND, V21; Shadaker S, 2017, JAIDS-J ACQ IMM DEF, V75, pS281, DOI [10.1097/QAI.0000000000001403, 10.1097/qai.0000000000001403]; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; Solomon SS, 2016, LANCET HIV, V3, pE183, DOI 10.1016/S2352-3018(16)00019-9; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; The Joint United Nations Programme on HIV/ AIDS, 2014, UNAIDS JC2684; Wong H T H, 2013, J Sex Transm Dis, V2013, P958967, DOI 10.1155/2013/958967; Yang Z, 2010, BIOMETRICAL J, V52, P638, DOI 10.1002/bimj.201000035; Yeo TED, 2016, AIDS CARE, V28, P314, DOI 10.1080/09540121.2015.1093597; Yoon IS, 2018, AIDS CARE, V30, P921, DOI 10.1080/09540121.2017.1417535; Zhu W, 2018, AIDS; 2017, LANCET HIV, V4, pE475, DOI DOI 10.1016/S2352-3018	48	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0209008	10.1371/journal.pone.0209008	http://dx.doi.org/10.1371/journal.pone.0209008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540851	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600105
J	Schultz, K; Grieger, C; Li, Y; Urbanek, P; Ruschel, A; Minnich, K; Bruder, D; Gereke, M; Sechi, A; Herrlich, P				Schultz, Kristin; Grieger (Lindner), Christina; Li, Yong; Urbanek, Pavel; Ruschel, Anne; Minnich, Kerstin; Bruder, Dunja; Gereke, Marcus; Sechi, Antonio; Herrlich, Peter			Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFIl 6 in cd44(-/-) tumor cells, MEFs and macrophages	PLOS ONE			English	Article							INTRACELLULAR DOMAIN; ECTODOMAIN CLEAVAGE; INDUCED EXPRESSION; HYALURONAN; TRANSCRIPTION; ACTIVATION; PROTEINS; RECEPTOR; IDENTIFICATION; PROLIFERATION	The adhesion molecule and co-receptor of receptor tyrosine kinases, CD44, is expressed in all cells of the immune system, but also in numerous non-immune cells. CD44 plays roles in the cellular response to different pathogens. The molecular actions of CD44 during these processes are by and large still unknown. The CD44 molecule undergoes a sequential proteolytic cleavage which leads to the release of a soluble intracellular domain (CD44-ICD). Previous reports had shown that the CD44-ICD is taken up into the nucleus where it enhances transcription of specific target genes. By RNA profiling we identified a CD44-dependent transcriptional increase of interferon-responsive genes, among them IF116. IF116 is important in the innate immune response. It senses and binds pathogenic DNA and, together with cGAS, activates the cGAS-cGAMP-STING pathway and induces the expression of genes relevant for the response, e.g. IFN-beta. Our results show that the enhancement of IFI16 expression depended on CD44 cleavage. A CD44-negative tumor cell line, embryonic fibroblasts and bone marrow-derived macrophages from cd441(-/-) mice were reduced in their response to IFN-gamma, to viral DNA fragments and to Listeria monocytogenes infection. We could rescue the deficiency of CD44 negative RPM-MC cells and cd441-MEFs by expressing only the soluble CD44-ICD in the absence of any other CD44 domain. Expression of the CD44-ICD carrying a mutation that prevented the uptake into the nucleus, could not rescue the absence of CD44. This molecular aspect of regulation by CD44 may explain part of the immune phenotypes of mice with cd44 gene disruption.	[Schultz, Kristin; Bruder, Dunja; Gereke, Marcus] Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany; [Schultz, Kristin; Bruder, Dunja; Gereke, Marcus] Otto von Guericke Univ, Inst Med Microbiol, Infect Prevent & Control, Magdeburg, Germany; [Grieger (Lindner), Christina; Li, Yong; Urbanek, Pavel; Ruschel, Anne; Minnich, Kerstin; Herrlich, Peter] FLI, Leibniz Inst Aging, Jena, Germany; [Sechi, Antonio] Inst Biomed Engn, Dept Cell Biol, Aachen, Germany; [Grieger (Lindner), Christina] Helios Klinikum Erfurt, Inst Pathol, Erfurt, Germany; [Li, Yong] Anhui Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Urbanek, Pavel] Friedrich Schiller Univ, Inst Nutr, Dept Nutrigen, Jena, Germany; [Minnich, Kerstin] Gipsenweg 5, D-82515 Wolfratshausen, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Helios Kliniken; Anhui University; Friedrich Schiller University of Jena	Herrlich, P (corresponding author), FLI, Leibniz Inst Aging, Jena, Germany.	peter.herrlich@leibniz-fli.de	Sechi, Antonio S/A-5595-2009	Sechi, Antonio S/0000-0002-1374-1794	Deutsche Forschungsgemeinschaft [DFGHe551]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFGHe551) Leibniz Association.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Archer KA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003861; Biolatti M, 2016, J VIROL, V90, P8238, DOI 10.1128/JVI.00923-16; Blass SL, 2001, J IMMUNOL, V166, P5726, DOI 10.4049/jimmunol.166.9.5726; Cho Y, 2015, ONCOTARGET, V6, P8709, DOI 10.18632/oncotarget.3325; Clarke CJP, 2003, J CELL BIOCHEM, V89, P80, DOI 10.1002/jcb.10475; Cole C, 2012, IMMUNITY, V36, P807, DOI 10.1016/j.immuni.2012.03.011; De Falco V, 2012, CANCER RES, V72, P1449, DOI 10.1158/0008-5472.CAN-11-3320; Dussurget O, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00050; Eriksson E, 2003, INFECT IMMUN, V71, P4102, DOI 10.1128/IAI.71.7.4102-4111.2003; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Geissler KJ, 2013, P NATL ACAD SCI USA, V110, P20587, DOI 10.1073/pnas.1222078110; Hansen K, 2014, EMBO J, V33, P1654, DOI 10.15252/embj.201488029; Hartmann M, 2015, J BIOL CHEM, V290, P17041, DOI 10.1074/jbc.M114.610204; Hartmann M, 2015, MOL CANCER RES, V13, P879, DOI 10.1158/1541-7786.MCR-15-0020-T; Hasan Z, 2011, SHOCK, V35, P567, DOI 10.1097/SHK.0b013e3182144935; Hill DR, 2012, J BIOL CHEM, V287, P30610, DOI 10.1074/jbc.M112.356238; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Johnson KE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004503; Jong A, 2012, J BIOL CHEM, V287, P15298, DOI 10.1074/jbc.M112.353375; Jordan AR, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00182; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Lindner C, 2013, FEBS LETT, V587, P2698, DOI 10.1016/j.febslet.2013.07.010; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Mrass P, 2008, IMMUNITY, V29, P971, DOI 10.1016/j.immuni.2008.10.015; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Parra LM, 2015, MOL CELL BIOL, V35, P3381, DOI 10.1128/MCB.00500-15; Piccaluga PP, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/747645; Pisano G, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0891-5; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Protin U, 1999, J IMMUNOL, V163, P4917; Rampanelli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084479; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Schmitt M, 2015, CELL DEATH DIFFER, V22, P677, DOI 10.1038/cdd.2014.156; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Sperka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027511; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van der Windt GJW, 2010, INFECT IMMUN, V78, P115, DOI 10.1128/IAI.00949-09; Wang Q, 2002, AM J PATHOL, V161, P2219, DOI 10.1016/S0002-9440(10)64498-7; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004; Zwaferink H, 2008, INFECT IMMUN, V76, P1649, DOI 10.1128/IAI.01251-07	57	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207358	10.1371/journal.pone.0207358	http://dx.doi.org/10.1371/journal.pone.0207358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540779	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600015
J	Lantier, L; Williams, AS; Hughey, CC; Bracy, DP; James, FD; Ansari, MA; Gius, D; Wasserman, DH				Lantier, Louise; Williams, Ashley S.; Hughey, Curtis C.; Bracy, Deanna P.; James, Freyja D.; Ansari, Muhammad A.; Gius, David; Wasserman, David H.			SIRT2 knockout exacerbates insulin resistance in high fat-fed mice	PLOS ONE			English	Article							MITOCHONDRIAL PROTEIN ACETYLATION; IN-VIVO; DEACETYLASE; METABOLISM; OBESITY; COA	The NAD(+)-dependent deacetylase SIRT2 is unique amongst sirtuins as it is effective in the cytosol, as well as the mitochondria. Defining the role of cytosolic acetylation state in specific tissues is difficult since even physiological effects at the whole body level are unknown. We hypothesized that genetic SIRT2 knockout (KO) would lead to impaired insulin action, and that this impairment would be worsened in HF fed mice. Insulin sensitivity was tested using the hyperinsulinemic-euglycemic clamp in SIRT2 KO mice and WT littermates. SIRT2 KO mice exhibited reduced skeletal muscle insulin-induced glucose uptake compared to lean WT mice, and this impairment was exacerbated in HF SIRT2 KO mice. Liver insulin sensitivity was unaffected in lean SIRT2 KO mice. However, the insulin resistance that accompanies HF-feeding was worsened in SIRT2 KO mice. It was notable that the effects of SIRT2 KO were largely disassociated from cytosolic acetylation state, but were closely linked to acetylation state in the mitochondria. SIRT2 KO led to an increase in body weight that was due to increased food intake in HF fed mice. In summary, SIRT2 deletion in vivo reduces muscle insulin sensitivity and contributes to liver insulin resistance by a mechanism that is unrelated to cytosolic acetylation state. Mitochondrial acetylation state and changes in feeding behavior that result in increased body weight correspond to the deleterious effects of SIRT2 KO on insulin action.	[Lantier, Louise; Williams, Ashley S.; Hughey, Curtis C.; Bracy, Deanna P.; James, Freyja D.; Ansari, Muhammad A.; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Lantier, Louise; Wasserman, David H.] Vanderbilt Mouse Metab Phenotyping Ctr, Nashville, TN 37212 USA; [Gius, David] Northwestern Univ, Dept Radiat Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Williams, Ashley S.] Duke Univ, Duke Mol Physiol Inst, Durham, NC USA	Vanderbilt University; Northwestern University; Feinberg School of Medicine; Duke University	Lantier, L (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.; Lantier, L (corresponding author), Vanderbilt Mouse Metab Phenotyping Ctr, Nashville, TN 37212 USA.	louise.lantier@vanderbilt.edu	Ansari, Muhammad/GQI-1517-2022	Lantier, Louise/0000-0002-6620-4976	NIH-NIDDK [DK054902, DK050277]; Avon Foundation for Breast Cancer Research; Lynn Sage Cancer Research Foundation; Zell Family Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NIH [DK059637]; NIDDK MMPC Consortium [DK076169];  [2R01CA152601-A1];  [1R01CA152799-01A1];  [1R01CA168292-01A1];  [1R01CA214025-01];  [DK020593];  [1S10RR028101-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059637, P30DK058404] Funding Source: NIH RePORTER	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Avon Foundation for Breast Cancer Research; Lynn Sage Cancer Research Foundation; Zell Family Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK MMPC Consortium; ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH-NIDDK grants DK054902, DK050277. DG is supported by 2R01CA152601-A1, 1R01CA152799-01A1, 1R01CA168292-01A1, 1R01CA214025-01, the Avon Foundation for Breast Cancer Research, the Lynn Sage Cancer Research Foundation, the Zell Family Foundation, the Chicago Biomedical Consortium, and the Searle Funds at The Chicago Community Trust. The mouse plasma insulin and leptin assays were performed by the VUMC Hormone Assay and Analytical Services Core supported by NIH grant DK059637. We also acknowledge DK020593. The indirect calorimetry experiments were carried out at the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC), supported by grants DK059637 and 1S10RR028101-01. The ANCOVA analysis was provided by the NIDDK MMPC Consortium supported by DK076169.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Carrer A, 2017, J BIOL CHEM, V292, P3312, DOI 10.1074/jbc.M116.750620; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Davies MN, 2016, CELL REP, V14, P243, DOI 10.1016/j.celrep.2015.12.030; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Ghanta S, 2013, CRIT REV BIOCHEM MOL, V48, P561, DOI 10.3109/10409238.2013.838204; Gomes P, 2015, TRENDS PHARMACOL SCI, V36, P756, DOI 10.1016/j.tips.2015.08.001; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaiyala KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103301; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; LaBarge S, 2015, MOL CELLS, V38, P297, DOI 10.14348/molcells.2015.0020; Lantier L, 2015, DIABETES, V64, P3081, DOI 10.2337/db14-1810; Lemos V, 2017, HUM MOL GENET, V26, P4105, DOI 10.1093/hmg/ddx298; LIGHTON JRB, 2008, PRESS, V201; Liu GX, 2017, ANTIOXID REDOX SIGN, V26, P849, DOI 10.1089/ars.2016.6662; LIU R, 2015, SCI REP UK, V5; Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326; Munoz-Cobo I, 2017, BEHAV BRAIN RES, V335, P128, DOI 10.1016/j.bbr.2017.07.045; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Nie Hui, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P65; Oh TS, 2016, AUTOPHAGY, V12, P2009, DOI 10.1080/15548627.2016.1215382; PMID, PUBMED, DOI DOI 10.1074/JBC.M116.750620; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seiler SE, 2015, CELL METAB, V22, P65, DOI 10.1016/j.cmet.2015.06.003; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silva DF, 2017, MOL NEUROBIOL, V54, P4021, DOI 10.1007/s12035-016-9951-x; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; WAGNER GR, 1945, PUBMED, DOI DOI 10.1074/JBC.M113.486753; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; WANG Q, 2007, PUBMED, DOI DOI 10.1126/SCIENCE.1179687; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Yang L, 2011, J PROTEOME RES, V10, P4134, DOI 10.1021/pr200313x; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu H, 2012, GLIA, V60, P69, DOI 10.1002/glia.21248	44	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208634	10.1371/journal.pone.0208634	http://dx.doi.org/10.1371/journal.pone.0208634			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533032	gold, Green Submitted, Green Published			2022-12-26	WOS:000452782500028
J	Moulton, E; Chamness, M; Knox, D				Moulton, Emily; Chamness, Marisa; Knox, Dayan			Characterizing changes in glucocorticoid receptor internalization in the fear circuit in an animal model of post traumatic stress disorder	PLOS ONE			English	Article							SINGLE PROLONGED STRESS; MINERALOCORTICOID RECEPTORS; DEHYDROGENASE TYPE-2; MAJOR DEPRESSION; MESSENGER-RNA; RAT-BRAIN; MEMORY; EXTINCTION; EXPRESSION; AMYGDALA	Glucocorticoid receptors (GRs) shuttle from the cytoplasm (cy) to the nucleus (nu) when bound with glucocorticoids (i.e. GR internalization) and alter transcriptional activity. GR activation within the fear circuit has been implicated in fear memory and post traumatic stress disorder (PTSD). However, no study to date has characterized GR internalization within the fear circuit during fear memory formation or examined how traumatic stress impacts this process. To address this, we assayed cy and nu GR levels at baseline and after auditory fear conditioning (FC) in the single prolonged stress (SPS) model of PTSD. Cy and nu GRs within the medial prefrontal cortex (mPFC), dorsal hippocampus (dHipp), ventral hippocampus (vHipp), and amygdala (AMY) were assayed using western blot. The distribution of GR in the cy and nu (at baseline and after FC) was varied across individual nodes of the fear circuit. At baseline, SPS enhanced cyGRs in the dHipp, but decreased cyGRs in the AMY. FC only enhanced GR internalization in the AMY and this effect was attenuated by SPS exposure. SPS also decreased cyGRs in the dHipp after FC. The results of this study suggests that GR internalization is varied across the fear circuit, which in turn suggests GR activation is selectively regulated within individual nodes of the fear circuit. The findings also suggest that changes in GR dynamics in the dHipp and AMY modulate the enhancing effect SPS has on fear memory persistence.	[Moulton, Emily; Chamness, Marisa; Knox, Dayan] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA	University of Delaware	Knox, D (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.	dknox@psych.udel.edu		Knox, Dayan/0000-0003-1882-5775	National Institute of General Medical Sciences - NIGMS [1P20GM103653]; University of Delaware Research Foundation; National Institute of General Medical Sciences - NIGMS from the National Institutes of Health [P20 GM103446]; state of Delaware; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446, P20GM103653] Funding Source: NIH RePORTER	National Institute of General Medical Sciences - NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Delaware Research Foundation; National Institute of General Medical Sciences - NIGMS from the National Institutes of Health; state of Delaware; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research in this report was funded by a target investigator grant from the National Institute of General Medical Sciences - NIGMS (1P20GM103653) awarded to DK and a University of Delaware Research Foundation grant awarded to DK. This publication was made possible by the Delaware INBRE program, supported by a grant from the National Institute of General Medical Sciences - NIGMS (P20 GM103446) from the National Institutes of Health and the state of Delaware. None of the funding agencies had any role to play in preparation of the manuscript or execution of experiments.	Armario A, 2008, NEUROSCI BIOBEHAV R, V32, P1121, DOI 10.1016/j.neubiorev.2008.04.003; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Bowers ME, 2015, BIOL PSYCHIAT, V78, pE15, DOI 10.1016/j.biopsych.2015.06.008; Daviu N, 2014, HORM BEHAV, V66, P713, DOI 10.1016/j.yhbeh.2014.09.015; de Kloet CS, 2007, MOL PSYCHIATR, V12, P443, DOI 10.1038/sj.mp.4001934; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Deslauriers J, 2018, BIOL PSYCHIAT, V83, P895, DOI 10.1016/j.biopsych.2017.11.019; Eagle AL, 2013, NEUROSCI RES, V75, P130, DOI 10.1016/j.neures.2012.11.001; Finsterwald C, 2014, NEUROBIOL LEARN MEM, V112, P17, DOI 10.1016/j.nlm.2013.09.017; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; George SA, 2015, PSYCHOPHARMACOLOGY, V232, P47, DOI 10.1007/s00213-014-3635-x; Hauer D, 2014, NEUROBIOL LEARN MEM, V112, P68, DOI 10.1016/j.nlm.2013.10.003; Herry C, 2014, NAT NEUROSCI, V17, P1644, DOI 10.1038/nn.3869; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Keller SM, 2015, BEHAV BRAIN RES, V287, P182, DOI 10.1016/j.bbr.2015.03.043; Knox D, 2012, NEUROSCIENCE, V223, P163, DOI 10.1016/j.neuroscience.2012.07.047; Knox D, 2016, LEARN MEMORY, V23, P689, DOI 10.1101/lm.043141.116; Knox D, 2012, LEARN MEMORY, V19, P43, DOI 10.1101/lm.024356.111; Knox D, 2010, NEUROSCI LETT, V480, P16, DOI 10.1016/j.neulet.2010.05.052; Laukova M, 2014, ENDOCRINOLOGY, V155, P3920, DOI 10.1210/en.2014-1192; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Maddox Stephanie A, 2013, Front Psychiatry, V4, P62, DOI 10.3389/fpsyt.2013.00062; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maren S, 2006, P NATL ACAD SCI USA, V103, P18020, DOI 10.1073/pnas.0608398103; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mitic M, 2013, NEUROPHARMACOLOGY, V70, P100, DOI 10.1016/j.neuropharm.2012.12.012; MOISAN MP, 1990, ENDOCRINOLOGY, V127, P1450, DOI 10.1210/endo-127-3-1450; Morris MC, 2012, CLIN PSYCHOL REV, V32, P301, DOI 10.1016/j.cpr.2012.02.002; Orsini CA, 2012, NEUROSCI BIOBEHAV R, V36, P1773, DOI 10.1016/j.neubiorev.2011.12.014; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Roland BL, 1996, ENDOCRINOLOGY, V137, P1123, DOI 10.1210/en.137.3.1123; ROLAND BL, 1995, ENDOCRINOLOGY, V136, P4697, DOI 10.1210/en.136.10.4697; ROLAND BL, 1995, MOL CELL ENDOCRINOL, V111, pR1, DOI 10.1016/0303-7207(95)03559-P; Roozendaal B, 1997, NEUROBIOL LEARN MEM, V67, P176, DOI 10.1006/nlme.1996.3765; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Roozendaal B, 1999, P NATL ACAD SCI USA, V96, P11642, DOI 10.1073/pnas.96.20.11642; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Roozendaal B, 2011, BEHAV NEUROSCI, V125, P797, DOI 10.1037/a0026187; Sarabdjitsingh RA, 2009, BRAIN RES, V1249, P43, DOI 10.1016/j.brainres.2008.10.048; Sawamura T, 2016, NEUROPSYCHOPHARMACOL, V41, P832, DOI 10.1038/npp.2015.210; Schelling G, 2004, BIOL PSYCHIAT, V55, P627, DOI 10.1016/j.biopsych.2003.09.014; Schelling G, 2001, BIOL PSYCHIAT, V50, P978, DOI 10.1016/S0006-3223(01)01270-7; Spencer RL, 2000, BRAIN RES, V868, P275, DOI 10.1016/S0006-8993(00)02341-6; Suris A, 2017, PSYCHIATRY, V80, P399, DOI 10.1080/00332747.2017.1286892; Uwaya A, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0092-1; van Zuiden M, 2013, BRAIN BEHAV IMMUN, V30, P12, DOI 10.1016/j.bbi.2012.08.015; van Zuiden M, 2011, AM J PSYCHIAT, V168, P89, DOI 10.1176/appi.ajp.2010.10050706; vanSteensel B, 1996, J CELL SCI, V109, P787; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wheelan N, 2018, PSYCHONEUROENDOCRINO, V89, P13, DOI 10.1016/j.psyneuen.2017.12.018; Wingenfeld K, 2014, FRONT NEUROL NEUROSC, V34, P109, DOI 10.1159/000356423; Wyrwoll CS, 2011, FRONT NEUROENDOCRIN, V32, P265, DOI 10.1016/j.yfrne.2010.12.001; Yamamoto S, 2008, NEUROPSYCHOPHARMACOL, V33, P2108, DOI 10.1038/sj.npp.1301605; Yau JLW, 2007, J NEUROSCI, V27, P10487, DOI 10.1523/JNEUROSCI.2190-07.2007; Yehuda R, 2000, J CLIN PSYCHIAT, V61, P14; Yehuda R, 2006, PSYCHONEUROENDOCRINO, V31, P447, DOI 10.1016/j.psyneuen.2005.10.007; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83	66	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0205144	10.1371/journal.pone.0205144	http://dx.doi.org/10.1371/journal.pone.0205144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6IO	30532228	Green Submitted, Green Published, gold			2022-12-26	WOS:000452640900003
J	Abe, K; Yawo, H				Abe, Kenta; Yawo, Hiromu			Quantitative study of the somatosensory sensitization underlying cross-modal plasticity	PLOS ONE			English	Article							BARREL CORTEX; OBJECT LOCALIZATION; INFORMATION; ACCURACY	Loss of one sensory modality can cause other types to become more perceptive (cross-modal plasticity). To test the hypothesis that the loss of vision changes the perceptual threshold in the somatosensory system, we applied optogenetics to directly manipulate the afferent inputs involved in the whisker-barrel system using a transgenic rat (W-TChR2V4) that expresses channelrhodopsin-2 (ChR2) selectively in the large mechanoreceptive neurons in the trigeminal ganglion (TG) and their peripheral nerve terminals. The licking behavior of W-TChR2V4 rat was conditioned to a blue LED light cue on the whisker area while the magnitude and duration of light pulses were varied. The perceptual threshold was thus quantitatively determined for each rat according to the relationship between the magnitude/duration of light and the reaction time between the LED light cue and the first licking event after it. We found that the perceptual threshold was more significantly reduced than the control non-deprived rats when the rats were visually deprived at postnatal 26-30 days (P26- 30, early VD group), but not at P58-66 (late VD group). However, the sensory threshold of a late VD animal was similar to that of a control. Our results suggest the presence of cross-modal plasticity by which the loss of vision at the juvenile period increased the sensitivity of the somatosensory system involved in the touch of whiskers.	[Abe, Kenta; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi, Japan; [Yawo, Hiromu] Tohoku Univ, Ctr Neurosci, Grad Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi, Japan.; Yawo, H (corresponding author), Tohoku Univ, Ctr Neurosci, Grad Sch Med, Sendai, Miyagi, Japan.	hiromu.yawo.c7@tohoku.ac.jp	Yawo, Hiromu/I-4871-2015	Yawo, Hiromu/0000-0002-4299-3288; Abe, Kenta/0000-0002-1634-7469	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [17J06669, 25250001, 15H01413, 25115701]; JST, Strategic International Collaborative Research Program, SICORP	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, Strategic International Collaborative Research Program, SICORP	This study was supported by a Grant-in-Aid for JSPS Fellows (No. 17J06669 to KA), a Grant-in-Aid for Scientific Research (No. 25250001 to HY), Grant-in-Aid for Challenging Exploratory Research (No. 15H01413 to HY), Grant-in-Aid for Scientific Research on Innovative Areas "Adaptive Circuit Shift" (No. 25115701 to HY) and Grant-in-Aid for Scientific Research on Innovative Areas " Platform of Advanced Animal Model Support" to HY) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan: http://www.jsps.go.jp/english/e-grants/grants01.html, JST, Strategic International Collaborative Research Program, SICORP (to HY): http://www.jst.go.jp/inter/english/sicorp/index.html.	Abe K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189439; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Dye MWG, 2007, NEUROPSYCHOLOGIA, V45, P1801, DOI 10.1016/j.neuropsychologia.2006.12.019; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; Honjoh T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093706; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Ji ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032699; Jitsuki S, 2011, NEURON, V69, P780, DOI 10.1016/j.neuron.2011.01.016; Kuki T, 2013, NEUROSCI RES, V75, P35, DOI 10.1016/j.neures.2012.10.007; Lee HK, 2015, CURR OPIN NEUROBIOL, V35, P119, DOI 10.1016/j.conb.2015.08.002; Mulder MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080222; Nakajima W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149068; Noorani I, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00067; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petrus E, 2015, J NEUROSCI, V35, P8790, DOI 10.1523/JNEUROSCI.4975-14.2015; Petrus E, 2014, NEURON, V81, P664, DOI 10.1016/j.neuron.2013.11.023; Phillips WA, 2015, NEUROSCI BIOBEHAV R, V52, P1, DOI 10.1016/j.neubiorev.2015.02.010; Saiki A, 2018, CEREB CORTEX, V28, P1024, DOI 10.1093/cercor/bhx012; Takahashi N, 2016, SCIENCE, V354, P1587, DOI 10.1126/science.aah6066; Templeton JP, 2012, MOL VIS, V18, P2147; TOLDI J, 1994, NEUROSCI LETT, V167, P1, DOI 10.1016/0304-3940(94)91014-6; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; van Ede F, 2012, J NEUROSCI, V32, P10408, DOI 10.1523/JNEUROSCI.1337-12.2012; Yamashita T, 2016, ELIFE, V5, DOI 10.7554/eLife.15798	29	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208089	10.1371/journal.pone.0208089	http://dx.doi.org/10.1371/journal.pone.0208089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517160	Green Submitted, gold, Green Published			2022-12-26	WOS:000452212400078
J	Streltsova, MA; Erokhina, SA; Kanevskiy, LM; Lee, DA; Telford, WG; Sapozhnikov, AM; Kovalenko, EI				Streltsova, Maria A.; Erokhina, Sofya A.; Kanevskiy, Leonid M.; Lee, Dean A.; Telford, William G.; Sapozhnikov, Alexander M.; Kovalenko, Elena, I			Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of "senescent" NK cells to lose CD57 expression and start expressing NKG2A	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PERIPHERAL-BLOOD; ACTIVATION; RECEPTOR; RESPONSES; INNATE; IL-21; EXPANSION	In this work, we analyzed the phenotype and growth of human NK cell clones obtained by the stimulation of individual NK cells with IL-2 and gene-modified K562 feeder cells expressing membrane-bound IL-21 (K562-mblL21). We generated clones from NK cells at distinct differentiation and activation stages, determined by CD56, CD57 and HLA-DR expression levels. Less differentiated CD56(bright) NK cell subsets showed higher cloning efficiency compared with more differentiated CD56(dim) subsets, especially with the CD57(bright) subset. However, clones from the CD56(dim) CD57(-) subset lived longer on average than other subsets. Moreover, several clones with the highest cell numbers were derived from CD56(dim) CD57(-)HLA-DR(-)cells. Most of the clones including those derived from more differentiated CD56(dim) CD57(+/-)NKG2A(-)NK cells showed a less-differentiated NKG2A(+) phenotype. Also, CD57(-) cells were frequently observed in clones derived from CD57(+) NK cells suggesting the loss of CD57 during the cloning process. On the other hand, KIR surface expression once detected for a clone never disappeared entirely, confirming irreversibility of the KIR expression. In summary, we have demonstrated that in specific conditions terminally differentiated CD57(+) human NK cells are able to acquire the CD57(-) phenotype that was previously not observed and, thus, was considered impossible.	[Streltsova, Maria A.; Erokhina, Sofya A.; Kanevskiy, Leonid M.; Sapozhnikov, Alexander M.; Kovalenko, Elena, I] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Immunol, Lab Cell Interact, Moscow, Russia; [Lee, Dean A.] Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Disorders, Res Inst, Columbus, OH USA; [Telford, William G.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kovalenko, EI (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Immunol, Lab Cell Interact, Moscow, Russia.	kovalenelen@gmail.com	Kovalenko, Elena/S-2086-2016; Куст, Софья/AAQ-1554-2021; Sapozhnikov, Alexander M/J-8704-2018; Streltsova, Maria/AAG-9220-2020; Kanevskiy, Leonid/ABH-1327-2020	Kovalenko, Elena/0000-0001-8119-8247; Streltsova, Maria/0000-0002-5403-0753; Sapozhnikov, Alexander/0000-0002-4934-677X	Russian Science Foundation [16-15-00309]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation, grant #16-15-00309 to EIK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Russian Science Foundation, grant #16-15-00309.	Aranami T, 2006, J IMMUNOL, V177, P5659, DOI 10.4049/jimmunol.177.8.5659; Berg M, 2009, CYTOTHERAPY, V11, P341, DOI 10.1080/14653240902807034; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Cella M, 2000, METH MOL B, V121, P1; Chaput N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23080; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Croce M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/696578; Denman CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030264; Dybkaer K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-230; Erokhina SA, 2018, IMMUNOL CELL BIOL, V96, P212, DOI 10.1111/imcb.1032; Evans JH, 2011, EUR J IMMUNOL, V41, P1924, DOI 10.1002/eji.201041180; Fogli M, 2004, EUR J IMMUNOL, V34, P2313, DOI 10.1002/eji.200425251; Fujisaki H, 2009, BRIT J HAEMATOL, V145, P606, DOI 10.1111/j.1365-2141.2009.07667.x; Granzin M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1219007; Kanevskiy LM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00011; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Kovalenko Elena I, 2017, Curr Protoc Cytom, V79, DOI 10.1002/cpcy.13; Lapteva N, 2016, METHODS MOL BIOL, V1441, P195, DOI 10.1007/978-1-4939-3684-7_16; Leivas A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1250051; Leung W, 2005, J IMMUNOL, V174, P6540, DOI 10.4049/jimmunol.174.10.6540; Li Q, 2015, IMMUNOBIOLOGY, V220, P876, DOI 10.1016/j.imbio.2015.01.009; Lichtfuss GF, 2012, J IMMUNOL, V189, P1491, DOI 10.4049/jimmunol.1200458; Lim DP, 2014, CYTOTHERAPY, V16, P1419, DOI 10.1016/j.jcyt.2014.04.008; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Loyon R, 2016, J IMMUNOL, V197, P85, DOI 10.4049/jimmunol.1501147; LUETKEEVERSLOH M, 2013, FRONT IMMUNOL, V4; Nielsen CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00422; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Romee R, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/205796; Skak K, 2008, IMMUNOLOGY, V123, P575, DOI 10.1111/j.1365-2567.2007.02730.x; Spits H., 1996, Methods (Orlando), V9, P416, DOI 10.1006/meth.1996.0047; Strbo N, 2008, AIDS, V22, P1551, DOI 10.1097/QAD.0b013e3283089367; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Wendt K, 2007, IMMUNOLOGY, V122, P486, DOI 10.1111/j.1365-2567.2007.02675.x; Yano N, 1996, HUM IMMUNOL, V49, P64, DOI 10.1016/0198-8859(96)00057-2	38	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208469	10.1371/journal.pone.0208469	http://dx.doi.org/10.1371/journal.pone.0208469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517188	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400099
J	Uthoff, RD; Song, BF; Sunny, S; Patrick, S; Suresh, A; Kolur, T; Keerthi, G; Spires, O; Anbarani, A; Wilder-Smith, P; Kuriakose, MA; Birur, P; Liang, RG				Uthoff, Ross D.; Song, Bofan; Sunny, Sumsum; Patrick, Sanjana; Suresh, Amritha; Kolur, Trupti; Keerthi, G.; Spires, Oliver; Anbarani, Afarin; Wilder-Smith, Petra; Kuriakose, Moni Abraham; Birur, Praveen; Liang, Rongguang			Point-of-care, smartphone-based, dual-modality, dual-view, oral cancer screening device with neural network classification for low-resource communities	PLOS ONE			English	Article							POTENTIALLY MALIGNANT DISORDERS; DIFFUSE-REFLECTANCE SPECTROSCOPY; BETEL-QUID; RISK-FACTOR; ARECA NUT; AUTOFLUORESCENCE CHARACTERISTICS; FLUORESCENCE SPECTROSCOPY; DIRECT VISUALIZATION; REVERSE SMOKING; ANDHRA-PRADESH	Oral cancer is a growing health issue in a number of low- and middle-income countries (LMIC), particularly in South and Southeast Asia. The described dual-modality, dual-view, point-of-care oral cancer screening device, developed for high-risk populations in remote regions with limited infrastructure, implements autofluorescence imaging (AFI) and white light imaging (WLI) on a smartphone platform, enabling early detection of pre-cancerousand cancerous lesions in the oral cavity with the potential to reduce morbidity, mortality, and overall healthcare costs. Using a custom Android application, this device synchronizes external light-emitting diode (LED) illumination and image capture for AFI and WLI. Data is uploaded to a cloud server for diagnosis by a remote specialist through a web app, with the ability to transmit triage instructions back to the device and patient. Finally, with the on-site specialist's diagnosis as the gold-standard, the remote specialist and a convolutional neural network (CNN) were able to classify 170 image pairs into 'suspicious' and 'not suspicious' with sensitivities, specificities, positive predictive values, and negative predictive values ranging from 81.25% to 94.94%.	[Uthoff, Ross D.; Song, Bofan; Spires, Oliver; Liang, Rongguang] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA; [Sunny, Sumsum; Suresh, Amritha; Kolur, Trupti; Kuriakose, Moni Abraham] Mazumdar Shaw Med Ctr, Bangalore, Karnataka, India; [Sunny, Sumsum; Suresh, Amritha; Kuriakose, Moni Abraham] Mazumdar Shaw Med Fdn, Bangalore, Karnataka, India; [Patrick, Sanjana; Birur, Praveen] Biocon Fdn, Bangalore, Karnataka, India; [Keerthi, G.; Birur, Praveen] KLE Soc Inst Dent Sci, Bangalore, Karnataka, India; [Anbarani, Afarin; Wilder-Smith, Petra] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA	University of Arizona; University of California System; University of California Irvine	Uthoff, RD; Song, BF; Liang, RG (corresponding author), Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA.	rossuthoff@email.arizona.edu; songb@email.arizona.edu; rliang@optics.arizona.edu	N, Praveen Birur/J-5307-2019; G, Keerthi/AAQ-9713-2020	N, Praveen Birur/0000-0001-5287-8323; G, Keerthi/0000-0003-4594-8674; Uthoff, Ross/0000-0003-1002-5546; Kuriakose, Moni/0000-0003-4229-752X	National Institutes Health, National Institute of Biomedical Imaging and Bioengineering [UH2EB022623]; National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, Graduate Training in Biomedical Imaging and Spectroscopy [T32EB000809]; NATIONAL CANCER INSTITUTE [UH3CA239682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB000809, UH2EB022623] Funding Source: NIH RePORTER	National Institutes Health, National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, Graduate Training in Biomedical Imaging and Spectroscopy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	RL received research funding from the National Institutes Health, National Institute of Biomedical Imaging and Bioengineering award UH2EB022623 (https://www.nibib.nih.gov/).RDU received research funding from the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, Graduate Training in Biomedical Imaging and Spectroscopy grant T32EB000809 (https://www.nibib.nih.gov/training-careers/postdoctoral/ruth-l-kirschstein-national-research-service-award-nrsa-institutional-research/supported-programs).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2011, INDIAN J OTOLARYNGOL, V63, P145, DOI 10.1007/s12070-011-0134-9; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Amarasinghe HK, 2010, ORAL ONCOL, V46, P297, DOI 10.1016/j.oraloncology.2010.01.017; [Anonymous], 2018, NON TRADITIONAL REF; Aubreville M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12320-8; Awais M, 2015, 2015 7TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND ELECTRICAL ENGINEERING (ICITEE), P209, DOI 10.1109/ICITEED.2015.7408943; Awan KH, 2011, ORAL ONCOL, V47, P274, DOI 10.1016/j.oraloncology.2011.02.001; BATLLE AMD, 1993, J PHOTOCH PHOTOBIO B, V20, P5; Bicknell LM, 2013, JAMA DERMATOL, V149, P1288, DOI 10.1001/jamadermatol.2013.7965; Boucher BJ, 2002, ADDICT BIOL, V7, P103, DOI 10.1080/13556210120091464; Burns PA, 2000, PICS 2000: IMAGE PROCESSING, IMAGE QUALITY, IMAGE CAPTURE, SYSTEMS CONFERENCE, PROCEEDINGS, P135; Burns PD, 2009, NON TRADITIONAL REF; Carestream Health, 2014, NON TRADITIONAL REF; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; de Veld DCG, 2005, LASER SURG MED, V36, P356, DOI 10.1002/lsm.20122; De Veld DCG, 2005, ORAL ONCOL, V41, P117, DOI 10.1016/j.oraloncology.2004.07.007; de Veld DCG, 2003, LASER SURG MED, V32, P367, DOI 10.1002/lsm.10185; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dental EZ, 2015, NON TRADITIONAL REF; Dhingra JK, 1996, ARCH OTOLARYNGOL, V122, P1181; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Farah CS, 2012, HEAD NECK-J SCI SPEC, V34, P856, DOI 10.1002/hed.21834; Fechner G.T., 1966, INTRO FECHNER; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garg A, 2014, INDIAN J MED PAEDIAT, V35, P3, DOI 10.4103/0971-5851.133702; Google Inc, 2018, NON TRADITIONAL REF; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Harvey JE, 2015, APPL OPTICS, V54, P2224, DOI 10.1364/AO.54.002224; Heintzelman DL, 2000, PHOTOCHEM PHOTOBIOL, V72, P103, DOI 10.1562/0031-8655(2000)072<0103:OEWFIV>2.0.CO;2; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans World Health Organization International Agency for Research on Cancer, 2004, NON TRADITIONAL REF, V85; Ingrams DR, 1997, HEAD NECK-J SCI SPEC, V19, P27, DOI 10.1002/(SICI)1097-0347(199701)19:1<27::AID-HED5>3.3.CO;2-3; International Agency for Research on Cancer World Health Organization, 2017, NON TRADITIONAL REF; Jacob BJ, 2004, ORAL ONCOL, V40, P697, DOI 10.1016/j.oraloncology.2004.01.005; Jeng JH, 2001, ORAL ONCOL, V37, P477, DOI 10.1016/S1368-8375(01)00003-3; Kingslake R, 2010, LENS DESIGN FUNDAMENTALS, 2ND EDITION, P1, DOI 10.1016/B978-0-12-374301-5.00005-X; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Lane P, 2012, GENDER MED, V9, pS78, DOI 10.1016/j.genm.2011.11.006; Lane P, 2012, GENDER MED, V9, pS25, DOI 10.1016/j.genm.2011.09.031; Lane PM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2193157; LED Apteryx Inc, 2015, VELSCOPE VX SYST; Lynch MA, 1994, BURKETS ORAL MED DIA; Mallia RJ, 2008, CANCER-AM CANCER SOC, V112, P1503, DOI 10.1002/cncr.23324; Mehrotra R, 2010, J AM DENT ASSOC, V141, P151, DOI 10.14219/jada.archive.2010.0132; Messadil DV, 2014, INT J ORAL SCI, V6, P162, DOI 10.1038/ijos.2014.39; Paderni C, 2011, INT J IMMUNOPATH PH, V24, P121, DOI 10.1177/03946320110240S221; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Petersen PE, 2005, COMMUNITY DENT ORAL, V33, P397, DOI 10.1111/j.1600-0528.2005.00251.x; Pierce MC, 2012, CANCER PREV RES, V5, P801, DOI 10.1158/1940-6207.CAPR-11-0555; PINDBORG JJ, 1971, BRIT J CANCER, V25, P10, DOI 10.1038/bjc.1971.2; Poh CF, 2007, HEAD NECK-J SCI SPEC, V29, P71, DOI 10.1002/hed.20468; Ponnam Srinivas Rao, 2012, J Oral Maxillofac Pathol, V16, P4, DOI 10.4103/0973-029X.92965; Poushter J., 2016, EMERGING EC, V22, P1, DOI DOI 10.1017/CBO9781107415324.004; Prabhu Rachana V, 2014, J Clin Exp Dent, V6, pe569, DOI 10.4317/jced.51318; Prahl S., 1998, TABULATED MOLAR EXTI; Prakash M, 2012, OSCAN SCREENING TOOL; Praveen BN, 2010, TXB ORAL MED ORAL DI, V1ST; Qin Z, 2010, OPT EXPRESS, V18, P17460, DOI 10.1364/OE.18.017460; Rahman M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907455; Rahman MS, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-10; Ram A P Bala, 1902, Ind Med Gaz, V37, P414; Rashid A, 2015, J ORAL PATHOL MED, V44, P307, DOI 10.1111/jop.12218; Reidy J, 2011, SURG-J R COLL SURG E, V9, P278, DOI 10.1016/j.surge.2011.01.010; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; Roblyer D, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2904658; Roblyer D, 2009, CANCER PREV RES, V2, P423, DOI 10.1158/1940-6207.CAPR-08-0229; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Sawan D, 2015, J INT SOC PREV COMMU, V5, P248, DOI 10.4103/2231-0762.159967; Schanda J, 2007, COLORIMETRY: UNDERSTANDING THE CIE SYSTEM, P1, DOI 10.1002/9780470175637; Scheer M, 2011, ORAL SURG ORAL MED O, V111, P568, DOI 10.1016/j.tripleo.2010.12.010; Schwarz RA, 2008, APPL OPTICS, V47, P825, DOI 10.1364/AO.47.000825; Sharma DC, 2001, LANCET ONCOL, V2, P464, DOI 10.1016/S1470-2045(01)00444-2; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Song H, 2015, ASIA-PAC J PUBLIC HE, V27, pNP47, DOI 10.1177/1010539513486921; Strickland SS, 2002, ADDICT BIOL, V7, P85, DOI 10.1080/13556210120091446; Svistun E, 2004, HEAD NECK-J SCI SPEC, V26, P205, DOI 10.1002/hed.10381; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; The World Bank, 2017, MOB CELL SUBSCR; Uthoff RD, 2018, PROC SPIE, V10486, DOI 10.1117/12.2296435; VANDEREB MM, 1993, INT J CANCER, V54, P754, DOI 10.1002/ijc.2910540508; Vicente MDGH, 1996, REV PORT QUIMICA, V3, P46; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Wood NK, 1991, DIFFERENTIAL DIAGNOS; World Health Organization, 2018, CANC COUNTR PROF 201; World Health Organization, 2006, AG STAND DEATH RAT 1; Wu YC, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2362741; Zuluaga AF, 1999, APPL SPECTROSC, V53, P302, DOI 10.1366/0003702991946695; ZWEIG MH, 1993, CLIN CHEM, V39, P561	90	52	52	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207493	10.1371/journal.pone.0207493	http://dx.doi.org/10.1371/journal.pone.0207493			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517120	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400037
J	Chen, J; Zhang, WM; Wang, Y; Zhao, D; Wu, MJ; Fan, JW; Li, JT; Gong, Y; Dan, NN; Yang, D; Liu, R; Zhan, QM				Chen, Jie; Zhang, Weimin; Wang, Yan; Zhao, Di; Wu, Mengjiao; Fan, Jiawen; Li, Jinting; Gong, Ying; Dan, Nana; Yang, Di; Liu, Rui; Zhan, Qimin			The diacylglycerol kinase alpha (DGK alpha)/Akt/NF-kappa B feedforward loop promotes esophageal squamous cell carcinoma (ESCC) progression via FAK-dependent and FAK-independent manner	ONCOGENE			English	Article							FOCAL ADHESION KINASE; NF-KAPPA-B; EPIDERMAL-GROWTH-FACTOR; ACTIVATION; INFLAMMATION; AKT; PROLIFERATION; INHIBITION; MIGRATION; SUBUNIT	Many reports have described DGK alpha as an oncogene, hence, we investigated its function and the underlying mechanisms in esophageal squamous cell carcinoma (ESCC) progression. This study demonstrated that DGK alpha was upregulated by inflammatory stimulants and formed feedforward loop with Akt/NF-kappa B signaling in ESCC cells. Mechanistically, DGK alpha-activated Akt/NF-kappa B signaling via stimulating PA production to reduce cAMP level and PTEN activity, and specifically, independently of its kinase function, through direct interaction with the FERM domain of FAK to relieve the auto-inhibitory effect of FERM domain on FAK. Overexpression of DGK alpha promoted cancer malignant progression both in vitro and in vivo, whereas depletion of DGK alpha suppressed these effects. Importantly, DGK alpha expression was tightly correlated with the malignancy of various inflammation-related squamous carcinomas and the oncogenic Akt/NF-kappa B activity. Therefore, DGK alpha is critically involved in inflammation-mediated ESCC progression, supporting DGK alpha as a potential target for ESCC therapy.	[Chen, Jie; Zhang, Weimin; Wang, Yan; Zhao, Di; Wu, Mengjiao; Fan, Jiawen; Li, Jinting; Gong, Ying; Dan, Nana; Yang, Di; Liu, Rui; Zhan, Qimin] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing,Lab Mol Oncol, Beijing 100142, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst, Beijing 100021, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhan, QM (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing,Lab Mol Oncol, Beijing 100142, Peoples R China.; Zhan, QM (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst, Beijing 100021, Peoples R China.; Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China.; Zhan, QM (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	zhanqimin@bjmu.edu.en			National 973 Program [2015CB553904]; National Natural Fund of China [81830086, 81490753, 81502110, 81772504]; Beijing Municipal Administration of Hospitals's Youth Program [QML20171105]	National 973 Program(National Basic Research Program of China); National Natural Fund of China; Beijing Municipal Administration of Hospitals's Youth Program	This work is supported by the National 973 Program (2015CB553904) and National Natural Fund of China (81830086, 81490753, 81502110, and 81772504). Beijing Municipal Administration of Hospitals's Youth Program, code: QML20171105.	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Castellano E, 2013, CANCER CELL, V24, P617, DOI 10.1016/j.ccr.2013.09.012; Chechlinska M, 2010, NAT REV CANCER, V10, P2, DOI 10.1038/nrc2782; Chen J, 2015, ONCOGENE, V34, P5114, DOI 10.1038/onc.2014.434; Chen J, 2015, CANCER RES, V75, P4198, DOI 10.1158/0008-5472.CAN-15-1062; Chen MF, 2012, J MOL MED, V90, P89, DOI 10.1007/s00109-011-0809-4; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dominguez CL, 2013, CANCER DISCOV, V3, P782, DOI 10.1158/2159-8290.CD-12-0215; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Guo ST, 2016, ONCOGENE, V35, P3049, DOI 10.1038/onc.2015.361; Guo W, 2005, CHINESE MED J-PEKING, V118, P1870; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; Ito T, 2008, CANCER RES, V68, P3214, DOI 10.1158/0008-5472.CAN-07-3043; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Li Y, 2018, CANCER LETT, V430, P57, DOI 10.1016/j.canlet.2018.05.013; Lin CY, 2013, CANCER RES, V73, P3638, DOI 10.1158/0008-5472.CAN-12-4028; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Luzzatto L, 2015, NEW ENGL J MED, V373, P84, DOI 10.1056/NEJMsb1502456; Martinez K, 2013, J LIPID RES, V54, P662, DOI 10.1194/jlr.M031211; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nemoz G, 1997, MOL PHARMACOL, V51, P242, DOI 10.1124/mol.51.2.242; Okada M, 2012, BIOCHEM BIOPH RES CO, V420, P479, DOI 10.1016/j.bbrc.2012.03.057; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Song LB, 2012, GASTROENTEROLOGY, V143, P995, DOI 10.1053/j.gastro.2012.06.033; Streblow DN, 2003, J BIOL CHEM, V278, P50456, DOI 10.1074/jbc.M307936200; Sugimoto N, 2011, NEUROSCI LETT, V497, P55, DOI 10.1016/j.neulet.2011.04.028; Takeishi K, 2012, J HEPATOL, V57, P77, DOI 10.1016/j.jhep.2012.02.026; Torres-Ayuso P, 2014, ONCOTARGET, V5, P9710, DOI 10.18632/oncotarget.2344; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang F, 2009, CURR OPIN PHARMACOL, V9, P389, DOI 10.1016/j.coph.2009.06.005; Wu DW, 2015, ONCOGENE, V34, P3882, DOI 10.1038/onc.2015.203; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Zhang B, 2017, DNA CELL BIOL, V36, P237, DOI 10.1089/dna.2016.3535; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023	41	17	19	1	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2533	2550		10.1038/s41388-018-0604-6	http://dx.doi.org/10.1038/s41388-018-0604-6			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30532074				2022-12-26	WOS:000463335200007
J	Grabosch, S; Bulatovic, M; Zeng, FTZ; Ma, TZ; Zhang, LX; Ross, M; Brozickl, J; Fang, YS; Tseng, G; Kim, E; Gambotto, A; Elishaev, E; Edwards, RP; Vlad, AM				Grabosch, Shannon; Bulatovic, Mirna; Zeng, Feitianzhi; Ma, Tianzhou; Zhang, Lixin; Ross, Malcolm; Brozickl, Joan; Fang, YuSi; Tseng, George; Kim, Eun; Gambotto, Andrea; Elishaev, Esther; Edwards, Robert P.; Vlad, Anda M.			Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles	ONCOGENE			English	Article							LONG-TERM SAFETY; CELLS; CHEMOTHERAPY; SURVIVAL; EXPRESSION; APOPTOSIS; ANTIBODY; THERAPY; TUMORS; PD-L1	The backbone of ovarian cancer treatment is platinum-based chemotherapy and aggressive surgical debulking. New therapeutic approaches using immunotherapy via immune checkpoint blockade, which have demonstrated clinical efficacy in other tumor types, have been less promising in ovarian cancer. To increase their clinical efficacy, checkpoint inhibitors are now being tested in clinical trials in combination with chemotherapy. Here, we evaluated the impact of cisplatin on tumor immunogenicity and its in vivo roles when used alone or in combination with anti-PD-L1, in two novel murine ovarian cancer cell models. The 2F8 and its platinum-resistant derivative 2F8cis model, display distinct inflammatory profiles and chemotherapy sensitivities, and mirror the primary and recurrent human disease, respectively. Acute and chronic exposure to cisplatin enhances tumor immunogenicity by increasing calreticulin, MHC class I, antigen presentation and T-cell infiltration. Cisplatin also upregulates PD-L1 expression in vitro and in vivo, demonstrating a dual, paradoxical immune modulatory effect and supporting the rationale for combination with immune checkpoint blockade. One of the pathways activated by cisplatin treatment is the cGAS/STING pathway. Chronic cisplatin treatment led to upregulation of cGAS and STING proteins in 2F8cis compared to parental 2F8 cells, while acute exposure to cisplatin further increases cGAS and STING levels in both 2F8 and 2F8cis cells. Overexpression of cGAS/STING modifies tumor immunogenicity by upregulating PD-L1, MHC I and calreticulin in tumor cells. Anti-PD-L1 alone in a platinum-sensitive model or with cisplatin in a platinum-resistant model increases survival. These studies have high translational potential in ovarian cancer.	[Grabosch, Shannon; Bulatovic, Mirna; Zeng, Feitianzhi; Zhang, Lixin; Ross, Malcolm; Brozickl, Joan; Edwards, Robert P.; Vlad, Anda M.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Grabosch, Shannon; Bulatovic, Mirna; Zeng, Feitianzhi; Zhang, Lixin; Ross, Malcolm; Edwards, Robert P.; Vlad, Anda M.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; [Grabosch, Shannon; Ross, Malcolm; Edwards, Robert P.] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA; [Zeng, Feitianzhi] Cent South Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Ma, Tianzhou; Fang, YuSi; Tseng, George] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Kim, Eun; Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Elishaev, Esther] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Ma, Tianzhou] Univ Maryland, Dept Epidemiol & Biostat, Sch Publ Hlth, Pittsburgh, MD 20742 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vlad, AM (corresponding author), Magee Womens Res Inst, Pittsburgh, PA 15213 USA.; Vlad, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.	vladam@upmc.edu	Ma, Tianzhou/AAC-8221-2021; Bulatovic, Mirna/L-6826-2015	Ma, Tianzhou/0000-0003-3605-0811; Bulatovic, Mirna/0000-0002-5472-6144	NIH/NCI [R01 CA163462]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA163462] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partly supported by the NIH/NCI R01 CA163462, Pennsylvania Department of Health and a philanthropic donation from Mr. Matthew Fletcher Deitch.	Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bilbao R, 2003, GENE THER, V10, P1821, DOI 10.1038/sj.gt.3302084; Budiu RA, 2013, ONCOGENE, V32, P3664, DOI 10.1038/onc.2012.397; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Di Blasio S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1192739; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; Ding L, 2015, BBA-MOL BASIS DIS, V1852, P2494, DOI 10.1016/j.bbadis.2015.08.011; Feili-Hariri M, 2003, HUM GENE THER, V14, P13, DOI 10.1089/10430340360464679; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Gaillard Stephanie L, 2016, Gynecol Oncol Res Pract, V3, P11; Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Grabosch S, 2017, GYNECOL ONCOL, V146, P137, DOI 10.1016/j.ygyno.2017.04.008; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hamanishi J, 2016, INT IMMUNOL, V28, P339, DOI 10.1093/intimm/dxw020; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; HAVRILESKY LJ, 1995, OBSTET GYNECOL, V85, P1007, DOI 10.1016/0029-7844(95)00058-Y; Hughes PE, 2016, TRENDS IMMUNOL, V37, P462, DOI 10.1016/j.it.2016.04.010; Jiang Run-De, 2003, Ai Zheng, V22, P337; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lemos H, 2016, CANCER RES, V76, P2076, DOI 10.1158/0008-5472.CAN-15-1456; Markman M, 2000, Oncologist, V5, P26, DOI 10.1634/theoncologist.5-1-26; McDermott DF, 2015, J CLIN ONCOL, V33, P2013, DOI 10.1200/JCO.2014.58.1041; Merritt RE, 2003, J THORAC CARDIOV SUR, V126, P1609, DOI 10.1016/S0022-5223(03)00707-4; Mesnage SJL, 2017, ANN ONCOL, V28, P651, DOI 10.1093/annonc/mdw625; Mony JT, 2015, CANCER IMMUNOL IMMUN, V64, P1095, DOI 10.1007/s00262-015-1712-6; Nejad EB, 2016, CANCER RES, V76, P6017, DOI 10.1158/0008-5472.CAN-16-0881; Oliveros J., 2007, VENNY INTERACTIVE TO; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Pujade-Lourraine E, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.TPS5600; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Varga A, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.5513; Webb JR, 2016, GYNECOL ONCOL, V141, P293, DOI 10.1016/j.ygyno.2016.03.008; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114	48	108	116	1	40	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2380	2393		10.1038/s41388-018-0581-9	http://dx.doi.org/10.1038/s41388-018-0581-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30518877	Green Accepted			2022-12-26	WOS:000462588000011
J	Grane-Boladeras, N; Williams, D; Tarmakova, Z; Stevanovic, K; Villani, LA; Mehrabi, P; Siu, KWM; Pastor-Anglada, M; Coe, IR				Grane-Boladeras, Natalia; Williams, Declan; Tarmakova, Zlatina; Stevanovic, Katarina; Villani, Linda A.; Mehrabi, Pedram; Siu, K. W. Michael; Pastor-Anglada, Marcal; Coe, Imogen R.			Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1	FASEB JOURNAL			English	Article						MYTH; NanoBiT; hENT1; hENT2; adenosine	PROTEIN-KINASE CK2; ADENOSINE; ENT1; MODULATION; NANOLUC; GLUCOSE; CELLS	Equilibrative nucleoside transporters (ENTs) translocate nucleosides and nucleobases across plasma membranes, as well as a variety of anti-cancer, -viral, and -parasite nucleoside analogs. They are also key members of the purinome complex and regulate the protective and anti-inflammatory effects of adenosine. Despite their important role, little is known about the mechanisms involved in their regulation. We conducted membrane yeast 2-hybrid and coimmunoprecipitation studies and identified, for the first time to our knowledge, the existence of protein-protein interactions between human ENT1 and ENT2 (hENT1 and hENT2) proteins in human cells and the formation of hetero- and homo-oligomers at the plasma membrane and the submembrane region. The use of NanoLuc Binary Technology allowed us to analyze changes in the oligomeric status of hENT1 and hENT2 and how they rapidly modify the uptake profile for nucleosides and nucleobases and allow cells to respond promptly to external signals or changes in the extracellular environment. These changes in hENTs oligomerization are triggered by PKC activation and subsequent action of protein phosphatase 1.Grane-Boladeras, N., Williams, D., Tarmakova, Z., Stevanovic, K., Villani, L. A., Mehrabi, P., Siu, K. W. M., Pastor-Anglada, M., Coe, I. R. Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.	[Grane-Boladeras, Natalia; Tarmakova, Zlatina; Stevanovic, Katarina; Coe, Imogen R.] Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 0A1, Canada; [Grane-Boladeras, Natalia; Pastor-Anglada, Marcal] Univ Barcelona, Inst Biomed, Dept Biochem & Mol Biomed, Barcelona, Spain; [Grane-Boladeras, Natalia; Pastor-Anglada, Marcal] Natl Biomed Res Inst Liver & Gastrointestinal Dis, Barcelona, Spain; [Williams, Declan; Siu, K. W. Michael] York Univ, Dept Chem, Toronto, ON, Canada; [Villani, Linda A.; Mehrabi, Pedram] York Univ, Dept Biol, Toronto, ON, Canada	Toronto Metropolitan University; University of Barcelona; York University - Canada; York University - Canada	Grane-Boladeras, N (corresponding author), Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 0A1, Canada.	nataliagrane@ryerson.ca	; Pastor Anglada, Marcal/C-3730-2017	Williams, Declan/0000-0002-6754-1624; Pastor Anglada, Marcal/0000-0003-3712-1773	Instituto de Salud Carlos III (Madrid, Spain); Ryerson University; Natural Science and Engineering Research Council of Canada; Ministry of Economy and Competitiveness (National Biomedicine Program, Ministry of Economy, Industry and Competiveness); Government of Spain [SAF2014-52067-R]; National Biomedical Research Institute (CIBER) of Liver and Gastrointestinal Diseases	Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Ryerson University; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of Economy and Competitiveness (National Biomedicine Program, Ministry of Economy, Industry and Competiveness); Government of Spain(Spanish Government); National Biomedical Research Institute (CIBER) of Liver and Gastrointestinal Diseases	This work was supported by an Instituto de Salud Carlos III (Madrid, Spain), Predoctoral Contracts of Training in Health Research Doctoral Fellowship; a Ryerson University Postdoctoral Fellowship (to N.G.B.); Natural Science and Engineering Research Council of Canada; Ryerson University (to I.R.C.); Ministry of Economy and Competitiveness (National Biomedicine Program, Ministry of Economy, Industry and Competiveness); Government of Spain (SAF2014-52067-R); and National Biomedical Research Institute (CIBER) of Liver and Gastrointestinal Diseases (to M.P.-A.). CIBER is an initiative of Instituto de Salud Carlos III. The authors declare no conflicts of interest.	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Balse E, 2009, P NATL ACAD SCI USA, V106, P14681, DOI 10.1073/pnas.0902809106; Bicket A, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160063; Bicket A, 2016, AM J PHYSIOL-CELL PH, V310, pC808, DOI 10.1152/ajpcell.00243.2015; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cabrita MA, 2002, BIOCHEM CELL BIOL, V80, P623, DOI 10.1139/O02-153; Coe I, 2002, FEBS LETT, V517, P201, DOI 10.1016/S0014-5793(02)02622-4; DELICADO EG, 1991, BIOCHEM J, V279, P651, DOI 10.1042/bj2790651; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; dos Santos-Rodrigues A, 2014, NEUROCHEM INT, V73, P229, DOI 10.1016/j.neuint.2014.03.014; Elsherbiny NM, 2015, LIFE SCI, V143, P8, DOI 10.1016/j.lfs.2015.10.026; Grane-Boladeras N, 2012, THESIS; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Kipp H, 2002, ANNU REV PHYSIOL, V64, P595, DOI 10.1146/annurev.physiol.64.081501.155793; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Longhi MS, 2013, J MOL MED, V91, P165, DOI 10.1007/s00109-012-0991-z; Lu G, 2010, J NEUROSCI, V30, P5058, DOI 10.1523/JNEUROSCI.0148-10.2010; Montecinos VP, 2000, J PHYSIOL-LONDON, V529, P777, DOI 10.1111/j.1469-7793.2000.00777.x; Nishio R, 2011, CANCER SCI, V102, P622, DOI 10.1111/j.1349-7006.2010.01837.x; Oh-hashi K, 2016, CELL BIOCHEM FUNCT, V34, P497, DOI 10.1002/cbf.3222; Olsen BB, 2010, METHOD ENZYMOL, V484, P515, DOI [10.1016/B978-0-12-381298-8.00025-3, 10.1016/S0076-6879(10)84025-X]; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Pinto-Duarte A, 2005, J NEUROCHEM, V93, P595, DOI 10.1111/j.1471-4159.2005.03071.x; Ramadan A, 2014, PURINERG SIGNAL, V10, P305, DOI 10.1007/s11302-013-9391-2; Ramakers BP, 2011, CRIT CARE, V15, DOI 10.1186/cc10576; Reyes G, 2011, MOL MEMBR BIOL, V28, P412, DOI 10.3109/09687688.2011.604861; Roma MG, 2008, WORLD J GASTROENTERO, V14, P6786, DOI 10.3748/wjg.14.6786; Rose JB, 2010, AM J PHYSIOL-HEART C, V298, pH771, DOI 10.1152/ajpheart.00711.2009; Sen RP, 1999, NEUROPHARMACOLOGY, V38, P1009, DOI 10.1016/S0028-3908(99)00029-5; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Stecula A, 2017, BIOCHEMISTRY-US, V56, P3475, DOI 10.1021/acs.biochem.7b00339; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Wang HJ, 2014, PEDIATR BLOOD CANCER, V61, P2230, DOI 10.1002/pbc.25221; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Weber S, 2016, J MOL CELL CARDIOL, V101, P116, DOI 10.1016/j.yjmcc.2016.09.007; Zhang SY, 1997, ARCH BIOCHEM BIOPHYS, V338, P227, DOI 10.1006/abbi.1996.9809	36	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3841	3850		10.1096/fj.201800440RR	http://dx.doi.org/10.1096/fj.201800440RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521377	Bronze			2022-12-26	WOS:000459794800060
J	Diarra, B; Kone, M; Togo, ACG; Sarro, YDS; Cisse, AB; Somboro, A; Degoga, B; Tolofoudie, M; Kone, B; Sanogo, M; Baya, B; Kodio, O; Maiga, M; Belson, M; Orsega, S; Krit, M; Dao, S; Maiga, II; Murphy, RL; Rigouts, L; Doumbia, S; Diallo, S; de Jong, BC				Diarra, Bassirou; Kone, Mahamadou; Togo, Antieme Combo Georges; Sarro, Yeya Dit Sadio; Cisse, Aissata Boubakar; Somboro, Amadou; Degoga, Boureima; Tolofoudie, Mohamed; Kone, Bourahima; Sanogo, Moumine; Baya, Bocar; Kodio, Ousmane; Maiga, Mamoudou; Belson, Michael; Orsega, Susan; Krit, Meryam; Dao, Sounkalo; Maiga, Ibrahim Izetiegouma; Murphy, Robert L.; Rigouts, Leen; Doumbia, Seydou; Diallo, Souleymane; de Jong, Bouke Catherine			Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali	PLOS ONE			English	Article							DRUG-RESISTANCE; COMPLEX; DIAGNOSIS	Objective Ancestral M. tuberculosis complex lineages such as M. africanum are underrepresented among retreatment patients and those with drug resistance. To test the hypothesis that they respond faster to TB treatment, we determined the rate of smear conversion of new pulmonary tuberculosis patients in Bamako, Mali by the main MTBc lineages. Methods Between 2015 and 2017, we conducted a prospective cohort study of new smear positive pulmonary tuberculosis patients in Bamako. Confirmed MTBc isolates underwent genotyping by spoligotyping for lineage classification. Patients were followed at 1 month (M), 2M and 5M to measure smear conversion in auramine (AR) and Fluorescein DiAcetate (FDA) vital stain microscopy. Result All the first six human MTBc lineages were represented in the population, plus M. bovis in 0.8% of the patients. The most widely represented lineage was the modern Euro-American lineage (L) 4, 57%, predominantly the T family, followed by L6 (M. africanum type 2) in 22.9%. Ancestral lineages 1, 5, 6 and M. bovis combined amounted to 28.8%. Excluding 25 patients with rifampicin resistance, smear conversion, both by AR and FDA, occurred later in L6 compared to L4 (HR 0.80 (95% CI 0.66-0.97) for AR, and HR 0.81 (95%CI 0.68-0.97) for FDA). In addition we found that HIV negative status, higher BMI at day 0, and patients with smear grade at baseline <= 1+ were associated with earlier smear conversion. Conclusion The six major human lineages of the MTBc all circulate in Bamako. Counter to our hypothesis, we found that patients diseased with modern M. tuberculosis complex L4 respond faster to TB treatment than those with M. africanum L6.	[Diarra, Bassirou; Kone, Mahamadou; Togo, Antieme Combo Georges; Sarro, Yeya Dit Sadio; Somboro, Amadou; Degoga, Boureima; Tolofoudie, Mohamed; Kone, Bourahima; Sanogo, Moumine; Baya, Bocar; Kodio, Ousmane; Dao, Sounkalo; Doumbia, Seydou; Diallo, Souleymane] USTTB, Univ Clin Res Ctr, SEREFO Lab, Bamako, Mali; [Diarra, Bassirou; Krit, Meryam; Rigouts, Leen; de Jong, Bouke Catherine] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Diarra, Bassirou; Rigouts, Leen] Antwerp Univ, Dept Biomed Sci, Antwerp, Belgium; [Cisse, Aissata Boubakar] INRSP, Lab Natl Reference Mycobacteries LNR, Bamako, Mali; [Maiga, Mamoudou] Northwestern Univ, Global Hlth, Chicago, IL 60611 USA; [Belson, Michael; Orsega, Susan] NIAID, Collaborat Clin Res Branch, Div Clin Res, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Maiga, Ibrahim Izetiegouma] Ctr Hosp Univ Point G, Lab Anal Med & Hyg Hosp, Bamako, Mali	University of Science & Technology of Bamako; Institute of Tropical Medicine (ITM); University of Antwerp; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Diarra, B (corresponding author), USTTB, Univ Clin Res Ctr, SEREFO Lab, Bamako, Mali.; Diarra, B (corresponding author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; Diarra, B (corresponding author), Antwerp Univ, Dept Biomed Sci, Antwerp, Belgium.	bdiarra@icermali.org		Diarra, Bassirou/0000-0002-1795-9379; Anou M., Somboro/0000-0002-1085-7740	TDR fellowship [B40072]; special programme for research and training in tropical diseases; UNICEF; UNDP; World Bank; WHO; Northwestern University (Chicago, IL, USA) through NIH/FIC [D43 TW10350]; University of Sciences, Techniques and Technologies of Bamako (USTTB) through NIH/R01 grant [R01AI110386]; ERC starting grant INTERRUPTB [311725]; NIH/FIC [D71 TW010428-01A1]; FOGARTY INTERNATIONAL CENTER [D43TW010350, D71TW010428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110386] Funding Source: NIH RePORTER	TDR fellowship; special programme for research and training in tropical diseases; UNICEF; UNDP; World Bank(The World Bank India); WHO(World Health Organization); Northwestern University (Chicago, IL, USA) through NIH/FIC; University of Sciences, Techniques and Technologies of Bamako (USTTB) through NIH/R01 grant; ERC starting grant INTERRUPTB; NIH/FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially funded by a TDR fellowship, TIMS ID B40072 to BD, the special programme for research and training in tropical diseases, co-sponsored by UNICEF, UNDP, World Bank and WHO; the Northwestern University (Chicago, IL, USA) through NIH/FIC D43 TW10350 to RLM, and the University of Sciences, Techniques and Technologies of Bamako (USTTB) through NIH/R01 grant R01AI110386 to SD. Bouke de Jong was supported by ERC starting grant INTERRUPTB (311725), and Bassirou Diarra was partially supported by NIH/FIC D71 TW010428-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2017, CAN J INFECT DIS MED, V2017, DOI 10.1155/2017/3276240; [Anonymous], 2018, GLOB TUB REP 2017; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x; Diarra B, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2060-7; Gehre F, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0704-5; Gehre F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110393; Heunis JC, 2014, PUBLIC HEALTH ACTION, V4, P66, DOI 10.5588/pha.13.0108; Homolka S, 2010, INT J MED MICROBIOL, V300, P489, DOI 10.1016/j.ijmm.2010.04.019; International Union Against Tuberculosis and Lung Disease, 2000, SPUT EX TUB DIR MICR; Joloba ML, 2001, INT J TUBERC LUNG D, V5, P579; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kang HK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004540; Kone B, 2017, J Blood Lymph, V7, DOI 10.4172/2165-7831.1000154; Ledru S, 1996, TUBERCLE LUNG DIS, V77, P429, DOI 10.1016/S0962-8479(96)90116-1; Ngabonziza JCS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187211; Ofori-Anyinam B, 2017, TUBERCULOSIS, V104, P58, DOI 10.1016/j.tube.2017.03.001; Sanogo M, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.01.004; Sanoussi CN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005900; Tientcheu Leopold D, 2016, Int J Mycobacteriol, V5 Suppl 1, pS99, DOI 10.1016/j.ijmyco.2016.09.033; Tientcheu LD, 2014, EUR J IMMUNOL, V44, P1387, DOI 10.1002/eji.201343956; Togo ACG, 2017, INT J MYCOBACT, V6, P379, DOI 10.4103/ijmy.ijmy_140_17; TOURE IM, 1994, B SOC PATHOL EXOT, V87, P152; Traore B, 2012, INT J TUBERC LUNG D, V16, P911, DOI 10.5588/ijtld.11.0397; van den ABBEELE K.G., 1962, ANN SOC BEIGE MED TROP, V42, P541; Van Deun A, 2012, INT J TUBERC LUNG D, V16, P1174, DOI 10.5588/ijtld.11.0166; Winglee K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004332; Yeboah-Manu D, 2017, ADV EXP MED BIOL, V1019, P117, DOI 10.1007/978-3-319-64371-7_6	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208603	10.1371/journal.pone.0208603	http://dx.doi.org/10.1371/journal.pone.0208603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540823	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600081
J	Gareau, BJ; Huang, XR; Gareau, TP				Gareau, Brian J.; Huang, Xiaorui; Gareau, Tara Pisani			Social and ecological conditions of cranberry production and climate change attitudes in New England	PLOS ONE			English	Article							CHANGE BELIEFS; ADAPTATION; MITIGATION; POLARIZATION; CONSERVATION; TEMPERATURE; PERCEPTIONS; YIELDS; VIEWS; GAP	Cranberry growers in New England are increasingly pressured by negative effects associated with global climate change, some of which are familiar to this group (such as precipitation fluctuations and pest pressures), others that are rather new (such as warmer winters that threaten needed chill hours for the plants to bloom). The first study of this population of its kind, we use a survey, supplemented with observations and interviews, to assess Massachusetts cranberry grower attitudes towards climate change, and whether certain conditions of production might be associated with their attitudes. Our findings suggest that certain personal and ecological conditions are associated with greater worry of climate change effects, and that communal conditions of the cranberry grower social network provide some ways to cope with a warming climate. While the cranberry growing community has created a strong social network that has allowed it to sustain production, a warming planet will likely require significant change in order to overcome general attitudes of climate skepticism so that cranberry production may continue in the future.	[Gareau, Brian J.; Huang, Xiaorui] Boston Coll, Dept Sociol, Chestnut Hill, MA 02167 USA; [Gareau, Tara Pisani] Boston Coll, Earth & Environm Sci, Chestnut Hill, MA 02167 USA	Boston College; Boston College	Gareau, BJ (corresponding author), Boston Coll, Dept Sociol, Chestnut Hill, MA 02167 USA.	Gareau@bc.edu		Huang, Xiaorui/0000-0002-3823-0253; Gareau, Brian/0000-0002-0529-3389	Vice Provost of Research at Boston College	Vice Provost of Research at Boston College	This research was funded by the Vice Provost of Research at Boston College (BJG and TPG).	Adger WN, 2005, GLOBAL ENVIRON CHANG, V15, P77, DOI [10.1016/j.gloenvcha.2004.12.005, 10.1016/j.gloenvcha.2005.03.001]; Arbuckle JG, 2013, CLIMATIC CHANGE, V118, P551, DOI 10.1007/s10584-013-0700-0; Arbuckle JG, 2015, ENVIRON BEHAV, V47, P205, DOI 10.1177/0013916513503832; Arbuckle JG, 2013, CLIMATIC CHANGE, V117, P943, DOI 10.1007/s10584-013-0707-6; Bakker K, 2010, PROG HUM GEOG, V34, P715, DOI 10.1177/0309132510376849; Bell M.M., 2004, FARMING US ALL PRACT; Bell Michael Mayerfeld, 2015, INVITATION ENV SOCIO; Chatrchyan AM, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.469; Chong D, 2014, CHANGING CLIMATE POL, P110; Climate Science Special Report, 2014, CLIM SCI SPEC REP 3; Diggs D.M., 1991, PLAINS RES, V1, P114; Dinar A, 2011, HANDBOOK ON CLIMATE CHANGE AND AGRICULTURE, P1; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; Dunlap RE, 2016, ENVIRONMENT, V58, P4, DOI 10.1080/00139157.2016.1208995; EADY FC, 1972, CAN J PLANT SCI, V52, P273, DOI 10.4141/cjps72-044; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fitzmaurice CJ, 2016, ORGANIC FUTURES STRU; Garcan B. J., 2005, CAPITALISM NATURE SO, V16, P127, DOI DOI 10.1080/10455750500376081; Gareau BJ, 2008, RETHINK MARXISM, V20, P120, DOI 10.1080/08935690701740152; Gareau BJ, 2007, RURAL SOCIOL, V72, P244, DOI 10.1526/003601107781169992; Hamilton LC, 2009, INT J CLIMATOL, V29, P2348, DOI 10.1002/joc.1930; Hatfield J., 2014, CLIMATE CHANGE IMPAC, P150; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; Iizumi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08214-4; Johnson CW, 1985, BOGS OF THE NORTHEAS; Kennedy EH, 2018, ENVIRON SOCIOL, V4, P299, DOI 10.1080/23251042.2018.1436891; Mao JF, 2016, NAT CLIM CHANGE, V6, P959, DOI [10.1038/NCLIMATE3056, 10.1038/nclimate3056]; Marchant M, 2013, J AGR APPL EC, V45, DOI [10.1017/S1074070800005216, DOI 10.1017/S1074070800005216]; McCright AM, 2014, WEATHER CLIM SOC, V6, P194, DOI 10.1175/WCAS-D-13-00058.1; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Menapace L, 2015, GLOBAL ENVIRON CHANG, V35, P70, DOI 10.1016/j.gloenvcha.2015.07.005; Milnes T., 2017, ENV SOCIOLOGY, V3, P260, DOI [10.1080/23251042.2017.1295837, DOI 10.1080/23251042.2017.1295837]; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; O'Connor J., 1988, CAPITALISM NATURE SO, V1, P11, DOI DOI 10.1080/10455758809358356; O'Connor J., 1998, NATURAL CAUSES ESSAY; O'Connor J, 1991, EXTERNAL NATURAL CON, DOI [10.1080/10455752.2017.1296479, DOI 10.1080/10455752.2017.1296479]; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Pfeffer MJ, 2001, RURAL SOCIOL, V66, P382, DOI 10.1111/j.1549-0831.2001.tb00073.x; Playfair S, 2014, AMERICAS FOUNDING FR; Reyes-Garcia V, 2016, WIRES CLIM CHANGE, V7, P109, DOI 10.1002/wcc.374; Running K, 2017, SOC NATUR RESOUR, V30, P659, DOI 10.1080/08941920.2016.1239151; Safi AS, 2012, RISK ANAL, V32, P1041, DOI 10.1111/j.1539-6924.2012.01836.x; Salant P, 1994, CONDUCT YOUR OWN SUR, DOI [10.1080/00139157.2016.1208995, DOI 10.1080/00139157.2016.1208995]; Sandler HA, 2008, U MASSACHUSETTS PUBL, VCP-08; Schattman R, 2016, VERMONT AGR RESILIEN; Stuart D, 2014, LAND USE POLICY, V36, P210, DOI 10.1016/j.landusepol.2013.08.011; Swyngedouw E, 1999, ANN ASSOC AM GEOGR, V89, P443, DOI 10.1111/0004-5608.00157; Twine TE, 2009, AGR FOREST METEOROL, V149, P2143, DOI 10.1016/j.agrformet.2009.05.012; US Global Change Research Program National CA United States National Oceanic and Atmospheric Administration, 2017, 4 NAT CLIM ASS; White DF., 2017, CAPITALISM NATURE SO, V28, P22, DOI [10.1080/10455752.2017.1296479, DOI 10.1080/10455752.2017.1296479]; White DF, 2016, ENV NATURES SOCIAL T; Williams R, 2016, J MATH SOCIOL, V40, P7, DOI 10.1080/0022250X.2015.1112384; Xu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156083; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114; Zipper SC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/094021	56	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207237	10.1371/journal.pone.0207237	http://dx.doi.org/10.1371/journal.pone.0207237			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540743	Green Submitted, gold, Green Published			2022-12-26	WOS:000452898600012
J	Lyatuu, GW; Naburi, H; Urrio, R; Mwashemele, SZ; Mdingi, S; Panga, R; Koda, H; Chende, Y; Tsere, M; Mhalu, A; Siril, H; Lema, IA; Aris, E; Muya, AN; Galanti, MR; Biberfeld, G; Kilewo, C; Ekstrom, AM				Lyatuu, Goodluck Willey; Naburi, Helga; Urrio, Roseline; Mwashemele, Shally Zumba; Mdingi, Sarah; Panga, Rehema; Koda, Happiness; Chende, Yusuph; Tsere, Martha; Mhalu, Aisa; Siril, Helen; Lema, Irene Andrew; Aris, Eric; Muya, Aisa Nkya; Galanti, Maria Rosaria; Biberfeld, Gunnel; Kilewo, Charles; Ekstrom, Anna Mia			Engaging community leaders to improve male partner participation in the prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania	PLOS ONE			English	Article							MALE INVOLVEMENT; ANTIRETROVIRAL THERAPY; ANTENATAL CARE; PROGRAM; WOMEN; PLUS; INTERVENTIONS; PREGNANCY; ADHERENCE; SERVICES	Background Male partner participation improves uptake, retention and outcomes of prevention of mother-to-child transmission of HIV (PMTCT) services. However, in patriarchal settings few men accompany their partners to antenatal care (ANC) and PMTCT services. We explored whether community leaders can improve male partner participation in ANC and PMTCT. Methods We integrated initiatives to increase male partner participation in routine ANC care in six health facilities (attending about 4,500 new pregnant women per quarter) in Dar es Salaam, Tanzania in 2015/16. These initiatives were adapted from a best performing health facility, on male partner participation in ANC and PMTCT, referred to as the "best practice site". At the six purposively selected intervention sites, we sensitized and garnered commitment from healthcare providers to provide couple friendly services. We then worked with the providers to sensitize and engage community leaders to integrate and promote male partner participation initiatives in their routine community activities. We assessed change in male partner participation in ANC and PMTCT using the proportion of women testing for HIV together with their partners (i.e. couple HIV testing) by quarter. We used 203 ANC facilities (attending about 31,000 new pregnant women per quarter) in the same area as control sites. Results After one year, couple HIV testing in the six intervention sites had tripled from 11.9% at baseline to 36.0% (p<0.001) while there was very little change (from 17.7% to 18.3%) in the 203 control sites (p = 0.07). Statistically significant improvements in couple testing were observed in four of the six intervention sites (6.7% to 19.1%; 9.3% to 74.6%; 46.2% to 95.2%; and 4.7% to 15.1% respectively. p<0.001 for all sites). Two of these four sites, located in the same administrative district as the best practice site, achieved remarkably high couple HIV testing (95.2% and 74.6%). This may be attributable to the greater engagement and active participation of the community leaders in these two sites compared to the other four. Conclusion Effective engagement and functional partnerships between healthcare providers and community leaders can contribute to improve male partner participation in ANC and PMTCT services. PMTCT programs should capitalize on community leaders, in addressing low male partner participation in ANC and PMTCT, in order to improve effective uptake, retention and outcomes of HIV prevention and treatment services among pregnant and breastfeeding women, their partners, infants and families.	[Lyatuu, Goodluck Willey; Urrio, Roseline; Mwashemele, Shally Zumba; Mdingi, Sarah; Koda, Happiness; Chende, Yusuph; Tsere, Martha; Mhalu, Aisa; Siril, Helen; Lema, Irene Andrew; Aris, Eric; Muya, Aisa Nkya] Management & Dev Hlth, Dar Es Salaam, Tanzania; [Lyatuu, Goodluck Willey; Urrio, Roseline; Kilewo, Charles] Muhimbili Univ Hlth & Allied Sci, Dept Obstet & Gynecol, Dar Es Salaam, Tanzania; [Lyatuu, Goodluck Willey; Naburi, Helga; Galanti, Maria Rosaria; Biberfeld, Gunnel; Ekstrom, Anna Mia] Karolinska Inst, Global Hlth IHCAR, Dept Publ Hlth Sci, Stockholm, Sweden; [Naburi, Helga] Muhimbili Univ Hlth & Allied Sci, Dept Pediat & Child Hlth, Dar Es Salaam, Tanzania; [Panga, Rehema] Ubungo Municipal Council, Dar Es Salaam, Tanzania; [Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Karolinska University Hospital	Lyatuu, GW (corresponding author), Management & Dev Hlth, Dar Es Salaam, Tanzania.; Lyatuu, GW (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Obstet & Gynecol, Dar Es Salaam, Tanzania.; Lyatuu, GW (corresponding author), Karolinska Inst, Global Hlth IHCAR, Dept Publ Hlth Sci, Stockholm, Sweden.	goodluck.lyatuu@ki.se		Lyatuu, Goodluck Willey/0000-0003-0779-5515; Naburi, Helga/0000-0003-1659-5224; Ekstrom, Anna Mia/0000-0002-3912-1171; Siril, Hellen Neema/0000-0002-0628-3617	Swedish International Development Cooperation Agency (SIDA); Muhimbili University of Health and Allied Sciences (MUHAS)	Swedish International Development Cooperation Agency (SIDA); Muhimbili University of Health and Allied Sciences (MUHAS)	Funding from the Swedish International Development Cooperation Agency (SIDA) to Muhimbili University of Health and Allied Sciences (MUHAS) supported the research aspects of this work including data abstraction, analysis, interpretation of findings, manuscript writing and review.	Aguiar C, 2015, MATERN CHILD HLTH J, V19, P2012, DOI 10.1007/s10995-015-1713-2; Aluisio AR, 2016, JAIDS-J ACQ IMM DEF, V73, P169, DOI 10.1097/QAI.0000000000001038; Ambia J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20309; Anigilaje EA, 2016, PATIENT PREFER ADHER, V10, P57, DOI 10.2147/PPA.S87228; [Anonymous], 2017, TANZ DISTR HLTH INF; [Anonymous], 2016, FAST TRACK AIDS FREE; Asefa A, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-66; Audet CM, 2016, QUAL HEALTH RES, V26, P1721, DOI 10.1177/1049732315580302; Audet CM, 2016, AIDS BEHAV, V20, P2090, DOI 10.1007/s10461-016-1341-x; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Ganle JK, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0083-y; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Kashitala J, 2015, AFR J REPROD HEALTH, V19, P117; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Klaus Kimberly, 2015, Ethiop Med J, V53, P91; Ladur AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133239; Makoni A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2939-7; Mohlala BKF, 2011, AIDS, V25, P1535, DOI 10.1097/QAD.0b013e328348fb85; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Mphonda SM, 2014, AFR J REPROD HEALTH, V18, P97; Murithi LK, 2015, AIDS BEHAV, V19, P645, DOI 10.1007/s10461-014-0939-0; Nesane K, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i2.929; Ngarina M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0914-z; Ngarina M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-450; Nyondo AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119273; Nyondo AL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-691; Odong J., 2018, COUPLES HIV TESTING; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Rawizza HE, 2015, CURR HIV RES, V13, P201, DOI 10.2174/1570162X1303150506183256; Sagay AS, 2015, CURR HIV RES, V13, P193, DOI 10.2174/1570162X1303150506182534; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sileo KM, 2017, J HEALTH PSYCHOL, V22, P1552, DOI 10.1177/1359105316630297; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) ICF International, 2013, TANZ HIV IMP SURV TH; Tanzania Forest Conservation Group, 2018, MAP DAR ES SAL 2006; Tanzania National Bureau of Statistics, 2013, 2012 POP HOUS CENS P; Tanzania National Bureau of Statistics Zanzibar Office of Chief Government Statistician, 2016, DAR ES SAL REG BAS D; Tanzania National Bureau of Statistics Zanzibar Office of Chief Government Statistician, 2018, TANZ TOT POP DISTR; Theuring S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152734; Vermeulen E, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0853-8; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2021, ANT DRUGS TREAT PREG	46	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207986	10.1371/journal.pone.0207986	http://dx.doi.org/10.1371/journal.pone.0207986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540794	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600049
J	Lee, JH; Park, M; Han, S; Hwang, JJ; Park, SH; Park, SY				Lee, Ji-Hoon; Park, MinA; Han, SeoungWoo; Hwang, Jae Joon; Park, So Hee; Park, So Young			An increase in mean platelet volume during admission can predict the prognoses of patients with pneumonia in the intensive care unit: A retrospective study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INFECTIOUS-DISEASES-SOCIETY; GUIDELINES; SEPSIS; COUNT; SIZE; IMMUNE	Platelets play an important role in hemostasis, inflammation, and immunity. Mean platelet volume (MPV), considered a marker of platelet function and activation, is associated with increased morbidity and mortality in sepsis, coronary artery disease, and chronic inflammatory disease. However, the clinical characteristics and prognostic significance of MPV changes for patients with pneumonia in the intensive care unit (ICU) have not been investigated. This retrospective study was conducted using data from an operational database of patients admitted to a medical ICU between October 2010 and October 2017. Of 235 adult patients with pneumonia admitted to the ICU, clinical characteristics and in-hospital mortality values were compared according to MPV, AMPV(day1-2), AMPV(day1-3), Delta MPVday1-4, and Delta MPVdayl-Discharge between those who survived and those who did not. The MPV increased during the first four days for both non-survivors and survivors (P < 0.001). However, repeated measures analysis of variance revealed a significantly higher MPV rate over the first four days in non-survivors than in survivors. Additionally, the Delta MPVday1-2, Delta MPVday1-3, Delta MPVday1-4, and AMPV(day1-Discharge) values were significantly greater in non-survivors than in survivors. For in-hospital mortality, the optimal MPV values were >0.9 fL, P= 0.020; >0.9 fL, P < 0.001; >0.8 fL, P < 0.001; and >1.3 fL, P<0.001 on day 2, day 3, day 4, and at discharge, respectively. In conclusion, our findings demonstrate that MPV during ICU admission may be used as a prognostic marker of mortality in ICU patients with pneumonia. Repeated MPV measurements throughout hospitalization may improve risk stratification for these patients, which could aid in improving patient outcomes.	[Lee, Ji-Hoon] Univ Ulsan, Coll Med, Dept Pulm & Crit Care Med, Asan Med Ctr, Seoul, South Korea; [Park, MinA] Cheonan Chungmu Hosp, Dept Pulmonol, Cheonan, South Korea; [Han, SeoungWoo] Kyung Hee Univ, Div Pulm & Crit Care Med, Dept Internal Med, Med Ctr, Seoul, South Korea; [Hwang, Jae Joon] Kyung Hee Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, So Hee] Inje Univ, Ilsan Paik Hosp, Dept Pulm & Crit Care Med, Ilsan, South Korea; [Park, So Young] Chugnam Natl Univ, Med Coll & Hosp, Dept Pulm & Crit Care Med, Daejeon, South Korea	University of Ulsan; Kyung Hee University; Kyung Hee University; Inje University	Park, SY (corresponding author), Chugnam Natl Univ, Med Coll & Hosp, Dept Pulm & Crit Care Med, Daejeon, South Korea.	sy.park12@gmail.com		Lee, Ji-Hoon/0000-0001-5904-7717; Hwang, Jae-Joon/0000-0003-1832-1024				Becchi C, 2006, MINERVA ANESTESIOL, V72, P749; BESSMAN JD, 1981, AM J CLIN PATHOL, V76, P289; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Gorelik O, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0483-6; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kapsoritakis AN, 2001, AM J GASTROENTEROL, V96, P776; Kim CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119437; Kitazawa T, 2013, INTERNAL MED, V52, P1487, DOI 10.2169/internalmedicine.52.9555; Liapikou A, 2009, CLIN INFECT DIS, V48, P377, DOI 10.1086/596307; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Oh GH, 2017, SHOCK, V47, P323, DOI 10.1097/SHK.0000000000000718; Pereira JM, 2012, EUR J INTERN MED, V23, P412, DOI 10.1016/j.ejim.2012.04.016; Restrepo MI, 2008, CHEST, V133, P610, DOI 10.1378/chest.07-1456; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Sezgi C, 2015, CLIN RESPIR J, V9, P403, DOI 10.1111/crj.12151; Shah B, 2014, PLATELETS, V25, P188, DOI 10.3109/09537104.2013.793794; Shah B, 2012, DIABETES CARE, V35, P1074, DOI 10.2337/dc11-1724; Shteinshnaider M, 2014, EUR J INTERN MED, V25, P646, DOI 10.1016/j.ejim.2014.05.016; Singanayagam A, 2009, QJM-INT J MED, V102, P379, DOI 10.1093/qjmed/hcp027; Tajarernmuang P, 2016, CRIT CARE RES PRACT, V2016, DOI 10.1155/2016/4370834; Taskesen T, 2017, AM J CARDIOL, V119, P192, DOI 10.1016/j.amjcard.2016.09.042; THOMPSON CB, 1982, BRIT J HAEMATOL, V50, P509, DOI 10.1111/j.1365-2141.1982.tb01947.x; Ucar H, 2014, PLATELETS, V25, P274, DOI 10.3109/09537104.2013.805406; Vasse M, 2012, THROMB RES, V130, P559, DOI 10.1016/j.thromres.2012.04.014; Vieira-de-Abreu A, 2012, SEMIN IMMUNOPATHOL, V34, P5, DOI 10.1007/s00281-011-0286-4; WEDZICHA JA, 1988, THORAX, V43, P61, DOI 10.1136/thx.43.1.61; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001	29	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208715	10.1371/journal.pone.0208715	http://dx.doi.org/10.1371/journal.pone.0208715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533065	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500031
J	Qi, JJ; Zhang, FQ; Wang, Y; Liu, T; Tan, L; Wang, SH; Tian, MX; Li, T; Wang, XL; Ding, C; Yu, SQ				Qi, Jingjing; Zhang, Fanqing; Wang, Yu; Liu, Ting; Tan, Lei; Wang, Shaohui; Tian, Mingxing; Li, Tao; Wang, Xiaolan; Ding, Chan; Yu, Shengqing			Characterization of Mycoplasma gallisepticum pyruvate dehydrogenase alpha and beta subunits and their roles in cytoadherence	PLOS ONE			English	Article							DISPLAYED GLYCOLYTIC-ENZYMES; CELL-SURFACE; STREPTOCOCCUS-PNEUMONIAE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; IMMUNOGENIC PROTEINS; BINDING PROTEINS; ENOLASE; PLASMINOGEN; IDENTIFICATION; ADHESION	Mycoplasma gallisepticum is a causative agent of chronic respiratory disease in chickens, typically causing great economic losses. Cytoadherence is the critical stage for mycoplasma infection, and the associated proteins are important for mycoplasma pathogenesis. Many glycolytic enzymes are localized on the cell surface and can bind the extracellular matrix of host cells. In this study, the M. gallisepticum pyruvate dehydrogenase El alpha subunit (PDHA) and beta subunit (PDHB) were expressed in Escherichia coli, and their enzymatic activities were identified based on 2,6-dichlorophenol indophenol reduction. When recombinant PDHA (rPDHA) and recombinant PDHB (rPDHB) were mixed at a 1:1 molar ratio, they exhibited strong enzymatic activity. Alone, rPDHA and rPDHB exhibited no or weak enzymatic activity. Further experiments indicated that both PDHA and PDHB were surface-exposed immunogenic proteins of M. gallisepticum. Bactericidal assays showed that the mouse anti-rPDHA and anti-rPDHB sera killed 48.0% and 75.1% of mycoplasmas respectively. A combination of rPDHA and rPDHB antisera had a mean bactericidal rate of 65.2%, indicating that rPDHA and rPDHB were protective antigens, and combining the two sera did not interfere with bactericidal activity. Indirect immunofluorescence and surface display assays showed that both PDHA and PDHB adhered to DF-1 chicken embryo fibroblast cells and adherence was significantly inhibited by antisera against PDHA and PDHB. Adherence inhibition of M. gallisepticum to DF-1 chicken embryo fibroblast cells was 30.2% for mouse anti-rPDHA serum, 45.1% for mouse anti-rPDHB serum and 72.5% for a combination of rPDHA and rPDHB antisera, suggesting that rPDHA and rPDHB antisera may have synergistically interfered with M. gallisepticum cytoadherence. Plasminogen (Plg)-binding assays further demonstrated that both PDHA and PDHB were Plg-binding proteins, which may have contributed to bacterial colonization. Our results clarified the enzymatic activity of M. gallisepticum PDHA and PDHB and demonstrated these compounds as Plg-binding proteins involved in cytoadherence.	[Qi, Jingjing; Zhang, Fanqing; Wang, Yu; Liu, Ting; Tan, Lei; Wang, Shaohui; Tian, Mingxing; Li, Tao; Wang, Xiaolan; Ding, Chan; Yu, Shengqing] CAAS, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Wang, Yu] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Ding, Chan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Yangzhou University	Ding, C; Yu, SQ (corresponding author), CAAS, Shanghai Vet Res Inst, Shanghai, Peoples R China.; Ding, C (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	shoveldeen@shvri.ac.cn; yus@shvri.ac.cn		Li, Tao/0000-0001-5080-3352	National Key Research and Development Program of China [2017YFD0500705]; Special Fund for Agro-scientific Research in the Public Interest [201303044]; Shanghai Nature Science Fund [15ZR1449700]	National Key Research and Development Program of China; Special Fund for Agro-scientific Research in the Public Interest; Shanghai Nature Science Fund	This work was financially supported through grants from the National Key Research and Development Program of China (2017YFD0500705, http://service.most.gov.cn/), the Special Fund for Agro-scientific Research in the Public Interest (201303044, http://www.mlr.gov.cn/), and the Shanghai Nature Science Fund (15ZR1449700, http://www.stcsm.gov.cn/).	Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bao S, 2015, J APPL MICROBIOL, V119, P236, DOI 10.1111/jam.12824; Bao SJ, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv140; Bao SJ, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0223-6; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Boguslavsky S, 2000, INFECT IMMUN, V68, P3956, DOI 10.1128/IAI.68.7.3956-3964.2000; Bower K, 2003, INFECT IMMUN, V71, P4823, DOI 10.1128/IAI.71.8.4823-4827.2003; Cacciotto C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-225; Chen HJ, 2011, MICROB PATHOGENESIS, V51, P285, DOI 10.1016/j.micpath.2011.03.012; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Corona L, 2013, VET MICROBIOL, V167, P434, DOI 10.1016/j.vetmic.2013.08.024; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; Furnkranz U, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-63; Grundel A, 2016, INT J MED MICROBIOL, V306, P675, DOI 10.1016/j.ijmm.2016.09.001; Grundel A, 2016, INFECT IMMUN, V84, P666, DOI 10.1128/IAI.01071-15; Grundel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126600; He SB, 2015, MICROB PATHOGENESIS, V89, P161, DOI 10.1016/j.micpath.2015.10.005; Hegde S, 2016, VET RES, V47, DOI 10.1186/s13567-016-0387-0; Hegde S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119706; Hnatow LL, 1998, INFECT IMMUN, V66, P3436, DOI 10.1128/IAI.66.7.3436-3442.1998; Hoelzle LE, 2007, MICROBES INFECT, V9, P466, DOI 10.1016/j.micinf.2007.01.004; Indikova I, 2013, INFECT IMMUN, V81, P1618, DOI 10.1128/IAI.00112-13; Jenkins C, 2007, MICROBIOL-SGM, V153, P1455, DOI 10.1099/mic.0.2006/004937-0; Jiang W, 2014, APPL MICROBIOL BIOT, V98, P4937, DOI 10.1007/s00253-013-5471-z; Jores J, 2009, VET IMMUNOL IMMUNOP, V131, P238, DOI 10.1016/j.vetimm.2009.04.016; Kinnby B, 2016, MICROB PATHOGENESIS, V100, P10, DOI 10.1016/j.micpath.2016.08.002; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Layh-Schmitt G, 2000, MICROBIOL-UK, V146, P741, DOI 10.1099/00221287-146-3-741; Levisohn S, 2000, REV SCI TECH OIE, V19, P425, DOI 10.20506/rst.19.2.1232; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Liu MM, 2014, RES VET SCI, V97, P282, DOI 10.1016/j.rvsc.2014.07.003; Much P, 2002, FEMS IMMUNOL MED MIC, V34, P181, DOI 10.1111/j.1574-695X.2002.tb00622.x; Mudahi-Orenstein S, 2003, INFECT IMMUN, V71, P3812, DOI 10.1128/IAI.71.7.3812-3820.2003; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Papazisi L, 2002, INFECT IMMUN, V70, P6839, DOI 10.1128/IAI.70.12.6839-6845.2002; Peterson SN, 2001, GENOME BIOL, V2; Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045; Schreiner SA, 2012, VET MICROBIOL, V156, P88, DOI 10.1016/j.vetmic.2011.10.010; Sun ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088328; Teles C, 2011, EUR J CLIN MICROBIOL, V30, P127, DOI 10.1007/s10096-010-1053-5; Thomas C, 2013, MICROBIOL-SGM, V159, P352, DOI 10.1099/mic.0.061184-0; Wang GQ, 2014, CURR ISSUES MOL BIOL, V16, P15; Wang Y, 2018, MICROBIOLOGY CHINA; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Yavlovich A, 2004, INFECT IMMUN, V72, P5004, DOI 10.1128/IAI.72.9.5004-5011.2004; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07; Zhang YN, 2015, ARCH MICROBIOL, V197, P277, DOI 10.1007/s00203-014-1050-7; Zhao P, 2012, J VET MED SCI, V74, P1109, DOI 10.1292/jvms.12-0095	57	10	11	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208745	10.1371/journal.pone.0208745	http://dx.doi.org/10.1371/journal.pone.0208745			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532176	Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700047
J	Ray, AS; Joardar, N; Mukherjee, S; Rahaman, CH; Babu, SPS				Ray, Anindya Sundar; Joardar, Nikhilesh; Mukherjee, Suprabhat; Rahaman, Chowdhury Habibur; Babu, Santi P. Sinha			Polyphenol enriched ethanolic extract of Cajanus scarabaeoides (L.) Thouars exerts potential antifilarial activity by inducing oxidative stress and programmed cell death	PLOS ONE			English	Article							PARASITE SETARIA-CERVI; AZADIRACHTA-INDICA; INDUCED APOPTOSIS; ACID; NANOPARTICLES	Development of antifilarial drug from the natural sources is considered as one of the most efficacious, safe, and affordable approaches. In this study, we report the antifilarial activity of a leguminous plant Cajanus scarabaeoides (L.) Thouars. The polyphenol-rich ethanolic extract obtained from the stem part of the plant C. scarabaeoides (EECs) was found to be efficient in killing the filarial nematode Setaria centi in all the three developmental stages viz. oocytes, microfilariae (Mf) and adults with LD50 values of 2.5, 10 and 35 mu g/ml, respectively. While studying the molecular mechanism of action, we found that induction of oxidative stress plays the key role in inducing the mortality in S. cervi. The redox imbalance finally results in activation of the nematode CED pathway that executes the death of the parasite. Intriguingly, EECs was found to be selectively active against the worm and absolutely nontoxic to the mammalian cells and tissues. Taken together, our experimental data demonstrate that C. scarabaeoides can be chosen as an affordable natural therapeutic for treating filarial infection in the future with high efficacy and less toxicity.	[Ray, Anindya Sundar; Rahaman, Chowdhury Habibur] Visva Bharati Univ, Dept Bot, Ethnopharmacol Lab, Santini Ketan, W Bengal, India; [Joardar, Nikhilesh; Mukherjee, Suprabhat; Babu, Santi P. Sinha] Visva Bharati Univ, Dept Zool, Parasitol Lab, Santini Ketan, W Bengal, India	Visva Bharati University; Visva Bharati University	Rahaman, CH (corresponding author), Visva Bharati Univ, Dept Bot, Ethnopharmacol Lab, Santini Ketan, W Bengal, India.; Babu, SPS (corresponding author), Visva Bharati Univ, Dept Zool, Parasitol Lab, Santini Ketan, W Bengal, India.	habibur_cr@yahoo.co.in; spsinhababu@gmail.com	Rahaman, Chowdhury Habibur/AAT-8871-2020; Mukherjee, Suprabhat/AAD-7187-2020; Joardar, Nikhilesh/AHE-8804-2022	Rahaman, Chowdhury Habibur/0000-0003-0503-1271; Sinha Babu, Santi P./0000-0002-7441-6426; JOARDAR, NIKHILESH/0000-0002-6460-0377	Department of Science and Technology, Govt. of India [SR/SO/AS-006/2014]; UGC-DRS-SAP Phase II, Govt. of India	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); UGC-DRS-SAP Phase II, Govt. of India	The work was funded by Department of Science and Technology (SR/SO/AS-006/2014), Govt. of India and UGC-DRS-SAP Phase II, Govt. of India.	Bourguinat C, 2006, PARASITOLOGY, V132, P255, DOI 10.1017/S0031182005008899; Chowdhury P, 2018, ADV COMPOS HYBRID MA, V1, P577, DOI 10.1007/s42114-018-0040-7; Gucchait A, 2018, EUR J MED CHEM, V143, P598, DOI 10.1016/j.ejmech.2017.11.047; Joardar N, 2018, INT J BIOL MACROMOL, V107, P2375, DOI 10.1016/j.ijbiomac.2017.10.114; KAUSHAL NA, 1987, IMMUNOL INVEST, V16, P139, DOI 10.3109/08820138709030571; Khare C, 2007, INDIAN MED PLANTS IL; Mondal Shovan, 2017, Current Bioactive Compounds, V13, P347, DOI 10.2174/1573407212666161028160745; Mukherjee N, 2019, J HELMINTHOL, V93, P519, DOI 10.1017/S0022149X18000615; Mukherjee N, 2016, MINI-REV MED CHEM, V16, P1415, DOI 10.2174/1389557516666151120121036; Mukherjee N, 2016, FREE RADICAL BIO MED, V93, P130, DOI 10.1016/j.freeradbiomed.2016.01.027; Mukherjee N, 2014, RES VET SCI, V97, P309, DOI 10.1016/j.rvsc.2014.04.017; Mukherjee N, 2014, EXP PARASITOL, V136, P41, DOI 10.1016/j.exppara.2013.11.006; Mukherjee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30610-7; Mukherjee S, 2016, CURR DRUG METAB, V17, P937, DOI 10.2174/1389200217666161004143152; Mukherjee S, 2015, INDIAN J EXP BIOL, V53, P574; Mukherjee S, 2014, J FOOD SCI TECH MYS, V51, P3301, DOI 10.1007/s13197-012-0848-z; Nayak A, 2012, PARASITOL RES, V111, P1173, DOI 10.1007/s00436-012-2948-0; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Pakrashi S. C., 2004, MED AROMATIC PLANTS; Pal D.C., 1998, TRIBAL MED; Quattrocchi U, 2012, CRC WORLD DICT MED P; Ray AS, 2018, RES J PHARMACOG PHYT, V10, P120; Roy B, 2014, RSC ADV, V4, P34487, DOI 10.1039/c4ra03732d; Saha SK, 2016, CARBOHYD POLYM, V137, P390, DOI 10.1016/j.carbpol.2015.11.007; Saini P, 2015, PHARM BIOL, V53, P813, DOI 10.3109/13880209.2014.943244; Saini P, 2014, PARASITOL INT, V63, P717, DOI 10.1016/j.parint.2014.06.008; Saini P, 2012, PARASITOL INT, V61, P520, DOI 10.1016/j.parint.2012.04.002; Sardar AH, 2013, J PROTEOMICS, V81, P185, DOI 10.1016/j.jprot.2013.01.011; Senathilake KS, 2017, EXP PARASITOL, V177, P13, DOI 10.1016/j.exppara.2017.03.007; Shenoy RK, 2008, KOREAN J PARASITOL, V46, P119, DOI 10.3347/kjp.2008.46.3.119; Uniting to Combat Neglected Tropical Diseases, LOND DECL; Verpoorte R, 2000, J PHARM PHARMACOL, V52, P253, DOI 10.1211/0022357001773931	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208201	10.1371/journal.pone.0208201	http://dx.doi.org/10.1371/journal.pone.0208201			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521546	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600031
J	Thaduri, S; Locke, B; Granberg, F; de Miranda, JR				Thaduri, Srinivas; Locke, Barbara; Granberg, Fredrik; de Miranda, Joachim R.			Temporal changes in the viromes of Swedish Varroa-resistant and Varroa-susceptible honeybee populations	PLOS ONE			English	Article							DEFORMED-WING VIRUS; APIS-MELLIFERA L.; LAKE SINAI VIRUS; BEE COLONIES; REPRODUCTIVE SUCCESS; GENOME SEQUENCE; READ ALIGNMENT; DESTRUCTOR; PATHOGENS; MITES	The parasitic mite, Varroa destructor, in combination with the viruses it vectors, is the main cause for global colony losses of the European honeybee, Apis mellifera. However, an isolated honeybee population established in 1999 on the Island of Gotland, Sweden has naturally acquired resistance to the mite, and has survived without mite control treatment for more than 18 years. A recent study has shown that this mite resistant (MR) population also appears to be resistant to Black queen cell virus (BQCV) and Sacbrood virus (SBV) and tolerant to Deformed wing virus (DWV), relative to nearby mite susceptible (MS) honeybee populations. In this study, RNA sequencing was employed to corroborate these previous findings and identify other viral factors that may play a role in the enhanced survival of this mite resistant honeybee population. Two additional honeybee-infecting viruses, Apis rhabdovirus-1 (ARV-1) and Lake Sinai virus (LSV), were identified and near-complete genomes of these two viruses were obtained. Phylogenetic analyses of the assembled virus sequences revealed consistent separation between the MR and MS honeybee populations, although it is unclear whether this is due to pre-existing differences between the viruses in the two populations when they were established, and isolated, or due to virus genetic adaptation towards reduced virulence in the MR population, to promote colony survival. Reverse transcription quantitative polymerase chain reaction(RT-qPCR) analyses show higher ARV and LSV titres in MS colonies compared to MR colonies, gradually increasing from summer to autumn 2009, and reaching maximum titres in the following spring 2010. While the DWV and BQCV titres in MR colonies increased between autumn 2009 and spring 2010, the SBV practically disappeared entirely by spring 2010. Possible explanations for the apparent virus tolerance or resistance in the Gotland mite-resistant honeybee population are discussed.	[Thaduri, Srinivas; Locke, Barbara; de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Granberg, Fredrik] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Thaduri, S (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	srinivas.thaduri@slu.se	locke, barbara/X-1857-2019; Granberg, Fredrik/AAH-6330-2021	locke, barbara/0000-0001-6083-9981; Granberg, Fredrik/0000-0001-5497-9611; Rodrigues de Miranda, Joachim/0000-0002-0335-0386	Swedish Research Council [231-20 3-1225]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grant dnr 231-20 3-1225 from the Swedish Research Council to JM which included a PhD fellowship to ST and part of the salary for JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2009, EXP GERONTOL, V44, P467, DOI 10.1016/j.exger.2009.02.013; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; ANDERSON DL, 1992, J ECON ENTOMOL, V85, P47, DOI 10.1093/jee/85.1.47; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; BAILEY L, 1972, ANN APPL BIOL, V72, P27, DOI 10.1111/j.1744-7348.1972.tb01268.x; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Cavigli I, 2016, APIDOLOGIE, V47, P251, DOI 10.1007/s13592-015-0395-5; Choe SE, 2012, VIROLOGY, V432, P155, DOI 10.1016/j.virol.2012.06.008; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Daughenbaugh KF, 2015, VIRUSES-BASEL, V7, P3285, DOI 10.3390/v7062772; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2013, JOURNAL OF APICULTUR, V52; DEJONG D, 1982, J APICULT RES, V21, P165, DOI 10.1080/00218839.1982.11100535; DONZE G, 1994, BEHAV ECOL SOCIOBIOL, V34, P305, DOI 10.1007/BF00197001; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Forsgren E, 2017, J VIROL METHODS, V246, P81, DOI 10.1016/j.jviromet.2017.04.010; Fries I, 2003, APIDOLOGIE, V34, P389, DOI 10.1051/apido:2003032; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Hermesh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037334; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Levin S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02482; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Locke B, 2016, APIDOLOGIE, V47, P583, DOI 10.1007/s13592-015-0403-9; Locke B, 2016, APIDOLOGIE, V47, P467, DOI 10.1007/s13592-015-0412-8; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; Locke B, 2012, ECOL EVOL, V2, P1144, DOI 10.1002/ece3.248; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Locke B, 2011, APIDOLOGIE, V42, P533, DOI 10.1007/s13592-011-0029-5; Longdon B, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev014; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257; Mordecai GJ, 2016, ISME J, V10, P1264, DOI 10.1038/ismej.2015.178; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Parmentier L, 2016, J INVERTEBR PATHOL, V134, P6, DOI 10.1016/j.jip.2015.12.003; Ravoet J, 2015, VIRUS RES, V201, P67, DOI 10.1016/j.virusres.2015.02.019; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Remnant EJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00158-17; Roberts JMK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07290-w; Rosenkranz P, 1999, APIDOLOGIE, V30, P159, DOI 10.1051/apido:19990206; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schoonvaere K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168456; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Strauss U, 2013, J INVERTEBR PATHOL, V114, P45, DOI 10.1016/j.jip.2013.05.003; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira EW, 2008, J INVERTEBR PATHOL, V99, P117, DOI 10.1016/j.jip.2008.03.014; Valles SM, 2017, J GEN VIROL, V98, P355, DOI 10.1099/jgv.0.000756; Walker PJ, 2018, J GEN VIROL, V99, P447, DOI 10.1099/jgv.0.001020; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	66	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0206938	10.1371/journal.pone.0206938	http://dx.doi.org/10.1371/journal.pone.0206938			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521535	Green Submitted, gold, Green Published			2022-12-26	WOS:000452307600006
J	Mencarini, L; Vignoli, D; Zeydanli, T; Kim, J				Mencarini, Letizia; Vignoli, Daniele; Zeydanli, Tugba; Kim, Jungho			Life satisfaction favors reproduction. The universal positive effect of life satisfaction on childbearing in contemporary low fertility countries	PLOS ONE			English	Article							HAPPINESS; CHILDREN; CHILDLESSNESS; PARENTHOOD; CHOICE; MATTER; WORK	Do people with higher life satisfaction have more children ? Having children requires considerable energy and investment on the part of parents. However, even in countries where contraceptives are easily available and widely used, where having children is optional and most of time the result of an intended action, parenthood has not gone "out of fashion". This paper tests the hypothesis that higher life satisfaction fosters reproductive behavior. We argue that people satisfied with their overall life feel better prepared to start the monumental task of childrearing. If, it is suggested, life satisfaction facilitates fertility, then this positive link should be observable in contemporary low fertility societies. The hypothesis is tested by taking overall life satisfaction as a determinant of fertility behavior using long longitudinal data available for developed countries: namely for Australia, Germany, Russia, South Korea, Switzerland, the United Kingdom, and the United States. We find that higher levels of subjective well-being are, indeed, associated with a higher probability of having children in all the countries considered. We, therefore, conclude that life satisfaction favors reproduction, at least in low fertility societies.	[Mencarini, Letizia] Bocconi Univ, Dept Management & Technol, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy; [Vignoli, Daniele] Univ Florence, Dept Stat Comp Sci Applicat, Florence, Italy; [Zeydanli, Tugba] Martin Luther Univ Halle Wittenberg, Dept Econ, Halle, Seale, Germany; [Kim, Jungho] Ajou Univ, Dept Econ, Suwon, South Korea; [Kim, Jungho] IZA, Bonn, Germany	Bocconi University; University of Florence; Martin Luther University Halle Wittenberg; Ajou University; IZA Institute Labor Economics	Mencarini, L (corresponding author), Bocconi Univ, Dept Management & Technol, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy.	letizia.mencarini@unibocconi.it	Zeydanli, Tugba/AAF-6169-2020; MENCARINI, LETIZIA/F-8307-2017	MENCARINI, LETIZIA/0000-0001-5070-6069	European Research Council under the FP7 European ERC [StG-313617]; Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2017S1A3A2066494]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069609] Funding Source: NIH RePORTER	European Research Council under the FP7 European ERC(European Research Council (ERC)); Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors gratefully acknowledge financial support from the European Research Council under the FP7 European ERC Grant Agreement n. StG-313617 (SWELL-FER: Subjective Well-being and Fertility, P.I. Letizia Mencarini) and the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2017S1A3A2066494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aassve A, 2015, EUR SOCIOL REV, V31, P749, DOI 10.1093/esr/jcv073; Aassve A, 2012, SOC INDIC RES, V108, P65, DOI 10.1007/s11205-011-9866-x; Ajzen I, 2013, DEMOGR RES, V29, P203; Bachrach CA, 2013, POPUL DEV REV, V39, P459, DOI 10.1111/j.1728-4457.2013.00612.x; Baltagi B. H., 2008, ECONOMETRIC ANAL PAN, DOI DOI 10.1108/IJSHE-06-2013-0065; Becker G.S., 1993, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; Billari F.C., 2009, GENERATIONS GENDER S, P7; Carmichael G.A., 2003, TRANSFORMATION AUSTR; Carmichael GA, 2007, EUR J POPUL, V23, P111, DOI 10.1007/s10680-006-9112-4; Carroll N, 2007, ECON REC, V83, P287, DOI 10.1111/j.1475-4932.2007.00415.x; Cetre S, 2016, EUR J POPUL, V32, P445, DOI 10.1007/s10680-016-9389-x; Clark AE, 2002, WORKING PAPER; Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x; Deaton A, 2014, P NATL ACAD SCI USA, V111, P1328, DOI 10.1073/pnas.1311600111; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Easterlin RA, 2004, DAEDALUS-US, V133, P26, DOI 10.1162/001152604323049361; Evans MDR, 2004, INT J PUBLIC OPIN R, V16, P3, DOI 10.1093/ijpor/16.1.3; Frey BS, 2000, ECON J, V110, P918, DOI 10.1111/1468-0297.00570; FRIEDMAN D, 1994, DEMOGRAPHY, V31, P375, DOI 10.2307/2061749; Hahn J, 2004, ECONOMETRICA, V72, P1295, DOI 10.1111/j.1468-0262.2004.00533.x; Hansen T, 2012, SOC INDIC RES, V108, P29, DOI 10.1007/s11205-011-9865-y; Headey B, 2008, SOC INDIC RES, V86, P213, DOI 10.1007/s11205-007-9138-y; Hobcraft J, 1995, EVOLUTION REVOLUTION, P27; Hobcraft J, 2006, POP STUD-J DEMOG, V60, P153, DOI 10.1080/00324720600646410; Kahneman D., 1999, WELL BEING FDN HEDON; Kohler HP, 2016, EUR J POPUL, V32, P327, DOI 10.1007/s10680-016-9392-2; Kohler HP, 2005, POPUL DEV REV, V31, P407, DOI 10.1111/j.1728-4457.2005.00078.x; Lancaster T, 2000, J ECONOMETRICS, V95, P391, DOI 10.1016/S0304-4076(99)00044-5; Lawson JF, 2014, EVOL HUM BEHAV, V35, P408, DOI 10.1016/j.evolhumbehav.2014.05.006; Le Moglie M, 2015, J ECON BEHAV ORGAN, V117, P453, DOI 10.1016/j.jebo.2015.07.006; Lesthaeghe R., 1986, BEVOLKING GROEI KRIM, P9; Margolis R, 2011, POPUL DEV REV, V37, P29, DOI 10.1111/j.1728-4457.2011.00389.x; Marroquin B, 2015, J SOC CLIN PSYCHOL, V34, P117, DOI 10.1521/jscp.2015.34.2.117; Matysiak A, 2016, EUR J POPUL, V32, P355, DOI 10.1007/s10680-016-9390-4; Mayer KU, 2009, ANNU REV SOCIOL, V35, P413, DOI 10.1146/annurev.soc.34.040507.134619; MCLANAHAN S, 1987, ANNU REV SOCIOL, V13, P237, DOI 10.1146/annurev.so.13.080187.001321; Mencarini L, 2015, ADV LIFE COURSE RES, V23, P14, DOI 10.1016/j.alcr.2014.12.004; Myrskyla M, 2014, DEMOGRAPHY, V51, P1843, DOI 10.1007/s13524-014-0321-x; Parr N, 2010, DEMOGR RES, V22, P635, DOI 10.4054/DemRes.2010.22.21; Perelli-Harris B, 2006, POPUL DEV REV, V32, P729, DOI 10.1111/j.1728-4457.2006.00148.x; Pudrovska T, 2008, J MARRIAGE FAM, V70, P168, DOI 10.1111/j.1741-3737.2007.00469.x; RAMU GN, 1984, CAN J SOCIOL, V9, P47, DOI 10.2307/3340467; Rindfuss RR, 1996, POPUL DEV REV, V22, P258, DOI 10.2307/2808014; Stanca L, 2012, J ECON BEHAV ORGAN, V81, P742, DOI 10.1016/j.jebo.2010.12.019; Tanturri ML, 2008, POPUL DEV REV, V34, P51, DOI 10.1111/j.1728-4457.2008.00205.x; Tov W., 2018, HDB WELL BEING, P30; VANDEKAA DJ, 1987, POPUL BULL, V42, P1; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2; Zemishlany Z, 2008, ADV PSYCHOSOM MED, V29, P89, DOI 10.1159/000126626; Zimmermann AC, 2006, POPUL DEV REV, V32, P511, DOI 10.1111/j.1728-4457.2006.00135.x	51	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206202	10.1371/journal.pone.0206202	http://dx.doi.org/10.1371/journal.pone.0206202			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517115	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400009
J	Qian, SS; Ji, HX; Wu, XX; Li, N; Yang, Y; Bu, JT; Zhang, XM; Qiao, L; Yu, HL; Xu, N; Zhang, C				Qian, Shasha; Ji, Hanxu; Wu, Xiaoxiao; Li, Ning; Yang, Yang; Bu, Jiangtao; Zhang, Xiaoming; Qiao, Ling; Yu, Henglin; Xu, Ning; Zhang, Chi			Detection and quantification analysis of chemical migrants in plastic food contact products	PLOS ONE			English	Article							MIGRATION; 2,4-DI-TERT-BUTYLPHENOL; ADDITIVES; SAMPLES	Plastic food contact materials (FCM)-based products were widely used in everyday life. These products were normally imposed to strict regulations in order to pass the enforcement tests of compliance as a prefix condition. However, even in these "qualified" materials, unknown chemical substances, not involving in legislation lists, could migrate from FCM. In this perspective, the present work aims to thoroughly analyze by means of Gas Chromatography-Mass Spectrometry (GC-MS) the different substances/migrants in 120 qualified FCM plastic products. Unexpectedly, among the identified compounds (nearly 100), only 13% was included in the permitted list of Commission Regulation EU No 10/2011. All the identified compounds were classified into 11 categories according to their chemical structure and the FCM type, whereas toxicology data were in addition analyzed. Each plastic type exhibited different preferences of chemical migrants. Fortunately, most of the compounds identified were of low toxicity, and only 4 chemicals were included in priority lists and previous literature reports as potential risk factors. Subsequently, the accurate amount of these 4 chemicals was determined. The amount of Bis(2-ethylhexyl) adipate (DEHA) and Bis(2-ethylhexyl) phthalate (DEHP) were lower than the SML in Commission Regulation EU No 10/2011, and that of stearamide was under the recommended use quantity. The 2,4-di-tertbutylphenol (2,4-DTBP) was widely exist in the investigated FCM products. Among them, the highest level is obtained in polypropylene/low density polyethylene (BOPP/LDPE) materials, up to 45.568 +/- 31.513 mg/kg. In summary, a panel of unlisted chemical migrants were discovered and identified by GS-MS screening. The results implied that plastic FCMs were not so "inert" as they usually considered, and further safety evaluation should be performed toward the complete identification of new substances in FCM products.	[Qian, Shasha; Ji, Hanxu; Wu, Xiaoxiao; Li, Ning; Yang, Yang; Bu, Jiangtao; Zhang, Xiaoming; Qiao, Ling; Yu, Henglin; Xu, Ning; Zhang, Chi] Nanjing Inst Supervis & Testing Prod Qual, Natl Supervis & Testing Ctr Food & Food Addict, Jiangsu Ctr Supervis & Testing Green Degradable M, Nanjing, Jiangsu, Peoples R China; [Wu, Xiaoxiao] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Zhang, C (corresponding author), Nanjing Inst Supervis & Testing Prod Qual, Natl Supervis & Testing Ctr Food & Food Addict, Jiangsu Ctr Supervis & Testing Green Degradable M, Nanjing, Jiangsu, Peoples R China.	wuwu3660@sina.com			National Key R&D Program of China [2018YFF0215200, 2017YFF0211201]; Science & Technology Project of Jiangsu Quality and Technical Supervision Bureau [KJ168383, KJ168373]; Science & Technology Project of China General Administration of Quality Supervision, Inspection and Quarantine [2015QK055]	National Key R&D Program of China; Science & Technology Project of Jiangsu Quality and Technical Supervision Bureau; Science & Technology Project of China General Administration of Quality Supervision, Inspection and Quarantine	This work was supported by the financial support from National Key R&D Program of China (2018YFF0215200 to C.Z. & 2017YFF0211201 to M.Y.), Science & Technology Project of Jiangsu Quality and Technical Supervision Bureau (KJ168383 to J.Z. & KJ168373 to C.Z.), Science & Technology Project of China General Administration of Quality Supervision, Inspection and Quarantine (2015QK055 to X.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, 50091562016 GB; [Anonymous], 2016, GB96852016; Baldev R, 2001, J PHARM SCI, V94, P2432; Barnes KA, 2007, CHEMICAL MIGRATION AND FOOD CONTACT MATERIALS, P1, DOI 10.1201/9781439824474; Begley TH, 2008, FOOD ADDIT CONTAM, V25, P384, DOI 10.1080/02652030701513784; Bolgar M, 2015, HDB CHEM ANAL PLASTI, V22, P95; Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011; Cao XL, 2015, FOOD ADDIT CONTAM A, V32, P1893, DOI 10.1080/19440049.2015.1079742; Choi SJ, 2013, J MED FOOD, V16, P977, DOI 10.1089/jmf.2012.2739; de Azeredo HMC, 2009, FOOD RES INT, V42, P1240, DOI 10.1016/j.foodres.2009.03.019; ECHA, 2017, CAND LIST SUBST VER; Erik Hansen C-D, 2013, HAZARDOUS SUBSTANCES; Farajzadeh MA, 2006, MICROCHIM ACTA, V153, P73, DOI 10.1007/s00604-005-0429-1; Gallart-Ayala H, 2013, TRAC-TREND ANAL CHEM, V42, P99, DOI 10.1016/j.trac.2012.09.017; Genualdi S, 2014, FOOD ADDIT CONTAM A, V31, P723, DOI 10.1080/19440049.2013.878040; GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140; Guart A, 2011, FOOD ADDIT CONTAM A, V28, P676, DOI 10.1080/19440049.2011.555845; HEICKLEN J, 1984, DRUG CHEM TOXICOL, V7, P315, DOI 10.3109/01480548408998260; Inoue K, 2001, FOOD ADDIT CONTAM, V18, P157, DOI 10.1080/02652030010018930; Lagaron JM, 2005, FOOD ADDIT CONTAM A, V22, P994, DOI 10.1080/02652030500239656; Lau OW, 2000, J CHROMATOGR A, V882, P255, DOI 10.1016/S0021-9673(00)00356-3; Marsh K, 2007, J FOOD SCI, V72, pR39, DOI 10.1111/j.1750-3841.2007.00301.x; Mertl J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100952; Muncke J, 2014, ENCY FOOD SAFETY, V430-7; National Health Commission of the P.R.C., 2016, 480672016 GB NAT HLT; Paris B, 2010, PROCESS DEV IND ORGA; Petersen J. H., 2016, International Journal of Food Contamination, V3, DOI 10.1186/s40550-016-0026-6; PRC. The expert committee in food contact materials in national food industry association, 2017, GUID SUPPL CHAIN RES, V27; Raj B, 2012, SAFETY REGULATORY AS; Rani M, 2015, ARCH ENVIRON CON TOX, V69, P352, DOI 10.1007/s00244-015-0224-x; Robertson GL, 2012, FOOD PACKAGING PRINC; Samide MJ, 2015, J CHROMATOGR A, V1426, P201, DOI 10.1016/j.chroma.2015.11.066; Simoneau C, 2015, ASTROPHYS J, V708, P796; Simoneau C, 2014, FOOD CONTACT MAT; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046110; Sun Y, 2016, CHIN J HLTH LAB TECH; Vilarinho F, 2012, LAB VALIDATION METHO; Wang ZQ, 2016, PEST MANAG SCI, V72, P897, DOI 10.1002/ps.4064; Yoon MA, 2006, BIOL PHARM BULL, V29, P735, DOI 10.1248/bpb.29.735; Zhang J, 2012, PLASTICS SCI TECH	40	21	23	8	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208467	10.1371/journal.pone.0208467	http://dx.doi.org/10.1371/journal.pone.0208467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517180	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400098
J	Zhang, JB; Schmidt, CJ; Lamont, SJ				Zhang, Jibin; Schmidt, Carl J.; Lamont, Susan J.			Distinct genes and pathways associated with transcriptome differences in early cardiac development between fast- and slow-growing broilers	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FED TYPICAL 1957; CARCASS COMPOSITION; OXIDATIVE STRESS; APOLIPOPROTEIN-B; ASCITES SYNDROME; BINDING PROTEIN; HEART-FAILURE; CHICKENS; GROWTH	Modern fast-growing broilers are susceptible to cardiac dysfunctions because their relatively small hearts cannot adequately meet the increased need of pumping blood through a large body mass. To improve cardiac health in broilers through breeding, we need to identify the genes and pathways that contribute to imbalanced cardiac development and occurrence of heart dysfunction. Two broiler lines-Ross 708 and Illinois-were included in this study as models of modern fast-growing and heritage slow-growing broilers, respectively. The left ventricular transcriptome were compared between the two broiler lines at day 6 and 21 post hatch through RNA-seq analysis to identify genes and pathways regulating compromised cardiac development in modern broilers. Number of differentially expressed genes (DEGs, p<0.05) between the two broiler lines increased from 321 at day 6 to 819 at day 21. As the birds grew, Ross broilers showed more DEGs (n = 1879) than Illinois broilers (n = 1117). Both broilers showed significant change of muscle related genes and immune genes, but Ross broilers showed remarkable change of expression of several lipid transporter genes including APOA4, APOB, APOH, FABP4 and RBP7. Ingenuity pathway analysis (IPA) suggested that increased cell apoptosis and inhibited cell cycle due to increased lipid accumulation, oxidative stress and endoplasmic reticulum stress may be related to the increased cardiac dysfunctions in fast-growing broilers. Cell cycle regulatory pathways like "Mitotic Roles of Polo-like Kinases" are ranked as the top changed pathways related to the cell apoptosis. These findings provide further insight into the cardiac dysfunction in modern broilers and also potential targets for improvement of their cardiac health through breeding.	[Zhang, Jibin; Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA; [Zhang, Jibin] Beckman Res Inst City Hope, Dept Cell & Mol Biol, Duarte, CA USA	Iowa State University; University of Delaware; City of Hope; Beckman Research Institute of City of Hope	Lamont, SJ (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	sjlamont@iastste.edu	Zhang, Jibin/D-7124-2016	Zhang, Jibin/0000-0003-3099-6665; Schmidt, Carl/0000-0002-8386-4781	Agriculture and Food Resource Initiative Foundational Program in the United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project [5358]; Agriculture and Food Research Initiative Competitive [2011-67003-30228]	Agriculture and Food Resource Initiative Foundational Program in the United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project; Agriculture and Food Research Initiative Competitive	This study was supported by Agriculture and Food Resource Initiative Foundational Program in the United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project number 5358 to SJL and by the Agriculture and Food Research Initiative Competitive Grant 2011-67003-30228 to CJS (https://nifa.usda.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124768; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antic V, 1999, AM J HYPERTENS, V12, P826, DOI 10.1016/S0895-7061(98)00231-3; Baghbanzadeh A, 2008, AVIAN PATHOL, V37, P117, DOI 10.1080/03079450801902062; Bi XK, 2018, CIRC RES, V122, P1545, DOI 10.1161/CIRCRESAHA.117.312641; BOTTJE W, 1995, POULTRY SCI, V74, P1356, DOI 10.3382/ps.0741356; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Carroll JF, 1996, AM J PHYSIOL-HEART C, V271, pH373, DOI 10.1152/ajpheart.1996.271.1.H373; Carroll JF, 1997, HYPERTENSION, V30, P1376, DOI 10.1161/01.HYP.30.6.1376; Carroll JF, 1999, HYPERTENSION, V33, P811, DOI 10.1161/01.HYP.33.3.811; CARROLL JF, 1995, HYPERTENSION, V26, P465, DOI 10.1161/01.HYP.26.3.465; Cheema MA, 2003, POULTRY SCI, V82, P1519, DOI 10.1093/ps/82.10.1519; Christiansen LB, 2015, AM J PHYSIOL-HEART C, V308, pH1237, DOI 10.1152/ajpheart.00727.2014; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Decuypere E, 2000, WORLD POULTRY SCI J, V56, P367, DOI 10.1079/WPS20000025; Deist MS, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00027-17, 10.1128/cvi.00027-17]; Drews O, 2014, ANTIOXID REDOX SIGN, V21, P2322, DOI 10.1089/ars.2013.5823; Fairweather D, 2005, J IMMUNOL, V174, P261, DOI 10.4049/jimmunol.174.1.261; HAVENSTEIN GB, 1994, POULTRY SCI, V73, P1785, DOI 10.3382/ps.0731785; HAVENSTEIN GB, 1994, POULTRY SCI, V73, P1795, DOI 10.3382/ps.0731795; Havenstein GB, 2003, POULTRY SCI, V82, P1509, DOI 10.1093/ps/82.10.1509; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Iso T, 2013, ARTERIOSCL THROM VAS, V33, P2549, DOI 10.1161/ATVBAHA.113.301588; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; Lin HH, 2014, HEART RHYTHM, V11, P266, DOI 10.1016/j.hrthm.2013.10.051; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; Mao CH, 2006, J BIOL CHEM, V281, P8877, DOI 10.1074/jbc.M505784200; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Olkowski AA, 2008, RES VET SCI, V85, P131, DOI 10.1016/j.rvsc.2007.08.006; Olkowski AA, 2007, POULTRY SCI, V86, P999, DOI 10.1093/ps/86.5.999; Olkowski AA, 1998, J VET MED A, V45, P83, DOI 10.1111/j.1439-0442.1998.tb00804.x; Olkowski AA, 2001, J VET MED A, V48, P1, DOI 10.1046/j.1439-0442.2001.00329.x; Plaisance V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163046; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Robinson MD, 2010, GENOME BIOL, V11, P3; Rodriguez-Calvo R, 2017, J ENDOCRINOL, V233, pR173, DOI 10.1530/JOE-17-0031; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schmidt CJ, 2009, POULTRY SCI, V88, P2610, DOI 10.3382/ps.2009-00055; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Tallentire CW, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0398-2; Tickle PG, 2014, PEERJ, V2, DOI 10.7717/peerj.432; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; Yokoyama M, 2004, J BIOL CHEM, V279, P4204, DOI 10.1074/jbc.M311995200; Zhang J, 2016, PLOS ONE, V11; Zhang JB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19754-8; Zhang JB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3675-9; Zhong XP, 2011, IMMUNOL RES, V49, P109, DOI 10.1007/s12026-010-8175-9; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	51	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207715	10.1371/journal.pone.0207715	http://dx.doi.org/10.1371/journal.pone.0207715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517173	Green Published, gold			2022-12-26	WOS:000452212400062
J	Gomes, AM; Carron, EC; Mills, KL; Dow, AM; Gray, Z; Fecca, CR; Lakey, MA; Carmeliet, P; Kittrell, F; Medina, D; Machado, HL				Gomes, Angelica M.; Carron, Emily C.; Mills, Kylie L.; Dow, Alexa M.; Gray, Zane; Fecca, Christopher R.; Lakey, Meredith A.; Carmeliet, Peter; Kittrell, Frances; Medina, Daniel; Machado, Heather L.			Stromal Gas6 promotes the progression of premalignant mammary cells	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; TO-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASE; AXL KINASE; CANCER; GROWTH; ACTIVATION; EXPRESSION; SURVIVAL; MODEL	Tumor progression is regulated by a complex interplay between neoplastic cells and the tumor microenvironment. Tumor-associated macrophages have been shown to promote breast cancer progression in advanced disease and more recently, in early stage cancers. However, little is known about the macrophage-derived factors that promote tumor progression in early stage lesions. Using a p53-null model of early stage mammary tumor progression, we found that Gas6 is highly expressed in pre-invasive lesions associated with increased infiltrating macrophages, as compared with those with few recruited macrophages. We show that F4/80(+)CD11b(+ )macrophages produce Gas6 in premalignant lesions in vivo, and that macrophage-derived Gas6 induces a tumor-like phenotype ex vivo. Using a 3-D co-culture system, we show that macrophage-derived Gas6 activates its receptor Axl and downstream survival signals including Akt and STAT3, which was accompanied by altered E-cadherin expression to induce a malignant morphology. In vivo studies demonstrated that deletion of stromal Gas6 delays early stage progression and decreases tumor formation, while tumor growth in established tumors remains unaffected. These studies suggest that macrophage-derived Gas6 is a critical regulator of the transition from premalignant to invasive cancer, and may lead to the development of unique biomarkers of neoplastic progression for patients with early stage breast cancer, including ductal carcinoma in situ.	[Gomes, Angelica M.; Mills, Kylie L.; Dow, Alexa M.; Gray, Zane; Fecca, Christopher R.; Machado, Heather L.] Tulane Sch Med, Tulane Canc Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Carron, Emily C.] La Jolla Inst Allergy & Immunol, Div Cellular Biol, La Jolla, CA USA; [Lakey, Meredith A.] Ochsner Clin Fdn, Ochsner Biorepository, Dept Res, New Orleans, LA USA; [Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Vasc Metab, Ctr Canc Biol, B-3000 Leuven, Belgium; [Carmeliet, Peter] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongsan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China; [Carmeliet, Peter] Katholieke Univ Leuven, Lab Angiogenesis & Vasc Metab, Dept Oncol, B-3000 Leuven, Belgium; [Carmeliet, Peter] Katholieke Univ Leuven, Leuven Canc Inst LKI, B-3000 Leuven, Belgium; [Kittrell, Frances; Medina, Daniel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Tulane University; La Jolla Institute for Immunology; Ochsner Health System; Flanders Institute for Biotechnology (VIB); Sun Yat Sen University; KU Leuven; KU Leuven; Baylor College of Medicine	Machado, HL (corresponding author), Tulane Sch Med, Tulane Canc Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	hmachado@tulane.edu	Carmeliet, Peter/AAQ-5140-2020	Carmeliet, Peter/0000-0001-7961-1821	Susan G. Komen [CCR16377665]; NIH [R01 CA212518]; Tulane Cancer Center through the Cancer Crusaders of New Orleans; NATIONAL CANCER INSTITUTE [R01CA212518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114732] Funding Source: NIH RePORTER	Susan G. Komen(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane Cancer Center through the Cancer Crusaders of New Orleans; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Susan G. Komen CCR16377665 (HLM), NIH R01 CA212518 (HLM), and the Tulane Cancer Center through the Cancer Crusaders of New Orleans. We would like to thank Dr. Dorota Wyczechowska from the LCRC Cell Immunology and Metabolism Core (NIH/NIGMS 1P30GM114732-01) for assistance with FACS and Dr. Leann Myers for help with statistical analysis. We would like to acknowledge Alexandra Giardina at the LCRC Biospecimen Core and Dr. Lyndsey Buckner Baiamonte, Jeannine Ascani, and Dr. Michelle Ponder at the Oschner Biorepository Unit for human DCIS tissues.	Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Behbod F, 2018, J MAMMARY GLAND BIOL, V23, P269, DOI 10.1007/s10911-018-9408-0; Ben-Batalla I, 2013, BLOOD, V122, P2443, DOI 10.1182/blood-2013-03-491431; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bohrer LR, 2014, CANCER RES, V74, P374, DOI 10.1158/0008-5472.CAN-13-2469; Bohrer LR, 2012, MOL CANCER RES, V10, P1294, DOI 10.1158/1541-7786.MCR-12-0275; Bottai G, 2016, NPJ BREAST CANCER, V2, P1, DOI 10.1038/npjbcancer.2016.33; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Buehler M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/238284; Carron EC, 2017, ONCOTARGET, V8, P50731, DOI 10.18632/oncotarget.14913; Geng K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01521; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goruppi S, 1996, ONCOGENE, V12, P471; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Goyette MA, 2018, CELL REP, V23, P1476, DOI 10.1016/j.celrep.2018.04.019; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jerry DJ, 1998, ONCOGENE, V17, P2305, DOI 10.1038/sj.onc.1202157; Kariolis MS, 2017, J CLIN INVEST, V127, P183, DOI 10.1172/JCI85610; Kirane A, 2015, CANCER RES, V75, P3699, DOI 10.1158/0008-5472.CAN-14-2887-T; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Lin Elaine Y, 2004, Novartis Found Symp, V256, P158; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Loges S, 2010, BLOOD, V115, P2264, DOI 10.1182/blood-2009-06-228684; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Mc Cormack O, 2008, BRIT J CANCER, V98, P1141, DOI 10.1038/sj.bjc.6604260; Medina D, 2005, CANCER RES, V65, P3493, DOI 10.1158/0008.5472.CAN-04-3869; Medina D, 2002, FASEB J, V16, P881, DOI 10.1096/fj.01-0885fje; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Paccez JD, 2013, ONCOGENE, V32, P689, DOI 10.1038/onc.2012.89; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Tjwa M, 2008, BLOOD, V111, P4096, DOI 10.1182/blood-2007-05-089565; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; Vouri M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.66; Wang W, 2015, MOL MED REP, V11, P2397, DOI 10.3892/mmr.2014.3018; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wu GL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.113; Wu XL, 2017, J CANCER RES CLIN, V143, P1947, DOI 10.1007/s00432-017-2408-4; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200; Zhang X., 2008, CURR PROTOC IMMUNOL; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zucca LE, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2017.09.003	55	21	23	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2437	2450		10.1038/s41388-018-0593-5	http://dx.doi.org/10.1038/s41388-018-0593-5			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30531835	Green Accepted			2022-12-26	WOS:000463335200001
J	Yi, XN; Verbeke, EJ; Chang, YR; Dickinson, DJ; Taylor, DW				Yi, Xiunan; Verbeke, Eric J.; Chang, Yiran; Dickinson, Daniel J.; Taylor, David W.			Electron microscopy snapshots of single particles from single cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cryo-electron microscopy; ribosome; proteasome; single-particle analysis; Caenorhabditis elegans (C. elegans)	CRYOELECTRON MICROSCOPY	Cryo-electron microscopy (cryo-EM) has become an indispensable tool for structural studies of biological macromolecules. Two additional predominant methods are available for studying the architectures of multiprotein complexes: 1) single-particle analysis of purified samples and 2) tomography of whole cells or cell sections. The former can produce high-resolution structures but is limited to highly purified samples, whereas the latter can capture proteins in their native state but has a low signal-to-noise ratio and yields lower-resolution structures. Here, we present a simple, adaptable method combining microfluidic single-cell extraction with single-particle analysis by EM to characterize protein complexes from individual Caenorhabditis elegans embryos. Using this approach, we uncover 3D structures of ribosomes directly from single embryo extracts. Moreover, we investigated structural dynamics during development by counting the number of ribosomes per polysome in early and late embryos. This approach has significant potential applications for counting protein complexes and studying protein architectures from single cells in developmental, evolutionary, and disease contexts.	[Yi, Xiunan; Verbeke, Eric J.; Chang, Yiran; Dickinson, Daniel J.; Taylor, David W.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Yi, Xiunan; Verbeke, Eric J.; Chang, Yiran; Dickinson, Daniel J.; Taylor, David W.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Yi, Xiunan; Verbeke, Eric J.; Chang, Yiran; Dickinson, Daniel J.; Taylor, David W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Taylor, David W.] Dell Med Sch, LIVESTRONG Canc Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Dickinson, DJ; Taylor, DW (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	daniel.dickinson@austin.utexas.edu; dtaylor@utexas.edu		Chang, Yiran/0000-0001-8306-4402; Taylor, David/0000-0002-6198-1194	Welch Foundation [F-1938]; NIH [R00 GM115964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM115964] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Welch Foundation Grant F-1938 (to D. W. T.) and NIH R00 GM115964 (D. J. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonina ZA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P445, DOI 10.1134/S0006297913050027; Arnold SA, 2017, J STRUCT BIOL, V197, P220, DOI 10.1016/j.jsb.2016.11.002; Beck M, 2016, TRENDS CELL BIOL, V26, P825, DOI 10.1016/j.tcb.2016.08.006; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Cianfrocco MA, 2015, ELIFE, V4, DOI 10.7554/eLife.06664; Dickinson AJ, 2013, ANAL CHEM, V85, P4797, DOI 10.1021/ac4005887; Dickinson DJ, 2017, DEV CELL, V42, P416, DOI 10.1016/j.devcel.2017.07.024; EDGAR LG, 1994, DEVELOPMENT, V120, P443; Galaz-Montoya Jesus G, 2017, Biophys Rep, V3, P17, DOI 10.1007/s41048-017-0040-0; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; Kastritis PL, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167412; Kemmerling S, 2013, J STRUCT BIOL, V183, P467, DOI 10.1016/j.jsb.2013.06.012; Kovarik ML, 2011, TRENDS BIOTECHNOL, V29, P222, DOI 10.1016/j.tibtech.2011.01.003; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Kumar P, 2017, DEVELOPMENT, V144, P17, DOI 10.1242/dev.133058; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Malyutin AG, 2017, EMBO J, V36, P854, DOI 10.15252/embj.201696012; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Scaiola A, 2018, EMBO J, V37, DOI 10.15252/embj.201798499; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schorb M, 2014, ULTRAMICROSCOPY, V143, P24, DOI 10.1016/j.ultramic.2013.10.015; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shaw D, 2008, J MOL BIOL, V383, P885, DOI 10.1016/j.jmb.2008.08.086; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Slavov N, 2015, CELL REP, V13, P865, DOI 10.1016/j.celrep.2015.09.056; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Verbeke EJ, 2018, CELL REP, V24, P259, DOI 10.1016/j.celrep.2018.06.022; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Zhan Xuanzhi, 2015, Curr Protoc Pharmacol, V68, DOI 10.1002/0471141755.ph0212s68	33	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1602	1608		10.1074/jbc.RA118.006686	http://dx.doi.org/10.1074/jbc.RA118.006686			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30541924	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000457879200015
J	Kumar, A; Batra, R; Gahlaut, V; Gautam, T; Kumar, S; Sharma, M; Tyagi, S; Singh, KP; Balyan, HS; Pandey, R; Gupta, PK				Kumar, Anuj; Batra, Ritu; Gahlaut, Vijay; Gautam, Tinku; Kumar, Sanjay; Sharma, Mansi; Tyagi, Sandhya; Singh, Krishna Pal; Balyan, Harindra Singh; Pandey, Renu; Gupta, Pushpendra Kumar			Genome-wide identification and characterization of gene family for RWP-RK transcription factors in wheat (Triticum aestivum L.)	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; PROTEIN; NITROGEN; MARKERS; MIRNAS; RICE; ASSOCIATION; MICRORNAS; EVOLUTION; PROMOTER	RWP-RKs represent a small family of transcription factors (TFs) that are unique to plants and function particularly under conditions of nitrogen starvation. These RWP-RKs have been classified in two sub-families, NLPs (NIN-like proteins) and RKDs (RWP-RK domain proteins). NLPs regulate tissue-specific expression of genes involved in nitrogen use efficiency (NUE) and RKDs regulate expression of genes involved in gametogenesis/embryogenesis. During the present study, using in silico approach, 37 wheat RWP-RKgenes were identified, which included 18 TaNLPs (2865 to 7340 bp with 4/5 exons), distributed on 15 chromosomes from 5 homoeologous groups (with two genes each on 4B,4D and 5A) and 19 TaRKDs (1064 to 5768 bp with 1 to 6 exons) distributed on 12 chromosomes from 4 homoeologous groups (except groups 1,4 and 5); 2-3 splice variants were also available in 9 of the 37 genes. Sixteen (16) of these genes also carried 24 SSRs (simple sequence repeats), while 11 genes had targets for 13 different miRNAs. At the protein level, MD simulation analysis suggested their interaction with nitrate-ions. Significant differences were observed in the expression of only two (TaNLP1 and TaNLP2) of the nine representative genes that were used for in silico expression analysis under varying levels of N at postanthesis stage (data for other genes was not available for in silico expression analysis). Differences in expression were also observed during qRT-PCR, when expression of four representative genes (TaNLP2, TaNLP7, TaRKD6 and TaRKD9) was examined in roots and shoots of seedlings (under different conditions of N supply) in two contrasting genotypes which differed in NUE (C306 with low NUE and HUW468 with high NUE). These four genes for qRT-PCR were selected on the basis of previous literature, level of homology and the level of expression (in silico study). In particular, the TaNLP7 gene showed significant up regulation in the roots and shoots of HUW468 (with higher NUE) during N-starvation; this gene has already been characterized in Arabidopsis and tobacco, and is known to be involved in nitrate-signal transduction pathway.	[Kumar, Anuj; Singh, Krishna Pal] UCB, Adv Ctr Computat & Appl Biotechnol, Dehra Dun, India; [Batra, Ritu; Gautam, Tinku; Balyan, Harindra Singh; Gupta, Pushpendra Kumar] CCS Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Gahlaut, Vijay] Univ Delhi, Dept Plant Mol Biol, South Campus, Delhi, India; [Kumar, Sanjay] Bioinformat Ctr, Biotech Pk, Lucknow, Uttar Pradesh, India; [Sharma, Mansi] ICMR Natl Inst Canc Prevent & Res, Noida, India; [Tyagi, Sandhya; Pandey, Renu] ICAR Indian Agr Res Inst, Div Plant Physiol, New Delhi, India; [Singh, Krishna Pal] Ch Charan Singh Haryana Agr Univ, Hisar, Haryana, India	Chaudhary Charan Singh University; University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; CCS Haryana Agricultural University	Gupta, PK (corresponding author), CCS Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India.	pkgopta36@gmail.com	Pandey, Renu/AES-7797-2022; Gahlaut, Vijay/K-4904-2012; Balyan, H./AAI-9077-2020; Kumar, Anuj/J-7067-2019; Kumar, Anuj/AAE-8773-2021	Pandey, Renu/0000-0002-9244-8579; Gahlaut, Vijay/0000-0003-4381-3573; Kumar, Anuj/0000-0002-5023-7618; Gautam, Tinku/0000-0001-6374-9148; Sharma, Mansi/0000-0002-4026-5498; Kumar, Sanjay/0000-0002-5950-3716; TYAGI, SANDHYA/0000-0002-8168-017X				Balyan HS, 2015, PLANT BREED REV, V40, P67; Batra R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00019; Bennetzen JL, 2008, RICE, V1, P109, DOI 10.1007/s12284-008-9015-6; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Chardin C, 2014, J EXP BOT, V65, P5577, DOI 10.1093/jxb/eru261; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Dawar C, 2013, J MOL MODEL, V19, P3351, DOI 10.1007/s00894-013-1851-7; DEVOS KM, 1995, THEOR APPL GENET, V91, P282, DOI 10.1007/BF00220890; Dhaliwal AK, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00657; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; Feuillet C, 1999, P NATL ACAD SCI USA, V96, P8265, DOI 10.1073/pnas.96.14.8265; Gajula M., 2016, BIO-PROTOCOL, V6, pe2051, DOI [https://doi.org/10.21769/BioProtoc.2051, DOI 10.21769/BIOPROTOC.2051]; Gajula MNVP, 2015, P INT C BIOINF COMP, V7, P211; Ge M, 2017, J PLANT GROWTH REGUL, V84, P95; Gojon A, 2017, J EXP BOT, V68, P2457, DOI 10.1093/jxb/erx171; Guleria Praveen, 2011, Genomics Proteomics & Bioinformatics, V9, P211, DOI 10.1016/S1672-0229(11)60024-7; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Gupta SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042578; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Han YS, 2009, SCI CHINA SER C, V52, P1091, DOI 10.1007/s11427-009-0144-y; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Jeong S, 2011, CURR BIOL, V21, P1268, DOI 10.1016/j.cub.2011.06.049; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Joo J, 2013, MOL CELLS, V35, P421, DOI 10.1007/s10059-013-0036-7; Koi S, 2016, CURR BIOL, V26, P1775, DOI 10.1016/j.cub.2016.05.013; Konishi M, 2014, J EXP BOT, V65, P5589, DOI 10.1093/jxb/eru267; Konishi M, 2013, SOIL SCI PLANT NUTR, V59, P612, DOI 10.1080/00380768.2013.809602; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Koszegi D, 2011, PLANT J, V67, P280, DOI 10.1111/j.1365-313X.2011.04592.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Kumar A., 2013, WORLD RES J PEPT PRO, V2, P52; Kumar Anuj, 2018, Proceedings of the Indian National Science Academy Part B Biological Sciences, V88, P1539, DOI 10.1007/s40011-017-0898-0; Kumar A, 2018, INT J BIOL MACROMOL, V118, P76, DOI 10.1016/j.ijbiomac.2018.06.009; Kumar A, 2016, COMPUT BIOL CHEM, V64, P217, DOI 10.1016/j.compbiolchem.2016.07.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li WL, 2002, GENETICS, V160, P1153; Li XS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00262; Lin H, 2007, GENETICS, V176, P913, DOI 10.1534/genetics.106.066167; Liu WX, 2015, MOLECULES, V20, P8759, DOI 10.3390/molecules20058759; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Ma JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064047; Marchive C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2650; Morishima A, 1998, PLANT MOL BIOL, V38, P633, DOI 10.1023/A:1006085812507; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; Nei M, 2000, MOL EVOLUTION PHYLOG, V25, P569; Pandey R, 2018, PLANT CELL REP, V37, P1231, DOI 10.1007/s00299-018-2307-4; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shang XD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020432; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tedeschi F, 2017, NEW PHYTOL, V213, P1909, DOI 10.1111/nph.14293; Tworak A, 2016, PLANT CELL REP, V35, P1043, DOI 10.1007/s00299-016-1936-8; Waki T, 2011, CURR BIOL, V21, P1277, DOI 10.1016/j.cub.2011.07.001; Wan Ping, 2011, Genomics Proteomics & Bioinformatics, V9, P37, DOI 10.1016/S1672-0229(11)60006-5; Wang M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2993-7; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yu LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27795; Zinati Z, 2016, MOL BIOL RES COMMUN, V5, P233	70	26	31	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208409	10.1371/journal.pone.0208409	http://dx.doi.org/10.1371/journal.pone.0208409			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540790	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600071
J	Nagasaka, R; Swist, E; Sarafin, K; Gagnon, C; Rondeau, I; Massarelli, I; Cheung, W; Laffey, P; Brooks, SPJ; Ratnayake, WMN				Nagasaka, Reiko; Swist, Eleonora; Sarafin, Kurtis; Gagnon, Claude; Rondeau, Isabelle; Massarelli, Isabelle; Cheung, Winnie; Laffey, Patrick; Brooks, Stephen P. J.; Ratnayake, W. M. Nimal			Low 25-hydroxyvitamin D levels are more prevalent in Canadians of South Asian than European ancestry inhabiting the National Capital Region of Canada	PLOS ONE			English	Article							VITAMIN-D STATUS; D-BINDING PROTEIN; BONE-MINERAL DENSITY; J-SHAPED ASSOCIATION; ALL-CAUSE MORTALITY; SKIN COLOR; GENETIC-VARIANTS; DIETARY; AFFINITY; ADULTS	The US Institute of Medicine defined serum 25-hydroxyvitamin D (25OHD) cut point values of 30 nmol/L and 40 nmol/L were used to assess the vitamin D status of South Asian and European Canadians of self-identified ancestry living in the National Capital Region of Canada. Serum 25OHD values were measured in the spring and fall of 2012 to represent status during the winter and summer months, respectively. A total of 1238 measurements were obtained from 669 participants (49% South Asian ancestry): some participants were measured only once (spring or fall). Median 250HD values were significantly higher in participants of European ancestry: 70.8 nmol/L (68.1, 73.5; 95% CI) versus South Asian ancestry: 42.7 nmol/L (40.5, 45.0; P<0.001). Spring vs. fall differences were small for each ethnic group and significant only for those of European ancestry (2.9, CI: 1.0-4.9 nmol/L; P = 0.01). Among participants of South Asian ancestry, 27.3% (fall) and 29.1% (spring) of females had values <40 nmol/L while the percentages for males were considerably higher (36.5% and 44.2%, respectively). The corresponding values for participants of European ancestry were <= 10%, showing that the South Asian participants were less likely to achieve the 25OHD concentrations established by the IOM for optimum bone health. Investigation of the factors related to serum 25OHD levels showed that supplement intake and ethnic background were associated with the biggest differences. Skin color was not a major factor, suggesting that genetic factors are responsible for the observed differences between participants of different ethnic backgrounds.	[Nagasaka, Reiko; Swist, Eleonora; Sarafin, Kurtis; Gagnon, Claude; Cheung, Winnie; Brooks, Stephen P. J.; Ratnayake, W. M. Nimal] Hlth Canada, Hlth Prod & Food Branch, Bur Nutr Sci, Ottawa, ON, Canada; [Rondeau, Isabelle; Massarelli, Isabelle; Laffey, Patrick] Hlth Canada, Hlth Prod & Food Branch, Bur Food Surveillance & Sci Integrat, Ottawa, ON, Canada; [Nagasaka, Reiko] Grad Sch Marine Sci & Technol, Dept Food Sci & Technol, Food Chem & Funct Nutr, Minato, Tokyo, Japan	Health Canada; Health Canada	Brooks, SPJ (corresponding author), Hlth Canada, Hlth Prod & Food Branch, Bur Nutr Sci, Ottawa, ON, Canada.	Steve.Brooks@canada.ca		Brooks, Stephen/0000-0002-1169-6221	Health Canada	Health Canada	This study was funded by Health Canada A Base funding. Health Canada employed all authors at the time of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Akeson PK, 2016, J PEDIATR GASTR NUTR, V62, P643, DOI 10.1097/MPG.0000000000001028; [Anonymous], 2010, INTERNET; ARNAUD J, 1993, HUM GENET, V92, P183; Berry D, 2011, CURR OPIN NEPHROL HY, V20, P331, DOI 10.1097/MNH.0b013e328346d6ba; BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8; BOUILLON R, 1977, J CLIN ENDOCR METAB, V45, P225, DOI 10.1210/jcem-45-2-225; BOUILLON R, 2018, CHAPTER 7 THE VITAMI, V7, P97; BOUTIN B, 1989, J STEROID BIOCHEM, V32, P59, DOI 10.1016/0022-4731(89)90014-9; [Canada Statistics Statistics Canada], 2013, IMMIGRATION AND ETHN; Carter GD, 2014, CLIN CHEM, V60, P809, DOI 10.1373/clinchem.2013.219386; Cashman KD, 2012, AM J CLIN NUTR, V95, P1350, DOI 10.3945/ajcn.111.031427; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Day Brent, 2007, Health Rep, V18 Suppl, P37; Del Bino S, 2013, BRIT J DERMATOL, V169, P33, DOI 10.1111/bjd.12529; Deng HW, 2002, J BONE MINER METAB, V20, P358, DOI 10.1007/s007740200052; Durazo-Arvizu RA, 2017, AM J EPIDEMIOL, V185, P720, DOI 10.1093/aje/kww244; Edvardsen K, 2009, INT J BIOMETEOROL, V53, P451, DOI 10.1007/s00484-009-0231-6; Farrar MD, 2011, AM J CLIN NUTR, V94, P1219, DOI 10.3945/ajcn.111.019976; Gaksch M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170791; Garriguet Didier, 2007, Health Rep, V18, P17; Gozdzik A, 2010, J NUTR, V140, P2213, DOI 10.3945/jn.110.126284; Heaney RP, 2013, J NUTR, V143, P571, DOI 10.3945/jn.112.168641; Henderson CM, 2016, CLIN CHEM, V62, P179, DOI 10.1373/clinchem.2015.244541; Hoofnagle AN, 2015, NEW ENGL J MED, V373, P1480, DOI 10.1056/NEJMc1502602; Katamay SW, 2007, NUTR REV, V65, P155, DOI 10.1301/nr.2007.apr.155-166; KAWAKAMI M, 1979, BIOCHEM J, V179, P413, DOI 10.1042/bj1790413; Khandewal S, 2012, BONE, V51, P1025, DOI 10.1016/j.bone.2012.08.118; Lucas M, 2009, PUBLIC HEALTH NUTR, V12, P1783, DOI 10.1017/S1368980008004333; MACLAUGHLIN JA, 1982, SCIENCE, V216, P1001, DOI 10.1126/science.6281884; Martin CA, 2016, NUTRITION, V32, P21, DOI 10.1016/j.nut.2015.07.007; Nagasaka R, 2014, LIPIDS, V49, P1057, DOI 10.1007/s11745-014-3942-3; Nessvi S, 2011, PHOTOCHEM PHOTOBIOL, V87, P1173, DOI 10.1111/j.1751-1097.2011.00956.x; Omand JA, 2014, PUBLIC HEALTH NUTR, V17, P1547, DOI 10.1017/S1368980013001328; PMID, 1991, PUBMED; PMID, PUBMED, P8279; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; RECKER RR, 1992, JAMA-J AM MED ASSOC, V268, P2403, DOI 10.1001/jama.268.17.2403; Rockell JEP, 2008, OSTEOPOROSIS INT, V19, P1639, DOI 10.1007/s00198-008-0620-4; Ross A. C., 2011, INSTITUTE OF MEDICIN; Sarafin K, 2015, AM J CLIN NUTR, V102, P1044, DOI 10.3945/ajcn.114.103689; Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; Taylor CL, 2014, J NUTR, V144, P654, DOI 10.3945/jn.113.189811; Taylor CL, 2013, AM J CLIN NUTR, V97, P72, DOI 10.3945/ajcn.112.046094; Terushkin V, 2010, J AM ACAD DERMATOL, V62, P929, DOI 10.1016/j.jaad.2009.07.028; TYLAVSKY FA, 1989, CALCIFIED TISSUE INT, V45, P265, DOI 10.1007/BF02556017; VERBEKE G, 2009, SPRINGER SCIENCE BUS; Whiting SJ, 2011, AM J CLIN NUTR, V94, P128, DOI 10.3945/ajcn.111.013268; Wu HY, 2009, NUTR RES, V29, P255, DOI 10.1016/j.nutres.2009.03.006; Xiao CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147648	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207429	10.1371/journal.pone.0207429	http://dx.doi.org/10.1371/journal.pone.0207429			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540776	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600020
J	Shanaki, M; Moradi, N; Fadaei, R; Zandieh, Z; Shabani, P; Vatannejad, A				Shanaki, Mehrnoosh; Moradi, Nariman; Fadaei, Reza; Zandieh, Zahra; Shabani, Parisa; Vatannejad, Akram			Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; INSULIN SENSITIVITY; WOMEN; ADIPONECTIN; PREVALENCE; EXPRESSION; ASSOCIATION; ADIPOKINE; PREDICTORS	Altered production of adipokines is suggested to play a pivotal role in the pathogenesis of polycystic ovarian syndrome (PCOS). C1q/INF-related proteins (CTRPs) play diverse roles in regulation of metabolism in physiologic and pathologic conditions. In the present study, we assessed serum concentrations of adiponectin, CTRP12, and CTRP13 in individuals with PCOS and those without PCOS. We also evaluated the possible association of these adipokines with metabolic and hormonal variables. A total of 171 premenopausal women (86 with PCOS and 85 without PCOS) enrolled in this study. Serum levels of adiponectin, CTRP12, and CTRP13 were measured. The results showed significantly lower serum concentrations of adiponectin, CTRP12, and CTRP13 in PCOS women compared to non-PCOS women. This difference remained significant after controlling for age, body mass index (BMI), and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). However, we did not observe any significant differences in serum levels of adiponectin, CTRP12, and CTRP13 between the overweight/obese and normal weight subgroups in PCOS and non-PCOS women. Multiple linear regression analysis showed associations of CTRP12 with adiponectin and BMI with CTRP13 in both the PCOS and non-PCOS groups. CTRP12 was significantly associated with BMI and adiponectin in the non-PCOS group, and fasting blood glucose (FBG) and CTRP13 in the PCOS group. Our results indicated that decreased adiponectin, CTRP12, and CTRP13 levels, regardless of obesity, could independently predict PCOS. This finding suggested a novel link between adipokines and PCOS.	[Shanaki, Mehrnoosh] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Med Lab Sci, Tehran, Iran; [Moradi, Nariman] Iran Univ Med Sci, Dept Biochem, Fac Med, Tehran, Iran; [Fadaei, Reza] Kermanshah Univ Med Sci, Sleep Disorders Res Ctr, Kermanshah, Iran; [Zandieh, Zahra] Iran Univ Med Sci, Sch Med, Cellular & Mol Res Ctr, Tehran, Iran; [Zandieh, Zahra] IUMS, Shahid Akbar Abadi Clin Res Dev Unit ShACRDU, Tehran, Iran; [Shabani, Parisa] Semnan Univ Med Sci, Dept Biochem, Fac Med, Semnan, Iran; [Vatannejad, Akram] Univ Tehran Med Sci, Sch Nutrit Sci & Dietet, Dept Cellular & Mol Nutr, Tehran, Iran; [Vatannejad, Akram] Univ Tehran Med Sci, SSRC, Tehran, Iran	Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; Kermanshah University of Medical Sciences; Iran University of Medical Sciences; Semnan University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Shabani, P (corresponding author), Semnan Univ Med Sci, Dept Biochem, Fac Med, Semnan, Iran.; Vatannejad, A (corresponding author), Univ Tehran Med Sci, Sch Nutrit Sci & Dietet, Dept Cellular & Mol Nutr, Tehran, Iran.; Vatannejad, A (corresponding author), Univ Tehran Med Sci, SSRC, Tehran, Iran.	parisa83j@gmail.com; Vatannejad@gmail.com	Fadaei, Reza/M-9456-2016; Zandieh, Zahra/AAY-5143-2020; Vatannejad, Akram/Q-6968-2019	Fadaei, Reza/0000-0002-4989-1137; Zandieh, Zahra/0000-0002-7720-9465; Vatannejad, Akram/0000-0002-8202-7914; Moradi, Nariman/0000-0001-7760-4804	Shahid Beheshti University of Medical Sciences [12535]; Shahid Beheshti University of Medical Sciences, Tehran, Iran	Shahid Beheshti University of Medical Sciences; Shahid Beheshti University of Medical Sciences, Tehran, Iran	This work was supported by: MS, grant number: 12535, Shahid Beheshti University of Medical Sciences, https://en.sbmu.ac.ir/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Shahid Beheshti University of Medical Sciences, Tehran, Iran.	Afrookhteh A, 2017, CLIN LAB, V63, P327, DOI 10.7754/Clin.Lab.2016.160609; Bai B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172271; Behboudi-Gandevani S, 2017, J ENDOCRINOL INVEST, V40, P859, DOI 10.1007/s40618-017-0650-x; Benrick A, 2017, P NATL ACAD SCI USA, V114, pE7187, DOI 10.1073/pnas.1708854114; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Chazenbalk G, 2012, J CLIN ENDOCR METAB, V97, pE765, DOI 10.1210/jc.2011-2377; Chen X, 2013, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2013/09/012; Corton M, 2007, J CLIN ENDOCR METAB, V92, P328, DOI 10.1210/jc.2006-1665; Echiburu B, 2018, STEROIDS, V130, P15, DOI 10.1016/j.steroids.2017.12.009; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Enomoto T, 2011, J BIOL CHEM; Esteghamati A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-26; Fadaei R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168773; Forouhi N, 2016, DIABETES METAB SYND, V10, pS131, DOI 10.1016/j.dsx.2016.03.012; Fr DD, 2004, FERTILITY STERILITY, V81; Fuster JJ, 2016, CIRC RES, V118, P1786, DOI 10.1161/CIRCRESAHA.115.306885; Guzel EC, 2014, GYNECOL ENDOCRINOL, V30, P419, DOI 10.3109/09513590.2014.888412; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Lecke SB, 2013, GENET MOL RES, V12, P4292, DOI 10.4238/2013.February.28.16; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Lizneva D, 2016, FERTIL STERIL, V106, P6, DOI 10.1016/j.fertnstert.2016.05.003; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, pE304, DOI 10.1210/jc.2010-1290; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Messinis IE, 2015, BEST PRACT RES CL OB, V29, P479, DOI 10.1016/j.bpobgyn.2014.11.001; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Olszanecka-Glinianowicz M, 2013, CLIN ENDOCRINOL, V79, P238, DOI 10.1111/cen.12120; Olszanecka-Glinianowicz M, 2012, EUR J OBSTET GYN R B, V162, P55, DOI 10.1016/j.ejogrb.2012.01.026; Orlik B, 2014, CLIN ENDOCRINOL, V81, P529, DOI 10.1111/cen.12381; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Peterson JM, 2010, J BIOL CHEM; Pinhas-Hamiel O, 2009, CLIN ENDOCRINOL, V71, P823, DOI 10.1111/j.1365-2265.2009.03604.x; Sam Susan, 2007, Obes Manag, V3, P69, DOI 10.1089/obe.2007.0019; Sarray S, 2015, FERTIL STERIL, V104, P460, DOI 10.1016/j.fertnstert.2015.05.007; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Shanaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168082; Shin HY, 2011, KOREAN J FAM MED, V32, P243, DOI 10.4082/kjfm.2011.32.4.243; Tan BK, 2014, CLIN ENDOCRINOL, V81, P841, DOI 10.1111/cen.12438; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Tan BK, 2014, J ENDOCRINOLOGY; Tan BK, 2013, J ENDOCRINOLOGY; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240	45	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208059	10.1371/journal.pone.0208059	http://dx.doi.org/10.1371/journal.pone.0208059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540803	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600054
J	Fesenmyer, KA; Dauwalter, DC; Evans, C; Allai, T				Fesenmyer, Kurt A.; Dauwalter, Daniel C.; Evans, Carol; Allai, Todd			Livestock management, beaver, and climate influences on riparian vegetation in a semi-arid landscape	PLOS ONE			English	Article							REDBAND TROUT HABITAT; WESTERN UNITED-STATES; GREAT-BASIN; EVAPORATIVE DEMAND; CUTTHROAT TROUT; SAGE-GROUSE; RIVER-BASIN; EL-NINO; RESTORATION; ECOSYSTEMS	Riparian and aquatic habitats support biodiversity and key environmental processes in semi-arid and arid landscapes, but stressors such as conventional livestock grazing, wildfire, and drought can degrade their condition. To enhance habitat for fish and wildlife and increase resiliency in these critical areas, land managers in the interior western United States increasingly use alternative grazing strategies, beaver management, or beaver dam surrogates as low-effort, low-expense restoration approaches. In this study we used historical archives of satellite and aerial imagery spanning three decades to characterize riparian vegetation productivity and document beaver dam occurrences, then evaluated vegetation productivity relative to land management associated with livestock grazing and beaver dam densities while accounting for climate and wildfire. After controlling for stream characteristics such as stream size, elevation, and stream slope, we demonstrate a positive response of riparian area vegetation to conservation-oriented grazing approaches and livestock exclosures, extensive beaver dam development, increased precipitation, and lack of wildfire. We show that livestock management which emphasizes riparian recovery objectives can be an important precursor to beaver activity and describe 11-39% increases in floodplain vegetation productivity where conservation-oriented grazing approaches or livestock exclosures and high beaver activity occur together on low-gradient sites. Land management decisions can therefore potentially confer resiliency to riparian areas under changing and variable climate conditions-the increased vegetation productivity resulting from conservation-oriented grazing or exclosures and high amounts of beaver activity at our sites is the equivalent to moving conventionally-grazed, low-gradient sites without beaver up at least 250 m in elevation or increasing water year precipitation by at least 250 mm.	[Fesenmyer, Kurt A.; Dauwalter, Daniel C.] Trout Unltd, Boise, ID 83702 USA; [Evans, Carol] US Bur Land Management, Elko, NV USA; [Allai, Todd] US Bur Land Management, Vale, OR USA		Fesenmyer, KA (corresponding author), Trout Unltd, Boise, ID 83702 USA.	kfesenmyer@tu.org	Dauwalter, Daniel/Z-2028-2019	Dauwalter, Daniel/0000-0003-3070-188X	Bureau of Land Management [L14AC00009]	Bureau of Land Management	This work was funded by the Bureau of Land Management under cooperative agreement L14AC00009 with Trout Unlimited. Bureau of Land Management staff had a role in conceptualizing the analysis and preparing the manuscript.	Agouridis CT, 2005, J AM WATER RESOUR AS, V41, P591, DOI 10.1111/j.1752-1688.2005.tb03757.x; Arkle RS, 2015, ECOL EVOL, V5, P3704, DOI 10.1002/ece3.1627; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baker BW, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00058.1; Baker BW, 2005, ECOL APPL, V15, P110, DOI 10.1890/03-5237; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Batchelor JL, 2015, ENVIRON MANAGE, V55, P930, DOI 10.1007/s00267-014-0436-2; Beechie TJ, 2008, EARTH SURF PROC LAND, V33, P784, DOI 10.1002/esp.1578; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Bendix J, 2000, HYDROL PROCESS, V14, P2977, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2977::AID-HYP130&gt;3.0.CO;2-4; Bernhardt ES, 2011, ECOL APPL, V21, P1926, DOI 10.1890/10-1574.1; Booth DT, 2007, ECOL INDIC, V7, P636, DOI 10.1016/j.ecolind.2006.07.005; Booth DT, 2012, ECOL INDIC, V18, P512, DOI 10.1016/j.ecolind.2011.12.017; Booth DT, 2003, ARID LAND RES MANAG, V17, P455, DOI 10.1080/713936105; Boudell JA, 2015, ECOHYDROLOGY, V8, P747, DOI 10.1002/eco.1664; Bouwes N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28581; Boyd C.S., 2014, J RANGELAND APPL, V1, P58; Bradley BA, 2011, INT J REMOTE SENS, P32; Bradley BA, 2008, GLOBAL CHANGE BIOL, V14, P334, DOI 10.1111/j.1365-2486.2007.01479.x; Brooks ML, 2015, 201511167 US GEOL SU; Brown DK, 2001, WEST N AM NATURALIST, V61, P139; Burnham KP, 2003, MODEL SELECTION MULT; Capon SJ, 2013, ECOSYSTEMS, V16, P359, DOI 10.1007/s10021-013-9656-1; Carlisle DM, 2010, RIVER RES APPL, V26, P118, DOI 10.1002/rra.1247; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Church M, 2002, FRESHWATER BIOL, V47, P541, DOI 10.1046/j.1365-2427.2002.00919.x; Connelly JW, 2011, STUD AVIAN BIOL, P69; Cooke HA, 2008, WEST N AM NATURALIST, V68, P365, DOI 10.3398/1527-0904(2008)68[365:IOBDDO]2.0.CO;2; Crawford JA, 2004, J RANGE MANAGE, V57, P2, DOI 10.2307/4003949; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Dalldorf KN, 2013, RANGELAND ECOL MANAG, V66, P34, DOI 10.2111/REM-D-11-00065.1; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dauwalter DC, 2018, N AM J FISH MANAGE, V38, P1187, DOI 10.1002/nafm.10224; Dauwalter DC, 2018, ECOL FRESHW FISH, V27, P606, DOI 10.1111/eff.12374; Dauwalter DC, 2015, T AM FISH SOC, V144, P1322, DOI 10.1080/00028487.2015.1088471; Demmer R, 2008, NORTHWEST SCI, V82, P309, DOI 10.3955/0029-344X-82.4.309; DeVries P, 2012, FISHERIES, V37, P246, DOI 10.1080/03632415.2012.687263; Donnelly JP, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1208; Dufurrena C., 2016, RANGE MAGAZINE   JUN; Dunham J, 2003, N AM J FISH MANAGE, V23, P1042, DOI 10.1577/02-029; Dunham JB, 2003, FOREST ECOL MANAG, V178, P183, DOI 10.1016/S0378-1127(03)00061-6; Dwire KA, 2003, FOREST ECOL MANAG, V178, P61, DOI 10.1016/S0378-1127(03)00053-7; Eidenshink J., 2007, FIRE ECOL, V3, P3, DOI [DOI 10.4996/FIREECOLOGY.0301003, 10.4996/fireecology.0301003]; Epskamp S, 2015, STRUCT EQU MODELING, V22, P474, DOI 10.1080/10705511.2014.937847; Gibson PP, 2014, AQUAT CONSERV, V24, P391, DOI 10.1002/aqc.2432; Gilbert JT, 2016, COMPUT GEOSCI-UK, V97, P1, DOI 10.1016/j.cageo.2016.07.014; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Goss LM, 2018, WEST N AM NATURALIST, V78, P76, DOI 10.3398/064.078.0108; Grace JB, 1998, AM NAT, V152, P151, DOI 10.1086/286156; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Hausner MB, 2018, ECOL ENG, V120, P432, DOI 10.1016/j.ecoleng.2018.06.024; Hobbins MT, 2016, J HYDROMETEOROL, V17, P1745, DOI 10.1175/JHM-D-15-0121.1; Holbert MR, 1991, RANGELANDS, V13, P125; Holland KA, 2005, RANGELAND ECOL MANAG, V58, P148, DOI 10.2111/1551-5028(2005)58&lt;148:GHAWCI&gt;2.0.CO;2; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Hough-Snee N, 2013, ECOL ENG, V58, P371, DOI 10.1016/j.ecoleng.2013.07.042; Huntington JL, B AM METEOROLOGICAL; Huntington J, 2016, REMOTE SENS ENVIRON, V185, P186, DOI 10.1016/j.rse.2016.07.004; Isaak DJ, 2015, GLOBAL CHANGE BIOL, V21, P2540, DOI 10.1111/gcb.12879; KAUFFMAN JB, 1984, J RANGE MANAGE, V37, P430, DOI 10.2307/3899631; Knopf F.L., 1985, U S Forest Service General Technical Report RM, P105; LI HW, 1994, T AM FISH SOC, V123, P627, DOI 10.1577/1548-8659(1994)123<0627:CEORDA>2.3.CO;2; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Macfarlane WW, 2017, GEOMORPHOLOGY, V277, P72, DOI 10.1016/j.geomorph.2015.11.019; Matthews WJ, 2003, FRESHWATER BIOL, V48, P1232, DOI 10.1046/j.1365-2427.2003.01087.x; McAdoo K, 2017, SHOESOLE RESOURCE MA; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McEvoy DJ, 2016, J HYDROMETEOROL, V17, P1763, DOI 10.1175/JHM-D-15-0122.1; MOLLES MC, 1990, J N AM BENTHOL SOC, V9, P68, DOI 10.2307/1467935; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; National Ocean and Atmospheric Adminstration Earth System Research Labortory, 2017, EDDI MAP ARCH; NUSSLE S, 2017, ECOSPHERE, V8; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Oregon Bureau of Land Management, 2010, BLM OR GRAZ ALL PAST; Patten DT, 1998, WETLANDS, V18, P498, DOI 10.1007/BF03161668; Pearl CA, 2015, WILDLIFE SOC B, V39, P319, DOI 10.1002/wsb.516; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pilliod D. S., 2017, Rangelands, V39, P1, DOI 10.1016/j.rala.2016.12.001; Pilliod DS, 2018, ENVIRON MANAGE, V61, P58, DOI 10.1007/s00267-017-0957-6; Poff NL, 1996, FRESHWATER BIOL, V36, P71, DOI 10.1046/j.1365-2427.1996.00073.x; Pollock MM, 2007, EARTH SURF PROC LAND, V32, P1174, DOI 10.1002/esp.1553; Pollock MM, 2014, BIOSCIENCE, V64, P279, DOI 10.1093/biosci/biu036; Roelstraete B, 2011, J STAT SOFTW, V44, P1; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Roy DP, 2016, REMOTE SENS ENVIRON, V185, P57, DOI 10.1016/j.rse.2015.12.024; Sada DW, 2002, SMITHSON CONTRIB EAR, P277; Sarr DA, 2002, ENVIRON MANAGE, V30, P516, DOI 10.1007/s00267-002-2608-8; Saunders WC, 2007, T AM FISH SOC, V136, P1216, DOI 10.1577/T06-260.1; Schultz LD, 2017, J ARID ENVIRON, V145, P60, DOI 10.1016/j.jaridenv.2017.05.008; Seavy N.E., 2009, ECOL RESTOR, V27, P330, DOI DOI 10.3368/ER.27.3.330; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; Shafroth PB, 2005, ENVIRON MANAGE, V35, P231, DOI 10.1007/s00267-004-0099-5; Shafroth PB, 2002, ECOL APPL, V12, P107, DOI 10.1890/1051-0761(2002)012[0107:RVRTAD]2.0.CO;2; Shipley B., 2000, CAUSE CORRELATIONS B; Silverman NL, 2018, RESTORATION ECOLOGY; Small BA, 2016, RESTOR ECOL, V24, P646, DOI [10.1111/rec.12364, 10.1111/rec.1236]; Smith GR, 2002, SMITHSON CONTRIB EAR, P175; Stromberg JC, 2007, FRESHWATER BIOL, V52, P651, DOI 10.1111/j.1365-2427.2006.01713.x; Stromberg JC, 2010, RIVER RES APPL, V26, P712, DOI 10.1002/rra.1272; Swanson S., 2015, J RANGELAND APPL, V2, P1; Thomas JW, 1979, PNWGTR080 USDA FOR S, V80; Timpane-Padgham BL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173812; TRIMBLE SW, 1995, GEOMORPHOLOGY, V13, P233, DOI 10.1016/0169-555X(95)00028-4; Walrath JD, 2016, T AM FISH SOC, V145, P821, DOI 10.1080/00028487.2016.1159613; Weber N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176313; Westerling AL, 2003, B AM METEOROL SOC, V84, P595, DOI 10.1175/BAMS-84-5-595; White SM, 2008, T AM FISH SOC, V137, P881, DOI 10.1577/T06-207.1; Wyman S, 2006, RIPARIAN AREA MANAGE, V1737, P1; Zoellick BW, 2006, N AM J FISH MANAGE, V26, P268, DOI 10.1577/M04-115.1; Zoellick BW, 2004, WEST N AM NATURALIST, V64, P18; Zoellick BW, 1999, GREAT BASIN NAT, V59, P136	113	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208928	10.1371/journal.pone.0208928	http://dx.doi.org/10.1371/journal.pone.0208928			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533026	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500050
J	Segawa, T; Sekizuka, T; Suzuki, S; Shibayama, K; Matsui, M; Kuroda, M				Segawa, Takaya; Sekizuka, Tsuyoshi; Suzuki, Satowa; Shibayama, Keigo; Matsui, Mari; Kuroda, Makoto			The plasmid-encoded transcription factor ArdK contributes to the repression of the IMP-6 metallo-beta-lactamase gene bla(IMP-6), leading to a carbapenem-susceptible phenotype in the bla(IMP-6)-positive Escherichia coli strain A56-1S	PLOS ONE			English	Article							ANTIRESTRICTION PROTEINS; FOSFOMYCIN RESISTANCE; ENTEROBACTERIACEAE; PREVALENCE; EXPRESSION; EVOLUTION; INTEGRONS; PKM101	Carbapenemase-producing Enterobacteriaceae (CPE) are a global concern because these bacteria are resistant to almost all beta-lactams. Horizontal interspecies gene transfer via plasmid conjugation has increased the global dissemination of CPE. Recently, an Enterobacteriaceae strain positive for carbapenemase gene but showing a carbapenem-susceptible phenotype was identified, suggesting that these susceptible strains may be challenging to detect solely via antimicrobial susceptibility tests without molecular analysis. Here, we isolated a bla(IMP-6) carbapenemase-gene positive but imipenem-and meropenem-susceptible Escherichia coli (ISMS-E) strain A56-1S (imipenem and meropenem minimum inhibitory concentration,. 0.125 mg/L), from a human urine specimen in Japan. A56-1S was carbapenemase negative by the Carba NP test, suggesting that IMP-6 production was low or undetectable. Thus, to characterize the mechanism of this phenotype, a meropenem-resistant E. coli A56-1R strain was obtained using meropenem-selection. A56-1R was positive for carbapenemase production by the Carba NP test, and bla(IMP-6) transcription in A56-1R was 53-fold higher than in A56-1S, indicating that bla(IMP-6) in A56-1S is negatively regulated at the transcriptional level. Comparative genomic analysis between the two strains revealed that the alleviation of restriction of DNA (ardK) gene encoding a putative transcription factor is disrupted by the IS26 insertion in A56-1R. A cotransformation assay of ardK and the regulatory element upstream of bla(IMP-6) showed repression of bla(IMP-6) transcription, indicating that ArdK negatively modulates bla(IMP-6) transcription. ArdK binding and affinity assays demonstrated that ArdK directly binds to the regulatory element upstream of bla(IMP-6) with dissociation constant values comparable to those of general transcription factors. The IMP-6 carbapenemase showed low hydrolytic activity against imipenem, resulting in an imipenem-susceptible and meropenem-resistant (ISMR) phenotype (previously reported as a stealth phenotype). However, the low expression of IMP-6 in the A56-1S strain could be a typical characteristic of ISMS-E due to gene repression, indicating that conventional antimicrobial susceptibility tests might be unable to detect such strains even when using both imipenem and meropenem. Bacteria that exhibit the ISMS phenotype could play a potential role as undetectable reservoirs and might facilitate gene transfer to other organisms while avoiding detection.	[Segawa, Takaya; Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Suzuki, Satowa; Matsui, Mari] Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Higashimurayama, Tokyo, Japan; [Shibayama, Keigo] Natl Inst Infect Dis, Bacteriol 2, Musashimurayama, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Segawa, T (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan.	tsegawa@nih.go.jp		Sekizuka, Tsuyoshi/0000-0002-1302-5472; Segawa, Takaya/0000-0001-6685-6053	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development [JP16fk0108119, JP16fk0108305, JP17fk0108121]	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (https://www.amed.go.jp/en/; grant numbers: JP16fk0108119, JP16fk0108305, and JP17fk0108121). The funders played no role in designing the study, collecting the data, analyzing the data, deciding to publish, or preparing the manuscript. There was no additional external funding received for this study.	Akiba M, 2016, ANTIMICROB AGENTS CH, V60, P2972, DOI 10.1128/AAC.01950-15; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; BELOGUROV AA, 1992, J BACTERIOL, V174, P5079, DOI 10.1128/JB.174.15.5079-5085.1992; BELOGUROV AA, 1993, J BACTERIOL, V175, P4843, DOI 10.1128/JB.175.15.4843-4850.1993; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Delver EP, 1997, J MOL BIOL, V271, P13, DOI 10.1006/jmbi.1997.1124; Demple B, 1996, GENE, V179, P53, DOI 10.1016/S0378-1119(96)00329-0; Dortet L, 2012, CLIN MICROBIOL INFEC, V18, pE144, DOI 10.1111/j.1469-0691.2012.03796.x; EUCAST, 2018, CLIN BREAKP BACT V 8; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2013, GUID DET RES MECH SP, P1; Fattouh R, 2016, ANTIMICROB AGENTS CH, V60, P1556, DOI 10.1128/AAC.02304-15; Harmer CJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00038-16; Harmer CJ, 2014, MBIO, V5, DOI 10.1128/mBio.01801-14; Ho PL, 2013, J MED MICROBIOL, V62, P1707, DOI 10.1099/jmm.0.062653-0; Kayama S, 2015, ANTIMICROB AGENTS CH, V59, P1356, DOI 10.1128/AAC.04759-14; Lee SY, 2012, J ANTIMICROB CHEMOTH, V67, P2843, DOI 10.1093/jac/dks319; LI ZY, 1994, J BIOL CHEM, V269, P18371; Loli A, 2006, J ANTIMICROB CHEMOTH, V58, P669, DOI 10.1093/jac/dkl302; Miriagou V, 2005, ANTIMICROB AGENTS CH, V49, P3541, DOI 10.1128/AAC.49.8.3541-3543.2005; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Oelschlaeger P, 2005, PROTEIN SCI, V14, P765, DOI 10.1110/ps.041093405; Segawa T, 2017, J MICROBIOL METH, V133, P35, DOI 10.1016/j.mimet.2016.12.015; Shigemoto N, 2012, DIAGN MICR INFEC DIS, V72, P109, DOI 10.1016/j.diagmicrobio.2011.09.019; Vogel SK, 2002, NUCLEIC ACIDS RES, V30, P4094, DOI 10.1093/nar/gkf519; Yano H, 2001, ANTIMICROB AGENTS CH, V45, P1343, DOI 10.1128/AAC.45.5.1343-1348.2001; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208976	10.1371/journal.pone.0208976	http://dx.doi.org/10.1371/journal.pone.0208976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533034	gold, Green Published, Green Submitted			2022-12-26	WOS:000452782500056
J	Bourgeois, A; Badier, E; Baron, N; Carruzzo, F; Vuilleumier, P				Bourgeois, Alexia; Badier, Emmanuel; Baron, Naem; Carruzzo, Fabien; Vuilleumier, Patrik			Influence of reward learning on visual attention and eye movements in a naturalistic environment: A virtual reality study	PLOS ONE			English	Article							CORTICAL CONTROL; INHIBITION; REINFORCEMENT; MODULATION; DOPAMINE; SALIENCE; PRIORITY; SACCADES; CAPTURE; NEGLECT	Rewards constitute crucial signals that motivate approach behavior and facilitate the perceptual processing of objects associated with favorable outcomes in past encounters. Reward-related influences on perception and attention have been reliably observed in studies where a reward is paired with a unidimensional low-level visual feature, such as the color or orientation of a line in visual search tasks. However, our environment is drastically different and composed of multidimensional and changing visual features, encountered in complex and dynamic scenes. Here, we designed an immersive virtual reality (VR) experiment using a 4-frame CAVE system to investigate the impact of rewards on attentional orienting and gaze patterns in a naturalistic and ecological environment. Forty-one healthy participants explored a virtual forest and responded to targets appearing on either the left or right side of their path. To test for reward -induced biases in spatial orienting, targets on one side were associated with high reward, whereas those on the opposite side were paired with a low reward. Eye-movements recording showed that left-side high rewards led to subsequent increase of eye gaze fixations towards this side of the path, but no such asymmetry was found after exposure to right-sided high rewards. A milder spatial bias was also observed after left-side high rewards during subsequent exploration of a virtual castle yard, but not during route turn choices along the forest path. Our results indicate that reward-related influences on attention and behavior may be better learned in left than right space, in line with a right hemisphere dominance, and could generalize to another environment to some extent, but not to spatial choices in another decision task, suggesting some domain- or context-specificity. This proof-of-concept study also outlines the advantages and the possible drawbacks of the use of the 3D CAVE immersive platform for VR in neuroscience.	[Bourgeois, Alexia; Carruzzo, Fabien; Vuilleumier, Patrik] Univ Geneva, Neurosci Dept, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland; [Badier, Emmanuel; Baron, Naem] Univ Geneva CISA, Swiss Ctr Affect Sci, Geneva, Switzerland	University of Geneva	Bourgeois, A (corresponding author), Univ Geneva, Neurosci Dept, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland.	alexia.bourgeois@unige.ch	Vuilleumier, Patrik/AAJ-1839-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Bourgeois, Alexia/0000-0002-7397-6835	Fondation Fyssen; Marie-Curie CoFund BRIDGE program from the European Union Seventh Framework Programme (FP7/2007-2013) [267171]; PRD of the University Hospital of Geneva; National Center of Competence in Research (NCCR) for the Affective Sciences - Swiss National Science Foundation (SNF) [51NF40-104897]; Geneva Academic Society (Foremane Fund)	Fondation Fyssen; Marie-Curie CoFund BRIDGE program from the European Union Seventh Framework Programme (FP7/2007-2013); PRD of the University Hospital of Geneva; National Center of Competence in Research (NCCR) for the Affective Sciences - Swiss National Science Foundation (SNF); Geneva Academic Society (Foremane Fund)	This work was supported by grants from the Fondation Fyssen (AB); the Marie-Curie CoFund BRIDGE program (AB) from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 267171"; the PRD of the University Hospital of Geneva; the National Center of Competence in Research (NCCR) for the Affective Sciences financed by the Swiss National Science Foundation (SNF No 51NF40-104897) and hosted by the University of Geneva; and an award from the Geneva Academic Society (Foremane Fund) to PV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2016, NEUROPSYCHOLOGIA, V89, P1, DOI 10.1016/j.neuropsychologia.2016.05.023; ANDERSON BA, 2013, FRONT HUM NEUROSCI, V7; Anderson BA, 2017, NEUROIMAGE, V157, P27, DOI 10.1016/j.neuroimage.2017.05.062; Anderson BA, 2016, CURR BIOL, V26, P550, DOI 10.1016/j.cub.2015.12.062; Anderson BA, 2015, PSYCHON B REV, V22, P750, DOI 10.3758/s13423-014-0724-0; Anderson BA, 2012, VIS COGN, V20, P647, DOI 10.1080/13506285.2012.679711; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Bartolomeo P, 2012, FRONT HUM NEUROSCI, V6; Bartolomeo P., 2000, NEUROLOGICAL SCI S4, pS132; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bijleveld E, 2010, COGNITION, V115, P330, DOI 10.1016/j.cognition.2009.12.012; Bourgeois A, 2016, PROG BRAIN RES, V229, P325, DOI 10.1016/bs.pbr.2016.06.004; Bourgeois A, 2017, COGNITION EMOTION, V31, P109, DOI 10.1080/02699931.2015.1085366; Bourgeois A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160469; Bourgeois A, 2015, NEUROPSYCHOLOGIA, V73, P1, DOI 10.1016/j.neuropsychologia.2015.04.013; Bourgeois A, 2013, CORTEX, V49, P2927, DOI 10.1016/j.cortex.2013.08.004; Bourgeois A, 2013, CORTEX, V49, P2229, DOI 10.1016/j.cortex.2012.10.017; Bourgeois A, 2012, NEUROPSYCHOLOGIA, V50, P800, DOI 10.1016/j.neuropsychologia.2012.01.014; Bourlon C, 2017, EXP BRAIN RES, V235, P3163, DOI 10.1007/s00221-017-5044-y; Chelazzi L, 2014, J NEUROSCI, V34, P8594, DOI 10.1523/JNEUROSCI.0277-14.2014; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Ding L, 2006, J NEUROSCI, V26, P6695, DOI 10.1523/JNEUROSCI.0836-06.2006; Gupta R, 2017, CORTEX; Gupta R, 2019, PSYCHOL RES-PSYCH FO, V83, P1798, DOI 10.1007/s00426-018-1028-1; Hickey C, 2015, J EXP PSYCHOL GEN, V144, P264, DOI 10.1037/a0038627; Hickey C, 2015, NEURON, V85, P512, DOI 10.1016/j.neuron.2014.12.049; Hickey C, 2013, VISION RES, V92, P67, DOI 10.1016/j.visres.2013.09.008; Hickey C, 2012, CURR BIOL, V22, pR219, DOI 10.1016/j.cub.2012.02.007; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hikosaka O, 2013, TRENDS COGN SCI, V17, P434, DOI 10.1016/j.tics.2013.07.001; Husain M, 2001, BRAIN, V124, P941, DOI 10.1093/brain/124.5.941; Ikeda T, 2007, J NEUROPHYSIOL, V98, P3163, DOI 10.1152/jn.00975.2007; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Lucas N, 2013, CORTEX, V49, P2616, DOI 10.1016/j.cortex.2013.06.004; Martin-Soelch C, 2011, EUR J NEUROSCI, V33, P1706, DOI 10.1111/j.1460-9568.2011.07642.x; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; McCoy B, 2016, J NEUROPHYSIOL, V116, P2453, DOI 10.1152/jn.00498.2016; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Rothkirch M, 2013, EXP BRAIN RES, V224, P35, DOI 10.1007/s00221-012-3284-4; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Theeuwes J, 2012, VISION RES, V74, P80, DOI 10.1016/j.visres.2012.07.024; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Towal RB, 2013, P NATL ACAD SCI USA, V110, pE3858, DOI 10.1073/pnas.1304429110; VAIDYA AR, 2015, NAT COMMUN, V6; Vaidya AR, 2015, J NEUROSCI, V35, P12813, DOI 10.1523/JNEUROSCI.1607-15.2015; Vuilleumier P, 2013, ANN NY ACAD SCI, V1296, P50, DOI 10.1111/nyas.12161	49	7	7	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207990	10.1371/journal.pone.0207990	http://dx.doi.org/10.1371/journal.pone.0207990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517170	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400074
J	Frutos, AM; Sloan, CD; Merrill, RM				Frutos, Aaron M.; Sloan, Chantel D.; Merrill, Ray M.			Modeling the effects of atmospheric pressure on suicide rates in the USA using geographically weighted regression	PLOS ONE			English	Article							ALTITUDE; DEPRESSION; HYPOXIA; OWNERSHIP; MORTALITY; DISEASE; STATES	Low atmospheric pressure may increase depression and suicide through inducing hypoxia. Previous studies have not evaluated the geographic variation of this relationship across the United States. Analyses were based on three groupings of age-adjusted completed suicide rates (all suicide, firearm-related suicide, non-firearm-related suicide) from 2286 counties in the United States. Multiple regression was used to determine the overall relationship between atmospheric pressure and completed suicide rates. Geographically weighted regression (GWR) models were used to obtain local coefficient estimates. A negative correlation between atmospheric pressure and completed suicide rates was observed for all three suicide groupings (p-value<0.0001). Significant, negative GWR coefficient estimates were located in the West and Northeast for the all suicides and firearm-related suicides, and in the Midwest for non-firearm-related suicides.	[Frutos, Aaron M.; Sloan, Chantel D.; Merrill, Ray M.] Brigham Young Univ, Dept Publ Hlth, Coll Life Sci, Provo, UT 84602 USA	Brigham Young University	Frutos, AM (corresponding author), Brigham Young Univ, Dept Publ Hlth, Coll Life Sci, Provo, UT 84602 USA.	aafrutos@gmail.com	Frutos, Aaron/GWC-2043-2022; Sloan-Aagard, Chantel/GWC-7572-2022	Frutos, Aaron Michael/0000-0001-6948-3918	Ira and Mary Lou Fulton Gift Fund at Brigham Young University	Ira and Mary Lou Fulton Gift Fund at Brigham Young University	This study was funded by the Ira and Mary Lou Fulton Gift Fund at Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTE K, 1986, PSYCHOPATHOLOGY, V19, P210, DOI 10.1159/000285157; Alameda-Palacios J, 2015, REV ESP SALUD PUBLIC, V89, P283, DOI 10.4321/S1135-57272015000300006; [Anonymous], 2017, MOD BAS SMALL AR INC; [Anonymous], 2017, GROUND SURF EL 30M; [Anonymous], 1997, JAMA-J AM MED ASSOC, V278, P974; [Anonymous], 2017, COMPR MORT FIL; [Anonymous], 2017, TIGER LIN SHAP TIGER; [Anonymous], 2017, COUNT DAT IND; Atmospheric pressure from altitude Calculator, 2017, ATMOSPHERIC PRESSURE; Aubin HJ, 2011, AM J PSYCHIAT, V168, P326, DOI 10.1176/appi.ajp.2010.10101501; Berman A, 2010, HDB DEPRESSION, P708; Betz ME, 2011, SUICIDE LIFE-THREAT, V41, P562, DOI 10.1111/j.1943-278X.2011.00054.x; Bezerra JG, 2012, CAD SAUDE PUBLICA, V28, P833, DOI 10.1590/S0102-311X2012000500003; BLUMTHALER M, 1994, GEOPHYS RES LETT, V21, P2805, DOI 10.1029/94GL02786; Brenner B, 2011, HIGH ALT MED BIOL, V12, P31, DOI 10.1089/ham.2010.1058; CDC, 2017, CDC WONDER; Center for Disease Control and Prevention, 2017, WEB BAS INJ STAT QUE; Cheng D, 2010, WILD ENVIRON MED, V21, P177, DOI 10.1016/j.wem.2010.01.004; DelMastro K, 2011, J AFFECT DISORDERS, V129, P376, DOI 10.1016/j.jad.2010.10.001; Dwyer-Lindgren L, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-5; Gamboa JL, 2011, HIGH ALT MED BIOL, V12, P403, DOI 10.1089/ham.2011.1014; GWR4 for Windows, 2017, GWR4 FOR WINDOWS; Haws CA, 2009, MED HYPOTHESES, V73, P587, DOI 10.1016/j.mehy.2009.05.040; Helbich M, 2013, GEOSPATIAL HEALTH, V7, P209, DOI 10.4081/gh.2013.81; Hong JH, 2013, J MENT HEALTH POLICY, V16, P109; Huber RS, 2014, MED HYPOTHESES, V82, P377, DOI 10.1016/j.mehy.2014.01.006; Ishikawa M, 2016, CULT MED PSYCHIAT, V40, P1, DOI 10.1007/s11013-015-9462-7; Ishikawa Motonao, 2013, Nihon Ronen Igakkai Zasshi, V50, P330; Jiang C, 2015, HLTH E STATS; Kanekar S, 2015, HIGH ALT MED BIOL, V16, P52, DOI 10.1089/ham.2014.1070; Kim J, 2014, PSYCHIAT INVEST, V11, P492, DOI 10.4306/pi.2014.11.4.492; Kim N, 2011, AM J PSYCHIAT, V168, P49, DOI 10.1176/appi.ajp.2010.10020289; Li X Y, 2000, Space Med Med Eng (Beijing), V13, P1; Littleton SW, 2017, RESP MED, V124, P15, DOI 10.1016/j.rmed.2017.01.004; MICCIOLO R, 1988, J AFFECT DISORDERS, V15, P163, DOI 10.1016/0165-0327(88)90085-7; Miller M, 2015, INJURY PREV, V21, pE116, DOI 10.1136/injuryprev-2013-040969; Miller M, 2012, ANNU REV PUBL HEALTH, V33, P393, DOI 10.1146/annurev-publhealth-031811-124636; MINKOFF K, 1973, AM J PSYCHIAT, V130, P455; Nakaya T, 2005, STAT MED, V24, P2695, DOI 10.1002/sim.2129; Oka M, 2015, PSYCHIAT CLIN NEUROS, V69, P375, DOI 10.1111/pcn.12254; Peacock A, 1988, BRIT MED J, V317, P1063; Shukitt-Hale B, 1998, INT J AVIAT PSYCHOL, V8, P319, DOI 10.1207/s15327108ijap0804_1; Siegel M, 2016, AM J PUBLIC HEALTH, V106, P1316, DOI 10.2105/AJPH.2016.303182; Trgovac AB, 2015, APPL GEOGR, V62, P201, DOI 10.1016/j.apgeog.2015.04.005; United States Census Bureau, 2017, AM FACTFINDER; Vyssoki B, 2014, JAMA PSYCHIAT, V71, P1231, DOI 10.1001/jamapsychiatry.2014.1198; Wallace J., 2006, ATMOSPHERIC SCI INTR, V2nd; Young SN, 2013, J PSYCHIATR NEUROSCI, V38, P423, DOI 10.1503/jpn.130002	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206992	10.1371/journal.pone.0206992	http://dx.doi.org/10.1371/journal.pone.0206992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517125	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400025
J	Liu, BY; Yi, JJ; Yan, X; Liu, L; Lou, XL; Zhang, ZY; Qi, H; Wang, Z; Zou, JH; Zhu, WG; Gu, W; Luo, JY				Liu, Boya; Yi, Jingjie; Yan, Xin; Liu, Lu; Lou, Xinlin; Zhang, Zeyuan; Qi, Hao; Wang, Zhe; Zou, Junhua; Zhu, Wei-Guo; Gu, Wei; Luo, Jianyuan			MDM2-mediated degradation of WRN promotes cellular senescence in a p53-independent manner	ONCOGENE			English	Article							WERNER-SYNDROME PROTEIN; DNA-DAMAGE; TARGETS WRN; P53 PATHWAY; S-PHASE; MDM2; HELICASE; PHOSPHORYLATION; E3; PRODUCT	MDM2 (Murine double minute 2) acts as a key repressor for p53-mediated tumor-suppressor functions, which includes cellular senescence. We found that MDM2 can promote cellular senescence by modulating WRN stability. Werner syndrome (WS), caused by mutations of the WRN gene, is an autosomal recessive disease, which is characterized by premature aging. Loss of WRN function induces cellular senescence in human cancer cells. Here, we found that MDM2 acts as an E3 ligase for WRN protein. MDM2 interacts with WRN both in vivo and in vitro. MDM2 induces ubiquitination of WRN and dramatically downregulates the levels of WRN protein in human cells. During DNA damage response, WRN is translocated to the nucleoplasm to facilitate its DNA repair functions; however, it is degraded by the MDM2-mediated ubiquitination pathway. Moreover, the senescent phenotype induced by DNA damage reagents, such as Etoposide, is at least in part mediated by MDM2-dependent WRN degradation as it can be significantly attenuated by ectopic expression of WRN. These results show that MDM2 is critically involved in regulating WRN function via ubiquitin-dependent degradation and reveal an unexpected role of MDM2 in promoting cellular senescence through a p53-independent manner.	[Liu, Boya; Yan, Xin; Liu, Lu; Lou, Xinlin; Zhang, Zeyuan; Qi, Hao; Wang, Zhe; Zou, Junhua; Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Dept Med Genet, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Yi, Jingjie; Gu, Wei] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Zhu, Wei-Guo] Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen, Peoples R China	Peking University; Columbia University; Shenzhen University	Luo, JY (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Med Genet, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	luojianyuan@bjmu.edu.cn	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zhu, Wei-Guo/0000-0001-8385-6581; Yang, Xin/0000-0003-0222-5839	National Natural Science Foundation of China [81270427, 81471405, 81671389, 81720108027, 81321003]; National Research Program of National Natural Science Foundation of China China [2013CB530801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Program of National Natural Science Foundation of China China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81270427, 81471405, 81671389, 81720108027 and 81321003) and from National Research Program of National Natural Science Foundation of China China (973 Program, 2013CB530801).	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; Bohr VA, 2000, EXP GERONTOL, V35, P695, DOI 10.1016/S0531-5565(00)00145-5; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Cheng WH, 2003, MOL CELL BIOL, V23, P6385, DOI 10.1128/MCB.23.18.6385-6395.2003; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Ghosh A, 2009, J BIOL CHEM, V284, P31074, DOI 10.1074/jbc.M109.027532; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Kusumoto R, 2007, MECH AGEING DEV, V128, P50, DOI 10.1016/j.mad.2006.11.010; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Mikawa T, 2014, J CELL BIOL, V204, P729, DOI 10.1083/jcb.201306149; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Muftuoglu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001918; Palermo V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12880; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Shamanna RA, 2016, ONCOTARGET, V7, P13269, DOI 10.18632/oncotarget.7906; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Su FT, 2016, ONCOTARGET, V7, P46, DOI 10.18632/oncotarget.6659; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tollini LA, 2014, CANCER CELL, V26, P235, DOI 10.1016/j.ccr.2014.06.006; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yannone SM, 2001, J BIOL CHEM, V276, P38242; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	41	13	13	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2501	2515		10.1038/s41388-018-0605-5	http://dx.doi.org/10.1038/s41388-018-0605-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30532073				2022-12-26	WOS:000463335200005
J	Chen, CW; Li, YM; Hu, SY; Zhou, W; Meng, YX; Li, ZZ; Zhang, Y; Sun, J; Bob, Z; DePamphilis, ML; Yen, Y; Han, ZY; Zhu, WG				Chen, Chi-Wei; Li, Yongming; Hu, Shuya; Zhou, Wei; Meng, Yunxiao; Li, Zongzhu; Zhang, Yi; Sun, Jing; Bob, Zhou; DePamphilis, Melvin L.; Yen, Yun; Han, Zhiyong; Zhu, Wenge			DHS (trans-4,4 '-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2)	ONCOGENE			English	Article							CHEMOPREVENTIVE AGENT RESVERATROL; CANCER CELL-LINES; TAMOXIFEN RESISTANCE; ENHANCED ANTIOXIDANT; DOWN-REGULATION; GEMCITABINE; ANALOG; DAMAGE; CYCLE; MOUSE	DNA replication machinery is responsible for accurate and efficient duplication of the chromosome. Since inhibition of DNA replication can lead to replication fork stalling, resulting in DNA damage and apoptotic death, inhibitors of DNA replication are commonly used in cancer chemotherapy. Ribonucleotide reductase (RNR) is the rate-limiting enzyme in the biosynthesis of deoxyribonucleoside triphosphates (dNTPs) that are essential for DNA replication and DNA damage repair. Gemcitabine, a nucleotide analog that inhibits RNR, has been used to treat various cancers. However, patients often develop resistance to this drug during treatment. Thus, new drugs that inhibit RNR are needed to be developed. In this study, we identified a synthetic analog of resveratrol (3,5,4'-trihydroxy-trans-stilbene), termed DHS (trans-4,4'-dihydroxystilbene), that acts as a potent inhibitor of DNA replication. Molecular docking analysis identified the RRM2 (ribonucleotide reductase regulatory subunit M2) of RNR as a direct target of DHS. At the molecular level, DHS induced cyclin F-mediated down-regulation of RRM2 by the proteasome. Thus, treatment of cells with DHS reduced RNR activity and consequently decreased synthesis of dNTPs with concomitant inhibition of DNA replication, arrest of cells at S-phase, DNA damage, and finally apoptosis. In mouse models of tumor xenografts, DHS was efficacious against pancreatic, ovarian, and colorectal cancer cells. Moreover, DHS overcame both gemcitabine resistance in pancreatic cancer and cisplatin resistance in ovarian cancer. Thus, DHS is a novel anti-cancer agent that targets RRM2 with therapeutic potential either alone or in combination with other agents to arrest cancer development.	[Chen, Chi-Wei; Li, Yongming; Zhou, Wei; Meng, Yunxiao; Li, Zongzhu; Zhang, Yi; Sun, Jing; Zhu, Wenge] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA; [Chen, Chi-Wei; Zhou, Wei; Meng, Yunxiao; Li, Zongzhu; Zhang, Yi; Sun, Jing; Zhu, Wenge] George Washington Univ, GW Canc Ctr, Washington, DC 20052 USA; [Li, Yongming] Dalian Med Univ, Coll Basic Med Sci, Dalian, Peoples R China; [Hu, Shuya; Yen, Yun] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Zhou, Wei] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Colorectal Surg, Hangzhou, Zhejiang, Peoples R China; [Bob, Zhou] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou, Gansu, Peoples R China; [DePamphilis, Melvin L.] NICHHD, Bethesda, MD 20892 USA; [Han, Zhiyong] Seton Hall Univ, Dept Med Sci, Hackensack Meridian Sch Med, S Orange, NJ 07079 USA	George Washington University; George Washington University; Dalian Medical University; City of Hope; Zhejiang University; Lanzhou University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Seton Hall University	Zhu, WG (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA.; Zhu, WG (corresponding author), George Washington Univ, GW Canc Ctr, Washington, DC 20052 USA.; Han, ZY (corresponding author), Seton Hall Univ, Dept Med Sci, Hackensack Meridian Sch Med, S Orange, NJ 07079 USA.	zhiyong.han@shu.edu; wz6812@gwu.edu	Zhang, Bob/HIR-3656-2022; li, yong/HDN-3885-2022	Chen, Chi-Wei/0000-0001-8658-055X	National Institutes of Health [CA177898, CA184717, RSG-13-214-01-DMC]; American Cancer Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000506] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA177898, R01CA184717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by funding from the National Institutes of Health (CA177898 and CA184717 to WZ). WZ was supported by a Research Scholar Grant, RSG-13-214-01-DMC from the American Cancer Society.	Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Balan KV, 2006, BIOCHEM PHARMACOL, V72, P573, DOI 10.1016/j.bcp.2006.05.023; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Cai YJ, 2004, ANTICANCER RES, V24, P999; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chen CW, 2016, NEOPLASIA, V18, P199, DOI 10.1016/j.neo.2016.02.005; Chen MC, 2015, MOL PHARMACOL, V87, P996, DOI 10.1124/mol.114.094987; Chen W, 2015, ANAL BIOANAL CHEM, V407, P5793, DOI 10.1007/s00216-015-8762-7; Chen ZH, 2004, CARCINOGENESIS, V25, P2005, DOI 10.1093/carcin/bgh183; Chen ZM, 2011, BIOCHEM BIOPH RES CO, V413, P383, DOI 10.1016/j.bbrc.2011.08.111; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Fabbrocini G, 2011, AM J CLIN DERMATOL, V12, P133, DOI 10.2165/11530630-000000000-00000; Fan GJ, 2009, BIOORGAN MED CHEM, V17, P2360, DOI 10.1016/j.bmc.2009.02.014; Fang JG, 2002, CHEM-EUR J, V8, P4191, DOI 10.1002/1521-3765(20020916)8:18<4191::AID-CHEM4191>3.0.CO;2-S; Fontecave M, 1998, FEBS LETT, V421, P277, DOI 10.1016/S0014-5793(97)01572-X; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Goan YG, 1999, CANCER RES, V59, P4204; Harikumar KB, 2010, INT J CANCER, V127, P257, DOI 10.1002/ijc.25041; Hehlmann R, 2003, LEUKEMIA, V17, P1010, DOI 10.1038/sj.leu.2402951; Hosseini A, 2015, AVICENNA J PHYTOMEDI, V5, P84; Hsieh YY, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.27; Hu S, 2016, ACTA BIOCH BIOPH SIN, V48, P528, DOI 10.1093/abbs/gmw026; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jung CP, 2001, CLIN CANCER RES, V7, P2527; Kimura Y, 2008, CANCER SCI, V99, P2083, DOI 10.1111/j.1349-7006.2008.00948.x; Kitao H, 2018, CANCER SCI, V109, P264, DOI 10.1111/cas.13455; Kohnken R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0446-6; Li GM, 2013, CANCER PREV RES, V6, P27, DOI 10.1158/1940-6207.CAPR-12-0349; Liu J, 2004, NEUROSCI LETT, V363, P257, DOI 10.1016/j.neulet.2004.03.075; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Lopez-Contreras AJ, 2015, GENE DEV, V29, P690, DOI 10.1101/gad.256958.114; Lu AG, 2012, WORLD J GASTROENTERO, V18, P4704, DOI 10.3748/wjg.v18.i34.4704; Ma LJ, 2015, INT J ONCOL, V47, P1460, DOI 10.3892/ijo.2015.3124; Maccario C, 2012, CARCINOGENESIS, V33, P2172, DOI 10.1093/carcin/bgs244; Minami K, 2015, J PHARMACOL SCI, V127, P319, DOI 10.1016/j.jphs.2015.01.006; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Morikawa T, 2010, HISTOPATHOLOGY, V57, P885, DOI 10.1111/j.1365-2559.2010.03725.x; Morikawa T, 2010, HUM PATHOL, V41, P1742, DOI 10.1016/j.humpath.2010.06.001; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Nessa MU, 2012, ANTICANCER RES, V32, P53; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Piotrowska H, 2013, TOXICOL IN VITRO, V27, P2127, DOI 10.1016/j.tiv.2013.09.012; Piotrowska H, 2012, TOXICOL APPL PHARM, V263, P53, DOI 10.1016/j.taap.2012.05.023; Plunkett W, 1995, ANTI-CANCER DRUG, V6, P7, DOI 10.1097/00001813-199512006-00002; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Puigvert JC, 2016, FEBS J, V283, P232, DOI 10.1111/febs.13574; Saha B, 2017, ONCOTARGET, V8, P73905, DOI 10.18632/oncotarget.17879; Saiki Y, 2012, BIOCHEM BIOPH RES CO, V421, P98, DOI 10.1016/j.bbrc.2012.03.122; Sale S, 2005, INT J CANCER, V115, P194, DOI 10.1002/ijc.20884; Savio M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19973; Scharadin TM, 2016, CHEM RES TOXICOL, V29, P1843, DOI 10.1021/acs.chemrestox.6b00247; Shah KN, 2015, MOL CANCER THER, V14, P2411, DOI 10.1158/1535-7163.MCT-14-0689; Shah KN, 2014, MOL CANCER RES, V12, P394, DOI 10.1158/1541-7786.MCR-13-0219; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Shewach DS, 2007, J CLIN ONCOL, V25, P4043, DOI 10.1200/JCO.2007.11.5287; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; THELANDER M, 1985, J BIOL CHEM, V260, P2737; Varoni EM, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00008; Wang LM, 2012, CHINESE MED J-PEKING, V125, P2151, DOI 10.3760/cma.j.issn.0366-6999.2012.12.013; Yamaguchi T, 2001, CANCER RES, V61, P8256; Zhang J, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080051; Zhou BS, 2013, CANCER RES, V73, P6484, DOI 10.1158/0008-5472.CAN-13-1094; Zhou BS, 1998, BIOCHEM PHARMACOL, V55, P1657, DOI 10.1016/S0006-2952(98)00042-2; Zhou W, 2018, ONCOGENE, V37, P3981, DOI 10.1038/s41388-018-0238-8; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	70	30	30	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2364	2379		10.1038/s41388-018-0584-6	http://dx.doi.org/10.1038/s41388-018-0584-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30518875	Green Accepted			2022-12-26	WOS:000462588000010
J	Kang, M; Kim, S; Ko, J				Kang, Minsoo; Kim, Suhyun; Ko, Jesang			Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer	FASEB JOURNAL			English	Article						extracellular vesicles; KRAS mutant; chemoresistance	EXTRACELLULAR VESICLES; TUMOR MICROENVIRONMENT; CELLS; MUTATIONS; PROMOTES; RELEASE; GROWTH; DIFFERENTIATION; EXOSOMES; GENE	Extracellular vesicles contain various cellular components that are involved in tumor growth, metastasis, and immune escape. Extracellular vesicles are classified into 2 groups, namely, exosomes and microvesicles (MV). Although the formation and roles of exosomes have been studied, the exact functions of MVs and mechanisms underlying MV release are not fully understood. We found that epidermal growth factor accelerates the release of MVs from the plasma membrane by inducing NF-B activation and CD133 expression. The amount and sizes of budding MVs were found to be dependent on the expression level of CD133, which regulates the activities of the small guanosine 5'-triphosphatases RhoA and Rac1. CD133-containing MVs released from KRAS mutant colon cancer cells delivered KRAS mutant to adjacent nontumorigenic cells and activated KRAS downstream signaling. CD133-containing MVs were found to promote the migration and invasion of adjacent cells. CD133-containing MVs induced the development of chemoresistance by abolishing the inhibitory effects of anti-epidermal growth factor receptor (EGFR) drugs on cell proliferation and motility in colon cancer. These results suggest that CD133 acts as a novel modulator in MV release and in oncoprotein trafficking. CD133 can serve as a therapeutic target for treatment of anti-EGFR drug-resistant colon cancer.Kang, M., Kim, S., Ko, J. Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer.	[Kang, Minsoo; Kim, Suhyun; Ko, Jesang] Korea Univ, Div Life Sci, 1 Anam Dong, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, 1 Anam Dong, Seoul 136701, South Korea.	jesangko@korea.ac.kr			Tunneling Nanotube Research Center through the National Research Foundation of Korea (NRF) - Korea government [NRF-2015R1A5A1009024]	Tunneling Nanotube Research Center through the National Research Foundation of Korea (NRF) - Korea government	This work was supported by the Tunneling Nanotube Research Center (NRF-2015R1A5A1009024) through the National Research Foundation of Korea (NRF) grant funded by the Korea government. The authors declare no conflicts of interest.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Chao OS, 2017, J CELL BIOCHEM, V118, P4414, DOI 10.1002/jcb.26095; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Krasinskas A. M., 2011, PATHOLOG RES INT, V2011, P6, DOI DOI 10.4061/2011/932932; Latorre E, 2016, CANCER RES, V76, P2626, DOI 10.1158/0008-5472.CAN-15-2018; Lim SH, 2014, J GASTROINTEST ONCOL, V5, P447, DOI 10.3978/j.issn.2078-6891.2014.071; Lucchetti D, 2017, AM J PATHOL, V187, P1633, DOI 10.1016/j.ajpath.2017.03.015; Maguire CA, 2012, MOL THER, V20, P960, DOI 10.1038/mt.2011.303; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Moon BS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt373; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rappa G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-62; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Santi A, 2015, BBA-MOL CELL RES, V1853, P3211, DOI 10.1016/j.bbamcr.2015.09.013; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Schneider M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-96; Sedgwick AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14748; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Wang MN, 2017, J CANCER, V8, P761, DOI 10.7150/jca.17648; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Won C, 2015, HEPATOLOGY, V62, P1160, DOI 10.1002/hep.27968; Yang ZL, 2011, WORLD J GASTROENTERO, V17, P932, DOI 10.3748/wjg.v17.i7.932; Zhang LH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02992; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	46	13	14	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4248	4260		10.1096/fj.201802018R	http://dx.doi.org/10.1096/fj.201802018R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521383	Bronze			2022-12-26	WOS:000459794800092
J	Schiano-di-Cola, C; Rojel, N; Jensen, K; Kari, J; Sorensen, TH; Borch, K; Westh, P				Schiano-di-Cola, Corinna; Rojel, Nanna; Jensen, Kenneth; Kari, Jeppe; Sorensen, Trine Holst; Borch, Kim; Westh, Peter			Systematic deletions in the cellobiohydrolase (CBH) Cel7A from the fungus Trichoderma reesei reveal flexible loops critical for CBH activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein engineering; cellulase; cellobiohydrolase; cellulose; enzyme kinetics; Trichoderma reesei; Cel7A; Cel7B; endoglucanase; loop engineering	CELLULOSE HYDROLYSIS; ENZYMATIC-HYDROLYSIS; PRODUCT INHIBITION; CRYSTAL-STRUCTURES; ENDOGLUCANASE-I; CATALYTIC CORE; CELLULASES; KINETICS; MECHANISM; ACID	Glycoside hydrolase family 7 (GH7) cellulases are some of the most efficient degraders of cellulose, making them particularly relevant for industries seeking to produce renewable fuels from lignocellulosic biomass. The secretome of the cellulolytic model fungus Trichoderma reesei contains two GH7s, termed TrCel7A and TrCel7B. Despite having high structural and sequence similarities, the two enzymes are functionally quite different. TrCel7A is an exolytic, processive cellobiohydrolase (CBH), with high activity on crystalline cellulose, whereas TrCel7B is an endoglucanase (EG) with a preference for more amorphous cellulose. At the structural level, these functional differences are usually ascribed to the flexible loops that cover the substrate-binding areas. TrCel7A has an extensive tunnel created by eight peripheral loops, and the absence of four of these loops in TrCel7B makes its catalytic domain a more open cleft. To investigate the structure-function relationships of these loops, here we produced and kinetically characterized several variants in which four loops unique to TrCel7A were individually deleted to resemble the arrangement in the TrCel7B structure. Analysis of a range of kinetic parameters consistently indicated that the B2 loop, covering the substrate-binding subsites -3 and -4 in TrCel7A, was a key determinant for the difference in CBH- or EG-like behavior between TrCel7A and TrCel7B. Conversely, the B3 and B4 loops, located closer to the catalytic site in TrCel7A, were less important for these activities. We surmise that these results could be useful both in further mechanistic investigations and for guiding engineering efforts of this industrially important enzyme family.	[Schiano-di-Cola, Corinna; Rojel, Nanna; Kari, Jeppe; Sorensen, Trine Holst] Roskilde Univ, Dept Sci & Environm, Univ Vej 1,Bldg 28, DK-4000 Roskilde, Denmark; [Jensen, Kenneth; Borch, Kim] Novozymes AS, Krogshojvej 36, DK-2880 Bagsvaerd, Denmark; [Schiano-di-Cola, Corinna; Rojel, Nanna; Westh, Peter] Tech Univ Denmark, Dept Biotechnol & Biomed, Bldg 224, DK-2800 Lyngby, Denmark	Roskilde University; Novozymes; Technical University of Denmark	Westh, P (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Bldg 224, DK-2800 Lyngby, Denmark.	petwe@dtu.dk	Jensen, Kenneth/G-3638-2011; Westh, Peter/AAR-9731-2021; Kari, Jeppe/AAP-6649-2021	Jensen, Kenneth/0000-0001-6286-5577; Kari, Jeppe/0000-0003-3792-3856; Sorensen, Trine Holst/0000-0002-2045-7580; Westh, Peter/0000-0002-6185-0637; Schiano-di-Cola, Corinna/0000-0002-6720-1734; Rojel, Nanna/0000-0003-2887-3738	Innovation Fund Denmark [5150-00020B]; Novo Nordisk Foundation [NNF15OC0016606]	Innovation Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by Innovation Fund Denmark Grant 5150-00020B to P.W.) and Novo Nordisk Foundation Grant NNF15OC0016606. K.J. and K.B. are employed by Novozymes, a major enzyme-producing company.	Akpa OM, 2011, DESALINATION, V272, P20, DOI 10.1016/j.desal.2010.12.057; Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Andersen M, 2018, MATH BIOSCI, V296, P93, DOI 10.1016/j.mbs.2017.11.011; Badino SF, 2017, BBA-PROTEINS PROTEOM, V1865, P1739, DOI 10.1016/j.bbapap.2017.08.013; BAILEY CJ, 1989, BIOCHEM J, V262, P1001; Bezerra RMF, 2004, APPL BIOCHEM BIOTECH, V112, P173, DOI 10.1385/ABAB:112:3:173; Borch K., 2014, WIPO patent, Patent No. 2014138672; Bu LT, 2013, J BIOL CHEM, V288, P12175, DOI 10.1074/jbc.M113.462465; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Hobdey SE, 2016, APPL ENVIRON MICROB, V82, P3395, DOI 10.1128/AEM.00163-16; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kletting P, 2009, PHYS MED BIOL, V54, pN501, DOI 10.1088/0031-9155/54/21/N01; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kostylev M, 2012, BIOFUELS-UK, V3, P61, DOI 10.4155/BFS.11.150; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Mertz B, 2009, BIOPOLYMERS, V91, P478, DOI 10.1002/bip.21154; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Murphy L, 2013, ENZYME MICROB TECH, V52, P163, DOI 10.1016/j.enzmictec.2013.01.002; Olsen JP, 2017, ENZYME MICROB TECH, V105, P45, DOI 10.1016/j.enzmictec.2017.06.009; Olsen JP, 2016, BIOTECHNOL BIOENG, V113, P1178, DOI 10.1002/bit.25900; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pellegrini VOA, 2014, LANGMUIR, V30, P12602, DOI 10.1021/la5024423; PENTTILA M, 1986, GENE, V45, P253, DOI 10.1016/0378-1119(86)90023-5; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosgaard L, 2007, BIOTECHNOL PROGR, V23, P1270, DOI 10.1021/bp070329p; Saloheimo M, 2012, MICROBIOL-SGM, V158, P46, DOI 10.1099/mic.0.053132-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silveira RL, 2018, PHYS CHEM CHEM PHYS, V20, P7498, DOI 10.1039/c8cp00101d; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	51	23	24	4	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1807	1815		10.1074/jbc.RA118.006699	http://dx.doi.org/10.1074/jbc.RA118.006699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30538133	Green Published, hybrid			2022-12-26	WOS:000459711400004
J	Contreras, DA; Hiriart, E; Bondeau, A; Kirman, A; Guiot, J; Bernard, L; Suarez, R; Van der Leeuw, S				Contreras, Daniel A.; Hiriart, Eneko; Bondeau, Alberte; Kirman, Alan; Guiot, Joel; Bernard, Loup; Suarez, Romain; Van der Leeuw, Sander			Regional paleoclimates and local consequences: Integrating GIS analysis of diachronic settlement patterns and process-based agroecosystem modeling of potential agricultural productivity in Provence (France)	PLOS ONE			English	Article							CLIMATIC CHANGES; LAND-USE; MEDITERRANEAN VEGETATION; NEOLITHIC TRANSITION; HOLOCENE; COLLAPSE; DYNAMICS; IMPACT; COMMUNITIES; TOPOGRAPHY	Holocene climate variability in the Mediterranean Basin is often cited as a potential driver of societal change, but the mechanisms of this putative influence are generally little explored. In this paper we integrate two tools agro-ecosystem modeling of potential agricultural yields and spatial analysis of archaeological settlement pattern data in order to examine the human consequences of past climatic changes. Focusing on a case study in Provence (France), we adapt an agro-ecosystem model to the modeling of potential agricultural productivity during the Holocene. Calibrating this model for past crops and agricultural practices and using a downscaling approach to produce high spatiotemporal resolution paleoclimate data from a Mediterranean Holocene climate reconstruction, we estimate realistic potential agricultural yields under past climatic conditions. These serve as the basis for spatial analysis of archaeological settlement patterns, in which we examine the changing relationship over time between agricultural productivity and settlement location. Using potential agricultural productivity (PAgP) as a measure of the human consequences of climate changes, we focus on the relative magnitudes of 1) climate-driven shifts in PAgP and 2) the potential increases in productivity realizable through agricultural intensification. Together these offer a means of assessing the scale and mechanisms of the vulnerability and resilience of Holocene inhabitants of Provence to climate change. Our results suggest that settlement patterns were closely tied to PAgP throughout most of the Holocene, with the notable exception of the period from the Middle Bronze Age through the Early Iron Age. This pattern does not appear to be linked to any climatically-driven changes in PAgP, and conversely the most salient changes in PAgP during the Holocene cannot be clearly linked to any changes in settlement pattern. We argue that this constitutes evidence that vulnerability and resilience to climate change are strongly dependent on societal variables.	[Contreras, Daniel A.; Bondeau, Alberte] Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, CNRS, IRD,Avignon Univ, Aix En Provence, France; [Contreras, Daniel A.] Aix Marseille Univ, GREQAM, Aix En Provence, France; [Contreras, Daniel A.] Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA; [Hiriart, Eneko] Aix Marseille Univ, CNRS, Minist Culture, MMSH,Ctr Camille Julian, Aix En Provence, France; [Hiriart, Eneko] Univ Bordeaux Montaigne, UMR 5060, IRAMAT CRP2A, Bordeaux, France; [Kirman, Alan] Ecole Hautes Etud Sci Sociales, CAMS EHESS, Aix En Provence, France; [Kirman, Alan] Aix Marseille Univ, Aix En Provence, France; [Guiot, Joel] Aix Marseille Univ, CNRS, IRD, INRA,Coll France,CEREGE, Aix En Provence, France; [Bernard, Loup] Univ Strasbourg, Univ Haute Alsace, CNRS, Archimede UMR, Strasbourg, France; [Suarez, Romain] Aix Marseille Univ, LabEx OT Med, Aix En Provence, France; [Van der Leeuw, Sander] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA; [Van der Leeuw, Sander] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Haute-Alsace (UHA); UDICE-French Research Universities; Aix-Marseille Universite; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Contreras, DA (corresponding author), Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, CNRS, IRD,Avignon Univ, Aix En Provence, France.; Contreras, DA (corresponding author), Aix Marseille Univ, GREQAM, Aix En Provence, France.; Contreras, DA (corresponding author), Univ Maryland, Dept Anthropol, College Pk, MD 20742 USA.	danielalexandercontreras@gmail.com	Bondeau, Alberte/E-9909-2012; van der Leeuw, Sander/AAF-7850-2019	Bondeau, Alberte/0000-0002-8729-5061; Hiriart, Eneko/0000-0003-4379-3672; Kirman, Alan/0000-0002-4152-6522	Laboratory of Excellence OT-Med [ANR-11- LABEX-0061]; Laboratory of Excellence OT-Med (AMidex project) [11-IDEX-0001-02]; Research Network ECCOREV (Ecosystemes Continentaux et Risques Environnementaux)	Laboratory of Excellence OT-Med; Laboratory of Excellence OT-Med (AMidex project); Research Network ECCOREV (Ecosystemes Continentaux et Risques Environnementaux)	This paper is a contribution to the AMEDEE project, which has received partial funding from Laboratory of Excellence OT-Med (Project ANR-11- LABEX-0061, AMidex project 11-IDEX-0001-02) and the Research Network ECCOREV (Ecosystemes Continentaux et Risques Environnementaux).	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2013, NASA SHUTTL RAD TOP; [Anonymous], 2000, PRACTICAL APPL GIS A; Antolin F, 2015, J ARCHAEOL SCI, V61, P90, DOI 10.1016/j.jas.2015.05.007; Baddeley A, 2015, SPATIAL POINT PATTER; Barton CM, 2015, LAND-BASEL, V4, P578, DOI 10.3390/land4030578; Barton CM, 1999, AM ANTIQUITY, V64, P609, DOI 10.2307/2694208; Baum T, 2016, VEG HIST ARCHAEOBOT, P1; Bayliss A, 2007, CAMB ARCHAEOL J, V17, P1, DOI 10.1017/S0959774307000145; Bayliss A, 2009, RADIOCARBON, V51, P123, DOI 10.1017/S0033822200033750; Berger J-F, 2009, REVOLUTION NEOLITHIQ, P121; Berger JF, 2016, QUATERNARY SCI REV, V136, P66, DOI 10.1016/j.quascirev.2015.11.019; Berger JF, 2009, QUATERN INT, V200, P31, DOI 10.1016/j.quaint.2008.05.013; Auban JB, 2016, QUATERN INT, V403, P201, DOI 10.1016/j.quaint.2015.09.020; Bernard L, 2015, CAA2014 21 CENTURY A, P401; Bernard L., 2016, ARKEOGIS; Bevan A, 2013, PUBL INST ARCHAEOL, P27; Binder D., 2009, EUROPES 1 FARMERS, P117, DOI [DOI 10.1017/CBO9780511607851.006, 10.1017/cbo9780511607851.006]; Binder D., 2008, B MUSEE ANTHROPOL S1, P49; Blondel J, 2010, MEDITERRANEAN REGION; Bogaard, 2004, NEOLITHIC FARMING CE, DOI DOI 10.4324/9780203358009; Bogaard A., 2004, DOCUMENTA PRAEHISTOR, V31, P49, DOI DOI 10.4312/dp.31.4; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Bouby L, 2011, AGE BRONZE MEDITERRA, P101; Bouby L, 2014, AGR BASSIN RHONE BRO; Brooks N, 2012, GEOGR TIDSSKR-DEN, V112, P93, DOI 10.1080/00167223.2012.741881; Buisson-Catil J., 2004, VAUCLUSE PREHISTORIQ; Cacho I, 2001, PALEOCEANOGRAPHY, V16, P40, DOI 10.1029/2000PA000502; Carozza L, 2015, TAGUNGEN LANDESMUSEU, V12, P333; Cesaretti R., 2015, CLIODYNAMICS, V6, P24; Clarke J, 2016, QUATERNARY SCI REV, V136, P96, DOI 10.1016/j.quascirev.2015.10.003; Contreras DA, 2018, PALEOCLIMATE VARIABL; Contreras D, 2018, J ARCHAEOL SCI, V93, P54, DOI 10.1016/j.jas.2018.02.013; Contreras DA, 2017, ROUT STUD ARCHAEOL, P3; dAlpoim Guedes JA, 2016, P NATL ACAD SCI; Danielisova A, 2015, ADV GEOGR INFORM SCI, P183, DOI 10.1007/978-3-319-00008-4__9; De Beaulieu JL, 2005, PLANT BIOSYST, V139, P114, DOI 10.1080/11263500500197858; Drake BL, 2017, J ARCHAEOL METHOD TH, V24, P796, DOI 10.1007/s10816-016-9286-y; Drake BL, 2012, J ARCHAEOL SCI, V39, P1862, DOI 10.1016/j.jas.2012.01.029; Fader M, 2015, GEOSCI MODEL DEV, V8, P3545, DOI 10.5194/gmd-8-3545-2015; Flohr P, 2016, QUATERNARY SCI REV, V136, P23, DOI 10.1016/j.quascirev.2015.06.022; Frigola J, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001307; Garcia D, 2010, GRECS INDIGENES CATA, P403; GARCIA D., 2006, CIVILISES BARBARES, V12, P63; Garcia D., 2014, CELTIQUE MEDITERRANE; Garcia Dominique, 2002, TERRITOIRE CELTIQUES; Gassin B, 2008, ACT 7EM RENC MET PRE, P1; GORENFLO L, 1986, J ANTHROPOL ARCHAEOL, V5, P199, DOI 10.1016/0278-4165(86)90006-1; Guilaine J., 2007, PONT ROQUE HAUTE NOU, P21; Guiot J, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00028; Halstead P., 2014, 2 OXEN AHEAD PREMECH; Hijmans R.J., 2021, PACKAGE RASTER; Hodder I., 1976, SPATIAL ANAL ARCHAEO; Isoardi D., 2010, ARQUEOLOGIA ESPACIAL, V28, P265; Jacomet S, 2016, HOLOCENE, P1; Jalut G, 2000, PALAEOGEOGR PALAEOCL, V160, P255, DOI 10.1016/S0031-0182(00)00075-4; Jalut G, 2009, QUATERN INT, V200, P4, DOI 10.1016/j.quaint.2008.03.012; Jean-Francois B, 2011, GEOMORPHOLOGY, V129, P167, DOI 10.1016/j.geomorph.2011.02.021; Kaniewski D, 2015, WIRES CLIM CHANGE, V6, P369, DOI 10.1002/wcc.345; Kintigh KW, 2014, P NATL ACAD SCI USA, V111, P879, DOI 10.1073/pnas.1324000111; Kohler TA, 2012, ORIG HUM BEHAV, V6, P1, DOI 10.1525/california/9780520270145.001.0001; Kohler TA, 2012, ECOL MODEL, V241, P30, DOI 10.1016/j.ecolmodel.2012.01.002; Kvamme KL, GIS ARCHAEOLOGICAL P; Magnin F, 2008, B ARCHEOLOGIQUE PROV, V5, P61; Magny M, 2002, PALAEOGEOGR PALAEOCL, V186, P47, DOI 10.1016/S0031-0182(02)00442-X; Magny M., 2013, CLIM PAST DISCUSS, V9, P1901; Magny M, 2011, QUATERNARY SCI REV, V30, P2459, DOI 10.1016/j.quascirev.2011.05.018; Magny M, 2009, HOLOCENE, V19, P823, DOI 10.1177/0959683609337360; Marinval P., 2004, PALLAS, V64, P233; Mehrer M, 2006, GIS ARCHAEOLOGICAL P; Middleton G, 2012, J ARCHAEOL RES, V20, P257, DOI 10.1007/s10814-011-9054-1; Mitasova H., 2013, TREATISE GEOMORPHOL, P228, DOI [10.1016/B978-0-12-374739-6.00052-X, DOI 10.1016/B978-0-12-374739-6.00052-X]; Peeters I, 2006, GEOMORPHOLOGY, V78, P250, DOI 10.1016/j.geomorph.2006.01.033; Rosch M, 2014, VEG HIST ARCHAEOBOT, V23, pS121, DOI 10.1007/s00334-014-0437-3; Rohling EJ, 2016, J ARCHAEOL SCI, V73, P17, DOI 10.1016/j.jas.2016.07.005; Rosen A.M., 2007, CIVILIZING CLIMATE S; Ruas M. P., 1991, ARCHEOLOGIE AGRAIRE, P409; Sarkar D, 2008, USE R, P1; SELTZER GO, 1990, J FIELD ARCHAEOL, V17, P397, DOI 10.1179/009346990791548600; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Stika H.-P., 2013, OXFORD HDB EUROPEAN, P348, DOI DOI 10.1093/OXFORDHB/9780199572861.013.0019; Terral JF, 1997, CR ACAD SCI II A, V324, P417; Thurston TL, 2007, STUD HUM ECOL ADAPT, V3, P1; Vanniere B, 2011, HOLOCENE, V21, P53, DOI 10.1177/0959683610384164; Verhagen P, 2007, CASE STUDIES ARCHAEO; Vermeer JAM, 2014, EARTH SURF PROC LAND, V39, P632, DOI 10.1002/esp.3472; Vital J., 2004, JC CYPSELA REV PREHI, V15, P11; Walsh K, 2003, AM J ARCHAEOL, V107, P45, DOI 10.3764/aja.107.1.45; Weinelt M., 2015, 2200 BC CLIMATIC BRE, V12, P461; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weninger B, 2009, DOC PRAEHIST, V36, P7, DOI 10.4312/dp.36.2; Wheatley D., 2002, SPATIAL TECHNOLOGY A, DOI [10.4324/9780203302392, DOI 10.4324/9780203302392]; Whittle A, 2007, CAMB ARCHAEOL J, V17, P21, DOI 10.1017/S0959774307000030; Wilkinson TJ, 2007, AM ANTHROPOL, V109, P52, DOI 10.1525/AA.2007.109.1.52	94	6	6	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207622	10.1371/journal.pone.0207622	http://dx.doi.org/10.1371/journal.pone.0207622			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540786	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600024
J	Teng, Z; van Haute, S; Zhou, B; Hapeman, CJ; Millner, PD; Wang, Q; Luo, YG				Teng, Zi; van Haute, Sam; Zhou, Bin; Hapeman, Cathleen J.; Millner, Patricia D.; Wang, Qin; Luo, Yaguang			Impacts and interactions of organic compounds with chlorine sanitizer in recirculated and reused produce processing water	PLOS ONE			English	Article							FRESH; DEMAND; VEGETABLES; KINETICS; CABBAGE; QUALITY; ACIDS	Water conservation and economics dictate that fresh produce processors reuse/recirculate the process water. However, the ensuing accumulation of organic matter in water depletes the chlorine sanitizer required for food safety. In this study, we comprehensively investigated chemical compounds that are responsible for water quality in relation to chemical oxygen demand (COD) and chlorine demand (CLD), the two most critical factors associated with water treatment and chlorine replenishment. Simulating commercial fresh-cut wash operations, multiple batches of diced cabbage (0.3 x 0.3 cm(2)) were washed in the same tank of water. The major components were isolated from the wash water and analyzed by HPLC. Sugars were the predominant compounds (82.7% dry weight) and the major contributor to COD (81.6%), followed by proteins/peptides (7.3% dry weight, 5.3% COD), organic acids (6.2% dry weight, 3.6% COD), and phenolics (0.5% dry weight, 0.5% COD). By repeated time course measures, the effect of these chemicals on CLD are dependent on the chemical structure, concentration in the wash water, and their rate of reaction. Proteins/peptides accounted for about 50% of the total CLD over a 120-min period and phenolics was 21% at 5 min, but diminished with time. The contribution by organic acids and sugars increased continuously, reaching 22% and 16% of total CLD at 120 min of chlorination, respectively. Collectively, these compounds represented 86% of the CLD in cabbage wash water at 5 min and greater than 94% CLD afterwards. This is the first systematic report on the source of COD and CLD during fresh produce washing. It provides essential information for the produce processors to develop safe, effective, and economical wash water treatment/reuse and chlorine replenishment strategies.	[Teng, Zi; van Haute, Sam; Zhou, Bin; Millner, Patricia D.; Luo, Yaguang] USDA ARS, Beltsville Agr Res Ctr, Environm Microbiol & Food Safety Lab, Beltsville, MD 20705 USA; [Teng, Zi; Wang, Qin] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Hapeman, Cathleen J.] USDA, Hydrol & Remote Sensing Lab, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Luo, YG (corresponding author), USDA ARS, Beltsville Agr Res Ctr, Environm Microbiol & Food Safety Lab, Beltsville, MD 20705 USA.	Yaguang.Luo@ars.usda.gov	Wang, Qin/ABE-1239-2021; Van Haute, Sam/ABA-4501-2021; Van Haute, Sam/AAQ-8996-2021; Teng, Zi/G-5747-2013	Van Haute, Sam/0000-0003-3727-3603; Teng, Zi/0000-0002-6029-7024; Zhou, Bin/0000-0002-0315-8204	USDA-NIFA (Specialty Crops Research Initiative) [2016-51181-25403]; USDA ARS [1275-43440-006-00D]	USDA-NIFA (Specialty Crops Research Initiative); USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project is funded by USDA-NIFA (Specialty Crops Research Initiative award no. 2016-51181-25403) and USDA ARS (project no. 1275-43440-006-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletor O, 2002, FOOD CHEM, V78, P63, DOI 10.1016/S0308-8146(01)00376-4; Casani S, 2005, WATER RES, V39, P1134, DOI 10.1016/j.watres.2004.12.015; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; EPA, 2012, BAS INF CHEM CONT RU; Gallard H, 2002, WATER RES, V36, P65, DOI 10.1016/S0043-1354(01)00187-7; Hach. Company, 2017, 1042 HACK CO; Hach. Company, 2014, 10236 HACH CO; Hach. Company, 2014, 8021 HACH CO; Hodges DM, 2006, POSTHARVEST BIOL TEC, V40, P123, DOI 10.1016/j.postharvbio.2005.12.019; Kolb M, 2017, WATER RES, V122, P645, DOI 10.1016/j.watres.2017.06.034; Lehto M, 2014, AGR FOOD SCI, V23, P246, DOI 10.23986/afsci.41306; Lester GE, 2012, J FOOD COMPOS ANAL, V27, P102, DOI 10.1016/j.jfca.2012.05.003; Luo YG, 2018, FOOD MICROBIOL, V70, P120, DOI 10.1016/j.fm.2017.09.013; Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007; Meneses YE, 2017, TRENDS FOOD SCI TECH, V61, P72, DOI 10.1016/j.tifs.2016.12.008; Moore J, 2005, J AGR FOOD CHEM, V53, P6649, DOI 10.1021/jf050481b; Rosa E, 2001, J SCI FOOD AGR, V81, P1145, DOI 10.1002/jsfa.919; Sun JY, 2013, ARCH ENVIRON CON TOX, V64, P243, DOI 10.1007/s00244-012-9824-x; Tandukar M, 2015, WATER RES, V87, P432, DOI 10.1016/j.watres.2015.04.031; Toivonen PMA, 2013, POSTHARVEST BIOL TEC, V86, P192, DOI 10.1016/j.postharvbio.2013.06.035; USDA-ARS, NAT NUTR DAT STAND R, P26; Van Haute S, 2013, APPL ENVIRON MICROB, V79, P2850, DOI 10.1128/AEM.03283-12; Van Wagenen J, 2015, WATER RES, V75, P301, DOI 10.1016/j.watres.2015.02.022; Waters BW, 2014, INT J FOOD SCI TECH, V49, P867, DOI 10.1111/ijfs.12379; Weng SC, 2016, FOOD CONTROL, V60, P543, DOI 10.1016/j.foodcont.2015.08.031; Xiao ZL, 2015, POSTHARVEST BIOL TEC, V110, P140, DOI 10.1016/j.postharvbio.2015.07.021; Zhou B, 2014, J FOOD PROCESS PRES, V38, P2201, DOI 10.1111/jfpp.12200	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208945	10.1371/journal.pone.0208945	http://dx.doi.org/10.1371/journal.pone.0208945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540850	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600100
J	Lim, JH; Ryu, JS; Kim, JH; Kim, HJ; Lee, D				Lim, Jun Hyeok; Ryu, Jeong-Seon; Kim, Jae Hoon; Kim, Hyun-Jung; Lee, DaeHyung			Gender as an independent prognostic factor in small-cell lung cancer: Inha Lung Cancer Cohort study using propensity score matching	PLOS ONE			English	Article							SURVIVAL; EPIDEMIOLOGY; CARCINOMA; HISTORY; SCLC; BIAS	Introduction The prognostic relevance of gender is undetermined in patients with small-cell lung cancer (SCLC). Therefore, we investigated whether gender is a prognostic factor in a SCLC cohort after controlling for confounding factors. Materials and methods Fifteen prognostic factors were classified into four groups (patient, stage migration, tumor, and treatment). The prognostic relevance of gender was evaluated using propensity score matching, Cox proportional hazards regression, and stepwise fashion adjustments. Results Of 591 patients with SCLC, 88 were women (14.9%). Women were more likely than men to have no history of smoking (48.9% vs. 2.0%, P < 0.001) and limited disease (48.9% vs. 37.8%, P = 0.050). Women had less progressive disease in M stage than men (52.3% vs. 62.8%, P = 0.031). Women had better survival than men in the entire cohort (median survival times [MSTs] and 95% confidence intervals [CIs]: 9.7 months and 7.8-11.6 for women, 8.0 months and 7.0-8.9 for men, log-rank P = 0.034) and in the matched cohort (MSTs and 95% CIs: 8.8 months and 5.8-11.8 for women, 5.9 months and 4.5-7.4 for men, log-rank P = 0.013). Female gender was a prognostic factor predicting better survival, even after stepwise and full adjustment with all prognostic variables (adjusted hazard ratios and 95% CIs: 0.51 and 0.34-0.77, P = 0.001 for entire cohort, 0.42 and 0.24-0.75, P = 0.003 for matched cohort). Conclusions Our results confirmed that gender is an independent prognostic factor in patients with SCLC.	[Lim, Jun Hyeok; Ryu, Jeong-Seon; Kim, Hyun-Jung] Inha Univ Hosp, Dept Internal Med, Incheon, South Korea; [Kim, Jae Hoon] Inha Univ, Sch Med, Incheon, South Korea; [Lee, DaeHyung] Inha Univ Hosp, Resp Publ Med Ctr, Incheon, South Korea	Inha University; Inha University Hospital; Inha University; Inha University; Inha University Hospital	Ryu, JS (corresponding author), Inha Univ Hosp, Dept Internal Med, Incheon, South Korea.	jsryu@inha.ac.kr	Lim, Jun Hyeok/ABA-5277-2021		National Research Foundation of Korea(NRF) [NRF-2017R1E1A1A01074863, HI16C0286]; Korea Health Technology RD Project	National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Korea Health Technology RD Project	This work was supported by grant (NRF-2017R1E1A1A01074863 and HI16C0286) from the National Research Foundation of Korea(NRF) and the Korea Health Technology R&D Project. (Recipient: JSR).	Cheng TYD, 2016, J THORAC ONCOL, V11, P1653, DOI 10.1016/j.jtho.2016.05.021; Dinan MA, 2012, J CLIN ONCOL, V30, P2725, DOI 10.1200/JCO.2011.40.4392; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hajage D, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0135-1; Howlader NNA, 2020, SEER CANC STAT REV; Ignatius SH, 2009, J THORAC ONCOL, V4, P37, DOI 10.1097/JTO.0b013e31819140fb; JOHNSON BE, 1988, AM J MED, V85, P194; LASSEN U, 1995, J CLIN ONCOL, V13, P1215, DOI 10.1200/JCO.1995.13.5.1215; MCCRACKEN JD, 1990, J CLIN ONCOL, V8, P892, DOI 10.1200/JCO.1990.8.5.892; Mennecier B, 2003, LUNG CANCER-J IASLC, V42, P141, DOI 10.1016/S0169-5002(03)00284-8; Nicholson AG, 2016, J THORAC ONCOL, V11, P300, DOI 10.1016/j.jtho.2015.10.008; Paesmans M, 2000, CANCER, V89, P523, DOI 10.1002/1097-0142(20000801)89:3<523::AID-CNCR7>3.0.CO;2-6; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Quoix E, 2000, LUNG CANCER-J IASLC, V30, P127, DOI 10.1016/S0169-5002(00)00131-8; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 2000, J AM STAT ASSOC, V95, P573, DOI 10.2307/2669400; Ryu JS, 2014, J CLIN ONCOL, V32, P960, DOI 10.1200/JCO.2013.50.5453; SAGMAN U, 1991, J CLIN ONCOL, V9, P1639, DOI 10.1200/JCO.1991.9.9.1639; Shin A, 2017, CANCER RES TREAT, V49, P616, DOI 10.4143/crt.2016.178; Sun JM, 2015, ANN ONCOL, V26, P161, DOI 10.1093/annonc/mdu504; WOLF M, 1991, BRIT J CANCER, V63, P986, DOI 10.1038/bjc.1991.215; ZELEN M, 1973, CANCER CHEMOTH REP 3, V4, P31	22	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208492	10.1371/journal.pone.0208492	http://dx.doi.org/10.1371/journal.pone.0208492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533016	gold, Green Submitted, Green Published			2022-12-26	WOS:000452782500022
J	Liu, XL; Kim, CS; Hong, KS				Liu, Xiaolong; Kim, Chang-Seok; Hong, Keum-Shik			An fNIRS-based investigation of visual merchandising displays for fashion stores	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CLASSIFICATION; FEATURES; SIGNAL; MOTOR; NIRS	This paper investigates a brain-based approach for visual merchandising display (VMD) in fashion stores. In marketing, VMD has become a research topic of interest. However, VMD research using brain activation information is rare. We examine the hemodynamic responses (HRs) in the prefrontal cortex (PFC) using functional near-infrared spectroscopy (fNIRS) while positive/negative displays of four stores (menswear, womenswear, underwear, and sportswear) are shown to 20 subjects. As features for classifying the HRs, the mean, variance, peak, skewness, kurtosis, t-value, and slope of the signals for a 20-sec time window for the activated channels are analyzed. Linear discriminant analysis is used for classifying two-class (positive and negative displays) and four-class (four fashion stores) models. PFC brain activation maps based on t-values depicting the data from the 16 channels are provided. In the two-class classification, the underwear store had the highest average classification result of 67.04%, whereas the menswear store had the lowest value of 64.15%. Men's classification accuracy for the underwear stores with positive and negative displays was 71.38%, whereas the highest classification accuracy obtained by women for womenswear stores was 73%. The average accuracy over the 20 subjects for positive displays was 50.68%, while that of negative displays was 51.07%. Therefore, these findings suggest that human brain activation is involved in the evaluation of the fashion store displays. It is concluded that fNIRS can be used as a brain-based tool in the evaluation of fashion stores in a daily life environment.	[Liu, Xiaolong; Hong, Keum-Shik] Pusan Natl Univ, Sch Mech Engn, Busan, South Korea; [Liu, Xiaolong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu, Sichuan, Peoples R China; [Kim, Chang-Seok; Hong, Keum-Shik] Pusan Natl Univ, Dept Cognomechatron Engn, Busan, South Korea	Pusan National University; University of Electronic Science & Technology of China; Pusan National University	Hong, KS (corresponding author), Pusan Natl Univ, Sch Mech Engn, Busan, South Korea.; Hong, KS (corresponding author), Pusan Natl Univ, Dept Cognomechatron Engn, Busan, South Korea.	kshong@pusan.ac.kr			China Scholarship Council [201408260012]; National Research Foundation of Korea under the Ministry of Science and ICT, Republic of Korea [NRF-2017R1A4A1015627]	China Scholarship Council(China Scholarship Council); National Research Foundation of Korea under the Ministry of Science and ICT, Republic of Korea	This research was supported by the China Scholarship Council (grant no. 201408260012) and the National Research Foundation of Korea under the auspices of the Ministry of Science and ICT, Republic of Korea (grant no. NRF-2017R1A4A1015627).	Achterberg M, 2016, SOC COGN AFFECT NEUR, V11, P712, DOI 10.1093/scan/nsv154; Adewuyi AA, 2016, FRONT NEUROROBOTICS, V10, DOI 10.3389/fnbot.2016.00015; Aydin S, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065716500131; Baek E, 2018, J BUS RES, V88, P91, DOI 10.1016/j.jbusres.2018.03.013; Bauernfeind G, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056010; Bercik J, 2016, APPETITE, V106, P101, DOI 10.1016/j.appet.2016.04.010; Bhutta MR, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4865124; Binzoni T, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0066-2; Boas DA, 2014, NEUROIMAGE, V85, P1, DOI 10.1016/j.neuroimage.2013.11.033; Breazeale M, 2013, J BUS RES, V66, P839, DOI 10.1016/j.jbusres.2011.06.009; Bui TTQ, 2016, INT J CONTROL AUTOM, V14, P616, DOI 10.1007/s12555-014-0502-9; Chiarelli AM, 2015, NEUROIMAGE, V112, P128, DOI 10.1016/j.neuroimage.2015.02.057; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Estes Z, 2018, J BUS RES, V85, P396, DOI 10.1016/j.jbusres.2017.10.017; Garrett D, 2003, IEEE T NEUR SYS REH, V11, P141, DOI 10.1109/TNSRE.2003.814441; Guerrero-Mosquera C, 2016, J NEUROSCI METH, V271, P128, DOI 10.1016/j.jneumeth.2016.07.010; Hammerslag LR, 2016, BEHAV BRAIN RES, V298, P15, DOI 10.1016/j.bbr.2015.04.008; Hiwa S., 2016, COMPUTATIONAL INTELL, V2016, P3; Hong KS, 2017, BEHAV BRAIN RES, V333, P225, DOI 10.1016/j.bbr.2017.06.034; Hong KS, 2016, HEARING RES, V333, P157, DOI 10.1016/j.heares.2016.01.009; Hong KS, 2015, NEUROSCI LETT, V587, P87, DOI 10.1016/j.neulet.2014.12.029; Hong KS, 2014, BIOMED OPT EXPRESS, V5, P1778, DOI 10.1364/BOE.5.001778; Hoppes CW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193710; Hu XS, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026012; Huppert TJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184918; Issa M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7453149; Jeong S, 2017, INT J CONTROL AUTOM, V15, P473, DOI 10.1007/s12555-015-0269-7; Jung S, 2017, INT J CONTROL AUTOM, V15, P952, DOI 10.1007/s12555-015-0070-7; Khan MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00244; Kim HH, 2017, INT J CONTROL AUTOM, V15, P2942, DOI 10.1007/s12555-016-0332-z; Kreplin U, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00879; Law D, 2012, EUR J MARKETING, V46, P112, DOI 10.1108/03090561211189266; Lee HG, 2017, INT J CONTROL AUTOM, V15, P2744, DOI 10.1007/s12555-016-0432-9; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Liu XL, 2017, J INNOV OPT HEAL SCI, V10, DOI 10.1142/S1793545817500067; Metereau E, 2015, CORTEX, V63, P42, DOI 10.1016/j.cortex.2014.08.012; Muthalib M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131951; Naseer N, 2014, EXP BRAIN RES, V232, P555, DOI 10.1007/s00221-013-3764-1; Nguyen HD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165146; Parisi GI, 2015, FRONT NEUROROBOTICS, V9, P1, DOI 10.3389/fnbot.2015.00003; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Petermans A, 2014, J BUS RES, V67, P2243, DOI 10.1016/j.jbusres.2014.06.012; Santosa H, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00418; Schecklmann M, 2014, NEURAL PLAST, V2014; Schmeichel BJ, 2016, SOC COGN AFFECT NEUR, V11, P282, DOI 10.1093/scan/nsv112; Shin JK, 2015, PSYCHOL MARKET, V32, P1148, DOI 10.1002/mar.20844; Tai K, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-39; Tonoyan Y, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065716500052; Vessel EA, 2012, FRONT HUM NEUROSCI, V6, P1, DOI 10.3389/fnhum.2012.00066; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Wang PC, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00217; Wei LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070195; Zafar A, 2017, BIOMED OPT EXPRESS, V8, P367, DOI 10.1364/BOE.8.000367; Zhang WH, 2015, HUM BRAIN MAPP, V36, P415, DOI 10.1002/hbm.22636	54	14	14	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208843	10.1371/journal.pone.0208843	http://dx.doi.org/10.1371/journal.pone.0208843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD8CS	30533055	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500042
J	Hernandez-Yumar, A; Wemrell, M; Alesson, IA; Lopez-Valcarcel, BG; Leckie, G; Merlo, J				Hernandez-Yumar, Aranzazu; Wemrell, Maria; Abasolo Alesson, Ignacio; Gonzalez Lopez-Valcarcel, Beatriz; Leckie, George; Merlo, Juan			Socioeconomic differences in body mass index in Spain: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; SELF-REPORTED WEIGHT; SOCIAL EPIDEMIOLOGY; PUBLIC-HEALTH; BMI TRAJECTORIES; RATED HEALTH; OBESITY; INEQUALITIES; POPULATION; RISK	Many studies have demonstrated the existence of simple, unidimensional socioeconomic gradients in body mass index (BMI). However, in the present paper we move beyond such traditional analyses by simultaneously considering multiple demographic and socioeconomic dimensions. Using the Spanish National Health Survey 2011-2012, we apply intersectionality theory and multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) to analyze 14,190 adults nested within 108 intersectional strata defined by combining categories of gender, age, income, educational achievement and living situation. We develop two multilevel models to obtain information on stratum-specific BMI averages and the degree of clustering of BMI within strata expressed by the intra-class correlation coefficient (ICC). The first model is a simple variance components analysis that provides a detailed mapping of the BMI disparities in the population and measures the accuracy of stratum membership to predict individual BMI. The second model includes the variables used to define the intersectional strata as a way to identify stratum-specific interactions. The first model suggests moderate but meaningful clustering of individual BMI within the intersectional strata (ICC = 12.4%). Compared with the population average (BMI = 26.07 Kg/m2), the stratum of cohabiting 18-35-year-old females with medium income and high education presents the lowest BMI (-3.7 Kg/m2), while cohabiting 36-64-year-old females with low income and low education show the highest BMI (+2.6 Kg/m2). In the second model, the ICC falls to 1.9%, suggesting the existence of only very small stratum specific interaction effects. We confirm the existence of a socioeconomic gradient in BMI. Compared with traditional analyses, the intersectional MAIHDA approach provides a better mapping of socioeconomic and demographic inequalities in BMI. Because of the moderate clustering, public health policies aiming to reduce BMI in Spain should not solely focus on the intersectional strata with the highest BMI, but should also consider whole population polices.	[Hernandez-Yumar, Aranzazu; Abasolo Alesson, Ignacio] ULL, Fac Econ Empresa & Turismo, Dept Econ Aplicada & Metodos Cuantitat, San Cristobal La Laguna, Santa Cruz De T, Spain; [Hernandez-Yumar, Aranzazu; Wemrell, Maria; Leckie, George; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden; [Wemrell, Maria] Lund Univ, Dept Gender Studies, Lund, Sweden; [Gonzalez Lopez-Valcarcel, Beatriz] ULPGC, Dept Metodos Cuantitat Econ & Gest, Las Palmas Gran Canaria, Spain; [Leckie, George] Univ Bristol, Ctr Multilevel Modelling, Bristol, Avon, England; [Merlo, Juan] Ctr Primary Hlth Care Res, Malmo, Sweden	Universidad de la Laguna; Lund University; Lund University; Universidad de Las Palmas de Gran Canaria; University of Bristol	Hernandez-Yumar, A (corresponding author), ULL, Fac Econ Empresa & Turismo, Dept Econ Aplicada & Metodos Cuantitat, San Cristobal La Laguna, Santa Cruz De T, Spain.; Hernandez-Yumar, A (corresponding author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.	ahernany@ull.es	Merlo, Juan/E-2136-2011; Wemrell, Maria/AAO-4079-2021; Leckie, George/F-4599-2010	Merlo, Juan/0000-0001-8379-9708; Leckie, George/0000-0003-1486-745X; Hernandez Yumar, Aranzazu/0000-0002-3299-4180; Wemrell, Maria/0000-0002-3186-9054; Abasolo, Ignacio/0000-0002-9297-232X	Fundacion Cajacanarias-La Caixa of the Universidad de La Laguna; Spanish State Program of R+D+I of the Spanish Ministry of Economy and Competitiveness [ECO2013-48217-C2-1-R, ECO2016-79588-R, ECO2017-83771-C3-2-R]; Swedish Research Council (VR) [2017-01321]; Ministry of Economy, Industry, Trade and Knowledge of the Government of the Canary Islands - European Social Fund [399820]	Fundacion Cajacanarias-La Caixa of the Universidad de La Laguna; Spanish State Program of R+D+I of the Spanish Ministry of Economy and Competitiveness; Swedish Research Council (VR)(Swedish Research Council); Ministry of Economy, Industry, Trade and Knowledge of the Government of the Canary Islands - European Social Fund	This study has been performed at the Unit for Social Epidemiology, Faculty of Medicine, Lund University with support from a Predoctoral Contract funded by Fundacion Cajacanarias-La Caixa of the Universidad de La Laguna (http://www.cajacanarias.com)(AHY), from the ECO2013-48217-C2-1-R (http://invesfeps.ulpgc.es/en) (BGLV), the ECO2016-79588-R (IAA) and the ECO2017-83771-C3-2-R (BGLV) projects funded by the Spanish State Program of R+D+I of the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/), and from the Swedish Research Council (VR) (https://www.vr.se/english.html) for the project "Multilevel Analyses of Individual Heterogeneity: innovative concepts and methodological approaches in Public Health and Social Epidemiology": (#2017-01321, JM). Finally, the financing granted to the ULL by the Ministry of Economy, Industry, Trade and Knowledge of the Government of the Canary Islands (http://www.gobiernodecanarias.org/ceic/), co-financed by 85% by the European Social Fund (http://ec.europa.eu/esf/home.jsp) (399820, AHY), is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailshire JA, 2011, SOC FORCES, V90, P397, DOI 10.1093/sf/sor001; Álvarez-Castaño Luz Stella, 2012, Rev. Gerenc. Polit. Salud, V11, P98; Alvarez-Dardet C, 2006, OPCIONES POLITICAS P; [Anonymous], 2011, SPAN NAT HLTH SURV; [Anonymous], 1989, FEMINIST LEGAL THEOR; [Anonymous], 2000, WHO TECHN REP SER; Antelo M, 2017, ECON HUM BIOL, V24, P61, DOI 10.1016/j.ehb.2016.11.002; Antentas Josep Maria, 2014, Gac Sanit, V28 Suppl 1, P58, DOI 10.1016/j.gaceta.2014.04.006; Axelsson FS, 2018, SSM POPULATION HLTH; Ballesteros Arribas JM, 2007, REV SALUD PUBLICA, V81; Banegas JR, 2011, ESTUDIO NUTR RIESGO; Basterra-Gortari F, 2008, ANALES SISTEMA SANIT, V30, P373; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Bes-Rastrollo M, 2005, REV ESP OBESIDAD, V3, P352; Bowleg L, 2012, AM J PUBLIC HEALTH, V102, P1267, DOI 10.2105/AJPH.2012.300750; Browne W. J., 2017, MCMC ESTIMATION MLWI; Browne WJ, 2017, MLWIN VERSION 301; Cecchini M, 2012, ISR J HEALTH POLICY, V1, DOI 10.1186/2045-4015-1-18; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chen CM, 2012, INT J PUBLIC HEALTH, V57, P485, DOI 10.1007/s00038-011-0239-7; Clarke P, 2009, INT J EPIDEMIOL, V38, P499, DOI 10.1093/ije/dyn214; Cohen AK, 2013, REV ESP NUTR HUM DIE, V17, P47, DOI 10.14306/renhyd.17.2.13; COLLINS Patricia Hill, 1990, BLACK FEMINIST THOUG; COM, 2005, PROM EUR FRAM CORP S; Costa-Font J, 2008, FOOD POLICY, V33, P61, DOI 10.1016/j.foodpol.2007.05.005; Costa-Font J, 2014, ECON HUM BIOL, V13, P66, DOI 10.1016/j.ehb.2013.03.003; Devaux M, 2011, OCED J EC STUD, V2011, P121, DOI DOI 10.1787/19952856; Devaux M, 2013, EUR J PUBLIC HEALTH, V23, P464, DOI 10.1093/eurpub/ckr058; Ecuador. Ministerio de Salud Publica/INEC, 2013, ENCUESTA NACL SALUD; Elu JU, 2013, AM EC REV; Evans CR, 2018, MULTILEVEL APPROACH, P64, DOI [10.1016/j.socscimed.2017.11.011, DOI 10.1016/J.SOCSCIMED.2017.11.011]; Garcia-Goni M., 2012, Eurohealth, V18, P22; Gil J, 2011, ECON HUM BIOL, V9, P78, DOI 10.1016/j.ehb.2010.05.016; Gonzalez Lopez-Valcarcel B, 2005, GESTION CLIN SANITAR, V7; Green MA, 2017, CAN INTERSECTIONALIT; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Gutierrez-Fisac Juan Luis, 2006, Gac Sanit, V20 Suppl 1, P48, DOI 10.1157/13086026; Hagenaars A., 1994, POVERTY STAT LATE 19; Hancock A.M., 2016, INTERSECTIONALITY IN; Hancock A-M, 2013, UC IRVINE LAW REV, V3; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Hinze SW, 2012, WOMEN HEALTH ISS, V22, pE91, DOI 10.1016/j.whi.2011.08.002; Hurtado Saa T, 2014, SOC EC, V26; INE, 2011, NAT HLTH SURV 2011 2; INE, 2014, CLAS PROGR NIV ED CN; Ivert AK, 2016, ETHNIC HEALTH, V21, P578, DOI 10.1080/13557858.2016.1143090; Jones K., 2016, METHODOL INNOV, V9, P1, DOI DOI 10.1177/2059799116672874; Juarez SP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005388; Kantola J., 2017, GENDER EC CRISIS EUR; Kapilashrami A, 2015, SOC THEOR HEALTH, V13, P288, DOI 10.1057/sth.2015.16; Leckie G, 2013, J STAT SOFTW, V52, P1; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Lobo F, 2007, REV ESPANOLA SALUD P, V81; Lunn D., 2012, BUGS BOOK PRACTICAL; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Mahendru R., 2014, DECENTRALIZING HLTH, P183; Martin Ruiz J-F, 2005, SCRIPTA NOVA REV ELE, V9; Martin-Lopez R, 2011, PUBLIC HEALTH NUTR, V14, P1259, DOI 10.1017/S1368980010003630; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; McCall L, 2005, SIGNS, V30, P1771, DOI 10.1086/426800; McDaid D, 2015, WHO OECD EUROPEAN OB; Ventos MM, 2016, ECON HUM BIOL, V22, P216, DOI 10.1016/j.ehb.2016.05.004; Merkur S., 2013, PROMOTING HLTH PREVE; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2015, EC SALUD B INFORM, V84; Merlo J, 2013, EUR J EPIDEMIOL S, V28, P148; Merlo J, 2018, SOC SCI MED, V203, P74, DOI 10.1016/j.socscimed.2017.12.026; Merlo J, 2017, SSM-POPUL HLTH, V3, P684, DOI 10.1016/j.ssmph.2017.08.005; Merlo J, 2015, EUR J PUBLIC HEALTH, V25, P910, DOI 10.1093/eurpub/ckv209; Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108; MSSSI, 2011, MOV FORW EQ PROP POL; Mulinari S, 2015, EUR J PUBLIC HEALTH, V25, P911, DOI 10.1093/eurpub/ckv099; Mullings L., 2006, GENDER RACE CLASS HL, P3; Nygren KG, 2014, SOCIOL COMPASS, V8, P1112, DOI 10.1111/soc4.12176; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; OECD, 2017, OB UPD 2017; Organisation for Economic Cooperation and Development (OECD), 2010, OBESITY EC PREVENTIO; Ortiz-Moncada R, 2015, EPIDEMIOLOGIA OBESID; Ortiz-Moncada R, 2011, MED CLIN-BARCELONA, V137, P678, DOI 10.1016/j.medcli.2010.12.025; Panetta J, 2016, REV CUATRIMESTRAL FA, V99, P46; Quiles Izquierdo J, 2008, REV ESPANOLA NUTR CO, V14; Raftopoulou A, 2017, ECON HUM BIOL, V24, P185, DOI 10.1016/j.ehb.2016.12.001; Rodriguez-Caro A, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0454-1; Savane FR, 2013, NUTR HOSP, V28, P1633, DOI 10.3305/nh.2013.28.5.6671; Ruwanpura KN, 2008, FEMINIST EC; Sarlio-Lahteenkorva S, 2004, AM J PUBLIC HLTH; Sassi F., 2009, OECD HLTH WORKING PA; Sen G, 2009, J HUM DEV CAPABIL, V10, P397, DOI 10.1080/19452820903048894; Seng JS, 2012, SOC SCI MED, V75, P2437, DOI 10.1016/j.socscimed.2012.09.023; SHELDON TA, 1992, J PUBLIC HEALTH MED, V14, P104; Siddiqi A, 2015, INT J EQUITY HLTH, V14; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Steele F., 2008, MODULE 5 INTRO MULTI, V5; Vallejo-Torres L, 2010, SOC SCI MED, V71, P1189, DOI 10.1016/j.socscimed.2010.06.008; Veenstra G, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-3; Wagner P, 2015, INT J EPIDEMIOL, V44, P49; Wardle J, 2002, AM J PUBLIC HEALTH, V92, P1299, DOI 10.2105/AJPH.92.8.1299; Wemrell M, 2015, SOCIOLOGY COMPASS, V10, P151; Wemrell M, 2017, SOC SCI MED, V178, P217, DOI 10.1016/j.socscimed.2017.02.040; Wemrell M, 2017, SOC SCI MED, V177, P213, DOI 10.1016/j.socscimed.2017.01.050; Witter S, 2017, HLTH POLICY PLANNING, V32, P4; Witter S, 2017, HEALTH POLICY PLANN, V32, pV4, DOI 10.1093/heapol/czx063; World Health Organization/Europe, 2006, WHO EUR MIN C COUNT; Yuval-Davis N., 2011, FRAMING INTERSECTION, P155	108	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208624	10.1371/journal.pone.0208624	http://dx.doi.org/10.1371/journal.pone.0208624			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6JR	30532244	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700039
J	Aromolaran, AS; Srivastava, U; Ali, A; Chahine, M; Lazaro, D; El-Sherif, N; Capecchi, PL; Laghi-Pasini, F; Lazzerini, PE; Boutjdir, M				Aromolaran, Ademuyiwa S.; Srivastava, Ujala; Ali, Alessandra; Chahine, Mohamed; Lazaro, Deana; El-Sherif, Nabil; Capecchi, Pier Leopoldo; Laghi-Pasini, Franco; Lazzerini, Pietro Enea; Boutjdir, Mohamed			Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RECTIFIER K+ CURRENT; JAK-STAT PATHWAY; RHEUMATOID-ARTHRITIS; I-KR; INTERVAL; HEART; IL-6; CARDIOMYOCYTES; ASSOCIATION	Increased proinflammatory interleukin-6 (IL-6) levels are associated with acquired long QT-syndrome (LQTS) in patients with systemic inflammation, leading to higher risks for life-threatening polymorphic ventricular tachycardia such as Torsades de Pointes. However, the functional and molecular mechanisms of this association are not known. In most cases of acquired LQTS, the target ion channel is the human ether-a-go-go-related gene (hERG) encoding the rapid component of the delayed rectifier K current, I-Kr, which plays a critical role in cardiac repolarization. Here, we tested the hypothesis that IL-6 may cause QT prolongation by suppressing I-Kr. Electrophysiological and biochemical assays were used to assess the impact of IL-6 on the functional expression of I-Kr in HEK293 cells and adult guinea-pig ventricular myocytes (AGPVM). In HEK293 cells, IL-6 alone or in combination with the soluble IL-6 receptor (IL-6R), produced a significant depression of I-Kr peak and tail current densities. Block of IL-6R or Janus kinase (JAK) reversed the inhibitory effects of IL-6 on I-Kr. In AGPVM, IL-6 prolonged action potential duration (APD) which was further prolonged in the presence of IL-6R. Similar to heterologous cells, IL-6 reduced endogenous guinea pig ERG channel mRNA and protein expression. The data are first to demonstrate that IL-6 inhibition of I-Kr and the resulting prolongation of APD is mediated via IL-6R and JAK pathway activation and forms the basis for the observed clinical QT interval prolongation. These novel findings may guide the development of targeted anti-arrhythmic therapeutic interventions in patients with LQTS and inflammatory disorders.	[Aromolaran, Ademuyiwa S.; Srivastava, Ujala; Lazaro, Deana; El-Sherif, Nabil; Boutjdir, Mohamed] VA New York Harbor Healthcare Syst, Cardiovasc Res Program, Brooklyn, NY 11209 USA; [Aromolaran, Ademuyiwa S.; Srivastava, Ujala; Boutjdir, Mohamed] Suny Downstate Med Ctr, Dept Cell Biol & Pharmacol, Brooklyn, NY 11203 USA; [Ali, Alessandra] Univ Siena, Dept Mol & Dev Med, Siena, Italy; [Chahine, Mohamed] Univ Laval, Dept Med, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Capecchi, Pier Leopoldo; Laghi-Pasini, Franco; Lazzerini, Pietro Enea] Univ Siena, Dept Med Sci Surg & Neurosci, Siena, Italy; [Boutjdir, Mohamed] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Boutjdir, Mohamed] NYU, Sch Med, Dept Med, New York, NY 10016 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Siena; Laval University; University of Siena; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Boutjdir, M (corresponding author), VA New York Harbor Healthcare Syst, Cardiovasc Res Program, Brooklyn, NY 11209 USA.; Boutjdir, M (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol & Pharmacol, Brooklyn, NY 11203 USA.; Boutjdir, M (corresponding author), Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA.; Boutjdir, M (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	mboutjdir@gmail.com	Aromolaran, Ademuyiwa/AAA-9265-2021; Aromolaran, Ademuyiwa/AAF-5555-2019	Boutjdir, Mohamed/0000-0002-6068-223X	American Heart Association [13SDG16850065, I01 BX002137]; Biomedical Laboratory Research & Development Service of Veterans Affairs Office of Research and Development; Veterans Affairs [I01BX002137] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Biomedical Laboratory Research & Development Service of Veterans Affairs Office of Research and Development; Veterans Affairs(US Department of Veterans Affairs)	This work was funded by the American Heart Association (13SDG16850065), http://www.heart.org/HEARTORG/; Merit Review grant I01 BX002137; and Biomedical Laboratory Research & Development Service of Veterans Affairs Office of Research and Development, https://www.research.va.gov/services/blrd/.	Adlan AM, 2015, J RHEUMATOL, V42, P421, DOI 10.3899/jrheum.140861; Aromolaran AS, 2016, BIOCHEM BIOPH RES CO, V474, P554, DOI 10.1016/j.bbrc.2016.04.113; Aromolaran AS, 2014, CARDIOVASC RES, V104, P501, DOI 10.1093/cvr/cvu231; Bai XL, 2014, CANCER LETT, V355, P281, DOI 10.1016/j.canlet.2014.09.048; Chauhan K, 2015, CLIN EXP RHEUMATOL, V33, P84; Chen WH, 2010, ACTA PHARMACOL SIN, V31, P915, DOI 10.1038/aps.2010.84; El-Sherif N, 2015, PHARMACOL THERAPEUT, V155, P132, DOI 10.1016/j.pharmthera.2015.09.002; Fernandez-Velasco M, 2007, AM J PHYSIOL-HEART C, V293, pH238, DOI 10.1152/ajpheart.01122.2006; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; George SA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00334; Grandy SA, 2009, J MOL CELL CARDIOL, V47, P238, DOI 10.1016/j.yjmcc.2009.02.025; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Hagiwara Y, 2007, J MOL CELL CARDIOL, V43, P710, DOI 10.1016/j.yjmcc.2007.09.004; Hashizume M, 2015, INT REV IMMUNOL, V34, P265, DOI 10.3109/08830185.2014.938325; Karle CA, 2002, CARDIOVASC RES, V53, P355, DOI 10.1016/S0008-6363(01)00509-0; Kawada H, 2006, CIRC J, V70, P605, DOI 10.1253/circj.70.605; KIKUCHI J, 2017, MOD RHEUMATOL, P1, DOI [10.1080/14397595.2017.1366092, DOI 10.1080/14397595.2017.1366092]; Kleveland O, 2016, EUR HEART J, V37, P2406, DOI 10.1093/eurheartj/ehw171; Kurdi M, 2007, J CARDIOVASC PHARM, V50, P126, DOI 10.1097/FJC.0b013e318068dd49; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Lazzerini PE, 2017, HEART, V103, P1821, DOI 10.1136/heartjnl-2016-311079; Lazzerini PE, 2017, NAT REV CARDIOL, V14, P521, DOI 10.1038/nrcardio.2017.61; Lazzerini PE, 2017, EUR HEART J, V38, P1717, DOI 10.1093/eurheartj/ehw208; Lazzerini Pietro Enea, 2015, Front Cardiovasc Med, V2, P26, DOI 10.3389/fcvm.2015.00026; Lazzerini PE, 2015, ARTHRIT CARE RES, V67, P332, DOI 10.1002/acr.22455; Lazzerini PE, 2014, AUTOIMMUN REV, V13, P936, DOI 10.1016/j.autrev.2014.05.007; Lazzerini PE, 2013, EUR J INTERN MED, V24, P368, DOI 10.1016/j.ejim.2013.02.009; LI YH, 1993, CARDIOVASC RES, V27, P525, DOI 10.1093/cvr/27.3.525; London B, 2003, AM J PHYSIOL-HEART C, V284, pH431, DOI 10.1152/ajpheart.00431.2002; Mackey RH, 2015, ARTHRITIS RHEUMATOL, V67, P2311, DOI 10.1002/art.39198; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Medenwald D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095994; Monnerat G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13344; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Narazaki M, 2017, EXPERT REV CLIN IMMU, V13, P535, DOI 10.1080/1744666X.2017.1295850; Pan J, 1999, CIRC RES, V84, P1127, DOI 10.1161/01.RES.84.10.1127; Panoulas VF, 2014, RHEUMATOLOGY, V53, P131, DOI 10.1093/rheumatology/ket338; Petkova-Kirova PS, 2006, AM J PHYSIOL-HEART C, V290, pH2098, DOI 10.1152/ajpheart.00097.2005; Pisoni CN, 2015, CLIN EXP RHEUMATOL, V33, P715; Puckerin A, 2016, HEART RHYTHM, V13, P1121, DOI 10.1016/j.hrthm.2016.01.012; Pujades-Rodriguez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151245; Schwartz PJ, 2013, EUR HEART J, V34, P3109, DOI 10.1093/eurheartj/eht089; Sordillo PP, 2015, IN VIVO, V29, P619; Szabo-Fresnais N, 2010, CELL SIGNAL, V22, P1143, DOI 10.1016/j.cellsig.2010.03.009; Tristani-Firouzi M, 2001, AM J MED, V110, P50, DOI 10.1016/S0002-9343(00)00623-9; Ukena C, 2011, EUR J HEART FAIL, V13, P398, DOI 10.1093/eurjhf/hfq229; Wang JX, 2004, J BIOL CHEM, V279, P13289, DOI 10.1074/jbc.C400025200; Wang YQ, 2016, EUR J PHARMACOL, V784, P129, DOI 10.1016/j.ejphar.2016.05.024; Wollert K C, 2001, Heart Fail Rev, V6, P95; Yang SL, 2004, AM J PHYSIOL-HEART C, V287, pH2183, DOI 10.1152/ajpheart.00624.2003; Yue YK, 2015, CIRCULATION, V132, P230, DOI 10.1161/CIRCULATIONAHA.115.009800	51	76	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208321	10.1371/journal.pone.0208321	http://dx.doi.org/10.1371/journal.pone.0208321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521586	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000452307600046
J	Bragato, JP; Melo, LM; Venturin, GL; Rebech, GT; Garcia, LE; Lopes, FL; de Lima, VMF				Bragato, Jaqueline Poleto; Melo, Larissa Martins; Venturin, Gabriela Lovizutto; Rebech, Gabriela Torres; Garcia, Leandro Encarnacao; Lopes, Flavia Lombardi; Felix de Lima, Valeria Marcal			Relationship of peripheral blood mononuclear cells miRNA expression and parasitic load in canine visceral leishmaniasis	PLOS ONE			English	Article							DECREASED EXPRESSION; IMMUNE-RESPONSE; DOGS; MICRORNA-21; INFANTUM; DISEASE; MIR-150; DIFFERENTIATION; SUPPRESSION; INFECTION	Visceral leishmaniasis (VL) in humans is a chronic and often fatal disease if left untreated. Dogs appear to be the main reservoir host for L. infantum infection, however, in many regions other canids such as jackals, foxes, wolves and other mammals, such as hares or black rats, have been implicated as wild reservoirs. Most dogs cannot form an effective immune response against this infection, and this could be modulated by small non-coding RNAs, called microRNAs, responsible for post-transcriptional control of gene expression. Here, we evaluated the expression of miRNAs in peripheral blood mononuclear cells (PBMC) of symptomatic dogs naturally infected with Leishmania (L.) infantum (n = 10) and compared to those of healthy dogs (n = 5). Microarray analysis revealed that miR-21, miR-424, miR-194 and miR-451 had a 3-fold increase in expression, miR-192, miR-503, and miR-371 had a 2-fold increase in expression, whereas a 2-fold reduction in expression was observed for miR-150 and miR-574. Real-time PCR validated the differential expression of miR-21, miR-150, miR-451, miR-192, miR-194, and miR-371. Parasite load of PBMC was measured by real-time PCR and correlated to the differentially expressed miRNAs, showing a strong positive correlation with expression of miR-194, a regular positive correlation with miR-371 expression, and a moderate negative correlation with miR-150 expression in PBMC. These findings suggest that Leishmania infection interferes with miRNAs expression in PBMC, and their correlation with parasite load may help in the identification of therapeutic targets in Canine Visceral Leishmaniasis (CVL).	[Bragato, Jaqueline Poleto; Melo, Larissa Martins; Venturin, Gabriela Lovizutto; Rebech, Gabriela Torres; Felix de Lima, Valeria Marcal] Sao Paulo State Univ, UNESP, Dept Anim Clin Surg & Reprod, Sao Paulo, Brazil; [Garcia, Leandro Encarnacao; Lopes, Flavia Lombardi] Sao Paulo State Univ, UNESP, Dept Support Prod & Anim Hlth, Sch Vet Med, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	de Lima, VMF (corresponding author), Sao Paulo State Univ, UNESP, Dept Anim Clin Surg & Reprod, Sao Paulo, Brazil.	vmflima@fmva.unesp.br	Garcia, Leandro Encarnação/I-7529-2019; Lopes, Flavia Lombardi/A-6608-2009; Lopes, Flavia/N-5912-2017; de Lima, Valéria M.F./B-7867-2013	Garcia, Leandro Encarnação/0000-0002-4556-1624; Lopes, Flavia Lombardi/0000-0002-3173-3712; Lopes, Flavia/0000-0002-3173-3712; de Lima, Valéria M.F./0000-0002-0954-5045; Poleto Bragato, Jaqueline/0000-0002-6144-2596; Venturin, Gabriela/0000-0002-2338-7039	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/16972-7, 2016/02359-4, 2015/16101-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br), grants 2015/16972-7, 2016/02359-4, and 2015/16101-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Bragato JP, 2018, DATA BRIEF, V17, P218, DOI 10.1016/j.dib.2018.01.007; Buates S, 2001, J IMMUNOL, V166, P3416, DOI 10.4049/jimmunol.166.5.3416; CABRAL M, 1992, PARASITE IMMUNOL, V14, P531, DOI 10.1111/j.1365-3024.1992.tb00026.x; Carissimi C, 2014, BIOCHIMIE, V107, P319, DOI 10.1016/j.biochi.2014.09.021; Chamekh M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/59430; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; De Luna R, 2000, J COMP PATHOL, V122, P213, DOI 10.1053/jcpa.1999.0357; Esch KJ, 2015, AM J PATHOL, V185, P2105, DOI 10.1016/j.ajpath.2015.04.017; Fisa R, 1999, VET PARASITOL, V83, P87, DOI 10.1016/S0304-4017(99)00074-6; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Garchow B, 2016, CLIN IMMUNOL, V162, P100, DOI 10.1016/j.clim.2015.11.010; Geraci NS, 2015, PARASITE IMMUNOL, V37, P43, DOI 10.1111/pim.12156; Ghosh J, 2013, CELL HOST MICROBE, V13, P277, DOI 10.1016/j.chom.2013.02.005; Hosokawa K, 2017, HAEMATOLOGICA, V102, P69, DOI 10.3324/haematol.2016.151076; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Lima VMF, 2003, BRAZ J MED BIOL RES, V36, P485, DOI 10.1590/S0100-879X2003000400010; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu YC, 2017, FRONT PHYSIOL, V8, P1, DOI 10.3389/fphys.2017.00538; Correa APFL, 2007, VET PARASITOL, V143, P267, DOI 10.1016/j.vetpar.2006.08.023; MANCIANTI F, 1988, T ROY SOC TROP MED H, V82, P566, DOI 10.1016/0035-9203(88)90510-X; Mazloom H, 2016, MOL CELL BIOCHEM, V419, P11, DOI 10.1007/s11010-016-2743-9; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nicolato RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082947; Nylen S, 2003, CLIN EXP IMMUNOL, V131, P457, DOI 10.1046/j.1365-2249.2003.02096.x; Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876; Silva KLO, 2013, VET PARASITOL, V197, P470, DOI 10.1016/j.vetpar.2013.07.012; Pan American Health Organization (PAHO), 2017, NON TRADITIONAL REF, P2; PANDEY RK, 2016, FRONT MICROBIOL, V7, P1, DOI DOI 10.3389/FMICB.2016.00206; Perosso J, 2014, VET PARASITOL, V205, P417, DOI 10.1016/j.vetpar.2014.09.006; Pinelli E, 1999, INFECT IMMUN, V67, P237, DOI 10.1128/IAI.67.1.237-243.1999; Qiu YY, 2017, AM J TRANSL RES, V9, P3184; Ranasinghe S, 2008, T ROY SOC TROP MED H, V102, P875, DOI 10.1016/j.trstmh.2008.04.003; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Sanches LD, 2016, REV BRAS PARASITOL V, V25, P465, DOI [10.1590/S1984-29612016071, 10.1590/s1984-29612016071]; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Schaut RG, 2016, J IMMUNOL, V196, P4100, DOI 10.4049/jimmunol.1502678; Silva SC, 2018, PARASITOL RES, V117, P2881, DOI 10.1007/s00436-018-5979-3; Singh AK, 2018, ANN OPER RES, V270, P433, DOI 10.1007/s10479-016-2332-z; Smigielska-Czepiel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076217; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Tian HQ, 2015, NUTRIENTS, V7, P3483, DOI 10.3390/nu7053483; Tiwari N, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00314, 10.3389/fmicb.2017.01190]; Wang JF, 2014, MED SCI MONITOR, V20, P283, DOI 10.12659/MSM.889937; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Wang Q, 2014, NANOTOXICOLOGY, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0108934; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang N, 2017, DIFFERENTIATION, V97, P33, DOI 10.1016/j.diff.2017.08.004; Zhang XM, 2012, CANCER RES, V72, P4707, DOI 10.1158/0008-5472.CAN-12-0639; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhou XR, 2016, ONCOTARGET, V7, P67196, DOI 10.18632/oncotarget.11950	58	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206876	10.1371/journal.pone.0206876	http://dx.doi.org/10.1371/journal.pone.0206876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517108	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400022
J	Ehrendorfer, F; Barfuss, MHJ; Manen, JF; Schneeweiss, GM				Ehrendorfer, Friedrich; Barfuss, Michael H. J.; Manen, Jean-Francois; Schneeweiss, Gerald M.			Phylogeny, character evolution and spatiotemporal diversification of the species-rich and world-wide distributed tribe Rubieae (Rubiaceae)	PLOS ONE			English	Article							GALIUM; DNA; MORPHOLOGY; MODEL; ANGIOSPERMS; SEQUENCE; CPDNA; TIME; CLASSIFICATION; DELIMITATION	The Rubiaceae tribe Rubieae has a world-wide distribution with up to 1,000 species. These collectively exhibit an enormous ecological and morphological diversity, making Rubieae an excellent group for macro- and microevolutionary studies. Previous molecular phylogenetic analyses used only a limited sampling within the tribe or missed lineages crucial for understanding character evolution in this group. Here, we analyze sequences from two plastid spacer regions as well as morphological and biogeographic data from an extensive and evenly distributed sampling to establish a sound phylogenetic framework. This framework serves as a basis for our investigation of the evolution of important morphological characters and the biogeographic history of the Rubieae. The tribe includes three major clades, the Kelloggiinae Clade (Kelloggia), the Rubiinae Clade (Didymaea, Rubia) and the most species-rich Galiinae Clade (Asperula, Callipeltis, Crucianella, Cruciata, Galium, Mericatpaea, Phuopsis, Sherardia, Valantia). Within the Galiinae Clade, the largest genera Galium and Asperula are para- and polyphyletic, respectively. Smaller clades, however, usually correspond to currently recognized taxa (small genera or sections within genera), which may be used as starting points for a refined classification in this clade. Life-form (perennial versus annual), flower shape (long versus short corolla tube) and fruit characters (dry versus fleshy, with or without uncinate hairs) are highly homoplasious and have changed multiple times independently. Inference on the evolution of leaf whorls, a characteristic feature of the tribe, is sensitive to model choice. Multi-parted leaf whorls appear to have originated from opposite leaves with two small interpetiolar stipules that are subsequently enlarged and increased in number. Early diversification of Rubieae probably started during the Miocene in western Eurasia. Disjunctions between the Old and the New World possibly are due to connections via a North Atlantic land bridge. Diversification of the Galiineae Clade started later in the Miocene, probably in the Mediterranean, from where lineages reached, often multiple times, Africa, eastern Asia and further on the Americas and Australia.	[Ehrendorfer, Friedrich; Barfuss, Michael H. J.; Schneeweiss, Gerald M.] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria; [Manen, Jean-Francois] Univ Geneva, Lab Systemat Vegetale & Biodiversite, Geneva, Switzerland	University of Vienna; University of Geneva	Ehrendorfer, F; Schneeweiss, GM (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria.	friedrich.ehrendorfer@univie.ac.at; gerald.schneeweiss@univie.ac.at	Schneeweiss, Gerald M./B-4344-2013; Barfuss, Michael/A-7361-2014	Schneeweiss, Gerald M./0000-0003-2811-3317; Barfuss, Michael/0000-0001-7172-9454				Backlund M, 2007, TAXON, V56, P315, DOI 10.1002/tax.562006; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; BATRA SWT, 1984, ENVIRON ENTOMOL, V13, P1113, DOI 10.1093/ee/13.4.1113; Bremer B, 2000, PLANT SYST EVOL, V225, P43, DOI 10.1007/BF00985458; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Chen J, 2011, FLORA CHINA, P346; Couvreur M, 2008, BASIC APPL ECOL, V9, P204, DOI 10.1016/j.baae.2006.12.002; Crowl AA, 2016, AM J BOT, V103, P233, DOI 10.3732/ajb.1500450; De Toni KLC, 2011, ANN MO BOT GARD, V98, P206, DOI 10.3417/2008016; Defelice MS, 2002, WEED TECHNOL, V16, P467, DOI 10.1614/0890-037X(2002)016[0467:CBOCGA]2.0.CO;2; Deng T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13543-5; Denk T, 2010, AM J BOT, V97, P276, DOI 10.3732/ajb.0900195; Dessein S, 2005, BOT REV, V71, P354, DOI 10.1663/0006-8101(2005)071[0354:PCATPS]2.0.CO;2; Doyle J. J., 1987, PHYTOCHEM B, P11; Drew BT, 2017, TAXON, V66, P133, DOI 10.12705/661.7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; ehrendorfer f., 2005, FLORA IRANICA, V176, P1; Ehrendorfer F, 2014, ANN MO BOT GARD, V100, P79, DOI 10.3417/2012088; Ehrendorfer F, 2009, BOT J LINN SOC, V160, P312, DOI 10.1111/j.1095-8339.2009.00861.x; Friedman J, 2015, AM J BOT, V102, P497, DOI 10.3732/ajb.1500062; Garcia PE, 2012, MOL ECOL, V21, P1255, DOI 10.1111/j.1365-294X.2012.05456.x; Govaerts R., 2017, WORLD CHECKLIST RUBI; Groeninckx I, 2009, ANN MO BOT GARD, V96, P109, DOI 10.3417/2006201; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hall T. A., 2013, BIOEDIT V7 2 5 BIOL; Jeong KS, 2016, BANGL J PLANT TAXON, V23, P237, DOI 10.3329/bjpt.v23i2.30858; Kastner A, 2016, ILLUSTRIERTE FLORA M; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Maddison, 2018, MESQUITE MODULAR SYS; MANEN JF, 1994, PLANT SYST EVOL, V190, P195, DOI 10.1007/BF00986193; McCann J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162299; Natali A, 1996, OPERA BOT BELG, V7, P193; Natali A., 1995, GIORN BOT ITAL, V129, P57, DOI DOI 10.1080/11263509509436102; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nie ZL, 2005, AM J BOT, V92, P642, DOI 10.3732/ajb.92.4.642; NIEWLAND JA, 2010, AM MIDL NAT, V1, P263, DOI DOI 10.2307/2992967; Pacheco-Trejo J, 2009, PLANT SYST EVOL, V281, P137, DOI 10.1007/s00606-009-0195-3; Pelser PB, 2007, TAXON, V56, P1077, DOI 10.2307/25065905; Pobedimova EG, 1958, FLORA SSSR 23, P287; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Preston RE, 2012, JEPSON MANUAL, P1206; PUFF C, 1982, BOT J LINN SOC, V84, P355, DOI 10.1111/j.1095-8339.1982.tb00369.x; RoBBRECHT E., 1988, OPERA BOT BELG, V1, P13, DOI DOI 10.2307/4110534; Robbrecht Elmar, 2006, Systematics and Geography of Plants, V76, P85; Rundel PW, 2016, ANNU REV ECOL EVOL S, V47, P383, DOI 10.1146/annurev-ecolsys-121415-032330; Rutishauser R, 1999, INT J PLANT SCI, V160, pS81, DOI 10.1086/314221; Rutishauser R, 1985, BEITR BIOL PFLANZ, V59, P375; Schneeweiss GM, 2004, SYST BIOL, V53, P856, DOI 10.1080/10635150490522566; Schonbeck-Temesy E, 1989, DAVIS HEDGE FESTSCHR, P111; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; Soza VL, 2010, AM J BOT, V97, P1630, DOI 10.3732/ajb.1000130; Soza VL, 2010, TAXON, V59, P755, DOI 10.1002/tax.593008; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; Tackenberg O, 2006, BASIC APPL ECOL, V7, P45, DOI 10.1016/j.baae.2005.05.001; Takeda H, 1916, ANN BOT-LONDON, V30, P197, DOI 10.1093/oxfordjournals.aob.a089591; thoMpson I. r., 2009, MUELLERIA, V27, P36; Tiffney BH, 2008, ANN MO BOT GARD, V95, P135, DOI 10.3417/2006199; Tremetsberger K, 2005, MOL PHYLOGENET EVOL, V35, P102, DOI 10.1016/j.ympev.2004.12.022; Viana DS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2406; Vrijdaghs A, 2015, PLANT ECOL EVOL, V148, P237, DOI 10.5091/plecevo.2015.1088; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Wikstrom N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126690; Will M, 2017, MOL PHYLOGENET EVOL, V109, P33, DOI 10.1016/j.ympev.2016.12.041; Willner W, 2014, PRESLIA, V86, P233; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yang LE, 2018, MOL PHYLOGENET EVOL, V126, P221, DOI [10.1016/j.ympev.2018.04.004, 10.1016/j]	68	12	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207615	10.1371/journal.pone.0207615	http://dx.doi.org/10.1371/journal.pone.0207615			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517138	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400050
J	Son, HY; Chae, BR; Choi, JY; Shin, DJ; Goo, YT; Lee, ES; Kang, TH; Kim, CH; Yoon, HY; Choi, YW				Son, Ho Yong; Chae, Bo Ram; Choi, Ji Yeh; Shin, Dong Jun; Goo, Yoon Tae; Lee, Eun Seok; Kang, Tae Hoon; Kim, Chang Hyun; Yoon, Ho Yub; Choi, Young Wook			Optimization of self-microemulsifying drug delivery system for phospholipid complex of telmisartan using D-optimal mixture design	PLOS ONE			English	Article							AMORPHOUS SOLID DISPERSIONS; BOX-BEHNKEN DESIGN; ORAL BIOAVAILABILITY; IN-VITRO; DISSOLUTION; PH; FORMULATION; RELEASE; SMEDDS; NANOPARTICLES	To improve the dissolution behavior of telmisartan (TMS), a poorly water-soluble angioten-sin II receptor blocker, TMS-phospholipid complex (TPC) was prepared by solvent evaporation method and characterized by differential scanning calorimetry and powder X-ray diffractometry. The crystalline structure of TMS was transited into an amorphous state by TPC formation. The equilibrium solubility of TPC (1.3-6.1 mg/mL) in various vehicles was about 100 times higher than that of TMS (0.009-0.058 mg/mL). TPC-loaded self-microemulsifying drug delivery system (SMEDDS) formulation was optimized using the D-optimal mixture design with the composition of 14% Capryol 90 (oil; X-1), 59.9% tween 80 (surfactant; X-2), and 26.1% tetraglycol (cosurfactant; X-3) as independent variables, which resulted in a droplet size of 22.17 nm (Y-1), TMS solubilization of 4.06 mg/mL (Y-2), and 99.4% drug release in 15 min (Y-3) as response factors. The desirability function value was 0.854, indicating the reliability and accuracy of optimization; in addition, good agreement was found between the model prediction and experimental values of Y-1, Y-2, and Y-3. Dissolution of raw TMS was poor and pH-dependent, where it had extremely low dissolution (< 1% for 2 h) in water, pH 4, and pH 6.8 media; however, it showed fast and high dissolution (< 90% in 5 min) in pH 1.2 medium. In contrast, the dissolution of the optimized TPC-loaded SMEDDS was pH-independent and reached over 90% within 5 min in all the media tested. Thus, we suggested that phospholipid complex formation and SMEDDS formulation using the experimental design method might be a promising approach to enhance the dissolution of poorly soluble drugs.	[Son, Ho Yong; Chae, Bo Ram; Shin, Dong Jun; Goo, Yoon Tae; Lee, Eun Seok; Kang, Tae Hoon; Kim, Chang Hyun; Yoon, Ho Yub; Choi, Young Wook] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Choi, Ji Yeh] Natl Univ Singapore, Dept Psychol, Singapore, Singapore	Chung Ang University; National University of Singapore	Choi, YW (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.	ywchoi@cau.ac.kr		Choi, Young Wook/0000-0003-2431-3995; Chae, Boram/0000-0002-3141-245X	Advanced Technology Center program - Ministry of Trade, Industry & Energy (MI, Korea) [10051950]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2016R1A2B4011449]	Advanced Technology Center program - Ministry of Trade, Industry & Energy (MI, Korea); National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the Advanced Technology Center program (10051950 to Y.W.C.) funded by the Ministry of Trade, Industry & Energy (MI, Korea). This research was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2016R1A2B4011449 to Y.W.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2011, J DISPER SCI TECHNOL, V32, P958, DOI 10.1080/01932691.2010.488511; Bhumika P, 2012, J PHARM BIOALLIED SC, V4, pS64, DOI 10.4103/0975-7406.94142; Bruning T, 2000, CRIT REV TOXICOL, V30, P253, DOI 10.1080/10408440091159202; Chae JS, 2018, AAPS PHARMSCITECH, V19, P2990, DOI 10.1208/s12249-018-1124-y; Cho HJ, 2013, J PHARM PHARMACOL, V65, P1440, DOI 10.1111/jphp.12115; Cui F, 2006, J CONTROL RELEASE, V114, P242, DOI 10.1016/j.jconrel.2006.05.013; Dukeck R, 2013, EUR J PHARM SCI, V49, P723, DOI 10.1016/j.ejps.2013.05.003; Gu B, 2015, INT J PHARMACEUT, V495, P393, DOI 10.1016/j.ijpharm.2015.08.089; Holm R, 2006, DRUG DEV IND PHARM, V32, P1025, DOI 10.1080/03639040600559024; Jaiswal P, 2014, INT J PHARM INVESTIG, V4, P195, DOI 10.4103/2230-973X.143123; Kang BK, 2004, INT J PHARMACEUT, V274, P65, DOI 10.1016/j.ijpharm.2003.12.028; Khoo SM, 1998, INT J PHARM, V167, P155, DOI 10.1016/S0378-5173(98)00054-4; Konno H, 2008, EUR J PHARM BIOPHARM, V70, P493, DOI 10.1016/j.ejpb.2008.05.023; Kothawade SN., 2010, INT J PHARM TECH RES, V2, P341; Liu Y, 2009, INT J PHARMACEUT, V365, P136, DOI 10.1016/j.ijpharm.2008.08.009; Liu YH, 2010, J PHARM PHARM SCI, V13, P589, DOI 10.18433/J3530J; Maiti K, 2007, INT J PHARMACEUT, V330, P155, DOI 10.1016/j.ijpharm.2006.09.025; Marasini N, 2013, INT J PHARMACEUT, V441, P424, DOI 10.1016/j.ijpharm.2012.11.012; Marasini N, 2012, J PHARM SCI-US, V101, P4584, DOI 10.1002/jps.23333; Mura P, 2005, J PHARMACEUT BIOMED, V37, P65, DOI 10.1016/j.jpba.2004.09.047; O'Neil M.J., 2013, MERCK INDEX ENCY CHE, P1691; Oh DH, 2011, INT J PHARMACEUT, V420, P412, DOI 10.1016/j.ijpharm.2011.09.007; Padia N, 2015, B PHARM RES, V5, P59; Ruan JH, 2010, INT J PHARMACEUT, V386, P282, DOI 10.1016/j.ijpharm.2009.11.026; Tran T, 2018, ASIAN J PHARM SCI, V13, P536, DOI 10.1016/j.ajps.2017.09.006; Tran PHL, 2008, J CONTROL RELEASE, V129, P59, DOI 10.1016/j.jconrel.2008.04.001; Vasconcelos T, 2007, DRUG DISCOV TODAY, V12, P1068, DOI 10.1016/j.drudis.2007.09.005; VENEMA FR, 1988, J COLLOID INTERF SCI, V125, P484, DOI 10.1016/0021-9797(88)90013-6; Wienen W, 2000, CARDIOVASC DRUG REV, V18, P127; Xiao YY, 2006, INT J PHARMACEUT, V307, P77, DOI 10.1016/j.ijpharm.2005.10.001; Yamashita Shinji, 2017, Journal of Pharmaceutical Investigation, V47, P163, DOI 10.1007/s40005-017-0310-3; Yang L, 2014, INT J PHARMACEUT, V471, P258, DOI 10.1016/j.ijpharm.2014.05.009; Yeom DW, 2017, INT J NANOMED, V12, P3533, DOI 10.2147/IJN.S136599; Yeom DW, 2015, INT J NANOMED, V10, P3865, DOI 10.2147/IJN.S83520; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Zhang JJ, 2011, INT J NANOMED, V6, P3405, DOI 10.2147/IJN.S25824; Zhang YZ, 2010, J CONTROL RELEASE, V145, P257, DOI 10.1016/j.jconrel.2010.04.029	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208339	10.1371/journal.pone.0208339	http://dx.doi.org/10.1371/journal.pone.0208339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517187	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400089
J	Behura, SK; Kelleher, AM; Spencer, TE				Behura, Susanta K.; Kelleher, Andrew M.; Spencer, Thomas E.			Evidence for functional interactions between the placenta and brain in pregnant mice	FASEB JOURNAL			English	Article						fetus; paralog; Foxa2; regulation; uterine	NEUROTROPHIC FACTOR BDNF; FETAL-BRAIN; MATERNAL-BEHAVIOR; SIGNALING PATHWAY; PROLACTIN FAMILY; EVOLUTION; EXPRESSION; IMPLANTATION; SEROTONIN; GENES	The placenta plays a pivotal role in the development of the fetal brain and also influences maternal brain function, but our understanding of communication between the placenta and brain remains limited. Using a gene expression and network analysis approach, we provide evidence that the placenta transcriptome is tightly interconnected with the maternal brain and fetal brain in d 15 pregnant C57BL/6J mice. Activation of serotonergic synapse signaling and inhibition of neurotrophin signaling were identified as potential mediators of crosstalk between the placenta and maternal brain and fetal brain, respectively. Genes encoding specific receptors and ligands were predicted to affect functional interactions between the placenta and brain. Paralogous genes, such as sex comb on midleg homolog 1/scm-like with 4 mbt domains 2 and polycomb group ring finger (Pcgf) 2/Pcgf5, displayed antagonistic regulation between the placenta and brain. Additionally, conditional ablation of forkhead box a2 (Foxa2) in the glands of the uterus altered the transcriptome of the d 15 placenta, which provides novel evidence of crosstalk between the uterine glands and placenta. Furthermore, expression of cathepsin 6 and monocyte to macrophage differentiation associated 2 was significantly different in the fetal brain of Foxa2 conditional knockout mice compared with control mice. These findings provide a better understanding of the intricacies of uterus-placenta-brain interactions during pregnancy and provide a foundation and model system for their exploration.Behura, S. K., Kelleher, A. M., Spencer, T. E. Evidence for functional interactions between the placenta and brain in pregnant mice.	[Behura, Susanta K.; Kelleher, Andrew M.; Spencer, Thomas E.] Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA; [Behura, Susanta K.] Univ Missouri, Informat Inst, Columbia, MO USA; [Spencer, Thomas E.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Behura, SK (corresponding author), Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA.	behuras@missouri.edu	Spencer, Thomas/AAD-6434-2020	Kelleher, Andrew/0000-0002-1484-4998; behura, Susanta/0000-0003-1057-2435	University of Missouri's Research Council; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Development [R21 HD076347, R01 HD096266]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD096266] Funding Source: NIH RePORTER	University of Missouri's Research Council; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. Gregory W. Burns (Grand Rapids Research Center, Michigan State University College of Human Medicine, Grand Rapids, MI, USA) for reading the manuscript. This work was supported, in part, by the University of Missouri's Research Council Grant (to S.K.B.), and by Grants R21 HD076347 and R01 HD096266 from the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Development (to T.E.S.) The authors declare no conflicts of interest.	Ain R, 2004, P NATL ACAD SCI USA, V101, P16543, DOI 10.1073/pnas.0406185101; Arora R, 2016, DEVELOPMENT, V143, P4749, DOI 10.1242/dev.144386; Belnoue L, 2016, SCI REP-UK, V6, DOI 10.1038/srep37615; Bonnin A, 2011, NEUROSCIENCE, V197, P1, DOI 10.1016/j.neuroscience.2011.10.005; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Brown CH, 2007, TRENDS ENDOCRIN MET, V18, P225, DOI 10.1016/j.tem.2007.04.003; Bu PL, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.138032; Budden DM, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0331-y; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Cameron EL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00067; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chakraborty G, 2012, ENDOCRINOLOGY, V153, P1311, DOI 10.1210/en.2011-1437; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; Daikoku T, 2014, ENDOCRINOLOGY, V155, P2718, DOI 10.1210/en.2014-1265; Das SK, 2009, REPRODUCTION, V137, P889, DOI 10.1530/REP-08-0539; Eisinger BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063824; Elyada YM, 2015, CURR OPIN NEUROBIOL, V35, P49, DOI 10.1016/j.conb.2015.06.007; Filant J, 2014, FASEB J, V28, P230, DOI 10.1096/fj.13-237446; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Galea LAM, 2014, J NEUROENDOCRINOL, V26, P641, DOI 10.1111/jne.12177; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gentleman R, 2005, STAT BIOL HEALTH, P189; Goasdoue K, 2017, PLACENTA, V54, P111, DOI 10.1016/j.placenta.2016.12.005; Goldman-Wohl D, 2004, PLACENTA, V25, P623, DOI 10.1016/j.placenta.2004.01.016; Gonez LJ, 2008, MOL MED, V14, P697, DOI 10.2119/2008-00072.Gonez; Guschanski K, 2017, GENOME RES, V27, P1461, DOI 10.1101/gr.215566.116; Han MV, 2009, GENOME RES, V19, P859, DOI 10.1101/gr.085951.108; Hillerer KM, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/574159; Hoekzema E, 2017, NAT NEUROSCI, V20, P287, DOI 10.1038/nn.4458; Hou ZC, 2012, GENOME BIOL EVOL, V4, P713, DOI 10.1093/gbe/evs045; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ihnatova I, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0763-1; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kelleher AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04848-8; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kelleher AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38078; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kinsley CH, 2011, J NEUROENDOCRINOL, V23, P974, DOI 10.1111/j.1365-2826.2011.02194.x; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Kodomari I, 2009, NEUROCHEM INT, V54, P95, DOI 10.1016/j.neuint.2008.11.005; KORPEINEN T, 1982, J NEUROCHEM, V39, P1737, DOI 10.1111/j.1471-4159.1982.tb08011.x; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Makieva S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092477; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Mozzi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10245-w; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nakajima A, 2000, BIOCHEM J, V349, P689, DOI 10.1042/bj3490689; Napso T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01091; Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019; Prince CS, 2017, PLACENTA, V49, P55, DOI 10.1016/j.placenta.2016.11.010; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Ray S, 2016, G3-GENES GENOM GENET, V6, P221, DOI [10.1534/g3.115.020982/-/DC1, 10.1534/g3.115.020982]; Roberts RM, 2016, REPRODUCTION, V152, pR179, DOI 10.1530/REP-16-0325; ROBINSON J, 1995, REPROD FERT DEVELOP, V7, P333, DOI 10.1071/RD9950333; Saenen ND, 2015, ENVIRON HEALTH PERSP, V123, P834, DOI 10.1289/ehp.1408549; Scrucca L, 2016, R J, V8, P289; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SLOTNICK BM, 1975, J COMP PHYSIOL PSYCH, V88, P118, DOI 10.1037/h0076200; Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005; Soares MJ, 2018, BIOL REPROD, V99, P196, DOI 10.1093/biolre/ioy049; Spencer TE, 2014, SEMIN REPROD MED, V32, P346, DOI 10.1055/s-0034-1376354; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Stolzenberg DS, 2012, HORM BEHAV, V62, P128, DOI 10.1016/j.yhbeh.2012.05.012; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; VADAKKADATH MS, 2005, CELL MOL LIFE SCI, V62, P257, DOI DOI 10.1007/S00018-004-4381-3; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wessels JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094036; Wildman DE, 2011, PLACENTA, V32, pS142, DOI 10.1016/j.placenta.2011.01.005; Woods L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00570; Yuan JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03092-4; Zeltser LM, 2011, P NATL ACAD SCI USA, V108, P15667, DOI 10.1073/pnas.1112239108; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038602; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	85	18	18	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4261	4272		10.1096/fj.201802037R	http://dx.doi.org/10.1096/fj.201802037R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521381	Green Published			2022-12-26	WOS:000459794800093
J	Miyawaki, S; Uemura, Y; Hongo, K; Kawata, Y; Mizobata, T				Miyawaki, Shiori; Uemura, Yumi; Hongo, Kunihiro; Kawata, Yasushi; Mizobata, Tomohiro			Acid-denatured small heat shock protein HdeA from Escherichia coli forms reversible fibrils with an atypical secondary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; protein folding; Gram-negative bacteria; protein aggregation; small heat shock protein (sHsp); amyloid; acid denaturation; periplasm; protein fibrillogenesis; reversible fibrillation	PERIPLASMIC CHAPERONE HDEA; SEQUENCE DETERMINANTS; ALPHA-SYNUCLEIN; RESISTANCE; DOMAIN; GROEL; IDENTIFICATION; PREDICTION; BINDING	The periplasmic small heat shock protein HdeA from Escherichia coli is inactive under normal growth conditions (at pH 7) and activated only when E. coli cells are subjected to a sudden decrease in pH, converting HdeA into an acid-denatured active state. Here, using in vitro fibrillation assays, transmission EM, atomic-force microscopy, and CD analyses, we found that when HdeA is active as a molecular chaperone, it is also capable of forming inactive aggregates that, at first glance, resemble amyloid fibrils. We noted that the molecular chaperone activity of HdeA takes precedence over fibrillogenesis under acidic conditions, as the presence of denatured substrate protein was sufficient to suppress HdeA fibril formation. Further experiments suggested that the secondary structure of HdeA fibrils deviates somewhat from typical amyloid fibrils and contains alpha-helices. Strikingly, HdeA fibrils that formed at pH 2 were immediately resolubilized by a simple shift to pH 7 and from there could regain molecular chaperone activity upon a return to pH 1. HdeA, therefore, provides an unusual example of a "reversible" form of protein fibrillation with an atypical secondary structure composition. The competition between active assistance of denatured polypeptides (its "molecular chaperone" activity) and the formation of inactive fibrillary deposits (its "fibrillogenic" activity) provides a unique opportunity to probe the relationship among protein function, structure, and aggregation in detail.	[Miyawaki, Shiori; Hongo, Kunihiro; Kawata, Yasushi; Mizobata, Tomohiro] Tottori Univ, Grad Sch Sustainabil Sci, Tottori 6808552, Japan; [Uemura, Yumi; Hongo, Kunihiro; Kawata, Yasushi; Mizobata, Tomohiro] Tottori Univ, Dept Engn, 4-101 Koyama Minami, Tottori, Tottori 6808552, Japan; [Hongo, Kunihiro; Kawata, Yasushi; Mizobata, Tomohiro] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 6808552, Japan	Tottori University; Tottori University; Tottori University	Mizobata, T (corresponding author), Tottori Univ, Dept Engn, 4-101 Koyama Minami, Tottori, Tottori 6808552, Japan.	mizobata@tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Mizobata, Tomohiro/V-6672-2019	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Tottori University, Japan Agency for Medical Research and Development (AMED) [JP18dm0107073]; Skylark Food Science Institute	Tottori University, Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Skylark Food Science Institute	This work was partially supported by Tottori University, Japan Agency for Medical Research and Development (AMED) Grant JP18dm0107073 and the Skylark Food Science Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dahl JU, 2015, J BIOL CHEM, V290, P65, DOI 10.1074/jbc.M114.612986; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Foit L, 2013, P NATL ACAD SCI USA, V110, pE1254, DOI 10.1073/pnas.1222458110; Fukui N, 2016, J BIOL CHEM, V291, P25217, DOI 10.1074/jbc.M116.751925; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Kim C, 2009, NUCLEIC ACIDS RES, V37, pW469, DOI 10.1093/nar/gkp351; Lazar KL, 2005, BIOCHEMISTRY-US, V44, P12681, DOI 10.1021/bi0509705; Lee AS, 2003, J MOL BIOL, V327, P699, DOI 10.1016/S0022-2836(03)00175-X; Luo F, 2018, NAT STRUCT MOL BIOL, V25, P341, DOI 10.1038/s41594-018-0050-8; Machida K, 2009, BBA-PROTEINS PROTEOM, V1794, P1344, DOI 10.1016/j.bbapap.2008.12.003; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McGlinchey RP, 2018, J MOL BIOL, V430, P3696, DOI 10.1016/j.jmb.2018.06.011; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; O'Donnell CW, 2011, BIOINFORMATICS, V27, pI34, DOI 10.1093/bioinformatics/btr238; Ojha B, 2016, SCI REP-UK, V6, DOI 10.1038/srep31041; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salmon L, 2018, J MOL BIOL, V430, P33, DOI 10.1016/j.jmb.2017.11.002; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tayeb-Fligelman E, 2017, SCIENCE, V355, P831, DOI 10.1126/science.aaf4901; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Wang WJ, 2012, J MOL BIOL, V415, P538, DOI 10.1016/j.jmb.2011.11.026; Waterman SR, 1996, MOL MICROBIOL, V21, P925, DOI 10.1046/j.1365-2958.1996.00058.x; Wu YE, 2008, BIOCHEM J, V412, P389, DOI 10.1042/BJ20071682; Yang F, 1998, NAT STRUCT BIOL, V5, P763, DOI 10.1038/1796; YOSHIDA T, 1993, MOL GEN GENET, V237, P113, DOI 10.1007/BF00282791; Yu XC, 2017, BIOCHEMISTRY-US, V56, P5748, DOI 10.1021/acs.biochem.7b00724; Zhang S, 2016, P NATL ACAD SCI USA, V113, P10872, DOI 10.1073/pnas.1606360113; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	43	4	4	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1590	1601		10.1074/jbc.RA118.005611	http://dx.doi.org/10.1074/jbc.RA118.005611			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30530490	Green Published, hybrid			2022-12-26	WOS:000457879200014
J	Okada, M; Okada, K; Fujii, K				Okada, Masahiro; Okada, Kosuke; Fujii, Kohyu			Influence of polypharmacy on heart rate variability in older adults at the Hiroshima Atomic Bomb Survivors Recuperation Research Center, Japan	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; PROGNOSTIC VALUE; NURSING-HOME; RISK; ASSOCIATION; DYNAMICS; FRAILTY; EVENTS	Background Many studies have identified the risk of polypharmacy, but physiological evidence and methods of evaluation in these studies were poor. The relationship between polypharmacy and heart rate variability in older adults remains unclear. We investigated the relationship between polypharmacy in older adults, including atomic bomb survivors, and heart rate variability. Methods We surveyed 56 older adults who did not need nursing care assistance in the Hiroshima Atomic Bomb Survivors Recuperation Center. Chronic diseases, types of medication, and lifestyle were assessed, and heart rate variability at rest was measured. We calculated heart rate variability indices including standard deviation of normal-to-normal RR intervals (SDNN), total power (TP), and very low frequency (VLF) and analyzed the relationship between the number of daily medication types and heart rate variability indices in older adults. The differences in heart rate variability indices were analyzed using six medications as a cut-off point. Results Participants included 36 atomic bomb survivors and 20 non-atomic bomb survivors. The mean number of medication types was 3.6 3.4 (mean standard deviation). SDNN, TP, and VLF decreased with an increased number of medications in all participants (P<0.01). When the standard of polypharmacy was set to more than six types of medications, SDNN, TP, and VLF were significantly lower in older adults who took six or more medications. Additionally, the mean number of medication types among atomic bomb survivors was higher than that of non-atomic bomb survivors (P= 0.008). The SDNN was significantly lower when atomic bomb survivors took six or more medications (P<0.001). Conclusions We found that a lower heart rate variability in older adults, including atomic bomb survivors, is associated with polypharmacy. We showed physiological evidence of the influence of polypharmacy, which may be important for the healthy life expectancy and prognosis in older adults.	[Okada, Masahiro; Fujii, Kohyu] Hiroshima Bunka Gakuen Two Year Coll, Dept Food & Dietet, Asaminami Ku, 3-5-1 Nagatsukanishi, Hiroshima, Japan; [Okada, Kosuke] COOP Saeki Hosp, Dept Internal Med, Saeki Ku, 3-11-29 Yahata Higashi, Hiroshima, Japan		Okada, M (corresponding author), Hiroshima Bunka Gakuen Two Year Coll, Dept Food & Dietet, Asaminami Ku, 3-5-1 Nagatsukanishi, Hiroshima, Japan.	okada@hbg.ac.jp		Okada, Masahiro/0000-0002-1876-3482				Abe J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190102; Balanescu S, 2004, MED SCI MONITOR, V10, pCR307; Benichou T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195166; Boskovic A, 2014, VOJNOSANIT PREGL, V71, P925, DOI 10.2298/VSP1410925B; Camm AJ, 1996, CIRCULATION, V93, P1043; Chaves PHM, 2008, J AM GERIATR SOC, V56, P1698, DOI 10.1111/j.1532-5415.2008.01858.x; Ernst G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180423; Gregorevic KJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0292-4; Guo Y, 2015, J CLIN NEUROPHYSIOL, V32, P516, DOI 10.1097/WNP.0000000000000210; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Janszky I, 2004, J INTERN MED, V256, P421, DOI 10.1111/j.1365-2796.2004.01403.x; Japan Geriatrics Society, 2015, MIDW IN JAP, P1; JensenUrstad K, 1997, ACTA PHYSIOL SCAND, V160, P235, DOI 10.1046/j.1365-201X.1997.00142.x; Kojima T, 2016, GERIATR GERONTOL INT, V16, P770, DOI 10.1111/ggi.12591; Kojima T, 2012, GERIATR GERONTOL INT, V12, P761, DOI 10.1111/j.1447-0594.2012.00868.x; Kojima T, 2011, GERIATR GERONTOL INT, V11, P438, DOI 10.1111/j.1447-0594.2011.00703.x; Kurita A, 2013, J NIPPON MED SCH, V80, P420, DOI 10.1272/jnms.80.420; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; Nguyen Julia K, 2006, Am J Geriatr Pharmacother, V4, P36, DOI 10.1016/j.amjopharm.2006.03.002; Ogliari G, 2015, CAN MED ASSOC J, V187, pE442, DOI 10.1503/cmaj.150462; Okada K, 2017, GERIATR GERONTOL INT, V17, P262, DOI 10.1111/ggi.12719; Okada Kosuke, 2016, Nihon Ronen Igakkai Zasshi, V53, P396; Okada M, 2014, INT J BIOMETEOROL, V58, P1973, DOI 10.1007/s00484-014-0800-1; Onder G, 2013, AGE AGEING, V42, P284, DOI 10.1093/ageing/aft038; Onder G, 2012, J GERONTOL A-BIOL, V67, P698, DOI 10.1093/gerona/glr233; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; Parvaneh S, 2016, GERONTOLOGY, V62, P3, DOI 10.1159/000431285; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Saum KU, 2017, J AM GERIATR SOC, V65, pE27, DOI 10.1111/jgs.14718; Stein PK, 2008, J AM GERIATR SOC, V56, P315, DOI 10.1111/j.1532-5415.2007.01564.x; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Steinman MA, 2011, J AM GERIATR SOC, V59, P1513, DOI 10.1111/j.1532-5415.2011.03500.x; Toba K, 1999, Nihon Ronen Igakkai Zasshi, V36, P181; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Vermeiren S, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.09.010; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0209081	10.1371/journal.pone.0209081	http://dx.doi.org/10.1371/journal.pone.0209081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540860	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600111
J	Parker, SS; Cohen, BS; Moore, J				Parker, Sophie S.; Cohen, Brian S.; Moore, James			Impact of solar and wind development on conservation values in the Mojave Desert	PLOS ONE			English	Article							ENERGY DEVELOPMENT; ENVIRONMENTAL IMPACTS; WILDLIFE CONSERVATION; OPERATION; KNOWLEDGE; STATE	In 2010, The Nature Conservancy completed the Mojave Desert Ecoregional Assessment, which characterizes conservation values across nearly 130,000 km(2) of the desert South-west. Since this assessment was completed, several renewable energy facilities have been built in the Mojave Desert, thereby changing the conservation value of these lands. We have completed a new analysis of land use to reassess the conservation value of lands in two locations in the Mojave Desert where renewable energy development has been most intense: lvanpah Valley, and the Western Mojave. We found that 99 of our 2.59-km(2) planning units were impacted by development such that they would now be categorized as having lower conservation value, and most of these downgrades in conservation value were due to solar and wind development. Solar development alone was responsible for a direct development footprint 86.79 km(2):25.81 km(2) of this was primarily high conservation value Bureau of Land Management lands in the lvanpah Valley, and 60.99 km(2) was privately owned lands, mostly of lower conservation value, in the Western Mojave. Our analyses allow us to understand patterns in renewable energy development in the mostly rapidly changing regions of the Mojave Desert. Our analyses also provide a baseline that will allow us to assess the effectiveness of the Desert Renewable Energy Conservation Plan in preventing development on lands of high conservation value over the coming decades.	[Parker, Sophie S.] Nature Conservancy, Los Angeles, CA 90071 USA; [Cohen, Brian S.] Nature Conservancy, San Diego, CA USA; [Moore, James] Nature Conservancy, Las Vegas, NV USA	Nature Conservancy; Nature Conservancy	Parker, SS (corresponding author), Nature Conservancy, Los Angeles, CA 90071 USA.	sophie_parker@tnc.org		Parker, Sophie S./0000-0002-9134-0742				ABB- Ventyx, 2017, 2017 E PLANTS POINT; Andre JM, 2009, MOJAVE NATL PRESERVE, V2, P1; [Anonymous], 2017, RENEWABLES WATC 0513; Butterfield HS., 2013, W SAN JOAQUIN VALLEY; California Energy Commission, 2017, TRACK PROGR REN EN O; Cameron D, 2012, SOLAR ENERGY DEV W M; Cameron D.R., 2017, ENERGY SPRAWL SOLUTI, P66; Cameron DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038437; Casalegno S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107822; Copeland Holly E., 2011, P7; Dai KS, 2015, RENEW ENERG, V75, P911, DOI 10.1016/j.renene.2014.10.074; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Flather CH, 1998, BIOSCIENCE, V48, P365, DOI 10.2307/1313375; Hardin E, 2017, SUSTAIN CITIES SOC, V28, P450, DOI 10.1016/j.scs.2016.09.004; Hernandez RR, 2014, RENEW SUST ENERG REV, V29, P766, DOI 10.1016/j.rser.2013.08.041; Hernandez RR, 2015, P NATL ACAD SCI USA, V112, P13579, DOI 10.1073/pnas.1517656112; Kreitler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140226; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Lovich JE, 2013, APPL ENERG, V103, P52, DOI 10.1016/j.apenergy.2012.10.001; Lovich JE, 2011, BIOSCIENCE, V61, P982, DOI 10.1525/bio.2011.61.12.8; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Miller NL, 2008, J APPL METEOROL CLIM, V47, P1834, DOI 10.1175/2007JAMC1480.1; Moore-O'Leary KA, 2017, FRONT ECOL ENVIRON, V15, P385, DOI 10.1002/fee.1517; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Randall J.M., 2010, MOJAVE DESERT ECOREG; Scheidel A, 2012, GLOBAL ENVIRON CHANG, V22, P588, DOI 10.1016/j.gloenvcha.2011.12.005; Schuster E, 2015, ENVIRON MANAGE, V56, P300, DOI 10.1007/s00267-015-0501-5; Smil Vaclav, 2008, ENERGY NATURE SOC GE; Stoms DM, 2013, RENEW ENERG, V57, P289, DOI 10.1016/j.renene.2013.01.055; Trainor AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162269; Turney D, 2011, RENEW SUST ENERG REV, V15, P3261, DOI 10.1016/j.rser.2011.04.023; Vandergast Amy G., 2013, Diversity-Basel, V5, P293	32	19	19	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207678	10.1371/journal.pone.0207678	http://dx.doi.org/10.1371/journal.pone.0207678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540781	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600029
J	Rafols, P; Vilalta, D; Torres, S; Calavia, R; Heijs, B; McDonnell, LA; Brezmes, J; del Castillo, E; Yanes, O; Ramirez, N; Correig, X				Rafols, Pere; Vilalta, Didac; Torres, Sonia; Calavia, Raul; Heijs, Bram; McDonnell, Liam A.; Brezmes, Jesus; del Castillo, Esteban; Yanes, Oscar; Ramirez, Noelia; Correig, Xavier			Assessing the potential of sputtered gold nanolayers in mass spectrometry imaging for metabolomics applications	PLOS ONE			English	Article							LASER-DESORPTION IONIZATION; MATRIX; NANOPARTICLES; TRIACYLGLYCEROLS; NANOMATERIALS; METABOLITES; ACIDS; TOOL	Mass spectrometry imaging (MSI) is a molecular imaging technique that maps the distribution of molecules in biological tissues with high spatial resolution. The most widely used MSI modality is matrix-assisted laser desorption/ionization (MALDI), mainly due to the large variety of analyte classes amenable for MALDI analysis. However, the organic matrices used in classical MALDI may impact the quality of the molecular images due to limited lateral resolution and strong background noise in the low mass range, hindering its use in metabolomics. Here we present a matrix-free laser desorption/ionization (LDI) technique based on the deposition of gold nanolayers on tissue sections by means of sputter-coating. This gold coating method is quick, fully automated, reproducible, and allows growing highly controlled gold nanolayers, necessary for high quality and high resolution MS image acquisition. The performance of the developed method has been tested through the acquisition of MS images of brain tissues. The obtained spectra showed a high number of MS peaks in the low mass region (m/z below 1000 Da) with few background peaks, demonstrating the ability of the sputtered gold nanolayers of promoting the desorption/ionization of a wide range of metabolites. These results, together with the reliable MS spectrum calibration using gold peaks, make the developed method a valuable alternative for MSI applications.	[Rafols, Pere; Vilalta, Didac; Torres, Sonia; Calavia, Raul; Brezmes, Jesus; del Castillo, Esteban; Yanes, Oscar; Ramirez, Noelia; Correig, Xavier] Univ Rovira & Virgili, Dept Elect Engn, Tarragona, Spain; [Rafols, Pere; Vilalta, Didac; Brezmes, Jesus; Yanes, Oscar; Ramirez, Noelia; Correig, Xavier] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Heijs, Bram; McDonnell, Liam A.] Leiden Univ, Ctr Prote & Metabol, Med Ctr, Leiden, Netherlands; [McDonnell, Liam A.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [McDonnell, Liam A.] Fdn Pisana Scienza ONLUS, Pisa, Italy; [Ramirez, Noelia; Correig, Xavier] Inst Invest Sanitaria Pere Virgili, Tarragona, Spain	Universitat Rovira i Virgili; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Rafols, P; Ramirez, N (corresponding author), Univ Rovira & Virgili, Dept Elect Engn, Tarragona, Spain.; Rafols, P; Ramirez, N (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.; Ramirez, N (corresponding author), Inst Invest Sanitaria Pere Virgili, Tarragona, Spain.	pere.rafols@urv.cat; noelia.ramirez@urv.cat	Ramirez, Noelia/B-1662-2014; delcastillo, esteban/B-4474-2016; Correig, Xavier/K-9836-2014; Yanes, Oscar/N-3630-2016; Heijs, Bram/GNM-6115-2022	Ramirez, Noelia/0000-0002-9251-0790; Correig, Xavier/0000-0002-6902-3054; Yanes, Oscar/0000-0003-3695-7157; Rafols, Pere/0000-0002-9240-4058; Heijs, Bram/0000-0001-6328-9305; McDonnell, Liam/0000-0003-0595-9491	Spanish Ministry of Economy and Competitiveness [TEC2012-31074, BES-2013-065572, IJCI-2015-23158, TEC2015-69076-P]; Direccio General de Recerca of the Government of Catalonia [2014 SGR 01267]; European Union [660034]; Tobacco Research Disease Related Program (TRDRP) of the University of California [22RT-0121, 23DT-0103]; Spanish Ministry of Economy and Competitivity [TEC2012-31074, BES-2013-065572, IJCI-2015-23158, TEC2015-69076-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Direccio General de Recerca of the Government of Catalonia; European Union(European Commission); Tobacco Research Disease Related Program (TRDRP) of the University of California; Spanish Ministry of Economy and Competitivity(Spanish Government)	The MSI project focused on spatial metabolomics within this work has been elaborated is funded by the following institutions: - Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/?lang_choosen=en) through projects: * TEC2012-31074 to XC, * TEC2015-69076-P to XC, * PR's predoctoral grant No. BES-2013-065572, * NR's Juan de la Cierva Incorporacion grant No. (IJCI-2015-23158); - Direccio General de Recerca of the Government of Catalonia (http://universitatsirecerca.gencat.cat/en/inici/index.html) through project 2014 SGR 01267; - European Union's Horizon 2020 research and innovation programme (https://ec.europa.eu/programmes/horizon2020/) under the Marie Sklodowska-Curie grant agreement No. 660034 to NR; - Tobacco Research Disease Related Program (TRDRP) of the University of California http://www.trdrp.org under projects 22RT-0121 and 23DT-0103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to acknowledge the financial support of the Spanish Ministry of Economy and Competitivity through projects TEC2012-31074 and TEC2015-69076-P, PR's predoctoral grant No. BES-2013-065572 and NR's Juan de la Cierva Incorporacion grant No. (IJCI-2015-23158) and the Direccio General de Recerca of the Government of Catalonia through project 2014 SGR 01267. NR and XC also acknowledge the financial support of the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 660034. All authors also acknowledge to Dr. M.Teresa Colomina, professor of Psychobiology at the Research Center for Behavioral Assessment (CRAMC) of the Universitat Rovira i Virgili for providing liver animal tissues; Prof. Martins-Green from the Cell Biology Department of the University of California Riverside for providing brain animal tissues funded by Tobacco Research Disease Related Program (TRDRP) grants under projects 22RT-0121 and 23DT-0103; Mrs. Lorena Garcia, from the Centre for Omics Sciences, for her assistance in sample handle and cryosectioning; and Dr. Josep Ferre, from the Department of Electronic Engineering at the Rovira i Virgili University for his support in the UV reflectance spectra acquisition.	Chiang CK, 2011, CHEM SOC REV, V40, P1269, DOI 10.1039/c0cs00050g; Duan JC, 2009, J AM SOC MASS SPECTR, V20, P1530, DOI 10.1016/j.jasms.2009.04.009; Dufresne M, 2016, ANAL CHEM, V88, P6018, DOI 10.1021/acs.analchem.6b01141; Dufresne M, 2013, ANAL CHEM, V85, P3318, DOI 10.1021/ac3037415; Frey R, 2005, BRUKER DALTONIK TECH; Goodwin RJA, 2011, RAPID COMMUN MASS SP, V25, P969, DOI 10.1002/rcm.4939; Goto-Inoue N, 2010, J AM SOC MASS SPECTR, V21, P1940, DOI 10.1016/j.jasms.2010.08.002; Guinan TM, 2015, ANAL CHEM, V87, P11195, DOI 10.1021/acs.analchem.5b02567; Hankin JA, 2007, J AM SOC MASS SPECTR, V18, P1646, DOI 10.1016/j.jasms.2007.06.010; Hayasaka T, 2010, J AM SOC MASS SPECTR, V21, P1446, DOI 10.1016/j.jasms.2010.04.005; Huang YF, 2007, ANAL CHEM, V79, P4852, DOI 10.1021/ac070023x; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kolarova L, 2017, J AM SOC MASS SPECTR, V28, P419, DOI 10.1007/s13361-016-1567-x; Kurczy ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6998; Kuzema PA, 2011, J ANAL CHEM+, V66, P1227, DOI 10.1134/S1061934811130065; Law KP, 2011, ANAL BIOANAL CHEM, V399, P2597, DOI 10.1007/s00216-010-4063-3; Li TG, 2015, SCI REP-UK, V5, DOI 10.1038/srep14089; Lim AY, 2012, ADV MATER, V24, P4211, DOI 10.1002/adma.201200027; de Laorden CL, 2015, ANAL CHEM, V87, P431, DOI 10.1021/ac5025864; Ly A, 2016, NAT PROTOC, V11, P1428, DOI 10.1038/nprot.2016.081; McLean JA, 2005, J AM CHEM SOC, V127, P5304, DOI 10.1021/ja043907w; Misiorek M, 2017, PHYTOCHEM ANALYSIS, V28, P479, DOI 10.1002/pca.2696; Norris JL, 2013, PROTEOM CLIN APPL, V7, P733, DOI 10.1002/prca.201300055; Northen TR, 2007, NATURE, V449, P1033, DOI 10.1038/nature06195; Peterson DS, 2007, MASS SPECTROM REV, V26, P19, DOI 10.1002/mas.20104; Pilolli R, 2012, ANAL BIOANAL CHEM, V402, P601, DOI 10.1007/s00216-011-5120-2; Potocnik NO, 2015, RAPID COMMUN MASS SP, V29, P2195, DOI 10.1002/rcm.7379; Puolitaival SM, 2008, J AM SOC MASS SPECTR, V19, P882, DOI 10.1016/j.jasms.2008.02.013; Qiao LA, 2010, NANOMEDICINE-UK, V5, P1641, DOI 10.2217/NNM.10.127; Rafols P, 2018, ANAL CHIM ACTA, V1022, P61, DOI 10.1016/j.aca.2018.03.031; Rafols P, 2017, BIOINFORMATICS, V33, P2427, DOI 10.1093/bioinformatics/btx182; Sekula J, 2015, ANAL CHIM ACTA, V875, P61, DOI 10.1016/j.aca.2015.01.046; Shroff R, 2007, RAPID COMMUN MASS SP, V21, P3295, DOI 10.1002/rcm.3216; Son J, 2014, J AM SOC MASS SPECTR, V25, P891, DOI 10.1007/s13361-014-0844-9; Su CL, 2007, ANAL CHEM, V79, P1626, DOI 10.1021/ac061747w; van Hove ERA, 2010, J CHROMATOGR A, V1217, P3946, DOI 10.1016/j.chroma.2010.01.033; Wiseman JM, 2006, ANGEW CHEM INT EDIT, V45, P7188, DOI 10.1002/anie.200602449; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wu HP, 2009, J AM SOC MASS SPECTR, V20, P875, DOI 10.1016/j.jasms.2009.01.002	39	16	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208908	10.1371/journal.pone.0208908	http://dx.doi.org/10.1371/journal.pone.0208908			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540827	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600097
J	Page, I; Nougarou, F; Lardoe, A; Descarreaux, M				Page, Isabelle; Nougarou, Francois; Lardoe, Arnaud; Descarreaux, Martin			Changes in spinal stiffness with chronic thoracic pain: Correlation with pain and muscle activity	PLOS ONE			English	Article							POSTEROANTERIOR LUMBAR STIFFNESS; LOW-BACK-PAIN; MANIPULATION; INDIVIDUALS; RELIABILITY; MOVEMENT; INDENTER; RIBCAGE; THERAPY; SCALE	Objective The objective was to compare thoracic spinal stiffness between healthy participants and participants with chronic thoracic pain and to explore the associations between spinal stiffness, pain and muscle activity. The reliability of spinal stiffness was also evaluated. Material and methods Spinal stiffness was assessed from T5 to T8 using a mechanical device in 25 healthy participants and 50 participants with chronic thoracic pain (symptoms had to be reported within the evaluated region of the back). The spinal levels for which spinal stiffness was measured were standardized (i.e. T5 to T8 for all participants) to minimize between-individual variations due to the evaluation of different spinal levels. The device load and displacement data were used to calculate the global and terminal spinal stiffness coefficients at each spinal level. Immediately after each assessment, participants were asked to rate their pain intensity during the trial, while thoracic muscle activity was recorded during the load application using surface electromyography electrodes (sEMG). Within- and between-day reliability were evaluated using intraclass correlation coefficients (ICC), while the effects of chronic thoracic pain and spinal levels on spinal stiffness and sEMG activity were assessed using mixed model ANOVAs. Correlations between pain intensity, muscle activity and spinal stiffness were also computed. Results ICC values for within-and between-day reliability of spinal stiffness ranged from 0.67 to 0.91 and from 0.60 to 0.94 (except at T5), respectively. A significant decrease in the global (F-1,F-73 = 4.04, p = 0.048) and terminal (F-1,F-73 = 4.93, p = 0.03) spinal stiffness was observed in participants with thoracic pain. sEMG activity was not significantly different between groups and between spinal levels. Pain intensity was only significantly and "moderately" correlated to spinal stiffness coefficients at one spinal level (-0.29 <= r <=-0.51), while sEMG activity and spinal stiffness were not significantly correlated. Conclusion The results suggest that spinal stiffness can be reliably assessed using a mechanical device and that this parameter is decreased in participants with chronic thoracic pain. Studies are required to determine the value of instrumented spinal stiffness assessment in the evaluation and management of patients with chronic spine-related pain.	[Page, Isabelle] Univ Quebec Trois Rivieres, Dept Anat, Trois Rivieres, PQ, Canada; [Nougarou, Francois] Univ Quebec Trois Rivieres, Dept Elect & Comp Engn, Trois Rivieres, PQ, Canada; [Lardoe, Arnaud; Descarreaux, Martin] Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ, Canada; [Lardoe, Arnaud] Inst Franco Europeen Chiropraxie, Ivry, France	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres	Page, I (corresponding author), Univ Quebec Trois Rivieres, Dept Anat, Trois Rivieres, PQ, Canada.	isabelle.page1@uqtr.ca	Pagé, Isabelle/AAR-6740-2021	Pagé, Isabelle/0000-0002-7175-0402; Lardon, Arnaud/0000-0002-0935-445X	Canadian Institutes of Health Research (CIHR) [314851]; Fonds de Recherche du Quebec-Sante (FRQS) [28916]; Fondation Chiropratique du Quebec (FCQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); Fondation Chiropratique du Quebec (FCQ)	IP received scholarships from the Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca, application number 314851) and the Fonds de Recherche du Quebec-Sante (FRQS, http://www.frqs.gouv.qc.ca/en/, application number 28916). This study was also funded by the Fondation Chiropratique du Quebec (FCQ, http://www.fondationchiropratique.ca) to MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JH, 2009, MANUAL THER, V14, P36, DOI 10.1016/j.math.2007.09.011; Allison GT, 1998, J MANIP PHYSIOL THER, V21, P534; Briggs AM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-77; Brodeur RR, 1999, JNMS-J NEUROMUSC SYS, V7, P127; Bruyere O, 2014, SPINE, V39, pE123, DOI 10.1097/BRS.0000000000000062; Caling B, 2001, J MANIP PHYSIOL THER, V24, P71, DOI 10.1067/mmt.2001.112568; Campbell BD, 2010, J ORTHOP SPORT PHYS, V40, P685, DOI 10.2519/jospt.2010.3271; Chansirinukor W, 2003, J MANIP PHYSIOL THER, V26, P176, DOI 10.1016/S0161-4754(02)54131-2; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Colloca CJ, 2001, J MANIP PHYSIOL THER, V24, P489, DOI 10.1067/mmt.2001.118209; Descarreaux M, 2013, J MANIP PHYSIOL THER, V36, P78, DOI 10.1016/j.jmpt.2012.12.007; Edmondston SJ, 1999, MANUAL THER, V4, P157, DOI 10.1054/math.1999.0202; Fritz JM, 2011, SPINE, V36, P1772, DOI 10.1097/BRS.0b013e318216337d; Haneline MT, 2009, J MANIP PHYSIOL THER, V32, P379, DOI 10.1016/j.jmpt.2009.04.010; Hazra A, 2016, INDIAN J DERMATOL, V61, P593, DOI 10.4103/0019-5154.193662; Hurwitz EL, 2012, J ELECTROMYOGR KINES, V22, P648, DOI 10.1016/j.jelekin.2012.01.006; Ingram LA, 2015, J ORTHOP SPORT PHYS, V45, P162, DOI 10.2519/jospt.2015.5711; Kawchuk GN, 2001, J MANIP PHYSIOL THER, V24, P84, DOI 10.1067/mmt.2001.112566; KOPEC JA, 1995, SPINE, V20, P341, DOI 10.1097/00007632-199502000-00016; Koppenhaver SL, 2014, MANUAL THER, V19, P589, DOI 10.1016/j.math.2014.06.001; Kumar S, 2012, PM&R, V4, P342, DOI 10.1016/j.pmrj.2011.12.009; Kumar S, 2011, J ELECTROMYOGR KINES, V21, P762, DOI 10.1016/j.jelekin.2011.07.008; Kumar S, 2011, J ELECTROMYOGR KINES, V21, P458, DOI 10.1016/j.jelekin.2011.01.001; Latimer J, 1996, J Manipulative Physiol Ther, V19, P587; Leboeuf-Yde C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-39; Lundberg M, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/494196; Merskey H, 1994, CLASSIFICATION CHRON, Vxvi; Murthy V, 2015, SPINE J, V15, P1870, DOI 10.1016/j.spinee.2015.04.049; Scrimshaw SV, 2001, J MANIP PHYSIOL THER, V24, P501, DOI 10.1067/mmt.2001.118208; Shaw JD, 2015, SPINE J, V15, P1645, DOI 10.1016/j.spinee.2015.03.007; Shirley D, 2002, MANUAL THER, V7, P19, DOI 10.1054/math.2001.0432; Shirley D., 1993, J MANUAL MANIPULATIV, V1, P22; Singh R, 2011, ASIAN SPINE J, V5, P20, DOI 10.4184/asj.2011.5.1.20; Snodgrass SJ, 2012, J ELECTROMYOGR KINES, V22, P708, DOI 10.1016/j.jelekin.2012.04.015; Snodgrass SJ, 2008, MANUAL THER, V13, P520, DOI 10.1016/j.math.2007.07.007; Squires MC, 2001, MANUAL THER, V6, P40, DOI 10.1054/math.2000.0379; Stochkendahl MJ, 2006, J MANIP PHYSIOL THER, V29, P475, DOI 10.1016/j.jmpt.2006.06.011; Wong AYL, 2017, PM&R, V9, P816, DOI 10.1016/j.pmrj.2016.12.001; Wong AYL, 2016, CLIN BIOMECH, V34, P45, DOI 10.1016/j.clinbiomech.2016.03.006; Wong AYL, 2015, SPINE, V40, P1329, DOI 10.1097/BRS.0000000000000981; Wong AYL, 2013, MANUAL THER, V18, P395, DOI 10.1016/j.math.2013.02.003	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208790	10.1371/journal.pone.0208790	http://dx.doi.org/10.1371/journal.pone.0208790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533059	gold, Green Submitted, Green Published			2022-12-26	WOS:000452782500036
J	Cedars, E; Kriss, H; Lazar, AA; Chan, C; Chan, DK				Cedars, Elizabeth; Kriss, Hayley; Lazar, Ann A.; Chan, Curtis; Chan, Dylan K.			Use of otoacoustic emissions to improve outcomes and reduce disparities in a community preschool hearing screening program	PLOS ONE			English	Article							UNITED-STATES; CHILDREN; PREVALENCE; INTERVENTION; ACCURACY; HEALTH; AGE	Introduction Hearing loss substantially impacts pediatric development, and early identification improves outcomes. While intervening before school-entry is critical to optimize learning, early-childhood hearing screening practices are highly variable. Conditioned play audiometry (CPA) is the gold standard for preschool hearing screening, but otoacoustic emission (OAE) testing provides objective data that may improve screening outcomes. Objectives To compare outcomes of a community-based low-income preschool hearing program before and after implementation of OAE in a single-visit, two-tiered paradigm. We hypothesized that this intervention would reduce referral rates and improve follow-up while maintaining stable rates of diagnosed sensorineural hearing loss. Methods We performed a cohort study of 3257 children screened from July 2014-June 2016. Department of Public Health data were analyzed pre- and post-implementation of second-line OAE testing for children referred on CPA screening with targeted follow-up by DPH staff. Primary outcomes included referral rates, follow-up rates, and diagnosis of sensorineural hearing loss. Results Demographics, pure-tone pass rates, and incidence of newly-diagnosed permanent hearing loss were similar across years. After intervention, overall pass rates increased from 92% to 95% (P = 0.0014), while only 0.7% remained unable to be tested (P<0.0001). 5% of children were unable to be tested by CPA screening but passed OAE testing, obviating further evaluation. Referral rate decreased from 8% to 5% (P = 0.0014), and follow-up improved from 36% to 91% (P<0.0001). Identification of pathology in children with follow-up increased from 19% to over 50%. Further, disparities in pass rates and ability to test seen in Year 1 were eliminated in Year 2. Conclusion and relevance In a community setting, implementation of second-line OAE screening for CPA referrals reduced referral rates, increased identification of hearing loss, reduced outcome disparities, and improved follow-up rates. This study provides lessons in how to improve outcomes and reduce disparities in early-childhood hearing screening.	[Cedars, Elizabeth; Chan, Dylan K.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; [Kriss, Hayley; Chan, Curtis] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Lazar, Ann A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; University of California System; University of California San Francisco	Chan, DK (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA.	dylan.chan@ucsf.edu			Campus-Community Partnership grant from the Mt. Zion Health Fund	Campus-Community Partnership grant from the Mt. Zion Health Fund	This project was funded by a Campus-Community Partnership grant to DKC from the Mt. Zion Health Fund (no website available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Pediatrics, REC PREV PED HLTH CA; Bamford J, 2007, HEALTH TECHNOL ASSES, V11, P1; Barnett W.S., 2016, STATE S HEAD START; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Bright K., 2011, AM ACAD AUDIOLOGY CH; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Cunningham SA, 2008, HEALTH PLACE, V14, P623, DOI 10.1016/j.healthplace.2007.12.002; Eiserman WD, 2008, INT J PEDIATR OTORHI, V72, P475, DOI 10.1016/j.ijporl.2007.12.006; Eiserman WD, 2007, EARLY CHILD RES Q, V22, P105, DOI 10.1016/j.ecresq.2006.09.001; Mehra S, 2009, OTOLARYNG HEAD NECK, V140, P461, DOI 10.1016/j.otohns.2008.12.022; Nelson HD, 2008, AHRQ PUBLICATION; Niskar AS, 1998, JAMA-J AM MED ASSOC, V279, P1071, DOI 10.1001/jama.279.14.1071; Prieve BA, 2015, AM J AUDIOL, V24, P250, DOI 10.1044/2015_AJA-14-0065; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Sideris I, 2006, J COMMUN DISORD, V39, P391, DOI 10.1016/j.jcomdis.2005.11.006; Watkin PM, 2011, ARCH DIS CHILD, V96, P62, DOI 10.1136/adc.2010.185819; Williams TR, 2015, MMWR-MORBID MORTAL W, V64, P351; Yoshinaga-Itano C, 1999, OTOLARYNG CLIN N AM, V32, P1089, DOI 10.1016/S0030-6665(05)70196-1	18	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208050	10.1371/journal.pone.0208050	http://dx.doi.org/10.1371/journal.pone.0208050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532159	Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700012
J	Polsinelli, GA; Yu, HWD				Polsinelli, Gregory A.; Yu, Hongwei D.			Regulation of histone deacetylase 3 by metal cations and 10-hydroxy-2E-decenoic acid: Possible epigenetic mechanisms of queen-worker bee differentiation	PLOS ONE			English	Article							HUMAN CLASS-I; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HUMAN HDAC8; ZINC; BINDING; VITELLOGENIN; INHIBITOR; COMPLEXES	Histone deacetylases (HDACs) catalyze the hydrolysis of epsilon-acetyl-lysine residues of histones. Removal of acetyl groups results in condensation of chromatin structure and repression of gene expression. Human class I, II, and IV HDACs are said to be zinc-dependent in that they require divalent zinc ions to catalyze the deacetylase reaction. HDACs are considered potential targets for the treatment of cancer due to their role in regulating transcription. They are also thought to play important roles in the development of organisms such as honey bees. The fatty acid, 10-hydroxy-2E-decenoic acid (10-HDA), which can account for up to 5% of royal jelly composition has been reported as an HDAC inhibitor. The crystal structure of the HDAC3:SMRT complex possesses two monovalent cations (MVCs) labeled as potassium with one MVC binding site near the active site Zn(II) and the second MVC binding site >= 20 angstrom from the active site Zn(II). We report here the inhibitory effects of excess Zn(II) on the catalytic activity of histone deacetylase 3 (HDAC3) bound to the deacetylase activating domain of nuclear receptor corepressor 2 (NCOR2). We also report the effects of varying concentrations of potassium ions where [K+] up to 10 mM increase HDAC3 activity with a maximum k(cat)/K-M of approximately 80,000 M (-1) s(-1) while [K+] above 10 mM inhibit HDAC3 activity. The inhibition constant (K-i) of 10-HDA was determined to be 5.32 mM. The regulatory effects of zinc, potassium, and 10-HDA concentration on HDAC3 activity suggest a strong correlation between these chemical species and epigenetic control over Apis mellifera caste differentiation among other control mechanisms.	[Polsinelli, Gregory A.] Bethany Coll, Dept Biol, Bethany, WV 26032 USA; [Yu, Hongwei D.] Marshall Univ, Joan C Edwards Sch Med, Dept Biomed Sci, Huntington, WV USA	Marshall University	Polsinelli, GA (corresponding author), Bethany Coll, Dept Biol, Bethany, WV 26032 USA.	gpolsinelli@bethanywv.edu		Yu, Hongwei/0000-0002-8546-0158; Polsinelli, Gregory/0000-0002-7681-5770	NIH [R44GM113545, P20GM103434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434, R44GM113545] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant P20GM103434 to the West Virginia IDeA Network for Biomedical Research Excellence (WV-INBRE) and NIH Grant R44GM113545. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Dowling DP, 2010, BIOCHEMISTRY-US, V49, P5048, DOI 10.1021/bi1005046; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gantt ML, 2016, BIOCHEMISTRY-US, V55, P820, DOI 10.1021/acs.biochem.5b01327; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Gantt SL, 2010, J BIOL CHEM, V285, P6036, DOI 10.1074/jbc.M109.033399; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haydak MH, 1943, J ECON ENTOMOL, V36, P778, DOI 10.1093/jee/36.5.778; Hernick M, 2005, ARCH BIOCHEM BIOPHYS, V433, P71, DOI 10.1016/j.abb.2004.08.006; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Johnson CA, 2002, J BIOL CHEM, V277, P9590, DOI 10.1074/jbc.M107942200; Kern S, 2007, FEBS J, V274, P3578, DOI 10.1111/j.1742-4658.2007.05887.x; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LARSEN KS, 1989, BIOCHEMISTRY-US, V28, P9620, DOI 10.1021/bi00451a012; Leipe DD, 1997, NUCLEIC ACIDS RES, V25, P3693, DOI 10.1093/nar/25.18.3693; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Maret W, 1999, P NATL ACAD SCI USA, V96, P1936, DOI 10.1073/pnas.96.5.1936; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Martin DJ, 1998, SCI TOTAL ENVIRON, V214, P133, DOI 10.1016/S0048-9697(98)00060-6; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; MONTORZI M, 1994, BIOCHEM BIOPH RES CO, V200, P1407, DOI 10.1006/bbrc.1994.1607; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nielsen TK, 2005, J MOL BIOL, V354, P107, DOI 10.1016/j.jmb.2005.09.065; Porter DJT, 2000, BBA-PROTEIN STRUCT M, V1476, P239, DOI 10.1016/S0167-4838(99)00246-0; REMBOLD HEINZ, 1965, VITAMINS HORMONES, V23, P359; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Schultz BE, 2004, BIOCHEMISTRY-US, V43, P11083, DOI 10.1021/bi0494471; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seehuus SC, 2006, EXP GERONTOL, V41, P1117, DOI 10.1016/j.exger.2006.08.004; Shi YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018808; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Spannhoff A, 2011, EMBO REP, V12, P238, DOI 10.1038/embor.2011.9; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Villar-Garea A, 2004, INT J CANCER, V112, P171, DOI 10.1002/ijc.20372; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Wang Y, 2016, APIDOLOGIE, V47, P48, DOI 10.1007/s13592-015-0374-x; Watson PJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11262; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wojciechowski M, 2018, GENOME RES, V28, P1532, DOI 10.1101/gr.236497.118; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200	49	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0204538	10.1371/journal.pone.0204538	http://dx.doi.org/10.1371/journal.pone.0204538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532259	Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700003
J	Franzo, G; Segales, J				Franzo, Giovanni; Segales, Joaquim			Porcine circovirus 2 (PCV-2) genotype update and proposal of a new genotyping methodology	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; EVOLUTIONARY GENETICS; PHYLOGENETIC ANALYSIS; REVEALS; EMERGENCE; STRAINS; FARMS; PIGS	Porcine circovirus 2 (PCV-2) is one of the most widespread viral infections of swine, causing a remarkable economic impact because of direct losses and indirect costs for its control. As other ssDNA viruses, PCV-2 is characterized by a high evolutionary rate, leading to the emergence of a plethora of variants with different biological and epidemiological features. Over time, several attempts have been made to organize PCV-2 genetic heterogeneity in recognized genotypes. This categorization has clearly simplified the epidemiological investigations, allowing to identify different spatial and temporal patterns among genotypes. Additionally, variable virulence and vaccine effectiveness have also been hypothesized. However, the rapid increase in sequencing activity, coupled with the per se high viral variability, has challenged the previously established nomenclature, leading to the definition of several study-specific genotypes and hindering the capability of performing comparable epidemiological studies. Based on these premises, an updated classification scheme is herein reported. Recognizing the impossibility of defining a clear inter-cluster p-distance cut-off, the present study proposes a phylogeny-grounded genotype definition based on three criteria: maximum intra-genotype p-distance of 13% (calculated on the ORF2 gene), bootstrap support at the corresponding internal node higher than 70% and at least 15 available sequences. This scheme allowed defining 8 genotypes (PCV-2a to PCV-2h), which six of those had been previously proposed. To minimize the inconvenience of implementing a new classification, the most common names already adopted have been maintained when possible. The analysis of sequence-associated metadata highlighted a highly unbalanced sequencing activity in terms of geographical, host and temporal distribution. The PCV-2 molecular epidemiology scenario appears therefore characterized by a severe bias that could lead to spurious associations between genetic and epidemiological/biological viral features. While the suggested classification can establish a "common language" for future studies, further efforts should be paid to achieve a more homogeneous and informative representation of the PCV-2 global scenario.	[Franzo, Giovanni] Univ Padua, Dept Anim Med Prod & Hlth, Legnaro, Italy; [Segales, Joaquim] UAB, IRTA, CRESA, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Fac Vet, Bellaterra, Spain	University of Padua; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Franzo, G (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth, Legnaro, Italy.	giovanni.franzo@unipd.it	Segalés, Joaquim/AAB-4815-2020; Segalés, Joaquim/A-4933-2011	Segalés, Joaquim/0000-0002-1539-7261; Segalés, Joaquim/0000-0002-1539-7261; Franzo, Giovanni/0000-0003-2991-217X				Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Anoopraj R, 2015, INFECT GENET EVOL, V31, P25, DOI 10.1016/j.meegid.2015.01.006; Bao F, 2018, TRANSBOUND EMERG DIS, V65, P432, DOI 10.1111/tbed.12721; Cadar D, 2012, INFECT GENET EVOL, V12, P420, DOI 10.1016/j.meegid.2012.01.014; Carman S, 2006, CAN VET J, V47, P761; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Correa-Fiz F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33849-2; Cortey M, 2011, VET J, V187, P363, DOI 10.1016/j.tvjl.2009.12.023; Davies B, 2016, VIRUS RES, V217, P32, DOI 10.1016/j.virusres.2016.02.010; Dupont K, 2008, VET MICROBIOL, V128, P56, DOI 10.1016/j.vetmic.2007.09.016; Firth C, 2009, J VIROL, V83, P12813, DOI 10.1128/JVI.01719-09; Franzo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep39458; Franzo G, 2016, MOL PHYLOGENET EVOL, V100, P269, DOI 10.1016/j.ympev.2016.04.028; Franzo G, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0361-x; Franzo G, 2015, VET MICROBIOL, V178, P158, DOI 10.1016/j.vetmic.2015.05.003; Grau-Roma L, 2012, RES VET SCI, V93, P1231, DOI 10.1016/j.rvsc.2012.07.001; Guo LJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-273; Guo LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041463; Harmon KM, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01315-15; Holmes EC, 2010, P NATL ACAD SCI USA, V107, P1742, DOI 10.1073/pnas.0906193106; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liu X, 2016, ARCH VIROL, V161, P1591, DOI 10.1007/s00705-016-2823-x; Manrubia SC, 2012, CURR OPIN VIROL, V2, P531, DOI 10.1016/j.coviro.2012.06.006; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Olvera A, 2007, VIROLOGY, V357, P175, DOI 10.1016/j.virol.2006.07.047; Opriessnig T, 2014, J GEN VIROL, V95, P2495, DOI 10.1099/vir.0.066423-0; Opriessnig T, 2013, VET MICROBIOL, V163, P177, DOI 10.1016/j.vetmic.2012.12.019; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Segales J, 2008, VET REC, V162, P867, DOI 10.1136/vr.162.26.867; Team RC, 2013, R A LANG ENV STAT CO; Timmusk S, 2008, VIRUS GENES, V36, P509, DOI 10.1007/s11262-008-0217-1; Wiederkehr DD, 2009, VET MICROBIOL, V136, P27, DOI 10.1016/j.vetmic.2008.10.028; Xiao CT, 2015, J GEN VIROL, V96, P1830, DOI 10.1099/vir.0.000100; Xiao CT, 2012, J VIROL, V86, P12469, DOI 10.1128/JVI.02345-12	36	89	96	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208585	10.1371/journal.pone.0208585	http://dx.doi.org/10.1371/journal.pone.0208585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521609	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600096
J	Tsegay, G; Deribe, K; Deyessa, N; Addissie, A; Davey, G; Cooper, M; Trueba, ML				Tsegay, Girmay; Deribe, Kebede; Deyessa, Negussie; Addissie, Adamu; Davey, Gail; Cooper, Max; Trueba, Mei L.			'I should not feed such a weak woman'. Intimate partner violence among women living with podoconiosis: A qualitative study in northern Ethiopia	PLOS ONE			English	Article							DOMESTIC VIOLENCE; WOLAITA ZONE; STIGMA; PREVALENCE; HEALTH; MULTICOUNTRY; STRATEGIES; SEX	Background Intimate Partner Violence (IPV) is a serious, preventable public health problem that affects millions of people worldwide. Research indicates that adults suffering from long term, disabling conditions are more likely to be victims of IPV due to the intersection of disease-associated stigma and discrimination. IPV in turn is known to worsen the overall health and wellbeing of those affected by it. Little research however explores the relationship between neglected tropical diseases such as podoconiosis and IPV. This study explores the relationship between IPV and podoconiosis in northern Ethiopia with the aim of identifying new avenues for limiting disability and promoting the wellbeing of people affected by this neglected tropical disease. Methods The study was conducted in East and West Gojjam zones, located in the Amhara Regional State of Ethiopia. Research participants were first screened using the domestic violence screening tool Hurt-Insult-Threaten-Scream (HITS). Data were collected by native speakers of the local language (Amharic) in the form of semi-structured interviews during January and February 2016. Thematic and content data analysis was carried out, using the Open Code 3.4 qualitative data analysis software for coding. Results A total of 15 women living with podoconiosis and experiencing IPV were interviewed (aged 31 to 75). Women experienced different forms of IPV, including beatings (with or without an object), insults, name calling, undermining, denial of equal rights over common assets, movement monitoring, cheating, abandonment, forced divorce, obstruction of health care access, inhibition of decision-making and sexual coercion. Podoconiosis increases the frequency and severity of IPV and in occasions shapes a change from physical to psychological and financial violence. In turn, frequent episodes of IPV worsen disease outcomes and contribute to disease persistence in the region, in that these impede women's ability to manage the disease and help perpetuate the conditions of poverty that influence disease onset. Conclusions Women living with podoconiosis are victims of various, overlapping forms of IPV that negatively impact their health and wellbeing. Poverty, scarce IPV prevention services in the area together with a social acceptance of IPV and these women's decreased ability to work due to the debilitating effects of podoconiosis and childcare responsibilities frequently prompt these women to tolerate IPV and remain in abusive relationships. Tackling disease-associated taboo and stigma, developing accessible IPV interventions, working towards greater gender equality at the household and societal levels and developing sustainable strategies for improving the socio-economic assets of women affected by podoconiosis are all necessary to both prevent IPV and to improve disease outcome.	[Tsegay, Girmay] Debre Markos Univ, Coll Med & Hlth Sci, Debre Markos, Ethiopia; [Deribe, Kebede; Davey, Gail; Cooper, Max; Trueba, Mei L.] Brighton & Sussex Med Sch, Wellcome Trust Brighton & Sussex Ctr Global Hlth, Brighton, E Sussex, England; [Deribe, Kebede; Deyessa, Negussie; Addissie, Adamu] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia	University of Brighton; University of Sussex; Addis Ababa University	Tsegay, G (corresponding author), Debre Markos Univ, Coll Med & Hlth Sci, Debre Markos, Ethiopia.	girmshe@gmail.com	Trueba, Mei/AAE-4377-2021; Trueba, Mei L./Y-1708-2018; Deribe, Kebede/I-5422-2019	Trueba, Mei L./0000-0002-3468-9411; Deribe, Kebede/0000-0002-8526-6996; Cooper, Maxwell/0000-0002-6754-2336; Kiros, Girmay/0000-0003-0158-6667	Wellcome Trust Fellowship in Public Health and Tropical Medicine [099876]; Wellcome Trust University award [091956]	Wellcome Trust Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Wellcome Trust University award(Wellcome Trust)	KD is supported by a Wellcome Trust Fellowship in Public Health and Tropical Medicine (grant number 099876). GD is supported by a Wellcome Trust University award (grant number 091956) to carry out work in podoconiosis.	Anderson AM, 2015, AIDS CARE, V27, P63, DOI 10.1080/09540121.2014.951597; [Anonymous], 2013, LANCET, V381, P2135, DOI 10.1016/S0140-6736(13)61222-2; [Anonymous], 1999, Popul Rep L, P1; Ayode D, 2016, J PUBLIC HLTH RES, V5; Banks HS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004878; Davey G, 2016, ETHIOPIAN J HLTH DEV, V22; Davis KB, 2012, SOC WORK HEALTH CARE, V51, P213, DOI 10.1080/00981389.2011.614835; Deribe K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1178; Deyessa N, 1998, ETHIOPIAN MED J, V36, P83; Dibaba Y, 2006, ETHIOPIAN J HLTH SCI, V16, P126; Ellsberg M., 2005, RES VIOLENCE WOMEN P; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; FDRE PCC (Federal Democratic Republic of Ethiopia Population Census Commission), 2008, SUMM STAT REP 2007 P; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gass JD, 2010, SAMJ S AFR MED J, V100, P582, DOI 10.7196/SAMJ.4274; Jones L, 2012, LANCET, V380, P899, DOI 10.1016/S0140-6736(12)60692-8; Katsui H, 2015, DEV PRACT, V25, P563, DOI 10.1080/09614524.2015.1031085; Kumar N, 2015, WORLD DEV, V67, P406, DOI 10.1016/j.worlddev.2014.10.029; Matjasko JL, 2013, J POLICY ANAL MANAG, V32, P122, DOI 10.1002/pam.21666; Molla YB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001744; Mousley E, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-122; Niebuhr D, 2012, BUNDESGESUNDHEITSBLA, V55, P715, DOI 10.1007/s00103-012-1482-7; Orza L, 2015, J INT AIDS SOC, V18; Riddell T, 2009, HEALTH CARE WOMEN IN, V30, P134, DOI 10.1080/07399330802523774; Saltzman LE, 2015, INTIMATE PARTNER VIO; Santaularia J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1286; Semahegn A, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-63; Shakil A, 2005, FAM MED, V37, P193; Sherin K M, 1998, Fam Med, V30, P508; Slayter E., 2009, J AGGRESS MALTREAT T, V18, P182, DOI [10.1080/10926770802675668, DOI 10.1080/10926770802675668]; Tegbar Yigzaw, 2004, Ethiopian Journal of Health Development, V18, P133; Tolossa D., 2005, RURAL LIVELIHOODS PO; Tomczyk S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001560; Tora A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-647; Tora A, 2011, INT HEALTH, V3, P176, DOI 10.1016/j.inhe.2011.06.006; van Blerk L, 2008, AREA, V40, P245, DOI 10.1111/j.1475-4762.2008.00799.x; Van Der Heijden I, 2014, WHAT WORKS PREVENT V; WHO, 2012, UND ADD VIOL WOM INT; Yigzaw T, 2010, ETHIOPIAN J HLTH DEV, V24; Yigzaw T., 2005, ETHIOPIAN J HLTH DEV, V18, P1, DOI [10.4314/ejhd.v18i3.9846, DOI 10.4314/EJHD.V18I3.9846]	40	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207571	10.1371/journal.pone.0207571	http://dx.doi.org/10.1371/journal.pone.0207571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521548	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600014
J	Wun, K; Theriault, BR; Pierre, JF; Chen, EB; Leone, VA; Harris, KG; Xiong, LQ; Jiang, Q; Spedale, M; Eskandari, OM; Chang, EB; Ho, KJ				Wun, Kelly; Theriault, Betty R.; Pierre, Joseph F.; Chen, Edmund B.; Leone, Vanessa A.; Harris, Katharine G.; Xiong, Liqun; Jiang, Qun; Spedale, Melanie; Eskandari, Owen M.; Chang, Eugene B.; Ho, Karen J.			Microbiota control acute arterial inflammation and neointimal hyperplasia development after arterial injury	PLOS ONE			English	Article							MOUSE CAROTID-ARTERY; GUT MICROBIOTA; VASCULAR REPAIR; SYSTEMIC INFLAMMATION; INTIMAL HYPERPLASIA; LAMINA PROPRIA; T-CELLS; MACROPHAGE; MICE; INFECTION	Background The microbiome has a functional role in a number of inflammatory processes and disease states. While neointimal hyperplasia development has been linked to inflammation, a direct role of the microbiota in neointimal hyperplasia has not yet been established. Germ-free (GF) mice are an invaluable model for studying causative links between commensal organisms and the host. We hypothesized that GF mice would exhibit altered neointimal hyperplasia following carotid ligation compared to conventionally raised (CONV-R) mice. Methods Twenty-week-old male C57BL/6 GF mice underwent left carotid ligation under sterile conditions. Maintenance of sterility was assessed by cultivation and 16S rRNA qPCR of stool. Neointimal hyperplasia was assessed by morphometric and histologic analysis of arterial sections after 28 days. Local arterial cell proliferation and inflammation was assessed by immunofluorescence for Ki67 and inflammatory cell markers at five days. Systemic inflammation was assessed by multiplex immunoassays of serum. CONV-R mice treated in the same manner served as the control cohort. GF and CONV-R mice were compared using standard statistical methods. Results All GF mice remained sterile during the entire study period. Twenty-eight days after carotid ligation, CONV-R mice had significantly more neointimal hyperplasia development compared to GF mice, as assessed by intima area, media area, intima+media area, and intima area/(intima+media) area. The collagen content of the neointimal lesions appeared qualitatively similar on Masson's trichrome staining. There was significantly reduced Ki67 immunoreactivity in the media and adventitia of GF carotid arteries 5 days after ligation. GF mice also had increased arterial infiltration of anti-inflammatory M2 macrophages compared to CONV-R mouse arteries and a reduced proportion of mature neutrophils. GF mice had significantly reduced serum IFN-gamma-inducible protein (IP)-10 and MIP-2 5 days after carotid ligation, suggesting a reduced systemic inflammatory response. Conclusions GF mice have attenuated neointimal hyperplasia development compared to CONV-R mice, which is likely related to altered kinetics of wound healing and acute inflammation. Recognizing the role of commensals in the regulation of arterial remodeling will provide a deeper understanding of the pathophysiology of restenosis and support strategies to treat or reduce restenosis risk by manipulating microbiota.	[Wun, Kelly; Chen, Edmund B.; Xiong, Liqun; Jiang, Qun; Eskandari, Owen M.; Ho, Karen J.] Northwestern Univ, Div Vasc Surg, Chicago, IL 60611 USA; [Theriault, Betty R.; Spedale, Melanie] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Theriault, Betty R.; Spedale, Melanie] Univ Chicago, Anim Resources Ctr, Chicago, IL 60637 USA; [Pierre, Joseph F.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Leone, Vanessa A.; Harris, Katharine G.; Chang, Eugene B.] Univ Chicago, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA	Northwestern University; University of Chicago; University of Chicago; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago	Ho, KJ (corresponding author), Northwestern Univ, Div Vasc Surg, Chicago, IL 60611 USA.	kho1@nm.org	Ho, Karen/AHC-8328-2022; Pierre, Joseph F./AAA-2469-2020; Pierre, Joseph/HCH-3993-2022	Pierre, Joseph/0000-0002-4248-1290	National Heart, Lung, and Blood Institute [T32HL094293, K08HL130601]; National Institute of Diabetes and Digestive Diseases [T32DK007074, R01DK097268, P30DK42086, R56DK102872, K01DK111785]; American College of Surgeons; Society for Vascular Surgery; Lanterman Vascular Surgery Student Award; Vascular Cures; Abbott Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094293, K08HL130601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, K01DK111785, R01DK097268, T32DK007074] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American College of Surgeons; Society for Vascular Surgery; Lanterman Vascular Surgery Student Award; Vascular Cures; Abbott Fund(Abbott Laboratories); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/), T32HL094293 to E.B. Chen, K08HL130601 to K.H.; National Institute of Diabetes and Digestive Diseases (https://www.niddk.nih.gov/), T32DK007074, R01DK097268, P30DK42086, R56DK102872 to E.B. Chang, K01DK111785 to V.L.; American College of Surgeons (https://www.facs.org/) to K.H.; Society for Vascular Surgery (https://vascular.org/) to K.H. and K.W.; Lanterman Vascular Surgery Student Award (no URL) to K.W. and O.E.; Vascular Cures (http://vascularcures.org/) to K.H.; Abbott Fund (http://www.abbottfund.org/) to E.B. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2013, STEM CELL REV REP, V9, P620, DOI 10.1007/s12015-013-9455-2; Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Alberts-Grill N, 2012, ARTERIOSCL THROM VAS, V32, P623, DOI 10.1161/ATVBAHA.111.242180; Atarashi K, 2010, VACCINE, V28, P8036, DOI 10.1016/j.vaccine.2010.09.026; Backhed F, 2010, CLIN EXP IMMUNOL, V160, P80, DOI 10.1111/j.1365-2249.2010.04123.x; Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Brown JM, 2018, NAT REV MICROBIOL, V16, P171, DOI 10.1038/nrmicro.2017.149; Canesso MCC, 2014, J IMMUNOL, V193, P5171, DOI 10.4049/jimmunol.1400625; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Danenberg HD, 2002, CIRCULATION, V105, P2917, DOI 10.1161/01.CIR.0000018168.15904.BB; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Dove WF, 1997, CANCER RES, V57, P812; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; FORRESTER JS, 1991, J AM COLL CARDIOL, V17, P758, DOI 10.1016/S0735-1097(10)80196-2; Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Giraud Antoine, 2008, V415, P321, DOI 10.1007/978-1-59745-570-1_19; Guo L, 2014, J MOL CELL CARDIOL, V66, P116, DOI 10.1016/j.yjmcc.2013.11.014; Ho KJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12627; Hu LN, 2014, HYPERTENSION, V63, P607, DOI 10.1161/HYPERTENSIONAHA.113.02141; Hu ZJ, 2012, CELL BIOCHEM BIOPHYS, V62, P125, DOI 10.1007/s12013-011-9270-9; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jackel S, 2017, BLOOD, V130, P542, DOI 10.1182/blood-2016-11-754416; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Jones DW, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000345; Jukema JW, 2012, NAT REV CARDIOL, V9, P79, DOI 10.1038/nrcardio.2011.148; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Karbach SH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003698; KIM MH, 2017, SCI REP UK, V7; Kinoshita M, 2006, CLIN EXP IMMUNOL, V143, P41, DOI 10.1111/j.1365-2249.2005.02973.x; Kumar A, 1997, CIRCULATION, V96, P4333; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; LORENZ HM, 1994, BLOOD, V83, P1862; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Marques FZ, 2017, CIRCULATION, V135, P964, DOI [10.1161/CIRCULATIONAHA.116.024545, 10.1161/circulationaha.116.024545]; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Niess JH, 2008, J IMMUNOL, V180, P559, DOI 10.4049/jimmunol.180.1.559; OHMORI Y, 1990, BIOCHEM BIOPH RES CO, V168, P1261, DOI 10.1016/0006-291X(90)91164-N; Oliveira MR, 2005, PARASITOLOGY, V131, P477, DOI 10.1017/S0031182005008073; Owens CD, 2008, J VASC SURG, V47, P1235, DOI 10.1016/j.jvs.2008.01.009; Owens CD, 2010, J VASC SURG, V51, P1152, DOI 10.1016/j.jvs.2009.12.051; Peterson SM, 2016, MOUSE MODELS OF VASC, P43; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Roberts AB, 2018, NAT MED, V24, P1407, DOI 10.1038/s41591-018-0128-1; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Saxena A, 2011, CARDIOVASC RES, V91, P350, DOI 10.1093/cvr/cvr075; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Souza DG, 2004, J IMMUNOL, V173, P4137, DOI 10.4049/jimmunol.173.6.4137; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Tang PCY, 2008, J EXP MED, V205, P3159, DOI 10.1084/jem.20081298; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Theriault B, 2015, TRANSPLANT DIRECT, V1, DOI 10.1097/TXD.0000000000000539; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; WANG CH, 2018, AEROSPACE, V5, DOI DOI 10.3390/IJMS19020565; Wang XK, 1996, J BIOL CHEM, V271, P24286, DOI 10.1074/jbc.271.39.24286; Welt FGP, 2000, ARTERIOSCL THROM VAS, V20, P2553, DOI 10.1161/01.ATV.20.12.2553; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Wu HX, 2016, ARTERIOSCL THROM VAS, V36, P1549, DOI 10.1161/ATVBAHA.115.307110; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Zhou J, 2010, J EXP MED, V207, P1951, DOI 10.1084/jem.20100098; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	75	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208426	10.1371/journal.pone.0208426	http://dx.doi.org/10.1371/journal.pone.0208426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521585	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600063
J	Oh, J; Shin, CI; Kim, SY				Oh, Jiseon; Shin, Cheong-Il; Kim, Sang Youn			Infected cyst in patients with autosomal dominant polycystic kidney disease: Analysis of computed tomographic and ultrasonographic imaging features	PLOS ONE			English	Article							DIAGNOSTIC PERFORMANCE	Purpose To investigate the imaging features of cyst infection in autosomal dominant polycystic kidney disease (ADPKD) patients using computed tomography (CT) and ultrasonography (US). Materials & methods The institutional review board approved this retrospective study. Fifty-one episodes with proven cyst infection in forty-three ADPKD patients were included. Two experienced abdominal radiologists reviewed CT and US images and evaluated the following imaging features in consensus: cyst size, location, cyst shape, intracystic attenuation, intracystic echogenicity, intracystic heterogeneity, wall thickness, the presence of fluid-fluid level, septation, intracystic gas, pericystic fat infiltration, and pericystic hyperemia. lntracystic attenuation was measured for all infected cysts and two presumed normal cysts and compared using the Wilcoxon rank-sum test. Results On CT scans, the median size of infected cysts was 5.5 cm (range: 2.3-18.8 cm) and 46 of 51(90.2%) infected cysts were located in the subcapsular region. Most (48 of 51, 94.1%) infected cysts showed lobulated, focal bulging or irregular shape. Discernible wall thickening (84.1%) was the most frequently found imaging feature of infected cysts followed by relatively higher intracystic attenuation compared to normal cysts (79.1%) and pericystic fat infiltration (52.9%). Fluid/fluid level was found in 3 of 51(5.9%) infected cysts and intracystic gas was found in 3 of 51(5.9%) infected cysts, respectively. For hepatic cysts, 11 of 14 (78.6%) infected cysts showed pericystic hyperemia. lntracystic attenuation was significantly higher in infected cysts (median; 19.0 HU) than in presumed normal cysts (median; 8.5 HU) (P<0.001), and exceeded 25 HU in 18 (35.3%) of 51 infected cysts. Among the 41 infected cysts for which US images were available, 35 (85.1%) showed heterogeneous echogenicity. Conclusion Minute imaging features such as minimal wall thickening or relatively high attenuation compared to normal cysts would be helpful to detect infected cysts in ADPKD patients.	[Oh, Jiseon; Shin, Cheong-Il; Kim, Sang Youn] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Oh, Jiseon; Shin, Cheong-Il; Kim, Sang Youn] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Shin, CI (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Shin, CI (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	cheongil.tree@gmail.com		Kim, Sang Youn/0000-0003-4038-7345; Oh, Jiseon/0000-0002-2516-2589				Balbo BEP, 2014, BRAZ J MED BIOL RES, V47, P584, DOI 10.1590/1414-431X20143584; Bobot M, 2016, CLIN MICROBIOL INFEC, V22, P71, DOI 10.1016/j.cmi.2015.09.024; Christophe JL, 1996, NEPHROL DIAL TRANSPL, V11, P1271, DOI 10.1093/ndt/11.7.1271; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Ichioka K, 2007, UROLOGY, V70, P1219, DOI 10.1016/j.urology.2007.09.040; Jouret F, 2012, NEPHROL DIAL TRANSPL, V27, P3746, DOI 10.1093/ndt/gfs352; Jouret F, 2011, CLIN J AM SOC NEPHRO, V6, P1644, DOI 10.2215/CJN.06900810; Katano K, 2011, CLIN NEPHROL, V75, pS24, DOI 10.5414/CN106439; Kwon HW, 2016, NUCL MED COMMUN, V37, P493, DOI 10.1097/MNM.0000000000000466; Neuville M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161277; Piccoli GB, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-48; Sallee M, 2009, CLIN J AM SOC NEPHRO, V4, P1183, DOI 10.2215/CJN.01870309; SCHWAB SJ, 1987, AM J MED, V82, P714, DOI 10.1016/0002-9343(87)90005-2; Suwabe T, 2012, CLIN EXP NEPHROL, V16, P892, DOI 10.1007/s10157-012-0650-2; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	17	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207880	10.1371/journal.pone.0207880	http://dx.doi.org/10.1371/journal.pone.0207880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517147	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400071
J	Fletcher, JS; Springer, MG; Choi, K; Jousma, E; Rizvi, TA; Dombi, E; Kim, MO; Wu, JQ; Ratner, N				Fletcher, Jonathan S.; Springer, Mitchell G.; Choi, Kwangmin; Jousma, Edwin; Rizvi, Tilat A.; Dombi, Eva; Kim, Mi-Ok; Wu, Jianqiang; Ratner, Nancy			STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma	ONCOGENE			English	Article							SCHWANN-CELLS; TARGETING STAT3; BONE-MARROW; NF1 LOSS; PLEXIFORM; ROLES; CCR2; ANGIOGENESIS; RECRUITMENT; DIAGNOSIS	Plexiform neurofibroma, a benign peripheral nerve tumor, is associated with the biallelic loss of function of the NF1 tumor suppressor in Schwann cells. Here, we show that FLLL32, a small molecule inhibitor of JAK2/STAT3 signaling, reduces neurofibroma growth in mice with conditional, biallelic deletion of Nf1 in the Schwann cell lineage. FLLL32 treatment or Stat3 deletion in tumor cells reduced inflammatory cytokine expression and tumor macrophage numbers in neurofibroma. Although STAT3 inhibition downregulated the chemokines CCL2 and CCL12, which can signal through CCR2 to recruit macrophages to peripheral nerves, deletion of Ccr2 did not improve survival or reduce macrophage numbers in neurofibroma-bearing mice. Interestingly, Iba1+; F4/80+;CD11b+ macrophages accounted for similar to 20-40% of proliferating cells in untreated tumors. FLLL32 suppressed macrophage proliferation, implicating STAT3-dependent, local proliferation in neurofibroma macrophage accumulation, and decreased Schwann cell proliferation and increased Schwann cell death. The functions of STAT3 signaling in neurofibroma Schwann cells and macrophages, and its relevance as a therapeutic target in neurofibroma, merit further investigation.	[Fletcher, Jonathan S.; Springer, Mitchell G.; Choi, Kwangmin; Jousma, Edwin; Rizvi, Tilat A.; Wu, Jianqiang; Ratner, Nancy] Univ Cincinnati, Div Expt Hematol & Canc Biol, Cincinnati Childrens Hosp, Dept Pediat,Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Fletcher, Jonathan S.] Univ Cincinnati, Coll Med, Grad Program Immunol, Cincinnati, OH 45229 USA; [Dombi, Eva] NCI, Ctr Canc Res, Bldg 10,Room 1-5750, Bethesda, MD 20892 USA; [Kim, Mi-Ok] UCSF Helen Diller Family Comprehens Canc Ctr, Dept Epidemiol & Biostat, UCS F Box 0128, San Francisco, CA 94143 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Wu, JQ; Ratner, N (corresponding author), Univ Cincinnati, Div Expt Hematol & Canc Biol, Cincinnati Childrens Hosp, Dept Pediat,Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Jianqiang.Wu@cchmc.org; Nancy.Ratner@cchmc.org		RATNER, NANCY/0000-0001-5030-9354; Kim, Mi-Ok/0000-0002-7712-3653	DOD [W81XWH-11-1-0057, W81XWH-11-1-0259]; Neurofibromatosis Therapeutic Acceleration Program (NTAP) at Johns Hopkins University;  [R01 NS28840];  [5 F30 NS096796]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS096796, R01NS028840] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Neurofibromatosis Therapeutic Acceleration Program (NTAP) at Johns Hopkins University; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank James Fuchs and Jiayuh Lin (The Ohio State University) for providing FLLL32, and the Imaging Resource Center at Cincinnati Children's Hospital Medical Center (R. Scott Dunn) for MRI Imaging. This work was supported by R01 NS28840 (to NR and JW), and DOD W81XWH-11-1-0057 (to NR), DOD W81XWH-11-1-0259 (to JW), and RNA-Seq by an Agreement with the Neurofibromatosis Therapeutic Acceleration Program (NTAP) at Johns Hopkins University (to NR). JSF was the recipient of 5 F30 NS096796.	Beert E, 2012, GENE CHROMOSOME CANC, V51, P852, DOI 10.1002/gcc.21969; Bournazou Eirini, 2013, JAKSTAT, V2, pe23828, DOI 10.4161/jkst.23828; Campana L, 2018, J IMMUNOL, V200, P1169, DOI 10.4049/jimmunol.1701247; Choi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep43315; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Ferner RE, 2013, HAND CLINIC, V115, P939, DOI 10.1016/B978-0-444-52902-2.00053-9; Furtek SL, 2016, ACS CHEM BIOL, V11, P308, DOI 10.1021/acschembio.5b00945; Gauri P, 2016, HISTOPATHOLOGY, V70, P946; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Herrmann A, 2010, CANCER RES, V70, P7455, DOI 10.1158/0008-5472.CAN-10-0736; Hiatt KK, 2001, J BIOL CHEM, V276, P7240, DOI 10.1074/jbc.M009202200; KIM HA, 1995, ONCOGENE, V11, P325; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Lederle W, 2011, INT J CANCER, V128, P2803, DOI 10.1002/ijc.25621; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Lin L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-217; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Muller M, 2008, GLIA, V56, P1005, DOI 10.1002/glia.20674; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Oberlander M, 2010, MOL CELL NEUROSCI, V45, P59, DOI 10.1016/j.mcn.2010.05.009; Pemov A, 2017, ONCOGENE, V36, P3168, DOI 10.1038/onc.2016.464; Prada CE, 2013, ACTA NEUROPATHOL, V125, P159, DOI 10.1007/s00401-012-1056-7; Prada CE, 2012, J PEDIATR-US, V160, P461, DOI 10.1016/j.jpeds.2011.08.051; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sherman LS, 2000, J BIOL CHEM, V275, P30740, DOI 10.1074/jbc.M001702200; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Staser K, 2010, BLOOD, V116, P157, DOI 10.1182/blood-2009-09-242875; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wu J, 2017, ONCOGENE, V36, P1669, DOI 10.1038/onc.2016.386; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Wu JQ, 2016, CELL REP, V14, P1979, DOI 10.1016/j.celrep.2016.01.074; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	39	26	27	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2876	2884		10.1038/s41388-018-0600-x	http://dx.doi.org/10.1038/s41388-018-0600-x			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30542122	Green Accepted			2022-12-26	WOS:000464121600015
J	Boyd, SD; Calvo, JS; Liu, L; Ullrich, MS; Skopp, A; Meloni, G; Winkler, DD				Boyd, Stefanie D.; Calvo, Jenifer S.; Liu, Li; Ullrich, Morgan S.; Skopp, Amelie; Meloni, Gabriele; Winkler, Duane D.			The yeast copper chaperone for copper-zinc superoxide dismutase (CCS1) is a multifunctional chaperone promoting all levels of SOD1 maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; copper transport; superoxide dismutase (SOD); protein complex; metallo-protein; metal ion-protein interaction; multifunctional enzyme; post-translational modification (PTM); oxidative stress; CCS1; dual chaperone; enzyme maturation; metallo-chaperone; copper-zinc superoxide dismutase (SOD1)	AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN-SUPEROXIDE DISMUTASE; HUMAN METALLOCHAPERONE; CRYSTAL-STRUCTURE; HSOD1 MATURATION; DOMAIN 1; ACTIVATION; MECHANISM; PROTEIN; BINDING	Copper (Cu) is essential for the survival of aerobic organisms through its interaction with molecular oxygen (O-2). However, Cu's chemical properties also make it toxic, requiring specific cellular mechanisms for Cu uptake and handling, mediated by Cu chaperones. CCS1, the budding yeast (S. cerevisiae) Cu chaperone for Cu-zinc (Zn) superoxide dismutase (SOD1) activates by directly promoting both Cu delivery and disulfide formation in SOD1. The complete mechanistic details of this transaction along with recently proposed molecular chaperone-like functions for CCS1 remain undefined. Here, we present combined structural, spectroscopic, kinetic, and thermodynamic data that suggest a multifunctional chaperoning role(s) for CCS1 during SOD1 activation. We observed that CCS1 preferentially binds a completely immature form of SOD1 and that the SOD1<bold>CCS</bold>1 interaction promotes high-affinity Zn(II) binding in SOD1. Conserved aromatic residues within the CCS1 C-terminal domain are integral in these processes. Previously, we have shown that CCS1 delivers Cu(I) to an entry site at the SOD1<bold>CCS</bold>1 interface upon binding. We show here that Cu(I) is transferred from CCS1 to the entry site and then to the SOD1 active site by a thermodynamically driven affinity gradient. We also noted that efficient transfer from the entry site to the active site is entirely dependent upon the oxidation of the conserved intrasubunit disulfide bond in SOD1. Our results herein provide a solid foundation for proposing a complete molecular mechanism for CCS1 activity and reclassification as a first-of-its-kind dual chaperone.	[Boyd, Stefanie D.; Liu, Li; Ullrich, Morgan S.; Skopp, Amelie; Winkler, Duane D.] Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd, Richardson, TX 75080 USA; [Calvo, Jenifer S.; Meloni, Gabriele] Univ Texas Dallas, Dept Chem & Biochem, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Winkler, DD (corresponding author), Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd, Richardson, TX 75080 USA.	duane.winkler@utdallas.edu	; Calvo, Jenifer/S-7772-2018	Winkler, Duane D./0000-0003-1045-0323; Meloni, Gabriele/0000-0003-4976-1401; Calvo, Jenifer/0000-0002-0938-2602	National Institutes of Health [R01 GM120252]; Robert A. Welch Foundation [AT-1935-20170325]; NIGMS, National Institutes of Health [R35GM128704]; University of Texas at Dallas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM128704, R01GM120252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Texas at Dallas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health Grant R01 GM120252 (to D.D.W.). This work was also supported by Robert A. Welch Foundation Grant AT-1935-20170325 and by NIGMS, National Institutes of Health, Grant R35GM128704 (to G.M.) and by funds from the University of Texas at Dallas. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen S, 2012, BIOCHEMISTRY-US, V51, P1439, DOI 10.1021/bi201370r; Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 2013, CHEMBIOCHEM, V14, P1839, DOI 10.1002/cbic.201300042; Banci L, 2012, P NATL ACAD SCI USA, V109, P13555, DOI 10.1073/pnas.1207493109; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; Boyd Stefanie D, 2018, J Proteomics Bioinform, V11, DOI 10.4172/jpb.1000473; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, J BIOL CHEM, V269, P25660; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Elam JS, 2002, ADV PROTEIN CHEM, V60, P151; Fetherolf MM, 2017, METALLOMICS, V9, P1047, DOI 10.1039/c6mt00298f; Fetherolf MM, 2017, J BIOL CHEM, V292, P12025, DOI 10.1074/jbc.M117.775981; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P14720, DOI 10.1021/bi002207a; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LoPachin RM, 2012, CHEM RES TOXICOL, V25, P239, DOI 10.1021/tx2003257; Luchinat E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17815-y; Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rae TD, 2001, J BIOL CHEM, V276, P5166, DOI 10.1074/jbc.M008005200; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Sea K, 2015, J BIOL CHEM, V290, P2405, DOI 10.1074/jbc.M114.588798; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; SOLOMON EI, 1993, SCIENCE, V259, P1575, DOI 10.1126/science.8384374; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Winkler DD, 2012, METHOD ENZYMOL, V512, P243, DOI 10.1016/B978-0-12-391940-3.00011-1; Winkler DD, 2009, BIOCHEMISTRY-US, V48, P3436, DOI 10.1021/bi8021735; Wright GSA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27691; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Zhu HN, 2000, BIOCHEMISTRY-US, V39, P5413, DOI 10.1021/bi992727+	54	15	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1956	1966		10.1074/jbc.RA118.005283	http://dx.doi.org/10.1074/jbc.RA118.005283			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30530491	Green Published, hybrid			2022-12-26	WOS:000459711400016
J	Reis, MD; Sakomura, NK; Teixeira, IAMA; da Silva, EP; Kebreab, E				Reis, Matheus De Paula; Sakomura, Nilva Kazue; Teixeira, Izabelle A. M. A.; da Silva, Edney Pereira; Kebreab, Ermias			Partitioning the efficiency of utilization of amino acids in growing broilers: Multiple linear regression and multivariate approaches	PLOS ONE			English	Article							STRAIN-CROSSES; REQUIREMENTS; METHIONINE; GROWTH; FACTORIAL; THREONINE; CYSTEINE; PULLETS; PIGS; AGE	Determining the efficiency of amino acid (AA) utilization in growing animals is crucial to estimate their requirement accurately. In broiler chickens, the composition of AA in feather is different from feather-free body and the proportion of feathers will change along broiler's growth, which may impact the efficiency of utilization on AA consumed. Therefore, in order to establish a method that predicts the efficiency of utilization for feather-free body and feather, two approaches were evaluated: a multiple linear regression and a multivariate analysis. Additionally, a new factorial model was proposed to predict AA requirements in broiler chickens. Data from 13 trials that evaluated the requirements for lysine (Lys), sulphur AA (SAA), threonine (Thr), and valine (Val) in male broilers were used for the analyses. Both methods of analysis were consistent in showing that the efficiency of utilization in feather free body and feather were different. Using multiple linear regression, the values of efficiency of utilization estimated in feather-free body were 0.68, 0.72, 0.81, 0.79 (mg of amino acid deposited / mg of amino acid consumed above maintenance) and in feather were 0.58, 0.77, 0.78, and 1.57 (mg/mg) for Lys, SAA, Thr, and Val, respectively. Applying the multivariate approach, the corresponding predicted values were 0.68, 0.67, 4.23, 0.27 (mg/mg) in feather-free body and 1.16, 0.86, 0.16, and 1.10 (mg/mg) in feather, respectively. According to the results, efficiency of utilization may be related, to some extent, on the concentration determined in each tissue. The uncertainty around the amount of AA consumed for gain directed to feather-free body or feather deposition could be a limitation for multivariate analyses. The results indicated that multiple linear regression predictions may be better estimates of utilization efficiency. However, more studies are needed to elucidate the effect of age on deposition and partitioning of dietary AA in different parts of the broiler.	[Reis, Matheus De Paula; Sakomura, Nilva Kazue; Teixeira, Izabelle A. M. A.; da Silva, Edney Pereira] Univ Estadual Paulista Unesp, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Kebreab, Ermias] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	Universidade Estadual Paulista; University of California System; University of California Davis	Reis, MD (corresponding author), Univ Estadual Paulista Unesp, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.	matheusdpreis@gmail.com	Sakomura, Nilva/ABA-4637-2020; Reis, Matheus/GLR-5410-2022; Silva, Edney/O-1682-2019; Teixeira, Izabelle/A-5408-2008	Sakomura, Nilva/0000-0001-5707-4113; Silva, Edney/0000-0001-8053-7681; Teixeira, Izabelle/0000-0002-7432-867X	Sao Paulo Research Foundation (FAPESP) [2013/25761-4, 2015/50444-8, 2016/11172-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financially supported by the Sao Paulo Research Foundation (FAPESP), grant 2013/25761-4, 2015/50444-8 and 2016/11172-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appuhamy JADRN, 2016, GLOBAL CHANGE BIOL, V22, P3039, DOI 10.1111/gcb.13339; Azevedo PA, 2005, J ANIM SCI, V83, P842; BATTERHAM ES, 1990, BRIT J NUTR, V64, P81, DOI 10.1079/BJN19900011; Bonato MA, 2011, S AFR J ANIM SCI, V41, P209, DOI 10.4314/sajas.v41i3.3; Cobb-Vantress, 2017, BROIL PERF NUTR SUPP; D'Mello J. P. F., 2003, Amino acids in animal nutrition, P237, DOI 10.1079/9780851996547.0237; de Lima MB, 2016, POULTRY SCI, V95, P842, DOI 10.3382/ps/pev380; Donato DCZ, 2016, ANIMAL, V10, P903, DOI 10.1017/S175173111500289X; Emmans G. C., 1989, Recent advances in turkey science. Poultry Science Symposium number 21., P135; Fatufe AA, 2004, POULTRY SCI, V83, P1314, DOI 10.1093/ps/83.8.1314; Ferreira NT, 2016, ANIM FEED SCI TECH, V214, P110, DOI 10.1016/j.anifeedsci.2016.02.017; FISHER C, 1970, BRIT POULTRY SCI, V11, P67, DOI 10.1080/00071667008415793; Fisher C., 2013, INT S MOD PIG POULTR, P1; FISHER ML, 1981, CAN J ANIM SCI, V61, P769, DOI 10.4141/cjas81-093; Gous RM, 2014, POULTRY SCI, V93, P1, DOI 10.3382/ps.2013-03466; HAN YM, 1991, POULTRY SCI, V70, P2108, DOI 10.3382/ps.0702108; HEGER J, 1985, BRIT J NUTR, V54, P499, DOI 10.1079/BJN19850135; Kielanowski J., 1965, ENERGY METABOLISM, V13, P121; KOONG LJ, 1977, J NUTR, V107, P1724, DOI 10.1093/jn/107.9.1724; MARTIN PA, 1994, BRIT POULTRY SCI, V35, P709, DOI 10.1080/00071669408417737; Nonis MK, 2012, S AFR J ANIM SCI, V42, P369, DOI 10.4314/sajas.v42i4.5; PULLAR JD, 1974, BRIT J NUTR, V31, P377, DOI 10.1079/BJN19740046; Robbins K R, 2006, J Anim Sci, V84 Suppl, pE155; Sakomura NK, 2015, J APPL POULTRY RES, V24, P267, DOI 10.3382/japr/pfv024; Sakomura NK, 2016, METODOS DE PESQUISA; Santiago Rostango H, 2017, COMPOSICION ALIMENTO, V4a, P488; Siqueira JC, 2013, BRAZ J POULTRY SCI, V15, P123, DOI 10.1590/S1516-635X2013000200008; Siqueira J.C., 2011, R. Bras. Zootec., V40, P812; Siqueira JC, 2011, MODEL ESTIMATE LYSIN, P306; Stilborn HL, 2010, J APPL POULTRY RES, V19, P13, DOI 10.3382/japr.2009-00053; Stilborn HL, 1997, J APPL POULTRY RES, V6, P205, DOI 10.1093/japr/6.2.205; Strathe AB, 2010, J ANIM SCI, V88, P2361, DOI 10.2527/jas.2009-2065; van Milgen J, 1999, J ANIM SCI, V77, P2154	33	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208488	10.1371/journal.pone.0208488	http://dx.doi.org/10.1371/journal.pone.0208488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540821	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600073
J	Suleman, Q; Hussain, I; Shehzad, S; Syed, MA; Raja, SA				Suleman, Qaiser; Hussain, Ishtiaq; Shehzad, Saqib; Syed, Makhdoom Ali; Raja, Sadaf Ayub			Relationship between perceived occupational stress and psychological well-being among secondary school heads in Khyber Pakhtunkhwa, Pakistan	PLOS ONE			English	Article							HAPPINESS; IMPACT	The purpose of the study was to examine the relationship between perceived occupational stress and psychological well-being among secondary school heads in Khyber Pakhtunkhwa. A sample of 402 secondary school heads (male n = 260, female n = 142) was selected through multistage sampling technique. A descriptive, quantitative and correlative research design was used. For gathering information from the participants, two standardized tools i.e., "Occupational Stress Index (OSI)" and "Ryff's Psychological Well-being Scale (RPWB)" were used for measuring perceived occupational stress and psychological wellbeing respectively. For statistical analysis, mean, standard deviation, Pearson's product moment correlation and multiple regression were employed. The findings revealed that there is a strong negative correlation between perceived occupational stress and psychological well-being. Furthermore, moderate negative correlation was found between all the sub scales of perceived occupational stress and psychological well-being. All the subscales of occupational stress except low status were found significant predictors and have negative effect on psychological well-being of secondary school heads. So, it was suggested that Elementary & Secondary Education Department Khyber Pakhtunkhwa should have a collaboration with policy makers to formulate a comprehensive strategy for stress reduction management for secondary school heads so that they may develop good psychological well-being and perform their duties effectively.	[Suleman, Qaiser; Hussain, Ishtiaq] Kohat Univ Sci & Technol, Inst Educ & Res, Kohat, Khyber Pakhtunk, Pakistan; [Shehzad, Saqib] Abdul Wali Khan Univ, Dept Educ, Mardan, Khyber Pakhtunk, Pakistan; [Syed, Makhdoom Ali] Univ Kotli, Dept Educ, Azad Jammu Kashmir, Pakistan; [Raja, Sadaf Ayub] Univ Haripur, Dept Educ, Haripur, Khyber Pakhtunk, Pakistan	Kohat University of Science & Technology; Abdul Wali Khan University	Suleman, Q (corresponding author), Kohat Univ Sci & Technol, Inst Educ & Res, Kohat, Khyber Pakhtunk, Pakistan.	qaiserkust2014@gmail.com		Suleman, Qaiser/0000-0002-2507-5055				Adegoke T. G., 2014, MULTIDISCIPLINARY J, V8, P302, DOI DOI 10.4314/AFRREV.V8I1.19; Akintayo D. I., 2012, RES J ORG PSYCHOL ED, V1, P289, DOI [10.1016/j.jad.2012.04.045, DOI 10.1016/J.JAD.2012.04.045]; Alam S., 2012, J INDIAN ACAD APPL P, V38, P242; Avey JB, 2010, J OCCUP HEALTH PSYCH, V15, P17, DOI 10.1037/a0016998; Awake, 2010, REL STRESS; Beehr T., 1998, THEORIES ORG STRESS; Bell A.S., 2012, E J APPL PSYCHOL, V8, P25, DOI DOI 10.7790/EJAP.V8I1.320; Brauckmann S, 2011, INT J EDUC MANAG, V25, P11, DOI 10.1108/09513541111100099; Chapman A., 2007, STRESS MANAGEMENT BA; Chaturvedula S., 2007, INDIAN J AEROSPACE M, V51, P17; Chaudhary R K, 2009, Ind Psychiatry J, V18, P22, DOI 10.4103/0972-6748.57853; Cheng C, 2005, J PERS, V73, P859, DOI 10.1111/j.1467-6494.2005.00331.x; Cooper CL, 1996, OCCUPATIONAL STRESS; Cooper CL., 2017, HDB STRESS HLTH GUID; Cooper CL., 1978, STRESS WORK; Division of Occupational Psychology, 2009, WHIT PAP PSYCH WELL; EMIS, 2015, ANN STAT REP GOV SCH; Fickova E, 2002, STUD PSYCHOL, V44, P219; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; Folkman S., 1991, STRESS COPING ANTHOL; French CC, 2002, 45 ANN CONV PAR ASS; French JR., 1982, MECH JOB STRESS STRA; Gay LR., 1992, RES METHODS BUSINESS; GAY LR, 1996, ED RES COMPETENCIES; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Harter JK, 2003, FLOURISHING: POSITIVE PSYCHOLOGY AND THE LIFE WELL-LIVED, P205, DOI 10.1037/10594-009; Huppert FA, 2009, APPL PSYCHOL-HLTH WE, V1, P137, DOI 10.1111/j.1758-0854.2009.01008.x; Ikonne CN, 2015, OPEN ACCESS LIB J, V2, pe163; Juhasz A., 2002, WORKPLACE STRESS WOR; Kahn H, 1993, STRESS DEALING ROOM; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Khan N., 2017, EUROPEAN SCI J, V13, P217; Kirsten T. J., 2009, HLTH SA GESONDHEID, V14, P1, DOI DOI 10.4102/HSAG.V14I1.407; Kompier M, 2003, HDB WORK HLTH PSYCHO; Kythreotis A, 2010, J EDUC ADMIN, V48, P218, DOI 10.1108/09578231011027860; Lazarus R.S., 1966, PSYCHOL STRESS COPIN; Lazarus RS, 1984, STRESS APPRAISAL AND; Lee YJ, 2014, SPORTS RECREATION RE, V9, P1; Llorens S., 2006, INT J STRESS MANAG, V13, P378, DOI [DOI 10.1037/1072-5245.13.3.378, 10.1037/1072-5245.13.3.378]; Lockanadha Reddy G., 2012, INT J ED PLANNING AD, V2, P109; Malek MDA, 2009, ASIAN SOC WORK POLIC, V3, P143, DOI 10.1111/j.1753-1411.2009.00030.x; Malek MDA, 2010, CROSS CULT MANAG, V17, P50, DOI 10.1108/13527601011016907; Marzano R.J., 2005, SCH LEADERSHIP WORKS; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Miller L., 2005, PRACTICAL POLICE PSY; Moe K., 2012, THESIS; Mohd Yunus J., 2011, J HUMAN RESOURCE ADU, V7, P40; Nafiri P.K, 2015, IBUSS MANAGEMENT, V3, P68; Netterstorm B, 1998, SCAND J WORK ENV HEA, V4, P237; O'Driscoll M, 2003, JOB STRESS BURNOUT, P188; Poormahmood A, 2017, ARCH HELL MED, V34, P504; Quick J.D., 1987, J ORGAN BEHAV MANAGE, V8, P19, DOI [DOI 10.1300/J075V08N02_03, https://doi.org/10.1300/J075v08n02_03]; Robertson I, 2011, WELL-BEING: PRODUCTIVITY AND HAPPINESS AT WORK, P1, DOI 10.1057/9780230306738; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Schaubroeck J, 1997, ACAD MANAGE J, V40, P738, DOI 10.2307/257061; Schiffrin HH, 2010, J HAPPINESS STUD, V11, P33, DOI 10.1007/s10902-008-9104-7; Schneider B, 2001, APPL PSYCHOL-INT REV, V50, P141, DOI 10.1111/1464-0597.00051; Schoeman JD, 2012, THESIS; Shagvaliyeva S., 2014, AM J IND BUSINESMA, V4, P20, DOI [DOI 10.4236/AJIBM.2014.41004, 10.4236/ajibm.2014.41004]; Sharma M., 2016, THEORETICAL FDN HLTH; Srivastava AK, 1981, MANUAL OCCUPATIONAL; Sutherland VJ, 2000, STRATEGIC STRESS MAN; Tsaur SH, 2012, INT J HOSP MANAG, V31, P1038, DOI 10.1016/j.ijhm.2011.12.009; Waesango N, 2015, J SOCIAL SCI, V45, P31, DOI DOI 10.1080/09718923.2015.11893484; Wang SW, 2014, J PERS SOC PSYCHOL, V107, P864, DOI 10.1037/a0037869; Wilhelm K, 2002, ACTA PSYCHIAT SCAND, V106, P45, DOI 10.1034/j.1600-0447.2002.02094.x; Willis JB, 2005, CRACKING STRESS PROB; Wright T. A., 2010, OXFORD HDB POSITIVE, P143, DOI [10.1093/oxfordhb/9780195335446.013.0012, DOI 10.1093/OXFORDHB/9780195335446.013.0012]; Yahaya Azizi, 2009, Journal of Social Sciences, V5, P390, DOI 10.3844/jssp.2009.390.397; Yin HB, 2013, TEACH TEACH EDUC, V35, P137, DOI 10.1016/j.tate.2013.06.006	70	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208143	10.1371/journal.pone.0208143	http://dx.doi.org/10.1371/journal.pone.0208143			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540807	gold, Green Submitted, Green Published			2022-12-26	WOS:000452898600060
J	Wells, RT; Camens, AB				Wells, Roderick T.; Camens, Aaron B.			New skeletal material sheds light on the palaeobiology of the Pleistocene marsupial carnivore, Thylacoleo carnifex	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; GREY-KANGAROO; OWEN THYLACOLEONIDAE; TAIL; MUSCULATURE; LION; SHOULDER; ANATOMY; NICHE; LIMB	The extinct marsupial 'lion' Thylacoleo carnifex was Australia's largest mammalian carnivore. Despite being the topic of more discussion than any other extinct Australian marsupial (excepting perhaps the Thylacine), basic aspects of its palaeobiology, including its locomotory repertoire, remain poorly understood. Recent discoveries allowed the first reconstruction of an entire skeleton including the first complete tail and hitherto-unrecognised clavicles. Here we describe these elements and re-assess the biomechanics of the postcranial skeleton via comparisons with a range of extant terrestrial, scansorial and arboreal Australian marsupials. Our analysis suggests that T. carnifexpossessed: a relatively stiff tail comprising half of the vertebral column length; proximal caudal centra exhibiting a relatively high resistance to sagittal and lateral bending (RSB and RTB); relatively enlarged areas of origin for caudal flexors and extensors; a rigid lumbar spine; and a shoulder girdle braced by strong clavicles. The lever arms of major muscle/tendon systems controlling the axial and appendicular skeleton were identified and RSB and RTB calculated. The combination of these features compared most closely overall with those of the much smaller Tasmanian Devil (Sarcophilus harrisil), a hunter/scavenger capable of climbing. Similar locomotor behaviour is proposed for Thylacoleo carnifex. Orientation of articular facets and RSB stresses also indicate that T. carnifex may have held its tail in a dorsally-flexed position.	[Wells, Roderick T.; Camens, Aaron B.] Flinders Univ S Australia, Coll Sci & Engn, Ecol & Evolut, Adelaide, SA, Australia; [Wells, Roderick T.] South Australian Museum, Palaeontol, Adelaide, SA, Australia	Flinders University South Australia; South Australian Museum	Wells, RT (corresponding author), Flinders Univ S Australia, Coll Sci & Engn, Ecol & Evolut, Adelaide, SA, Australia.; Wells, RT (corresponding author), South Australian Museum, Palaeontol, Adelaide, SA, Australia.	rod.wells@flinders.edu.au		Camens, Aaron/0000-0003-0464-0665				Adnams- Hodges WAJ, 1988, THESIS; ANDERSON C., 1929, REC AUSTRALIAN MUS, V17, P35; Anderson W., 1890, BINGARA RECORDS GEOL, V1, P116; [Anonymous], 1885, INTRO OSTEOLOGY MAMM; [Anonymous], 2012, NOMINA ANATOMICA VET, VFifth; Arman SD, 2016, SCI REPORTS, P6; BARBOUR R. A., 1963, AUSTRALIAN JOUR ZOOL, V11, P488, DOI 10.1071/ZO9630488; BARNETT CH, 1953, J ANAT, V87, P207; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; Boszczyk BM, 2001, ANAT RECORD, V264, P157, DOI 10.1002/ar.1156; Broom R, 1898, P LINNEAN SOC NEW S, V23, P57; Camens AB, 2010, THESIS; CASE J A, 1985, Australian Mammalogy, V8, P45; Chapman F., 1934, THE BOOK OF FOSSILS; Christian A, 1996, PALAEONTOLOGY, V39, P801; Cope E. D., 1884, American Naturalist, Vxviii, P686; Cope E. D., 1882, AM NAT, V26, P520; Davis DD, 1949, SHOULDER ARCHITECTUR; Dawson R, 2014, AUST J ZOOL, V62, P166, DOI 10.1071/ZO13085; Dawson T.J., 1995, KANGAROOS BIOL LARGE; De Vis CW, 1883, P LINNEAN SOC NEW S, V8, P187; Elftman HO, 1929, B AM MUS NAT HIST, V58, P189; Evans H.E., 2013, MILLERS ANATOMY DOG; Figueirido B, 2016, PALEOBIOLOGY, V42, P508, DOI 10.1017/pab.2015.55; Finch E., 1971, AUST NAT HIST, V17, P7; Finch M. E., 1982, CARNIVOROUS MARSUPIA, P537; FINCH ME, 1986, AUST J ZOOL, V34, P1, DOI 10.1071/ZO9860001; FINCH ME, 1988, AUST J ZOOL, V36, P251, DOI 10.1071/ZO9880251; Flower W. H., 1868, Q J GEOLOGICAL SOC, VXXIV, P307; GERMAN RZ, 1982, AM J PHYS ANTHROPOL, V58, P453, DOI 10.1002/ajpa.1330580414; GILL EDMUND D., 1954, VICTORIAN NAT, V71, P18; Glauert L., 1912, Records of the Western Australian Museum, V1; Harvey Kathryn J., 2010, Australian Mammalogy, V32, P1, DOI 10.1071/AM08022; Helgen K, 2015, HDB MAMMALS WORLD, V5; Hermanson JW, 2013, MILLERS ANATOMY DOG, V4th, P185; Hildebrand M., 2001, ANAL VERTEBRATE STRU; HOPWOOD PR, 1974, J ANAT, V118, P445; HOPWOOD PR, 1976, J ANAT, V121, P259; Horton D. R., 1981, ARCHAEOL OCEAN, V6, P73; Jarman PJ, 1989, KANGAROOS WALLABIES, P641; JENKINS FA, 1974, J MORPHOL, V144, P71, DOI 10.1002/jmor.1051440105; Jones ME, 2000, J MAMMAL, V81, P434, DOI 10.1644/1545-1542(2000)081<0434:NDASAD>2.0.CO;2; Juschke S., 1972, ANAT EMBRYOL, V137, P47; Krefft G., 1873, T ROYAL SOC NEW S WA, V1872, P135; Krefft G., 1872, ANN MAGAZINE NATURAL, V10, P169; Krefft Gerard, 1866, J NAT HIST, V18, P148; LEMELIN P, 1995, J MORPHOL, V224, P351, DOI 10.1002/jmor.1052240308; Lydekker R., 1896, LLOYDS NATURAL HIST; Lydekker R., 1894, MARSUPIALS MONOTREME; McCoy F., 1874, PRODROMUS PALEONTOLO; Murray P.F., 1987, POSSUMS OPOSSUMS STU, P433; NEDIN C, 1991, LETHAIA, V24, P115, DOI 10.1111/j.1502-3931.1991.tb01184.x; Nicholson H.A., 1889, MANUAL PALAEONTOLOGY; O'Connor SM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0381; Owen R., 1859, FOSSIL MAMMALS AUS 1, V149, P309; Owen R., 1877, RES FOSSIL REMAINS E; PEMBERTON D, 1993, AUST J ZOOL, V41, P507, DOI 10.1071/ZO9930507; Plotnick RE, 2000, PALEOBIOLOGY, V26, P305, DOI 10.1666/0094-8373(2000)26[305:IBEFAI]2.0.CO;2; Prideaux GJ, 2007, NATURE, V445, P422, DOI 10.1038/nature05471; Reighard JE, 1930, ANATOMY OF THE CAT; Russo GA, 2015, ANAT REC, V298, P354, DOI 10.1002/ar.23004; Slijper E. J., 1946, Verh K nod Akad Wet Amsterdam (2), V42, P1; Spencer B., 1911, P ROYAL SOC VICTORIA, V24, P92; Thomason J, 1997, FUNCTIONAL MORPHOLOG, V1st; Tomes CS., 1914, NATURE, V94, P445; Vogelnest L, 2015, RADIOLOGY OF AUSTRALIAN MAMMALS, P1; Voisin JL, 2006, ANAT REC PART A, V288A, P944, DOI 10.1002/ar.a.20354; Wells R.T., 1982, P573; WELLS R T, 1977, Transactions of the Royal Society of South Australia, V101, P139; Wells R.T., 1995, B AM MUS NAT HIST, V225, P111; Wells RT, 2009, J VERTEBR PALEONTOL, V29, P1335, DOI 10.1671/039.029.0424; Wilson D. E., 2015, HDB MAMMALS WORLD, V5; Wroe S, 1999, AUST J ZOOL, V47, P489, DOI 10.1071/ZO99006; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008; Youlatos D, 2003, J ZOOL, V259, P423, DOI 10.1017/S0952836903003431; Zeitz A, 1907, P REPORTS ROYAL SOC, V13, P245	76	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208020	10.1371/journal.pone.0208020	http://dx.doi.org/10.1371/journal.pone.0208020			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540785	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600050
J	Janco, M; Bocking, T; He, S; Coster, ACF				Janco, Miro; Bocking, Till; He, Stanley; Coster, Adelle C. F.			Interactions of tropomyosin Tpm1.1 on a single actin filament: A method for extraction and processing of high resolution TIRF microscopy data	PLOS ONE			English	Article							TRACKING; BINDING; MUSCLE; MECHANISM; REVEALS; PROTEIN	Skeletal muscle tropomyosin (Tpm1.1) is an elongated, rod-shaped, alpha-helical coiled-coil protein that forms continuous head-to-tail polymers along both sides of the actin filament. In this study we use single molecule fluorescence TIRF microscopy combined with a microfluidic device and fluorescently labelled proteins to measure Tpm1.1 association to and dissociation from single actin filaments. Our experimental setup allows us to clearly resolve Tpm1.1 interactions on both sides of the filaments. Here we provide a semi-automated method for the extraction and quantification of kymograph data for individual actin filaments bound at different Tpm1.1 concentrations. We determine boundaries on the kymograph on each side of the actin filament, based on intensity thresholding, performing fine manual editing of the boundaries (if needed) and extracting user defined kinetic properties of the system. Using our analytical tools we can determine (i) nucleation point(s) and rates, (ii) elongation rates of Tpm1.1, (iii) identify meeting points after the saturation of filament, and when dissociation occurs, (iv) initiation point(s), (v) the final dissociation point(s), as well as (vi) dissociation rates. All of these measurements can be extracted from both sides of the filament, allowing for the determination of possible differences in behaviour on the two sides of the filament, and across concentrations. The robust and repeatable nature of the method allows quantitative, semi-automated analyses to be made of large studies of acto-tropomyosin interactions, as well as for other actin binding proteins or filamentous structures, opening the way for dissection of the dynamics underlying these interactions.	[Janco, Miro; Bocking, Till] Univ New South Wales, Single Mol Sci, Sydney, NSW, Australia; [Janco, Miro; Bocking, Till] Univ New South Wales, ARC Ctr Excellence Adv Mol Imaging, Sydney, NSW, Australia; [He, Stanley; Coster, Adelle C. F.] Univ New South Wales, Sch Math & Stat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Coster, ACF (corresponding author), Univ New South Wales, Sch Math & Stat, Sydney, NSW, Australia.	a.coster@unsw.edu.au	Coster, Adelle CF/A-7234-2013; Böcking, Till/A-5829-2010; Coster, Adelle/AAX-4829-2020	Coster, Adelle CF/0000-0002-5572-6832; Böcking, Till/0000-0003-1165-3122; Coster, Adelle/0000-0002-5572-6832; Janco, Miro/0000-0002-0072-7483	Australian Research Council [DP130100936]	Australian Research Council(Australian Research Council)	This research was supported by Australian Research Council (www.arc.gov.au) grant DP130100936 (TB, ACFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioscha-Perez M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005063; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Bohner G, 2016, J MICROSC-OXFORD, V261, P67, DOI 10.1111/jmi.12316; CASELLA JF, 1986, J BIOL CHEM, V261, P915; Chaphalkar AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167620; Christensen JR, 2017, ELIFE, V6, DOI 10.7554/eLife.23152; Ecklund KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02004-2; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gateva G, 2017, CURR BIOL, V27, P705, DOI 10.1016/j.cub.2017.01.018; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Graham JE, 2017, CELL, V169, P1201, DOI 10.1016/j.cell.2017.05.041; Hoffmann C, 2014, J CELL SCI, V127, P583, DOI 10.1242/jcs.134536; Hsiao JY, 2015, CURR BIOL, V25, P1573, DOI 10.1016/j.cub.2015.04.038; Janco Miro, 2016, Bioarchitecture, V6, P61, DOI 10.1080/19490992.2016.1201619; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359; Masedunskas A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212654; Meiring JCM, 2018, CURR BIOL, V28, P2331, DOI 10.1016/j.cub.2018.05.053; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Nicovich PR, 2016, CYTOSKELETON, V73, P729, DOI 10.1002/cm.21342; Prahl LS, 2014, METHOD ENZYMOL, V540, P35, DOI 10.1016/B978-0-12-397924-7.00003-0; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schmidt WM, 2015, CYTOSKELETON, V72, P292, DOI 10.1002/cm.21225; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; Xu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09081	26	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208586	10.1371/journal.pone.0208586	http://dx.doi.org/10.1371/journal.pone.0208586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532204	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700031
J	Magallanes-Puebla, A; Espinosa-Cueto, P; Lopez-Marin, LM; Mancilla, R				Magallanes-Puebla, Alejandro; Espinosa-Cueto, Patricia; Lopez-Marin, Luz M.; Mancilla, Raul			Mycobacterial glycolipid Di-O-acyl trehalose promotes a tolerogenic profile in dendritic cells	PLOS ONE			English	Article							T-CELLS; TUBERCULOSIS; MATURATION	Due to prolonged coevolution with the human being, Mycobacterium tuberculosis has acquired a sophisticated capacity to evade host immunity and persist in a latent state in the infected individual. As part of this evolutive process, mycobacteria have developed a highly complex cell wall that acts as a protective barrier. Herein we studied the effects of Di-O-acyl trehalose, a cell-wall glycolipid of virulent mycobacteria on murine bone marrow-derived dendritic cells. We have demonstrated that Di-O-Acyl-trehalose promotes a tolerogenic phenotype in bone marrow-derived murine DCs activated with mycobacterial antigens and Toll-like receptor agonists. This phenotype included low expression of antigen presentation and costimulatory molecules and altered cytokine production with downregulation of IL-12 and upregulation of IL-10, an anti-inflammatory cytokine. Additional markers of tolerogenicity were the expression of Indoleamine 2,3-dioxygenase and CD25. Furthermore, Di-O-AcylTrehalose promoted the expansion of FoxP3(+) regulatory T lymphocytes. A better understanding of mycobacterial cell-wall components involved in the evasion of immunity is a prerequisite to designing better strategies to fight tuberculosis.	[Magallanes-Puebla, Alejandro; Espinosa-Cueto, Patricia; Mancilla, Raul] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico; [Lopez-Marin, Luz M.] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Dept Ingn Mol Mat, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Mancilla, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City, DF, Mexico.	mancilla@biomedicas.unam.mx	Magallanes-Puebla, Alejandro/GQI-0001-2022; Lopez-Marin, Luz M./B-3033-2011	Magallanes-Puebla, Alejandro/0000-0001-9679-4949; Lopez-Marin, Luz M./0000-0002-7503-6169	Programa de Apoyos a Proyectos de Investigacion e Inovacion Tecnologica [IN210816]; Consejo Nacional de Ciencia y Tecnologia [429313]	Programa de Apoyos a Proyectos de Investigacion e Inovacion Tecnologica; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	RM recieved funding for this work by Programa de Apoyos a Proyectos de Investigacion e Inovacion Tecnologica No. IN210816 (URL: http://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit).AMP is recipent of doctoral scholarship from Consejo Nacional de Ciencia y Tecnologia Grant number 429313 (URL: http://www.conacyt.mx/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; BESRA GS, 1992, BIOCHEMISTRY-US, V31, P9832, DOI 10.1021/bi00155a040; Biyikli OO, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.20224; Blumenthal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037314; Brennan PJ, 2009, TUBERCULOSIS, V83, P91; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Demangel C, 2000, IMMUNOL CELL BIOL, V78, P318, DOI 10.1046/j.1440-1711.2000.00935.x; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; Driesen J, 2008, IMMUNOBIOLOGY, V213, P849, DOI 10.1016/j.imbio.2008.07.026; Dulphy N, 2007, CELL MICROBIOL, V9, P1412, DOI 10.1111/j.1462-5822.2006.00881.x; Espinosa-Cueto P, 2015, BMC IMMUNOL, V23, P1; Gautam US, 2018, P NATL ACAD SCI USA, V115, pE62, DOI 10.1073/pnas.1711373114; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; Harden JL, 2012, IMMUNOL INVEST, V41, P738, DOI 10.3109/08820139.2012.676122; Henderson RA, 1997, J IMMUNOL, V159, P635; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Iberg CA, 2017, TRENDS IMMUNOL, V38, P793, DOI 10.1016/j.it.2017.07.007; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Lazarevic V, 2003, IMMUNITY, V19, P823, DOI 10.1016/S1074-7613(03)00324-8; Lin PL, 2015, SEMIN IMMUNOPATHOL, V37, P239, DOI 10.1007/s00281-015-0490-8; Mazurek J, 2012, CELL IMMUNOL, V39, P260; Mihret A, 2012, VIRULENCE, V3, P654, DOI 10.4161/viru.22586; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Palma-Nicolas JP, 2010, IMMUNOBIOLOGY, V215, P143, DOI 10.1016/j.imbio.2009.03.010; Saavedra R, 2006, MICROBES INFECT, V8, P533, DOI 10.1016/j.micinf.2005.08.005; Saavedra R, 2001, CLIN DIAGN LAB IMMUN, V8, P1081, DOI 10.1128/CDLI.8.6.1-91-1088.2001; Salazar F, 2017, SCI REP-UK, V7, DOI 10.1038/srep43337; Sia JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006530; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Wang YC, 2009, J BIOL CHEM, V284, P15993, DOI 10.1074/jbc.M901144200; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0207202	10.1371/journal.pone.0207202	http://dx.doi.org/10.1371/journal.pone.0207202			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532264	Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700008
J	McGee, JA; York, R				McGee, Julius Alexander; York, Richard			Asymmetric relationship of urbanization and CO2 emissions in less developed countries	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ENERGY-CONSUMPTION; ECONOMIC-GROWTH; PANEL; IMPACT; CARBONIZATION; NATIONS	Understanding the relationship between carbon dioxide (CO2) emissions and the urbanization of national populations has been a key concern for environmental scholars for several decades. Although sophisticated modeling techniques have been developed to explore the connection between increases in urban populations and CO2 emissions, none has attempted to assess whether declines in urbanization have an effect on emissions that is not symmetrical with that of growth in urbanization. The present study uses panel data on CO2 emissions and the percentage of individuals living in urban areas, as well as a variety of other structural factors, for less-developed countries from 1960-2010, to empirically assess whether the effect of growth in urban populations on emissions is symmetrical with the effect of decline. Findings indicate that the effect of growth/decline in urban populations on CO2 emissions is asymmetrical, where a decline in urbanization reduces emissions to a much greater degree than urbanization increases emissions. We hypothesize that this is at least in part because deurbanization is connected with disruptions to the production and distribution of goods and services and/or access to electricity and other energy sources. Our finding suggests that not only the absolute level of urbanization of nations matters for emissions, but also how the patterns of migration between rural and urban areas change over time. Future research should be mindful of the processes behind deurbanization when exploring socioeconomic drivers of CO2 emissions.	[McGee, Julius Alexander] Portland State Univ, Dept Sociol, Portland, OR 97207 USA; [York, Richard] Univ Oregon, Dept Sociol, Eugene, OR 97403 USA	Portland State University; University of Oregon	McGee, JA (corresponding author), Portland State Univ, Dept Sociol, Portland, OR 97207 USA.	cjulius@pdx.edu						Al-mulali U, 2013, RENEW SUST ENERG REV, V23, P107, DOI 10.1016/j.rser.2013.02.041; Alexiades MN, 2015, J LAT AM CARIBB ANTH, V20, P1, DOI 10.1111/jlca.12133; Anderson C.H., 1976, SOCIOLOGY SURVIVAL S; BURAWOY M, 1992, AM SOCIOL REV, V57, P16, DOI 10.2307/2096142; Burawoy M., 1997, AM J SOCIOL, V102, P1430; Burawoy M, 1992, END SOVIETOLOY RENAI; Burawoy M., 2000, ETHNOGRAPHY, V1, P43, DOI [DOI 10.1177/14661380022230633, 10.1177/14661380022230633]; Chew S., 2006, RECURRING DARK AGES; Chew SC, 2001, WORLD ECOLOGICAL DEGRADATION, P1; Clement MT, 2011, SOCIOL FORUM, V26, P581, DOI 10.1111/j.1573-7861.2011.01263.x; Cole MA, 2004, POPUL ENVIRON, V26, P5, DOI 10.1023/B:POEN.0000039950.85422.eb; Elliott JR, 2014, SOC SCI QUART, V95, P795, DOI 10.1111/ssqu.12079; Foster John Bellamy, 2000, MARXS ECOLOGY MAT NA; Franks S, 2005, POLIT QUART, V76, P446, DOI 10.1111/j.1467-923X.2005.00704.x; Gerber TP, 2002, AM SOCIOL REV, V67, P629, DOI 10.2307/3088910; Gerber TP, 1998, AM J SOCIOL, V104, P1; Givens JE, 2015, HUM ECOL REV, V22, P107; Green BE, 2004, INT J SOCIOLOGY, V34, P9; He ZX, 2017, J CLEAN PROD, V140, P1719, DOI 10.1016/j.jclepro.2016.08.155; Hossain MS, 2011, ENERG POLICY, V39, P6991, DOI 10.1016/j.enpol.2011.07.042; Jorgenson A. K., 2010, ORG ENV, V23, P189; JORGENSON AK, 2005, AM J SOCIOL, V118, P1, DOI DOI 10.1086/665990; Jorgenson AK, 2014, CLIMATIC CHANGE, V127, P561, DOI 10.1007/s10584-014-1267-0; Jorgenson AK, 2011, SOC SCI RES, V40, P226, DOI 10.1016/j.ssresearch.2010.09.004; Liddle B, 2010, POPUL ENVIRON, V31, P317, DOI 10.1007/s11111-010-0101-5; Lieberson S., 1987, MAKING IT COUNT IMPR; MCGEE J, 2015, ENV SOCIOL, V1, P81, DOI DOI 10.1080/23251042.2014.1002193; McGee JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189024; Munya A, 2015, GEOJOURNAL, V80, P427, DOI 10.1007/s10708-014-9559-5; OKPALA DCI, 1987, URBAN STUD, V24, P137, DOI 10.1080/713703867; POTTS D, 1995, GEOGR J, V161, P245, DOI 10.2307/3059830; Potts D, 2005, URBAN STUD, V42, P583, DOI 10.1080/00420980500060137; Potts D, 2012, WORLD DEV, V40, P1382, DOI 10.1016/j.worlddev.2011.12.004; Potts D, 2009, ENVIRON URBAN, V21, P253, DOI 10.1177/0956247809103026; Poumanyvong P, 2010, ECOL ECON, V70, P434, DOI 10.1016/j.ecolecon.2010.09.029; United Nations 2007, 2014, WORLD URB PROSP; Wooldridge J.M., 2015, INTRO ECONOMETRICS M; World Bank Group, 2020, WORLD DEV IND; Xu SC, 2016, REG ENVIRON CHANGE, V16, P777, DOI 10.1007/s10113-015-0795-0; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; York R, 2017, SOCIUS, V3; York R, 2008, SOC PROBL, V55, P370, DOI 10.1525/sp.2008.55.3.370; York R, 2007, SOC SCI RES, V36, P855, DOI 10.1016/j.ssresearch.2006.06.007; York R, 2012, NAT CLIM CHANGE, V2, P762, DOI 10.1038/nclimate1699	44	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208388	10.1371/journal.pone.0208388	http://dx.doi.org/10.1371/journal.pone.0208388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6IO	30532262	gold, Green Published, Green Submitted			2022-12-26	WOS:000452640900016
J	Park, MW; Park, GM; Han, S; Yang, YJ; Kim, YG; Roh, JH; Park, HW; Suh, J; Cho, YR; Won, KB; Ann, SH; Kim, SJ; Kim, DW; Her, SH; Lee, SG				Park, Mahn-Won; Park, Gyung-Min; Han, Seungbong; Yang, Yujin; Kim, Yong-Giun; Roh, Jae-Hyung; Park, Hyun Woo; Suh, Jon; Cho, Young-Rak; Won, Ki-Bum; Ann, Soe Hee; Kim, Shin-Jae; Kim, Dae-Won; Her, Sung Ho; Lee, Sang-Gon			Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis	PLOS ONE			English	Article							LIPID-LOWERING THERAPY; ARTERY-DISEASE; JAPANESE PATIENTS; INTRAVASCULAR ULTRASOUND; MYOCARDIAL-INFARCTION; LDL-CHOLESTEROL; RISK; ROSUVASTATIN; ATORVASTATIN; PREVENTION	Objectives It is unclear whether high-intensity statin therapy provides incremental clinical benefits over moderate-intensity statin therapy in Asian patients with angina. This study sought to compare the clinical outcomes of moderate- and high-intensity statin therapies in patients undergoing percutaneous coronary intervention (PCI) for angina in Korean patients. Methods Based on the national health insurance claims data in South Korea, patients aged 18 years or older without a known history of coronary artery disease, who underwent PCI with drug-eluting stents due to angina between 2011 and 2015, were enrolled. According to the intensity of statin therapy, patients were categorized into moderate-intensity statin therapy (n = 23,863) and high-intensity statin therapy (n = 9,073) groups. The primary endpoint, defined as a composite of all-cause death and myocardial infarction, was compared between the two groups using a propensity-score matching analysis. Results During the follow-up period (median, 2.0 years; interquartile range, 1.1-3.1), 1,572 patients had 1,367 deaths and 242 myocardial infarctions. After propensity-score matching, there were 8,939 matched pairs. There was no significant difference in the incidence of the primary endpoint between the two groups (adjusted hazard ratio of high-intensity statin therapy, 1.093; 95% confidence interval: 0.950-1.259; p = 0.212). Conclusions In Korean patients undergoing PCI with drug-eluting stents for angina, the high-intensity statin therapy did not provide additional clinical benefits over the moderate-intensity statin therapy.	[Park, Mahn-Won; Kim, Dae-Won; Her, Sung Ho] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Cardiol, Daejeon, South Korea; [Park, Gyung-Min; Yang, Yujin; Kim, Yong-Giun; Won, Ki-Bum; Ann, Soe Hee; Kim, Shin-Jae; Lee, Sang-Gon] Univ Ulsan, Ulsan Univ Hosp, Dept Cardiol, Coll Med, Ulsan, South Korea; [Han, Seungbong] Gachon Univ, Dept Appl Stat, Seongnam, South Korea; [Roh, Jae-Hyung] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Cardiol, Sch Med, Daejeon, South Korea; [Park, Hyun Woo; Suh, Jon] Soon Chun Hyang Univ Hosp Bucheon, Dept Cardiol, Bucheon, South Korea; [Cho, Young-Rak] Dong A Univ Hosp, Dept Cardiol, Busan, South Korea	Catholic University of Korea; University of Ulsan; Ulsan University Hospital; Gachon University; Chungnam National University; Chungnam National University Hospital; Dong A University	Park, GM (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Dept Cardiol, Coll Med, Ulsan, South Korea.; Han, S (corresponding author), Gachon Univ, Dept Appl Stat, Seongnam, South Korea.	min8684@hanmail.net; hanseungbong@gmail.com	Kim, Shin-Jae/CAE-9456-2022	Roh, Jae-Hyung/0000-0003-3675-3541	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2017R1C1B1006717]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2017R1C1B1006717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Dai W, 2016, INT J CARDIOL, V204, P57, DOI 10.1016/j.ijcard.2015.11.164; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Furukawa Y, 2008, CIRC J, V72, P1937, DOI 10.1253/circj.CJ-08-0293; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; Keevil JG, 2007, CIRCULATION, V115, P1363, DOI 10.1161/CIRCULATIONAHA.106.645473; Kong SH, 2017, DIABETES METAB J, V41, P23, DOI 10.4093/dmj.2017.41.1.23; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee CW, 2012, AM J CARDIOL, V109, P1700, DOI 10.1016/j.amjcard.2012.01.399; Lee E, 2005, CLIN PHARMACOL THER, V78, P330, DOI 10.1016/j.clpt.2005.06.013; Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057; Lee SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166246; Lin GA, 2008, JAMA-J AM MED ASSOC, V300, P1765, DOI 10.1001/jama.300.15.1765; Miyauchi K, 2010, CIRC J, V74, P1718, DOI 10.1253/circj.CJ-10-0565; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Park GM, 2016, J NUCL MED, V57, P1364, DOI 10.2967/jnumed.115.169318; Park GM, 2014, CIRC-CARDIOVASC QUAL, V7, P944, DOI 10.1161/CIRCOUTCOMES.114.001305; PEDERSEN TR, 1994, LANCET, V344, P1383; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosenson RS, 2015, J AM COLL CARDIOL, V65, P270, DOI 10.1016/j.jacc.2014.09.088; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sakamoto T, 2010, CIRC J, V74, P1731, DOI 10.1253/circj.CJ-10-0537; Schomig A, 2002, J AM COLL CARDIOL, V40, P854, DOI 10.1016/S0735-1097(02)02053-3; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taguchi I, 2018, CIRCULATION, V137, P1997, DOI 10.1161/CIRCULATIONAHA.117.032615; Takayama T, 2009, CIRC J, V73, P2110, DOI 10.1253/circj.CJ-09-0358; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Youn JC, 2017, KOREAN CIRC J, V47, P316, DOI 10.4070/kcj.2017.0075; Zhao SP, 2014, ATHEROSCLEROSIS, V233, P707, DOI 10.1016/j.atherosclerosis.2013.12.003	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0207889	10.1371/journal.pone.0207889	http://dx.doi.org/10.1371/journal.pone.0207889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532220	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900005
J	Froon-Torenstra, D; Beket, E; Khader, AM; Hababeh, M; Nasir, A; Seita, A; Benninga, MA; van den Berg, MM				Froon-Torenstra, Denise; Beket, Elise; Khader, Ali M.; Hababeh, Majed; Nasir, Arwa; Seita, Akihiro; Benninga, Marc A.; van den Berg, Maartje M.			Prevalence of functional constipation among Palestinian preschool children and the relation to stressful life events	PLOS ONE			English	Article							GASTROINTESTINAL DISORDERS; EPIDEMIOLOGY; INFANTS	Aim Increasing evidence exists with respect to the relation between stressful life events and functional constipation (FC). We aimed to investigate the prevalence of FC in Palestinian refugee preschool children and to determine if stress and trauma exposure are risk factors of FC in these children. Methods From November 2013 until May 2014, a cross-sectional survey was conducted in West Bank, Gaza and Jordan. Mothers of 862 Palestinian refugee children aged 7-48 months were interviewed on defecation pattern, socio-economic factors and the child's exposure to traumatic events. Results Twelve percent of the Palestinian refugee children fulfilled the criteria for FC. The prevalence of constipation was significantly lower in Gaza compared to Jordan (2% vs. 17%, p <0,001). Living in Gaza was associated with lower odds of FC (OR 0,08, 95% CI 0,030,20). Trauma exposure was associated with higher odds of FC (OR 1,19, 95% CI 1,061,35), however only a small number of children had been exposed to traumatic events. Conclusion The overall prevalence of FC in Palestinian preschool children is comparable to prevalence rates among older children worldwide. In this age group stressful life events and trauma exposure seem not to play an important role in the development of FC.	[Froon-Torenstra, Denise; Beket, Elise; Benninga, Marc A.] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands; [Khader, Ali M.; Hababeh, Majed; Seita, Akihiro] UN Relief & Works Agcy Palestinian Refuge Near Ea, Amman, Jordan; [Nasir, Arwa] Univ Nebraska Med Ctr, Omaha, NE 68198 USA; [van den Berg, Maartje M.] Haaglanden Med Ctr, The Hague, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Nebraska System; University of Nebraska Medical Center; Haaglanden Medical Center	Froon-Torenstra, D (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands.	denisetorenstra@gmail.com	Nasir, Arwa/AAP-1824-2020		Emma's Children Hospital/Academic Medical Center Amsterdam; United Nations Relief and Works Agency for Palestine refugees in the Near East	Emma's Children Hospital/Academic Medical Center Amsterdam; United Nations Relief and Works Agency for Palestine refugees in the Near East	This research was supported by Emma's Children Hospital/Academic Medical Center Amsterdam, and United Nations Relief and Works Agency for Palestine refugees in the Near East.	Altamimi E, 2014, PEDIATR GASTROENTERO, V17, P155, DOI 10.5223/pghn.2014.17.3.155; Bellini M, 2018, NEUROGASTROENT MOTIL, V30, P1; Benninga MA, 1996, J PEDIATR GASTR NUTR, V23, P241, DOI 10.1097/00005176-199610000-00007; Blum NJ, 2015, PEDIATRICS, V113; Bonilla S, 2013, REV GASTROENTEROL ME, V78, P82, DOI 10.1016/j.rgmx.2013.02.001; Devanarayana NM, 2010, J TROP PEDIATRICS, V56, P144, DOI 10.1093/tropej/fmp077; Di Lorenzo C, 2013, J PEDIATR GASTR NUTR, V57, pS15, DOI 10.1097/01.mpg.0000441928.28554.cc; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Hyman PE, 2006, GASTROENTEROLOGY, V130, P1519, DOI [10.1053/j.gastro.2005.11.065, 10.1053/j.gastro.2016.02.016]; Koppen IJN, 2018, J PEDIATR-US, V198, P121, DOI 10.1016/j.jpeds.2018.02.029; Lane MM, 2011, J PEDIATR-US, V159, P437, DOI 10.1016/j.jpeds.2011.03.002; Loening-Baucke V, 2005, J PEDIATR-US, V146, P359, DOI 10.1016/j.jpeds.2004.10.046; Mugie SM, 2011, BEST PRACT RES CL GA, V25, P3, DOI 10.1016/j.bpg.2010.12.010; Philips EM, 2015, J PEDIATR GASTR NUTR, V61, P384, DOI 10.1097/MPG.0000000000000882; Rajindrajith S, 2012, ARCH DIS CHILD, V97, P43, DOI 10.1136/adc.2009.173716; Rajindrajith S, 2011, J NEUROGASTROENTEROL, V17, P35, DOI 10.5056/jnm.2011.17.1.35; Thabet AAM, 1999, J CHILD PSYCHOL PSYC, V40, P385, DOI 10.1111/1469-7610.00456; Thabet AAM, 2004, J CHILD PSYCHOL PSYC, V45, P533, DOI 10.1111/j.1469-7610.2004.00243.x; UNRWA, 2013, ANN HLTH REP, P1; van den Berg MM, 2006, AM J GASTROENTEROL, V101, P2401, DOI 10.1111/j.1572-0241.2006.00771.x; van Tilburg MAL, 2015, J PEDIATR-US, V166, P684, DOI 10.1016/j.jpeds.2014.11.039; Walker LS, 2006, ROME 3 FUNCTIONAL GA, P963	23	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208571	10.1371/journal.pone.0208571	http://dx.doi.org/10.1371/journal.pone.0208571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521620	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600093
J	Indest, KJ; Everman, SJ; Lindsay, JH; Jung, CM; Smith, JC; Newell, SB				Indest, Karl J.; Everman, Steven J.; Lindsay, James H.; Jung, Carina M.; Smith, Jared C.; Newell, Sandra B.			Effects of acute exposures of 2,4,6-trinitrotoluene and inorganic lead on the fecal microbiome of the green anole (Anolis carolinensis)	PLOS ONE			English	Article							GUT MICROBIOTA; SCELOPORUS-OCCIDENTALIS; LOCOMOTOR PERFORMANCE; NITROREDUCTASE; DIVERSITY; COMMUNITIES; GENES; FLORA; MICE; RDX	Microbiome studies focused on ecologically relevant vertebrate models like reptiles have been limited. Because of their relatively small home range, fast maturation, and high fecundity, lizards are an excellent reptilian terrestrial indicator species. For this study we used the green anole, Anolis carolinensis, to assess the impact of military relevant contaminants on fecal microbiome composition. Fourteen day sub-acute exposures were conducted via oral gavage with 2,4,6-Trinitrotoluene (TNT) and inorganic lead at doses of 60 mg/kg and 20 mg/ kg of body weight, respectively. Body weights and food consumption were monitored and fecal samples were collected for high-throughput 16S rRNA gene amplicon sequencing and analytical chemistry at days 0 and 15. At the end of the study, liver and gut were harvested for body burden data. Chemical analysis confirmed accumulation of TNT, TNT transformation products, and lead in liver tissue and fecal samples. Bacterial community analysis of fecal material revealed significant differences between day 0 and day 15 of TNT exposed anoles with an operational taxonomic unit (OTU) within the genus Erwinia representing 32% of the microbial community in TNT exposed anoles. Predictable changes in gut microbiome composition could offer an easily assayed, noninvasive biomarker for specific chemical exposure providing enhanced scientific support to risk assessments on military installations.	[Indest, Karl J.; Lindsay, James H.; Jung, Carina M.; Smith, Jared C.; Newell, Sandra B.] US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA; [Everman, Steven J.] Bennett Aerosp, Cary, NC USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Indest, KJ (corresponding author), US Army Engineer Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA.	karl.J.Indest@usace.army.mil		Jung, Carina/0000-0002-3171-7341; Everman, Steven/0000-0002-3452-4369	U.S. Army Corps of Engineers' Environmental Quality Program [16-024]; U.S. Army Corps of Engineers' Environmental Quality Program	U.S. Army Corps of Engineers' Environmental Quality Program; U.S. Army Corps of Engineers' Environmental Quality Program	This project was funded to KJI through the U.S. Army Corps of Engineers' Environmental Quality Program (16-024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded through the U.S. Army Corps of Engineers' Environmental Quality Program. Views, opinions and/or findings contained herein are those of the authors and should not be construed as an Official Department of the Army position or decision unless so designated by other official documentation.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Betts Kellyn S, 2011, Environ Health Perspect, V119, pA340, DOI 10.1289/ehp.119-a340; Brasfield SM, 2002, ENVIRON TOXICOL CHEM, V21, P1410, DOI 10.1897/1551-5028(2002)021<1410:DRATCR>2.0.CO;2; BRYANT C, 1991, J BIOL CHEM, V266, P4119; BRYANT C, 1991, J BIOL CHEM, V266, P4126; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; CLAUS SP, 2016, NPJ BIOFILMS MICROBI, V2, P62295; Dietert RR, 2015, TOXICOL SCI, V144, P208, DOI 10.1093/toxsci/kfv013; DuRant SE, 2007, ENVIRON POLLUT, V149, P18, DOI 10.1016/j.envpol.2006.12.025; Eaton HL, 2013, APPL MICROBIOL BIOT, V97, P3699, DOI 10.1007/s00253-012-4172-3; Guo XC, 2014, CHEMOSPHERE, V112, P1, DOI 10.1016/j.chemosphere.2014.03.068; Holem RR, 2008, ENVIRON POLLUT, V152, P92, DOI 10.1016/j.envpol.2007.05.017; HOLT R, 1967, LANCET, V1, P1259; Hong PY, 2015, MICROB ECOL, V69, P444, DOI 10.1007/s00248-014-0547-6; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Indest KJ, 2014, J MOL MICROB BIOTECH, V24, P114, DOI 10.1159/000361027; Jenkins T.F., 2001, CHARACTERIZATION EXP; Jiang HY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02073; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kitts CL, 2000, CAN J MICROBIOL, V46, P278, DOI 10.1139/cjm-46-3-278; Kohl KD, 2017, MOL ECOL, V26, P1175, DOI 10.1111/mec.13921; Lafond S, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1371-6; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110505; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; Liu B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146596; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; Lu K, 2013, CHEM RES TOXICOL, V26, P1893, DOI 10.1021/tx4002868; Mcfarland CA, 2008, ENVIRON TOXICOL CHEM, V27, P1102, DOI 10.1897/07-312.1; McFarland CA, 2012, ECOTOXICOLOGY, V21, P2372, DOI 10.1007/s10646-012-0993-1; McFarland CA, 2009, ENVIRON TOXICOL CHEM, V28, P1043, DOI 10.1897/08-419.1; MIRSALIS JC, 1982, NATURE, V295, P322, DOI 10.1038/295322a0; Nelson DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010785; Pass DA, 2015, ENVIRON MICROBIOL, V17, P1884, DOI 10.1111/1462-2920.12712; Perumbakkam S, 2011, ANTON LEEUW INT J G, V99, P231, DOI 10.1007/s10482-010-9481-x; Phillips ML, 2009, ENVIRON HEALTH PERSP, V117, pA198, DOI 10.1289/ehp.117-a198; Ren TT, 2016, MOL ECOL, V25, P4793, DOI 10.1111/mec.13796; Richardson JB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24931-w; Salice CJ, 2009, ENVIRON POLLUT, V157, P3457, DOI 10.1016/j.envpol.2009.06.013; Sebaihia M, 2010, J Bacteriol, V192, P2020, DOI 10.1128/JB.00022-10; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tiquia-Arashiro SM, 2018, APPL MICROBIOL BIOTE; Van de Wiele T, 2005, ENVIRON HEALTH PERSP, V113, P6, DOI 10.1289/ehp.7259; Van de Wiele T, 2010, ENVIRON HEALTH PERSP, V118, P1004, DOI 10.1289/ehp.0901794; Weir SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099666; WOLPERT MK, 1973, J PHARMACOL EXP THER, V185, P202; Wu GF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15216-9; Xia JZ, 2018, COMP BIOCHEM PHYS C, V209, P1, DOI 10.1016/j.cbpc.2018.03.007; Xia JZ, 2018, SCI TOTAL ENVIRON, V631-632, P439, DOI 10.1016/j.scitotenv.2018.03.053; Zhang WY, 2018, ECOL EVOL, V8, P4695, DOI 10.1002/ece3.4029	52	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208281	10.1371/journal.pone.0208281	http://dx.doi.org/10.1371/journal.pone.0208281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521592	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600042
J	Ishikawa, M; Yokoyama, T; Sagehastn, M; Kunugita, N; Miura, H				Ishikawa, Midori; Yokoyama, Tetsuji; Sagehastn, Masaki; Kunugita, Naoki; Miura, Hiroko			Diagnosing the double burden of malnutrition using estimated deviation values in low- and lower-middle-income countries	PLOS ONE			English	Article								Objective To examine the possibility of diagnosing the double burden of malnutrition using estimated deviation values in low- and lower-middle-income countries. Methods A modified version of the Japanese Diagnostic Tool was used. Data on 194 countries were analyzed, including data from the United Nations International Children's Fund, World Health Organization and World Bank. After conducting a Box-Cox transformation, deviation values were calculated. The degree to which the values deviated relative to a deviation cutoff value of 50 was assessed. Focusing on countries with low- and middle-income economic levels, we examined the utility of this tool to show characteristic nutritional problems in each country. Results The deviation values had normal, distorted, bimodal, or trimodal distributions. In the lower-middle-income countries, almost all countries had values ranging from 40 to 60 for education and water environments (urban and rural), and the differences were minimal. However, different causes of noncommunicable disease-related deaths were considered, and the primary cause appeared to be related to lifestyle factors, particularly alcohol consumption and tobacco smoking. In comparison, the deviation values related to death among low-income countries also appeared to be related to differences in education and sanitation in urban and rural areas. Conclusion The study results can help to determine the status of nutritional inequalities and plan country-specific strategies to reduce the double burden of malnutrition.	[Ishikawa, Midori; Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan; [Sagehastn, Masaki; Kunugita, Naoki] Natl Inst Publ Hlth, Dept Environm Hlth, Saitama, Japan; [Miura, Hiroko] Natl Inst Publ Hlth, Dept Int Hlth & Collaborat, Saitama, Japan	National Institute of Public Health - Japan; National Institute of Public Health - Japan; National Institute of Public Health - Japan	Ishikawa, M (corresponding author), Natl Inst Publ Hlth, Dept Hlth Promot, Saitama, Japan.	ishikawa.m.aa@niph.go.jp	Ishikawa, Midori/AAZ-1374-2021	Kunugita, Naoki/0000-0002-6516-8379	Health and Labour Sciences Research Grant [H27 Global Scale/issue General 002, H29 Sukoyaka ippan 003]	Health and Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	This study was funded by a Health and Labour Sciences Research Grant in 2015 for "Research for process analysis and evaluation framework for determinants of indicators on sustainable and evidence-based healthrelated post-millennium development goals" (H27 Global Scale/issue General 002 to H.M.) and Health and Labour Sciences Research Grant in 2018 for "Development of a food, nutrition and dietary guide for healthy development in early childhood" (H29 Sukoyaka ippan 003 to M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nguyen BKL, 2013, BRIT J NUTR, V110, pS45, DOI 10.1017/S0007114513002080; Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Borowy I, 2014, B WORLD HEALTH ORGAN, V92, P699, DOI 10.2471/BLT.14.145219; BOX GEP, 1982, J AM STAT ASSOC, V77, P209, DOI 10.2307/2287791; Chasekwa B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199393; Corsi DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025120; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Ministry of Health Labour and Welfare, 2013, HLTH JAP 21 2 TERM; Ministry of Health Labour and Welfare, 2014, DAT HLTH PLANS MED I; Monyeki MA, 2015, INT J ENV RES PUB HE, V12, P1156, DOI 10.3390/ijerph120201156; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19; Salvia John, 2009, ASSESSMENT SPECIAL I, P43; Teague J, 2014, INT J PUBLIC HEALTH, V59, P913, DOI 10.1007/s00038-014-0580-8; UNICEF, 2014, ANN REP 2014; United Nations Development Program (UNDP), 2018 GLOB MULT POV I; United Nations Sustainable Development Knowledge Platform, PROC GOAL 2 GOAL 3; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2015, HLTH 2015 MDGS SDGS, P10; WHO and UNICEF, 2017, PROGR HOUS DRINK WAT PROGR HOUS DRINK WAT, P22; WHO FAO, 2014, 2 INT C NUTR C OUTC; WHO SDG data, GLOB HLTH OBS RES; World Bank Group, 2014, IBNET WAT SUPPL SAN, P37; World Health Organization, 2017, GLOB NUTR TARG 2025; Yokoyama T., 2014, STUDY DEV MONITORING, P40; Zeba AN, 2012, PUBLIC HEALTH NUTR, V15, P2210, DOI 10.1017/S1368980012000729	25	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208525	10.1371/journal.pone.0208525	http://dx.doi.org/10.1371/journal.pone.0208525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521645	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600085
J	Demir, KK; Cheng, MP; Lee, TC				Demir, Koray K.; Cheng, Matthew P.; Lee, Todd C.			Predictive factors of Clostridioides difficile infection in hospitalized patients with new diarrhea: A retrospective cohort study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; DIAGNOSIS; EPIDEMIC; OUTBREAK; DISEASE; RISK	Introduction and objective Diagnostic testing for Clostridioides difficile infection (CDI) by nucleic acid amplification test (NAAT) cannot distinguish between colonization and infection. A positive NAAT may therefore represent a false positive for infection, since diarrhea due to various aetiologies may occur in hospitalized patients. Our objective was to help answer the question: "does this medical inpatient with diarrhea have CDI ?" Design We conducted a retrospective cohort study (n = 248) on the Clinical Teaching Units of the Royal Victoria Hospital (Montreal, Canada). Patients were included if they had a NAAT between January 2014 and September 2015 and their admission diagnosis was not CDI. CDI cases and non-CDI cases were compared, and independent predictors of CDI were determined by logistic regression. Results Several factors were independently associated with CDI, including: hemodialysis (OR: 13.5, 95% CI: 2.85-63.8), atrial fibrillation (OR: 3.70, 95% CI: 1.52-9.01), whether the patient received empiric treatment (OR: 3.01, 95% CI: 1.04-8.68), systemic antibiotic therapy prior to testing (OR: 4.23, 95% CI: 1.71-10.5), previous positive NAAT (OR: 3.70, 95% CI: 1.41-9.72), and a leukocyte count of 11x10(9)/L or higher (OR: 3.43, 95% CI: 1.42-8.26). The area under the curve was 0.80. Conclusion For patients presenting with hospital-onset diarrhea, various parameters can help differentiate between CDI and other causes. A clinical prediction calculator derived from our cohort (http://individual.utoronto.ca/leet/cdiff.html) might assist clinicians in estimating the risk of CDI for inpatients; those with low pre-test probability may not require immediate testing, treatment, nor prolonged isolation.	[Demir, Koray K.] McGill Univ, Dept Med, Hlth Ctr, Montreal, PQ, Canada; [Cheng, Matthew P.; Lee, Todd C.] McGill Univ, Dept Med, Div Infect Dis, Hlth Ctr, Montreal, PQ, Canada; [Lee, Todd C.] McGill Univ, Dept Med, Clin Practice Assessment Unit, Hlth Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Lee, TC (corresponding author), McGill Univ, Dept Med, Div Infect Dis, Hlth Ctr, Montreal, PQ, Canada.; Lee, TC (corresponding author), McGill Univ, Dept Med, Clin Practice Assessment Unit, Hlth Ctr, Montreal, PQ, Canada.	koray.demir@mail.mcgill.ca	Cheng, Matthew P./AAO-7051-2020					[Anonymous], 2018, NON TRADITIONAL REF; Burnham CAD, 2013, CLIN MICROBIOL REV, V26, P604, DOI 10.1128/CMR.00016-13; Carrier M, 2006, THROMB RES, V117, P469, DOI 10.1016/j.thromres.2005.04.005; de Jong E, 2012, EUR J CLIN MICROBIOL, V31, P2219, DOI 10.1007/s10096-012-1558-1; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lewington A, 2011, NEPHRON CLIN PRACT, V118, pC349, DOI 10.1159/000328075; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Polage CR, 2015, JAMA INTERN MED, V175, P1792, DOI 10.1001/jamainternmed.2015.4114; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Sailhamer EA, 2009, ARCH SURG-CHICAGO, V144, P433, DOI 10.1001/archsurg.2009.51; Tenover FC, 2011, J MOL DIAGN, V13, P573, DOI 10.1016/j.jmoldx.2011.06.001; Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207128	10.1371/journal.pone.0207128	http://dx.doi.org/10.1371/journal.pone.0207128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517148	gold, Green Submitted, Green Published			2022-12-26	WOS:000452212400026
J	Mantula, PS; Outinen, TK; Jaatinen, P; Hamalainen, M; Huhtala, H; Porsti, IH; Vaheri, A; Mustonen, JT; Makela, SM				Mantula, Paula S.; Outinen, Tuula K.; Jaatinen, Pia; Hamalainen, Mari; Huhtala, Heini; Porsti, Ilkka H.; Vaheri, Antti; Mustonen, Jukka T.; Makela, Satu M.			High plasma resistin associates with severe acute kidney injury in Puumala hantavirus infection	PLOS ONE			English	Article							VIRUS NUCLEOCAPSID PROTEIN; NEPHROPATHIA-EPIDEMICA; LEPTIN; ADIPONECTIN; DISEASE; INTERLEUKIN-6; INFLAMMATION; DEFICIENCY; CORRELATE	Background Puumala hantavirus (PUUV) infected patients typically suffer from acute kidney injury (AKI). Adipokines have inflammation modulating functions in acute diseases including AKI. We examined plasma levels of three adipokines (resistin, leptin, and adiponectin) in acute PUUV infection and their associations with disease severity. Methods This study included 79 patients hospitalized due to acute PUUV infection. Plasma resistin, leptin, adiponectin, as well as IL-6 and CRP, were measured at the acute phase, recovery phase and one year after hospitalization. Results Plasma resistin levels were significantly higher in the acute phase compared to the recovery phase and one year after (median resistin 28 pg/mL (11-107) vs. 17 pg/mL (7-36) vs. 14 pg/mL (7-31), p<0.001). Maximum resistin concentration correlated with maximum plasma creatinine levels (r = 0.63; p<0.001). The higher the amount of albuminuria in the urine dipstick test (0-1+, 2+ or 3+) at admission, the higher the median of maximum resistin (24.7 pg/ mL, 25.4 pg/mL and 39.6 pg/mL, respectively, p = 0.002). High resistin was also an independent risk factor for severe AKI (creatinine >= 353.6 mu mol/L) (OR 1.08, 95% CI 1.02-1.14). Neither plasma leptin nor adiponectin level had any correlation with creatinine concentration or the amount of albuminuria. Conclusions Plasma resistin independently associates with the severity of AKI in acute PUUV infection. The association of resistin with the amount of albuminuria suggests that the level of plasma resistin is not only influenced by renal clearance but could have some role in the pathogenesis of AKI during PUUV infection.	[Mantula, Paula S.; Outinen, Tuula K.; Porsti, Ilkka H.; Mustonen, Jukka T.; Makela, Satu M.] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Jaatinen, Pia; Porsti, Ilkka H.; Mustonen, Jukka T.; Makela, Satu M.] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Jaatinen, Pia] Seinajoki Cent Hosp, Div Intermal Med, Seinajoki, Finland; [Hamalainen, Mari] Univ Tampere, Fac Med & Life Sci, Immunopharmacol Grp, Tampere, Finland; [Hamalainen, Mari] Tampere Univ Hosp, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Fac Social Sci, Tampere, Finland; [Vaheri, Antti] Univ Helsinki, Dept Virol Med, Medicum, Helsinki, Finland	Tampere University; Tampere University Hospital; Tampere University; Seinajoki Central Hospital; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Helsinki	Mantula, PS (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	paula.mantula@gmail.com	Vaheri, Antti/AAV-1523-2020	Hamalainen, Mari/0000-0002-6409-3758; Makela, Satu/0000-0001-6967-2401; Outinen, Tuula/0000-0002-2773-4077; Mantula, Paula/0000-0003-0271-1458	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Tampere Tuberculosis Foundation; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Finnish Kidney Foundation	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Tampere Tuberculosis Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Finnish Kidney Foundation	This study was financially supported by the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (JM and SM), Tampere Tuberculosis Foundation (JM), Sigrid Juselius Foundation (JM), Magnus Ehrnrooth Foundation (JM), and the Finnish Kidney Foundation (PM). The funders had no role in study design, data collection or analysis, decision to publish, or the preparation of the manuscript.	Ala-Houhala I, 2002, NEPHROL DIAL TRANSPL, V17, P246, DOI 10.1093/ndt/17.2.246; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; Braun N, 2010, NEPHROL DIAL TRANSPL, V25, P2997, DOI 10.1093/ndt/gfq118; Bunz H, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1180-9; Diez JJ, 2005, CLIN ENDOCRINOL, V62, P242, DOI 10.1111/j.1365-2265.2005.02207.x; Ficek R, 2004, CLIN NEPHROL, V62, P84; Filkova M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013; Fonseca I, 2015, METABOLISM, V64, P202, DOI 10.1016/j.metabol.2014.10.003; HEDMAN K, 1991, LANCET, V338, P1353, DOI 10.1016/0140-6736(91)92235-T; Hentzien M, 2018, EMERG INFECT DIS, V24, P1045, DOI 10.3201/eid2406.172160; Jamaluddin MS, 2012, BRIT J PHARMACOL, V165, P622, DOI 10.1111/j.1476-5381.2011.01369.x; Jin XG, 2013, KIDNEY INT, V83, P604, DOI 10.1038/ki.2012.408; Kallio J, 2017, UROL ONCOL, V35, pe25; Kallio J, 2017, UROL ONCOL, V35, P544; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Kontunen P, 2011, SCAND J RHEUMATOL, V40, P256, DOI 10.3109/03009742.2010.548827; Koskinen A, 2014, SCAND J RHEUMATOL, V43, P249, DOI 10.3109/03009742.2013.853096; Laine OK, 2014, BLOOD COAGUL FIBRIN, V25, P612, DOI 10.1097/MBC.0000000000000117; Latus J, 2015, EMERG INFECT DIS, V21, P76, DOI 10.3201/eid2101.140861; Laurikka A, 2014, EUR J CARDIO-THORAC, V46, P729, DOI 10.1093/ejcts/ezt634; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Leivo-Korpela S, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-12; Liu KT, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1759-9; Macdonald SPJ, 2017, INFLAMM RES, V66, P611, DOI 10.1007/s00011-017-1043-5; Macdonald SPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110678; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; Mancuso P, 2016, IMMUNOTARGETS THER, V5, P47, DOI 10.2147/ITT.S73223; Mantula PS, 2017, NEPHRON, V136, P193, DOI 10.1159/000459634; MUSTONEN J, 1994, CLIN NEPHROL, V41, P121; Mustonen J, 1996, KIDNEY INT, V49, P217, DOI 10.1038/ki.1996.29; Mustonen J, 2017, INFECT DIS-NOR, V49, P321, DOI 10.1080/23744235.2016.1274421; Mustonen J, 2013, ANTIVIR RES, V100, P589, DOI 10.1016/j.antiviral.2013.10.001; Oh J, 2013, KIDNEY INT, V83, P546, DOI 10.1038/ki.2012.479; Outinen TK, 2014, J INTERN MED, V276, P387, DOI 10.1111/joim.12257; Outinen TK, 2017, INFECT DIS-NOR, V49, P840, DOI 10.1080/23744235.2017.1358461; Outinen TK, 2015, NEPHRON, V130, P182, DOI 10.1159/000433563; Outinen TK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071335; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Park HK, 2017, KOREAN J INTERN MED, V32, P239, DOI 10.3904/kjim.2016.229; Sauni R, 2012, OCCUP ENVIRON MED, V69, P256, DOI 10.1136/oemed-2011-100347; Schwartz DR, 2011, TRENDS ENDOCRIN MET, V22, P259, DOI 10.1016/j.tem.2011.03.005; Singbartl K, 2016, CRIT CARE MED, V44, pE492, DOI 10.1097/CCM.0000000000001472; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Tavladaki T, 2017, PEDIATR CRIT CARE ME, V18, pE494, DOI 10.1097/PCC.0000000000001300; Temonen M, 1996, CLIN IMMUNOL IMMUNOP, V78, P47, DOI 10.1006/clin.1996.0007; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vaheri A, 2013, REV MED VIROL, V23, P35, DOI 10.1002/rmv.1722; VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402; Vapalahti O, 1996, J CLIN MICROBIOL, V34, P119, DOI 10.1128/JCM.34.1.119-125.1996; Vassiliadi DA, 2012, J CRIT CARE, V27, P400, DOI 10.1016/j.jcrc.2012.04.007; Wang W, 2004, J AM SOC NEPHROL, V15, P645, DOI 10.1097/01.ASN.0000113551.14276.0B; Yilmaz G, 2015, J MED VIROL, V87, P310, DOI 10.1002/jmv.24021	53	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208017	10.1371/journal.pone.0208017	http://dx.doi.org/10.1371/journal.pone.0208017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517161	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400076
J	Peixoto, RF; de Andrade, LM; Brito, MD; Nobile, PM; Martins, APB; Carlin, SD; Ribeiro, RV; Goldman, MHD; de Oliveira, JFNC; Figueira, AVD; Creste, S				Peixoto-Junior, Rafael Favero; de Andrade, Larissa Mara; Brito, Michael dos Santos; Nobile, Paula Macedo; Boer Martins, Alexandre Palma; Carlin, Samira Domingues; Ribeiro, Rafael Vasconcelos; de Souza Goldman, Maria Helena; Nebo Carlos de Oliveira, Joao Felipe; de Oliveira Figueira, Antonio Vargas; Creste, Silvana			Overexpression of ScMYBAS1 alternative splicing transcripts differentially impacts biomass accumulation and drought tolerance in rice transgenic plants	PLOS ONE			English	Article							R2R3-MYB GENE FAMILY; MYB-GENE; ABIOTIC STRESS; ABSCISIC-ACID; ARABIDOPSIS; EXPRESSION; EVOLUTIONARY; SENSITIVITY; RESPONSES; COLD	Drought is the most significant environmental stress for agricultural production worldwide, and tremendous efforts have been made to improve crop yield under the increasing water scarcity. Transcription factors are major players in the regulation of water stress-related genes in plants. Recently, different MYB transcription factors were characterized for their involvement in drought response. A sugarcane R2R3-MYB gene (ScMYBAS1) and its four alternative forms of transcript (ScMYAS1-2, ScMYBAS1-3, ScMYBAS1-4 and ScMYBAS1-5) were identified in this study. The subcellular localization, in Nicotiniana benthamiana, of the TFs fused in frame with GFP revealed that ScMYBAS1-2-GFP and ScMYBAS1-3-GFP were observed in the nucleus. The overexpression of ScMYBAS1-2 and ScMYBAS1-3 spliced transcripts in rice promoted change in plant growth under both well-watered and drought conditions. The ScMYBAS1-2 and ScMYBAS1-3 transgenic lines revealed a higher relative water content (RWC) compared to the wild type before maximum stress under drought conditions. The ScMYBAS1-2 transgenic lines showed a reduction in biomass (total dry weight). Conversely, ScMYBAS1-3 showed an increased biomass (total dry weight) relative to the wild-type. The overexpression of ScMYBAS1-3 in rice transgenic lines showed involvement with drought tolerance and biomass and, for this reason, was considered a good target for plant transformation, particularly for use in developing genotypes with drought tolerance and biomass accumulation.	[Peixoto-Junior, Rafael Favero; de Andrade, Larissa Mara; Boer Martins, Alexandre Palma; Creste, Silvana] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, SP, Brazil; [Brito, Michael dos Santos; Nobile, Paula Macedo; Carlin, Samira Domingues; Creste, Silvana] Inst Agron, Ctr Cana, Ribeirao Preto, SP, Brazil; [Ribeiro, Rafael Vasconcelos] Univ Estadual Campinas, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil; [de Souza Goldman, Maria Helena] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, SP, Brazil; [Nebo Carlos de Oliveira, Joao Felipe; de Oliveira Figueira, Antonio Vargas] Univ Sao Paulo, Ctr Energia Nucl Agr, Piracicaba, SP, Brazil; [Brito, Michael dos Santos] Univ Fed Sao Paulo, Inst Ciencia & Tecnol, Dept Ciencia & Tecnol, Sao Jose Dos Campos, Brazil	Universidade de Sao Paulo; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Creste, S (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, SP, Brazil.; Creste, S (corresponding author), Inst Agron, Ctr Cana, Ribeirao Preto, SP, Brazil.	screste@iac.sp.gov.br	dos Santos Brito, Michael/AAE-2100-2019; Figueira, Antonio/D-5556-2011; Nobile, Paula M/J-3069-2013; Ribeiro, Rafael Vasconcelos/L-1929-2013; Ribeiro, Rafael V/C-5521-2012; Goldman, Maria Helena/D-1424-2012	dos Santos Brito, Michael/0000-0003-0990-5626; Figueira, Antonio/0000-0001-8641-2556; Nobile, Paula M/0000-0003-0490-654X; Goldman, Maria Helena/0000-0002-6786-9320; Favero Peixoto-Junior, Rafael/0000-0002-6459-8684	Sao Paulo Research Foundation (FAPESP) [2011/50661-8]; National Council of Scientific and Technological Development (CNPq) [141996/2012-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Sao Paulo Research Foundation (FAPESP Grant #2011/50661-8) and by the National Council of Scientific and Technological Development (CNPq Grant #141996/2012-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Ali GS, 2008, CURR TOP MICROBIOL, V326, P103; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Andrade LM, 2016, PLANT GENE, V5, P31, DOI DOI 10.1016/J.PLGENE.2015.11.004; Araki S, 2004, J BIOL CHEM, V279, P32979, DOI 10.1074/jbc.M403171200; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Ding ZH, 2009, J GENET GENOMICS, V36, P17, DOI 10.1016/S1673-8527(09)60003-5; Du H, 2013, DNA RES, V20, P437, DOI 10.1093/dnares/dst021; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Guo JL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41922; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; HSIAO TC, 1984, PLANT PHYSIOL, V75, P338, DOI 10.1104/pp.75.2.338; Inman-Bamber NG, 2005, FIELD CROP RES, V92, P185, DOI 10.1016/j.fcr.2005.01.023; Ito M, 2005, J PLANT RES, V118, P61, DOI 10.1007/s10265-005-0192-8; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Jiang LX, 2009, J AGR FOOD CHEM, V57, P3525, DOI 10.1021/jf803166p; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kitamura-Abe Sumie, 2004, J Bioinform Comput Biol, V2, P309, DOI 10.1142/S0219720004000570; Krannich CT, 2015, INT J MOL SCI, V16, P16378, DOI 10.3390/ijms160716378; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Li CN, 2015, ENVIRON EXP BOT, V114, P80, DOI 10.1016/j.envexpbot.2014.06.014; Li JG, 2006, J EXP BOT, V57, P1263, DOI 10.1093/jxb/erj094; Li JG, 2006, BIOCHEM BIOPH RES CO, V341, P1155, DOI 10.1016/j.bbrc.2006.01.077; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mason Giovanna, 2002, BMC Biotechnol, V2, P20, DOI 10.1186/1472-6750-2-20; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Mu RL, 2009, CELL RES, V19, P1291, DOI 10.1038/cr.2009.83; Nayyar H, 2006, ENVIRON EXP BOT, V58, P106, DOI 10.1016/j.envexpbot.2005.06.021; Olivera JFNC, 2012, NON TRADITIONAL REF; Pasquali G, 2008, PLANT CELL REP, V27, P1677, DOI 10.1007/s00299-008-0587-9; Prabu G. R., 2011, Journal of Phytology, V3, P77; Prabu G, 2011, PLANT MOL BIOL REP, V29, P291, DOI 10.1007/s11105-010-0230-0; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shingote PR, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1961-1; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; TAKEMOTO Y, 1994, FEBS LETT, V350, P55, DOI 10.1016/0014-5793(94)00733-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Urao T, 1996, PLANT J, V10, P1145, DOI 10.1046/j.1365-313X.1996.10061145.x; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431	65	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207534	10.1371/journal.pone.0207534	http://dx.doi.org/10.1371/journal.pone.0207534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517137	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400042
J	Hillebrand, LE; Wickberg, SM; Gomez-Auli, A; Follo, M; Maurer, J; Busch, H; Boerries, M; Reinheckel, T				Hillebrand, Larissa E.; Wickberg, Sarah M.; Gomez-Auli, Alejandro; Follo, Marie; Maurer, Jochen; Busch, Hauke; Boerries, Melanie; Reinheckel, Thomas			MMP14 empowers tumor-initiating breast cancer cells under hypoxic nutrient-depleted conditions	FASEB JOURNAL			English	Article						mammary carcinoma; phenotypic plasticity; proteases	TYPE-1 MATRIX-METALLOPROTEINASE; IN-VITRO PROPAGATION; STEM-CELLS; EXPRESSION; PROMOTES; MT1-MMP; PROGRESSION; IDENTIFICATION; ANGIOGENESIS; METASTASIS	Tumor-initiating cells (TICs) existing in breast cancer are thought to be involved in initiation, progression, and relapse of tumors. In these processes, the epithelial-to-mesenchymal transition (EMT) and proteases are crucial factors that also dependent on the tumor milieu, including hypoxic nutrient-deprived, as well as normoxic nutrient-rich, environments. Therefore, we investigated EMT and proteases in TICs and their response to different environments by means of a newly generated immortalized TIC (iTIC) line. With the use of primary CD24(+)CD90(+)CD45(-) TICs from the mouse mammary tumor virus-polyoma middle T mouse breast cancer model, iTICs were generated by single cell-initiated sphere and subsequent 2-dimensional monolayer culture. Our data demonstrate the possibility to generate iTICs that are highly tumorigenic in culture and in mouse mammary fat pad. Contrasting environmental conditions provide these cells with a phenotypic and molecular plasticity that has a growth-promoting character in nutrient-rich normoxia and a motile character in nutrient-deprived hypoxia. Expression profiling revealed partial and dynamically changing EMT states, as well as a significantly up-regulated proteolytic signature, including many metalloproteinases, such as matrix metalloproteinase 14 (Mmp14). Inhibitor treatment of metalloproteinases, as well as short hairpin RNA-mediated knockdown of Mmp14 strongly impacted TIC characteristics, including tumor initiation, cell growth, migration, and invasion, especially in starved environments. We conclude that metalloproteinases empower TICs to adapt to changing environments.Hillebrand, L. E., Wickberg, S. M., Gomez-Auli, A., Follo, M., Maurer, J., Busch, H., Boerries, M., Reinheckel, T. MMP14 empowers tumor-initiating breast cancer cells under hypoxic nutrient-depleted conditions.	[Hillebrand, Larissa E.; Wickberg, Sarah M.; Gomez-Auli, Alejandro; Busch, Hauke; Boerries, Melanie; Reinheckel, Thomas] Univ Freiburg, Med Fac, Inst Mol Med & Cell Res, Freiburg, Germany; [Follo, Marie] Univ Freiburg, Med Ctr, Dept Med 1, Lighthouse Core Facil,Fac Med, Freiburg, Germany; [Hillebrand, Larissa E.; Reinheckel, Thomas] BIOSS Ctr Biol Signaling Studies, Freiburg, Germany; [Maurer, Jochen; Boerries, Melanie; Reinheckel, Thomas] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Boerries, Melanie; Reinheckel, Thomas] Comprehens Canc Ctr Freiburg, Freiburg, Germany; [Maurer, Jochen] Rheinisch Westfalische TH Aachen Univ, Aachen, Germany; [Busch, Hauke] Univ Lubeck, Lubeck, Germany	University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); RWTH Aachen University; University of Lubeck	Reinheckel, T (corresponding author), Albert Ludwigs Univ Freiburg, Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@mol-med.uni-freiburg.de	Reinheckel, Thomas/AAL-9761-2021; Maurer, Jochen/G-4832-2018; Boerries, Melanie/AAM-2602-2021; Busch, Hauke/R-6452-2016	Reinheckel, Thomas/0000-0001-9866-9105; Maurer, Jochen/0000-0003-3962-3128; Busch, Hauke/0000-0003-4763-4521	Deutsche Forschungsgemeinschaft [SFB850]; Excellence Initiative of the German Federal and State Governments [EXC 294, EXC 306]; German Cancer Consortium Program Oncogenic Pathways [L625, L627]; German Federal Ministry of Education and Research [FKZ 01ZX1409B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; German Cancer Consortium Program Oncogenic Pathways; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The authors thank Nicole Klemm (Institute of Molecular Medicine and Cell Research) for excellent technical support, and Dr. Melanie Bewerunge-Hudler and Dr. Stephan Wolf (German Cancer Research Center Genomics and Proteomics Core Facility, Heidelberg, Germany) for providing the Illumina Whole-Genome Expression BeadChips and related service. This work was supported by the Deutsche Forschungsgemeinschaft SFB850 Projects B7 (to T.R.) and Z1 (to M.B.), the Excellence Initiative of the German Federal and State Governments (EXC 294, BIOSS, Project B10 to T.R.; EXC 306 to H.B.), the German Cancer Consortium Program Oncogenic Pathways (Project L625 to M.B.; L627 to T.R.), and the German Federal Ministry of Education and Research, including the framework of the e:Med research and funding concept (FKZ 01ZX1409B to M.B.). The authors declare no conflicts of interest.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bengsch F, 2014, ONCOGENE, V33, P4474, DOI 10.1038/onc.2013.395; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Carnero A, 2016, BIOESSAYS, V38, pS65, DOI 10.1002/bies.201670911; Castro DJ, 2013, STEM CELLS, V31, P12, DOI 10.1002/stem.1224; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fantozzi A, 2014, CANCER RES, V74, P1566, DOI 10.1158/0008-5472.CAN-13-1641; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hamdan FH, 2014, GENOMICS, V104, P477, DOI 10.1016/j.ygeno.2014.10.010; Hardee ME, 2009, CURR MOL MED, V9, P435, DOI 10.2174/156652409788167122; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hillebrand LE, 2016, ONCOTARGET, V7, P58244, DOI 10.18632/oncotarget.11309; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Jiang WG, 2006, INT J MOL MED, V17, P583; Jolly MK, 2016, ONCOTARGET, V7, P27067, DOI 10.18632/oncotarget.8166; Kessenbrock K, 2015, MATRIX BIOL, V44-46, P184, DOI 10.1016/j.matbio.2015.01.022; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Ma J, 2012, TUMOR BIOL, V33, P1983, DOI 10.1007/s13277-012-0458-4; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; McMahon S, 2005, J BIOL CHEM, V280, P6561, DOI 10.1074/jbc.M413248200; Michor F, 2010, CANCER PREV RES, V3, P1361, DOI 10.1158/1940-6207.CAPR-10-0234; Miyoshi A, 2006, INT J ONCOL, V29, P1533; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; Thompson EW, 2018, NATURE, V556, P442, DOI 10.1038/d41586-018-04403-x; Turunen SP, 2017, BBA-MOL CELL RES, V1864, P1974, DOI 10.1016/j.bbamcr.2017.04.002; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459	56	19	21	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4124	4140		10.1096/fj.201801127R	http://dx.doi.org/10.1096/fj.201801127R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521382				2022-12-26	WOS:000459794800082
J	Gunther, LK; Rohde, JA; Tang, WJ; Walton, SD; Unrath, WC; Trivedi, DV; Muretta, JM; Thomas, DD; Yengo, CM				Gunther, Laura K.; Rohde, John A.; Tang, Wanjian; Walton, Shane D.; Unrath, William C.; Trivedi, Darshan V.; Muretta, Joseph M.; Thomas, David D.; Yengo, Christopher M.			Converter domain mutations in myosin alter structural kinetics and motor function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; actin; muscle; fluorescence resonance energy transfer (FRET); cardiomyopathy; ATPase; mechanochemistry; motor protein; structural kinetics	REAL-TIME DETECTION; DILATED CARDIOMYOPATHY; CARDIAC MYOSIN; ACTIN-BINDING; MUSCLE MYOSIN; MECHANISM; FORCE; INSIGHTS; STATES; REVEAL	Myosins are molecular motors that use a conserved ATPase cycle to generate force. We investigated two mutations in the converter domain of myosin V (R712G and F750L) to examine how altering specific structural transitions in the motor ATPase cycle can impair myosin mechanochemistry. The corresponding mutations in the human beta-cardiac myosin gene are associated with hypertrophic and dilated cardiomyopathy, respectively. Despite similar steady-state actin-activated ATPase and unloaded in vitro motility-sliding velocities, both R712G and F750L were less able to overcome frictional loads measured in the loaded motility assay. Transient kinetic analysis and stopped-flow FRET demonstrated that the R712G mutation slowed the maximum ATP hydrolysis and recovery-stroke rate constants, whereas the F750L mutation enhanced these steps. In both mutants, the fast and slow power-stroke as well as actin-activated phosphate release rate constants were not significantly different from WT. Time-resolved FRET experiments revealed that R712G and F750L populate the pre- and post-power-stroke states with similar FRET distance and distance distribution profiles. The R712G mutant increased the mole fraction in the post-power-stroke conformation in the strong actin-binding states, whereas the F750L decreased this population in the actomyosin ADP state. We conclude that mutations in key allosteric pathways can shift the equilibrium and/or alter the activation energy associated with key structural transitions without altering the overall conformation of the pre- and post-power-stroke states. Thus, therapies designed to alter the transition between structural states may be able to rescue the impaired motor function induced by disease mutations.	[Gunther, Laura K.; Tang, Wanjian; Walton, Shane D.; Unrath, William C.; Trivedi, Darshan V.; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Rohde, John A.; Muretta, Joseph M.; Thomas, David D.] Univ Minnesota, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Minnesota System; University of Minnesota Twin Cities	Yengo, CM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cmy11@psu.edu		Gunther, Laura/0000-0003-4588-2572; Walton, Shane/0000-0002-6779-8112; Tang, Wanjian/0000-0001-7374-6442; Yengo, Christopher/0000-0003-3987-9019	National Institutes of Health [HL127699, R01AR32961, R37AG26160]; American Heart Association [14SDG20480032]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR032961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant HL127699 (to C. M. Y.) and Grants R01AR32961 and R37AG26160 (to D. D. T.) and American Heart Association Grant 14SDG20480032 (to J. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksel T, 2015, CELL REP, V11, P910, DOI 10.1016/j.celrep.2015.04.006; Bloemink MJ, 2016, J BIOL CHEM, V291, P1763, DOI 10.1074/jbc.M115.688002; Brenner B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00392; BRISSETTE P, 1989, ANAL BIOCHEM, V181, P234, DOI 10.1016/0003-2697(89)90235-2; Chinthalapudi K, 2017, ELIFE, V6, DOI 10.7554/eLife.32742; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Enjuto M, 2000, J MOL CELL CARDIOL, V32, P2307, DOI 10.1006/jmcc.2000.1260; Fenn WO, 1924, J PHYSIOL-LONDON, V58, P0373, DOI 10.1113/jphysiol.1924.sp002141; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Greenberg MJ, 2016, BIOPHYS J, V110, P2568, DOI 10.1016/j.bpj.2016.05.021; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Homburger JR, 2016, P NATL ACAD SCI USA, V113, P6701, DOI 10.1073/pnas.1606950113; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Houdusse A, 2016, TRENDS BIOCHEM SCI, V41, P989, DOI 10.1016/j.tibs.2016.09.006; Jacobs DJ, 2011, J MOL BIOL, V407, P716, DOI 10.1016/j.jmb.2011.02.001; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kawana M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601959; Kohler J, 2002, P NATL ACAD SCI USA, V99, P3557, DOI 10.1073/pnas.062415899; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kronert WA, 2014, J BIOL CHEM, V289, P12779, DOI 10.1074/jbc.M114.550673; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Llinas P, 2015, DEV CELL, V33, P401, DOI 10.1016/j.devcel.2015.03.025; Manstein DJ, 2004, PHILOS T ROY SOC B, V359, P1907, DOI 10.1098/rstb.2004.1565; Maron BJ, 2016, AM J MED, V129, P1170, DOI 10.1016/j.amjmed.2016.02.031; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mentes A, 2018, P NATL ACAD SCI USA, V115, P1292, DOI 10.1073/pnas.1718316115; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Muretta JM, 2013, P NATL ACAD SCI USA, V110, P7211, DOI 10.1073/pnas.1222257110; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Park HY, 2017, KOREAN CIRC J, V47, P291, DOI 10.4070/kcj.2016.0017; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sasaki N, 1998, ADV BIOPHYS, V35, P1; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Seebohm B, 2009, BIOPHYS J, V97, P806, DOI 10.1016/j.bpj.2009.05.023; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; Swenson AM, 2014, J BIOL CHEM, V289, P23977, DOI 10.1074/jbc.M114.562231; Syamaladevi DP, 2012, BIOINFORM BIOL INSIG, V6, P11, DOI 10.4137/BBI.S8451; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Tayal U, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0410-8; Trivedi DV, 2015, P NATL ACAD SCI USA, V112, P14593, DOI 10.1073/pnas.1517566112; Trivedi DV, 2013, BIOCHEMISTRY-US, V52, P4710, DOI 10.1021/bi4004364; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Wulf SF, 2016, P NATL ACAD SCI USA, V113, pE1844, DOI 10.1073/pnas.1516598113; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	69	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1554	1567		10.1074/jbc.RA118.006128	http://dx.doi.org/10.1074/jbc.RA118.006128			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30518549	Green Published, hybrid			2022-12-26	WOS:000457879200011
J	Gaal, E; Valarik, M; Molnar, I; Farkas, A; Linc, G				Gaal, Eszter; Valarik, Miroslav; Molnar, Istvan; Farkas, Andras; Linc, Gabriella			Identification of COS markers specific for Thinopyrum elongatum chromosomes preliminary revealed high level of macrosyntenic relationship between the wheat and Th. elongatum genomes	PLOS ONE			English	Article							TRANSLOCATIONS CONFERRING RESISTANCE; MOLECULAR CYTOGENETIC ANALYSIS; HEAD BLIGHT RESISTANCE; LOPHOPYRUM-ELONGATUM; WILD RELATIVES; SALT TOLERANCE; BREAD WHEAT; LEAF RUST; CHROMATIN; EVOLUTION	Thinopyrum elongatum (Host) D.R. Dewey has served as an important gene source for wheat breeding improvement for many years. The exact characterization of its chromosomes is important for the detailed analysis of prebreeding materials produced with this species. The major aim of this study was to identify and characterize new molecular markers to be used for the rapid analysis of E genome chromatin in wheat background. Sixty of the 169 conserved orthologous set (COS) markers tested on diverse wheat-Th. elongatum disomic/ditelosomic addition lines were assigned to various Th. elongatum chromosomes and will be used for marker-assisted selection. The macrosyntenic relationship between the wheat and Th. elongatum genomes was investigated using EST sequences. Several rearrangements were revealed in homoeologous chromosome groups 2, 5, 6 and 7, while chromosomes 1 and 4 were conserved. Molecular cytogenetic and marker analysis showed the presence of rearranged chromosome involved in 6ES and 2EL arms in the 6E disomic addition line. The selected chromosome arm-specific COS markers will make it possible to identify gene introgressions in breeding programmes and will also be useful in the development of new chromosome -specific markers, evolutionary analysis and gene mapping.	[Gaal, Eszter; Molnar, Istvan; Farkas, Andras; Linc, Gabriella] Hungarian Acad Sci, Agr Inst, Ctr Agr Res, Martonvasar, Hungary; [Valarik, Miroslav; Molnar, Istvan] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Molnar, I (corresponding author), Hungarian Acad Sci, Agr Inst, Ctr Agr Res, Martonvasar, Hungary.; Molnar, I (corresponding author), Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic.	molnar.istvan@agrar.mta.hu	Farkas, András/AAA-5663-2022; Valárik, Miroslav/F-6129-2014; Molnar, istvan/L-9779-2019	Valárik, Miroslav/0000-0003-0143-6853; Molnar, Istvan/0000-0002-7167-9319	Hungarian National Research, Development and Innovation Office [OTKA K108555, OTKA K116277]; Hungarian Academy of Sciences [MTA KEP-5/2016, MTA KEP-5/2017]; Marie Curie Fellowship Grant 'AEGILWHEAT' under the H2020 framework programme of the European Union [H2020-MSCA-IF-2016-746253]	Hungarian National Research, Development and Innovation Office; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Marie Curie Fellowship Grant 'AEGILWHEAT' under the H2020 framework programme of the European Union	This work was financed by grants from the Hungarian National Research, Development and Innovation Office (http://nkfih.gov.hu/english) (OTKA K108555) to GL and (OTKA K116277) to IM and by the Hungarian Academy of Sciences (http://mta.hu/) (MTA KEP-5/2016 and MTA KEP-5/2017). IM gratefully acknowledges support from a Marie Curie Fellowship Grant 'AEGILWHEAT' [H2020-MSCA-IF-2016-746253] under the H2020 framework programme of the European Union (http://cordis.europa.eu/project/rcn/208891_en.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; Anderson JM, 2010, EUPHYTICA, V172, P251, DOI 10.1007/s10681-009-0061-y; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Ardalani S, 2016, PLANT BREEDING, V135, P286, DOI 10.1111/pbr.12359; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Burt C, 2011, THEOR APPL GENET, V123, P1387, DOI 10.1007/s00122-011-1674-9; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Cai XW, 1996, GENOME, V39, P56, DOI 10.1139/g96-008; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Copete A, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1981-6; Daron J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0546-4; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; DVORAK J, 1988, P NATL ACAD SCI USA, V85, P3805, DOI 10.1073/pnas.85.11.3805; DVORAK J, 1974, CAN J GENET CYTOL, V16, P399, DOI 10.1139/g74-043; FEDAK G, 1985, EUPHYTICA, V34, P673, DOI 10.1007/BF00035403; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; FRIEBE B, 1994, CROP SCI, V34, P400, DOI 10.2135/cropsci1994.0011183X003400020018x; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Garg M, 2009, J CEREAL SCI, V50, P358, DOI 10.1016/j.jcs.2009.06.012; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Glover NM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0754-6; Gou L, 2016, CROP SCI, V56, P354, DOI 10.2135/cropsci2015.03.0184; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; Howard T, 2011, J EXP BOT, V62, P2217, DOI 10.1093/jxb/erq423; Hu LJ, 2012, GENES GENOM, V34, P67, DOI 10.1007/s13258-011-0153-7; Jauhar PP, 2009, GENOME, V52, P467, DOI [10.1139/G09-014, 10.1139/g09-014]; JIANG J, 1993, THEOR APPL GENET, V86, P41, DOI 10.1007/BF00223806; Lammer D, 2004, J EXP BOT, V55, P1715, DOI 10.1093/jxb/erh209; Le HT, 1989, PLANT MOL BIO REP, V7, P150, DOI DOI 10.1007/BF02669631; Li HJ, 2009, J GENET GENOMICS, V36, P557, DOI 10.1016/S1673-8527(08)60147-2; Li XM, 2007, GENOME, V50, P400, DOI 10.1139/G07-025; Liewlaksaneeyanawin C, 2009, TREE GENET GENOMES, V5, P247, DOI 10.1007/s11295-008-0189-2; Linc G, 2012, CYTOGENET GENOME RES, V136, P138, DOI 10.1159/000334835; Linc G, 1999, GENOME, V42, P497, DOI 10.1139/gen-42-3-497; Linc G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173623; Lou HJ, 2017, MOL ECOL RESOUR, V17, P1318, DOI 10.1111/1755-0998.12659; LUKASZEWSKI AJ, 1995, THEOR APPL GENET, V90, P714, DOI 10.1007/BF00222138; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Molnar I, 2016, PLANT J, V88, P452, DOI 10.1111/tpj.13266; Molnar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070844; Monneveux P, 2003, PLANT BREEDING, V122, P379, DOI 10.1046/j.1439-0523.2003.00856.x; Mullan DJ, 2005, GENOME, V48, P811, DOI 10.1139/g05-040; Murphy KM, 2009, RENEW AGR FOOD SYST, V24, P285, DOI 10.1017/S1742170509990159; NAGAKI K, 1995, GENOME, V38, P479, DOI 10.1139/g95-063; OMIELAN JA, 1991, GENOME, V34, P961, DOI 10.1139/g91-149; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Quraishi UM, 2009, FUNCT INTEGR GENOMIC, V9, P473, DOI 10.1007/s10142-009-0129-8; Rakszegi M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01529; RAYBURN AL, 1987, AM J BOT, V74, P574, DOI 10.2307/2443837; Rey E., 2015, ALIEN INTROGRESSION, P347, DOI DOI 10.1007/978-3-319-23494-6; Reynolds MP, 2001, EUPHYTICA, V119, P137, DOI 10.1023/A:1017521800795; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; SCHACHERMAYR GM, 1995, THEOR APPL GENET, V90, P982, DOI 10.1007/BF00222911; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; SHARMA HC, 1984, PHYTOPATHOL Z, V110, P143; Shen R, 2004, THEOR APPL GENET, V108, P808, DOI 10.1007/s00122-003-1492-9; Shen X, 2006, PLANT BREEDING, V125, P424, DOI 10.1111/j.1439-0523.2006.01274.x; Talbert LE, 1996, THEOR APPL GENET, V93, P463, DOI 10.1007/BF00223191; Wang RRC, 2010, GENOME, V53, P1083, DOI 10.1139/G10-088; Xu GH, 2012, GENET MOL RES, V11, P1741, DOI 10.4238/2012.June.29.7; You MingShan, 2003, Journal of Agricultural Biotechnology, V11, P577; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang H, 1998, THEOR APPL GENET, V96, P69, DOI 10.1007/s001220050710; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhou SH, 2018, PLANT BIOTECHNOL J, V16, P818, DOI 10.1111/pbi.12831	69	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208840	10.1371/journal.pone.0208840	http://dx.doi.org/10.1371/journal.pone.0208840			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540828	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600091
J	Johansen, H; Bathen, T; Andersen, LO; Rand-Hendriksen, S; Ostlie, K				Johansen, Heidi; Bathen, Trine; Andersen, Liv Oinaes; Rand-Hendriksen, Svend; Ostlie, Kristin			Education and work participation among adults with congenital unilateral upper limb deficiency in Norway: A cross-sectional study	PLOS ONE			English	Article							REDUCTION DEFICIENCY; CHRONIC PAIN; LIFE; FATIGUE; PREVALENCE; CLASSIFICATION; POPULATION; PREDICTORS	Objectives To describe level of education and work participation among adults with congenital unilateral upper limb deficiency (CUULD) in Norway and to explore associations between work participation and demographic and clinical factors. Methods Cross-sectional study. In 2012, a postal questionnaire was sent to 186 persons with congenital limb deficiency (CLD), age > 20 years, registered at the TRS National Resource Center for Rare Disorders. In the original CLD study, 77 persons with CUULD responded. In this paper 64 persons with CUULD of working age (20-67 years) are included. Data on demographic factors as education level and work participation, and clinical factors including limb deficiency characteristics, chronic pain (Standardized Nordic Questionnaire), fatigue (Fatigue Severity Scale), physical and mental health (SF-36) were analyzed through descriptive and comparable statistics and logistic regression analyses. Results Sixty-four persons participated, mean age 43.4 (SD 13.7; range 20-67 years), 45 were women. Education level >13 years was reported by 34. Forty-three of the 64 participants were employed, 21 were prematurely retired (disability benefits). 11 of the 43 employed, and 6 of the 21 prematurely retired had completed vocational education. Physically demanding occupations (work activities that required standing, walking and lifting) were reported by 25 of the 43 employed and 13 of the 21 prematurely retired. 17 of the 64 reported need for further adaptions in their workplaces. The strongest predictors of work participation were younger age (OR 0.86) and good physical health (OR 1.21). Conclusion Two thirds of persons with CUULD were employed; while one third was prematurely retired and had left work earlier than expected. This suggests that persons with CUULD may experience challenges in work participation. Although levels of education were relatively high, several had chosen careers that required physical strain. Younger age and good physical health were the most important factors mediating work participation.	[Johansen, Heidi; Bathen, Trine; Andersen, Liv Oinaes; Rand-Hendriksen, Svend] Sunnaas Rehabil Hosp, Natl Resource Ctr Rare Disorders, TRS, Nesodden, Norway; [Ostlie, Kristin] Innlandet Hosp Trust, Dept Phys Med & Rehabil, Ottestad, Norway	Innlandet Hospital Trust	Johansen, H (corresponding author), Sunnaas Rehabil Hosp, Natl Resource Ctr Rare Disorders, TRS, Nesodden, Norway.	heidi.johansen@sunnaas.no		Bathen, Trine/0000-0002-1339-9319	TRS National Resource Center for Rare Disorders	TRS National Resource Center for Rare Disorders	This study was funded by the TRS National Resource Center for Rare Disorders. No additional external funding was received for this study.	Bo TP, 2014, REPORTS STAT NORWAY; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Bureau U.S.C., 2017, POP TRENDS ED ATT; Burger H, 2016, PROSTHET ORTHOT INT, V40, P497, DOI 10.1177/0309364615584658; DAY HJB, 1991, PROSTHET ORTHOT INT, V15, P67; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Gold NB, 2011, AM J MED GENET A, V155A, P1225, DOI 10.1002/ajmg.a.33999; Hermansson L., 2004, THESIS; Johansen H, 2014, ERGOTERAPEUTEN OSLO, V57, P36; Johansen H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190567; Johansen H, 2016, DISABIL REHABIL, V38, P2305, DOI 10.3109/09638288.2015.1129450; Johansen H, 2015, DISABIL REHABIL, V37, P2076, DOI 10.3109/09638288.2014.998781; Johansen H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-10; Krantz O, 2008, SCAND J DISABIL RES, V10, P209, DOI 10.1080/15017410801900374; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lankhorst IMF, 2017, DISABIL REHABIL, V39, P1623, DOI 10.1080/09638288.2016.1206632; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Postema SG, 2016, ARCH PHYS MED REHAB, V97, P1137, DOI 10.1016/j.apmr.2016.01.031; Postema SG, 2016, ARCH PHYS MED REHAB, V97, P892, DOI 10.1016/j.apmr.2015.12.022; Pransky GS, 2016, J OCCUP REHABIL, V26, P465, DOI 10.1007/s10926-016-9670-1; Ricci JA, 2007, J OCCUP ENVIRON MED, V49, P1, DOI 10.1097/01.jom.0000249782.60321.2a; Sjoberg L, 2014, DISABIL REHABIL, V36, P1562, DOI 10.3109/09638288.2013.854839; Vasluian E, 2015, J REHABIL MED, V47, P346, DOI 10.2340/16501977-1922; Vasluian E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-323; Vasluian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067101; Velvin G, 2015, AM J MED GENET A, V167, P3082, DOI 10.1002/ajmg.a.37370; Ware JE Jr KM, 2005, SF 36 R HLTH SURVEY; Wekre LL, 2010, DISABIL REHABIL, V32, P579, DOI 10.3109/09638280903204690	29	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207846	10.1371/journal.pone.0207846	http://dx.doi.org/10.1371/journal.pone.0207846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540806	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600038
J	Solari, KA; Ramakrishnan, U; Hadly, EA				Solari, Katherine A.; Ramakrishnan, Uma; Hadly, Elizabeth A.			Gene expression is implicated in the ability of pikas to occupy Himalayan elevational gradient	PLOS ONE			English	Article							PERIPHERAL-BLOOD TRANSCRIPTOME; ALTITUDE DEER MICE; POPULATION-GENETICS; REVEALS ADAPTATION; OCHOTONA-PRINCEPS; GENOME; PLASTICITY; INFERENCE; SELECTION; HYPOXIA	Species are shifting their ranges due to climate change, many moving to cooler and higher locations. However, with elevation increase comes oxygen decline, potentially limiting a species' ability to track its environment depending on what mechanisms it has available to compensate for hypoxic stress. Pikas (Family Ochotonidae), cold-specialist small mammal species, are already undergoing elevational range shifts. We collected RNA samples from one population of Ochotona roylei in the western Himalaya at three sites 3,600, 4,000, and 5,000 meters and found no evidence of significant population genetic structure nor positive selection among sites. However, out of over 10,000 expressed transcripts, 26 were significantly upregulated at the 5,000 m site and were significantly enriched for pathways consistent with physiological compensation for limited oxygen. These results suggest that differences in gene expression may play a key role in enabling hypoxia tolerance on this local scale, indicating elevational flexibility that may facilitate successful range shifts in response to climate change.	[Solari, Katherine A.; Hadly, Elizabeth A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Solari, Katherine A.; Hadly, Elizabeth A.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Ramakrishnan, Uma] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Ramakrishnan, Uma; Hadly, Elizabeth A.] Stanford Univ, Program Conservat Genom, Stanford, CA 94305 USA; [Hadly, Elizabeth A.] Stanford Univ, Ctr Innovat Global Hlth, Stanford, CA 94305 USA	Stanford University; Stanford University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Stanford University; Stanford University	Solari, KA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Solari, KA (corresponding author), Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA.	ksolari@stanford.edu			Stanford University; Stanford Center for Computational, Evolutionary, and Human Genomics; National Center for Biological Sciences; Stanford Professor Gilda H. Loew Fellowship; Indo-US Science and Technology Forum Research Internship in Science and Engineering	Stanford University(Stanford University); Stanford Center for Computational, Evolutionary, and Human Genomics; National Center for Biological Sciences; Stanford Professor Gilda H. Loew Fellowship; Indo-US Science and Technology Forum Research Internship in Science and Engineering	This work was supported by Stanford University; The Stanford Center for Computational, Evolutionary, and Human Genomics (awarded to KAS; https://cehg.stanford.edu/); The National Center for Biological Sciences; the Stanford Professor Gilda H. Loew Fellowship (awarded to KAS); and the Indo-US Science and Technology Forum Research Internship in Science and Engineering (awarded to KAS; http://www.iusstf.org/program/research-internships-in-science-engineering).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2014, R LANG ENV STAT COMP; Appenzeller O, 2006, J NEUROL SCI, V247, P93, DOI 10.1016/j.jns.2006.03.021; Baze MM, 2010, PHYSIOL GENOMICS, V41, P275, DOI 10.1152/physiolgenomics.00075.2009; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cheviron ZA, 2008, MOL ECOL, V17, P4556, DOI 10.1111/j.1365-294X.2008.03942.x; Cheviron ZA, 2014, EVOLUTION, V68, P48, DOI 10.1111/evo.12257; Cheviron ZA, 2012, P NATL ACAD SCI USA, V109, P8635, DOI 10.1073/pnas.1120523109; Cho YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3433; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ernst P, 1996, MOL CELL BIOL, V16, P6121; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Flamant L, 2009, EXP CELL RES, V315, P733, DOI 10.1016/j.yexcr.2008.11.020; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Ge DY, 2012, PALAEOGEOGR PALAEOCL, V326, P160, DOI 10.1016/j.palaeo.2012.02.016; Gou X, 2014, GENOME RES, V24, P1308, DOI 10.1101/gr.171876.113; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; HAFNER DJ, 1994, ARCTIC ALPINE RES, V26, P375, DOI 10.2307/1551799; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Henry P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039077; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZX, 2016, MOL ECOL RESOUR, V16, P150, DOI 10.1111/1755-0998.12447; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IPCC, 2007, IPCC 4 ASS REP AR4, V1, P976; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jia CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168161; Kawamichi T., 1968, Journal of the Faculty of Science Hokkaido University (Ser 6), V16, P582; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecocq T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065642; LEMAY MA, 2013, BMC GENOMICS, V14, P94021; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Lissovsky AA, 2014, MAMMALIA, V78, P199, DOI 10.1515/mammalia-2012-0134; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; MACARTHUR RA, 1974, CAN J ZOOL, V52, P353, DOI 10.1139/z74-042; Mcmaster ML, 2013, J IMMUNOL, V190, P3661, DOI [10.4049/jimmunol.1202792, DOI 10.4049/JIMMUNOL.1202792]; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P493, DOI 10.1657/1938-4246-42.4.493; Minchenko Dmytro O, 2016, Endocr Regul, V50, P43, DOI 10.1515/enr-2016-0008; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mosqueira M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037497; Niu YD, 2004, FOLIA ZOOL, V53, P141; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Pimentel HJ, 2016, BIORXIV058164, DOI 10.1101/058164; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Quintero I, 2013, ECOL LETT, V16, P1095, DOI 10.1111/ele.12144; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Reches A, 2016, J IMMUNOL, V196, P4967, DOI 10.4049/jimmunol.1501550; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scott GR, 2015, MOL BIOL EVOL, V32, P1962, DOI 10.1093/molbev/msv076; Scott GR, 2011, MOL BIOL EVOL, V28, P351, DOI 10.1093/molbev/msq205; Singh AK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5603; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; Smith Andrew T., 2008, P1; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; Smith AT, 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T41268A45184591.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T41268A45184591.EN]; Solari KA, 2018, INTEGR ZOOL, V13, P517, DOI 10.1111/1749-4877.12332; Solari KA, 2016, EVOL ECOL RES, V17, P787; Song L, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0089-y; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Storz JF, 2012, GENETICS, V190, P203, DOI 10.1534/genetics.111.134494; Tomasco IH, 2014, GENE, V534, P371, DOI 10.1016/j.gene.2013.09.097; Tufts DM, 2015, MOL BIOL EVOL, V32, P287, DOI 10.1093/molbev/msu311; Udartseva OO, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7260562; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Velotta JP, 2016, MOL ECOL, V25, P2870, DOI 10.1111/mec.13661; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Wu RC, 2013, P NATL ACAD SCI USA, V110, P4616, DOI 10.1073/pnas.1218318110; Xu Shu-Qing, 2005, Genomics Proteomics & Bioinformatics, V3, P5; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang J, 2005, FEBS LETT, V579, P559, DOI 10.1016/j.febslet.2004.10.112; Zhang WP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004466; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439	84	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207936	10.1371/journal.pone.0207936	http://dx.doi.org/10.1371/journal.pone.0207936			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540800	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600046
J	Strittmatter-Keller, U; Walter, C; Rauld, C; Egli, N; Regairaz, C; Rabe, S; Zenke, G; Carballido, J; Schweighoffer, T				Strittmatter-Keller, Ulrike; Walter, Caroline; Rauld, Celine; Egli, Nicole; Regairaz, Camille; Rabe, Sabine; Zenke, Gerhard; Carballido, Jose; Schweighoffer, Tamas			Fingerprints of CD8(+) T cells on human pre-plasma and memory B cells	PLOS ONE			English	Article							HUMAN BLOOD; EXPRESSION; SURFACE; IDENTIFICATION; MOBILIZATION; MYELOMA; ANTIGEN; ILDR1	Differentiation of B cells is a stringently controlled multi-step process, which is still incompletely understood. Here we identify and characterize a rare population of human B cells, which surprisingly carry CD8AB on their surface. Existence of such cells was demonstrated both in tonsils and in human apheresis material. Gene expression profiling and real time PCR detected however no CD8A or CD8B message in these cells. Instead, we found that surface CD8 was hijacked from activated CD8+ T cells by a transfer process that required direct cell-to-cell contact. A focused transcriptome analysis at single cell level allowed the dissection of the CD8 positive B cell population. We found that the affected cells are characteristically of the CD27+CD200- phenotype, and consist of two discrete late-stage subpopulations that carry signatures of activated memory B like cells, and early plasmablasts. Thus, there is only a restricted time window in the differentiation process during which B cells can intimately interact with CD8+ T cells. The findings point to a novel link between the T and B arms of the adaptive immune system, and suggest that CD8+ T cells have the capability to directly shape the global antibody repertoire.	[Strittmatter-Keller, Ulrike; Walter, Caroline; Rauld, Celine; Egli, Nicole; Regairaz, Camille; Rabe, Sabine; Zenke, Gerhard; Carballido, Jose; Schweighoffer, Tamas] NIBR, Basel, Switzerland	Novartis	Schweighoffer, T (corresponding author), NIBR, Basel, Switzerland.	tamas.schweighoffer@novartis.com						Alapat D, 2012, AM J CLIN PATHOL, V137, P93, DOI 10.1309/AJCP59UORCYZEVQO; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Caraux A, 2011, IMMUNOLOGY, V132, P266, DOI 10.1111/j.1365-2567.2010.03361.x; Caraux A, 2010, HAEMATOL-HEMATOL J, V95, P1016, DOI 10.3324/haematol.2009.018689; Carulli G, 2009, AM J CLIN PATHOL, V132, P186, DOI 10.1309/AJCPNCOHS92ARWRQ; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Dhainaut M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00112; Dhodapkar MV, 2016, BLOOD, V128, P2599, DOI 10.1182/blood-2016-09-692954; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Eisenberg G, 2013, J IMMUNOL, V190, P5856, DOI 10.4049/jimmunol.1202879; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Ellmeier W, 2013, CELL MOL LIFE SCI, V70, P4537, DOI 10.1007/s00018-013-1393-2; Flores-Montero J, 2016, CYTOM PART B-CLIN CY, V90, P61, DOI 10.1002/cyto.b.21265; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; GIBLIN P, 1989, P NATL ACAD SCI USA, V86, P998, DOI 10.1073/pnas.86.3.998; Gong YF, 2017, P NATL ACAD SCI USA, V114, P5271, DOI 10.1073/pnas.1701006114; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hauge H, 2004, BIOCHEM BIOPH RES CO, V323, P970, DOI 10.1016/j.bbrc.2004.08.188; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Imamura R, 2005, J IMMUNOL, V175, P2647, DOI 10.4049/jimmunol.175.4.2647; Kolar GR, 2007, BLOOD, V109, P2545, DOI 10.1182/blood-2006-07-037150; Krautler NJ, 2017, J EXP MED; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li HF, 2016, J IMMUNOL, V196, P4064, DOI 10.4049/jimmunol.1501027; McCall MN, 2014, BIOINFORMATICS, V30, P2310, DOI 10.1093/bioinformatics/btu239; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Morozko EL, 2015, HUM MOL GENET, V24, P609, DOI 10.1093/hmg/ddu474; Oracki SA, 2010, IMMUNOL REV, V237, P140, DOI 10.1111/j.1600-065X.2010.00940.x; Pejoski D, 2016, J IMMUNOL, V196, P4814, DOI 10.4049/jimmunol.1502005; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; RABINOWITZ R, 1995, CLIN IMMUNOL IMMUNOP, V76, P148, DOI 10.1006/clin.1995.1109; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Saraceni F, 2015, BONE MARROW TRANSPL, V50, P886, DOI 10.1038/bmt.2014.330; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SHARROW SO, 1981, J IMMUNOL, V126, P1327; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Shinnakasu R, 2017, CURR OPIN IMMUNOL, V45, P126, DOI 10.1016/j.coi.2017.03.003; Thakral D, 2008, J IMMUNOL, V180, P7431, DOI 10.4049/jimmunol.180.11.7431; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thompson AM, 2014, LAB CHIP, V14, P3135, DOI 10.1039/c4lc00175c; Thorarinsdottir K, 2016, CLIN EXP IMMUNOL, V185, P252, DOI 10.1111/cei.12795; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vikstrom I, 2010, SCIENCE; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208187	10.1371/journal.pone.0208187	http://dx.doi.org/10.1371/journal.pone.0208187			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540814	Green Submitted, gold, Green Published			2022-12-26	WOS:000452898600062
J	Dinesen, PT; Rix, TA; Joensen, AM; Dahm, CC; Lundbye-Christensenm, S; Schmidt, EB; Overvad, K				Dinesen, Pia Thisted; Rix, Thomas Andersen; Joensen, Albert Marni; Dahm, Christina Cathrine; Lundbye-Christensenm, Soren; Schmidt, Erik Berg; Overvad, Kim			Patterns of adipose tissue fatty acids and the risk of atrial fibrillation: A case-cohort study	PLOS ONE			English	Article							TREELET TRANSFORM; DIETARY PATTERNS; CANCER; POPULATION	Fatty acids in adipose tissue share dietary sources and metabolic pathways and therefore occur in patterns. The aim of the present study was to investigate the association between adipose tissue fatty acid patterns identified by the data-driven dimension-reducing method treelet transform and the risk of atrial fibrillation. A total of 57,053 Danish men and women aged 50-64 years participating in the Diet, Cancer and Health cohort had an adipose tissue biopsy taken at baseline. During a median follow-up of 14.6 years, a total of 4,710 participants developed atrial fibrillation or atrial flutter. Adipose tissue biopsies were analysed for fatty acid content by gas chromatography for all cases of atrial fibrillation and for a randomly drawn subcohort (n = 3,500) representative for the entire cohort. Hazard ratios with 95% confidence intervals for atrial fibrillation according to quintiles of factor scores were determined by weighted Cox proportional hazards regression analyses for men and women separately. From the 32 fatty acids measured, 7 major factors/patterns of fatty acids were identified using treelet transform. We found that a pattern consisting of n-6 polyunsaturated fatty acids (PUFA) (except linoleic acid) was associated with a lower hazard of atrial fibrillation. Patterns consisting of marine n-3 PUFA and containing n-9 fatty acids were associated with a lower hazard of atrial fibrillation in women. In conclusion, patterns of fatty acids in adipose tissue identified by treelet transform may be differentially associated with the risk of atrial fibrillation.	[Dinesen, Pia Thisted; Rix, Thomas Andersen; Joensen, Albert Marni; Schmidt, Erik Berg; Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Dinesen, Pia Thisted; Lundbye-Christensenm, Soren; Schmidt, Erik Berg; Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg AF Study Grp, Aalborg, Denmark; [Dahm, Christina Cathrine; Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark; [Lundbye-Christensenm, Soren] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Schmidt, Erik Berg] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aalborg University	Dinesen, PT (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.; Dinesen, PT (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg AF Study Grp, Aalborg, Denmark.	p.dinesen@m.dk	Dahm, Christina C/G-9787-2014	Dahm, Christina C/0000-0003-0481-2893; Overvad, Kim/0000-0001-6429-7921; Dinesen, Pia Thisted/0000-0001-8541-3442	Danish Council for Strategic Research [09-066965]; Danish Cancer Society	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Cancer Society(Danish Cancer Society)	This work was supported by a grant from the Danish Council for Strategic Research (grant number 09-066965) and the Danish Cancer Society funded the Diet, Cancer and Health cohort study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Arab L, 2002, PUBLIC HEALTH NUTR, V5, P865, DOI 10.1079/PHN2002391; Assi N, 2016, PUBLIC HEALTH NUTR, V19, P242, DOI 10.1017/S1368980015000294; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BERRY EM, 1986, AM J CLIN NUTR, V44, P220, DOI 10.1093/ajcn/44.2.220; BEYNEN AC, 1980, AM J CLIN NUTR, V33, P81, DOI 10.1093/ajcn/33.1.81; BEYNEN AC, 1985, AM J CLIN NUTR, V42, P317, DOI 10.1093/ajcn/42.2.317; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Camm AJ, 2012, EUR HEART J, V33; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chiuve SE, 2015, J NUTR, V145, P2092, DOI 10.3945/jn.115.212860; Dahm CC, 2012, AM J CLIN NUTR, V96, P1354, DOI 10.3945/ajcn.112.034157; Dahm CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022587; Dinesen PT, 2017, EUR J CLIN INVEST, V47, DOI 10.1111/eci.12836; Dinesen PT, 2017, AM J CARDIOL, V120, P1129, DOI 10.1016/j.amjcard.2017.06.053; Foerster J, 2015, METABOLISM, V64, P1348, DOI 10.1016/j.metabol.2015.07.004; Fretts AM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000889; Fretts AM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003814; Gillis AM, 2017, CIRCULATION, V135, P593, DOI 10.1161/CIRCULATIONAHA.116.025312; Gorst-Rasmussen A, 2012, STATA J, V12, P130, DOI 10.1177/1536867X1201200108; Gorst-Rasmussen A, 2011, AM J EPIDEMIOL, V173, P1097, DOI 10.1093/aje/kwr060; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hodson L, 2013, CURR OPIN CLIN NUTR, V16, P225, DOI 10.1097/MCO.0b013e32835d2edf; Joensen AM, 2011, CIRCULATION, V124, P1232, DOI 10.1161/CIRCULATIONAHA.110.987057; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Lee AB, 2008, ANN APPL STAT, V2, P435, DOI 10.1214/07-AOAS137; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; PHINNEY SD, 1994, AM J CLIN NUTR, V60, P725, DOI 10.1093/ajcn/60.5.725; Pottala JV, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/160520; Rix TA, 2013, HEART, P1, DOI [10.1136/heartjnl-2012-302968, DOI 10.1136/HEARTJNL-2012-302968]; Rix TA, 2012, FRONT PHYSIOL, P1, DOI [10.3389/fphys.2012.00001, DOI 10.3389/FPHYS.2012.00001]; Rix TA, 2012, SCAND CARDIOVASC J, V46, P149, DOI 10.3109/14017431.2012.673728; Schmidt JA, 2014, EUR J CLIN NUTR, V68, P1088, DOI 10.1038/ejcn.2014.28; Schoenaker DAJM, 2013, J NUTR, V143, P392, DOI 10.3945/jn.112.169011; Shen JA, 2011, AM J CLIN NUTR, V93, P261, DOI 10.3945/ajcn.110.001305; Smith DE, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-21; Sullivan EM, 2018, J BIOL CHEM, V293, P466, DOI [10.1074/jbc.m117.812834, 10.1074/jbc.M117.812834]; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208833	10.1371/journal.pone.0208833	http://dx.doi.org/10.1371/journal.pone.0208833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533060	Green Published, gold, Green Submitted			2022-12-26	WOS:000452782500041
J	Ohlendorf, D; Maurer, C; Bolender, E; Kocis, V; Song, M; Groneberg, DA				Ohlendorf, Daniela; Maurer, Christian; Bolender, Elisabeth; Kocis, Veronica; Song, Martha; Groneberg, David A.			Influence of ergonomic layout of musician chairs on posture and seat pressure in musicians of different playing levels	PLOS ONE			English	Article							PROFESSIONAL ORCHESTRA MUSICIANS; 3-DIMENSIONAL MOTION ANALYSIS; MUSCULOSKELETAL DISORDERS; INSTRUMENTAL MUSICIANS; BOWING ARM; PREVALENCE; VIOLINISTS; COMPLAINTS; PAIN; FREQUENCY	Introduction Musicians often perform in forced postures over a long period of time, which in the worst case may lead to playing-related musculoskeletal disorders. In this context, the ergonomics of the musician's chair (construction and surface quality) can be an influencing factor, with impact on the seating position of the upper body and the pressure distribution of the bottom. Therefore, the relationship between different musician chairs and musicians of different playing levels (professional, amateur or student) was analyzed in order to gain useful insights whether playing experience, playing level, playing style (symmetrical or asymmetrical) or gender have an impact. Method The total dataset of 47 musicians (3 playing levels: professional, amateur, student) were analysed on six musician chairs with different ergonomic layout. Sitting on each chair without instrument (condition 1) and with instrument (condition 2), the upper body posture (videorasterstereography) and the seat pressure (load distribution) were recorded.as Also, a subjective assessment concerning constitutional data, sitting behaviour, prevailing pain in the musculoskeletal system, sport activity and chair comfort rating, was completed using a questionnaire. Results There were significant differences shown in 6 of 17 variables, where all between and within factors were accounted for with a MANOVA. Two measurements of the upper body posture (scapular distance and scapular height) differentiated between playing level. Four of the pressure measurements (pressure under the sit bone and the thigh for the left and the right side) differentiated between chairs and the two conditions (with and without instrument). Chairs with soft cushioning had a mean pressure reduction of about 30%. The pressure was increased by about 10% while playing an instrument. Subjective rating was correlated to age for some of the chairs. Discussion Differences between chairs are mainly associated with the pressure distribution under the sitting surface. Playing with an instrument puts an additional force onto the surface of the chair that is more than the weight of the instrument. No relationship between pressure data and upper body posture data could be found. Therefore, it can be speculated that the inter subject variability is larger than systematic differences introduced by the chair or instrument.	[Ohlendorf, Daniela; Bolender, Elisabeth; Kocis, Veronica; Song, Martha; Groneberg, David A.] Goethe Univ Frankfurt Main, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany; [Maurer, Christian] Move Funct, Berndorf Bei Salzburg, Austria	Goethe University Frankfurt	Ohlendorf, D (corresponding author), Goethe Univ Frankfurt Main, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.	ohlendorf@med.uni-frankfurt.de	Groneberg, David/A-5132-2018; Maurer, Christian/AAS-9688-2020	Groneberg, David/0000-0001-8551-6556; Maurer, Christian/0000-0002-8426-813X				Ajidahun AT, 2013, MED PROBL PERFORM AR, V28, P96; Baadjou Vera, 2018, Disabil Rehabil, V40, P2946, DOI 10.1080/09638288.2017.1362707; Berque P, 2016, MED PROBL PERFORM AR, V31, P78, DOI 10.21091/mppa.2016.2015; Moraes GFD, 2012, ACTA ORTOP BRAS, V20, P43, DOI 10.1590/S1413-78522012000100009; Federolf PA, 2016, J BIOMECH, V49, P364, DOI 10.1016/j.jbiomech.2015.12.030; FISHBEIN M, 1988, MED PROBL PERFORM AR, V3, P1; Fotiadis DG, 2013, MED PROBL PERFORM AR, V28, P91; Kelleher LK, 2013, MED PROBL PERFORM AR, V28, P212; Kenny DT, 2016, MED PROBL PERFORM AR, V31, P1, DOI 10.21091/mppa.2016.1001; Kok LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191772; Kok LM, 2016, INT ARCH OCC ENV HEA, V89, P373, DOI 10.1007/s00420-015-1090-6; Kok LM, 2015, MED PROBL PERFORM AR, V30, P163, DOI 10.21091/mppa.2015.3031; Kok LM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-9; de Araujo NCK, 2009, MED PROBL PERFORM AR, V24, P108; Maurer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135712; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; NICOL K, 1993, J BIOMECH, V26, P1479, DOI 10.1016/0021-9290(93)90099-Z; Ohlendorf D, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-017-0151-z; Paarup Helene M, 2012, BMC Res Notes, V5, P541, DOI 10.1186/1756-0500-5-541; Paarup HM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-223; Rietveld ABM, 2013, CLIN RHEUMATOL, V32, P425, DOI 10.1007/s10067-013-2184-8; Schmale H, 1985, ORCHESTERMUSIKER SEI; Shan GB, 2003, MED PROBL PERFORM AR, V18, P3; Siemon B, 2002, Handchir Mikrochir Plast Chir, V34, P89, DOI 10.1055/s-2002-32310; Sousa CM, 2017, ACTA MEDICA PORT, V30, P302, DOI 10.20344/amp.7568; Spahn C, 2011, MUSIKERMEDIZIN DIAGN, P1; Steinmetz A, 2015, CLIN RHEUMATOL, V34, P965, DOI 10.1007/s10067-013-2470-5; TULCHINSKY E, 1994, MED PROBL PERFORM AR, V9, P119; Turner-Stokes L, 1999, CLIN BIOMECH, V14, P426, DOI 10.1016/S0268-0033(98)00110-7; Vervainioti A, 2015, MED PROBL PERFORM AR, V30, P197, DOI 10.21091/mppa.2015.4037; Wasmer C, 2011, VERGLEICHENDE UNTERS, P1; Woldendorp KH, 2018, INT ARCH OCC ENV HEA, V91, P215, DOI 10.1007/s00420-017-1264-5; Yagisan N, 2009, MED PROBL PERFORM AR, V24, P181	33	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208758	10.1371/journal.pone.0208758	http://dx.doi.org/10.1371/journal.pone.0208758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533063	gold, Green Published, Green Submitted			2022-12-26	WOS:000452782500033
J	van Leeuwen, LM; Pronk, M; Merkus, P; Goverts, ST; Anema, JR; Kramer, SE				van Leeuwen, Lisette M.; Pronk, Marieke; Merkus, Paul; Goverts, S. Theo; Anema, Johannes R.; Kramer, Sophia E.			Barriers to and enablers of the implementation of an ICF-based intake tool in clinical otology and audiology practice -A qualitative pre-implementation study	PLOS ONE			English	Article							PATIENT-REPORTED OUTCOMES; INTERNATIONAL CLASSIFICATION; BEHAVIOR-CHANGE; HEARING-LOSS; OLDER-ADULTS; HEALTH-CARE; CORE SETS; DISABILITY; IMPACT; GUIDE	The authors are developing an intake tool based on the Brief International Classification of Functioning Disability and Health Core Set for Hearing Loss, by operationalizing its categories into a Patient Reported Outcome Measure. This study was aimed at identifying enablers and barriers to using this tool as perceived by hearing health professionals (HHPs) and patients. Focus groups and interviews were held with HHPs (ENT surgeons, N = 14; audiologists, N = 8) and patients (N = 18). Interview questions were based on the Capability Opportunity-Motivation-Behavior (COM-B) model. Using the COM-B model and the Theoretical Domains Framework (TDF), transcript fragments were divided into meaning units, which were then categorized into capability-, opportunity- and motivation-related barriers and enablers. These were further specified into TDF domains. HHP barriers included: lack of time to use the tool (0); and fear of being made responsible for addressing any emerging problems, which may be outside the expertise of the HHP (M). Enablers included integration of the tool in the electronic patient record (0); opportunity for the patient to be better prepared for the intake visit (M); and provision of a complete picture of the patient's functioning via the tool (M). Patient' barriers included fear of losing personal contact with the HHP (M); and fear that use of the tool might negatively affect conversations with the HHP (M). Enablers included knowledge on the aim and relevance of the tool (C); expected better self preparation (M); and a more focused intake (M). These findings suggest that an intervention is needed to enhance HHPs' knowledge, skills and motivation regarding the relevance and the clinical usefulness of the tool. Providing clear and specific information on the purpose of the tool can also enhance patient motivation. For both HHPs and patients, opportunities relating to the (digital) administration and the design of the tool provide additional targets for successful implementation.	[van Leeuwen, Lisette M.; Pronk, Marieke; Merkus, Paul; Goverts, S. Theo; Kramer, Sophia E.] Vrije Univ Amsterdam, Amsterdam UMC, Otolaryngol Head & Neck Surg, Ear & Hearing,Amsterdam Publ Hlth, Amsterdam, Netherlands; [Anema, Johannes R.] Vrije Univ Amsterdam, Amsterdam UMC, Publ & Occupat Hlth, Amsterdam Publ Hlth, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	van Leeuwen, LM (corresponding author), Vrije Univ Amsterdam, Amsterdam UMC, Otolaryngol Head & Neck Surg, Ear & Hearing,Amsterdam Publ Hlth, Amsterdam, Netherlands.	lm.vanleeuwen@vumc.nl	Pronk, Marieke/AAY-5839-2020	Pronk, Marieke/0000-0001-8472-4900; Merkus, Paul/0000-0002-5859-7386; Kramer, Sophia E./0000-0002-0451-8179	Stichting Het Heinsius-Houbolt Foundation	Stichting Het Heinsius-Houbolt Foundation	The study was financially supported by the Stichting Het Heinsius-Houbolt Foundation.; The study was financially supported by the Stichting Het Heinsius-Houbolt Foundation. The work presented in this manuscript was a collaboration between all authors. LvL organized and carried out the data collection. LvL, MP and SK analyzed the data. All authors participated in the interpretation of the data. LvL had the leading role in the writing process. All authors revised the manuscript critically for important intellectual content and approved the current version to be submitted to PLOS ONE.	Aaronson N, 2015, USERS GUIDE IMPLEMEN; Antunes B, 2014, PALLIATIVE MED, V28, P158, DOI 10.1177/0269216313491619; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Barker F, 2018, ANN BEHAV MED, V52, P489, DOI 10.1007/s12160-016-9843-3; Barker F, 2016, INT J AUDIOL, V55, pS90, DOI 10.3109/14992027.2015.1120894; Basch E, 2007, J CLIN ONCOL, V25, P5374, DOI 10.1200/JCO.2007.11.2243; Basch E, 2015, VALUE HEALTH, V18, P493, DOI 10.1016/j.jval.2015.02.018; Basch E, 2013, JAMA-J AM MED ASSOC, V310, P139, DOI 10.1001/jama.2013.6855; Black N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2495; Blazer D., 2016, HEARING HLTH CARE AD, P75; Boisvert I, 2017, TRENDS HEAR, V21, DOI 10.1177/2331216517706397; Boothroyd Arthur, 2007, Trends Amplif, V11, P63, DOI 10.1177/1084713807301073; Boyce MB, 2014, BMJ QUAL SAF, V23, P508, DOI 10.1136/bmjqs-2013-002524; Boyce MB, 2013, QUAL LIFE RES, V22, P2265, DOI 10.1007/s11136-013-0390-0; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Cella D, 2015, PATIENT REPORTED OUT; Neil S, 2016, INT J AUDIOL, V55, pS99, DOI 10.3109/14992027.2016.1161851; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Danermark B, 2013, AM J AUDIOL, V22, P323, DOI 10.1044/1059-0889(2013/12-0052); Danermark B, 2010, INT J AUDIOL, V49, P256, DOI 10.3109/14992020903410110; Davis R, 2015, HEALTH PSYCHOL REV, V9, P323, DOI 10.1080/17437199.2014.941722; Dawson J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c186; Engelen V, 2012, PEDIATR BLOOD CANCER, V58, P766, DOI 10.1002/pbc.23158; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Fishbein M., 1975, BELIEF ATTITUDE INTE; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Greenhalgh J, 2005, SOC SCI MED, V60, P833, DOI 10.1016/j.socscimed.2004.06.022; Greenhalgh J, 2009, QUAL LIFE RES, V18, P115, DOI 10.1007/s11136-008-9430-6; Grenness Caitlin, 2016, Seminars in Hearing, V37, P187, DOI 10.1055/s-0036-1584411; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Hanbury A., 2017, EUR J PERSON CENTERE, V5, P35; Haverman L., 2014, CLIN PRACTICE PEDIAT, V2, P50, DOI DOI 10.1037/CPP0000043; Hickson Louise, 2007, Seminars in Speech and Language, V28, P283, DOI 10.1055/s-2007-986525; Kirk JW, 2016, J CLIN NURS, V25, P2786, DOI 10.1111/jocn.13275; Knudsen LV, 2012, INT J AUDIOL, V51, P83, DOI 10.3109/14992027.2011.606283; Kyte DG, 2015, PHYSIOTHERAPY, V101, P119, DOI 10.1016/j.physio.2014.11.003; Locklear T., STRATEGIES OVERCOMIN; Marshall S, 2006, J EVAL CLIN PRACT, V12, P559, DOI 10.1111/j.1365-2753.2006.00650.x; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S., 2011, IMPLEMENT SCI, V6; Miller D, 2015, PATIENT, V8, P293, DOI 10.1007/s40271-014-0095-7; Miriovsky BA, 2013, PRINCIPLES AND PRACT; Noonan VK, 2017, J CLIN EPIDEMIOL, V89, P125, DOI 10.1016/j.jclinepi.2017.04.017; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; Selb M, 2015, EUR J PHYS REHAB MED, V51, P105; Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x; Valderas JM, 2008, QUAL LIFE RES, V17, P179, DOI 10.1007/s11136-007-9295-0; van Leeuwen LM, 2017, EAR HEARING, V38, P103, DOI 10.1097/AUD.0000000000000358; Velikova G, 2008, PSYCHO-ONCOL, V17, P690, DOI 10.1002/pon.1295; WHO, 2001, WHO INT CLASS FUNCT; Wiering B, 2017, HEALTH EXPECT, V20, P11, DOI 10.1111/hex.12442; Wintner LM, 2016, EUR J CANCER, V68, P73, DOI 10.1016/j.ejca.2016.08.024; Wood WA, 2013, BIOL BLOOD MARROW TR, V19, P450, DOI 10.1016/j.bbmt.2012.11.014	56	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208797	10.1371/journal.pone.0208797	http://dx.doi.org/10.1371/journal.pone.0208797			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD8CS	30533057	gold, Green Published, Green Submitted			2022-12-26	WOS:000452782500038
J	Yamamoto, T; Endo, J; Kataoka, M; Matsuhashi, T; Katsumata, Y; Shirakawa, K; Yoshida, N; Isobe, S; Moriyama, H; Goto, S; Yamashita, K; Nakanishi, H; Shimanaka, Y; Kono, N; Shinmura, K; Arai, H; Fukuda, K; Sano, M				Yamamoto, Tsunehisa; Endo, Jin; Kataoka, Masaharu; Matsuhashi, Tomohiro; Katsumata, Yoshinori; Shirakawa, Kohsuke; Yoshida, Naohiro; Isobe, Sarasa; Moriyama, Hidenori; Goto, Shinichi; Yamashita, Kaoru; Nakanishi, Hiroki; Shimanaka, Yuta; Kono, Nozomu; Shinmura, Ken; Arai, Hiroyuki; Fukuda, Keiichi; Sano, Motoaki			Decrease in membrane phospholipids unsaturation correlates with myocardial diastolic dysfunction	PLOS ONE			English	Article							PALMITATE-INDUCED APOPTOSIS; MONOUNSATURATED FATTY-ACIDS; ENDOPLASMIC-RETICULUM; PPAR-ALPHA; HEART; CARDIOMYOCYTES; LIPOTOXICITY; MITOCHONDRIA; HYPERTROPHY; ACTIVATION	Increase in saturated fatty acid (SFA) content in membrane phospholipids dramatically affects membrane properties and cellular functioning. We sought to determine whether exogenous SFA from the diet directly affects the degree of membrane phospholipid unsaturation in adult hearts and if these changes correlate with contractile dysfunction. Although both SFA-rich high fat diets (HFDs) and monounsaturated FA (MUFA)-rich HFDs cause the same degree of activation of myocardial FA uptake, triglyceride turnover, and mitochondrial FA oxidation and accumulation of toxic lipid intermediates, the former induced more severe diastolic dysfunction than the latter, which was accompanied with a decrease in membrane phospholipid unsaturation, induction of unfolded protein response (UPR), and a decrease in the expression of Sirt1 and stearoyl-CoA desaturase-1 (SCD1), catalyzing the conversion of SFA to MUFA. When the SFA supply in the heart overwhelms the cellular capacity to use it for energy, excess exogenous SFA channels to membrane phospholipids, leading to UPR induction, and development of diastolic dysfunction.	[Yamamoto, Tsunehisa; Endo, Jin; Kataoka, Masaharu; Matsuhashi, Tomohiro; Katsumata, Yoshinori; Shirakawa, Kohsuke; Yoshida, Naohiro; Isobe, Sarasa; Moriyama, Hidenori; Goto, Shinichi; Yamashita, Kaoru; Shinmura, Ken; Fukuda, Keiichi; Sano, Motoaki] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Endo, Jin; Sano, Motoaki] Japan Sci & Technol Agcy, Tokyo, Japan; [Yoshida, Naohiro; Yamashita, Kaoru] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan; [Nakanishi, Hiroki] Akita Univ, Res Ctr Biosignal, Akita, Japan; [Shimanaka, Yuta; Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Shinmura, Ken] Hyogo Coll Med, Dept Gen Med, Nishinomiya, Hyogo, Japan	Keio University; Japan Science & Technology Agency (JST); Tokyo Women's Medical University; Akita University; University of Tokyo; Hyogo College of Medicine	Sano, M (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.; Sano, M (corresponding author), Japan Sci & Technol Agcy, Tokyo, Japan.	msano@a8.keio.jp	KONO, nozomu/AAM-3178-2020; Goto, Shinichi/AAL-3011-2021; Sano, Motoaki/L-3405-2013; Katsumata, Yoshinori/AAC-4159-2021; Goto, Shinya/AAU-6045-2020; Shimanaka, Yuta/AHA-3394-2022	Katsumata, Yoshinori/0000-0001-5576-5789; Goto, Shinya/0000-0002-6821-1504; Shimanaka, Yuta/0000-0002-2333-0091; Yamamoto, Tsunehisa/0000-0002-5241-9482; Shinmura, Ken/0000-0002-1419-3574; Goto, Shinichi/0000-0002-0450-0331; Moriyama, Hidenori/0000-0002-8045-113X; Nakanishi, Hiroki/0000-0002-5108-1598; Yamashita, Kaoru/0000-0001-7922-8275	Japan Science and Technology Agency PRESTO; Japan Society for the Promotion of Science KAKENHI [15H04825, 15H01160, 16K21358]; Takeda Science Foundation	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants from the Japan Science and Technology Agency PRESTO to Motoaki Sano (2013-2015), the Japan Society for the Promotion of Science KAKENHI to Motoaki Sano (15H04825, 15H01160), to Tsunehisa Yamamoto (16K21358), and the Takeda Science Foundation to Tsunehisa Yamamoto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Asp ML, 2013, BBA-MOL CELL RES, V1833, P895, DOI 10.1016/j.bbamcr.2012.09.007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; DAVIS PJ, 1987, P NATL ACAD SCI USA, V84, P118, DOI 10.1073/pnas.84.1.118; deVries JE, 1997, J LIPID RES, V38, P1384; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Haffar T, 2015, ENDOPLASMIC RETICULU, V2, DOI [10.1152/ajpheart.2000.279.5.H2124, DOI 10.1152/AJPHEART.2000.279.5.H2124]; Herrero P, 2006, J AM COLL CARDIOL, V47, P598, DOI 10.1016/j.jacc.2005.09.030; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Katsumata Y, 2014, HYPERTENSION, V63, P80, DOI 10.1161/HYPERTENSIONAHA.113.01639; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Kuwabara Y, 2015, CIRC RES, V116, P279, DOI 10.1161/CIRCRESAHA.116.304707; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Matsuhashi T, 2015, J MOL CELL CARDIOL, V82, P116, DOI 10.1016/j.yjmcc.2015.02.021; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Peana D, 2017, CURR OPIN PHARMACOL, V33, P17, DOI 10.1016/j.coph.2017.03.005; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; ROSS AC, 1984, J BIOL CHEM, V259, P815; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Tsushima K, 2018, CIRC RES, V122, P58, DOI 10.1161/CIRCRESAHA.117.311307; Turner MD, 2004, BBA-MOL CELL RES, V1693, P1, DOI 10.1016/j.bbamcr.2004.05.002; van der Meer RW, 2008, EUR HEART J, V29, P1516, DOI 10.1093/eurheartj/ehn207; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145	47	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208396	10.1371/journal.pone.0208396	http://dx.doi.org/10.1371/journal.pone.0208396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533011	Green Published, gold, Green Submitted			2022-12-26	WOS:000452782500019
J	Asif, M; Martiniano, HFMCM; Vicente, AM; Couto, FM				Asif, Muhammad; Martiniano, Hugo F. M. C. M.; Vicente, Astrid M.; Couto, Francisco M.			Identifying disease genes using machine learning and gene functional similarities, assessed through Gene Ontology	PLOS ONE			English	Article							SEMANTIC SIMILARITY	Identifying disease genes from a vast amount of genetic data is one of the most challenging tasks in the post-genomic era. Also, complex diseases present highly heterogeneous genotype, which difficult biological marker identification. Machine learning methods are widely used to identify these markers, but their performance is highly dependent upon the size and quality of available data. In this study, we demonstrated that machine learning classifiers trained on gene functional similarities, using Gene Ontology (GO), can improve the identification of genes involved in complex diseases. For this purpose, we developed a supervised machine learning methodology to predict complex disease genes. The proposed pipeline was assessed using Autism Spectrum Disorder (ASD) candidate genes. A quantitative measure of gene functional similarities was obtained by employing different semantic similarity measures. To infer the hidden functional similarities between ASD genes, various types of machine learning classifiers were built on quantitative semantic similarity matrices of ASD and non-ASD genes. The classifiers trained and tested on ASD and non-ASD gene functional similarities outperformed previously reported ASD classifiers. For example, a Random Forest (RF) classifier achieved an AUC of 0. 80 for predicting new ASD genes, which was higher than the reported classifier (0.73). Additionally, this classifier was able to predict 73 novel ASD candidate genes that were enriched for core ASD phenotypes, such as autism and obsessive-compulsive behavior. In addition, predicted genes were also enriched for ASD co-occurring conditions, including Attention Deficit Hyperactivity Disorder (ADHD). We also developed a KNIME workflow with the proposed methodology which allows users to configure and execute it without requiring machine learning and programming skills. Machine learning is an effective and reliable technique to decipher ASD mechanism by identifying novel disease genes, but this study further demonstrated that their performance can be improved by incorporating a quantitative measure of gene functional similarities. Source code and the workflow of the proposed methodology are available at https://github.com/Muh-Asif/ASD-genes-prediction.	[Asif, Muhammad; Martiniano, Hugo F. M. C. M.; Vicente, Astrid M.] Inst Nacl Saude Doutor Ricardo Jorge, Ave Padre Cruz, Lisbon, Portugal; [Asif, Muhammad; Martiniano, Hugo F. M. C. M.; Vicente, Astrid M.] Univ Lisbon, BioISI Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal; [Asif, Muhammad; Couto, Francisco M.] Univ Lisbon, Fac Ciencias, LASIGE, Lisbon, Portugal; [Vicente, Astrid M.] Inst Gulbenkian Ciencias, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge; BIOISI; Universidade de Lisboa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia	Asif, M (corresponding author), Inst Nacl Saude Doutor Ricardo Jorge, Ave Padre Cruz, Lisbon, Portugal.; Asif, M (corresponding author), Univ Lisbon, BioISI Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal.; Asif, M (corresponding author), Univ Lisbon, Fac Ciencias, LASIGE, Lisbon, Portugal.	masif@fc.ul.pt	Martiniano, Hugo/R-7571-2017; Couto, Francisco M/A-4066-2010; Asif, Muhammad/U-9266-2017	Martiniano, Hugo/0000-0003-2490-8913; Couto, Francisco M/0000-0003-0627-1496; Asif, Muhammad/0000-0001-9144-7630	Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/52485/2014]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia (SFRH/BD/52485/2014 to MA and DeST: Deep Semantic Tagger PTDC/CCI-BIO/28685/2017). (https://www.fct.pt/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; [Anonymous], 2015, PACKAGE RANDOMFOREST, DOI DOI 10.5244/C.22.54; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carlson M., 2015, ORG HS EG DB GENOME, DOI [10.18129/B9.bioc.org.Hs.eg.db, DOI 10.18129/B9.BIOC.ORG.HS.EG.DB]; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Couto FM, 2011, J BIOMED SEMANT, V2, DOI 10.1186/2041-1480-2-5; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Le DH, 2012, COMPUT BIOL CHEM, V37, P17, DOI 10.1016/j.compbiolchem.2012.02.004; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Geschwind DH, 2015, LANCET NEUROL, V14, P1109, DOI 10.1016/S1474-4422(15)00044-7; Krishnan A, 2016, NAT NEUROSCI, V19, P1454, DOI 10.1038/nn.4353; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Le D-H, 2015, KNOWLEDGE SYSTEMS EN, P577; Leitner Y, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00268; Leppa VM, 2016, AM J HUM GENET, V99, P540, DOI 10.1016/j.ajhg.2016.06.036; Lewis DD, 1998, LECT NOTES COMPUTER; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Liu B, 2015, J BIOMED INFORM, V57, P1, DOI 10.1016/j.jbi.2015.07.005; Lobo M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8565739; Luo P, 2016, IEEE INT C BIOINFORM, P1259, DOI 10.1109/BIBM.2016.7822699; Peng J, 2017, BMC GENOMICS, V18, DOI [10.1186/s12864-016-3397-4, DOI 10.1186/S12864-016-3397-4]; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sanders SJ, 2015, CURR OPIN GENET DEV, V33, P80, DOI 10.1016/j.gde.2015.10.002; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Smalter A, 2007, IEEE INT C BIOINFORM, P209, DOI 10.1109/BIBM.2007.47; Voineagu I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00738; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064	31	32	34	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208626	10.1371/journal.pone.0208626	http://dx.doi.org/10.1371/journal.pone.0208626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532199	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700040
J	Gonzalez, C; Jensen, EW; Gambus, PL; Vallverdu, M				Gonzalez, Carmen; Jensen, Erik W.; Gambus, Pedro L.; Vallverdu, Montserrat			Poincare plot analysis of cerebral blood flow signals: Feature extraction and classification methods for apnea detection	PLOS ONE			English	Article							HEART-RATE; ELECTROENCEPHALOGRAM; INFORMATION; DYNAMICS; INDEXES	Objective Rheoencephalography is a simple and inexpensive technique for cerebral blood flow assessment, however, it is not used in clinical practice since its correlation to clinical conditions has not yet been extensively proved. The present study investigates the ability of Poincare Plot descriptors from rheoencephalography signals to detect apneas in volunteers. Methods A group of 16 subjects participated in the study. Rheoencephalography data from baseline and apnea periods were recorded and Poincare Plot descriptors were extracted from the reconstructed attractors with different time lags (tau). Among the set of extracted features, those presenting significant differences between baseline and apnea recordings were used as inputs to four different classifiers to optimize the apnea detection. Results Three features showed significant differences between apnea and baseline signals: the Poincare Plot ratio (SDratio), its correlation (R) and the Complex Correlation Measure (CCM). Those differences were optimized for time lags smaller than those recommended in previous works for other biomedical signals, all of them being lower than the threshold established by the position of the inflection point in the CCM curves. The classifier showing the best performance was the classification tree, with 81% accuracy and an area under the curve of the receiver operating characteristic of 0.927. This performance was obtained using a single input parameter, either SDratio or R. Conclusions Poincare Plot features extracted from the attractors of rheoencephalographic signals were able to track cerebral blood flow changes provoked by breath holding. Even though further validation with independent datasets is needed, those results suggest that nonlinear analysis of rheoencephalography might be a useful approach to assess the correlation of cerebral impedance with clinical changes.	[Gonzalez, Carmen; Vallverdu, Montserrat] Univ Politecn Cataluna, CIBER BBN, Biomed Engn Res Ctr, Barcelona, Spain; [Gonzalez, Carmen; Jensen, Erik W.] Quantium Med Res & Dev Dept, Mataro, Spain; [Gambus, Pedro L.] Hosp Clin Barcelona, Dept Anaesthesiol, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona	Gonzalez, C (corresponding author), Univ Politecn Cataluna, CIBER BBN, Biomed Engn Res Ctr, Barcelona, Spain.; Gonzalez, C (corresponding author), Quantium Med Res & Dev Dept, Mataro, Spain.	cgz@quantiummedical.com	Gambus, Pedro/AAF-1278-2020	Gambus, Pedro/0000-0001-8802-6237; Gonzalez, Carmen/0000-0002-8584-8531	MINECO from Spanish Government [DPI2017-89827-R]; Regional Catalan Government (Generalitat de Catalunya, Spain) [DI-2015]; CIBER of Bioengineering, Biomaterials and Nanomedicine is an initiative of ISCIII; Quantium Medical	MINECO from Spanish Government(Spanish Government); Regional Catalan Government (Generalitat de Catalunya, Spain); CIBER of Bioengineering, Biomaterials and Nanomedicine is an initiative of ISCIII; Quantium Medical	This work was supported by MINECO (DPI2017-89827-R) from Spanish Government. CIBER of Bioengineering, Biomaterials and Nanomedicine is an initiative of ISCIII. This work was also funded within the Industrial PhD program by the Regional Catalan Government (DI-2015, Generalitat de Catalunya, Spain) in collaboration with Quantium Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Quantium Medical provided support in the form of salaries for authors CG and EWJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by MINECO (DPI2017-89827-R) from Spanish Government. CIBER of Bioengineering, Biomaterials and Nanomedicine is an initiative of ISCIII. This work was also developed under the scope of the Industrial PhD program by the Regional Catalan Government (DI-2015, Generalitat de Catalunya, Spain) in collaboration with Quantium Medical S.L.U.	ABARBANEL HDI, 1990, PHYS REV A, V41, P1782, DOI 10.1103/PhysRevA.41.1782; ALBANO AM, 1988, PHYS REV A, V38, P3017, DOI 10.1103/PhysRevA.38.3017; Bodo M., 2010, J ELECT BIOIMPEDANCE, V1, P18, DOI 10.5617/jeb.109; Breiman L., 1984, CLASSIFICATION REGRE; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Chen WT, 2007, IEEE T NEUR SYS REH, V15, P266, DOI 10.1109/TNSRE.2007.897025; Contreras P., 2006, PHYSIOL MEAS, V28, P85; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; D'Addio G, 2004, COMPUT CARDIOL, V31, P457, DOI 10.1109/CIC.2004.1442973; Dimitriev DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146131; Ebrahimzadeh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081896; Entezarimaleki R., 2009, J CONVERG INF TECHNO, V4, P94, DOI DOI 10.4156/JCIT.VOL4.ISSUE3.14; Fan RE, 2005, J MACH LEARN RES, V6, P1889; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Goshvarpour A, 2011, DIGIT SIGNAL PROCESS, V21, P208, DOI 10.1016/j.dsp.2010.06.015; Hayashi K, 2015, ANAESTHESIA, V70, P310, DOI 10.1111/anae.12885; Hayashi K, 2015, CLIN NEUROPHYSIOL, V126, P404, DOI 10.1016/j.clinph.2014.04.019; Hoshi RA, 2013, AUTON NEUROSCI-BASIC, V177, P271, DOI 10.1016/j.autneu.2013.05.004; Hoyer D, 1997, IEEE ENG MED BIOL, V16, P31, DOI 10.1109/51.566150; Karmakar CK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-17; Karmakar CK, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-17; Kastrup A, 1999, AM J NEURORADIOL, V20, P1233; Kastrup A, 2001, MAGN RESON IMAGING, V19, P13, DOI 10.1016/S0730-725X(01)00227-2; Kenji K, 1992, P 9 INT WORKSH MACH, P249, DOI DOI 10.1016/B978-1-55860-247-2.50037-1; King G. P., 1987, Nuclear Physics B, Proceedings Supplements, V2, P379, DOI 10.1016/0920-5632(87)90029-6; Koichubekov B, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19100523; Lerma C, 2003, CLIN PHYSIOL FUNCT I, V23, P72; Lovett Doust J W, 1974, Eur Neurol, V12, P47, DOI 10.1159/000114604; MONTGOMERY LD, 1995, BIOL PSYCHOL, V40, P143, DOI 10.1016/0301-0511(95)05117-1; Moskalenko YE., 2015, INT J ADV LIFE SCI T, V2, P1, DOI [10.18488/journal.72/2015.2.1/72.1.1.15, DOI 10.18488/JOURNAL.72/2015.2.1/72.1.1.15]; Piskorski J, 2005, COMPUT METH SCI TECH, V11, P39, DOI [DOI 10.12921/CMST.2005.11.01.39-48, 10.12921/cmst.2005.11.01.39-48]; Son HJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7862539; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Thakre Tushar P, 2006, BMC Cardiovasc Disord, V6, P27, DOI 10.1186/1471-2261-6-27; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; Voss A, 2010, METHOD INFORM MED, V49, P511, DOI 10.3414/ME09-02-0050; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308; WOO MA, 1992, AM HEART J, V123, P704, DOI 10.1016/0002-8703(92)90510-3; Xiong A, 2014, ADV INTELL SYST COMP, V2, P805, DOI DOI 10.1007/978-3-319-05582-4_71; Zauner A, 1997, HEAD INJURY PATHOPHY, P90	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208642	10.1371/journal.pone.0208642	http://dx.doi.org/10.1371/journal.pone.0208642			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532232	Green Submitted, gold, Green Published			2022-12-26	WOS:000452640900030
J	Saul, J; Bachman, G; Allen, S; Toiv, NF; Cooney, C; Beamon, T				Saul, Janet; Bachman, Gretchen; Allen, Shannon; Toiv, Nora F.; Cooney, Caroline; Beamon, Ta'Adhmeeka			The DREAMS core package of interventions: A comprehensive approach to preventing HIV among adolescent girls and young women	PLOS ONE			English	Article							INTIMATE-PARTNER VIOLENCE; FEMALE SEX WORKERS; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; PREEXPOSURE PROPHYLAXIS; MALE CIRCUMCISION; POSTEXPOSURE PROPHYLAXIS; RISK-REDUCTION; EDUCATION INTERVENTIONS; SOCIAL PROTECTION	In sub-Saharan Africa, adolescent girls and young women (AGYW) are 5 to 14 times more likely to be infected with HIV than their male peers. Every day, more than 750 AGYW are infected with HIV. Many factors make girls and young women particularly vulnerable to HIV, including gender-based violence, exclusion from economic opportunities, and a lack of access to secondary school. The President's Emergency Plan for AIDS Relief (PEPFAR) is dedicating significant resources through the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) partnership to impact the lives of women and girls based on PEPFAR's mission to help countries achieve epidemic control of HIV/AIDS. The data show that new HIV infections must be reduced in AGYW, or the global community risks losing the extensive progress made towards reaching epidemic control. With support from PEPFAR and private sector partners-the Bill & Melinda Gates Foundation, Gilead Sciences, Girl Effect, Johnson & Johnson and ViiV Healthcare, DREAMS works together with partner governments to deliver a core package of interventions that combines evidence-based approaches that go beyond the health sector, addressing the structural drivers that directly and indirectly increase girls' HIV risk. Not only is DREAMS an effort to reduce new HIV infections, but it aims to reduce other critical vulnerabilities such as gender-based violence. When girls and young women thrive, the effects are felt throughout their families, communities and countries.	[Saul, Janet; Bachman, Gretchen; Allen, Shannon; Toiv, Nora F.; Cooney, Caroline; Beamon, Ta'Adhmeeka] US Dept State, Off US Global AIDS Coordinator & Hlth Diplomacy, Washington, DC 20520 USA		Saul, J (corresponding author), US Dept State, Off US Global AIDS Coordinator & Hlth Diplomacy, Washington, DC 20520 USA.	jsaul@cdc.gov			US President's Emergency Plan For AIDS Relief (PEPFAR); Bill & Melinda Gates Foundation [OPP1136774]	US President's Emergency Plan For AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This is an overview paper describing a program, not a research paper. The program described (DREAMS) was funded by the US President's Emergency Plan For AIDS Relief (PEPFAR). The authors of the manuscript all work on the PEPFAR DREAMS program. Funding for the publication of this special collection on DREAMS was provided by the Bill & Melinda Gates Foundation, Grant number OPP1136774.	Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; [Anonymous], 2016, TECHN BRIEF; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974; Bandiera O., 2012, EMPOWERING ADOLESCEN; Behrman JA, 2015, SOC SCI MED, V127, P108, DOI 10.1016/j.socscimed.2014.06.034; Benn P, 2011, INT J STD AIDS, V22, P695, DOI 10.1258/ijsa.2011.171011; Chin HB, 2012, AM J PREV MED, V42, P272, DOI 10.1016/j.amepre.2011.11.006; Cho H, 2011, J ADOLESCENT HEALTH, V48, P523, DOI 10.1016/j.jadohealth.2010.08.007; Christofides NJ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18585; Cluver LD, 2016, JAIDS-J ACQ IMM DEF, V72, P96, DOI 10.1097/QAI.0000000000000938; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Neve JW, 2015, LANCET GLOB HEALTH, V3, pE470, DOI 10.1016/S2214-109X(15)00087-X; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Denno DM, 2012, J ADOLESCENT HEALTH, V51, P106, DOI 10.1016/j.jadohealth.2012.01.004; Dunbar MS, 2010, J PREV INTERV COMMUN, V38, P147, DOI 10.1080/10852351003640849; Erickson M, 2015, INT J GYNECOL OBSTET, V131, P91, DOI 10.1016/j.ijgo.2015.04.029; Erulkar A, 2005, EVALUATION SAVINGS M; Erulkar A, 2013, VULNERABLE CHILD YOU, V8, P182, DOI 10.1080/17450128.2012.736645; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Gibbs A, 2012, J INT AIDS SOC, V15, P187; Gibbs A, 2016, AJAR-AFR J AIDS RES, V15, P141, DOI 10.2989/16085906.2016.1204331; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gupta J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-46; Haberland N, 2015, J ADOLESCENT HEALTH, V56, pS15, DOI 10.1016/j.jadohealth.2014.08.013; Haberland NA, 2015, INT PERSPECT SEX R H, V41, P31, DOI 10.1363/4103115; Hallfors D, 2011, AM J PUBLIC HEALTH, V101, P1082, DOI 10.2105/AJPH.2010.300042; Hallfors DD, 2015, J ADOLESCENT HEALTH, V56, P79, DOI 10.1016/j.jadohealth.2014.09.004; Hallman K, 2007, ENHANCING FINANCIAL; Hallman KR, 2011, SIYAKHA BUILDING EC; Hamlyn E, 2007, OCCUP MED-OXFORD, V57, P329, DOI 10.1093/occmed/kqm046; Hanscom B, 2016, JAIDS-J ACQ IMM DEF, V73, P606, DOI 10.1097/QAI.0000000000001160; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hargreaves JB, 2006, T GIRL POWER IMPACT; HC3, 2017, STRAT COMM FRAM HORM; ICAP, 2016, ZAMB POP BAS HIV IMP; ICAP, 2016, MAL POP BAS HIV IMP; ICAP, 2016, ZIMB POP BAS HIV IMP; Jewkes R., 2012, Journal of AIDS and Clinical Research, V3, P158; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kahn JO, 2001, J INFECT DIS, V183, P707, DOI 10.1086/318829; Kayeyi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033652; Kennedy CE, 2014, AIDS CARE, V26, P659, DOI 10.1080/09540121.2013.845287; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kirby D, 2006, WHO TECH REP SER, V938, P103; Kirby DB, 2007, J ADOLESCENT HEALTH, V40, P206, DOI 10.1016/j.jadohealth.2006.11.143; Knopf AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173225; Krieger JN, 2012, WORLD J UROL, V30, P3, DOI 10.1007/s00345-011-0696-x; Kyegombe N, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25082; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Limaye RJ, 2015, INT Q COMMUNITY HEAL, V36, P53, DOI 10.1177/0272684X15615446; Lippman SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078208; Mack N, 2015, AFR J REPROD HEALTH, V19, P54; Mason-Jones AJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006417.pub3; Mavedzenge SN, 2014, JAIDS-J ACQ IMM DEF, V66, pS154, DOI 10.1097/QAI.0000000000000178; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Murnane PM, 2013, AIDS, V27, P2155, DOI 10.1097/QAD.0b013e3283629037; Neal SE, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-13; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Okigbo CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129286; Pettifor A, 2018, CURR OPIN HIV AIDS, V13, P265, DOI [10.1097/coh.0000000000000453, 10.1097/COH.0000000000000453]; Pettifor A, 2013, JAIDS-J ACQ IMM DEF, V63, pS155, DOI 10.1097/QAI.0b013e31829871fb; Pettifor AE, 2008, INT J EPIDEMIOL, V37, P1266, DOI 10.1093/ije/dyn131; Phillips SJ, 2016, INT J GYNECOL OBSTET, V132, P1, DOI 10.1016/j.ijgo.2015.10.005; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Roland ME, 2011, CLIN INFECT DIS, V53, P76, DOI 10.1093/cid/cir333; Rosenberg NE, 2013, AIDS, V27, P2765, DOI 10.1097/01.aids.0000432454.68357.6a; Rotheram-Borus MJ, 2012, AIDS BEHAV, V16, P1133, DOI 10.1007/s10461-011-0007-y; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; Spangaro J, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0047-4; Ssewamala FM, 2010, AM J PUBLIC HEALTH, V100, P483, DOI 10.2105/AJPH.2008.158840; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; Sumner SA, 2015, MMWR-MORBID MORTAL W, V64, P565; Taljaard D., 2014, MALE CIRCUMCISION AS; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Toska E, 2016, AJAR-AFR J AIDS RES, V15, P123, DOI 10.2989/16085906.2016.1194299; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; U. S. President's Emergency Plan for AIDS Relief (PEPFAR), 2016, PEPFAR 2016 ANN REP; UN, 2015, POP FACTS YOUTH POP; UNAIDS, 2016, HIV PREV AD GIRLS YO; UNAIDS, 2015, EMP YOUNG WOM AD GIR; UNAIDS A, TREND NEW HIV INF 20; UNESCO, 2012, WORLD ATL GEND EQ ED; Vyas S, 2009, J INT DEV, V21, P577, DOI 10.1002/jid.1500; Wagman JA, 2015, LANCET GLOB HEALTH, V3, pE23, DOI 10.1016/S2214-109X(14)70344-4; Wang B, 2014, AIDS EDUC PREV, V26, P500, DOI 10.1521/aeap.2014.26.6.500; WELLER SC, 1993, SOC SCI MED, V36, P1635, DOI 10.1016/0277-9536(93)90352-5; WHO, HLTH CAR WOM SUBJ IN; WHO, 2015, GUID START ANT PREEX; Wight D, 2013, J ADOLESCENT HEALTH, V52, P4, DOI 10.1016/j.jadohealth.2012.04.014; Wodon Q, 2017, EC IMPACTS CHILD MAR; Wolfson, 2015, GENDER DIFFERENCES E, DOI [10.1596/1813-9450-6545, DOI 10.1596/1813-9450-6545]; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2011, PREVENTION TREATMENT; Yam EA, 2016, CONTRACEPTION, V93, P222, DOI 10.1016/j.contraception.2015.11.010; Yam EA, 2013, INT PERSPECT SEX R H, V39, P69, DOI 10.1363/3906913; Young TN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002835.pub3	105	115	116	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208167	10.1371/journal.pone.0208167	http://dx.doi.org/10.1371/journal.pone.0208167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6IO	30532210	Green Submitted, Green Published, gold			2022-12-26	WOS:000452640900009
J	Rau, MJ; Ackleson, SG; Smith, GB				Rau, Matthew J.; Ackleson, Steven G.; Smith, Geoffrey B.			Effects of turbulent aggregation on clay floc breakup and implications for the oceanic environment	PLOS ONE			English	Article							PARTICLE-SIZE; FRACTAL DIMENSIONS; MARINE SNOW; STRENGTH; FLOCCULATION; COAGULATION; DISAGGREGATION; ATTENUATION; EXISTENCE; ABUNDANCE	Understanding how turbulence impacts marine floc formation and breakup is key to predicting particulate carbon transport in the ocean. While floc formation and sinking rate has been studied in the laboratory and in-situ, the breakup response to turbulence has attracted less attention. To address this problem, the breakup response of bentonite clay particles flocculated in salt water was studied experimentally. Flocs were grown in a large aggregation tank under unmixed and mixed aggregation conditions and then subjected to turbulent pipe flow. Particle size was quantified using microscope imaging and in-situ measurements obtained from standard optical oceanographic instruments; a Sequoia Scientific LISST-100X and two WET Labs ac-9 spectrophotometers. The LISST instrument was found to capture the breakup response of flocs to turbulent energy, though the resulting particle size spectra appear to have underestimated the largest floc lengthscales in the flow while overestimating the abundance of primary particles. Floc breakup and the resulting shift towards smaller particles caused an increase in spectral slope of attenuation as measured by the ac-9 instruments. The Kolmogorov lengthscale was not found to have a limiting effect on floc size in these experiments. While the flocs were found to decrease in overall strength over the course of the two-month experimental time period, repeatable breakup responses to turbulence exposure were observed. Hydrodynamic conditions during floc formation were found to have a large influence on floc strength and breakup response. A non-constant strength exponent was observed for flocs formed with more energetic mixing. Increased turbulence from mixing during aggregation was found to increase floc fractal dimension and apparent density, resulting in a shift in the breakup relationships to higher turbulence dissipation rates. The results suggest that marine particle aggregation and vertical carbon transport concepts should include the turbulence energy responsible for aggregate formation and the resulting impact on floc strength, density, and the disruption potential.	[Rau, Matthew J.] Penn State Univ, Mech & Nucl Engn Dept, University Pk, PA 16802 USA; [Ackleson, Steven G.; Smith, Geoffrey B.] US Naval Res Lab, Remote Sensing Div, Washington, DC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Defense; United States Navy; Naval Research Laboratory	Rau, MJ (corresponding author), Penn State Univ, Mech & Nucl Engn Dept, University Pk, PA 16802 USA.	mjr79@engr.psu.edu		Rau, Matthew/0000-0001-7346-9262	United States Naval Research Laboratory; National Research Council; Naval Research Laboratory	United States Naval Research Laboratory; National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Naval Research Laboratory(United States Department of Defense)	This work was supported by the United States Naval Research Laboratory and was performed while the first author held a National Research Council Research Associateship award through the United States National Academies of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the National Research Council and the Naval Research Laboratory for the financial support necessary to conduct this work.	Ackleson SG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003214; Agrawal YC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004403; Agrawal YC, 2000, MAR GEOL, V168, P89, DOI 10.1016/S0025-3227(00)00044-X; ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; ALLDREDGE AL, 1990, LIMNOL OCEANOGR, V35, P1415, DOI 10.4319/lo.1990.35.7.1415; Bache DH, 2004, CHEM ENG SCI, V59, P2521, DOI 10.1016/j.ces.2004.01.055; BAKEWELL HP, 1967, PHYS FLUIDS, V10, P1880, DOI 10.1063/1.1762382; Bevington PR., 2002, DATA REDUCTION ERROR; Boss E, 2001, J GEOPHYS RES-OCEANS, V106, P9509, DOI 10.1029/2000JC900077; Bouyer D, 2001, CHEM ENG RES DES, V79, P1017, DOI 10.1205/02638760152721587; Braithwaite KM, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007094; Burd AB, 2009, ANNU REV MAR SCI, V1, P65, DOI 10.1146/annurev.marine.010908.163904; Cross J, 2013, MAR GEOL, V343, P29, DOI 10.1016/j.margeo.2013.06.014; DIEHL P, 1980, OCEANOL ACTA, V3, P89; Dubovskii PB, 1996, MATH METHOD APPL SCI, V19, P571, DOI 10.1002/(SICI)1099-1476(19960510)19:7<571::AID-MMA790>3.0.CO;2-Q; EDZWALD JK, 1974, ENVIRON SCI TECHNOL, V8, P58, DOI 10.1021/es60086a003; Ehrl L, 2009, J PHYS CHEM B, V113, P10587, DOI 10.1021/jp903557m; Eppley RW, 1967, J EXP MAR BIOL ECOL, V1, P191, DOI [10.1016/0022-0981(67)90014-7, DOI 10.1016/0022-0981(67)90014-7]; Flesch JC, 1999, AICHE J, V45, P1114, DOI 10.1002/aic.690450518; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; FRANCOIS RJ, 1987, WATER RES, V21, P1023, DOI 10.1016/0043-1354(87)90023-6; FRANCOIS RJ, 1987, WATER RES, V21, P523, DOI 10.1016/0043-1354(87)90060-1; Friedlander SK, 1977, SMOKE DUST HAZE FUND; Fugate DC, 2003, ESTUAR COAST SHELF S, V58, P389, DOI 10.1016/S0272-7714(03)00107-0; GLASGOW LA, 1980, IND ENG CHEM FUND, V19, P148, DOI 10.1021/i160074a003; Graham RM, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007887; HAWLEY N, 1982, J GEOPHYS RES-OCEANS, V87, P9489, DOI 10.1029/JC087iC12p09489; HINZE JO, 1955, AICHE J, V1, P289, DOI 10.1002/aic.690010303; Hsu JP, 1983, PARTICUL SCI TECHNOL, V1, P205; Jarvis P, 2005, WATER RES, V39, P3121, DOI 10.1016/j.watres.2005.05.022; JEFFREY DJ, 1982, ADV COLLOID INTERFAC, V17, P213, DOI 10.1016/0001-8686(82)80020-1; JIANG Q, 1991, ENVIRON SCI TECHNOL, V25, P2031, DOI 10.1021/es00024a007; Johnson CP, 1996, ENVIRON SCI TECHNOL, V30, P1911, DOI 10.1021/es950604g; Kramer TA, 1999, J COLLOID INTERF SCI, V216, P116, DOI 10.1006/jcis.1999.6305; Lee C, 2004, ADV COLLOID INTERFAC, V112, P49, DOI 10.1016/j.cis.2004.07.001; LEENTVAAR J, 1983, WATER RES, V17, P895, DOI 10.1016/0043-1354(83)90163-X; Li T, 2007, INT J MINER PROCESS, V82, P23, DOI 10.1016/j.minpro.2006.09.012; LOGAN BE, 1990, LIMNOL OCEANOGR, V35, P130, DOI 10.4319/lo.1990.35.1.0130; LOGAN BE, 1995, WATER RES, V29, P443, DOI 10.1016/0043-1354(94)00186-B; MCCAVE IN, 1984, DEEP-SEA RES, V31, P329, DOI 10.1016/0198-0149(84)90088-8; PANDYA JD, 1982, J COLLOID INTERF SCI, V90, P517, DOI 10.1016/0021-9797(82)90317-4; PARKER DS, 1972, J SANIT ENG DIV ASCE, V98, P79; PASSOW U, 1994, DEEP-SEA RES PT I, V41, P335, DOI 10.1016/0967-0637(94)90007-8; Paul E. L., 2003, HDB IND MIXING SCI P; Pegau S, 2003, NASA TECH MEMO, VIV; Qing JA, 1996, J AM WATER WORKS ASS, V88, P100; Ramkrishna D., 2000, POPULATION BALANCES; Ramkrishna D, 1985, REV CHEM ENG, V3, P49, DOI [10.1515/REVCE.1985.3.1.49, DOI 10.1515/REVCE.1985.3.1.49]; SAFFMAN PG, 1956, J FLUID MECH, V1, P16, DOI 10.1017/S0022112056000020; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlichting H., 1955, BOUNDARY LAYER THEOR, V7; Shanks AL, 2002, CONT SHELF RES, V22, P2045, DOI 10.1016/S0278-4343(02)00015-8; Slade WH, 2011, OPT EXPRESS, V19, P7945, DOI 10.1364/OE.19.007945; Smith S. J., 2011, CONTINENTAL SHELF RE, V31, P50; Spicer PT, 1996, AICHE J, V42, P1612, DOI 10.1002/aic.690420612; Spicer PT, 1998, POWDER TECHNOL, V97, P26, DOI 10.1016/S0032-5910(97)03389-5; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; TAMBO N, 1979, WATER RES, V13, P421, DOI 10.1016/0043-1354(79)90034-4; Thorpe S. A, 2005, TURBULENT OCEAN; Van Olphen H., 1977, GEOLOGISTS SOIL SCI, V2nd; WHITE WH, 1980, P AM MATH SOC, V80, P273, DOI 10.2307/2042961; Yang MY, 2014, J CONTROL RELEASE, V193, P228, DOI 10.1016/j.jconrel.2014.04.055; Zhu ZF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148895	65	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207809	10.1371/journal.pone.0207809	http://dx.doi.org/10.1371/journal.pone.0207809			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521537	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600020
J	Scheibler, AG; Gotschi, T; Widmer, J; Holenstein, C; Steffen, T; Camenzind, RS; Snedeker, JG; Farshad, M				Scheibler, Anne-Gita; Gotschi, Tobias; Widmer, Jonas; Holenstein, Claude; Steffen, Thomas; Camenzind, Roland S.; Snedeker, Jess G.; Farshad, Mazda			Feasibility of the annulus fibrosus repair with in situ gelating hydrogels - A biomechanical study	PLOS ONE			English	Article							CROSS-LINKING; LUMBAR SPINE; DISC; THERAPIES; SEALANTS; COLLAGEN; INJURY; BIOMATERIALS; DISKECTOMY; MECHANICS	The surgical standard of care for lumbar discectomy leaves the annulus fibrosus (AF) defect unrepaired, despite considerable risk for a recurrent herniation. Identification of a viable defect repair strategy has until now been elusive. The scope of this ex vivo biomechanical study was to evaluate crosslinking hydrogels as potentially promising AF defect sealants, and provide a baseline for their use in combination with collagen scaffolds that restore disc volume. This study directly compared genipin crosslinked fibrin hydrogel (FibGen) as a promising preclinical candidate against a clinically available adhesive composed of glutaraldehyde and albumin (BioGlue). Forty-two bovine coccygeal functional spine units (FSU) were randomly allocated into four groups, namely untreated (control, n = 12), repaired with either one of the tested hydrogels (BioGlue, n = 12; FibGen, n = 12), or FibGen used in combination with a collagen hydrogel scaffold (FibGen+Scaffold, n = 6). All specimens underwent a moderate mechanical testing protocol in intact, injured and repaired states. After completion of the moderate testing protocol, the samples underwent a ramp-to-failure test. Lumbar discectomy destabilized the FSU as quantified by increased torsional range of motion (28.0 degrees (19.1, 45.1) vs. 41.39 degrees (27.3, 84.9), p<0.001), torsional neutral zone (3.1 degrees (1.2, 7.7) vs. 4.8 degrees (2.1, 12.1), Z = -3.49, p < 0.001), hysteresis(24.4 J (12.8, 76.0) vs. 27.6 J (16.4, 54.4), Z = -2.61, p = 0.009), with loss of both disc height (7.0 mm (5.0, 10.5) vs 6.1 mm (4.0, 9.3), Z = -5.16, p < 0.001) and torsional stiffness (0.76 Nmdeg(-1) (0.38, 1.07) vs. 0.66 Nmdeg(-1) (0.38, 0.97), Z = -3.98, p < 0.001). Most FibGen repaired AF endured the entire testing procedure whereas only a minority of BioGlue repaired AF and all FibGen+Scaffold repaired AF failed (6/10 vs. 3/12 vs. 0/6 respectively, p = 0.041). Both BioGlue and FibGen +Scaffold repaired AF partially restored disc height (0.47 mm (0.07, 2.41), p = 0.048 and 1.52 mm (0.41, 2.57), p = 0.021 respectively) compared to sham treatment (0.08 mm (-0.63, 0.88)) whereas FibGen-only repaired AF had no such effect (0.04 mm (-0.73, 1.13), U = 48.0, p = 1). The AF injury model demonstrated considerable change of FSU mechanics that could be partially restored by use of an AF sealant. While inclusion of a volumetric collagen scaffold led to repair failure, use of FibGen alone demonstrated clinically relevant promise for prevention of mechanical reherniation, outperforming an FDA approved sealant in this ex vivo test series.	[Scheibler, Anne-Gita; Gotschi, Tobias; Widmer, Jonas; Holenstein, Claude; Camenzind, Roland S.; Snedeker, Jess G.; Farshad, Mazda] Balgrist Univ Hosp, Dept Orthoped, Zurich, Switzerland; [Scheibler, Anne-Gita; Gotschi, Tobias; Widmer, Jonas; Holenstein, Claude; Snedeker, Jess G.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Steffen, Thomas] Univ Zurich, CABMM, Musculoskeletal Res Unit MSRU, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Farshad, M (corresponding author), Balgrist Univ Hosp, Dept Orthoped, Zurich, Switzerland.	mazda.farshad@balgrist.ch	Snedeker, Jess G./X-2098-2019; Snedeker, Jess/C-2105-2009; Camenzind, Roland S/M-1778-2018	Snedeker, Jess G./0000-0002-8115-0275; Snedeker, Jess/0000-0002-8115-0275; Camenzind, Roland S/0000-0002-9096-2910; Widmer, Jonas/0000-0003-3676-008X; Farshad, Mazda/0000-0002-7190-1127	Brian Park	Brian Park	The authors gratefully acknowledge the contribution of Brian Park for his support with the mechanical test set-up and Nikola Vulin for his contribution to the mechanical testing. They also thank Philipp Gaehwiler for his technical support during radiological imaging.	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Annabi N, 2015, EUR J PHARM BIOPHARM, V95, P27, DOI 10.1016/j.ejpb.2015.05.022; Bouma GJ, 2013, EUR SPINE J, V22, P1030, DOI 10.1007/s00586-013-2656-1; Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z; Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x; Camenzind RS, 2018, EX VIVO ANIMAL STUDY, P1, DOI [10.1007/s11999.0000000000000247, DOI 10.1007/S11999.0000000000000247]; Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016; Chao H, 2003, BIOGLUE ALBUMIN GLUT, P500; Chen I H, 1994, J Clin Neurosci, V1, P121, DOI 10.1016/0967-5868(94)90087-6; Cruz MA, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036623; Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Epstein NE, 2010, SPINE J, V10, P1065, DOI 10.1016/j.spinee.2010.09.017; Fessel G, 2014, ACTA BIOMATER, V10, P1897, DOI 10.1016/j.actbio.2013.12.048; Fessel G, 2012, J SHOULDER ELB SURG, V21, P209, DOI 10.1016/j.jse.2011.10.002; Georgakoudi I, 2002, CANCER RES, V62, P682; Gray DT, 2006, SPINE, V31, P1957, DOI 10.1097/01.brs.0000229148.63418.c1; Guterl CC, 2014, TISSUE ENG PT A, V20, P2536, DOI [10.1089/ten.tea.2012.0714, 10.1089/ten.TEA.2012.0714]; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Kuang X, 2016, POLYMER, V84, P1, DOI 10.1016/j.polymer.2015.12.033; Likhitpanichkul M, 2014, EUR CELLS MATER, P367, DOI [10.1146/annurev-immunol-032713-120240.Microglia, DOI 10.1146/ANNUREV-IMMUNOL-032713-120240.MICROGLIA]; Long RG, 2018, J TISSUE ENG REGEN M, V12, pE727, DOI [10.1002/term.2463, 10.1002/term.2356]; Long RG, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032353; Long RG, 2016, ACTA BIOMATER, V30, P116, DOI 10.1016/j.actbio.2015.11.015; Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001; Muzzarelli RAA, 2015, MAR DRUGS, V13, P7314, DOI 10.3390/md13127068; OSHIMA H, 1993, J ORTHOP RES, V11, P332, DOI 10.1002/jor.1100110304; PANJABI MM, 1984, SPINE, V9, P707, DOI 10.1097/00007632-198410000-00010; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Pedersen TB, 2012, ANN THORAC SURG, V94, P234, DOI 10.1016/j.athoracsur.2012.03.050; Popovich JM, 2011, SPINE, V36, P939, DOI 10.1097/BRS.0b013e3181e8b1d5; Quint U, 2008, EUR SPINE J, V17, P1705, DOI 10.1007/s00586-008-0787-6; Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHULTZ A, 1982, J BONE JOINT SURG AM, V64, P713, DOI 10.2106/00004623-198264050-00008; Slusarewicz P, 2010, OPTIMIZATION PROTEIN, V36, P7; Stylli SS, 2004, J CLIN NEUROSCI, V11, P631, DOI 10.1016/j.jocn.2004.03.018; Sunni N, 2014, P I MECH ENG H, V228, P1100, DOI 10.1177/0954411914556789; Suzuki S, 2014, GEN THORAC CARDIOVAS, V62, P207, DOI 10.1007/s11748-013-0343-0; Taruilli AW, 2007, NEUROL CLIN, V25, P387, DOI 10.1016/j.ncl.2007.01.008; Tsilimigras DI, 2017, J THORAC DIS, V9, P568, DOI 10.21037/jtd.2017.02.57; Weinstein JN, 2008, SPINE, V33, P2789, DOI 10.1097/BRS.0b013e31818ed8f4; Wilke H J, 1994, Eur Spine J, V3, P91, DOI 10.1007/BF02221446; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x; Wilke HJ, 2003, SPINE, V28, P2585, DOI 10.1097/01.BRS.0000096673.16363.C7; Wilke HJ, 1996, J ORTHOPAED RES, V14, P500, DOI 10.1002/jor.1100140321	47	12	13	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208460	10.1371/journal.pone.0208460	http://dx.doi.org/10.1371/journal.pone.0208460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521633	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000452307600073
J	Grum, T; Brhane, E				Grum, Teklit; Brhane, Ermyas			Magnitude and factors associated with late antenatal care booking on first visit among pregnant women in public health centers in central zone of Tigray Region, Ethiopia: A cross sectional study	PLOS ONE			English	Article								Background Antenatal care (ANC) is a care given for pregnant women and is a good opportunity to deliver maternal health interventions. Even though pregnant women should start their first antenatal care within 12 weeks of gestational age, many pregnant women start their first ANC late. So, the aim of this study is to determine magnitude of late ANC booking at first visit and factors associated with it. Methods Institutional based cross sectional study design was conducted in central zone of Tigray Region, Ethiopia from November 1/2017 to January 30/2018 among total of 632 pregnant women. Stratified multi stage cluster sampling method was used to select health centers and systematic random sampling technique was used during the selection of study units. Data were collected using interview administer questionnaire by face to face. The collected data were entered into EPI info-7. Later on, it was exported to STATA-14 for further analysis. Proportion was used to estimate the magnitude of late ANC booking. Bivariable and multi-variable analysis were done to see factors associated with the magnitude of late ANC booking. Results The magnitude of late ANC booking at first visit were 85.67% (95%, CI: 82.89, 88.45). Factors that were independently associated with the late ANC booking at first visit in multivariable analysis were; having home delivery in previous delivery (AOR = 2.2, 95%, CI: 1.1, 4.49), women who had no previous ANC follow up (AOR = 3.43, 95%, CI: 1.32, 8.92) and women with poor knowledge about the advantage and service availability of ANC (AOR = 3.9, 95%, CI: 1.83, 8.29). Conclusion In summary, most of pregnant women were not started their first ANC at the recommended time. Home delivery and history of ANC in previous pregnancy as well as women with poor knowledge about ANC were associated with late ANC booking at first visit. Health workers should work on avoiding home delivery and increasing the knowledge of pregnant women on ANC may help on reducing late ANC booking at first visit.	[Grum, Teklit] Aksum Univ, Coll Hlth Sci, Dept Reprod Hlth, Aksum, Ethiopia; [Brhane, Ermyas] Aksum Univ, Coll Hlth Sci, Dept Human Nutr, Aksum, Ethiopia		Grum, T (corresponding author), Aksum Univ, Coll Hlth Sci, Dept Reprod Hlth, Aksum, Ethiopia.	teklitvip@gmail.com		Grum, Teklit/0000-0003-4541-471X	Health sciences College, Aksum University	Health sciences College, Aksum University	This study was funded by Health sciences College, Aksum University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekanle DA, 2008, ONLINE J HLTH ALLIED, V7, P1; [Anonymous], 2012, ETHIOPIA DEMOGRAPHIC; Aung TZ., 2017, INT J COMMUNITY MED, V3, P900; Central Statistical Agency, 2007, POP HOUS CENS REP AD; Central Statistical Agency [Ethiopia] ICF, 2016, ETH DEM HLTH SURV 20; Ejeta E, 2017, PAN AFRICAN MED J; Federal democratic republic of Ethiopia Ministry of Health, 2015, HLTH SECT TRANSF PLA; Geta M. B., 2017, EARLY INITIATION ANT; Gudayu TW, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-287; Kisuule I, 2013, KAMPALA UGANDA BMC P, V13, P121, DOI DOI 10.1371/J0URNAL.P0NE.0101893; Lerebo W, 2015, CLIN MOTHER CHILD HL, V12; Lilungulu AG., 2016, TANZANIA J PEDIAT NE, V4, P8; Maano NE, 2017, INT J MED MUSHROOMS, V5, P37, DOI [10.14419/ijm.v5i1.7152, DOI 10.14419/IJM.V5I1.7152]; Okhiai O., 2015, INT J PUBLIC HEAL RE, V3, P331; Tekelab T., 2014, SCI TECHNOL ARTS RES, V3, P108, DOI [10.4314/star.v3i1.17, DOI 10.4314/STAR.V3I1.17]; Tesfaye G, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0412-4; WHO, 2016, WHO REC ANT CAR POST	17	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207922	10.1371/journal.pone.0207922	http://dx.doi.org/10.1371/journal.pone.0207922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517182	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400073
J	Causse, SZ; Marcion, G; Chanteloup, G; Uyanik, B; Boudesco, C; Grigorash, BB; Douhard, R; Dias, AMM; Dumetier, B; Dondaine, L; Gozzi, GJ; Moussay, E; Paggetti, J; Mirjolet, C; de Thonel, A; Dubrez, L; Demidov, ON; Gobbo, J; Garrido, C				Causse, Sebastien Z.; Marcion, Guillaume; Chanteloup, Gaetan; Uyanik, Burhan; Boudesco, Christophe; Grigorash, Bogdan B.; Douhard, Romain; Dias, Alexandre M. M.; Dumetier, Baptiste; Dondaine, Lucile; Gozzi, Gustavo J.; Moussay, Etienne; Paggetti, Jerome; Mirjolet, Celine; de Thonel, Aurelie; Dubrez, Laurence; Demidov, Oleg N.; Gobbo, Jessica; Garrido, Carmen			HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells	ONCOGENE			English	Article							HEAT-SHOCK PROTEINS; EXPRESSION; HSP70	A multicenter clinical study demonstrated the presence of a loss-of-function HSP110 mutation in about 15% of colorectal cancers, which resulted from an alternative splicing and was produced at the detriment of wild-type HSP110. Patients expressing low levels of wild-type HSP110 had excellent outcomes (i.e. response to an oxaliplatin-based chemotherapy). Here, we show in vitro, in vivo, and in patients' biopsies that HSP110 co-localizes with DNA damage (gamma-H2AX). In colorectal cancer cells, HSP110 translocates into the nucleus upon treatment with genotoxic chemotherapy such as oxaliplatin. Furthermore, we show that HSP110 interacts with the Ku70/Ku80 heterodimer, an essential element of the nonhomologous end joining (NHEJ) repair machinery. We also demonstrate by evaluating the resolved 53BP1 foci that depletion in HSP110 impairs repair steps of the NHEJ pathway, which is associated with an increase in DNA double-strand breaks and in the cells' sensitivity to oxaliplatin. HSP110-depleted cells sensitization to oxaliplatin-induced DNA damage is abolished upon re-expression of HSP110. Confirming a role for HSP110 in DNA non-homologous repair, SCR7 and NU7026, two inhibitors of the NHEJ pathway, circumvents HSP110-induced resistance to chemotherapy. In conclusion, HSP110 through its interaction with the Ku70/80 heterodimer may participate in DNA repair, thereby inducing a protection against genotoxic therapy.	[Causse, Sebastien Z.; Marcion, Guillaume; Chanteloup, Gaetan; Uyanik, Burhan; Boudesco, Christophe; Grigorash, Bogdan B.; Douhard, Romain; Dias, Alexandre M. M.; Dumetier, Baptiste; Dondaine, Lucile; Gozzi, Gustavo J.; Dubrez, Laurence; Demidov, Oleg N.; Gobbo, Jessica; Garrido, Carmen] INSERM, Equipe Labellisee Ligue Natl Canc, UMR 1231, Dijon, France; [Causse, Sebastien Z.; Marcion, Guillaume; Chanteloup, Gaetan; Uyanik, Burhan; Boudesco, Christophe; Grigorash, Bogdan B.; Douhard, Romain; Dias, Alexandre M. M.; Dumetier, Baptiste; Dondaine, Lucile; Gozzi, Gustavo J.; Dubrez, Laurence; Demidov, Oleg N.; Gobbo, Jessica; Garrido, Carmen] Lab Excellence LipSTIC, Dijon, France; [Causse, Sebastien Z.; Marcion, Guillaume; Chanteloup, Gaetan; Uyanik, Burhan; Boudesco, Christophe; Grigorash, Bogdan B.; Douhard, Romain; Dias, Alexandre M. M.; Dumetier, Baptiste; Dondaine, Lucile; Gozzi, Gustavo J.; Dubrez, Laurence; Demidov, Oleg N.; Gobbo, Jessica; Garrido, Carmen] Univ Bourgogne Franche Comte, Dijon, France; [Moussay, Etienne; Paggetti, Jerome] Luxembourg Inst Hlth, 84 Val Fleuri, L-1526 Luxembourg, Luxembourg; [Mirjolet, Celine; Gobbo, Jessica; Garrido, Carmen] Anticanc Ctr Georges Francois Leclerc Unicanc, Dijon, France; [de Thonel, Aurelie] Univ Paris Diderot, Unite Epigenet & Destin Cellulaire, Paris, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Luxembourg Institute of Health; UDICE-French Research Universities; Universite Paris Cite	Garrido, C (corresponding author), INSERM, Equipe Labellisee Ligue Natl Canc, UMR 1231, Dijon, France.; Garrido, C (corresponding author), Lab Excellence LipSTIC, Dijon, France.; Garrido, C (corresponding author), Univ Bourgogne Franche Comte, Dijon, France.; Garrido, C (corresponding author), Anticanc Ctr Georges Francois Leclerc Unicanc, Dijon, France.	cgarrido@u-bourgogne.fr	Laurence, Dubrez/P-9472-2019; Causse, Sebastien Zwe/AAZ-7365-2021; Garrido, Carolina/GWM-5557-2022; Garrido, carmen/G-1633-2018; Moussay, Etienne/I-3729-2019; Demidov, Oleg/AAC-4462-2021; Paggetti, Jerome/I-2786-2019	Laurence, Dubrez/0000-0002-7030-2181; Garrido, carmen/0000-0003-1368-1493; Moussay, Etienne/0000-0002-0879-8067; Demidov, Oleg/0000-0003-4323-7174; Paggetti, Jerome/0000-0001-9460-5876; de Thonel, Aurelie/0000-0003-0405-0745; Causse, Sebastien/0000-0003-3246-3491; DUMETIER, Baptiste/0000-0001-9087-2344; Mirjolet Didelot, Celine/0000-0003-0047-9421; Marcion, Guillaume/0000-0002-3634-6316	Institut National du Cancer; Ligue Nationale Contre le Cancer; Conseil Regional de Bourgogne; French Government [ANR-11-LABX-0021]; European Union programme FEDER; La Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer; "Fondation de France"; "Fondation pour la Recherche Medicale [ECO20160736090]	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); French Government; European Union programme FEDER(European Commission); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); "Fondation de France"(Fondation de France); "Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We are grateful professor Gorbunova for allowing us using her NHEJ DNA repair system and to Alex Duval and Ada Collura for helpful discussions. We also thank the Platforms of cytometry Cellimap. This work was supported by grants from the Institut National du Cancer, Ligue Nationale Contre le Cancer, and the Conseil Regional de Bourgogne. The work was also supported by a French Government grant managed by the French National Research Agency under the program "Investissements d'Avenir" with reference ANR-11-LABX-0021 (LabEX LipSTIC). We thank the European Union programme FEDER for their financial support. SC had a fellowship from La Ligue Nationale contre le Cancer, GM from the Association pour la Recherche sur le Cancer, GG from the "Fondation de France", and GC from the "Fondation pour la Recherche Medicale (ECO20160736090)".	Berthenet K, 2017, ONCOGENE, V36, P2328, DOI 10.1038/onc.2016.403; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Collura A, 2014, GASTROENTEROLOGY, V146, P401, DOI 10.1053/j.gastro.2013.10.054; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; Dufour A, 2011, IEEE T IMAGE PROCESS, V20, P1925, DOI 10.1109/TIP.2010.2099125; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0085-1; Guttmann DM, 2011, CANCER BIOL THER, V12, P1023, DOI 10.4161/cbt.12.12.18374; Kai M, 2003, ONCOL REP, V10, P1777; Kimura A, 2016, ONCOTARGET, V7, P18415, DOI 10.18632/oncotarget.7821; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Saito Y, 2007, EXP CELL RES, V313, P3707, DOI 10.1016/j.yexcr.2007.06.009; Thomas X, 2005, LEUKEMIA RES, V29, P1049, DOI 10.1016/j.leukres.2005.02.010; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Yang ZG, 2015, INT J MED SCI, V12, P256, DOI 10.7150/ijms.10735; Yu N, 2015, MOL CELL BIOL, V35, P1390, DOI 10.1128/MCB.01307-14	20	20	21	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2767	2777		10.1038/s41388-018-0616-2	http://dx.doi.org/10.1038/s41388-018-0616-2			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30542121				2022-12-26	WOS:000464121600007
J	Zhang, R; Hong, JJ; Yang, QY; Ong, CT; Li, BA; Liou, YC				Zhang, Rui; Hong, Jing-Jing; Yang, Qiaoyun; Ong, Chin-Tong; Li, Bo-An; Liou, Yih-Cherng			Poly(ADP-ribosyl)ation of OVOL2 regulates aneuploidy and cell death in cancer cells	ONCOGENE			English	Article							DROSOPHILA-OVO; CYCLIN-E; CHROMOSOMAL INSTABILITY; CENTROSOME; PHOSPHORYLATION; UBIQUITINATION; IDENTIFICATION; POLYMERASE; EXPRESSION; MECHANISM	Poly(ADP-ribosyl)ation (PARylation) is a post-translational modification by which poly ADP-ribose (PAR) polymers are covalently added to proteins through a PAR polymerase (PARP). Here, using proteomic approach, we identify the transcriptional regulator, OVOL2, is a novel substrate of PARP1 and can be PARylated at residues Lysine 145, Lysine 176, and Lysine 212 within its C2H2 zinc finger domains. Overexpression of PARylated OVOL2 alters cell morphology and induces lagging chromosomes and aneuploidy. To define the underlying molecular mechanism by which OVOL2 induces abnormal cell cycle and centrosome amplification, we uncover that the OVOL2 elevates the protein levels of Cyclin E by enhancing its stability. Furthermore, we identify Skp2, the E3 ubiquitin ligase of Cyclin E, as a direct target of PARylated OVOL2. Using ChIP assay, the OVOL2 binding site on the promoter region of Skp2 is mapped. To further explore the physiological effect, we show that PARylated OVOL2 can induce cell death. Furthermore, to investigate PARylated OVOL2 function in vivo, we further develop a null-mice xenograft model and generate MMTV-PyVT transgenic mice and monitor the effect of wild-type OVOL2 and non-PARylated OVOL2-3IQA mutants on tumor progression. Consistently, overexpression of wild-type OVOL2 in both null-mice xenograft and MMTV-PyVT transgenic mice displays significantly reduction of tumor progression, respectively, further indicating that the function of OVOL2 as a tumor suppressor in vivo is highly regulated by PARylation. Taken together, our study sheds new light on PARP1-induced PARylation as a critical event in the OVOL2-mediated regulation of chromosomal integrity and suppression of cancer cells growth.	[Zhang, Rui; Yang, Qiaoyun; Ong, Chin-Tong; Liou, Yih-Cherng] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117543, Singapore; [Hong, Jing-Jing; Li, Bo-An] Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Ong, Chin-Tong] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Liou, Yih-Cherng] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117573, Singapore	National University of Singapore; Xiamen University; National University of Singapore; National University of Singapore	Liou, YC (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117543, Singapore.; Li, BA (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.; Liou, YC (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117573, Singapore.	bali@xmu.edu.cn; dbslyc@nus.edu.sg		ZHANG, RUI/0000-0003-2250-8617	Ministry of Education, Singapore [R-154-000-A61-112, A15-114]; National Natural Science Foundation of China [U1705284, 81772958]	Ministry of Education, Singapore(Ministry of Education, Singapore); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all members in the Y-C Liou laboratory for their support and valuable discussion. We would also like to thank the Center of BioImaging Sciences (CBIS) for their technical support on confocal microscopy, and Flow Cytometry Laboratory in Yong Loo Lin School of Medicine at the National University of Singapore for FACS assay. In addition, the authors thank Protein Proteomic Center (PPC) for the technical support on protein identification. We particularly thank Dr. Boon Chuan Low for kindly providing several reagents and helpful discussions and suggestions. In addition, we thank Dr. Kyunghee Lee for helping imaging and cell cycle assay. This work was supported in part by MOE grants Tier 2, R-154-000-A61-112 and Tier 1, A15-114 from the Ministry of Education, Singapore to Y.-C.L; grants from the National Natural Science Foundation of China (Grant Numbers U1705284, 81772958) to B.-A.L.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; ALVAREZGONZALEZ R, 1987, BIOCHEMISTRY-US, V26, P3218, DOI 10.1021/bi00385a042; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Coldwell MJ, 2013, CELL CYCLE, V12, P3615, DOI 10.4161/cc.26588; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Giam M, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0009-7; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Gonzalez-Sanchez M, 2004, GENETICS, V166, P999, DOI 10.1534/genetics.166.2.999; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; JUAREZSALINAS H, 1982, J BIOL CHEM, V257, P607; Kanai M, 2007, BIOCHEM BIOPH RES CO, V359, P426, DOI 10.1016/j.bbrc.2007.05.108; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Lee S, 2000, NUCLEIC ACIDS RES, V28, P826, DOI 10.1093/nar/28.3.826; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leung AKL, 2014, J CELL BIOL, V205, P613, DOI 10.1083/jcb.201402114; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Liu DW, 2015, ONCOTARGET, V6, P38552, DOI 10.18632/oncotarget.6035; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mackay DR, 2006, DEV BIOL, V291, P38, DOI 10.1016/j.ydbio.2005.12.003; Masutani M, 2003, GENE CHROMOSOME CANC, V38, P339, DOI 10.1002/gcc.10250; MIWA M, 1981, J BIOL CHEM, V256, P2916; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Oei SL, 1998, BIOCHEMISTRY-US, V37, P1465, DOI 10.1021/bi9727390; Ogden A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.164; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ong CT, 2013, CELL, V155, P148, DOI 10.1016/j.cell.2013.08.052; Salisbury JL, 2004, J MAMMARY GLAND BIOL, V9, P275, DOI 10.1023/B:JOMG.0000048774.27697.30; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Teng A, 2007, BBA-MOL BASIS DIS, V1772, P89, DOI 10.1016/j.bbadis.2006.08.012; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Unezaki S, 2007, GENES CELLS, V12, P773, DOI 10.1111/j.1365-2443.2007.01084.x; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Wells J, 2009, J BIOL CHEM, V284, P29125, DOI 10.1074/jbc.M109.008847; Ye GD, 2016, GASTROENTEROLOGY, V150, P659, DOI 10.1053/j.gastro.2015.11.041	49	6	7	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2750	2766		10.1038/s41388-018-0615-3	http://dx.doi.org/10.1038/s41388-018-0615-3			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30542118				2022-12-26	WOS:000464121600006
J	Gianni, M; Terao, M; Kurosaki, M; Paroni, G; Brunelli, L; Pastorelli, R; Zanetti, A; Lupi, M; Acquavita, A; Bolis, M; Fratelli, M; Rochette-Egly, C; Garattini, E				Gianni, Maurizio; Terao, Mineko; Kurosaki, Mami; Paroni, Gabriela; Brunelli, Laura; Pastorelli, Roberta; Zanetti, Adriana; Lupi, Monica; Acquavita, Andrea; Bolis, Marco; Fratelli, Maddalena; Rochette-Egly, Cecile; Garattini, Enrico			S100A3 a partner protein regulating the stability/activity of RAR alpha and PML-RAR alpha in cellular models of breast/lung cancer and acute myeloid leukemia	ONCOGENE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; UNION-OF-PHARMACOLOGY; GROWTH-FACTOR; NUCLEAR; RECEPTOR; CELLS; DEGRADATION; PHOSPHORYLATION; EXPRESSION	All trans-retinoic acid (ATRA) is used in the treatment of acute promyelocytic leukemia (APL) and it is a promising agent also in solid tumors. The pharmacological activity of ATRA is mediated by the ligand-activated RAR and RXR transcription factors. In the present study, we define the basal and ATRA dependent RAR alpha interactome in a RAR alpha-overexpressing breast cancer cellular model, identifying 28 nuclear proteins. We focus our attention on the S100A3 calcium-binding protein, which interacts with RAR alpha constitutively. In ATRA-sensitive breast cancer cells, S100A3 binds to RAR alpha in basal conditions and binding is reduced by the retinoid. The interaction of S100A3 with RAR alpha is direct and in lung cancer, APL and acute-myeloid-leukemia (AML) cells. In APL, S100A3 interacts not only with RAR alpha, but also with PML-RAR alpha. The interaction surface maps to the RAR alpha ligand-binding domain, where the I396 residue plays a crucial role. Binding of S100A3 to RARWPML-RAR alpha controls the constitutive and ATRA-dependent degradation of these receptors. S100A3 knockdown decreases the amounts of RAR alpha in breast- and lung cancer cells, inducing resistance to ATRA-dependent antiproliferative/differentiating effects. Conversely, S100A3 knockdown in PML-RAR alpha(+) APL and PML-RAR alpha(-) AML cells reduces the amounts of RAR alpha/PML-RAR alpha and increases basal and ATRA-induced differentiation. In this cellular context, opposite effects on RAR alpha/PML-RAR alpha levels and ATRA-induced differentiation are observed upon S100A3 overexpression. Our results provide new insights into the molecular mechanisms controlling RARa activity and have practical implications, as S100A3 represents a novel target for rational drug combinations aimed at potentiating the activity of ATRA.	[Gianni, Maurizio; Terao, Mineko; Kurosaki, Mami; Paroni, Gabriela; Zanetti, Adriana; Acquavita, Andrea; Bolis, Marco; Fratelli, Maddalena; Garattini, Enrico] IRCCS, Ist Ric Farmacol Mario Negri, Lab Mol Biol, Via La Masa 19, I-20156 Milan, Italy; [Brunelli, Laura; Pastorelli, Roberta] IRCCS, Ist Ric Farmacol Mario Negri, Lab Mass Spectrometry, Via La Masa 19, I-20156 Milan, Italy; [Lupi, Monica] IRCCS, Ist Ric Farmacol Mario Negri, Lab Canc Pharmacol, Via La Masa 19, I-20156 Milan, Italy; [Rochette-Egly, Cecile] Univ Strasbourg, CNRS, Dept Funct Genom & Canc, IGBMC,INSERM,U964,UMR7104, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Garattini, E (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Lab Mol Biol, Via La Masa 19, I-20156 Milan, Italy.	enrico.garattini@marionegri.it	adriana, zanetti/ABA-1189-2020; terao, mineko/AAU-8089-2020; Paroni, Gabriela/J-4848-2018; Pastorelli, Roberta/AAA-6736-2020; Bolis, Marco/AAC-2379-2019; Terao, Mineko/AAA-6415-2020; Brunelli, Laura/J-8664-2018; Gianni, Maurizio/ABG-6322-2020; Garattini, Enrico/AAI-1998-2019; KUROSAKI, Mami/ABG-2224-2020; Fratelli, Maddalena/AAA-6446-2020; Lupi, Monica/AAH-5704-2019	adriana, zanetti/0000-0002-5825-9707; Paroni, Gabriela/0000-0003-0132-0869; Pastorelli, Roberta/0000-0001-5097-600X; Bolis, Marco/0000-0003-4377-5079; Terao, Mineko/0000-0002-9976-9869; Brunelli, Laura/0000-0002-5465-9586; Gianni, Maurizio/0000-0002-6945-708X; KUROSAKI, Mami/0000-0001-8231-713X; Fratelli, Maddalena/0000-0002-1769-3427; Lupi, Monica/0000-0002-9835-7870; Garattini, Enrico/0000-0001-8983-886X	Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) [to Enrico Garattini] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)		Benbrook DM, 2014, SUBCELL BIOCHEM, V70, P1, DOI 10.1007/978-94-017-9050-5_1; Berry DC, 2007, PPAR RES, V2007, DOI 10.1155/2007/73256; Bolis M, 2017, ANN ONCOL, V28, P611, DOI 10.1093/annonc/mdw660; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Caccamo D, 2013, AMINO ACIDS, V44, P151, DOI 10.1007/s00726-011-1083-z; Carrier M, 2018, FEBS LETT, V592, P1426, DOI 10.1002/1873-3468.13033; Centritto F, 2015, EMBO MOL MED, V7, P950, DOI 10.15252/emmm.201404670; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; DANIELPOUR D, 1991, J CELL PHYSIOL, V148, P235, DOI 10.1002/jcp.1041480208; de The H, 2018, NAT REV CANCER, V18, P117, DOI 10.1038/nrc.2017.103; de The H, 2017, CANCER CELL, V32, P552, DOI 10.1016/j.ccell.2017.10.002; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Gaillard E, 2006, P NATL ACAD SCI USA, V103, P9548, DOI 10.1073/pnas.0509717103; Garattini E, 2007, VITAM HORM, V75, P301, DOI 10.1016/S0083-6729(06)75012-9; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Gianni M, 2012, LEUKEMIA, V26, P1850, DOI 10.1038/leu.2012.50; Gianni M, 1996, BLOOD, V87, P1520, DOI 10.1182/blood.V87.4.1520.bloodjournal8741520; Gianni' M, 2001, BLOOD, V97, P3234, DOI 10.1182/blood.V97.10.3234; Gianni M, 2017, ONCOTARGET, V8, P37041, DOI 10.18632/oncotarget.10556; Gianni M, 2009, CANCER RES, V69, P1016, DOI 10.1158/0008-5472.CAN-08-2603; Hatakeyama D, 2002, BBA-MOL CELL RES, V1589, P15, DOI 10.1016/S0167-4889(01)00183-5; Heizmann C. W., 2007, V45, P93; Hoedt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104563; Hu LZ, 2014, J STEROID BIOCHEM, V144, P237, DOI 10.1016/j.jsbmb.2013.11.002; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Huang D, 2017, FRONT MED-PRC, V11, P410, DOI 10.1007/s11684-017-0527-6; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kani K, 2017, METHODS MOL BIOL, V1550, P171, DOI 10.1007/978-1-4939-6747-6_13; Kizawa K, 2013, BBA-MOL CELL RES, V1833, P1712, DOI 10.1016/j.bbamcr.2012.07.009; Kizawa K, 2011, BIOCHIMIE, V93, P2038, DOI 10.1016/j.biochi.2011.05.028; Lalevee S, 2010, METHODS MOL BIOL, V647, P251, DOI 10.1007/978-1-60761-738-9_15; le Maire A, 2010, NAT STRUCT MOL BIOL, V17, P801, DOI 10.1038/nsmb.1855; Levi L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9794; Li XP, 2016, ONCOL LETT, V11, P2839, DOI 10.3892/ol.2016.4294; Luscinskas FW, 2012, EUR J IMMUNOL, V42, P296, DOI 10.1002/eji.201142342; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; O'Connell PA, 2011, BLOOD, V117, P4095, DOI 10.1182/blood-2010-07-298851; Ovcharenko A, 2013, LEUKEMIA RES, V37, P956, DOI 10.1016/j.leukres.2013.03.010; Paroni G, 2012, ONCOGENE, V31, P3431, DOI 10.1038/onc.2011.506; Parrella E, 2004, J BIOL CHEM, V279, P42026, DOI 10.1074/jbc.M406530200; Piskunov A, 2014, SUBCELL BIOCHEM, V70, P103, DOI 10.1007/978-94-017-9050-5_6; Sahin U, 2014, J PATHOL, V234, P289, DOI 10.1002/path.4426; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Soderstrom M, 1997, MOL ENDOCRINOL, V11, P682, DOI 10.1210/me.11.6.682; Steinbach D, 2007, CANCER GENET CYTOGEN, V177, P51, DOI 10.1016/j.cancergencyto.2007.05.011; TAHAYATO A, 1993, MOL ENDOCRINOL, V7, P1642, DOI 10.1210/me.7.12.1642; Wu YZ, 2004, LEUKEMIA RES, V28, P203, DOI 10.1016/S0145-2126(03)00211-X; Yoshida H, 1996, CANCER RES, V56, P2945; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu YL, 2017, FRONT MED-PRC, V11, P87, DOI 10.1007/s11684-016-0469-4	52	15	16	5	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2482	2500		10.1038/s41388-018-0599-z	http://dx.doi.org/10.1038/s41388-018-0599-z			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30532072	hybrid, Green Published			2022-12-26	WOS:000463335200004
J	Anaokar, S; Kodali, R; Jonik, B; Renne, MF; Brouwers, JFHM; Lager, I; de Kroon, AIPM; Patton-Vogt, J				Anaokar, Sanket; Kodali, Ravindra; Jonik, Benjamin; Renne, Mike F.; Brouwers, Jos F. H. M.; Lager, Ida; de Kroon, Anton I. P. M.; Patton-Vogt, Jana			The glycerophosphocholine acyltransferase Gpc1 is part of a phosphatidylcholine (PC)-remodeling pathway that alters PC species in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylcholine; phospholipid metabolism; acyltransferase; yeast; membrane turnover; Ale1; glycerophosphocholine; Gpc1; lipid remodeling	SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; GENE-EXPRESSION; GLOBAL ANALYSIS; METABOLISM; IDENTIFICATION; TRANSCRIPTION; GLYCEROPHOSPHOINOSITOL; GLYCEROLIPIDS; BIOSYNTHESIS	Phospholipase B-mediated hydrolysis of phosphatidylcholine (PC) results in the formation of free fatty acids and glycerophosphocholine (GPC) in the yeast Saccharomyces cerevisiae. GPC can be reacylated by the glycerophosphocholine acyltransferase Gpc1, which produces lysophosphatidylcholine (LPC), and LPC can be converted to PC by the lysophospholipid acyltransferase Ale1. Here, we further characterized the regulation and function of this distinct PC deacylation/reacylation pathway in yeast. Through in vitro and in vivo experiments, we show that Gpc1 and Ale1 are the major cellular GPC and LPC acyltransferases, respectively. Importantly, we report that Gpc1 activity affects the PC species profile. Loss of Gpc1 decreased the levels of monounsaturated PC species and increased those of diunsaturated PC species, whereas Gpc1 overexpression had the opposite effects. Of note, Gpc1 loss did not significantly affect phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine profiles. Our results indicate that Gpc1 is involved in postsynthetic PC remodeling that produces more saturated PC species. qRT-PCR analyses revealed that GPC1 mRNA abundance is regulated coordinately with PC biosynthetic pathways. Inositol availability, which regulates several phospholipid biosynthetic genes, down-regulated GPC1 expression at the mRNA and protein levels and, as expected, decreased levels of monounsaturated PC species. Finally, loss of GPC1 decreased stationary phase viability in inositol-free medium. These results indicate that Gpc1 is part of a postsynthetic PC deacylation/reacylation remodeling pathway (PC-DRP) that alters the PC species profile, is regulated in coordination with other major lipid biosynthetic pathways, and affects yeast growth.	[Anaokar, Sanket; Jonik, Benjamin; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Kodali, Ravindra] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA; [Renne, Mike F.; de Kroon, Anton I. P. M.] Univ Utrecht, Bijvoet Ctr, Dept Membrane Biochem & Biophys, NL-3584 CH Utrecht, Netherlands; [Renne, Mike F.; de Kroon, Anton I. P. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Brouwers, Jos F. H. M.] Univ Utrecht, Inst Biomembranes, Dept Biochem & Cell Biol, NL-3584 CH Utrecht, Netherlands; [Lager, Ida] Swedish Univ Agr Sci, Dept Plant Breeding, SE-23053 Alnarp, Sweden	Duquesne University; Duquesne University; Utrecht University; Utrecht University; Utrecht University; Swedish University of Agricultural Sciences	Patton-Vogt, J (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA.	pattonvogt@duq.edu	de Kroon, Anton I/O-4119-2016; Brouwers, Jos F/AAH-1444-2019	Brouwers, Jos F/0000-0003-2924-3279; de Kroon, Anton/0000-0003-1209-756X	National Science Foundation [MRIDBI-0821401]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104876] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The purchase of mass spectrometers was supported by National Science Foundation Grant MRIDBI-0821401 to Duquesne University. We thank Dr. Amrah Weijn for help with the MS sample preparation.	Almaguer C, 2003, EUKARYOT CELL, V2, P729, DOI 10.1128/EC.2.4.729-736.2003; Almaguer C, 2006, CURR GENET, V50, P367, DOI 10.1007/s00294-006-0096-8; Amberg D. C., 2005, METHODS YEAST GENETI, P109; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; De Smet CH, 2013, BBA-MOL CELL BIOL L, V1831, P1167, DOI 10.1016/j.bbalip.2013.03.002; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Ernst R, 2016, J MOL BIOL, V428, P4776, DOI 10.1016/j.jmb.2016.08.013; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fernandez-Murray JP, 2009, J BIOL CHEM, V284, P36034, DOI 10.1074/jbc.M109.063958; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Glab B, 2016, J BIOL CHEM, V291, P25066, DOI 10.1074/jbc.M116.743062; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hishikawa D, 2014, J LIPID RES, V55, P2444, DOI 10.1194/jlr.R046094ERR; Hofbauer HF, 2014, DEV CELL, V29, P729, DOI 10.1016/j.devcel.2014.04.025; Hoppen J, 2005, YEAST, V22, P601, DOI 10.1002/yea.1209; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Jasieniecka-Gazarkiewicz K, 2016, LIPIDS, V51, P15, DOI 10.1007/s11745-015-4102-0; Kishino H, 2014, BIOCHEM BIOPH RES CO, V445, P289, DOI 10.1016/j.bbrc.2014.01.136; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Lager I, 2015, PLANTA, V241, P347, DOI 10.1007/s00425-014-2184-1; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee JCM, 2011, J NEUROCHEM, V116, P813, DOI 10.1111/j.1471-4159.2010.07033.x; LEE KS, 1994, J BIOL CHEM, V269, P19725; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marchan R, 2012, CELL CYCLE, V11, P4499, DOI 10.4161/cc.22544; Morisada S, 2018, FEBS LETT, V592, P1829, DOI 10.1002/1873-3468.13103; Moser R, 2014, MOL MICROBIOL, V91, P736, DOI 10.1111/mmi.12492; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Patton-Vogt JL, 1998, GENETICS, V149, P1707; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reimand J, 2010, NUCLEIC ACIDS RES, V38, P4768, DOI 10.1093/nar/gkq232; Renne MF, 2018, FEBS LETT, V592, P1330, DOI 10.1002/1873-3468.12944; Renne Mike F, 2015, Lipid Insights, V8, P33, DOI 10.4137/LPI.S31780; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Salsaa M, 2017, J BIOL CHEM, V292, P18729, DOI 10.1074/jbc.H117.809970; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Stalberg K, 2008, J LIPID RES, V49, P1794, DOI 10.1194/jlr.M800129-JLR200; Surlow BA, 2014, J BIOL CHEM, V289, P31591, DOI 10.1074/jbc.M114.581157; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Tanaka K, 2008, BBA-MOL CELL BIOL L, V1781, P391, DOI 10.1016/j.bbalip.2008.06.001; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; WAGNER S, 1994, YEAST, V10, P1429, DOI 10.1002/yea.320101106; Wykoff DD, 2001, GENETICS, V159, P1491; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang K, 2011, METABOLITES, V1, P21, DOI 10.3390/metabo1010021; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zhu X, 2015, GENETICS, V201, P525, DOI 10.1534/genetics.115.178293	70	7	7	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1189	1201		10.1074/jbc.RA118.005232	http://dx.doi.org/10.1074/jbc.RA118.005232			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30514764	Green Published, hybrid			2022-12-26	WOS:000457879500011
J	Karlsson, E; Andersson, E; Dogan, J; Gianni, S; Jemth, P; Camilloni, C				Karlsson, Elin; Andersson, Eva; Dogan, Jakob; Gianni, Stefano; Jemth, Per; Camilloni, Carlo			A structurally heterogeneous transition state underlies coupled binding and folding of disordered proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; pre-steady-state kinetics; protein folding; protein-protein interaction; molecular dynamics	NUCLEATION-CONDENSATION MECHANISM; MOLECULAR RECOGNITION; DOMAIN; MODEL; KINETICS; KIX; ASSOCIATION; FRUSTRATION; BEHAVIOR; ENZYME	Many intrinsically disordered proteins (IDPs) attain a well-defined structure in a coupled folding and binding reaction with another protein. Such reactions may involve early to late formation of different native structural regions along the reaction pathway. To obtain insights into the transition state for a coupled binding and folding reaction, we performed restrained molecular dynamics simulations using previously determined experimental binding phi(b) values of the interaction between two IDP domains: the activation domain from the p160 transcriptional co-activator for thyroid hormone and retinoid receptors (ACTR) and the nuclear co-activator binding domain (NCBD) of CREB-binding protein, each forming three well-defined alpha-helices upon binding. These simulations revealed that both proteins are largely disordered in the transition state for complex formation, except for two helices, one from each domain, that display a native-like structure. The overall transition state structure was extended and largely dynamic with many weakly populated contacts. To test the transition state model, we combined site-directed mutagenesis with kinetic experiments, yielding results consistent with overall diffuse interactions and formation of native intramolecular interactions in the third NCBD helix during the binding reaction. Our findings support the view that the transition state and, by inference, any encounter complex in coupled binding and folding reactions are structurally heterogeneous and largely independent of specific interactions. Furthermore, experimental phi(b) values and Bronsted plots suggested that the transition state is globally robust with respect to most mutations but can display more native-like features for some highly destabilizing mutations, possibly because of Hammond behavior or ground-state effects.	[Karlsson, Elin; Andersson, Eva; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Dogan, Jakob] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Gianni, Stefano] Sapienza Univ Roma, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gianni, Stefano] Sapienza Univ Roma, Ist Biol Patol & Mol, CNR, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Camilloni, Carlo] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy	Uppsala University; Stockholm University; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University of Milan	Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.; Camilloni, C (corresponding author), Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy.	Per.Jemth@imbim.uu.se; carlo.camilloni@unimi.it	Camilloni, Carlo/A-4395-2009	Camilloni, Carlo/0000-0002-9923-8590; Karlsson, Elin/0000-0001-5526-4968; Jemth, Per/0000-0003-1516-7228	Swedish Research Council [2016-04965]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grant 2016-04965 (to P. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; BASHFORD D, 1984, J BIOMOL STRUCT DYN, V1, P1243, DOI 10.1080/07391102.1984.10507515; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Bonetti D, 2017, BIOCHEMISTRY-US, V56, P3780, DOI 10.1021/acs.biochem.7b00350; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; COHEN FE, 1980, NATURE, V286, P632, DOI 10.1038/286632a0; Crabtree MD, 2018, J BIOL CHEM, V293, P9718, DOI 10.1074/jbc.RA118.002791; Dahal L, 2017, BIOPHYS J, V113, P2713, DOI 10.1016/j.bpj.2017.10.016; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dogan J, 2016, BIOCHEMISTRY-US, V55, P5289, DOI 10.1021/acs.biochem.6b00573; Dogan J, 2015, BIOCHEMISTRY-US, V54, P4741, DOI 10.1021/acs.biochem.5b00520; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Fuxreiter M, 2019, CURR OPIN STRUC BIOL, V54, P19, DOI 10.1016/j.sbi.2018.09.008; Fuxreiter M, 2018, J MOL BIOL, V430, P2278, DOI 10.1016/j.jmb.2018.02.015; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Gianni S, 2016, CURR OPIN STRUC BIOL, V36, P18, DOI 10.1016/j.sbi.2015.11.012; Gianni S, 2014, P NATL ACAD SCI USA, V111, P14141, DOI 10.1073/pnas.1405233111; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Parra RG, 2016, NUCLEIC ACIDS RES, V44, pW356, DOI 10.1093/nar/gkw304; HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Hultqvist G, 2017, ELIFE, V6, DOI 10.7554/eLife.16059; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Jemth P, 2014, J BIOL CHEM, V289, P5528, DOI 10.1074/jbc.M113.537068; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS M, 1976, NATURE, V260, P404, DOI 10.1038/260404a0; Kjaergaard M, 2013, BIOCHEMISTRY-US, V52, P1686, DOI 10.1021/bi4001062; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Knott M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4873710; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Lindstrom I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26213-x; Lindstrom I, 2017, BIOCHEMISTRY-US, V56, P4145, DOI 10.1021/acs.biochem.7b00428; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; Paci E, 2003, P NATL ACAD SCI USA, V100, P394, DOI 10.1073/pnas.232704999; Paci E, 2002, J MOL BIOL, V324, P151, DOI 10.1016/S0022-2836(02)00944-0; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Schneider R, 2015, J AM CHEM SOC, V137, P1220, DOI 10.1021/ja511066q; Sturzenegger F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07043-x; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Toto A, 2016, BIOCHEMISTRY-US, V55, P3957, DOI 10.1021/acs.biochem.6b00505; Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Uversky VN, 2012, ANAL CHEM, V84, P2096, DOI 10.1021/ac203096k; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; Zhang WH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002353; Zosel F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05725-0	61	26	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1230	1239		10.1074/jbc.RA118.005854	http://dx.doi.org/10.1074/jbc.RA118.005854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30514761	Green Published, hybrid			2022-12-26	WOS:000457879500014
J	Shojaee, S; Hajizadeh, N; Najafimehr, H; Busani, L; Pourhoseingholi, MA; Baghestani, AR; Nasserinejad, M; Ashtari, S; Zali, MR				Shojaee, Sajad; Hajizadeh, Nastaran; Najafimehr, Hadis; Busani, Luca; Pourhoseingholi, Mohamad Amin; Baghestani, Ahmad Reza; Nasserinejad, Maryam; Ashtari, Sara; Zali, Mohammad Reza			Bayesian adjustment for trend of colorectal cancer incidence in misclassified registering across Iranian provinces	PLOS ONE			English	Article							DIAGNOSTIC MISCLASSIFICATION; HUMAN-PAPILLOMAVIRUS; MORTALITY; RISK; REGISTRY; REGRESSION	Misclassification error is a common problem of cancer registries in developing countries that leads to biased cancer rates. The purpose of this research is to use Bayesian method for correcting misclassification in registered cancer incidence of eighteen provinces in Iran. Incidence data of patients with colorectal cancer were extracted from Iranian annual of national cancer registration reports from 2005 to 2008. A province with proper medical facilities can always be compared to its neighbors. Almost 28% of the misclassification was estimated between the province of East Azarbaijan and West Azarbaijan, 56% between Fars and Hormozgan, 43% between Isfahan and Charmahal and Bakhtyari, 46% between Isfahan and Lorestan, 58% between Razavi Khorasan and North Khorasan, 50% between Razavi Khorasan and South Khorasan, 74% between Razavi Khorasan and Sistan and Balochestan, 43% between Mazandaran and Golestan, 37% between Tehran and Qazvin, 45% between Tehran and Markazi, 42% between Tehran and Qom, 47% between Tehran and Zanjan. Correcting the regional misclassification and obtaining the correct rates of cancer incidence in different regions is necessary for making cancer control and prevention programs and in healthcare resource allocation.	[Shojaee, Sajad; Ashtari, Sara] Shahid Beheshti Univ Med Sci, Basic & Mol Epidemiol Gastrointestinal Disorders, Res Inst Gastroenterol & Liver Dis, Tehran, Iran; [Hajizadeh, Nastaran; Baghestani, Ahmad Reza; Nasserinejad, Maryam] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Physiotherapy Res Ctr, Dept Biostat, Tehran, Iran; [Najafimehr, Hadis; Pourhoseingholi, Mohamad Amin; Zali, Mohammad Reza] Shahid Beheshti Univ Med Sci, Gastroenterol & Liver Dis Res Ctr, Res Inst Gastroenterol & Liver Dis, Tehran, Iran; [Busani, Luca] Ist Super Sanita, Dept Infect Dis, Rome, Italy	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Istituto Superiore di Sanita (ISS)	Pourhoseingholi, MA (corresponding author), Shahid Beheshti Univ Med Sci, Gastroenterol & Liver Dis Res Ctr, Res Inst Gastroenterol & Liver Dis, Tehran, Iran.	Aminphg@gmail.com	zali, mohammadreza/AAD-4452-2022; Busani, Luca/J-9253-2012	Busani, Luca/0000-0002-6081-2794; Ashtari, Sara/0000-0003-1108-664X; Pourhoseingholi, Mohamad Amin/0000-0002-0121-8031; shojaei, sajad/0000-0002-0860-8390	Elite Researcher Grant Committee from the National Institutes for Medical Research Development (NIMAD), Tehran, Iran [958696]	Elite Researcher Grant Committee from the National Institutes for Medical Research Development (NIMAD), Tehran, Iran	Research reported in this publication was supported by Elite Researcher Grant Committee under award number 958696 from the National Institutes for Medical Research Development (NIMAD), Tehran, Iran.; Research reported in this publication was supported by Elite Researcher Grant Committee under award number 958696 from the National Institutes for Medical Research Development (NIMAD), Tehran, Iran.	[Anonymous], 2009, NON TRADITIONAL REF; Arnold M, 2015, EUR J CANCER, V51, P1164, DOI 10.1016/j.ejca.2013.09.002; Corbin M, 2013, THESIS; Das Ananya, 2009, V471, P31, DOI 10.1007/978-1-59745-416-2_2; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hajizadeh Nastaran, 2017, Gastroenterol Hepatol Bed Bench, V10, pS54; Hajizadeh N, 2017, WORLD J HEPATOL, V9, P704, DOI 10.4254/wjh.v9.i15.704; Hajizadeh N, 2017, WORLD J GASTRO ONCOL, V9, P87, DOI 10.4251/wjgo.v9.i2.87; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Khosravi Shadmani F, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017020; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Liu Y, 2004, STAT MED, V23, P1901, DOI 10.1002/sim.1773; Lyles RH, 2002, BIOMETRICS, V58, P1034, DOI 10.1111/j.0006-341X.2002.1034_1.x; Mahaki B, 2011, ASIAN PAC J CANCER P, V12, P2353; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McInturff P, 2004, STAT MED, V23, P1095, DOI 10.1002/sim.1656; Mehrabani D, 2008, IRAN RED CRESCENT ME, V10, P314; Mohagheghi MA, 2010, ASIAN PAC J CANCER P, V11, P1155; Mohagheghi MA, 2009, ARCH IRAN MED, V12, P15; Pandey S, 2012, ASIAN PAC J CANCER P, V13, P2643, DOI 10.7314/APJCP.2012.13.6.2643; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Paulino CD, 2005, COMPUT STAT DATA AN, V49, P1120, DOI 10.1016/j.csda.2004.07.004; Paulino CD, 2003, BIOMETRICS, V59, P670; Pourhoseingholi MA., 2014, TRANSL GASTROINTEST, V3, P144, DOI [10.3978/j.issn.2224-4778.2014.08.08, DOI 10.3978/J.ISSN.2224-4778.2014.08.08]; Pourhoseingholi MA, 2009, ASIAN PAC J CANCER P, V10, P691; Pourhoseingholi MA, 2009, ASIAN PAC J CANCER P, V10, P107; SPOSTO R, 1992, BIOMETRICS, V48, P605, DOI 10.2307/2532315; Stamey JD, 2008, STAT MED, V27, P2440, DOI 10.1002/sim.3134; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; WHITTEMORE AS, 1991, J R STAT SOC C-APPL, V40, P81; Yavari P, 2008, ASIAN PAC J CANCER P, V9, P145; Zayeri Farid, 2015, Asian Pac J Cancer Prev, V16, P5225; Zou L, 2011, ASIAN PAC J CANCER P, V12, P781; [No title captured]	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2018	13	12							e0199273	10.1371/journal.pone.0199273	http://dx.doi.org/10.1371/journal.pone.0199273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE3IL	30543626	Green Submitted, gold, Green Published			2022-12-26	WOS:000453247500002
J	Samarra, FIP; Bassoi, M; Beesau, J; Eliasdottir, MO; Gunnarsson, K; Mrusczok, MT; Rasmussen, M; Rempel, JN; Thorvaldsson, B; Vikingsson, GA				Samarra, Filipa I. P.; Bassoi, Manuela; Beesau, Julie; Eliasdottir, Margret O.; Gunnarsson, Karl; Mrusczok, Marie-Therese; Rasmussen, Marianne; Rempel, Jonathan N.; Thorvaldsson, Baldur; Vikingsson, Gisli A.			Prey of killer whales (Orcinus orca) in Iceland	PLOS ONE			English	Article							NORTH-ATLANTIC; COMMON EIDERS; MINKE WHALES; SPERM-WHALES; DIVERGENCE; SIGHTINGS; PREDATION; ECOLOGY; ATTACKS; WATERS	Killer whales have a cosmopolitan distribution and as a species are generalists, feeding on a variety of prey. However, local populations tend to specialise on specific prey types. In Icelandic waters, killer whales are generally associated with herring and, thus, have been presumed to be herring specialists. However, recent studies suggest a more complex foraging ecology, possibly including a mosaic of strategies. With increased observational effort in recent years due to research and whale-watching activities, there have been several reports of interactions with different prey, including confirmed predation events. In this study we aimed to summarise the range of potential prey of killer whales observed in Icelandic waters. We report on 12 previously unpublished accounts and review 15 accounts published in the scientific literature or local newspapers, making a total of 27 events where killer whales were observed interacting with actual or potential prey. Thirteen different species, including birds (n = 1), cephalopods (n = 1), fish (n = 5) and marine mammals (n = 6), are reported, although herring is by far the species that killer whales are most often observed interacting with. This study provides the first summary of actual and suspected killer whale prey in Icelandic waters, and contributes towards our understanding of this population's prey preferences. However, describing the diet of individuals/groups was not possible and this study points to a need for continued monitoring to understand the intricacies of killer whale foraging behaviour in this area.	[Samarra, Filipa I. P.; Gunnarsson, Karl; Vikingsson, Gisli A.] Marine & Freshwater Res Inst, Reykjavik, Iceland; [Samarra, Filipa I. P.; Beesau, Julie] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Bassoi, Manuela] Reykjaviks Old Harbour, Elding Whale Watching, Reykjavik, Iceland; [Eliasdottir, Margret O.] Whales Hauganes Ehf, Hafnargata, Hauganesi, Iceland; [Mrusczok, Marie-Therese] Orca Guardians Iceland, Hrannarstigur, Grundarfjorour, Iceland; [Mrusczok, Marie-Therese] Laki Tours, Nesvegur, Grundarfjorour, Iceland; [Rasmussen, Marianne] Univ Iceland, Husavik Res Ctr, Hafnarstett, Husavik, Iceland; [Rempel, Jonathan N.] Reykjaviks Old Harbour, Special Tours, Reykjavik, Iceland; [Thorvaldsson, Baldur] Iceland Pro Cruises, Reykjavik, Iceland	Marine & Freshwater Research Institute (MFRI); University of St Andrews; University of Iceland	Samarra, FIP (corresponding author), Marine & Freshwater Res Inst, Reykjavik, Iceland.; Samarra, FIP (corresponding author), Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews, Fife, Scotland.	fipsamarra@grnail.com		Samarra, Filipa/0000-0002-9909-0565; Vikingsson, Gisli/0000-0002-4501-193X; Gunnarsson, Karl/0000-0002-4086-7771; Mrusczok, Marie-Therese/0000-0002-6539-3701	Icelandic Research Fund	Icelandic Research Fund	MB was employed by Elding Whale Watching, MOE was employed by Whales Hauganes ehf., MTM was employed by Laki Tours, JNR was employed by Special Tours and BT was employed by Iceland Pro Cruises. The funders provided support in the form of salaries for authors and in all cases (except Iceland Pro Cruises) provided platforms from where observations were made, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'uthor contributions' section. Funding for dedicated research was provided by the Icelandic Research Fund. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, SJOMANNABLAOIO VIKIN, V41, P39; [Anonymous], 1915, FRETTIR         1103, V33, P137; [Anonymous], 1971, JOOVILJINN      0725, P12; [Anonymous], 1967, TRMINN, V51, P16; [Anonymous], 1978, DAGBLAOIO       0427, P1; [Anonymous], 1982, MORGUNBLAOIO, P20; [Anonymous], 2006, MORGUNBLAOIO    1128, P18; [Anonymous], 2002, MORGUNBLAOIO    1015, V90, P8; [Anonymous], 1992, MORGUNBLAOIO    0513; [Anonymous], 1997, SJORNANNABLAOIO VIKI, V59, P52; [Anonymous], 1970, VISIR           0804; [Anonymous], 2017, 2017ACOM08 ICES CM; Baird RW, 2006, PAC SCI, V60, P523, DOI 10.1353/psc.2006.0024; Baird RW, 1990, 3RD INT ORC S VICT, P3; Bertulli C.G., 2012, Journal of Marine Animals and their Ecology, V5, P29; Bertulli CG, 2016, J MAR BIOL ASSOC UK, V96, P807, DOI 10.1017/S0025315415000284; BLOCH D, 1988, Rit Fiskideildar, V11, P55; Bolanos-Jimenez J, 2014, MAMMAL REV, V44, P177, DOI 10.1111/mam.12021; Bolt HE, 2009, AQUAT CONSERV, V19, P671, DOI 10.1002/aqc.1030; Booth Chris J., 2006, British Birds, V99, P533; Christensen I., 1982, REP INT WHAL COMM, V32; Christensen I., 1978, FISK HAV, P23; Cosentino A. Mel, 2015, Marine Biodiversity Records, V8, pe108, DOI 10.1017/S1755267215000895; De Stephanis R, 2015, ACTA ETHOL, V18, P69, DOI 10.1007/s10211-014-0189-1; Deecke VB, 2011, AQUAT BIOL, V13, P79, DOI 10.3354/ab00353; Donovan G, 1988, REP INT WHAL COMM, V39, P437; Esteban R, 2016, ECOL INDIC, V66, P291, DOI 10.1016/j.ecolind.2016.01.043; EVANS P G H, 1988, Rit Fiskideildar, V11, P42; Foote AD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11693; Foote AD, 2011, MOL ECOL, V20, P629, DOI 10.1111/j.1365-294X.2010.04957.x; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford J. K., 2014, PRIMATES CETACEANS, P75, DOI DOI 10.1007/978-4-431-54523-1_4; Ford JKB, 2005, MAR MAMMAL SCI, V21, P603, DOI 10.1111/j.1748-7692.2005.tb01254.x; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Galatius Anders, 2016, Mammalian Species, P35, DOI 10.1093/mspecies/sew003; Garoarsson Arnpor, 2009, BLIKI, V30, P49; Gilles A, 2011, 2011SC18AESP11 NAMMC; Hanson MB, 2014, AQUAT MAMM, V40, P274, DOI 10.1578/AM.40.3.2014.274; Hauksson Erlingur, 2007, NAMMCO Scientific Publications, V6, P85; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; Hoyt E., 1990, ORCA WHALE CALLED KI, V3rd; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; JONSGARD A, 1970, Nytt Magasin for Zoologi (Oslo), V18, P41; JONSGARD A, 1968, NOR HVALFANGST TID, V57, P84; Jonsson B, 2014, VMST14001 I FRESHW F; Jourdain E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180099; Kennedy J, 2015, ICES J MAR SCI, V72, P880, DOI 10.1093/icesjms/fsu170; Luque PL, 2006, AQUAT LIVING RESOUR, V19, P403, DOI 10.1051/alr:2007009; MARTIN AR, 1986, J MAR BIOL ASSOC UK, V66, P779, DOI 10.1017/S0025315400048426; McCordic JA, 2014, J MAR BIOL ASSOC UK, V94, P1311, DOI 10.1017/S0025315413001008; Mehta AV, 2007, MAR ECOL PROG SER, V348, P297, DOI 10.3354/meps07015; MFRI, 2017, ASS HAL; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; orbjornsson JG, HV2017009 MAR FRESHW; Oskarsson GJ, 2009, CAN J FISH AQUAT SCI, V66, P1666, DOI 10.1139/F09-095; Pedro S, 2017, SCI TOTAL ENVIRON, V601, P237, DOI 10.1016/j.scitotenv.2017.05.193; Pitman RL, 2007, J MAMMAL, V88, P43, DOI 10.1644/06-MAMM-A-118R1.1; Pitman Robert L., 2003, Journal of Cetacean Research and Management, V5, P131; Pitman RL, 2015, MAR MAMMAL SCI, V31, P629, DOI 10.1111/mms.12182; Pitman RL, 2012, MAR MAMMAL SCI, V28, P16, DOI 10.1111/j.1748-7692.2010.00453.x; Pitman RL, 2010, POLAR BIOL, V33, P1589, DOI 10.1007/s00300-010-0853-5; Pitman RL, 2011, POLAR BIOL, V34, P303, DOI 10.1007/s00300-010-0871-3; Rasmussen M., 2014, WHALE WATCHING SUSTA, P81, DOI [DOI 10.1017/CBO9781139018166.009, 10.1017/cbo9781139018166.009]; Robinson KP, 2017, AQUAT MAMM, V43, P26, DOI 10.1578/AM.43.1.2017.26; Samarra FIP, 2015, AQUAT BIOL, V24, P75, DOI 10.3354/ab00637; Samarra FIP, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3187-9; Samarra FIP, 2017, MAR ECOL PROG SER, V564, P199, DOI 10.3354/meps11998; Samarra FIP, 2017, HV2017005 MAR FRESHW; SIGURJONSSON J, 1988, Rit Fiskideildar, V11, P99; Simila T, 1996, CAN J FISH AQUAT SCI, V53, P769, DOI 10.1139/cjfas-53-4-769; Skulason A., 2010, MORGUNBLAOIO    1201, P9; Smith William E., 2006, British Birds, V99, P264; Smmundsson B., 1932, ISLENSK DYR 2 SPENDY; Solmundsson J, 2007, MAR BIOL RES, V3, P231, DOI 10.1080/17451000701477513; STENERSEN J., 2004, NORWEGIAN KILLER WHA; Tixier P, 2015, ANIM CONSERV, V18, P207, DOI 10.1111/acv.12161; Vester Heike, 2013, Marine Biodiversity Records, V6, pe9, DOI 10.1017/S1755267212001030; VIKINGSSON GA, 2004, ISLENSK SPENDYR, P166; Vongraven D, 2014, J MAR BIOL ASSOC UK, V94, P1357, DOI 10.1017/S0025315413001707; Weir Caroline R., 2002, British Wildlife, V14, P106; Whitt AD, 2015, AQUAT MAMM, V41, P252, DOI 10.1578/AM.41.3.2015.252; Williams A.J., 1990, Marine Ornithology, V18, P37	83	15	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207287	10.1371/journal.pone.0207287	http://dx.doi.org/10.1371/journal.pone.0207287			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540762	Green Published, gold			2022-12-26	WOS:000452898600014
J	Chen, YY; Kao, TW; Wang, CC; Chen, YJ; Wu, CJ; Chen, WL				Chen, Yuan-Yuei; Kao, Tung-Wei; Wang, Chung-Ching; Chen, Ying-Jen; Wu, Chen-Jung; Chen, Wei-Liang			Exploring the link between metabolic syndrome and risk of dysmobility syndrome in elderly population	PLOS ONE			English	Article							INSULIN-RESISTANCE; FAT MASS; DIABETES-MELLITUS; MUSCLE STRENGTH; SKELETAL-MUSCLE; NATIONAL-HEALTH; SEX-DIFFERENCES; SARCOPENIA; BONE; OSTEOPOROSIS	Dysmobility syndrome (DMS) was considered as a comprehensive approach to evaluate the condition of musculoskeletal system and adverse health problems in older population. The objective of our study was to examine the association between metabolic syndrome (MetS) and DMS in a U. S. adult population. 1760 eligible participants from the National Health and Nutrition Examination Survey (NHANES) 1999-2002 were enrolled in the study. The criteria of DMS consisted of six domains including increased body fat, declined muscle mass, reduced muscle strength, osteoporosis, slow gait speed, and balance problem. A multivariate regression analysis was investigated to clarify the relationship among MetS and its components and DMS. A positive association between increased number of MetS components and the presence of DMS achieved significance (beta = 0.142, 95% CI = 0.035, 0.249, p = 0.009). Among the components of MetS, hyperglycemia had a central place in the DMS after adjustment of clinical variables (beta = 0.083, 95% CI = 0.030, 0.136, p = 0.002). Notably, insulin resistance assessed by homeostatic model assessment (HOMA-IR) was correlated to increased body fat (r = 0.092, p< 0.05), osteoporosis (r = -0.105, p< 0.05) and balance (r = 0.105, p< 0.05) among these participants with MetS. Our study demonstrated a strong relationship between DMS and the presence of MetS and its components in elderly population, highlighting a possible mechanism through insulin resistance.	[Chen, Yuan-Yuei] Triserv Gen Hosp, Dept Internal Med, Songshan Branch, Taipei, Taiwan; [Chen, Yuan-Yuei; Kao, Tung-Wei; Wang, Chung-Ching; Wu, Chen-Jung; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Chen, Yuan-Yuei; Kao, Tung-Wei; Wang, Chung-Ching; Wu, Chen-Jung; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Kao, Tung-Wei; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Ying-Jen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Dept Community Med, Div Family Med, Taoyuan, Taiwan	Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital	Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.	weiliang0508@gmail.com						Andersen H, 2004, DIABETES CARE, V27, P2382, DOI 10.2337/diacare.27.10.2382; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; BARRETTCONNOR E, 1992, JAMA-J AM MED ASSOC, V268, P3333; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Binkley N, 2013, OSTEOPOROSIS INT, V24, P2955, DOI 10.1007/s00198-013-2427-1; Boccardi V, LINK INSULIN RESISTA; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Carriere I, 2014, J GERONTOL A-BIOL, V69, P79, DOI 10.1093/gerona/glt101; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Liefde II, 2005, OSTEOPOROSIS INT, V16, P1713, DOI 10.1007/s00198-005-1909-1; Duarte VMG, 2005, J BONE MINER METAB, V23, P58, DOI 10.1007/s00774-004-0542-y; Dufour AB, 2013, J GERONTOL A-BIOL, V68, P168, DOI 10.1093/gerona/gls109; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; GREGORIO F, 1994, DIABETES RES CLIN PR, V23, P43, DOI 10.1016/0168-8227(94)90126-0; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Hwang DK, 2010, OSTEOPOROSIS INT, V21, P425, DOI 10.1007/s00198-009-0990-2; Ishii S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112718; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Kalyani RR, 2014, DIABETES CARE, V37, P830, DOI 10.2337/dc13-1755; Katzmarzyk PT, 2005, DIABETES CARE, V28, P391, DOI 10.2337/diacare.28.2.391; Kayal RA, 2007, J BONE MINER RES, V22, P560, DOI 10.1359/JBMR.070115; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lee CG, 2011, J AM GERIATR SOC, V59, P1217, DOI 10.1111/j.1532-5415.2011.03472.x; Liaw FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22750; Looker AC, 2015, OSTEOPOROSIS INT, V26, P93, DOI 10.1007/s00198-014-2904-1; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45; Melton LJ, 2005, OSTEOPOROSIS INT, V16, P1558, DOI 10.1007/s00198-005-1871-y; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Ormsbee MJ, 2014, J CACHEXIA SARCOPENI, V5, P183, DOI 10.1007/s13539-014-0146-x; Ostchega Y, 2004, J AM GERIATR SOC, V52, P977, DOI 10.1111/j.1532-5415.2004.52268.x; Patel P, 2013, NUTRIENTS, V5, P2019, DOI 10.3390/nu5062019; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Ryder JW, 2001, FRONT BIOSCI-LANDMRK, V6, pD154, DOI 10.2741/Ryder; SCHAAP LA, 2009, THE JOURNALS OF GERO, V64, P1183, DOI DOI 10.1093/GERONA/GLP097; Shin D, 2014, J CLIN ENDOCR METAB, V99, P988, DOI 10.1210/jc.2013-3338; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; U. S. Department of Health and Human Services NH Lung and Blood Institute, 2018, WHAT IS MET SYNDR; Umegaki H, 2016, GERIATR GERONTOL INT, V16, P293, DOI 10.1111/ggi.12688; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Viscogliosi G, 2016, J AM MED DIR ASSOC, V17, P364, DOI 10.1016/j.jamda.2016.01.005; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang WW, 2010, MOL CELL BIOCHEM, V338, P115, DOI 10.1007/s11010-009-0344-6; Zhou JJ, 2013, BONE, V57, P30, DOI 10.1016/j.bone.2013.07.013	51	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0207608	10.1371/journal.pone.0207608	http://dx.doi.org/10.1371/journal.pone.0207608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD8CS	30533044	Green Submitted, Green Published, gold			2022-12-26	WOS:000452782500009
J	Raz, L; Yang, Y; Thompson, J; Hobson, S; Pesko, J; Mobashery, S; Chang, M; Rosenberg, G				Raz, Limor; Yang, Yi; Thompson, Jeffrey; Hobson, Sasha; Pesko, John; Mobashery, Shahriar; Chang, Mayland; Rosenberg, Gary			MMP-9 inhibitors impair learning in spontaneously hypertensive rats	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; MATRIX METALLOPROTEINASES; VASCULAR CONTRIBUTIONS; MINOCYCLINE; BRAIN; GELATINASE; DEMENTIA; STROKE; MATRIX-METALLOPROTEINASE-9; NEUROINFLAMMATION	Vascular cognitive impairment dementia (VCID) is a major cause of cognitive loss in the elderly. Matrix metalloproteinases (MMPs) are a family of proteases involved in remodeling the extracellular matrix in development, injury and repair. Blood-brain barrier (BBB) disruption due to inflammation mediated by MMPs is a mechanism of white matter injury. Currently there are no treatments besides the control of vascular risk factors. We tested two MMP-9 inhibitors that improved outcome in acute stroke: DP-460 and SB-3CT. We hypothesized that these inhibitors would have a beneficial effect in chronic stroke by reducing edema in white matter and improving behavioral outcomes. Spontaneously hypertensive stroke-prone rats (SHRSPs) with unilateral carotid artery occlusion (UCAO) fed a Japanese Permissive Diet (JPD) were used as a model of VCID. JPD was begun in the 12 th week of life. Rats were treated with DP-460 (500 mg/kg) for 4 weeks, or SB-3CT (10 mg/kg) for 8 weeks, beginning at the UCAO/JPD onset. Rats treated with a dextrose or DMSO solution served as vehicle controls. Naive SHRSPs on a standard diet served as sham control. Magnetic resonance imaging (MRI) analyses of the corpus callosum, external capsule, hippocampus and Morris water maze behavioral tests were conducted. We found an increase in body weight (p = 0.004) and blood pressure (p = 0.007) at 15 weeks with the DP-460 drug. SB-3CT increased body weight at 14 weeks (p = 0.015) and had significant but variable effects on blood pressure. Neither drug affected imaging parameters. Behavioral studies showed an impaired ability to learn with DP-460 (p<0.001) and no effect on learning with SB-3CT. Unchanged MMP-9 levels were detected in DP-460-treated rats via gel zymography. Our findings suggest that MMPs are not major factors in white matter damage in the SHRSP model of VCID and that drugs that are relatively selective for MMP-9 can interfere with learning.	[Raz, Limor; Yang, Yi; Rosenberg, Gary] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Thompson, Jeffrey; Hobson, Sasha] Univ New Mexico, NM Memory & Aging Ctr, Albuquerque, NM 87131 USA; [Pesko, John] AbbVie, Data & Stat Sci, N Chicago, IL USA; [Mobashery, Shahriar; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of New Mexico; University of New Mexico; AbbVie; University of Notre Dame	Raz, L (corresponding author), Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA.	Dr.liraz@gmail.com			National Institute of Health [R01 NS045847-071A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045847] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is funded by the National Institute of Health and awarded to Gary Rosenberg, PhD, R01 NS045847-071A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JC, 2004, STROKE, V35, pE159, DOI 10.1161/01.STR.0000127420.10990.76; Candelario-Jalil E, 2011, STROKE, V42, P1345, DOI 10.1161/STROKEAHA.110.600825; Cuadrado E, 2009, J PROTEOME RES, V8, P3191, DOI 10.1021/pr801012x; Diener HC, 2008, STROKE, V39, P1774, DOI 10.1161/STROKEAHA.107.506378; Dziembowska M, 2012, J NEUROSCI, V32, P14538, DOI 10.1523/JNEUROSCI.6028-11.2012; Forbes C, 2009, CHEM BIOL DRUG DES, V74, P527, DOI 10.1111/j.1747-0285.2009.00881.x; Gao M, 2015, P NATL ACAD SCI USA, V112, P15226, DOI 10.1073/pnas.1517847112; Giuliani F, 2005, J LEUKOCYTE BIOL, V78, P135, DOI 10.1189/jlb.0804477; Gooyit M, 2014, ACS CHEM BIOL, V9, P105, DOI 10.1021/cb4005468; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jalal FY, 2015, J CEREBR BLOOD F MET, V35, P1145, DOI 10.1038/jcbfm.2015.21; Jalal FY, 2012, STROKE, V43, P1115, DOI 10.1161/STROKEAHA.111.643080; Jin XC, 2013, EXP NEUROL, V240, P9, DOI 10.1016/j.expneurol.2012.11.018; Kitamura A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.033; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Madigan JB, 2016, STROKE, V47, P1953, DOI 10.1161/STROKEAHA.116.012066; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Petri S, 2007, J NEUROCHEM, V102, P991, DOI 10.1111/j.1471-4159.2007.04604.x; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; ROSENBERG GA, 1994, LAB INVEST, V71, P417; Rosenberg GA, 2016, CELL MOL NEUROBIOL, V36, P195, DOI 10.1007/s10571-015-0277-4; Rosenberg GA, 2016, J CEREBR BLOOD F MET, V36, P6, DOI 10.1038/jcbfm.2015.172; Sironi L, 2004, J NEUROSCI RES, V78, P115, DOI 10.1002/jnr.20219; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Sood R, 2007, J MAGN RESON IMAGING, V25, P39, DOI 10.1002/jmri.20802; Tsilibary E, 2014, PROG BRAIN RES, V214, P135, DOI 10.1016/B978-0-444-63486-3.00006-2; Vafadari B, 2015, J NEUROCHEM, DOI [10.1111/JNE.13415, DOI 10.1111/JNE.13415]; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Wojcik-Stanaszek L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022465; Yang Y, 2018, NEUROBIOL DIS, V114, P95, DOI 10.1016/j.nbd.2018.02.012; Yang Y, 2016, TRANSL STROKE RES, V7, P407, DOI 10.1007/s12975-016-0486-2; Yeghiazaryan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099789; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	38	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208357	10.1371/journal.pone.0208357	http://dx.doi.org/10.1371/journal.pone.0208357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533010	Green Submitted, Green Published, gold			2022-12-26	WOS:000452782500018
J	Tinker, KA; Ottesen, EA				Tinker, Kara A.; Ottesen, Elizabeth A.			The hindgut microbiota of praying mantids is highly variable and includes both prey-associated and host-specific microbes	PLOS ONE			English	Article							GUT MICROBIOTA; TERMITES; DIVERSITY; COCKROACH; COMMUNITY; MANTODEA; INSECTS; DIET; PHYLOGENY; EVOLUTION	Praying mantids are predators that consume a wide variety of insects. While the gut micro-biome of carnivorous mammals is distinct from that of omnivores and herbivores, the role of the gut microbiome among predatory insects is relatively understudied. Praying mantids are the closest known relatives to termites and cockroaches, which are known for their diverse gut microbiota. However, little is known about the mantid gut microbiota or their importance to host health. In this work, we report the results of a 16S rRNA gene-based study of gut microbiome composition in adults and late-instar larvae of three mantid species. We found that the praying mantis gut microbiome exhibits substantial variation in bacterial diversity and community composition. The hindgut of praying mantids were often dominated by microbes that are present in low abundance or not found in the guts of their insect prey. Future studies will explore the role of these microbes in the digestion of the dietary substrates and/or the degradation of toxins produced by their insect prey.	[Tinker, Kara A.; Ottesen, Elizabeth A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Ottesen, EA (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	ottesen@uga.edu		Ottesen, Elizabeth/0000-0002-7898-2425; Tinker, Kara/0000-0002-4860-6277	University of Georgia	University of Georgia	This work was supported by funds provided by the University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Arkin RC, 2000, ROBOT AUTON SYST, V32, P39, DOI 10.1016/S0921-8890(99)00121-9; Beckman N, 2003, ENVIRON ENTOMOL, V32, P881, DOI 10.1603/0046-225X-32.4.881; Berlanga M, 2016, SYMBIOSIS, V68, P49, DOI 10.1007/s13199-016-0388-9; Berlanga M, 2015, INT MICROBIOL, V18, P159, DOI [10.2436/20.1501.01.246, 10.2436/20.1501.01.246.]; Bertino-Grimaldi D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-609; Brannoch SK, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.696.12542; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; Brune A, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P439, DOI 10.1007/978-90-481-3977-4_16; Carle T, 2017, J COMP NEUROL, V525, P1685, DOI 10.1002/cne.24159; Carrasco P, 2014, INT MICROBIOL, V17, P99, DOI 10.2436/20.1501.01.212; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Claus SP, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.3; de Almeida LG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174754; deHart PAP, 2015, ENTOMOL NEWS, V125, P153, DOI 10.3157/021.125.0302; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; DITTMER J, 2016, FRONT MICROBIOL, V7; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Perez-Cobas AE, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv022; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fukudome M, 2016, J ETHOL, V34, P231, DOI 10.1007/s10164-016-0468-6; Glockner FO, 2017, J BIOTECHNOL, V261, P169, DOI 10.1016/j.jbiotec.2017.06.1198; Hammer TJ, 2017, P NATL ACAD SCI USA, V114, P9641, DOI 10.1073/pnas.1707186114; Hammer TJ, 2015, OECOLOGIA, V179, P1, DOI 10.1007/s00442-015-3327-1; Harishankar MK, 2013, 3 BIOTECH, V3, P137, DOI 10.1007/s13205-012-0078-0; Hurd LE, 2015, ENVIRON ENTOMOL, V44, P239, DOI 10.1093/ee/nvv004; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Kwong WK, 2015, GUT MICROBES, V6, P214, DOI 10.1080/19490976.2015.1047129; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; McCue MD, 2016, J INSECT PHYSIOL, V93-94, P64, DOI 10.1016/j.jinsphys.2016.08.008; Mebs D, 2017, TOXICON, V131, P16, DOI 10.1016/j.toxicon.2017.03.010; Mikaelyan A, 2016, APPL ENVIRON MICROB, V82, P1256, DOI 10.1128/AEM.03700-15; Mikaelyan A, 2015, SYST APPL MICROBIOL, V38, P472, DOI 10.1016/j.syapm.2015.07.004; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nityananda V, 2018, CURR BIOL, V28, P588, DOI 10.1016/j.cub.2018.01.012; Nityananda V, 2017, J COMP PHYSIOL A, V203, P77, DOI 10.1007/s00359-016-1139-3; Nityananda V, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0262; O''Hanlon JC, 2014, AM NAT, V183, P126, DOI 10.1086/673858; Oksanen J., **DATA OBJECT**; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Rafter JL, 2017, ENVIRON ENTOMOL, V46, P626, DOI 10.1093/ee/nvx038; Rafter JL, 2017, INSECTS, V8, DOI 10.3390/insects8010023; Rafter JL, 2013, ECOL ENTOMOL, V38, P76, DOI 10.1111/j.1365-2311.2012.01408.x; REITZE M, 1991, OECOLOGIA, V86, P568, DOI 10.1007/BF00318324; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rivera J, 2017, ZOOTAXA, V4337, P361, DOI 10.11646/zootaxa.4337.3.3; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2018, MISEQ SOP; Speed MP, 2014, ANIM BEHAV, V98, P53, DOI 10.1016/j.anbehav.2014.09.011; Szczecinski NS, 2017, ARTHROPOD STRUCT DEV, V46, P736, DOI 10.1016/j.asd.2017.03.001; Tegtmeier D, 2016, APPL ENVIRON MICROB, V82, P1080, DOI 10.1128/AEM.03130-15; Tiede J, 2017, ECOL EVOL, V7, P8545, DOI 10.1002/ece3.3390; Tinker KA, 2016, APPL ENVIRON MICROB, V82, P6603, DOI 10.1128/AEM.01837-16; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wada-Katsumata A, 2015, P NATL ACAD SCI USA, V112, P15678, DOI 10.1073/pnas.1504031112; Westcott SL, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00073-17; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zvereva EL, 2016, ECOL MONOGR, V86, P107, DOI 10.1890/15-0911.1	65	5	6	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208917	10.1371/journal.pone.0208917	http://dx.doi.org/10.1371/journal.pone.0208917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533025	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500047
J	Amatya, P; Ghimire, S; Callahan, KE; Baral, BK; Poudel, KC				Amatya, Prabisha; Ghimire, Saruna; Callahan, Karen E.; Baral, Binaya Kumar; Poudel, Krishna C.			Practice and lived experience of menstrual exiles (Chhaupadi) among adolescent girls in far-western Nepal	PLOS ONE			English	Article							HEALTH	Background Menstrual exile, also known as Chhaupadi, is a tradition of "untouchability" in far-western Nepal. Forbidden from touching other people and objects, women and girls are required to live away from the community, typically in a livestock shed, during menstruation. We assessed the lived experiences of Chhaupadi among Nepalese adolescent girls in the far-western Achham district of Nepal, observed the safety and sanitation of their living spaces during Chhaupadi, and assessed the perceptions of local adult stakeholders towards the practice of Chhaupadi. Methods We collected data from 107 adolescent girls using a self-administered survey in two local schools in Achham. We also conducted a focus group discussion with seven girls, held key informant interviews, and observed the girls' living spaces during Chhaupadi, using a checklist. Descriptive statistics of the quantitative survey and thematic analyses of qualitative interviews are presented. Results The majority of the girls (n = 77, 72%) practiced exile, or Chhaupadi, during their menstruation, including 3 (4%) exiled to traditional Chhau sheds, 63 (82%) to livestock sheds, and 11 (14%) to courtyards outside their home. The remaining girls (n = 30, 28%) stayed inside the house, yet practiced some form of menstrual taboos. Of the 77 observed living spaces where the girls stayed during exile, only 30% (n = 23) had a toilet facility. Most exiled girls (97.4%) were restricted from eating dairy products. Participants reported having various psychological problems, including lonliness and difficulty sleeping while practicing Chhaupadi. Three of the girls were physically abused; nine were bitten by a snake. Notably high proportions of the living spaces lacked ventilation/windows (n = 20, 26%), electricity (n = 29, 38%), toilets (n = 54, 70%) and a warm blanket and mattress for sleeping (n = 29, 38%). Our qualitative findings supported our quantitative results. Conclusions Chhaupadi has been condemned by human rights organizations. While the government has banned the practice, implementation on the ban is proceeding slowly, especially in far-western Nepal. Thus, as a temporary measure, public health professionals must work towards promoting the health and safety of Nepalese women and girls still practicing Chhaupadi.	[Amatya, Prabisha] Pokhara Univ, Cent Inst Sci & Technol CIST Coll, Dept Publ Hlth, Kathmandu, Nepal; [Ghimire, Saruna] Agrata Hlth & Educ AHEAD Nepal, Kathmandu, Nepal; [Ghimire, Saruna; Callahan, Karen E.] Univ Nevada, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Baral, Binaya Kumar] Nepal Med Coll & Teaching Hosp, Dept Biochem, Kathmandu, Nepal; [Poudel, Krishna C.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Hlth Promot & Policy, Amherst, MA 01003 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Massachusetts System; University of Massachusetts Amherst	Ghimire, S (corresponding author), Agrata Hlth & Educ AHEAD Nepal, Kathmandu, Nepal.; Ghimire, S (corresponding author), Univ Nevada, Sch Community Hlth Sci, Las Vegas, NV 89154 USA.	sarunaghimire@gmail.com	Ghimire, Saruna/Y-7905-2019	Ghimire, Saruna/0000-0002-2662-2006				ADB, 2010, OV GEND EQ SOC INCL; [Anonymous], 2017, BBC; [Anonymous], 2017, THE KATHMANDU POST; Aryal KK, 2016, ADOLESCENT NUTR SURV; Bhandari R, 2013, P 2 INT C S AS SOC C; Bhandari R, 2017, NY TIMES; Bowman V., 2018, GUARDIAN; CBS, 2012, NAT POP HOUS CENS 20; CBS, 2016, ANN HOUS SURV 2014 1; CBS and ICIMOD, 2003, DISTR NEP IND DEV UP; Chapman AL, 2015, J ROY COLL PHYS EDIN, V45, P201, DOI 10.4997/JRCPE.2015.305; Crawford M, 2014, CULT HEALTH SEX, V16, P426, DOI 10.1080/13691058.2014.887147; Creswell J. W., 2017, QUAL INQ; Dahal K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2520; DEO, 2014, 2 DEO MIN ED GOV NEP; Gaelstel A, 2013, NY TIMES; Guterman M., 2008, INTERNET J WORLD HLT, V5, P2; Hodal Kate, 2016, GUARDIAN; House S., 2013, REPROD HEALTH MATTER, V21, P257, DOI [DOI 10.1016/S0968-8080(13)41712-3, 10.1016/S0968-8080(13)41712-3]; Kadariya, 2015, MEDICOLEGAL BIOETHIC, V5, P53, DOI [10.2147/MB.S83825, DOI 10.2147/MB.S83825, 10.2147/mb.s83825]; Karki K. B., 2017, SCOPING REV PRELIMIN; Lama D, 2015, PUBLIC HLTH RES SERI, V22; Lynn B, 2008, CASTE ETHNIC REGIONA; Moustakas C., 1994, PHENOMENOLOGICAL RES; Nations United, 2011, FIELD B CHAUP FAR W; NDHS, 2012, NEP DEM HLTH SURV 20; NFCC, 2015, ASS STUD CHHAUP NEP; Pokharel S, 2017, CNN; Preiss D, 2017, NATL PUBLIC RADIO; Preiss D, 2016, NATL PUBLIC RADIO; Rana B, 2012, GLOBAL SCHOLARS PROG; Ranabhat C, 2015, ASIA-PAC J PUBLIC HE, V27, P785, DOI 10.1177/1010539515602743; Robinson Hannah, 2015, Int J Womens Dermatol, V1, P193, DOI 10.1016/j.ijwd.2015.10.002; Schwarz D, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-473; Sharma N., 2006, ANTHROPOLOGIST, V8, P55; Soliman Ashraf, 2014, Indian J Endocrinol Metab, V18, pS39, DOI 10.4103/2230-8210.145073; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Tuladhar Heera, 2005, Nepal Med Coll J, V7, P107; UNICEF, 2006, SIT CHILDR WOM NEP; UNRCHCO, 2013, UNDAF DISTR PROF ACH; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290; WASH United, 2017, UND MENSTR HYG MAN H; World Health Organization, 2011, STRAT DIR IMPR AD HL, V4; World Health Organization Regional Office for South-East Asia, 2006, ADD NUTR REV SIT SEL; Worldwide PHASE, 2013, CHHAUP GIV BIRTH COW	45	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208260	10.1371/journal.pone.0208260	http://dx.doi.org/10.1371/journal.pone.0208260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532183	Green Submitted, Green Published, gold			2022-12-26	WOS:000452644700016
J	Richaud, D; Stange, C; Gadaleta, A; Colasuonno, P; Parada, R; Schwember, AR				Richaud, Daniela; Stange, Claudia; Gadaleta, Agata; Colasuonno, Pasqualina; Parada, Roberto; Schwember, Andres R.			Identification of Lycopene epsilon cyclase (LCYE) gene mutants to potentially increase beta-carotene content in durum wheat (Triticum turgidum L.ssp. durum) through TILLING	PLOS ONE			English	Article							PHYTOENE SYNTHASE; BIOSYNTHESIS; ACCUMULATION; EXPRESSION; TOMATO; LUTEIN; PLANTS; L.; PROVITAMIN; REVEALS	Increasing beta-carotene (a vitamin A precursor) content in Triticum turgidum L. ssp. durum (durum wheat) grains is important to improve pasta nutritional quality. Studies in other species show that altering the expression of LCYE genes increases the flux towards the beta-beta branch, accumulating higher beta-carotene levels. Durum wheat is a tetraploid species that has two LCYE genes (LCYE-A and LCYE-B) associated to the A and B genomes. The objective of this work was to produce durum wheat LCYE mutants through EMS to potentially increase beta-carotene content. The LCYE point mutations created with EMS were identified using a Kronos TILLING (Targeting Induced Local Lesion IN Genomes) mutant population. Specific primers that amplified exons 3 through 10 of the LCYE genes were designed and validated. To simplify the TILLING procedure, fragments were digested with CJE (Celery Juice Extract) and visualized on 2% agarose gels. 6X mutant pools were identified, which showed cleavage products and then made into 2X pools to identify mutant individuals. LCYE mutants were then sequenced and evaluated with BLOSUM62, SIFT and PSSM algorithms. Mutants with substitutions W437*, P334L and G368R in LCYE-A and P405L, G352R and T3931 in LCYE-B predicted to affect protein function were selected. Substitution W437* increased beta-carotene in 75% and overall total carotenoids content in leaves of the mutant 2426 (A1 mutant line), but no significant differences relative to the control were found in grains through HPLC. Finally, the increased levels of beta-carotene on leaves have potential applications to improving plant resistance under contaminated environmental conditions.	[Richaud, Daniela; Parada, Roberto; Schwember, Andres R.] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Lab Fitomejoramiento Mol, Santiago, Chile; [Stange, Claudia] Univ Chile, Fac Ciencias, Lab Biol Mol Vegetal, Santiago, Chile; [Gadaleta, Agata; Colasuonno, Pasqualina] Univ Bari Aldo Moro, Dept Environm & Terr Sci DiSAAT, Bari, Italy	Pontificia Universidad Catolica de Chile; Universidad de Chile; Universita degli Studi di Bari Aldo Moro	Schwember, AR (corresponding author), Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Lab Fitomejoramiento Mol, Santiago, Chile.	aschwember@uc.cl	Gadaleta, Agata/H-2627-2012	Gadaleta, Agata/0000-0002-6312-249X; Schwember, Andres/0000-0003-1862-3110	Conicyt [1161298, 1130245]	Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was financially supported by Conicyt (grants Fondecyt Regular no 1161298 [Andres R. Schwember] and no 1130245 [Claudia Stange]).	Abdel-Aal ESM, 2007, J AGR FOOD CHEM, V55, P787, DOI 10.1021/jf062764p; Apel W, 2009, PLANT PHYSIOL, V151, P59, DOI 10.1104/pp.109.140533; Botticella E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-156; Braun HJ, 2010, CABI CLIM CHANGE SER, V1, P115, DOI 10.1079/9781845936334.0115; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chiapusio G, 2007, PLANT SOIL, V294, P103, DOI 10.1007/s11104-007-9234-4; Colasuonno P, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0350-0; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; Cunningham FX, 2001, P NATL ACAD SCI USA, V98, P2905, DOI 10.1073/pnas.051618398; Digesu AM, 2009, J CEREAL SCI, V50, P210, DOI 10.1016/j.jcs.2009.05.002; Diretto G, 2006, BMC PLANT BIOL, P6, DOI [10.1186/1471-2229-6-6, DOI 10.1186/1471-2229-6-6]; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ficco DBM, 2014, CROP PASTURE SCI, V65, P1, DOI 10.1071/CP13293; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Fraser PD, 1999, PLANT MOL BIOL, V40, P687, DOI 10.1023/A:1006256302570; Fratianni A, 2005, J AGR FOOD CHEM, V53, P2373, DOI 10.1021/jf040351n; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fuentes P, 2012, PLANT MOL BIOL, V79, P47, DOI 10.1007/s11103-012-9893-2; Giorio G, 2008, FEBS J, V275, P527, DOI 10.1111/j.1742-4658.2007.06219.x; Granado F, 2003, BRIT J NUTR, V90, P487, DOI 10.1079/BJN2003927; Greber B, 2005, HUM MUTAT, V25, P483, DOI 10.1002/humu.20168; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Howitt CA, 2009, FUNCT INTEGR GENOMIC, V9, P363, DOI 10.1007/s10142-009-0121-3; Kammholz SJ, 2001, AUST J AGR RES, V52, P1079, DOI 10.1071/AR01043; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459; Lichtenthaler HK, 2001, CURR PROTOC FOOD ANA, V1; Ma L, 2010, J SCI FOOD AGR, V90, P2, DOI 10.1002/jsfa.3785; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Moreno JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058144; NAGAO A, 1994, FASEB J, V8, P968, DOI 10.1096/fasebj.8.12.8088462; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nishino H, 2009, ARCH BIOCHEM BIOPHYS, V483, P165, DOI 10.1016/j.abb.2008.09.011; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Pecker I, 1996, PLANT MOL BIOL, V30, P807, DOI 10.1007/BF00019013; Pogson B, 1996, PLANT CELL, V8, P1627, DOI 10.1105/tpc.8.9.1627; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; Qin XQ, 2016, CROP SCI, V56, P3173, DOI 10.2135/cropsci2016.06.0520; Qin XQ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0848-7; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Ramachandran A, 2010, J CEREAL SCI, V52, P30, DOI 10.1016/j.jcs.2010.02.014; Rawat N, 2012, BMC PLANT BIOL, P12, DOI [10.1186/1471-2229-12-12, DOI 10.1186/1471-2229-12-12]; Ribaya-Mereado JD, 2004, J AM COLL NUTR, V23, p567S, DOI 10.1080/07315724.2004.10719427; Rosas-Saavedra C, 2016, SUBCELL BIOCHEM, V79, P35, DOI 10.1007/978-3-319-39126-7_2; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; Shen Y, 2018, CHEMOSPHERE, V197, P513, DOI 10.1016/j.chemosphere.2018.01.036; Simkin AJ, 2008, J PLANT PHYSIOL, V165, P1087, DOI 10.1016/j.jplph.2007.06.016; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slade AJ, 2012, BMC PLANT BIOL, P12; Sommer A, 2002, J NUTR, V132, p2845S, DOI 10.1093/jn/132.9.2845S; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Uauy C, 2009, BMC PLANT BIOL, P9; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yeung A, 2005, BIOTECHNIQUES, V38, P749, DOI 10.2144/05385RV01; Young A. J, 1993, CAROTENOIDS PHOTOSYN; Yu BY, 2008, TRANSGENIC RES, V17, P573, DOI 10.1007/s11248-007-9131-x; Zhua CF, 2003, BBA-GENE STRUCT EXPR, V1625, P305, DOI 10.1016/S0167-4781(03)00017-4	64	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208948	10.1371/journal.pone.0208948	http://dx.doi.org/10.1371/journal.pone.0208948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532162	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700060
J	Scheuter, C; Wertli, MM; Haynes, AG; Panczak, R; Chiolero, A; Perrier, A; Rodondi, N; Aujesky, D				Scheuter, Claudia; Wertli, Maria M.; Haynes, Alan G.; Panczak, Radoslaw; Chiolero, Arnaud; Perrier, Arnaud; Rodondi, Nicolas; Aujesky, Drahomir			Unwarranted regional variation in vertebroplasty and kyphoplasty in Switzerland: A population-based small area variation analysis	PLOS ONE			English	Article							VERTEBRAL COMPRESSION FRACTURES; PERCUTANEOUS VERTEBROPLASTY; RANDOMIZED-TRIAL; AUGMENTATION; CARE; OSTEOPOROSIS; ASSOCIATION; TRENDS; LIFE; ACR	Background Percutaneous vertebroplasty (VP) and balloon kyphoplasty (BKP) for treating painful osteoporotic vertebral fractures are controversial. Objective We assessed the regional variation in the use of VP/BKP in Switzerland. Methods We conducted a population-based small area variation analysis using patient discharge data for VP/BKP from all Swiss hospitals and Swiss census data for calendar years 2012/13. We derived hospital service areas (HSAs) by analyzing patient flows, assigning regions from which most residents were discharged to the same VP/BKP specific HSA. We calculated age-/sex-standardized mean VP/BKP-rates and measures of regional variation (extremal quotient [EQ], systematic component of variation [SCV]). We estimated the reduction in variation of VP/BKP rates using negative binomial regression, with adjustment for patient demographic and regional socioeconomic factors (socioeconomic status, urbanization, and language region). We considered the residual, unexplained variation most likely to be unwarranted. Results Overall, 4955 VP/BKPs were performed in Switzerland in 2012/13. The age-/sex-standardized mean VP/BKP rate was 4.6/10,000 persons and ranged from 1.0 to 10.1 across 26 HSAs. The EQ was 10.2 and the SCV 57.6, indicating a large variation across VP/BKP specific HSAs. After adjustment for demographic and socioeconomic factors, the total reduction in variance was 32.2% only, with the larger part of the variation remaining unexplained. Conclusions We found a 10-fold variation in VP/BKP rates across Swiss VP/BKP specific HSAs. As only one third of the variation was explained by differences in patient demographics and regional socioeconomic factors, VP/BKP in the highest-use areas may, at least partially, represent overtreatment.	[Scheuter, Claudia; Wertli, Maria M.; Rodondi, Nicolas; Aujesky, Drahomir] Univ Bern, Bern Univ Hosp, Div Gen Internal Med, Inselspital, Bern, Switzerland; [Haynes, Alan G.; Panczak, Radoslaw] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Haynes, Alan G.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Chiolero, Arnaud; Rodondi, Nicolas] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Chiolero, Arnaud] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Perrier, Arnaud] Geneva Univ Hosp, Div Internal Med Rehabil & Geriatr, Geneva, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; McGill University; University of Geneva	Wertli, MM (corresponding author), Univ Bern, Bern Univ Hosp, Div Gen Internal Med, Inselspital, Bern, Switzerland.	Maria.Wertli@insel.ch	; Wertli, Maria/Q-3349-2017	Chiolero, Arnaud/0000-0002-5544-8510; Wertli, Maria/0000-0001-6347-0198; Rodondi, Nicolas/0000-0001-9083-6896; Haynes, Alan G/0000-0003-1374-081X	Health Services Research funding program of the Gottfried and Julia Bangerter-Rhyner-Stiftung; Swiss Society of General Internal Medicine Foundation	Health Services Research funding program of the Gottfried and Julia Bangerter-Rhyner-Stiftung; Swiss Society of General Internal Medicine Foundation	This study was funded by the Health Services Research funding program of the Gottfried and Julia Bangerter-Rhyner-Stiftung and the Swiss Society of General Internal Medicine Foundation. The sponsors did not have an influence on the study design, the collection, analysis and interpretation of the data, the writing of the report, and in the decision to submit the paper for publication.	American Academy of Orthopaedic Surgeons (AAOS), 2017, TREATM SYMPT OST SPI; Anthony DL, 2009, HEALTH AFFAIR, V28, P864, DOI 10.1377/hlthaff.28.3.864; Barr JD, 2014, J VASC INTERV RADIOL, V25, P171, DOI 10.1016/j.jvir.2013.10.001; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Bornemann R, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS131, DOI 10.1007/s00590-013-1257-3; BRESLOW NE, 1975, J CHRON DIS, V28, P289, DOI 10.1016/0021-9681(75)90010-7; Buchbinder R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006349.pub3; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Carli D, 2017, TRIAL VERTEBROPLASTY; Clark W, 2016, LANCET, V388, P1408, DOI 10.1016/S0140-6736(16)31341-1; Deyo RA, 2000, MED CARE, V38, P959, DOI 10.1097/00005650-200009000-00009; Dohm M, 2014, AM J NEURORADIOL, V35, P2227, DOI 10.3174/ajnr.A4127; Farrokhi MR, 2011, J NEUROSURG-SPINE, V14, P561, DOI 10.3171/2010.12.SPINE10286; Firanescu C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-93; Firanescu CE, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1551; Goebel V, 2014, RAUM STADTISCHEM CHA, P1; Goldberg H I, 2001, Eff Clin Pract, V4, P95; Hirsch JA, 2016, J NEUROINTERV SURG, V8, P1299, DOI 10.1136/neurintsurg-2016-012767; Hussein MA, 2008, LEUKEMIA, V22, P1479, DOI 10.1038/leu.2008.127; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Klauss G, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-33; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Lad SP, 2009, SURG NEUROL, V71, P580, DOI 10.1016/j.surneu.2008.02.043; Leake CB, 2011, AM J NEURORADIOL, V32, P1464, DOI 10.3174/ajnr.A2503; Lyscom, 2017, VARIATIONS HEALTHCAR; Manchikanti L, 2013, J NEUROINTERV SURG, V5, P467, DOI 10.1136/neurintsurg-2012-010337; McConnell CT, 2014, J AM COLL RADIOL, V11, P757, DOI 10.1016/j.jacr.2014.04.011; McCulloch P, 2013, LANCET, V382, P1130, DOI 10.1016/S0140-6736(13)61216-7; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; McPherson K, 1996, 2 LOND SCH HYG TROP; Medical Service Advisory Committee (MSAC), 2017, REV KYPH TREATM VERT; Moser A, 2014, J EPIDEMIOL COMMUN H, V68, P1125, DOI 10.1136/jech-2014-204352; National Institute for Health and Care Excellence (NICE), 2017, PERC VERT PERC BALL, DOI [10.1136/neurintsurg-2016-012767, DOI 10.1136/NEURINTSURG-2016-012767]; National Institute for Health and Care Excellence (NICE), MET SPIN CORD COMP A; OECD, 2015, ENTR GLANC 2015, DOI 10.1787/health_glance-2015-en; Panczak R, 2017, MED CARE, V55, P155, DOI 10.1097/MLR.0000000000000634; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; Pellegrini S, 2014, VARIATIONS GEOGRAPHI, P42; R Development Core Team, 2016, R LANG ENV STAT COMP; Rousing R, 2010, SPINE, V35, P478, DOI 10.1097/BRS.0b013e3181b71bd1; Solomon DH, 2007, SPINE, V32, P2910, DOI 10.1097/BRS.0b013e31815b7563; Swiss Federal Statistical Office (SFSO), 2013, MEDST REG SCHWEIZ WO; Swiss Federal Statistical Office (SFSO), 2015, MED STAT KRANK 2013, P1; Swiss Federal Statistical Office (SFSO), 2014, MED STAT KRANK US 20, P1; Swiss Medical Board, 2011, VERT KYPH BEI OST WI, P1; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Wennberg JE, 2010, TRACKING MED RES QUE; Wennberg JE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1513; Yang EZ, 2016, SPINE, V41, P653, DOI 10.1097/BRS.0000000000001298	53	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208578	10.1371/journal.pone.0208578	http://dx.doi.org/10.1371/journal.pone.0208578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532141	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700030
J	Brinkley-Rubinstein, L; Peterson, M; Arnold, T; Nunn, AS; Beckwith, CG; Castonguay, B; Junious, E; Lewis, C; Chan, PA				Brinkley-Rubinstein, Lauren; Peterson, Meghan; Arnold, Trisha; Nunn, Amy S.; Beckwith, Curt G.; Castonguay, Breana; Junious, Eric; Lewis, Chantal; Chan, Philip A.			Knowledge, interest, and anticipated barriers of pre-exposure prophylaxis uptake and adherence among gay, bisexual, and men who have sex with men who are incarcerated	PLOS ONE			English	Article							HEALTH-CARE; BLACK-MEN; CONDOM DISTRIBUTION; HIV PREVENTION; PUBLIC-HEALTH; YOUNG MEN; ACCEPTABILITY; FACILITATORS; PEOPLE; INFECTIONS	Criminal justice (CJ) settings disproportionately include populations at high risk for acquiring HIV, and CJ-involved individuals are often at the intersection of multiple overlapping risk factors. However, few studies have examined attitudes about pre-exposure prophylaxis (PrEP) among incarcerated men who have sex with men (MSM). This study explored interest in, knowledge of, and barriers to PrEP uptake among gay, bisexual, and other men who have sex with men at the Rhode Island Department of Corrections. Using semi-structured interviews, 26 MSM were interviewed about PrEP knowledge, interest, timing preferences for provision (e.g. before or after release), and barriers to uptake and adherence during community re-entry. Interviews were coded and analyzed using a general inductive approach. Participants demonstrated low initial knowledge of PrEP but high interest after being told more about it. Participants self-identified risk factors for HIV acquisition, including condomless sex and substance use. In addition, participants preferred provision of PrEP prior to release. Post-release barriers to PrEP uptake and adherence included 1) concerns about costs of PrEP medications; 2) anticipated partner or family disapproval; 3) lack of access to transportation; 4) unstable housing; 5) compounding impacts of multiple hardships leading to a de-prioritization of PrEP and 6) fears of future re-incarceration. These results point to the need for future PrEP interventions among incarcerated populations that address incarceration and PrEP related barriers during community re-entry via wraparound services that address PrEP and incarceration-related barriers.	[Brinkley-Rubinstein, Lauren] Univ N Carolina, Dept Social Med, Chapel Hill, NC 27515 USA; [Brinkley-Rubinstein, Lauren; Lewis, Chantal] Univ N Carolina, Ctr Hlth Equ Res, Chapel Hill, NC 27515 USA; [Peterson, Meghan] Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA; [Arnold, Trisha] Jackson State Univ, Dept Psychol, Jackson, MO USA; [Arnold, Trisha] Rhode Isl Hosp, Providence, RI USA; [Nunn, Amy S.; Chan, Philip A.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Beckwith, Curt G.; Chan, Philip A.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Castonguay, Breana] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27515 USA; [Junious, Eric] Univ N Carolina, Coll Hlth & Human Serv, Charlotte, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Lifespan Health Rhode Island; Miriam Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Charlotte	Brinkley-Rubinstein, L (corresponding author), Univ N Carolina, Dept Social Med, Chapel Hill, NC 27515 USA.; Brinkley-Rubinstein, L (corresponding author), Univ N Carolina, Ctr Hlth Equ Res, Chapel Hill, NC 27515 USA.	Lauren_Brinkley@med.unc.edu			National Institute of Drug Abuse [R25DA037190, R25DA035692]; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA035692, R25DA037190] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was received from the National Institute of Drug Abuse supported this study: R25DA037190, R25DA035692 (LB-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2006, SEX TRANSM DIS, V33, pS39, DOI 10.1097/01.olq.0000228298.07826.68; Althoff AL, 2013, AIDS BEHAV, V17, P156, DOI 10.1007/s10461-012-0372-1; Arnold T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172354; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Brewer RA, 2014, JAIDS-J ACQ IMM DEF, V65, P218, DOI 10.1097/01.qai.0000434953.65620.3d; Brinkley-Rubinstein L., BMC PUBLIC HLTH; Brinkley-Rubinstein L, 2013, AIDS PATIENT CARE ST, V27, P450, DOI 10.1089/apc.2012.0457; Cahill S, 2017, AIDS CARE, P1; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Chen JL, 2003, AIDS EDUC PREV, V15, P117, DOI 10.1521/aeap.15.1.5.117.23614; Cohen SE, 2015, JAIDS-J ACQ IMM DEF, V70, pE33, DOI 10.1097/QAI.0000000000000716; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; Cunningham WE, 2018, JAMA INTERN MED, V178, P542, DOI 10.1001/jamainternmed.2018.0150; Dolan K, 2004, J LAW MED ETHICS, V32, P124, DOI 10.1111/j.1748-720X.2004.tb00457.x; Dumont DM, 2012, ANNU REV PUBL HEALTH, V33, P325, DOI 10.1146/annurev-publhealth-031811-124614; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Herbert Claire W, 2015, RSF, V1, P44; Herron PD, 2016, LGBT HEALTH, V3, P103, DOI 10.1089/lgbt.2014.0114; Holloway IW, 2017, AIDS PATIENT CARE ST, V31, P517, DOI 10.1089/apc.2017.0082; Javanbakht M, 2009, SEX TRANSM DIS, V36, pS17, DOI 10.1097/OLQ.0b013e31815e4152; Kalichman SC, 2015, J COMMUN HEALTH, V40, P702, DOI 10.1007/s10900-014-9988-6; Krakower D, 2012, CURR OPIN HIV AIDS, V7, P593, DOI 10.1097/COH.0b013e3283590446; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; LaVigne, 2008, RELEASE PLANNING SUC; Leibowitz AA, 2013, AIDS BEHAV, V17, P2695, DOI 10.1007/s10461-012-0190-5; Lim JR, 2011, J URBAN HEALTH, V88, P677, DOI 10.1007/s11524-011-9566-5; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Luther JB, 2011, AIDS PATIENT CARE ST, V25, P475, DOI 10.1089/apc.2010.0372; Maloney KM, 2017, LGBT HEALTH, V4, P310, DOI 10.1089/lgbt.2016.0068; Maruschak LM, 2012, HIV PRISONS 2001 201; Nunn AS, 2017, AIDS, V31, P731, DOI 10.1097/QAD.0000000000001385; Oldenburg C, 2015, AIDS; Penniman TV, 2007, J NATL MED ASSOC, V99, P419; Peters M, 2018, STUD LATEINAMERIKA, V32, P1, DOI 10.5771/9783845286846; Philbin MM, 2016, AIDS PATIENT CARE ST, V30, P282, DOI 10.1089/apc.2016.0037; Rajabiun S, 2007, AIDS PATIENT CARE ST, V21, pS20, DOI 10.1089/apc.2007.9990; Rhode Island Department of Corrections, 2011, DAT RES PLANN; Rucinski KB, 2013, AIDS BEHAV, V17, P2180, DOI 10.1007/s10461-013-0443-y; Schneider JA, 2017, SOC NETWORKS, V51, P73, DOI 10.1016/j.socnet.2017.04.001; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Western B, 2015, AM J SOCIOL, V120, P1512, DOI 10.1086/681301; WHO, GUID START ANT THER; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7	48	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0205593	10.1371/journal.pone.0205593	http://dx.doi.org/10.1371/journal.pone.0205593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6IO	30532275	gold, Green Published, Green Submitted			2022-12-26	WOS:000452640900004
J	Lu, S; Zhang, M; Zhang, Z; Wang, ZH; Wu, N; Song, Y; Wang, PW				Lu, Shi; Zhang, Mo; Zhang, Zhuo; Wang, Zhenhui; Wu, Nan; Song, Yang; Wang, Piwu			Screening and verification of genes associated with leaf angle and leaf orientation value in inbred maize lines	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POPULATION; ARCHITECTURE; YIELD; RESISTANCE; TRAITS; PLANT; QTL	Leaf angle and leaf orientation value are important traits affecting planting density and photosynthetic efficiency. To identify the genes involved in controlling leaf angle and leaf orientation value, we utilized 1.49x10(6) single nucleotide polymorphism (SNP) markers obtained after sequencing 80 backbone inbred maize lines in Jilin Province, based on phenotype data from two years, and analyzed these two traits in a genome-wide association study (GWAS). A total of 33 SNPs were significantly associated (P<0.000001) with the two target traits. Twenty-two SNPs were significantly associated with leaf angle and distributed on chromosomes 1, 3, 4, 5, 6, 7, 8, and 9, explaining 21.62% of the phenotypic variation. Eleven SNPs were significantly associated with leaf orientation value and distributed on chromosomes 1, 3, 4, 5, 6, 7, and 9, explaining 29.63% of the phenotypic variation. Within the mean linkage disequilibrium (LD) distance of 9.7 kb for the significant SNP locus, 22 leaf angle candidate genes were detected, and 3 of these candidate genes harbored significant SNPs, with phenotype contribution rates greater than 10%. Two candidate genes at distances less than 100 bp from significant SNPs showed phenotype contribution rates greater than 8%. Seven leaf orientation value candidate genes were detected: 3 of these candidate genes harbored significant SNPs, with phenotype contribution rates greater than 10%. Eight inbred maize lines with significant differences in leaf angle and leaf orientation value were selected to test candidate gene expression levels from 182 recombinant inbred lines (RILs). The 5 leaf angle candidate genes and 3 leaf orientation value candidate genes were verified using quantitative real-time PCR (qRT-PCR). The results showed significant differences in the expression levels of the above eight genes between inbred maize lines with significant differences in leaf angle and leaf orientation value.	[Lu, Shi; Zhang, Mo; Zhang, Zhuo; Wang, Zhenhui; Wu, Nan; Song, Yang; Wang, Piwu] Jilin Agr Univ, Changchun, Jilin, Peoples R China	Jilin Agricultural University	Wang, PW (corresponding author), Jilin Agr Univ, Changchun, Jilin, Peoples R China.	peiwuw@163.com			Modern Crop Seed Industry development of Jilin Province, China - Modern Crop Seed Industry development of Jilin Province, China	Modern Crop Seed Industry development of Jilin Province, China - Modern Crop Seed Industry development of Jilin Province, China	This study was funded by the Modern Crop Seed Industry development of Jilin Province, China, (to Piwu Wang).; This study was funded by the Modern Crop Seed Industry development of Jilin Province, China. The authors are grateful to American Journal Experts for providing language help. We thank the Novogene Biological Company for providing sequencing services. We also thank two anonymous reviewers for their valuable suggestions and careful corrections.	Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; [鲍永美 BAO YongMei], 2005, [植物学通报, Chinese Bulletin of Botany], V22, P715; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; [常立国 Chang Liguo], 2016, [玉米科学, Journal of Maize Science], V24, P49; DUNCAN WG, 1971, CROP SCI, V11, P482, DOI 10.2135/cropsci1971.0011183X001100040006x; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Bondino HG, 2012, PLANTA, V235, P1299, DOI 10.1007/s00425-011-1575-9; Gilad Y, 2009, TRENDS GENET, V25, P463, DOI 10.1016/j.tig.2009.09.003; Harper LC, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar016; Huang H., 2007, PROTEOLYTIC FUNCTION, DOI [10.1098/rstb.2007.2030, DOI 10.1098/RSTB.2007.2030]; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Ku LX, 2012, J EXP BOT, V63, P261, DOI 10.1093/jxb/err277; Ku LX, 2010, STUDIES MOL GENETIC; LAMBERT RJ, 1978, CROP SCI, V18, P499, DOI 10.2135/cropsci1978.0011183X001800030037x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2011, CROP SCI, V51, P2391, DOI 10.2135/cropsci2011.03.0148; Liu CL, 2014, EUR J PLANT PATHOL, V139, P205, DOI 10.1007/s10658-014-0383-z; Liu XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005767; Liu Zheng, 2014, Journal of Agricultural Biotechnology, V22, P177; Mickelson SM, 2002, CROP SCI, V42, P1902, DOI 10.2135/cropsci2002.1902; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Pelleschi S, 2006, MOL BREEDING, V17, P21, DOI 10.1007/s11032-005-1031-2; PENDLETON JW, 1968, AGRON J, V60, P422, DOI 10.2134/agronj1968.00021962006000040027x; PEPPER GE, 1977, CROP SCI, V17, P883, DOI 10.2135/cropsci1977.0011183X001700060017x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vlieghe K, 2005, CURR BIOL, V15, P59, DOI 10.1016/j.cub.2004.12.038; WANG K, 2010, NUCLEIC ACIDS RES, V38; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhang Y, 2010, AGR SCI CHINA, V9, P1400, DOI 10.1016/S1671-2927(09)60231-5; Zhang ZiLi, 2014, Journal of China Agricultural University, V19, P7; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; [朱捷 Zhu Jie], 2009, [生物技术通报, Biotechnology Bulletin], P73	38	10	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208386	10.1371/journal.pone.0208386	http://dx.doi.org/10.1371/journal.pone.0208386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532152	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900015
J	Dewan, S; De Frenne, P; Vanden Broeck, A; Steenackers, M; Vander Mijnsbrugge, K; Verheyen, K				Dewan, Sumitra; De Frenne, Pieter; Vanden Broeck, An; Steenackers, Marijke; Vander Mijnsbrugge, Kristine; Verheyen, Kris			Transgenerational effects in asexually reproduced offspring of Populus	PLOS ONE			English	Article							CLIMATE-CHANGE; EPIGENETIC MEMORY; LEAF PHENOLOGY; BUD PHENOLOGY; TEMPERATURE; PLASTICITY; ADAPTATION; RESPONSES; POPLAR; GROWTH	The response of trees to a changing climate can be affected by transgenerational phenotypic plasticity, i.e. phenotypic variation that is conserved and transferred to the offspring. Transgenerational plasticity that is influenced by epigenetics (heritable changes in gene function that do not result from changes in DNA sequence) during both sexual and asexual reproduction are of major relevance for adaptation of plants to climate change. To understand the transgenerational effects on the responses of vegetatively propagated poplar (Populus deltoides and P. trichocarpa) ramets (cuttings) to a changing environment, we tested whether the temperature and photoperiod experienced by the mother trees (genets) persistently affects the phenology of the cuttings grown in a common environment. We weekly monitored the bud phenology of the cuttings collected from the parent trees that have been growing across Europe along a >2100 km latitudinal gradient for at least 18 years. In addition, we asked whether there was variation in DNA methylation as measured by Methylation Sensitive Amplified Fragment Length Polymorphism (MSAPs) in the clones due to the different environmental conditions experienced by the parent trees. Our results indicate a transgenerational effect on bud phenology in the asexually reproduced offspring (vegetative cuttings). The temperatures experienced by the parent tree clones (from different geographic regions) altered the bud flush of the cuttings in the common garden. However, no significant epigenetic variation was detected in the cuttings of the parent trees within single genotypes growing under different climates. In sum, our results show that trees have the potential to respond to rapid climate change but the mechanism behind these changes needs to be further investigated by more powerful molecular methods like whole-genome bisulphite sequencing techniques.	[Dewan, Sumitra; De Frenne, Pieter; Verheyen, Kris] Univ Ghent, Dept Environm, Forest & Nat Lab, Gontrode, Belgium; [Vanden Broeck, An; Steenackers, Marijke; Vander Mijnsbrugge, Kristine] Res Inst Nat & Forest INBO, Geraardsbergen, Belgium	Ghent University; Research Institute for Nature & Forest	Dewan, S (corresponding author), Univ Ghent, Dept Environm, Forest & Nat Lab, Gontrode, Belgium.	Sumitra.dewan@ugent.be	Broeck, An Vanden/A-5734-2008; De Frenne, Pieter/N-4969-2014	Broeck, An Vanden/0000-0001-8773-7280; De Frenne, Pieter/0000-0002-8613-0943; Dewan, Sumitra/0000-0001-5344-122X; Verheyen, Kris/0000-0002-2067-9108; Vander Mijnsbrugge, Kristine/0000-0003-1687-8152	Belgian Science Policy Office (BELSPO) under the project FORBIO Climate-Adaptation potential of biodiverse forests in the face of climate change via the BRAIN-be programme; European Research Council through the PASTFORWARD project (ERC Consolidator Grant) [614839]; FORMICA project (ERC Starting Grant) [757833]; BELSPO	Belgian Science Policy Office (BELSPO) under the project FORBIO Climate-Adaptation potential of biodiverse forests in the face of climate change via the BRAIN-be programme; European Research Council through the PASTFORWARD project (ERC Consolidator Grant); FORMICA project (ERC Starting Grant); BELSPO(Belgian Federal Science Policy Office)	This study was supported by the Belgian Science Policy Office (BELSPO) under the project FORBIO Climate-Adaptation potential of biodiverse forests in the face of climate change via the BRAIN-be programme to Kris Verheyen. Kris Verheyen was also supported by the European Research Council through the PASTFORWARD project (ERC Consolidator Grant 614839). Pieter De Frenne was supported through the FORMICA project (ERC Starting Grant 757833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sabrina Neyrinck, Leen Verschaeve, Wim De Clercq, Stefaan Moreels, Kurt Schamp and Serge Goossens for the assistance in the lab and common garden. We are also thankful to Anneli Adler, Hortensia Sixto, Catherine Bastien and Gianni Facciotto for sampling assistance. This research was funded by BELSPO within the scope of the FORBIO Climate project.	Arrigo N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-33; Basler D, 2014, TREE PHYSIOL, V34, P377, DOI 10.1093/treephys/tpu021; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Canty A., 2021, R PACKAGE VERSION 1; Carneros E, 2017, PLANTA, V246, P553, DOI 10.1007/s00425-017-2713-9; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Dmitry AG, 2016, RFC CLIENT FETCHCLIM; Donelson JM, 2018, GLOBAL CHANGE BIOL, V24, P13, DOI 10.1111/gcb.13903; Dreesen FE, 2012, ENVIRON EXP BOT, V79, P21, DOI 10.1016/j.envexpbot.2012.01.005; Evans LM, 2016, ECOL EVOL, V6, P4565, DOI 10.1002/ece3.2222; Farmer Robert E. Jr., 1996, P33; Fu YSH, 2014, P NATL ACAD SCI USA, V111, P7355, DOI 10.1073/pnas.1321727111; FU YS, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0047324.G001; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Gonzalez APR, 2017, EVOL ECOL, V31, P345, DOI 10.1007/s10682-016-9844-5; Groot MP, 2017, NEW PHYTOL, V215, P1221, DOI 10.1111/nph.14642; Guarino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131480; Gunderson CA, 2012, GLOBAL CHANGE BIOL, V18, P2008, DOI 10.1111/j.1365-2486.2011.02632.x; Herman JJ, 2014, EVOLUTION, V68, P632, DOI 10.1111/evo.12324; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Jablonka E., 1995, EPIGENETIC INHERITAN; Johansson T, 2011, BIOMASS BIOENERG, V35, P1925, DOI 10.1016/j.biombioe.2011.01.040; Korner C, 2018, PERSPECT PLANT ECOL, V30, P16, DOI 10.1016/j.ppees.2017.04.004; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Latzel V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01354; Latzel V, 2015, FOLIA GEOBOT, V50, P75, DOI 10.1007/s12224-015-9208-x; Latzel V, 2010, EVOL ECOL, V24, P1537, DOI 10.1007/s10682-010-9385-2; Liesebach H, 2010, TREE GENET GENOMES, V6, P259, DOI 10.1007/s11295-009-0246-5; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Munzbergova Z, 2017, ECOL EVOL, V7, P5236, DOI 10.1002/ece3.3105; NELSON ND, 1983, PHOTOSYNTHETICA, V17, P537; Olson MS, 2013, MOL ECOL, V22, P1214, DOI 10.1111/mec.12067; Pellis A, 2004, PLANT BIOLOGY, V6, P38, DOI 10.1055/s-2003-44746; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; R Core Team, 2021, R LANGUAGE ENV STAT; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richardson AD, 2018, NATURE, V560, P368, DOI 10.1038/s41586-018-0399-1; Rohde A, 2011, TREE PHYSIOL, V31, P472, DOI 10.1093/treephys/tpr038; Rohde A, 2011, NEW PHYTOL, V189, P106, DOI 10.1111/j.1469-8137.2010.03469.x; Schield DR, 2016, METHODS ECOL EVOL, V7, P60, DOI 10.1111/2041-210X.12435; Schreiber SG, 2013, J APPL ECOL, V50, P939, DOI 10.1111/1365-2664.12102; Schueler S, 2015, PLANT ECOL, V216, P111, DOI 10.1007/s11258-014-0420-1; Siegmund JF, 2016, BIOGEOSCIENCES, V13, P5541, DOI 10.5194/bg-13-5541-2016; Sivadasan U, 2017, ECOL EVOL, V7, P7998, DOI 10.1002/ece3.3352; Smulders MJM, 2001, MOL ECOL NOTES, V1, P188, DOI 10.1046/j.1471-8278.2001.00071.x; Vanden Broeck A, 2004, THESIS; Vanden Broeck A, 2018, VARIABILITY DNA METH, V9, DOI [10.3389/fpls.2018.01635, DOI 10.3389/FPLS.2018.01635]; Vanden-Broeck A, 2012, BIOL INVASIONS, V14, P1683, DOI 10.1007/s10530-012-0180-6; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Verhoeven KJF, 2014, EVOLUTION, V68, P644, DOI 10.1111/evo.12320; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang YJ, 2017, NEW PHYTOL, V216, P1072, DOI 10.1111/nph.14820; Way DA, 2011, TREE PHYSIOL, V31, P469, DOI 10.1093/treephys/tpr044; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Yakovlev IA, 2014, TREE GENET GENOMES, V10, P355, DOI 10.1007/s11295-013-0691-z; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhan J, 2006, MOL PLANT PATHOL, V7, P259, DOI 10.1111/J.1364-3703.2006.00336.X; Zohner CM, 2016, NAT CLIM CHANGE, V6, P1120, DOI [10.1038/NCLIMATE3138, 10.1038/nclimate3138]	65	8	8	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208591	10.1371/journal.pone.0208591	http://dx.doi.org/10.1371/journal.pone.0208591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521624	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600098
J	Guo, YC; Hu, HP; Liu, YP; Leng, Y; Gao, X; Cui, QH; Chen, JX; Geng, B; Zhou, Y				Guo, Yuchen; Hu, Hongpu; Liu, Yingping; Leng, Yue; Gao, Xing; Cui, Qinghua; Chen, Jianxin; Geng, Bin; Zhou, Yong			Gender differences in the relationship between alcohol consumption and insomnia in the northern Chinese population	PLOS ONE			English	Article							SLEEP DISTURBANCES; RISK-FACTORS; ASSOCIATION; MEDICATION; DISORDERS; DRINKING; ETHANOL; HEALTH; SCALE; AIDS	Background Insomnia is one of the main symptoms of sleep disorders. Previous studies have suggested that alcohol intake is associated with several adverse health outcomes. The association between alcohol consumption and insomnia has been addressed in several studies with different results. However, whether gender may modify the association between alcohol consumption and insomnia is not clear. This study will focus on gender differences in the relationship between alcohol consumption and insomnia. Methods The final study includes 8081 subjects aged between 18 and 65 years from the Jidong cohort. The data on alcohol consumption is collected by questionnaires, and insomnia problems are assessed using the entire 8-item Athens Insomnia Scale (AIS-8). Logistic analysis is used to evaluate the association between alcohol consumption and insomnia. Results Among the 8081 participants in this study, 2618 (32.4%) are alcohol drinkers, including 2424 males and 194 females. The prevalence of insomnia is 9.6% in the male and 10.6% in the female. The adjusted odds ratios (ORs) with 95% confidence interval (CI) of mild-to-moderate drinkers and heavy drinkers for insomnia are 1.27 (1.02-1.58) and 1.02 (0.79-1.32), respectively. Heavy alcohol consumption is significantly correlated with insomnia in the female, after controlling for potential confounding factors (OR: 2.11, 95% CI: 1.28-3.49, p for interaction = 0.002). Conclusion A significant association between alcohol consumption and insomnia is found in females, but not in males from the northern Chinese population.	[Guo, Yuchen; Hu, Hongpu; Gao, Xing] Chinese Acad Med Sci, Inst Med Informat, Dept Hlth Informat Management, Beijing, Peoples R China; [Guo, Yuchen; Hu, Hongpu; Gao, Xing] Peking Union Med Coll, Beijing, Peoples R China; [Liu, Yingping] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing, Peoples R China; [Leng, Yue] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Cui, Qinghua] Peking Univ, Hlth Sci Ctr, Ctr Noncoding RNA Med,Sch Basic Med Sci,Minist Ed, Key Lab Mol Cardiovasc Sci,Dept Biomed Informat, Beijing, Peoples R China; [Chen, Jianxin] Beijing Univ Chinese Med, Beijing, Peoples R China; [Geng, Bin] Chinese Acad Med Sci, Fuwai Hosp, Hypertens Ctr, Beijing, Peoples R China; [Geng, Bin] Peking Union Med Coll, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Zhou, Yong] Capital Med Univ, Sanbo Brain Hosp, Sanbo Brain Inst, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; University of California System; University of California San Francisco; Peking University; Beijing University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Zhou, Y (corresponding author), Capital Med Univ, Sanbo Brain Hosp, Sanbo Brain Inst, Beijing, Peoples R China.	yongzhou78214@163.com	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710; guo, yuchen/0000-0002-0045-3558	National Natural Science Foundation of China [81202279, 81473057]; National Social Science Foundation of China [17BGL184]; NATIONAL INSTITUTE ON AGING [K99AG056598] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is support by grants from the National Natural Science Foundation of China (No. 81202279); (No. 81473057) and the National Social Science Foundation of China (17BGL184).	Ancoli-Israel S, 1999, SLEEP, V22, pS347; Arnedt JT, 2011, ALCOHOL CLIN EXP RES, V35, P870, DOI 10.1111/j.1530-0277.2010.01417.x; Brower KJ, 2001, J STUD ALCOHOL, V62, P335, DOI 10.15288/jsa.2001.62.335; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Chaudhary NS, 2015, ADDICT BEHAV, V50, P165, DOI 10.1016/j.addbeh.2015.06.021; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; DEWIT H, 1990, ALCOHOL CLIN EXP RES, V14, P482; Fabsitz RR, 1997, J SLEEP RES, V6, P50, DOI 10.1046/j.1365-2869.1997.00026.x; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Gao X, 2018, CHINESE MED J-PEKING, V131, P1003, DOI 10.4103/0366-6999.229885; Gowing LR, 2015, ADDICTION, V110, P904, DOI 10.1111/add.12899; Hao ZR, 2016, SCI REP-UK, V6, DOI 10.1038/srep31720; Harma M, 1998, SCAND J WORK ENV HEA, V24, P300; Hartwell EE, 2015, ALCOHOL ALCOHOLISM, V50, P536, DOI 10.1093/alcalc/agv046; Huang S, 2017, AM J CLIN NUTR, V105, P905, DOI 10.3945/ajcn.116.144832; Janson C, 2001, SLEEP, V24, P425, DOI 10.1093/sleep/24.4.425; Johnson EO, 1998, SLEEP, V21, P178, DOI 10.1093/sleep/21.2.178; Kaneita Y, 2007, SLEEP MED, V8, P723, DOI 10.1016/j.sleep.2006.10.009; Kolla BP, ELECTRONIC, P1521; KUPPERMANN M, 1995, J GEN INTERN MED, V10, P25, DOI 10.1007/BF02599573; Li LQ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1075-3; Li RHY, 2002, J PSYCHOSOM RES, V53, P601, DOI 10.1016/S0022-3999(02)00437-3; Li Z, 2016, INT J CARDIOL, V215, P257, DOI 10.1016/j.ijcard.2016.04.095; Lin YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02426-4; Lindberg E, 1997, SLEEP, V20, P381, DOI 10.1093/sleep/20.6.381; Manber R, 1999, SLEEP, V22, P540; McGuire S, 2012, ADV NUTR, V3, P215, DOI 10.3945/an.111.001701; Morioka H, 2013, ALCOHOL, V47, P619, DOI 10.1016/j.alcohol.2013.09.041; Mumenthaler MS, 1999, ALCOHOL RES HEALTH, V23, P55; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Pearson TA, 2013, CIRCULATION, V127, P1730, DOI 10.1161/CIR.0b013e31828f8a94; REYNER A, 1995, SLEEP, V18, P127; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Roehrs T, 2001, SLEEP MED REV, V5, P287, DOI 10.1053/smrv.2001.0162; Roehrs T, 1999, NEUROPSYCHOPHARMACOL, V20, P279, DOI 10.1016/S0893-133X(98)00068-2; Singareddy R, 2012, SLEEP MED, V13, P346, DOI 10.1016/j.sleep.2011.10.033; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Song QF, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0239-y; STEIGER A, 1991, J PSYCHIATR RES, V25, P169, DOI 10.1016/0022-3956(91)90021-2; Stein Michael D, 2005, Subst Abus, V26, P1, DOI 10.1300/J465v26n01_01; Wang YX, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1046-y; Wu RN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09851-5	44	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207392	10.1371/journal.pone.0207392	http://dx.doi.org/10.1371/journal.pone.0207392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521547	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600011
J	Khalil, Y; Flower, K; Siddique, KHM; Ward, P				Khalil, Yaseen; Flower, Ken; Siddique, Kadambot H. M.; Ward, Phil			Effect of crop residues on interception and activity of prosulfocarb, pyroxasulfone, and trifluralin	PLOS ONE			English	Article							RYEGRASS LOLIUM-RIGIDUM; CONSERVATION AGRICULTURE; SOIL RECEPTION; S-METOLACHLOR; WHEAT-STRAW; NO-TILLAGE; HERBICIDE; RESISTANCE; DEGRADATION; PERSISTENCE	Crop residue retention on the soil surface in no-tillage system can intercept pre-emergent herbicides and reduce their efficacy. Three experiments were conducted to investigate the effect of crop residue amount (0, 1, 2 and 4 t ha(-1)), moisture (wet versus dry), type (wheat, barley, canola, chickpea and lupin) and age (fresh or aged for one year) on the interception and subsequent leaching of prosulfocarb, pyroxasulfone, and trifluralin from the residue into soil. Bioassays, using cucumber and annual ryegrass as indicator plants, were used to assess herbicide activity/availability in the soil and on the residue. Herbicide interception increased considerably as residue quantity increased from 2 to 4 t ha(-1) . After simulated rainfall, which washed herbicide into the soil, complete control of ryegrass occurred for trifluralin with 0 t ha(-1) residue, for prosulfocarb with 0 and 1 t ha(-1) residue, and for pyroxasulfone with all residue rates. Therefore, with rain or irrigation, pyroxasulfone was the herbicide least affected by high residue loads. Less chemical leached from the crop residue into the soil after rainfall, when prosulfocarb and trifluralin were applied to wet residue compared with dry residue, but the initial moisture condition had no effect on the leaching of pyroxasulfone from residue. If practically possible, farmers should minimise spraying prosulfocarb and trifluralin onto wet crop residue. Barley and wheat residues intercepted more herbicide than an equivalent mass of canola, chickpea or lupin residue, which was largely due to the increased ground cover with cereal residues. The effect of residue age on herbicide interception and leaching was relatively small and variable. Overall, more herbicide reached the soil when sprayed on one-year old residue than new residue, which was largely due to reduced ground cover with aged residue. A strong positive linear relationship existed between ground cover percentage and growth of bioassay species (r(2) = 0.75). This means that there was little difference in the ability of residue to adsorb and retain herbicide between crop residue types and ages, such that farmers can simply use the ground cover of the crop residue to assess interception.	[Khalil, Yaseen; Flower, Ken; Siddique, Kadambot H. M.; Ward, Phil] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia; [Khalil, Yaseen; Flower, Ken; Siddique, Kadambot H. M.] Univ Western Australia, UWA Inst Agr, Perth, WA, Australia; [Ward, Phil] CSIRO, Wembley, WA, Australia	University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Khalil, Y (corresponding author), Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia.; Khalil, Y (corresponding author), Univ Western Australia, UWA Inst Agr, Perth, WA, Australia.	yaseen.khalil@uwa.edu.au	Ward, Phil/A-2623-2008; Flower, Ken/H-1748-2012; Siddique, Kadambot H.M./B-3462-2011	Ward, Phil/0000-0002-1748-1133; Siddique, Kadambot H.M./0000-0001-6097-4235; Flower, Kenneth/0000-0002-7477-9921; Khalil, Yaseen/0000-0002-4156-2486				Aslam S, 2015, PEST MANAG SCI, V71, P278, DOI 10.1002/ps.3803; Bailly GC, 2012, EFFECTIVENESS PROSUL; Banks P, 1983, P SO WEED SCI SOC; BANKS PA, 1986, WEED SCI, V34, P607, DOI 10.1017/S0043174500067527; BANKS PA, 1982, WEED SCI, V30, P164, DOI 10.1017/S0043174500062263; BAUMAN TT, 1983, WEED SCI, V31, P423, DOI 10.1017/S0043174500069290; Borger CPD, 2013, WEED TECHNOL, V27, P649, DOI 10.1614/WT-D-12-00117; Boutsalis P, 2014, WEED TECHNOL, V28, P332, DOI 10.1614/WT-D-13-00094.1; Boutsalis P, 2012, WEED TECHNOL, V26, P391, DOI 10.1614/WT-D-11-00150.1; Busi R, 2012, WEED RES, V52, P489, DOI 10.1111/j.1365-3180.2012.00948.x; Busi R, 2016, PEST MANAG SCI, V72, P1664, DOI 10.1002/ps.4253; Busi R, 2014, PEST MANAG SCI, V70, P1378, DOI 10.1002/ps.3746; Chauhan BS, 2006, AUST J EXP AGR, V46, P1557, DOI 10.1071/EA05291; Coppens F, 2006, EUR J SOIL SCI, V57, P894, DOI 10.1111/j.1365-2389.2006.00783.x; CRUTCHFIELD DA, 1986, WEED SCI, V34, P110, DOI 10.1017/S0043174500026564; Dairy-One-Forage-Laboratory, 2015, AN PROC 2052 ON ROAD; Dang A, 2016, J AGR FOOD CHEM, V64, P3967, DOI 10.1021/acs.jafc.5b04717; DAO TH, 1991, J ENVIRON QUAL, V20, P203, DOI 10.2134/jeq1991.00472425002000010032x; Day BE, 1968, PRINCIPLES PLANT ANI; de Silva SHSA, 2003, COMMUN SOIL SCI PLAN, V34, P1039, DOI 10.1081/CSS-120019108; ERBACH DC, 1975, WEED SCI, V23, P512, DOI 10.1017/S0043174500065127; Farooq M, 2015, CONSERVATION AGR; Gaston LA, 2001, SOIL SCI, V166, P681, DOI 10.1097/00010694-200110000-00004; GHADIRI H, 1984, WEED SCI, V32, P24, DOI 10.1017/S0043174500058458; GROVER R, 1971, WEED SCI, V19, P417, DOI 10.1017/S0043174500049274; Hermsmeier LF, 1963, CONSTRUCTION OPERATI; ISENSEE AR, 1995, CHEMOSPHERE, V30, P671, DOI 10.1016/0045-6535(94)00433-U; Issa S, 2005, PEST MANAG SCI, V61, P126, DOI 10.1002/ps.951; Kassam A, 2012, FIELD CROP RES, V132, P7, DOI 10.1016/j.fcr.2012.02.023; Khalil Y, 2018, CROP PASTURE SCI, V69, P606, DOI 10.1071/CP18026; LAL R, 1976, SOIL SCI SOC AM J, V40, P762, DOI 10.2136/sssaj1976.03615995004000050039x; Lamari L., 2008, ASSESS 2 0 IMAGE ANA; Leonard L., 1993, MANAGING STUBBLE RET; Leys J. F., 1991, SIMULATED WIND EROSI; Liebl RA, 1983, P SO WEED SCI SOC; Llewellyn RS, 2012, FIELD CROP RES, V132, P204, DOI 10.1016/j.fcr.2012.03.013; Mangin AR, 2016, THESIS; MARTIN CD, 1978, T ASAE, V21, P1164, DOI 10.13031/2013.35461; MEYER L. D., 1960, Soil Science Society of America. Proceedings, V24, P319; MORRISON MW, 1985, SOIL SCI SOC AM J, V49, P427, DOI 10.2136/sssaj1985.03615995004900020031x; Payne RW, 2009, GENSTAT FOR WINDOWS; Prasad R., 1991, Advances in Soil Science, V15, P205; PRIHAR S S, 1975, Indian Journal of Ecology, V2, P13; Rayment G.E., 2011, SOIL CHEM METHODS; REDDY KN, 1995, J AGR FOOD CHEM, V43, P2752, DOI 10.1021/jf00058a038; Reddy KN, 1997, SOIL SCI, V162, P501, DOI 10.1097/00010694-199707000-00005; REINERTSEN SA, 1984, SOIL BIOL BIOCHEM, V16, P459, DOI 10.1016/0038-0717(84)90052-X; Roper MM, 2010, AUST J SOIL RES, V48, P274, DOI 10.1071/SR09143; Saini RK, 2015, WEED TECHNOL, V29, P578, DOI 10.1614/WT-D-14-00143.1; Serraj R, 2012, FIELD CROP RES, V132, P1, DOI 10.1016/j.fcr.2012.03.002; Somasegaran P., 1985, METHODS LEGUME RHIZO; Strek H, 1981, P SO WEED SCI SOC US; Strek J, 1982, P SO WEED SCI SOC; Tanetani Y., 2011, J PESTIC SCI, V36, P152; Tanetani Y, 2009, PESTIC BIOCHEM PHYS, V95, P47, DOI 10.1016/j.pestbp.2009.06.003; Taylor-Lovell S, 2002, J AGR FOOD CHEM, V50, P5626, DOI 10.1021/jf011486l; Tidemann BD, 2014, POTENTIAL PYROXASULF; Unger P. W., 1994, MANAGING AGR RESIDUE; UNGER PW, 1979, SOIL SCI SOC AM J, V43, P582, DOI 10.2136/sssaj1979.03615995004300030030x; Verhulst N, 2010, ADV SOIL SCI-SER, P137; Zablotowicz RM, 1998, CHEMOSPHERE, V37, P87, DOI 10.1016/S0045-6535(98)00025-3	61	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208274	10.1371/journal.pone.0208274	http://dx.doi.org/10.1371/journal.pone.0208274			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521564	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600040
J	Koutras, A; Lazaridis, G; Koliou, GA; Kouvatseas, G; Christodoulou, C; Pectasides, D; Kotoula, V; Batistatou, A; Bobos, M; Tsolaki, E; Papadopoulou, K; Pentheroudakis, G; Papakostas, P; Pervana, S; Petraki, K; Chrisafi, S; Razis, E; Psyrri, A; Bafaloukos, D; Kalogeras, KT; Kalofonos, HP; Fountzilas, G				Koutras, Angelos; Lazaridis, Georgios; Koliou, Georgia-Angeliki; Kouvatseas, George; Christodoulou, Christos; Pectasides, Dimitrios; Kotoula, Vassiliki; Batistatou, Anna; Bobos, Mattheos; Tsolaki, Eleftheria; Papadopoulou, Kyriaki; Pentheroudakis, George; Papakostas, Pavlos; Pervana, Stavroula; Petraki, Kalliopi; Chrisafi, Sofia; Razis, Evangelia; Psyrri, Amanda; Bafaloukos, Dimitrios; Kalogeras, Konstantine T.; Kalofonos, Haralambos P.; Fountzilas, George			Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GROWTH-FACTOR RECEPTORS; PROTEIN EXPRESSION; QUANTITATIVE PCR; PREDICTIVE-VALUE; HER2; EGFR; BENEFIT; IMMUNOHISTOCHEMISTRY; RECOMMENDATIONS	In the current study, we performed a complete analysis, with four different methods, of all four HER family receptors, in a series of patients with metastatic breast cancer treated with trastuzumab-based regimens and evaluated their prognostic value. Formalin-fixed paraffin-embedded tumor tissue samples were collected from 227 patients, considered to be HER2-positive when assessed at the local laboratories. We evaluated gene amplification, copy number variations (CNVs), mRNA and protein expression of all four HER family members. In addition, our analysis included the evaluation of several other factors by immunohistochemistry (IHC), such as pHER2(Tyr1221/1222), pHER2(Tyr877) and PTEN. Central review of HER2 status by IHC and fluorescence in situ hybridization revealed that of the 227 patients, only 139 (61.2%) were truly HER2-positive. Regarding the 191 patients treated with trastuzumab as first-line therapy, median time to progression (TTP) was 15.3 and 10.4 months for HER2-positive and HER2-negative participants, respectively, whereas median survival was 50.4 and 38.1 months, respectively. In HER2-positive patients, high HER3 mRNA expression was of favorable prognostic significance for TTP and survival (HR = 0.43, 95% CI 0.21-0.88, Wald's p = 0.022 and HR = 0.43, 95% CI 0.21-0.88, p = 0.021, respectively), while EGFR copy gain and EGFR protein expression were associated with higher risk for disease progression in HER2-negative patients (HR = 3.53, 95% CI 1.19-10.50, p = 0.023 and HR = 3.37, 95% CI 1.12-10.17, p = 0.031, respectively). Positive HER3 protein expression was a favorable factor for TTP in HER2-negative patients (HR = 0.43, 95% CI 0.22-0.84, p = 0.014). In the multivariate analysis, only EGFR copy gain retained its prognostic significance for TTP in the HER2-negative population (HR = 3.96, 95% CI 1.29-12.16, p = 0.016), while high HER3 mRNA expression retained its favorable prognostic significance for TTP in the HER2-positive subgroup (HR = 0.47, 95% CI 0.23-0.99, p = 0.048). The present study suggests that EGFR copy gain represents a negative prognostic factor for TTP in HER2-negative patients with metastatic breast cancer treated with trastuzumab. In addition, high HER3 mRNA expression appears to be of favorable prognostic significance for TTP in HER2-positive patients. Given the small number of patients included in the current analysis and the retrospective nature of the study, our findings should be validated in larger cohorts.	[Koutras, Angelos; Kalofonos, Haralambos P.] Univ Patras, Univ Hosp, Dept Med, Div Oncol,Med Sch, Patras, Greece; [Lazaridis, Georgios] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Fac Med, Dept Med Oncol,Sch Hlth Sci, Thessaloniki, Greece; [Koliou, Georgia-Angeliki] Hellen Cooperat Oncol Grp, Data Off, Sect Biostat, Athens, Greece; [Kouvatseas, George] Hlth Data Specialists Ltd, Athens, Greece; [Christodoulou, Christos] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece; [Kotoula, Vassiliki] Aristotle Univ Thessaloniki, Fac Med, Sch Hlth Sci, Dept Pathol, Thessaloniki, Greece; [Kotoula, Vassiliki; Bobos, Mattheos; Tsolaki, Eleftheria; Papadopoulou, Kyriaki; Chrisafi, Sofia; Kalogeras, Konstantine T.; Fountzilas, George] Aristotle Univ Thessaloniki, Lab Mol Oncol, Hellen Fdn Canc Res, Thessaloniki, Greece; [Batistatou, Anna] Ioannina Univ Hosp, Dept Pathol, Ioannina, Greece; [Pentheroudakis, George] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Papakostas, Pavlos] Hippokrateion Hosp, Oncol Unit, Athens, Greece; [Pervana, Stavroula] Papageorgiou Hosp, Dept Pathol, Thessaloniki, Greece; [Petraki, Kalliopi] Metropolitan Hosp, Pathol Dept, Piraeus, Greece; [Razis, Evangelia] Hygeia Hosp, Dept Med Oncol 3, Athens, Greece; [Psyrri, Amanda] Attikon Univ Hosp, Dept Internal Med 2, Div Oncol, Athens, Greece; [Bafaloukos, Dimitrios] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece; [Kalogeras, Konstantine T.] Hellen Cooperat Oncol Grp, Translat Res Sect, Athens, Greece; [Fountzilas, George] Aristotle Univ Thessaloniki, Thessaloniki, Greece	University of Patras; Aristotle University of Thessaloniki; Papageorgiou Hospital; Hellenic Cooperative Oncology Group; Hippokration General Hospital; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; University Hospital Ioannina; University Hospital Ioannina; Hippokration General Hospital; Papageorgiou Hospital; Hygeia Hospital; University Hospital Attikon; Hellenic Cooperative Oncology Group; Aristotle University of Thessaloniki	Koutras, A (corresponding author), Univ Patras, Univ Hosp, Dept Med, Div Oncol,Med Sch, Patras, Greece.	angkoutr@otenet.gr	Fountzilas, George/ABF-2139-2020; Chrisafi, Sofia/AAH-2823-2020	Fountzilas, George/0000-0001-8045-2186; Papadopoulou, Kyriaki/0000-0003-0389-4209; Bobos, Mattheos/0000-0001-5662-9201	Roche Hellas SA [11P/05]; internal HeCOG research grant (HE TRANS_BR)	Roche Hellas SA(Roche Holding); internal HeCOG research grant (HE TRANS_BR)	The study was supported by a research grant from Roche Hellas SA (11P/05) and by an internal HeCOG research grant (HE TRANS_BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett J, 2003, J PATHOL, V199, P411, DOI 10.1002/path.1354; Bellezza G, 2013, VIRCHOWS ARCH, V463, P663, DOI 10.1007/s00428-013-1445-x; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Cheng H, 2014, BRIT J CANCER, V111, P1065, DOI 10.1038/bjc.2014.442; Dafni U, 2010, BREAST CANCER RES TR, V119, P621, DOI 10.1007/s10549-009-0630-8; Denkert C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3384; FOUNTZILAS G, 2012, J TRANSL MED, V10; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Gjerdrum LM, 2004, J MOL DIAGN, V6, P42, DOI 10.1016/S1525-1578(10)60490-4; Gogas H, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0883-z; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Gori S, 2012, TUMORI, V98, P39, DOI 10.1700/1053.11498; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Koumarianou A, 2015, CANCER CHEMOTH PHARM, V75, P1289, DOI 10.1007/s00280-015-2762-3; Koutras AK, 2008, BRIT J CANCER, V99, P1775, DOI 10.1038/sj.bjc.6604769; Koutras A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0530-0; Koutras AK, 2010, CRIT REV ONCOL HEMAT, V74, P73, DOI 10.1016/j.critrevonc.2009.04.011; Lee HJ, 2015, BRIT J CANCER, V112, P103, DOI 10.1038/bjc.2014.556; Lee Y, 2007, AM J CLIN PATHOL, V128, P1041, DOI 10.1309/GA5VRFQFY5D0MVKD; Lipton A, 2013, BREAST CANCER RES TR, V141, P43, DOI 10.1007/s10549-013-2665-0; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Pavlakis K, 2015, PATHOL ONCOL RES, V21, P273, DOI 10.1007/s12253-014-9818-2; Pawlowski V, 2000, CLIN CANCER RES, V6, P4217; Press MF, 2011, J CLIN ONCOL, V29, P859, DOI 10.1200/JCO.2009.27.5644; QUINN CM, 1994, HISTOPATHOLOGY, V25, P247, DOI 10.1111/j.1365-2559.1994.tb01324.x; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Roche PC, 2002, JNCI-J NATL CANCER I, V94, P855, DOI 10.1093/jnci/94.11.855; Sanchez-Navarro I, 2010, BIOTECHNIQUES, V48, P389, DOI 10.2144/000113388; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Sassen A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2339; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Skarlos P, 2012, CANCER CHEMOTH PHARM, V69, P533, DOI 10.1007/s00280-011-1730-9; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Suo Z, 2002, J PATHOL, V196, P17, DOI 10.1002/path.1003; Timotheadou E, 2017, TRANSL ONCOL, V10, P589, DOI 10.1016/j.tranon.2017.05.006; Tsutsui S, 2002, BREAST CANCER RES TR, V71, P67, DOI 10.1023/A:1013397232011; Tzaida O, 2007, ONCOLOGY-BASEL, V72, P388, DOI 10.1159/000113148; Vassilakopoulou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099131; Watters AD, 2003, BREAST CANCER RES TR, V77, P109, DOI 10.1023/A:1021399923825; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yonemori K, 2010, J SURG ONCOL, V101, P222, DOI 10.1002/jso.21486; Zhang F, 2010, ACTA PHARMACOL SIN, V31, P111, DOI 10.1038/aps.2009.178	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207707	10.1371/journal.pone.0207707	http://dx.doi.org/10.1371/journal.pone.0207707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521571	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600018
J	Iwasa, Y; Tsukada, K; Kobayashi, M; Kitano, T; Mori, K; Yoshimura, H; Fukuoka, H; Usami, S				Iwasa, Yoh-ichiro; Tsukada, Keita; Kobayashi, Masafumi; Kitano, Tomohiro; Mori, Kentaro; Yoshimura, Hidekane; Fukuoka, Hisakuni; Usami, Shin-ichi			Bilateral delayed endolymphatic hydrops evaluated by bilateral intratympanic injection of gadodiamide with 3T-MRI	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; INNER-EAR; SPACE	The purpose of this study was to assess the diagnostic performance of 3T MRI after intratympanic injection of gadodiamide for delayed endolymphatic hydrops (DEH), and assess the relationship between endolymphatic hydrops (ELH) and vestibular function in patients diagnosed with DEH and confirmed by 3T MRI. Nineteen patients clinically diagnosed with DEH (11 ipsilateral DEH, 8 contralateral DEH) participated in this study. Diluted gadodiamide was administered to the bilateral tympanic cavity by injection through the tympanic membrane. At 24 hours post-injection,the ELH was evaluated by MRI. Patient vestibular functions were evaluated by caloric testing and cVEMP. ELH was observed in all patients (19/19: positive rate 100%). The distribution patterns of ELH varied between the cochlear or vestibular region. Vestibular ELH was observed in the affected ear in all ipsilateral DEH patients. In the contralateral DEH patients, however, there were individual differences in the distribution patterns of ELH. Six patients (1 ipsilateral DEH, 5 contralateral DEH) had bilateral ELH. No obvious relationships were observed between ELH and vestibular function. ELH distribution was complicated, particularly in the contralateral DEH cases. It was difficult to identify the existence of ELH by vestibular functional testing alone; therefore, 3T MRI is thought to be useful for identifying the affected ear. A significant number of cases had "bilateral" DEH, particularly among the contralateral DEH cases, indicating that we should pay careful attention to this pathology when treating DEH.	[Iwasa, Yoh-ichiro; Tsukada, Keita; Kobayashi, Masafumi; Kitano, Tomohiro; Mori, Kentaro; Yoshimura, Hidekane; Fukuoka, Hisakuni; Usami, Shin-ichi] Shinshu Univ, Dept Otorhinolaryngol, Sch Med, Matsumoto, Nagano, Japan	Shinshu University	Usami, S (corresponding author), Shinshu Univ, Dept Otorhinolaryngol, Sch Med, Matsumoto, Nagano, Japan.	usami@shinshu-u.ac.jp		Iwasa, Yoh-ichiro/0000-0001-8989-9021				Fujiwara K, 2017, AUDIOL NEURO-OTOL, V22, P190, DOI 10.1159/000481426; Fukuoka H, 2012, ACTA OTO-LARYNGOL, V132, P141, DOI 10.3109/00016489.2011.635383; Fukushima M, 2016, ACTA OTO-LARYNGOL, V136, P451, DOI 10.3109/00016489.2015.1129554; Gu X, 2014, J LARYNGOL OTOL, V128, P53, DOI 10.1017/S0022215113003289; Kasai S, 2009, ACTA OTO-LARYNGOL, V129, P1169, DOI 10.3109/00016480802691143; Komatsuzaki A., 1987, EQUILIB RES, V47, P249; Midorikawa C, 1984, Nihon Jibiinkoka Gakkai Kaiho, V87, P1111; Naganawa S, 2006, EUR RADIOL, V16, P733, DOI 10.1007/s00330-005-0046-8; Nakashima T, 2007, LARYNGOSCOPE, V117, P415, DOI 10.1097/MLG.0b013e31802c300c; Nonoyama H, 2014, ACTA OTO-LARYNGOL, V134, P221, DOI 10.3109/00016489.2013.850741; SCHUKNECHT HF, 1978, ANN OTO RHINOL LARYN, V87, P743, DOI 10.1177/000348947808700601	11	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206891	10.1371/journal.pone.0206891	http://dx.doi.org/10.1371/journal.pone.0206891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517123	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400024
J	Kido, T; Miyagawa, S; Goto, T; Tamai, K; Ueno, T; Toda, K; Kuratani, T; Sawa, Y				Kido, Takashi; Miyagawa, Shigeru; Goto, Takasumi; Tamai, Katsuto; Ueno, Takayoshi; Toda, Koichi; Kuratani, Toru; Sawa, Yoshiki			The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; HEART; TISSUE; HMSCS; DIFFERENTIATION; TSG-6; VEGF; MICE	Objectives We hypothesized that systemic administration of high-mobility group box 1 fragment attenuates the progression of myocardial fibrosis and cardiac dysfunction in a hamster model of dilated cardiomyopathy by recruiting bone marrow mesenchymal stem cells thus causing enhancement of a self-regeneration system. Methods Twenty-week-old J2N-k hamsters, which are 6-sarcoglycan-deficient, were treated with systemic injection of high-mobility group box 1 fragment (HMGB1, n = 15) or phosphate buffered saline (control, n = 11). Echocardiography for left ventricular function, cardiac histology, and molecular biology were analyzed. The life-prolonging effect was assessed separately using the HMGB1 and control groups, in addition to a monthly HMGB1 group which received monthly systemic injections of high-mobility group box 1 fragment, 3 times (HMGB1, n = 11, control, n = 9, monthly HMGB1, n = 9). Results The HMGB1 group showed improved left ventricular ejection fraction, reduced myocardial fibrosis, and increased capillary density. The number of platelet-derived growth factor receptor-alpha and CD106 positive mesenchymal stem cells detected in the myocardium was significantly increased, and intra-myocardial expression of tumor necrosis factor a stimulating gene 6, hepatic growth factor, and vascular endothelial growth factor were significantly upregulated after high-mobility group box 1 fragment administration. Improved survival was observed in the monthly HMGB1 group compared with the control groups. Conclusions Systemic high-mobility group box 1 fragment administration attenuates the progression of left ventricular remodeling in a hamster model of dilated cardiomyopathy by enhanced homing of bone marrow mesenchymal stem cells into damaged myocardium, suggesting that high-mobility group box 1 fragment could be a new treatment for dilated cardiomyopathy.	[Kido, Takashi; Miyagawa, Shigeru; Goto, Takasumi; Ueno, Takayoshi; Toda, Koichi; Kuratani, Toru; Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka, Japan; [Tamai, Katsuto] Osaka Univ, Dept Stem Cell Therapy Sci, Grad Sch Med, Osaka, Japan	Osaka University; Osaka University	Sawa, Y (corresponding author), Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp		Miyagawa, Shigeru/0000-0003-0015-6569; Kido, Takashi/0000-0002-0570-8513				Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aikawa E, 2015, SCI REP-UK, V5, DOI 10.1038/srep11008; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen Y, 2008, INT J BIOCHEM CELL B, V40, P815, DOI 10.1016/j.biocel.2008.01.007; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Fischer-Rasokat U, 2009, CIRC-HEART FAIL, V2, P417, DOI 10.1161/CIRCHEARTFAILURE.109.855023; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Guo XF, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0773-9; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; He ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep38438; Hoshikawa E, 2011, AM J CARDIOL, V107, P1065, DOI 10.1016/j.amjcard.2010.11.033; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Itoh M, 2015, EUROPACE, V17, P1407, DOI 10.1093/europace/euu361; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kawamura M, 2015, TISSUE ENG PT A, V21, P2272, DOI [10.1089/ten.tea.2014.0036, 10.1089/ten.TEA.2014.0036]; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; Kondoh H, 2005, J THORAC CARDIOV SUR, V130, P295, DOI 10.1016/j.jtcvs.2004.11.001; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lee RH, 2014, P NATL ACAD SCI USA, V111, P16766, DOI 10.1073/pnas.1416121111; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Luk A, 2009, J CLIN PATHOL, V62, P219, DOI 10.1136/jcp.2008.060731; Maekawa K, 2013, J MOL CELL CARDIOL, V59, P76, DOI 10.1016/j.yjmcc.2013.02.008; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; Megeney LA, 1999, P NATL ACAD SCI USA, V96, P220, DOI 10.1073/pnas.96.1.220; Mela T, 1999, AM J CARDIOL, V83, P1277, DOI 10.1016/S0002-9149(99)00074-0; Meng ER, 2008, STEM CELLS DEV, V17, P805, DOI 10.1089/scd.2008.0276; Mitsuhashi S, 2003, J BIOCHEM, V134, P269, DOI 10.1093/jb/mvg140; Miwa H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.155879; Miyagawa S, 2002, CIRCULATION, V105, P2556, DOI 10.1161/01.CIR.0000016722.37138.F2; Nakamura K, 2002, CIRCULATION, V105, P2867, DOI 10.1161/01.CIR.0000018605.14470.DD; Nakamura T, 2005, AM J PHYSIOL-HEART C, V288, pH2131, DOI 10.1152/ajpheart.01239.2003; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Osmanov T, 2013, BIOCHEM BIOPH RES CO, V432, P231, DOI 10.1016/j.bbrc.2013.02.008; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Roura S, 2007, EUR J HEART FAIL, V9, P995, DOI 10.1016/j.ejheart.2007.07.008; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Seth S, 2010, J AM COLL CARDIOL, V55, P1643, DOI 10.1016/j.jacc.2009.11.070; Shafei AE, 2018, J CELL BIOCHEM, V119, P5274, DOI 10.1002/jcb.26637; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Theiss HD, 2007, EUR HEART J, V28, P1258, DOI 10.1093/eurheartj/ehm011; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Weintraub RG, 2017, LANCET, V390, P400, DOI 10.1016/S0140-6736(16)31713-5; Zisa D, 2009, AM J PHYSIOL-REG I, V297, pR1503, DOI 10.1152/ajpregu.00227.2009	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0202838	10.1371/journal.pone.0202838	http://dx.doi.org/10.1371/journal.pone.0202838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517097	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400004
J	Pawar, GN; Parayath, NN; Nocera, AL; Bleier, BS; Amiji, MM				Pawar, Grishma N.; Parayath, Neha N.; Nocera, Angela L.; Bleier, Benjamin S.; Amiji, Mansoor M.			Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting	PLOS ONE			English	Article							INTRANASAL DELIVERY; MECHANISMS; JUNCTIONS; MODELS; TIGHT; DRUGS	Delivering therapeutics across the blood-brain barrier (BBB) for treating central nervous system (CNS) diseases is one of the biggest challenges today as the BBB limits the uptake of molecules greater than 500 Da into the CNS. Here we describe a novel trans-nasal mucosal drug delivery as an alternative to the intranasal drug delivery to overcome its limitations and deliver high molecular weight (HMW) therapeutics efficiently to the brain. This approach is based on human endoscopic skull base surgical techniques in which a surgical defect is repaired by engrafting semipermeable nasal mucosa over a skull base defect. Based on endoscopic skull based surgeries, our groups has developed a trans-nasal mucosal rodent model where we have evaluated the permeability of ovalbumin (45 kDa) as a model protein through the implanted mucosal graft for delivering HMW therapeutics to the brain. A thermo sensitive liposome-in-gel (LiG) system was developed for creating a drug depot allowing for a sustained release from the site of delivery to the brain through the implanted nasal graft. We would like to report this as an exploratory pilot study where we are using this novel surgical model to show that the implanted nasal mucosal graft and the LiG delivery system result in an efficient and a sustained brain delivery of HMW proteins. Hence, this study demonstrates that the trans-nasal mucosal engrafting technique could overcome the limitations for intranasal drug delivery and enable the uptake of HMW protein therapeutics into the CNS for the treatment of a wide range of neurodegenerative diseases.	[Pawar, Grishma N.; Parayath, Neha N.; Nocera, Angela L.; Amiji, Mansoor M.] Northeastern Univ, Sch Pharm, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Bleier, Benjamin S.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Boston, MA USA	Northeastern University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Amiji, MM (corresponding author), Northeastern Univ, Sch Pharm, Dept Pharmaceut Sci, Boston, MA 02115 USA.	m.amiji@northeastern.edu	Bleier, Benjamin S/H-6726-2019; Amiji, Mansoor M/AAK-1531-2020	Bleier, Benjamin S/0000-0003-0783-8861; Amiji, Mansoor M/0000-0001-6170-881X; Parayath, Neha/0000-0003-0860-1663; Pawar, Grishma/0000-0001-5223-152X				Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Bleier BS, 2016, NEUROSURGERY, V78, P448, DOI 10.1227/NEU.0000000000001016; Bleier BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061694; Bleier BS, 2011, INT FORUM ALLERGY RH, V1, P361, DOI 10.1002/alr.20041; Bleier Benjamin S, 2009, Otolaryngol Clin North Am, V42, P901, DOI 10.1016/j.otc.2009.07.002; Chaaban MR, 2013, ADV OTO-RHINO-LARYNG, V74, P148, DOI 10.1159/000342291; Chaize B, 2004, ARTIF CELL BLOOD SUB, V32, P67, DOI 10.1081/BIO-120028669; Cuomo F, 2014, LANGMUIR, V30, P7993, DOI 10.1021/la501978u; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Djupesland PG, 2014, THER DELIV, V5, P709, DOI [10.4155/tde.14.41, 10.4155/TDE.14.41]; Enna SJ, 2009, J PHARMACOL EXP THER, V329, P404, DOI 10.1124/jpet.108.143420; Escobar-Chavez JJ, 2006, J PHARM PHARM SCI, V9, P339; Gitler AD, 2017, DIS MODEL MECH, V10, P499, DOI 10.1242/dmm.030205; Gudis D, 2012, AM J RHINOL ALLERGY, V26, P1, DOI 10.2500/ajra.2012.26.3716; Harvey RJ, 2012, LARYNGOSCOPE, V122, P452, DOI 10.1002/lary.22475; Illum L, 2004, J PHARM PHARMACOL, V56, P3, DOI 10.1211/0022357022539; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kohman RE, 2014, JOVE-J VIS EXP, DOI 10.3791/51452; Krishan M, 2014, DRUG DELIV, V21, P8, DOI 10.3109/10717544.2013.840017; Kumar NN, 2016, SCI REP-UK, V6, DOI 10.1038/srep31732; Lu CT, 2014, INT J NANOMED, V9, P2241, DOI 10.2147/IJN.S61288; Marcel M, 2015, WORLD J OTORHINOLARY, V1, P11, DOI [10.1016/j.wjorl.2015.09.001, DOI 10.1016/J.WJORL.2015.09.001]; Meredith ME, 2015, AAPS J, V17, P780, DOI 10.1208/s12248-015-9719-7; Noble Wendy, 2010, Front Psychiatry, V1, P7, DOI 10.3389/fpsyt.2010.00007; Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161; Ooi EH, 2008, AM J RHINOL, V22, P13, DOI 10.2500/ajr.2008.22.3127; Pardridge William M, 2005, NeuroRx, V2, P1, DOI 10.1602/neurorx.2.1.1; Pathan Shadab A, 2009, Recent Pat Drug Deliv Formul, V3, P71; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.13, 10.1111/ene.14108]; Quintana DS, 2016, MOL PSYCHIATR, V21, P29, DOI 10.1038/mp.2015.166; Sandeep Nema DMK, 1994, PDA J PHARM SCI TECH, V48; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Steinke A, 2008, HISTOCHEM CELL BIOL, V130, P339, DOI 10.1007/s00418-008-0441-8; van Woensel Matthias, 2013, Cancers (Basel), V5, P1020, DOI 10.3390/cancers5031020; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208122	10.1371/journal.pone.0208122	http://dx.doi.org/10.1371/journal.pone.0208122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517163	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400080
J	Rao, YS; Wang, ZF; Luo, W; Sheng, WT; Zhang, RD; Chai, XW				Rao, Yousheng; Wang, Zhangfeng; Luo, Wen; Sheng, Wentao; Zhang, Rendian; Chai, Xuewen			Base composition is the primary factor responsible for the variation of amino acid usage in zebra finch (Taeniopygia guttata)	PLOS ONE			English	Article							TRANSFER-RNA GENES; CODON USAGE; ESCHERICHIA-COLI; GC-CONTENT; EXPRESSION; TRANSLATION; BIAS; EFFICIENCY; BUCHNERA; NUMBER	In the present study, we carried out an examination of the amino acid usage in the zebra finch (Taeniopygia guttata) proteome. We found that tRNA abundance, base composition, hydrophobicity and aromaticity, protein second structure, cysteine residue (Cys) content and protein molecular weight had significant impact on the amino acid usage of the zebra finch. The above factors explained the total variability of 22.85%, 25.37%, 10.91%, 5.06%, 4.21%, and 3.14%, respectively. Altogether, approximately 70% of the total variability in zebra finch could be explained by such factors. Comparison of the amino acid usage between zebra finch, (Gallus gallus) and human (Homo sapiens) suggested that the average frequency of various amino acid usage is generally consistent among them. Correspondence analysis indicated that base composition was the primary factor affecting the amino acid usage in zebra finch. This trend was different from but similar to human. Other factors affecting the amino acid usage in zebra finch, such as isochore structure, protein second structure, Cys frequency and protein molecular weight also showed the similar trends with human. We do not know whether the similar amino acid usage trend between human and zebra finch is related to the distinctive neural and behavioral traits, but it is worth studying in depth.	[Rao, Yousheng; Wang, Zhangfeng; Sheng, Wentao; Zhang, Rendian; Chai, Xuewen] Nanchang Normal Univ, Dept Biol Technol, Nanchang, Jiangxi, Peoples R China; [Rao, Yousheng; Wang, Zhangfeng; Luo, Wen; Sheng, Wentao; Zhang, Rendian; Chai, Xuewen] Jiang Xi Prov Key Lab Genet Improvement Indigenou, Nanchang, Jiangxi, Peoples R China	Nanchang Normal University	Rao, YS (corresponding author), Nanchang Normal Univ, Dept Biol Technol, Nanchang, Jiangxi, Peoples R China.; Rao, YS (corresponding author), Jiang Xi Prov Key Lab Genet Improvement Indigenou, Nanchang, Jiangxi, Peoples R China.	rys8323571@aliyun.com		Sheng, Wentao/0000-0002-7077-8921	National Nature Science Foundation of China [31460595]; Major Projects of Jiangxi Provincial Science and Technology [2015ACF60019]; Jiangxi Provincial Science and Technology Landing Project [KJLD14102]; Science Technology Program of Jiangxi Education Department [GJJ14781]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Projects of Jiangxi Provincial Science and Technology; Jiangxi Provincial Science and Technology Landing Project; Science Technology Program of Jiangxi Education Department	Funded by National Nature Science Foundation of China (31460595), Major Projects of Jiangxi Provincial Science and Technology (2015ACF60019), Jiangxi Provincial Science and Technology Landing Project (KJLD14102), and Science Technology Program of Jiangxi Education Department (GJJ14781).	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Behura SK, 2011, INSECT MOL BIOL, V20, P177, DOI 10.1111/j.1365-2583.2010.01055.x; Blazej P, 2017, G3-GENES GENOM GENET, V7, P967, DOI 10.1534/g3.116.038125; Du MZ, 2017, DNA RES, V24, P623, DOI 10.1093/dnares/dsx030; Dufton MJ, 1997, J THEOR BIOL, V187, P165, DOI 10.1006/jtbi.1997.0443; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; HOLM S, 1979, SCAND J STAT, V6, P65; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Lafay B, 1999, NUCLEIC ACIDS RES, V27, P1642, DOI 10.1093/nar/27.7.1642; Li J, 2015, G3-GENES GENOM GENET, V5, P2027, DOI 10.1534/g3.115.019877; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; LOBRY JR, 1994, NUCLEIC ACIDS RES, V22, P3174, DOI 10.1093/nar/22.15.3174; Mackiewicz P, 1999, GENOME RES, V9, P409; Mackiewicz P, 1999, PHYSICA A, V273, P103, DOI 10.1016/S0378-4371(99)00345-3; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Mello Claudio V, 2014, Cold Spring Harb Protoc, V2014, P1237, DOI 10.1101/pdb.emo084574; Mondal SK, 2016, J BIOMOL STRUCT DYN, V34, P1649, DOI 10.1080/07391102.2015.1087334; Palacios C, 2002, MOL BIOL EVOL, V19, P1575, DOI 10.1093/oxfordjournals.molbev.a004219; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Rao YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110381; Rispe C, 2004, GENOME RES, V14, P44, DOI 10.1101/gr.1358104; Sabbia V, 2007, J BIOMOL STRUCT DYN, V25, P55, DOI 10.1080/07391102.2007.10507155; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Whittle CA, 2016, GENOME BIOL EVOL, V8, P2722, DOI 10.1093/gbe/evw068; Williford A, 2012, MOL BIOL EVOL, V29, P3755, DOI 10.1093/molbev/mss184	27	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0204796	10.1371/journal.pone.0204796	http://dx.doi.org/10.1371/journal.pone.0204796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517105	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400006
J	Deng, YJ; Cai, Y; Liu, LL; Lin, XP; Lu, PF; Guo, YY; Han, M; Xu, G				Deng, Yuanjun; Cai, Yang; Liu, Lele; Lin, Xueping; Lu, Pingfan; Guo, Yiyan; Han, Min; Xu, Gang			Blocking Tyr265 nitration of protein phosphatase 2A attenuates nitrosative stress-induced endothelial dysfunction in renal microvessels	FASEB JOURNAL			English	Article						nitration; endothelial cells; peptide drugs	NITRIC-OXIDE; CELL; PEPTIDE; PP2A; INACTIVATION; FIBROBLASTS; MODULATION; INHIBITION; OXIDATION; JUNCTIONS	Protein tyrosine (Tyr) nitration, the covalent addition of a nitro group ((NO2)-N-center dot) to Tyr residues, is emerging as a candidate mechanism of endothelial dysfunction. Previous studies have shown that Tyr nitration is primarily induced by nitrosative stress, a process characterized by the production of reactive nitrogen species, especially peroxynitrite anion (ONOO-), which is considered a secondary product of NO in the presence of superoxide radicals (O-2(center dot-)). However, the impact of nitrosative stress-induced Tyr nitration on endothelial dysfunction has not been thoroughly elucidated to date. We developed an endothelial dysfunction model, a process called endothelial-to-mesenchymal transition (EndMT), and evaluated the production of NO, O-2(center dot-), and protein nitration during EndMT. The results showed that TGF-1 stimulation induced EndMT and elevated endothelial NO and O-2(center dot-) production as well as nitration of the catalytic subunit of protein phosphatase (PP)2A. Mass spectrometry analysis showed that Tyr265 was the nitration site in the catalytic subunit of protein phosphatase (PP)2A, and this Tyr nitration increased PP2A activity and disrupted endothelial integrity. To devise an endothelial-targeted anti-PP2Ac nitration strategy, a mimic peptide, tyrosine 265 wild type (Y265WT), conjugated with the cell-penetrating peptide HIV-1 TAT protein (TAT) was synthesized. PP2Ac nitration and PP2A activity were significantly inhibited by pretreatment with TAT-265WT, and the integrity of endothelial cells was maintained. Furthermore, injection of TAT-265WT attenuated renal nitration formation and caused anticapillary rarefaction in a unilateral urethral obstructive nephropathy model. Taken together, these results offer preclinical proof of concept for TAT-265WT as a tractable agent to protect against nitrosative stress-induced endothelial dysfunction in renal microvessels.Deng,Y., Cai, Y., Liu, L., Lin, X., Lu, P., Guo, Y., Han, M., Xu, G. Blocking Tyr265 nitration of protein phosphatase 2A attenuates nitrosative stress-induced endothelial dysfunction in renal microvessels.	[Deng, Yuanjun; Cai, Yang; Liu, Lele; Lin, Xueping; Lu, Pingfan; Guo, Yiyan; Han, Min; Xu, Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol,Dept Internal Med, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology	Han, M; Xu, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol,Dept Internal Med, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	minhan@tjh.tjmu.edu.cn; xugang@tjh.tjmu.edu.cn			National Natural Science Foundation of China [81370798, 81670633, 81770686]; Huazhong University of Science and Technology [2017KFYXJJ101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong University of Science and Technology	The authors thank Yajun Ruan (Tongji Hospital, Huazhong University of Science and Technology) for technical assistance for the whole-body fluorescence imaging experiment. This research was supported by National Natural Science Foundation of China Grants 81370798, 81670633, and 81770686, and by Huazhong University of Science and Technology research funds for Self-Dependent Innovation (Grant 2017KFYXJJ101). The authors declare no conflicts of interest.	Bailey JC, 2014, PHARMACOL THERAPEUT, V144, P303, DOI 10.1016/j.pharmthera.2014.06.009; Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; Batthyany C, 2005, BIOCHEMISTRY-US, V44, P8038, DOI 10.1021/bi0474620; Bellmann-Sickert K, 2010, TRENDS PHARMACOL SCI, V31, P434, DOI 10.1016/j.tips.2010.06.003; Bohle A, 1996, KIDNEY BLOOD PRESS R, V19, P191, DOI 10.1159/000174072; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brovkovych V, 1999, J PHYSIOL PHARMACOL, V50, P575; Carlstrom M, 2015, PHYSIOL REV, V95, P405, DOI 10.1152/physrev.00042.2012; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Del Carlo M, 2003, ARTHRITIS RHEUM-US, V48, P3419, DOI 10.1002/art.11338; Deng YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19821; Deshmukh PA, 2007, AM J PHYSIOL-HEART C, V292, pH792, DOI 10.1152/ajpheart.00225.2006; Dunagan M, 2012, AM J PHYSIOL-GASTR L, V303, pG1356, DOI 10.1152/ajpgi.00526.2011; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Fine LG, 1998, KIDNEY INT, pS74; Han F, 2011, J PINEAL RES, V50, P281, DOI 10.1111/j.1600-079X.2010.00838.x; Heigold S, 2002, J LEUKOCYTE BIOL, V72, P554; Ichikawa T, 2008, AM J PHYSIOL-LUNG C, V295, pL800, DOI 10.1152/ajplung.90264.2008; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jung HJ, 2006, BIOCHEM BIOPH RES CO, V345, P222, DOI 10.1016/j.bbrc.2006.04.059; Kasa A, 2013, MICROVASC RES, V89, P86, DOI 10.1016/j.mvr.2013.05.003; Kim DH, 2014, ENVIRON SCI TECHNOL, V48, P4030, DOI 10.1021/es500001q; Knepler JL, 2001, AM J PHYSIOL-CELL PH, V281, pC1064, DOI 10.1152/ajpcell.2001.281.3.C1064; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Liu RH, 2012, J CONTROL RELEASE, V161, P893, DOI 10.1016/j.jconrel.2012.05.002; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Malinski T, 2007, J ALZHEIMERS DIS, V11, P207; Mathews MT, 2008, ARTERIOSCL THROM VAS, V28, P711, DOI 10.1161/ATVBAHA.107.156406; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nakahata S, 2014, BLOOD, V124, P2163, DOI 10.1182/blood-2014-08-594093; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; Panth N., 2016, ADV MED, V2016, P9152732, DOI [10.1155/2016/9152732, DOI 10.1155/2016/9152732]; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Sun L, 2015, BIOMOLECULES, V5, P1284, DOI 10.3390/biom5031284; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Wu F, 2009, CARDIOVASC RES, V81, P38, DOI 10.1093/cvr/cvn246; Yang D, 2013, EXP NEUROL, V247, P447, DOI 10.1016/j.expneurol.2013.01.015; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	41	4	4	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3718	3730		10.1096/fj.201800885RR	http://dx.doi.org/10.1096/fj.201800885RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521379	Bronze			2022-12-26	WOS:000459794800051
J	Jie, ZW; Shen, SY; Zhao, XD; Xu, WB; Zhang, XY; Huang, B; Tang, P; Qin, A; Fan, SW; Xie, Z				Jie, Zhiwei; Shen, Shuying; Zhao, Xiangde; Xu, Wenbin; Zhang, Xuyang; Huang, Bao; Tang, Pan; Qin, An; Fan, Shunwu; Xie, Ziang			Activating -catenin/Pax6 axis negatively regulates osteoclastogenesis by selectively inhibiting phosphorylation of p38/MAPK	FASEB JOURNAL			English	Article						bone loss; osteoclast; VX-745; SKL2001; therapeutic	P38 MAP KINASE; NF-KAPPA-B; BETA-CATENIN; ALKALINE-PHOSPHATASE; CROSS-TALK; RANKL; MECHANISMS; INDUCTION; NFATC1; GENES	Balance of osteoclast formation is regulated by the receptor activator of NF-B ligand and extracellular negative regulators such as IFN- and IFN-. However, very little is known about the intrinsic negative regulatory factors of osteoclast differentiation. Recently, the paired-box homeodomain transcription factor Pax6 was shown to negatively regulate receptor activator of NF-B ligand-mediated osteoclast differentiation. However, the mechanism underlying this regulation is still unclear. In this study, we show that a p38 inhibitor (VX-745) up-regulates the expression of Pax6 during osteoclast differentiation. Subsequently, we found that -catenin could bind to the proximal region of Pax6 promoter to induce its expression, and this action could be impaired by p38-induced ubiquitin-mediated degradation of -catenin. Our results suggest that Pax6 is regulated by a novel p38/-catenin pathway. Pax6 can further regulate the nuclear translocation of NF of activated T cells, cytoplasmic 1. Our study indicates that this novel p38/-catenin/Pax6 axis contributes to negative regulation of osteoclastogenesis. In addition, our study proposes a novel approach to treat osteoclast-related diseases through the use of VX-745 complemented with the -catenin activator SKL2001.Jie, Z., Shen, S., Zhao, X., Xu, W., Zhang, X., Huang, B., Tang, P., Qin, A., Fan, S., Xie, Z. Activating -catenin/Pax6 axis negatively regulates osteoclastogenesis by selectively inhibiting phosphorylation of p38/MAPK.	[Jie, Zhiwei; Shen, Shuying; Zhao, Xiangde; Xu, Wenbin; Zhang, Xuyang; Huang, Bao; Fan, Shunwu; Xie, Ziang] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Hangzhou, Zhejiang, Peoples R China; [Jie, Zhiwei; Shen, Shuying; Zhao, Xiangde; Xu, Wenbin; Zhang, Xuyang; Huang, Bao; Fan, Shunwu; Xie, Ziang] Key Lab Musculoskeletal Syst Degenerat & Regenera, Hangzhou, Zhejiang, Peoples R China; [Tang, Pan] Zhejiang Univ, Huzhou Hosp, Dept Orthopaed, Hangzhou, Zhejiang, Peoples R China; [Qin, An] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant, Dept Orthopaed,Sch Med, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Shanghai Jiao Tong University	Fan, SW; Xie, Z (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed, 3rd Qingchun Rd, Hangzhou, Zhejiang, Peoples R China.	shunwu_fan@zju.edu.cn; ziang_xie@zju.edu.cn	zhang, xuyang/GQH-3712-2022; Tang, Pan/AIC-2118-2022	Jie, Zhiwei/0000-0002-9469-4490; Zhang, Xuyang/0000-0002-4665-3934	National Key Research and Development Program of China [2018YFC1105200]; Key Research and Development Plan in Zhejiang Province [2018C03060]; National Nature Science Fund of China [81871797, 81802680, 81772387]; Natural Science Fund of Zhejiang Province [Z15H060002]	National Key Research and Development Program of China; Key Research and Development Plan in Zhejiang Province; National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	The authors thank Dr. Xiangqian Fang (Sir Run Run Shaw Hospital) for contributing to revisions to the manuscript. This research was supported by the National Key Research and Development Program of China (2018YFC1105200 to S.F.), the Key Research and Development Plan in Zhejiang Province (2018C03060), the National Nature Science Fund of China [81871797, 81802680 (to S.F.), and 81772387], and the Natural Science Fund of Zhejiang Province (Z15H060002). The authors declare no conflicts of interest.	ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Bohm C, 2009, J IMMUNOL, V183, P5938, DOI 10.4049/jimmunol.0901026; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Cong Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep45964; Cott C, 2016, BBA-MOL CELL RES, V1863, P1106, DOI 10.1016/j.bbamcr.2016.02.004; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; Deepak V, 2015, BIOFACTORS, V41, P403, DOI 10.1002/biof.1241; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Gan QN, 2014, STEM CELLS, V32, P45, DOI 10.1002/stem.1561; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grabowski P, 2009, ENDOCR DEV, V16, P32, DOI 10.1159/000223687; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Hinoi E, 2012, J BONE MINER RES, V27, P2526, DOI 10.1002/jbmr.1708; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Kim H, 2017, J BONE MINER RES, V32, P397, DOI 10.1002/jbmr.2974; Kogawa M, 2013, J BIOL CHEM, V288, P31299, DOI 10.1074/jbc.M113.461848; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Lin J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005867; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; McGuire VA, 2013, MOL CELL BIOL, V33, P4152, DOI 10.1128/MCB.01691-12; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Rey A, 2007, BONE, V41, P59, DOI 10.1016/j.bone.2007.02.031; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Suzuki A, 2002, BONE, V30, P91, DOI 10.1016/S8756-3282(01)00660-3; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Xie Z, 2018, J BONE MINER RES, V33, P667, DOI 10.1002/jbmr.3334; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yamashita T, 2008, BIOCHEM BIOPH RES CO, V365, P252, DOI 10.1016/j.bbrc.2007.10.169; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhou FH, 2006, J BONE MINER RES, V21, P1075, DOI 10.1359/JBMR.060410	45	12	12	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4236	4247		10.1096/fj.201801977R	http://dx.doi.org/10.1096/fj.201801977R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526042	Bronze			2022-12-26	WOS:000459794800091
J	Barayeu, U; Lange, M; Mendez, L; Arnhold, J; Shadyro, OI; Fedorova, M; Flemmig, J				Barayeu, Uladzimir; Lange, Mike; Mendez, Lucia; Arnhold, Juergen; Shadyro, Oleg I.; Fedorova, Maria; Flemmig, Joerg			Cytochrome c autocatalyzed carbonylation in the presence of hydrogen peroxide and cardiolipins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c; cardiolipin; peroxidase; mitochondria; apoptosis; proteomics; carbonylation; lipid hydroperoxides; oxidation; peroxidase activity; self-inactivation; auto-inactivation	STRUCTURAL TRANSITIONS; KEY ROLE; MITOCHONDRIA; PROTEIN; OXIDATION; MEMBRANE; RELEASE; ANTIOXIDANT; ACTIVATION; MECHANISMS	Cytochrome c (cyt c) is a small hemoprotein involved in electron shuttling in the mitochondrial respiratory chain and is now also recognized as an important mediator of apoptotic cell death. Its role in inducing programmed cell death is closely associated with the formation of a complex with the mitochondrion-specific phospholipid cardiolipin (CL), leading to a gain of peroxidase activity. However, the molecular mechanisms behind this gain and eventual cyt c autoinactivation via its release from mitochondrial membranes remain largely unknown. Here, we examined the kinetics of the H2O2-mediated peroxidase activity of cyt c both in the presence and absence of tetraoleoyl cardiolipin (TOCL)- and tetralinoleoyl cardiolipin (TLCL)-containing liposomes to evaluate the role of cyt c-CL complex formation in the induction and stimulation of cyt c peroxidase activity. Moreover, we examined peroxide-mediated cyt c heme degradation to gain insights into the mechanisms by which cyt c self-limits its peroxidase activity. Bottom-up proteomics revealed >50 oxidative modifications on cyt c upon peroxide reduction. Of note, one of these by-products was the Tyr-based cofactor trihydroxyphenylalanine quinone (TPQ) capable of inducing deamination of Lys E-amino groups and formation of the carbonylated product aminoadipic semialdehyde. In view of these results, we propose that autoinduced carbonylation, and thus removal of a positive charge in Lys, abrogates binding of cyt c to negatively charged CL. The proposed mechanism may be responsible for release of cyt c from mitochondrial membranes and ensuing inactivation of its peroxidase activity.	[Barayeu, Uladzimir; Lange, Mike; Mendez, Lucia; Fedorova, Maria] Univ Leipzig, Fac Chem & Mineral, Inst Bioanalyt Chem, D-04103 Leipzig, Germany; [Barayeu, Uladzimir; Lange, Mike; Mendez, Lucia; Fedorova, Maria] Univ Leipzig, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany; [Barayeu, Uladzimir; Arnhold, Juergen; Flemmig, Joerg] Univ Leipzig, Med Fac, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany; [Mendez, Lucia] Spanish Council Sci Res IIM CSIC, Inst Marine Res, Vigo 36208, Spain; [Shadyro, Oleg I.] Belarusian State Univ, Dept Chem, Minsk 220030, BELARUS	Leipzig University; Leipzig University; Leipzig University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Belarusian State University	Flemmig, J (corresponding author), Univ Leipzig, Med Fac, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.; Fedorova, M (corresponding author), Univ Leipzig, Biotechnol Biomed Zentrum, Fac Chem & Mineral, Inst Bioanalyt Chem, Deutsch Pl 5, D-04103 Leipzig, Germany.	maria.fedorova@bbz.uni-leipzig.de; joerg.flemmig@medizin.uni-leipzig.de	Méndez, Lucía/AAA-9264-2020; Méndez, Lucía/T-7016-2017; Barayeu, Uladzimir/AAC-7522-2019; Fedorova, Maria/GWD-0509-2022	Méndez, Lucía/0000-0002-9711-2994; Méndez, Lucía/0000-0002-9711-2994; Barayeu, Uladzimir/0000-0001-8426-166X; Fedorova, Maria/0000-0002-4692-3885; Flemmig, Jorg/0000-0001-5872-3373; Shadyro, Oleg/0000-0002-8589-4490	German Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft (DFG) [FE-1236/3-1]; European Regional Development Fund (ERDF; European Union) [100146238, 100121468]; European Regional Development Fund (ERDF; Free State Saxony) [100146238, 100121468]; Xunta de Galicia postdoctoral scholarship	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Regional Development Fund (ERDF; European Union); European Regional Development Fund (ERDF; Free State Saxony); Xunta de Galicia postdoctoral scholarship	This work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept for the SysMedOS project, Deutsche Forschungsgemeinschaft (DFG) Grant FE-1236/3-1 (to M.F.), European Regional Development Fund (ERDF; European Union and Free State Saxony) Grants 100146238 and 100121468 (to M.F.), and a Xunta de Galicia postdoctoral scholarship (to L.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aluri HS, 2014, BBA-GEN SUBJECTS, V1840, P3199, DOI 10.1016/j.bbagen.2014.07.017; Alvarez-Paggi D, 2017, CHEM REV, V117, P13382, DOI 10.1021/acs.chemrev.7b00257; Annibal A, 2016, J CHROMATOGR B, V1019, P147, DOI 10.1016/j.jchromb.2015.12.022; Ascenzi P, 2015, IUBMB LIFE, V67, P98, DOI 10.1002/iub.1350; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; BEERS RF, 1952, J BIOL CHEM, V195, P133; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YR, 2004, J BIOL CHEM, V279, P18054, DOI 10.1074/jbc.M307706200; Fedorova M., 2017, PROTEIN CARBONYLATIO, P48; Firsov AM, 2016, FEBS LETT, V590, P2836, DOI 10.1002/1873-3468.12319; Firsov AM, 2015, BBA-BIOMEMBRANES, V1848, P767, DOI 10.1016/j.bbamem.2014.11.027; Garcia-Heredia JM, 2010, BBA-BIOENERGETICS, V1797, P981, DOI 10.1016/j.bbabio.2010.03.009; Giorgio Marco, 2007, Nat Rev Mol Cell Biol, V8, P722, DOI 10.1038/nrm2240; Gose M, 2015, BIOMACROMOLECULES, V16, P757, DOI 10.1021/bm5016688; Griesser E, 2017, REDOX BIOL, V11, P438, DOI 10.1016/j.redox.2016.12.028; HAREL S, 1988, FREE RADICAL RES COM, V5, P11, DOI 10.3109/10715768809068554; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Isom AL, 2004, J AM SOC MASS SPECTR, V15, P1136, DOI 10.1016/j.jasms.2004.03.013; Josephs TM, 2014, BIOCHEM J, V458, P259, DOI 10.1042/BJ20131386; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kim NH, 2006, MOL CELLS, V22, P220; Klema VJ, 2012, INT J MOL SCI, V13, P5375, DOI 10.3390/ijms13055375; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maitra D, 2011, FREE RADICAL BIO MED, V51, P364, DOI 10.1016/j.freeradbiomed.2011.03.040; Mandal A, 2015, BIOPHYS J, V109, P1873, DOI 10.1016/j.bpj.2015.09.016; Mandal B, 2016, ANAL SCI, V32, P571, DOI 10.2116/analsci.32.571; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Miyamoto S, 2012, PHOTOCH PHOTOBIO SCI, V11, P1536, DOI 10.1039/c2pp25119a; Mohammadyani D, 2018, BBA-BIOMEMBRANES, V1860, P1057, DOI 10.1016/j.bbamem.2018.01.009; Moreno-Beltran B, 2017, P NATL ACAD SCI USA, V114, pE3041, DOI 10.1073/pnas.1618008114; NAKAMURA T, 1991, LIPIDS, V26, P765, DOI 10.1007/BF02535628; NOBLE RW, 1970, J BIOL CHEM, V245, P2409; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pandiscia LA, 2015, J PHYS CHEM B, V119, P1334, DOI 10.1021/jp5104752; Patriarca A, 2009, BIOCHEMISTRY-US, V48, P3279, DOI 10.1021/bi801837e; Puchkov MN, 2013, BBA-BIOMEMBRANES, V1828, P208, DOI 10.1016/j.bbamem.2012.10.002; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P118, DOI 10.1016/0003-9861(91)90172-F; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinibaldi F, 2017, J BIOL INORG CHEM, V22, P19, DOI 10.1007/s00775-016-1404-5; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Vemula V, 2015, REDOX BIOL, V5, P195, DOI 10.1016/j.redox.2015.04.006; Yin V, 2017, J AM CHEM SOC, V139, P15701, DOI 10.1021/jacs.7b07106; Yurkova R, 2009, CHEM PHYS LIPIDS, V158, P16, DOI 10.1016/j.chemphyslip.2008.09.005; Zschaler J, 2015, FREE RADICAL BIO MED, V85, P148, DOI 10.1016/j.freeradbiomed.2015.04.015	51	14	14	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1816	1830		10.1074/jbc.RA118.004110	http://dx.doi.org/10.1074/jbc.RA118.004110			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30541920	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000459711400005
J	Hara, S; Fukumura, S; Ichinose, H				Hara, Satoshi; Fukumura, Soichiro; Ichinose, Hiroshi			Reversible S-glutathionylation of human 6-pyruvoyl tetrahydropterin synthase protects its enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						redox regulation; glutathionylation; thiol; oxidative stress; tetrahydrobiopterin (BH4); macrophage; 6-pyruvoyl tetrahydropterin synthase; immune cell; neopterin	GTP-CYCLOHYDROLASE-I; REACTIVE OXYGEN; IMMUNE-SYSTEM; NEOPTERIN; TETRAHYDROBIOPTERIN; CELL; BIOSYNTHESIS; IDENTIFICATION; NITROSYLATION; INFLAMMATION	6-Pyruvoyl tetrahydropterin synthase (PTS) converts 7,8-dihydroneopterin triphosphate into 6-pyruvoyltetrahydropterin and is a critical enzyme for the de novo synthesis of tetrahydrobiopterin, an essential cofactor for aromatic amino acid hydroxylases and nitric-oxide synthases. Neopterin derived from 7,8-dihydroneopterin triphosphate is secreted by monocytes/macrophages, and is a well-known biomarker for cellular immunity. Because PTS activity in the cell can be a determinant of neopterin production, here we used recombinant human PTS protein to investigate how its activity is regulated, especially depending on redox conditions. Human PTS has two cysteines: Cys-43 at the catalytic site and Cys-10 at the N terminus. PTS can be oxidized and consequently inactivated by H2O2 treatment, oxidized GSH, or S-nitrosoglutathione, and determining the oxidized modifications of PTS induced by each oxidant by MALDI-TOF MS, we show that PTS is S-glutathionylated in the presence of GSH and H2O2. S-Glutathionylation at Cys-43 protected PTS from H2O2-induced irreversible sulfinylation and sulfonylation. We also found that PTS expressed in HeLa and THP-1 cells is reversibly modified under oxidative stress conditions. Our findings suggest that PTS activity and S-glutathionylation is regulated by the cellular redox environment and that reversible S-glutathionylation protects PTS against oxidative stress.	[Hara, Satoshi; Fukumura, Soichiro; Ichinose, Hiroshi] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Ichinose, H (corresponding author), Tokyo Inst Technol, Yokohama, Kanagawa 2268501, Japan.	hichinos@bio.titech.ac.jp	Hara, Satoshi/C-1341-2015; Ichinose, Hiroshi/D-8986-2015	Hara, Satoshi/0000-0001-6275-6469; Ichinose, Hiroshi/0000-0001-6008-6860	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H01422, 17H05555]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Adaptive circuit shift Grants 15H01422 and 17H05555. The authors declare that they have no conflicts of interest with the contents of this article.	BECKSPEIER I, 1988, FEBS LETT, V227, P1, DOI 10.1016/0014-5793(88)81401-7; Bhaskar A, 2015, J BIOL CHEM, V290, P1020, DOI 10.1074/jbc.M114.588913; BLAU N, 1989, EUR J CANCER CLIN ON, V25, P603, DOI 10.1016/0277-5379(89)90192-2; BURGISSER DM, 1995, J MOL BIOL, V253, P358, DOI 10.1006/jmbi.1995.0558; BURGISSER DM, 1994, EUR J BIOCHEM, V219, P497, DOI 10.1111/j.1432-1033.1994.tb19964.x; Cirillo P, 2006, J THROMB HAEMOST, V4, P2248, DOI 10.1111/j.1538-7836.2006.02125.x; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Deng J, 2012, J IMMUNOL, V188, P5734, DOI 10.4049/jimmunol.1101323; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Duggan S, 2002, BBA-MOL CELL RES, V1591, P139, DOI 10.1016/S0167-4889(02)00272-0; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; Ghisoni K, 2016, BRAIN BEHAV IMMUN, V56, P156, DOI 10.1016/j.bbi.2016.02.019; Gieche J, 2001, BBA-MOL CELL RES, V1538, P321, DOI 10.1016/S0167-4889(01)00083-0; Hazeldine J, 2014, AGING CELL, V13, P690, DOI 10.1111/acel.12222; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; Hoffmann G, 1996, FEBS LETT, V391, P181, DOI 10.1016/0014-5793(96)00729-6; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kalinina EV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1493, DOI 10.1134/S0006297908130099; Kaneko R, 2003, J MASS SPECTROM, V38, P526, DOI 10.1002/jms.466; Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03257-z; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Liang Y, 2013, BIOCHEM BIOPH RES CO, V442, P72, DOI 10.1016/j.bbrc.2013.11.002; Lonn ME, 2008, ANTIOXID REDOX SIGN, V10, P547, DOI 10.1089/ars.2007.1821; MANNERVIK B, 1980, BIOCHEM J, V190, P125, DOI 10.1042/bj1900125; Martins RD, 2018, FREE RADICAL BIO MED, V115, P371, DOI 10.1016/j.freeradbiomed.2017.11.022; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Ploom T, 1999, J MOL BIOL, V286, P851, DOI 10.1006/jmbi.1998.2511; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schobersberger W, 1996, FEBS LETT, V397, P263, DOI 10.1016/S0014-5793(96)01194-5; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Subramani J, 2016, J BIOL CHEM, V291, P23374, DOI 10.1074/jbc.M116.745034; TAKIKAWA SI, 1986, EUR J BIOCHEM, V161, P295, DOI 10.1111/j.1432-1033.1986.tb10446.x; TANI Y, 1993, J CHROMATOGR-BIOMED, V617, P249, DOI 10.1016/0378-4347(93)80495-P; Tao RK, 2017, NAT METHODS, V14, P720, DOI 10.1038/nmeth.4306; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; WEISS G, 1993, FEBS LETT, V321, P89, DOI 10.1016/0014-5793(93)80627-7; WERNER ER, 1990, J BIOL CHEM, V265, P3189; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293	44	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1420	1427		10.1074/jbc.RA118.005280	http://dx.doi.org/10.1074/jbc.RA118.005280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30514762	Green Published, hybrid			2022-12-26	WOS:000457879500030
J	Hemo, B; Shahar, DR; Geva, D; Heymann, AD				Hemo, Beatriz; Shahar, Danit R.; Geva, Dikla; Heymann, Anthony D.			Adherence to quality of care measurements among 58,182 patients with new onset diabetes and its association with mortality	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; MANAGED CARE; ALL-CAUSE; HEALTH; REGISTRIES; SURVIVAL; SYSTEM	Objectives Disease registry for diabetes care encourages transparency and benchmarking of quality of care (QoC) measurements for all service providers and seems to improve diabetes care. This study evaluate changes over time in QoC measurement performance in a large diabetes registry among newly diagnosed diabetics and it association with mortality. Methods Retrospective cohort study of patients in a large health maintenance organization diabetes registry from years 2000 to 2013. We identified 58,182 patients diagnosed with diabetes from 2000-2008 and examined the level of performance for seven QoC measurements (HbA1c, LDL, albumin-creatinine-ratio, fundus/foot examinations, BMI and Blood-pressure) at diagnosis year. We also searched data regarding visits to dietitians or endocrinologists, and purchase of diabetes and statin medications. We used Mantel-Haenszel's chi(2) test to assess QoC performance and mortality rate by calendar year of entry into the registry, and Cox regression to calculate hazard ratios (HRs) and 95% confidence intervals (Cis) for all cause mortality up to 5 years from diagnosis adjusted for age, gender, socio-economic status and comorbidities. Results The total QoC measurements improved from a mean of 2.71 tests performed in 2000 to 5.69 in 2008 (p<0.001). The mortality rate dropped from 7.7% in 2000 to 5.7% in 2008 (p<0.001). Patients with more QoC measurements performance who visited a dietitian and purchased statin medications had a lower mortality risk (HRs (95% CIs) 0.89 (0.87-0.92), 0.83 (0.76-0.91) and 0.70(0.65-0.75) respectively). Visits to endocrinologists and purchases of oral diabetes medication and insulin were associated with a higher risk of mortality (HRs (95% CIs) 1.20(1.07-1.35), 1.35(1.26-1.46) and 3.36(2.92-3.87) respectively). Conclusion Performance of QoC measurements including visiting a dietitian and purchase of statin medications were associated with lower mortality in patients with diabetes. It may be that the early active involvement of the patients in their care plays a protective role in long term mortality.	[Hemo, Beatriz] Maccabi Healthcare Serv, Tel Aviv, Israel; [Hemo, Beatriz; Shahar, Danit R.; Geva, Dikla] Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, S Daniel Abraham Int Ctr Hlth & Dis, Beer Sheva, Israel; [Heymann, Anthony D.] Tel Aviv Univ, Sackler Fac Med, Dept Family Med, Tel Aviv, Israel	Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine	Hemo, B (corresponding author), Maccabi Healthcare Serv, Tel Aviv, Israel.; Hemo, B (corresponding author), Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, S Daniel Abraham Int Ctr Hlth & Dis, Beer Sheva, Israel.	hemo_b@yahoo.com		heymann, anthony/0000-0003-2353-9933; Shahar, Danit/0000-0003-1000-1819	Chief Physician of Maccabi Healthcare Services (MHS) [8733101]; MHS	Chief Physician of Maccabi Healthcare Services (MHS); MHS	This study was funded by the Chief Physician of Maccabi Healthcare Services (MHS) (8733101). The MHS provided funding for statistical analysis assistance to author DG. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American Diabetes Association (ADA), 2002, CLIN DIABETES, V20, P24; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Barnett KN, 2010, DIABETIC MED, V27, P1124, DOI 10.1111/j.1464-5491.2010.03075.x; Calderon- Margalit R, 2018, ISR J HEALTH POLICY, V7, P887, DOI [10.1007/s10552-010-9515-8, DOI 10.1007/S10552-010-9515-8]; Cederholm J, 2009, DIABETES RES CLIN PR, V86, P74, DOI 10.1016/j.diabres.2009.07.003; Chodick G, 2003, EUR J EPIDEMIOL, V18, P1143, DOI 10.1023/B:EJEP.0000006635.36802.c8; Chodick G, 2010, CANCER CAUSE CONTROL, V21, P879, DOI 10.1007/s10552-010-9515-8; Emilsson L, 2015, J INTERN MED, V277, P94, DOI 10.1111/joim.12303; Faerch K, 2014, J CLIN ENDOCR METAB, V99, pE642, DOI 10.1210/jc.2013-3210; Friedman NL, 2003, ISRAEL MED ASSOC J, V5, P3; Gliklich RE, 2014, REGISTRIES EVALUATIN; Han WC, 2016, J AM MED INFORM ASSN, V23, P242, DOI 10.1093/jamia/ocv040; Heymann AD, 2006, DIABETES RES CLIN PR, V71, P290, DOI 10.1016/j.diabres.2005.07.002; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Jaffe DH, 2012, ISR J HEALTH POLICY, V1, DOI 10.1186/2045-4015-1-3; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Larsson S, 2012, HEALTH AFFAIR, V31, P220, DOI 10.1377/hlthaff.2011.0762; Lind M, 2013, DIABETOLOGIA, V56, P2601, DOI 10.1007/s00125-013-3063-1; Rosen B, 2011, INT J QUAL HEALTH C, V23, P15, DOI 10.1093/intqhc/mzq065; Rossi MCE, 2011, DIABETES CARE, V34, P347, DOI 10.2337/dc10-1709; Shalev V, 2011, INT J CARDIOL, V152, P345, DOI 10.1016/j.ijcard.2010.08.002; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith NL, 2006, DIABETES CARE, V29, P2012, DOI 10.2337/dc06-0574; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; The National Program for Quality Indicators for Community Health Care in Israel, REP YEARS 2011 2015; Zucker I, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0583-x	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208539	10.1371/journal.pone.0208539	http://dx.doi.org/10.1371/journal.pone.0208539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540832	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600078
J	Singh, JP; Kar, BR				Singh, Jay Prakash; Kar, Bhoomika R.			Effect of language proficiency on proactive occulo-motor control among bilinguals	PLOS ONE			English	Article							COGNITIVE CONTROL; EXECUTIVE CONTROL; DUAL MECHANISMS; CONFLICT-RESOLUTION; LEXICAL ACCESS; INHIBITION; 2ND-LANGUAGE; ATTENTION; TASK; PLASTICITY	We examined the effect of language proficiency on the status and dynamics of proactive inhibitory control in an occulo-motor cued go-no-go task. The first experiment was designed to demonstrate the effect of second language proficiency on proactive inhibitory cost and adjustments in control by evaluating previous trial effects. This was achieved by introducing uncertainty about the upcoming event (go or no-go stimulus). High- and low-proficiency Hindi-English bilingual adults participated in the study. Saccadic latencies and errors were taken as the measures of performance. The results demonstrate a significantly lower proactive inhibitory cost and better up-regulation of proactive control under uncertainty among high-proficiency bilinguals. An analysis based on previous trial effects suggests that high proficiency bilinguals were found to be better at releasing inhibition and adjustments in control, in an ongoing response activity in the case of uncertainty. To further understand the dynamics of proactive inhibitory control as a function of proficiency, the second experiment was designed to test the default versus temporary state hypothesis of proactive inhibitory control. Certain manipulations were introduced in the cued go-no-go task in order to make the upcoming go or no-go trial difficult to predict, which increased the demands on the implementation and maintenance of proactive control. High- proficiency bilinguals were found to rely on a default state of proactive inhibitory control whereas low-proficiency bilinguals were found to rely on temporary/transient proactive inhibition. Language proficiency, as one of the measures of bilingualism, was found to influence proactive inhibitory control and appears to modulate the dynamics of proactive inhibitory control.	[Singh, Jay Prakash; Kar, Bhoomika R.] Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad, Uttar Pradesh, India	University of Allahabad	Kar, BR (corresponding author), Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad, Uttar Pradesh, India.	bhoomika@cbcs.ac.in	Kar, Bhoomika/W-3580-2019; Singh, Jay Prakash/ABI-8011-2020	Singh, Jay Prakash/0000-0002-5685-8124				Alladi S, 2013, NEUROLOGY, V81, P1938, DOI 10.1212/01.wnl.0000436620.33155.a4; Dunabeitia JA, 2014, EXP PSYCHOL, V61, P234, DOI 10.1027/1618-3169/a000243; Anton Eneko, 2014, Front Psychol, V5, P398, DOI 10.3389/fpsyg.2014.00398; Bialystok E, 2004, CHILD DEV, V75, P562, DOI 10.1111/j.1467-8624.2004.00693.x; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E, 2005, NEUROIMAGE, V24, P40, DOI 10.1016/j.neuroimage.2004.09.044; Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859; Bialystok E, 2006, J EXP PSYCHOL LEARN, V32, P1341, DOI 10.1037/0278-7393.32.6.1341; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boulinguez P, 2008, J NEUROPHYSIOL, V99, P1572, DOI 10.1152/jn.01198.2007; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Coderre EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103424; Colzato LS, 2008, J EXP PSYCHOL LEARN, V34, P302, DOI 10.1037/0278-7393.34.2.302; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; Criaud M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00059; Dash T., 2012, INT J MIND BRAIN COG, V3, P73; Dash T, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/679706; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Gonzalez CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165380; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Green DW, 2013, J COGN PSYCHOL, V25, P515, DOI 10.1080/20445911.2013.796377; Green DW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00103; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hilchey MD, 2014, CAMBRIDGE HDB BILING; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; Jaffard M, 2007, BRAIN RES, V1179, P106, DOI 10.1016/j.brainres.2007.08.032; Kapoor V, 2008, J VISION, V8, DOI 10.1167/8.1.20; Kar BR., 2011, LANGUAGE COGNITION S; Khare V, 2013, PSYCHOL RES-PSYCH FO, V77, P728, DOI 10.1007/s00426-012-0466-4; Kroll JF, 2013, J COGN PSYCHOL, V25, P497, DOI 10.1080/20445911.2013.799170; Ladas AI, 2015, CHILD DEV, V86, P557, DOI 10.1111/cdev.12332; Lemhofer K, 2012, BEHAV RES METHODS, V44, P325, DOI 10.3758/s13428-011-0146-0; Luk G, 2011, BILING-LANG COGN, V14, P588, DOI 10.1017/S1366728911000010; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mishra RK, 2011, INT J MIND BRAIN COG, V2, P131; Morales J, 2015, NEUROPSYCHOLOGIA, V66, P157, DOI 10.1016/j.neuropsychologia.2014.11.014; Morales J, 2013, J COGN PSYCHOL, V25, P531, DOI 10.1080/20445911.2013.807812; Paap KR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00962; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Pivneva I, 2012, FRONT PSYCHOL, P3; Prior A, 2012, COGNITION, V125, P1, DOI 10.1016/j.cognition.2012.06.019; Ray S, 2004, VISION RES, V44, P2707, DOI 10.1016/j.visres.2004.05.029; Rodriguez-Fornells A, 2006, LANG LEARN, V56, P133, DOI 10.1111/j.1467-9922.2006.00359.x; Rosselli M, 2016, BILING-LANG COGN, V19, P489, DOI 10.1017/S1366728915000309; Ruschemeyer SA, 2008, BRAIN LANG, V104, P132, DOI 10.1016/j.bandl.2007.01.004; Singh JP, 2015, INT J BILING; Singh N, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01481; Singh N, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00322; Singh N, 2012, BILING-LANG COGN, V15, P771, DOI 10.1017/S1366728912000065; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tse CS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00954; Tse CS, 2012, BILING-LANG COGN, V15, P663, DOI 10.1017/S1366728912000077; Valian V, 2015, BILING-LANG COGN, V18, P3, DOI 10.1017/S1366728914000522; Vivas A. B., 2017, LANGUAGE COGNITION N, P1; von Bastian CC, 2016, J EXP PSYCHOL GEN, V145, P246, DOI 10.1037/xge0000120; Xie ZL, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014563040; Zhou B, 2016, BILINGUALISM ENHANCE, DOI [10.1017/S1366728916000869, DOI 10.1017/S1366728916000869]	63	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207904	10.1371/journal.pone.0207904	http://dx.doi.org/10.1371/journal.pone.0207904			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540761	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600044
J	Adhikari, B; Phommasone, K; Pongvongsa, T; Soundala, X; Koummarasy, P; Henriques, G; Peto, TJ; von Seidlein, L; White, NJ; Day, NPJ; Dondorp, AM; Newton, PN; Cheah, PY; Mayxay, M; Pell, C				Adhikari, Bipin; Phommasone, Koukeo; Pongvongsa, Tiengkham; Soundala, Xayaphone; Koummarasy, Palingnaphone; Henriques, Gisela; Peto, Thomas J.; von Seidlein, Lorenz; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Newton, Paul N.; Cheah, Phaik Yeong; Mayxay, Mayfong; Pell, Christopher			Perceptions of asymptomatic malaria infection and their implications for malaria control and elimination in Laos	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; EPIDEMIOLOGY; PARASITEMIA; VILLAGES; PROVINCE; SPREAD	Background In the Greater Mekong Sub-region (GMS), malaria elimination efforts are targeting the asymptomatic parasite reservoirs. Understanding community perceptions about asymptomatic malaria infections and interventions that target this reservoir is critical to the design of community engagement. This article examines knowledge, attitudes, perceptions and practices related to asymptomatic malaria infections and mass drug administration (MDA) in malaria-endemic villages in southern Savannakhet Province, Laos. Methods A questionnaire consisting of questions on socio-demographic characteristics, knowledge, attitudes, perceptions and practices on malaria and MDA was administered to each household head or representative (n = 281) in four villages. These topics were also further discussed in 12 single-gender focus group discussions (FGDs). The FGDs were conducted in all four villages and consisted of eight to 10 participants. Results A minority (14.2%; 40/281) of respondents agreed that a seemingly healthy person could have malaria parasite in his or her blood. Half (52%; 146/281) disagreed and one third (33.8%, 95/281) were unsure. Respondents who responded that "MDA aims to cure everyone" [AOR = 4.6; CI: 1.6-13.1], "MDA is to make our community malaria free" [AOR = 3.3; CI: 1.3-8.1] and "I will take part in future MDA" [AOR = 9.9; CI: 1.2-78.8] were more likely to accept the idea of asymptomatic malaria. During FGDs, respondents recalled signs and symptoms of malaria (fever, chills and headache), and described malaria as a major health problem. Symptomatic and asymptomatic malaria infections were associated with their work in the forest and living conditions. Measures described to eliminate malaria included using mosquito nets, wearing long-sleeved clothes and taking medicine when symptomatic. Most respondents were unaware of MDA as a tool to eliminate malaria. Conclusions Awareness of asymptomatic malaria infections, and MDA as a tool to eliminate malaria, was low. With the need to target asymptomatic malaria carriers for elimination efforts in the GMS, as well as informing target groups about asymptomatic infection, accompanying community engagement must build trust in interventions through the active collaboration of government stakeholders, key local persons and community members. This entails training and devolving responsibilities to the community members to implement and sustain the control and elimination efforts.	[Adhikari, Bipin; Henriques, Gisela; Peto, Thomas J.; von Seidlein, Lorenz; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Cheah, Phaik Yeong] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok, Thailand; [Adhikari, Bipin; Peto, Thomas J.; von Seidlein, Lorenz; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.; Newton, Paul N.; Cheah, Phaik Yeong; Mayxay, Mayfong] Churchill Hosp, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Adhikari, Bipin] Univ Oxford, Kellogg Coll, Oxford, England; [Phommasone, Koukeo; Soundala, Xayaphone; Koummarasy, Palingnaphone; Newton, Paul N.; Mayxay, Mayfong] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Microbiol Lab, Viangchan, Laos; [Pongvongsa, Tiengkham] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Pongvongsa, Tiengkham] Savannakhet Prov Hlth Dept, Savannakhet, Savannakhet Pro, Laos; [Henriques, Gisela] Imperial Coll London, Dept Life Sci, London, England; [Cheah, Phaik Yeong] Univ Oxford, Ethox Ctr, Nuffield Dept Populat Hlth, Oxford, England; [Mayxay, Mayfong] Univ Hlth Sci, Inst Res & Educ Dev, Viangchan, Laos; [Pell, Christopher] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Pell, Christopher] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Oxford; Mahidol University; Imperial College London; University of Oxford; University of Amsterdam	Adhikari, B (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok, Thailand.; Adhikari, B (corresponding author), Churchill Hosp, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.; Adhikari, B (corresponding author), Univ Oxford, Kellogg Coll, Oxford, England.	Bipin@tropmedres.ac	White, Nick/AAC-6527-2019; Adhikari, Bipin/X-3110-2019	White, Nick/0000-0002-1897-1978; Adhikari, Bipin/0000-0001-8981-3910; Newton, Paul/0000-0002-4608-6431; Cheah, Phaik Yeong/0000-0001-6327-3266; Pell, Christopher/0000-0001-9405-5851; Peto, Thomas/0000-0003-3197-9891	Bill and Melinda Gates Foundation; Wellcome Trust, UK	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust, UK(Wellcome Trust)	Funded by Bill and Melinda Gates Foundation and the Wellcome Trust, UK.	Adhikari B, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2158-4; Adhikari B, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2070-y; Adhikari B, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1366136; Adhikari B, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00121; Andrew EVW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119077; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Cheah PY, 2016, INT HEALTH, V8, P235, DOI 10.1093/inthealth/ihw027; De Martin S, 2001, TROP MED INT HEALTH, V6, P442, DOI 10.1046/j.1365-3156.2001.00723.x; Ghimire P, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1864-2; Henriques G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2390-6; Howes RE, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.16-0141; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/S1473-3099(17)30048-8, 10.1016/s1473-3099(17)30048-8]; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Iwagami M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006148; Kajeechiwa L, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1528-7; Kounnavong S, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0283-5; Kuuire VZ, 2016, J PUBLIC HEALTH-UK, V38, pE545, DOI 10.1093/pubmed/fdv176; Landier J, 2018, LANCET, V391, P1916, DOI [10.1016/S0140-6736(18)30792-X, 10.1016/s0140-6736(18)30792-x]; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Lover AA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2367-5; Lubell Y, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001704; MAYXAY M, 2013, BMC PUBLIC HEALTH, V13; Menaca A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-257; Musoke D, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.36; Niang M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182189; Pell C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1854-4; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Peto TJ, 2018, AM J TROP MED HYG, V98, P100, DOI 10.4269/ajtmh.17-0428; Peto TJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1284-8; Peto TJ, 2018, T R SOC TROP MED HYG; Phommasone K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1336-0; Phrasisombath K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-37; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; Rijal KR, 2018, AM J TROP MED HYG, V99, P680, DOI 10.4269/ajtmh.18-0373; Saenz FE, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1947-0; Sahan K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1718-y; Syhakhang L, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-3; Taffon P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195809; Thanabouasy C, 2009, J HEALTH RES, V23, P11; Nguyen TN, 2018, LANCET INFECT DIS, V18, P565, DOI 10.1016/S1473-3099(18)30046-X; Tripura R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1224-7; Tun STT, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2130-3; Uza Miyoko, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P246; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; WHO, 2015, MASS DRUG ADM MASS S; World Health Organization, 2015, STRATEGY MALARIA ELI; 2008, COMMUNITY DIRECTED I	48	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208912	10.1371/journal.pone.0208912	http://dx.doi.org/10.1371/journal.pone.0208912			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533024	gold, Green Published, Green Submitted			2022-12-26	WOS:000452782500046
J	Ismagulova, T; Shebanova, A; Gorelova, O; Baulina, O; Solovchenko, A				Ismagulova, Tatiana; Shebanova, Anastasia; Gorelova, Olga; Baulina, Olga; Solovchenko, Alexei			A new simple method for quantification and locating P and N reserves in microalgal cells based on energy-filtered transmission electron microscopy (EFTEM) elemental maps	PLOS ONE			English	Article							BIOLUMINESCENT PARTICLES; UNCONVENTIONAL METHODS; MORPHOMETRIC-ANALYSIS; RAMAN MICROSCOPY; ENTROPY; POLYPHOSPHATE; CYANOPHYCIN; PHOSPHATE; ACCUMULATION; PHOSPHORUS	We established a new simple approach to study phosphorus (P) and nitrogen (N) reserves at subcellular level potentially applicable to various types of cells capable of accumulating P and/or N-rich inclusions. Here, we report on using this approach for locating and assessing the abundance of the P and N reserves in microalgal and cyanobacterial cells. The approach includes separation of the signal from P- or N-rich structures from noise on the energy-filtered transmission electron microscopy (EFTEM) P- or N-maps. The separation includes (i) relative entropy estimation for each pixel of the map, (ii) binary thresholding of the map, and (iii) segmenting the image to assess the inclusion relative area and localization in the cell section. The separation is based on comparing the a posteriori probability that a pixel of the map contains information about the sample vs. Gaussian a priori probability that the pixel contains noise. The difference is expressed as relative entropy value for the pixel; positive values are characteristic of the pixels containing the payload information about the sample. This is the first known method for quantification and locating at a subcellular level P-rich and N-rich inclusions including tiny (< 180 nm) structures. We demonstrated the applicability of the proposed method both to the cells of eukaryotic green microalgae and cyanobacteria. Using the new method, we elucidated the heterogeneity of the studied cells in accumulation of P and N reserves across different species. The proposed approach will be handy for any cytological and microbiological study requiring a comparative assessment of subcellular distribution of cyanophycin, polyphosphates or other type of P- or N-rich inclusions. An added value is the potential of this approach for automation of the data processing and evaluation enabling an unprecedented increase of the EFTEM analysis throughput.	[Ismagulova, Tatiana; Shebanova, Anastasia; Gorelova, Olga; Baulina, Olga; Solovchenko, Alexei] Lomonosov Moscow State Univ, Dept Bioengn, Fac Biol, Moscow, Russia; [Solovchenko, Alexei] Lomonosov Moscow State Univ, Eurasian Ctr Food Secur, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University	Ismagulova, T (corresponding author), Lomonosov Moscow State Univ, Dept Bioengn, Fac Biol, Moscow, Russia.	ismagulova@mail.bio.msu.ru	Solovchenko, Alexei/B-5996-2009; Baulina, Olga/C-4206-2019; Gorelova, Olga A/A-8280-2014	Solovchenko, Alexei/0000-0001-6746-8511; Baulina, Olga/0000-0003-0749-8668; 	Ministry of Science and Education of Russian Federation [14.616.21.0080]	Ministry of Science and Education of Russian Federation(Ministry of Education and Science, Russian Federation)	The work was supported by the Ministry of Science and Education of Russian Federation (project 14.616.21.0080). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Raouf N, 2012, SAUDI J BIOL SCI, V19, DOI 10.1016/j.sjbs.2012.04.005; ALBERTANO P, 1993, PROTOPLASMA, V173, P158, DOI 10.1007/BF01379004; ALLEN MM, 1984, ANNU REV MICROBIOL, V38, P1, DOI 10.1146/annurev.mi.38.100184.000245; Aronova MA, 2012, MRS BULL, V37, P53, DOI 10.1557/mrs.2011.329; Bar-Yosef Y, 2010, CURR BIOL, V20, P1557, DOI 10.1016/j.cub.2010.07.032; CEMBELLA AD, 1984, CRC CR REV MICROBIOL, V10, P317; Chang CI, 2006, IEE P-VIS IMAGE SIGN, V153, P837, DOI 10.1049/ip-vis:20050032; CHANG CI, 1994, PATTERN RECOGN, V27, P1275, DOI 10.1016/0031-3203(94)90011-6; Clode PL, 2009, PLANT CELL ENVIRON, V32, P170, DOI 10.1111/j.1365-3040.2008.01909.x; DESA R, 1968, J GEN PHYSIOL, V51, P105, DOI 10.1085/jgp.51.1.105; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Erickson NA, 2001, BBA-GEN SUBJECTS, V1526, P5, DOI 10.1016/S0304-4165(01)00098-8; FOGEL M, 1972, J CELL SCI, V11, P305; Gobler CJ, 2016, HARMFUL ALGAE, V54, P87, DOI 10.1016/j.hal.2016.01.010; Gorelova OA, 2002, MICROBIOLOGY+, V71, P563, DOI 10.1023/A:1020510803800; Gorelova OA, 2003, MICROBIOLOGY+, V72, P318, DOI 10.1023/A:1024252116667; Gorelova OA, 2015, PROTOPLASMA, V252, P489, DOI 10.1007/s00709-014-0694-0; Heintzmann Rainer, 2006, Briefings in Functional Genomics & Proteomics, V5, P289, DOI 10.1093/bfgp/ell036; Hupfer M, 2008, INT REV HYDROBIOL, V93, P1, DOI 10.1002/iroh.200610935; Jager KM, 1997, BOT ACTA, V110, P151; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Koop A, 2007, BIOMACROMOLECULES, V8, P2675, DOI 10.1021/bm0611230; Kopp C, 2013, MBIO, V4, DOI 10.1128/mBio.00052-13; Korzhenevskaya TG, 1999, MICROBIOLOGY+, V68, P158; Kuhl A, 1974, ALGAL PHYSL BIOCH, P636; Kulakova AN, 2011, ENVIRON SCI TECHNOL, V45, P7799, DOI 10.1021/es201123r; LAWRY NH, 1982, J PHYCOL, V18, P391; LAZINSKY D, 1990, AQUAT TOXICOL, V16, P127, DOI 10.1016/0166-445X(90)90082-Z; Leapman RD, 2004, CURR OPIN NEUROBIOL, V14, P591, DOI 10.1016/j.conb.2004.08.004; Lee SS, 1999, IEEE T IMAGE PROCESS, V8, P1229, DOI 10.1109/83.784435; Lorenz B, 1999, Prog Mol Subcell Biol, V23, P217; Lutz-Meindl U, 2007, MICRON, V38, P181, DOI 10.1016/j.micron.2006.03.017; Majed N, 2012, CURR OPIN BIOTECH, V23, P852, DOI 10.1016/j.copbio.2012.06.002; Martin P, 2014, P NATL ACAD SCI USA, V111, P8089, DOI 10.1073/pnas.1321719111; Moudrikova S, 2017, ANAL CHEM, V89, P12006, DOI 10.1021/acs.analchem.7b02393; Moudrikova S, 2017, ALGAL RES, V23, P216, DOI 10.1016/j.algal.2017.02.009; Mulbry W, 2005, BIORESOURCE TECHNOL, V96, P451, DOI 10.1016/j.biortech.2004.05.026; Nishikawa K, 2006, PLANT SCI, V170, P307, DOI 10.1016/j.plantsci.2005.08.025; Ohtomo R, 2008, ANAL BIOCHEM, V383, P210, DOI 10.1016/j.ab.2008.08.002; PAL NR, 1991, IEEE T SYST MAN CYB, V21, P1260, DOI 10.1109/21.120079; PUN T, 1981, COMPUT VISION GRAPH, V16, P210, DOI 10.1016/0146-664X(81)90038-1; PUN T, 1980, SIGNAL PROCESS, V2, P223, DOI 10.1016/0165-1684(80)90020-1; PUN T, 1985, J MICROSC-OXFORD, V137, P93, DOI 10.1111/j.1365-2818.1985.tb02565.x; Raina JB, 2017, ELIFE, V6, DOI 10.7554/eLife.23008; REIMER L, 1995, SPRINGER SERIES OPTI, V71, P347; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rosset S, 2017, MAR POLLUT BULL, V118, P180, DOI 10.1016/j.marpolbul.2017.02.044; Sahoo PK, 1997, OPT ENG, V36, P1976, DOI 10.1117/1.601404; SAHOO PK, 1988, COMPUT VISION GRAPH, V41, P233, DOI 10.1016/0734-189X(88)90022-9; SCHMITTER RE, 1971, J CELL SCI, V9, P147; Shebanova A, 2017, PROTOPLASMA, V254, P1323, DOI 10.1007/s00709-016-1024-5; SICKOGOAD L, 1982, PROTOPLASMA, V110, P75, DOI 10.1007/BF01281533; SICKOGOAD L, 1986, ARCH ENVIRON CON TOX, V15, P617, DOI 10.1007/BF01054908; SIMON RD, 1973, J BACTERIOL, V114, P1213, DOI 10.1128/JB.114.3.1213-1216.1973; Solovchenko A, 2016, BIOTECHNOL ADV, V34, P550, DOI 10.1016/j.biotechadv.2016.01.002; TREBBIA P, 1990, ULTRAMICROSCOPY, V34, P179, DOI 10.1016/0304-3991(90)90071-S; TREBBIA P, 1990, ULTRAMICROSCOPY, V34, P165, DOI 10.1016/0304-3991(90)90070-3	57	10	10	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12								10.1371/journal.pone.0208830	http://dx.doi.org/10.1371/journal.pone.0208830			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533056	gold, Green Submitted, Green Published			2022-12-26	WOS:000452782500040
J	Dutta, B; Gitaitis, R; Agarwal, G; Coutinho, T; Langston, D				Dutta, Bhabesh; Gitaitis, Ronald; Agarwal, Gaurav; Coutinho, Teresa; Langston, David			Pseudomonas coronafaciens sp. nov., a new phytobacterial species diverse from Pseudomonas syringae	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID; AMPLIFICATION; IDENTIFICATION; HYBRIDIZATION; ATROPURPUREA; RELATEDNESS; DNA	We propose Pseudomonas coronafaciens sp. nov. as a new species in genus Pseudomonas, which is diverse from P. syringae. We also classified strains from onions which are responsible for yellow bud (YB) disease as P. coronafaciens. Sequencing of 16S rRNA gene and multi-locus sequence analysis (MLSA) of housekeeping genes (gyrB, rpoD, gltA and gap1 genes) for the P. syringae pv. coronafaciens strains along with other strains of P. syringae pathovars resulted in a distinct cluster separate from other P. syringae pathovars. Based on DNA-DNA relatedness, pathotype strain of P. syringae pv. coronafaciens (CFBP 2216(PT)) exhibited <= 35.5% similarity with the pathotype strains of P. syringae pv. syringae (CFBP 1392(PT), 4702(T)) but exhibited >= 90.6% with the YB strains (YB 12-1, YB 12-4, YB 09-1). Also, the YB strains (YB 12-1, YB 12-4, YB 09-1) were able to infect only onion but not oat, rye and Italian ryegrass (common hosts for P. syrinage pv. coronafaciens). Contrastingly, P. syringae pv. coronafaciens strains (NCPPB 600(PT), ATCC 19608, Pcf 83-300) produced typical halo blight symptoms on oat, rye and Italian rye grass but did not produce any symptoms on onion. These results provide evidence that P. syringae pv. coronafaciens should be elevated to a species level and the new YB strains may potentially be a novel pathovar of hereto proposed P. coronafaciens species.	[Dutta, Bhabesh; Gitaitis, Ronald; Agarwal, Gaurav] Univ Georgia, Coastal Plain Expt Stn, Dept Plant Pathol, Tifton, GA 31793 USA; [Coutinho, Teresa] Univ Pretoria, FABI, Dept Microbiol & Plant Pathol, Pretoria, South Africa; [Langston, David] Virginia Tech, Tidewater Agr Res & Extens Ctr, Dept Plant Pathol Physiol & Weed Sci, Suffolk, VA USA	University System of Georgia; University of Georgia; University of Pretoria; Virginia Polytechnic Institute & State University	Dutta, B (corresponding author), Univ Georgia, Coastal Plain Expt Stn, Dept Plant Pathol, Tifton, GA 31793 USA.	bhabesh@uga.edu		Dutta, Bhabesh/0000-0001-9841-257X	Vidalia Onion Committee	Vidalia Onion Committee	This work was supported in part by Vidalia Onion Committee. There was no additional external funding received for this study.	BERESWILL S, 1994, APPL ENVIRON MICROB, V60, P2924, DOI 10.1128/AEM.60.8.2924-2930.1994; Bull CT, 2010, J PLANT PATHOL, V92, P551; Bull CT, 2010, SYST APPL MICROBIOL, V33, P105, DOI 10.1016/j.syapm.2010.02.001; Cleenwerck I, 2002, INT J SYST EVOL MICR, V52, P1551, DOI 10.1099/00207713-52-5-1551; Doudoroff M, 1984, PROTEOBACTERIA B, P217; Dye D. W., 1980, Review of Plant Pathology, V59, P153; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; Ferrante P, 2010, PLANT PATHOL, DOI [10.1111/j.1365-3059.2010.02304, DOI 10.1111/J.1365-3059.2010.02304]; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; GARDAN L, 1991, RES MICROBIOL, V142, P995, DOI 10.1016/0923-2508(91)90010-8; Gitaitis R, 2012, PLANT DIS, V96, P285, DOI 10.1094/PDIS-05-11-0400; Gomila M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02422; Goris J, 1998, CAN J MICROBIOL, V44, P1148, DOI 10.1139/cjm-44-12-1148; Hildebrand DC, 1988, LABORATORY GUIDE IDE, P60; Hwang MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005; Inoue Yasuhiro, 2006, Journal of General Plant Pathology, V72, P26, DOI 10.1007/s10327-005-0252-x; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; MILLER I, 1985, BACTERIA IDENTIFICAT, P228; PALLERONI NJ, 1984, PSEUDOMONACEAE WINSL, P141; Rombouts S, 2016, EUR J PLANT PATHOL, V144, P185, DOI 10.1007/s10658-015-0761-1; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; SCHAAD NW, 1979, INT J SYST BACTERIOL, V29, P213, DOI 10.1099/00207713-29-3-213; Shintani M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00242; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Takahashi Y, 1996, PLANT DIS, V80, P783, DOI 10.1094/PD-80-0783; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wilson K., 1987, CURRENT PROTOCOLS MO; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; YOUNG JM, 1992, ANNU REV PHYTOPATHOL, V30, P67, DOI 10.1146/annurev.py.30.090192.000435	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208271	10.1371/journal.pone.0208271	http://dx.doi.org/10.1371/journal.pone.0208271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521563	gold, Green Submitted, Green Published			2022-12-26	WOS:000452307600038
J	Weinschenk, F; Dittrich, R; Muller, A; Lotz, L; Beckmann, MW; Weinschenk, SW				Weinschenk, Fabian; Dittrich, Ralf; Mueller, Andreas; Lotz, Laura; Beckmann, Matthias W.; Weinschenk, Stefan W.			Uterine contractility changes in a perfused swine uterus model induced by local anesthetics procaine, lidocaine, and ropivacaine	PLOS ONE			English	Article							EXTRACORPOREAL PERFUSION; IN-VITRO; PERTUBATION; DYSMENORRHEA; MEPIVACAINE; BUPIVACAINE; MECHANISMS; LIGNOCAINE; RECEPTORS; SURGERY	Background Local anesthetics (LAs) are increasingly used as therapeutics due to their multiple molecular effects. They may be potential agents also in gynecology and reproductive medicine. The objective of this study was to investigate the contractility response of the perfused swine uterus to different concentrations of the LAs procaine, lidocaine, and ropivacaine. Methods and findings In an extracorporeal perfusion model with fresh swine uteri, effects of administered boli of these three LAs in concentrations of 0.1 mg/mL, 0.5 mg/mL and 1.0 mg/mL on uterine contractility and peristalsis were assessed using an intrauterine double-chip micro-catheter. A dose-dependent increase in intrauterine pressure (IUP) in the isthmus and corpus uteri was observed after the administration of the ester-LA procaine 0.1, 0.5, and 1.0%, which was not seen with lower concentrations, or buffer solution. An increase-decrease curve was found after increasing concentrations of the amide-LA lidocaine and ropivacaine, with an IUP plateau with 0.1 and 0.5%, and a decrease with 1% (p<0.01). All reactions were seen in both the isthmus and corpus uteri. The difference of the contractility pattern between ester- and amide-LA at 1% concentration was significant. Conclusion LAs dose-dependently modulate contractility in non-pregnant swine uteri. The amid-LAs lidocaine and ropivacaine reduce contractility in higher concentrations and may be used as therapeutics in disorders with increased uterine contractility, as dysmenorrhoea, endometriosis, and infertility. The multiple molecular effects of LAs may explain these effects. This in-vitro pilot study in vitro provides initial data for designing further studies to transfer the results onto humans.	[Weinschenk, Fabian] Acad Teaching Hosp Tech Univ, StKM Klinikum Bogenhausen, Dept Plast Reconstruct Hand & Burn Surg, Munich, Germany; [Weinschenk, Fabian; Dittrich, Ralf; Lotz, Laura; Beckmann, Matthias W.] Univ Hosp Erlangen, Dept Obstet & Gynecol, Erlangen, Germany; [Mueller, Andreas] Stadt Klinikum Karlsruhe, Dept Obstet & Gynecol, Karlsruhe, Germany; [Weinschenk, Stefan W.] Heidelberg Univ, Dept Gynecol Endocrinol & Fertil Disorders, Heidelberg, Germany; [Weinschenk, Stefan W.] Outpatient OB GYN Practice Weinschenk Scherer & C, Karlsruhe, Germany; [Weinschenk, Stefan W.] Heidelberg Univ Neural Therapy Educ & Res Grp HUN, Heidelberg, Germany	Munchen Klinik; University of Erlangen Nuremberg; Municipal Hospital Karlsruhe; Ruprecht Karls University Heidelberg	Weinschenk, SW (corresponding author), Heidelberg Univ, Dept Gynecol Endocrinol & Fertil Disorders, Heidelberg, Germany.; Weinschenk, SW (corresponding author), Outpatient OB GYN Practice Weinschenk Scherer & C, Karlsruhe, Germany.; Weinschenk, SW (corresponding author), Heidelberg Univ Neural Therapy Educ & Res Grp HUN, Heidelberg, Germany.	stefan.weinschenk@med.uni-heidelberg.de		Dittrich, Ralf/0000-0003-1078-4702				Arici G, 2004, INT J OBSTET ANESTH, V13, P95, DOI 10.1016/j.ijoa.2003.10.007; Batai I, 2009, ANESTH ANALG, V108, P666, DOI 10.1213/ane.0b013e31818f887e; BUTTERWORTH JF, 1988, ANESTHESIOLOGY, V68, P501, DOI 10.1097/00000542-198804000-00005; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Dittrich R, 2003, HORM METAB RES, V35, P517; Dittrich R, 2009, FERTIL STERIL, V92, P1694, DOI 10.1016/j.fertnstert.2008.08.117; Dullebkopf A, 2003, ANAESTHESIST, V52, P329, DOI 10.1007/s00101-003-0463-5; Edelstam G, 2008, HUM REPROD, V23, P852, DOI 10.1093/humrep/den003; Edelstam G, 2012, SEX REPROD HEALTHC, V3, P93, DOI 10.1016/j.srhc.2012.02.001; Fanning RA, 2008, ANESTH ANALG, V107, P1303, DOI 10.1213/ane.0b013e3181804245; Fauza DO, 2003, FETAL DIAGN THER, V18, P292, DOI 10.1159/000071968; FLECKENSTEIN A, 1950, KLIN WOCHENSCHR, V28, P452, DOI 10.1007/BF01485539; Hahnenkamp K, 2006, BRIT J ANAESTH, V96, P77, DOI 10.1093/bja/aei271; Herroeder S, 2007, ANN SURG, V246, P192, DOI 10.1097/SLA.0b013e31805dac11; Hollmann MW, 2001, REGION ANESTH PAIN M, V26, P565, DOI 10.1053/rapm.2001.25923; Hurd WW, 1998, AM J OBSTET GYNECOL, V178, P1077, DOI 10.1016/S0002-9378(98)70551-4; Karsli B, 2003, POL J PHARMACOL, V55, P51; Kasaba T, 2003, ANESTH ANALG, V97, P85, DOI 10.1213/01.ANE.0000065905.88771.0D; Kaynak G, 2012, GYNECOL OBSTET INVES, V73, P43, DOI 10.1159/000329332; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; Leyendecker G, 2015, ARCH GYNECOL OBSTET, V291, P917, DOI 10.1007/s00404-014-3437-8; Lirk P, 2014, EUR J ANAESTH, V31, P575, DOI 10.1097/EJA.0000000000000137; Lo B, 2001, ANESTH ANALG, V93, P1240, DOI 10.1097/00000539-200111000-00040; Maltaris T, 2006, EUR J OBSTET GYN R B, V126, P56, DOI 10.1016/j.ejogrb.2005.07.026; McCarthy GC, 2010, DRUGS, V70, P1149, DOI 10.2165/10898560-000000000-00000; Pineda MH, 2008, MCDONALDS VET ENDOCR, P283; POSTE G, 1972, J GEN VIROL, V16, P21, DOI 10.1099/0022-1317-16-1-21; Richter O, 2000, HUM REPROD, V15, P1235, DOI 10.1093/humrep/15.6.1235; TANEIKE T, 1991, BIOL REPROD, V45, P831, DOI 10.1095/biolreprod45.6.831; Weinschenk S., 2012, ACUPUNCT REL, V4, P25; Wickstrom K, 2012, HUM REPROD, V27, P695, DOI 10.1093/humrep/der434; Wickstrom K, 2013, DRUGS R&D, V13, P235, DOI 10.1007/s40268-013-0022-8	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0206053	10.1371/journal.pone.0206053	http://dx.doi.org/10.1371/journal.pone.0206053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521531	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600004
J	Boonyalai, N; Collins, CR; Hackett, F; Withers-Martinez, C; Blackman, MJ				Boonyalai, Nonlawat; Collins, Christine R.; Hackett, Fiona; Withers-Martinez, Chrislaine; Blackman, Michael J.			Essentiality of Plasmodium falciparum plasmepsin V	PLOS ONE			English	Article							PROTEIN EXPORT; MALARIA PARASITE; VIRULENCE; PURIFICATION; ELEMENT; PTEX	The malaria parasite replicates within erythrocytes. The pathogenesis of clinical malaria is in large part due to the capacity of the parasite to remodel its host cell. To do this, intraerythrocytic stages of Plasmodium falciparum export more than 300 proteins that dramatically alter the morphology of the infected erythrocyte as well as its mechanical and adhesive properties. P. falciparum plasmepsin V (PfPMV) is an aspartic protease that processes proteins for export into the host erythrocyte and is thought to play a key role in parasite virulence and survival. However, although standard techniques for gene disruption as well as conditional protein knockdown have been previously attempted with the pfpmv gene, complete gene removal or knockdown was not achieved so direct genetic proof that PMV is an essential protein has not been established. Here we have used a conditional gene excision approach combining CRISPR-Cas9 gene editing and DiCre-mediated recombination to functionally inactivate the pfpmv gene. The resulting mutant parasites displayed a severe growth defect. Detailed phenotypic analysis showed that development of the mutant parasites was arrested early in the ring-to-trophozoite transition in the erythrocytic cycle following gene excision. Our findings are the first to elucidate the effects of PMV gene disruption, showing that it is essential for parasite viability in asexual blood stages. The mutant parasites can now be used as a platform to further dissect the Plasmodium protein export pathway.	[Boonyalai, Nonlawat] Kasetsart Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Collins, Christine R.; Hackett, Fiona; Withers-Martinez, Chrislaine; Blackman, Michael J.] Francis Crick Inst, Malaria Biochem Lab, London, England; [Blackman, Michael J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England; [Boonyalai, Nonlawat] USAMD AFRIMS, Dept Immunol & Med, Bangkok, Thailand	Kasetsart University; Francis Crick Institute; University of London; London School of Hygiene & Tropical Medicine	Boonyalai, N (corresponding author), Kasetsart Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Blackman, MJ (corresponding author), Francis Crick Inst, Malaria Biochem Lab, London, England.; Blackman, MJ (corresponding author), London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London, England.; Boonyalai, N (corresponding author), USAMD AFRIMS, Dept Immunol & Med, Bangkok, Thailand.	nonlawat.b@ku.ac.th; mike.blackman@crick.ac.uk	Boonyalai, Nonlawat/O-6446-2018	Boonyalai, Nonlawat/0000-0002-9058-0840; Blackman, Michael/0000-0002-7442-3810	Royal Society Newton Mobility Grant [NI160028]; Office of Higher Education Commission, Thailand; Francis Crick Institute; Cancer Research UK [FC001043]; UK Medical Research Council [FC001043]; Wellcome Trust [FC001043]; Wellcome ISSF2	Royal Society Newton Mobility Grant; Office of Higher Education Commission, Thailand; Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome ISSF2	This work was supported by a Royal Society Newton Mobility Grant (NI160028; https://royalsociety.org/) and by the Office of Higher Education Commission, Thailand (to NB). The work was also supported by the Francis Crick Institute (to MJB; https://www.crick.ac.uk/) which receives its core funding from Cancer Research UK (FC001043; https://www.cancerresearchuk.org), the UK Medical Research Council (FC001043; https://www.mrc.ac.uk/), and the Wellcome Trust (FC001043; https://wellcome.ac.uk/).The authors also acknowledge Wellcome ISSF2 funding to the London School of Hygiene & Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Birnbaum J, 2017, NAT METHODS, V14, P450, DOI 10.1038/nmeth.4223; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Collins CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006453; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Elsworth B, 2014, CELL MICROBIOL, V16, P355, DOI 10.1111/cmi.12261; Gambini L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142509; Garten M, 2018, NAT MICROBIOL, V3, P1090, DOI 10.1038/s41564-018-0222-7; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Goldberg DE, 2015, NAT STRUCT MOL BIOL, V22, P647, DOI 10.1038/nsmb.3077; Haase S, 2010, CELL MICROBIOL, V12, P580, DOI 10.1111/j.1462-5822.2010.01455.x; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Ho CM, 2018, NATURE, V561, P70, DOI 10.1038/s41586-018-0469-4; Hodder AN, 2015, NAT STRUCT MOL BIOL, V22, P590, DOI 10.1038/nsmb.3061; Jones ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep21800; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Knuepfer E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03984-3; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Perrin AJ, 2018, MBIO, V9, DOI [10.1128/mbio.00905-18, 10.1128/mBio.00905-18]; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; SAUL A, 1982, B WORLD HEALTH ORGAN, V60, P755; Sherling ES, 2017, ELIFE, V6, DOI [10.7554/eLife.23239, 10.7554/elife.23239]; Sleebs BE, 2014, J MED CHEM, V57, P7644, DOI 10.1021/jm500797g; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Stallmach R, 2015, MOL MICROBIOL, V96, P368, DOI 10.1111/mmi.12941; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tarr SJ, 2013, MOL MICROBIOL, V87, P835, DOI 10.1111/mmi.12133; Thomas JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157873; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WHO, 2017, WORLD MALARIA REPORT	47	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207621	10.1371/journal.pone.0207621	http://dx.doi.org/10.1371/journal.pone.0207621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517136	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000452212400051
J	Choppala, G; Burton, ED				Choppala, Girish; Burton, Edward D.			Chromium(III) substitution inhibits the Fe(II)-accelerated transformation of schwertmannite	PLOS ONE			English	Article							ACID SULFATE SOILS; TRACE-ELEMENTS; IRON-RICH; ORGANIC-MATTER; WATER-QUALITY; GOETHITE; FE(II); CR; PH; PRECIPITATION	Schwertmannite is an Fe(III)-oxyhydroxysulfate which is common in acid mine drainage (AMD) and acid sulfate soil (ASS) environments. Natural schwertmannite is often enriched in Cr(III), yet the effects of Cr(III) substitution on schwertmannite transformation to more stable Fe(III) minerals has not been addressed. Here we examine, for the first time, the effects of Cr(III) substitution on the Fe(ll)-accelerated transformation of schwertmannite. X-ray diffraction (XRD) and Fe K-edge extended X-ray absorption fine structure (EXAFS) spectroscopy shows that Cr(III) substitution inhibits schwertmannite transformation. Substitution at a Cr(III):Fe(III) ratio of 0.025 decreased schwertmannite transformation (at pH 6.5) by 18-49% (depending on Fe(II) concentrations) relative to that of Cr(III)-free schwertmannite. Formation of crystalline secondary phases (predominantly goethite) caused associated decreases in solid-phase Fe and Cr extractability by 1 M HCl. The extractability of Cr was consistently greater than that of Fe, suggesting some accumulation of Cr(III) at the residual schwertmannite surface-a phenomenon which passivates the surface against Fe(II)/Fe(III) electron transfer and atom exchange required for the Fe(II)-accelerated transformation process. The finding that Cr(III)-substitution inhibits schwertmannite transformation implies that it may also significantly impact associated Fe, S and trace metal(loid) behaviour.	[Choppala, Girish; Burton, Edward D.] Southern Cross Univ, Southern Cross GeoSci, Lismore, NSW, Australia	Southern Cross University	Choppala, G (corresponding author), Southern Cross Univ, Southern Cross GeoSci, Lismore, NSW, Australia.	girish.choppala@scu.edu.au	Burton, Edward D/B-9434-2012; Choppala, Girish/N-7383-2015	Burton, Edward D/0000-0002-9628-089X; Choppala, Girish/0000-0002-8866-5001	 [10333]		TEM work was conducted at ANSTO, Sydney, under grant no. 10333 to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero M, 2005, APPL GEOCHEM, V20, P1368, DOI 10.1016/j.apgeochem.2005.03.001; Acero P, 2006, GEOCHIM COSMOCHIM AC, V70, P4130, DOI 10.1016/j.gca.2006.06.1367; American Public Health Association (APHA), 2012, STANDARD METHODS EXA, DOI [10.2105/SMWW.2882?gclid=CjwKCAiA25v_BRBNEiwAZb4-ZRdKz6ceq6, DOI 10.2105/SMWW.2882?GCLID=CJWKCAIA25V_BRBNEIWAZB4-ZRDKZ6CEQ6]; Antelo J, 2012, J COLLOID INTERF SCI, V386, P338, DOI 10.1016/j.jcis.2012.07.008; Bartlett R. J., 1996, Methods of soil analysis. Part 3 - chemical methods., P683; BIGHAM JM, 1990, GEOCHIM COSMOCHIM AC, V54, P2743; Bigham JM, 1996, GEOCHIM COSMOCHIM AC, V60, P2111, DOI 10.1016/0016-7037(96)00091-9; Bigham JM, 1996, APPL GEOCHEM, V11, P845, DOI 10.1016/S0883-2927(96)00052-2; Bigham JM, 2000, REV MINERAL GEOCHEM, V40, P351, DOI 10.2138/rmg.2000.40.7; Blodau C, 2003, APPL GEOCHEM, V18, P25, DOI 10.1016/S0883-2927(02)00052-5; Blodau C, 2006, SCI TOTAL ENVIRON, V369, P307, DOI 10.1016/j.scitotenv.2006.05.004; Blodau C, 2006, CHEM GEOL, V235, P366, DOI 10.1016/j.chemgeo.2006.08.003; Bousserrhine N, 1999, GEOMICROBIOL J, V16, P245, DOI 10.1080/014904599270622; Burton ED, 2008, GEOCHIM COSMOCHIM AC, V72, P4551, DOI 10.1016/j.gca.2008.06.019; Burton ED, 2008, CHEM GEOL, V253, P64, DOI 10.1016/j.chemgeo.2008.04.006; Burton ED, 2007, GEOCHIM COSMOCHIM AC, V71, P4456, DOI 10.1016/j.gca.2007.07.007; Burton ED, 2006, GEOCHIM COSMOCHIM AC, V70, P5455, DOI 10.1016/j.gca.2006.08.016; Burton ED, 2013, ENVIRON SCI TECHNOL, V47, P2221, DOI 10.1021/es303867t; Burton ED, 2012, GEOCHIM COSMOCHIM AC, V96, P134, DOI 10.1016/j.gca.2012.08.007; Burton ED, 2011, GEOCHIM COSMOCHIM AC, V75, P3072, DOI 10.1016/j.gca.2011.03.001; Carbone C, 2013, J GEOCHEM EXPLOR, V132, P188, DOI 10.1016/j.gexplo.2013.07.001; Catalano JG, 2010, GEOCHIM COSMOCHIM AC, V74, P1498, DOI 10.1016/j.gca.2009.12.018; Collins RN, 2010, GEOCHIM COSMOCHIM AC, V74, P482, DOI 10.1016/j.gca.2009.10.014; Dai C, 2016, ENVIRON SCI TECHNOL, V50, P1741, DOI 10.1021/acs.est.5b04319; Davidson LE, 2008, AM MINERAL, V93, P1326, DOI 10.2138/am.2008.2761; Fitzpatrick RW, 2017, GEODERMA, V308, P235, DOI 10.1016/j.geoderma.2017.08.012; Frierdich AJ, 2012, ENVIRON SCI TECHNOL, V46, P10031, DOI 10.1021/es302137d; Fukushi K, 2003, ENVIRON SCI TECHNOL, V37, P3581, DOI 10.1021/es026427i; Gagliano WB, 2004, GEOCHIM COSMOCHIM AC, V68, P2119, DOI 10.1016/j.gca.2003.10.038; Handler RM, 2009, ENVIRON SCI TECHNOL, V43, P1102, DOI 10.1021/es802402m; Johnston SG, 2011, CHEM GEOL, V280, P257, DOI 10.1016/j.chemgeo.2010.11.014; Johnston SG, 2009, ESTUAR COAST SHELF S, V81, P257, DOI 10.1016/j.ecss.2008.11.002; Johnston SG, 2005, AUST J SOIL RES, V43, P1, DOI 10.1071/SR04073; Jones AM, 2009, GEOCHIM COSMOCHIM AC, V73, P4409, DOI 10.1016/j.gca.2009.04.025; Keene AF, 2011, BIOGEOCHEMISTRY, V103, P263, DOI 10.1007/s10533-010-9461-2; Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2; Kumpulainen S, 2008, CLAY MINER, V43, P437, DOI 10.1180/claymin.2008.043.3.08; Manceau A, 2000, GEOCHIM COSMOCHIM AC, V64, P3643, DOI 10.1016/S0016-7037(00)00427-0; Murad E, 2003, AM MINERAL, V88, P1915, DOI 10.2138/am-2003-11-1234; Paikaray S, 2017, GEOCHIM COSMOCHIM AC, V217, P292, DOI 10.1016/j.gca.2017.08.026; Paikaray S, 2015, MINE WATER ENVIRON, V34, P213, DOI 10.1007/s10230-014-0309-1; Papassiopi N, 2014, CHEMOSPHERE, V111, P169, DOI 10.1016/j.chemosphere.2014.03.059; Pedersen HD, 2005, GEOCHIM COSMOCHIM AC, V69, P3967, DOI 10.1016/j.gca.2005.03.016; Peine A, 2000, LIMNOL OCEANOGR, V45, P1077, DOI 10.4319/lo.2000.45.5.1077; Peretyazhko T, 2009, CHEM GEOL, V262, P169, DOI 10.1016/j.chemgeo.2009.01.017; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Regenspurg S, 2004, GEOCHIM COSMOCHIM AC, V68, P1185, DOI 10.1016/j.gca.2003.07.015; Regenspurg S, 2005, APPL GEOCHEM, V20, P1226, DOI 10.1016/j.apgeochem.2004.12.002; SASS BM, 1987, INORG CHEM, V26, P2228, DOI 10.1021/ic00261a013; SCHWERTMANN U, 1989, GEOCHIM COSMOCHIM AC, V53, P1293, DOI 10.1016/0016-7037(89)90063-X; Tang YZ, 2010, CHEM MATER, V22, P3589, DOI 10.1021/cm1000472; WINLAND RL, 1991, J ENVIRON QUAL, V20, P452, DOI 10.2134/jeq1991.00472425002000020019x; Xie YY, 2017, CHEM GEOL, V475, P52, DOI 10.1016/j.chemgeo.2017.10.031	53	13	13	8	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208355	10.1371/journal.pone.0208355	http://dx.doi.org/10.1371/journal.pone.0208355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517205	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400090
J	Mastrangelo, S; Biscarini, F; Tolone, M; Auzino, B; Ragatzu, M; Spaterna, A; Ciampolini, R				Mastrangelo, Salvatore; Biscarini, Filippo; Tolone, Marco; Auzino, Barbara; Ragatzu, Marco; Spaterna, Andrea; Ciampolini, Roberta			Genomic characterization of the Braque Francais type Pyrenees dog and relationship with other breeds	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; ANALYSES REVEAL; WIDE SNP	The evaluation of genetic variability is a useful research tool for the correct management of selection and conservation strategies in dog breeds. In addition to pedigree genealogies, genomic data allow a deeper knowledge of the variability and genetic structure of populations. To date, many dog breeds, such as small regional breeds, still remain uncharacterized. Braque Francais type Pyrenees (BRA) is a dog breed originating from a very old type of gun-dog used for pointing the location of game birds to hunters. Despite the ancient background, the knowledge about levels of genetic diversity, degree of inbreeding and population structure is scarce. This may raise concerns on the possibility that few inbred bloodlines may dominate the breed, and on its future health. The aim of this work was therefore to provide a high-resolution representation of the genome-wide diversity and population structure of BRA dogs, using the 170K genome-wide SNP array. Genome-wide polymorphisms in BRA were compared with those of other worldwide dog breeds. Between-dog relationships estimated from genomic data were very similar to pedigree relationships (Pearson correlation r(g,a) = 0.92). Results showed that BRA generally presents moderate levels of genetic diversity when compared with the major canine breeds. The estimated effective population size (recent N-e = 51) shows a similar declining pattern over generations as all other dog breeds, pointing at a common demographic history of modern canine breeds, clearly different from the demography of feral wolves. Multidimensional scaling (MDS), Bayesian clustering and Neighbor Joining tree were used to visualize and explore the genetic relationships among breeds, and revealed that BRA was highly differentiated and presented only low levels of admixture with other breeds. Brittany Spaniel, English Setter, Gordon Setter and Weimaraner dogs are the closest breeds to BRA. The exact reason for BRA being so divergent from other dog breeds, based on these results, is not yet clear. Further studies including additional "braccoid" breeds will be needed to refine the results presented here and to investigate the origin of the BRA breed. Nonetheless, the genome-wide characterization	[Mastrangelo, Salvatore; Tolone, Marco] Univ Palermo, Dipartimento Sci Agr Alimentari & Forestali, Palermo, Italy; [Biscarini, Filippo] CNR IBBA, Via Bassini 15, I-20133 Milan, Italy; [Auzino, Barbara; Ciampolini, Roberta] Univ Pisa, Dipartimento Sci Vet, Vle Piagge 2, I-56124 Pisa, Italy; [Ragatzu, Marco] Club Italiano Braque Francais Type Pyrenees, Capalbio, GR, Italy; [Spaterna, Andrea] Univ Camerino, Scuola Sci Med Vet, Matelica, MC, Italy; [Spaterna, Andrea; Ciampolini, Roberta] Ctr Interuniv Ric & Consulenza Genet & Clin Cane, Matelica, MC, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Biotecnologia Agraria (IBBA-CNR); University of Pisa; University of Camerino	Biscarini, F (corresponding author), CNR IBBA, Via Bassini 15, I-20133 Milan, Italy.	filippo.biscarini@ibba.cnr.it	CIAMPOLINI, ROBERTA RC/B-9173-2019; Biscarini, Filippo/H-3334-2019; Tolone, M./AAT-1392-2020	Biscarini, Filippo/0000-0002-3901-2354; Tolone, M./0000-0002-6043-9782; CIAMPOLINI, ROBERTA/0000-0001-5676-1798; MASTRANGELO, Salvatore/0000-0001-6511-1981	"ENCI" - Ente Nazionale della Cinofilia Italiana (Italian Kennel Club)	"ENCI" - Ente Nazionale della Cinofilia Italiana (Italian Kennel Club)	We thank "ENCI" - Ente Nazionale della Cinofilia Italiana (Italian Kennel Club) for funding this research and contributing the data used for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; ANTHENAISE Cd, 2002, LIVRE CHASSE GASTON; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Bjelland DW, 2013, J DAIRY SCI, V96, P4697, DOI 10.3168/jds.2012-6435; Bosse M, 2015, GENOME RES, V25, P970, DOI 10.1101/gr.187039.114; Caniglia R, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4916-2; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Daetwyler HD, 2007, J ANIM BREED GENET, V124, P369, DOI 10.1111/j.1439-0388.2007.00693.x; Dreger DL, 2016, GENETICS, V204, P737, DOI 10.1534/genetics.116.192427; Ferencakovic M, 2013, J ANIM BREED GENET, V130, P286, DOI 10.1111/jbg.12012; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Kardos M, 2015, HEREDITY, V115, P63, DOI 10.1038/hdy.2015.17; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Makina SO, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00337; Mastrangelo Salvatore, 2018, BMC Research Notes, V11, P13, DOI 10.1186/s13104-017-3112-9; Mastrangelo S, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0360-z; McRae AF, 2002, GENETICS, V160, P1113; Meadows JRS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-61; Mortlock SA, 2015, BIOINFORM BIOL INSIG, V9, P37, DOI 10.4137/BBI.S30524; Mortlock SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147941; Mrode R.A, 2014, LINEAR MODELS PREDIC; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parker HG, 2017, CELL REP, V19, P697, DOI 10.1016/j.celrep.2017.03.079; Parker HG, 2012, MAMM GENOME, V23, P19, DOI 10.1007/s00335-011-9387-6; Pilot M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2189; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Ralls K, 2004, CONDOR, V106, P215, DOI 10.1650/7348; RCore Team, 2020, R LANG ENV STAT COMP; Shariflou MR, 2011, VET J, V189, P203, DOI 10.1016/j.tvjl.2011.06.020; Stern JA, 2013, MAMM GENOME, V24, P409, DOI 10.1007/s00335-013-9474-y; SVED J A, 1971, Theoretical Population Biology, V2, P125; VanLiere JM, 2008, THEOR POPUL BIOL, V74, P130, DOI 10.1016/j.tpb.2008.05.006; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wiener P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3933-x; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zanella R, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0203-3; Zhang QQ, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0227-7	46	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208548	10.1371/journal.pone.0208548	http://dx.doi.org/10.1371/journal.pone.0208548			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517199	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400106
J	Ke, YB; Karki, P; Kim, J; Son, S; Berdyshev, E; Bochkov, VN; Birukova, AA; Birukov, KG				Ke, Yunbo; Karki, Pratap; Kim, Junghyun; Son, Sophia; Berdyshev, Evgeny; Bochkov, Valery N.; Birukova, Anna A.; Birukov, Konstantin G.			Elevated truncated oxidized phospholipids as a factor exacerbating ALI in the aging lungs	FASEB JOURNAL			English	Article						lung injury; vascular permeability; inflammation	OXIDATIVE STRESS; PERMEABILITY; PATHWAY; ACETYLHYDROLASE; INHIBITION; INJURY	As mechanisms controlling redox homeostasis become impaired with aging, exaggerated oxidant stress may cause disproportional oxidation of cell membranes and circulating phospholipids (PLs), leading to the formation of truncated oxidized PL products (Tr-OxPLs), which exhibit deleterious effects. This study investigated the role of elevated Tr-OxPLs as a factor exacerbating inflammation and lung barrier dysfunction in an animal model of aging. Mass spectrometry analysis of Tr-OxPL species in young (2-4 mo) and aging (18-24 mo) mice revealed elevated basal levels of several products [1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-phosphocholine (POVPC), 1-palmitoyl-2-glutaroyl-sn-glycero-phosphocholine, lysophosphocholine, 1-palmitoyl-2-(9-oxo-nonanoyl)-sn-glycero-3-phosphocholine, 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine, O-1-O-palmitoyl-2-O-(5,8-dioxo-8-hydroxy-6-octenoyl)-l-glycero-3-phosphocholine, and others] in the aged lungs. An intratracheal (i.t.) injection of bacterial LPS caused increased generation of Tr-OxPLs in the lungs but not in the liver, with higher levels detected in the aged group. In addition, OxPLs clearance from the lung tissue after LPS challenge was delayed in the aged group. The impact of Tr-OxPLs on endothelial cell (EC) barrier compromise under inflammatory conditions was further evaluated in the 2-hit cell culture model of acute lung injury (ALI). EC barrier dysfunction caused by cell treatment with a cytokine mixture (CM) was augmented by cotreatment with low-dose Tr-OxPLs, which did not significantly affect endothelial function when added alone. Deleterious effects of Tr-OxPLs on inflamed ECs stimulated with CM were associated with further weakening of cell junctions and more robust EC hyperpermeability. Aged mice injected intratracheally with TNF- exhibited a more pronounced elevation of cell counts and protein content in bronchoalveolar lavage (BAL) samples. Interestingly, intravenous administration of low POVPC doseswhich did not affect BAL parameters alone in young mice exposed to i.t. TNF- challengeaugmented lung injury to the levels observed in aged mice stimulated with TNF- alone. Inhibition of Tr-OxPL generation by ectopic expression of PL-specific platelet-activating factor acetylhydrolase 2 (PAFAH2) markedly reduced EC dysfunction induced by CM, whereas PAFAH2 pharmacologic inhibition augmented deleterious effects of cytokines on EC barrier function. Moreover, exacerbating effects of PAFAH2 inhibition on TNF--induced lung injury were observed in vivo. These results demonstrate an age-dependent increase in Tr-OxPL production under basal conditions and augmented Tr-OxPL generation upon inflammatory stimulation, suggesting a major role for elevated Tr-OxPLs in more severe ALI and delayed resolution in aging lungs.Ke, Y., Karki, P., Kim, J., Son, S., Berdyshev, E., Bochkov, V. N., Birukova, A. A., Birukov, K. G. Elevated truncated oxidized phospholipids as a factor exacerbating ALI in the aging lungs.	[Ke, Yunbo; Kim, Junghyun; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Karki, Pratap; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Son, Sophia] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Berdyshev, Evgeny] Natl Jewish Hlth, Denver, CO USA; [Bochkov, Valery N.] Karl Franzens Univ Graz, Dept Pharmaceut Chem, Graz, Austria	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Chicago; National Jewish Health; University of Graz	Birukov, KG (corresponding author), Univ Maryland, Sch Med, UMSOM Lung Biol Program, Dept Anesthesiol, 20 Penn St,HSF 2,Room S145, Baltimore, MD 21201 USA.	kbirukov@som.umaryland.edu	Birukov, Konstantin/FJB-5755-2022		U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL076259, HL087823, HL107920, HL130431]; NIH National Institute on Aging Grant [AG048231]; NIH National Institute of General Medical Sciences [GM122940, GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076259, R01HL107920, R01HL130431, R01HL087823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171, R01GM122940] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging Grant; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL076259 (to K.G.B.), HL087823, HL107920, and HL130431; NIH National Institute on Aging Grant AG048231 (to K.G.B.); and NIH National Institute of General Medical Sciences Grants GM122940 (to K.G.B.) and GM114171 (to A.A.B.). The authors declare no conflicts of interest.	Akbaraly TN, 2009, BRIT J NUTR, V101, P86, DOI 10.1017/S0007114508998445; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016; Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008; Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957; Bochkov VN, 2006, CURR RESPIR MED REV, V2, P27, DOI 10.2174/157339806775486182; Cao LC, 2004, J STEROID BIOCHEM, V88, P61, DOI 10.1016/j.jsbmb.2003.10.007; Chabot F, 1998, EUR RESPIR J, V11, P745; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Gruber F, 2012, J LIPID RES, V53, P1232, DOI 10.1194/jlr.D025270; Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009; Hecker L, 2018, AM J PHYSIOL-LUNG C, V314, P1642, DOI 10.1152/ajplung.00275.2017; Heffern CTR, 2013, CHEM PHYS LIPIDS, V175, P9, DOI 10.1016/j.chemphyslip.2013.07.003; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jozsef L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195; Kalyanaraman B, 2004, P NATL ACAD SCI USA, V101, P11527, DOI 10.1073/pnas.0404309101; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; McIntyre TM, 2012, BBA-BIOMEMBRANES, V1818, P2456, DOI 10.1016/j.bbamem.2012.03.004; Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014; Morrow JD, 2002, AM J RESP CRIT CARE, V166, pS25, DOI 10.1164/rccm.2206011; Munoz Nilda M, 2012, Pulm Circ, V2, P182, DOI 10.4103/2045-8932.97604; Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805; Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Prauchner CA, 2017, BURNS, V43, P471, DOI 10.1016/j.burns.2016.09.023; Sprong RC, 1998, AM J RESP CRIT CARE, V157, P1283; Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC; Starr ME, 2011, FREE RADICAL BIO MED, V50, P371, DOI 10.1016/j.freeradbiomed.2010.11.013; Stengle J, 1994, Crit Care Nurs Clin North Am, V6, P421; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Tanaka K, 2017, AM J RESP CELL MOL, V56, P179, DOI 10.1165/rcmb.2016-0158OC; Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP; von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799; Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1; Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312	41	15	15	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3887	3900		10.1096/fj.201800981R	http://dx.doi.org/10.1096/fj.201800981R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521374	Green Published, Bronze			2022-12-26	WOS:000459794800063
J	Lu, DY; Sun, SJ; Zhang, F; Luo, CH; Zheng, L; Wu, Y; Li, N; Zhang, C; Wang, CZ; Chen, Q; Long, M				Lu, Dongyuan; Sun, Shujin; Zhang, Fan; Luo, Chunhua; Zheng, Lu; Wu, Yi; Li, Ning; Zhang, Chen; Wang, Chengzhi; Chen, Qin; Long, Mian			Microgravity-induced hepatogenic differentiation of rBMSCs on board the SJ-10 satellite	FASEB JOURNAL			English	Article						mesenchymal stem cells; mechanotransduction; hepatocyte; signaling pathway	MESENCHYMAL STEM-CELLS; SIMULATED MICROGRAVITY; OSTEOGENIC DIFFERENTIATION; ENDOTHELIAL-CELLS; LIVER; HEPATOCYTES; EXPRESSION; GRAVITY; ACTIVATION; CAPACITY	Bone marrow-derived mesenchymal stem cells (BMSCs) are able to differentiate into functional hepatocytelike cells, which are expected to serve as a potential cell source in regenerative medicine, tissue engineering, and clinical treatment of liver injury. Little is known about whether and how space microgravity is able to direct the hepatogenic differentiation of BMSCs in the actual space microenvironment. In this study, we examined the effects of space microgravity on BMSC hepatogenic differentiation on board the SJ-10 Recoverable Scientific Satellite. Rat BMSCs were cultured and induced in hepatogenic induction medium for 3 and 10 d in custom-made space cell culture hardware. Cell growth was monitored periodically in orbit, and the fixed cells and collected supernatants were retrieved back to the Earth for further analyses. Data indicated that space microgravity improves the differentiating capability of the cells by up-regulating hepatocyte-specific albumin and cytokeratin 18. The resulting cells tended to be maturated, with an in-orbit period of up to 10 d. In space, mechanosensitive molecules of 1-integrin, -actin, -tubulin, and Ras homolog gene family member A presented enhanced expression, whereas those of cell-surface glycoprotein CD44, intercellular adhesion molecule 1, vascular cell adhesion molecule 1, vinculin, cell division control protein 42 homolog, and Rho-associated coiled-coil kinase yielded reduced expression. Also observed in space were the depolymerization of actin filaments and the accumulation of microtubules and vimentin through the altered expression and location of focal adhesion complexes, Rho guanosine 5'-triphosphatases, as well as the enhanced exosome-mediated mRNA transfer. This work furthers the understanding of the underlying mechanisms of space microgravity in directing hepatogenic differentiation of BMSCs.Lu, D., Sun, S., Zhang, F., Luo, C., Zheng, L., Wu, Y., Li, N., Zhang, C., Wang, C., Chen, Q., Long, M. Microgravity-induced hepatogenic differentiation of rBMSCs on board the SJ-10 satellite.	[Lu, Dongyuan; Sun, Shujin; Zhang, Fan; Luo, Chunhua; Zheng, Lu; Wu, Yi; Li, Ning; Zhang, Chen; Wang, Chengzhi; Chen, Qin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, Key Lab Micrograv, Beijing, Peoples R China; [Lu, Dongyuan; Sun, Shujin; Zhang, Fan; Luo, Chunhua; Zheng, Lu; Wu, Yi; Li, Ning; Zhang, Chen; Wang, Chengzhi; Chen, Qin; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing, Peoples R China; [Lu, Dongyuan; Sun, Shujin; Zhang, Fan; Zheng, Lu; Wu, Yi; Li, Ning; Wang, Chengzhi; Long, Mian] Univ Chinese Acad Sci, Sch Engn Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Long, M (corresponding author), Chinese Acad Sci, Inst Mech, 15 North 4th Ring Rd, Beijing 100190, Peoples R China.	mlong@imech.ac.cn			National Natural Science Foundation of China [U1738115, 31661143044]; Strategic Priority Research Program; Frontier Science Key Project of Chinese Academy of Sciences [XDA0402020219, XDA04020416, XDA04073800, QYZDJSSW-JSC018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program(Chinese Academy of Sciences); Frontier Science Key Project of Chinese Academy of Sciences	The authors thank Lei Zhang, Jianquan Zhang, Zhongfang Deng, Xiang Li, Teng Xie, and Namei Du (Technology and Engineering Center for Space Utilization, Chinese Academy of Sciences) for help in developing hardware and software; Juan Chen and Yuxin Gao (Institute of Mechanics, Chinese Academy of Sciences) for technical support; and Shenbao Chen, Luwen Zhou, Xiao Zhang, Yuzhen Bi, Bing Shangguan, and Hao Yang (Institute of Mechanics, Chinese Academy of Sciences) for contributions to implement the space experiment. The authors are grateful to the staff members from the National Space Science Center, Chinese Academy of Sciences, and from the China Academy of Space Technology, China Aerospace Science and Technology Corporation, for contributions to the mission of the SJ-10 Recoverable Scientific Satellite. This work was supported by National Natural Science Foundation of China Grants U1738115 and 31661143044, and Strategic Priority Research Program and Frontier Science Key Project of Chinese Academy of Sciences Grants XDA0402020219, XDA04020416, XDA04073800, and QYZDJSSW-JSC018. The authors declare no conflicts of interest.	Aldridge V, 2012, HEPATOLOGY, V56, P1063, DOI 10.1002/hep.25716; Aleshcheva G, 2015, FASEB J, V29, P2303, DOI 10.1096/fj.14-268151; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Bi HJ, 2017, J TISSUE ENG REGEN M, V11, P2685, DOI 10.1002/term.2161; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Chen Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep30322; Cipriano M, 2017, ARCH TOXICOL, V91, P2469, DOI 10.1007/s00204-016-1901-x; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Esmaeli S, 2017, BIOLOGICALS, V47, P52, DOI 10.1016/j.biologicals.2017.01.006; Godoy P, 2015, J HEPATOL, V63, P934, DOI 10.1016/j.jhep.2015.05.013; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Herrmann H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018242; Hu WR, 2014, MICROGRAVITY SCI TEC, V26, P159, DOI 10.1007/s12217-014-9390-0; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kiss C, 1997, CYTOGENET CELL GENET, V79, P228, DOI 10.1159/000134729; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Lee JW, 2004, BIOMATERIALS, V25, P1901, DOI 10.1016/j.biomaterials.2003.08.037; Lee SW, 2015, BIOCHEM BIOPH RES CO, V464, P1178, DOI 10.1016/j.bbrc.2015.07.100; Li N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01025; Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059; Liu HZ, 2010, SCAND J UROL NEPHROL, V44, P277, DOI 10.3109/00365599.2010.492787; Long M, 2015, MICROGRAVITY SCI TEC, V27, P505, DOI 10.1007/s12217-015-9464-7; Luna C, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.7; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Miyazaki M, 2002, BIOCHEM BIOPH RES CO, V298, P24, DOI 10.1016/S0006-291X(02)02340-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Popov C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.71; Ratushnyy A, 2018, STEM CELLS DEV, V27, P831, DOI 10.1089/scd.2017.0262; Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017; Ronningen T, 2015, GENOME RES, V25, P1825, DOI 10.1101/gr.193748.115; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Sheyn D, 2010, TISSUE ENG PT A, V16, P3403, DOI 10.1089/ten.tea.2009.0834; Song K, 2014, MOL MED REP, V10, P755, DOI 10.3892/mmr.2014.2264; Speicher T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4862; Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7; Talbot NC, 2013, J ANIM SCI, V91, P66, DOI 10.2527/jas.2012-5748; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Wang ND, 2014, CYTOTECHNOLOGY, V66, P119, DOI 10.1007/s10616-013-9544-8; Wu HH, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0259-y; Yan CH, 2014, BIOMATERIALS, V35, P3035, DOI 10.1016/j.biomaterials.2013.12.037; Yin HY, 2016, ACTA BIOMATER, V33, P96, DOI 10.1016/j.actbio.2016.01.024; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zhang C, 2017, FASEB J, V31, P802, DOI 10.1096/fj.201600897RR; Zhang C, 2018, FASEB J, V32, P4444, DOI 10.1096/fj.201700208RR; Zhou LW, 2018, BIOMECH MODEL MECHAN, V17, P191, DOI 10.1007/s10237-017-0954-y; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	59	10	12	2	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4273	4286		10.1096/fj.201802075R	http://dx.doi.org/10.1096/fj.201802075R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521385	Bronze			2022-12-26	WOS:000459794800094
J	Adachi, N; Hess, DT; Kaku, M; Ueda, C; Numa, C; Saito, N				Adachi, Naoko; Hess, Douglas T.; Kaku, Mika; Ueda, Chie; Numa, Chisato; Saito, Naoaki			Differential S-palmitoylation of the human and rodent beta(3)-adrenergic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein acylation; G protein-coupled receptor (GPCR); adrenergic receptor; protein palmitoylation; receptor regulation; acyl-RAC; ADRB3; beta 3-adrenergic receptor; lipidation; S-palmitoylation	G-PROTEIN; BETA-3-ADRENERGIC RECEPTOR; TAIL; ACYLATION; AGONIST; SITES	With few reported exceptions, G protein-coupled receptors (GPCRs) are modified by Cys palmitoylation (S-palmitoylation). In multiple GPCRs, S-palmitoylation targets a canonical site within the C-terminal cytoplasmic tail adjacent to the C terminus of the seventh transmembrane domain, but modification of additional sites is exemplified by the beta-adrenergic receptors (beta ARs). The beta(1)AR is S-palmitoylated at a second, more distal site within the C-terminal tail, and the beta(2)AR is modified at a second site within the third intracellular loop, neither of which is conserved in other beta AR isoforms. The functional roles of S-palmitoylation of disparate sites are incompletely characterized for any GPCR family. Here, we describe S-palmitoylation of the beta(3)AR. We compared mouse and human beta(3)ARs and found that both were S-palmitoylated at the canonical site within the C-terminal tail, Cys-358 and Cys-361/363 in mouse and human beta(3)ARs, respectively. Surprisingly, the human beta(3)AR was S-palmitoylated at two additional sites, Cys-153 and Cys-292 within the second and third intracellular loops, respectively. Cys-153 is apparently unique to the human beta(3)AR, and Cys-292 is conserved primarily in primates. Mutational substitution of C-tail Cys in human but not mouse beta(3)ARs resulted in diminished ligand-induced cAMP production. Substitution of Cys-153, Cys-292, or Cys-361/363 within the human beta(3)AR diminished membrane-receptor abundance, but only Cys-361/363 substitution diminished membrane-receptor half-life. Thus, S-palmitoylation of different sites differentially regulates the human beta(3)AR, and differential S-palmitoylation distinguishes human and rodent beta(3)ARs, potentially contributing to species-specific differences in the clinical efficacy of beta(3)AR-directed pharmacological approaches to disease.	[Adachi, Naoko; Kaku, Mika; Ueda, Chie; Numa, Chisato; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Hess, Douglas T.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Hess, Douglas T.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA	Kobe University; Case Western Reserve University; Case Western Reserve University	Adachi, N (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	na@gold.kobe-u.ac.jp		Adachi, Naoko/0000-0002-8797-0717	Japan Society for the Promotion of Science (JSPS), KAKENHI [JP15K18988, JP16KK0181, JP17K08595]; National Institutes of Health [P01 HL128129]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL128129] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Japan Society for the Promotion of Science (JSPS) AR (9), whereas the KAKENHI Grants JP15K18988, JP16KK0181, and JP17K08595 with additional support from National Institutes of Health Grant P01 HL128129 (to D. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi N, 2016, J BIOL CHEM, V291, P20232, DOI 10.1074/jbc.M116.725762; Amici SA, 2012, J BIOL CHEM, V287, P23119, DOI 10.1074/jbc.M111.328294; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Cannavo A, 2017, J CARDIOVASC PHARM, V69, P71, DOI 10.1097/FJC.0000000000000444; Chen SY, 2017, NATURE, V549, P399, DOI 10.1038/nature23887; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Collins MO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04580-1; Dessy C, 2004, CIRCULATION, V110, P948, DOI 10.1161/01.CIR.0000139331.85766.AF; Ebersole B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140661; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; Ernst AM, 2018, DEV CELL, V47, P479, DOI 10.1016/j.devcel.2018.10.024; Evans BA, 1999, BRIT J PHARMACOL, V127, P1525, DOI 10.1038/sj.bjp.0702688; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gottlieb CD, 2017, BIOCHEM SOC T, V45, P923, DOI 10.1042/BST20160304; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hainer V, 2016, EXPERT OPIN PHARMACO, V17, P2125, DOI 10.1080/14656566.2016.1233177; KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191; NANTEL F, 1993, MOL PHARMACOL, V43, P548; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Papoucheva E, 2004, J BIOL CHEM, V279, P3280, DOI 10.1074/jbc.M308177200; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001; Takasu T, 2007, J PHARMACOL EXP THER, V321, P642, DOI 10.1124/jpet.106.115840; Uribe A, 2008, BIOL REPROD, V78, P869, DOI 10.1095/biolreprod.107.063925; Won SJ, 2018, CRIT REV BIOCHEM MOL, V53, P83, DOI 10.1080/10409238.2017.1409191; Zhang X, 2016, BIOCHEM BIOPH RES CO, V479, P398, DOI 10.1016/j.bbrc.2016.09.094; Zhang XW, 2016, BBA-BIOMEMBRANES, V1858, P2152, DOI 10.1016/j.bbamem.2016.06.021; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6; Zuckerman DM, 2011, J BIOL CHEM, V286, P19014, DOI 10.1074/jbc.M110.189977	30	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2569	2578		10.1074/jbc.RA118.004978	http://dx.doi.org/10.1074/jbc.RA118.004978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30541923	Green Published, hybrid			2022-12-26	WOS:000458895400030
J	Dionne, KL; Bergeron, D; Landry-Voyer, AM; Bachand, F				Dionne, Kiersten L.; Bergeron, Danny; Landry-Voyer, Anne-Marie; Bachand, Francois			The 40S ribosomal protein uS5 (RPS2) assembles into an extraribosomal complex with human ZNF277 that competes with the PRMT3-uS5 interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc finger; ribosome; proteomics; protein-protein interaction; protein complex; PRMT3; ribosomal protein; RPS2; uS5; ZNF277	NUCLEAR IMPORT; P53; METHYLTRANSFERASE; TRANSCRIPTION; INHIBITION; BIOGENESIS; EXPRESSION; MATURATION; SUBSTRATE; CHAPERONE	Ribosomal (r)-proteins are generally viewed as ubiquitous, constitutive proteins that simply function to maintain ribosome integrity. However, findings in the past decade have led to the idea that r-proteins have evolved specialized functions beyond the ribosome. For example, the 40S ribosomal protein uS5 (RPS2) is known to form an extraribosomal complex with the protein arginine methyltransferase PRMT3 that is conserved from fission yeast to humans. However, the full scope of uS5's extraribosomal functions, including whether uS5 interacts with any other proteins, is not known. In this study, we identify the conserved zinc finger protein 277 (ZNF277) as a new uS5-associated protein by using quantitative proteomics approaches in human cells. As previously shown for PRMT3, we found that ZNF277 uses a C2H2-type zinc finger domain to recognize uS5. Analysis of protein-protein interactions in living cells indicated that the ZNF277-uS5 complex is found in the cytoplasm and the nucleolus. Furthermore, we show that ZNF277 and PRMT3 compete for uS5 binding, because overexpression of PRMT3 inhibited the formation of the ZNF277-uS5 complex, whereas depletion of cellular ZNF277 resulted in increased levels of uS5-PRMT3. Notably, our results reveal that ZNF277 recognizes nascent uS5 in the course of mRNA translation, suggesting cotranslational assembly of the ZNF277-uS5 complex. Our findings thus unveil an intricate network of evolutionarily conserved protein-protein interactions involving extraribosomal uS5, suggesting a key role for uS5 beyond the ribosome.	[Dionne, Kiersten L.; Bergeron, Danny; Landry-Voyer, Anne-Marie; Bachand, Francois] Univ Sherbrooke, Dept Biochem, RNA Grp, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Bachand, F (corresponding author), Univ Sherbrooke, Dept Biochem, RNA Grp, Sherbrooke, PQ J1E 4K8, Canada.	f.bachand@usherbrooke.ca			Canadian Institutes of Health Research Grant [MOP-273292]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes of Health Research Grant MOP-273292 (to F.B.) and by a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada (to A.-M. L.-V.). The authors declare that they have no conflicts of interest with the contents of this article.	Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bergeron D, 2015, MOL CELL BIOL, V35, P2503, DOI 10.1128/MCB.00070-15; Ceroni F, 2014, EUR J HUM GENET, V22, P1165, DOI 10.1038/ejhg.2014.4; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Nguyen D, 2015, CELL REP, V13, P2244, DOI 10.1016/j.celrep.2015.11.003; Frank Joachim, 2017, F1000Res, V6, P198, DOI 10.12688/f1000research.9760.1; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grade M, 2011, INT J CANCER, V128, P1069, DOI 10.1002/ijc.25453; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Holzer S, 2013, J MOL BIOL, V425, P4154, DOI 10.1016/j.jmb.2013.08.022; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Koch B, 2012, J BIOL CHEM, V287, P21806, DOI 10.1074/jbc.M112.365791; Kressler D, 2012, SCIENCE, V338, P666, DOI 10.1126/science.1226960; Landry-Voyer AM, 2016, MOL CELL BIOL, V36, P3019, DOI 10.1128/MCB.00303-16; Li H, 2018, CELL SYST, V6, P90, DOI 10.1016/j.cels.2017.10.016; Liliensiek B, 1998, BLOOD, V92, P3394, DOI 10.1182/blood.V92.9.3394.421k33_3394_3404; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mallet PL, 2013, TRAFFIC, V14, P282, DOI 10.1111/tra.12036; Minakhina S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147631; Mitterer V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36714; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Negishi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012373; Nerurkar P, 2015, INT REV CEL MOL BIO, V319, P107, DOI 10.1016/bs.ircmb.2015.07.002; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Pena C, 2017, NAT STRUCT MOL BIOL, V24, P689, DOI 10.1038/nsmb.3454; Perreault A, 2008, NUCLEIC ACIDS RES, V36, P6132, DOI 10.1093/nar/gkn625; Perreault A, 2009, J BIOL CHEM, V284, P15026, DOI 10.1074/jbc.M109.004812; Pillet B, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600153; Pillet B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005565; Ramanathan M, 2018, NAT METHODS, V15, P207, DOI [10.1038/NMETH.4601, 10.1038/nmeth.4601]; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Ting YH, 2017, J BIOL CHEM, V292, P585, DOI 10.1074/jbc.M116.747634; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Wang M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-6; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Williams NK, 2018, BIOCHEM SOC T, V46, P197, DOI 10.1042/BST20170451; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; Wyler E, 2014, FEBS LETT, V588, P3685, DOI 10.1016/j.febslet.2014.08.013	55	14	14	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1944	1955		10.1074/jbc.RA118.004928	http://dx.doi.org/10.1074/jbc.RA118.004928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30530495	Green Published, hybrid			2022-12-26	WOS:000459711400015
J	Kontur, WS; Olmsted, CN; Yusko, LM; Niles, AV; Walters, KA; Beebe, ET; Vander Meulen, KA; Karlen, SD; Gall, DL; Noguera, DR; Donohue, TJ				Kontur, Wayne S.; Olmsted, Charles N.; Yusko, Larissa M.; Niles, Alyssa V.; Walters, Kevin A.; Beebe, Emily T.; Vander Meulen, Kirk A.; Karlen, Steven D.; Gall, Daniel L.; Noguera, Daniel R.; Donohue, Timothy J.			A heterodimeric glutathione S-transferase that stereospecifically breaks lignin's (R)-aryl ether bond reveals the diversity of bacterial -etherases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lignin degradation; stereoselectivity; protein evolution; bacterial metabolism; enzyme mutation; -aryl ether bond; -etherase; glutathione S-transferase; Novosphingobium aromaticivorans; sphingomonads	BETA-ARYL ETHER; ENZYMATIC CLEAVAGE; ESCHERICHIA-COLI; STRAIN; DEPOLYMERIZATION; CATABOLISM; EVOLUTION; CHEMICALS; HYDROGEN; GUAIACYL	Lignin is a heterogeneous polymer of aromatic subunits that is a major component of lignocellulosic plant biomass. Understanding how microorganisms deconstruct lignin is important for understanding the global carbon cycle and could aid in developing systems for processing plant biomass into valuable commodities. Sphingomonad bacteria use stereospecific glutathione S-transferases (GSTs) called -etherases to cleave the -aryl ether (-O-4) bond, the most common bond between aromatic subunits in lignin. Previously characterized bacterial -etherases are homodimers that fall into two distinct GST subclasses: LigE homologues, which cleave the (R) stereoisomer of the bond, and LigF homologues, which cleave the (S) stereoisomer. Here, we report on a heterodimeric -etherase (BaeAB) from the sphingomonad Novosphingobium aromaticivorans that stereospecifically cleaves the (R)-aryl ether bond of the di-aromatic compound -(2-methoxyphenoxy)--hydroxypropiovanillone (MPHPV). BaeAB's subunits are phylogenetically distinct from each other and from other -etherases, although they are evolutionarily related to LigF, despite the fact that BaeAB and LigF cleave different -aryl ether bond stereoisomers. We identify amino acid residues in BaeAB's BaeA subunit important for substrate binding and catalysis, including an asparagine that is proposed to activate the GSH cofactor. We also show that BaeAB homologues from other sphingomonads can cleave (R)-MPHPV and that they may be as common in bacteria as LigE homologues. Our results suggest that the ability to cleave the -aryl ether bond arose independently at least twice in GSTs and that BaeAB homologues may be important for cleaving the (R)-aryl ether bonds of lignin-derived oligomers in nature.	[Kontur, Wayne S.; Olmsted, Charles N.; Yusko, Larissa M.; Niles, Alyssa V.; Walters, Kevin A.; Beebe, Emily T.; Vander Meulen, Kirk A.; Karlen, Steven D.; Gall, Daniel L.; Noguera, Daniel R.; Donohue, Timothy J.] Univ Wisconsin, Wisconsin Energy Inst, Madison, WI 53706 USA; [Kontur, Wayne S.; Olmsted, Charles N.; Yusko, Larissa M.; Niles, Alyssa V.; Walters, Kevin A.; Beebe, Emily T.; Vander Meulen, Kirk A.; Karlen, Steven D.; Gall, Daniel L.; Noguera, Daniel R.; Donohue, Timothy J.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI 53706 USA; [Beebe, Emily T.; Vander Meulen, Kirk A.; Karlen, Steven D.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Noguera, Daniel R.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Donohue, Timothy J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Donohue, TJ (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	tdonohue@bact.wisc.edu	; Donohue, Timothy/C-3273-2015	Walters, Kevin/0000-0001-7063-6651; Noguera, Daniel/0000-0003-0372-3063; Donohue, Timothy/0000-0001-8738-2467	United States Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science Biological and Environmental Research (BER)) [DE-FC02-07ER64494, DE-SC0018409]	United States Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science Biological and Environmental Research (BER))(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science Biological and Environmental Research (BER) Grants DE-FC02-07ER64494 and DE-SC0018409). The authors declare that they have no conflicts of interest with the contents of this article.	ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Azadi P, 2013, RENEW SUST ENERG REV, V21, P506, DOI 10.1016/j.rser.2012.12.022; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Chen Z, 2017, RENEW SUST ENERG REV, V73, P610, DOI 10.1016/j.rser.2017.01.166; DOHERTY AJ, 1995, NUCLEIC ACIDS RES, V23, P2074, DOI 10.1093/nar/23.11.2074; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; FREDRICKSON JK, 1991, APPL ENVIRON MICROB, V57, P796, DOI 10.1128/AEM.57.3.796-803.1991; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Gall DL, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02076-17; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Goren MA, 2009, METHOD ENZYMOL, V463, P647, DOI 10.1016/S0076-6879(09)63037-8; Helmich KE, 2016, J BIOL CHEM, V291, P5234, DOI 10.1074/jbc.M115.694307; Husarcikova J, 2018, APPL MICROBIOL BIOT, V102, P5391, DOI 10.1007/s00253-018-9040-3; Jarecki BW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01040; Kamimura N, 2017, ENV MICROBIOL REP, V9, P679, DOI 10.1111/1758-2229.12597; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; Kontur WS, 2018, J BIOL CHEM, V293, P4955, DOI 10.1074/jbc.RA117.001268; Lal R, 2008, ENERG ENVIRON SCI, V1, P86, DOI 10.1039/b809492f; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Llado S, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00063-16; Makino SI, 2014, METHODS MOL BIOL, V1091, P161, DOI 10.1007/978-1-62703-691-7_11; Marinovic M, 2018, ACS SUSTAIN CHEM ENG, V6, P2878, DOI 10.1021/acssuschemeng.7b03619; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Mathieu Y, 2012, J BIOL CHEM, V287, P39001, DOI 10.1074/jbc.M112.402776; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Ohta Y, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00267-18; Ohta Y, 2017, CHEMSUSCHEM, V10, P425, DOI 10.1002/cssc.201601235; Ohta Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15105; Palamuru S, 2015, APPL ENVIRON MICROB, V81, P8164, DOI 10.1128/AEM.01573-15; Picart P, 2017, APPL MICROBIOL BIOT, V101, P6277, DOI 10.1007/s00253-017-8360-z; Picart P, 2015, GREEN CHEM, V17, P4931, DOI [10.1039/C5GC01078K, 10.1039/c5gc01078k]; Picart P, 2014, CHEMSUSCHEM, V7, P3164, DOI 10.1002/cssc.201402465; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reiter J, 2013, GREEN CHEM, V15, P1373, DOI 10.1039/c3gc40295a; Rosini E, 2016, CATAL SCI TECHNOL, V6, P2195, DOI 10.1039/c5cy01591j; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; Schutyser W, 2018, CHEM SOC REV, V47, P852, DOI 10.1039/c7cs00566k; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SISTROM WR, 1962, J GEN MICROBIOL, V28, P607, DOI 10.1099/00221287-28-4-607; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanamura K, 2011, BIOSCI BIOTECH BIOCH, V75, P2404, DOI 10.1271/bbb.110525; Thuillier A, 2013, FEBS LETT, V587, P2125, DOI 10.1016/j.febslet.2013.05.031; United States Department of Energy, 2015, DOESC0170; United States Department of Energy, 2008, CARB CYCL BIOS MARCH; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X	54	23	23	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1877	1890		10.1074/jbc.RA118.006548	http://dx.doi.org/10.1074/jbc.RA118.006548			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30541921	hybrid, Green Published			2022-12-26	WOS:000459711400009
J	Hallingstad, EC; Rabie, PA; Telander, AC; Roppe, JA; Nagy, LR				Hallingstad, Eric C.; Rabie, Paul A.; Telander, Andrew C.; Roppe, Jerry A.; Nagy, Laura R.			Developing an efficient protocol for monitoring eagle fatalities at wind energy facilities	PLOS ONE			English	Article							SEARCHER EFFICIENCY; BIRD; MORTALITY; FARMS; AREAS	Researchers typically conduct fatality monitoring to determine a wind energy facility's direct impacts on wildlife. In the United States, wind energy impacts on eagles have received increased attention in recent years because eagle incidental take permits became available. Permit holders are required to conduct fatality monitoring to evaluate compliance with permitted eagle take. Our objective was to develop an efficient eagle fatality monitoring protocol with a quantifiable detection probability based on a stationary scanning search method. We conducted scanning searches for eagle carcasses at four wind energy facilities. We estimated searcher efficiency of the scanning search method using feathered turkey decoys as eagle carcass surrogates, used publicly available data on large raptor carcass distances from turbines to evaluate the proportion of carcasses expected to occur in searched areas, and estimated carcass persistence rates for game birds and raptors. These three bias adjustments were combined to estimate the overall probability of detection for the scanning search method. We found generally high searcher efficiency for the scanning search method, with 76% of decoys detected; however, detection decreased with distance and difficulty of visibility class. Mean carcass persistence time varied between 28 and 76 days for raptors and between three and nine days for game birds, showing that game birds do not persist as long as raptors. We estimated that 95% of large avian carcasses fall within 100 m of turbine bases, and 99% fall within 150 m. Using these estimates and assuming a 30-day search interval for all facility turbines, we estimated that the probability of detecting a large raptor carcass using the scanning search method at a wind facility ranged from 0.50 to 0.69. Our research suggests a monitoring program that uses scanning searches can be a costeffective approach for gathering data necessary to meet incidental eagle take permit requirements.	[Hallingstad, Eric C.; Rabie, Paul A.; Telander, Andrew C.] Western EcoSyst Technol Inc, Cheyenne, WY 82001 USA; [Roppe, Jerry A.; Nagy, Laura R.] Avangrid Renewables LLC, Portland, OR USA		Hallingstad, EC (corresponding author), Western EcoSyst Technol Inc, Cheyenne, WY 82001 USA.	ehallingstad@west-inc.com			Avangrid Renewables, LLC	Avangrid Renewables, LLC	Funding for this research was provided by Avangrid Renewables, LLC. The funders had no role in data collection and analysis, or preparation of the manuscript. Jerry Roppe and Laura Nagy, who both work for Avangrid Renewables LLC and co-authored the manuscript, contributed to the protocol conceptualization, reviewed the manuscript, and participated in the decision to publish.	[Anonymous], 2016, BALD GOLDEN EAGLES P; Barrientos R, 2018, BIOL CONSERV, V222, P146, DOI 10.1016/j.biocon.2018.04.014; Bay K, 2016, J WILDLIFE MANAGE, V80, P1000, DOI 10.1002/jwmg.21086; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CABLE DR, 1975, ECOLOGY, V56, P981, DOI 10.2307/1936309; Dalthorp D, 2015, US GEOLOGICAL SURVEY; Dalthorp D, 2014, US GEOLOGICAL SURVEY, V881; Environmental Protection Agency, 2015, CARB POLL EM GUID EX; Erickson WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107491; Global Wind Energy Council, 2017, GLOB STAT; Hull CL, 2010, AUSTRALAS J ENV MAN, V17, P77, DOI 10.1080/14486563.2010.9725253; Hunt WG, 2002, GOLDEN EAGLES PERILO; Huso M, 2012, USGS DATA SERIES, V729; Huso M, 2017, WILDLIFE WIND FARMS, V2; Huso MMP, 2015, ECOL APPL, V25, P1213, DOI 10.1890/14-0764.1; Huso MMP, 2014, J WILDLIFE MANAGE, V78, P347, DOI 10.1002/jwmg.663; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Korner-Nievergelt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067997; Lehman RN, 2010, J WILDLIFE MANAGE, V74, P459, DOI 10.2193/2008-332; Loss SR, 2013, BIOL CONSERV, V168, P201, DOI 10.1016/j.biocon.2013.10.007; Pagel JE, 2013, J RAPTOR RES, V47, P311, DOI 10.3356/JRR-12-00019.1; Peron G, 2013, J APPL ECOL, V50, P902, DOI 10.1111/1365-2664.12100; Reyes GA, 2016, J WILDLIFE MANAGE, V80, P1488, DOI 10.1002/jwmg.21126; Shoenfeld P., 2004, SUGGESTIONS REGARDIN; Smallwood KS, 2007, J WILDLIFE MANAGE, V71, P2781, DOI 10.2193/2007-006; Smallwood KS, 2018, J WILDLIFE MANAGE, V82, P1169, DOI 10.1002/jwmg.21468; Smallwood KS, 2013, WILDLIFE SOC B, V37, P19, DOI 10.1002/wsb.260; Strickland M.D., 2011, COMPREHENSIVE GUIDE; Thompson C., 2009, TUNDRA TROPICS CONNE, P262; Urquhart B, 2015, BIRD STUDY, V62, P552, DOI 10.1080/00063657.2015.1053751; US Energy Information Administration, 2018, REN CARB DIOX EM; US Fish and Wildlife Service (USFWS), 2009, EAGL PERM TAK NEC PR; US Fish and Wildlife Service (USFWS), 2016, EAGL PERM REV REG EA; US Fish and Wildlife Service (USFWS), 2012, LAND BAS WIND EN GUI; US Fish and Wildlife Service (USFWS), 2013, EAGL CONS PLAN GUID; Whitfield D. P, 2017, 982 SCOTT NAT HER; Wolpert RL, 2012, IMPROVING METHODS ES	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208700	10.1371/journal.pone.0208700	http://dx.doi.org/10.1371/journal.pone.0208700			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540840	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600084
J	Suga, H; Hashimoto, H				Suga, Hitomi; Hashimoto, Hideki			Age threshold for recommending higher protein intake to prevent age-related muscle weakness: A cross-sectional study in Japan	PLOS ONE			English	Article							DIETARY-PROTEIN; OLDER-PEOPLE; SARCOPENIA; STRENGTH; HEALTH; MASS; PREVALENCE; INGESTION; ADEQUATE; WOMEN	Although insufficient dietary protein intake is a known risk factor for age-related muscle weakness, the optimal age at which higher protein intake is required to prevent muscle weakness is yet to be determined. Using a population-based panel survey of community-dwelling people aged 50-75 years, this cross-sectional study aimed to find the age threshold at which a higher protein intake is associated with higher muscle strength. We utilized a dataset from the Japanese Study of Aging and Retirement conducted between 2007 and 2011. Dietary protein intake was estimated using a validated dietary questionnaire and energy-adjusted via density method. Grip strength was measured using a Smedley-type handheld dynamometer. We calculated the marginal effect (and 95% confidence intervals) of protein intake on grip strength with stratification by age using multiple linear regression analyses with robust variance adjusting for potential confounders. There were 9,485 observations from 5,790 participants in the final analysis. Marginal effects of protein intake on grip strength increased with age, and it reached significance and had a positive impact only among men aged >= 75 years and women aged >= 65 years. With an additional 1% energy of protein intake, grip strength was increased by 0.10 kg and 0.19 kg for men and women aged >= 75 years, respectively. Our result indicated the possibility that women needed a high protein intake from a younger age compared with men. Further studies are needed to clarify from when a higher protein intake is recommended to prevent muscle weakness.	[Suga, Hitomi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo, Japan; [Hashimoto, Hideki] Univ Tokyo, Sch Publ Hlth, Dept Hlth, Bunkyo Ku, Tokyo, Japan; [Hashimoto, Hideki] Univ Tokyo, Sch Publ Hlth, Dept Social Behav, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Suga, H (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo, Japan.	hitomis-tky@umin.ac.jp		Hashimoto, Hideki/0000-0003-3663-6564	Japan Society for the Promotion of Science [24249032]; ImPACT Program 2016 of Council for Science, Technology and Innovation, Cabinet Office, Government of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ImPACT Program 2016 of Council for Science, Technology and Innovation, Cabinet Office, Government of Japan	This work was partially funded by a Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science [H.H., grant number 24249032] and by the ImPACT Program 2016 of Council for Science, Technology and Innovation, Cabinet Office, Government of Japan [H.H., Human Security System Development for Social Risk Reduction through Big-data Platform]. Information about the Grant-in-Aid for Scientific Research and the ImPACT Program 2016 is available from https://www.jsps.go.jp/english/e-grants/index.html and https://www.jst.go.jp/impact/en/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian National Health and Medical Research Council New Zealand Ministry of Health, PROT NUTR REF VAL; Bartali B, 2012, J AM GERIATR SOC, V60, P480, DOI 10.1111/j.1532-5415.2011.03833.x; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Beasley JM, 2013, J AM GERIATR SOC, V61, P1863, DOI 10.1111/jgs.12503; Callahan DM, 2014, J APPL PHYSIOL, V116, P1582, DOI 10.1152/japplphysiol.01362.2013; Campbell WW, 2001, J GERONTOL A-BIOL, V56, pM373, DOI 10.1093/gerona/56.6.M373; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cherin P, 2014, AGING CLIN EXP RES, V26, P137, DOI 10.1007/s40520-013-0132-8; Deutsche Gesellschaft fur Ernahrung e. V, REF NAHRST PROT; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2832; Gheller BJF, 2016, ANNU REV NUTR, V36, P129, DOI 10.1146/annurev-nutr-071715-050901; Granic A, 2018, CLIN NUTR, V37, P2260, DOI 10.1016/j.clnu.2017.11.005; Gregorio L, 2014, J NUTR HEALTH AGING, V18, P155, DOI 10.1007/s12603-013-0391-2; Hideki H., 2009, JSTAR 1 RESULTS 2009; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Katsanos CS, 2005, AM J CLIN NUTR, V82, P1065, DOI 10.1093/ajcn/82.5.1065; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Landi F, 2017, J NUTR HEALTH AGING, V21, P1050, DOI 10.1007/s12603-017-0974-4; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Mangano KM, 2017, AM J CLIN NUTR, V105, P714, DOI 10.3945/ajcn.116.136762; Ministry of Health Labour and Welfare, 2015, DIET REF INT JAP 201, P2015; Moore DR, 2015, J GERONTOL A-BIOL, V70, P57, DOI 10.1093/gerona/glu103; Mulla UZ, 2013, AGE AGEING, V42, P81, DOI 10.1093/ageing/afs101; Nordic Council of Ministers, 2014, NORDIC NUTR RECOMMEN, V5th, DOI [10.6027/Nord2014-002, DOI 10.6027/NORD2014-002]; Research Institute of Economy Trade and Industry, 2011, STAT RESP JSTAR SURV; Research Institute of Economy Trade and Industry, STAT RESP 2009 JSTAR; Robinson SM, 2008, J AM GERIATR SOC, V56, P84, DOI 10.1111/j.1532-5415.2007.01478.x; Rondanelli M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/524948; Sahni S, 2015, J NUTR, V145, P1569, DOI 10.3945/jn.114.204925; Sasaki S, 1998, J Epidemiol, V8, P203; Science and Technology Agency, 2005, STAND TABL FOOD COMP, V5th ed.; Scott D, 2010, J AM GERIATR SOC, V58, P2129, DOI 10.1111/j.1532-5415.2010.03147.x; Smith GI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001875; Sousa AS, 2016, EUR J CLIN NUTR, V70, P1046, DOI 10.1038/ejcn.2016.73; Sousa AS, 2016, EUR J CLIN NUTR, V70, P595, DOI 10.1038/ejcn.2015.207; Symons TB, 2007, AM J CLIN NUTR, V86, P451, DOI 10.1093/ajcn/86.2.451; Symons TB, 2009, J AM DIET ASSOC, V109, P1582, DOI 10.1016/j.jada.2009.06.369; Thompson BJ, 2015, NUTR RES, V35, P280, DOI 10.1016/j.nutres.2015.02.003; Wakai K, 2009, J EPIDEMIOL, V19, P1, DOI 10.2188/jea.JE20081007; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Witard OC, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040181; Yamada M, 2013, J AM MED DIR ASSOC, V14, P911, DOI 10.1016/j.jamda.2013.08.015	45	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208169	10.1371/journal.pone.0208169	http://dx.doi.org/10.1371/journal.pone.0208169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540812	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600061
J	Garcia-Martin, I; Penketh, RJA; Janssen, AB; Jones, RE; Grimstead, J; Baird, DM; John, RM				Garcia-Martin, Isabel; Penketh, Richard J. A.; Janssen, Anna B.; Jones, Rhiannon E.; Grimstead, Julia; Baird, Duncan M.; John, Rosalind M.			Metformin and insulin treatment prevent placental telomere attrition in boys exposed to maternal diabetes	PLOS ONE			English	Article							PREGNANCIES; LENGTH; MELLITUS; OBESITY; RISK	Shortened leukocyte and placental telomeres associated with gestational diabetes mellitus (GDM) suggest this exposure triggers telomere attrition contributing to adverse outcomes. We applied high resolution Single Telomere Length Analysis (STELA) to placenta from GDM pregnancies with different treatment pathways to determine their effectiveness at preventing telomere attrition. Differences in telomere length between control (N = 69), GDM lifestyle intervention (n = 14) and GDM treated with metformin and/or insulin (n = 17) was tested by Analysis of Covariance (ANCOVA) followed by group comparisons using Fisher's least significant difference. For male placenta only, there were differences in mean telomere length (F(2,54) = 4.98, P = 0.01) and percentage of telomeres under 5 kb (F(2,54) = 4.65, P = 0.01). Telomeres were shorter in the GDM lifestyle intervention group compared to both controls (P = 0.02) and medically treated pregnancies (P = 0.003). There were more telomeres under 5 kb in the GDM lifestyle intervention group compared to the other two groups (P = 0.03 and P = 0.004). Although further work is necessary, we suggest that early adoption of targeted medical treatment of GDM pregnancies where the fetus is known to be male may be an effective strategy for ameliorating adverse outcomes for children.	[Garcia-Martin, Isabel; Janssen, Anna B.; John, Rosalind M.] Cardiff Univ, Cardiff Sch Biosci, Div Biomed, Cardiff, S Glam, Wales; [Penketh, Richard J. A.] Univ Hosp Wales, Dept Obstet & Gynaecol, Cardiff, S Glam, Wales; [Jones, Rhiannon E.; Grimstead, Julia; Baird, Duncan M.] Cardiff Univ, Cardiff Sch Med, Div Canc & Genet, Cardiff, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	John, RM (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Div Biomed, Cardiff, S Glam, Wales.	JohnRM@Cardiff.ac.uk	John, Rosalind/AAQ-8221-2021; John, Ros/AFI-8619-2022; John, Rosalind M/A-4491-2010; Baird, Duncan M/C-9671-2011; John, Ros/AAF-4229-2022	John, Ros/0000-0002-3827-7617; John, Rosalind M/0000-0002-3827-7617; Baird, Duncan M/0000-0001-8408-5467; John, Ros/0000-0002-3827-7617; Garcia Martin, Isabel/0000-0003-3295-854X	Cardiff School of Biosciences PhD studentship; Biotechnology and Biological Sciences Research Council [BB/F016557/1]; Medical Research Council [MR/M013960/1]; Cancer Research UK [C17199/A18246]; Cancer Research UK [18246] Funding Source: researchfish; MRC [MR/M013960/1] Funding Source: UKRI	Cardiff School of Biosciences PhD studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	IGM was funded by a Cardiff School of Biosciences PhD studentship; ABJ was supported by Biotechnology and Biological Sciences Research Council PhD studentship BB/F016557/1; RMJ lab supported by Medical Research Council grant MR/M013960/1; DMB lab supported by Cancer Research UK (C17199/A18246).	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Biron-Shental T, 2015, PLACENTA, V36, P199, DOI 10.1016/j.placenta.2014.11.011; Biron-Shental T, 2016, PLACENTA, V44, P13, DOI 10.1016/j.placenta.2016.05.009; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2010, ANGEW CHEM INT EDIT, V49, P7405, DOI 10.1002/anie.201002387; Brown J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011970.pub2; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Cross JA, 2010, DIABETIC MED, V27, P1264, DOI 10.1111/j.1464-5491.2010.03099.x; Diman A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600031; Entringer S, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0151; Fraser A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0489-x; Garcia-Martin I, 2017, PLACENTA, V59, P61, DOI 10.1016/j.placenta.2017.09.007; Giannubilo SR, 2018, CLIN THER, V40, P587, DOI 10.1016/j.clinthera.2018.02.015; Girchenko P, 2018, INT J OBESITY, V42, P995, DOI 10.1038/s41366-018-0061-x; Harville Emily W, 2010, BMC Res Notes, V3, P113, DOI 10.1186/1756-0500-3-113; Hinkle SN, 2016, DIABETOLOGIA, V59, P2594, DOI 10.1007/s00125-016-4086-1; Hjort L, 2018, DIABETOLOGIA, V61, P870, DOI 10.1007/s00125-018-4549-7; Holder T, 2014, DIABETOLOGIA, V57, P2413, DOI 10.1007/s00125-014-3345-2; Janssen AB, 2015, PLACENTA, V36, P790, DOI 10.1016/j.placenta.2015.06.011; John R, 2012, REPROD BIOMED ONLINE, V25, P5, DOI 10.1016/j.rbmo.2012.03.018; Jones CW, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.11.1027; Kim C, 2014, DIABETIC MED, V31, P292, DOI 10.1111/dme.12382; Kirchner H, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070176; Kuhlow D, 2010, AGING-US, V2, P650, DOI 10.18632/aging.100200; Lao TT, 2006, DIABETES CARE, V29, P948, DOI 10.2337/diacare.29.04.06.dc05-2568; Le Moullec N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195531; Li SS, 2017, INT J EPIDEMIOL, V46, P1533, DOI [10.1093/ije/dyx211, 10.1093/ije/dyx151]; Menendez JA, 2011, AGING-US, V3, P348, DOI 10.18632/aging.100316; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nan WQ, 2015, EXPERT OPIN THER TAR, V19, P849, DOI 10.1517/14728222.2015.1016500; Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; SIMPSON RA, 1992, PLACENTA, V13, P501, DOI 10.1016/0143-4004(92)90055-X; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086161; Yuen LL, 2015, WORLD J DIABETES, V6, P1024, DOI 10.4239/wjd.v6.i8.1024	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208533	10.1371/journal.pone.0208533	http://dx.doi.org/10.1371/journal.pone.0208533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533028	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500024
J	Jerez-Roig, J; Bosque-Prous, M; Gine-Garriga, M; Bagur-Calafat, C; de Souza, DLB; Teixido-Compano, E; Espelt, A				Jerez-Roig, Javier; Bosque-Prous, Marina; Gine-Garriga, Maria; Bagur-Calafat, Caritat; Bezerra de Souza, Dyego L.; Teixido-Compano, Ester; Espelt, Albert			Regional differences in the profile of disabled community-dwelling older adults: A European population-based cross-sectional study	PLOS ONE			English	Article							D SCALE; DISABILITY; HEALTH; DEPRESSION; PREVALENCE; SYMPTOMS; VERSION; GENDER; SHARE; LIFE	The main objective of this work was to estimate the prevalence of disability in European community-dwelling older adults, as well as to investigate differences in the profile of disabled older adults between European regions (Northern, Central, Eastern and Southern). A cross-sectional study based on wave 6 (2015) of the Survey of Health, Ageing and Retirement in Europe (SHARE) was conducted. Community-dwelling participants aged 65-84 were selected (n = 33,369). Disability was defined as presenting at least one functional limitation in basic activities of daily living (BADL). Sociodemographic, health services, lifestyle and health-related variables were analyzed. Statistical analysis was carried out through the Chi-square and ANOVA tests for bivariate analysis, and Poisson regression for multivariate analysis. Overall prevalence of disability was 13.8%: 9.4% in the Northern region, 13.1% in the Southern region, 13.6% in the Central region, and 16.6% in the Eastern region. Portugal, Poland, Estonia and Belgium showed the highest prevalence of BADL limitations, while Sweden, Denmark, Greece and Switzerland showed the lowest prevalence. Besides, disabled older adults from East Europe presented the most disadvantaged health profile, followed by the Southern region. On the other hand, disabled older adults living in the Northern region showed the most advantaged characteristics of most variables, except for smoking and polypharmacy.	[Jerez-Roig, Javier] Univ Vic, Univ Catalonia UVIC UCC, Res Grp Methodol Methods Models & Outcomes Hlth &, Fac Hlth Sci & Welf,Ctr Hlth & Social Care Res CE, Vic, Spain; [Jerez-Roig, Javier; Gine-Garriga, Maria] Ramon Llull Univ, Blanquerna Fac Psychol Educ & Sport Sci, Barcelona, Spain; [Jerez-Roig, Javier; Bezerra de Souza, Dyego L.] Univ Fed Rio Grande do Norte, Odontol Dept, Postgrad Program Collect Hlth, Natal, RN, Brazil; [Bosque-Prous, Marina] Univ Oberta Catalunya, Fac Hlth Sci, Barcelona, Spain; [Gine-Garriga, Maria] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Bagur-Calafat, Caritat] Univ Int Catalunya, Dept Physiotherapy, Sant Cugat Del Valles, Spain; [Bezerra de Souza, Dyego L.] Univ Fed Rio Grande do Norte, Dept Collect Hlth, Grad Program Collect Hlth, Natal, RN, Brazil; [Teixido-Compano, Ester; Espelt, Albert] Univ Vic, Fac Hlth Sci Manresa, Cent Univ Catalonia, Manresa, Spain	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Universitat Ramon Llull; Universidade Federal do Rio Grande do Norte; UOC Universitat Oberta de Catalunya; Glasgow Caledonian University; Universitat Internacional de Catalunya (UIC); Universidade Federal do Rio Grande do Norte; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Bosque-Prous, M (corresponding author), Univ Oberta Catalunya, Fac Hlth Sci, Barcelona, Spain.	mbosquep@uoc.edu	Teixidó-Compañó, Ester/ABD-9912-2021; Jerez-Roig, Javier/V-6119-2018; Teixidó-Compañó, Ester/AAD-9055-2020; Bosque-Prous, Marina/AAE-1562-2020; Giné-Garriga, Maria/F-4089-2016; Giné-Garriga, Maria/AAF-9828-2019; Espelt, Albert/G-2281-2014; Bagur-Calafat, Caritat/R-7937-2017	Jerez-Roig, Javier/0000-0002-1968-4452; Teixidó-Compañó, Ester/0000-0002-0565-7023; Bosque-Prous, Marina/0000-0002-8830-8880; Giné-Garriga, Maria/0000-0003-4449-3524; Giné-Garriga, Maria/0000-0003-4449-3524; Espelt, Albert/0000-0002-8625-4356; Souza, Dyego L.B./0000-0001-8426-3120; Bagur-Calafat, Caritat/0000-0002-8637-5035				[Anonymous], 2011, WORLD REP DIS; de Lima ALB, 2018, CIENC SAUDE COLETIVA, V23, P2991, DOI 10.1590/1413-81232018239.20662016; Borrat-Besson CV, 2015, EVALUATION CASP 12 S; Castro-Costa E, 2008, INT J METH PSYCH RES, V17, P12, DOI 10.1002/mpr.236; Chatterji S, 2015, LANCET, V385, P563, DOI 10.1016/S0140-6736(14)61462-8; Crimmins EM, 2011, EUR J PUBLIC HEALTH, V21, P81, DOI 10.1093/eurpub/ckq022; Eikemo TA, 2008, SOCIOL HEALTH ILL, V30, P565, DOI 10.1111/j.1467-9566.2007.01073.x; Espelt A, 2017, ADICCIONES, V29, P105, DOI 10.20882/adicciones.823; Espelt A, 2010, J WOMENS HEALTH, V19, P927, DOI 10.1089/jwh.2009.1608; Green G, 2013, J URBAN HEALTH, V90, pS116, DOI 10.1007/s11524-012-9765-8; Hank K, 2011, J GERONTOL B-PSYCHOL, V66, P230, DOI 10.1093/geronb/gbq089; Hank K, 2010, AGEING SOC, V30, P1041, DOI 10.1017/S0144686X10000280; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Larraga L, 2006, INT J GERIATR PSYCH, V21, P1199, DOI 10.1002/gps.1642; Leonardi M, 2014, CLIN PSYCHOL PSYCHOT, V21, P193, DOI 10.1002/cpp.1856; Lunenfeld B, 2013, BEST PRACT RES CL OB, V27, P643, DOI 10.1016/j.bpobgyn.2013.02.005; Malter F, 2015, SHARE WAVE 5 INNOVAT, DOI [10.1002/wdev.204, DOI 10.1002/WDEV.204]; Ministry of Health and Social Protection, 2017, PRESS RELEASE; Perales J, 2014, INT PSYCHOGERIATR, V26, P1363, DOI 10.1017/S1041610214000520; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Serrano-Alarcon M, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0673-0; UNESCO, 2013, INT STAND CLASS ED 2; Wahrendorf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071893; Zunzunegui MV, 2006, AGING CLIN EXP RES, V18, P352, DOI 10.1007/BF03324830; Zunzunegui MV, 2011, GAC SANIT, V25, P12, DOI 10.1016/j.gaceta.2011.07.026	25	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208946	10.1371/journal.pone.0208946	http://dx.doi.org/10.1371/journal.pone.0208946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD8CS	30533039	Green Published, gold, Green Submitted			2022-12-26	WOS:000452782500053
J	de Rotte, MCFJ; Pluijm, SMF; de Jong, PHP; Calasan, MB; Wulffraat, NM; Weel, AEAM; Lindemans, J; Hazes, JMW; de Jonge, R				de Rotte, Maurits C. F. J.; Pluijm, Saskia M. F.; de Jong, Pascal H. P.; Calasan, Maja Bulatovic; Wulffraat, Nico M.; Weel, Angelique E. A. M.; Lindemans, Jan; Hazes, J. M. W.; de Jonge, Robert			Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis	PLOS ONE			English	Article							PHARMACOGENETIC MODEL; AMERICAN-COLLEGE; MONOTHERAPY; RECOMMENDATIONS; NONRESPONSE; DIAGNOSIS; EFFICACY; CRITERIA; LEAGUE; FOLATE	Objective The objective was to predict insufficient response to 3 months methotrexate (MTX) in DMARD naive rheumatoid arthritis patients. Methods A Multivariable logistic regression model of rheumatoid arthritis patients starting MTX was developed in a derivation cohort with 285 patients starting MTX in a clinical multicentre, stratified single-blinded trial, performed in seven secondary care clinics and a tertiary care clinic. The model was validated in a validation cohort with 102 patients starting MTX at a tertiary care clinic. Outcome was insufficient response (disease activity score (DAS)28 >3.2) after 3 months of MTX treatment. Clinical characteristics, lifestyle variables, genetic and metabolic biomarkers were determined at baseline in both cohorts. These variables were dichotomized and used to construct a multivariable prediction model with backward logistic regression analysis. Results The prediction model for insufficient response in the derivation cohort, included: DAS28>5.1, Health Assessment Questionnaire>0.6, current smoking, BMI>25 kg/m(2), ABCB1 rs1045642 genotype, ABCC3 rs4793665 genotype, and erythrocyte-folate<750 nmol/L. In the derivation cohort, AUC of ROC curve was 0.80 (95%CI: 0.73-0.86), and 0.80 (95%CI: 0.69-0.91) in the validation cohort. Betas of the prediction model were transformed into total risk score (range 0-8). At cutoff of >= 4, probability for insufficient response was 44%. Sensitivity was 71%, specificity 72%, with positive and negative predictive value of 72% and 71%. Conclusions A prognostics prediction model for insufficient response to MTX in 2 prospective RA cohorts by combining genetic, metabolic, clinical and lifestyle variables was developed and validated. This model satisfactorily identified RA patients with high risk of insufficient response to MTX.	[de Rotte, Maurits C. F. J.; Lindemans, Jan; de Jonge, Robert] Erasmus Univ, Dept Clin Chem, Med Ctr, Rotterdam, Netherlands; [de Rotte, Maurits C. F. J.; de Jonge, Robert] Univ Amsterdam, Dept Clin Chem, Med Ctr, Amsterdam, Netherlands; [Pluijm, Saskia M. F.] Prinses Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [de Jong, Pascal H. P.; Weel, Angelique E. A. M.; Hazes, J. M. W.] Erasmus Univ, Dept Rheumatol, Med Ctr, Rotterdam, Netherlands; [Calasan, Maja Bulatovic; Wulffraat, Nico M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands; [Weel, Angelique E. A. M.] Maasstad Hosp, Dept Rheumatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Maasstad Hospital	de Rotte, MCFJ (corresponding author), Erasmus Univ, Dept Clin Chem, Med Ctr, Rotterdam, Netherlands.; de Rotte, MCFJ (corresponding author), Univ Amsterdam, Dept Clin Chem, Med Ctr, Amsterdam, Netherlands.	mcfj.derotte@gmail.com	Wulffraat, Nico M/AAE-8929-2020; de Jong, Pascal/AAA-5360-2022	Wulffraat, Nico M/0000-0001-9548-5562; 	Pfizer [0881-102217]; Dutch Arthritis Association [06-02-402, 09-1-402]	Pfizer(Pfizer); Dutch Arthritis Association	This work was supported by tREACH: Unrestricted grant from Pfizer (https://www.pfizer.nl) 0881-102217 to JMWH and the Dutch Arthritis Association (https://reumanederland.nl) 06-02-402 and 09-1-402 to RdJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2018, JAMA-J AM MED ASSOC, V320, P1360, DOI 10.1001/jama.2018.13103; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Bulatovic M, 2012, ANN RHEUM DIS, V71, P1484, DOI 10.1136/annrheumdis-2011-200942; Calasan MB, 2015, ANN RHEUM DIS, V74, P402, DOI 10.1136/annrheumdis-2013-203723; Chan ESL, 2013, BULL HOSP JT DIS, V71, pS5; Claessen SJJ, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-71; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; de Jong PH, 2013, ANN RHEUM DIS, V72, P72, DOI 10.1136/annrheumdis-2011-201162; de Rotte MCFJ, 2013, ARTHRITIS RHEUM-US, V65, P2803, DOI 10.1002/art.38113; de Rotte MCFJ, 2015, ANN RHEUM DIS, V74, P408, DOI 10.1136/annrheumdis-2013-203725; de Rotte MCFJ, 2012, J RHEUMATOL, V39, P2032, DOI 10.3899/jrheum.111593; Ducros V, 2006, CLIN CHEM LAB MED, V44, P987, DOI 10.1515/CCLM.2006.178; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fransen J, 2012, PHARMACOGENOMICS, V13, P1087, DOI [10.2217/PGS.12.83, 10.2217/pgs.12.83]; Katchamart W, 2010, ARTHRIT CARE RES, V62, P1128, DOI 10.1002/acr.20188; Maetzel A, 2000, RHEUMATOLOGY, V39, P975, DOI 10.1093/rheumatology/39.9.975; Nesher G, 2003, ARTHRITIS RHEUM, V48, P571, DOI 10.1002/art.10766; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raza K, 2010, RHEUMATOLOGY, V49, P406, DOI 10.1093/rheumatology/kep392; Romao VC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-17; Saevarsdottir S, 2011, ARTHRITIS RHEUM-US, V63, P26, DOI 10.1002/art.27758; Saevarsdottir S, 2011, ANN RHEUM DIS, V70, P469, DOI 10.1136/ard.2010.139212; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Stamp LK, 2009, ARTHRITIS RHEUM, V60, P2248, DOI 10.1002/art.24653; Stavropoulos-Kalinoglou A, 2009, CLIN RHEUMATOL, V28, P439, DOI 10.1007/s10067-008-1073-z; van Zelst BD, 2012, J CHROMATOGR B, V903, P134, DOI 10.1016/j.jchromb.2012.07.007; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Wessels JAM, 2007, ARTHRITIS RHEUM-US, V56, P1765, DOI 10.1002/art.22640; Zemlin AE, 2010, CLIN LAB, V56, P391	31	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208534	10.1371/journal.pone.0208534	http://dx.doi.org/10.1371/journal.pone.0208534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532219	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700027
J	Murillo, JR; Kuras, M; Rezeli, M; Milliotis, T; Betancourt, L; Marko-Varga, G				Murillo, Jimmy Rodriguez; Kuras, Magdalena; Rezeli, Melinda; Milliotis, Tasso; Betancourt, Lazaro; Marko-Varga, Gyorgy			Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue	PLOS ONE			English	Article							PHOSPHORYLATION; PATHWAY	To acquire a deeper understanding of malignant melanoma (MM), it is essential to study the proteome of patient tissues. In particular, phosphoproteomics of MM has become of significant importance because of the central role that phosphorylation plays in the development of MM. Investigating clinical samples, however, is an extremely challenging task as there is usually only very limited quantities of material available to perform targeted enrichment approaches. Here, an automated phosphopeptide enrichment protocol using the AssayMap Bravo platform was applied to MM tissues and assessed for performance. The strategy proved to be highly-sensitive, less prone to variability, less laborious than existing techniques and adequate for starting quantities at the microgram level. An Fe(III)-NTA-IMACbased enrichment workflow was applied to a dilution series of MM tissue lysates. The workflow was efficient in terms of sensitivity, reproducibility and phosphosite localization; and from only 12.5 mu g of sample, more than 1,000 phosphopeptides were identified. In addition, from 60 mu g of protein material the number of identified phosphoproteins from individual MM samples was comparable to previous reports that used extensive fractionation methods. Our data set included key pathways that are involved in MM progression; such as MAPK, melanocyte development and integrin signaling. Moreover, tissue-specific immunological proteins were identified, that have not been previously observed in the proteome of MMderived cell lines. In conclusion, this workflow is suitable to study large cohorts of clinical samples that demand automatic and careful handling.	[Murillo, Jimmy Rodriguez; Kuras, Magdalena; Rezeli, Melinda; Milliotis, Tasso; Betancourt, Lazaro; Marko-Varga, Gyorgy] Lund Univ, Dept Clin Sci Lund, Dept Biomed Engn, Clin Prot Sci & Imaging, Lund, Sweden; [Milliotis, Tasso] AstraZeneca, IMED Biotech Unit, Translat Sci Cardiovasc Renal & Metab, Gothenburg, Sweden	Lund University; AstraZeneca	Betancourt, L (corresponding author), Lund Univ, Dept Clin Sci Lund, Dept Biomed Engn, Clin Prot Sci & Imaging, Lund, Sweden.	lazaro.betancourt@med.lu.es		Kuras, Magdalena/0000-0002-9479-423X	Swedish Research Council; Vinnova; SSF under the program Biomedical engineering for better health; Berta Kamprad Foundation; National Research Foundation of Korea - government of Republic of Korea (MSIP) [2012M3A9D1054520, 2015K1A1A2028365, 2015M3A9C4076 321]; Brain Korea 21 Plus Project, Republic of Korea; AstraZeneca	Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova(Vinnova); SSF under the program Biomedical engineering for better health; Berta Kamprad Foundation; National Research Foundation of Korea - government of Republic of Korea (MSIP); Brain Korea 21 Plus Project, Republic of Korea; AstraZeneca(AstraZeneca)	This work was supported by Swedish Research Council, Vinnova, SSF, under the program Biomedical engineering for better health and the Berta Kamprad Foundation; and the National Research Foundation of Korea, funded by the government of Republic of Korea (MSIP; 2012M3A9D1054520, 2015K1A1A2028365, 2015M3A9C4076 321); and Brain Korea 21 Plus Project, Republic of Korea. The funders (including the commercial company AstraZeneca) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca provided support in the form of salaries for author TM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abelin JG, 2016, MOL CELL PROTEOMICS, V15, P1622, DOI 10.1074/mcp.M116.058354; Abildgaard C, 2015, TRENDS MOL MED, V21, P164, DOI 10.1016/j.molmed.2014.12.007; Ardito F, 2017, INT J MOL MED, V40, P271, DOI 10.3892/ijmm.2017.3036; Basken J, 2018, MOL CELL PROTEOMICS, V17, P550, DOI 10.1074/mcp.RA117.000335; Batth TS, 2014, J PROTEOME RES, V13, P6176, DOI 10.1021/pr500893m; Boersema PJ, 2008, ANAL BIOANAL CHEM, V391, P151, DOI 10.1007/s00216-008-1865-7; Burotto M, 2014, CANCER-AM CANCER SOC, V120, P3446, DOI 10.1002/cncr.28864; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Danen EHJ, 2000, INTEGRINS OVERVIEW S; de Graaf EL, 2016, J PROTEOME RES, V15, P4722, DOI 10.1021/acs.jproteome.6b00889; Felicetti F, 2009, INT J CANCER, V125, P1514, DOI 10.1002/ijc.24451; Fu P, 2017, ONCOTARGETS THER, V10, P819, DOI 10.2147/OTT.S123912; Galan JA, 2014, P NATL ACAD SCI USA, V111, pE2918, DOI 10.1073/pnas.1405601111; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hu-Lieskovan S, 2014, J CLIN ONCOL, V32, P2248, DOI 10.1200/JCO.2013.52.1377; Huang RX, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0763-x; Lombardi Benedetta, 2015, EuPA Open Proteom, V6, P10; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; Ma MW, 2012, MODERN PATHOL, V25, P1000, DOI 10.1038/modpathol.2012.43; Post H, 2017, J PROTEOME RES, V16, P728, DOI 10.1021/acs.jproteome.6b00753; Pulliam SR, 2016, IMMUNOL LETT, V169, P61, DOI 10.1016/j.imlet.2015.11.007; Rodriguez-Cerdeira C, 2018, J PROTEOMICS, V188, P152, DOI 10.1016/j.jprot.2017.11.005; Russell JD, 2016, AGILENT ASSAYMAP BRA, P1; Schadendorf D, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.3; Shain AH, 2016, NAT REV CANCER, V16, P345, DOI 10.1038/nrc.2016.37; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Slipicevic A, 2015, J INVEST DERMATOL, V135, P337, DOI 10.1038/jid.2014.417; Smit MA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145450; Szasz AM, 2019, CELL BIOL TOXICOL, V35, P1, DOI 10.1007/s10565-018-9446-9; Szasz AM, 2017, SEMIN CELL DEV BIOL, V64, P132, DOI 10.1016/j.semcdb.2016.08.026; Thingholm TE, 2016, METHODS MOL BIOL, V1355, P147, DOI 10.1007/978-1-4939-3049-4_10; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; Vincent KM, 2017, ONCOTARGET, V8, P10498, DOI 10.18632/oncotarget.14443; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Welinder C, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-7	36	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208562	10.1371/journal.pone.0208562	http://dx.doi.org/10.1371/journal.pone.0208562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532160	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700029
J	Buhmann, J; Moens, B; Van Dyck, E; Dotov, D; Leman, M				Buhmann, Jeska; Moens, Bail; Van Dyck, Edith; Dotov, Dobromir; Leman, Marc			Optimizing beat synchronized running to music	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; MOTIVATIONAL QUALITIES; INITIAL VALIDATION; EXERCISE; INSTRUMENT; FREQUENCY; ENJOYMENT; FEEDBACK	The use of music and specifically tempo-matched music has been shown to affect running performance. But can we maximize the synchronization of movements to music and does maximum synchronization influence kinematics and motivation? In this study, we explore the effect of different types of music-to-movement alignment strategies on phase coherence, cadence and motivation. These strategies were compared to a control condition where the music tempo was deliberately not aligned to the running cadence. Results show that without relative phase alignment, a negative mean asynchrony (NMA) of footfall timings with respect to the beats is obtained. This means that footfalls occurred slightly before the beat and that beats were anticipated. Convergence towards this NMA or preferred relative phase angle was facilitated when the first music beat of a new song started close to the step, which means that entrainment occurred. The results also show that using tempo and phase alignment, the relative phase can be manipulated or forced in a certain angle with a high degree of accuracy. Ensuring negative angles larger than NMA (step before beat) results in increased motivation and decreasing cadence. Running in NMA or preferred relative phase angles results in a null effect on cadence. Ensuring a positive phase angle with respect to NMA results in higher motivation and higher cadence. None of the manipulations resulted in change in perceived exhaustion or a change in velocity. Results also indicate that gender plays an important role when using forced phase algorithms: effects were more pronounced for the female population than for the male population. The implementation of the proposed alignment strategies and control of beat timing while running opens possibilities optimizing the individual running cadence and motivation.	[Buhmann, Jeska; Moens, Bail; Van Dyck, Edith; Leman, Marc] Univ Ghent, IPEM, Ghent, Belgium; [Dotov, Dobromir] McMaster Univ, LIVELab, Hamilton, ON, Canada	Ghent University; McMaster University	Buhmann, J (corresponding author), Univ Ghent, IPEM, Ghent, Belgium.	jeska.buhmann@ugent.be	Dotov, Dobromir G/J-8257-2015; Buhmann, Jeska/L-1233-2019; Van Dyck, Edith/ABE-4913-2020; Dotov, Dobromir/HGF-2586-2022	Dotov, Dobromir G/0000-0002-5543-360X; Buhmann, Jeska/0000-0001-6659-6247; Van Dyck, Edith/0000-0001-7239-1918; Leman, Marc/0000-0002-9780-2194	BeatHealth, a collaborative project - European Commission under the Seventh Framework Programme [610633]	BeatHealth, a collaborative project - European Commission under the Seventh Framework Programme	This research has been supported by BeatHealth (contract #610633), a collaborative project funded by the European Commission under the Seventh Framework Programme: https://cordis.europa.eu/project/rcn/110990_en.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter DA, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0017-9; Aschersleben G, 1997, J MOTOR BEHAV, V29, P35, DOI 10.1080/00222899709603468; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bood RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070758; Borg G., 1998, BORGS PERCEIVED EXER; Buhmann J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154414; Cole Z, 2015, PERCEPT MOTOR SKILL, V121, P390, DOI 10.2466/06.PMS.121c20x9; Corcos A, 2018, SOCIOAFFECTIVE NEURO, V8, DOI 10.1080/20009011.2018.1474668; Dixon S, 2007, J NEW MUSIC RES, V36, P39, DOI 10.1080/09298210701653310; Du Y, 2017, EXP BRAIN RES, V235, P1541, DOI 10.1007/s00221-017-4918-3; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher N., 1995, STAT ANAL CIRCULAR D; Franek M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01361; Fritz TH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00448; Fritz TH, 2013, P NATL ACAD SCI USA, V110, P17784, DOI 10.1073/pnas.1217252110; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; International Telecommunication Union, 2012, 17703 ITUR BS; Janata P, 2012, J EXP PSYCHOL GEN, V141, P54, DOI 10.1037/a0024208; Karageorghis CI, 1999, J SPORT SCI, V17, P713, DOI 10.1080/026404199365579; Karageorghis CI, 2006, J SPORT SCI, V24, P899, DOI 10.1080/02640410500298107; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Leman M., 2016, EXPRESSIVE MOMENT; Leman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067932; Lim HBT, 2014, MED SCI SPORT EXER, V46, P407, DOI 10.1249/MSS.0b013e3182a6378c; Lyons EJ, 2015, GAMES HEALTH J, V4, P12, DOI 10.1089/g4h.2014.0072; Maes PJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00548; MARDIA KV, 1972, J ROY STAT SOC B, V34, P102; Mendonca C, 2014, HUM MOVEMENT SCI, V33, P33, DOI 10.1016/j.humov.2013.11.006; Moens B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114234; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; MORTON J, 1976, PSYCHOL REV, V83, P405, DOI 10.1037/0033-295X.83.5.405; Mullen SP, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-103; Paillard J., 1991, LANNE PSYCHOLOGIQUE, V48, P2847; Pappas IPI, 2001, IEEE T NEUR SYS REH, V9, P113, DOI 10.1109/7333.928571; Priest DL, 2004, J SPORT MED PHYS FIT, V44, P77; Ramji R, 2016, PSYCHOL MUSIC, V44, P984, DOI 10.1177/0305735615603239; Reenalda J, 2016, INT J SPORT PHYSIOL, V11, P920, DOI 10.1123/ijspp.2015-0182; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Terry PC, 2012, J SCI MED SPORT, V15, P52, DOI 10.1016/j.jsams.2011.06.003; Van Dyck E, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0025-9; Zplane E, 2002, LASTIQUE TIME STRETC	44	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208702	10.1371/journal.pone.0208702	http://dx.doi.org/10.1371/journal.pone.0208702			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521634	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600104
J	Dareng, EO; Olaniyan, Y; Odutola, MK; Adebamowo, SN; Famooto, A; Offiong, R; Obende, K; Adewole, SA; Achara, P; Dakum, PS; Adebamowo, CA				Dareng, Eileen O.; Olaniyan, Yinka; Odutola, Michael K.; Adebamowo, Sally N.; Famooto, Ayotunde; Offiong, Richard; Obende, Kayode; Adewole, Stephen A.; Achara, Peter; Dakum, Patrick S.; Adebamowo, Clement A.			Secular trend in interobserver agreement of VIA diagnosis for cervical cancer screening in Nigeria	PLOS ONE			English	Article							VISUAL INSPECTION; ACETIC-ACID; GLOBAL BURDEN; CRYOTHERAPY; PROGRAM	Objective In low resource settings, visual inspection with acetic acid (VIA) by allied health workers, has been suggested as an alternative for cervical cancer screening. However, there are concerns about the objectivity and time to diagnostic concordance with specialists. We evaluated the secular trend in interobserver agreement between nurse providers and a gynecologist/colposcopist over a five-year period. Methods Nurses provided VIA screening with digital cervivography to 4,961 participants in five screening clinics from October 2010 to May 2014 in Nigeria in this observational study. Cervigraphs were reviewed at meetings where a gynaecologist/colposcopist made an assessment from the cervigraphs. We used weighted kappa statistics to calculate agreement in diagnosis between nurse providers and the gynecologist/colposcopist; linear regression models to examine overall trend and investigate potential clinic characteristics that may influence agreement; and time series models to characterize month to month variations. Results Mean age of participants was 37 +/- 8 years. Overall agreement was 0.89 at Site D, 0.78 and 0.73 at Sites A and C respectively, 0.50 for Site E and 0.34 for Site C. The number of trainings attended by nurse providers(beta = 0.47,95%CI:0.02-0.93, p = 0.04), high level of engagement by site gynecologists(beta = 0.11,95%CI:0.01-0.21,p = 0.04) were associated with increased agreement; while increasing distance from the coordinating site(beta = -0.47,95%CI:-0.92-0.02,p = 0.04) was associated with decreased agreement. There were no associations between number of years screening clinics were operational(beta = 0.01,95%CI: -0.01-0.03,p = 0.29), cumulative experience of nurse providers(beta = 0.04,95%CI:-0.03-0.12,p = 0.19) and agreement. There were no significant increases in weighted kappa statistics over time for all sites considered. Monthly variations were significant for only one of two sites considered in time series models (AR1 term = -0.40, 95%CI:-0.71-0.09,p = 0.01). Conclusion Our results showed a lack of objectivity, persistent variation and lack of convergence of diagnostic capabilities of nurse led VIA cervical cancer screening with the diagnostic capabilities of a specialist in a cervical cancer screening program in Nigeria.	[Dareng, Eileen O.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Dareng, Eileen O.; Odutola, Michael K.; Famooto, Ayotunde; Dakum, Patrick S.; Adebamowo, Clement A.] Inst Human Virol Nigeria, Dept Strateg Informat & Res, Abuja, Nigeria; [Olaniyan, Yinka] Natl Hosp, Dept Obstet & Gynaecol, Abuja, Nigeria; [Adebamowo, Sally N.; Adebamowo, Clement A.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Adebamowo, Sally N.; Adebamowo, Clement A.] Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Offiong, Richard] Univ Abuja, Dept Obstet & Gynaecol, Teaching Hosp, Gwagwalada, Abuja, Nigeria; [Obende, Kayode] Garki Hosp Abuja, Dept Obstet & Gynaecol, Abuja, Nigeria; [Adewole, Stephen A.] Mother & Child Hosp Ondo, Dept Obstet & Gynaecol, Ondo, Nigeria; [Achara, Peter] Fed Med Ctr, Dept Obstet & Gynaecol, Keffi, Nigeria; [Adebamowo, Clement A.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	University of Cambridge; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Adebamowo, CA (corresponding author), Inst Human Virol Nigeria, Dept Strateg Informat & Res, Abuja, Nigeria.; Adebamowo, CA (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.; Adebamowo, CA (corresponding author), Univ Maryland, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.; Adebamowo, CA (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	cadebamowo@som.umaryland.edu	; Adebamowo, Clement/C-8778-2011	Odutola, Michael/0000-0002-3612-3702; Adebamowo, Clement/0000-0002-6571-2880; Dareng, Eileen/0000-0003-0802-419X	United States National Institute of Health (NIH) grants Capacity Development for Research in AIDS Associated Malignancies [ID43CA153792]; African Collaborative Center for Microbiome and Genomics Research [U54HG006947]; President's Emergency Fund for AIDS Relief (PEPFAR) grant - AIDS Care and Treatment in Nigeria (ACTIONPlus) - United States Centers for Disease Control and Prevention (CDC) [PS000651]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006947] Funding Source: NIH RePORTER	United States National Institute of Health (NIH) grants Capacity Development for Research in AIDS Associated Malignancies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); African Collaborative Center for Microbiome and Genomics Research; President's Emergency Fund for AIDS Relief (PEPFAR) grant - AIDS Care and Treatment in Nigeria (ACTIONPlus) - United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was funded by the United States National Institute of Health (NIH) grants Capacity Development for Research in AIDS Associated Malignancies (ID43CA153792) to CAA; African Collaborative Center for Microbiome and Genomics Research (U54HG006947) to CAA and the President's Emergency Fund for AIDS Relief (PEPFAR) grant - AIDS Care and Treatment in Nigeria (ACTIONPlus) which is supported by the United States Centers for Disease Control and Prevention (CDC) (Cooperative Agreement No PS000651) to PSD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adefuye PO, 2015, INT J GYNECOL OBSTET, V129, P62, DOI 10.1016/j.ijgo.2014.10.032; Ajenifuja KO, 2013, INT J GYNECOL CANCER, V23, P507, DOI 10.1097/IGC.0b013e318280f395; Almonte M, 2007, INT J CANCER, V121, P796, DOI 10.1002/ijc.22757; Almonte M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115355; Altobelli E, 2015, INT J GYNECOL CANCER, V25, P474, DOI 10.1097/IGC.0000000000000374; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Chigbu CO, 2017, NIGER J CLIN PRACT, V20, P239, DOI 10.4103/1119-3077.187315; DeGregorio G, 2017, ONCOLOGIST, V22, P850, DOI 10.1634/theoncologist.2016-0383; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Ferlay J, 2014, GLOBOCAN 2012 V1 0 C, V11; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Global Burden of Disease Cancer Collaboration, 2017, JAMA Oncol, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Jeronimo J, 2017, J GLOB ONCOL, V3, P635, DOI 10.1200/JGO.2016.006577; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lantz CA, 1996, J CLIN EPIDEMIOL, V49, P431, DOI 10.1016/0895-4356(95)00571-4; Parham GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122169; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sherris J, 2009, INT PERSPECT SEX R H, V35, P147, DOI [10.1363/3514709, 10.1363/ifpp.35.147.09]; WHO, 2014, COMPR CERV CANC CONT	21	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208531	10.1371/journal.pone.0208531	http://dx.doi.org/10.1371/journal.pone.0208531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521595	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600086
J	Wang, LG; Yu, Y; Tao, T; Zhang, JY; Gao, WB				Wang, Ligang; Yu, Yan; Tao, Ting; Zhang, Jingyi; Gao, Wenbin			The self-care dilemma of type 2 diabetic patients: The mechanism of self-regulation resource depletion	PLOS ONE			English	Article							STRENGTH MODEL; COGNITIVE CONTROL; EGO DEPLETION; FAILURE; BEHAVIORS; MEMORY; LIFE	Self-care is important for type 2 diabetes mellitus (T2DM) patients' disease prognosis, but there is a common phenomenon of self-regulation failure in T2DMs. In order to figure this problem out, the current study explored the interaction between self-regulation resource depletion and diabetes self-care based on the limited resource model of self-regulation. 104 patients were surveyed using the Self-Regulatory Fatigue Scale (SRF-S) and the Diabetes Self-care Scale (DSCS) in study 1. Study 2 recruited 30 T2DM patients and 30 healthy controls, and used a sequential-task paradigm to test the effect of self-regulation resource depletion on them. Participants in study 3 were 60 T2DM patients under different levels of self-regulation resource depletion manipulation, and their self-regulation performance was recorded and compared. Study 1 indicated that the correlation between self-regulation resource depletion and exercise and diet was significant and negative, suggesting that patients with greater self-regulation resource depletion performed poorly in exercise and diet. In Study 2, T2DM patients exhibited a poorer performance on the Spatial Incompatibility Task than the participants in the control group, suggesting that their self-regulation resource was insufficient. Study 3 indicated that there was no difference in Spatial Incompatibility Task performance, reaction time or error number among patients who were requested to complete a dietary record for one week and patients who were only requested to record eating times. This research demonstrated that low levels of diabetes self-care execution was associated with patients' deficiency in self-regulatory resource, and self-care as a series of goal-directed behaviors consumed patients' self-regulatory resources before these behaviors became a habit.	[Wang, Ligang; Yu, Yan; Tao, Ting; Zhang, Jingyi; Gao, Wenbin] Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China; [Wang, Ligang; Yu, Yan; Tao, Ting; Zhang, Jingyi; Gao, Wenbin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, WB (corresponding author), Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China.; Gao, WB (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	gaowb@psych.ac.cn		Gao, Wenbin/0000-0002-6526-5013	National Natural Science Foundation of China [31400885]; Foundation for Cooperation between Hebei Province and University [130000115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Cooperation between Hebei Province and University	This work was supported by the National Natural Science Foundation of China (No. 31400885; URL: http://www.nsfc.gov.cn/publish/portal1/).The work was also supported by the Foundation for Cooperation between Hebei Province and University (No. 130000115; URL: http://www.hebjh.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausili D, 2016, INT J NURS STUD, V63, P18, DOI 10.1016/j.ijnurstu.2016.08.006; Bagozzi RP, 2004, BASIC APPL SOC PSYCH, V26, P199, DOI 10.1207/s15324834basp2602&3_7; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Biessels GJ, 2014, DIABETES, V63, P2244, DOI 10.2337/db14-0348; Burkard C, 2014, NEUROPSYCHOL REHABIL, V24, P266, DOI 10.1080/09602011.2014.887023; Dahm T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026351; Dang JH, 2013, CONSCIOUS COGN, V22, P816, DOI 10.1016/j.concog.2013.05.005; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; de Bresser J, 2010, DIABETES CARE, V33, P1309, DOI 10.2337/dc09-1923; Denson TF, 2010, J EXP SOC PSYCHOL, V46, P1023, DOI 10.1016/j.jesp.2010.05.023; DERIDDER DTD, 2012, TAKING STOCK OF SELF, V16, P76, DOI DOI 10.1177/1088868311418749; Detweiler-Bedell JB, 2008, CLIN PSYCHOL REV, V28, P1426, DOI 10.1016/j.cpr.2008.09.002; Ginis KAM, 2010, PSYCHOL HEALTH, V25, P1147, DOI 10.1080/08870440903111696; Hagger MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076888; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hagger MS, 2009, HEALTH PSYCHOL REV, V3, P208, DOI 10.1080/17437190903414387; Heatherton TF, 1998, PSYCHOL INQ, V9, P212, DOI 10.1207/s15327965pli0903_4; Hofmann W, 2012, PSYCHOL SCI, V23, P582, DOI 10.1177/0956797612437426; Hofmann W, 2009, J EXP SOC PSYCHOL, V45, P431, DOI 10.1016/j.jesp.2008.09.013; Hurley A C, 1992, Diabetes Educ, V18, P146, DOI 10.1177/014572179201800208; Jostmann NB, 2007, J EXP PSYCHOL GEN, V136, P593, DOI 10.1037/0096-3445.136.4.593; Kargar Jahromi Marzieh, 2014, Glob J Health Sci, V7, P10, DOI 10.5539/gjhs.v7n1p10; Liu Y, 2011, JILIN MED J, V32, P5738; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Monette MCE, 2014, CAN J DIABETES, V38, P401, DOI 10.1016/j.jcjd.2014.01.014; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Muraven M, 1999, J SOC PSYCHOL, V139, P446, DOI 10.1080/00224549909598404; Nes LS, 2010, PAIN, V151, P37, DOI 10.1016/j.pain.2010.05.009; Pan J, 2006, J NURSING SCI, V21, P7; Pare G, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1357; Saleh F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-431; Shah AK, 2012, SCIENCE, V338, P682, DOI 10.1126/science.1222426; Shmueli D, 2009, HEALTH PSYCHOL, V28, P300, DOI 10.1037/a0013826; SN L, 2013, J PAIN RES; van den Berg E, 2010, DIABETOLOGIA, V53, P58, DOI 10.1007/s00125-009-1571-9; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Wagner DD, 2013, PSYCHOL SCI, V24, P2262, DOI 10.1177/0956797613492985; Walker RJ, 2014, ETHNIC DIS, V24, P349; Wang LG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142220; [王利刚 Wang LiGang], 2015, [中国心理卫生杂志, Chinese Mental Health Journal], V29, P290; Wang Q., 2009, J NURS SCI, V24, P14; Williams IC, 2014, DIABETES EDUCATOR, V40, P231, DOI 10.1177/0145721713520570; Wills TA, 2007, J ADOLESCENT HEALTH, V41, P551, DOI 10.1016/j.jadohealth.2007.06.013; Yu Pingping, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P425, DOI 10.3969/j.issn.1672-7347.2013.04.015; Yuan C, 2014, EFFECT DIABETES SELF, V2014, DOI [10.1155/2014/789761, DOI 10.1155/2014/789761]	45	4	4	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208690	10.1371/journal.pone.0208690	http://dx.doi.org/10.1371/journal.pone.0208690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521626	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600103
J	Yang, Z; Qu, CB; Zhang, Y; Zhang, WF; Wang, DD; Gao, CC; Ma, L; Chen, JS; Liu, KL; Zheng, B; Zhang, XH; Zhang, ML; Wang, XL; Wen, JK; Li, W				Yang, Zhan; Qu, Chang-Bao; Zhang, Yong; Zhang, Wen-Feng; Wang, Dan-Dan; Gao, Chun-Cheng; Ma, Long; Chen, Jin-Suo; Liu, Kai-Long; Zheng, Bin; Zhang, Xin-Hua; Zhang, Man-Li; Wang, Xiao-Lu; Wen, Jin-Kun; Li, Wei			Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULAR RNA; REVEALS; THERAPY; P53; PROTOCADHERINS; METHYLATION; EXPRESSION; ANGIOMOTIN; MIGRATION	p53, circRNAs and miRNAs are important components of the regulatory network that activates the EMT program in cancer metastasis. In prostate cancer (PCa), however, it has not been investigated whether and how p53 regulates EMT by circRNAs and miRNAs. Here we show that a Amotll-derived circRNA, termed circAMOTL1L, is downregulated in human PCa, and that decreased circAMOTL1L facilitates PCa cell migration and invasion through downregulating E-cadherin and upregulating vimentin, thus leading to EMT and PCa progression. Mechanistically, we demonstrate that circAMOTL1L serves as a sponge for binding miR-193a-5p in PCa cells, relieving miR-193a-5p repression of Pcdha gene cluster (a subset of the cadherin superfamily members). Accordingly, dysregulation of the circAMOTL1L-miR-193a-5p-Pcdha8 regulatory pathway mediated by circAMOTL1L downregulation contributes to PCa growth in vivo. Further, we show that RBM25 binds directly to circAMOTL1L and induces its biogenesis, whereas p53 regulates EMT via direct activation of RBM25 gene. These findings have linked p53/RBM25-mediated circAMOTL1L-miR-193a-5p-Pcdha regulatory axis to EMT in metastatic progression of PCa. Targeting this newly identified regulatory axis provides a potential therapeutic strategy for aggressive PCa.	[Yang, Zhan; Qu, Chang-Bao; Zhang, Yong; Zhang, Wen-Feng; Wang, Dan-Dan; Gao, Chun-Cheng; Ma, Long; Chen, Jin-Suo; Liu, Kai-Long; Wang, Xiao-Lu; Li, Wei] Hebei Med Univ, Dept Urol, Hosp 2, 215 Heping W Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Yang, Zhan; Zheng, Bin; Zhang, Xin-Hua; Zhang, Man-Li; Wen, Jin-Kun] Hebei Med Univ, Dept Biochem & Mol Biol, Minist Educ China, 361 Zhongshan E Rd, Shijiazhuang 050017, Hebei, Peoples R China; [Yang, Zhan] Hebei Med Univ, Dept Sci & Technol, Hosp 2, 215 Heping W Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Zhang, Man-Li] Hebei Med Univ, Dept Emergency Med, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Ministry of Education, China; Hebei Medical University; Hebei Medical University	Wang, XL; Li, W (corresponding author), Hebei Med Univ, Dept Urol, Hosp 2, 215 Heping W Rd, Shijiazhuang 050000, Hebei, Peoples R China.; Wen, JK (corresponding author), Hebei Med Univ, Dept Biochem & Mol Biol, Minist Educ China, 361 Zhongshan E Rd, Shijiazhuang 050017, Hebei, Peoples R China.	wx12106@126.com; wjk@hebmu.edu.cn; Weill_hb2h@163.com	Yang, Zhan/GQG-9995-2022	Wen, Jinkun/0000-0002-8453-4549; Yang, Zhan/0000-0001-7191-2910	National Natural Science Foundation of China [81672555, 81600237]; Hebei Province Natural Science Foundation [H2017206032]; Higher Education Science and Technology Research Project of Hebei Province [BJ2018001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Natural Science Foundation(Natural Science Foundation of Hebei Province); Higher Education Science and Technology Research Project of Hebei Province	We thank Dr. Yu-mei Ma (Department of Pathology, The Second Hospital of Hebei Medical University) for scoring PCa histology and pathological analysis. We are grateful to Hao Huang (Leica, China) and Qian Du (Biocaring Biotechnology Co., Ltd, Shijiazhuang) for technical support. This study was partially supported by The National Natural Science Foundation of China (No. 81672555 and 81600237), Hebei Province Natural Science Foundation (H2017206032), and Higher Education Science and Technology Research Project of Hebei Province (No. BJ2018001).	Amini-Nik S, 2014, J CLIN INVEST, V124, P2599, DOI 10.1172/JCI62059; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Banelli B, 2012, LAB INVEST, V92, P458, DOI 10.1038/labinvest.2011.169; Biferi MG, 2017, MOL THER, V25, P2038, DOI 10.1016/j.ymthe.2017.05.017; Carlson SM, 2017, J BIOL CHEM, V292, P13381, DOI 10.1074/jbc.M117.784371; Castellanos JA, 2013, ONCOTARGETS THER, V6, P1261, DOI 10.2147/OTT.S34670; Chen YH, 2016, J MED GENET, V53, P359, DOI 10.1136/jmedgenet-2016-103758; Cho HJ, 2014, CANCER DISCOV, V4, P318, DOI 10.1158/2159-8290.CD-13-0346; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Dallosso AR, 2012, ONCOGENE, V31, P4409, DOI 10.1038/onc.2011.609; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Ebbesen KK, 2016, BBA-GENE REGUL MECH, V1859, P163, DOI 10.1016/j.bbagrm.2015.07.007; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Guo F, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-19; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Han MH, 2010, MOL CELL PROTEOMICS, V9, P71, DOI 10.1074/mcp.M900343-MCP200; Han ZW, 2018, CANCER RES, V78, P2550, DOI 10.1158/0008-5472.CAN-17-1575; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Keeler AB, 2015, CELL ADHES MIGR, V9, P214, DOI 10.1080/19336918.2014.1000069; Khan MAF, 2016, CIRC RES, V119, P996, DOI 10.1161/CIRCRESAHA.116.309568; Kong Z, 2017, BIOCHEM BIOPH RES CO, V493, P1217, DOI 10.1016/j.bbrc.2017.07.162; Lee HM, 2017, MOL CELL ENDOCRINOL, V457, P103, DOI 10.1016/j.mce.2016.12.026; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2017, MOL CELL, V67, P214, DOI 10.1016/j.molcel.2017.05.023; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Matsumoto A, 2009, INT J UROL, V16, P687, DOI 10.1111/j.1442-2042.2009.02341.x; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Ortiz A, 2015, FASEB J, V29, P1080, DOI 10.1096/fj.14-261594; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ren D, 2013, INT J ONCOL, V42, P1473, DOI 10.3892/ijo.2013.1825; Sun Y, 2017, CIRC RES, V121, P628, DOI 10.1161/CIRCRESAHA.117.311441; Waha A, 2005, NEOPLASIA, V7, P193, DOI 10.1593/neo.04490; Wang LZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6909; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wetherill YB, 2006, MOL CANCER THER, V5, P3181, DOI 10.1158/1535-7163.MCT-06-0272; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang W, 2016, ONCOGENE, V35, P3919, DOI 10.1038/onc.2015.460; Yang Z, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0649-3; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zeng Y, 2017, THERANOSTICS, V7, P3842, DOI 10.7150/thno.19764; Zhang GW, 2018, BIOMED PHARMACOTHER, V97, P736, DOI 10.1016/j.biopha.2017.10.163; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	54	90	94	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2516	2532		10.1038/s41388-018-0602-8	http://dx.doi.org/10.1038/s41388-018-0602-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30531834	Green Published, hybrid			2022-12-26	WOS:000463335200006
J	Yan, JK; Zhang, T; Dai, LN; Gu, BL; Zhu, J; Yan, WH; Cai, W; Wang, Y				Yan, Jun-Kai; Zhang, Tian; Dai, Li-Na; Gu, Bei-Lin; Zhu, Jie; Yan, Wei-Hui; Cai, Wei; Wang, Ying			CELF1/p53 axis: a sustained antiproliferative signal leading to villus atrophy under total parenteral nutrition	FASEB JOURNAL			English	Article						IEC proliferation; RNA binding protein	CUG-BINDING PROTEIN-1; EPITHELIAL-CELL PROLIFERATION; MESSENGER-RNA; MOUSE MODEL; DOWN-REGULATION; CACO-2 CELLS; CANCER-CELLS; E-CADHERIN; APOPTOSIS; TRANSLATION	Intestinal villus atrophy is a major complication of total parenteral nutrition (TPN). Our previous study revealed that TPN-induced villus atrophy is accompanied by elevated expression of CUGBP, Elav-like family member 1 (CELF1); however, its mechanism of action has not been fully understood. Herein, we report a pivotal role of CELF1/p53 axis, which induces a sustained antiproliferative signal, leading to suppressed proliferation of intestinal epithelial cells (IECs). By using a rat model of TPN, we found synchronous upregulation of CELF1 and p53 in jejunum mucosa, accompanied by a 51% decrease in crypt cell proliferation rate. By using HCT-116 cells as an IEC model in vitro, we found that the expression of CELF1 altered dynamically in parallel to proliferation rate, suggesting a self-adaptive expression pattern in IECs in vitro. Furthermore, ectopic overexpression of CELF1 elicited a significant antiproliferative effect in HCT-116, Caco-2, and IEC-6 cells, whereas knockdown of CELF1 elicited a significant proproliferative effect. Moreover, cell-cycle assay revealed that ectopic overexpression of CELF1 induced sustained G2 arrest and G1 arrest in HCT-116 and IEC-6 cells, respectively, which could be abolished by p53 silencing. Mechanistically, polysomal profiling and nascent protein analysis revealed that regulation of p53 by CELF1 was mediated through accelerating its protein translation in polysomes. Taken together, our findings revealed a sustained suppression of IEC proliferation evoked by CELF1/p53 axis, which may be a potential therapeutic target for the treatment of TPN-induced villus atrophy.Yan, J.-K., Zhang, T., Dai, L.-N., Gu, B.-L., Zhu, J., Yan, W.-H., Cai, W., Wang, Y. CELF1/p53 axis: a sustained antiproliferative signal leading to villus atrophy under total parenteral nutrition.	[Yan, Jun-Kai; Zhang, Tian; Dai, Li-Na; Gu, Bei-Lin; Zhu, Jie; Yan, Wei-Hui; Cai, Wei; Wang, Ying] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai, Peoples R China; [Yan, Jun-Kai; Gu, Bei-Lin; Cai, Wei; Wang, Ying] Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Cai, W; Wang, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Xin Hua Hosp,Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	caiw204@sjtu.edu.cn; wangying02@xinhuamed.com.cn			Shanghai Municipal Commission of Health and Family Planning [20184Y0337]; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [17DZ2272000]; National Natural Science Foundation of China [81630039, 81700787]	Shanghai Municipal Commission of Health and Family Planning; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shanghai Municipal Commission of Health and Family Planning (20184Y0337); Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition (17DZ2272000); and National Natural Science Foundation of China [81630039 (to W.C.) and 81700787 (to Y.K.Y.)]. The authors declare no conflicts of interest.	Belcheva A, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600200; Braga M, 2009, CLIN NUTR, V28, P378, DOI 10.1016/j.clnu.2009.04.002; Breaux M, 2015, MOL CELL BIOL, V35, P3005, DOI 10.1128/MCB.00421-15; BROOK, 1992, CELL, V69, P385; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang ET, 2012, BIOCHEM J, V446, P113, DOI 10.1042/BJ20120112; Cui YH, 2012, MOL BIOL CELL, V23, P151, DOI 10.1091/mbc.E11-05-0456; Dupont A, 2014, GUT MICROBES, V5, P761, DOI 10.4161/19490976.2014.972238; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Feng YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG236, DOI 10.1152/ajpgi.00142.2011; Feng YJ, 2010, AM J PHYSIOL-GASTR L, V298, pG833, DOI 10.1152/ajpgi.00030.2010; Feng YJ, 2009, J PHYSIOL-LONDON, V587, P641, DOI 10.1113/jphysiol.2008.162719; Freeman JJ, 2015, FASEB J, V29, P2943, DOI 10.1096/fj.14-269480; Grossmann J, 1998, AM J PATHOL, V153, P53, DOI 10.1016/S0002-9440(10)65545-9; Hansraj NZ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12858; He C, 2017, GASTROENTEROLOGY, V152, P1434, DOI 10.1053/j.gastro.2017.01.049; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Jain AK, 2012, AM J PHYSIOL-GASTR L, V302, pG218, DOI 10.1152/ajpgi.00280.2011; Jones K, 2012, AGEING RES REV, V11, P442, DOI 10.1016/j.arr.2012.02.007; Kim HH, 2008, MOL CELL, V29, P151, DOI 10.1016/j.molcel.2008.01.005; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18174; Liu JB, 2011, ARCH ANIM NUTR, V65, P376, DOI 10.1080/1745039X.2011.594352; Liu L, 2015, MOL BIOL CELL, V26, P1797, DOI 10.1091/mbc.E14-11-1500; Liu L, 2014, MOL BIOL CELL, V25, P3308, DOI 10.1091/mbc.E14-03-0853; Natarajan G, 2008, AM J PHYSIOL-GASTR L, V294, pG1235, DOI 10.1152/ajpgi.00037.2008; Nightingale J, 2006, GUT S4, V55, piv1, DOI [10.1136/gut.2006.091108, DOI 10.1136/GUT.2006.091108]; Oste M, 2010, BRIT J NUTR, V104, P989, DOI 10.1017/S0007114510001613; Qi LW, 2015, AM J CHINESE MED, V43, P743, DOI 10.1142/S0192415X15500469; Ray RM, 2001, AM J PHYSIOL-GASTR L, V281, pG37, DOI 10.1152/ajpgi.2001.281.1.G37; Ray RM, 1999, AM J PHYSIOL-CELL PH, V276, pC684, DOI 10.1152/ajpcell.1999.276.3.C684; Rowland KJ, 2008, MOL CELL ENDOCRINOL, V288, P63, DOI 10.1016/j.mce.2008.02.014; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Shalimar, 2013, ARCH PATHOL LAB MED, V137, P1262, DOI 10.5858/arpa.2012-0354-OA; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Talwar S, 2013, RNA BIOL, V10, P277, DOI 10.4161/rna.23315; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timmons Jennifer, 2012, J Gastrointest Dig Syst, V2; Tolhurst Gwen, 2012, Handb Exp Pharmacol, P309, DOI 10.1007/978-3-642-24716-3_14; Vincent A, 2015, STEM CELL RES, V14, P105, DOI 10.1016/j.scr.2014.12.002; Vlasova IA, 2008, RNA BIOL, V5, P201, DOI 10.4161/rna.7056; Wang JY, 2007, AMINO ACIDS, V33, P241, DOI 10.1007/s00726-007-0518-z; Wang J. Y., 2017, WILEY INTERDISCIP RE, V8; Wang XF, 2016, THORAC CANCER, V7, P32, DOI 10.1111/1759-7714.12268; Wu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep10501; Xiao L, 2014, CURR OPIN PHARMACOL, V19, P46, DOI 10.1016/j.coph.2014.07.006; Xiao L, 2011, MOL BIOL CELL, V22, P3055, DOI 10.1091/mbc.E11-01-0069; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yan JK, 2018, J CELL MOL MED, V22, P1562, DOI 10.1111/jcmm.13430; Yan JK, 2017, CELL PHYSIOL BIOCHEM, V41, P711, DOI 10.1159/000458430; Yan JK, 2016, CELL PHYSIOL BIOCHEM, V39, P1581, DOI 10.1159/000447860; Yu TX, 2016, AM J PHYSIOL-CELL PH, V310, pC54, DOI 10.1152/ajpcell.00112.2015; Zhou Y, 2014, CELL BIOL INT, V38, P1408, DOI 10.1002/cbin.10356; Zhu J., 2016, JPEN J PARENTER ENTE, V42, P436	55	4	4	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3378	3391		10.1096/fj.201801695R	http://dx.doi.org/10.1096/fj.201801695R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30514107	Bronze			2022-12-26	WOS:000459794800025
J	Adame-Garcia, SR; Cervantes-Villagrana, RD; Orduna-Castillo, LB; del Rio, JC; Gutkind, JS; Reyes-Cruz, G; Taylor, SS; Vazquez-Prado, J				Rafael Adame-Garcia, Sendi; Daniel Cervantes-Villagrana, Rodolfo; Beatriz Orduna-Castillo, Lennis; del Rio, Jason C.; Gutkind, J. Silvio; Reyes-Cruz, Guadalupe; Taylor, Susan S.; Vazquez-Prado, Jose			cAMP-dependent activation of the Rac guanine exchange factor P-REX1 by type I protein kinase A (PKA) regulatory subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); protein kinase A (PKA); G protein-coupled receptor (GPCR); guanine nucleotide exchange factor (GEF); cell signaling; cell migration; endothelial cell; Rac (Rac GTPase); heterotrimeric G protein; chemotaxis; EP2 receptors; P-REX1; regulatory subunit alpha (RI alpha); Rho guanine nucleotide exchange factor (RhoGEF); wound healing	CELL-MIGRATION; MAMMALIAN TARGET; RI-ALPHA; ACRODYSOSTOSIS; LOCALIZATION; EXPRESSION; SUBSTRATE; RECEPTOR; GPCR	Regulatory subunits of protein kinase A (PKA) inhibit its kinase subunits. Intriguingly, their potential as cAMP-dependent signal transducers remains uncharacterized. We recently reported that type I PKA regulatory subunits (RI alpha) interact with phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchange factor 1 (P-REX1), a chemotactic Rac guanine exchange factor (RacGEF). Because P-REX1 is known to be phosphorylated and inhibited by PKA, its interaction with RI alpha suggests that PKA regulatory and catalytic subunits may fine-tune P-REX1 activity or those of its target pools. Here, we tested whether RI alpha acts as a cAMP-dependent factor promoting P-REX1-mediated Rac activation and cell migration. We observed that G(s)-coupled EP2 receptors indeed promote endothelial cell migration via RI alpha-activated P-REX1. Expression of the P-REX1-PDZ1 domain prevented RI alpha/P-REX1 interaction, P-REX1 activation, and EP2-dependent cell migration, and P-REX1 silencing abrogated RI alpha-dependent Rac activation. RI alpha-specific cAMP analogs activated P-REX1, but lost this activity in RI alpha-knockdown cells, and cAMP pulldown assays revealed that P-REX1 preferentially interacts with free RI alpha. Moreover, purified RI alpha directly activated P-REX1 in vitro. We also found that the RI alpha CNB-B domain is critical for the interaction with P-REX1, which was increased in RI alpha mutants, such as the acrodysostosis-associated mutant, that activate P-REX1 at basal cAMP levels. RI alpha and C alpha PKA subunits targeted distinct P-REX1 molecules, indicated by an absence of phosphorylation in the active fraction of P-REX1. This was in contrast to the inactive fraction in which phosphorylated P-REX1 was present, suggesting co-existence of dual stimulatory and inhibitory effects. We conclude that PKA's regulatory subunits are cAMP-dependent signal transducers.	[Rafael Adame-Garcia, Sendi; Beatriz Orduna-Castillo, Lennis; Reyes-Cruz, Guadalupe] IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07360, DF, Mexico; [Daniel Cervantes-Villagrana, Rodolfo; Vazquez-Prado, Jose] IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Pharmacol, Mexico City 07360, DF, Mexico; [Gutkind, J. Silvio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [del Rio, Jason C.; Gutkind, J. Silvio; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Vazquez-Prado, J (corresponding author), IPN, CINVESTAV, Dept Pharmacol, Ave Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico.	jvazquez@cinvestav.mx	Gutkind, J. Silvio/J-1201-2016; Cervantes-Villagrana, Rodolfo Daniel/T-6458-2019; VAZQUEZ-PRADO, JOSE/C-1630-2017; Cervantes-Villagrana, Rodolfo Daniel/E-6804-2019	Gutkind, J. Silvio/0000-0002-5150-4482; VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643; Cervantes-Villagrana, Rodolfo Daniel/0000-0002-6599-7994; Del Rio, Jason/0000-0001-8540-2065; Orduna Castillo, Lennis Beatriz/0000-0001-7013-861X	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [286274, 240119]; National Institutes of Health [R01 GM34921]; National Institutes of Health/NCI Grant [CA221289]; NATIONAL CANCER INSTITUTE [R01CA221289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NCI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) Grants 286274 (to J. V.-P.) and 240119 (to G. R.-C.) and National Institutes of Health Grant R01 GM34921 (to S. S. T). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by fellowships from CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico).; Supported by the National Institutes of Health/NCI Grant CA221289.	Ledezma-Sanchez BA, 2010, BIOCHEM BIOPH RES CO, V391, P1647, DOI 10.1016/j.bbrc.2009.12.108; Bachmann VA, 2016, P NATL ACAD SCI USA, V113, P7786, DOI 10.1073/pnas.1608061113; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; BOSHART M, 1991, CELL, V66, P849, DOI 10.1016/0092-8674(91)90432-X; Bruystens JGH, 2016, J MOL BIOL, V428, P4890, DOI 10.1016/j.jmb.2016.10.033; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chavez-Vargas L, 2016, J BIOL CHEM, V291, P6182, DOI 10.1074/jbc.M115.712216; Cervantes-Villagrana RD, 2019, J BIOL CHEM, V294, P531, DOI 10.1074/jbc.RA118.006254; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; Hernandez-Garcia R, 2015, VASC PHARMACOL, V74, P60, DOI 10.1016/j.vph.2015.10.003; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Keshwani MM, 2015, P NATL ACAD SCI USA, V112, P12681, DOI 10.1073/pnas.1516057112; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Guzman-Hernandez ML, 2009, J BIOL CHEM, V284, P18334, DOI 10.1074/jbc.M109.008839; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Pan DX, 2016, J BIOL CHEM, V291, P6359, DOI 10.1074/jbc.M115.686592; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Torres-Quesada O, 2017, CELL SIGNAL, V37, P1, DOI 10.1016/j.cellsig.2017.05.012; Vazquez-Prado J, 2016, MOL PHARMACOL, V90, P573, DOI 10.1124/mol.116.105338; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Yang LH, 2014, J NEUROSCI, V34, P4896, DOI 10.1523/JNEUROSCI.3460-13.2014	34	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2232	2246		10.1074/jbc.RA118.006691	http://dx.doi.org/10.1074/jbc.RA118.006691			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30530493	hybrid, Green Published			2022-12-26	WOS:000458895400002
J	Son, S; Bowie, LE; Maiuri, T; Hung, CLK; Desmond, CR; Xia, JR; Truant, R				Son, Susie; Bowie, Laura E.; Maiuri, Tamara; Hung, Claudia L. K.; Desmond, Carly R.; Xia, Jianrun; Truant, Ray			High-mobility group box 1 links sensing of reactive oxygen species by huntingtin to its nuclear entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington disease; nuclear transport; reactive oxygen species (ROS); oxidative stress; DNA damage; neurodegenerative disease; high-mobility group box protein; N17 domain; PY-NLS; ROS sensing	N-17 DOMAIN; HMGB1; ASSOCIATION; PROTEINS; IDENTIFICATION; LOCALIZATION; AGGREGATION; INTERACTS; BINDING; STRESS	Huntington's disease (HD) is a neurodegenerative, age-onset disorder caused by a CAG DNA expansion in exon 1 of the HTT gene, resulting in a polyglutamine expansion in the huntingtin protein. Nuclear accumulation of mutant huntingtin is a hallmark of HD, resulting in elevated mutant huntingtin levels in cell nuclei. Huntingtin is normally retained at the endoplasmic reticulum via its N17 amphipathic -helix domain but is released by oxidation of Met-8 during reactive oxygen species (ROS) stress. Huntingtin enters the nucleus via an importin 1- and 2-dependent proline-tyrosine nuclear localization signal (PY-NLS), which has a unique intervening sequence in huntingtin. Here, we have identified the high-mobility group box 1 (HMGB1) protein as an interactor of the intervening sequence within the PY-NLS. Nuclear levels of HMGB1 positively correlated with varying levels of nuclear huntingtin in both HD and normal human fibroblasts. We also found that HMGB1 interacts with the huntingtin N17 region and that this interaction is enhanced by the presence of ROS and phosphorylation of critical serine residues in the N17 region. We conclude that HMGB1 is a huntingtin N17/PY-NLS ROS-dependent interactor, and this protein bridging is essential for relaying ROS sensing by huntingtin to its nuclear entry during ROS stress. ROS may therefore be a critical age-onset stress that triggers nuclear accumulation of mutant huntington in Huntington's disease.	[Son, Susie; Bowie, Laura E.; Maiuri, Tamara; Hung, Claudia L. K.; Desmond, Carly R.; Xia, Jianrun; Truant, Ray] McMaster Univ, Dept Biochem & Biomed Res, Hamilton, ON L8S 4L8, Canada	McMaster University	Truant, R (corresponding author), HSC4N54 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	truantr@mcmaster.ca	Surette, Michael G/AAE-8825-2020	Maiuri, Tamara/0000-0002-6103-5835; Hung, Claudia Lin-Kar/0000-0003-4811-5280	Canadian Institutes of Health Research Project [MOP-119391]; Krembil Foundation; Huntington Society of Canada	Canadian Institutes of Health Research Project(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Huntington Society of Canada	This work was supported by Canadian Institutes of Health Research Project Grant MOP-119391, The Krembil Foundation, and the Huntington Society of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Anggayasti WL, 2016, BBA-PROTEINS PROTEOM, V1864, P1620, DOI 10.1016/j.bbapap.2016.07.008; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Bowles KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144864; BROUILLET E, 1993, J NEUROCHEM, V60, P356, DOI 10.1111/j.1471-4159.1993.tb05859.x; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Correia K, 2015, J HUNTINGTONS DIS, V4, P279, DOI 10.3233/JHD-150169; Desmond Carly R, 2013, Commun Integr Biol, V6, pe23318, DOI 10.4161/cib.23318; Desmond CR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412379; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DiGiovanni LF, 2016, HUM MOL GENET, V25, P3937, DOI 10.1093/hmg/ddw234; Dintilhac A, 2002, J BIOL CHEM, V277, P7021, DOI 10.1074/jbc.M108417200; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Farg MA, 2017, HUM MOL GENET, V26, P2882, DOI 10.1093/hmg/ddx170; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Fujita Kyota, 2017, Brain Nerve, V69, P925, DOI 10.11477/mf.1416200844; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Han YH, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002063; He SJ, 2017, ONCOTARGET, V8, P64534, DOI 10.18632/oncotarget.17885; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hung CLK, 2018, MOL BIOL CELL, V29, P2809, DOI 10.1091/mbc.E18-09-0590; Ito H, 2015, EMBO MOL MED, V7, P78, DOI 10.15252/emmm.201404392; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Knapp S, 2004, BIOCHEMISTRY-US, V43, P11992, DOI 10.1021/bi049364k; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Maiuri T, 2017, HUM MOL GENET, V26, P395, DOI 10.1093/hmg/ddw395; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Michalek M, 2013, BIOPHYS J, V105, P699, DOI 10.1016/j.bpj.2013.06.030; Moss DJH, 2017, LANCET NEUROL, V16, P701, DOI 10.1016/S1474-4422(17)30161-8; Nath S, 2015, HUM MOL GENET, V24, P450, DOI 10.1093/hmg/ddu460; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Vezzoli M, 2010, ANN NY ACAD SCI, V1209, P83, DOI 10.1111/j.1749-6632.2010.05748.x; Walker C, 2017, NAT NEUROSCI, V20, P1225, DOI 10.1038/nn.4604; Wang J, 2013, BIOCHEM BIOPH RES CO, V441, P701, DOI 10.1016/j.bbrc.2013.10.085; YU SS, 1977, EUR J BIOCHEM, V78, P497, DOI 10.1111/j.1432-1033.1977.tb11762.x	44	9	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1915	1923		10.1074/jbc.RA117.001440	http://dx.doi.org/10.1074/jbc.RA117.001440			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30538129	Green Published, hybrid			2022-12-26	WOS:000459711400012
J	Bandivadekar, RR; Pandit, PS; Sollmann, R; Thomas, MJ; Logan, SM; Brown, JC; Klimley, AP; Tell, LA				Bandivadekar, Ruta R.; Pandit, Pranav S.; Sollmann, Rahel; Thomas, Michael J.; Logan, Scott M.; Brown, Jennifer C.; Klimley, A. Peter; Tell, Lisa A.			Use of RFID technology to characterize feeder visitations and contact network of hummingbirds in urban habitats	PLOS ONE			English	Article							SURVIVAL; TERRITORIAL; POXVIRUS; TORPOR; FLIGHT; RATES; FOOD; MASS	Despite the popular use of hummingbird feeders, there are limited studies evaluating the effects of congregation, sharing food resources and increased contact when hummingbirds visit feeders in urban landscapes. To evaluate behavioral interactions occurring at feeders, we tagged 230 individuals of two species, Anna's and Allen's Hummingbirds, with passive integrated transponder tags and recorded their visits with RFID transceivers at feeders. For detecting the presence of tagged birds, we developed an RFID equipped feeding station using a commercially available antenna and RFID transceiver. Data recorded included the number of feeder visits, time spent at the feeder, simultaneous feeder visitation by different individuals, and identifying which feeders were most commonly visited by tagged birds. For the study period (September 2016 to March 2018), 118,017 detections were recorded at seven feeding stations located at three California sites. The rate of tagged birds returning to RFID equipped feeders at least once was 61.3% (141/230 birds). Females stayed at feeders longer than males per visit. We identified primary, secondary and tertiary feeders at Sites 2 and 3, according to the frequency of visitation to them, with a mean percentage of 86.9% (SD +/- 19.13) visits to a primary feeder for each tagged hummingbird. During spring and summer, hummingbirds visited feeders most often in morning and evening hours. Feeder visits by males overlapped in time with other males more frequently than other females. The analysis of the contact network at the feeders did not distinguish any significant differences between age or sex. Although most hummingbirds visited the feeders during the daytime, our system recorded night feeder visitations (n = 7 hummingbirds) at one site. This efficient use of RFID technology to characterize feeder visitations and contact networks of hummingbirds in urban habitats could be used in the future to elucidate behaviors, population dynamics and community structure of hummingbirds visiting feeders.	[Bandivadekar, Ruta R.; Tell, Lisa A.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Pandit, Pranav S.] Univ Calif Davis, Sch Vet Med, EpiCenter Dis Dynam, One Hlth Inst, Davis, CA 95616 USA; [Sollmann, Rahel; Thomas, Michael J.; Klimley, A. Peter] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Logan, Scott M.] Wild Wings Ecol, Sherman Oaks, CA USA; [Brown, Jennifer C.] US Fish & Wildlife Serv, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of the Interior; US Fish & Wildlife Service	Tell, LA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	latell@ucdavis.edu	Pandit, Pranav/H-7484-2019	Pandit, Pranav/0000-0001-7649-0649	Daniel and Susan Gottlieb Foundation; Glide Foundation; Zoological Society of San Diego; UC Davis Interdisciplinary Research Grant Award	Daniel and Susan Gottlieb Foundation; Glide Foundation; Zoological Society of San Diego; UC Davis Interdisciplinary Research Grant Award	Funding for this project was provided by The Daniel and Susan Gottlieb Foundation, Glide Foundation, Zoological Society of San Diego, and a UC Davis Interdisciplinary Research Grant Award (Tell). The funders provided support in the form of salaries for one author [RRB] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wild Wings Ecology provided support in the form of salary for author SML but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adelman JS, 2015, P R SOC B; [Anonymous], 2017, R LANG ENV STAT COMP; BARTHOLOMEW GEORGE A., 1957, CONDOR, V59, P145, DOI 10.2307/1364720; Becker DJ, 2018, PHIL T R SOC B; Blake JG, 2008, BIOTROPICA, V40, P485, DOI 10.1111/j.1744-7429.2007.00395.x; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brewer LW, 2011, J WILDLIFE MANAGE, V75, P1664, DOI 10.1002/jwmg.222; Brittingham M.C., 1988, Passenger Pigeon, V50, P195; Burnham K P, 2003, MODEL SELECT MULTIMO; Camfield AF, 2006, J FIELD ORNITHOL, V77, P120, DOI 10.1111/j.1557-9263.2006.00031.x; Charette Y, TRACKING HUMMINGBIRD; Civitello DJ, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0101; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Cox DTC, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0092; Craft M.E., 2015, PHIL T R SOC B, V370; Craft ME, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0107; Rodrigues LD, 2013, ACTA ORNITHOL, V48, P211, DOI 10.3161/000164513X678801; Dale T., 2012, DO HUMMINGBIRDS FLY; DOCHERTY DE, 1986, J WILDLIFE DIS, V22, P420, DOI 10.7589/0090-3558-22.3.420; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Galbraith JA, 2015, P NATL ACAD SCI USA, V112, pE2648, DOI 10.1073/pnas.1501489112; GILL FB, 1988, ECOLOGY, V69, P1933, DOI 10.2307/1941170; Godoy LA, 2014, J ORNITHOL, V155, P1, DOI 10.1007/s10336-013-0990-z; Godoy LA, 2013, J WILDLIFE DIS, V49, P978, DOI 10.7589/2012-09-230; GOERTZ JW, 1980, WILSON BULL, V92, P398; HAINSWORTH FR, 1977, PHYSIOL ZOOL, V50, P215, DOI 10.1086/physzool.50.3.30155724; HIEBERT SM, 1991, CONDOR, V93, P526, DOI 10.2307/1368184; Hilton B, 2003, CONDOR, V105, P54, DOI 10.1650/0010-5422(2003)105[54:ASARIR]2.0.CO;2; Hou LL, 2015, J AVIAN BIOL, V46, P1, DOI 10.1111/jav.00478; HUDSON C. B., 1957, CORNELL VET, V47, P394; Ibarra V, 2015, SENSORS-BASEL, V15, P31751, DOI 10.3390/s151229886; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Laake JL, 2013, METHODS ECOL EVOL, V4, P885, DOI 10.1111/2041-210X.12065; LASIEWSKI ROBERT C., 1963, PHYSIOL ZOOL, V36, P122; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; McClintock BT, 2009, BIOMETRICS, V65, P237, DOI 10.1111/j.1541-0420.2008.01047.x; Mulvihill RS, 1987, BIRD BANDING POWDERM; OTIS DL, 1978, WILDLIFE MONOGR, P1; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Powers DR, 2003, PHYSIOL BIOCHEM ZOOL, V76, P389, DOI 10.1086/374286; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Russell SM., 2001, N AM BANDERS MANUAL; Schuchmann K.-L., 1983, Bonner Zoologische Beitraege, V34, P273; Smith WL, 2005, INT J SERVICES STAND, V2, P1, DOI DOI 10.1504/IJSS.2006.008156; Sorensen A, 2014, PREV VET MED, V113, P356, DOI 10.1016/j.prevetmed.2013.11.010; Strandin T, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0088; SUAREZ RK, 1992, EXPERIENTIA, V48, P565, DOI 10.1007/BF01920240; WELLS DJ, 1993, J EXP BIOL, V178, P59; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilkie D, 1983, RAYLEIGH TEST RANDOM	52	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208057	10.1371/journal.pone.0208057	http://dx.doi.org/10.1371/journal.pone.0208057			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540787	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600053
J	Cho, YK; Nam, CW; Koo, BK; Schulman-Marcus, J; Hartaigh, BO; Gransar, H; Lu, Y; Achenbach, S; Al-Mallah, M; Andreini, D; Bax, JJ; Budoff, MJ; Cademartiri, F; Callister, TQ; Chang, HJ; Chinnaiyan, K; Chow, BJW; Cury, RC; Delago, A; Feuchtner, G; Hadamitzky, M; Hausleiter, J; Kaufmann, PA; Kim, YJ; Leipsic, J; Maffei, E; Marques, H; Pontone, G; Raff, GL; Rubinshtein, R; Shaw, LJ; Villines, TC; Berman, DS; Jones, EC; Pena, JM; Lin, FY; Min, JK				Cho, Yun-Kyeong; Nam, Chang-Wook; Koo, Bon-Kwon; Schulman-Marcus, Joshua; Hartaigh, Briain O.; Gransar, Heidi; Lu, Yao; Achenbach, Stephan; Al-Mallah, Mouaz; Andreini, Daniele; Bax, Jeroen J.; Budoff, Matthew J.; Cademartiri, Filippo; Callister, Tracy Q.; Chang, Hyuk-Jae; Chinnaiyan, Kavitha; Chow, Benjamin J. W.; Cury, Ricardo C.; Delago, Augustin; Feuchtner, Gudrun; Hadamitzky, Martin; Hausleiter, Joerg; Kaufmann, Philipp A.; Kim, Yong-Jin; Leipsic, Jonathon; Maffei, Erica; Marques, Hugo; Pontone, Gianluca; Raff, Gilbert L.; Rubinshtein, Ronen; Shaw, Leslee J.; Villines, Todd C.; Berman, Daniel S.; Jones, Erica C.; Pena, Jessica M.; Lin, Fay Y.; Min, James K.			Usefulness of baseline statin therapy in non-obstructive coronary artery disease by coronary computed tomographic angiography: From the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) study	PLOS ONE			English	Article							PROGNOSTIC VALUE; PRIMARY PREVENTION; RISK PREDICTION; CARDIAC EVENTS; CALCIUM SCORE; EXTENT	Background The extent to which the presence and extent of subclinical atherosclerosis by coronary computed tomography angiography influences a potential mortality benefit of statin is unknown. We evaluated the relationship between statin therapy, mortality, and subclinical atherosclerosis. Methods In the CONFIRM study, patients with normal or non-obstructive plaque (<50% diameter stenosis) for whom data on baseline statin use was available were included. Coronary artery calcium (CAC) was quantified using the Agatston score. The extent of non-obstructive coronary atherosclerosis was quantified using the segment involvement score (SIS). 8,016 patients were followed for a median of 2.5 years with analysis of all-cause mortality and major adverse cardiac events (MACE) including all-cause mortality, myocardial infarction, unstable angina, target vessel revascularization, and coronary artery disease-related hospitalization. Results 1.2% of patients experienced all-cause mortality. Patients not on baseline statin therapy had a stepwise increased risk of all-cause mortality by CAC (relative to CAC = 0; CAC 1-99: hazard ratio [HR] 1.65, CAC 100-299: HR 2.19, and CAC >= 300: HR 2.98) or SIS (relative to SIS = 0; SIS 1: HR 1.62, SIS 2-3: 2.48 and SIS >= 4: 2.95). Conversely, in patients on baseline statin therapy, there was no significant increase in mortality risk with increasing CAC (p value for interaction = 0.049) or SIS (p value for interaction = 0.007). The incidence of MACE was 2.1%. Similar to the all-cause mortality, the risk of MACE was increased with CAC or SIS strata in patient not on baseline statin therapy. However, this relation was not observed in patient on baseline statin therapy. Conclusion In individuals with non-obstructive coronary artery disease, increased risk of adverse events occurs with increasing CAC or SIS who are not on baseline statin therapy. Statin therapy is associated with a mitigation of risk of cardiac events in the presence of increasing atherosclerosis, with no particular threshold of disease burden.	[Cho, Yun-Kyeong; Nam, Chang-Wook] Keimyung Univ, Dongsan Med Ctr, Dept Cardiol, Daegu, South Korea; [Koo, Bon-Kwon; Kim, Yong-Jin] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Koo, Bon-Kwon; Kim, Yong-Jin] Seoul Natl Univ, Coll Med, Cardiovasc Ctr, Seoul, South Korea; [Schulman-Marcus, Joshua; Hartaigh, Briain O.; Shaw, Leslee J.; Jones, Erica C.; Pena, Jessica M.; Lin, Fay Y.; Min, James K.] NewYork Presbyterian Hosp, Dept Radiol, New York, NY 10034 USA; [Schulman-Marcus, Joshua; Hartaigh, Briain O.; Lu, Yao; Shaw, Leslee J.; Jones, Erica C.; Pena, Jessica M.; Lin, Fay Y.; Min, James K.] Weill Cornell Med Coll, New York, NY 10065 USA; [Gransar, Heidi] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Dept Imaging, Los Angeles, CA 90048 USA; [Lu, Yao] New York Presbyterian Hosp, Dept Healthcare Policy & Res, New York, NY USA; [Achenbach, Stephan] Friedrich Alexander Univ Erlangen Nuremburg, Dept Cardiol, Erlangen, Germany; [Al-Mallah, Mouaz] King Saud Bin Abdulaziz Univ Hlth Sci, Minist Natl Guard, King AbdulAziz Cardiac Ctr, King Abdullah Int Med Res Ctr,Hlth Affairs, Riyadh, Saudi Arabia; [Andreini, Daniele; Pontone, Gianluca] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Bax, Jeroen J.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Budoff, Matthew J.] Los Angeles Biomed Res Inst, Dept Med, Torrance, CA USA; [Cademartiri, Filippo] IRCCS, SDN, Cardiovasc Imaging Ctr, Naples, Italy; [Callister, Tracy Q.] Tennessee Heart & Vasc Inst, Hendersonville, TN USA; [Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Yonsei Univ, Coll Med, Div Cardiol,Severance Cardiovasc Hosp, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Chinnaiyan, Kavitha; Raff, Gilbert L.] William Beaumont Hosp, Div Cardiol, Royal Oak, MI 48072 USA; [Chow, Benjamin J. W.] Univ Ottawa, Dept Med & Radiol, Ottawa, ON, Canada; [Cury, Ricardo C.] Miami Cardiac & Vasc Inst, Dept Radiol, Miami, FL USA; [Delago, Augustin] Capitol Cardiol Associates, Albany, NY USA; [Feuchtner, Gudrun] Med Univ Innsbruck, Dept Radiol, Innsbruck, Austria; [Hadamitzky, Martin] German Heart Ctr Munich, Dept Radiol & Nucl Med, Munich, Germany; [Hausleiter, Joerg] Ludwig Maximilians Univ Munchen, Med Klin, Munich, Germany; [Kaufmann, Philipp A.] Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland; [Leipsic, Jonathon] Univ British Columbia, Dept Med & Radiol, Vancouver, BC, Canada; [Maffei, Erica] Area Vasta 1 ASUR Marche, Dept Radiol, Urbino, Italy; [Marques, Hugo] Hosp Luz, Unit Cardiovasc Imaging, UNICA, Lisbon, Portugal; [Rubinshtein, Ronen] Technion Israel Inst Technol, Ruth & Bruce Rappaport Sch Med, Lady Davis Carmel Med Ctr, Dept Cardiol, Haifa, Israel; [Villines, Todd C.] Walter Reed Natl Mil Ctr, Serv Cardiol, Bethesda, MD USA; [Berman, Daniel S.] Cedars Sinai Med Ctr, Dept Imaging & Med, Los Angeles, CA 90048 USA	Keimyung University; Seoul National University (SNU); Seoul National University (SNU); NewYork-Presbyterian Hospital; Cornell University; Cedars Sinai Medical Center; NewYork-Presbyterian Hospital; University of Erlangen Nuremberg; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Cardiac Center (KACC); King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; IRCCS Centro Cardiologico Monzino; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Tennessee Heart & Vascular; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Beaumont Health; University of Ottawa; Baptist Cardiac & Vascular Institute; Medical University of Innsbruck; German Heart Centre Munich; University of Munich; University of Zurich; University Zurich Hospital; University of British Columbia; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Walter Reed National Military Medical Center; Cedars Sinai Medical Center	Nam, CW (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Cardiol, Daegu, South Korea.; Min, JK (corresponding author), NewYork Presbyterian Hosp, Dept Radiol, New York, NY 10034 USA.; Min, JK (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	ncwcv@dsmc.or.kr; jkm2001@med.cornell.edu	Budoff, Matthew/ABD-5175-2021; Hausleiter, Jörg/V-4206-2019; Lin, Fay/AAJ-9453-2021; Leipsic, Jonathon/ABE-6194-2020; Villines, Todd/AAJ-3744-2021; Cademartiri, Filippo/H-7336-2015; Maffei, Erica/J-2370-2016; Andreini, Daniele/ABG-9647-2020	Budoff, Matthew/0000-0002-9616-1946; Cademartiri, Filippo/0000-0002-0579-3279; Maffei, Erica/0000-0002-0388-4433; Chow, Benjamin/0000-0001-8631-0234; Nam, Chang-Wook/0000-0002-3370-5774; Marques, Hugo/0000-0001-8210-2075; Al-Mallah, Mouaz/0000-0003-2348-0484; Chang, Hyuk-Jae/0000-0002-6139-7545; Kaufmann, Philipp/0000-0002-9451-5210; Pontone, Gianluca/0000-0002-1339-6679	National Institute of Health (Bethesda, MD, USA) [R01HL115150]; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2012027176]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115150] Funding Source: NIH RePORTER	National Institute of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. James K. Min is supported by the National Institute of Health (Bethesda, MD, USA) under grant number R01HL115150 (https://www.nih.gov/grants-funding).This research was also supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) under grant No. 2012027176 to HJC (http://english.msip.go.kr/).This study was also funded, in part, by a generous gift from the Dalio Institute of Cardiovascular Imaging (New York, NY) and the Michael Wolk Foundation (New York, NY) (https://hearthealth.weillcornell.org/about-us/dalio-institute).	Abdulla J, 2011, INT J CARDIOVAS IMAG, V27, P413, DOI 10.1007/s10554-010-9652-x; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ahmed K, 2012, CIRC J, V76, P721, DOI 10.1253/circj.CJ-11-1013; Bittencourt MS, 2014, CIRC-CARDIOVASC IMAG, V7, P282, DOI 10.1161/CIRCIMAGING.113.001047; Chow BJW, 2015, ARTERIOSCL THROM VAS, V35, P981, DOI 10.1161/ATVBAHA.114.304351; de Azevedo CF, 2011, JACC-CARDIOVASC IMAG, V4, P740, DOI 10.1016/j.jcmg.2011.02.017; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; de Graaf MA, 2014, AM J CARDIOL, V113, P1947, DOI 10.1016/j.amjcard.2014.03.034; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Habib PJ, 2013, INT J CARDIOL, V169, P112, DOI 10.1016/j.ijcard.2013.08.096; Hoffmann H, 2010, EUR RADIOL, V20, P2824, DOI 10.1007/s00330-010-1880-x; Maddox TM, 2014, JAMA-J AM MED ASSOC, V312, P1754, DOI 10.1001/jama.2014.14681; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Min JK, 2014, ATHEROSCLEROSIS, V232, P298, DOI 10.1016/j.atherosclerosis.2013.09.025; Min JK, 2011, J CARDIOVASC COMPUT, V5, P84, DOI 10.1016/j.jcct.2011.01.007; Nakazato R, 2014, EUR HEART J-CARD IMG, V15, P586, DOI 10.1093/ehjci/jet132; Nakazato R, 2012, ATHEROSCLEROSIS, V225, P148, DOI 10.1016/j.atherosclerosis.2012.08.002; Otagiri K, 2011, CIRC J, V75, P633, DOI 10.1253/circj.CJ-10-0600; PEDERSEN TR, 1994, LANCET, V344, P1383; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Schulman-Marcus J, 2016, JACC-CARDIOVASC IMAG, V9, P364, DOI 10.1016/j.jcmg.2016.02.010; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Zeb I, 2013, ATHEROSCLEROSIS, V231, P198, DOI 10.1016/j.atherosclerosis.2013.08.019	28	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207194	10.1371/journal.pone.0207194	http://dx.doi.org/10.1371/journal.pone.0207194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540755	gold, Green Published, Green Accepted			2022-12-26	WOS:000452898600009
J	Mindjah, YAA; Essiben, F; Foumane, P; Dohbit, JS; Mboudou, ET				Mindjah, Yvette Audrey Assouni; Essiben, Felix; Foumane, Pascal; Dohbit, Julius Sama; Mboudou, Emile Telesphore			Risk factors for ectopic pregnancy in a population of Cameroonian women: A case-control study	PLOS ONE			English	Article							LEVONORGESTREL EMERGENCY CONTRACEPTION; CILIARY BEAT; ADRENOMEDULLIN; ASSOCIATION; FREQUENCY; SMOKING	Objective To identify the risk factors for ectopic pregnancy (EP) in a population of Cameroonian women. Sample and methods We performed a matched case-control study; 88 women with diagnosed EP (cases), and 176 women with first trimester intrauterine pregnancy (IUP) (controls), who underwent questionnaires. Odds Ratio (OR) and 95% confidence intervals (Cis) were calculated and adjusted for potential confounding factors via multivariate logistic regression analysis. Results Of the fifteen identified risk factors, 4 were independently associated with increased odds of EP: prior pelvic inflammatory disease (PID) (adjusted odds ratio [AOR] 13.18; 95% CI 6.19-27.42), followed by current use of levonorgestrel-only pills for emergency contraception (LNG-EC) (AOR 10.15; 95% CI 2.21-46.56), previous use of depot medroxyprogesterone acetate (DMPA) (AOR 3.01; 95% CI 1.04-8.69) and smoking at the time of conception (AOR 2.68; 95% CI 1.12-6.40). Conclusion The present study confirms the wide variety of EP's risk factors. Moreover, some new findings including current use of LNG-EC, previous use of DMPA, smoking at the time of conception are noteworthy. Thus, in our limited resources country where prevention remains the cornerstone for reducing EP chances of occurrence, clinicians should do enough counselling, especially to women with known risk factors. The necessity to facilitate access to more equipment to enable early diagnosis of EP is very crucial and should be seriously considered, in order to reduce the burden of EP in Cameroonian women.	[Mindjah, Yvette Audrey Assouni] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Essiben, Felix; Foumane, Pascal; Dohbit, Julius Sama; Mboudou, Emile Telesphore] Univ Yaounde I, Fac Med & Biomed Sci, Dept Obstet & Gynaecol, Yaounde, Cameroon	University of Yaounde I; University of Yaounde I	Mindjah, YAA (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.	amyt.2017@gmail.com		ASSOUNI, Audrey/0000-0002-2448-6987				Abubakar P, 2012, ANN NIGERIAN MED, V6, P87, DOI DOI 10.4103/0331-3131.108128; Adewunmi A., 2015, OPEN J OBSTET GYNECO, V5, P115; Agholor K, 2013, AFR HEALTH SCI, V13, P430, DOI 10.4314/ahs.v13i2.33; Ahman E, 2004, 4 WHO, P13; American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V111, P1479, DOI 10.1097/AOG.0b013e31817d201e; Ankum WM, 1996, FERTIL STERIL, V65, P1093, DOI 10.1016/S0015-0282(16)58320-4; Anorlu RI, 2005, ACTA OBSTET GYN SCAN, V84, P184, DOI 10.1111/j.0001-6349.2005.00684.x; ARAL SO, 1992, REPROD BIOL, P185; Atrash HK, 1997, OBSTET GYNECOL, V89, P512, DOI 10.1016/S0029-7844(97)00050-1; Barnhart KT, 2006, FERTIL STERIL, V86, P36, DOI 10.1016/j.fertnstert.2005.12.023; Bhuria V, 2016, INT J REPROD CONTRAC, V5, P2224; Bjartling C, 2000, ACTA OBSTET GYN SCAN, V79, P123, DOI 10.1034/j.1600-0412.2000.079002123.x; Bouyer J, 1998, REV EPIDEMIOL SANTE, V46, P93; Bouyer J, 2003, AM J EPIDEMIOL, V157, P185, DOI 10.1093/aje/kwf190; Bray Madoue G, 2016, GROSSESSE EXTRAUTERI; Cates Jr W., 1990, ADOLESCENT MED STATE, V1; CDC, 1990, MMWR-MORBID MORTAL W, V39, P929; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P46; Chiu PCN, 2010, ENDOCRINOLOGY, V151, P3336, DOI 10.1210/en.2010-0077; Der E M, 2013, Ghana Med J, V47, P158; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; Foumane P, 2010, CLIN MOTHER CHILD HL, V7, P452; Gervaise A, 2010, J GYNECOL OBST BIO R, V39, P17; Ghosh B, 2009, CONTRACEPTION, V79, P155, DOI 10.1016/j.contraception.2008.08.006; Goyaux N, 2003, ACTA OBSTET GYN SCAN, V82, P305, DOI 10.1034/j.1600-0412.2003.00175.x; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Ikeme A C C, 2005, J Obstet Gynaecol, V25, P596, DOI 10.1080/01443610500239552; Institut National de la Statistique (INS), 2013, NOM CAM MET; Institut National de la Statistique (INS) ICF International, 2012, 5 INS ICF, P103; Kamwendo F, 2000, SEX TRANSM INFECT, V76, P28, DOI 10.1136/sti.76.1.28; Li C, 2014, PLOS ONE, V9; Li C, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0613-1; Li HWR, 2010, J CLIN ENDOCR METAB, V95, pE18, DOI 10.1210/jc.2010-0273; Li YY, 2008, BIOL REPROD, V79, P200, DOI 10.1095/biolreprod.107.064022; Marinoni E, 2000, REGUL PEPTIDES, V87, P15, DOI 10.1016/S0167-0115(99)00094-4; Nkwabong E, 2015, AFR J REPROD HEALTH, V19, P87; Omokanye L O, 2013, Niger Postgrad Med J, V20, P341; Paltieli Y, 2000, J ASSIST REPROD GEN, V17, P103, DOI 10.1023/A:1009465900824; Rongieres C, 2003, J GYNECOL OBST BIO R, V32, P83; Saraiya M, 1998, AM J OBSTET GYNECOL, V178, P493, DOI 10.1016/S0002-9378(98)70427-2; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Shao RJ, 2012, AM J TRANSL RES, V4, P269; Shaw JLV, 2010, AM J PATHOL, V177, P2509, DOI 10.2353/ajpath.2010.100243; Sheffer-Mimouni G, 2003, CONTRACEPTION, V67, P267, DOI 10.1016/S0010-7824(02)00539-5; Tebeu P-M, 2015, PAN AFR MED J, V21; Wanggren K, 2008, HUM REPROD, V23, P2359, DOI 10.1093/humrep/den260; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08487	47	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207699	10.1371/journal.pone.0207699	http://dx.doi.org/10.1371/journal.pone.0207699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540783	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600030
J	Ross, CT; Winterhalder, B				Ross, Cody T.; Winterhalder, Bruce			Evidence for encounter-conditional, area-restricted search in a preliminary study of Colombian blowgun hunters	PLOS ONE			English	Article							MARINE PREDATOR; FINE-SCALE; LEVY; STRATEGIES; PATTERNS; BEHAVIOR; CONTEXT; PREY	Active search for prey is energetically costly, so understanding how foragers optimize search has been central to foraging theory. Some theoretical work has suggested that foragers of randomly distributed prey should search using Levy flights, while work on area restricted and intermittent search strategies has demonstrated that foragers can use the information provided by prey encounters to more effectively adapt search direction and velocity. Previous empirical comparisons of these search modes have tended to rely on distribution -level analyses, due to the difficulty of collecting event-level data on encounters linked to the GPS tracks of foragers. Here we use a preliminary event-level data-set (18.7 hours of encounter-annotated focal follows over 6 trips) to show that two Colombian blowgun hunters use adaptive encounter-conditional heuristics, not non-conditional Levy flights, when searching for prey. Using a theoretically derived Bayesian model, we estimate changes in turning-angle and search velocity as a function of encounters with prey at lagged time-steps, and find that: 1) hunters increase average turning-angle in response to encounters, producing a more tortuous search of patches of higher prey density, but adopt more efficient uni-directional, inter-patch movement after failing to encounter prey over a sufficient period of time; and, 2) hunters reduce search velocity in response to encounters, causing them to spend more of their search time in patches with demonstrably higher prey density. These results illustrate the importance of using event-level data to contrast encounter-conditional, area-restricted search and Levy flights in explaining the search behavior of humans and other organisms.	[Ross, Cody T.] Max Planck Inst Evolutionary Anthropol, Dept Human Behav Ecol & Culture, Leipzig, Germany; [Winterhalder, Bruce] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA	Max Planck Society; University of California System; University of California Davis	Ross, CT (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Behav Ecol & Culture, Leipzig, Germany.	cody_ross@eva.mpg.de		Ross, Cody/0000-0002-0067-4799	Max Planck Institute for Evolutionary Anthropology, Department of Human Behavior, Ecology and Culture	Max Planck Institute for Evolutionary Anthropology, Department of Human Behavior, Ecology and Culture	This research was supported by the Max Planck Institute for Evolutionary Anthropology, Department of Human Behavior, Ecology and Culture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvard M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115552; [Anonymous], 2021, LANG ENV STAT COMP; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; BENEDIX JH, 1993, BEHAV ECOL, V4, P318, DOI 10.1093/beheco/4.4.318; Benhamou S, 2015, J THEOR BIOL, V387, P221, DOI 10.1016/j.jtbi.2015.09.034; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gomez V Zuluaga, 1988, HIST COMUNIDAD INDIG; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Hamilton James D., 1994, TIME SERIES ANAL, V2; Hill S, 2000, J FISH BIOL, V56, P1497; Hills TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060488; Humphries NE, 2014, J THEOR BIOL, V358, P179, DOI 10.1016/j.jtbi.2014.05.032; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kolzsch A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0424; Martinez-Garcia R, 2017, SCI REP-UK, V7, DOI 10.1038/srep40029; Martinez-Garcia R, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032718; Martinez-Garcia R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.248106; McElreath R, 2018, STAT RETHINKING BAYE; Miramontes O, 2012, HUM ECOL, V40, P167, DOI 10.1007/s10745-012-9465-8; Pearce- Duvet JM, 2011, BEHAV ECOLOGY; Plank MJ, 2009, ECOLOGY, V90, P3546, DOI 10.1890/09-0079.1; Pyke GH, 2015, METHODS ECOL EVOL, V6, P1, DOI 10.1111/2041-210X.12298; Raichlen DA, 2014, P NATL ACAD SCI USA, V111, P728, DOI 10.1073/pnas.1318616111; Reynolds A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199099; Reynolds A, 2015, PHYS LIFE REV, V14, P59, DOI 10.1016/j.plrev.2015.03.002; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Rodriguez JP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00165-0; Ross C, 2018, J THEOR BIOL, V455, P357, DOI 10.1016/j.jtbi.2018.07.031; Ross CT, 2015, J THEOR BIOL, V387, P76, DOI 10.1016/j.jtbi.2015.09.022; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Stan Development Team, 2016, RSTAN R INT STAN; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weisstein EW, 2002, POLAR COORDINATES; Wosniack ME, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005774	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207633	10.1371/journal.pone.0207633	http://dx.doi.org/10.1371/journal.pone.0207633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540780	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600026
J	Tambo, M; Mwinga, M; Mumbengegwi, DR				Tambo, Munyaradzi; Mwinga, Mary; Mumbengegwi, Davis R.			Loop-mediated isothermal amplification (LAMP) and Polymerase Chain Reaction (PCR) as quality assurance tools for Rapid Diagnostic Test (RDT) malaria diagnosis in Northern Namibia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PERFORMANCE; INFECTIONS; KIT	Malaria cases sometimes go undetected using RDTs due to their inaccurate use, poor storage conditions and failure to detect low parasitaemia (<50parasites/mu L). This could result in continuous transmission of malaria and sustenance of parasite reservoirs. Molecular diagnostic tools are more sensitive and specific than RDTs in the detection of plasmodium parasites. However, the Polymerase Chain Reaction (PCR) is not routinely used because equipment and reagents are expensive and requires highly skilled personnel. Loop-mediated isothermal amplification (LAMP) is a relatively new molecular diagnostic tool for malaria with all the advantages of PCR (sensitive and specific) without the mentioned disadvantages. However, it has not been evaluated extensively as a point of care diagnostic in the field. One hundred and fifteen used RDTs were collected from health facilities in Northern Namibia in a blind study and PCR and LAMP were used to determine the presence of Plasmodium DNA. The sensitivities and PPV were 40.91% and 90% respectively for RDTs, 72.73% and 100% respectively for PCR with LAMP as the golden standard. In low malaria transmission settings, LAMP can be also be considered for use as a surveillance tool to detect all sources of malaria and determine proportion of low parasitaemia infections in order to eliminate them.	[Tambo, Munyaradzi; Mumbengegwi, Davis R.] Univ Namibia, Multidisciplinary Res Ctr, Sci Technol & Innovat Div, Windhoek, Namibia; [Mwinga, Mary] Univ Namibia, Dept Biol Sci, Windhoek, Namibia	University of Namibia; University of Namibia	Mumbengegwi, DR (corresponding author), Univ Namibia, Multidisciplinary Res Ctr, Sci Technol & Innovat Div, Windhoek, Namibia.	dmumbengegwi@unam.na		Tambo, Munyaradzi/0000-0002-5707-6335	Directorate of Research Science and Technology, Ministry of Education, Namibia	Directorate of Research Science and Technology, Ministry of Education, Namibia	The funding to carry out this research was obtained from the Directorate of Research Science and Technology, Ministry of Education, Namibia. There was no grant number and the Directorate has since been replaced by the National Commission for Research Science and Technology. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Auala JR, 2016, INVESTIGATION EPIDEM; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Cojoc D, 2012, BIOMED OPT EXPRESS, V3, P991, DOI 10.1364/BOE.3.000991; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Das S, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2268-7; Gonzalez I. J, 2012, MOL DIAGNOSIS SCR S1, V11; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hsiang M. S., 2014, J INFECT DIS, P1; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-6; Landier J, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00565-18, 10.1128/jcm.00565-18]; Lee EH, 2017, HEALTH POLICY PLANN, V32, P75, DOI 10.1093/heapol/czx114; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Mace KE, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6707a1; Mumbengegwi DR, 2018, PUBLIC HEALTH ACTION, V8, pS44, DOI 10.5588/pha.17.0077; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ocker R, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658027, 10.1590/s1678-9946201658027]; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Rabinovich RN, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002456; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Tadesse FG, 2018, CLIN INFECT DIS, V66, P1883, DOI 10.1093/cid/cix1123; Tambo M, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2399-x; Van den Broek I, 2006, AM J TROP MED HYG, V75, P1209, DOI 10.4269/ajtmh.2006.75.1209; Wilson ML, 2013, ARCH PATHOL LAB MED, V137, P805, DOI 10.5858/arpa.2011-0602-RA; World Health Organization, 2016, WORLD MAL REP FACT S; Wu L, 2015, NATURE, V528, pS86, DOI 10.1038/nature16039; 2010, WORLD MAL REP 2010, P1	30	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0206848	10.1371/journal.pone.0206848	http://dx.doi.org/10.1371/journal.pone.0206848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540744	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600005
J	Liu, Z; Zang, XN; Cao, XX; Wang, ZD; Liu, C; Sun, DG; Guo, YL; Zhang, F; Yang, Q; Hou, P; Pang, CH				Liu, Zhu; Zang, Xiaonan; Cao, Xuexue; Wang, Zhendong; Liu, Chang; Sun, Deguang; Guo, Yalin; Zhang, Feng; Yang, Qin; Hou, Pan; Pang, Chunhong			Cloning of the pks3 gene of Aurantiochytrium limacinum and functional study of the 3-ketoacyl-ACP reductase and dehydratase enzyme domains	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; DOCOSAHEXAENOIC-ACID; TRANSGENE EXPRESSION; SCHIZOCHYTRIUM; SYSTEM; OMEGA-3-FATTY-ACIDS; OVEREXPRESSION; TRANSFORMATION; INFLAMMATION; MICROALGA	Aurantiochytrium limacinum has received attention because of its abundance of polyunsaturated fatty acids (PUFAs), particularly docosahexaenoic acid (DHA). DHA is synthesized through the polyketide synthase (PKS) pathway in A. limacinum. The related enzymes of the PKS pathway are mainly expressed by three gene clusters, called pks1, pks2 and pks3. In this study, the full-length pks3 gene was obtained by polymerase chain reaction amplification and Genome Walking technology. Based on a domain analysis of the deduced amino acid sequence of the pks3 gene, 3-ketoacyl-ACP reductase (KR) and dehydratase (DH) enzyme domains were identified. Herein, A. limacinum OUC168 was engineered by gene knock-in of KR and DH using the 18S rDNA sequence as the homologous recombination site. Total fatty acid contents and the degree of unsaturation of total fatty acids increased after the kr or dh gene was knocked in. The cloning and functional study of the pks3 gene of A. limacinum establishes a foundation for revealing the DHA synthetic pathway. Gene knock-in of the enzyme domain associated with PKS synthesis has the potential to provide effective recombinant strains with higher DHA content for industrial applications.	[Liu, Zhu; Zang, Xiaonan; Cao, Xuexue; Wang, Zhendong; Liu, Chang; Sun, Deguang; Guo, Yalin; Zhang, Feng; Yang, Qin; Hou, Pan; Pang, Chunhong] Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao, Peoples R China	Ocean University of China	Liu, Z (corresponding author), Ocean Univ China, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao, Peoples R China.	xnzang@ouc.edu.cn			National Natural Science Foundation of China [31872555, 31472255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (Grant No. 31872555 and Grant No. 31472255). The recipient is Xiaonan Zang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Natural Science Foundation of China (Grant No. 31872555 and Grant No. 31472255).	Cao YJ, 2010, APPL MICROBIOL BIOT, V87, P271, DOI 10.1007/s00253-009-2377-x; Cheng RB, 2011, WORLD J MICROB BIOT, V27, P737, DOI 10.1007/s11274-010-0510-8; Cheng YR, 2016, ENZYME MICROB TECH, V93-94, P182, DOI 10.1016/j.enzmictec.2016.08.019; Cui GZ, 2016, ALGAL RES, V19, P138, DOI 10.1016/j.algal.2016.08.005; Das U., 2002, MED SCI MONITOR, V8, P79; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Gao M, 2013, J OLEO SCI, V62, P143, DOI 10.5650/jos.62.143; Hirota K, 2005, INT J SYST EVOL MICR, V55, P2355, DOI 10.1099/ijs.0.63804-0; Jacobs MN, 2004, J AGR FOOD CHEM, V52, P1780, DOI 10.1021/jf035310q; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kristan K, 2009, CHEM-BIOL INTERACT, V178, P310, DOI 10.1016/j.cbi.2008.09.030; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; La R., 2012, BMC RES NOTES, V5, P1, DOI [10.1186/1756-0500-5-1, DOI 10.1186/1756-0500-5-1]; Lai XJ, 2014, RUSS J PLANT PHYSL+, V61, P298, DOI 10.1134/S1021443714030078; Li M, 2018, J INTEGR AGR, V17, P530, DOI [10.1016/S2095-3119(17)61721-0, 10.1016/s2095-3119(17)61721-0]; [李清 Li Qing], 2012, [武汉大学学报. 理学版, Journal of Wuhan University. Natural Science Edition], V58, P275; Lippmeier JC, 2009, LIPIDS, V44, P621, DOI 10.1007/s11745-009-3311-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorente-Cebrian S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4; Furlan VJM, 2017, BRAZ J MICROBIOL, V48, P359, DOI 10.1016/j.bjm.2017.01.001; Metz JG, 2009, PLANT PHYSIOL BIOCH, V47, P472, DOI 10.1016/j.plaphy.2009.02.002; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Morita N, 2000, BIOCHEM SOC T, V28, P943, DOI 10.1042/BST0280943; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Napier JA, 2001, LIPIDS, V36, P761, DOI 10.1007/s11745-001-0782-9; Oyola-Robles D, 2014, ENZYME MICROB TECH, V55, P133, DOI 10.1016/j.enzmictec.2013.10.010; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Qu L, 2013, APPL BIOCHEM BIOTECH, V171, P1865, DOI 10.1007/s12010-013-0456-z; Ren LJ, 2018, ALGAL RES, V29, P193, DOI 10.1016/j.algal.2017.11.021; Robinson LE, 2013, LIPIDS, V48, P319, DOI 10.1007/s11745-013-3774-6; Rogers LK, 2013, PHARMACOL RES, V70, P13, DOI 10.1016/j.phrs.2012.12.003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakaguchi K, 2012, APPL ENVIRON MICROB, V78, P3193, DOI 10.1128/AEM.07129-11; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Savary S, 2012, CURR DRUG METAB, V13, P1358, DOI 10.2174/138920012803762729; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Song XJ, 2013, J AGR FOOD CHEM, V61, P9876, DOI 10.1021/jf403153p; Sun HY, 2015, MOLECULES, V20, P10110, DOI 10.3390/molecules200610110; Wallis JG, 2002, TRENDS BIOCHEM SCI, V27, P467, DOI 10.1016/S0968-0004(02)02168-0; Wheeler David, 2007, V395, P149; Wu ST, 2005, PROCESS BIOCHEM, V40, P3103, DOI 10.1016/j.procbio.2005.03.007; Zhu L, 2014, APPL BIOCHEM MICRO+, V50, P411, DOI 10.1134/S0003683814040140	42	12	12	9	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208853	10.1371/journal.pone.0208853	http://dx.doi.org/10.1371/journal.pone.0208853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533058	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500043
J	Cobo-Angel, C; Jaramillo-Jaramillo, AS; Lasso-Rojas, LM; Aguilar-Marin, SB; Sanchez, J; Rodriguez-Lecompte, JC; Ceballos-Marquez, A; Zadoks, RN				Cobo-Angel, Claudia; Jaramillo-Jaramillo, Ana S.; Lasso-Rojas, Laura M.; Aguilar-Marin, Sandra B.; Sanchez, Javier; Rodriguez-Lecompte, Juan C.; Ceballos-Marquez, Alejandro; Zadoks, Ruth N.			Streptococcus agalactiae is not always an obligate intramammary pathogen: Molecular epidemiology of GBS from milk, feces and environment in Colombian dairy herds	PLOS ONE			English	Article							BULK TANK MILK; GROUP-B STREPTOCOCCUS; MASTITIS PATHOGENS; STAPHYLOCOCCUS-AUREUS; SOMATIC-CELL; BOVINE; CATTLE; PREVALENCE; MANAGEMENT; RESISTANCE	For many years Streptococcus agalactiae has been considered an obligate intramammary and strictly contagious pathogen in dairy cattle. However, recent reports of S. agalactiae isolation from extramammary sources have contradicted that premise. To gain further insight into the epidemiology of S. agalactiae infection in cattle, we examined its distribution and heterogeneity of strains in bovine milk, bovine feces, and the environment in Colombian dairy farms. First, a longitudinal study was conducted at herd level in 152 dairy herds. Bulk tank milk samples from each herd where collected twice a month for six months. A follow-up study with a cross sectional design at the cow level was conducted in a subset of 25 farms positive for S. agalactiae. Cow-level milk samples from 1712 lactatting cows and 1545 rectal samples were collected, as well as 120 environmental samples. Samples were used for S. agalactiae detection and genotyping using Multi Locus Sequence Typing. Results showed sporadic rather than repeated isolation of S. agalactiae from bulk tank milk in 40% of the positive herds, challenging the idea that S. agalactiae is a highly contagious pathogen causing chronic infections. S. agalactiae was isolated from rectal or environmental samples in 32% and 12% of cross-sectional study farms, respectively, demonstrating that the bacteria can survive in extramammary sources and that S. agalactiae is not an obligate intramammary pathogen. The same strain was isolated from rectal and bulk tank milk samples in eight farms, suggesting that fecal shedding is frequent, and contributes to the presence of S. agalactiae in bulk tank. High within-herd heterogeneity of strains was found, which is distinct from the situation in developed dairy industries. These new epidemiological findings should be considered to adjust surveillance and control recommendations for S. agalactiae.	[Cobo-Angel, Claudia; Jaramillo-Jaramillo, Ana S.; Lasso-Rojas, Laura M.; Aguilar-Marin, Sandra B.; Ceballos-Marquez, Alejandro] Univ Caldas, Fac Agr Sci, Res Grp Milk Qual & Vet Epidemiol, Manizales, Colombia; [Sanchez, Javier; Rodriguez-Lecompte, Juan C.] Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE, Canada; [Zadoks, Ruth N.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Zadoks, Ruth N.] Moredun Res Inst, Penicuik, Midlothian, Scotland	Universidad de Caldas; University of Prince Edward Island; University of Glasgow; Moredun Research Institute	Cobo-Angel, C (corresponding author), Univ Caldas, Fac Agr Sci, Res Grp Milk Qual & Vet Epidemiol, Manizales, Colombia.	claudia.cobo@ucaldas.edu.co	Rodriguez-Lecompte, Juan/AAN-4012-2020; sanchez, javier/AAA-4179-2022	CEBALLOS-MARQUEZ, ALEJANDRO/0000-0002-1835-3280; Zadoks, Ruth/0000-0002-1164-8000; Jaramillo-Jaramillo, Ana Soffia/0000-0002-0565-7867; Cobo-Angel, Claudia/0000-0002-1298-8402	Colciencias [811-2015]; Universidad de Caldas [1572916, 1647614]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Caldas	This study was funded by Colciencias (Grant 811-2015, http://www.colciencias.gov.co/) and Universidad de Caldas (Grants 1572916 and 1647614, http://www.ucaldas.edu.co). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2016, ENVIRON MICROBIOL, V18, P4216, DOI 10.1111/1462-2920.13550; Bi YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155621; Boers SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039630; Botelho ACN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196925; Carvalho-Castro GA, 2017, BRAZ J MICROBIOL, V48, P551, DOI 10.1016/j.bjm.2017.02.004; Crespo-Ortiz MDP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-428; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Evans JJ, 2008, J MED MICROBIOL, V57, P1369, DOI 10.1099/jmm.0.47815-0; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Flores AR, 2015, P NATL ACAD SCI USA, V112, P6431, DOI 10.1073/pnas.1504725112; Francoz D, 2012, CAN VET J, V53, P1071; Huijps K, 2008, J DAIRY RES, V75, P113, DOI 10.1017/S0022029907002932; Jayarao BM, 2004, J DAIRY SCI, V87, P3561, DOI 10.3168/jds.S0022-0302(04)73493-1; JENSEN NE, 1982, NORD VET MED, V34, P441; Jorgensen HJ, 2016, VET MICROBIOL, V184, P64, DOI 10.1016/j.vetmic.2015.12.014; Katholm J, 2012, J DAIRY SCI, V95, P5702, DOI 10.3168/jds.2011-5307; Keefe GP, 1997, CAN VET J, V38, P429; Keefe GP, 2010, PREVALENCE STREPTOCO; Keefe G, 2012, VET CLIN N AM-FOOD A, V28, P203, DOI 10.1016/j.cvfa.2012.03.010; Lancefield RC, 1934, J EXP MED, V59, P441, DOI 10.1084/jem.59.4.441; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lyhs U, 2016, EMERG INFECT DIS, V22, P2097, DOI 10.3201/eid2212.151447; Mahmmod YS, 2015, J DAIRY SCI, V98, P6913, DOI 10.3168/jds.2015-9397; Manning SD, 2008, CLIN INFECT DIS, V47, P388, DOI 10.1086/589864; Manning SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008795; Melin P, 2011, CLIN MICROBIOL INFEC, V17, P1294, DOI 10.1111/j.1469-0691.2011.03576.x; Middleton JR, 2002, EPIDEMIOL INFECT, V129, P387, DOI 10.1017/S095026880200746X; Moitoso M, 2016, VET REC OPEN, V3, P1, DOI [10.1136/vetreco-2016-000181, DOI 10.1136/VETRECO-2016-000181]; Phuektes P, 2001, J DAIRY SCI, V84, P1140, DOI 10.3168/jds.S0022-0302(01)74574-2; Reyes J, 2017, J DAIRY SCI, V100, P9294, DOI 10.3168/jds.2017-13363; Reyes J, 2017, VET J, V220, P34, DOI 10.1016/j.tvjl.2016.12.011; Riekerink RGMO, 2007, J DAIRY SCI, V90, P1704, DOI 10.3168/jds.2006-567; Rysanek D, 2009, J DAIRY RES, V76, P117, DOI 10.1017/S0022029908003816; Springman AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-159; Tenhagen BA, 2006, J DAIRY SCI, V89, P2542, DOI 10.3168/jds.S0022-0302(06)72330-X; Wang SM, 1999, EPIDEMIOL INFECT, V123, P317, DOI 10.1017/S0950268899002745; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067755; Zadoks RN, 2009, IRISH VET J, V62, P59, DOI 10.1186/2046-0481-62-S4-S59; Zadoks RN, 2005, VET MICROBIOL, V109, P257, DOI 10.1016/j.vetmic.2005.05.008; Zadoks RN, 2011, J MAMMARY GLAND BIOL, V16, P357, DOI 10.1007/s10911-011-9236-y	40	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208990	10.1371/journal.pone.0208990	http://dx.doi.org/10.1371/journal.pone.0208990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532177	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000452644700062
J	Kachel, S; Radtke, A; Skuk, VG; Zaske, R; Simpson, AP; Steffens, MC				Kachel, Sven; Radtke, Andre; Skuk, Verena G.; Zaeske, Romi; Simpson, Adrian P.; Steffens, Melanie C.			Investigating the common set of acoustic parameters in sexual orientation groups: A voice averaging approach	PLOS ONE			English	Article							FUNDAMENTAL-FREQUENCY; GENDER; GAY; ADAPTATION; ACCURACY; PITCH; STEREOTYPES; PERCEPTION; JUDGMENTS; SPEECH	While the perception of sexual orientation in voices often relies on stereotypes, it is unclear whether speech stereotypes and accurate perceptions of sexual orientation are each based on acoustic cues common to speakers of a given group. We ask if the stereotypical belief, that members of the same sexual orientation group share similar acoustic patterns, is accurate to some degree. To address this issue, we are the first to use a novel voice morphing technique to create voice averages from voices that represent extremes of a given sexual orientation group either in terms of actual or perceived sexual orientation. Importantly, averaging preserves only those acoustic cues shared by the original speakers. 144 German listeners judged the sexual orientation of twelve natural-sounding sentence stimuli, each representing an average of five original utterances. Half of the averages were based on targets' self-ratings of sexual orientation: On a 7-point Kinsey-like scale, we selected targets who were most typical for a certain sexual orientation group according to their self-identifications. The other half were based on extreme ratings by others (i.e., on speech-related sexual-orientation stereotypes). Listeners judged sexual orientation from the voice averages with above-chance accuracy suggesting 1) that the perception of actual and stereotypical sexual orientation, respectively, are based on acoustic cues shared by speakers of the same group, and 2) that the stereotypical belief that members of the same sexual orientation group share similar acoustic patterns is accurate to some degree. Mean fundamental frequency and other common acoustic parameters showed systematic variation depending on speaker gender and sexual orientation. Effects of sexual orientation were more pronounced for stereotypical voice averages than for those based on speakers' self-ratings, suggesting that sexual-orientation stereotypes exaggerate even those differences present in the most salient groups of speakers. Implications of our findings for stereotyping and discrimination are discussed.	[Kachel, Sven; Radtke, Andre; Skuk, Verena G.; Zaeske, Romi; Simpson, Adrian P.] Friedrich Schiller Univ Jena, Inst Psychol, DFG Res Unit Person Percept, Jena, Germany; [Kachel, Sven; Radtke, Andre; Steffens, Melanie C.] Univ Koblenz Landau, Dept Social Environm & Econ Psychol, Landau, Germany; [Skuk, Verena G.; Zaeske, Romi] Friedrich Schiller Univ Jena, Dept Gen Psychol & Cognit Neurosci, Inst Psychol, Jena, Germany; [Skuk, Verena G.; Zaeske, Romi] Jena Univ Hosp, Dept Otorhinolaryngol, Jena, Germany; [Simpson, Adrian P.] Friedrich Schiller Univ Jena, Dept German Linguist, Jena, Germany	Friedrich Schiller University of Jena; University of Koblenz & Landau; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kachel, S (corresponding author), Friedrich Schiller Univ Jena, Inst Psychol, DFG Res Unit Person Percept, Jena, Germany.; Kachel, S (corresponding author), Univ Koblenz Landau, Dept Social Environm & Econ Psychol, Landau, Germany.	sven.kachel@uni-jena.de		Kachel, Sven/0000-0002-4641-946X	Deutsche Forschungsgemeinschaft [DFG STE 938/10-2, FOR 1097]; German Research Foundation [DFG STE 938/10-2, FOR 1097]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	Melanie Steffens received funding from the Deutsche Forschungsgemeinschaft. Grant number: DFG STE 938/10-2; FOR 1097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The current research was funded by a grant from the German Research Foundation to the last two authors (DFG STE 938/10-2; FOR 1097). We thank Jorg Dreyer, Dr. Susanne Fuchs, and Dr. Stefanie Jannedy for providing the phonetic laboratory at the Zentrum fur Allgemeine Sprachwissenschaft in Berlin, we thank Rebecca Aust, Susanne Friedrich, Alexander Makosch, Sonja Gaukel, Felicia Schuld, Felix Sokoll, Karoline Nestler, and Anna Theresa Prokein for help with data collection, data pre-processing, and formatting of the manuscript. The authors declare no conflicts of financial, personal, or other interests.	Allport G. W., 1954, NATURE PREJUDICE; ARONOVITCH CD, 1976, J SOC PSYCHOL, V99, P207, DOI 10.1080/00224545.1976.9924774; Baeck H, 2011, J VOICE, V25, pE211, DOI 10.1016/j.jvoice.2010.10.019; Bailey JM, 2003, ANN M HUM BEH EV SOC; Bestelmeyer PEG, 2010, COGNITION, V117, P217, DOI 10.1016/j.cognition.2010.08.008; Boersma P., 2014, PRAAT DOING PHONETIC; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Camprubi M. G., 2011, THESIS, P1; Chiang S.-F., 2003, THESIS; Cox WTL, 2016, J SEX RES, V53, P157, DOI 10.1080/00224499.2015.1015714; Dekker A, 1999, Z SEX FORSCH, V12, P350; Eckert P, 2011, AM SPEECH, V86, P6, DOI 10.1215/00031283-1277465; Fai D, 1988, ACTES C TENDANCES AC, P35; Friedrich S, 2016, THESIS; GAUDIO RP, 1994, AM SPEECH, V69, P30, DOI 10.2307/455948; Jacobs G, 1996, AM SPEECH, V71, P49, DOI 10.2307/455469; JUDD CM, 1993, PSYCHOL REV, V100, P109, DOI 10.1037/0033-295X.100.1.109; JUDD CM, 1991, J PERS SOC PSYCHOL, V61, P366, DOI 10.1037/0022-3514.61.3.366; Kachel S, 2017, EXPRESSION PER UNPUB; Kachel S, 2017, THESIS; Kachel S, 2018, J SPEECH LANG HEAR R; Kachel S, 2017, J ACOUST SOC AM, V141, P4793, DOI 10.1121/1.4988684; Kachel S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00956; Kawahara H, 2013, 2013 AS SIGN INF; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; KITE ME, 1987, PSYCHOL WOMEN QUART, V11, P83, DOI 10.1111/j.1471-6402.1987.tb00776.x; LERMAN JW, 1969, FOLIA PHONIATR, V21, P340, DOI 10.1159/000263268; Lick DJ, 2014, PERS SOC PSYCHOL B, V40, P1494, DOI 10.1177/0146167214549323; Linville SE, 1998, FOLIA PHONIATR LOGO, V50, P35, DOI 10.1159/000021447; Mack S., 2010, SEL P 12 HISP LING S, P136; Meyer IH, 2009, J COUNS PSYCHOL, V56, P23, DOI 10.1037/a0014587; Munson B, 2006, J PHONETICS, V34, P202, DOI 10.1016/j.wocn.2005.05.003; Munson B, 2011, AM SPEECH, V86, P14, DOI 10.1215/00031283-1277492; Munson B, 2007, LANG LINGUIST COMPAS, V1, DOI 10.1111/j.1749-818x.2007.00028.x; Panfili L, 2011, LINGUISTICS HONORS P; Piccolo F., 2008, THESIS; Pierrehumbert JB, 2004, J ACOUST SOC AM, V116, P1905, DOI 10.1121/1.1788729; Prothro ET, 1955, J SOC PSYCHOL, V41, P3, DOI 10.1080/00224545.1955.9714248; QUATTRONE GA, 1980, J PERS SOC PSYCHOL, V38, P141, DOI 10.1037/0022-3514.38.1.141; Rendall D, 2008, ARCH SEX BEHAV, V37, P188, DOI 10.1007/s10508-007-9269-x; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Sandfort TGM, 1997, KINSEY INST, V5, P261; Schweinberger SR, 2014, WIRES COGN SCI, V5, P15, DOI 10.1002/wcs.1261; Simpson AP, 2009, LANG LINGUIST COMPAS, V3, P621, DOI 10.1111/j.1749-818x.2009.00125.x; Sisson C., 2003, PHONETIC CUES EVALUA; Skuk VG, 2015, J ACOUST SOC AM, V138, P1180, DOI 10.1121/1.4927696; Skuk VG, 2014, J SPEECH LANG HEAR R, V57, P285, DOI 10.1044/1092-4388(2013/12-0314); Skuk VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081691; Smyth R, 2003, LANG SOC, V32, P329, DOI 10.1017/S0047404503323024; Stern C, 2013, J PERS SOC PSYCHOL, V104, P520, DOI 10.1037/a0031187; Sulpizio S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128882; Valentova JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082417; Van Borsel J, 2013, J VOICE, V27, DOI 10.1016/j.jvoice.2013.04.008; Weirich M, 2008, P ISCA TUT RES WORKS; Zaske R, 2013, ACTA PSYCHOL, V144, P583, DOI 10.1016/j.actpsy.2013.09.009; Zaske R, 2010, HEARING RES, V268, P38, DOI 10.1016/j.heares.2010.04.011; Zimman L, 2010, COLORADO RES LINGUIS, V22; Zwicky A., 1997, QUEERLY PHRASED LANG, P21	59	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208686	10.1371/journal.pone.0208686	http://dx.doi.org/10.1371/journal.pone.0208686			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6JR	30532156	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700042
J	Kim, H; Lim, YM; Oh, YJ; Lee, EJ; Kim, KK				Kim, Hyunjin; Lim, Young-Min; Oh, Yeo Jin; Lee, Eun-Jae; Kim, Kwang-Kuk			Comparison of brain magnetic resonance imaging between myotonic dystrophy type 1 and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy	PLOS ONE			English	Article							TEMPORAL-LOBE; HYPERINTENSITIES; SPECTRUM; MRI	Background Anterior temporal lobe hyperintensities detected by brain MRI are a recognized imaging hallmark of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Because similar findings may be present in patients with myotonic dystrophy type 1 (DM1), the brain MRI in these two diseases is often misinterpreted. We compared the MRI findings between the two entities to examine whether they display distinctive characteristics. Methods This retrospective, cross-sectional study reviewed medical records of patients with DM1 or CADASIL admitted to Asan Medical Center between September 1999 and September 2017. We compared the frequency and grades of white matter changes in specific spatial regions between the groups according to age-related white matter change scores. We also evaluated the presence of cerebral microbleeds. Results A total of 29 patients with DM1 and 68 with CADASIL who had undergone MRI were included in the analysis. The overall prevalence of white matter hyperintensities was 20 (69%) and 66 (97%) in DM1 and CADASIL, respectively (p < 0.001), whereas the frequency of anterior temporal lobe hyperintensities was comparable between the groups (10 [34.5%] in DM1 vs. 35 [51.5%] in CADASIL, p = 0.125). The brain MRI of patients with DM1 revealed more limited involvement of the frontal, parieto-occipital, external capsule and basal ganglia regions compared with imaging in patients with CADASIL. Cerebral microbleeds were not observed in any case of DM1 but were present in 31 of 45 (68.9%) cases of CADASIL. Conclusions Anterior temporal lobe involvement in DM1 is not infrequent compared with CADASIL. However, because brain MRI in patients with DM1 lacks other distinctive features seen in CADASIL, imaging might assist in differentiating these two conditions.	[Kim, Hyunjin; Lim, Young-Min; Oh, Yeo Jin; Lee, Eun-Jae; Kim, Kwang-Kuk] Univ Ulsan, Asan Med Ctr, Dept Neurol, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kim, KK (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Neurol, Coll Med, Seoul, South Korea.	kkkim@amc.seoul.kr		Kim, Hyunjin/0000-0003-0264-4531				Caillet-Boudin ML, 2014, FRONT MOL NEUROSCI, V6, DOI [10.3389/fnmo1.2013.00057, 10.3389/fnmol.2013.00057]; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Donahue LA, 2009, NEUROLOGY, V73, P1931, DOI 10.1212/WNL.0b013e3181c3fdb0; Enzinger C, 2007, J NEUROL SCI, V257, P5, DOI 10.1016/j.jns.2007.01.018; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Konzen D, 2017, JAMA NEUROL, V74, P866, DOI 10.1001/jamaneurol.2017.0399; Lee YC, 2009, J NEUROL, V256, P249, DOI 10.1007/s00415-009-0091-3; Leroy O, 2006, J NEUROSCI RES, V84, P852, DOI 10.1002/jnr.20980; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Muino E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091964; O'Sullivan M, 2001, NEUROLOGY, V56, P628, DOI 10.1212/WNL.56.5.628; Okkersen K, 2017, NEUROLOGY, V89, P960, DOI 10.1212/WNL.0000000000004300; Sureka J, 2012, BRIT J RADIOL, V85, pE782, DOI 10.1259/bjr/30039090; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Ueda A, 2015, J NEUROL, V262, P1828, DOI 10.1007/s00415-015-7782-8; Vermersch P, 1996, NEUROLOGY, V47, P711, DOI 10.1212/WNL.47.3.711; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang ZX, 2011, J NEUROL NEUROSUR PS, V82, P534, DOI 10.1136/jnnp.2010.209247; Yamamoto Y, 2009, STROKE, V40, P2004, DOI 10.1161/STROKEAHA.108.528299	19	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208620	10.1371/journal.pone.0208620	http://dx.doi.org/10.1371/journal.pone.0208620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521610	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600099
J	King, RE; Steed, K; Rivera, AE; Wisco, JJ; Thibeault, SL				King, Renee E.; Steed, Kevin; Rivera, Ana E.; Wisco, Jonathan J.; Thibeault, Susan L.			Magnetic resonance imaging quantification of dehydration and rehydration in vocal fold tissue layers	PLOS ONE			English	Article							PHONATION; HYDRATION; PIG; PARAMETERS; LESIONS; MODEL	Clinicians commonly recommend increased hydration to patients with voice disorders. However, effects on clinical voice outcome measures have been inconsistent. Hydration-induced change within different layers of vocal fold tissue is currently unknown. Magnetic Resonance Imaging (MRI) is a promising method of noninvasively measuring water content in vocal folds. We sought to image and quantify changes in water content within vocal fold mucosa and thyroarytenoid muscle after dehydration and rehydration. Excised porcine larynges were imaged using proton density (PD) weighted MRI (1) at baseline and (2) after immersion in one of five hypertonic, isotonic, or hypotonic solutions or in dry air. Larynges dehydrated in hypertonic solutions or dry air were rehydrated and imaged a third time. Scans revealed fluid-rich vocal fold mucosa that was distinct from muscle at baseline. Baseline normalized signal intensity in mucosa and muscle varied by left vs. right vocal fold (p < 0.01) and by anterior, middle, or posterior location (p < 0.0001). Intensity changes in the middle third of vocal fold mucosa differed by solution after immersion (p < 0.01). Hypertonic solutions dehydrated the middle third of mucosa by over 30% (p < 0.001). No difference from baseline was found in anterior or posterior mucosa or in muscle after immersion. No association was found between intensity change in mucosa and muscle after immersion. After rehydration, intensity did not differ by solution in any tissue, and was not different from baseline, but post-rehydration intensity was correlated with post-immersion intensity in both mucosa and muscle (p < 0.05), suggesting that degree of change in vocal fold water content induced by hypertonic solutions ex vivo persists after rehydration. These results indicate that PD-MRI can be used to visualize large mammalian vocal fold tissue layers and to quantify changes in water content within vocal fold mucosa and thyroarytenoid muscle independently.	[King, Renee E.; Rivera, Ana E.; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol, Madison, WI 53706 USA; [King, Renee E.; Thibeault, Susan L.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Steed, Kevin; Wisco, Jonathan J.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA; [Rivera, Ana E.] Ponce Hlth Sci Univ, Sch Med, Ponce, PR USA; [Wisco, Jonathan J.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Wisco, Jonathan J.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Brigham Young University; Ponce Health Sciences University; Boston University; Utah System of Higher Education; University of Utah	Thibeault, SL (corresponding author), Univ Wisconsin, Dept Surg, Div Otolaryngol, Madison, WI 53706 USA.; Thibeault, SL (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA.	thibeault@surgery.wisc.edu		Rivera, Ana/0000-0002-3813-611X; Steed, Kevin/0000-0002-8908-3812	NIH NIDCD [T32DC009401, R01DC004336, 2R56DC009616-06]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004336, T32DC009401] Funding Source: NIH RePORTER	NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH NIDCD T32DC009401 (SLT); NIH NIDCD R01DC004336 (SLT); NIH NIDCD 2R56DC009616-06 (JJW).	Alipoura F, 2008, J ACOUST SOC AM, V123, P4572, DOI 10.1121/1.2908289; Alves M, 2019, J VOICE, V33, DOI 10.1016/j.jvoice.2017.10.001; Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Chan RW, 2006, J ACOUST SOC AM, V119, P2351, DOI 10.1121/1.2173516; Chan RW, 2002, OTOLARYNG HEAD NECK, V126, P528, DOI 10.1067/mhn.2002.124936; Chen T, 2012, J VOICE, V26, P555, DOI 10.1016/j.jvoice.2011.03.012; Cheuvront SN, 2010, AM J CLIN NUTR, V92, P565, DOI 10.3945/ajcn.2010.29490; Dickson JM, 2005, INT J SPORTS MED, V26, P481, DOI 10.1055/s-2004-821318; DIKKERS FG, 1995, ANN OTO RHINOL LARYN, V104, P698, DOI 10.1177/000348949510400905; Fisher KV, 2001, J APPL PHYSIOL, V91, P1401, DOI 10.1152/jappl.2001.91.3.1401; Frifdman JN, 2004, J PEDIATR-US, V145, P201, DOI 10.1016/j.jpeds.2004.05.035; Gartner-Schmidt JL, 2013, J VOICE, V27, P210, DOI 10.1016/j.jvoice.2012.11.007; Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115; Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001; Gray SD, 2000, OTOLARYNG CLIN N AM, V33, P679, DOI 10.1016/S0030-6665(05)70237-1; HACKNEY KJ, 2012, EXTREME PHYSIOL MED, V1; Hanson KP, 2011, J VOICE, V25, P657, DOI 10.1016/j.jvoice.2010.06.005; Hanson KP, 2010, LARYNGOSCOPE, V120, P1363, DOI 10.1002/lary.20927; Hartley NA, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2014.01.007; Herrera VLM, 2009, LARYNGOSCOPE, V119, P2187, DOI 10.1002/lary.20643; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Hirano M., 1983, VOCAL FOLD PHYSL, P22; Hirano M., 1981, VOCAL FOLD PHYSL, P33; Hochman I, 1999, ANN OTO RHINOL LARYN, V108, P10, DOI 10.1177/000348949910800102; ISERI LT, 1952, AM HEART J, V43, P215, DOI 10.1016/0002-8703(52)90212-3; Jackson EF, 1997, SURG NEUROL, V47, P185, DOI 10.1016/S0090-3019(96)00375-8; Jiang JJ, 1998, ANN OTO RHINOL LARYN, V107, P603, DOI 10.1177/000348949810700711; Jiang JJ, 2001, ANN OTO RHINOL LARYN, V110, P1120, DOI 10.1177/000348940111001207; Karamzadeh AM, 2005, ARCH OTOLARYNGOL, V131, P499, DOI 10.1001/archotol.131.6.499; Kempton MJ, 2009, HUM BRAIN MAPP, V30, P291, DOI 10.1002/hbm.20500; Kishimoto AO, 2016, DIS MODEL MECH, V9, P1397, DOI 10.1242/dmm.026526; Klepacek I, 2016, J VOICE, V30, P529, DOI 10.1016/j.jvoice.2015.08.004; Knight MJ, 2005, EUR ARCH OTO-RHINO-L, V262, P281, DOI 10.1007/s00405-004-0803-3; KNIGHT P, 1988, MEAT SCI, V24, P275, DOI 10.1016/0309-1740(88)90040-X; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kurita S., 1983, VOCAL FOLD PHYSL CON, P3; LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429; Leydon C, 2010, J VOICE, V24, P637, DOI 10.1016/j.jvoice.2009.06.001; Leydon C, 2009, J VOICE, V23, P658, DOI 10.1016/j.jvoice.2008.03.010; Miri AK, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2014.03.001; Moore J, 2012, J VOICE, V26, P269, DOI 10.1016/j.jvoice.2011.05.003; Office of Regulatory Affairs; Center for Food Safety and Applied Nutrition U. S. Food and Drug Administration Div of Environmental Hazards and Health Effects National Center for Environmental Health; Div of Nutrition and Physical Activity National Center for Chronic Disease Prevention and Health Promotion CDC, 1997, MMWR-MORBID MORTAL W, V1998, P47; Oleson S, 2018, LARYNGOSCOPE, V128, pE222, DOI 10.1002/lary.26978; Ori Y, 2006, NEPHRON CLIN PRACT, V103, pC144, DOI 10.1159/000092911; Phillips R, 2009, J ACOUST SOC AM, V125, P2282, DOI 10.1121/1.3086276; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Sivasankar M, 2010, OTOLARYNG HEAD NECK, V142, P79, DOI 10.1016/j.otohns.2009.09.011; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044195; Tao C, 2007, J BIOMECH, V40, P2191, DOI 10.1016/j.jbiomech.2006.10.030; Thibeault Susan L, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P148, DOI 10.1097/01.moo.0000163450.90455.fb; Thurlow S, 2018, EUR J CLIN NUTR, V72, P148, DOI 10.1038/ejcn.2017.110; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; Vaghefi E, 2011, AM J PHYSIOL-REG I, V301, pR335, DOI 10.1152/ajpregu.00173.2011; Ward PD, 2002, J VOICE, V16, P303, DOI 10.1016/S0892-1997(02)00101-7; Ward SR, 2005, J BIOMECH, V38, P2317, DOI 10.1016/j.jbiomech.2004.10.001; Watson P, 2010, MED SCI SPORT EXER, V42, P2197, DOI 10.1249/MSS.0b013e3181e39788; Woodson G, 2012, J VOICE, V26, P706, DOI 10.1016/j.jvoice.2012.03.003; Wu L, 2016, J ACOUST SOC AM, V140, pEL159, DOI 10.1121/1.4959599	58	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208763	10.1371/journal.pone.0208763	http://dx.doi.org/10.1371/journal.pone.0208763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521642	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600106
J	Lim, YT; Prabhu, N; Dai, LY; Go, KD; Chen, D; Sreekumar, L; Egeblad, L; Eriksson, S; Chen, LY; Veerappan, S; Teo, HL; Tan, CSH; Lengqvist, J; Larsson, A; Sobota, RM; Nordlund, P				Lim, Yan Ting; Prabhu, Nayana; Dai, Lingyun; Go, Ka Diam; Chen, Dan; Sreekumar, Lekshmy; Egeblad, Louise; Eriksson, Staffan; Chen, Liyan; Veerappan, Saranya; Teo, Hsiang Ling; Tan, Chris Soon Heng; Lengqvist, Johan; Larsson, Andreas; Sobota, Radoslaw M.; Nordlund, Par			An efficient proteome-wide strategy for discovery and characterization of cellular nucleotide-protein interactions	PLOS ONE			English	Article							DRUG TARGET ENGAGEMENT; THERMAL SHIFT ASSAY; BINDING PROTEINS; CYCLIC-AMP; KINASE; METABOLISM; THYMIDINE; PKA; PHOSPHORYLATION; IDENTIFICATION	Metabolite-protein interactions define the output of metabolic pathways and regulate many cellular processes. Although diseases are often characterized by distortions in metabolic processes, efficient means to discover and study such interactions directly in cells have been lacking. A stringent implementation of proteome-wide Cellular Thermal Shift Assay (CETSA) was developed and applied to key cellular nucleotides, where previously experimentally confirmed protein-nucleotide interactions were well recaptured. Many predicted, but never experimentally confirmed, as well as novel protein-nucleotide interactions were discovered. Interactions included a range of different protein families where nucleotides serve as substrates, products, co-factors or regulators. In cells exposed to thymidine, a limiting precursor for DNA synthesis, both dose- and time-dependence of the intracellular binding events for sequentially generated thymidine metabolites were revealed. Interactions included known cancer targets in deoxyribonucleotide metabolism as well as novel interacting proteins. This stringent CETSA based strategy will be applicable for a wide range of metabolites and will therefore greatly facilitate the discovery and studies of interactions and specificities of the many metabolites in human cells that remain uncharacterized.	[Lim, Yan Ting; Prabhu, Nayana; Dai, Lingyun; Go, Ka Diam; Chen, Dan; Sreekumar, Lekshmy; Chen, Liyan; Veerappan, Saranya; Larsson, Andreas; Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Egeblad, Louise] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Eriksson, Staffan; Lengqvist, Johan; Nordlund, Par] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden; [Teo, Hsiang Ling] Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore; [Tan, Chris Soon Heng; Sobota, Radoslaw M.; Nordlund, Par] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Swedish University of Agricultural Sciences; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Nordlund, P (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Nordlund, P (corresponding author), Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden.; Sobota, RM; Nordlund, P (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.	rmsobota@imcb.a-star.edu.sg; par.nordlund@ki.se		Teo, Hsiang Ling/0000-0002-3849-809X; Prabhu, Nayana/0000-0002-2350-6552; Chen, Liyan/0000-0002-5255-0296; KA DIAM, GO/0000-0003-1782-2775; Sobota, Radoslaw/0000-0002-2455-2526	Nanyang Technological University; Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden); Radiumhemmets research fund; Knut and Alice Wallenberg foundation (Knut och Alice Wallenbergs Stiftelse); Singapore Ministry of Health's National Medical Research Council [MOHIAFCAT2/004/2015]; Agency for Science, Technology and Research Council (A-STAR BMRC) YIG2015 grant; Swedish Research Council; Swedish Cancer Society; Knut and Alice Wallenberg foundation; A-STAR BMRC YIG2015 grant	Nanyang Technological University(Nanyang Technological University); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Radiumhemmets research fund; Knut and Alice Wallenberg foundation (Knut och Alice Wallenbergs Stiftelse)(Knut & Alice Wallenberg Foundation); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Agency for Science, Technology and Research Council (A-STAR BMRC) YIG2015 grant(Agency for Science Technology & Research (A*STAR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); A-STAR BMRC YIG2015 grant(Agency for Science Technology & Research (A*STAR))	This work was supported by Nanyang Technological University, http://www.ntu.edu.sg, to PN, the Swedish Research Council (Vetenskapsradet), https://www.vr.se, to PN, the Swedish Cancer Society (Cancerfonden), https://www.cancerfonden.se, to PN, Radiumhemmets research fund, to PN, the Knut and Alice Wallenberg foundation (Knut och Alice Wallenbergs Stiftelse), https://kaw.wallenberg.org, to PN, Singapore Ministry of Health's National Medical Research Council, www.nmrc.gov.sg, MOHIAFCAT2/004/2015, to PN, RMS, and AL, and Agency for Science, Technology and Research Council (A-STAR BMRC) YIG2015 grant, https://www.a-star.edu.sg/About-A-STAR/Biomedical-Research-Council/BMRC-Board, to RMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; P.N. acknowledges a startup grant from Nanyang Technological University and grants from the Swedish Research Council, the Swedish Cancer Society, Radiumhemmets research fund and the Knut and Alice Wallenberg foundation. This research is also supported by the Singapore Ministry of Health's National Medical Research Council under its MOHIAFCAT2/004/2015 to P.N., R.M.S and A.L, and A-STAR BMRC YIG2015 grant to R.M.S. We would like to acknowledge of Dr Gen Lin for his assistance in the development of the R script for data analysis and Dr Mingwei Chen for the scientific discussion.	Almqvist H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11040; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Becher I, 2016, NAT CHEM BIOL, V12, P908, DOI [10.1038/NCHEMBIO.2185, 10.1038/nchembio.2185]; Burgers PP, 2016, FEBS J, V283, P2132, DOI 10.1111/febs.13726; Burgers PP, 2012, J BIOL CHEM, V287, P43789, DOI 10.1074/jbc.M112.395970; Buschmann J, 2013, J BIOL CHEM, V288, P2441, DOI 10.1074/jbc.M112.426700; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chiarugi P, 2001, IUBMB LIFE, V52, P55, DOI 10.1080/15216540252774775; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Corradini E, 2015, METHODS MOL BIOL, V1294, P191, DOI 10.1007/978-1-4939-2537-7_15; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Dai LY, 2018, CELL, V173, P1481, DOI 10.1016/j.cell.2018.03.065; DANENBERG PV, 1977, BIOCHIM BIOPHYS ACTA, V473, P73, DOI 10.1016/0304-419X(77)90001-4; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; DERDA DF, 1980, J BIOL CHEM, V255, P1112; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Grogan A, 1997, J CELL SCI, V110, P3071; Hanke SE, 2011, NEW BIOTECHNOL, V28, P294, DOI 10.1016/j.nbt.2010.12.001; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Kierdaszuk B, 1998, ADV EXP MED BIOL, V431, P623; KIT S, 1985, MICROBIOL SCI, V2, P369; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; KUO JF, 1984, MOL CELL ENDOCRINOL, V35, P65, DOI 10.1016/0303-7207(84)90001-7; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Lorendeau D, 2015, BIOL CELL, V107, P251, DOI 10.1111/boc.201500015; Lu LL, 1997, J CHROMATOGR A, V776, P81, DOI 10.1016/S0021-9673(97)00151-9; Ma YX, 2015, CURR MED CHEM, V22, P1239, DOI 10.2174/0929867322666150209154420; Madamanchi NR, 2010, AM J PHYSIOL-HEART C, V298, pH1, DOI 10.1152/ajpheart.01020.2009; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; PASSONEAU J, 1962, BIOCHEM BIOPH RES CO, V7, P10, DOI 10.1016/0006-291X(62)90134-1; Paytubi S, 2008, BIOCHEM J, V409, P223, DOI 10.1042/BJ20070811; Piazza I, 2018, CELL, V172, P358, DOI 10.1016/j.cell.2017.12.006; PILKIS SJ, 1988, ADV SEC MESS PHOSPH, V22, P175; PIPER RC, 1993, J BIOL CHEM, V268, P16557; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Scholten A, 2006, J PROTEOME RES, V5, P1435, DOI 10.1021/pr0600529; SERGEANT S, 1985, J BIOL CHEM, V260, P4677; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SOLD G, 1974, EUR J BIOCHEM, V44, P143, DOI 10.1111/j.1432-1033.1974.tb03467.x; SUTHERLA.EW, 1969, DIABETES, V18, P797, DOI 10.2337/diab.18.12.797; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; Tiwari M, 2012, J CANCER RES THER, V8, P510, DOI 10.4103/0973-1482.106526; Tsuchimoto D, 2010, MUTAT RES-GEN TOX EN, V703, P37, DOI 10.1016/j.mrgentox.2010.06.005; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; VOGEL W, 1978, HUM GENET, V45, P193, DOI 10.1007/BF00286962; Welin M, 2010, BIOCHEM BIOPH RES CO, V396, P157, DOI 10.1016/j.bbrc.2010.04.054; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Wintersberger E, 1997, BIOCHEM SOC T, V25, P303, DOI 10.1042/bst0250303; XEROS N, 1962, NATURE, V194, P682, DOI 10.1038/194682a0; Xiao YS, 2013, ANAL CHEM, V85, P3198, DOI 10.1021/ac303383c; Yizhak K, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145307; Yue WW, 2011, J INHERIT METAB DIS, V34, P575, DOI 10.1007/s10545-011-9296-6; Zinn N, 2012, METHODS, V57, P430, DOI 10.1016/j.ymeth.2012.05.008	66	21	22	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208273	10.1371/journal.pone.0208273	http://dx.doi.org/10.1371/journal.pone.0208273			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521565	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600039
J	Melo, HN; Stoots, SJM; Pool, MA; Carvalho, VO; Aragao, MLD; Gurgel, RQ; Agyemang, C; Cipolotti, R				Melo, Hugo Nivaldo; Stoots, Simone Joanna-Maria; Pool, Marijn Aimee; Carvalho, Vitor Oliveira; Aragao, Max Luan De Carvalho; Gurgel, Ricardo Queiroz; Agyemang, Charles; Cipolotti, Rosana			Objectively measured physical activity levels and sedentary time in children and adolescents with sickle cell anemia	PLOS ONE			English	Article							MODERATE ENDURANCE EXERCISE; OXIDATIVE STRESS; CLINICAL SEVERITY; RECOMMENDATIONS; VARIABILITY; CALIBRATION; PATTERNS	The aim of this study was to identify the levels of physical activity and sedentary behaviour of children and adolescents with sickle cell disease (SCA) compared to healthy individuals. A cross-sectional study with a quantitative approach was performed at a reference center for the treatment of patients with hemoglobinopathies in northeastern Brazil. Patients were recruited between October 2015 and January 2017. Eligible participants answered a Physical Activity Questionnaire for Older Children and Adolescents (PAQ-C) and were instructed to use an ActiGraph wGT3X-BT triaxial accelerometer for seven consecutive days. Fifty patients (and their 50 controls matched for age and sex) were then evaluated. We observed lower moderate (19.2 +/- 11.9 and 27.1 +/- 13.8 min/d; p<0.01) and vigorous PA (3.6 +/- 4.1 and 7.8 +/- 7.4 min/d; p<0.01) in cases than controls, respectively. There was also a significant difference among cases and controls in the following variables: total of steps (51010 +/- 19600 and 59105 +/- 22650; p = 0.04) and "total caloric expenditure" (1015 +/- 516 and 2404 +/- 1308; p<0.01), with the lowest values for the patients with SCA for all variables. Children and adolescents with SCA presented lower levels of physical activity than healthy children and adolescents, either when evaluated by PAQs or by accelerometer.	[Melo, Hugo Nivaldo; Carvalho, Vitor Oliveira; Aragao, Max Luan De Carvalho; Gurgel, Ricardo Queiroz; Cipolotti, Rosana] Univ Fed Sergipe, Aracaju, Brazil; [Stoots, Simone Joanna-Maria; Pool, Marijn Aimee] Univ Amsterdam, Amsterdam, Netherlands; [Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands	Universidade Federal de Sergipe; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Melo, HN (corresponding author), Univ Fed Sergipe, Aracaju, Brazil.	hugomelo88@hotmail.com	Gurgel, RQ/N-5105-2018; Carvalho, Vitor Oliveira/CAH-3162-2022	Gurgel, RQ/0000-0001-9651-3713; carvalho, vitor/0000-0003-0007-2541				Al-Rimawi Hala, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P214; Balayssac-Siransy E, 2011, BRIT J HAEMATOL, V154, P398, DOI 10.1111/j.1365-2141.2011.08728.x; Buchheit M, 2007, INT J SPORTS MED, V28, P204, DOI 10.1055/s-2006-924296; Buchowski MS, 2002, J PEDIATR-US, V140, P86, DOI 10.1067/mpd.2002.120689; Charlot K, 2015, PEDIATR BLOOD CANCER, V62, P1962, DOI 10.1002/pbc.25604; Charrin E, 2015, BRIT J HAEMATOL, V168, P747, DOI 10.1111/bjh.13207; Chirico EN, 2012, J APPL PHYSIOL, V112, P1445, DOI 10.1152/japplphysiol.01452.2011; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; da Silva R C, 2000, Cad Saude Publica, V16, P1091, DOI 10.1590/S0102-311X2000000400027; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Faes C, 2014, BRIT J HAEMATOL, V164, P124, DOI 10.1111/bjh.12594; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; GRETEBECK RJ, 1992, MED SCI SPORT EXER, V24, P1167; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; HEDREVILLE M, 2014, PLOS ONE, V0009; Kettner S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-895; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Laguna M, 2013, J PAEDIATR CHILD H, V49, P942, DOI 10.1111/jpc.12442; Landry BW, 2012, PM&R, V4, P826, DOI 10.1016/j.pmrj.2012.09.585; Ortega FB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060871; Pearson SR, 2005, CLIN AUTON RES, V15, P400, DOI 10.1007/s10286-005-0300-9; PLATT OS, 1984, NEW ENGL J MED, V311, P7, DOI 10.1056/NEJM198407053110102; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sangkatumvong S, 2011, AM J RESP CRIT CARE, V184, P474, DOI 10.1164/rccm.201103-0537OC; Singhal A, 1997, AM J CLIN NUTR, V66, P386, DOI 10.1093/ajcn/66.2.386; Strouse JJ, 2012, PEDIATR BLOOD CANCER, V59, P365, DOI 10.1002/pbc.24178; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Utsal L, 2012, HORM RES PAEDIAT, V78, P31, DOI 10.1159/000339831; Ware RE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002120	31	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208916	10.1371/journal.pone.0208916	http://dx.doi.org/10.1371/journal.pone.0208916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521638	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600108
J	Correa, M; Zimic, M; Barrientos, F; Barrientos, R; Roman-Gonzalez, A; Pajuelo, MJ; Anticona, C; Mayta, H; Alva, A; Solis-Vasquez, L; Figueroa, DA; Chavez, MA; Lavarello, R; Castaneda, B; Paz-Soldan, VA; Checkley, W; Gilman, RH; Oberhelman, R				Correa, Malena; Zimic, Mirko; Barrientos, Franklin; Barrientos, Ronald; Roman-Gonzalez, Avid; Pajuelo, Monica J.; Anticona, Cynthia; Mayta, Holger; Alva, Alicia; Solis-Vasquez, Leonardo; Anibal Figueroa, Dante; Chavez, Miguel A.; Lavarello, Roberto; Castaneda, Benjamin; Paz-Soldan, Valerie A.; Checkley, William; Gilman, Robert H.; Oberhelman, Richard			Automatic classification of pediatric pneumonia based on lung ultrasound pattern recognition	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; AGED 2-59 MONTHS; ORAL AMOXICILLIN; DIAGNOSIS; CHILDREN; DISTRICT; PAKISTAN	Pneumonia is one of the major causes of child mortality, yet with a timely diagnosis, it is usually curable with antibiotic therapy. In many developing regions, diagnosing pneumonia remains a challenge, due to shortages of medical resources. Lung ultrasound has proved to be a useful tool to detect lung consolidation as evidence of pneumonia. However, diagnosis of pneumonia by ultrasound has limitations: it is operator-dependent, and it needs to be carried out and interpreted by trained personnel. Pattern recognition and image analysis is a potential tool to enable automatic diagnosis of pneumonia consolidation without requiring an expert analyst. This paper presents a method for automatic classification of pneumonia using ultrasound imaging of the lungs and pattern recognition. The approach presented here is based on the analysis of brightness distribution patterns present in rectangular segments (here called "characteristic vectors") from the ultrasound digital images. In a first step we identified and eliminated the skin and subcutaneous tissue (fat and muscle) in lung ultra-sound frames, and the "characteristic vectors"were analyzed using standard neural networks using artificial intelligence methods. We analyzed 60 lung ultrasound frames corresponding to 21 children under age 5 years (15 children with confirmed pneumonia by clinical examination and X-rays, and 6 children with no pulmonary disease) from a hospital based population in Lima, Peru. Lung ultrasound images were obtained using an Ultrasonix ultrasound device. A total of 1450 positive (pneumonia) and 1605 negative (normal lung) vectors were analyzed with standard neural networks, and used to create an algorithm to differentiate lung infiltrates from healthy lung. A neural network was trained using the algorithm and it was able to correctly identify pneumonia infiltrates, with 90.9% sensitivity and 100% specificity. This approach may be used to develop operator-independent computer algorithms for pneumonia diagnosis using ultrasound in young children.	[Correa, Malena; Pajuelo, Monica J.; Anticona, Cynthia; Mayta, Holger; Paz-Soldan, Valerie A.; Oberhelman, Richard] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA; [Correa, Malena; Zimic, Mirko; Barrientos, Franklin; Barrientos, Ronald; Roman-Gonzalez, Avid; Pajuelo, Monica J.; Anticona, Cynthia; Alva, Alicia; Solis-Vasquez, Leonardo] Univ Peruana Cayetano Heredia, Fac Sci, Dept Cellular & Mol Sci, Bioinformat & Mol Biol Lab, Lima, Peru; [Roman-Gonzalez, Avid; Solis-Vasquez, Leonardo] Univ Peruana Cayetano Heredia, Sci & Philosophy Fac, Res & Dev Lab, Lima, Peru; [Mayta, Holger] Univ Peruana Cayetano Heredia, Dept Cellular & Mol Sci, Infect Dis Res Lab, Lima, Peru; [Anibal Figueroa, Dante] Inst Nacl Salud Nino, Unidad Rehidratac Oral, Lima, Peru; [Chavez, Miguel A.] Asociac Benefice Prisma, Biomed Res Unit, Lima, Peru; [Lavarello, Roberto; Castaneda, Benjamin] Pontificia Univ Catolica Peru, Dept Ingn, Secc Electricidad & Elect, Lab Imagenes Med, Lima, Peru; [Checkley, William] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Baltimore, MD 21218 USA; [Checkley, William] Johns Hopkins Univ, Program Global Dis Epidemiol & Control, Bloombeg Sch Publ Hlth, Baltimore, MD 21218 USA; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Tulane University; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Pontificia Universidad Catolica del Peru; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Correa, M (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA.; Correa, M (corresponding author), Univ Peruana Cayetano Heredia, Fac Sci, Dept Cellular & Mol Sci, Bioinformat & Mol Biol Lab, Lima, Peru.	morrea1@tulane.edu	Solis-Vasquez, Leonardo/AAH-6983-2020; Mayta, Holger/ABA-4755-2020; Roman-Gonzalez, Avid/H-2356-2011; Correa, Malena/ABA-8684-2021; Correa, Malena/ABA-8236-2021	Solis-Vasquez, Leonardo/0000-0001-6896-9879; Mayta, Holger/0000-0001-5306-628X; Roman-Gonzalez, Avid/0000-0002-3338-0041; Correa, Malena/0000-0002-8938-0091; Castaneda, Benjamin/0000-0002-1913-0636; Lavarello, Roberto/0000-0001-8472-5161; Anticona Huaynate, Cynthia/0000-0001-9321-6174; Checkley, William/0000-0003-1106-8812; Paz-Soldan, Valerie/0000-0002-1065-4919; pajuelo, monica/0000-0003-3662-2250; Alva, Alicia/0000-0001-6706-5966	Grand Challenges Canada [0542-01-10, 0688-01-10]; National Institutes of Health [1D43TW009349-03]; CONCYTEC-FONDECIT [054-2014]; PUCP-DGI [70242-2149]; FOGARTY INTERNATIONAL CENTER [D43TW010913, D43TW009349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002733] Funding Source: NIH RePORTER	Grand Challenges Canada(CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONCYTEC-FONDECIT; PUCP-DGI; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by Grand Challenges Canada; grant number: 0542-01-10, Grand Challenges Canada; grant number: 0688-01-10 URL: www.grandchallenges.ca, National Institutes of Health; grant number: 1D43TW009349-03 URL: https://www.nih.gov, CONCYTEC-FONDECIT; grant number: 054-2014 URL: https://portal.concytec.gob.pe, PUCP-DGI; grant number: 70242-2149 URL: http://www.pucp.edu.pe.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Boden MAMA, NON TRADITIONAL REF; Copetti R, 2008, RADIOL MED, V113, P190, DOI 10.1007/s11547-008-0247-8; Demuth HB, 2014, NON TRADITIONAL REF; Ginsburg AS, 2013, LANCET GLOB HEALTH, V1, pE326, DOI 10.1016/S2214-109X(13)70117-7; Haykin S, 1999, P842; Iuri D, 2009, RADIOL MED, V114, P321, DOI 10.1007/s11547-008-0336-8; Izadnegahdar R, 2013, LANCET RESP MED, V1, P574, DOI 10.1016/S2213-2600(13)70075-4; Koenig SJ, 2011, CHEST, V140, P1332, DOI 10.1378/chest.11-0348; Lichtenstein DA, 2007, CRIT CARE MED, V35, pS250, DOI 10.1097/01.CCM.0000260674.60761.85; Lichtenstein DA, 2009, PEDIATR CRIT CARE ME, V10, P693, DOI 10.1097/PCC.0b013e3181b7f637; Reissig A, 2012, CHEST, V142, P965, DOI 10.1378/chest.12-0364; Rueden C., 2016, IMAGEJ OPS; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SHANN F, 1984, B WORLD HEALTH ORGAN, V62, P749; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; The MathWorks Inc., 2014, MATLAB STAT TOOLB RE; Trinavarat P, 2014, EUR J RADIOL, V83, P1507, DOI 10.1016/j.ejrad.2014.04.011; UNICEF, 2009, GLOB ACT PLAN PREV C; UNICEF, 2013, PNEUM DIARRH TACKL D; Volpicelli G, 2010, EUR J EMERG MED, V17, P63, DOI 10.1097/MEJ.0b013e3283101685; Wang S.C., 2003, INTERDISCIPLINARY CO, P81	23	43	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206410	10.1371/journal.pone.0206410	http://dx.doi.org/10.1371/journal.pone.0206410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517102	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400012
J	Holt, R; Kung, C; Demuth, K				Holt, Rebecca; Kung, Carmen; Demuth, Katherine			Listener characteristics modulate the semantic processing of native vs. foreign-accented speech	PLOS ONE			English	Article							WORKING-MEMORY; PERCEPTION; YOUNGER	Foreign accents have been shown to have considerable impact on how language is processed [1]. However, the impact of a foreign accent on semantic processing is not well understood. Conflicting results have been reported by previous event-related potential (ERP) studies investigating the impact of foreign-accentedness on the N400 effect elicited by semantic violations. Furthermore, these studies have only examined a subset of the four characteristics of the N400 (i.e. onset latency, latency, amplitude, and scalp distribution), and have been conducted in linguistic environments where foreign-accented speech is relatively uncommon. The current study therefore compared the N400 effect elicited by semantic violations in native Australian English vs. Mandarin-accented English, in a context where foreign-accented speech is common. Factors which may be responsible for individual variability in N400 amplitude were also investigated. The results showed no differences between the N400s elicited by native and foreign-accented speech in any of the four afore-mentioned characteristics. However, the analysis of individual variability revealed an effect of familiarity with foreign-accented speech on the amplitude of N400 effects for semantic violations. An effect of working memory capacity on N400 amplitude was also found. These findings highlight the relevance of the ambient linguistic environment for studies of speech processing, and demonstrate the interacting influences of both speaker- and listener-related factors on semantic processing.	[Holt, Rebecca; Kung, Carmen; Demuth, Katherine] Macquarie Univ, Dept Linguist, Sydney, NSW, Australia; [Holt, Rebecca; Kung, Carmen; Demuth, Katherine] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia	Macquarie University; Macquarie University	Holt, R (corresponding author), Macquarie Univ, Dept Linguist, Sydney, NSW, Australia.; Holt, R (corresponding author), Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia.	rebecca.holt@mq.edu.au	Kung, Carmen/AAI-2560-2020	Kung, Carmen/0000-0003-3981-6990; Demuth, Katherine/0000-0003-3884-8886	Australian Research Council Laureate Fellowship [ARC FL130100014]; Australian Research Council Centre of Excellence in Cognition and its Disorders [ARC CE110001021]; Macquarie University	Australian Research Council Laureate Fellowship(Australian Research Council); Australian Research Council Centre of Excellence in Cognition and its Disorders(Australian Research Council); Macquarie University	This study was funded by an Australian Research Council Laureate Fellowship (ARC FL130100014; www.arc.gov.au) awarded to KD; the Australian Research Council Centre of Excellence in Cognition and its Disorders (ARC CE110001021; www.ccd.edu.au); and postgraduate student funding awarded to RH by Macquarie University (www.mq.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, US CENSUS BUREAU QUI; Baese-Berk M, P 18 INT C PHON SCI; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boersma P., 2015, PRAAT; Bornkessel-Schlesewsky I, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00217; Bornkessel-Schlesewsky I, 2013, BRAIN LANG, V125, P60, DOI 10.1016/j.bandl.2013.01.010; Boudewyn MA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00060; Brinkoff T, CITY POPULATION; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Chen H, 2017, J ACOUST SOC AM, V142, P1707, DOI 10.1121/1.4995994; Dave S, 2018, NEUROPSYCHOLOGIA, V117, P135, DOI 10.1016/j.neuropsychologia.2018.05.023; Federmeier KD, 2002, PSYCHOPHYSIOLOGY, V39, P133, DOI 10.1111/1469-8986.3920133; Ferreira F, 2007, LANG LINGUIST COMPAS, V1, P71, DOI 10.1111/j.1749-818x.2007.00007.x; Floccia C, 2009, J PSYCHOLINGUIST RES, V38, P379, DOI 10.1007/s10936-008-9097-8; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Goslin J, 2012, BRAIN LANG, V122, P92, DOI 10.1016/j.bandl.2012.04.017; Grey S, 2017, J NEUROLINGUIST, V42, P93, DOI 10.1016/j.jneuroling.2016.12.001; Hagoort P., 2016, NEUROBIOLOGY LANGUAG, P339, DOI [10.1016/B978-0-12-407794-2.00028-6, DOI 10.1016/B978-0-12-407794-2.00028-6]; Hanulikova A, 2012, J COGNITIVE NEUROSCI, V24, P878, DOI 10.1162/jocn_a_00103; Hasting AS, 2008, J COGNITIVE NEUROSCI, V20, P1207, DOI 10.1162/jocn.2008.20083; Holt R, 2016, 16 AUSTR INT C SPEEC; Ingvalson EM, 2017, J ACOUST SOC AM, V141, P4652, DOI 10.1121/1.4986930; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luck SJ, 2017, PSYCHOPHYSIOLOGY, V54, P146, DOI 10.1111/psyp.12639; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martin AE, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00120; Mok P. P., 2008, P SPEECH PROS 2008 C, P423; Nakano H, 2010, J COGNITIVE NEUROSCI, V22, P2886, DOI 10.1162/jocn.2009.21400; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OOSTENVELD R, 2011, COMPUT INTEL NEUROSC; Payne BR, 2018, BRAIN RES, V1687, P117, DOI 10.1016/j.brainres.2018.02.021; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Piske T, 2001, J PHONETICS, V29, P191, DOI 10.1006/jpho.2001.0134; Porretta V, 2017, J NEUROLINGUIST, V44, P54, DOI 10.1016/j.jneuroling.2017.03.002; Romero-Rivas C, 2016, NEUROPSYCHOLOGIA, V85, P245, DOI 10.1016/j.neuropsychologia.2016.03.022; Romero-Rivas C, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.7015.00167, 10.3389/fnhum.2015.00167]; Royle P, 2013, MENT LEX, V8, P216, DOI 10.1075/ml.8.2.05roy; Simons Gary, 2017, ETHNOLOGUE; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; van de Meerendonk N, 2010, J COGNITIVE NEUROSCI, V22, P67, DOI 10.1162/jocn.2008.21170; van den Brink D, 2012, SOC COGN AFFECT NEUR, V7, P173, DOI 10.1093/scan/nsq094; Van Engen KJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00577; van Heuven WJB, 2014, Q J EXP PSYCHOL, V67, P1176, DOI 10.1080/17470218.2013.850521; VanPetten C, 1997, PSYCHOL SCI, V8, P238, DOI 10.1111/j.1467-9280.1997.tb00418.x; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Wechsler D., 2008, WECHSLER ADULT INTEL; Xu N., 2012, P 14 AUSTR INT C SPE, P41	53	7	7	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207452	10.1371/journal.pone.0207452	http://dx.doi.org/10.1371/journal.pone.0207452			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517122	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400035
J	Kadariya, R; Shimozuru, M; Maldonado, JE; Moustafa, MAM; Sashika, M; Tsubota, T				Kadariya, Rabin; Shimozuru, Michito; Maldonado, Jesus E.; Moustafa, Mohamed Abdallah Mohamed; Sashika, Mariko; Tsubota, Toshio			High genetic diversity and distinct ancient lineage of Asiatic black bears revealed by non-invasive surveys in the Annapurna Conservation Area, Nepal	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; URSUS-THIBETANUS; INDIVIDUAL IDENTIFICATION; MICROSATELLITE GENOTYPES; COMPREHENSIVE ANALYSIS; INBREEDING DEPRESSION; POPULATION-STRUCTURE; COMPUTER-PROGRAM; PROTECTED AREAS; BROWN BEARS	Asiatic black bears (Ursus thibetanus) have a widespread distribution in mountain landscapes, and are considered vulnerable globally, but are low-priority species for conservation in Nepal. Habitat fragmentation, illegal hunting, and human-bear conflict are the major threats to Asiatic black bears across their global range. Having an adequate level of genetic variation in a population helps with adapting to rapidly changing environments, and thus is important for the long-term health of bear populations. Accordingly, we conducted non-invasive surveys of bear populations in the Annapurna Conservation Area (ACA) to elucidate genetic diversity, genetic structure, and the phylogenetic relationship of Asiatic black bears from this region of Nepal to other subspecies. To assess levels of genetic diversity and population genetic structure, we genotyped eight microsatellite loci using 147 samples, identifying 60 individuals in an area of approximately 525 km(2). We found that the Asiatic black bear population in the ACA has maintained high levels of genetic diversity (H-E = 0.76) as compared to other bear populations from range countries. We did not detect a signature of population substructure among sampling localities and this suggests that animals are moving freely across the landscape within the ACA. We also detected a moderate population size that may increase with the availability of suitable habitat in the ACA, so bear-related conflict should be addressed to ensure the long-term viability of this expanding bear populations. Primers specific to bears were designed to amplify a 675 bp fragment of the mitochondrial control region from the collected samples. Three haplotypes were observed from the entire conservation area. The complete mitochondrial genome (16,771 bp), the first obtained from wild populations of the Himalayan black bear (U. t. laniger), was also sequenced to resolve the phylogenetic relationships of closely related subspecies of Asiatic black bears. The resulting phylogeny indicated that Himalayan black bear populations in Nepal are evolutionary distinct from other known subspecies of Asiatic black bears.	[Kadariya, Rabin; Shimozuru, Michito; Moustafa, Mohamed Abdallah Mohamed; Sashika, Mariko; Tsubota, Toshio] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Lab Wildlife Biol & Med, Sapporo, Hokkaido, Japan; [Kadariya, Rabin] Natl Trust Nat Conservat, Khumaltar, Lalitpur, Nepal; [Maldonado, Jesus E.] Smithsonian Conservat Biol Inst, Ctr Conservat Genom, Natl Zool Pk, Washington, DC USA; [Moustafa, Mohamed Abdallah Mohamed] South Valley Univ, Fac Vet Med, Dept Anim Med, Qena, Egypt	Hokkaido University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Egyptian Knowledge Bank (EKB); South Valley University Egypt	Tsubota, T (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Lab Wildlife Biol & Med, Sapporo, Hokkaido, Japan.	tsubota@vetmed.hokudai.ac.jp	Maldonado, Jesus/AIE-8664-2022	Maldonado, Jesus/0000-0002-4282-1072; Moustafa, Mohamed Abdallah Mohamed/0000-0002-9413-694X; Kadariya, Rabin/0000-0002-0490-6892	Program for Leading Graduate Schools of Hokkaido University; Rufford Foundation [18343-1/7382bb-2]	Program for Leading Graduate Schools of Hokkaido University; Rufford Foundation	This study was partially funded by Grant-in-Aid from the Program for Leading Graduate Schools of Hokkaido University (RK), URL: http://leading.vetmed.hokudai.ac.jp/en/and The Rufford Foundation, Grant No. 18343-1/7382bb-2 (RK), URL: https://www.rufford.org/projects/rabin_ kadariya_ 0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161717; Allendorf F, 2013, CONSERV GENET, V2nd; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Aramilev Vladimir V., 2006, P86; Bajracharya SB, 2005, ENVIRON CONSERV, V32, P239, DOI 10.1017/S0376892905002298; Bajracharya SB, 2006, BIODIVERS CONSERV, V15, P2765, DOI 10.1007/s10531-005-1343-x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bhattarai BR, 2017, J MT SCI-ENGL, V14, P964, DOI 10.1007/s11629-016-3980-9; Brinkman TJ, 2010, CONSERV GENET, V11, P1547, DOI 10.1007/s10592-009-9928-7; Choi EH, 2010, MITOCHONDR DNA, V21, P105, DOI 10.3109/19401736.2010.491864; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dutta T, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0132005, DOI 10.1371/JOURNAL.PONE.0132005]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Frankham R, 2009, INTRO CONSERVATION G; Galbreath GJ, 2008, URSUS, V19, P85, DOI 10.2192/07SC007R2.1; Garshelis D., 2016, IUCN RED LIST THREAT, DOI [DOI 10.1037/a0029314, 10.2305/IUCN.UK.2016-3.RLTS.T22824A45034242.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22824A45034242.EN]; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Heptner VG, 1998, MAMMALS SOVIET UNION, V2; Hirata D, 2013, MOL BIOL EVOL, V30, P1644, DOI 10.1093/molbev/mst077; Hou WR, 2007, INT J BIOL SCI, V3, P85; Hwang DS, 2008, MITOCHONDR DNA, V19, P418, DOI 10.1080/19401730802389525; JIMENEZ JA, 1994, SCIENCE, V266, P271, DOI 10.1126/science.7939661; Jnawali SR, 2011, STATUS NEPAL MAMMALS; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kim YK, 2011, J HERED, V102, P165, DOI 10.1093/jhered/esq121; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitahara E, 2000, MOL ECOL, V9, P1661, DOI 10.1046/j.1365-294x.2000.01030.x; KRAUSE J, 2008, BMC EVOL BIOL, V8; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lan TY, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1804; Lande R., 1987, VIABLE POPULATIONS C, P87, DOI DOI 10.1017/CBO9780511623400.007; Latham E, 2012, URSUS, V23, P145, DOI 10.2192/URSUS-D-11-00022R2.1; Malcolm KD, 2014, GLOB ECOL CONSERV, V2, P267, DOI 10.1016/j.gecco.2014.09.010; Meredith EP, 2009, CONSERV GENET, V10, P693, DOI 10.1007/s10592-008-9617-y; Mukesh, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132005; Mukesh, 2013, CONSERV GENET RESOUR, V5, P1079, DOI 10.1007/s12686-013-9988-3; Murphy MA, 2007, CONSERV GENET, V8, P1219, DOI 10.1007/s10592-006-9264-0; Nei M., 2000, MOL EVOLUTION PHYLOG; Nepal Ministry of Forests and Social Conservation (MoFSC), 2016, CONS LANDSC NEP, P60; Ngoprasert Dusit, 2013, International Bear News, V22, P30; Ngoprasert D, 2012, URSUS, V23, P117, DOI 10.2192/URSUS-D-11-00009.1; Niraula RR, 2013, J ENVIRON MANAGE, V126, P20, DOI 10.1016/j.jenvman.2013.04.006; NTNC, 2017, ANN CONS AR MAN PLAN; Ohnishi N, 2009, HEREDITY, V102, P579, DOI 10.1038/hdy.2009.28; Ohnishi N, 2007, CONSERV GENET, V8, P1331, DOI 10.1007/s10592-006-9281-z; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pocock RI., 1941, FAUNA BRIT INDIA INC, V2; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; Prugh LR, 2005, MOL ECOL, V14, P1585, DOI 10.1111/j.1365-294X.2005.02533.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Rambaut A., 2018, TRACER V1 7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saito M, 2008, URSUS, V19, P162, DOI 10.2192/08GR006.1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith DA, 2006, MOL ECOL, V15, P387, DOI 10.1111/j.1365-294X.2005.02841.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stubblefield CH, 2007, URSUS, V18, P101, DOI 10.2192/1537-6176(2007)18[101:SOABBI]2.0.CO;2; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai CL, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.1971.1.2; Uno R, 2015, MAMM STUDY, V40, P231; Uno R, 2012, POPUL ECOL, V54, P509, DOI 10.1007/s10144-012-0328-3; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wasser SK, 1997, MOL ECOL, V6, P1091, DOI 10.1046/j.1365-294X.1997.00281.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White TH, 2000, BIOL CONSERV, V95, P323, DOI 10.1016/S0006-3207(00)00024-0; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Wu JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136398; Yadav Bhupendra Prasad, 2012, International Bear News, V21, P20; Yadav Shailendra Kumar, 2017, International Bear News, V26, P23; Yamamoto K, 2002, J VET MED SCI, V64, P505, DOI 10.1292/jvms.64.505; Yasukochi Y, 2009, J HERED, V100, P297, DOI 10.1093/jhered/esn097; YU L, 2007, BMC EVOL BIOL, V7; [No title captured]	89	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207662	10.1371/journal.pone.0207662	http://dx.doi.org/10.1371/journal.pone.0207662			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517155	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400057
J	Shibata, D; Ito, K; Nagai, H; Okahisa, T; Kinoshita, A; Aramaki, E				Shibata, Daisaku; Ito, Kaoru; Nagai, Hiroyuki; Okahisa, Taro; Kinoshita, Ayae; Aramaki, Eiji			Idea density in Japanese for the early detection of dementia based on narrative speech	PLOS ONE			English	Article								Background Idea density (ID), a natural language processing-based index, was developed to aid in the detection of dementia through the analysis of English narratives. However, it has not been applied to non-English languages due to the difficulties in translating grammatical concepts. In this study, we defined rules to count ideas in Japanese narratives based on a previous study and proposed a novel method to estimate ID in Japanese text using machine translation. Materials The study participants comprised 42 Japanese patients with dementia aged 69-98 years (mean: 84.95 years). We collected free narratives from the participants to build a speech corpus. The narratives of the patients were translated into English using three machine translation systems: Google Translate, Bing Translator, and Excite Translator. The ID in the translated text was then calculated using the Dependency-based Propositional ID (DEPID), an English ID scoring tool. Results The maximum correlation coefficient between ID calculated using DEPID-R-ADD (a modified DEPID method to calculate ID after removing vague sentences) and the Mini-Mental State Examination score was 0.473, indicating a moderate correlation. Discussion The results demonstrate the feasibility of machine translation-based ID measurement. We believe that the basic concept of this translation approach can be applied to other non-English languages.	[Shibata, Daisaku; Ito, Kaoru; Aramaki, Eiji] Nara Inst Sci & Technol NAIST, Grad Sch Sci & Technol, 8916-5 Takayama, Ikoma City 6300192, Japan; [Nagai, Hiroyuki; Okahisa, Taro] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto 6068501, Japan; [Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan	Nara Institute of Science & Technology; Kyoto University; Kyoto University	Aramaki, E (corresponding author), Nara Inst Sci & Technol NAIST, Grad Sch Sci & Technol, 8916-5 Takayama, Ikoma City 6300192, Japan.	socialcomputing-office@is.naist.jp		ARAMAKI, Eiji/0000-0003-0201-3609	JST CREST [JPMJCR16E2]; JSPS KAKENHI [JP16H06395, JP16H06399, JP16K12489]	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST CREST (https://www.jst.go.jp/EN/index.html) JPMJCR16E2 and JSPS KAKENHI (https://www.jsps.go.jp/english/index.html), JP16H06395, JP16H06399, and JP16K12489. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown C, 2008, BEHAV RES METHODS, V40, P540, DOI 10.3758/BRM.40.2.540; Chand V, 2012, CURRENT PROTOCOLS NE, P10; De Marneffe M.-C., 2008, TECHNICAL REPORT; Jarrold WL, 2010, LECT NOTES ARTIF INT, V6334, P299, DOI 10.1007/978-3-642-15314-3_28; KINTSCH W, 1973, COGNITIVE PSYCHOL, V5, P257, DOI 10.1016/0010-0285(73)90036-4; Kudo T., 2004, P C EMP METH NAT LAN; Li JJ, 2015, AAAI CONF ARTIF INTE, P2281; Morita H., 2015, P 2015 C EMP METH NA, P2292; Prince M, 2015, WORLD ALZHEIMERS REP; Roark B, 2011, IEEE T AUDIO SPEECH, V19, P2081, DOI 10.1109/TASL.2011.2112351; Sirts K., 2017, P 21 C COMP NAT LANG, P322; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528	12	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208418	10.1371/journal.pone.0208418	http://dx.doi.org/10.1371/journal.pone.0208418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517200	gold, Green Submitted, Green Published			2022-12-26	WOS:000452212400095
J	Vazquez-Del Mercado, M; Perez-Vazquez, FD; Gomez-Banuelos, E; Chavarria-Avila, E; Llamas-Garcia, A; Arrona-Rios, KI; Diaz-Rubio, GI; Duran-Barragan, S; Navarro-Hernandez, RE; Jordan-Estrada, BP; Prado-Bachega, N; Gonzalez-Beltran, MAA; Ramos-Becerra, C; Grover-Paez, F; Cardona-Muller, D; Cardona-Munoz, EG				Vazquez-Del Mercado, Monica; Perez-Vazquez, Felipe de J.; Gomez-Banuelos, Eduardo; Chavarria-Avila, Efrain; Llamas-Garcia, Arcelia; Arrona-Rios, Karla, I; Diaz-Rubio, Gustavo Ignacio; Duran-Barragan, Sergio; Navarro-Hernandez, Rosa E.; Jordan-Estrada, Bethel P.; Prado-Bachega, Natalia; Gonzalez-Beltran, Miguel A. A.; Ramos-Becerra, Carlos; Grover-Paez, Fernando; Cardona-Muller, David; Cardona-Munoz, Ernesto G.			Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; INTIMA-MEDIA THICKNESS; DISEASE-ACTIVITY; ATHEROSCLEROSIS; WOMEN; INDEX	It is well known that cardiovascular diseases (CVD) are a major contributor of death in systemic lupus erythematosus (SLE) as well in other rheumatic illness. In the last decades, there has been a growing development of different methodologies with the purpose of early detection of CVD. Objective: The aim of this study is to correlate the usefulness of subclinical parameters of vascular aging and QRISK 3-2017 score for early detection of CVD in SLE. Methods: Clinical assessment including systemic lupus erythematosus disease activity index (SLEDAI) and systemic lupus international collaborating clinics / american college of rheumatology damage index (SLICC/ACR DI), laboratory measurements, carotid ultra-sound examination, carotid intima media thickness (cIMT) measurement, carotid distention and diameter analysis, arterial stiffness measurement measured by tonometry and QRISK 3-2017 were done. All results were analyzed by SPSS 24 software. Results: We observed correlation between QRISK3 and mean cIMT (rs = 0.534, P <0.001), PWV (rs = 0.474, P < 0.001), cfPWV (rs = 0.569, P <0.001) and distensibility (rs = -0.420, P = 0.006). Consistent with above, SLE patients in middle and high risk QRISK 3-2017 showed increased arterial stiffness versus low risk group. Conclusions: We encourage to the rheumatology community to assess cardiovascular risk in SLE patients with QRISK 3-2017 risk calculator as an alternative method at the outpatient clinic along a complete cardiovascular evaluation when appropriate.	[Vazquez-Del Mercado, Monica; Perez-Vazquez, Felipe de J.; Chavarria-Avila, Efrain; Diaz-Rubio, Gustavo Ignacio; Duran-Barragan, Sergio; Navarro-Hernandez, Rosa E.; Jordan-Estrada, Bethel P.; Prado-Bachega, Natalia; Gonzalez-Beltran, Miguel A. A.] Univ Guadalajara, Ctr Univ Ciencias Salud, IIRSME, Guadalajara, Jalisco, Mexico; [Vazquez-Del Mercado, Monica; Gomez-Banuelos, Eduardo; Llamas-Garcia, Arcelia; Arrona-Rios, Karla, I; Duran-Barragan, Sergio] Hosp Civil Guadalajara Dr Juan I Menchaca, Serv Reumatol, Div Med Interna, CONACyT PNPC, Guadalajara, Jalisco, Mexico; [Ramos-Becerra, Carlos; Grover-Paez, Fernando; Cardona-Muller, David; Cardona-Munoz, Ernesto G.] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Terapeut Expt & Clin INTEC, Guadalajara, Jalisco, Mexico	Universidad de Guadalajara; Universidad de Guadalajara	Vazquez-Del Mercado, M (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Salud, IIRSME, Guadalajara, Jalisco, Mexico.; Vazquez-Del Mercado, M (corresponding author), Hosp Civil Guadalajara Dr Juan I Menchaca, Serv Reumatol, Div Med Interna, CONACyT PNPC, Guadalajara, Jalisco, Mexico.	dravme@hotmail.com	; NAVARRO-HERNANDEZ, ROSA-ELENA/B-3242-2015; Duran-Barragan, Sergio/G-2863-2019; Vazquez-Del Mercado, Monica/F-5856-2017; CHAVARRIA-AVILA, EFRAIN/G-5153-2017	Llamas Garcia, Arcelia/0000-0003-4140-1508; NAVARRO-HERNANDEZ, ROSA-ELENA/0000-0001-5531-5403; Duran-Barragan, Sergio/0000-0003-4581-7260; Diaz-Rubio, Gustavo Ignacio/0000-0002-6643-2186; Cardona-Muller, David/0000-0002-9470-2489; Vazquez-Del Mercado, Monica/0000-0002-3823-4676; Perez-Vazquez, Felipe/0000-0003-0697-9371; CHAVARRIA-AVILA, EFRAIN/0000-0001-7588-3870				Ahmad HM, 2014, RHEUMATOL INT, V34, P617, DOI 10.1007/s00296-013-2875-0; Bjarnegard N, 2006, LUPUS, V15, P644, DOI 10.1177/0961203306071402; Cacciapaglia F, 2009, LUPUS, V18, P249, DOI 10.1177/0961203308097571; Cardoso CRL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122044; Chirinos JA, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005903; Croca S, 2017, BEST PRACT RES CL RH, V31, P364, DOI 10.1016/j.berh.2017.09.012; Crowson CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174656; Cypiene A, 2009, LUPUS, V18, P522, DOI 10.1177/0961203308099625; Fadda S, 2015, Z RHEUMATOL, V74, P529, DOI 10.1007/s00393-014-1473-1; Frieri M, 2016, AUTOIMMUN REV, V15, P16, DOI 10.1016/j.autrev.2015.08.007; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Greene ER, 2009, IEEE ENG MED BIO, P1109, DOI 10.1109/IEMBS.2009.5334459; Gustafsson JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174572; HAWKER G, 1993, J RHEUMATOL, V20, P657; HIPPISLEYCOX J, 2017, BMJ BRIT MED J, V357; HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78; Hoeks APG, 1997, ULTRASOUND MED BIOL, V23, P1017, DOI 10.1016/S0301-5629(97)00119-1; Kao AH, 2013, AM J CARDIOL, V112, P1025, DOI 10.1016/j.amjcard.2013.05.040; Kocabay G, 2012, J CARDIOL, V59, P72, DOI 10.1016/j.jjcc.2011.09.004; Kravvariti E, 2018, RHEUMATOLOGY, V57, P2158, DOI 10.1093/rheumatology/key233; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Sabio JM, 2015, J RHEUMATOL, V42, P2310, DOI 10.3899/jrheum.150531; Pike MM, 2016, J CARDIOVASC TRANSL, V9, P214, DOI 10.1007/s12265-016-9687-z; Rivera-Lopez R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152291; Teixeira V, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00262; Tziomalos K, 2017, RHEUMATOL INT, V37, P293, DOI 10.1007/s00296-016-3610-4; Vazquez-Del Mercado M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007862; Wang P, 2018, ANGIOLOGY, V69, P228, DOI 10.1177/0003319717715964; Yildiz M, 2008, KARDIOL POL, V66, P1194; Zhang L, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-39	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207520	10.1371/journal.pone.0207520	http://dx.doi.org/10.1371/journal.pone.0207520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517121	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400040
J	Chan, JKY; Gil-Farina, I; Johana, N; Rosales, C; Tan, YW; Ceiler, J; Mcintosh, J; Ogden, B; Waddington, SN; Schmidt, M; Biswas, A; Choolani, M; Nathwani, AC; Mattar, CNZ				Chan, Jerry K. Y.; Gil-Farina, Irene; Johana, Nuryanti; Rosales, Cecilia; Tan, Yi Wan; Ceiler, Jessika; Mcintosh, Jenny; Ogden, Bryan; Waddington, Simon N.; Schmidt, Manfred; Biswas, Arijit; Choolani, Mahesh; Nathwani, Amit C.; Mattar, Citra N. Z.			Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques	FASEB JOURNAL			English	Article						nonhuman primate; immune tolerance; genotoxicity	INNATE IMMUNE-RESPONSES; LONG-TERM SAFETY; IN-UTERO; EFFICIENT TRANSDUCTION; VIRUS VECTORS; HUMAN FIX; PROTHROMBIN COMPLEX; MURINE MODEL; LIVER; AAV	Adeno-associated viral vectors (AAVs) achieve stable therapeutic expression without long-term toxicity in adults with hemophilia. To avert irreversible complications in congenital disorders producing early pathogenesis, safety and efficacy of AAV-intrauterine gene transfer (IUGT) requires assessment. We therefore performed IUGT of AAV5 or -8 with liver-specific promoter-1 encoding either human coagulation factors IX (hFIX) or X (hFX) into Macaca fascicularis fetuses at approximate to 0.4 gestation. The initial cohort received 1 x 10(12) vector genomes (vgs) of AAV5-hFIX (n = 5; 0.45 x 10(13) vg/kg birth weight), resulting in approximate to 3.0% hFIX at birth and 0.6-6.8% over 19-51 mo. The next cohort received 0.2-1 x 10(13) vg boluses. AAV5-hFX animals (n = 3; 3.57 x 10(13) vg/kg) expressed <1% at birth and 9.4-27.9% up to 42 mo. AAV8-hFIX recipients (n = 3; 2.56 x 10(13) vg/kg) established 4.2-41.3% expression perinatally and 9.8-25.3% over 46 mo. Expression with AAV8-hFX (n = 6, 3.12 x 10(13) vg/kg) increased from <1% perinatally to 9.8-13.4% >35 mo. Low expressers (<1%, n = 3) were postnatally challenged with 2 x 10(11) vg/kg AAV5 resulting in 2.4-13.2% expression and demonstrating acquired tolerance. Linear amplification-mediated-PCR analysis demonstrated random integration of 57-88% of AAV sequences retrieved from hepatocytes with no events occurring in or near oncogenesis-associated genes. Thus, early-IUGT in macaques produces sustained curative expression related significantly to integrated AAV in the absence of clinical toxicity, supporting its therapeutic potential for early-onset monogenic disorders.Chan, J. K. Y., Gil-Farina I., Johana, N., Rosales, C., Tan, Y. W., Ceiler, J., Mcintosh, J., Ogden, B., Waddington, S. N., Schmidt, M., Biswas, A., Choolani, M., Nathwani, A. C., Mattar, C. N. Z. Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques.	[Chan, Jerry K. Y.; Johana, Nuryanti; Tan, Yi Wan] KK Womens & Childrens Hosp, Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke Natl Univ Singapore NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Gil-Farina, Irene; Ceiler, Jessika; Biswas, Arijit] German Canc Res Ctr, Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Rosales, Cecilia; Schmidt, Manfred; Nathwani, Amit C.] UCL, United Coll London UCL Canc Inst, London, England; [Waddington, Simon N.] UCL, Inst Womens Hlth, London, England; [Mcintosh, Jenny; Choolani, Mahesh; Mattar, Citra N. Z.] Natl Univ Singapore, Yong Loo Lin Sch Med, Obstet & Gynaecol, Level 12 Tower Block, Singapore 119228, Singapore; [Ogden, Bryan] Singapore Hlth Serv Pte, SingHlth Expt Med Ctr, Singapore, Singapore; [Waddington, Simon N.] Univ Witwatersrand, Fac Hlth Sci, Wits South African Med Res Council SAMRC Antivira, Johannesburg, South Africa; [Schmidt, Manfred] GeneWerk, Heidelberg, Germany	KK Women's & Children's Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of London; University College London; University of London; University College London; National University of Singapore; University of Witwatersrand	Chan, JKY (corresponding author), KK Womens & Childrens Hosp, Reprod Med, Singapore, Singapore.; Mattar, CNZ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Obstet & Gynaecol, Level 12 Tower Block, Singapore 119228, Singapore.	jerrychan@duke-nus.edu.sg; citramattar@nus.edu.sg	Waddington, Simon/G-3778-2011	Waddington, Simon/0000-0003-4970-4730; Mattar, Citra Nurfarah/0000-0003-0068-6957	Singapore Ministry of Health's National Medical Research Council (NMRC) [NMRC/CSA/043/2012, NMRC/CSA(SI)/008/2016, CIRG/1459/2016]; NMRC [NMRC/TA/0003/2012, NMRC/CSA-INV/0012/2016]; Singapore's Ministry of Health's NMRC Grant [NMRC/CSA(SI)/008/2016]; NC3Rs Grant [NC/L001780/1]; Medical Research Council [MR/P026494/1]; MRC [MR/R015325/1, G0902219, G0502121, MR/P026494/1, MR/L013185/1] Funding Source: UKRI	Singapore Ministry of Health's National Medical Research Council (NMRC)(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NMRC(National Medical Research Council, Singapore); Singapore's Ministry of Health's NMRC Grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NC3Rs Grant(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Durga Elangovam, Rowell Fragata, Lay Geok Tan (all from the Yong Loo Lin School of Medicine, National University of Singapore), Darvi Michell B. Sergi, Jose Sebastian David, and Vivienne Liang (all from SingHealth Experimental Medicine Centre) for contributions to the animal experiments and for providing veterinary support for the macaque colony. This work was supported by research funding from the Singapore Ministry of Health's National Medical Research Council (NMRC) Grants NMRC/CSA/043/2012, NMRC/CSA(SI)/008/2016 and CIRG/1459/2016 (to J.K.Y.C.); and NMRC Grants NMRC/TA/0003/2012 and NMRC/CSA-INV/0012/2016 (both to C.N.Z.M.). Salary support came from the Singapore's Ministry of Health's NMRC Grant NMRC/CSA(SI)/008/2016 (to J.C.); from the NC3Rs Grant NC/L001780/1 and Medical Research Council Grant MR/P026494/1 (to S.N.W.); and from NMRC/CSA/007/2009 and NMRC/CSA/0059/2014 (to M.C.). This work was produced in Singapore, London, United Kingdom, and Heidelberg, Germany. A.C.N. reports patents related to factor IX in gene therapy vectors (U.S. Patent No. 8,030,065, U.S. Patent No. 8,168,425, and European Patent No. 1,804,839). M.S. is cofounder and CEO of GeneWerk. The remaining authors declare no conflicts of interest.	Arens A, 2012, HUM GENE THER METHOD, V23, P111, DOI 10.1089/hgtb.2011.219; Attard C, 2013, J THROMB HAEMOST, V11, P1850, DOI 10.1111/jth.12372; Behrman R. E., 2007, MEASUREMENT FETAL IN; Binny C, 2012, BLOOD, V119, P957, DOI 10.1182/blood-2011-09-377630; Boelig MM, 2016, BIOL BLOOD MARROW TR, V22, P991, DOI 10.1016/j.bbmt.2016.01.017; Buckley SMK, 2011, THER DELIV, V2, P461, DOI 10.4155/TDE.11.17; Chandler RJ, 2017, HUM GENE THER, V28, P314, DOI 10.1089/hum.2017.009; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Chong MSK, 2010, METHODS MOL BIOL, V614, P135, DOI 10.1007/978-1-60761-533-0_9; Cooper DN, 1997, THROMB HAEMOSTASIS, V78, P161; Cotugno G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033286; David AL, 2006, ULTRASOUND OBST GYN, V28, P82, DOI 10.1002/uog.2815; David Anna L, 2012, Methods Mol Biol, V891, P9, DOI 10.1007/978-1-61779-873-3_2; David AL, 2011, HUM GENE THER, V22, P419, DOI 10.1089/hum.2010.007; Davidoff AM, 2005, MOL THER, V11, P875, DOI 10.1016/j.ymthe.2004.12.022; Del Monte U, 2009, CELL CYCLE, V8, P505, DOI 10.4161/cc.8.3.7608; Descamps D, 2009, CURR GENE THER, V9, P115, DOI 10.2174/156652309787909544; Epcacan S, 2015, EUR J CLIN INVEST, V45, P1087, DOI 10.1111/eci.12511; Ferreira Carlos R, 2017, Transl Sci Rare Dis, V2, P1, DOI 10.3233/TRD-160005; George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; Guedj F, 2013, PRENATAL DIAG, V33, P614, DOI 10.1002/pd.4134; HANSMANN M, 1991, ULTRASOUND OBST GYN, V1, P162, DOI 10.1046/j.1469-0705.1991.01030162.x; Hinderer C, 2018, HUM GENE THER, V29, P285, DOI 10.1089/hum.2018.015; Inagaki K, 2008, J VIROL, V82, P9513, DOI 10.1128/JVI.01001-08; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kohler M, 1998, THROMB HAEMOSTASIS, V80, P399; Lechler E, 1999, THROMB RES, V95, pS39, DOI 10.1016/S0049-3848(99)00083-3; Leone P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003454; Li H, 2011, MOL THER, V19, P2021, DOI 10.1038/mt.2011.81; Liu YC, 2012, STEM CELLS, V30, P1911, DOI 10.1002/stem.1164; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P697, DOI 10.1016/j.bpobgyn.2012.06.006; Mattar Citra N, 2012, Methods Mol Biol, V891, P249, DOI 10.1007/978-1-61779-873-3_12; Mattar CNZ, 2017, MOL THER, V25, P1843, DOI 10.1016/j.ymthe.2017.04.003; Mattar CNZ, 2011, MOL THER, V19, P1950, DOI 10.1038/mt.2011.107; Mauldin Jill, 2000, Indian Journal of Pediatrics, V67, P899, DOI 10.1007/BF02723955; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Merianos DJ, 2009, J CLIN INVEST, V119, P2590, DOI 10.1172/JCI38979; Miao CH, 2000, J VIROL, V74, P3793, DOI 10.1128/JVI.74.8.3793-3803.2000; Miesbach W, 2018, BLOOD, V131, P1022, DOI 10.1182/blood-2017-09-804419; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Monahan PE, 2000, MOL MED TODAY, V6, P433, DOI 10.1016/S1357-4310(00)01810-4; Morovvati S., 2015, HEMATOLOGY, DOI [10.1179/1607845415Y.0000000019, DOI 10.1179/1607845415Y.0000000019]; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nakai H, 2002, J VIROL, V76, P11343, DOI 10.1128/JVI.76.22.11343-11349.2002; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2002, BLOOD, V100, P1662, DOI 10.1182/blood-2002-02-0589; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Nathwani AC, 2007, BLOOD, V109, P1414, DOI 10.1182/blood-2006-03-010181; Nathwani AC, 2017, HEMATOL ONCOL CLIN N, V31, P853, DOI 10.1016/j.hoc.2017.06.011; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Nijagal A, 2011, J CLIN INVEST, V121, P582, DOI 10.1172/JCI44907; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Pipe SW, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26865; Rogers GL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00194; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; Sugano H, 2012, HUM GENE THER, V23, P399, DOI 10.1089/hum.2011.148; Thrasher AJ, 2005, BLOOD, V105, P4255, DOI 10.1182/blood-2004-12-4837; Uprichard J, 2002, BLOOD REV, V16, P97, DOI 10.1054/blre.2002.0191; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Wang LL, 2011, MOL THER, V19, P2012, DOI 10.1038/mt.2011.151; Wang YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043039; Zaiss AK, 2005, CURR GENE THER, V5, P323, DOI 10.2174/1566523054065039; Zaiss AK, 2002, J VIROL, V76, P4580, DOI 10.1128/JVI.76.9.4580-4590.2002; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456	72	15	15	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3954	3967		10.1096/fj.201801391R	http://dx.doi.org/10.1096/fj.201801391R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30517034	hybrid, Green Published			2022-12-26	WOS:000459794800068
J	Tascher, G; Gerbaix, M; Maes, P; Chazarin, B; Ghislin, S; Antropova, E; Vassilieva, G; Ouzren-Zarhloul, N; Gauquelin-Koch, G; Vico, L; Frippiat, JP; Bertile, F				Tascher, Georg; Gerbaix, Maude; Maes, Pauline; Chazarin, Blandine; Ghislin, Stephanie; Antropova, Evgenia; Vassilieva, Galina; Ouzren-Zarhloul, Nassima; Gauquelin-Koch, Guillemette; Vico, Laurence; Frippiat, Jean-Pol; Bertile, Fabrice			Analysis of femurs from mice embarked on board BION-M1 biosatellite reveals a decrease in immune cell development, including B cells, after 1 wk of recovery on Earth	FASEB JOURNAL			English	Article						lymphopoiesis; bone; immunity; proteomics; gravity	AMPHIBIAN PLEURODELES-WALTL; IMMUNOGLOBULIN HEAVY-CHAINS; BONE-MARROW; SPACEFLIGHT CONDITIONS; TRANSCRIPTION; HYPERGRAVITY; REPERTOIRE; PRECURSORS; EXPRESSION; INFECTION	Bone loss and immune dysregulation are among the main adverse outcomes of spaceflight challenging astronauts' health and safety. However, consequences on B-cell development and responses are still under-investigated. To fill this gap, we used advanced proteomics analysis of femur bone and marrow to compare mice flown for 1 mo on board the BION-M1 biosatellite, followed or not by 1 wk of recovery on Earth, to control mice kept on Earth. Our data revealed an adverse effect on B lymphopoiesis 1 wk after landing. This phenomenon was associated with a 41% reduction of B cells in the spleen. These reductions may contribute to explain increased susceptibility to infection even if our data suggest that flown animals can mount a humoral immune response. Future studies should investigate the quality/efficiency of produced antibodies and whether longer missions worsen these immune alterations.Tascher, G., Gerbaix, M., Maes, P., Chazarin, B., Ghislin, S., Antropova, E., Vassilieva, G., Ouzren-Zarhloul, N., Gauquelin-Koch, G., Vico, L., Frippiat, J.-P., Bertile, F. Analysis of femurs from mice embarked on board BION-M1 biosatellite reveals a decrease in immune cell development, including B cells, after 1 wk of recovery on Earth.	[Tascher, Georg; Maes, Pauline; Chazarin, Blandine; Bertile, Fabrice] Univ Strasbourg, CNRS, IPHC, UMR 7178, 25 Rue Becquerel, F-67087 Strasbourg 2, France; [Tascher, Georg; Gerbaix, Maude; Chazarin, Blandine; Gauquelin-Koch, Guillemette] CNES, Paris, France; [Gerbaix, Maude; Vico, Laurence] Univ Jean Monnet, Univ Lyon, Fac Med, INSERM,Unite 1059 Sainbiose, Campus Sante Innovat, St Etienne, France; [Ghislin, Stephanie; Ouzren-Zarhloul, Nassima; Frippiat, Jean-Pol] Lorraine Univ, Fac Med, Stress Immun Pathogens Lab, Equipe Accueil 7300, Vandoeuvre Les Nancy, France; [Antropova, Evgenia; Vassilieva, Galina] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences	Bertile, F (corresponding author), Univ Strasbourg, CNRS, IPHC, UMR 7178, 25 Rue Becquerel, F-67087 Strasbourg 2, France.	fbertile@unistra.fr	Bertile, Fabrice/ABE-1479-2020; Vico, Laurence/O-1927-2018; Vassilieva, Galina Yu./AAG-3853-2020; Bertile, Fabrice/F-1287-2019	Bertile, Fabrice/0000-0001-5510-4868; Vico, Laurence/0000-0002-2110-287X; Vassilieva, Galina Yu./0000-0003-0879-889X; Bertile, Fabrice/0000-0001-5510-4868; Tascher, Georg/0000-0002-5907-3947	French Space Agency (CNES); French National Center for Scientific Research, Strasbourg University; French Proteomic Infrastructure (ProFI) [ANR-10-INSB-08-03]; French Ministry of Higher Education and Research; Universite de Lorraine; Region Lorraine [65.1]; Program of Fundamental Research of the Institute for Biomedical Problems [65.1]; Impact Biomolecules Project of the Lorraine Universite d'Excellence [ANR 15-004]	French Space Agency (CNES)(Centre National D'etudes Spatiales); French National Center for Scientific Research, Strasbourg University; French Proteomic Infrastructure (ProFI); French Ministry of Higher Education and Research; Universite de Lorraine; Region Lorraine(Region Grand-Est); Program of Fundamental Research of the Institute for Biomedical Problems; Impact Biomolecules Project of the Lorraine Universite d'Excellence	This work was supported by the French Space Agency (CNES), the French National Center for Scientific Research, Strasbourg University (H2E projEx; IdEx), the French Proteomic Infrastructure (ProFI; ANR-10-INSB-08-03), the French Ministry of Higher Education and Research, the Universite de Lorraine, the Region Lorraine, and the Program of Fundamental Research (Theme 65.1) of the Institute for Biomedical Problems. Members of the Stress Immunity Pathogens Laboratory acknowledge support from the Impact Biomolecules Project of the Lorraine Universite d'Excellence (Investissements d'Avenir-ANR 15-004). The authors are also grateful to the neXtProt team, who helped extract target tissue expression information. The authors declare no conflicts of interest.	Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Belay T, 2002, J ALLERGY CLIN IMMUN, V110, P262, DOI 10.1067/mai.2002.126459; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carapito C, 2014, PROTEOMICS, V14, P1014, DOI 10.1002/pmic.201300415; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Crucian B, 2016, INT J GEN MED, V9, P383, DOI 10.2147/IJGM.S114188; Fonte C, 2015, DEV COMP IMMUNOL, V53, P371, DOI 10.1016/j.dci.2015.08.006; Frippiat JP, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.40; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Gerbaix M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00746; Gerbaix M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03014-2; Gerbaix M, 2015, BONE, V71, P94, DOI 10.1016/j.bone.2014.10.011; Ghislin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09318; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; R Core Team, 2018, R LANG ENV STAT COMP; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Sotnezova EV, 2017, B EXP BIOL MED+, V162, P496, DOI 10.1007/s10517-017-3647-8; Thiel CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05580-x; VACEK A, 1991, FOLIA BIOL-PRAGUE, V37, P35; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Woods CC, 2003, FASEB J, V17, P1526, DOI 10.1096/fj.02-0749fje; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639	40	22	22	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3772	3783		10.1096/fj.201801463R	http://dx.doi.org/10.1096/fj.201801463R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521760	Bronze, Green Submitted			2022-12-26	WOS:000459794800055
J	Li, JL; Paris, SA; Thakur, H; Kapiloff, MS; Dodge-Kafka, KL				Li, Jinliang; Paris, Shania Aponte; Thakur, Hrishikesh; Kapiloff, Michael S.; Dodge-Kafka, Kimberly L.			Muscle A-kinase-anchoring protein-beta-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; skeletal muscle; signal transduction; scaffold protein; phosphorylation; calcineurin; histone deacetylase; mAKAP beta; MEF2D; HDAC5; transcription factor; gene regulation; myoblast; A-kinase-anchoring protein; signalosome	IIA HISTONE DEACETYLASES; MAKAP-BETA; DEPENDENT REGULATION; MEF2; PHOSPHORYLATION; SCAFFOLD; DIFFERENTIATION; HYPERTROPHY; CONTRIBUTES; ACTIVATION	Myocyte enhancer factor 2 (MEF2) transcription factors are key regulators of the development and adult phenotype of diverse tissues, including skeletal and cardiac muscles. Controlled by multiple post-translational modifications, MEF2D is an effector for the Ca2+/calmodulin-dependent protein phosphatase calcineurin (CaN, PP2B, and PPP3). CaN-catalyzed dephosphorylation promotes the desumoylation and acetylation of MEF2D, increasing its transcriptional activity. Both MEF2D and CaN bind the scaffold protein muscle A-kinase-anchoring protein beta (mAKAP beta), which is localized to the nuclear envelope, such that C2C12 skeletal myoblast differentiation and neonatal rat ventricular myocyte hypertrophy are inhibited by mAKAP beta signalosome targeting. Using immunoprecipitation and DNA-binding assays, we now show that the formation of mAKAP beta signalosomes is required for MEF2D dephosphorylation, desumoylation, and acetylation in C2C12 cells. Reduced MEF2D phosphorylation was coupled to a switch from type IIa histone deacetylase to p300 histone acetylase binding that correlated with increased MEF2D-dependent gene expression and ventricular myocyte hypertrophy. Together, these results highlight the importance of mAKAP beta signalosomes for regulating MEF2D activity in striated muscle, affirming mAKAP beta as a nodal regulator in the myocyte intracellular signaling network.	[Li, Jinliang; Thakur, Hrishikesh; Kapiloff, Michael S.] Stanford Univ, Dept Ophthalmol, Byers Eye Inst, Palo Alto, CA 94304 USA; [Li, Jinliang; Thakur, Hrishikesh; Kapiloff, Michael S.] Stanford Univ, Dept Cardiovasc Med, Byers Eye Inst, Palo Alto, CA 94304 USA; [Li, Jinliang; Thakur, Hrishikesh; Kapiloff, Michael S.] Stanford Univ, Stanford Cardiovasc Inst, Spencer Ctr Vis Res, Palo Alto, CA 94304 USA; [Paris, Shania Aponte; Dodge-Kafka, Kimberly L.] Univ Connecticut, Ctr Hlth, Calhoun Ctr Cardiol, Farmington, CT 06030 USA	Stanford University; Stanford University; Stanford University; University of Connecticut	Kapiloff, MS (corresponding author), Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA.; Kapiloff, MS (corresponding author), Stanford Univ, Dept Cardiovasc Med, Palo Alto, CA 94304 USA.; Dodge-Kafka, KL (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA.; Dodge-Kafka, KL (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Cardiol, Farmington, CT 06030 USA.	kapiloff@stanford.edu; dodge@uchc.edu		Kapiloff, Michael/0000-0002-7005-6953; Li, Jinliang/0000-0002-3018-0570	State of Connecticut Department of Public Health [2014-0133]; National Institutes of Health [HL126825, HL126950, EY026766, EY026877]; NATIONAL EYE INSTITUTE [P30EY026877, R01EY026766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126825, R01HL126950] Funding Source: NIH RePORTER	State of Connecticut Department of Public Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by State of Connecticut Department of Public Health Grant 2014-0133 (to K. D. K.) and National Institutes of Health Grants HL126825 (to K. D. K. and M. S. K.) and HL126950, EY026766, and EY026877 (to M. S. K). K. L. D.-K., J. L., and M. S. K. are co-inventors of patented intellectual property concerning the targeting of mAKAP for the treatment of heart failure. M. S. K. owns equity in Anchored RSK3 Inhibitors, LLC, and Cardiac RSK3 Inhibitors, LLC, companies interested in developing mAKAP beta-based therapies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bueno OF, 2004, CIRC RES, V94, P91, DOI 10.1161/01.RES.0000107197.99679.77; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Dewenter M, 2017, CIRC RES, V121, P1000, DOI 10.1161/CIRCRESAHA.117.310355; Dietrich JB, 2013, CELL TISSUE RES, V352, P179, DOI 10.1007/s00441-013-1565-2; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2018, J MOL CELL CARDIOL, V118, P13, DOI 10.1016/j.yjmcc.2018.03.001; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kritzer MD, 2014, CIRC-HEART FAIL, V7, P663, DOI 10.1161/CIRCHEARTFAILURE.114.001266; Lee SW, 2015, SCI REP-UK, V5, DOI 10.1038/srep16523; Li JL, 2013, EXP CELL RES, V319, P447, DOI 10.1016/j.yexcr.2012.12.016; Li JL, 2010, J MOL CELL CARDIOL, V48, P387, DOI 10.1016/j.yjmcc.2009.10.023; Lindqvist J, 2017, J CELL SCI, V130, P2833, DOI 10.1242/jcs.202226; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Molinari S, 2004, MOL CELL BIOL, V24, P2944, DOI 10.1128/MCB.24.7.2944-2957.2004; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Parra V, 2017, J MOL CELL CARDIOL, V103, P121, DOI 10.1016/j.yjmcc.2016.12.006; Passariello CL, 2015, J CARDIOVASC PHARM, V65, P218, DOI 10.1097/FJC.0000000000000206; Passariello CL, 2013, AM J PHYSIOL-HEART C, V305, pH1010, DOI 10.1152/ajpheart.00237.2013; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Taylor MV, 2017, SEMIN CELL DEV BIOL, V72, P33, DOI 10.1016/j.semcdb.2017.11.020; Vargas MAX, 2012, CELL SIGNAL, V24, P1496, DOI 10.1016/j.cellsig.2012.03.017; Xie M, 2013, TRENDS CARDIOVAS MED, V23, P229, DOI 10.1016/j.tcm.2012.12.006; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	44	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2543	2554		10.1074/jbc.RA118.005465	http://dx.doi.org/10.1074/jbc.RA118.005465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30523159	Green Published, hybrid			2022-12-26	WOS:000458895400028
J	Yu, SMW; Jean-Charles, PY; Abraham, DM; Kaur, S; Gareri, C; Mao, L; Rockman, HA; Shenoy, SK				Yu, Samuel Mon-Wei; Jean-Charles, Pierre-Yves; Abraham, Dennis M.; Kaur, Suneet; Gareri, Clarice; Mao, Lan; Rockman, Howard A.; Shenoy, Sudha K.			The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial beta(1)-adrenergic receptor expression and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitylation (ubiquitination); protein kinase A (PKA); lysosome; G protein-coupled receptor (GPCR); endocytosis	IN-VIVO; CARDIAC DYSFUNCTION; BETA(2)-ADRENERGIC RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; PLASMA NOREPINEPHRINE; ADRENERGIC-RECEPTORS; CONTRACTILE FUNCTION; TARGETED DISRUPTION; HEART-FAILURE; KINASE 1	Reversible ubiquitination of G protein-coupled receptors regulates their trafficking and signaling; whether deubiquitinases regulate myocardial beta(1)-adrenergic receptors (beta(1)ARs) is unknown. We report that ubiquitin-specific protease 20 (USP20) deubiquitinates and attenuates lysosomal trafficking of the beta(1)AR. beta(1)AR-induced phosphorylation of USP20 Ser-333 by protein kinase A-alpha (PKA alpha) was required for optimal USP20-mediated regulation of beta(1)AR lysosomal trafficking. Both phosphomimetic (S333D) and phosphorylation-impaired (S333A) USP20 possess intrinsic deubiquitinase activity equivalent to WT activity. However, unlike USP20 WT and S333D, the S333A mutant associated poorly with the beta(1)AR and failed to deubiquitinate the beta(1)AR. USP20-KO mice showed normal baseline systolic function but impaired beta(1)AR-induced contractility and relaxation. Dobutamine stimulation did not increase cAMP in USP20-KO left ventricles (LVs), whereas NKH477-induced adenylyl cyclase activity was equivalent to WT. The USP20 homolog USP33, which shares redundant roles with USP20, had no effect on beta(1)AR ubiquitination, but USP33 was up-regulated in USP20-KO hearts suggesting compensatory regulation. Myocardial beta(1)AR expression in USP20-KO was drastically reduced, whereas beta(2)AR expression was maintained as determined by radioligand binding in LV sarcolemmal membranes. Phospho-USP20 was significantly increased in LVs of wildtype (WT) mice after a 1-week catecholamine infusion and a 2-week chronic pressure overload induced by transverse aortic constriction (TAC). Phospho-USP20 was undetectable in beta(1)AR KO mice subjected to TAC, suggesting a role for USP20 phosphorylation in cardiac response to pressure overload. We conclude that USP20 regulates beta(1)AR signaling in vitro and in vivo. Additionally, beta(1)AR-induced USP20 phosphorylation may serve as a feed-forward mechanism to stabilize beta(1)AR expression and signaling during pathological insults to the myocardium.	[Yu, Samuel Mon-Wei; Jean-Charles, Pierre-Yves; Abraham, Dennis M.; Kaur, Suneet; Gareri, Clarice; Mao, Lan; Rockman, Howard A.; Shenoy, Sudha K.] Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27710 USA	Duke University	Shenoy, SK (corresponding author), Duke Univ, Med Ctr, Rm 412,SANDS Bldg,POB 103204,303 Res Dr, Durham, NC 27710 USA.	skshenoy@dm.duke.edu	Kaur, Suneet/ABB-4807-2020; gareri, clarice/AAC-3127-2019; Shenoy, Sudha/AAN-4075-2021	Kaur, Suneet/0000-0001-9271-8519; gareri, clarice/0000-0002-4859-8780; Shenoy, Sudha/0000-0002-2565-4663; Holloway, Courtney Jean/0000-0003-3661-1957	National Institutes of Health [HL118369, HL125905, HL56687, P01 HL75443]; American Heart Association [15GRNT25550051]; Mandel Center for Hypertension and Atherosclerosis Research; Duke O'Brien Center for Kidney Research National Institutes of Health/NIDDK Award [P30-DK096493]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443, R01HL118369, K08HL125905, R01HL056687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mandel Center for Hypertension and Atherosclerosis Research; Duke O'Brien Center for Kidney Research National Institutes of Health/NIDDK Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants HL118369 (to S. K. S.), HL125905 (to D. A.), and HL56687 and P01 HL75443 (to H. A. R.), American Heart Association Grant 15GRNT25550051(to S. K. S.), the Mandel Center for Hypertension and Atherosclerosis Research, and Duke O'Brien Center for Kidney Research National Institutes of Health/NIDDK Award P30-DK096493. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AARONS RD, 1982, J PHARMACOL EXP THER, V221, P439; Asano K, 2001, J CARDIOVASC PHARM, V37, P678, DOI 10.1097/00005344-200106000-00005; Bernstein D, 2005, AM J PHYSIOL-HEART C, V289, pH2441, DOI 10.1152/ajpheart.00005.2005; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bohm M, 1998, CARDIOVASC RES, V40, P146, DOI 10.1016/S0008-6363(98)00099-6; Borodovsky A, 2005, CHEMBIOCHEM, V6, P287, DOI 10.1002/cbic.200400236; Bristow MR, 1997, CARDIOVASC DRUG THER, V11, P291, DOI 10.1023/A:1007748131847; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; CHIDSEY CA, 1965, AM J MED, V39, P442, DOI 10.1016/0002-9343(65)90211-1; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Cleland JGF, 2006, J AM COLL CARDIOL, V47, P1603, DOI 10.1016/j.jacc.2005.11.069; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Devic E, 2001, MOL PHARMACOL, V60, P577; Dores MR, 2012, MOL PHARMACOL, V82, P563, DOI 10.1124/mol.112.079418; Engelhardt S, 1996, J AM COLL CARDIOL, V27, P146, DOI 10.1016/0735-1097(95)00425-4; Feuerstein G, 1998, EUR J PHARMACOL, V351, P341, DOI 10.1016/S0014-2999(98)00326-4; Flesch M, 2001, CARDIOVASC RES, V49, P371, DOI 10.1016/S0008-6363(00)00277-7; FRANCIS GS, 1982, AM J CARDIOL, V49, P1152, DOI 10.1016/0002-9149(82)90039-X; GINSBURG R, 1983, AM HEART J, V106, P535, DOI 10.1016/0002-8703(83)90698-1; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Hegde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116458; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hewings DS, 2017, FEBS J, V284, P1555, DOI 10.1111/febs.14039; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Jean-Charles PY, 2016, PROG MOL BIOL TRANSL, V141, P1, DOI 10.1016/bs.pmbts.2016.05.001; Jean-Charles PY, 2018, ARTERIOSCL THROM VAS, V38, P2295, DOI 10.1161/ATVBAHA.118.311071; Jean-Charles PY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95998; Jean-Charles PY, 2017, J CARDIOVASC PHARM, V70, P142, DOI 10.1097/FJC.0000000000000482; Jean-Charles PY, 2016, J BIOL CHEM, V291, P7450, DOI 10.1074/jbc.M115.687129; Keys JR, 2003, AM J PHYSIOL-HEART C, V285, pH2201, DOI 10.1152/ajpheart.00112.2003; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kommaddi RP, 2015, J BIOL CHEM, V290, P8888, DOI 10.1074/jbc.M114.630541; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mangmool S, 2010, J CELL BIOL, V189, P573, DOI 10.1083/jcb.200911047; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Morisco C, 2008, CARDIOVASC RES, V78, P36, DOI 10.1093/cvr/cvn008; Naik E, 2016, J IMMUNOL, V196, P3438, DOI 10.4049/jimmunol.1403165; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Perrino C, 2007, CIRCULATION, V116, P2571, DOI 10.1161/CIRCULATIONAHA.107.706515; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rohrer DK, 1998, ANNU REV PHARMACOL, V38, P351, DOI 10.1146/annurev.pharmtox.38.1.351; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Rohrer DK, 1998, AM J PHYSIOL-HEART C, V274, pH1184, DOI 10.1152/ajpheart.1998.274.4.H1184; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Salazar NC, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-64; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Sigmund M, 1996, EUR J CLIN PHARMACOL, V51, P127, DOI 10.1007/s002280050172; Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Tachibana H, 2006, BIOCHEM BIOPH RES CO, V343, P1060, DOI 10.1016/j.bbrc.2006.03.065; Tachibana H, 2005, CIRCULATION, V111, P591, DOI 10.1161/01.CIR.0000142291.70954.DF; THOMAS JA, 1978, AM J CARDIOL, V41, P233, DOI 10.1016/0002-9149(78)90162-5; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; Yoshikawa T, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_B.8; YUE TL, 1992, EUR J PHARMACOL, V214, P277; Zhao MM, 2011, AM J PHYSIOL-HEART C, V301, pH1461, DOI 10.1152/ajpheart.00453.2010; Zhou JB, 2010, J CLIN INVEST, V120, P2280, DOI 10.1172/JCI41407	77	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2500	2518		10.1074/jbc.RA118.004926	http://dx.doi.org/10.1074/jbc.RA118.004926			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30538132	Green Published, hybrid			2022-12-26	WOS:000458895400025
J	Real, D; Hoffmann, S; Leonardi, D; Salomon, C; Goycoolea, FM				Real, Daniel; Hoffmann, Stefan; Leonardi, Dario; Salomon, Claudio; Goycoolea, Francisco M.			Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations	PLOS ONE			English	Article							SPONTANEOUS EMULSIFICATION; ORAL BIOAVAILABILITY; HUMAN FASCIOLIASIS; NANOPARTICLES; ALBENDAZOLE; MICROPARTICLES; SOLUBILITY; DELIVERY; NANOCAPSULES; PRAZIQUANTEL	Triclabendazole is a poorly-water soluble (0.24 mu g/mL) compound classified into the Class I I/IV of the Biopharmaceutical Classification System. It is the drug of choice to treat fascioliasis, a neglected parasitic disease worldwide disseminated. Triclabendazole is registered as veterinary medicine and it is only available for human treatment as 250 mg tablets. Thus, the aim of this work was to develop novel drug delivery systems based on nanotechnology approaches. The chitosan-based nanocapsules and nanoemulsions of triclabendazole were fully characterized regarding their particle size distribution, polydispersity index and zeta potential, in-vitro release and stability in biological media. Cytotoxicity evaluation and cellular uptake studies using CaCo-2 cell line were also investigated. The results indicated an average hydrodynamic size around similar to 160 nm were found for unloaded nanoemulsions which were slightly increased up to-190 nm for loaded one. In contrast, the average hydrodynamic size of the nanocapsules increased from similar to 160 nm up to similar to 400 nm when loaded with triclabendazole. The stability studies upon 30 days storage at 4, 25 and 37 degrees C showed that average size of nanoemulsions was not modified with varying amounts of loaded TCBZ while an opposite result was seen in case of loaded nanocapsules. In addition, a slight reduction of zeta potential values over time was observed in both triclabendazole nanosystems. Release of TCBZ from nanoformulations over 6 h in simulated gastric fluid was 9 to 16-fold higher than with untreated TCBZ dispersion. In phosphate buffer saline solution there was no drug release for neither nanocapsules nor nanoemulsions. Cell viabilities studies indicated that at certain concentrations, drug encapsulation can lower its cytotoxic effects when compared to untreated drug. Confocal laser scanning microscopy study has shown that nanocapsules strongly interacted with Caco-2 cells in vitro which could increase the passage time of triclabendazole after oral administration. The results of this study constitute the first step towards the development of nanoformulations intended for the oral delivery of anti-parasitic drugs of enhanced bioavailability.	[Real, Daniel; Leonardi, Dario; Salomon, Claudio] Consejo Nacl Invest Cient & Tecn, Inst Quim Rosario, Rosario, Santa Fe, Argentina; [Real, Daniel; Leonardi, Dario; Salomon, Claudio] Univ Nacl Rosario, Dept Farm, Fac Cs Bioquim & Farmaceut, Rosario, Santa Fe, Argentina; [Hoffmann, Stefan; Goycoolea, Francisco M.] Westfalische Wilhelms Univ Munster, Inst Plant Biol & Biotechnol IBBP, Munster, Germany; [Hoffmann, Stefan; Goycoolea, Francisco M.] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Munster; University of Leeds	Salomon, C (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Quim Rosario, Rosario, Santa Fe, Argentina.; Salomon, C (corresponding author), Univ Nacl Rosario, Dept Farm, Fac Cs Bioquim & Farmaceut, Rosario, Santa Fe, Argentina.; Goycoolea, FM (corresponding author), Westfalische Wilhelms Univ Munster, Inst Plant Biol & Biotechnol IBBP, Munster, Germany.; Goycoolea, FM (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.	csalomon@fbioyf.unr.edu.ar; f.m.goycoolea@leeds.ac.uk	Goycoolea, Francisco M./Q-5841-2017; Real, Daniel Andrés/AAW-5198-2021	Goycoolea, Francisco M./0000-0001-7949-5429; Real, Daniel Andrés/0000-0002-5189-680X; Hoffmann, Stefan/0000-0002-1959-1686; Salomon, Claudio/0000-0003-1599-790X	European Union's Seventh Framework Programme for research, technological development and demonstration [613931]; Deutsche Akademischer Austauschdienst (DAAD) Programme PROALAR [57134511]; Universidad Nacional de Rosario (Argentina); MINCyT (Argentina); CONICET (Argentina)	European Union's Seventh Framework Programme for research, technological development and demonstration; Deutsche Akademischer Austauschdienst (DAAD) Programme PROALAR; Universidad Nacional de Rosario (Argentina); MINCyT (Argentina); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no613931. All authors are indebted to the funding by the Deutsche Akademischer Austauschdienst (DAAD) Programme PROALAR, project no 57134511. DR, DL, and CJS gratefully acknowledge the Universidad Nacional de Rosario (Argentina), MINCyT (Argentina) and CONICET (Argentina) for financial support. DR thanks CONICET (Argentina) for a Ph.D. fellowship.	Binnebose AM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004173; Calvo P, 1997, COLLOID POLYM SCI, V275, P46, DOI 10.1007/s003960050050; Chua BY, 2012, MOL PHARMACEUT, V9, P81, DOI 10.1021/mp200264m; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; El-Feky GS, 2015, ANTIMICROB AGENTS CH, V59, P3501, DOI 10.1128/AAC.04875-14; Fairweather I, 2009, J HELMINTHOL, V83, P139, DOI 10.1017/S0022149X09321173; Garcia A, 2019, DRUG DELIV TRANSL RE, V9, P273, DOI 10.1007/s13346-018-0591-8; Goycoolea FM, 2012, COLLOID POLYM SCI, V290, P1423, DOI 10.1007/s00396-012-2669-z; Gu DY, 2017, EXPERT OPIN DRUG DEL, V14, P879, DOI 10.1080/17425247.2017.1245290; Hafner A, 2011, J MICROENCAPSUL, V28, P807, DOI 10.3109/02652048.2011.622053; Huang YB, 2014, ACTA PHARM SIN B, V4, P18, DOI 10.1016/j.apsb.2013.11.001; Jain S, 2015, DRUG DEV IND PHARM, V41, P875, DOI 10.3109/03639045.2014.971027; Paredes AJ, 2018, J PHARM PHARMACOL, V70, P51, DOI 10.1111/jphp.12834; Kaiser M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10048; Kaiser M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141017; Kang BS, 2015, MATERIALS, V8, P486, DOI 10.3390/ma8020486; Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513; Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301; Lecaillon JB, 1998, BRIT J CLIN PHARMACO, V45, P601, DOI 10.1046/j.1365-2125.1998.00725.x; Liu Y, 2013, J BIOMED MATER RES B, V101B, P998, DOI 10.1002/jbm.b.32908; Lopez-Montilla JC, 2002, J DISPER SCI TECHNOL, V23, P219, DOI 10.1080/01932690208984202; Lozano MV, 2008, BIOMACROMOLECULES, V9, P2186, DOI 10.1021/bm800298u; Mas-Coma S, 2014, PARASITOLOGY, V141, P1918, DOI 10.1017/S0031182014000869; Mas-Coma S, 2009, ADV PARASIT, V69, P41, DOI 10.1016/S0065-308X(09)69002-3; MILLER CA, 1988, COLLOID SURFACE, V29, P89, DOI 10.1016/0166-6622(88)80173-2; Morgen M, 2012, PHARM RES-DORDR, V29, P427, DOI 10.1007/s11095-011-0558-7; Mourao SC, 2005, INT J PHARMACEUT, V295, P157, DOI 10.1016/j.ijpharm.2005.02.009; Omwenga EO, 2018, COLLOID SURFACE B, V164, P125, DOI 10.1016/j.colsurfb.2018.01.019; Piccirilli GN, 2014, DRUG DEV IND PHARM, V40, P1476, DOI 10.3109/03639045.2013.829486; PRICHARD RK, 1987, INT J PARASITOL, V17, P473, DOI 10.1016/0020-7519(87)90123-8; Qin XF, 2017, COLLOID SURFACE B, V149, P358, DOI 10.1016/j.colsurfb.2016.10.031; Real D, 2018, AAPS PHARMSCITECH, V19, P2311, DOI 10.1208/s12249-018-1057-5; Rial MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006119; Santander-Ortega MJ, 2011, COLLOID SURFACE B, V82, P571, DOI 10.1016/j.colsurfb.2010.10.019; Saokham P, 2018, MOLECULES, V23, DOI 10.3390/molecules23051161; Silva LD, 2018, DRUG DELIV TRANSL RE, V8, P1265, DOI 10.1007/s13346-018-0576-7; Smith J, 2004, PHARM RES-DORDR, V21, P43, DOI 10.1023/B:PHAM.0000012150.60180.e3; Solans C, 2016, CURR OPIN COLLOID IN, V22, P88, DOI 10.1016/j.cocis.2016.03.002; Sonvico F, 2006, INT J PHARMACEUT, V324, P67, DOI 10.1016/j.ijpharm.2006.06.036; Tsao NH, 2017, LANGMUIR, V33, P12960, DOI 10.1021/acs.langmuir.7b02954; Valenzano MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133926; Villegas F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001720; Vllasaliu D, 2010, INT J PHARMACEUT, V400, P183, DOI 10.1016/j.ijpharm.2010.08.020; Watts AB., 2016, AAPS ADV PHARM SCI, V22, DOI [10.1007/978-3-319-42609-9, DOI 10.1007/978-3-319-42609-9]; Williams HD, 2013, PHARMACOL REV, V65, P315, DOI 10.1124/pr.112.005660	45	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207625	10.1371/journal.pone.0207625	http://dx.doi.org/10.1371/journal.pone.0207625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540811	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600025
J	Reidelbach, M; Weber, M; Imhofl, P				Reidelbach, Marco; Weber, Marcus; Imhofl, Petra			Prediction of perturbed proton transfer networks	PLOS ONE			English	Article							FINDING SADDLE-POINTS; ELASTIC BAND METHOD; CONFORMATIONAL-CHANGE; TRANSITION NETWORKS; WATER CHANNELS; REACTION PATHS; GRAMICIDIN; MECHANISM; DYNAMICS; TRANSPORT	The transfer of protons through proton translocating channels is a complex process, for which direct samplings of different protonation states and side chain conformations in a transition network calculation provide an efficient, bias-free description. In principle, a new transition network calculation is required for every unsampled change in the system of interest, e.g. an unsampled protonation state change, which is associated with significant computational costs. Transition networks void of or including an unsampled change are termed unperturbed or perturbed, respectively. Here, we present a prediction method, which is based on an extensive coarse-graining of the underlying transition networks to speed up the calculations. It uses the minimum spanning tree and a corresponding sensitivity analysis of an unperturbed transition network as initial guess and refinement parameter for the determination of an unknown, perturbed transition network. Thereby, the minimum spanning tree defines a sub-network connecting all nodes without cycles and minimal edge weight sum, while the sensitivity analysis analyzes the stability of the minimum spanning tree towards individual edge weight reductions. Using the prediction method, we are able to reduce the calculation costs in a model system by up to 80%, while important network properties are maintained in most predictions.	[Reidelbach, Marco; Imhofl, Petra] Free Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Weber, Marcus] Zuse Inst Berlin, Math Life & Mat Sci, Berlin, Germany	Free University of Berlin; Zuse Institute Berlin	Imhofl, P (corresponding author), Free Univ Berlin, Inst Theoret Phys, Berlin, Germany.	petra.imhof@fu-berlin.de			Deutsche Forschungsgemeinschaft [CRC 1078]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Project C5 in CRC 1078, Deutsche Forschungsgemeinschaft, www.dfg.de (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtyl JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7539; AGRE P, 1993, AM J PHYSIOL, V265, pF463; [Anonymous], [No title captured]; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Becker OM, 1997, J CHEM PHYS, V106, P1495, DOI 10.1063/1.473299; Bowman GR, 2008, INTRO MARKOV STATE M; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Calvo F, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2749725; Cukierman S, 2000, BIOPHYS J, V78, P1825, DOI 10.1016/S0006-3495(00)76732-4; de Grotthuss C, 1806, ANN CHIM, V58, P54; DEAMER DW, 1989, J MEMBRANE BIOL, V107, P91, DOI 10.1007/BF01871715; DeCoursey TE, 1997, J GEN PHYSIOL, V109, P415, DOI 10.1085/jgp.109.4.415; DEWAR MJS, 1984, J CHEM SOC FARAD T 2, V80, P227, DOI 10.1039/f29848000227; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; FINKELSTEIN A, 1981, J MEMBRANE BIOL, V59, P155, DOI 10.1007/BF01875422; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Friedman R, 2007, J PHYS CHEM B, V111, P6059, DOI 10.1021/jp070781r; Ghane T, 2018, J MEMBRANE BIOL, V251, P299, DOI 10.1007/s00232-018-0019-x; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Helabad MB, 2017, BIOPHYS J, V113, P817, DOI 10.1016/j.bpj.2017.07.005; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Henkelman G, 1999, J CHEM PHYS, V111, P7010, DOI 10.1063/1.480097; Henkelmann G, 2002, THEORETICAL METHODS, P269, DOI DOI 10.1007/0-306-46949-9_10.; Henry RM, 2009, J MOL BIOL, V387, P1165, DOI 10.1016/j.jmb.2009.02.042; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Imhof P, 2016, METHOD ENZYMOL, V578, P249, DOI 10.1016/bs.mie.2016.05.025; IONOVA IV, 1993, J CHEM PHYS, V98, P6377, DOI 10.1063/1.465100; Ito Y, 2015, BIOPHYS J, V108, P85, DOI 10.1016/j.bpj.2014.11.1853; Jonsson H., 1998, CLASSICAL QUANTUM DY; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Lane N, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600217; Levi Y, 1998, PHYS REV LETT, V81, P1121; LEVITT DG, 1978, BIOCHIM BIOPHYS ACTA, V512, P436, DOI 10.1016/0005-2736(78)90266-3; Liang RB, 2017, P NATL ACAD SCI USA, V114, P5924, DOI 10.1073/pnas.1703654114; Liang RB, 2016, P NATL ACAD SCI USA, V113, P7420, DOI 10.1073/pnas.1601982113; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; Marcus D., 2015, GRAPH THEORY PROBLEM, P41; Martini L, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.031060; Nesetril J, 2001, DISCRETE MATH, V233, P3, DOI 10.1016/S0012-365X(00)00224-7; NICHOLS JW, 1980, P NATL ACAD SCI-BIOL, V77, P2038, DOI 10.1073/pnas.77.4.2038; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Noe F, 2006, J CHEM THEORY COMPUT, V2, P840, DOI 10.1021/ct050162r; Peng YX, 2015, J PHYS CHEM B, V119, P9212, DOI 10.1021/jp5095118; Reidelbach M, 2016, CHEM PHYS LETT, V659, P169, DOI 10.1016/j.cplett.2016.07.021; Rosta E, 2011, J AM CHEM SOC, V133, P8934, DOI 10.1021/ja200173a; Sansom MSP, 1997, VIROLOGY, V233, P163, DOI 10.1006/viro.1997.8578; Sharma V, 2017, P NATL ACAD SCI USA, V114, pE10339, DOI 10.1073/pnas.1708628114; SHEN CC, 1985, IEEE T COMPUT, V34, P197, DOI 10.1109/TC.1985.1676563; Stillinger FH, 1999, PHYS REV E, V59, P48, DOI 10.1103/PhysRevE.59.48; Trygubenko SA, 2004, J CHEM PHYS, V120, P2082, DOI 10.1063/1.1636455; Wales DJ, 1996, SCIENCE, V271, P925, DOI 10.1126/science.271.5251.925; Weber W, 2000, THEOR CHEM ACC, V103, P495, DOI 10.1007/s002149900083; Weinan E, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.052301; Wu X, 2013, J CHEM THEORY COMPUT, V9, P2672, DOI 10.1021/ct400224n; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002	61	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207718	10.1371/journal.pone.0207718	http://dx.doi.org/10.1371/journal.pone.0207718			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540792	gold, Green Submitted, Green Published			2022-12-26	WOS:000452898600031
J	Baumgartner, C; Spath-Blass, V; Niederkofler, V; Bergmoser, K; Langthaler, S; Lassnig, A; Rienmuller, T; Baumgartner, D; Asnani, A; Gerszten, RE				Baumgartner, Christian; Spath-Blass, Verena; Niederkofler, Verena; Bergmoser, Katharina; Langthaler, Sonja; Lassnig, Alexander; Rienmueller, Theresa; Baumgartner, Daniela; Asnani, Aarti; Gerszten, Robert E.			A novel network-based approach for discovering dynamic metabolic biomarkers in cardiovascular disease	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; SIGNALING PATHWAY; CARNOSINE	Metabolic biomarkers may play an important role in the diagnosis, prognostication and assessment of response to pharmacological therapy in complex diseases. The process of discovering new metabolic biomarkers is a non-trivial task which involves a number of bioanalytical processing steps coupled with a computational approach for the search, prioritization and verification of new biomarker candidates. Kinetic analysis provides an additional dimension of complexity in time-series data, allowing for a more precise interpretation of biomarker dynamics in terms of molecular interaction and pathway modulation. A novel network-based computational strategy for the discovery of putative dynamic biomarker candidates is presented, enabling the identification and verification of unexpected metabolic signatures in complex diseases such as myocardial infarction. The novelty of the proposed method lies in combining metabolic time-series data into a superimposed graph representation, highlighting the strength of the underlying kinetic interaction of preselected analytes. Using this approach, we were able to confirm known metabolic signatures and also identify new candidates such as carnosine and glycocholic acid, and pathways that have been previously associated with cardiovascular or related diseases. This computational strategy may serve as a complementary tool for the discovery of dynamic metabolic or proteomic biomarkers in the field of clinical medicine.	[Baumgartner, Christian; Spath-Blass, Verena; Niederkofler, Verena; Bergmoser, Katharina; Langthaler, Sonja; Lassnig, Alexander; Rienmueller, Theresa] Graz Univ Technol, Inst Hlth Care Engn, European Testing Ctr Med Devices, Graz, Austria; [Baumgartner, Daniela] Med Univ Graz, Dept Pediat Cardiol, Graz, Austria; [Asnani, Aarti; Gerszten, Robert E.] Beth Israel Deaconess Med Ctr, Cardiovasc Med, Boston, MA 02215 USA; [Baumgartner, Daniela] Harvard Med Sch, Boston, MA USA	Graz University of Technology; Medical University of Graz; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Baumgartner, C (corresponding author), Graz Univ Technol, Inst Hlth Care Engn, European Testing Ctr Med Devices, Graz, Austria.	christian.baumgartner@tugraz.at	Rienmüller, Theresa/AGX-6123-2022	Rienmüller, Theresa/0000-0002-9623-106X; Baumgartner, Daniela/0000-0001-8141-2426; Lassnig, Alexander/0000-0002-0918-4550; Baumgartner, Christian/0000-0002-3763-5195	Graz University of Technology Open Access Publishing Fund; NIH [R01HL098280, U01DK048489, R01DK081572]; Sarnoff Cardiovascular Research Foundation; Breast Cancer Alliance; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R01DK081572, U01DK048489] Funding Source: NIH RePORTER	Graz University of Technology Open Access Publishing Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sarnoff Cardiovascular Research Foundation; Breast Cancer Alliance; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Graz University of Technology Open Access Publishing Fund and by NIH R01HL098280, U01DK048489 and R01DK081572 (to R.E.G.). A.A. is supported by a Scholar Award from the Sarnoff Cardiovascular Research Foundation and a Young Investigator Award from the Breast Cancer Alliance.	Adachi Y, 2018, MOL METAB, V17, P61, DOI 10.1016/j.molmet.2018.08.002; Aldous SJ, 2013, INT J CARDIOL, V164, P282, DOI 10.1016/j.ijcard.2012.01.081; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Apple FS, 1999, CLIN CHIM ACTA, V284, P151, DOI 10.1016/S0009-8981(99)00077-7; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baumgartner C., 2011, J CLIN BIOINFORMATIC, V1, P1; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Desai MS, 2017, HEPATOLOGY, V65, P189, DOI 10.1002/hep.28890; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Januzzi JL, 2010, CIRCULATION, V121, P1227, DOI 10.1161/CIRCULATIONAHA.109.893826; Klein C, 2012, BRIEF FUNCT GENOMICS, V11, P420, DOI 10.1093/bfgp/els030; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Lewis GD, 2008, J AM COLL CARDIOL, V52, P117, DOI 10.1016/j.jacc.2008.03.043; Luo LN, 2014, TOXICOL SCI, V137, P12, DOI 10.1093/toxsci/kft221; Mal M, 2016, FUTUR SCI OA, V2, DOI 10.4155/fsoa-2015-0014; McDermott Jason E, 2013, Expert Opin Med Diagn, V7, P37; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mythili S, 2015, BIOMED REP, V3, P743, DOI 10.3892/br.2015.500; Netzer M, 2011, J CLIN BIOINFORMA, V1, P1; Paulovich AG, 2008, PROTEOM CLIN APPL, V2, P1386, DOI 10.1002/prca.200780174; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; R Development Core Team, 2008, R LANG ENV STAT COMP; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salt IP, 2017, CIRC RES, V120, P1825, DOI 10.1161/CIRCRESAHA.117.309633; Sauerhofer S, 2007, DIABETES, V56, P2425, DOI 10.2337/db07-0177; Smith JG, 2017, CIRCULATION, V135, P1651, DOI 10.1161/CIRCULATIONAHA.116.025446; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Tucker JF, 1997, ACAD EMERG MED, V4, P13, DOI 10.1111/j.1553-2712.1997.tb03637.x; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; WHO,, 2001, BIOMARKERS RISK ASSE; [No title captured]	36	6	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208953	10.1371/journal.pone.0208953	http://dx.doi.org/10.1371/journal.pone.0208953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533038	Green Submitted, gold, Green Published			2022-12-26	WOS:000452782500054
J	Carrascoso, I; Alcalde, J; Tabas-Madrid, D; Oliveros, JC; Izquierdo, JM				Carrascoso, Isabel; Alcalde, Jose; Tabas-Madrid, Daniel; Oliveros, Juan Carlos; Izquierdo, Jose M.			Transcriptome-wide analysis links the short-term expression of the b isoforms of TIA proteins to protective proteostasis-mediated cell quiescence response	PLOS ONE			English	Article							RNA-BINDING PROTEIN; SPLICING REGULATOR; MESSENGER-RNAS; INTRACELLULAR ANTIGENS; HUR; IDENTIFICATION; RECRUITMENT; DISCOVERY; INTERACTS; AUTOPHAGY	Control of gene expression depends on genetics and environmental factors. The T-cell intracellular antigens T-cell intracellular antigen 1 (TIA1), TIA1-like/related protein (TIAL1/TIAR) and human antigen R (HuR/ELAVL1) are RNA-binding proteins that play crucial roles in regulating gene expression in both situations. This study used massive sequencing analysis to uncover molecular and functional mechanisms resulting from the short-time expression of the b isoforms of TIA1 and TIAR, and of HuR in HEK293 cells. Our gene profiling analysis identified several hundred differentially expressed genes (DEGs) and tens of alternative splicing events associated with TIA1b, TIARb and HuR overexpression. Gene ontology analysis revealed that the controlled expression of these proteins strongly influences the patterns of DEGs and RNA variants preferentially associated with development, reproduction, cell cycle, metabolism, autophagy and apoptosis. Mechanistically, TIA1b and TIARb isoforms display both common and differential effects on the regulation of gene expression, involving systematic perturbations of cell biosynthetic machineries (splicing and translation). The transcriptome outputs were validated using functional assays of the targeted cellular processes as well as expression analysis for selected genes. Collectively, our observations suggest that early TIA1b and TIARb expression operates to connect the regulatory crossroads to protective proteostasis responses associated with a survival quiescence phenotype.	[Carrascoso, Isabel; Alcalde, Jose; Izquierdo, Jose M.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Tabas-Madrid, Daniel; Oliveros, Juan Carlos] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Izquierdo, JM (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jmizquierdo@cbm.csic.es		Izquierdo, Jose M/0000-0002-7942-4046	Spanish Ministry of Economic Affairs and Competitiveness [BFU2014-57735R]; Fundacion Ramon Areces and Banco Santander	Spanish Ministry of Economic Affairs and Competitiveness(Spanish Government); Fundacion Ramon Areces and Banco Santander	This work was supported by a grant from the Spanish Ministry of Economic Affairs and Competitiveness to JMI (BFU2014-57735R). The CBMSO receives institutional funding from Fundacion Ramon Areces and Banco Santander. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Al-Ahmadi W, 2009, NUCLEIC ACIDS RES, V37, P3612, DOI 10.1093/nar/gkp223; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Carrascoso I, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00299-18; Carrascoso I, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00174-17; Carrascoso I, 2014, BIOCHEM J, V461, P43, DOI 10.1042/BJ20140227; Carrascoso I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-90; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Garcia-Maurino SM, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00071; Ge D, 2014, AUTOPHAGY, V10, P957, DOI 10.4161/auto.28363; Gorospe M, 2012, AGEING RES REV, V11, P421, DOI 10.1016/j.arr.2012.09.001; Heck MV, 2014, NEUROGENETICS, V15, P135, DOI 10.1007/s10048-014-0397-x; Howell MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07468-2; Huang SY, 2015, AUTOPHAGY, V11, P2172, DOI 10.1080/15548627.2015.1106663; Huang SY, 2014, INT J BIOCHEM CELL B, V57, P115, DOI 10.1016/j.biocel.2014.10.015; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kharraz Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011352; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2016, MOL CANCER THER, V15, P2232, DOI 10.1158/1535-7163.MCT-16-0008; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masuda K, 2009, AGING-US, V1, P681, DOI 10.18632/aging.100073; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; Meyer C, 2018, MOL CELL, V69, P622, DOI 10.1016/j.molcel.2018.01.011; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Niso-Santano M, 2013, AUTOPHAGY, V9, P415, DOI 10.4161/auto.22910; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park JW, 2013, METHODS MOL BIOL, V1038, P171, DOI 10.1007/978-1-62703-514-9_10; Perks KL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700677; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Rayman JB, 2018, CELL REP, V22, P59, DOI 10.1016/j.celrep.2017.12.036; Reid MA, 2017, NAT CELL BIOL, V19, P1298, DOI 10.1038/ncb3629; Reyes R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r87; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rothenburg S, 2016, EVOLUTION EIF2ALPHA, P235; Sanchez-Jimenez C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.43; Sanchez-Jimenez C, 2015, CELL CYCLE, V14, P2033, DOI 10.1080/15384101.2015.1053668; Sanchez-Jimenez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075127; Shang J, 2017, ACTA BIOCH BIOPH SIN, V49, P753, DOI 10.1093/abbs/gmx071; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Taniuchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32886; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108	76	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208526	10.1371/journal.pone.0208526	http://dx.doi.org/10.1371/journal.pone.0208526			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533021	Green Published, Green Submitted, gold			2022-12-26	WOS:000452782500023
J	Kang, HM; Koh, HJ; Lee, SC				Kang, Hae Min; Koh, Hyoung Jun; Lee, Sung Chul			Spectral domain optical coherence tomography as an adjunctive tool for screening Behcet uveitis	PLOS ONE			English	Article							FLUORESCEIN ANGIOGRAPHIC FINDINGS; INDOCYANINE GREEN ANGIOGRAPHY; MACULAR EDEMA; CHOROIDAL THICKNESS; VISUAL-ACUITY; MANIFESTATIONS; PATTERNS; ANTERIOR; DISEASE; BARRIER	Background This study investigated the association of central macular thickness (CMT) and macular volume (MV) with severity of Behcet uveitis in the absence of macular edema (ME). Methods This retrospective, interventional study included a total 131 treatment-naive Behcet patients with varying degree of uveitis in the absence of ME. The mean CMT and MV were obtained by spectral domain optical coherence tomography (SD ODT). The patients were classified according to the anatomical classification of Behcet uveitis. The main outcome measure was comparison of mean CMT and MV with the types of Behcet et uveitis. Results Sixty patients (45.8%) with no uveitis, 41 patients (31.3%) with anterior uveitis, 18 patients (13.7%) with posterior uveitis, and 12 patients (9.2%) with panuveitis. The mean CMT were 261.6 +/- 22.2 mu m in no uveitis, 268.1 +/- 17.8 mu m in anterior uveitis, 306.4 +/- 32.9 mu m in posterior uveitis, and 300.4 +/- 44.0 mu m in panuveitis (P < 0.001). The mean MV was 8.7 +/- 0.3 mm(3) in those without uveitis, 8.8 +/- 0.3 mm(3) in anterior uveitis, 9.9 +/- 1.1 mm(3) in those with posterior uveitis, and 9.7 +/- 0.4 mm(3) in panuveitis (P < 0.001). Types of Behcet uveitis was the only significant factor correlated with the mean CMT (B = 18.170, beta = 0.408, P < 0.001) and the mean MV (B = 0.328, beta = 0.652, P < 0.001). Conclusions The mean CMT and MV were significantly thicker in the Behcet uveitis with posterior involvement. SD OCT can be used for an adjunctive tool for screening Behcet uveitis, especially for the presence of posterior involvement.	[Kang, Hae Min] Catholic Kwandong Univ, Coll Med, Dept Ophthalmol, Int St Marys Hosp, Incheon, South Korea; [Koh, Hyoung Jun; Lee, Sung Chul] Yonsei Univ, Inst Vis Res, Dept Ophthalmol, Coll Med, Seoul, South Korea	Catholic Kwandong University; Yonsei University; Yonsei University Health System	Kang, HM (corresponding author), Catholic Kwandong Univ, Coll Med, Dept Ophthalmol, Int St Marys Hosp, Incheon, South Korea.	liebe05@naver.com						Ahn SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180109; Atmaca LS, 2003, BRIT J OPHTHALMOL, V87, P1466, DOI 10.1136/bjo.87.12.1466; ATMACA LS, 1989, GRAEF ARCH CLIN EXP, V227, P340, DOI 10.1007/BF02169409; Bang Dongsik, 1997, Yonsei Medical Journal, V38, P428; Bazvand F, 2017, SEMIN OPHTHALMOL, V32, P764, DOI 10.1080/08820538.2016.1178310; BENEZRA D, 1986, BRIT J OPHTHALMOL, V70, P589, DOI 10.1136/bjo.70.8.589; Deuter CME, 2008, PROG RETIN EYE RES, V27, P111, DOI 10.1016/j.preteyeres.2007.09.002; Fardeau Christine, 2007, International Ophthalmology, V27, P163, DOI 10.1007/s10792-006-9024-7; Gedik S, 2005, OCUL IMMUNOL INFLAMM, V13, P51, DOI 10.1080/09273940490518757; Gehl Z, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-103; Grajewski RS, 2016, EYE, V30, P1415, DOI 10.1038/eye.2016.133; Grajewski RS, 2017, ACTA OPHTHALMOL, V95, pE77, DOI 10.1111/aos.12920; Hassenstein A, 2000, AM J OPHTHALMOL, V130, P669, DOI 10.1016/S0002-9394(00)00586-9; Ishikawa S, 2014, BRIT J OPHTHALMOL, V98, P1508, DOI 10.1136/bjophthalmol-2014-305333; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kim Ji Na, 2017, Clin Exp Rheumatol, V35 Suppl 108, P38; Kim M, 2013, INVEST OPHTH VIS SCI, V54, P6033, DOI 10.1167/iovs.13-12231; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Markomichelakis NN, 2004, OPHTHALMOLOGY, V111, P946, DOI 10.1016/j.ophtha.2003.08.037; Mizushima Y, 1988, Ryumachi, V28, P66; Nicholson BP, 2014, OPHTHALMOLOGY, V121, P2393, DOI 10.1016/j.ophtha.2014.06.015; Omri S, 2011, AM J PATHOL, V179, P942, DOI 10.1016/j.ajpath.2011.04.018; Onal S, 2018, RETINA-J RET VIT DIS, V38, P828, DOI 10.1097/IAE.0000000000001587; Onal S, 2014, INT OPHTHALMOL, V34, P401, DOI 10.1007/s10792-013-9822-7; Ozdal PC, 2002, EUR J OPHTHALMOL, V12, P424; Park UC, 2018, OCUL IMMUNOL INFLAMM, V26, P397, DOI 10.1080/09273948.2016.1268169; Pavesio CE, 2001, CURR OPIN OPHTHALMOL, V12, P471, DOI 10.1097/00055735-200112000-00013; SHIMIZU T, 1979, SEMIN ARTHRITIS RHEU, V8, P223, DOI 10.1016/0049-0172(79)90004-0; Szepessy Z, 2016, OCUL IMMUNOL INFLAMM, V24, P153, DOI 10.3109/09273948.2014.946149; Tomkins-Netzer O, 2015, OPHTHALMOLOGY, V122, P2351, DOI 10.1016/j.ophtha.2015.07.036; Towler H M, 1993, Ocul Immunol Inflamm, V1, P249, DOI 10.3109/09273949309085025; Tran THC, 2008, BRIT J OPHTHALMOL, V92, P922, DOI 10.1136/bjo.2007.136846; TSO MOM, 1982, OPHTHALMOLOGY, V89, P902; Valentincic NV, 2011, MOL VIS, V17, P2003; WRIGHT BE, 1978, BRIT J OPHTHALMOL, V62, P609, DOI 10.1136/bjo.62.9.609; YAZICI H, 1984, ANN RHEUM DIS, V43, P783, DOI 10.1136/ard.43.6.783; Yu HG, 2009, OCUL IMMUNOL INFLAMM, V17, P41, DOI 10.1080/09273940802553279	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208254	10.1371/journal.pone.0208254	http://dx.doi.org/10.1371/journal.pone.0208254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533014	Green Published, gold, Green Submitted			2022-12-26	WOS:000452782500015
J	Kasahara, K; Minami, S; Aizawa, Y				Kasahara, Kota; Minami, Shintaro; Aizawa, Yasunori			Characteristics of interactions at protein segments without non-local intramolecular contacts in the Protein Data Bank	PLOS ONE			English	Article							SECONDARY STRUCTURE; SEQUENCE; PATTERNS; HELICES; SINGLE	The principle of three-dimensional protein structure formation is a long-standing conundrum in structural biology. A globular domain of a soluble protein is formed by a network of atomic contacts among amino acid residues, but regions without intramolecular non-local contacts are often observed in the protein structure, especially in loop, linker, and peripheral segments with secondary structures. Although these regions can play key roles for protein function as interfaces for intermolecular interactions, their nature remains unclear. Here, we termed protein segments without non-local contacts as floating segments and sought them in tens of thousands of entries in the Protein Data Bank. As a result, we found that 0.72% of residues are in floating segments. Regarding secondary structural elements, coil structures are enriched in floating segments, especially for long segments. Interactions with polypeptides and polynucleotides, but not chemical compounds, are enriched in floating segments. The amino acid preferences of floating segments are similar to those of surface residues, with exceptions; the small side chain amino acids, Gly and Ala, are preferred, and some charged side chains, Arg and His, are disfavored for floating segments compared to surface residues. Our comprehensive characterization of floating segments may provide insights into understanding protein sequence-structure-function relationships.	[Kasahara, Kota] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan; [Minami, Shintaro] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Okazaki, Aichi, Japan; [Aizawa, Yasunori] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Nagatsuda Cho, Yokohama, Kanagawa, Japan	Ritsumeikan University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Tokyo Institute of Technology	Kasahara, K (corresponding author), Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan.	ktkshr@fc.ritsumei.ac.jp		Aizawa, Yasunori/0000-0002-4524-4194; Minami, Shintaro/0000-0001-9321-9279	Japan Society for the Promotion of Science KAKENHI [JP16K18526]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI, Grant-in-Aid for Young Scientists (Grant Number: JP16K18526).	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; [Anonymous], 2005, SCIENCE, V309, P78, DOI [10.1126/science.309.5731.78b, DOI 10.1126/SCIENCE.309.5731.78B]; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Costantini S, 2006, BIOCHEM BIOPH RES CO, V342, P441, DOI 10.1016/j.bbrc.2006.01.159; Crasto CJ, 2001, PROTEINS, V42, P399, DOI 10.1002/1097-0134(20010215)42:3<399::AID-PROT100>3.0.CO;2-E; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawabata T, 2007, PROTEINS, V68, P516, DOI 10.1002/prot.21283; Kinjo Akira R, 2005, Biophysics (Nagoya-shi), V1, P67, DOI 10.2142/biophysics.1.67; Kinoshita K, 2003, CURR OPIN STRUC BIOL, V13, P396, DOI 10.1016/S0959-440X(03)00074-5; Kulandaisamy A, 2018, J MOL RECOGNIT, V31, DOI 10.1002/jmr.2692; Kurt N, 2008, BIOTECHNOL PROGR, V24, P570, DOI 10.1021/bp070475v; Lobb B, 2016, CURR OPIN STRUC BIOL, V38, P53, DOI 10.1016/j.sbi.2016.05.017; Monastyrskyy B, 2014, PROTEINS, V82, P138, DOI 10.1002/prot.24340; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Pal L, 2003, J MOL BIOL, V326, P273, DOI 10.1016/S0022-2836(02)01338-4; Rani P, 2014, BBA-PROTEINS PROTEOM, V1844, P1827, DOI 10.1016/j.bbapap.2014.07.020; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Spek EJ, 1999, J AM CHEM SOC, V121, P5571, DOI 10.1021/ja990056x; Sudha G, 2014, PROG BIOPHYS MOL BIO, V116, P141, DOI 10.1016/j.pbiomolbio.2014.07.004; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Wang JW, 2003, PROTEIN ENG, V16, P799, DOI 10.1093/protein/gzg101; Westbrook J, 2005, BIOINFORMATICS, V21, P988, DOI 10.1093/bioinformatics/bti082; Zhang J, 2019, BRIEF BIOINFORM, V20, P1250, DOI 10.1093/bib/bbx168	27	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0205052	10.1371/journal.pone.0205052	http://dx.doi.org/10.1371/journal.pone.0205052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30537764	Green Submitted, Green Published, gold			2022-12-26	WOS:000452782500003
J	Stoeckle, MY; Das Mishu, M; Charlop-Powers, Z				Stoeckle, Mark Y.; Das Mishu, Mithun; Charlop-Powers, Zachary			GoFish: A versatile nested PCR strategy for environmental DNA assays for marine vertebrates	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; BIODIVERSITY; EDNA; DIVERSITY; SURVEILLANCE; SENSITIVITY; EVOLUTION; WATERS	Here we describe GoFish, a strategy for single-species environmental DNA (eDNA) presence/absence assays using nested PCR. The assays amplify a mitochondrial 12S rDNA segment with vertebrate metabarcoding primers, followed by nested PCR with M13-tailed, species-specific primers. Sanger sequencing confirms positives detected by gel electrophoresis. We first obtained 12S sequences from 77 fish specimens for 36 northwestern Atlantic taxa not well documented in GenBank. Using these and existing 12S records, we designed GoFish assays for 11 bony fish species common in the lower Hudson River estuary and tested seasonal abundance and habitat preference at two sites. Additional assays detected nine cartilaginous fish species and a marine mammal, bottlenose dolphin, in southern New York Bight. GoFish sensitivity was equivalent to Illumina MiSeq metabarcoding. Unlike quantitative PCR (qPCR), GoFish does not require tissues of target and related species for assay development and a basic thermal cycler is sufficient. Unlike Illumina metabarcoding, indexing and batching samples are unnecessary and advanced bioinformatics expertise is not needed. From water collection to Sanger sequencing results, the assay can be carried out in three days. The main limitations to this approach, which employs metabarcoding primers, are the same as for metabarcoding, namely, inability to distinguish species with shared target sequences and inconsistent amplification of rarer eDNA. In addition, the performance of the 20 assays reported here as compared to other single-species eDNA assays is not known. This approach will be a useful addition to current eDNA methods when analyzing presence/absence of known species, when turnaround time is important, and in educational settings.	[Stoeckle, Mark Y.] Rockefeller Univ, Program Human Environm, 1230 York Ave, New York, NY 10021 USA; [Das Mishu, Mithun] Hunter Coll, New York, NY USA; [Charlop-Powers, Zachary] Rockefeller Univ, Lab Genet Encoded Small Mol, 1230 York Ave, New York, NY 10021 USA	Rockefeller University; City University of New York (CUNY) System; Hunter College (CUNY); Rockefeller University	Stoeckle, MY (corresponding author), Rockefeller Univ, Program Human Environm, 1230 York Ave, New York, NY 10021 USA.	mark.stoeckle@rockefeller.edu	Stoeckle, Mark/D-3729-2011	Stoeckle, Mark/0000-0002-8280-4795; Charlop-Powers, Zachary/0000-0001-8816-4680	Monmouth University-Rockefeller University Marine Science Policy Initiative	Monmouth University-Rockefeller University Marine Science Policy Initiative	This work received support from Monmouth University-Rockefeller University Marine Science Policy Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLE K W, 1992, Bulletin New Jersey Academy of Science, V37, P1; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Andruszkiewicz EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176343; [Anonymous], 2011, FIELD GUIDE COASTAL; Baker CS, 2018, FRONT MAR SCI, V9, P968; Bakker J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17150-2; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bigelow H.B., 1953, FISHERIES B FISH WIL, V53, P307; Briggs PT, 2002, NORTHEAST NAT, V9, P47; Bylemans J, 2018, ECOL EVOL, V8, P8697, DOI 10.1002/ece3.4387; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Clusa L, 2017, PEERJ, V5, DOI 10.7717/peerj.3045; Dalen L, 2007, CAN FIELD NAT, V121, P321, DOI 10.22621/cfn.v121i3.482; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Djurhuus A, 2018, LIMNOL OCEANOGR-METH, V16, P209, DOI 10.1002/lom3.10237; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETT, V4; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Furlan EM, 2016, MOL ECOL RESOUR, V16, P641, DOI 10.1111/1755-0998.12483; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Griekspoor A, 4PEAKS SOFTWARE; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Head IM, 1998, MICROB ECOL, V35, P1, DOI 10.1007/s002489900056; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jackson M, 2017, SOIL BIOL BIOCHEM, V113, P215, DOI 10.1016/j.soilbio.2017.06.009; Kelly RP, 2017, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00283; Kelly RP, 2016, PEERJ, V4, DOI 10.7717/peerj.2444; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martellini A, 2005, WATER RES, V39, P541, DOI 10.1016/j.watres.2004.11.012; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; O'Donnell JL, 2017, PEERJ, V5, DOI 10.7717/peerj.3044; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pechgit P, 2011, EXP PARASITOL, V127, P559, DOI 10.1016/j.exppara.2010.10.022; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Pompanon F, 2011, BIOFUTUR, P30; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Rees HC, 2014, ECOL EVOL, V4, P4023, DOI 10.1002/ece3.1272; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sato H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14978-6; Sigsgaard EE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0004; Sigsgaard EE, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3147-4; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Stat M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12501-5; Stoeckle BC, 2016, AQUAT CONSERV, V26, P1120, DOI 10.1002/aqc.2611; Stoeckle MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175186; Stoeckle MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043992; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilson C, 2014, MANAG BIOL INVASION, V5, P225, DOI 10.3391/mbi.2014.5.3.05; Yamamoto S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40368; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	74	11	11	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0198717	10.1371/journal.pone.0198717	http://dx.doi.org/10.1371/journal.pone.0198717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533051	Green Published, gold			2022-12-26	WOS:000452782500001
J	Kaspar, U; von Lutzau, A; Schlattmann, A; Roesler, U; Kock, R; Becker, K				Kaspar, Ursula; von Luetzau, Alexa; Schlattmann, Andreas; Roesler, Uwe; Koeck, Robin; Becker, Karsten			Zoonotic multidrug-resistant microorganisms among small companion animals in Germany	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS MRSA; COAGULASE-NEGATIVE STAPHYLOCOCCI; URINARY-TRACT-INFECTIONS; METHICILLIN-RESISTANT; ANTIMICROBIAL RESISTANCE; MOLECULAR CHARACTERIZATION; ANTIBIOTIC SUSCEPTIBILITY; SPECIES DISTRIBUTION; BETA-LACTAMASES; RIBOSOMAL-RNA	Antimicrobial multidrug-resistant microorganisms (MDRO) can be transmitted between companion animals and their human owners. Aim of this study was to determine the prevalence of extended spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) and Staphylococcus aureus including methicillin-resistant S. aureus (MRSA) in different companion animal species. Dogs (n = 192), cats (n = 74), and rabbits (n = 17), treated in a veterinary practice and hospital or living in an animal shelter and private households, were sampled. All facilities were located in a region characterized by a high density of pig production. Nasal, buccal and perianal swabs were enriched and cultured on solid chromogenic selective media. A subgroup of 20 animals (13 dogs, 3 cats, 4 rabbits) was analyzed for the presence of staphylococci other than S. aureus. Amongst all animals (n = 283), twenty dogs (10.4%) and six cats (8.1%) carried S. aureus. MRSA was found in five dogs (2.6%) and two cats (2.7%). Isolates were of spa types t011, t034, t108 (all mecA-positive, ST398), and t843 (mecC-positive, ST130), typical for livestock-associated (LA)-MRSA. Except for one dog, MRSA-positive animals did not have direct contact to husbandry. ESBL-Escherichia coli (bla(CTX-M)/bla(TEM)/bla(SHV) genes) were present in seven dogs (3.6%), one cat (1.4%) possessed a cefotaxime-resistant Citrobacter freundii isolate (bla(TEM)/bla(CMY-2) genes). MDRO carriage was associated with animals from veterinary medical settings (p<0.05). One dog and one rabbit carried methicillin-resistant coagulase-negative staphylococci. The exclusive occurrence of MRSA lineages typically described for livestock stresses the impact of MDRO strain dissemination across species barriers in regional settings. Presence of ESBL-E and LA-MRSA among pets and probable dissemination in clinical settings support the necessity of a "One Health" approach to address the potential threats due to MDRO-carrying companion animals.	[Kaspar, Ursula; von Luetzau, Alexa; Schlattmann, Andreas; Koeck, Robin; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Roesler, Uwe] FU Berlin, Dept Vet Med, Inst Anim Hyg & Environm Hlth, Berlin, Germany; [Koeck, Robin] DRK Kliniken Berlin, Inst Hyg, Berlin, Germany	University of Munster; Free University of Berlin	Becker, K (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	kbecker@uni-muenster.de	Köck, Robin/AAC-1552-2019; Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341	German Federal Ministry for Education and Research (BMBF) within the research consortia MedVet-Staph [01KI1301A]; German Federal Ministry for Education and Research (BMBF) within the RESET [01KI1013C]; German Federal Ministry for Education and Research (BMBF) within the Research Network Zoonotic Infectious Diseases [01KI1727A]; Bundesinstitut fur Risikobewertung (BfR) [1329-557]	German Federal Ministry for Education and Research (BMBF) within the research consortia MedVet-Staph(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for Education and Research (BMBF) within the RESET(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for Education and Research (BMBF) within the Research Network Zoonotic Infectious Diseases(Federal Ministry of Education & Research (BMBF)); Bundesinstitut fur Risikobewertung (BfR)	This work was supported in part by the German Federal Ministry for Education and Research (BMBF) within the research consortia MedVet-Staph (grant no. 01KI1301A to KB and RK), RESET (grant no. 01KI1013C to UR) and the Research Network Zoonotic Infectious Diseases (project #1Health-PREVENT, grant no. 01KI1727A to KB and RK) and in part by the Bundesinstitut fur Risikobewertung (BfR) (grant no. 1329-557 to KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baede VO, 2015, ANTIMICROB AGENTS CH, V59, P3117, DOI 10.1128/AAC.04576-14; Becker K, 2018, EMERG INFECT DIS, V24, P242, DOI 10.3201/eid2402.171074; Becker K, 2017, VET MICROBIOL, V200, P33, DOI 10.1016/j.vetmic.2015.11.013; Becker K, 2017, INT J MED MICROBIOL, V307, P21, DOI 10.1016/j.ijmm.2016.11.007; Becker K, 2014, INT J MED MICROBIOL, V304, P794, DOI 10.1016/j.ijmm.2014.06.007; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; BIBERSTEIN EL, 1984, J CLIN MICROBIOL, V19, P610, DOI 10.1128/JCM.19.5.610-615.1984; Bierowiec K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3070524; Bos MEH, 2016, J EXPO SCI ENV EPID, V26, P263, DOI 10.1038/jes.2014.85; Breitkopf C, 2005, CIRCULATION, V111, P1415, DOI 10.1161/01.CIR.0000158481.07569.8D; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Cuny C, 2017, VET MICROBIOL, V200, P59, DOI 10.1016/j.vetmic.2016.01.013; Davis JA, 2014, LETT APPL MICROBIOL, V59, P1, DOI 10.1111/lam.12254; De Lucia M, 2011, RES VET SCI, V91, P346, DOI 10.1016/j.rvsc.2010.09.014; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Eriksson A, 2013, APMIS, V121, P72, DOI 10.1111/j.1600-0463.2012.02937.x; Fazakerley J, 2010, VET DERMATOL, V21, P578, DOI 10.1111/j.1365-3164.2010.00894.x; Feld L, 2018, ANN WORK EXPOS HEAL, V62, P147, DOI 10.1093/annweh/wxx108; Gandolfi-Decristophoris P, 2013, AM J INFECT CONTROL, V41, P831, DOI 10.1016/j.ajic.2012.11.013; Ganiere JP, 2005, J VET MED B, V52, P25, DOI 10.1111/j.1439-0450.2004.00816.x; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Guggenheim M, 2009, BURNS, V35, P553, DOI 10.1016/j.burns.2008.09.004; HAJEK V, 1976, INT J SYST BACTERIOL, V26, P401, DOI 10.1099/00207713-26-4-401; Harada K, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-11; Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13; HEDMAN P, 1990, J INFECTION, V21, P11, DOI 10.1016/0163-4453(90)90554-L; HEDMAN P, 1993, SCAND J INFECT DIS, V25, P57, DOI 10.3109/00365549309169670; Hellmark B, 2009, CLIN MICROBIOL INFEC, V15, P238, DOI 10.1111/j.1469-0691.2008.02663.x; Hoekstra KA, 2002, J APPL MICROBIOL, V93, P406, DOI 10.1046/j.1365-2672.2002.01708.x; Hoet AE, 2013, VECTOR-BORNE ZOONOT, V13, P385, DOI 10.1089/vbz.2012.1089; Hordijk J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00242; Idelevich EA, 2014, CLIN MICROBIOL INFEC, V20, P1001, DOI 10.1111/1469-0691.12640; Jones ME, 2003, INT J ANTIMICROB AG, V22, P406, DOI 10.1016/S0924-8579(03)00154-7; Kaspar U, 2016, ENVIRON MICROBIOL, V18, P2130, DOI 10.1111/1462-2920.12891; Koeck R., 2016, New Microbes and New Infections, V9, P24, DOI 10.1016/j.nmni.2015.11.004; Kock R, 2011, J HOSP INFECT, V79, P292, DOI 10.1016/j.jhin.2011.08.011; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Koksal F, 2009, MICROBIOL RES, V164, P404, DOI 10.1016/j.micres.2007.03.004; Kriegeskorte A, 2012, EMERG INFECT DIS, V18, P1016, DOI 10.3201/eid1806.110910; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Mani I, 2009, TOP COMPANION ANIM M, V24, P164, DOI 10.1053/j.tcam.2009.07.002; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Misic AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0052-7; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; Morgan M, 2008, J ANTIMICROB CHEMOTH, V62, P1181, DOI 10.1093/jac/dkn405; Murphy C, 2009, CAN VET J, V50, P1047; Nys S, 2006, J ANTIMICROB CHEMOTH, V57, P955, DOI 10.1093/jac/dkl082; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Piette A, 2009, VET MICROBIOL, V134, P45, DOI 10.1016/j.vetmic.2008.09.009; Pomba C, 2017, J ANTIMICROB CHEMOTH, V72, P957, DOI 10.1093/jac/dkw481; Rahman SU, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9519718; Raz R, 2005, CLIN INFECT DIS, V40, P896, DOI 10.1086/428353; Ruzauskas M, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0117-z; Schaumburg F, 2012, AM J PRIMATOL, V74, P1071, DOI 10.1002/ajp.22067; Schmiedel J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-187; Schneider PF, 1996, EUR J EPIDEMIOL, V12, P51, DOI 10.1007/BF00144428; Schwendener S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43797; Shin JH, 2011, PERITON DIALYSIS INT, V31, P340, DOI 10.3747/pdi.2010.00073; Souna D, 2014, MED MALADIES INFECT, V44, P146, DOI 10.1016/j.medmal.2014.01.008; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Szewczyk Eligia M., 2003, Microbial Ecology in Health and Disease, V15, P51, DOI 10.1080/08910600310014908; van Alen S, 2017, VET MICROBIOL, V200, P19, DOI 10.1016/j.vetmic.2016.01.021; van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009; van Duijkeren E, 2011, J ANTIMICROB CHEMOTH, V66, P2705, DOI 10.1093/jac/dkr367; Vincze S, 2013, APPL ENVIRON MICROB, V79, P655, DOI 10.1128/AEM.02704-12; Vincze S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085656; Waller KP, 2011, VET MICROBIOL, V152, P112, DOI 10.1016/j.vetmic.2011.04.006; WALLMARK G, 1978, J INFECT DIS, V138, P791, DOI 10.1093/infdis/138.6.791; Walther B, 2017, VET MICROBIOL, V200, P71, DOI 10.1016/j.vetmic.2016.05.017; Walther B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035197; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wedley AL, 2014, VET MICROBIOL, V170, P81, DOI 10.1016/j.vetmic.2014.01.015; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Weese JS, 2011, COMPANION ANIMAL ZOO, DOI [10.1002/9780470958957, DOI 10.1002/9780470958957]; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009; Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003	79	33	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208364	10.1371/journal.pone.0208364	http://dx.doi.org/10.1371/journal.pone.0208364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532196	Green Published, gold, Green Submitted			2022-12-26	WOS:000452640900014
J	Kasurinen, A; Tervahartiala, T; Laitinen, A; Kokkola, A; Sorsa, T; Bockelman, C; Haglund, C				Kasurinen, Aaro; Tervahartiala, Taina; Laitinen, Alli; Kokkola, Arto; Sorsa, Timo; Bockelman, Camilla; Haglund, Caj			High serum MMP-14 predicts worse survival in gastric cancer	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TUMOR INVASION; PRINOMASTAT; EXPRESSION; INHIBITOR	Matrix metalloproteinases (MMPs), endopeptidases with diverse biochemical functions, can promote cancer cell invasion and metastasis by degrading the extracellular matrix. A high matrix metalloproteinase-14 (MMP-14) expression in gastric cancer tissue has been associated with metastasis and poor prognosis. To further understand this association, we investigated serum MMP-14 as a biomarker in gastric cancer patients. The patient cohort consisted of 240 gastric adenocarcinoma patients who underwent surgery at Helsinki University Hospital, Finland, between 2000 and 2009. We determined the soluble MMP-14 serum levels using an enzyme-linked immunosorbent assay. We then calculated the associations between serum levels and clinicopathologic variables using the Mann-Whitney U-test or the Kruskal-Wallis test. We constructed survival curves using the Kaplan-Meier method and calculating the hazard ratios using the Cox proportional hazard model. We revealed a positive association between a high serum MMP-14 level and stages III-IV (p = 0.029), and between a high serum MMP-14 and distant metastasis (p = 0.022). Patients with a low serum MMP-14 had a 5-year disease-specific survival of 49.2% (95% confidence interval [CI] 45.5-52.9), whereas patients with a high serum MMP-14 had a 5-year survival of 22.1% (95% CI 15.2-29.0; p = 0.001). High serum MMP-14 was a statistically significant prognostic factor among patients with an intestinal type of cancer (hazard ratio [HR] 3.54; 95% CI 1.51-8.33; p = 0.004), but not among patients with a diffuse type. The serum MMP-14 level remained an independent prognostic factor in our multivariate survival analysis (HR 1.55; 95% CI 1.02-2.35; p = 0.040). This study indicates for the first time that high serum soluble MMP-14 levels in gastric cancer serves as a marker for a poor prognosis, possibly indicating the presence of distant metastases.	[Kasurinen, Aaro; Laitinen, Alli; Bockelman, Camilla; Haglund, Caj] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland; [Tervahartiala, Taina; Sorsa, Timo] Helsinki Univ Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Tervahartiala, Taina; Sorsa, Timo] Biomed Helsinki, Helsinki, Finland; [Laitinen, Alli; Kokkola, Arto; Bockelman, Camilla; Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Laitinen, Alli; Kokkola, Arto; Bockelman, Camilla; Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Sorsa, Timo] Karolinska Inst, Dept Dent Med, Huddinge, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet	Kasurinen, A (corresponding author), Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland.	aaro.kasurinen@helsinki.fi	Böckelman, Camilla/AFX-4447-2022	Bockelman, Camilla/0000-0002-1628-0305	Faculty of Medicine, University of Helsinki, Helsinki, Finland; Karolinska Institutet, Stockholm, Sweden; Helsinki University Hospital Research Foundation, Helsinki, Finland; Competitive State Research Financing of the Expert Responsibility of Helsinki University Hospital, Helsinki, Finland; Finnish Cancer Foundation; Finska Lakaresallskapet; Sigrid Juselius Foundation	Faculty of Medicine, University of Helsinki, Helsinki, Finland; Karolinska Institutet, Stockholm, Sweden; Helsinki University Hospital Research Foundation, Helsinki, Finland; Competitive State Research Financing of the Expert Responsibility of Helsinki University Hospital, Helsinki, Finland; Finnish Cancer Foundation; Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was financially supported by the Faculty of Medicine, University of Helsinki, Helsinki, Finland (CB), Karolinska Institutet, Stockholm, Sweden (TS, TT), Helsinki University Hospital Research Foundation, Helsinki, Finland (TS, TT), Competitive State Research Financing of the Expert Responsibility of Helsinki University Hospital, Helsinki, Finland (CH), the Finnish Cancer Foundation (CH), Finska Lakaresallskapet (CH), and the Sigrid Juselius Foundation (CH, AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalinkeel R, 2011, IMMUNOL INVEST, V40, P447, DOI 10.3109/08820139.2011.557795; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Bissett D, 2005, J CLIN ONCOL, V23, P842, DOI 10.1200/JCO.2005.03.170; Choi YY, 2016, J PATHOL TRANSL MED, V50, P1, DOI 10.4132/jptm.2015.09.10; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; de la Pena S, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/285906; Dong YC, 2015, GENE, V563, P29, DOI 10.1016/j.gene.2015.03.003; Duraes C, 2014, VIRCHOWS ARCH, V464, P367, DOI 10.1007/s00428-013-1533-y; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; He L, 2013, DIGEST DIS SCI, V58, P1264, DOI 10.1007/s10620-012-2513-9; Joergensen MT, 2010, ANTICANCER RES, V30, P587; Kaimal R, 2013, CANCER RES, V73, P2457, DOI 10.1158/0008-5472.CAN-12-1426; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Laudanski P, 2010, FOLIA HISTOCHEM CYTO, V48, P101, DOI 10.2478/v10042-009-0085-0; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Liu J, 2003, LUNG CANCER, V42, P335, DOI 10.1016/S0169-5002(03)00355-6; Makinen LK, 2012, J ORAL PATHOL MED, V41, P394, DOI 10.1111/j.1600-0714.2011.01110.x; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Naseh G, 2016, IUBMB LIFE, V68, P799, DOI 10.1002/iub.1543; Nonaka T, 2005, MOL CANCER THER, V4, P1157, DOI 10.1158/1535-7163.MCT-05-0127; Peng CW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-153; Sano T, 2017, GASTRIC CANCER, V20, P217, DOI 10.1007/s10120-016-0601-9; Shimizu D, 2018, HISTOL HISTOPATHOL, V33, P11, DOI 10.14670/HH-11-898; Shirian J, 2018, FEBS LETT, V592, P1122, DOI 10.1002/1873-3468.13016; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STETLERSTEVENSON WG, 1990, CANCER METAST REV, V9, P289, DOI 10.1007/BF00049520; Yin Li-Kui, 2015, Asian Pac J Cancer Prev, V16, P3867; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zheng LD, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-74	30	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208800	10.1371/journal.pone.0208800	http://dx.doi.org/10.1371/journal.pone.0208800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532247	Green Published, gold, Green Submitted			2022-12-26	WOS:000452640900046
J	Rondeau, S; Giovenazzo, P; Fournier, V				Rondeau, Sabrina; Giovenazzo, Pierre; Fournier, Valerie			Risk assessment and predation potential of Stratiolaelaps scimitus (Acari: Laelapidae) to control Varroa destructor (Acari: Varroidae) in honey bees	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; BIOLOGICAL-CONTROL AGENT; APIS-MELLIFERA L.; HYPOASPIS-MILES; PARASITIC MITES; JACOBSONI OUD.; OXALIC-ACID; BRADYSIA; THRIPS; HYMENOPTERA	The biocontrol of the honey bee ectoparasite Varroa destructor is an underexploited but promising avenue that would benefit from being integrated in a Varroa management program. Our study aimed to investigate the potential of the predatory mite Stratiolaelaps scimitus to control Varroa infestations in honey bees. Tests on safety and predation were carried out to: (1) assess the risk of predation of the honey bee brood by S. scimitus under laboratory conditions and within the colony, and (2) evaluate the predation potential of S. scimitus on phoretic Varroa mites. Under laboratory conditions, S. scimitus was able to feed upon free Varroa mites, but also attacked every unprotected honey bee brood stages with a strong preference for bee eggs. When introduced inside colonies, however, S. scimitus does not have negative effects on the survival of the bee brood. Moreover, observations made in the laboratory revealed that S. scimitus does not attack Varroa mites when they are attached to the body of bees. However, all Varroa mites that had naturally fallen from the bees were predated upon by S. scimitus and died in less than 24h. This study provides evidence that S. scimitus does not represent a significant threat to the bee brood, but also suggests that its effect in Varroa control will probably be limited as it does not attack phoretic Varroa mites. Our results represent a first step in assessing the potential of S. scimitus to control V. destructor and provide novel information about the predator's behavior inside the honey bee colony.	[Rondeau, Sabrina; Fournier, Valerie] Univ Laval, Dept Phytol, Quebec City, PQ, Canada; [Giovenazzo, Pierre] Univ Laval, Dept Biol, Quebec City, PQ, Canada; [Rondeau, Sabrina] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada	Laval University; Laval University; University of Guelph	Rondeau, S (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ, Canada.; Rondeau, S (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON, Canada.	sabrina.rondeau.1@ulaval.ca	Rondeau, Sabrina/Y-7230-2019	Rondeau, Sabrina/0000-0002-5916-7441; giovenazzo, pierre/0000-0002-8080-4935	North American Pollinator Protection Campaign (NAPPC) from the 2017 NAPPC Honey Bee Health Improvement Project Grant; Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche du Quebec - Nature et technologies (FRQNT); Canadian Federation of University Women (CFUW)	North American Pollinator Protection Campaign (NAPPC) from the 2017 NAPPC Honey Bee Health Improvement Project Grant; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et technologies (FRQNT); Canadian Federation of University Women (CFUW)	This research was funded by the North American Pollinator Protection Campaign (NAPPC; http://pollinator.org/nappc) from the 2017 NAPPC Honey Bee Health Improvement Project Grant. SR also received Graduate Research Scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC), the Fonds de recherche du Quebec - Nature et technologies (FRQNT), and the Canadian Federation of University Women (CFUW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Naggar Y, 2015, J APICULT RES, V54, P548, DOI 10.1080/00218839.2016.1186917; Alayrangues J, 2016, ECOTOXICOLOGY, V25, P856, DOI 10.1007/s10646-016-1642-x; Ali W, 2012, VET PARASITOL, V187, P341, DOI 10.1016/j.vetpar.2012.01.014; Berg MP, 2000, EUR J SOIL BIOL, V36, P127, DOI 10.1016/S1164-5563(00)01055-4; Berndt O, 2004, ENTOMOL EXP APPL, V112, P107, DOI 10.1111/j.0013-8703.2004.00185.x; Berndt O, 2004, BIOL CONTROL, V30, P17, DOI 10.1016/j.biocontrol.2003.09.009; Berndt O, 2003, EXP APPL ACAROL, V31, P1, DOI 10.1023/B:APPA.0000005108.72167.74; BOOT WJ, 1992, EXP APPL ACAROL, V16, P295, DOI 10.1007/BF01218571; BOOT WJ, 1993, J APICULT RES, V32, P167, DOI 10.1080/00218839.1993.11101302; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Cabras P, 1997, APIDOLOGIE, V28, P91, DOI 10.1051/apido:19970206; Cabrera AR, 2005, EXP APPL ACAROL, V36, P71, DOI 10.1007/s10493-005-0242-x; Castilho RC, 2009, INT J PEST MANAGE, V55, P181, DOI 10.1080/09670870902725783; CHAMBERS RJ, 1993, BIOCONTROL SCI TECHN, V3, P285, DOI 10.1080/09583159309355283; Chandler D, 2001, BIOCONTROL SCI TECHN, V11, P429, DOI 10.1080/09583150120067472; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Maggi MD, 2009, EXP APPL ACAROL, V47, P317, DOI 10.1007/s10493-008-9216-0; Delaplane KS, 2005, J APICULT RES, V44, P157, DOI 10.1080/00218839.2005.11101171; Desai SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159615; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.16; Elzen PJ, 2000, APIDOLOGIE, V31, P437, DOI 10.1051/apido:2000134; Emsen B, 2014, CAN ENTOMOL, V146, P236, DOI 10.4039/tce.2013.68; Fagerland MW, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-91; Floris I, 2004, J ECON ENTOMOL, V97, P187, DOI 10.1603/0022-0493-97.2.187; FRIES I, 1991, AM BEE J, V131, P313; Giovenazzo P, 2011, EXP APPL ACAROL, V55, P65, DOI 10.1007/s10493-011-9447-3; Gregorc A, 2007, APIDOLOGIE, V38, P296, DOI 10.1051/apido:2007014; Harbo JR, 2004, J APICULT RES, V43, P114, DOI 10.1080/00218839.2004.11101120; Hoy MA, 2011, AGRICULTURAL ACAROLOGY: INTRODUCTION TO INTEGRATED MITE MANAGEMENT, P1, DOI 10.1201/b10909; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Jacques A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172591; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Koleoglu G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169669; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lesna I, 2012, EXP APPL ACAROL, V58, P371, DOI 10.1007/s10493-012-9596-z; McMenamin AJ, 2015, CURR OPIN INSECT SCI, V8, P121, DOI 10.1016/j.cois.2015.01.015; Mendyk Robert W., 2015, Journal of Herpetological Medicine and Surgery, V25, P24, DOI 10.5818/1529-9651-25.1.24; Milani N, 1999, APIDOLOGIE, V30, P229, DOI 10.1051/apido:19990211; Navarro-Campos C, 2016, EXP APPL ACAROL, V70, P69, DOI 10.1007/s10493-016-0061-2; Nazzi F, 2016, ANNU REV ENTOMOL, V61, P417, DOI 10.1146/annurev-ento-010715-023731; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Pernal SF, 2015, MALADIES ORG NUISIBL; Pettis JS, 1999, AM BEE J, V139, P471; Pritchard DJ, 2016, J APICULT RES, V55, P38, DOI 10.1080/00218839.2016.1196016; R Core Team, 2021, R LANGUAGE ENV STAT; Rangel J, 2018, J APICULT RES, V57, P425, DOI 10.1080/00218839.2018.1457864; Reinbacher L, 2018, ACAROLOGIA, V58, P287, DOI 10.24349/acarologia/20184241; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Saito T, 2016, BIOL CONTROL, V92, P92, DOI 10.1016/j.biocontrol.2015.10.003; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; SAS Institute Inc, 2017, SAS STAT 14 3 US GUI; Schneider S, 2012, APIDOLOGIE, V43, P218, DOI 10.1007/s13592-011-0102-0; Bonvehi JS, 2016, J ESSENT OIL RES, V28, P22, DOI 10.1080/10412905.2015.1076741; The Honey Bee Health Coalition, 2017, TOOLS VARR MAN GUID, P1; The Niagara Beeway, 2018, VARR MIT 2014 REP; Van Driesche R., 2008, CONTROL PESTS WEEDS; Vandervalk LP, 2014, J ECON ENTOMOL, V107, P2030, DOI 10.1603/EC14048; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Walter D.E., 2013, MITES ECOLOGY EVOLUT, DOI DOI 10.1007/978-94-007-7164-2; Walter DE, 2003, BIOL CONTROL, V26, P253, DOI 10.1016/S1049-9644(02)00171-8; Webster TC, 2000, J ECON ENTOMOL, V93, P1596, DOI 10.1603/0022-0493-93.6.1596; WRIGHT EM, 1994, ENTOMOPHAGA, V39, P225, DOI 10.1007/BF02372360; Wu SY, 2016, BIOCONTROL, V61, P717, DOI 10.1007/s10526-016-9762-z; Wu SY, 2014, BIOCONTROL SCI TECHN, V24, P1110, DOI 10.1080/09583157.2014.924478	64	8	10	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208812	10.1371/journal.pone.0208812	http://dx.doi.org/10.1371/journal.pone.0208812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532269	Green Submitted, Green Published, gold			2022-12-26	WOS:000452640900049
J	Cooper, L; Hailes, L; Sheikh, A; Zaph, C; Belz, GT; Groom, JR; Good-Jacobson, KL				Cooper, Lucy; Hailes, Lauren; Sheikh, Amania; Zaph, Colby; Belz, Gabrielle T.; Groom, Joanna R.; Good-Jacobson, Kim L.			Assessing the role of the T-box transcription factor Eomes in B cell differentiation during either Th1 or Th2 cell-biased responses	PLOS ONE			English	Article							EOMESODERMIN EXPRESSION; CUTTING EDGE; C-MYB; BET; MEMORY; EFFECTOR; INFLAMMATION	Successful T-dependent humoral responses require the production of antibody-secreting plasmablasts, as well as the formation of germinal centers which eventually form high-affinity B cell memory. The ability of B cells to differentiate into germinal center and plasma cells, as well as the ability to tailor responses to different pathogens, is driven by transcription factors. In T cells, the T-box transcription factors T-bet and Eomesodermin (Eomes) regulate effector and memory T cell differentiation, respectively. While T-bet has a critical role in regulating anti-viral B cell responses, a role for Eomes in B cells has yet to be described. We therefore investigated whether Eomes was required for B cell differentiation during either Th1 or Th2 cell-biased immune responses. Here, we demonstrate that deletion of Eomes specifically in B cells did not affect B cell differentiation in response to vaccination, as well as following viral or helminth infection. In contrast to its established role in CD8(+) T cells, Eomes did not influence memory B cell differentiation. Finally, the use of an Eomes reporter mouse confirmed the lack of Eomes expression during immune responses. Thus, germinal center and plasma cell differentiation and the formation of isotype-switched memory B cells in response to infection are independent of Eomes expression.	[Cooper, Lucy; Hailes, Lauren; Zaph, Colby; Good-Jacobson, Kim L.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Cooper, Lucy; Hailes, Lauren; Zaph, Colby; Good-Jacobson, Kim L.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Sheikh, Amania; Belz, Gabrielle T.; Groom, Joanna R.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Sheikh, Amania; Belz, Gabrielle T.; Groom, Joanna R.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia	Monash University; Monash University; Walter & Eliza Hall Institute; University of Melbourne	Good-Jacobson, KL (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Good-Jacobson, KL (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.	kim.jacobson@monash.edu	Sheikh, Amania Anwar/AHE-3533-2022; Belz, Gabrielle T/C-9350-2013	Sheikh, Amania Anwar/0000-0003-0769-2081; Belz, Gabrielle T/0000-0002-9660-9587; Zaph, Colby/0000-0002-9889-9848; Good-Jacobson, Kim/0000-0003-1891-7274; Groom, Joanna/0000-0001-5251-7835; Cooper, Lucy/0000-0002-7153-5358	National Health and Medical Research Council (NHMRC) [1057707]; NHMRC program [1054925]; NHMRC Career Development Fellowship [1108066]; NHMRC Senior Principal Research Fellowship [1135898]; Australian Research Council Future Fellowship [FT130100708]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by a National Health and Medical Research Council (NHMRC; www.nhmrc.gov.au) project grant to KLG-J (1057707), and a NHMRC program grant to GTB (1054925). KLG-J is supported by an NHMRC Career Development Fellowship (1108066). GTB is supported by a NHMRC Senior Principal Research Fellowship (1135898) and JRG is supported by an Australian Research Council Future Fellowship (FT130100708) (www.arc.gov.au). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barnett BE, 2016, J IMMUNOLOGY, V197; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Good-Jacobson KL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00482; Good-Jacobson KL, 2015, J EXP MED, V212, P1001, DOI 10.1084/jem.20150191; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kallies A, 2017, TRENDS IMMUNOL, V38, P287, DOI 10.1016/j.it.2017.02.003; Kara EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9644; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Piovesan D, 2017, CELL REP, V19, P461, DOI 10.1016/j.celrep.2017.03.060; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Simonetta F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00241; Simonetta F, 2014, J VIROL, V88, P11861, DOI 10.1128/JVI.02013-14; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tripathi SK, 2014, IMMUNOL REV, V261, P62, DOI 10.1111/imr.12204; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhang P, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah7152	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208343	10.1371/journal.pone.0208343	http://dx.doi.org/10.1371/journal.pone.0208343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521606	Green Published, gold			2022-12-26	WOS:000452307600050
J	Korsa, MG; Devlin, JM; Hartley, CA; Browning, GF; Coppo, MJC; Quinteros, JA; Loncoman, CA; Onasanya, AE; Thilakarathne, D; Diaz-Mendez, A				Korsa, Mesula G.; Devlin, Joanne M.; Hartley, Carol A.; Browning, Glenn F.; Coppo, Mauricio J. C.; Quinteros, Jose A.; Loncoman, Carlos A.; Onasanya, Adepeju E.; Thilakarathne, Dulari; Diaz-Mendez, Andres			Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens	PLOS ONE			English	Article							IN-OVO VACCINATION; EFFICACY; STRAIN; GENE; SAFETY; REPLICATION; HERPESVIRUS; TRANSMISSION; VIRULENCE; ANTIBODY	Infectious laryngotracheitis (ILT) is an upper respiratory tract disease of chickens that is caused by infectious laryngotracheitis virus (ILTV), an alphaherpesvirus. This disease causes significant economic loses in poultry industries worldwide. Despite widespread use of commercial live attenuated vaccines, many poultry industries continue to experience outbreaks of disease caused by ILTV. Efforts to improve the control of this disease have resulted in the generation of new vaccine candidates, including ILTV mutants deficient in virulence factors. A glycoprotein G deletion mutant vaccine strain of ILTV (Delta gG ILTV), recently licenced as Vaxsafe ILT (Bioproperties Pty Ltd), has been extensively characterised in vitro and in vivo, but the minimum effective dose required to protect inoculated animals has not been determined. This study performed a vaccination and challenge experiment to determine the minimum dose of Delta gG ILTV that, when delivered by eye-drop to seven-day-old specific pathogen-free chickens, would protect the birds from a robust challenge with a virulent field strain of virus (class 9 ILTV). A dose of 10(3.8) plaque forming units was the lowest dose capable of providing a high level of protection against challenge, as measured by clinical signs of disease, tracheal pathology and virus replication after challenge. This study has shown that the Delta gG ILTV vaccine strain is capable of inducing a high level of protection against a virulent field virus at a commercially feasible dose. These results lay the foundations upon which a commercial vaccine can be developed, thereby offering the potential to provide producers with another important tool to help control ILTV.	[Korsa, Mesula G.; Devlin, Joanne M.; Hartley, Carol A.; Browning, Glenn F.; Coppo, Mauricio J. C.; Quinteros, Jose A.; Loncoman, Carlos A.; Onasanya, Adepeju E.; Thilakarathne, Dulari; Diaz-Mendez, Andres] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic, Australia	University of Melbourne	Diaz-Mendez, A (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic, Australia.	andres.diaz@unimelb.edu.au	Browning, Glenn Francis/P-4459-2014; Loncoman, Carlos/AAE-6481-2020; Quinteros, Jose Antonio/Q-2482-2016	Browning, Glenn Francis/0000-0002-0903-2469; Loncoman, Carlos/0000-0002-4321-8873; Coppo, Mauricio/0000-0002-4344-9532; Hartley, Carol/0000-0001-6174-7341; Quinteros, Jose Antonio/0000-0002-3194-9783; Devlin, Joanne/0000-0003-0400-9670; Diaz-Mendez, Andres/0000-0003-3004-8518	Poultry Cooperative Research Centre; Asia Pacific Centre for Animal Health; Australian Government Research Training Program (RTP) scholarship; Australian Poultry Cooperative Research Centre; Bioproperties Pty Ltd	Poultry Cooperative Research Centre; Asia Pacific Centre for Animal Health; Australian Government Research Training Program (RTP) scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Poultry Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Bioproperties Pty Ltd	This work was funded by the Poultry Cooperative Research Centre through Sub-Project 1.1.10 awarded to project leader Joanne M Devlin and was funded by the Asia Pacific Centre for Animal Health. Mesula G. Korsa was supported by Australian Government Research Training Program (RTP) scholarship. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Mesula G. Korsa was supported by Australian Government Research Training Program (RTP) scholarship. This work was partially funded by the Australian Poultry Cooperative Research Centre. We thank Dr. Pollob Shil, June Daly and Janece Wheeler for providing care for the animals. We thank Bioproperties Pty Ltd, and particularly Dr Greg Underwood, for support, advice and valuable discussions.	Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; BAGUST TJ, 1995, AVIAN PATHOL, V24, P373, DOI 10.1080/03079459508419079; Coppo MJC, 2018, J VIROL, V92, DOI [10.1128/JVI.01534-17, 10.1128/jvi.01534-17]; Coppo MJC, 2013, AVIAN PATHOL, V42, P195, DOI 10.1080/03079457.2013.800634; Coppo MJC, 2011, AVIAN PATHOL, V40, P411, DOI 10.1080/03079457.2011.588686; Davison S, 2006, AVIAN DIS, V50, P50, DOI 10.1637/7398-062105R.1; Devlin JM, 2008, AVIAN PATHOL, V37, P83, DOI 10.1080/03079450701802214; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; Devlin JM, 2016, CURR OPIN VIROL, V19, P23, DOI 10.1016/j.coviro.2016.06.007; Devlin JM, 2011, VACCINE, V29, P5699, DOI 10.1016/j.vaccine.2011.06.002; Devlin JM, 2010, VACCINE, V28, P1325, DOI 10.1016/j.vaccine.2009.11.013; Esaki M, 2013, AVIAN DIS, V57, P192, DOI 10.1637/10383-092412-Reg.1; FAHEY KJ, 1990, J GEN VIROL, V71, P2401, DOI 10.1099/0022-1317-71-10-2401; FAHEY KJ, 1984, AVIAN PATHOL, V13, P265, DOI 10.1080/03079458408418530; Fuchs W, 2005, VIRUS RES, V112, P108, DOI 10.1016/j.virusres.2005.03.002; Garcia M, 2016, J GEN VIROL; Garcia M, 2016, VET MICROBIOL; Garcia M., 2013, DIS POULTRY, V13, P161, DOI 10.1002/9781119421481.ch5; Gimeno IM, 2011, AVIAN PATHOL, V40, P395, DOI 10.1080/03079457.2011.588196; Godoy A, 2013, AVIAN DIS, V57, P432, DOI 10.1637/10345-090312-Reg.1; GUY JS, 1990, AVIAN DIS, V34, P106, DOI 10.2307/1591340; GUY JS, 1991, AVIAN DIS, V35, P348, DOI 10.2307/1591188; Han MG, 2002, ARCH VIROL, V147, P1017, DOI 10.1007/s00705-001-0794-y; Helferich D, 2007, J GEN VIROL, V88, P732, DOI 10.1099/vir.0.82533-0; HONDA T, 1994, J VET MED SCI, V56, P1051, DOI 10.1292/jvms.56.1051; Johnson DI, 2010, AVIAN DIS, V54, P1251, DOI 10.1637/9401-052310-Reg.1; Korsa MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137719; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Legione AR, 2012, VACCINE, V30, P7193, DOI 10.1016/j.vaccine.2012.10.023; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Mashchenko A, 2013, AVIAN DIS, V57, P523, DOI 10.1637/10413-100512-Reg.1; Pavlova SP, 2010, J GEN VIROL, V91, P847, DOI 10.1099/vir.0.016634-0; Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198; Rodriguez-Avila A, 2007, AVIAN DIS, V51, P905, DOI 10.1637/8011-041907-REGR.1; Rodriguez-Avila A, 2008, AVIAN PATHOL, V37, P287, DOI 10.1080/03079450802043742; SCHNITZLEIN WM, 1995, VIROLOGY, V209, P304, DOI 10.1006/viro.1995.1262; Shil NK, 2015, AVIAN DIS, V59, P7, DOI 10.1637/10810-030414-Reg.1; Shil NK, 2012, AVIAN DIS, V56, P509, DOI 10.1637/10054-010912-Reg.1; Vagnozzi A, 2012, AVIAN PATHOL, V41, P21, DOI 10.1080/03079457.2011.631983; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207611	10.1371/journal.pone.0207611	http://dx.doi.org/10.1371/journal.pone.0207611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521554	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600015
J	Romanello, KS; Teixeira, KKL; Silva, JPMO; Nagamatsu, ST; Bezerra, MAC; Domingos, IF; Martine, DAP; Araujo, AS; Lanaro, C; Breyer, CA; Ferreira, RA; Franco-Penteado, C; Costa, FF; Malavazi, I; Netto, LES; de Oliveira, MA; Cunha, AF				Romanello, Karen S.; Teixeira, Karina K. L.; Silva, Joao Pedro M. O.; Nagamatsu, Sheila T.; Bezerra, Marcos Andre C.; Domingos, Igor F.; Martine, Diego A. P.; Araujo, Aderson S.; Lanaro, Carolina; Breyer, Carlos A.; Ferreira, Regiane A.; Franco-Penteado, Carla; Costa, Fernando F.; Malavazi, Iran; Netto, Luis E. S.; de Oliveira, Marcos A.; Cunha, Anderson F.			Global analysis of erythroid cells redox status reveals the involvement of Prdx1 and Prdx2 in the severity of beta thalassemia	PLOS ONE			English	Article							OXIDATIVE STRESS; PEROXIREDOXIN 2; HYDROGEN-PEROXIDE; LIFE-SPAN; NF-E2-RELATED FACTOR-2; NRF2; ACTIVATION; EXPRESSION; GENE; MEMBRANE	beta-thalassemia is a worldwide distributed monogenic red cell disorder, characterized by an absent or reduced beta globin chain synthesis. The unbalance of alpha-gamma chain and the presence of pathological free iron promote severe oxidative damage, playing crucial a role in erythrocyte hemolysis, exacerbating ineffective erythropoiesis and decreasing the lifespan of red blood cells (RBC). Catalase, glutathione peroxidase and peroxiredoxins act together to protect RBCs from hydrogen peroxide insult. Among them, peroxiredoxins stand out for their overall abundance and reactivity. In RBCs, Prdx2 is the third most abundant protein, although Prdxs 1 and 6 isoforms are also found in lower amounts. Despite the importance of these enzymes, Prdx1 and Prdx2 may have their peroxidase activity inactivated by hyperoxidation at high hydroperoxide concentrations, which also promotes the molecular chaperone activity of these proteins. Some studies have demonstrated the importance of Prdx1 and Prdx2 for the development and maintenance of erythrocytes in hemolytic anemia. Now, we performed a global analysis comparatively evaluating the expression profile of several antioxidant enzymes and their physiological reducing agents in patients with beta thalassemia intermedia (BTI) and healthy individuals. Furthermore, increased levels of ROS were observed not only in RBC, but also in neutrophils and mononuclear cells of BTI patients. The level of transcripts and the protein content of Prx1 were increased in reticulocyte and RBCs of BTI patients and the protein content was also found to be higher when compared to beta thalassemia major (BTM), suggesting that this peroxidase could cooperate with Prx2 in the removal of H2O2. Furthermore, Prdx2 production is highly increased in RBCs of BTM patients that present high amounts of hyperoxidized species. A significant increase in the content of Trx1, Srx1 and Sod1 in RBCs of BTI patients suggested protective roles for these enzymes in BTI patients. Finally, the upregulation of Nrf2 and Keap1 transcription factors found in BTI patients may be involved in the regulation of the antioxidant enzymes analyzed in this work.	[Romanello, Karen S.; Teixeira, Karina K. L.; Silva, Joao Pedro M. O.; Malavazi, Iran; Cunha, Anderson F.] Univ Fed Sao Carlos UFSCar, Dept Genet & Evolucao, Sao Carlos, SP, Brazil; [Nagamatsu, Sheila T.] Univ Estadual Campinas, UNICAMP, Dept Genet Evolucao & Bioagentes, Campinas, SP, Brazil; [Bezerra, Marcos Andre C.; Domingos, Igor F.; Martine, Diego A. P.] Univ Fed Pernambuco UFPE, Dept Genet, Recife, PE, Brazil; [Araujo, Aderson S.] Fundacao Hematol & Hemoterapia Estado Pernambuco, Recife, PE, Brazil; [Lanaro, Carolina; Ferreira, Regiane A.; Franco-Penteado, Carla; Costa, Fernando F.] Univ Estadual Campinas, UNICAMP, Hemoctr, Campinas, SP, Brazil; [Breyer, Carlos A.; de Oliveira, Marcos A.] Univ Estadual Paulista, UNESP, Campus Litoral Paulista, Sao Vicente, SP, Brazil; [Netto, Luis E. S.] Univ Sao Paulo, Dept Genet, Biol Evolut, Sao Paulo, Brazil	Universidade Federal de Sao Carlos; Universidade Estadual de Campinas; Universidade Federal de Pernambuco; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo	Cunha, AF (corresponding author), Univ Fed Sao Carlos UFSCar, Dept Genet & Evolucao, Sao Carlos, SP, Brazil.	anderf@ufscar.br	da Cunha, Anderson Ferreira/M-9038-2019; Netto, Luis/A-3783-2008; Nagamatsu, Sheila T/F-5688-2017; de Oliveira, Marcos A/K-5746-2015; da Cunha, Anderson Ferreira/B-7931-2012; Malavazi, Iran/E-4132-2013	da Cunha, Anderson Ferreira/0000-0003-3485-5659; Netto, Luis/0000-0002-4250-9177; de Oliveira, Marcos A/0000-0002-1192-7296; Malavazi, Iran/0000-0002-4526-4961; Silva, Joao/0000-0002-4158-9259; Nagamatsu, Sheila/0000-0002-4986-5094; Pereira-Martins, Diego/0000-0002-3302-4311	Sao Paulo Research Foundation (FAPESP) [2011/50358-3]; Coordination for the Improvement of Higher Education Personnel-CAPES; Brazilian National Council for Scientific and Technological Development- CNPq; FAPESP [2011/13500-6]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development- CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP, grant number 2011/50358-3). Fellowships were granted to KSR and JPMOS (from Coordination for the Improvement of Higher Education Personnel-CAPES), to KKL (from the Brazilian National Council for Scientific and Technological Development- CNPq) and FAPESP to CAB and MAO (2011/13500-6).; The authors would like to thank all patients and volunteers who participated in the study. This work was supported by the Sao Paulo Research Foundation (FAPESP, grant number 2011/50358-3). Fellowships were granted to KSR and JPMOS (from Coordination for the Improvement of Higher Education Personnel-CAPES), to KKL (from the Brazilian National Council for Scientific and Technological Development- CNPq) and FAPESP to CAB and MAO (2011/13500-6).	Amer J, 2005, BRIT J HAEMATOL, V129, P435, DOI 10.1111/j.1365-2141.2005.05463.x; Bayer SB, 2016, FREE RADICAL RES, V50, P1329, DOI 10.1080/10715762.2016.1241995; Bayer SB, 2013, FASEB J, V27, P3315, DOI 10.1096/fj.13-227298; Birgens H, 2007, SCAND J CLIN LAB INV, V67, P11, DOI 10.1080/00365510601046417; Boudrahem-Addour N, 2015, HEMOGLOBIN, V39, P36, DOI 10.3109/03630269.2014.979997; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; Cao ZB, 2017, SUBCELL BIOCHEM, V83, P127, DOI 10.1007/978-3-319-46503-6_5; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Cho CS, 2014, P NATL ACAD SCI USA, V111, P12043, DOI 10.1073/pnas.1401100111; Cho CS, 2010, ANTIOXID REDOX SIGN, V13, P1, DOI 10.1089/ars.2009.2978; Cighetti G, 2002, EUR J CLIN INVEST, V32, P55, DOI 10.1046/j.1365-2362.2002.0320s1055.x; da Cunha AF, 2010, CELL PROLIFERAT, V43, P297, DOI 10.1111/j.1365-2184.2010.00679.x; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; De Franceschi L, 2011, HAEMATOL-HEMATOL J, V96, P1595, DOI 10.3324/haematol.2011.043612; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Gertz M, 2009, AGING-US, V1, P254, DOI 10.18632/aging.100017; Ghatreh-Samani M, 2016, CENT EUR J IMMUNOL, V41, P116, DOI 10.5114/ceji.2015.56973; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Han YH, 2012, BMB REP, V45, P560, DOI 10.5483/BMBRep.2012.45.10.082; Hanzen S, 2016, CELL, V166, P140, DOI 10.1016/j.cell.2016.05.006; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006; Kazama H, 2014, BRIT J HAEMATOL, V166, P720, DOI 10.1111/bjh.12954; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Macari ER, 2011, BLOOD, V117, P5987, DOI 10.1182/blood-2010-10-314096; Mathew B, 2013, AM J RESP CELL MOL, V49, P269, DOI 10.1165/rcmb.2012-0291OC; Matte A, 2010, FREE RADICAL BIO MED, V49, P457, DOI 10.1016/j.freeradbiomed.2010.05.003; McNeill E, 2015, FREE RADICAL BIO MED, V79, P206, DOI 10.1016/j.freeradbiomed.2014.10.575; Meissner U, 2007, MICRON, V38, P29, DOI 10.1016/j.micron.2006.04.010; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Morot-Gaudry-Talarmain Y, 2009, FREE RADICAL BIO MED, V47, P1715, DOI 10.1016/j.freeradbiomed.2009.09.014; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; OLIVIERI O, 1994, BLOOD, V84, P315; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Park Jinah, 2014, Int J Cell Biol, V2014, P715867, DOI 10.1155/2014/715867; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Quinn GP, 2003, EXPT DESIGN DATA ANA; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rocha S, 2009, BLOOD CELL MOL DIS, V43, P68, DOI 10.1016/j.bcmd.2009.03.002; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Satoh T, 2011, J NEUROCHEM, V119, P569, DOI 10.1111/j.1471-4159.2011.07449.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schrier SL, 2003, REDOX REP, V8, P241, DOI 10.1179/135100003225002835; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Stacey MM, 2009, FREE RADICAL BIO MED, V47, P1468, DOI 10.1016/j.freeradbiomed.2009.08.022; Starzynski RR, 2009, BIOCHEM J, V420, P383, DOI 10.1042/BJ20082137; Stocker S, 2018, NAT CHEM BIOL, V14, P148, DOI 10.1038/nchembio.2536; Thamsen M, 2011, ANTIOXID REDOX SIGN, V14, P725, DOI 10.1089/ars.2010.3717; Urbinati Fabrizia, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010805; Veal EA, 2018, ANTIOXID REDOX SIGN, V28, P574, DOI 10.1089/ars.2017.7214; Voskou S, 2015, REDOX BIOL, V6, P226, DOI 10.1016/j.redox.2015.07.018; Weatherall DJ, 2006, WILLIAMS HEMATOLOGY, V7; WINTERBOURN CC, 1985, ENVIRON HEALTH PERSP, V64, P321, DOI 10.2307/3430020; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yang HY, 2007, BIOCHEM BIOPH RES CO, V359, P1030, DOI 10.1016/j.bbrc.2007.06.007	75	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208316	10.1371/journal.pone.0208316	http://dx.doi.org/10.1371/journal.pone.0208316			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521599	Green Submitted, gold, Green Published			2022-12-26	WOS:000452307600045
J	Thareja, G; Mathew, S; Mathew, LS; Mohamoud, YA; Suhre, K; Malek, JA				Thareja, Gaurav; Mathew, Sweety; Mathew, Lisa S.; Mohamoud, Yasmin Ali; Suhre, Karsten; Malek, Joel A.			Genotyping-by-sequencing identifies date palm clone preference in agronomics of the State of Qatar	PLOS ONE			English	Article							1ST REPORT; CULTIVARS; DISEASE; DIVERSITY; TREES	Understanding the genetic diversity in a crop population is key to its targeted breeding for desired traits, such as higher yields, better fruit quality and resistance to disease and changing climates. Date fruits represent a major crop in the Middle East and are key to achieving future food independence in arid countries like Qatar. We previously determined the genome of the date palm Phoenix dactylifera and showed that date palm trees world-wide divide into two distinct subpopulations of Eastern and Western origins. Here we applied a resource of SNPs from 179 commercially available date fruits to assess the genetic diversity of date palm trees grown in the State of Qatar. We found that palm trees in Qatar are mainly of Eastern origin, and that their genetic diversity doesn't associate with regions of the State. Together with targeted genetic assays, our resource can be used in the future for date palm cultivar identification, to aid selecting suitable cultivars for targeted breeding, to improve a country's date palm genetic diversity, and to certify the origin of date fruits and trees.	[Thareja, Gaurav; Mathew, Sweety; Suhre, Karsten] Weill Cornell Med Qatar, Bioinformat Core, Doha, Qatar; [Mathew, Lisa S.; Mohamoud, Yasmin Ali; Malek, Joel A.] Weill Cornell Med Qatar, Genom Core, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Suhre, K (corresponding author), Weill Cornell Med Qatar, Bioinformat Core, Doha, Qatar.; Malek, JA (corresponding author), Weill Cornell Med Qatar, Genom Core, Doha, Qatar.	karsten@suhre.fr; jom2042@qatar-med.cornell.edu	Thareja, Gaurav/GRE-8285-2022; Suhre, Karsten/AAF-1778-2020	Suhre, Karsten/0000-0001-9638-3912	NPRP-EP from the Qatar National Research Fund, a member of Qatar Foundation [X-014-4-001]	NPRP-EP from the Qatar National Research Fund, a member of Qatar Foundation	This project was funded by NPRP-EP grant X-014-4-001 to KS from the Qatar National Research Fund, a member of Qatar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas EH, 2004, PLANT PATHOL, V53, P815, DOI 10.1111/j.1365-3059.2004.01084.x; Abbas EH, 2003, PLANT PATHOL, V52, P790, DOI 10.1111/j.1365-3059.2003.00899.x; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Khayri, 2015, DATE PALM GENETIC RE, P323, DOI [https://doi.org/10.1007/978-94-017-9694-1, DOI 10.1007/978-94-017-9694-1]; Al-Khayri J.M., 2015, DATE PALM GENETIC RE, V1; [Anonymous], 2017, R LANG ENV STAT COMP; BENDIAB K, 1993, EUPHYTICA, V65, P23, DOI 10.1007/BF00022196; Benzohra I. E., 2015, African Journal of Biotechnology, V14, P542; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cabezas JA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-153; Caramante M, 2011, FOOD CONTROL, V22, P549, DOI 10.1016/j.foodcont.2010.10.002; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chao CT, 2007, HORTSCIENCE, V42, P1077, DOI 10.21273/HORTSCI.42.5.1077; Chung YS, 2017, HORTIC ENVIRON BIOTE, V58, P425, DOI 10.1007/s13580-017-0297-8; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Davis RH, 1996, PALMS WORLD, P410; Dong QH, 2010, SCI HORTIC-AMSTERDAM, V125, P233, DOI 10.1016/j.scienta.2010.03.023; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; El Modafar C, 2010, PHYSIOL MOL PLANT P, V74, P287, DOI 10.1016/j.pmpp.2010.06.008; GOVINDARAJ M., 2015, GENETICS RES INT, V2015; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; Hinze LL, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0981-y; Hirsch CD, 2014, BRIEF FUNCT GENOMICS, V13, P257, DOI 10.1093/bfgp/elt051; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Abraham-Juarez MJ, 2009, REV FITOTEC MEX, V32, P171; Korir NK, 2013, CRIT REV BIOTECHNOL, V33, P111, DOI 10.3109/07388551.2012.675314; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu ZX, 2017, CROP J, V5, P326, DOI 10.1016/j.cj.2016.11.001; Mathew LS, 2015, G3-GENES GENOM GENET, V5, P1429, DOI 10.1534/g3.115.018341; Mrabet Abdessalem, 2008, Pak J Biol Sci, V11, P1003, DOI 10.3923/pjbs.2008.1003.1008; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Rao V. R., 2002, PLANT CELL TISSUE OR, V68, P1, DOI DOI 10.1023/A:1013359015812; Stephan N, 2018, DATA BRIEF, V18, P1313, DOI 10.1016/j.dib.2018.04.012; Zhao M. Z., 2011, African Journal of Plant Science, V5, P273	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207299	10.1371/journal.pone.0207299	http://dx.doi.org/10.1371/journal.pone.0207299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517143	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400031
J	Yao, Y; Zia, A; Wyrozemski, L; Lindeman, I; Sandve, GK; Qiao, SW				Yao, Ying; Zia, Asima; Wyrozemski, Lukasz; Lindeman, Ida; Sandve, Geir Kjetil; Qiao, Shuo-Wang			Exploiting antigen receptor information to quantify index switching in single-cell transcriptome sequencing experiments	PLOS ONE			English	Article							CLONALITY INFERENCE; RNA-SEQ	By offering high sequencing speed and ultra-high-throughput at a low price, Illumina next-generation sequencing platforms have been widely adopted in recent years. However, an experiment with multiplexed library could be at risk of molecular recombination, known as "index switching", which causes a proportion of the reads to be assigned to an incorrect sample. It is reported that a new advance, exclusion amplification (ExAmp) in conjunction with the patterned flow cell technology introduced on HiSeq 3000/HiSeq 4000/HiSeq X sequencing systems, potentially suffers from a higher rate of index switching than conventional bridge amplification. We took advantage of the diverse but highly cell-specific expression of antigen receptors on immune cells to quantify index switching on single cell RNA-seq data that were sequenced on HiSeq 3000 and HiSeq 4000. By utilizing the unique antigen receptor expression, we could quantify the spread-of-signal from many different wells (n = 55 from total of three batches) due to index switching. Based on full-length T cell receptor (TCR) sequences from all samples reconstructed by TraCeR and TCR gene expression quantified by Kallisto, we found index switching in all three batches of experiments investigated. The median percentage of incorrectly detected markers was estimated to be 3.9% (interquartile. range (IQR): 1.7%-7.3%). We did not detect any consistent patterns of certain indices to be more prone to switching than others, suggesting that index switching is a stochastic process. Our results confirm that index switching is a problem that affects samples run in multiplexed libraries on Illumina HiSeq 3000 and HiSeq 4000 platforms.	[Yao, Ying; Zia, Asima; Lindeman, Ida; Qiao, Shuo-Wang] Univ Oslo, Dept Immunol, Ctr Immune Regulat, Oslo, Norway; [Wyrozemski, Lukasz; Lindeman, Ida; Sandve, Geir Kjetil; Qiao, Shuo-Wang] Univ Oslo, KG Jebsen Coeliac Dis Res Ctr, Oslo, Norway; [Sandve, Geir Kjetil] Univ Oslo, Dept Informat, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Yao, Y; Qiao, SW (corresponding author), Univ Oslo, Dept Immunol, Ctr Immune Regulat, Oslo, Norway.; Qiao, SW (corresponding author), Univ Oslo, KG Jebsen Coeliac Dis Res Ctr, Oslo, Norway.	ying.xiaodai2@gmail.com; s.w.qiao@medisin.uio.no	Lindeman, Ida/T-4183-2019; Qiao, Shuo-Wang/ABE-8148-2020	Lindeman, Ida/0000-0001-8343-2842; Qiao, Shuo-Wang/0000-0002-0935-8397; Wyrozemski, Lukasz/0000-0003-3830-5064; Zia, Asima/0000-0003-1732-6560; Sandve, Geir Kjetil/0000-0002-4959-1409	Stiftelsen Kristian Gerhard Jebsen [SKGJ-MED-017]; Research Council of Norway through the Centre of Excellence funding scheme [179573/V40]; Research Council of Norway [233885]	Stiftelsen Kristian Gerhard Jebsen; Research Council of Norway through the Centre of Excellence funding scheme(Research Council of Norway); Research Council of Norway(Research Council of Norway)	This study was supported by grants from Stiftelsen Kristian Gerhard Jebsen (project SKGJ-MED-017) to S.W.Q, G.K.S., and L.A.W.; and the Research Council of Norway (project 179573/V40 through the Centre of Excellence funding scheme and project 233885) to S.W.Q., A.Z. and Y.Y.	Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Illumina Inc, EFF IND MIS MULT DOW; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Li AH, 2004, BLOOD, V103, P4602, DOI 10.1182/blood-2003-11-3857; Lindeman I, 2018, NAT METHODS, V15, P563, DOI 10.1038/s41592-018-0082-3; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Parham P, 2014, IMMUNE SYSTEM; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Sinha R, 2017, BIORXIV, DOI [10.1101/125724, DOI 10.1101/125724]; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Vezzi F., 2018, BIORXIV, DOI [10.1101/179028, DOI 10.1101/179028]	12	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208484	10.1371/journal.pone.0208484	http://dx.doi.org/10.1371/journal.pone.0208484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517183	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400101
J	Sun, ZQ; Ou, CL; Liu, JB; Chen, C; Zhou, QB; Yang, SX; Li, GY; Wang, GX; Song, JM; Li, Z; Zhang, ZY; Yuan, WT; Li, XY				Sun, Zhenqiang; Ou, Chunlin; Liu, Jinbo; Chen, Chen; Zhou, Quanbo; Yang, Shuaixi; Li, Guiyuan; Wang, Guixian; Song, Junmin; Li, Zhen; Zhang, Zhiyong; Yuan, Weitang; Li, Xiayu			YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer	ONCOGENE			English	Article							LONG NONCODING RNA; OSTEOSARCOMA DEVELOPMENT; EXPRESSION PROFILES; CELL-PROLIFERATION; POOR-PROGNOSIS; TUMOR-GROWTH; YAP1; METASTASIS; ONCOGENE; PROGRESSION	Yes-associated protein 1 (YAP1) exerts significant effects in various malignancies. However, the oncogenic role of YAP1 remains controversial, and the mechanism by which YAP1 regulates non-coding RNAs is still largely unknown. The present study aimed to assess the effect of YAP1 on the malignant behaviors of colorectal carcinoma (CRC) and explore the underlying regulatory mechanism of the YAP1-MALAT1-miR-126-5p axis. YAP1 was highly expressed in CRC tissues as assessed by GSE20916 and its expression was negatively correlated with overall survival in 83 CRC cases. Meanwhile, YAP1 promoted proliferation, invasion, and migration in colon cancer cells, in vitro and in vivo. MALAT1 was obviously expressed, with differential expression of 11 lncRNAs in HCT116 cells after transfection with siYAP1 or si-Ctl. Based on bioinformatics prediction, immunoprecipitation (IP), and chromatin immunoprecipitation (ChIP), the interaction of YAP1 with TCF4/beta-catenin was regulated by MALAT1. Bioinformatics prediction, dual luciferase assay, RNA-IP, and RNA pulldown assay demonstrated that YAP1-induced MALAT1 promoted the expression of metastasis-associated molecules such as VEGFA, SLUG, and TWIST, by sponging miR-126-5p in CRC. These findings indicated that the YAP1-MALAT1-miR126-5p axis could control angiogenesis and epithelial-mesenchymal transition in CRC, providing potential biomarkers and therapeutic targets for CRC.	[Sun, Zhenqiang; Liu, Jinbo; Chen, Chen; Zhou, Quanbo; Yang, Shuaixi; Wang, Guixian; Song, Junmin; Li, Zhen; Zhang, Zhiyong; Yuan, Weitang] Zhengzhou Univ, Dept Anorectal Surg, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Sun, Zhenqiang; Ou, Chunlin; Li, Guiyuan] Cent S Univ, Dept Pathol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Sun, Zhenqiang; Ou, Chunlin; Li, Guiyuan] Cent S Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Ou, Chunlin; Li, Xiayu] Cent S Univ, Xiangya Hosp 3, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha 410013, Hunan, Peoples R China; [Li, Xiayu] Cent S Univ, Dept Gastroenterol, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China	Zhengzhou University; Central South University; Central South University; Central South University; Central South University	Sun, ZQ; Yuan, WT (corresponding author), Zhengzhou Univ, Dept Anorectal Surg, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China.; Sun, ZQ (corresponding author), Cent S Univ, Dept Pathol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.; Sun, ZQ (corresponding author), Cent S Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China.; Li, XY (corresponding author), Cent S Univ, Xiangya Hosp 3, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha 410013, Hunan, Peoples R China.; Li, XY (corresponding author), Cent S Univ, Dept Gastroenterol, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China.	zqsun82@csu.edu.cn; yuanweitang@zzu.edu.cn; lixiayu002@sina.com	li, xia/HHZ-7468-2022	Ou, Chunlin/0000-0003-2313-4186	National Natural Science Foundation of China [81560385]; Natural Science Foundation of Xinjiang Uygur Autonomous Region [2015211C136]; Medical Scientific and Technological Research Project of Henan Province [201702027]; China Postdoctoral Science Foundation [2017M610462]; Youth Innovation Fund Project of The First Affiliated Hospital of Zhengzhou University [YNQN2017035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xinjiang Uygur Autonomous Region; Medical Scientific and Technological Research Project of Henan Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Fund Project of The First Affiliated Hospital of Zhengzhou University	This work was supported by the National Natural Science Foundation of China (81560385), the Natural Science Foundation of Xinjiang Uygur Autonomous Region (2015211C136), the Medical Scientific and Technological Research Project of Henan Province (201702027), China Postdoctoral Science Foundation (2017M610462), and the Youth Innovation Fund Project of The First Affiliated Hospital of Zhengzhou University (YNQN2017035).	Ai FY, 2015, ONCOTARGET, V6, P5412, DOI 10.18632/oncotarget.3027; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Bottomley A, 2002, LANCET, V359, P1537, DOI 10.1016/S0140-6736(02)08526-4; Chan LH, 2014, ONCOGENE, V33, P4857, DOI 10.1038/onc.2013.433; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Di Cecilia S, 2016, CANCER RES, V76, P5615, DOI 10.1158/0008-5472.CAN-15-1824; Ebrahimi F, 2015, EXP CELL RES, V339, P333, DOI 10.1016/j.yexcr.2015.10.004; Fiala O, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317709283; Ghosh A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.123; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Hong Y, 2010, CLIN EXP METASTAS, V27, P83, DOI 10.1007/s10585-010-9305-4; Hu Y, 2015, CLIN GASTROENTEROL H, V75, P6890; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Lee KW, 2015, CLIN CANCER RES, V21, P357, DOI 10.1158/1078-0432.CCR-14-1374; Lee NK, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-2988-4; Li C, 2017, ONCOTARGET, V8, P28683, DOI 10.18632/oncotarget.15640; Li HL, 2018, BIOCHEM BIOPH RES CO, V495, P2350, DOI 10.1016/j.bbrc.2017.12.114; Li PL, 2017, MOL CANCER THER, V16, P739, DOI 10.1158/1535-7163.MCT-16-0591; Li QL, 2016, CANCER LETT, V383, P28, DOI 10.1016/j.canlet.2016.09.019; Li S, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2015.06.003; Li W, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0612-3; Li Y, 2017, CANCER LETT, V395, P31, DOI 10.1016/j.canlet.2017.02.035; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Liu K, 2017, CELL CYCLE, V16, P578, DOI 10.1080/15384101.2017.1288324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2018, CANCER LETT, V423, P36, DOI 10.1016/j.canlet.2018.02.015; Ma XY, 2017, J BIOL CHEM, V292, P17046, DOI 10.1074/jbc.M117.805655; Ma YL, 2016, GUT, V65, P1494, DOI 10.1136/gutjnl-2014-308392; Matsumura K, 2017, ONCOGENE, V36, P1191, DOI 10.1038/onc.2016.282; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nagy ZB, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-016-0305-3; de Almeida ALNR, 2016, ACTA CIR BRAS, V31, P13, DOI 10.1590/S0102-86502016001300004; Okazaki S, 2012, INT J ONCOL, V40, P209, DOI [10.3892/ijo.2011.1201, 10.3892/ijo.2011.120]; Ou CL, 2017, CANCER LETT, V399, P53, DOI 10.1016/j.canlet.2017.04.011; Ou CL, 2015, ONCOL REP, V33, P2779, DOI 10.3892/or.2015.3913; Park J, 2015, ONCOTARGET, V6, P34658, DOI 10.18632/oncotarget.5778; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Ren WG, 2016, ARCH MED RES, V47, P214, DOI 10.1016/j.arcmed.2016.07.001; Ross J, 2009, NUCLEIC ACIDS RES, V37, P5295, DOI 10.1093/nar/gkp545; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Seton-Rogers S, 2014, NAT REV CANCER, V14, DOI 10.1038/nrc3791; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sun D, 2016, ONCOTARGET, V7, P81062, DOI 10.18632/oncotarget.13188; Sun M, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0445-8; Sun ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135119; Tan DSW, 2017, NAT MED, V23, P1167, DOI 10.1038/nm.4401; Tan XY, 2017, J CELL BIOCHEM, V118, P3643, DOI 10.1002/jcb.25862; Tsai KW, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0821-1; Wang K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4596; Wang Z, 2017, CANCER RES, V77, P2413, DOI 10.1158/0008-5472.CAN-16-3229; Watanabe T, 2011, CLIN TRANSL ONCOL, V13, P419, DOI 10.1007/s12094-011-0676-z; Xiong W, 2008, BLOOD, V112, P4235, DOI 10.1182/blood-2007-10-119123; Yamada N, 2017, HUM PATHOL, V60, P151, DOI 10.1016/j.humpath.2016.10.007; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zeng ZY, 2007, HUM PATHOL, V38, P120, DOI 10.1016/j.humpath.2006.06.023; Zeng ZY, 2016, TUMOR BIOL, V37, P729, DOI 10.1007/s13277-015-3860-x; Zhang XM, 2015, INT J CANCER, V137, P2803, DOI 10.1002/ijc.29671; Zheng HT, 2014, INT J CLIN EXP PATHO, V7, P3174; Zhou Y., 2017, J CELLULAR PHYSL, V233, P5805, DOI 10. 1002/jcp. 26357; Zhou Y, 2013, INT J SYST DYN APPL, V2, P1, DOI 10.4018/ijsda.2013040101	67	146	149	5	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2627	2644		10.1038/s41388-018-0628-y	http://dx.doi.org/10.1038/s41388-018-0628-y			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30531836	Green Published, hybrid			2022-12-26	WOS:000463335200013
J	Savoia, M; Cencioni, C; Mori, M; Atlante, S; Zaccagnini, G; Devanna, P; Di Marcotullio, L; Botta, B; Martelli, F; Zeiher, AM; Pontecorvi, A; Farsetti, A; Spallotta, F; Gaetano, C				Savoia, Matteo; Cencioni, Chiara; Mori, Mattia; Atlante, Sandra; Zaccagnini, Germana; Devanna, Paolo; Di Marcotullio, Lucia; Botta, Bruno; Martelli, Fabio; Zeiher, Andreas M.; Pontecorvi, Alfredo; Farsetti, Antonella; Spallotta, Francesco; Gaetano, Carlo			P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation	FASEB JOURNAL			English	Article						PCAF; IDH2; -ketoglutarate; metabolism; mitochondrion	EPSILON-LYSINE ACETYLATION; CARDIAC MESENCHYMAL CELLS; FATTY-ACID OXIDATION; MOLECULAR-DYNAMICS; SIR2 HOMOLOG; PCAF; METABOLISM; SUBSTRATE; DISTINCT; CANCER	The epigenetic enzyme p300/CBP-associated factor (PCAF) belongs to the GCN5-related N-acetyltransferase (GNAT) family together with GCN5. Although its transcriptional and post-translational function is well characterized, little is known about its properties as regulator of cell metabolism. Here, we report the mitochondrial localization of PCAF conferred by an 85 aa mitochondrial targeting sequence (MTS) at the N-terminal region of the protein. In mitochondria, one of the PCAF targets is the isocitrate dehydrogenase 2 (IDH2) acetylated at lysine 180. This PCAF-regulated post-translational modification might reduce IDH2 affinity for isocitrate as a result of a conformational shift involving predictively the tyrosine at position 179. Site-directed mutagenesis and functional studies indicate that PCAF regulates IDH2, acting at dual level during myoblast differentiation: at a transcriptional level together with MyoD, and at a post-translational level by direct modification of lysine acetylation in mitochondria. The latter event determines a decrease in IDH2 function with negative consequences on muscle fiber formation in C2C12 cells. Indeed, a MTS-deprived PCAF does not localize into mitochondria, remains enriched into the nucleus, and contributes to a significant increase of muscle-specific gene expression enhancing muscle differentiation. The role of PCAF in mitochondria is a novel finding shedding light on metabolic processes relevant to early muscle precursor differentiation.Savoia, M., Cencioni, C., Mori, M., Atlante, S., Zaccagnini, G., Devanna, P., Di Marcotullio, L., Botta, B., Martelli, F., Zeiher, A. M., Pontecorvi, A., Farsetti, A., Spallotta, F., Gaetano, C. P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation.	[Savoia, Matteo; Atlante, Sandra; Spallotta, Francesco] Goethe Univ, Dept Cardiol, Div Cardiovasc Epigenet, Frankfurt, Germany; [Zeiher, Andreas M.] Goethe Univ, Dept Cardiol, Internal Med Clin 3, Frankfurt, Germany; [Cencioni, Chiara; Farsetti, Antonella] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Mori, Mattia] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy; [Zaccagnini, Germana; Martelli, Fabio] Policlin San Donato, Ist Ricovero & Cura Carattere Sci, Mol Cardiol Lab, Milan, Italy; [Devanna, Paolo] Max Plank Inst Psycholinguist, Neurogenet Vocal Commun Grp, Nijmegen, Netherlands; [Di Marcotullio, Lucia] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Botta, Bruno] Sapienza Univ Rome, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Di Marcotullio, Lucia] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Pontecorvi, Alfredo] Univ Cattolica Sacro Cuore Roma, Inst Med Pathol, Rome, Italy; [Pontecorvi, Alfredo] Fdn Policlin Univ A Gemelli Ist Ricovero & Cura C, Rome, Italy; [Gaetano, Carlo] Ist Clin Sci Maugeri, Lab Epigenet, Via Maugeri 4, I-27100 Pavia, Italy; [Spallotta, Francesco] Ist Ricovero & Cura Carattere Sci, Candiolo Canc Inst, Fdn Piemonte Oncol, Turin, Italy	Goethe University Frankfurt; Goethe University Frankfurt; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Siena; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Policlinico San Donato; Max Planck Society; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituti Clinici Scientifici Maugeri IRCCS; IRCCS Fondazione del Piemonte per l'Oncologia	Gaetano, C (corresponding author), Ist Clin Sci Maugeri, Lab Epigenet, Via Maugeri 4, I-27100 Pavia, Italy.; Spallotta, F (corresponding author), Ist Ricovero & Cura Carattere Sci, Candiolo Canc Inst, Fdn Piemonte Oncol, Turin, Italy.	fspallotta@gmail.com; carlo.gaetano@icsmaugeri.it	Martelli, Fabio/AAL-3788-2020; Farsetti, Antonella/I-8710-2018; Atlante, Sandra/K-3917-2018; Zaccagnini, Germana/J-7722-2016; Spallotta, Francesco/AAB-6261-2019; Cencioni, Chiara/I-8490-2018; Gaetano, Carlo/P-9997-2019	Martelli, Fabio/0000-0002-8624-7738; Farsetti, Antonella/0000-0002-8603-7925; Atlante, Sandra/0000-0001-8090-9895; Zaccagnini, Germana/0000-0002-9441-4735; Spallotta, Francesco/0000-0002-0466-6286; Cencioni, Chiara/0000-0001-6284-539X; Gaetano, Carlo/0000-0002-5238-1832; Mori, Mattia/0000-0003-2398-1254; Botta, Bruno/0000-0001-8707-4333; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178	LOEWE Cell and Gene Therapy Center (LOEWE-CGT), Goethe University; Deutsche Forschungsgemeinschaft [SFB834]; Ph.D. Program in Sciences of Nutrition, Metabolism, Ageing, and Gender Pathologies (Universita Cattolica del Sacro Cuore, Rome, Italy); August Scheidel-Stiftung; Amandus und Barbara Pauli Stiftung; German Research Foundation (DFG) Excellence Cluster Cardio Pulmonary; Italian Ministry of Health (Ricerca Corrente); Italian Ministry of Health [5X1000, RF-2011-02347907, PE-2011-02348537]; Telethon-Italy [GGP14092]; French Muscular Dystrophy Association (AFM-Telethon) Grant [18477]; Italian Ministry of Education, University and Research [PRIN2015ZHKFTA, PRIN2015HPMLFY_004]; Italian Association for Cancer Research (AIRC) Grant [IG20801]	LOEWE Cell and Gene Therapy Center (LOEWE-CGT), Goethe University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ph.D. Program in Sciences of Nutrition, Metabolism, Ageing, and Gender Pathologies (Universita Cattolica del Sacro Cuore, Rome, Italy); August Scheidel-Stiftung; Amandus und Barbara Pauli Stiftung; German Research Foundation (DFG) Excellence Cluster Cardio Pulmonary(German Research Foundation (DFG)); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Italian Ministry of Health(Ministry of Health, Italy); Telethon-Italy(Fondazione Telethon); French Muscular Dystrophy Association (AFM-Telethon) Grant; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research (AIRC) Grant(Fondazione AIRC per la ricerca sul cancro)	The authors thank Dr. Rosaria Benedetti and Prof. Lucia Altucci (Universita degli Studi della Campania L. Vanvitelli, Naples, Italy), for their help with the PCAF radioactivity assay. This work was supported by the following: LOEWE Cell and Gene Therapy Center (LOEWE-CGT), Goethe University, and Deutsche Forschungsgemeinschaft Program SFB834 "Endothelial Signaling and Vascular Repair," Project B11 Grants (to C.G.) M.S. was the recipient of a fellowship from the Ph.D. Program in Sciences of Nutrition, Metabolism, Ageing, and Gender Pathologies (Universita Cattolica del Sacro Cuore, Rome, Italy). C.C. and F.S. were funded by August Scheidel-Stiftung and Amandus und Barbara Pauli Stiftung 2016. F.S. was funded by the German Research Foundation (DFG) Excellence Cluster Cardio Pulmonary. This work was also supported by Italian Ministry of Health (Ricerca Corrente; to C.G., G.Z., and F.M.), The Italian Ministry of Health (5X1000, RF-2011-02347907, and PE-2011-02348537), Telethon-Italy (Grant GGP14092), and French Muscular Dystrophy Association (AFM-Telethon) Grant 18477 supported F.M. This work was also partially funded by the Italian Ministry of Education, University and Research (PRIN2015ZHKFTA to A.F. and PRIN2015HPMLFY_004 to A.P.), and by Italian Association for Cancer Research (AIRC) Grant IG20801 (to L.D.M.). The authors declare no conflicts of interest.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Atlante S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0802-8; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Bastiaansen AJNM, 2013, ARTERIOSCL THROM VAS, V33, P1902, DOI 10.1161/ATVBAHA.113.301579; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016; Chatterjee A, 2016, CELL, V167, P722, DOI 10.1016/j.cell.2016.09.052; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colussi C, 2012, ARTERIOSCL THROM VAS, V32, P2435, DOI 10.1161/ATVBAHA.112.254011; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Davuluri G, 2016, J PHYSIOL-LONDON, V594, P7341, DOI 10.1113/JP272796; de Jong RCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185820; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Foster DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067513; GABRIEL JL, 1986, METABOLISM, V35, P661, DOI 10.1016/0026-0495(86)90175-7; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hofer A, 2014, EXP GERONTOL, V56, P202, DOI 10.1016/j.exger.2014.03.006; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Maurice T, 2008, NEUROPSYCHOPHARMACOL, V33, P1584, DOI 10.1038/sj.npp.1301551; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Papamokos GV, 2012, BIOPHYS J, V102, P1926, DOI 10.1016/j.bpj.2012.03.030; Ponnaluri VKC, 2017, EPIGENETICS-US, V12, P123, DOI 10.1080/15592294.2016.1265713; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Schiaffino S, 2015, SCAND J MED SCI SPOR, V25, P41, DOI 10.1111/sms.12606; Shintaku J, 2016, CELL REP, V17, P514, DOI 10.1016/j.celrep.2016.09.010; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Spallotta F, 2018, CIRC RES, V122, P31, DOI 10.1161/CIRCRESAHA.117.311300; Spallotta Francesco, 2013, Commun Integr Biol, V6, pe25466, DOI 10.4161/cib.25466; Spallotta F, 2013, J BIOL CHEM, V288, P22915, DOI 10.1074/jbc.M113.484337; Sun C, 2014, CELL REP, V9, P2250, DOI 10.1016/j.celrep.2014.11.029; Suryanarayanan V., 2018, J BIOMOL STRUCT DYN, V120, P823; Swaminathan V, 2007, Subcell Biochem, V41, P397; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Vecellio M, 2014, DIABETES, V63, P2132, DOI 10.2337/db13-0731; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Xie XL, 2017, STRUCTURE, V25, P506, DOI 10.1016/j.str.2016.12.017; Xu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10337-7; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang H, 2008, J BIOL CHEM, V283, P7580, DOI 10.1074/jbc.M707192200; Zhong X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43539; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643; Zou XH, 2017, CANCER RES, V77, P3990, DOI 10.1158/0008-5472.CAN-16-2393	70	9	9	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4107	4123		10.1096/fj.201800788R	http://dx.doi.org/10.1096/fj.201800788R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526058	Bronze			2022-12-26	WOS:000459794800081
J	Bandini, G; Leon, DR; Hoppe, CM; Zhang, Y; Agop-Nersesian, C; Shears, MJ; Mahal, LK; Routier, FH; Costello, CE; Samuelson, J				Bandini, Giulia; Leon, Deborah R.; Hoppe, Carolin M.; Zhang, Yue; Agop-Nersesian, Carolina; Shears, Melanie J.; Mahal, Lara K.; Routier, Francoise H.; Costello, Catherine E.; Samuelson, John			O-Fucosylation of thrombospondin-like repeats is required for processing of microneme protein 2 and for efficient host cell invasion by Toxoplasma gondii tachyzoites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						invasion; Toxoplasma gondii; fucosyltransferase; glycosylation; glycoprotein secretion; apicomplexa parasite; MIC2; O-fucosylation; protein glycosylation; thrombospondin-like repeat	C-MANNOSYLATION; STRUCTURAL BASIS; TYPE-1 REPEATS; GDP-FUCOSE; SECRETION; GROWTH; MIC2; IDENTIFICATION; GLYCOSYLATION; CARBOHYDRATE	Toxoplasma gondii is an intracellular parasite that causes disseminated infections that can produce neurological damage in fetuses and immunocompromised individuals. Microneme protein 2 (MIC2), a member of the thrombospondin-related anonymous protein (TRAP) family, is a secreted protein important for T. gondii motility, host cell attachment, invasion, and egress. MIC2 contains six thrombospondin type I repeats (TSRs) that are modified by C-mannose and O-fucose in Plasmodium spp. and mammals. Here, using MS analysis, we found that the four TSRs in T. gondii MIC2 with protein O-fucosyltransferase 2 (POFUT2) acceptor sites are modified by a dHexHex disaccharide, whereas Trp residues within three TSRs are also modified with C-mannose. Disruption of genes encoding either POFUT2 or the putative GDP-fucose transporter (NST2) resulted in loss of MIC2 O-fucosylation, as detected by an antibody against the GlcFuc disaccharide, and in markedly reduced cellular levels of MIC2. Furthermore, in 10-15% of the pofut2 or nst2 vacuoles, MIC2 accumulated earlier in the secretory pathway rather than localizing to micronemes. Dissemination of tachyzoites in human foreskin fibroblasts was reduced for these knockouts, which both exhibited defects in attachment to and invasion of host cells comparable with the mic2 phenotype. These results, indicating that O-fucosylation of TSRs is required for efficient processing of MIC2 and for normal parasite invasion, are consistent with the recent demonstration that Plasmodium falciparum pofut2 strain has decreased virulence and also support a conserved role for this glycosylation pathway in quality control of TSR-containing proteins in eukaryotes.	[Bandini, Giulia; Agop-Nersesian, Carolina; Samuelson, John] Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, 72 E Concord St, Boston, MA 02118 USA; [Leon, Deborah R.; Costello, Catherine E.] Boston Univ, Dept Biochem, Ctr Biomed Mass Spectrometry, Sch Med, Boston, MA 02118 USA; [Hoppe, Carolin M.; Routier, Francoise H.] Hannover Med Sch, Dept Clin Biochem OE4340, D-30625 Hannover, Germany; [Zhang, Yue; Mahal, Lara K.] NYU, Dept Chem, Biomed Chem Inst, New York, NY USA; [Shears, Melanie J.] Johns Hopkins Malaria Res Inst, Baltimore, MD 21205 USA; [Shears, Melanie J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Boston University; Boston University; Hannover Medical School; New York University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Samuelson, J (corresponding author), Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, 72 E Concord St, Boston, MA 02118 USA.	jsamuels@bu.edu	Bandini, Giulia/ABC-4413-2021; Mahal, Lara/GRY-7287-2022	Routier, Francoise/0000-0002-7163-0590; Costello, Catherine/0000-0003-1594-5122; Bandini, Giulia/0000-0002-8885-3643; Mahal, Lara/0000-0003-4791-8524; Shears, Melanie/0000-0002-8226-4354	Boston College Imaging Core (National Science Foundation) [1626072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER	Boston College Imaging Core (National Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Maryse Lebrun for the AMA4 antibody and Prof. Markus Meissner, Prof. Vern Carruthers, and Prof. Marc Jan Gubbels for reagents and helpful discussions. We thank Bret Judson and the Boston College Imaging Core for infrastructure and support (National Science Foundation Grant 1626072).	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Doucey MA, 1998, MOL BIOL CELL, V9, P291, DOI 10.1091/mbc.9.2.291; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; Ferguson DJP, 2004, INT J PARASITOL, V34, P347, DOI 10.1016/j.ijpara.2003.11.024; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Gras Simon, 2017, Wellcome Open Res, V2, P32, DOI [10.12688/wellcomeopenres.11594.2, 10.12688/wellcomeopenres.11594.1]; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Harper JM, 2004, MOL BIOCHEM PARASIT, V134, P201, DOI 10.1016/j.molbiopara.2003.12.001; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; Hoppe CM, 2018, GLYCOBIOLOGY, V28, P333, DOI 10.1093/glycob/cwy013; Hu H, 2016, GLYCOCONJUGATE J, V33, P285, DOI 10.1007/s10719-015-9633-3; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2015, J BIOL CHEM, V290, P1432, DOI 10.1074/jbc.M114.613646; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Kaltgrad E, 2007, CHEMBIOCHEM, V8, P1455, DOI 10.1002/cbic.200700225; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Khurana S, 2019, J BIOL CHEM, V294, P1541, DOI 10.1074/jbc.RA118.005357; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lopaticki S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00571-y; Lu LC, 2010, J BIOL CHEM, V285, P36245, DOI 10.1074/jbc.M110.126003; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; Huynh MH, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00012-16; Ouologuem DT, 2014, J CELL SCI, V127, P3320, DOI 10.1242/jcs.147736; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Rahman K, 2017, J BIOL CHEM, V292, P18644, DOI 10.1074/jbc.M117.809301; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shcherbakova A, 2017, P NATL ACAD SCI USA, V114, P2574, DOI 10.1073/pnas.1613165114; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siupka P, 2015, GENES IMMUN, V16, P405, DOI 10.1038/gene.2015.22; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wuhrer M, 2011, MASS SPECTROM REV, V30, P664, DOI 10.1002/mas.20337; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	65	13	15	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1967	1983		10.1074/jbc.RA118.005179	http://dx.doi.org/10.1074/jbc.RA118.005179			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30538131	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000459711400017
J	Nishtala, SN; Arora, A; Reyes, J; Akabas, MH				Nishtala, Sita Nirupama; Arora, Avish; Reyes, Jorge; Akabas, Myles H.			Accessibility of substituted cysteines in TM2 and TM10 transmembrane segments in the Plasmodium falciparum equilibrative nucleoside transporter PfENT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosine; malaria; membrane transport; purine; nucleoside; nucleotide transport; sulfhydryl; antimalarial drug; substituted cysteine accessibility method (SCAM); water accessibility	NUCLEOBASE TRANSPORT; CHANNEL STRUCTURE; PLASMA-MEMBRANE; PURINE SALVAGE; IDENTIFICATION; PFNT1; RESISTANCE; PATHWAYS; TARGET; GATE	Infection with Plasmodium species parasites causes malaria. Plasmodium parasites are purine auxotrophic. They import purines via an equilibrative nucleoside transporter (ENT). In P. falciparum, the most virulent species, the equilibrative nucleoside transporter 1 (PfENT1) represents the primary purine uptake pathway. This transporter is a potential target for the development of antimalarial drugs. In the absence of a high-resolution structure for either PfENT1 or a homologous ENT, we used the substituted cysteine accessibility method (SCAM) to investigate the membrane-spanning domain structure of PfENT1 to identify potential inhibitor-binding sites. We previously used SCAM to identify water-accessible residues that line the permeation pathway in transmembrane segment 11 (TM11). TM2 and TM10 lie adjacent to TM11 in an ab initio model of a homologous Leishmania donovani nucleoside transporter. To identify TM2 and TM10 residues in PfENT1 that are at least transiently on the water-accessible transporter surface, we assayed the reactivity of single cysteine-substitution mutants with three methanethiosulfonate (MTS) derivatives. Cysteines substituted for 12 of 14 TM2 segment residues reacted with MTS-ethyl-ammonium-biotin (MTSEA-biotin). At eight positions, MTSEA-biotin inhibited transport, and at four positions substrate transport was potentiated. On an helical wheel projection of TM2, the four positions where potentiation occurred were located in a cluster on one side of the helix. In contrast, although MTSEA-biotin inhibited 9 of 10 TM10 cysteine-substituted mutants, the reactive residues did not form a pattern consistent with either an helix or sheet. These results may help identify the binding site(s) of PfENT1 inhibitors.	[Nishtala, Sita Nirupama; Arora, Avish; Reyes, Jorge; Akabas, Myles H.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Akabas, Myles H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Akabas, Myles H.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Reyes, Jorge] Princeton Univ, Princeton, NJ 08544 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Princeton University	Akabas, MH (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	myles.akabas@einstein.yu.edu		Akabas, Myles/0000-0001-8781-7846; Reyes, Jorge/0000-0002-2084-1013	National Institutes of Health [R01-AI116665]; GlaxoSmithKline (GSK) as part of the GSK Discovery Fast Track Competition; GSK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline (GSK) as part of the GSK Discovery Fast Track Competition; GSK(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-AI116665 (to M.H.A.). In 2015, Dr. Akabas received a one-year unrestricted research grant from GlaxoSmithKline (GSK) as part of the GSK Discovery Fast Track Competition to fund the performance of hit validation assays in Dr. Akabas' laboratory related to the high throughput screen GSK performed with our yeast based assay to identify inhibitors of PfENT1 as potential starting points for the development of novel antimalarial drugs. The only connection between the work supported by GSK and the current work is that they both involve PfENT1. Dr. Akabas holds patents on derivatives of the hits identified by GSK. GSK has no interests in the patents or subsequent work.	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Akabas MH, 2015, ADV EXP MED BIOL, V869, P25, DOI 10.1007/978-1-4939-2845-3_3; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Frame IJ, 2015, ANN NY ACAD SCI, V1342, P19, DOI 10.1111/nyas.12568; Frame IJ, 2015, ACS CHEM BIOL, V10, P775, DOI 10.1021/cb500981y; Harrington SE, 2009, STRUCTURE, V17, P1092, DOI 10.1016/j.str.2009.06.009; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kirk K, 2009, TRENDS PARASITOL, V25, P246, DOI 10.1016/j.pt.2009.03.006; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Lu F, 2017, NEW ENGL J MED, V376, P991, DOI 10.1056/NEJMc1612765; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Riegelhaupt PM, 2010, J BIOL CHEM, V285, P17001, DOI 10.1074/jbc.M110.115758; Riegelhaupt PM, 2010, MOL BIOCHEM PARASIT, V169, P40, DOI 10.1016/j.molbiopara.2009.10.001; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sa JM, 2011, ESSAYS BIOCHEM, V51, P137, DOI [10.1042/BSE0510137, 10.1042/bse0510137]; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Sutherland CJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02382-16, 10.1128/aac.02382-16]; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Valdes R, 2014, J BIOL CHEM, V289, P8799, DOI 10.1074/jbc.M113.546960; Valdes R, 2012, J BIOL CHEM, V287, P44036, DOI 10.1074/jbc.M112.414433; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847	37	1	2	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1924	1935		10.1074/jbc.RA118.006547	http://dx.doi.org/10.1074/jbc.RA118.006547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30541922	hybrid, Green Published			2022-12-26	WOS:000459711400013
J	Patel, A; Sibbet, GJ; Huang, DT				Patel, Amrita; Sibbet, Gary J.; Huang, Danny T.			Structural insights into non-covalent ubiquitin activation of the cIAP1-UbcH5B similar to ubiquitin complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin ligase; allosteric regulation; structural biology; ubiquitin-conjugating enzyme (E2 enzyme); ubiquitylation (ubiquitination); E3 ubiquitin ligase; activation; cIAP1; non-covalent; RING E3; UbcH5B; activation; protein degradation; apoptosis	E3 LIGASE; CATALYTIC ACTIVATION; CRYSTAL-STRUCTURE; CELL-SURVIVAL; RING DOMAIN; CIAP1; MECHANISM; INHIBITOR; DEGRADATION; PROTEINS	Ubiquitin (Ub)-conjugating enzymes and Ub ligases control protein degradation and regulate many cellular processes in eukaryotes. Cellular inhibitor of apoptosis protein-1 (cIAP1) plays a central role in apoptosis and tumor necrosis factor signaling. It harbors a C-terminal RING domain that homodimerizes to recruit E2 similar to Ub (where similar to denotes a thioester bond) complex to catalyze Ub transfer. Noncovalent Ub binding to the backside of the E2 Ub-conjugating enzyme UbcH5 has previously been shown to enhance RING domain activity, but the molecular basis for this enhancement is unclear. To investigate how dimeric cIAP1 RING activates E2 similar to Ub for Ub transfer and what role noncovalently bound Ub has in Ub transfer, here we determined the crystal structure of the cIAP1 RING dimer bound to both UbcH5B covalently linked to Ub (UbcH5B-Ub) and a noncovalent Ub to 1.7 A resolution. The structure along with biochemical analyses revealed that the cIAP1 RING domain interacts with UbcH5B-Ub and thereby promotes the formation of a closed UbcH5B-Ub conformation that primes the thioester bond for Ub transfer. We observed that the noncovalent Ub binds to the backside of UbcH5B and abuts UbcH5B's alpha 1 beta 1-loop, which, in turn, stabilizes the closed UbcH5B-Ub conformation. Our results disclose the mechanism by which cIAP1 RING dimer activates UbcH5B similar to Ub and indicate that noncovalent Ub binding further stabilizes the cIAP1-UbcH5B similar to Ub complex in the active conformation to stimulate Ub transfer.	[Patel, Amrita; Sibbet, Gary J.; Huang, Danny T.] Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Patel, Amrita; Sibbet, Gary J.; Huang, Danny T.] Univ Glasgow, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute; University of Glasgow	Huang, DT (corresponding author), Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	d.huang@beatson.gla.ac.uk	Huang, Danny/AAM-3631-2021	Huang, Danny/0000-0002-6192-259X	Cancer Research UK [A23278]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [647849]	Cancer Research UK(Cancer Research UK); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	This work was supported by Cancer Research UK Grant A23278 and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Grant Agreement 647849). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Dawidziak DM, 2017, PROTEINS, V85, P1957, DOI 10.1002/prot.25348; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Dynek JN, 2013, CANCER LETT, V332, P206, DOI 10.1016/j.canlet.2010.06.013; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Koliopoulos MG, 2016, EMBO J, V35, P1204, DOI 10.15252/embj.201593741; Li SJ, 2015, J BIOL CHEM, V290, P30225, DOI 10.1074/jbc.M115.685867; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Middleton AJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01665-3; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Nomura K, 2017, NAT STRUCT MOL BIOL, V24, P578, DOI 10.1038/nsmb.3414; Peltzer N, 2016, TRENDS CELL BIOL, V26, P445, DOI 10.1016/j.tcb.2016.01.006; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Ranaweera RS, 2013, J BIOL CHEM, V288, P18939, DOI 10.1074/jbc.M113.454470; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sanchez JG, 2016, CELL REP, V16, P1315, DOI 10.1016/j.celrep.2016.06.070; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wright JD, 2016, NAT STRUCT MOL BIOL, V23, P45, DOI 10.1038/nsmb.3142; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	52	8	8	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1240	1249		10.1074/jbc.RA118.006045	http://dx.doi.org/10.1074/jbc.RA118.006045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30523153	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000457879500015
J	Bergmann, G; Kutzner, I; Bender, A; Dymke, J; Trepczynski, A; Duda, GN; Felsenberg, D; Damm, P				Bergmann, Georg; Kutzner, Ines; Bender, Alwina; Dymke, Joern; Trepczynski, Adam; Duda, Georg N.; Felsenberg, Dieter; Damm, Philipp			Loading of the hip and knee joints during whole body vibration training	PLOS ONE			English	Article							IN-VIVO MEASUREMENTS; FORCE DISTRIBUTION; MUSCLE-ACTIVITY; EXERCISE; WALKING; MAGNITUDE; IMPLANT; ENHANCE	During whole body vibrations, the total contact force in knee and hip joints consists of a static component plus the vibration-induced dynamic component. In two different cohorts, these forces were measured with instrumented joint implants at different vibration frequencies and amplitudes. For three standing positions on two platforms, the dynamic forces were compared to the static forces, and the total forces were related to the peak forces during walking. A biomechanical model served for estimating muscle force increases from contact force increases. The median static forces were 122% to 168% (knee), resp. 93% to 141% (hip), of the body weight. The same accelerations produced higher dynamic forces for alternating than for parallel foot movements. The dynamic forces individually differed much between 5.3% to 27.5% of the static forces in the same positions. On the Powerplate, they were even close to zero in some subjects. The total forces were always below 79% of the forces during walking. The dynamic forces did not rise proportionally to platform accelerations. During stance (Galileo, 25 Hz, 2 mm), the damping of dynamic forces was only 8% between foot and knee but 54% between knee and hip. The estimated rises in muscle forces due to the vibrations were in the same ranges as the contact force increases. These rises were much smaller than the vibration-induced EMG increases, reported for the same platform accelerations. These small muscle force increases, along with the observation that the peak contact and muscle forces during vibrations remained far below those during walking, indicate that dynamic muscle force amplitudes cannot be the reason for positive effects of whole body vibrations on muscles, bone remodelling or arthritic joints. Positive effects of vibrations must be caused by factors other than raised forces amplitudes.	[Bergmann, Georg; Kutzner, Ines; Bender, Alwina; Dymke, Joern; Trepczynski, Adam; Duda, Georg N.; Damm, Philipp] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [Felsenberg, Dieter] Charite Univ Med Berlin, Ctr Muscle & Bone Res, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Damm, P (corresponding author), Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany.	philipp.damm@charite.de	; Duda, Georg/H-2085-2016	Bender, Alwina/0000-0002-4444-6309; Damm, Philipp/0000-0001-8471-7284; Duda, Georg/0000-0001-7605-3908	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [01EC1408A]; Deutsche Arthrose-Hilfe [Be 804/18-1, Be 804/19-1]; OrthoLoad Club; Charite	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe; OrthoLoad Club; Charite	The Julius Wolff Institute obtained funding for this research from A) Bundesministerium fur Bildung und Forschung (www.bmbf.de/en).Funding for collecting and evaluating the data of this study (project 01EC1408A, Overload-PrevOP, SP03). B) Deutsche Forschungsgemeinschaft (www.dfg.de/en).Funding for performing two clinical studies (project Be 804/18-1 (hip) and project Be 804/19-1 (knee). C) Deutsche Arthrose-Hilfe (www.arthrose.de/).Funding for a temporary employment of GB by the Charite. D) OrthoLoad Club (www.club.orthoload.com).Funding for a temporary employment of PD by the Charite. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazrgari B, 2008, J BIOMECH, V41, P2639, DOI 10.1016/j.jbiomech.2008.06.026; Bender A, 2012, COMPUT METHOD BIOMEC, V15, P761, DOI 10.1080/10255842.2011.560841; BERGMANN G, 1993, J BIOMECH, V26, P969, DOI 10.1016/0021-9290(93)90058-M; Bergmann G, 2007, ORTHOPADE, V36, P195, DOI 10.1007/s00132-007-1055-x; Bergmann G, 2010, BIO-MED MATER ENG, V20, P65, DOI 10.3233/BME-2010-0616; Bergmann G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155612; Bergmann G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086035; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Boyer KA, 2007, J BIOMECH ENG-T ASME, V129, P594, DOI 10.1115/1.2746384; BURKE D, 1976, J NEUROL NEUROSUR PS, V39, P729, DOI 10.1136/jnnp.39.8.729; Cardinale M, 2005, BRIT J SPORT MED, V39, P585, DOI 10.1136/bjsm.2005.016857; Cardinale M, 2003, EXERC SPORT SCI REV, V31, P3, DOI 10.1097/00003677-200301000-00002; D'Lima DD, 2008, CLIN ORTHOP RELAT R, V466, P2605, DOI 10.1007/s11999-008-0345-x; Damm P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120438; Damm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078373; Damm P, 2013, CLIN BIOMECH, V28, P530, DOI 10.1016/j.clinbiomech.2012.12.003; Damm P, 2010, MED ENG PHYS, V32, P95, DOI 10.1016/j.medengphy.2009.10.003; Ewen AM, 2012, GAIT POSTURE, V36, P1, DOI 10.1016/j.gaitpost.2011.12.024; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Gruber K, 1998, J BIOMECH, V31, P439, DOI 10.1016/S0021-9290(98)00033-5; Halder A, 2012, J BONE JOINT SURG AM, V94A, P1023, DOI 10.2106/JBJS.K.00927; Heinlein B, 2007, J BIOMECH, V40, pS4, DOI 10.1016/j.jbiomech.2007.02.014; Heinlein B, 2009, CLIN BIOMECH, V24, P315, DOI 10.1016/j.clinbiomech.2009.01.011; Heller MO, 2014, OSTEOARTHR CARTILAGE, V22, pS100, DOI 10.1016/j.joca.2014.02.190; Hof AL, 1979, SPORTVERLETZ SPORTSC, V11, P79; Judex S, 2010, J MUSCULOSKEL NEURON, V10, P3; Kaufman KR, 1996, J BIOMECH, V29, P667, DOI 10.1016/0021-9290(95)00124-7; Kerschan-Schindl K, 2001, CLIN PHYSIOL, V21, P377, DOI 10.1046/j.1365-2281.2001.00335.x; KOTZAR GM, 1991, J ORTHOPAED RES, V9, P621, DOI 10.1002/jor.1100090502; Kutzner I, 2017, BONE JOINT J, V99B, P779, DOI [10.1302/0301-620X.99B6.BJJ-2016-0713.R1, 10.1302/0301-620X.99B6.BJJ-20160713.R1]; Kutzner I, 2010, J BIOMECH, V43, P2164, DOI 10.1016/j.jbiomech.2010.03.046; Kutzner I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171972; Kutzner I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081036; Kutzner I, 2013, J BIOMECH, V46, P796, DOI 10.1016/j.jbiomech.2012.11.020; Kutzner I, 2012, J ORTHOP SPORT PHYS, V42, P1032, DOI 10.2519/jospt.2012.4001; Kutzner I, 2011, J ORTHOP RES, V29, P1910, DOI 10.1002/jor.21477; Kutzner I, 2011, J BIOMECH, V44, P1354, DOI 10.1016/j.jbiomech.2011.01.014; Lienhard K, 2017, J BIOMECH, V52, P55, DOI 10.1016/j.jbiomech.2016.12.009; Modenese L, 2012, MULTIBODY SYST DYN, V28, P157, DOI 10.1007/s11044-011-9274-7; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Pope ZK, 2015, SOMATOSENS MOT RES, V32, P254, DOI 10.3109/08990220.2015.1091770; Richards C, 2010, J BIOMECH, V43, P2595, DOI 10.1016/j.jbiomech.2010.05.006; Rohlmann A, 2014, EUR SPINE J, V23, P666, DOI 10.1007/s00586-013-3087-8; Rohlmann A, 2010, EUR SPINE J, V19, P1129, DOI 10.1007/s00586-010-1346-5; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rydell NW, 1966, ACTA ORTHOP SCAND, V88; Sonza A, 2015, MED ENG PHYS, V37, P642, DOI 10.1016/j.medengphy.2015.04.003; Tankisheva E, 2013, J STRENGTH COND RES, V27, P2533, DOI 10.1519/JSC.0b013e31827f1225	51	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207014	10.1371/journal.pone.0207041	http://dx.doi.org/10.1371/journal.pone.0207041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540775	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600006
J	Cai, ST; Liu, K; Yang, M; Tango, JL; Xiong, XM; Xiao, MQ				Cai, Shuting; Liu, Kun; Yang, Ming; Tango, Jianliang; Xiong, Xiaoming; Xiao, Mingqing			A new development of non-local image denoising using fixed-point iteration for non-convex l(p) sparse optimization	PLOS ONE			English	Article							DECOMPOSITION; RESTORATION; DOMAIN	We proposed a new efficient image denoising scheme, which mainly leads to four important contributions whose approaches are different from existing ones. The first is to show the equivalence between the group-based sparse representation and the Schatten-p norm minimization problem, so that the sparsity of the coefficients for each group can be measured by estimating the underlying singular values. The second is that we construct the proximal operator for sparse optimization in l(p) space with p is an element of (0, 1] by using fixed-point iteration and obtained a new solution of Schatten-p norm minimization problem, which is more rigorous and accurate than current available results. The third is that we analyze the suitable setting of power p for each noise level sigma = 20, 30, 50, 60, 75, 100, respectively. We find that the optimal value of p is inversely proportional to the noise level except for high level of noise, where the best values of p are 1 and 0.95, when the noise levels are respectively 75 and 100. Last we measure the structural similarity between two image patches and extends previous deterministic annealing-based solution to sparsity optimization problem through incorporating the idea of dictionary learning. Experimental results demonstrate that for every given noise level, the proposed Spatially Adaptive Fixed Point Iteration (SAFPI) algorithm attains the best denoising performance on the value of Peak Signal-to-Noise Ratio (PSNR) and structure similarity (SSIM), being able to retain the image structure information, which outperforms many state-of-the-art denoising methods such as Block-matching and 3D filtering (BM3D), Weighted Nuclear Norm Minimization (WNNM) and Weighted Schatten p-Norm Minimization (WSNM).	[Cai, Shuting; Liu, Kun; Xiong, Xiaoming] Guangdong Univ Technol, Sch Automat, Guangzhou, Guangdong, Peoples R China; [Yang, Ming] Southern Illinois Univ, Dept Comp Sci, Carbondale, IL 62901 USA; [Xiao, Mingqing] Southern Illinois Univ, Dept Math, Carbondale, IL 62901 USA; [Tango, Jianliang] Shenzhen Univ, Coll Math & Stat, Shenzhen, Guangdong, Peoples R China	Guangdong University of Technology; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Shenzhen University	Yang, M (corresponding author), Southern Illinois Univ, Dept Comp Sci, Carbondale, IL 62901 USA.	yangmingmath@gmail.com		Yang, Ming/0000-0003-1810-1566; Yang, Ming/0000-0002-2654-8643	NSF of the United States [140928]; National Natural Science Foundation of China [61201392]; Natural Science Foundation of Guangdong Province, China [2015A030313497]	NSF of the United States; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was funded by NSF 140928 of the United States, National Natural Science Foundation of China (61201392), and in part by the Natural Science Foundation of Guangdong Province, China (No. 2015A030313497).	Barbu V., 2014, CONVEXITY OPTIMIZATI; Brunet D, 2012, IEEE T IMAGE PROCESS, V21, P1488, DOI 10.1109/TIP.2011.2173206; Cai ST, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10050167; Chatterjee P, 2012, IEEE T IMAGE PROCESS, V21, P1635, DOI 10.1109/TIP.2011.2172799; Chatterjee P, 2010, IEEE T IMAGE PROCESS, V19, P895, DOI 10.1109/TIP.2009.2037087; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Dong B, 2015, P INT C IND APPL MAT, P65; Dong HL, 2017, NONLINEAR DYNAM, V87, P727, DOI 10.1007/s11071-016-3071-z; Dong WS, 2015, INT J COMPUT VISION, V114, P217, DOI 10.1007/s11263-015-0808-y; Dong WS, 2013, IEEE T IMAGE PROCESS, V22, P700, DOI 10.1109/TIP.2012.2221729; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Gu SH, 2014, PROC CVPR IEEE, P2862, DOI 10.1109/CVPR.2014.366; Han Y, 2017, IEEE T MULTIMEDIA, V19, P80, DOI 10.1109/TMM.2016.2608000; Ito K, 2014, INVERSE PROBL, V30, DOI 10.1088/0266-5611/30/1/015001; Kang Z., 2018, KNOWLEDGE BASED SYST; Kang Z, 2017, NEUROCOMPUTING, V267, P210, DOI 10.1016/j.neucom.2017.06.005; Lahmiri S, 2017, HEALTHC TECHNOL LETT, V4, P25, DOI 10.1049/htl.2016.0021; Lahmiri S, 2017, OPT LASER TECHNOL, V90, P128, DOI 10.1016/j.optlastec.2016.11.015; Lahmiri S, 2016, HEALTHC TECHNOL LETT, V3, P67, DOI 10.1049/htl.2015.0007; Lebrun M, 2012, ACTA NUMER, V21, P475, DOI 10.1017/S0962492912000062; Li M, 2017, CHINESE J ELECTRON, V26, P1017, DOI 10.1049/cje.2017.08.021; Lin Z., 2016, BIG DATA INF ANAL, V1, P139, DOI [10.3934/bdia.2016001, DOI 10.3934/BDIA.2016001]; Lorenz D, VARIATIONAL DENOISIN; Lu CY, 2015, AAAI CONF ARTIF INTE, P1805; Mairal J., 2014, ARXIV14113230; Makitalo M, 2013, IEEE T IMAGE PROCESS, V22, P91, DOI 10.1109/TIP.2012.2202675; Peng C, 2018, ACM T INTEL SYST TEC, V9, DOI 10.1145/3200488; Qiong Wang, 2017, IEEE Signal Processing Letters, V24, P1686, DOI 10.1109/LSP.2017.2731791; Slavova A., 2011, 2011 European Conference on Circuit Theory and Design (ECCTD 2011), P226, DOI 10.1109/ECCTD.2011.6043323; Suli E., 2003, INTRO NUMERICAL ANAL; Sun PF, 2018, SPEECH COMMUN, V101, P57, DOI 10.1016/j.specom.2018.05.006; Talebi H, 2014, IEEE T IMAGE PROCESS, V23, P755, DOI 10.1109/TIP.2013.2293425; Tian C., 2018, ICGEC 2018 ADV INTEL; Voyevodin V. V., 1983, LINEAR ALGEBRA; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Xie Y, 2016, IEEE T IMAGE PROCESS, V25, P4842, DOI 10.1109/TIP.2016.2599290; Xu C, 2017, AAAI CONF ARTIF INTE, P926; Xu ZY, 2018, MED IMAGE ANAL, V46, P229, DOI 10.1016/j.media.2018.03.007; Zha ZY, 2017, IEEE INT CON MULTI, P883, DOI 10.1109/ICME.2017.8019334; Zha ZY, 2017, INT CONF ACOUST SPEE, P1787, DOI 10.1109/ICASSP.2017.7952464; Zhang Z, 2015, IEEE ACCESS, V3, P490, DOI 10.1109/ACCESS.2015.2430359; Zoran D, 2011, IEEE I CONF COMP VIS, P479, DOI 10.1109/ICCV.2011.6126278; Zuo WM, 2013, IEEE I CONF COMP VIS, P217, DOI 10.1109/ICCV.2013.34	44	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208503	10.1371/journal.pone.0208503	http://dx.doi.org/10.1371/journal.pone.0208503			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540797	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600075
J	Lai, DWL; Qin, N				Lai, Daniel W. L.; Qin, Nan			Extraversion personality, perceived health and activity participation among community-dwelling aging adults in Hong Kong	PLOS ONE			English	Article							SOCIAL ENGAGEMENT; OLDER-ADULTS; LIFE SATISFACTION; PHYSICAL-ACTIVITY; DEPRESSIVE SYMPTOMS; LEISURE; ASSOCIATION; LIMITATIONS; POPULATION; BENEFIT	Activity participation is essential to the wellbeing of aging adults. Divergent levels of activity participation within aging populations have been explained from diverse perspectives, but the interaction effects of key determinants, such as personality and health, are often ignored. This study examines the effects of extravert personality on aging adults' activity levels by addressing its interaction with perceived physical health and mental health. A sample of 304 adults aged 50 and older was selected using systematic sampling from participants of an institute for promoting active aging at a university in Hong Kong in 2017. Data on socio-demographic characteristics, perceived physical and mental health, extraversion personality traits, and level of activity participation were collected using a telephone survey. Most participants (46.7%) reported moderate activity levels and over a quarter (26.6%) reported high or low activity levels. Multi-nominal logistic regression analyses show that extraversion was associated with an increased likelihood of reporting moderate (OR = 1.85, p =.036) but not high (p >.05) activity levels when adjusted for perceived physical and mental health and socio-demographics, with low activity levels being the constant comparison. Meanwhile, extraversion predicted both moderate (OR = 3.84, p =.014) and high (OR = 5.06, p =.032) activity levels for participants with poor or average perceived mental health. However, the interaction effects of extraversion with perceived physical health or mental health were not significant in predicting either moderate or high activity levels (p >.05). The implications for enhancing activity participation among aging adults are discussed in view of both personality and perceived health status.	[Lai, Daniel W. L.] Hong Kong Polytech Univ, Dept Appl Social Sci, Hung Hom, Kowloon, Kowloon, Hong Kong, Peoples R China; [Qin, Nan] Guangdong Univ Finance & Econ, Sch Humanities & Commun, Guangzhou, Guangdong, Peoples R China	Hong Kong Polytechnic University; Guangdong University of Finance & Economics	Qin, N (corresponding author), Guangdong Univ Finance & Econ, Sch Humanities & Commun, Guangzhou, Guangdong, Peoples R China.	d.lai@polyu.edu.hk; nanqin@gdufe.edu.cn	; Lai, Daniel W.L./C-6974-2014	Qin, Nan/0000-0002-8354-1798; Lai, Daniel W.L./0000-0001-6365-3189				Ahmad F, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-398; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; Ajzen I., 1988, ATTITUDES PERSONALIT; Alexandris K, 2007, EUR REV AGING PHYS A, V4, P39, DOI 10.1007/s11556-007-0014-1; Bai X, 2017, GERIATRICS GERONTOLO; Bielak AAM, 2007, J GERONTOL B-PSYCHOL, V62, pP331, DOI 10.1093/geronb/62.6.P331; Brink P, 2007, GERONTOLOGIST, V47, P633, DOI 10.1093/geront/47.5.633; Burr JA, 2007, J GERONTOL B-PSYCHOL, V62, pS267, DOI 10.1093/geronb/62.4.S267; Chief Medical Officers of England Scotland Wales and Northern Ireland, 2011, START ACT STAY ACT R; CRAWFORD DW, 1991, LEISURE SCI, V13, P309, DOI 10.1080/01490409109513147; Croezen S, 2009, J NUTR HEALTH AGING, V13, P776, DOI 10.1007/s12603-009-0213-8; Fernandez-Mayoralas G, 2015, AGING MENT HEALTH, V19, P1031, DOI 10.1080/13607863.2014.996734; Franco MR, 2015, BRIT J SPORT MED, V49, P1268, DOI 10.1136/bjsports-2014-094015; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; FURNHAM A, 1990, INT J SPORT PSYCHOL, V21, P218; Furnham A., 2004, PSYCHOBIOLOGY PERSON, P167, DOI [10.1016/b978-008044209-9/50011-7, DOI 10.1016/B978-008044209-9/50011-7]; Glass TA, 2006, J AGING HEALTH, V18, P604, DOI 10.1177/0898264306291017; Herero VG, 2010, PERS INDIV DIFFER, V49, P124, DOI 10.1016/j.paid.2010.03.019; Gray JA, 1991, NEUROBIOLOGY LEARNIN, P273; Jang Y, 2004, J APPL GERONTOL, V23, P266, DOI 10.1177/0733464804267579; Janke M, 2006, LEISURE SCI, V28, P285, DOI 10.1080/01490400600598145; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; John O.P., 1991, BIG 5 INVENTORY VERS; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Lai DWL, 2017, HEALTH SOC WORK, V42, pE94, DOI 10.1093/hsw/hlx018; LEMON BW, 1972, J GERONTOL, V27, P511, DOI 10.1093/geronj/27.4.511; Li YQ, 2005, J HEALTH SOC BEHAV, V46, P68, DOI 10.1177/002214650504600106; Li YQ, 2006, SOC FORCES, V85, P497, DOI 10.1353/sof.2006.0132; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Mhaolain AMN, 2012, INT PSYCHOGERIATR, V24, P316, DOI 10.1017/S1041610211001360; Morrow-Howell N, 2014, J GERONTOL B-PSYCHOL, V69, P809, DOI 10.1093/geronb/gbu002; Ness KK, 2006, ANN EPIDEMIOL, V16, P197, DOI 10.1016/j.annepidem.2005.01.009; Oerlemans WGM, 2011, J GERONTOL B-PSYCHOL, V66, P665, DOI 10.1093/geronb/gbr040; Paillard-Borg S, 2009, AGEING SOC, V29, P803, DOI 10.1017/S0144686X08008337; Public health action support team CIC, 2017, CONC HLTH ILLN; Putnam M, 2014, GERONTOLOGIST, V54, P818, DOI 10.1093/geront/gnt074; Rhodes RE, 2006, BRIT J SPORT MED, V40, P958, DOI 10.1136/bjsm.2006.028860; Simonsick EM, 1998, J GERONTOL B-PSYCHOL, V53, pS209, DOI 10.1093/geronb/53B.4.S209; Stephan Y, 2014, BRIT J PSYCHOL, V105, P564, DOI 10.1111/bjop.12056; Stephan Y, 2014, J RES PERS, V49, P1, DOI 10.1016/j.jrp.2013.12.003; Taylor S, 1993, SOCIOLOGY HLTH HLTH; Thomas PA, 2011, SOC SCI MED, V73, P1428, DOI 10.1016/j.socscimed.2011.07.035; Washburn AM, 2003, GERONTOLOGIST, V43, P203, DOI 10.1093/geront/43.2.203; Wen M, 2006, SOC SCI MED, V63, P2575, DOI 10.1016/j.socscimed.2006.06.025; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilson KE, 2015, PERS INDIV DIFFER, V72, P230, DOI 10.1016/j.paid.2014.08.023; Wilson RS, 2005, PSYCHOSOM MED, V67, P841, DOI 10.1097/01.psy.0000190615.20656.83; World Health Organization, 2007, J GERONTOLOGY B; World Health Organization, COMM LANG FUNCT DIS; Yeung GTY, 2007, EUR J AGEING, V4, P219, DOI 10.1007/s10433-007-0065-1; Zautra AJ, 2000, OCCUP THER J RES, V20, p21S, DOI 10.1177/15394492000200S103	53	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0209154	10.1371/journal.pone.0209154	http://dx.doi.org/10.1371/journal.pone.0209154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540853	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600112
J	Yan, KK; Xue, ML; Ye, D; Yang, CJ; Chang, J; Jiang, MH; Zhao, MY; Zhang, HL; Fang, Y				Yan, Kangkang; Xue, Meiling; Ye, Dan; Yang, Caijun; Chang, Jie; Jiang, Minghuan; Zhao, Mingyue; Zhang, Hongli; Fang, Yu			Antibiotic prescribing practices in secondary and tertiary hospitals in Shaanxi province, western China, 2013-2015	PLOS ONE			English	Article							HEALTH; RESISTANCE; STEWARDSHIP; INFECTIONS	Introduction The irrational use of antibiotics is a major driver of antimicrobial resistance. This study aimed to explore how antibiotics were used in secondary and tertiary hospitals in Shaanxi Province, western China from 2013 to 2015. Method A retrospective study was conducted with a sample of 16 hospitals in Shaanxi Province (2 tertiary and 14 secondary hospitals; 8 public and 8 private hospitals) using a stratified random sampling method. All of the macro data from these hospitals from 2013 to 2015 were analyzed. All collected data were double-entered and analyzed using Excel 2007. Results The percentage of injectable antibiotic prescriptions was 26.6% of all of the antibiotic prescriptions in the secondary hospitals and 14.2% in the tertiary hospitals. Injectable antibiotic prescriptions in private tertiary hospitals (enter %) were more than two times that of public tertiary hospitals (enter %). In both tertiary and secondary hospitals, the percentage of antibiotic prescriptions for outpatients, emergency patients and inpatients were within the scope of the national standards, while the intensity of antibiotic use was higher than the national standard of 40 DDD/100 bed-days. The prophylactic antibiotic use rate in clean surgery was 40.4% in tertiary hospitals and 60.7% in secondary hospitals, which were both higher than the national standard of 30%. The preventive use rate of antibiotics in private tertiary hospitals (55.00%) was more than two times that of public tertiary hospitals (25.90%), and the rate was also higher in private secondary hospitals (61.50%) than in public secondary hospitals (59.70%). Conclusions Substantial antibiotic abuse occurred in the sample Chinese hospitals, especially in secondary hospitals. The government should continue to strengthen the administration of antimicrobial use in hospitals. At the same time, medical professional training and interventions for physicians should be conducted to fundamentally reduce the irrational use of antibiotics.	[Yan, Kangkang; Yang, Caijun; Chang, Jie; Jiang, Minghuan; Zhao, Mingyue; Fang, Yu] Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Shaanxi, Peoples R China; [Yan, Kangkang; Yang, Caijun; Chang, Jie; Jiang, Minghuan; Zhao, Mingyue; Fang, Yu] Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Shaanxi, Peoples R China; [Yan, Kangkang; Yang, Caijun; Chang, Jie; Jiang, Minghuan; Zhao, Mingyue; Fang, Yu] Shaanxi Ctr Hlth Reform & Dev Res, Xian, Shaanxi, Peoples R China; [Yan, Kangkang; Ye, Dan] Xian 3 Hosp, Dept Pharm, Xian, Shaanxi, Peoples R China; [Xue, Meiling] 521 Hosp Ordnance Ind, Dept Drug & Equipment, Xian, Shaanxi, Peoples R China; [Zhang, Hongli] Xian Cent Hosp, Dept Pharm, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Shaanxi, Peoples R China.; Fang, Y (corresponding author), Xi An Jiao Tong Univ, Ctr Drug Safety & Policy Res, Xian, Shaanxi, Peoples R China.; Fang, Y (corresponding author), Shaanxi Ctr Hlth Reform & Dev Res, Xian, Shaanxi, Peoples R China.	yufang@mail.xjtu.edu.cn	Chang, Jie/AAE-5797-2019	Chang, Jie/0000-0001-7296-8641	National Natural Science Foundation of China [71603199]; Central University Basic Research Fund [2015qngz05]; "Young Talent Support Plan" of Xi'an Jiaotong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central University Basic Research Fund; "Young Talent Support Plan" of Xi'an Jiaotong University	This study was financially supported by the National Natural Science Foundation of China (grant number 71603199 to KY), the Central University Basic Research Fund (2015qngz05 to YF), and the "Young Talent Support Plan" of Xi'an Jiaotong University to YF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou VG, 2010, SURG INFECT, V11, P343, DOI 10.1089/sur.2009.023; [Anonymous], FULL TEXT G20 LEAD C; Arason VA, 2006, MICROB DRUG RESIST, V12, P169, DOI 10.1089/mdr.2006.12.169; Bao LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118868; Baur D, 2017, LANCET INFECT DIS, V17, P990, DOI 10.1016/S1473-3099(17)30325-0; Bennett D, 2015, J IND ECON, V63, P371, DOI 10.1111/joie.12075; Cars Hakan, 1995, Scandinavian Journal of Primary Health Care, V13, P3, DOI 10.3109/02813439508996727; CDC, 2013, ANTIBIOTIC RESISTANC; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Currie J, 2011, J HEALTH ECON, V30, P933, DOI 10.1016/j.jhealeco.2011.05.009; Dar-Odeh NS, 2010, THER CLIN RISK MANAG, V6, P301; Dong LF, 2011, FAM PRACT, V28, P63, DOI 10.1093/fampra/cmq077; Fang Y, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4233; Fridkin SK, 2015, EMERG INFECT DIS, V21, P1578, DOI 10.3201/eid2109.150512; GHEI P, 1995, HEALTH POLICY, V34, P73, DOI 10.1016/0168-8510(95)90068-3; Gutema G, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3107-9; Hiltunen T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0039; Ma XD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2051-8; [毛小红 Mao Xiaohong], 2013, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V23, P3739; Ministry of Health of the People's Republic of China, 2012, REG CLIN APPL ANT AG, P4; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079532; National Health and Family Planning Commission of the People's Republic of China, 2015, GUID PRINC CLIN APPL, P7; Naylor NR, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0364-8; Paterson DL, 2017, LANCET INFECT DIS, V17, P351, DOI 10.1016/S1473-3099(17)30053-1; Ran SP, 2016, CHINESE J INFECT CON, V15, P330; Shi W, 2014, CLIN MED J, V12, P21; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; World Health Organization, 2014, MED J, V4, P237; World Health Organization, 2006, AN THER CHEM CLASS S; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Xiao YH, 2013, LANCET INFECT DIS, V13, P189, DOI 10.1016/S1473-3099(13)70011-2; Yao KH, 2008, VACCINE, V26, P4425, DOI 10.1016/j.vaccine.2008.06.052; Yezli S, 2012, INT J ANTIMICROB AG, V40, P389, DOI 10.1016/j.ijantimicag.2012.07.009	34	9	9	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207229	10.1371/journal.pone.0207229	http://dx.doi.org/10.1371/journal.pone.0207229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540753	gold, Green Published, Green Submitted			2022-12-26	WOS:000452898600010
J	Coura-Vital, W; Leal, GGD; Marques, LA; Pinheiro, AD; Carneiro, M; Reis, AB				Coura-Vital, Wendel; de Almeida Leal, Gleisiane Gomes; Marques, Luana Araujo; Pinheiro, Aimara da Costa; Carneiro, Mariangela; Reis, Alexandre Barbosa			Effectiveness of deltamethrin-impregnated dog collars on the incidence of canine infection by Leishmania infantum: A large scale intervention study in an endemic area in Brazil	PLOS ONE			English	Article							ZOONOTIC VISCERAL LEISHMANIASIS; PROTECT DOGS; TRANSMISSION; COHORT	To reduce morbidity and mortality caused by visceral leishmaniasis (VL), the Brazilian Visceral Leishmaniasis Control and Surveillance Program promotes the diagnosis and treatment of cases, vector control, euthanasia of seropositive dogs, and health education. Nevertheless, the effectiveness of these measures is questionable as they lead to little reduction in the transmission of the disease. Thus, the effectiveness of strategies such as insecticide-impregnated collars, spot-on insecticides, and immunization of dogs should be assessed. Herein, we evaluated the effectiveness of deltamethrin-impregnated collars on reducing the incidence of Leishmania infantum infection in dogs living in an endemic area of VL. An intervention study was conducted and a total 5,850 dogs were analyzed in baseline. Of these 3,742 seronegative dogs were divided into two groups: collared and uncollared (control). Dogs were followed for 12 months and three interventions were performed. The Cox regression model was used to evaluate the effectiveness of the collar. All analyzes were performed by Intention-to-treat and per-protocol. By intention-to-treat, the incidence rates of L. infantum infection were 7.5 and 7.9 in the collar group, and 6.5 and 13.2 per 1,000 dogs-months in the control group after 6 and 12 months, respectively. In the per-protocol analysis, the incidence rates in the control group were similar to those observed in the intention-to-treat analysis. In the collar group, the incidence rate was 5.1/1,000 dogs-months after 6 and 12 months. The effectiveness by intention-to-treat after adjustment by the multivariate Cox model was 48%. In the analysis per-protocol, the effectiveness increased to 63%. Although collar use was effective when it was evaluated by intention-to-treat, higher effectiveness was found in the per-protocol analysis after one year of follow-up. The data emphasize the importance of the uninterrupted use of deltamethrin-impregnated collars to increase protection against canine VL.	[Coura-Vital, Wendel] Univ Fed Ouro Preto, Dept Anal Clin, Escola Farm, Programa Posgrad Ciencias Farmaceut, Ouro Preto, MG, Brazil; [Coura-Vital, Wendel; de Almeida Leal, Gleisiane Gomes; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Programa Posgrad Ciencias Biol, Nucleo Pesquisa Ciencias Biol, Ouro Preto, MG, Brazil; [Marques, Luana Araujo; Pinheiro, Aimara da Costa] Secretaria Municipal Saude, Ctr Controle Zoonoses, Governador Valadares, MG, Brazil; [Carneiro, Mariangela] Univ Fed Minas Gerais, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitaries, Belo Horizonte, MG, Brazil; [Reis, Alexandre Barbosa] INCT DT, Salvador, BA, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais	Coura-Vital, W (corresponding author), Univ Fed Ouro Preto, Dept Anal Clin, Escola Farm, Programa Posgrad Ciencias Farmaceut, Ouro Preto, MG, Brazil.; Coura-Vital, W (corresponding author), Univ Fed Ouro Preto, Lab Imunopatol, Programa Posgrad Ciencias Biol, Nucleo Pesquisa Ciencias Biol, Ouro Preto, MG, Brazil.	wendelcoura@ufop.edu.br	Coura-Vital, Wendel/AAP-9624-2021; Reis, Alexandre Barbosa/I-9945-2014	Reis, Alexandre Barbosa/0000-0001-8123-4164; /0000-0002-1434-7676; Reis, AlessanRSS/0000-0001-8486-7469	Brazilian Ministry of Health/Fundo Nacional de Saude/National Leishmaniasis Control Program [25000.204799/2013-65]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [409869/2016-3]; Universidade Federal de Ouro Preto; CNPq; CAPES; FAPEMIG	Brazilian Ministry of Health/Fundo Nacional de Saude/National Leishmaniasis Control Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal de Ouro Preto; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by grants from the Brazilian Ministry of Health/Fundo Nacional de Saude/National Leishmaniasis Control Program (no. 25000.204799/2013-65) (MC), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) grant 409869/2016-3 (WCV), and by the research assistance grant from the Universidade Federal de Ouro Preto (WCV). ABR and MC are grateful to CNPq for the researcher fellowships, GGAL is grateful to CAPES for the fellowship, and MC is grateful to FAPEMIG for PPM/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Barata RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/405083; Brianti E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004987; von Zuben APB, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00087415; Coura-Vital W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003374; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Courtenay O, 2009, MED VET ENTOMOL, V23, P245, DOI 10.1111/j.1365-2915.2009.00815.x; Davoust B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-323; Ferroglio E, 2008, ZOONOSES PUBLIC HLTH, V55, P145, DOI 10.1111/j.1863-2378.2007.01092.x; Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Guarga JL, 2000, ACTA TROP, V77, P203, DOI 10.1016/S0001-706X(00)00141-8; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; IBGE-Instituto Brasileiro de Geografia e estatistica, 2017, CENS DEM 2010; KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x; Manzillo VF, 2006, VET PARASITOL, V142, P142, DOI 10.1016/j.vetpar.2006.06.029; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Ministerio da Saude, 2006, MAN VIG CONTR LEISHM; Ministerio da Saude, 2011, 01201CGDTCGLABDEVITS; Ministerio da Saude, 2014, PORT SAUD SVS LEISHM; Ministerio da Saude Ministerio da Agricultura Pecuaria e Abastecimento, 2016, 0012016 MAPAMS; de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Molina R, 2001, Vet Ther, V2, P261; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI 10.1590/S0037-86822011005000014; Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; PAHO, 2017, INF EP AM INF LEISHM; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Ranganathan Priya, 2016, Perspect Clin Res, V7, P144, DOI 10.4103/2229-3485.184823; Regina-Silva S, 2016, VACCINE, V34, P2233, DOI 10.1016/j.vaccine.2016.03.019; Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006; Reithinger R, 2001, EMERG INFECT DIS, V7, P872; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Rossi PG, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-28; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h681; Werneck GL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00ED010616; Werneck GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003172	40	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208613	10.1371/journal.pone.0208613	http://dx.doi.org/10.1371/journal.pone.0208613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532255	Green Published, gold			2022-12-26	WOS:000452644700037
J	Hu, WJ; Wei, N; Li, ZM; Li, K				Hu, Wenjing; Wei, Na; Li, Zong-Ming; Li, Ke			Effects of muscle fatigue on directional coordination of fingertip forces during precision grip	PLOS ONE			English	Article							MANIPULATION; PERFORMANCE; ACTIVATION; OBJECTS	Object manipulation requires well-coordinated force vectors involving both magnitudes and directions. Despite extensive studies about force magnitudes during manipulation, relatively little is known how the muscle fatigue could affect the directional coordination of fingertip forces. This study aims to examine the effects of muscle fatigue on inter-digit coordination of force directions during precision grip. Sixteen female subjects performed precision grip with their thumb and index finger before and after fatigue tasks, which required subjects to produce continuous submaximal pinch strength on the apparatus for a duration more than 200 s. Both their left and right hands were evaluated using the same testing protocol. The means and standard deviations of the coordination angle and the projection angle were applied to quantify the directional coordination across the digits and the force vector direction of each individual digit. Results showed that fatigue led to significant reduction in the mean values of coordination angle and that of projection angle of the index finger in the ipsilateral hand (p < 0.05). Meanwhile, fatigue induced increases in both the standard deviations of coordination angle and projection angle of both digits in the ipsilateral hand (p < 0.05). These results imply that the muscle fatigue could interfere with the grasping stability by altering the directional coordination of all the involved digits and the control of force directions for each individual digit. These findings provide insights into fatigue-related changes of force directional regulation and coordination in dexterous manipulation.	[Hu, Wenjing; Li, Ke] Shandong Univ, Sch Control Sci & Engn, Jinan, Shandong, Peoples R China; [Wei, Na] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan, Shandong, Peoples R China; [Li, Zong-Ming] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Wei, Na] Shandong Univ, Suzhou Inst, Suzhou, Peoples R China	Shandong University; Shandong University; Cleveland Clinic Foundation; Shandong University	Li, K (corresponding author), Shandong Univ, Sch Control Sci & Engn, Jinan, Shandong, Peoples R China.	kli@sdu.edu.cn		Li, Ke/0000-0002-8660-0116	National Natural Science Foundation of China [31200744]; Natural Science Foundation of Shandong [ZR2017MF002]; Natural Science Foundation of Jiangsu [BK20170398]; Jinan Science and Technology Development Plan [201704104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Jinan Science and Technology Development Plan	This work was supported by 31200744, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, KL; ZR2017MF002, http://www.sdstc.gov.cn/, Natural Science Foundation of Shandong, KL; BK20170398, http://www.jstd.gov.cn/, Natural Science Foundation of Jiangsu, NW; and 201704104, http://www.jnsti.gov.cn/jnsti/technet, Jinan Science and Technology Development Plan, NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burstedt MKO, 1997, EXP BRAIN RES, V117, P67, DOI 10.1007/s002210050200; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Emge N, 2013, NEUROSCI LETT, V550, P46, DOI 10.1016/j.neulet.2013.07.008; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Feeney D, 2017, MOTOR CONTROL, V21, P26, DOI 10.1123/mc.2015-0037; Fu QS, 2011, J NEUROSCI, V31, P13576, DOI 10.1523/JNEUROSCI.1143-11.2011; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Goodwin AW, 1998, J NEUROSCI, V18, P10724; Jaric S, 2005, NEUROSCI LETT, V381, P51, DOI 10.1016/j.neulet.2005.01.086; Johanson ME, 2001, J HAND SURG-AM, V26A, P698, DOI 10.1053/jhsu.2001.26188; Kapur S, 2010, J APPL PHYSIOL, V109, P1827, DOI 10.1152/japplphysiol.00430.2010; Li K, 2015, EXP BRAIN RES, V233, P2053, DOI 10.1007/s00221-015-4276-y; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079400; Li K, 2012, MED ENG PHYS, V34, P832, DOI 10.1016/j.medengphy.2011.09.025; Lu SC, 2017, J MED BIOL ENG, V37, P328, DOI 10.1007/s40846-017-0232-6; Marquardt TL, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500474; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Milner TE, 2002, EXP BRAIN RES, V146, P197, DOI 10.1007/s00221-002-1177-7; MORITANI T, 1986, J APPL PHYSIOL, V60, P1179, DOI 10.1152/jappl.1986.60.4.1179; Naceri A, 2015, HAPTICS S IEEE, V26, P35; Nataraj R, 2015, J BIOMECH, V48, P672, DOI 10.1016/j.jbiomech.2014.12.040; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parikh PJ, 2012, J APPL PHYSIOL, V112, P1095, DOI 10.1152/japplphysiol.01385.2011; Pearlman JL, 2004, J ORTHOP RES, V22, P306, DOI 10.1016/j.orthres.2003.08.001; Salomoni SE, 2012, HUM MOVEMENT SCI, V31, P758, DOI 10.1016/j.humov.2011.08.012; Seo NJ, 2011, HUM FACTORS, V53, P740, DOI 10.1177/0018720811420256; Seo NJ, 2011, ARCH PHYS MED REHAB, V92, P24, DOI 10.1016/j.apmr.2010.08.016; Seo NJ, 2010, EXP BRAIN RES, V202, P891, DOI 10.1007/s00221-010-2193-7; Seo NJ, 2008, HUM FACTORS, V50, P734, DOI 10.1518/001872008X354192; Todd G, 2010, EUR J NEUROSCI, V32, P1686, DOI 10.1111/j.1460-9568.2010.07444.x; WESTLING G, 1984, EXP BRAIN RES, V53, P277	32	10	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208740	10.1371/journal.pone.0208740	http://dx.doi.org/10.1371/journal.pone.0208740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD6JR	30532161	gold, Green Published, Green Submitted			2022-12-26	WOS:000452644700045
J	Willkommen, D; Lucio, M; Moritz, F; Forcisi, S; Kanawati, B; Smirnov, KS; Schroeter, M; Sigaroudi, A; Schmitt-Kopplin, P; Michalke, B				Willkommen, Desiree; Lucio, Marianna; Moritz, Franco; Forcisi, Sara; Kanawati, Basem; Smirnov, Kirill S.; Schroeter, Michael; Sigaroudi, Ali; Schmitt-Kopplin, Philippe; Michalke, Bernhard			Metabolomic investigations in cerebrospinal fluid of Parkinson's disease	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ARACHIDONIC-ACID; BRAIN; GLUTATHIONE; BIOMARKERS; PLASMA; MITOCHONDRIAL; GENDER; METABOLITES; DYSFUNCTION	The underlying mechanisms of Parkinson's disease are not completely revealed. Especially, early diagnostic biomarkers are lacking. To characterize early pathophysiological events, research is focusing on metabolomics. In this case-control study we investigated the metabolic profile of 31 Parkinson's disease-patients in comparison to 95 neurologically healthy controls. The investigation of metabolites in CSF was performed by a 12 Tesla SolariX Fourier transform-ion cyclotron resonance-mass spectrometer (FT-ICR-MS). Multivariate statistical analysis sorted the most important biomarkers in relation to their ability to differentiate Parkinson versus control. The affected metabolites, their connection and their conversion pathways are described by means of network analysis. The metabolic profiling by FT-ICR-MS in CSF yielded in a good group separation, giving insights into the disease mechanisms. A total number of 243 metabolites showed an affected intensity in Parkinson's disease, whereas 15 of these metabolites seem to be the main biological contributors. The network analysis showed a connection to the tricarboxylic cycle (TCA cycle) and therefore to mitochondrial dysfunction and increased oxidative stress within mitochondria. The metabolomic analysis of CSF in Parkinson's disease showed an association to pathways which are involved in lipid/ fatty acid metabolism, energy metabolism, glutathione metabolism and mitochondrial dysfunction.	[Willkommen, Desiree; Lucio, Marianna; Moritz, Franco; Forcisi, Sara; Kanawati, Basem; Smirnov, Kirill S.; Schmitt-Kopplin, Philippe; Michalke, Bernhard] Helmholtz Zentrum Munchen, Analyt BioGeoChem, Neuherberg, Germany; [Schroeter, Michael] Uniklin Koln, Klin & Poliklin Neurol, Cologne, Germany; [Sigaroudi, Ali] Univ Spital Zurich, Klin Klin Pharmakol & Toxikol, Zurich, Switzerland; [Sigaroudi, Ali] Uniklin Koln, Inst Pharmakol, Zentrum Pharmakol, Cologne, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Wissenschaftszentrum Weihenstephan, Analyt Lebensmittelchem, Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cologne; University of Zurich; University Zurich Hospital; University of Cologne; Technical University of Munich	Willkommen, D; Lucio, M (corresponding author), Helmholtz Zentrum Munchen, Analyt BioGeoChem, Neuherberg, Germany.	ddesiree.willkommen@helmholtz-muenchen.de; marianna.lucio@helmholtz-muenchen.de	Schmitt-Kopplin, Philippe/H-6271-2011	Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Sigaroudi, Ali/0000-0002-3176-4631; Lucio, Marianna/0000-0002-5844-0098				Ahmed SSSJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-63; Ames Bruce N., 2005, Molecular Aspects of Medicine, V26, P363, DOI 10.1016/j.mam.2005.07.007; Anandhan A, 2017, BRAIN RES BULL, V133, P12, DOI 10.1016/j.brainresbull.2017.03.009; Andersen AD, 2017, ACTA NEUROL SCAND, V135, P34, DOI 10.1111/ane.12590; Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bosetti F, 2007, J NEUROCHEM, V102, P577, DOI 10.1111/j.1471-4159.2007.04558.x; Breitling R, 2006, METABOLOMICS, V2, P155, DOI 10.1007/s11306-006-0029-z; Breitling R, 2006, TRENDS BIOTECHNOL, V24, P543, DOI 10.1016/j.tibtech.2006.10.006; Burte F, 2017, MOVEMENT DISORD, V32, P927, DOI 10.1002/mds.26992; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Cassol E, 2014, AIDS, V28, P1579, DOI 10.1097/QAD.0000000000000303; de Farias CC, 2016, NEUROSCI LETT, V617, P66, DOI 10.1016/j.neulet.2016.02.011; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Forcisi S, 2015, ANAL CHEM, V87, P8917, DOI 10.1021/acs.analchem.5b02049; Havelund JF, 2017, METABOLITES, V7, DOI 10.3390/metabo7030042; Izumi Y, 2009, NEUROSCIENCE, V161, P847, DOI 10.1016/j.neuroscience.2009.04.008; Jimenez-Jimenez FJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00369; Julien C, 2006, NEUROCHEM INT, V48, P404, DOI 10.1016/j.neuint.2005.12.002; Kaling M, 2018, PLANT PHYSIOL, V176, P2639, DOI 10.1104/pp.17.01810; Lazzer S, 2010, OBESITY, V18, P71, DOI 10.1038/oby.2009.162; Lee HJ, 2010, NEUROCHEM RES, V35, P613, DOI 10.1007/s11064-009-0106-6; Lei S, 2014, ACS CHEM BIOL, V9, P2032, DOI 10.1021/cb400894a; LeWitt PA, 2017, NEUROLOGY, V88, P862, DOI 10.1212/WNL.0000000000003663; LeWitt PA, 2013, MOVEMENT DISORD, V28, P1653, DOI 10.1002/mds.25555; Liu XB, 2008, J BIOL CHEM, V283, P34887, DOI 10.1074/jbc.M805682200; Liu YZ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0970-4; Lohner S, 2013, ANN NUTR METAB, V62, P98, DOI 10.1159/000345599; Lucio M, 2011, HDB MOL MICROBIAL EC, P683, DOI DOI 10.1002/9781118010518.CH72; Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005; Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9; Michalke B, 2007, ELECTROPHORESIS, V28, P1380, DOI 10.1002/elps.200600686; Michalke B, 2011, J ANAL ATOM SPECTROM, V26, P165, DOI 10.1039/c0ja00106f; Michell AW, 2008, METABOLOMICS, V4, P191, DOI 10.1007/s11306-008-0111-9; Miller DB, 2015, METABOLISM, V64, pS40, DOI 10.1016/j.metabol.2014.10.030; Molnar D, 1997, EUR J PEDIATR, V156, P376, DOI 10.1007/s004310050618; Moon HE, 2015, EXP NEUROBIOL, V24, P103, DOI 10.5607/en.2015.24.2.103; Moritz F, 2017, PLANT CELL ENVIRON, V40, P1057, DOI 10.1111/pce.12878; Neth K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138270; Neth K, 2015, CHEM RES TOXICOL, V28, P1434, DOI 10.1021/acs.chemrestox.5b00104; Pearce RKB, 1997, J NEURAL TRANSM, V104, P661, DOI 10.1007/BF01291884; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Sanyal I, 2009, EUR REV MED PHARMACO, V13, P129; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SIAN J, 1994, ANN NEUROL, V36, P356, DOI 10.1002/ana.410360306; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Smirnov KS, 2016, INT J MED MICROBIOL, V306, P266, DOI 10.1016/j.ijmm.2016.03.006; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Sunday OP., 2014, INT J NUTR PHARM NEU, V4, P146, DOI DOI 10.4103/2231-0738.132671; Trezzi JP, 2017, MOVEMENT DISORD, V32, P1401, DOI 10.1002/mds.27132; Trupp M, 2014, J PARKINSON DIS, V4, P549, DOI 10.3233/JPD-140389; Tziotis D, 2011, EUR J MASS SPECTROM, V17, P415, DOI 10.1255/ejms.1135; Umeda-Sawada R, 2006, BIOSCI BIOTECH BIOCH, V70, P2121, DOI 10.1271/bbb.60057; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Willkommen D, 2018, J TRACE ELEM MED BIO, V49, P164, DOI 10.1016/j.jtemb.2018.01.005; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Witten IH, 2017, DATA MINING PRACTICA, Vxxxii; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu JF, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1041-6; YOSHII F, 1988, J CEREBR BLOOD F MET, V8, P654, DOI 10.1038/jcbfm.1988.112	65	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208752	10.1371/journal.pone.0208752	http://dx.doi.org/10.1371/journal.pone.0208752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532185	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000452644700049
J	Dimeglio, C; Beau, F; Broult, J; Gouy, P; Izopet, J; Lastere, S; Abravanel, F				Dimeglio, Chloe; Beau, Frederic; Broult, Julien; Gouy, Patrice; Izopet, Jacques; Lastere, Stephane; Abravanel, Florence			Hepatitis E prevalence in French Polynesian blood donors	PLOS ONE			English	Article							E VIRUS; ANTIBODIES; INFECTION; HUMANS	The HEV seroprevalence in mainland France is elevated (22.4%). In contrast, anti-HEV seroprevalence appears to be lower in Oceania. However, none is available for French Polynesia. We assessed the anti-HEV IgG and IgM prevalence on samples from 300 consecutive blood donors living on Tahiti and Moorea islands. Epidemiological information was collected using a specific questionnaire. Overall IgM seroprevalence was 0.6% and overall IgG seroprevalence was 7.7%. The presence of anti-HEV IgG was associated with increasing age (p = 0.01), eating chicken offal (p = 0.01) and cooked rabbit (p = 0.02). Conversely, eating fafaru-traditional Polynesian condiment-was associated with a lower rate of anti-HEV IgG (p<0.01). All donors who surfed or practiced va'a (traditional outrigger canoe) were HEV seronegative. The Polynesian lifestyle and the particular food consumption patterns-especially the very well cooked pork-may be the key to understand the low HEV seroprevalence in French Polynesia.	[Dimeglio, Chloe; Izopet, Jacques; Abravanel, Florence] CHU Toulouse, Hop Purpan, Lab Virol, Ctr Natl Reference Virus Hepatite E, Toulouse, France; [Beau, Frederic; Broult, Julien; Gouy, Patrice] Ctr Hosp Polynesie Francaise, Ctr Transfus Sanguine, Pirae, French Polynesi, France; [Izopet, Jacques; Abravanel, Florence] CPTP, CNRS UMR 5282, INSERM UMR 1043, Toulouse, France; [Lastere, Stephane] Ctr Hosp Polynesie Francaise, Lab Biol Med, Pirae, French Polynesi, France	CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Abravanel, F (corresponding author), CHU Toulouse, Hop Purpan, Lab Virol, Ctr Natl Reference Virus Hepatite E, Toulouse, France.; Abravanel, F (corresponding author), CPTP, CNRS UMR 5282, INSERM UMR 1043, Toulouse, France.	Abravanel.f@chu-toulouse.fr	Abrvaanel, florence/K-3776-2014; ABRAVANEL, Florence/AAC-2993-2021	ABRAVANEL, Florence/0000-0002-1753-1065; IZOPET, JACQUES/0000-0002-8462-3234				Abravanel F, 2017, EMERG INFECT DIS, V23, P1191, DOI 10.3201/eid2307.170318; Abravanel F, 2014, J INFECT DIS, V209, P1900, DOI 10.1093/infdis/jiu032; Abravanel F, 2012, J CLIN MICROBIOL, V50, P897, DOI 10.1128/JCM.05942-11; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Cleland A, 2013, VOX SANG, V105, P283, DOI 10.1111/vox.12056; Dalton HR, 2007, J GASTROEN HEPATOL, V22, P1236, DOI 10.1111/j.1440-1746.2007.04894.x; Hewitt J, 2018, NEW ZEAL MED J, V131, P38; Huang SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013560; Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057; Mansuy JM, 2016, HEPATOLOGY, V63, P1145, DOI 10.1002/hep.28436; Shrestha AC, 2016, TRANSFUSION, V56, P3086, DOI 10.1111/trf.13799; Wenzel JJ, 2013, J INFECT DIS, V207, P497, DOI 10.1093/infdis/jis688; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211	13	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208934	10.1371/journal.pone.0208934	http://dx.doi.org/10.1371/journal.pone.0208934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532225	gold, Green Published, Green Submitted			2022-12-26	WOS:000452640900054
J	Muakrong, N; Kikuchi, S; Fukuhara, S; Tanya, P; Srinives, P				Muakrong, Narathid; Kikuchi, Shinji; Fukuhara, Shuto; Tanya, Patcharin; Srinives, Peerasak			Two jatropha karyotypes constructed from meiotic pachytene chromosomes: Pericentric distribution of heterochromatin and variation in repetitive DNAs	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CURCAS L.; CYTOLOGICAL CHARACTERIZATION; RIBOSOMAL DNA; POPULATION; GENOME; GENES; BASE	Jatropha (Jatropha curcas) is an oil-bearing plant used for biodiesel production. Construction of its standard karyotype and identification of the euchromatin/heterochromatin distribution associated with gene expression and meiotic recombination are essential to fully characterize its genome. Here, we developed a J. curcas karyotype based on meiotic pachytene chromosomes. In addition, a karyotype of J. integerrima, a useful species for jatropha breeding, was also constructed. Five out of eleven J. curcas chromosomes were metacentric, but only two were metacentric in J. integerrima. Almost all of the heterochromatin was distributed around the pericentric regions. The interstitial and distal regions were euchromatic without heterochromatic knobs, except for small heterochromatin regions associated with the subtelomeric repeat sequence JcSat1. These pericentric heterochromatin distribution patterns, together with chromosome structure data and the results of FISH probing with rDNA and JcSat1, allowed us to classify all chromosomes of both species. The two species had two 35S rDNA loci and one 5S rDNA locus; one 35S rDNA locus in J. integerrima was located on the interstitial region of the short arms. In addition, JcSat1 was found at only the heterochromatic ends of the J. curcas chromosome, not the J. integerrima chromosome. Despite the same chromosome number, the two pachytene chromosome-based karyotypes suggest variation in chromosome structure and distribution of repetitive DNAs in these two species.	[Muakrong, Narathid] Princess Naradhiwas Univ, Fac Agr, Narathiwat, Thailand; [Muakrong, Narathid; Kikuchi, Shinji; Fukuhara, Shuto] Chiba Univ, Grad Sch Hort, Lab Genet & Plant Breeding, Matsudo, Chiba, Japan; [Muakrong, Narathid; Tanya, Patcharin; Srinives, Peerasak] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Kamphaeng Saen, Nakhon Pathom, Thailand; [Srinives, Peerasak] Royal Soc Thailand, Bangkok, Thailand	Princess of Naradhiwas University; Chiba University; Kasetsart University	Kikuchi, S (corresponding author), Chiba Univ, Grad Sch Hort, Lab Genet & Plant Breeding, Matsudo, Chiba, Japan.; Srinives, P (corresponding author), Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Kamphaeng Saen, Nakhon Pathom, Thailand.; Srinives, P (corresponding author), Royal Soc Thailand, Bangkok, Thailand.	skikuchi@faculty.chiba-u.jp; agrpss@yahoo.com	Kikuchi, Shinji/N-7380-2019		JSPS [25711024]; Thailand's NSTDA Chair Professor Project [P-11-00599]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Thailand's NSTDA Chair Professor Project	This work was supported by JSPS Grant-in-Aid for Young Scientists, Grant Number 25711024 to S.K. A part of this work was also supported by Thailand's NSTDA Chair Professor Project (grant no. P-11-00599) to P.T. and P.S. https://www.jsps.go.jp/english/e-grants/index.html https://www.nstda.or.th/th/index.php; This work was supported by a JSPS Grant-in-Aid for Young Scientists (A), Grant Number 25711024 to S.K. A part of this work was also supported by Thailand's NSTDA Chair Professor Project (Grant No. P-11-00599) to P.T. and P.S.	Achten WMJ, 2010, J ARID ENVIRON, V74, P164, DOI 10.1016/j.jaridenv.2009.08.010; Alipour A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-129; Basha SD, 2007, EUPHYTICA, V156, P375, DOI 10.1007/s10681-007-9387-5; Carels N., 2013, JATROPHA CHALLENGES, V2, P263; Carvalho CR, 2008, PLANT SCI, V174, P613, DOI 10.1016/j.plantsci.2008.03.010; Chen CC, 2000, THEOR APPL GENET, V101, P30, DOI 10.1007/s001220051445; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Fukuhara S, 2016, BREEDING SCI, V66, P838, DOI 10.1270/jsbbs.16069; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Han YH, 2015, GENETICS, V200, P771, DOI 10.1534/genetics.115.177642; Hirakawa H, 2012, PLANT BIOTECHNOL-NAR, V29, P123, DOI 10.5511/plantbiotechnology.12.0515a; Jiranapapan Jiraporn, 2011, Chromosome Science, V14, P29; Kikuchi Shinji, 2008, Chromosome Science, V11, P37; Lou QF, 2014, PLANT J, V78, P169, DOI 10.1111/tpj.12453; Marinho ACTA, 2018, GENET MOL BIOL, V41, P442, DOI [10.1590/1678-4685-GMB-2017-0120, 10.1590/1678-4685-gmb-2017-0120]; Mohannath G, 2016, P NATL ACAD SCI USA, V113, P13426, DOI 10.1073/pnas.1608140113; Montes J. M., 2014, Diversity, V6, P551; Muakrong N, 2018, CYTOLOGIA, V83, P57, DOI 10.1508/cytologia.83.57; One KT, 2014, J AM SOC HORTIC SCI, V139, P582, DOI 10.21273/JASHS.139.5.582; Peng RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033847; Raskina O, 2004, CHROMOSOME RES, V12, P153, DOI 10.1023/B:CHRO.0000013168.61359.43; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; Tanya P, 2011, PLANT MOL BIOL REP, V29, P252, DOI 10.1007/s11105-010-0220-2; Wang LX, 2015, J PLANT RES, V128, P653, DOI 10.1007/s10265-015-0720-0; Witkowska M, 2009, CYTOLOGIA, V74, P133, DOI 10.1508/cytologia.74.133; Zhang W. L., 2010, Tropical Plant Biology, V3, P166, DOI 10.1007/s12042-010-9053-2	26	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208549	10.1371/journal.pone.0208549	http://dx.doi.org/10.1371/journal.pone.0208549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521604	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600089
J	Shastri, AA; Hegde, V; Peddibhotla, S; Feizy, Z; Dhurandhar, NV				Shastri, Anuradha A.; Hegde, Vijay; Peddibhotla, Swetha; Feizy, Zahra; Dhurandhar, Nikhil, V			E4orf1: A protein for enhancing glucose uptake despite impaired proximal insulin signaling	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; CELL-PROLIFERATION; GLYCEMIC CONTROL; ADIPOSE-TISSUE; EMERGING DRUGS; ADENOVIRUS 36; MUSCLE; TRANSLOCATION; SENSITIVITY; RESISTANCE	Background Type 2 diabetes is often linked with impaired proximal insulin signaling. Hence, a therapeutic agent that enhances cellular glucose uptake without requiring proximal insulin signaling would be desirable for improving glycemic control. The E4orf1 peptide (E4) derived from human adenovirus 36 (Ad36) promotes cellular glucose uptake in vitro and in vivo, independent of insulin. E4 bypasses a part of insulin signaling to upregulate cellular glucose uptake. We tested the hypothesis that E4 requires the distal but not proximal insulin signaling to enhance cellular glucose disposal. Methods 3T3-L1 preadipocytes inducibly expressing E4 or a null vector (NV) were treated with inhibitor of insulin receptor (S961), inhibitor of insulin like growth factor-1receptor (IGF-1R) (Picropodophyllin, PPP), PPP+S961, or phosphatidyl inositol-3 kinase (P13K) inhibitor (Wortmannin, WM). We used PPP and S961 to block the proximal insulin signaling, or WM to block the distal insulin signaling. Cells were exposed to 0 or 100nM insulin. Results As expected, when the proximal or distal insulin signaling was blocked in NV cells, insulin could not enhance pAKT protein abundance, Glut4 translocation, or glucose uptake. Whereas, E4 cells significantly increased pAKT abundance, Glut4 translocation and glucose uptake independent of the presence of insulin or proximal insulin signaling. Enhanced glucose disposal in E4 cells was completely abrogated when the distal insulin signaling was blocked. Conclusions E4 bypasses the proximal insulin signaling but uses the distal insulin signaling to activate pAkt and in turn Glut4 translocation to improve cellular glucose uptake. E4 offers a promising template to improve glycemic control when the proximal insulin signaling is impaired.	[Shastri, Anuradha A.; Hegde, Vijay; Peddibhotla, Swetha; Feizy, Zahra; Dhurandhar, Nikhil, V] Texas Tech Univ, Dept Nutr Sci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Dhurandhar, NV (corresponding author), Texas Tech Univ, Dept Nutr Sci, Lubbock, TX 79409 USA.	Nikhil.Dhurandhar@TTU.EDU	Shastri, Anuradha/ABC-3222-2020	Shastri, Anuradha/0000-0002-4248-4328	Vital Health Interventions (VHI); Texas Tech University	Vital Health Interventions (VHI); Texas Tech University	The study was supported in part by a grant from Vital Health Interventions (VHI) to NVD and internal funding from Texas Tech University. VHI was originally an offshoot from a philanthropic organization in Dayton, OH. However, I believe that it does not exist any longer. We do not have their funding now. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Dhurandhar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047813; Dhurandhar EJ, 2011, OBESITY, V19, pS86; Dhurandhar EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023394; Dhurandhar NV, 2013, J DIABETES COMPLICAT, V27, P191, DOI 10.1016/j.jdiacomp.2012.09.006; Dhurandhar NV, 2011, LANCET INFECT DIS, V11, P963, DOI 10.1016/S1473-3099(11)70274-2; Doscas ME, 2014, NEOPLASIA, V16, P824, DOI 10.1016/j.neo.2014.08.006; Frese KK, 2003, ONCOGENE, V22, P710, DOI 10.1038/sj.onc.1206151; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Hegde V, 2016, BIOCHIMIE, V121, P140, DOI 10.1016/j.biochi.2015.12.002; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Knudsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051972; KOBAYASHI M, 1992, DIABETES, V41, P476, DOI 10.2337/diabetes.41.4.476; Kong K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004102; Krishnapuram R, 2013, INT J OBESITY, V37, P146, DOI 10.1038/ijo.2012.6; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; Krishnapuram R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060651; Kumar M, 2014, J VIROLOGY; Kusminski CM, 2015, MOL METAB, V4, P653, DOI 10.1016/j.molmet.2015.07.004; Li RS, 2009, J MED CHEM, V52, P4981, DOI 10.1021/jm9002395; McMurphy TB, 2017, DIABETES, V66, P358, DOI 10.2337/db16-0876; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Miller BR, 2014, AM HEALTH DRUG BENEF, V7, P452; Na Ha-Na H V, 2016, PLOS ONE, V11, P1, DOI [10.1371/journal.pone.0161275, DOI 10.1371/JOURNAL.PONE.0161275]; Na HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156385; Na HN, 2013, OBESITY ABSTRACT BOO, pS210; Nguyen QT, 2011, AM HEALTH DRUG BENEF, V4, P303; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Rogers PM, 2008, DIABETES, V57, P2321, DOI 10.2337/db07-1311; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SIRTORI CR, 1994, PHARMACOL RES, V30, P187, DOI 10.1016/1043-6618(94)80104-5; Stamateris RE, 2016, DIABETES, V65, P981, DOI 10.2337/db15-0529; Trovato GM, 2009, INT J OBESITY, V33, P1402, DOI 10.1038/ijo.2009.196; Trovato GM, 2010, LIVER INT, V30, P184, DOI 10.1111/j.1478-3231.2009.02127.x; Vikram A, 2010, BIOCHEM BIOPH RES CO, V398, P260, DOI 10.1016/j.bbrc.2010.06.070; Voss JD, 2015, REV MED VIROL, V25, P379, DOI 10.1002/rmv.1852; Wang ZQ, 2008, DIABETES, V57, P1805, DOI 10.2337/db07-1313; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Yoon IS, 2017, INT J OBESITY, V41, P1601, DOI 10.1038/ijo.2017.142	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208427	10.1371/journal.pone.0208427	http://dx.doi.org/10.1371/journal.pone.0208427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521580	Green Submitted, gold, Green Published			2022-12-26	WOS:000452307600064
J	Abadie, R; Goldenberg, S; Welch-Lazoritz, M; Fisher, CB				Abadie, Roberto; Goldenberg, Shira; Welch-Lazoritz, Melissa; Fisher, Celia B.			Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research	PLOS ONE			English	Article							FEMALE SEX WORKERS; NEW-YORK-CITY; CLINICAL-TRIALS; UNDERREPRESENTED POPULATIONS; MINORITY PARTICIPATION; HIV-INFECTION; BARRIERS; USERS; PERSPECTIVES; STRATEGIES	Background The establishment of trust between researchers and participants is critical to advance HIV and HCV prevention particularly among people who inject drugs (PWID) and other marginalized populations, yet empirical research on how to establish and maintain trust in the course of community health research is lacking. This paper documents ideas about trust between research participants and researchers amongst a sub-sample of PWID who were enrolled in a large, multi-year community health study of social networks and HIV/HCV risk that was recently conducted in rural Puerto Rico. Methods Qualitative research was nested within a multi-year Social Network and HIV/HCV Risk study involving N = 360 PWID > 18 years of age living in four small, rural Puerto Rican communities. Semi-structured interviews were conducted between March 2017 and April 2017 with a subset of 40 active PWID who had been enrolled in the parent study. Interview questions invited participants to draw upon their recent experience as research participants to better understand how PWID perceive and understand participant-researcher trust within the context of HIV/HCV-related epidemiological research. Results Fear of police, stigma and concerns regarding confidentiality and anonymity were identified as structural factors that could compromise participation in HIV/HCV-related research for PWID. While monetary compensation was an important motivation, participants also valued the opportunity to learn about their HIV/HCV status. During their participation in the study, gaining knowledge of safe injection practices was perceived as a valuable benefit. Participant narratives suggested that PWID may adopt an incremental and ongoing approach in their assessment of the trustworthiness of researchers, continuously assessing the extent to which they trust the research staff throughout the course of the research. Trust was initially generated through peer Respondent Driven Sampling recruitment. Research staff who maintained a presence in the community for the entire duration of the prospective study reinforced trust between participants and the research team. Conclusion Although PWID face numerous structural barriers to research-related trust in HIV/HCV research, we found that using a peer-based recruitment method like RDS, and employing a research staff who are knowledgeable about the targeted population, culturally sensitive to their needs, and who maintain a long-term presence in the community may help mitigate many of these barriers. The reputation of the research is built incrementally as participants join the study. This contributes to a "street reputation" that grows as current or former participants vouch for the study. Establishing trust was identified as only the first step towards building a collaborative relationship with participants, and our findings suggest that steps to address criminalization and stigmatization also are necessary to support research trust.	[Abadie, Roberto] Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA; [Goldenberg, Shira] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Welch-Lazoritz, Melissa] Univ Nebraska, Med Ctr, Pharmaceut & Nutr Care, Omaha, NE USA; [Fisher, Celia B.] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA	University of Nebraska System; University of Nebraska Lincoln; Simon Fraser University; University of Nebraska System; University of Nebraska Medical Center; Fordham University	Abadie, R (corresponding author), Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA.	rabadie2@unl.edu	Goldenberg, Shira/C-9627-2009	Goldenberg, Shira/0000-0003-1633-9749; Abadie, Roberto/0000-0002-4276-1620	Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes of Drug Abuse [R25DA031608-01]; National Institute of Drug Abuse; National Institute of Health [R01DA037117]; Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes on Drug Abuse [R25DA031608-01]; National Institute on Drug Abuse; National Institutes of Health [R01DA037117]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037117, R25DA031608] Funding Source: NIH RePORTER	Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes of Drug Abuse; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes on Drug Abuse; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes of Drug Abuse (R25DA031608-01; Director, Celia B. Fisher) to RA. The research infrastructure in Puerto Rico was supported by a National Institute of Drug Abuse and National Institute of Health grant, [R01DA037117] to RA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; The authors acknowledge our Community Advisory Board. We also thank research staff Carmen Davila Torres and Angelica Rivera. We thank Celia Fisher and the RETI faculty and trainees for input on an earlier draft of this article. This research was funded by the Fordham University HIV and Drug Abuse Prevention Research Ethics Training Institute/National Institutes on Drug Abuse (R25DA031608-01; Director, Celia B. Fisher). The research infrastructure in Puerto Rico was supported by a National Institute on Drug Abuse and National Institutes of Health grant, [R01DA037117]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abadie R, 2018, INT J DRUG POLICY, V51, P121, DOI 10.1016/j.drugpo.2017.06.011; Abadie R., 2010, PROFESSIONAL GUINEA; Abadie Roberto, 2017, Addict Behav Rep, V5, P29, DOI 10.1016/j.abrep.2017.01.004; Abadie R, 2016, HARM REDUCT J, V13, DOI 10.1186/s12954-016-0099-9; Abdul-Quader AS, 2006, J URBAN HEALTH, V83, P459, DOI 10.1007/s11524-006-9052-7; Adih W. K., 2010, Morbidity and Mortality Weekly Report, V59, P1297; Adriaanse M, 2016, EUR CHILD ADOLES PSY, V25, P1067, DOI 10.1007/s00787-016-0829-2; Allman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100058; Arbour L, 2006, COMMUNITY GENET, V9, P153, DOI 10.1159/000092651; Bourgois, 2009, RIGHTEOUS DOPEFIEND; Brodwin P, 2005, CULT MED PSYCHIAT, V29, P145, DOI 10.1007/s11013-005-7423-2; Brown B, 2015, ETHICS BEHAV, V25, P115, DOI 10.1080/10508422.2014.950269; Castillo AG, 2012, J COMMUN HEALTH, V37, P59, DOI 10.1007/s10900-011-9416-0; Dawson L, 2018, J MED ETHICS, V44, P149, DOI 10.1136/medethics-2015-102895; De Las Nueces D, 2012, HEALTH SERV RES, V47, P1363, DOI 10.1111/j.1475-6773.2012.01386.x; Durant RW, 2014, CANCER-AM CANCER SOC, V120, P1097, DOI 10.1002/cncr.28574; Epstein S, 2008, SOC STUD SCI, V38, P801, DOI 10.1177/0306312708091930; Faden RR, 1996, J AM MED ASS; Fisher C. B., 2004, APPL DEV SCI, V8, P91, DOI DOI 10.1207/s1532480xads0803_3; Fisher CB, 2011, SUBST USE MISUSE, V46, P728, DOI 10.3109/10826084.2010.528125; Fisher JA, 2011, AM J PUBLIC HEALTH, V101, P2217, DOI 10.2105/AJPH.2011.300279; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; Ford ME, 2013, HEALTH SOC WORK, V38, P29, DOI 10.1093/hsw/hlt001; Garcia Angela., 2010, PASTORAL CLIN ADDICT; George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706; Glaser BG, 1967, THE DISCOVERY OF GRO; Goldenberg SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155048; Goldenberg SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072982; Guillemin M, 2016, J EMPIR RES HUM RES, V11, P370, DOI 10.1177/1556264616668975; Guillemin M, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0301-4; Guta A, 2013, CRIT PUBLIC HEALTH, V23, P432, DOI 10.1080/09581596.2012.761675; Habecker P, 2018, SUBST USE MISUSE, V53, P1128, DOI 10.1080/10826084.2017.1400562; Harris M, 2013, SOC SCI MED, V83, P19, DOI 10.1016/j.socscimed.2013.01.031; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; Heller C, 2014, CONTEMP CLIN TRIALS, V39, P169, DOI 10.1016/j.cct.2014.08.004; Holmes W, 2002, SOC SCI MED, V54, P1267, DOI 10.1016/S0277-9536(01)00095-8; Hood GA, 2015, PRIM HEALTH CARE RES, V16, P53, DOI 10.1017/S1463423614000061; Johnston LG, 2013, AIDS BEHAV, V17, P2202, DOI 10.1007/s10461-012-0394-8; Jones JH., 1981, BAD BLOOD TUSKEGEE S; Jones R, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023861; Jozaghi E, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23698; Kaiser BL, 2017, RES NURS HEALTH, V40, P70, DOI 10.1002/nur.21753; Katz J, 1972, EXPT HUMAN BEINGS AU; Kiriazova T, 2017, AIDS CARE, V29, P559, DOI 10.1080/09540121.2016.1259451; Kolar SK, 2015, J RACIAL ETHN HEALTH, V2, P77, DOI 10.1007/s40615-014-0050-2; Lang K, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-35; Lunze K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136030; Mamotte N, 2012, AJAR-AFR J AIDS RES, V11, P1, DOI 10.2989/16085906.2012.671256; McKnight DH, 2000, AM C INF SYST AMCIS; Meyerson B, 2014, AIDS PATIENT CARE ST, V28, P22, DOI 10.1089/apc.2013.0238; Moreno JD, 2008, CAMBRIDGE WORLD HIST, P625; Moreno-John G, 2004, J AGING HEALTH, V16, p93S, DOI 10.1177/0898264304268151; Morgan K, 2015, INT J DRUG POLICY, V26, P380, DOI 10.1016/j.drugpo.2014.11.001; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; Pacheco CM, 2013, AM J PUBLIC HEALTH, V103, P2152, DOI 10.2105/AJPH.2013.301480; Quinn SC, 2004, AM J PUBLIC HEALTH, V94, P918, DOI 10.2105/AJPH.94.6.918; Reverby Susan M., 2009, EXAMINING TUSKEGEE I; Reyes JC, 2006, J URBAN HEALTH, V83, P1105, DOI 10.1007/s11524-006-9109-7; Rhodes T, 2008, NON TRADITIONAL REF; Rivera AV, 2014, DRUG ALCOHOL DEPEN, V144, P259, DOI 10.1016/j.drugalcdep.2014.09.778; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Sarang A, 2013, HEALTH POLICY PLANN, V28, P681, DOI 10.1093/heapol/czs107; Shannon K, 2014, CURR OPIN HIV AIDS, V9, P174, DOI 10.1097/COH.0000000000000042; Shore N, 2006, J COMMUNITY PRACT, V14, P5, DOI 10.1300/J125v14n04_02; Skloot R, 2011, IMMORTAL LIFE HENRIE; Sugarman J, 2014, CLIN TRIALS, V11, P239, DOI 10.1177/1740774513505157; TallBear K., 2013, NATIVE AM DNA TRIBAL; Toledo Lauren, 2014, Am J Health Promot, V29, pe82, DOI 10.4278/ajhp.130125-QUAL-48; Treloar C, 2016, INT J DRUG POLICY, V27, P138, DOI 10.1016/j.drugpo.2015.08.018; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Zamudio-Haas S, 2016, INT J DRUG POLICY, V30, P43, DOI 10.1016/j.drugpo.2016.01.012; Zimbardo PG, 2000, OBENDIENCE AUTHORITY; Zucker L., 1986, RES ORGAN BEHAV, V8, P1840, DOI DOI 10.1023/A	74	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208410	10.1371/journal.pone.0208410	http://dx.doi.org/10.1371/journal.pone.0208410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517202	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400094
J	Eichelberger, P; Pohl, J; Jaspers, T; Ferraro, M; Krause, F; Baur, H				Eichelberger, Patric; Pohl, Johannes; Jaspers, Theo; Ferraro, Matteo; Krause, Fabian; Baur, Heiner			Cranio-caudal and medio-lateral navicular translation are representative surrogate measures of foot function in asymptomatic adults during walking	PLOS ONE			English	Article							KINEMATICS; ANKLE; COMPLEX; MOTION; DROP; REPEATABILITY; BIOMECHANICS; REARFOOT; FOREFOOT; MODEL	Introduction The translation of the navicular bone is thought to be a representative surrogate measure to assess foot pronation and hence foot function; however, it is not known how it is related to multi-segment foot kinematics. Methods Cranio-caudal (NCC) and medio-lateral (NML) navicular translation and multi-segment foot kinematics from the Oxford Foot Model (OFM) were simultaneously assessed during the stance phase of walking in 20 healthy adults. Relationships to forefoot to hindfoot (FFtoHF), hindfoot to tibia (HFtoTBA) and global hindfoot (HFL) motion were explored by cross-correlations at zero phase shift. Results FFtoHF sagittal, transversal and frontal plane angles showed median cross correlations of -0.95, 0.82 and 0.53 with NCC and of 0.78, -0.81 and -0.90 with NML. HFtoTBA transversal and frontal plane angles had correlations of 0.15 and 0.74 with NCC and of -0.38 and -0.83 with NML. The HFL frontal plane angle showed correlations of 0.41 and -0.44 with NCC and NML, respectively. Discussion The strongest relationships were found between FFtoHF sagittal plane angles and NCC and between FFtoHF frontal plane angles and NML. However, cranio-caudal and medio-lateral navicular translation seem to be reasonable surrogates for the triplanar motion between the fore- and hindfoot. The medial longitudinal arch dropped and bulged medially, while the forefoot dorsiflexed, abducted and everted with respect to the hindfoot and vice-versa. The lower cross-correlation coefficients between the rear foot parameters and NCC/NML indicated no distinct relationships between rearfoot frontal plane and midfoot kinematics. The validity of rearfoot parameters, like Achilles tendon or Calcaneal angle, to assess midfoot function must be therefore questioned. The study could also not confirm a systematic relationship between midfoot kinematics and the internal/external rotation between the hindfoot and the tibia. The measurement of navicular translation is suggested as an alternative to more complex multi-segment foot models to assess foot function.	[Eichelberger, Patric; Pohl, Johannes; Jaspers, Theo; Ferraro, Matteo; Baur, Heiner] Bern Univ Appl Sci, Dept Hlth Profess, Div Physiotherapy, Bern, Switzerland; [Eichelberger, Patric] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Krause, Fabian] Univ Hosp Bern, Dept Orthoped Surg, Inselspital, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Eichelberger, P (corresponding author), Bern Univ Appl Sci, Dept Hlth Profess, Div Physiotherapy, Bern, Switzerland.; Eichelberger, P (corresponding author), Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.	patric.eichelberger@bfh.ch	Baur, Heiner/M-9995-2019; Baur, Heiner/A-8673-2017	Baur, Heiner/0000-0002-4780-225X	Swiss National Science Foundation (SNSF) [140928]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The authors report no financial relationships related to any products involved in this study. The research was part of a project funded by the Swiss National Science Foundation (SNSF, grant number 140928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was part of a project funded by the Swiss National Science Foundation (SNSF, grant number 140928). The authors would like to thank Duncan Cummins for professional proofreading.	Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Barton CJ, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0063-z; BRODY DM, 1982, ORTHOP CLIN N AM, V13, P541; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Dicharry JM, 2009, J ORTHOP SPORT PHYS, V39, P628, DOI 10.2519/jospt.2009.2968; Eichelberger P, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-018-0257-2; Hoffman SE, 2015, GAIT POSTURE, V41, P825, DOI 10.1016/j.gaitpost.2015.02.017; LUNDBERG A, 1989, FOOT ANKLE, V9, P248, DOI 10.1177/107110078900900508; LUNDBERG A, 1989, FOOT ANKLE, V9, P304, DOI 10.1177/107110078900900609; LUNDBERG A, 1989, FOOT ANKLE, V9, P194, DOI 10.1177/107110078900900409; Lundgren P, 2008, GAIT POSTURE, V28, P93, DOI 10.1016/j.gaitpost.2007.10.009; MCPOIL TG, 2009, J FOOT ANKLE RES, V2; Menz HB, 1998, J AM PODIAT MED ASSN, V88, P119, DOI 10.7547/87507315-88-3-119; MUELLER MJ, 1993, J AM PODIAT MED ASSN, V83, P198, DOI 10.7547/87507315-83-4-198; Nester CJ, 2007, J BIOMECH, V40, P1927, DOI 10.1016/j.jbiomech.2006.09.008; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Pohl MB, 2007, GAIT POSTURE, V25, P295, DOI 10.1016/j.gaitpost.2006.04.012; RODGERS MM, 1988, PHYS THER, V68, P1822, DOI 10.1093/ptj/68.12.1822; Simon J, 2006, GAIT POSTURE, V23, P411, DOI 10.1016/j.gaitpost.2005.07.003; Stebbins J, 2006, GAIT POSTURE, V23, P401, DOI 10.1016/j.gaitpost.2005.03.002; Wolf P, 2008, GAIT POSTURE, V28, P434, DOI 10.1016/j.gaitpost.2008.02.004; Wright CJ, 2011, GAIT POSTURE, V33, P108, DOI 10.1016/j.gaitpost.2010.10.084	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208175	10.1371/journal.pone.0208175	http://dx.doi.org/10.1371/journal.pone.0208175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517158	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400084
J	Lantyer-Silva, ASF; Waldron, A; Zina, J; Sole, M				Ferreira Lantyer-Silva, Amanda Santiago; Waldron, Anthony; Zina, Juliana; Sole, Mirco			Reproductive site selection in a bromeliad breeding treefrog suggests complex evolutionary trade-offs	PLOS ONE			English	Article							APARASPHENODON-ARAPAPA PIMENTA; OVIPOSITION SITE; PHYLLODYTES-LUTEOLUS; MATING SUCCESS; 2009 ANURA; LONG-TERM; PREDATION; BEHAVIOR; QUALITY; RISK	Reproductive site selection is a key determinant of fitness in many taxa. However, if the site characteristics that enhance offspring survival are detrimental to the parent's survival or mating success, then complex evolutionary trade-offs occur. In the Brazilian Atlantic Forest, males of the treefrog species Aparasphenodon arapapa use the temporary water bodies in forest-floor bromeliads to court and mate. Males fit tightly into the plant with the head blocking the access and after mating, stay in the bromeliad with the offspring. Since evaporation of the temporary water body inside the bromeliad results in reproductive failure, we expected that males would simply choose the largest bromeliad tanks with the most water. We found that although this was generally true, males seemed to avoid both very large bromeliads and very high water volumes. Field observations suggested a trade-off mechanism for this pattern, whereby very large and water-filled tanks would reduce the male's ability to effectively seal the tank entrance, avoid predation, or call to mating females. Males also avoided bromeliads with leaf litter and preferred slightly inclined plants. Our results indicate that during reproductive site selection, this bromeliad-breeder needs to engage in complex trade-offs between selection pressures, balancing water requirements against the need for defense and potentially, the ability to attract a mate.	[Ferreira Lantyer-Silva, Amanda Santiago] Univ Estadual Paulista, Dept Zool, Herpetol Lab, Rio Claro, SP, Brazil; [Waldron, Anthony; Sole, Mirco] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Zina, Juliana] Univ Estadual Sudoeste Bahia, Dept Ciencias Biol, Lab Vertebrados, Jequie, BA, Brazil; [Waldron, Anthony] Univ Oxford, Dept Zool, Oxford OX1 2JD, England; [Sole, Mirco] Zool Forsch Museum Alexander Koenig, Herpetol Sect, Bonn, Germany	Universidade Estadual Paulista; Universidade Estadual de Santa Cruz; Universidade Estadual do Sudoeste da Bahia; University of Oxford; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Sole, M (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.; Sole, M (corresponding author), Zool Forsch Museum Alexander Koenig, Herpetol Sect, Bonn, Germany.	msole@uesc.br	Zina, Juliana/G-6202-2012; Solé, Mirco/A-9722-2008; LANTYER-SILVA, AMANDA/H-5913-2016	Solé, Mirco/0000-0001-7881-6227; LANTYER-SILVA, AMANDA/0000-0003-2044-4533	Fundacao de Amparo a Pesquisa do Estado da Bahia [PET0025/2010]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Alexander von Humboldt-Stiftung/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BEX 0585/16-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [304999/2015-6]	Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Alexander von Humboldt-Stiftung/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado da Bahia - PET0025/2010-www.fapesb.ba.gov.br - MS. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - master scholarship www.capes.gov.br - ASFL-S. Alexander von Humboldt-Stiftung/Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - BEX 0585/16-5 - https://www.humboldt-foundation.de - MS. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - 304999/2015-6 - cnpq.br - MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Alves-Silva R, 2009, J NAT HIST, V43, P205, DOI 10.1080/00222930802568808; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; BARTON K, 2015, MUMIN MULTIMODEL INF, V15, P1; BEST LB, 1977, CONDOR, V79, P192, DOI 10.2307/1367162; Boulinier Thierry, 2008, P285; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Buxton VL, 2017, ETHOLOGY, V123, P397, DOI 10.1111/eth.12608; Cunha MS, 2016, STUD NEOTROP FAUNA E, V51, P144, DOI 10.1080/01650521.2016.1201998; De Oliveira FB, 2004, J HERPETOL, V38, P331, DOI 10.1670/205-03A; deAndrade DV, 1997, COMP BIOCHEM PHYS A, V118, P685, DOI 10.1016/S0300-9629(96)00481-1; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eterovick PC, 1999, J HERPETOL, V33, P17, DOI 10.2307/1565538; Grossman GD, 1998, ECOL FRESHW FISH, V7, P108, DOI 10.1111/j.1600-0633.1998.tb00178.x; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Lantyer-Silva ASF, 2014, AN ACAD BRAS CIENC, V86, P867, DOI 10.1590/0001-3765201420130521; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lourenco-De-Moraes R, 2013, J HERPETOL, V47, P575, DOI 10.1670/11-326; Mageski MM, 2016, J HERPETOL, V50, P108, DOI 10.1670/14-166; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OGDEN JC, 1981, MAR ECOL PROG SER, V4, P97, DOI 10.3354/meps004097; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Osses F, 2008, J ETHOL, V26, P233, DOI 10.1007/s10164-007-0054-z; Pimenta BVS, 2009, ZOOTAXA, P46, DOI 10.11646/zootaxa.2123.1.2; Poelman EH, 2013, EVOL ECOL, V27, P661, DOI 10.1007/s10682-013-9633-3; R Core Team, 2015, R LANG ENV STAT COMP; Reaney LT, 2007, BEHAV ECOL, V18, P521, DOI 10.1093/beheco/arm014; RESETARITS WJ, 1989, ECOLOGY, V70, P220, DOI 10.2307/1938428; Rojas B, 2014, BEHAV ECOL SOCIOBIOL, V68, P551, DOI 10.1007/s00265-013-1670-y; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; SADINSKI WJ, 1992, J HERPETOL, V26, P413, DOI 10.2307/1565117; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SULLIVAN BK, 1992, ANIM BEHAV, V44, P733, DOI 10.1016/S0003-3472(05)80299-4; Thomas W.W., 2003, CORREDOR BIODIVERSID; Tieleman BI, 2008, CONDOR, V110, P116, DOI 10.1525/cond.2008.110.1.116; Toledo LF, 2011, ETHOL ECOL EVOL, V23, P1, DOI 10.1080/03949370.2010.534321; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; WAICHMAN A V, 1992, Herpetological Review, V23, P19; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Zuur Alain F., 2009, P1	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207131	10.1371/journal.pone.0207131	http://dx.doi.org/10.1371/journal.pone.0207131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517134	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400027
J	Moreau-Le Lan, S; Aller, E; Calabria, I; Gonzalez-Tarancon, L; Cardona-Gay, C; Martinez-Matilla, M; Aparisi, MJ; Selles, J; Sagath, L; Pitarch, I; Muelas, N; Cervera, JV; Millan, JM; Pedrola, L				Moreau-Le Lan, Sarah; Aller, Elena; Calabria, Ines; Gonzalez-Tarancon, Lola; Cardona-Gay, Cristina; Martinez-Matilla, Marina; Aparisi, Maria J.; Selles, Jorge; Sagath, Lydia; Pitarch, Inmaculada; Muelas, Nuria; Cervera, Jose, V; Millan, Jose M.; Pedrola, Laia			New mutations found by Next-Generation Sequencing screening of Spanish patients with Nemaline Myopathy	PLOS ONE			English	Article							NEBULIN; VARIANTS	Nemaline Myopathy (NM) is a rare genetic disorder that encompasses a large spectrum of myopathies characterized by hypotonia and generalized muscle weakness. To date, mutations in thirteen different genes have been associated with NM. The most frequently responsible genes are NEB (50% of cases) and ACTA1 (15-25% of cases). In this report all known NM related genes were screened by Next Generation Sequencing in five Spanish patients in order to genetically confirm the clinical and histological diagnosis of NM. Four mutations in NEB (c.17779_17780delTA, c.11086A>C, c.21076C>T and c.2310+5G>A) and one mutation in ACTA1 (c.871A>T) were found in four patients. Three of the four mutations in NEB were novel. A cDNA sequencing assay of the nove/variants c.17779_17780delTA, c.11086A>C and c.2310+5G>A revealed that the intronic variant c.2310+5G>A affected the splicing process. Mutations reported here could help clinicians and geneticists in NM diagnosis.	[Moreau-Le Lan, Sarah; Calabria, Ines; Gonzalez-Tarancon, Lola; Cardona-Gay, Cristina; Martinez-Matilla, Marina; Aparisi, Maria J.; Selles, Jorge; Millan, Jose M.; Pedrola, Laia] Hlth Res Inst Hosp La Fe IIS La Fe, Genom Unit, Valencia, Spain; [Aller, Elena; Cervera, Jose, V] La Fe Univ Hosp, Genet Unit, Valencia, Spain; [Aller, Elena; Millan, Jose M.] Inst Invest Sanitaria La Fe, Res Grp Mol Cellular & Genom Biomed, Valencia, Spain; [Aller, Elena; Millan, Jose M.] Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain; [Sagath, Lydia] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Sagath, Lydia] Univ Helsinki, Dept Med & Clin Genet, Med, Helsinki, Finland; [Pitarch, Inmaculada] La Fe Univ Hosp, Unit Rare Neuromuscular Dis, Valencia, Spain; [Muelas, Nuria; Cervera, Jose, V] Biomed Network Res Ctr Oncol CIBERONC, Madrid, Spain; [Muelas, Nuria] La Fe Univ Hosp, Neurol Dept, Neuromuscular Dis Unit, Valencia, Spain; [Muelas, Nuria] Inst Invest Sanitaria La Fe, Neuromuscular & Ataxias Res Grp, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Helsinki; University of Helsinki	Pedrola, L (corresponding author), Hlth Res Inst Hosp La Fe IIS La Fe, Genom Unit, Valencia, Spain.	sequencing_service@iislafe.es	Aller, Elena/A-4803-2010; Cervera, Jose/ABF-2143-2020; Sagath, Lydia/ABA-9092-2020; Calabria Torres, Ines/I-1108-2015	Cervera, Jose/0000-0001-8252-1106; Sagath, Lydia/0000-0002-6754-3830; Calabria Torres, Ines/0000-0002-6400-1075; Aparisi, Maria Jose/0000-0002-6778-4415; Cardona, Cristina/0000-0002-8079-2903; Aller, Elena/0000-0001-7973-5250; Pedrola, Laia/0000-0002-3031-6124; Pitarch Castellano, Inmaculada/0000-0002-3864-7374	Instituto de Salud Carlos III [CB16/12/00284, PT17/0015/0043, PI16/01113]; Muscular Dystrophy UK [16NEB-PG36-0094-2]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Muscular Dystrophy UK	Funded by Instituto de Salud Carlos III grant CB16/12/00284 to JVC, Instituto de Salud Carlos III grant PT17/0015/0043, Instituto de Salud Carlos III grant PI16/01113 to JVC, and Muscular Dystrophy UK grant 16NEB-PG36-0094-2 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1102-1; Anderson SL, 2004, HUM GENET, V115, P185, DOI 10.1007/s00439-004-1140-8; Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Chu MS, 2016, J EXP BIOL, V219, P146, DOI 10.1242/jeb.126383; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Aparisi MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057506; LABEIT S, 1991, FEBS LETT, V282, P313, DOI 10.1016/0014-5793(91)80503-U; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370; Lehtokari VL, 2014, HUM MUTAT, V35, P1418, DOI 10.1002/humu.22693; Lelieveld SH, 2015, HUM MUTAT, V36, P815, DOI 10.1002/humu.22813; Lornage X, 2017, ANN NEUROL, V81, P467, DOI 10.1002/ana.24900; Maggi L, 2013, NEUROMUSCULAR DISORD, V23, P195, DOI 10.1016/j.nmd.2013.01.004; Malfatti Edoardo, 2015, J Neuromuscul Dis, V2, P219; Miyatake S, 2017, AM J HUM GENET, V100, P169, DOI 10.1016/j.ajhg.2016.11.017; Nowak KJ, 2015, EUR J HUM GENET, V23, DOI 10.1038/ejhg.2015.12; Pelin K, 2002, NEUROMUSCULAR DISORD, V12, P680, DOI 10.1016/S0960-8966(02)00066-4; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; Sagath Lydia, 2018, J Neuromuscul Dis, V5, P307, DOI 10.3233/JND-170298; Sandaradura SA, 2018, HUM MUTAT, V39, P383, DOI 10.1002/humu.23385; Wallgren-Pettersson C, 2001, Neuromuscul Disord, V11, P589, DOI 10.1016/S0960-8966(01)00208-5; Wang K, 1996, J BIOL CHEM, V271, P4304	24	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207296	10.1371/journal.pone.0207296	http://dx.doi.org/10.1371/journal.pone.0207296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517146	Green Submitted, Green Published, gold			2022-12-26	WOS:000452212400029
J	Papah, MB; Brannick, EM; Schmidt, CJ; Abasht, B				Papah, Michael B.; Brannick, Erin M.; Schmidt, Carl J.; Abasht, Behnam			Gene expression profiling of the early pathogenesis of wooden breast disease in commercial broiler chickens using RNA-sequencing	PLOS ONE			English	Article							PECTORALIS MAJOR MUSCLE; BINDING-PROTEIN-ALPHA; ACUTE-PHASE PROTEINS; ENDOPLASMIC-RETICULUM; O-GLCNACYLATION; SEQ EXPERIMENTS; INDUCTION; SKELETAL; PATHWAY; QUALITY	Wooden Breast Disease (WBD), a myopathy in commercial broiler chickens characterized by abnormally firm consistency of the pectoral muscle, impacts the poultry industry negatively due to severe reduction in meat quality traits. To unravel the molecular profile associated with the onset and early development of WBD in broiler chickens, we compared time-series gene expression profiles of Pectoralis (P.) major muscles between unaffected and affected birds from a high-breast-muscle-yield, purebred broiler line. P. major biopsy samples were collected from the cranial and caudal aspects of the muscle belly in birds that were raised up to 7 weeks of age (i.e. market age). Three subsets of biopsy samples comprising 6 unaffected (U) and 10 affected (A) from week 2 (cranial) and 4 (caudal), and 4U and 11A from week 3 (cranial) were processed for RNA-sequencing analysis. Sequence reads generated were processed using a suite of bioinformatics programs producing differentially expressed (DE) genes for each dataset at fold-change (A/U or U/A) >1.3 and False Discovery Ratio (FDR) <0.05 (week 2: 41 genes; week 3: 618 genes and week 4: 39 genes). Functional analysis of DE genes using literature mining, BioDBnet and IPA revealed several biological processes and pathways associated with onset and progress of WBD. Top among them were dysregulation of energy metabolism, response to inflammation, vascular disease and remodeling of extracellular matrix. This study reveals that presence of molecular perturbations involving the vasculature, extracellular matrix and metabolism are pertinent to the onset and early pathogenesis of WBD in commercial meat-type chickens.	[Papah, Michael B.; Brannick, Erin M.; Schmidt, Carl J.; Abasht, Behnam] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA	University of Delaware	Abasht, B (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA.	abasht@udel.edu	Babak, Michael/AAJ-1448-2021	Babak Papah, Michael/0000-0003-0306-7510; Abasht, Behnam/0000-0003-2374-8145; Brannick, Erin/0000-0002-7045-3430	U.S. Poultry and Egg Association [059F]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	U.S. Poultry and Egg Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by a grant from U.S. Poultry and Egg Association [grant number 059F]. The generous gift provided by the Arthur W. Perdue Foundation to the University of Delaware towards the establishment of the Arthur W. Perdue Graduate Fellowship Program in the university's Department of Animal and Food Sciences is greatly appreciated (to BA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153750; ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Akram M, 2014, CELL BIOCHEM BIOPHYS, V68, P475, DOI 10.1007/s12013-013-9750-1; ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Andrews S., 2010, FASTQC QUALITY CONTR; Baldi G, 2018, ANIMAL, V12, P164, DOI 10.1017/S1751731117001069; Bhattacharyya S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11703; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Brinchmann MF, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9186940; Brotto MAP, 2004, CELL RES, V14, P373, DOI 10.1038/sj.cr.7290237; Calderon Juan C, 2014, Biophys Rev, V6, P133, DOI 10.1007/s12551-013-0135-x; Cancedda FD, 1996, J BIOL CHEM, V271, P20163, DOI 10.1074/jbc.271.33.20163; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cieniewski-Bernard C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00421; Clark DL, 2016, POULTRY SCI, V95, P2930, DOI 10.3382/ps/pew243; Cooper C, 2012, MUSCLE BIOPSY, DOI [10.5772/30714, DOI 10.5772/30714]; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Fu WX, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0430-1; Fu WX, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0098-4; Gong CX, 2012, P NATL ACAD SCI USA, V109, P17319, DOI 10.1073/pnas.1215395109; Hakamata Y, 2018, J POULT SCI, V55, P210, DOI 10.2141/jpsa.0170141; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kubota S, 2015, CLIN SCI, V128, P181, DOI 10.1042/CS20140264; Lv Y, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0062-6; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Matsusue K, 2004, MOL ENDOCRINOL, V18, P2751, DOI 10.1210/me.2004-0213; McCarthy C, 2014, J PROTEOME RES, V13, P3131, DOI 10.1021/pr500146y; McIvor Z, 2003, EXP HEMATOL, V31, P39, DOI 10.1016/S0301-472X(02)01017-2; Mudalal S, 2015, ANIMAL, V9, P728, DOI 10.1017/S175173111400295X; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Mutryn MF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1623-0; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; Olofsson LE, 2008, J CLIN ENDOCR METAB, V93, P4880, DOI 10.1210/jc.2008-0574; Papah MB, 2017, AVIAN PATHOL, V46, P623, DOI 10.1080/03079457.2017.1339346; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Petracci M, 2015, WORLD POULTRY SCI J, V71, P363, DOI 10.1017/S0043933915000367; Poon E, 2002, J BIOL CHEM, V277, P3433, DOI 10.1074/jbc.M105273200; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Sage AT, 2010, AM J PHYSIOL-ENDOC M, V298, pE499, DOI 10.1152/ajpendo.00507.2009; Schmidt CJ, 2009, POULTRY SCI, V88, P2610, DOI 10.3382/ps.2009-00055; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Sihvo HK, 2017, VET PATHOL, V54, P119, DOI 10.1177/0300985816658099; Sihvo HK, 2014, VET PATHOL, V51, P619, DOI 10.1177/0300985813497488; SILLER WG, 1985, POULTRY SCI, V64, P1591, DOI 10.3382/ps.0641591; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Suddason T, 2015, CELL DEATH DIFFER, V22, P540, DOI 10.1038/cdd.2014.239; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; Tasoniero G, 2016, POULTRY SCI, V95, P2707, DOI 10.3382/ps/pew215; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uezumi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.161; Velleman SG, 2015, AVIAN DIS, V59, P410, DOI 10.1637/11097-042015-Reg.1; Xie H, 2002, POULTRY SCI, V81, P112, DOI 10.1093/ps/81.1.112; Yamazaki K., 2014, HDB GLYCOSYLTRANSFER, DOI [10.1007/978-4-431-54240-7_154, DOI 10.1007/978-4-431-54240-7_154]; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yoshida M, 2005, J BIOL CHEM, V280, P3500, DOI 10.1074/jbc.M406618200; Zambonelli P, 2016, POULTRY SCI, V95, P2771, DOI 10.3382/ps/pew268; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zhou N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1364-0; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zuidhof MJ, 2014, POULTRY SCI, V93, P2970, DOI 10.3382/ps.2014-04291	70	43	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207346	10.1371/journal.pone.0207346	http://dx.doi.org/10.1371/journal.pone.0207346			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517117	gold, Green Submitted, Green Published			2022-12-26	WOS:000452212400032
J	Kumar, S; Rani, R; Karns, R; Gandhi, CR				Kumar, Sudhir; Rani, Richa; Karns, Rebekah; Gandhi, Chandrashekhar R.			Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression	FASEB JOURNAL			English	Article						PPAR; PMP70; ACOX1; CPT1a	STELLATE CELLS; NONALCOHOLIC STEATOHEPATITIS; FIBROSIS; PEROXISOME; COENZYME	Levels of augmenter of liver regeneration (ALR), a multifunctional protein, are reduced in steatohepatitis. ALR depletion from ALR(flox/flox)/Alb-Cre [ALR-L-knockout (KO)] mouse causes robust steatosis and apoptosis of hepatocytes, and pericellular fibrosis between 1 and 2 wk postbirth. Steatosis regresses by 4 wk upon reappearance of ALR-expressing hepatocytes. We investigated mechanisms of ALR depletion-induced steatosis. ALR-L-KO mice (1-, 2-, and 4 wk old) and Adeno-Cre-transfected ALR(flox/flox) hepatocytes were used for in vivo and in vitro studies. ALR depletion from hepatocytes in vivo downregulated peroxisome proliferator-activated receptor (PPAR)-, carnitine palmitoyl transferase I (CPT1)a, peroxisomal membrane protein 70 (PMP70) (modest down-regulation), and acyl-CoA oxidase 1 (ACOX1). The markedly up-regulated (20X) novel microRNA-540 (miR-540) was identified to target PPAR, PMP70, ACOX1, and CPT1a. ALR depletion from primary hepatocytes increased oxidative stress, miR-540 expression, and steatosis and down-regulated PPAR, ACOX1, PMP70, and CPT1a expression. Anti-miR-540 mitigated ALR depletion-induced steatosis and prevented loss of PPAR, ACOX1, PMP70, and CPT1a expression. Antioxidant N-acetylcysteine and recombinant ALR (rALR) both inhibited ALR depletion-induced miR-540 expression and lipid accumulation in hepatocytes. Finally, treatment of ALR-L-KO mice with rALR between 1 and 2 wk prevented miR-540 expression, and arrested steatosis and fibrosis. We conclude that ALR deficiency-mediated oxidative stress induces generation of miR-540, which promotes steatosis by dysregulating peroxisomal and mitochondrial lipid homeostasis.Kumar, S., Rani, R., Karns, R., Gandhi, C. R. Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.	[Kumar, Sudhir; Rani, Richa; Karns, Rebekah; Gandhi, Chandrashekhar R.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Kumar, Sudhir; Rani, Richa; Gandhi, Chandrashekhar R.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA; [Gandhi, Chandrashekhar R.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati	Gandhi, CR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 3333 Burnett Ave, Cincinnati, OH 45229 USA.	chandrashekhar.gandhi@cchmc.org	Kumar, Sudhir/J-3844-2019		U.S. Department of Defense Congressionally Direct Medical Research Program [W81XWH-14-PRMRP-IIRA]; U.S. National Institutes of Health Exploratory/Developmental Research, National Institute on Alcohol Abuse and Alcoholism [R21 AA020846]; Veterans Affairs Merit Review Award [1IO1BX001174]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	U.S. Department of Defense Congressionally Direct Medical Research Program; U.S. National Institutes of Health Exploratory/Developmental Research, National Institute on Alcohol Abuse and Alcoholism; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. Department of Defense Congressionally Direct Medical Research Program Grant W81XWH-14-PRMRP-IIRA, U.S. National Institutes of Health Exploratory/Developmental Research, National Institute on Alcohol Abuse and Alcoholism Grant R21 AA020846, and Veterans Affairs Merit Review Award 1IO1BX001174 (to C.R.G.). The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Davoodian Parivash, 2017, Gastroenterol Hepatol Bed Bench, V10, P112; Ding JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13729; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; FRANCAVILLA A, 1994, HEPATOLOGY, V20, P747, DOI 10.1002/hep.1840200328; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Fu RQ, 2017, MOL MED REP, V16, P4327, DOI 10.3892/mmr.2017.7054; Gandhi CR, 2017, J HEPATOL, V67, P1104, DOI 10.1016/j.jhep.2017.06.001; Gandhi CR, 2015, GASTROENTEROLOGY, V148, P379, DOI 10.1053/j.gastro.2014.10.008; Gandhi CR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-10; Gandhi CR, 2010, J CELL PHYSIOL, V222, P365, DOI 10.1002/jcp.21957; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; Iwase T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03081; Kennedy LL, 2016, LAB INVEST, V96, P1256, DOI 10.1038/labinvest.2016.112; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Khanizadeh S, 2017, MICROB PATHOGENESIS, V110, P688, DOI 10.1016/j.micpath.2017.03.004; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar S, 2017, J LEUKOCYTE BIOL, V101, P429, DOI 10.1189/jlb.2A0516-239R; Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147864; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loyer X, 2016, GUT, V65, P1882, DOI 10.1136/gutjnl-2014-308883; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Mello T, 2016, PPAR RES, V2016, DOI 10.1155/2016/7403230; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Murakami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116434; Murakami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106314; Nalesnik MA, 2017, HEPATOLOGY, V66, P266, DOI 10.1002/hep.29047; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Osmundsen H., 1987, PEROXISOMES BIOL MED, P152; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Polimeno L, 2000, DIGEST LIVER DIS, V32, P510, DOI 10.1016/S1590-8658(00)80009-2; Rani R, 2017, AM J PATHOL, V187, P2008, DOI 10.1016/j.ajpath.2017.05.015; SANTOS MJ, 1994, J BIOL CHEM, V269, P24890; Sanyal A. J., 1675, NEW ENGL J MED, V362, P1675; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tryndyak VP, 2012, TOXICOL APPL PHARM, V262, P52, DOI 10.1016/j.taap.2012.04.018; Uemura T, 2001, BRIT J PHARMACOL, V133, P1125, DOI 10.1038/sj.bjp.0704151; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Varanasi U, 1996, J BIOL CHEM, V271, P2147, DOI 10.1074/jbc.271.4.2147; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Yang F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00929; Zhou Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15089	52	17	18	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3825	3840		10.1096/fj.201802015R	http://dx.doi.org/10.1096/fj.201802015R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30540918	Green Published, Bronze			2022-12-26	WOS:000459794800059
J	Hussack, G; Ryan, S; van Faassen, H; Rossotti, M; MacKenzie, CR; Tanha, J				Hussack, Greg; Ryan, Shannon; van Faassen, Henk; Rossotti, Martin; MacKenzie, C. Roger; Tanha, Jamshid			Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; FRIZZLED PROTEINS; STRUCTURAL BASIS; INFECTION; PROTECTION; RECEPTOR; BINDING; TCDA; IDENTIFICATION; BEZLOTOXUMAB	An increasing number of antibody-based therapies are being considered for controlling bacterial infections, including Clostridium difficile by targeting toxins A and B. In an effort to develop novel C. difficile immunotherapeutics, we previously isolated several single-domain antibodies (V(H)Hs) capable of toxin A neutralization through recognition of the extreme C-terminal combined repetitive oligopeptides (CROPs) domain, but failed at identifying neutralizing V(H)Hs that bound a similar region on toxin B. Here we report the isolation of a panel of 29 V(H)Hs targeting at least seven unique epitopes on a toxin B immunogen composed of a portion of the central delivery domain and the entire CROPs domain. Despite monovalent affinities as high as K-D = 70 pM, none of the V(H)Hs tested were capable of toxin B neutralization; however, modest toxin B inhibition was observed with VHH-VHH dimers and to a much greater extent with VHH-Fc fusions, reaching the neutralizing potency of the recently approved anti-toxin B monoclonal antibody bezlotoxumab in in vitro assays. Epitope binning revealed that several VHH-Fcs bound toxin B at sites distinct from the region recognized by bezlotoxumab, while other VHH-Fcs partially competed with bezlotoxumab for toxin binding. Therefore, the V(H)Hs described here are effective at toxin B neutralization when formatted as bivalent VHH-Fc fusions by targeting toxin B at regions both similar and distinct from the bezlotoxumab binding site.	[Hussack, Greg; Ryan, Shannon; van Faassen, Henk; Rossotti, Martin; MacKenzie, C. Roger; Tanha, Jamshid] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Ottawa, ON, Canada; [Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Tanha, Jamshid] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada	National Research Council Canada; University of Ottawa; University of Guelph	Hussack, G (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Ottawa, ON, Canada.	Greg.Hussack@nrc-cnrc.gc.ca			National Research Council Canada	National Research Council Canada	This study was funded by the National Research Council Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2017, ANNU REV MICROBIOL, V71, P281, DOI 10.1146/annurev-micro-090816-093458; Andersen KK, 2016, INFECT IMMUN, V84, P395, DOI 10.1128/IAI.00870-15; Anosova NG, 2015, CLIN VACCINE IMMUNOL, V22, P711, DOI 10.1128/CVI.00763-14; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Baral Toya Nath, 2013, Curr Protoc Immunol, V103, DOI 10.1002/0471142735.im0217s103; Chandrasekaran R, 2017, FEMS MICROBIOL REV, V41, P723, DOI 10.1093/femsre/fux048; Chen P, 2018, SCIENCE, V360, P664, DOI 10.1126/science.aar1999; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Iezzi ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00273; Henry KA, 2017, MOL IMMUNOL, V90, P190, DOI 10.1016/j.molimm.2017.07.006; Henry KA, 2015, PROTEIN ENG DES SEL, V28, P379, DOI 10.1093/protein/gzv039; Hopkins RJ, 2018, GASTROENTEROL REP, V6, P21, DOI 10.1093/gastro/gox041; Hussack G, 2016, CLIN EXP GASTROENTER, V9, P209, DOI 10.2147/CEG.S84017; Hussack G, 2012, PROTEIN ENG DES SEL, V25, P313, DOI 10.1093/protein/gzs014; Hussack G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028218; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Kroh HK, 2017, J BIOL CHEM, V292, P14401, DOI 10.1074/jbc.M117.781112; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Mullard A, 2016, NAT REV DRUG DISCOV, V15, P811, DOI 10.1038/nrd.2016.257; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Napolitano LM, 2017, SURGERY, V162, P325, DOI 10.1016/j.surg.2017.01.018; Navalkele BD, 2018, BIOL-TARGETS THER, V12, P11, DOI 10.2147/BTT.S127099; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Rossotti MA, 2015, MABS-AUSTIN, V7, P820, DOI 10.1080/19420862.2015.1068491; Schmidt DJ, 2016, CLIN VACCINE IMMUNOL, V23, P774, DOI 10.1128/CVI.00730-15; Shkoporov AN, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv083; Sulea T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20599-4; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Unger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07850; Yang ZY, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw078; Yang ZY, 2015, INFECT IMMUN, V83, P822, DOI 10.1128/IAI.02897-14; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208978	10.1371/journal.pone.0298978	http://dx.doi.org/10.1371/journal.pone.0298978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540857				2022-12-26	WOS:000452898600102
J	Aloudah, NM; Scott, NW; Aljadhey, HS; Araujo-Soares, V; Alrubeaan, KA; Watson, MC				Aloudah, Nouf M.; Scott, Neil W.; Aljadhey, Hisham S.; Araujo-Soares, Vera; Alrubeaan, Khalid A.; Watson, Margaret C.			Medication adherence among patients with Type 2 diabetes: A mixed methods study	PLOS ONE			English	Article							ORAL HYPOGLYCEMIC MEDICATION; QUALITY-OF-LIFE; GLYCEMIC CONTROL; MELLITUS; ASSOCIATION; PERCEPTION; PHARMACIST; KNOWLEDGE; BELIEFS; SUPPORT	Objective Oral hypoglycemic agents (OHAs) are highly effective in managing Type 2 diabetes if taken appropriately. This study assessed adherence to OHAs among patients with Type 2 diabetes and explored factors associated with adherence behaviour. Research design and methods Mixed methods were used comprising a cross-sectional study using the Arabic version of the Morisky Medication Adherence Scale followed by semi-structured interviews using the Theoretical Domain Framework to explore key determinants of adherence. Results The cross-sectional study included 395 patients of whom 40% achieved a high level of OHA adherence. Lower adherence was associated with younger age (Odds Ratio (OR) 1.084; 95% CI 1.056 to 1.112), higher numbers of non-OHAs (OR 0.848; 95% CI 0.728 to 0.986) and higher HbA1c levels (OR 0.808; 95% CI 0.691 to 0.943). Semi structured interviews based on the Theoretical Domain Framework were completed with 20 patients and identified a wide range of factors potentially associated with OHA adherence, particularly behavioural related factors (e.g. scheduling medication intake, ability to develop a habitual behaviour), social influences (e.g. acting as a role model, the effect of family support), and gaps in knowledge about diabetes and its management with OHAs. Conclusions This unique mixed-methods study has highlighted possible reasons for the low levels of OHA adherence in this patient population. Whilst the theoretically-derived determinants of behaviour illustrate the complexities associated with OHA adherence, they also provide a robust underpinning for future intervention(s) development to improve adherence and maximise patient health outcomes.	[Aloudah, Nouf M.; Aljadhey, Hisham S.] King Saud Univ, Clin Pharm Dept, Riyadh, Saudi Arabia; [Scott, Neil W.] Univ Aberdeen, Med Stat Team, Aberdeen, Scotland; [Araujo-Soares, Vera] Newcastle Univ, Inst Hlth & Soc, Newcastle, England; [Alrubeaan, Khalid A.] King Saud Univ, Univ Diabet Ctr, Riyadh, Saudi Arabia; [Watson, Margaret C.] Univ Bath, Sch Pharm & Pharmacol, Bath, Avon, England	King Saud University; University of Aberdeen; Newcastle University - UK; King Saud University; University of Bath	Watson, MC (corresponding author), Univ Bath, Sch Pharm & Pharmacol, Bath, Avon, England.	m.c.watson@bath.ac.uk	Araujo-Soares, Vera/ABF-8144-2021; Aloudah, Nouf/AAZ-4305-2020; Aloudah, Nouf M/K-2061-2019	Araujo-Soares, Vera/0000-0003-4044-2527; Aloudah, Nouf M/0000-0002-7603-1642; , Margaret/0000-0002-8198-9273; Al-Rubeaan, Khalid/0000-0003-3615-7192; Scott, Neil/0000-0002-8067-9660	Saudi Arabian Ministry of Higher Education; Saudi Culture Bureau; University of Aberdeen, Scotland	Saudi Arabian Ministry of Higher Education; Saudi Culture Bureau; University of Aberdeen, Scotland	This research was funded by the Saudi Arabian Ministry of Higher Education and the Saudi Culture Bureau in the form of Dr N Aloudah's PhD which was undertaken and awarded by the University of Aberdeen, Scotland.	Ahmed NO, 2017, INT J HEALTH SCI-IJH, V11, P45; Al Hamid AM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017664; Al-Qazaz HK, 2011, INT J CLIN PHARM-NET, V33, P1028, DOI 10.1007/s11096-011-9582-2; Al-Qazaz HK, 2011, RES SOC ADMIN PHARM, V7, P180, DOI 10.1016/j.sapharm.2010.04.005; Al-Rubeaan K, 2014, ANN SAUDI MED, V34, P465, DOI 10.5144/0256-4947.2014.465; ALAboudi I, 2014, RES SOC ADMIN PHARM, V10, pE52, DOI 10.1016/j.sapharm.2014.07.132; Alatawi YM, 2016, RES SOC ADMIN PHARM, V12, P914, DOI 10.1016/j.sapharm.2015.11.006; Albargawi M, 2016, Int J Nurs Sci, V3, P39, DOI 10.1016/j.ijnss.2016.02.007; Alhazmi T., 2017, INT J ADV RES, V5, P966; Arulmozhi S, 2014, J CLIN DIAGN RES, V8, pUC1, DOI 10.7860/JCDR/2014/7732.4256; Borgsteede SD, 2011, INT J CLIN PHARM-NET, V33, P779, DOI 10.1007/s11096-011-9534-x; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Chew BH, 2015, QUAL LIFE RES, V24, P2723, DOI 10.1007/s11136-015-1006-7; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Doggrell SA, 2014, INT J CLIN PHARM-NET, V36, P488, DOI 10.1007/s11096-014-9929-6; Esposito K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008222; George J, 2004, ANN PHARMACOTHER, V38, P1369, DOI 10.1345/aph.1D479; Guenette L, 2015, PATIENT PREFER ADHER, V9, P413, DOI 10.2147/PPA.S78628; Hatah E, 2015, PATIENT PREFER ADHER, V9, P589, DOI 10.2147/PPA.S79477; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Jeragh-Alhaddad FB, 2015, PATIENT PREFER ADHER, V9, P1491, DOI 10.2147/PPA.S86719; Loveman E, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7220; Maciejewski ML, 2013, HEALTH SERV RES, V48, P1468, DOI 10.1111/1475-6773.12043; Manan MM, 2014, J CLIN DIAGN RES, V8, pJC5, DOI 10.7860/JCDR/2014/10481.5309; Mayberry LS, 2012, DIABETES CARE, V35, P1239, DOI 10.2337/dc11-2103; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Mohd MMMAH, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0254-6; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Omran D, 2012, CAN J DIABETES, V36, P292, DOI 10.1016/j.jcjd.2012.07.002; Peeters B, 2015, ETHNIC HEALTH, V20, P87, DOI 10.1080/13557858.2014.890174; Rabbap A., 2017, INT J PHARM PHARM SC, P247, DOI DOI 10.22159/IJPPS.2017V9I11.16963; Schoenthaler AM, 2012, DIABETES EDUCATOR, V38, P397, DOI 10.1177/0145721712440333; South J., 2010, COMMUNITY HLTH CHAMP; Stack RJ, 2010, J DIABETES VASCULAR, V10, P148, DOI DOI 10.1177/1474651409357034; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wermeille J, 2004, PHARM WORLD SCI, V26, P18, DOI 10.1023/B:PHAR.0000013465.24857.a8; World Health Organisation, 2003, REPORT ON MEDICATION	40	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0207583	10.1371/journal.pone.0207583	http://dx.doi.org/10.1371/journal.pone.0207583			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD8CS	30533042	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000452782500007
J	Brenes-Soto, A; Dierenfeld, ES; Janssens, GPJ				Brenes-Soto, Andrea; Dierenfeld, Ellen S.; Janssens, Geert P. J.			The interplay between voluntary food intake, dietary carbohydrate-lipid ratio and nutrient metabolism in an amphibian, (Xenopus laevis)	PLOS ONE			English	Article							MACRONUTRIENT SELECTION; PROTEIN/LIPID RATIO; GROWTH-PERFORMANCE; LEPTIN SENSITIVITY; GEOMETRIC ANALYSIS; DOMESTIC CAT; FEED-INTAKE; DIGESTIBILITY; PASSAGE; TEMPERATURE	Digestion of food and metabolism of frogs are little studied at the moment, and such processes could be very particular in the case of amphibians, given their ectothermic and carnivorous nature which may lead them to use nutrients through specific biochemical pathways. In the present study, 24 adult Xenopus laevis (six replicates with two frogs per treatment) were randomly assigned to two diets with different carbohydrate:fat ratio (4.5:1 and 2.1:1), changing the dietary glucogenic and lipogenic proportions. Food intake (FI) per unit metabolic body weight (MBW) as well as macronutrient digestibility were calculated, and circulating blood acylcarnitines and amino acids measured, in order to evaluate the effect of the diet treatments. Results demonstrated that food intake regulated most of the changes in the parameters evaluated; significant differences were obtained in crude protein and fat digestibilities through the effect of FI/MBW (p<0.05), whereas diet treatment had a significant effect on the levels of malonyl-CoA. Food intake also significantly impacted malonyl, isovaleryl, hydroxyisovaleryl and long chain fatty acid concentrations; significant (p<0.05) interactions between those metabolites were detected owing to diet. The findings obtained suggest that food intake was the main factor controlling digestion and metabolism in X. laevis, with frogs preferring to utilise protein and fat as primary sources for energy production in the citric acid cycle, reflecting characteristics of a strict carnivore physiological model.	[Brenes-Soto, Andrea; Janssens, Geert P. J.] Univ Ghent, Fac Vet Med, Lab Anim Nutr, Merelbeke, Belgium; [Brenes-Soto, Andrea] Univ Costa Rica, Anim Sci Dept, San Jose, Costa Rica; [Dierenfeld, Ellen S.] Ellen S Dierenfeld LLC, St Louis, MO USA	Ghent University; Universidad Costa Rica	Brenes-Soto, A (corresponding author), Univ Ghent, Fac Vet Med, Lab Anim Nutr, Merelbeke, Belgium.; Brenes-Soto, A (corresponding author), Univ Costa Rica, Anim Sci Dept, San Jose, Costa Rica.	brenes.andrea14@gmail.com	Janssens, Geert/C-2264-2008		Universidad de Costa Rica	Universidad de Costa Rica	Andrea Brenes-Soto received a scholarship from Universidad de Costa Rica. Ellen S. Dierenfeld is affiliated to Ellen S. Dierenfeld, LLC. Ellen S. Dierenfeld, LLC provided support in the form of salary for author ESD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Adeosun TA, 2014, J ANIM PROD RES, V26, P20; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; [Anonymous], 2012, BIOCH PATHWAYS ATLAS; Association of Official Analytical Chemists, 2016, OFFICIAL METHODS ANA; Azeez OI, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-71; BENNETT AF, 1973, J COMP PHYSIOL, V87, P351, DOI 10.1007/BF00695269; Bosch G, 2015, BRIT J NUTR, V113, pS40, DOI 10.1017/S0007114514002311; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; Brenes A, 2011, P ASS REPT AMPH VET, P4; CarmonaOsalde C, 1996, AQUACULTURE, V141, P223, DOI 10.1016/0044-8486(95)01232-X; Case L, 2011, CANINE FELINE NUTR R, P431; Castro C. S., 2017, Archivos de Zootecnia, V66, P126; Chudy A., 2000, Modelling nutrient utilization in farm animals, P329, DOI 10.1079/9780851994499.0329; Clauss M, 2007, OIKOS, V116, P209, DOI [10.1111/j.2006.0030-1299.15461.x, 10.1111/j.0030-1299.2007.15461.x]; COLUCCI PE, 1982, J DAIRY SCI, V65, P1445, DOI 10.3168/jds.S0022-0302(82)82367-9; Costanzo JP, 2013, J EXP BIOL, V216, P3461, DOI 10.1242/jeb.089342; Cramp RL, 2003, J EXP ZOOL PART A, V300A, P126, DOI 10.1002/jez.a.10272; de Castro CS, 2014, AQUACULTURE, V433, P1, DOI 10.1016/j.aquaculture.2014.05.044; Dermauw V, 2013, TROP ANIM HEALTH PRO, V45, P1139, DOI 10.1007/s11250-012-0337-4; Dierenfeld Ellen S., 2008, Journal of Herpetological Medicine and Surgery, V18, P100; Edwards JR, 2004, J EXP ZOOL PART A, V301A, P521, DOI 10.1002/jez.a.81; Figueiredo MRC, 1999, REV BRAS ZOOTECN, V28, P661, DOI 10.1590/S1516-35981999000400001; Geda F, 2017, J THERM BIOL, V65, P57, DOI 10.1016/j.jtherbio.2017.02.004; Glencross BD, 2017, BRIT J NUTR, V117, P500, DOI 10.1017/S0007114517000307; GOSSLING J, 1980, J HERPETOL, V14, P407, DOI 10.2307/1563697; Goytortua E., 2007, MANUAL INGREDIENTES, P56; Green SL, 2010, LAB XENOPUS SP; GrisdaleHelland B, 1997, AQUACULTURE, V152, P167, DOI 10.1016/S0044-8486(97)00003-3; Gurdon JB, 2000, INT J DEV BIOL, V44, P43; Haghparast Parisa, 2016, Iranian Journal of Ichthyology, V3, P304; Henry M, 2014, FISH SHELLFISH IMMUN, V37, P215, DOI 10.1016/j.fsi.2014.02.005; Hewson-Hughes AK, 2013, BEHAV ECOL, V24, P293, DOI 10.1093/beheco/ars168; Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429; Huang KangKang, 2014, Journal of Fisheries of China, V38, P877; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Khempaka S, 2011, J APPL POULTRY RES, V20, P1, DOI 10.3382/japr.2010-00162; Krogdahl A, 2005, AQUACULT NUTR, V11, P103, DOI 10.1111/j.1365-2095.2004.00327.x; LARSEN T, 1991, BRIT J NUTR, V65, P29, DOI 10.1079/BJN19910063; Levin BE, 2002, AM J PHYSIOL-REG I, V283, pR941, DOI 10.1152/ajpregu.00245.2002; Li JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40815; Mader DR, 1996, REPTILE MED SURG; Mansano CFM, 2017, AQUACULT NUTR, V23, P1368, DOI 10.1111/anu.12512; Martinez IP, 2004, AQUACULTURE, V241, P387, DOI 10.1016/j.aquaculture.2004.08.027; Marvin GA, 2017, J THERM BIOL, V69, P319, DOI 10.1016/j.jtherbio.2017.09.003; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; McDonald P., 2010, ANIM NUTR; MCGARRY JD, 1978, J BIOL CHEM, V253, P8294; MCGILVERY RW, 1970, BIOCH FUNCTIONAL APP; Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Sanchez-Vazquez FJ, 1999, PHYSIOL BEHAV, V66, P45, DOI 10.1016/S0031-9384(98)00313-8; Savage J.M., 2002, AMPHIBIANS REPTILES; Schauf S, 2018, J ANIM PHYSIOL AN N, V102, pE21, DOI 10.1111/jpn.12696; Schermerhorn T., 2013, FRONT ENDOCRINOL, V4, P1; Somsueb P, 2001, AQUAC RES, V32, P33, DOI 10.1046/j.1355-557x.2001.00033.x; Stein HH, 2007, LIVEST SCI, V109, P282, DOI 10.1016/j.livsci.2007.01.019; Lopez MT, 2006, REV BIOL TROP, V54, P687; van Rooijen C, 2014, J AGR FOOD CHEM, V62, P8883, DOI 10.1021/jf502064h; Van Weyenberg S, 2013, J ANIM PHYSIOL AN N, V97, P624, DOI 10.1111/j.1439-0396.2012.01300.x; VANBEURDEN EK, 1980, COPEIA, P787, DOI 10.2307/1444458; Verbrugghe A, 2010, BRIT J NUTR, V104, P214, DOI 10.1017/S0007114510000358; Verbrugghe A, 2009, BRIT J NUTR, V102, P694, DOI 10.1017/S0007114509288982; Warne RW, 2014, INTEGR COMP BIOL, V54, P864, DOI 10.1093/icb/icu071; Weingart C, 2012, J VET DIAGN INVEST, V24, P295, DOI 10.1177/1040638711428332; Zhang CX, 2015, AQUACULTURE, V437, P38, DOI 10.1016/j.aquaculture.2014.11.015; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	66	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208445	10.1371/journal.pone.0208445	http://dx.doi.org/10.1371/journal.pone.0208445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532132	gold, Green Published, Green Submitted			2022-12-26	WOS:000452640900017
J	Tomasetti, SJ; Morrell, BK; Merlo, LR; Gobler, CJ				Tomasetti, Stephen J.; Morrell, Brooke K.; Merlo, Lucas R.; Gobler, Christopher J.			Individual and combined effects of low dissolved oxygen and low pH on survival of early stage larval blue crabs, Callinectes sapidus	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CHESAPEAKE BAY; DEAD ZONES; MARINE; HYPOXIA; JUVENILE; RESPONSES; EUTROPHICATION; TOLERANCE; RATHBUN	A large number of coastal ecosystems globally are subjected to concurrent hypoxic and acidified conditions that will likely intensify and expand with continued climate change. In temperate regions, the spawning of many important organisms including the Atlantic blue crab Callinectes sapidus occurs during the summer months when the severity of coastal hypoxia and acidification is the greatest. While the blue crab earliest larval stage can be exposed to co-occurring hypoxia and acidification observed in many coastal ecosystems, the effects of these concurrent stressors on larval blue crab survival is unknown. This study investigated the individual and combined consequences of low dissolved oxygen (DO) and low pH on blue crab larvae survival through a series of short-term experiments. During 14-day experiments with moderately hypoxic conditions (117-127 mu M O-2 or 3.74-4.06 mg L-1) and acidified conditions (pH on total scale of 7.16-7.33), low DO and low pH individually and significantly reduced larval survival by 60% and 49%, respectively, with the combination of stressors reducing survival by 87% compared to the control treatment (210-269 mu M O-2 or 6.72-8.61 mg L-1, 7.91-7.94 DO and pH, respectively). During 4-day experiments with lower DO levels (68-83 mu M O-2 or 2.18-2.62 mg L-1) and comparable pH levels of 7.297.39, low DO individually reduced survival by >90% compared to the control (261-267 mu M O-2 or 8.35-8.54 mg L-1, 7.92-7.97 DO and pH, respectively), whereas low pH had no effect and there was no interaction between stressors. Over a 4-day period, the DO threshold at which 50% of the larval blue crab population died (LC50) was 121 mu M 0 2 (3.86 mgL(-1)). In 14day experiments, the DO and pH effects were additive, yielding survival rates lower than the individual treatments, and significantly correlated with DO and pH concentrations. Collectively, these findings indicate that blue crab sensitivity to both low DO and low pH are acute within the larval stage, depend on the intensity and duration of exposure, and leads to mortality, thereby potentially contributing to the interannual variability and possible regional declines of this fishery.	[Tomasetti, Stephen J.; Morrell, Brooke K.; Merlo, Lucas R.; Gobler, Christopher J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11968 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11968 USA.	christopher.gobler@stonybrook.edu		Tomasetti, Stephen/0000-0001-6947-5141	New York Sea Grant [R-FMB-38]; Chicago Community Foundation; Pritchard Foundation	New York Sea Grant; Chicago Community Foundation; Pritchard Foundation	This work was supported by New York Sea Grant R-FMB-38 and grants from the Chicago Community Foundation and the Pritchard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ryan Wallace, Dr. Andrew Griffith, Chris Paparo, Darren de Silva, and Odi Zmora for logistical support of this project. This work was supported by New York Sea Grant R-FMB-38 and grants from the Chicago Community Foundation and the Pritchard Foundation.	Aguilar R, 2005, J EXP MAR BIOL ECOL, V319, P117, DOI 10.1016/j.jembe.2004.08.030; Amato CG, 2008, J CRUSTACEAN BIOL, V28, P587, DOI 10.1651/08-2985.1; BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Baumann H, 2018, ESTUAR COAST, V41, P1102, DOI 10.1007/s12237-017-0321-3; Baumann H, 2015, ESTUAR COAST, V38, P220, DOI 10.1007/s12237-014-9800-y; Boudreau SA, 2012, MAR ECOL PROG SER, V469, P195, DOI 10.3354/meps09862; Breitburg D, 2018, SCIENCE, V359, P46, DOI 10.1126/science.aam7240; Burnett LE, 1997, AM ZOOL, V37, P633; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Campanati C, 2016, ICES J MAR SCI, V73, P791, DOI 10.1093/icesjms/fsv221; COSTLOW JD, 1959, BIOL BULL, V116, P373, DOI 10.2307/1538947; DePasquale E, 2015, MAR ECOL PROG SER, V523, P145, DOI 10.3354/meps11142; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1993, DEEP-SEA RES PT I, V40, P107, DOI 10.1016/0967-0637(93)90055-8; Dixon RL, 2017, J EXP MAR BIOL ECOL, V493, P20, DOI 10.1016/j.jembe.2017.04.001; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dybas CL, 2005, BIOSCIENCE, V55, P552, DOI 10.1641/0006-3568(2005)055[0552:DZSIWO]2.0.CO;2; EPIFANIO CE, 1984, ESTUAR COAST SHELF S, V18, P1, DOI 10.1016/0272-7714(84)90002-7; Giltz SM, 2017, J SHELLFISH RES, V36, P481, DOI 10.2983/035.036.0219; Glandon HL, 2017, ICES J MAR SCI, V74, P1201, DOI 10.1093/icesjms/fsw171; Glandon HL, 2018, J EXP MAR BIOL ECOL, V498, P39, DOI 10.1016/j.jembe.2017.11.005; Glaspie CN, 2017, J EXP MAR BIOL ECOL, V489, P58, DOI 10.1016/j.jembe.2016.11.010; Gobler CJ, 2017, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00282; Gobler CJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0976; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Hagy JD, 2004, ESTUARIES, V27, P634, DOI 10.1007/BF02907650; Hines AH, 2003, B MAR SCI, V72, P423; Holman JD, 2004, BIOL BULL-US, V206, P188, DOI 10.2307/1543642; Jansson A, 2015, J SEA RES, V102, P41, DOI 10.1016/j.seares.2015.04.006; Keppel AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161088; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Long WC, 2013, MAR POLLUT BULL, V69, P38, DOI 10.1016/j.marpolbul.2013.01.011; Long WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060959; Mangum CP, 1997, AM ZOOL, V37, P604; MCCONAUGHA JR, 1983, J CRUSTACEAN BIOL, V3, P582, DOI 10.2307/1547953; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Miller DC, 2002, MAR BIOL, V140, P287, DOI 10.1007/s002270100702; Millero FJ, 2010, MAR FRESHWATER RES, V61, P139, DOI 10.1071/MF09254; Millikin MR., 1984, CALLINECTES SAPIDUS; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Perry H.M., 1982, GULF STATES MAR FISH, P17; Portner HO, 2012, MAR ECOL PROG SER, V470, P273, DOI 10.3354/meps10123; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; PROVENZANO AJ, 1983, ESTUAR COAST SHELF S, V16, P489, DOI 10.1016/0272-7714(83)90081-1; Rabalais NN, 2014, OCEANOGRAPHY, V27, P172, DOI 10.5670/oceanog.2014.21; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; ROER R, 1984, AM ZOOL, V24, P893; ROSENBERG R, 1985, MAR POLLUT BULL, V16, P227, DOI 10.1016/0025-326X(85)90505-3; SANDIFER P A, 1973, Chesapeake Science, V14, P235, DOI 10.2307/1350753; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Small DP, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2834-x; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Steckbauer A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00049; Storch D, 2009, J EXP BIOL, V212, P1371, DOI 10.1242/jeb.030205; SULKIN SD, 1980, BIOL BULL, V159, P402, DOI 10.2307/1541103; Sunda WG, 2012, ENVIRON SCI TECHNOL, V46, P10651, DOI 10.1021/es300626f; Tagatz M. E., 1968, Fishery Bulletin Fish and Wildlife Service US, V67, P17; Tankersley RA, 2002, J EXP MAR BIOL ECOL, V273, P1, DOI 10.1016/S0022-0981(02)00135-1; Tanner CA, 2006, COMP BIOCHEM PHYS A, V144, P218, DOI 10.1016/j.cbpa.2006.02.042; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Van ENGEL W. A., 1958, COMMERCIAL FISH REV, V20, P6; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Wahl M, 2016, MAR FRESHWATER RES, V67, P25, DOI 10.1071/MF14154; Wallace RB, 2014, ESTUAR COAST SHELF S, V148, P1, DOI 10.1016/j.ecss.2014.05.027; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Zmora O, 2005, AQUACULTURE, V244, P129, DOI 10.1016/j.aquaculture.2004.11.012	75	16	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208629	10.1371/journal.pone.0208629	http://dx.doi.org/10.1371/journal.pone.0208629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532265	gold, Green Published, Green Submitted			2022-12-26	WOS:000452640900029
J	Truhlar, AM; Denes, TG; Cantilina, KK; Leung, SK; Walter, T; Hay, AG				Truhlar, Allison M.; Denes, Thomas G.; Cantilina, Keiran K.; Leung, Selene K.; Walter, Todd; Hay, Anthony G.			Absence of genetic selection in a pathogenic Escherichia coli strain exposed to the manure-amended soil environment Escherichia coli	PLOS ONE			English	Article							INDICATOR ORGANISMS; SURVIVAL; PATTERNS; O157-H7; EXPRESSION; ADHERENCE; VARIANTS; BACTERIA; FITNESS; BOVINE	Escherichia coli that express curli are more common in subsurface soil drainage when manure is surface applied. However, it is unknown whether this arises from mutations in individual strains leading to curli expression or by selection for individuals already expressing higher levels of curli. To test this, we examined curli production in pathogenic E. coli O157:H7 EDL933 as a function of manure management. Five treatments were investigated: (1) soil only, (2) soil with surface-applied E. coli O157:H7 EDL933 Delta stx(1-2) (EcO157), (3) soil with incorporated EcO157, (4) soil with surface-applied EcO157-inoculated manure, and (5) soil with incorporated EcO157-inoculated manure. EcO157 was reisolated from soils immediately after application and weekly thereafter for 8 weeks. EcO157 in the surface-applied treatments died faster than their incorporated treatment counterparts. Phenotypic assays revealed differences between treatments as well. Half of surface-applied manure reisolates from week 6 developed a mixed red and white colony morphology on Congo Red plates, indicating changes in curli production that were not seen in other treatments or times. In 37 degrees C growth tests, week 6 reisolates from all treatments except soil surface-applied EcO157 left the lag phase at a significantly greater rate than week 0 isolates. We applied whole genome sequencing technology to interrogate the genetic underpinnings of these phenotypes. Surprisingly, we only found single-nucleotide polymorphisms in two of the 94 resequenced isolates from the different treatments, neither of which correlated with curli phenotype. Likewise, we found no differences in other genomic characteristics that might account for phenotypic differences including the count of gaps and the origin of discarded reads that failed to map to the parental strain. These results suggest there were no systematic genomic differences (i.e. individual-level selection) that correlated with time or treatment. We recommend future research focus on population-level selection of E. coli strains in the manure-amended soil environment.	[Truhlar, Allison M.; Cantilina, Keiran K.; Leung, Selene K.; Walter, Todd] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14850 USA; [Denes, Thomas G.] Univ Tennessee, Dept Food Sci, Knoxville, TN USA; [Hay, Anthony G.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Cornell University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Cornell University	Truhlar, AM (corresponding author), Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14850 USA.	amt94@cornell.edu		Truhlar, Allison M/0000-0002-7520-7773; Cantilina, Keiran/0000-0003-3583-5609; Denes, Thomas/0000-0002-2631-0846	United States Department of Agriculture, National Institute of Food and Agriculture, Hatch Grant [NYC-123425]; United States Department of Agriculture, National Institute of Food and Agriculture [2014-67019-21636]; National Science Foundation [DGE-1144153]	United States Department of Agriculture, National Institute of Food and Agriculture, Hatch Grant; United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by: United States Department of Agriculture, National Institute of Food and Agriculture, Hatch Grant No. NYC-123425, MTW. United States Department of Agriculture, National Institute of Food and Agriculture, Grant No. 2014-67019-21636, MTW. National Science Foundation, Graduate Research Fellowship Program, https://www.nsfgrfp.org/, Grant No. DGE-1144153, AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SOIL SAMPLING METHOD; Castaneda MDA, 2015, INT J FOOD MICROBIOL, V193, P15, DOI 10.1016/j.ijfoodmicro.2014.10.003; BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989; BENZ I, 1992, MOL MICROBIOL, V6, P1539, DOI 10.1111/j.1365-2958.1992.tb00875.x; Bergholz PW, 2011, APPL ENVIRON MICROB, V77, P211, DOI 10.1128/AEM.01880-10; Berry ED, 2005, J ENVIRON QUAL, V34, P656, DOI 10.2134/jeq2005.0656; Blount ZD, 2015, ELIFE, V4; Brennan FP, 2014, SCI TOTAL ENVIRON, V468, P302, DOI 10.1016/j.scitotenv.2013.08.037; Buchanan BP, 2013, HYDROL PROCESS, V27, P2422, DOI 10.1002/hyp.9305; Carter MQ, 2011, APPL ENVIRON MICROB, V77, P3685, DOI 10.1128/AEM.02315-10; Cools D, 2001, APPL SOIL ECOL, V17, P53, DOI 10.1016/S0929-1393(00)00133-5; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; den Bakker HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/eid2008.131399; Denes T, 2015, APPL ENVIRON MICROB, V81, P4295, DOI 10.1128/AEM.00087-15; Evans ML, 2014, BBA-MOL CELL RES, V1843, P1551, DOI 10.1016/j.bbamcr.2013.09.010; Falbo K, 2013, J ENVIRON MANAGE, V128, P1050, DOI 10.1016/j.jenvman.2013.05.021; Franz E, 2008, ENVIRON MICROBIOL, V10, P313, DOI 10.1111/j.1462-2920.2007.01453.x; Franz E, 2011, APPL ENVIRON MICROB, V77, P8088, DOI 10.1128/AEM.00745-11; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Harris LJ, 2013, J FOOD PROTECT, V76, P1062, DOI 10.4315/0362-028X.JFP-13-007; Hutchison ML, 2004, APPL ENVIRON MICROB, V70, P5111, DOI 10.1128/AEM.70.9.5111-5118.2004; Iqbal Z, 2013, BIOINFORMATICS, V29, P275, DOI 10.1093/bioinformatics/bts673; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Jamieson R. C., 2002, CAN BIOSYST ENG, V44, P1; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Latif H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00821-14; Ma J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024768; McDonald JH, 2014, HDB BIOL STAT, P254; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mubiru DN, 2000, J ENVIRON QUAL, V29, P1821, DOI 10.2134/jeq2000.00472425002900060012x; Naghili Hossein, 2013, Vet Res Forum, V4, P179; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Ravva SV, 2014, PATHOGENS, V3, P528, DOI 10.3390/pathogens3030528; REDDY KR, 1981, J ENVIRON QUAL, V10, P255, DOI 10.2134/jeq1981.00472425001000030001x; SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984; SJOGREN RE, 1994, WATER AIR SOIL POLL, V75, P389, DOI 10.1007/BF00482948; Truhlar AM, 2015, ENVIRON SCI TECHNOL, V49, P2099, DOI 10.1021/es5053039; Van den Hoecke S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1284-z; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; van Hoek AHAM, 2013, FEMS MICROBIOL LETT, V338, P18, DOI 10.1111/1574-6968.12024; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Vidovic S, 2007, CAN J MICROBIOL, V53, P822, DOI 10.1139/W07-041; WHO, 2011, GUID DRINK WAT QUAL; Yergeau E, 2010, FEMS MICROBIOL ECOL, V71, P34, DOI 10.1111/j.1574-6941.2009.00777.x; J BACTERIOL	49	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208346	10.1371/journal.pone.0208346	http://dx.doi.org/10.1371/journal.pone.0208346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532241	Green Published, gold, Green Submitted			2022-12-26	WOS:000452640900013
J	Buckton, CH; Patterson, C; Hyseni, L; Katikireddi, SV; Lloyd-Williams, F; Elliott-Green, A; Capewell, S; Hilton, S				Buckton, Christina H.; Patterson, Chris; Hyseni, Lirije; Katikireddi, S. Vittal; Lloyd-Williams, Ffion; Elliott-Green, Alex; Capewell, Simon; Hilton, Shona			The palatability of sugar-sweetened beverage taxation: A content analysis of newspaper coverage of the UK sugar debate	PLOS ONE			English	Article							NEWSPRINT COVERAGE; CHILDHOOD OBESITY; PUBLIC SUPPORT; MASS-MEDIA; POLICY; ALCOHOL; HEALTH; SMOKING; CONSUMPTION; PREVENTION	Background Excess sugar consumption, including sugar-sweetened beverages (SSBs), contributes to a variety of negative health outcomes, particularly for young people. The mass media play a powerful role in influencing public and policy-makers' perceptions of public health issues and their solutions. We analysed how sugar and SSB policy debates were presented in UK newspapers at a time of heightened awareness and following the announcement of the UK Government's soft drinks industry levy (SDIL), to inform future public health advocacy. Methods & findings We carried out quantitative content analysis of articles discussing the issues of sugar and SSB consumption published in 11 national newspapers from April 2015 to November 2016. 684 newspaper articles were analysed using a structured coding frame. Coverage peaked in line with evidence publication, campaigner activities and policy events. Articles predominantly supportive of SSB taxation (23.5%) outnumbered those that were predominantly oppositional (14.2%). However, oppositional articles outnumbered supportive ones in the month of the announcement of the SDIL. Sugar and SSB consumption were presented as health risks, particularly affecting young people, with the actions of industry often identified as the cause of the public health problem. Responsibility for addressing sugar overconsumption was primarily assigned to government intervention. Conclusion Our results suggest that the policy landscape favouring fiscal solutions to curb sugar and SSB consumption has benefited from media coverage characterising the issue as an industry-driven problem. Media coverage may drive greater public acceptance of the SDIL and any future taxation of products containing sugar. However, future advocacy efforts should note the surge in opposition coinciding with the announcement of the SDIL, which echoes similar patterns of opposition observed in tobacco control debates.	[Buckton, Christina H.; Patterson, Chris; Katikireddi, S. Vittal; Hilton, Shona] Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Hyseni, Lirije; Lloyd-Williams, Ffion; Elliott-Green, Alex; Capewell, Simon] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Liverpool	Buckton, CH (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	christina.buckton@glasgow.ac.uk		Katikireddi, Srinivasa/0000-0001-6593-9092; Hilton, Shona/0000-0003-0633-8152; Buckton, Christina/0000-0002-6004-4334	UK Medical Research Council as part of the Informing Healthy Public Policy programme [MC_ UU_ 12017/15]; Chief Scientist Office of the Scottish Government Health Directorates at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow [SPHSU15]; MRC [MC_UU_12017/15] Funding Source: UKRI	UK Medical Research Council as part of the Informing Healthy Public Policy programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorates at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CHB, CP, SVK and SH received funding from the UK Medical Research Council as part of the Informing Healthy Public Policy programme (MC_ UU_ 12017/15) and from the Chief Scientist Office of the Scottish Government Health Directorates (SPHSU15) at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow; www.mrc.ac.uk/funding, www.cso.scot.nhs.uk/funding-2.The funders had no role in commissioning the study, study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Barry CL, 2013, POLIT PSYCHOL, V34, P327, DOI 10.1111/pops.12018; Barry CL, 2009, MILBANK Q, V87, P7, DOI 10.1111/j.1468-0009.2009.00546.x; Bates B., 2017, NATL DIET NUTR SURVE; Bonilla-Chacin ME, 2016, LEARNING MEXICAN EXP; BRIGGS ADM, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6189; Capewell S, 2016, BMJ, V355; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Colchero MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163463; Conolly A, 2017, HLTH SURVEY ENGLAND; Daubler T, 2012, BRIT J POLIT SCI, V42, P937, DOI 10.1017/S0007123412000105; Dew C., 2016, NHS OUTCOMES FRAMEWO; Elliott-Green A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011295; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Gander, 2016, INDEPENDENT; Gollust SE, 2013, AM J PUBLIC HEALTH, V103, pE96, DOI 10.2105/AJPH.2013.301271; Gorini G, 2011, ANN I SUPER SANITA, V47, P260, DOI 10.4415/ANN_11_03_04; Harris JK, 2010, TOB CONTROL, V19, P37, DOI 10.1136/tc.2009.032516; Her Majesty's Treasury, 2016, BUDG 2016; Her Majesty's Treasury, 2017, SPRING BUDG 2017; Her Majesty's Treasury, 2016, SOFT DRINKS IND LEV; Her Majesty's Treasury, 2016, POL PAP SOFT DRINKS; Hester JB, 2007, J MASS COMMUN Q, V84, P811, DOI 10.1177/107769900708400410; Hilton S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1116; Hilton S, 2014, SOC SCI MED, V102, P157, DOI 10.1016/j.socscimed.2013.11.041; Hilton S, 2012, OBESITY, V20, P1688, DOI 10.1038/oby.2012.27; Hilton S, 2010, SOC SCI MED, V70, P942, DOI 10.1016/j.socscimed.2009.11.027; Katikireddi SV, 2015, DRUG-EDUC PREV POLIC, V22, P125, DOI 10.3109/09687637.2014.977228; Knai C, 2015, FOOD POLICY, V54, P1, DOI 10.1016/j.foodpol.2015.04.002; Krippendorff K. H., 2013, CONTENT ANAL INTRO I; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; Mekonnen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081723; Moody A, 2017, HLTH SURVEY ENGLAND; National Readership Survey, 2016, NEWSPAPERS SUPPL JAN; Niederdeppe J, 2013, AM J PUBLIC HEALTH, V103, pE92, DOI 10.2105/AJPH.2012.301023; OTTEN AL, 1992, HEALTH AFFAIR, V11, P111, DOI 10.1377/hlthaff.11.4.111; Patterson C, 2016, ADDICTION, V111, P1267, DOI 10.1111/add.13320; Patterson C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2110-x; Petticrew M, 2017, J EPIDEMIOL COMMUN H, V71, P1078, DOI 10.1136/jech-2017-209710; Public Health England, 2017, SUG RED EV ACT 2015; Riffe D, 1996, JOURNALISM MASS COMM, V73, P159, DOI 10.1177/107769909607300114; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH LOND; Smith K, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00064; Stone D.A, 1997, POLICY PARADOX ART P, V13; Weishaar H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3594-8; Whitehead R, 2016, BEVERAGE DAILY; Williams SJ, 2008, HEALTH, V12, P251, DOI 10.1177/1363459307086846; Wood K, 2014, ADDICTION, V109, P578, DOI 10.1111/add.12427; World Health Organization, 2018, GUID SUG INT AD CHIL	53	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207576	10.1371/journal.pone.0207576	http://dx.doi.org/10.1371/journal.pone.0207576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0QO	30517133	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400045
J	Finley, AO; Forsythe, PS; Crossman, JA; Baker, EA; Scribner, KT				Finley, Andrew O.; Forsythe, Patrick S.; Crossman, James A.; Baker, Edward A.; Scribner, Kim T.			Assessing impact of exogenous features on biotic phenomena in the presence of strong spatial dependence: A lake sturgeon case study in natural stream settings	PLOS ONE			English	Article							ACIPENSER-FULVESCENS; SALMONID EGGS; LIFE-HISTORY; RIVER; HABITAT; MODELS; FISH; NONSTATIONARY; REPRODUCTION; EVOLUTIONARY	Modeling spatially explicit data provides a powerful approach to identify the effects of exogenous features associated with biological processes, including recruitment of stream fishes. However, the complex spatial and temporal dynamics of the stream and the species' reproductive and early life stage behaviors present challenges to drawing valid inference using traditional regression models. In these settings it is often difficult to ensure the spatial independence among model residuals-a key assumption that must be met to ensure valid inference. We present statistical models capable of capturing complex residual anisotropic patterns through the addition of spatial random effects within an inferential framework that acknowledges uncertainty in the data and parameters. Proposed models are used to explore the impact of environmental variables on Lake sturgeon (Acipenser fulvescens) reproduction, particularly questions about patterns in egg deposition. Our results demonstrate the need to apply valid statistical methods to identify relationships between response variables, e.g., egg counts, across locations, and environmental covariates in the presence of strong and anisotropic autocorrelation in stream systems. The models may be applied to other settings where gamete distribution or, more generally, other biotic phenomena may be associated with spatially dynamic and anisotropic processes.	[Finley, Andrew O.] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA; [Forsythe, Patrick S.] Univ Wisconsin, Dept Nat & Appl Sci, Green Bay, WI 54302 USA; [Crossman, James A.] BC Hydro & Power Author, Water License Requirements, Castlegar, BC, Canada; [Baker, Edward A.] Michigan Dept Nat Resources, Fisheries Div, Marquette, MI USA; [Scribner, Kim T.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Scribner, Kim T.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; University of Wisconsin System; Michigan State University; Michigan State University	Finley, AO (corresponding author), Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA.	finleya@msu.edu		Crossman, James/0000-0002-7134-982X	Michigan Department of Natural Resources; Great Lakes Fishery Trust; National Science Foundation [DMS-1513481, EF-1253225]	Michigan Department of Natural Resources; Great Lakes Fishery Trust; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Michigan Department of Natural Resources, http://dx.doi.org/10.13039/100011028, Dr. Kim T Scribner; the Great Lakes Fishery Trust, http://dx.doi.org/10.13039/100001145, Dr. Kim T Scribner; National Science Foundation, http://dx.doi.org/10.13039/501100008982, DMS-1513481, Dr. Andrew O. Finley; and National Science Foundation, http://dx. doi. org/10.13039/501100008982, EF-1253225, Dr. Andrew O. Finley.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Banerjee S., 2014, CHAPMAN HALL CRC MON, Vsecond; Bernier-Bourgault I, 2002, ENVIRON BIOL FISH, V64, P333, DOI 10.1023/A:1016006303854; Bond NR, 2003, FRESHWATER BIOL, V48, P455, DOI 10.1046/j.1365-2427.2003.01016.x; Bruch RM, 2002, J APPL ICHTHYOL, V18, P570, DOI 10.1046/j.1439-0426.2002.00421.x; Bruch RM, 2006, J APPL ICHTHYOL, V22, P116, DOI 10.1111/j.1439-0426.2007.00938.x; Bunn N.A., 2000, SCI SERIES TECHNICAL; Chiotti JA, 2008, N AM J FISH MANAGE, V28, P1009, DOI 10.1577/M07-051.1; Cressie N., 2015, STAT SPATIO TEMPORAL; Cressie N., 1993, STAT SPATIAL DATA WI; Cressie N, 2006, J AGR BIOL ENVIR ST, V11, P127, DOI 10.1198/108571106X110649; Curriero FC, 2006, MATH GEOL, V38, P907, DOI 10.1007/s11004-006-9055-7; Curry RA, 2004, J N AM BENTHOL SOC, V23, P140, DOI 10.1899/0887-3593(2004)023<0140:PRTSDE>2.0.CO;2; Esselman Peter C., 2011, Ecological Restoration, V29, P133, DOI 10.3368/er.29.1-2.133; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Finley AO, 2011, METHODS ECOL EVOL, V2, P143, DOI 10.1111/j.2041-210X.2010.00060.x; Fitzsimons JD, 2007, J FISH BIOL, V71, P1, DOI 10.1111/j.1095-8649.2007.01437.x; Forsythe PS, 2013, T AM FISH SOC, V142, P1005, DOI 10.1080/00028487.2013.790847; Forsythe PS, 2012, J FISH BIOL, V81, P35, DOI 10.1111/j.1095-8649.2012.03308.x; Forsythe PS, 2012, CAN J FISH AQUAT SCI, V69, P60, DOI 10.1139/F2011-132; Frimpong EA, 2010, AM FISH S S, V73, P109; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Gergel SE, 2002, AQUAT SCI, V64, P118, DOI 10.1007/s00027-002-8060-2; GONCZI A P, 1989, Regulated Rivers Research and Management, V3, P221, DOI 10.1002/rrr.3450030121; Hendry AP, 2001, OIKOS, V93, P407, DOI 10.1034/j.1600-0706.2001.930306.x; Hoeting JA, 2009, ECOL APPL, V19, P574, DOI 10.1890/08-0836.1; Johnson JH, 2006, J APPL ICHTHYOL, V22, P465, DOI 10.1111/j.1439-0426.2006.00812.x; Jorgensen C, 2008, ECOLOGY, V89, P3436, DOI 10.1890/07-1469.1; Kamler E, 2002, REV FISH BIOL FISHER, V12, P79, DOI 10.1023/A:1022603204337; Katt JD, 2012, N AM J FISH MANAGE, V32, P44, DOI 10.1080/02755947.2012.655842; Keefer ML, 2009, ENVIRON BIOL FISH, V85, P253, DOI 10.1007/s10641-009-9490-7; Kempinger J.J., 1988, AM FISHERIES SOC S, V5, P110; Kimura DK, 2006, REV FISH SCI, V14, P245, DOI 10.1080/10641260600621761; Knapp RA, 1999, CAN J FISH AQUAT SCI, V56, P1576, DOI 10.1139/cjfas-56-9-1576; Kristensen K., 2013, CANADIAN J FISHERIES, V71, P326; LAHAYE M, 1992, CAN J ZOOL, V70, P1681, DOI 10.1139/z92-234; Malcolm IA, 2003, RIVER RES APPL, V19, P303, DOI 10.1002/rra.706; Malcolm IA, 2004, HYDROL PROCESS, V18, P1543, DOI 10.1002/hyp.1405; Melles SJ, 2009, LANDSCAPE ECOL, V24, P519, DOI 10.1007/s10980-009-9329-9; Mulli KE, 2007, N AM J FISH MANAGE, V27, P1343, DOI 10.1577/M06-054.1; Paciorek CJ, 2006, ENVIRONMETRICS, V17, P483, DOI 10.1002/env.785; Parsley MJ, 2002, AM FISH S S, V28, P55; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Petitgas P, 2001, FISH FISH, V2, P231, DOI 10.1046/j.1467-2960.2001.00047.x; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Schabenberger O., 2004, STAT METHODS SPATIAL; Schlosser IJ, 1995, AM FISH S S, V17, P392; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Smith SJ, 2009, N AM J FISH MANAGE, V29, P859, DOI 10.1577/M07-196.1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; THUROW RF, 1994, T AM FISH SOC, V123, P37, DOI 10.1577/1548-8659(1994)123&lt;0037:AOYCTR&gt;2.3.CO;2; Trippel Edward A., 1997, Fish and Fisheries Series, V21, P31; van der Leeuw BK, 2006, 20065225 US GEOL SUR, V5225, P20; Ver Hoef JM, 2006, ENVIRON ECOL STAT, V13, P449, DOI 10.1007/s10651-006-0022-8; Workman RD, 2002, T AM FISH SOC, V131, P463, DOI 10.1577/1548-8659(2002)131<0463:AMOSMI>2.0.CO;2; Youngson AF, 2004, CAN J FISH AQUAT SCI, V61, P2278, DOI 10.1139/F04-217	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0204150	10.1371/journal.pone.0204150	http://dx.doi.org/10.1371/journal.pone.0204150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517091	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400005
J	Groves, HE; Guo-Parke, H; Broadbent, L; Shields, MD; Power, UF				Groves, Helen E.; Guo-Parke, Hong; Broadbent, Lindsay; Shields, Michael D.; Power, Ultan F.			Characterisation of morphological differences in well-differentiated nasal epithelial cell cultures from preterm and term infants at birth and one-year	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PEDIATRIC BRONCHIAL EPITHELIUM; MUCOUS METAPLASIA; INFECTION; KERATINOCYTES; ASTHMA	Background Innate immune responses of airway epithelium are important defences against respiratory pathogens and allergens. Newborn infants are at greater risk of severe respiratory infections compared to older infants, while premature infants are at greater risk than full term infants. However, very little is known regarding human neonatal airway epithelium immune responses and whether age-related morphological and/or innate immune changes contribute to the development of airway disease. Methods We collected nasal epithelial cells from 41 newborn infants (23 term, 18 preterm) within 5 days of birth. Repeat sampling was achieved for 24 infants (13 term, 11 preterm) at a median age of 12.5 months. Morphologically- and physiologically-authentic well-differentiated primary paediatric nasal epithelial cell (WD-PNEC) cultures were generated and characterised using light microscopy and immunofluorescence. Results WD-PNEC cultures were established for 15/23 (65%) term and 13/18 (72%) preterm samples at birth, and 9/13 (69%) term and 8/11(73%) preterm samples at one-year. Newborn and infant WD-PNEC cultures demonstrated extensive cilia coverage, mucous production and tight junction integrity. Newborn WD-PNECs took significantly longer to reach full differentiation and were noted to have much greater proportions of goblet cells compared to one-year repeat WD-PNECs. No differences were evident in ciliated/goblet cell proportions between term- and preterm-derived WD-PNECs at birth or one-year old. Conclusion We describe the successful generation of newborn-derived WD-PNEC cultures and their revival from frozen. We also compared the characteristics of WD-PNECs derived from infants born at term with those born prematurely at birth and at one-year-old. The development of WD-PNEC cultures from newborn infants provides a powerful and exciting opportunity to study the development of airway epithelium morphology, physiology, and innate immune responses to environmental or infectious insults from birth.	[Groves, Helen E.; Guo-Parke, Hong; Broadbent, Lindsay; Shields, Michael D.; Power, Ultan F.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland; [Shields, Michael D.] Royal Belfast Hosp Sick Children, Dept Paediat Resp Med, Belfast, Antrim, North Ireland	Queens University Belfast	Power, UF (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland.	u.power@qub.ac.uk	Broadbent, Lindsay/GWQ-4931-2022	Groves, Helen/0000-0001-9244-9961; Broadbent, Lindsay/0000-0002-8755-6946; Guo-Parke, Hong/0000-0001-8210-5321; Power, Ultan/0000-0003-3246-3774	Wellcome Trust [104516/Z/14/Z]; HSC R&D Division, Northern Ireland [RRG 9.44]	Wellcome Trust(Wellcome TrustEuropean Commission); HSC R&D Division, Northern Ireland	This work was supported by The Wellcome Trust [104516/Z/14/Z]; this work was conducted as part of a research program supported by funding from the HSC R&D Division, Northern Ireland [RRG 9.44]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battersby AJ, 2013, PEDIAT ALLERG IMM-UK, V24, P414, DOI 10.1111/pai.12079; Birkhaug IM, 2013, PEDIATR INFECT DIS J, V32, pE235, DOI 10.1097/INF.0b013e31828ab9ff; Broadbent L, 2016, HUMAN RESP SYNCYTIAL, P199; Bush A, 2000, ALLERGY, V55, P685, DOI 10.1034/j.1398-9995.2000.00031.x; Chu CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33994; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Comer DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032924; Fauroux B, 2014, EPIDEMIOL INFECT, V142, P1362, DOI 10.1017/S0950268813001738; Guo-Parke H, 2013, AM J RESP CRIT CARE, V188, P842, DOI 10.1164/rccm.201304-0750OC; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Krejci E, 2015, PHYSIOL RES, V64, P561, DOI 10.33549/physiolres.932893; Marodi L, 2006, INFECT IMMUN, V74, P1999, DOI 10.1128/IAI.74.4.1999-2006.2006; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Mateu R, 2016, INT J MOL MED, V38, P1063, DOI 10.3892/ijmm.2016.2706; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Miller D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078321; Mosler K, 2008, J CYST FIBROS, V7, P44, DOI 10.1016/j.jcf.2007.04.005; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Schneider D, 2012, J IMMUNOL, V188, P2894, DOI 10.4049/jimmunol.1101391; Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13; Thavagnanam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085802; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109	25	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0201328	10.1371/journal.pone.0201328	http://dx.doi.org/10.1371/journal.pone.0201328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517096	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400003
J	Wang, L; Chang, QR; Yang, J; Zhang, XH; Li, FL				Wang, Li; Chang, Qingrui; Yang, Jing; Zhang, Xiaohua; Li, Fenling			Estimation of paddy rice leaf area index using machine learning methods based on hyperspectral data from multi-year experiments	PLOS ONE			English	Article							VEGETATION INDEXES; SQUARES REGRESSION; YIELD ESTIMATION; LANDSAT IMAGERY; NITROGEN STATUS; SPECTRAL INDEX; WINTER-WHEAT; GREEN LAI; BIOMASS; REFLECTANCE	The performance of three machine learning methods (support vector regression, random forests and artificial neural network) for estimating the LAI of paddy rice was evaluated in this study. Traditional univariate regression models involving narrowband NDVI with optimized band combinations as well as linear multivariate calibration partial least squares regression models were also evaluated for comparison. A four year field-collected dataset was used to test the robustness of LAI estimation models against temporal variation. The partial least squares regression and three machine learning methods were built on the raw hyperspectral reflectance and the first derivative separately. Two different rules were used to determine the models' key parameters. The results showed that the combination of the red edge and NIR bands (766 nm and 830 nm) as well as the combination of SWIR bands (1114 nm and 1190 nm) were optimal for producing the narrowband NDVI. The models built on the first derivative spectra yielded more accurate results than the corresponding models built on the raw spectra. Properly selected model parameters resulted in comparable accuracy and robustness with the empirical optimal parameter and significantly reduced the model complexity. The machine learning methods were more accurate and robust than the VI methods and partial least squares regression. When validating the calibrated models against the standalone validation dataset, the VI method yielded a validation RMSE value of 1.17 for NDVI(766,830) and 1.01 for NDVI(1114,1190), while the best models for the partial least squares, support vector machine and artificial neural network methods yielded validation RMSE values of 0.84, 0.82, 0.67 and 0.84, respectively. The RF models built on the first derivative spectra with mtry = 10 showed the highest potential for estimating the LAI of paddy rice.	[Wang, Li; Chang, Qingrui; Yang, Jing; Zhang, Xiaohua; Li, Fenling] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Zhang, Xiaohua] China Nucl Ind CO LTD, Surveying & Mapping Inst, Xian, Shaanxi, Peoples R China	Northwest A&F University - China	Chang, QR (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.	changqr@nwsuaf.edu.cn	wang, li/I-1708-2013	Wang, Li/0000-0002-6597-5533	Natural Science Foundation of China [41701398]; Hi-Tech Research and Development Program (863) of China [2013AA102401-2]; Fundamental Research Funds for the Central Universities [2452017108]; Institute of Agricultural Resources and Environment, Ningxia Academy of Agro-forestry science, Yinchuan	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Institute of Agricultural Resources and Environment, Ningxia Academy of Agro-forestry science, Yinchuan	This work is supported by the Natural Science Foundation of China (41701398 to F.L.), the Hi-Tech Research and Development Program (863) of China (2013AA102401-2 to Q.C.) and the Fundamental Research Funds for the Central Universities (2452017108 to F.L.). We acknowledge the support given by the Institute of Agricultural Resources and Environment, Ningxia Academy of Agro-forestry science, Yinchuan. The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Atkinson PM, 1997, INT J REMOTE SENS, V18, P699, DOI 10.1080/014311697217224; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Camps-Valls G, 2006, IEEE GEOSCI REMOTE S, V3, P339, DOI 10.1109/LGRS.2006.871748; Cho MA, 2007, INT J APPL EARTH OBS, V9, P414, DOI 10.1016/j.jag.2007.02.001; Chollet F., 2017, R INTERFACE TO KERAS; Darvishzadeh R, 2008, ISPRS J PHOTOGRAMM, V63, P409, DOI 10.1016/j.isprsjprs.2008.01.001; Delegido J, 2013, EUR J AGRON, V46, P42, DOI 10.1016/j.eja.2012.12.001; Gnyp ML, 2014, FIELD CROP RES, V155, P42, DOI 10.1016/j.fcr.2013.09.023; Goetz AFH, 2009, REMOTE SENS ENVIRON, V113, pS5, DOI 10.1016/j.rse.2007.12.014; Gong P, 2003, IEEE T GEOSCI REMOTE, V41, P1355, DOI 10.1109/TGRS.2003.812910; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Jin XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086938; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kiala Z, 2016, J APPL REMOTE SENS, V10, DOI 10.1117/1.JRS.10.036015; Kira O, 2016, AGR FOREST METEOROL, V218, P243, DOI 10.1016/j.agrformet.2015.12.064; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Li GX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183338; Li ZW, 2017, J INTEGR AGR, V16, P286, DOI [10.1016/S2095-3119(15)61303-X, 10.1016/s2095-3119(15)61303-x]; Liu K, 2016, J INTEGR AGR, V15, P475, DOI 10.1016/S2095-3119(15)61073-5; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Milton EJ, 2009, REMOTE SENS ENVIRON, V113, pS92, DOI 10.1016/j.rse.2007.08.001; Mokhtari A, 2018, AGR FOREST METEOROL, V250, P159, DOI 10.1016/j.agrformet.2017.12.250; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Nguyen HT, 2006, PRECIS AGRIC, V7, P249, DOI 10.1007/s11119-006-9010-0; R Core Team, 2021, R LANGUAGE ENV STAT; Shen L., 2014, INT J APPL SCI TECHN, V4, P46; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Tanaka S, 2015, REMOTE SENS-BASEL, V7, P5329, DOI 10.3390/rs70505329; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7; Verrelst J, 2015, ISPRS J PHOTOGRAMM, V108, P273, DOI 10.1016/j.isprsjprs.2015.05.005; Wang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167679; Wang FM, 2011, PRECIS AGRIC, V12, P439, DOI 10.1007/s11119-010-9185-2; Wang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03901-8; Wei CZ, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010080; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xie Y, 2017, AGR FOREST METEOROL, V246, P194, DOI 10.1016/j.agrformet.2017.06.015; Yao X, 2015, REMOTE SENS-BASEL, V7, P14939, DOI 10.3390/rs71114939; Yuan HH, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9040309; Zhao DH, 2007, ISPRS J PHOTOGRAMM, V62, P25, DOI 10.1016/j.isprsjprs.2007.01.003; Zheng G, 2009, SENSORS-BASEL, V9, P2719, DOI 10.3390/s90402719	42	25	28	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207624	10.1371/journal.pone.0207624	http://dx.doi.org/10.1371/journal.pone.0207624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517144	Green Published, gold, Green Submitted			2022-12-26	WOS:000452212400052
J	Zhang, L; Cheng, FL; Wei, YJ; Zhang, LJ; Guo, DS; Wang, BF; Li, W				Zhang, Lei; Cheng, Fangling; Wei, Yiju; Zhang, Lijun; Guo, Dongsheng; Wang, Baofeng; Li, Wei			Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells	ONCOGENE			English	Article							IONIZING-RADIATION; GLIOBLASTOMA-MULTIFORME; HIPPO PATHWAY; GENE; EXPRESSION; PROGRESSION; SUBTYPES; THERAPY	Glioblastoma (GBM) is the most aggressive brain tumor and resistant to current available therapeutics, such as radiation. To improve the clinical efficacy, it is important to understand the cellular mechanisms underlying tumor responses to radiation. Here, we investigated long-term cellular responses of human GBM cells to ionizing radiation. Comparing to the initial response within 12 hours, gene expression modulation at 7 days after radiation is markedly different. While genes related to cell cycle arrest and DNA damage responses are mostly modulated at the initial stage; immune-related genes are specifically affected as the long-term effect. This later response is associated with increased cellular senescence and inhibition of transcriptional coactivator with PDZ-binding motif (TAZ). Mechanistically, TAZ inhibition does not depend on the canonical Hippo pathway, but relies on enhanced degradation mediated by the beta-catenin destruction complex in the Wnt pathway. We further showed that depletion of TAZ by RNAi promotes radiation-induced senescence and growth arrest. Pharmacological activation of the beta-catenin destruction complex is able to promote radiation-induced TAZ inhibition and growth arrest in these tumor cells. The correlation between senescence and reduced expression of TAZ as well as beta-catenin also occurs in human gliomas treated by radiation. Collectively, these findings suggested that inhibition of TAZ is involved in radiation-induced senescence and might benefit GBM radiotherapy.	[Zhang, Lei; Wei, Yiju; Li, Wei] Penn State Coll Med, Div Pediat Hematol Oncol, Dept Pediat, Penn State Hlth Hershey Med Ctr, Hershey, PA 17033 USA; [Zhang, Lei] Huazhong Univ Sci & Technol, Hepat Surg Ctr, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Cheng, Fangling; Guo, Dongsheng; Wang, Baofeng] Huazhong Univ Sci & Technol, Dept Neurosurg, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Zhang, Lijun] Penn State Coll Med, Inst Personalized Med, Penn State Hlth Hershey Med Ctr, Hershey, PA 17033 USA; [Zhang, Lijun; Li, Wei] Penn State Coll Med, Dept Biochem & Mol Biol, Penn State Hlth Hershey Med Ctr, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Li, W (corresponding author), Penn State Coll Med, Div Pediat Hematol Oncol, Dept Pediat, Penn State Hlth Hershey Med Ctr, Hershey, PA 17033 USA.; Li, W (corresponding author), Penn State Coll Med, Dept Biochem & Mol Biol, Penn State Hlth Hershey Med Ctr, Hershey, PA 17033 USA.	weili@pennstatehealth.psu.edu	Zhang, Lei/AAJ-2148-2020	Zhang, Lei/0000-0002-2227-0613; Li, Wei/0000-0001-5696-4309	National Natural Science Foundation of China [81472364]; National Institutes of Health [K22 5K22CA190440]; American Cancer Society-Institutional Research Grant [124171-IRG-13-043-01]; Four Diamonds Fund for Pediatric Cancer Research; NATIONAL CANCER INSTITUTE [K22CA190440] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Institutional Research Grant(American Cancer Society); Four Diamonds Fund for Pediatric Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Brian J. Lorah, Kim Powell, Bryan E. Achey and Steven P. Leibig in the Division of Health Physics, Yuka Imamura Kawasawa in the Institute for Personalized Medicine of Penn State College of Medicine for technical support. We thank Dong Kuang and Yan-Bing Chen in Department of Pathology of Tongji Hospital, Tongji Medical College, HUST for pathologic analysis. This work was supported by the National Natural Science Foundation of China 81472364 (to B.W.), the National Institutes of Health Grant K22 5K22CA190440 (to W.L.), the American Cancer Society-Institutional Research Grant 124171-IRG-13-043-01 (to W.L.), and the Four Diamonds Fund for Pediatric Cancer Research (to W.L.).	Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bassi CL, 2008, HUM EXP TOXICOL, V27, P919, DOI 10.1177/0960327108102045; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; BURGER PC, 1983, J NEUROSURG, V58, P159, DOI 10.3171/jns.1983.58.2.0159; Camphausen KV, 2005, CANCER RES, V65, P10389, DOI 10.1158/0008-5472.CAN-05-1904; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Godoy PRDV, 2013, MUTAT RES-GEN TOX EN, V756, P46, DOI 10.1016/j.mrgentox.2013.06.010; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002; Jin X, 2017, NAT MED, V23, P1352, DOI 10.1038/nm.4415; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu ZJ, 2019, ONCOGENE, V38, P120, DOI 10.1038/s41388-018-0425-7; Lv DG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01731-w; Ma H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.412; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Otomo T, 2004, J RADIAT RES, V45, P53, DOI 10.1269/jrr.45.53; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Quick QA, 2006, J NEUROSURG, V105, P111, DOI 10.3171/jns.2006.105.1.111; Schosserer M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00278; Tihan T, 2006, HUM PATHOL, V37, P272, DOI 10.1016/j.humpath.2005.11.010; Tsai MH, 2007, CANCER RES, V67, P3845, DOI 10.1158/0008-5472.CAN-06-4250; VAN MEIR EG, 1994, CANCER RES, V54, P649; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang J, 2017, J CLIN INVEST, V127, P3075, DOI 10.1172/JCI89092; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zamorano L, 1989, Acta Neurochir Suppl (Wien), V46, P90; Zhang LH, 2015, ONCOGENE, V34, P600, DOI 10.1038/onc.2013.593	34	28	28	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2788	2799		10.1038/s41388-018-0626-0	http://dx.doi.org/10.1038/s41388-018-0626-0			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30542117	Green Accepted			2022-12-26	WOS:000464121600009
J	Shirai, YT; Mizutani, A; Nishijima, S; Horie, M; Kikuguchi, C; Elisseeva, O; Yamamoto, T				Shirai, Yo-Taro; Mizutani, Anna; Nishijima, Saori; Horie, Masafumi; Kikuguchi, Chisato; Elisseeva, Olga; Yamamoto, Tadashi			CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development	ONCOGENE			English	Article							MESSENGER-RNA DEADENYLATION; KRUPPEL-LIKE FACTOR-2; GENE-EXPRESSION; CCR4-NOT COMPLEX; DNA METHYLATION; ROLES; ADENOCARCINOMA; SUBUNITS; LEVEL	Lung cancer is one of the major causes of cancer death and clarification of its molecular pathology is highly prioritized. The physiological importance of mRNA degradation through the CCR4-NOT deadenylase has recently been highlighted. For example, mutation in CNOT3, a gene coding for CNOT3 subunit of the CCR4-NOT complex, is found to be associated with T-cell acute lymphoblastic leukemia, T-ALL, though its contribution to other cancers has not been reported. Here, we provide evidence suggesting that CNOT3 is required for the growth of non-small cell lung cancer. Depletion of CNOT3 suppresses proliferation of A549 human non-small cell lung cancer cells with enhanced mRNA stability and subsequent elevated expression of p21. In addition, we identified the mRNA for Kruppel-like factor 2 transcription factor, an inducer of p21, as a novel mRNA degradation target of CNOT3 in non-small cell lung cancer cells. Aberrant up-regulation of Kruppel-like factor 2 by CNOT3 depletion leads to impairment in the proliferation of A549 cells. Consistent with these findings, elevated mRNA expression of CNOT3 in non-small cell lung cancer in comparison with the paired normal lung epithelium was confirmed through scrutinization of the RNA-sequencing datasets from The Cancer Genome Atlas. Moreover, we found an inverse correlation between CNOT3 and CDKN1A (encoding p21) mRNA expression using the combined datasets of normal lung epithelium and non-small cell lung cancer. Thus, we propose that the up-regulation of CNOT3 facilitates the development of non-small cell lung cancer through down-regulation of Kruppel-like factor 2 and p21, contrary to tumor suppressive functions of CNOT3 in T-ALL.	[Shirai, Yo-Taro; Nishijima, Saori; Kikuguchi, Chisato; Elisseeva, Olga; Yamamoto, Tadashi] Grad Univ, Okinawa Inst Sci & Technol, Cell Signal Unit, Onna Son, Okinawa, Japan; [Mizutani, Anna] Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Div Mol Biotherapy, Koto Ku, Tokyo, Japan; [Horie, Masafumi] Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Horie, Masafumi] Univ Tokyo, Div Hlth Serv Promot, Bunkyo Ku, Tokyo, Japan; [Kikuguchi, Chisato; Elisseeva, Olga; Yamamoto, Tadashi] RIKEN Ctr Integrat Sci, Lab Immunogenet, Yokohama, Kanagawa, Japan; [Shirai, Yo-Taro] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Okinawa Institute of Science & Technology Graduate University; Japanese Foundation for Cancer Research; University of Tokyo; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shirai, YT; Yamamoto, T (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Cell Signal Unit, Onna Son, Okinawa, Japan.; Yamamoto, T (corresponding author), RIKEN Ctr Integrat Sci, Lab Immunogenet, Yokohama, Kanagawa, Japan.; Shirai, YT (corresponding author), NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.	yo-taro.shirai@nih.gov; tadashi.yamamoto@oist.jp			OIST; KAKENHI from the Japan Society for the Promotion of Science (JSPS) [21229006, 25121734, 26830066, 16K18437, 24890289, 26893050]	OIST(Okinawa Institute of Science & Technology Graduate University); KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors would like to thank Dr. Hiroyuki Miyoshi (RIKEN) for lentivirus vector system. The authors also thank all the members of Cell Signal Unit at the Okinawa Institute of Science and Technology Graduate University (OIST) for discussion and advice. This research was supported by subsidiary of OIST and KAKENHI Grants-in-Aid for scientific research (S) (21229006 to TY), for Scientific Research on Innovative Areas (25121734 to TY), for Young Scientists (B) (26830066 to AM and 16K18437 to MH), and for Research Activity Start-up (24890289 to Y-TS and 26893050 to MH) from the Japan Society for the Promotion of Science (JSPS).	Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Bartlam M, 2010, PROTEIN CELL, V1, P443, DOI 10.1007/s13238-010-0060-8; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Castro D, 2017, ONCOTARGET, V8, P81679, DOI 10.18632/oncotarget.20955; Cejas P, 2017, CANCER RES, V77, P766, DOI 10.1158/0008-5472.CAN-16-1346; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Faraji F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005820; Faraji F, 2014, GENOME RES, V24, P227, DOI 10.1101/gr.166223.113; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Harris T, 2011, CLIN CANCER RES, V17, P690, DOI 10.1158/1078-0432.CCR-10-1892; Horie M, 2017, MOL CANCER RES, V15, P1354, DOI 10.1158/1541-7786.MCR-17-0191; Horie M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33666; Hoshina N, 2013, NEURON, V78, P839, DOI 10.1016/j.neuron.2013.03.031; Hoshino Y, 2011, J BIOCHEM, V149, P55, DOI 10.1093/jb/mvq114; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inoue T, 2015, J EXP MED, V212, P1465, DOI 10.1084/jem.20150384; Ito K, 2011, PROTEIN CELL, V2, P755, DOI 10.1007/s13238-011-1092-4; Jiang WB, 2017, AM J TRANSL RES, V9, P2024; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Kawabe S, 2000, ONCOGENE, V19, P5359, DOI 10.1038/sj.onc.1203935; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Li WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13770; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; Morita M, 2011, EMBO J, V30, P4678, DOI 10.1038/emboj.2011.320; Nabel EG, 2002, NAT REV DRUG DISCOV, V1, P587, DOI 10.1038/nrd869; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Petersen I, 2016, J CANCER RES CLIN, V142, P895, DOI 10.1007/s00432-015-2004-4; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schuster K, 2014, MOL CANCER RES, V12, P912, DOI 10.1158/1541-7786.MCR-13-0620-T; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shirai YT, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00286; Shirai Y, 2011, AM J PATHOL, V179, P2920, DOI 10.1016/j.ajpath.2011.08.022; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Suzuki T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14779; Takahashi A, 2012, BIOCHEM BIOPH RES CO, V419, P268, DOI 10.1016/j.bbrc.2012.02.007; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Watanabe C, 2014, P NATL ACAD SCI USA, V111, P2692, DOI 10.1073/pnas.1316932111; Wehrkamp CJ, 2018, RNA BIOL, V15, P391, DOI 10.1080/15476286.2017.1422471; Winkelmann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097953; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Yin L, 2015, TUMOR BIOL, V36, P3075, DOI 10.1007/s13277-014-2943-4; Zheng XF, 2016, STEM CELL REP, V7, P897, DOI 10.1016/j.stemcr.2016.09.007; Zheng XF, 2012, STEM CELLS, V30, P910, DOI 10.1002/stem.1070	59	9	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 4	2019	38	14					2580	2594		10.1038/s41388-018-0603-7	http://dx.doi.org/10.1038/s41388-018-0603-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HR7LI	30531840	Green Submitted			2022-12-26	WOS:000463335200010
J	Gao, LX; Lang, LW; Zhao, XD; Shay, C; Shull, AY; Teng, Y				Gao, Lixia; Lang, Liwei; Zhao, Xiangdong; Shay, Chloe; Shull, Austin Y.; Teng, Yong			FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma	ONCOGENE			English	Article							GROWTH-FACTOR 19; SKELETAL-MUSCLE MASS; HEPATOCELLULAR-CARCINOMA; CANCER; GENE; EXPRESSION; FGFR4	The fibroblast growth factor 19 gene FGF19 has previously been reported to be amplified in several cancer types and encodes for a key autocrine signaler known to promote tumorigenic growth. Thus, it is imperative to understand which cancers are oncogenically addicted to FGF19 amplification as well as the role it serves in these cancer types. We report for the first time high FGF19 amplification in head and neck squamous cell carcinomas (HNSCC), which is associated with increased autocrine secretion of FGF19 and poor patient outcome in HNSCC. FGF19 amplification corresponded with constitutive activation of FGF receptor 4 (FGFR4)-dependent ERK/AKT-p70S6K-S6 signaling activation in HNSCC cells, and addition of human recombinant FGF19 could promote cell proliferation and soft agar colony formation in HNSCC cells with low FGF19 expression through activation of FGFR4 and downstream signaling cascades. In contrast, FGF19 knockout counteracts the observed effects in HNSCC cells carrying high endogenous FGF19, with knockout of FGF19 significantly suppressing tumor growth in an orthotopic mouse model of HNSCC. Collectively, this study demonstrates that FGF19 gene amplification corresponds with an increased dependency upon FGF19/FGFR4 autocrine signaling in HNSCC, revealing a therapeutic target for this cancer type.	[Gao, Lixia; Lang, Liwei; Zhao, Xiangdong; Teng, Yong] Augusta Univ, Dept Oral Biol & Diagnost Sci, Augusta, GA 30912 USA; [Shay, Chloe] Emory Univ, Emory Childrens Ctr, Atlanta, GA 30322 USA; [Shull, Austin Y.] Presbyterian Coll, Dept Biol, Clinton, SC USA; [Teng, Yong] Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA	University System of Georgia; Augusta University; Emory University; University System of Georgia; Augusta University	Teng, Y (corresponding author), Augusta Univ, Dept Oral Biol & Diagnost Sci, Augusta, GA 30912 USA.; Teng, Y (corresponding author), Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA.	yteng@augusta.edu	Lang, Liwei/I-7744-2019; Teng, Yong/AAK-4160-2020	Teng, Yong/0000-0002-1856-7289; Lang, Liwei/0000-0002-2374-645X	Dental College of Georgia Special Funding Initiative; Department of Defense [W81XWH-14-1-0412]	Dental College of Georgia Special Funding Initiative; Department of Defense(United States Department of Defense)	This work was supported in part by Dental College of Georgia Special Funding Initiative and a grant from the Department of Defense (W81XWH-14-1-0412) (to Y.T.). The authors sincerely thank Dr. Andrew W. Yeudall (Augusta University) for providing HNSCC cells for this study.	Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198; Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; Benoit B, 2017, NAT MED, V23, P990, DOI 10.1038/nm.4363; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Chi AC, 2015, CA-CANCER J CLIN, V65, P401, DOI 10.3322/caac.21293; de Mello RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086697; Gao LX, 2018, CELL ONCOL, V41, P85, DOI 10.1007/s13402-017-0354-4; Gao LX, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0478-9; Gibcus JH, 2007, CLIN CANCER RES, V13, P6257, DOI 10.1158/1078-0432.CCR-07-1247; Glass DJ, 2017, CELL METAB, V26, P287, DOI 10.1016/j.cmet.2017.07.017; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Katoh M, 2003, INT J MOL MED, V12, P45; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Lang LW, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0623-3; Lang LW, 2019, CURR CANCER DRUG TAR, V19, P17, DOI 10.2174/1568009618666180319091731; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Marcelin G, 2014, MOL METAB, V3, P19, DOI 10.1016/j.molmet.2013.10.002; Morrison C, 2006, J CLIN ONCOL, V24, P2376, DOI 10.1200/JCO.2005.03.4827; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; Schwab M, 1999, ONCOGENE AMPLIFICATI, P319; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0485-0; Tiong KH, 2016, ONCOTARGET, V7, P57633, DOI 10.18632/oncotarget.9328; Wan ZY, 2016, HEPATOLOGY, V64, P1289, DOI 10.1002/hep.28639; Xie XY, 2016, ONCOTARGET, V7, P58111, DOI 10.18632/oncotarget.11185; YEUDALL WA, 1994, CARCINOGENESIS, V15, P2683, DOI 10.1093/carcin/15.12.2683; Zhao HK, 2016, ONCOTARGET, V7, P13575, DOI 10.18632/oncotarget.6185; Zhao XD, 2018, MOL CARCINOGEN, V57, P1616, DOI 10.1002/mc.22884; Zhou M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15433	34	39	42	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 28	2019	38	13					2394	2404		10.1038/s41388-018-0591-7	http://dx.doi.org/10.1038/s41388-018-0591-7			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HQ7GN	30518874				2022-12-26	WOS:000462588000012
J	Wang, XT; Xin, LB; Duan, ZC; Zuo, ZY; Wang, Y; Ren, YY; Zhang, W; Sun, XM; Liu, X; Ge, L; Yang, X; Yao, Z; Yang, J				Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yang, Xi; Yao, Zhi; Yang, Jie			Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance	FASEB JOURNAL			English	Article						Tudor-SN; Srebp2; cholesterol; HFD	FATTY-ACID SYNTHESIS; P100 COACTIVATOR; LIPID DROPLETS; LIVER-DISEASE; PROTEIN; CHOLESTEROL; HOMEOSTASIS; OVEREXPRESSION; METABOLISM; TGF-BETA-1	In the current study, we explored the impact of Tudor-staphylococcal nuclease (SN) on obesity induced by a high-fat diet (HFD) in mice, because the functional involvement of Tudor-SN in lipid metabolism in vivo is unknown. HFD-transgenic (Tg) mice exhibited reductions in hepatic steatosis and systemic insulin resistance. There was no difference in hepatic lipid accumulation between chow-fed wild-type (WT) and chow-fed Tg mice; consistently, no difference in activation of the lipogenic pathway was detected. Overactivation of hepatic nuclear sterol regulatory element-binding protein (nSrebp2)-2, the central regulator of cholesterol metabolic proteins, was observed in HFD-Tg livers along with improved cholesterol homeostasis, but no such changes were observed in HFD-WT livers. Consistent results were observed in vitro in -mouse liver 12 cells treated with palmitate mimicking the HFD state. In addition, global gene analysis indicated that various downstream targets of nSrebp2, were up-regulated in HFD-Tg livers. Moreover, HFD-WT mice displayed islet hypertrophy and suppression of glucose-induced insulin secretion from islets, whereas HFD-Tg mice had normal pancreatic islets. This finding suggests that the improved pancreatic metabolism of HFD-Tg mice is related to the systemic effect of insulin resistance, not to the autonomous influence of pancreatic cells. Tudor-SN is likely to be a key regulator for ameliorating HFD-induced hepatic steatosis and systemic insulin resistance in vivo.Wang, X., Xin, L., Duan, Z., Zuo, Z., Wang, Y., Ren, Y., Zhang, W., Sun, X., Liu, X., Ge, L., Yang, X., Yao, Z., Yang, J. Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance.	[Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Minist Educ, Key Lab Immune Microenvironm & Dis, Tianjin, Peoples R China; [Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Key Lab Cellular & Mol Immunol, Tianjin, Peoples R China; [Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Wang, Xinting; Xin, Lingbiao; Duan, Zhongchao; Zuo, Zhiyu; Wang, Yuan; Ren, Yuanyuan; Zhang, Wei; Sun, Xiaoming; Liu, Xin; Ge, Lin; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin, Peoples R China; [Yang, Xi] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of Manitoba	Yao, Z; Yang, J (corresponding author), Tianjin Med Univ, 22 Qixiangtailu Rd, Tianjin 300070, Peoples R China.	yaozhi@tmu.edu.cn; yangj@tmu.edu.cn		Ge, Lin/0000-0001-7653-2554; Yang, Xi/0000-0002-8831-7488; Wang, Xinting/0000-0001-9292-3619	National Science Foundation for Distinguished Young Scholars of China [31125012]; Innovation Team Development Plan of the Ministry of Education [IRT13085]; National Natural Science Foundation of China [31300709, 31870747, 31370749]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Innovation Team Development Plan of the Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge histology assistancefrom Hongshuai Li (Tianjin Medical University). This work was supported by Grant 31125012 from the National Science Foundation for Distinguished Young Scholars of China (to J.Y.), Grant IRT13085 from the Innovation Team Development Plan of the Ministry of Education (to J.Y.), Grant 31300709 (to X.W.), and Grants 31870747 and 31370749 (to J.Y.) from National Natural Science Foundation of China. The authors declare no conflicts of interest.	Arretxe E, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv858; Beaven SW, 2013, CELL METAB, V18, P106, DOI 10.1016/j.cmet.2013.04.021; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Broadhurst MK, 2001, J ENDOCRINOL, V171, P329, DOI 10.1677/joe.0.1710329; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Ding YY, 2016, EBIOMEDICINE, V7, P135, DOI 10.1016/j.ebiom.2016.04.002; Duan ZC, 2014, J BIOL CHEM, V289, P8364, DOI 10.1074/jbc.M113.523456; Fashe T, 2013, TISSUE CELL, V45, P21, DOI 10.1016/j.tice.2012.09.001; Fu X, 2018, CELL DEATH DIFFER, V25, P1625, DOI 10.1038/s41418-018-0068-9; Gao XJ, 2015, FEBS J, V282, P874, DOI 10.1111/febs.13186; Garcia-Arcos I, 2010, J PHYSIOL BIOCHEM, V66, P73, DOI 10.1007/s13105-010-0011-0; Gutierrez-Beltran E, 2016, CELL DEATH DIFFER, V23, P1739, DOI 10.1038/cdd.2016.93; Haas ME, 2013, TRENDS ENDOCRIN MET, V24, P391, DOI [10.101, 10.1016/j.tem.2013.04.001]; Han S, 2009, J CLIN INVEST, V119, P1029, DOI 10.1172/JCI36523; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Keenan TW, 2000, BBA-GEN SUBJECTS, V1523, P84, DOI 10.1016/S0304-4165(00)00106-9; Krishan S, 2016, DIABETES METAB SYND, V10, pS77, DOI 10.1016/j.dsx.2016.01.034; Laatsch A, 2009, ATHEROSCLEROSIS, V204, P105, DOI 10.1016/j.atherosclerosis.2008.07.046; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Liu CC, 2015, J NEUROSCI, V35, P5851, DOI 10.1523/JNEUROSCI.5180-14.2015; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Miao J, 2014, J LIPID RES, V55, P659, DOI 10.1194/jlr.M043711; Mobin MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12848; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Navarro-Imaz H, 2016, BBA-MOL CELL BIOL L, V1861, P988, DOI 10.1016/j.bbalip.2016.05.011; Palacios L, 2006, BBA-MOL CELL BIOL L, V1761, P698, DOI 10.1016/j.bbalip.2006.05.005; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Ponziani FR, 2015, EXPERT REV GASTROENT, V9, P1055, DOI 10.1586/17474124.2015.1056156; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Scherer T, 2016, DIABETES, V65, P1511, DOI 10.2337/db15-1552; Su C, 2017, BBA-MOL CELL RES, V1864, P562, DOI 10.1016/j.bbamcr.2016.12.018; Su C, 2015, J BIOL CHEM, V290, P7208, DOI 10.1074/jbc.M114.625046; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Yu L, 2017, ONCOGENE, V36, P3903, DOI 10.1038/onc.2017.30; Yu L, 2015, CANCER RES, V75, P1275, DOI 10.1158/0008-5472.CAN-14-2387	43	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3731	3745		10.1096/fj.201801253RR	http://dx.doi.org/10.1096/fj.201801253RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30521378	Bronze			2022-12-26	WOS:000459794800052
J	Yu, YT; Situ, QJ; Jia, WY; Li, JX; Wu, Q; Lei, JZ				Yu, Yingting; Situ, Qiaojun; Jia, Wangyue; Li, Junxiang; Wu, Qiong; Lei, Jinzhi			Data driven mathematical modeling reveals the dynamic mechanism of MSC-induced neovascularization	FASEB JOURNAL			English	Article						extracellular matrix; COL1A1; endothelial cells	MESENCHYMAL STEM-CELLS; BLOOD-VESSELS; ANGIOGENESIS; MIGRATION; MATRIX; MMP-2	Coculture of mesenchymal stem cells (MSCs) and vascular endothelial cells (ECs) in vitro leads to the formation of a capillary-like reticular structure by ECs, which has great potential as a better substitute for artificial blood vessels in terms of stability and functionality. To investigate the mechanisms of the early neovascularization induced by MSCs, we analyzed the kinematic features of the motion of ECs and concluded that the dynamic interaction between cells and the extracellular matrix would reveal the capillary-like structure formation. Based on this hypothesis, we proposed a mathematical model to simulate the vascular-like migration pattern of ECs in silico, which was confirmed by in vitro studies. These in vitro studies validated that the dynamic secretion and degradation of collagen I is the critical factor for capillary structure formation. The model proposed based on cell tracking, single cell sequencing, and mathematical simulation provides a better understanding of the neovascularization process induced by MSCs and a possible simple explanation guiding this important cellular behavior.Yu, Y., Situ, Q., Jia, W., Li, J., Wu, Q., Lei, J. Data driven mathematical modeling reveals the dynamic mechanism of MSC-induced neovascularization.	[Yu, Yingting; Jia, Wangyue; Li, Junxiang; Wu, Qiong; Lei, Jinzhi] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Yu, Yingting; Jia, Wangyue; Li, Junxiang; Wu, Qiong] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing, Peoples R China; [Yu, Yingting; Jia, Wangyue; Li, Junxiang; Wu, Qiong] Tsinghua Univ, Sch Life Sci, Life Sci New Bldg,Tsinghua Yuan 1, Beijing 100084, Peoples R China; [Situ, Qiaojun; Lei, Jinzhi] Tsinghua Univ, Zhou Pei Yuan Ctr Appl Math, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Wu, Q (corresponding author), Tsinghua Univ, Sch Life Sci, Life Sci New Bldg,Tsinghua Yuan 1, Beijing 100084, Peoples R China.; Lei, JZ (corresponding author), Tsinghua Univ, Zhou Pei Yuan Ctr Appl Math, Beijing 100084, Peoples R China.	wuqiong@mail.tsinghua.edu.cn; jzlei@mail.tsinghua.edu.cn	wu, qiong/GRY-4672-2022; Lei, Jinzhi/M-6311-2018	Lei, Jinzhi/0000-0002-2670-6760	Natural Sciences Foundation of China [31470933, 31170940, 91730301]; Tsinghua University Initiative Scientific Research Program [20131089199]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	This research was supported by the Natural Sciences Foundation of China (grant Nos. 31470933, 31170940, and 91730301), and the Tsinghua University Initiative Scientific Research Program (no. 20131089199). The authors declare no conflicts of interest.	Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Burns JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021888; Czirok A, 2013, WIRES SYST BIOL MED, V5, P587, DOI 10.1002/wsbm.1233; D'Alessio A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/126582; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Freiman A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0251-6; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Holmes D, 2017, NATURE, V548, pS42, DOI 10.1038/548S42a; Hu GW, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt546; Kim SW, 2006, STEM CELLS, V24, P1620, DOI 10.1634/stemcells.2005-0365; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135; Lee H, 2013, BIOCHEM BIOPH RES CO, V437, P232, DOI 10.1016/j.bbrc.2013.06.046; Li HY, 2013, J CELL BIOCHEM, V114, P650, DOI 10.1002/jcb.24407; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016767; Li JX, 2015, STEM CELLS DEV, V24, P610, DOI 10.1089/scd.2014.0330; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Melchiorri AJ, 2014, TISSUE ENG PART B-RE, V20, P218, DOI [10.1089/ten.teb.2013.0541, 10.1089/ten.TEB.2013.0541]; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Merks RMH, 2006, NONLINEARITY, V19, pC1, DOI 10.1088/0951-7715/19/1/000; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; Samuel R, 2013, P NATL ACAD SCI USA, V110, P12774, DOI 10.1073/pnas.1310675110; Scianna M, 2013, J THEOR BIOL, V333, P174, DOI 10.1016/j.jtbi.2013.04.037; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; Sipp D, 2018, NATURE, V561, P455, DOI 10.1038/d41586-018-06756-9; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; van Oers RFM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003774; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287	37	4	4	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3496	3509		10.1096/fj.201801652R	http://dx.doi.org/10.1096/fj.201801652R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30517036	Bronze			2022-12-26	WOS:000459794800033
J	Gustafson, CR; Kent, R; Prate, MR				Gustafson, Christopher R.; Kent, Rachel; Prate, Michael R., Jr.			Retail-based healthy food point-of-decision prompts (PDPs) increase healthy food choices in a rural, low-income, minority community	PLOS ONE			English	Article							COGNITIVE LOAD; OBESITY; PREVALENCE; ATTRIBUTES; CONSUMERS; AWARENESS; TRENDS	This study examines the potential for point-of-decision prompts (PDPs) to promote healthier food choices among shoppers in a rural, low-income, minority community. We hypothesized that a narrowly defined PDP (focused on fresh produce) would be easier for shoppers to remember than a broadly defined PDP (focused on any healthy items), resulting in a higher proportion of healthy items purchased. PDPs were placed at the entrance to a supermarket in Mission, South Dakota, United States of America, on the Rosebud Sioux Reservation for alternating time periods, July 9-10,2017. Sales records from 653 transactions were retrieved from the supermarket, comprising periods in which PDPs were in place and control periods. We examined the proportion of selected items and proportion of total expenditures that were a) any healthy foods and b) fresh fruits and vegetables. Data were analyzed in 2018. The narrowly defined prompt consistently resulted in a higher proportion of items and expenditures on healthy foods than either the broad prompt or the control condition. Shoppers in the narrow prompt condition purchased and spent significantly more on any healthy foods and fresh produce than shoppers in the control condition. While shoppers in the narrow prompt condition purchased more healthy foods and fresh produce than shoppers in the broad prompt condition, the differences were not statistically significant. Shoppers exposed to the narrow PDP consistently purchased more healthy foods than shoppers in a control group, while shoppers in the broad PDP did not, highlighting the importance of considering cognitive processes when designing health promotion messages.	[Gustafson, Christopher R.] Univ Nebraska, Dept Agr Econ, Lincoln, NE 68588 USA; [Kent, Rachel; Prate, Michael R., Jr.] Rosebud Food Sovereignty Initiat, Mission, SD USA	University of Nebraska System; University of Nebraska Lincoln	Gustafson, CR (corresponding author), Univ Nebraska, Dept Agr Econ, Lincoln, NE 68588 USA.	cgustafson6@uni.edu	Gustafson, Christopher/L-4248-2019	Gustafson, Christopher/0000-0001-6894-9456	Duke-UNC USDA BECR Center [343-0641]; University of Nebraska Rural Futures Institute; Nebraska Agricultural Experiment Station; Hatch Act through the USDA National Institute of Food and Agriculture [1011290]	Duke-UNC USDA BECR Center; University of Nebraska Rural Futures Institute; Nebraska Agricultural Experiment Station; Hatch Act through the USDA National Institute of Food and Agriculture	The authors acknowledge support from Duke-UNC USDA BECR Center (Award #343-0641) and the University of Nebraska Rural Futures Institute (Award #N/A). Additionally, this project was partially supported by the Nebraska Agricultural Experiment Station with funding from the Hatch Act (Accession Number 1011290) through the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkovic M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01784; Allais O, 2017, SOC SCI MED, V192, P18, DOI 10.1016/j.socscimed.2017.09.006; Cantor J, 2015, HEALTH AFFAIR, V34, P1893, DOI 10.1377/hlthaff.2015.0623; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Cawley John, 2016, INCENTIVIZING NUTR D; Cobb N, 2014, AM J PUBLIC HEALTH, V104, pS481, DOI 10.2105/AJPH.2014.301879; Crosetto P, 2016, J ECON PSYCHOL, V55, P30, DOI 10.1016/j.joep.2016.03.006; Cummins S, 2014, HEALTH AFFAIR, V33, P283, DOI 10.1377/hlthaff.2013.0512; Deck C, 2015, EUR ECON REV, V78, P97, DOI 10.1016/j.euroecorev.2015.05.004; Downs JS, 2009, AM ECON REV, V99, P159, DOI 10.1257/aer.99.2.159; Enax L, 2016, JUDGM DECIS MAK, V11, P460; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fulton JE, 2017, AM J PUBLIC HEALTH, V107, P1143, DOI 10.2105/AJPH.2017.303766; Gallagher KM, 2012, ANN BEHAV MED, V43, P101, DOI 10.1007/s12160-011-9308-7; Gustafson Christopher R, 2018, Prev Med Rep, V12, P186, DOI 10.1016/j.pmedr.2018.09.013; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Jackson JE, 2005, J RURAL HEALTH, V21, P140, DOI 10.1111/j.1748-0361.2005.tb00074.x; Lim S-L, 2018, PSYCHOL SCI; List J.A., 2015, SSRN ELECT J, DOI [10.2139/ssrn.2664818, DOI 10.2139/SSRN.2664818]; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Nichols AL, 2008, J GEN PSYCHOL, V135, P151, DOI 10.3200/GENP.135.2.151-166; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Preston SH, 2018, P NATL ACAD SCI USA, V115, P957, DOI 10.1073/pnas.1716802115; Rangel A, 2013, NAT NEUROSCI, V16, P1717, DOI 10.1038/nn.3561; Schwartz J, 2012, HEALTH AFFAIR, V31, P399, DOI 10.1377/hlthaff.2011.0224; Sullivan N, 2015, PSYCHOL SCI, V26, P122, DOI 10.1177/0956797614559543; U. S. Census Bureau, 2018, QUICKFACTS TODD COUN; Variyam JN, 2008, HEALTH ECON, V17, P695, DOI 10.1002/hec.1287; Wee CC, 2015, J GEN INTERN MED, V30, P229, DOI 10.1007/s11606-014-3041-4; Zhu C, 2016, AM J AGR ECON, V98, P41, DOI 10.1093/ajae/aav057; Zimmerman FJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-342	32	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207792	10.1371/journal.pone.0207792	http://dx.doi.org/10.1371/journal.pone.0207792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD9QX	30540771	Green Submitted, Green Published, gold			2022-12-26	WOS:000452898600036
J	Wunderlich, M; Chou, FS; Sexton, C; Presicce, P; Chougnet, CA; Aliberti, J; Mulloy, JC				Wunderlich, Mark; Chou, Fu-Sheng; Sexton, Christina; Presicce, Pietro; Chougnet, Claire A.; Aliberti, Julio; Mulloy, James C.			Improved multilineage human hematopoietic reconstitution and function in NSGS mice	PLOS ONE			English	Article							SCID IL2R-GAMMA(NULL) MICE; COLONY-STIMULATING FACTOR; UMBILICAL-CORD BLOOD; HUMAN CD34(+) CELLS; STEM-CELLS; TOXOPLASMA-GONDII; IMMUNE-RESPONSES; NOD/SCID MICE; MOUSE MODEL; HUMAN HSCS	Genetic manipulation of NOD/SCID (NS) mice has yielded numerous sub-strains with specific traits useful for the study of human hematopoietic xenografts, each with unique characteristics. Here, we have compared the engraftment and output of umbilical cord blood (UCB) CD34+ cells in four immune-deficient strains: NS, NS with additional IL2RG knockout (NSG), NS with transgenic expression of human myeloid promoting cytokines SCF, GMCSF, and IL-3 (NSS), and NS with both IL2RG knockout and transgenic cytokine expression (NSGS). Overall engraftment of human hematopoietic cells was highest in the IL2RG knockout strains (NSG and NSGS), while myeloid cell output was notably enhanced in the two strains with transgenic cytokine expression (NSS and NSGS). In further comparisons of NSG and NSGS mice, several additional differences were noted. NSGS mice were found to have a more rapid reconstitution of T cells, improved B cell differentiation, increased levels of NK cells, reduced platelets, and reduced maintenance of primitive CD34+ cells in the bone marrow. NSGS were superior hosts for secondary engraftment and both strains were equally suitable for experiments of graft versus host disease. Increased levels of human cytokines as well as human IgG and IgM were detected in the serum of humanized NSGS mice. Furthermore, immunization of humanized NSGS mice provided evidence of a functional response to repeated antigen exposure, implying a more complete hematopoietic graft was generated in these mice. These results highlight the important role that myeloid cells and myeloid-supportive cytokines play in the formation of a more functional xenograft immune system in humanized mice.	[Wunderlich, Mark; Chou, Fu-Sheng; Sexton, Christina; Mulloy, James C.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Presicce, Pietro; Chougnet, Claire A.; Aliberti, Julio] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Chou, Fu-Sheng] Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64108 USA; [Presicce, Pietro] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90095 USA; [Presicce, Pietro] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Dev Biol, Los Angeles, CA 90095 USA; [Aliberti, Julio] NIAID, Div Extramural Act, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Missouri System; University of Missouri Kansas City; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wunderlich, M; Mulloy, JC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	mark.wunderlich@cchmc.org; James.mulloy@cchmc.org	Presicce, Pietro/AAN-8719-2020	Presicce, Pietro/0000-0002-2690-1814; Chou, Fu-Sheng/0000-0002-5770-0580	NIH/NCI [R50CA211404]; NATIONAL CANCER INSTITUTE [R50CA211404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070549] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by NIH/NCI R50CA211404 (MW). There was no additional external funding received for this study.	Beaman MH, 2000, IMMUNOL CELL BIOL, V78, P608, DOI 10.1046/j.1440-1711.2000.00957.x; Beyer AI, 2017, STEM CELLS DEV, V26, P102, DOI 10.1089/scd.2016.0083; Billerbeck E, 2013, J IMMUNOL, V191, P1753, DOI 10.4049/jimmunol.1201518; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Bueno C, 2010, CYTOTHERAPY, V12, P45, DOI 10.3109/14653240903377052; Cosgun KN, 2014, CELL STEM CELL, V15, P227, DOI 10.1016/j.stem.2014.06.001; Coughlan AM, 2016, STEM CELLS DEV, V25, P530, DOI 10.1089/scd.2015.0289; Gazzinelli RT, 2014, CELL HOST MICROBE, V15, P132, DOI 10.1016/j.chom.2014.01.004; Hiramatsu H, 2003, BLOOD, V102, P873, DOI 10.1182/blood-2002-09-2755; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Huang J, 2015, J IMMUNOL METHODS, V427, P42, DOI 10.1016/j.jim.2015.09.005; Huang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088205; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Jangalwe S, 2016, IMMUN INFLAMM DIS, V4, P427, DOI 10.1002/iid3.124; Kavirayani AM, 2010, VET PATHOL, V47, P482, DOI 10.1177/0300985810363699; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Lee J, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-53; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Meyer DJ, 2000, PARASITE IMMUNOL, V22, P567, DOI 10.1046/j.1365-3024.2000.00338.x; Miller PH, 2013, BLOOD, V121, pE1, DOI 10.1182/blood-2012-09-456566; Najima Y, 2016, BLOOD, V127, P722, DOI 10.1182/blood-2014-10-604777; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Noort WA, 2001, BONE MARROW TRANSPL, V28, P163, DOI 10.1038/sj.bmt.1703120; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Patton J, 2015, J IMMUNOL METHODS, V422, P13, DOI 10.1016/j.jim.2015.02.007; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Sharma A, 2016, J VIROL, V90, P5068, DOI 10.1128/JVI.00259-16; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2003, EXP HEMATOL, V31, P551, DOI 10.1016/S0301-472X(03)00076-6; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Tay S P, 1998, Malays J Pathol, V20, P91; Verstegen MMA, 1998, BLOOD, V91, P1966, DOI 10.1182/blood.V91.6.1966.1966_1966_1976; Vlad G, 2009, HUM IMMUNOL, V70, P663, DOI 10.1016/j.humimm.2009.06.001; Walker JA, 2017, STEM CELLS DEV, V26, P1715, DOI 10.1089/scd.2017.0156; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Wunderlich M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88181; Wunderlich Mark, 2009, V538, P263, DOI 10.1007/978-1-59745-418-6_13; YAN XQ, 1994, BLOOD, V84, P795; Yoshimi A, 2017, BLOOD, V130, P397, DOI 10.1182/blood-2017-01-763219; Zeng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173754; Zhang Y, 2017, BLOOD ADV, V1, P972, DOI 10.1182/bloodadvances.2017004903	49	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0209034	10.1371/journal.pone.0209034	http://dx.doi.org/10.1371/journal.pone.0209034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540841	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600109
J	Kang, SH; Lee, JY; Lee, TH; Park, SY; Kim, CK				Kang, Sang-Ho; Lee, Jong-Yeol; Lee, Tae-Ho; Park, Soo-Yun; Kim, Chang-Kug			De novo transcriptome assembly of the Chinese pearl barley, adlay, by full-length isoform and short-read RNA sequencing	PLOS ONE			English	Article							MA-YUEN STAPF; LACHRYMAJOBI VAR. MAYUEN; COIX-LACRYMA-JOBI; VITAMIN-E; ANTIOXIDANT ACTIVITY; ETHANOLIC EXTRACT; RICH FRACTION; SEED; TOCOTRIENOL; PROTEIN	Adlay (Coix lacryma-jobi) is a tropical grass that has long been used in traditional Chinese medicine and is known for its nutritional benefits. Recent studies have shown that vitamin E compounds in adlay protect against chronic diseases such as cancer and heart disease. However, the molecular basis of adlay's health benefits remains unknown. Here, we generated adlay gene sets by de novo transcriptome assembly using long-read isoform sequencing (Iso-Seq) and short-read RNA-Sequencing (RNA-Seq). The gene sets obtained from Iso-seq and RNA-seq contained 31,177 genes and 57,901 genes, respectively. We confirmed the validity of the assembled gene sets by experimentally analyzing the levels of prolamin and vitamin E biosynthesis-associated proteins in adlay plant tissues and seeds. We compared the screened adlay genes with known gene families from closely related plant species, such as rice, sorghum and maize. We also identified tissue-specific genes from the adlay leaf, root, and young and mature seed, and experimentally validated the differential expression of 12 randomly-selected genes. Our study of the adlay transcriptome will provide a valuable resource for genetic studies that can enhance adlay breeding programs in the future.	[Kang, Sang-Ho] RDA, Int Technol Cooperat Ctr, Jeonju, South Korea; [Lee, Jong-Yeol] RDA, Metab Engn Div, Natl Inst Agr Sci, Jeonju, South Korea; [Lee, Tae-Ho; Kim, Chang-Kug] RDA, Genom Div, Natl Inst Agr Sci, Jeonju, South Korea; [Park, Soo-Yun] RDA, Biosafety Div, Natl Inst Agr Sci, Jeonju, South Korea	Rural Development Administration (RDA); National Institute of Agricultural Sciences; Rural Development Administration (RDA); National Institute of Agricultural Sciences; Rural Development Administration (RDA); National Institute of Agricultural Sciences; Rural Development Administration (RDA)	Kim, CK (corresponding author), RDA, Genom Div, Natl Inst Agr Sci, Jeonju, South Korea.	chang@korea.kr			"Cooperative Research Program for National Agricultural Genome Program" Rural Development Administration, Republic of Korea [PJ013373]	"Cooperative Research Program for National Agricultural Genome Program" Rural Development Administration, Republic of Korea	This work was carried out with the support of "Cooperative Research Program for National Agricultural Genome Program (Project No. PJ013373)" Rural Development Administration, Republic of Korea.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERS S, 2010, GENOME BIOL, V11; Azlina MFN, 2005, ASIA PAC J CLIN NUTR, V14, P358; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1025; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Chang HC, 2003, J AGR FOOD CHEM, V51, P3656, DOI 10.1021/jf021142a; Charng YY, 2006, PLANT PHYSIOL, V140, P1297, DOI 10.1104/pp.105.074898; Chen HJ, 2012, J ETHNOPHARMACOL, V141, P119, DOI 10.1016/j.jep.2012.02.009; Chen HJ, 2011, FOOD CHEM, V126, P1741, DOI 10.1016/j.foodchem.2010.12.074; Chen HJ, 2010, J AGR FOOD CHEM, V58, P2596, DOI 10.1021/jf904356q; Chen HH, 2011, J AGR FOOD CHEM, V59, P6444, DOI 10.1021/jf200539r; Chung CP, 2011, J AGR FOOD CHEM, V59, P1185, DOI 10.1021/jf104088x; Conesa A., 2008, INTERNATIONAL JOURNA, V2008; de Souza RSC, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.06.0027; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; Do TH, 2010, J MED FOOD, V13, P1331, DOI 10.1089/jmf.2010.1155; Fukushima A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hermizi H, 2009, CALCIFIED TISSUE INT, V84, P65, DOI 10.1007/s00223-008-9190-x; Hsu HY, 2003, J AGR FOOD CHEM, V51, P3763, DOI 10.1021/jf021154w; Huang BW, 2005, PHYTOMEDICINE, V12, P433, DOI 10.1016/j.phymed.2004.02.010; Huang DW, 2009, J AGR FOOD CHEM, V57, P10651, DOI 10.1021/jf9028514; Huang DW, 2009, J AGR FOOD CHEM, V57, P2259, DOI 10.1021/jf803255p; Ishiguro Y, 1993, J AGR CHEM SOC JAPAN; Jin J, 2016, NUCLEIC ACIDS RES; Kim JK, 2012, J AGR FOOD CHEM, V60, P2257, DOI 10.1021/jf204977x; Kim SO, 2004, LIFE SCI, V75, P1391, DOI 10.1016/j.lfs.2004.03.006; Kim SO, 2007, AM J CHINESE MED, V35, P297, DOI 10.1142/S0192415X07004825; Kuhad A, 2009, NEUROPHARMACOLOGY, V57, P456, DOI 10.1016/j.neuropharm.2009.06.013; Kuhad A, 2009, PHARMACOL BIOCHEM BE, V92, P251, DOI 10.1016/j.pbb.2008.12.012; Kuo CC, 2001, J AGR FOOD CHEM, V49, P1564, DOI 10.1021/jf001215v; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee MY, 2008, FOOD CHEM TOXICOL, V46, P1933, DOI 10.1016/j.fct.2008.01.033; LEITE A, 1990, PLANT MOL BIOL, V14, P743, DOI 10.1007/BF00016507; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li SC, 2011, J SCI FOOD AGR, V91, P547, DOI 10.1002/jsfa.4219; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nesaretnam K, 2012, GENES NUTR, V7, P3, DOI 10.1007/s12263-011-0224-z; Norazlina M., 2007, SMJ Singapore Medical Journal, V48, P195; NUMATA M, 1994, PLANTA MED, V60, P356, DOI 10.1055/s-2006-959500; OTSUKA H, 1988, J NAT PROD, V51, P74, DOI 10.1021/np50055a009; OTTOBONI LMM, 1990, J AGR FOOD CHEM, V38, P631, DOI 10.1021/jf00093a010; OTTOBONI LMM, 1993, PLANT MOL BIOL, V21, P765, DOI 10.1007/BF00027110; Patel Ravi K., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030619, DOI 10.1371/JOURNAL.PONE.0030619]; Qu D, 2016, INT J PHARMACEUT, V503, P90, DOI 10.1016/j.ijpharm.2016.03.001; Qureshi AA, 2002, ATHEROSCLEROSIS, V161, P199, DOI 10.1016/S0021-9150(01)00619-0; Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669; Shi XP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2357-8; Shih CK, 2004, FOOD CHEM TOXICOL, V42, P1339, DOI 10.1016/j.fct.2004.03.011; Springett GM, 2015, EBIOMEDICINE, V2, P1987, DOI 10.1016/j.ebiom.2015.11.025; Stafford-Banks CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094447; Teerawatananon A, 2011, TELOPEA, V13, P115; Tiwari V, 2009, PAIN, V145, P129, DOI 10.1016/j.pain.2009.05.028; Tiwari V, 2009, PHARMACOL BIOCHEM BE, V93, P183, DOI 10.1016/j.pbb.2009.05.009; Wang LF, 2016, FOOD CHEM, V196, P509, DOI 10.1016/j.foodchem.2015.09.083; Wang LF, 2013, J AGR FOOD CHEM, V61, P5103, DOI 10.1021/jf400556s; Wu TT, 2007, FOOD CHEM, V104, P1509, DOI 10.1016/j.foodchem.2007.02.027; Xu ZC, 2015, PLANT J, V82, P951, DOI 10.1111/tpj.12865; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu F, 2011, J SCI FOOD AGR, V91, P1843, DOI 10.1002/jsfa.4393; Yuen KH, 2011, FUNCT FOODS HEALTH D, V1, P106; Zhou LL, 2010, PLANT MOL BIOL, V74, P631, DOI 10.1007/s11103-010-9705-5	70	8	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208344	10.1371/journal.pone.0208344	http://dx.doi.org/10.1371/journal.pone.0208344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533012	Green Published, gold, Green Submitted			2022-12-26	WOS:000452782500017
J	Hwang, J; Park, HS; Jun, SW; Choi, SW; Lee, CH; Kim, IC; Cho, YK; Yoon, HJ; Kim, H; Nam, CW; Hur, SH; Lee, SH; Han, S				Hwang, Jongmin; Park, Hyoung-Seob; Jun, Seung-Woon; Choi, Sang-Woong; Lee, Cheol Hyun; Kim, In-Cheol; Cho, Yun-Kyeong; Yoon, Hyuck-Jun; Kim, Hyungseop; Nam, Chang-Wook; Hur, Seung-Ho; Lee, Sang Hoon; Han, Seongwook			The incidence of left atrial appendage thrombi on transesophageal echocardiography after pretreatment with apixaban for cardioversion in the real-world practice	PLOS ONE			English	Article							SPONTANEOUS ECHO CONTRAST; MITRAL-VALVE DISEASE; THROMBOEMBOLIC RISK; CATHETER ABLATION; ANTICOAGULANT-THERAPY; ORAL ANTICOAGULANTS; FIBRILLATION; WARFARIN; AMIODARONE; PREVALENCE	The risk of thromboembolisms during the post-cardioversion period is high. For patients with persistent atrial fibrillation (AF), anticoagulation with warfarin (INR 2.0 similar to 3.0) is recommended for at least three weeks prior and four weeks after cardioversion. We aimed to evaluate the efficacy of apixaban in preventing thromboembolic events during post-cardioversion. We enrolled 127 consecutive persistent AF patients (83 persistent, 44 longstanding persistent AF), scheduled to undergo cardioversion and were pretreated with apixaban. All patients underwent transesophageal echocardiography (TEE) to rule out thrombi in the left atrium (LA) or LA appendage (LAA) after anticoagulation with apixaban. The median duration of anticoagulation before the TEE was 37 (interquartile range [IQR] 34, 50) days. There were 7 patients (5.5%) with visible thrombi in the LAA. A spontaneous echo contrast was noted in 24 (18.9%) patients. Cardioversion was attempted in 117 patients, and they were prescribed amiodarone before the elective DC cardioversion. Sinus rhythm was achieved in 37 patients (31.6%) by amiodarone itself. DC cardioversion was attempted in 80 patients and was successful in 73 (91.3%). None of the cardioverted patients had any thromboembolic events within one month. Transient ischemic attacks were observed in one patient during a median follow up period of 202 days (IQR 143, 294). In conclusion, apixaban could be used as an anticoagulant for patients scheduled for cardioversion. However, the incidence of thrombi was not negligible. TEE or other imaging modalities should be considered before cardioversion or other invasive procedures.	[Hwang, Jongmin; Park, Hyoung-Seob; Jun, Seung-Woon; Choi, Sang-Woong; Lee, Cheol Hyun; Kim, In-Cheol; Cho, Yun-Kyeong; Yoon, Hyuck-Jun; Kim, Hyungseop; Nam, Chang-Wook; Hur, Seung-Ho; Han, Seongwook] Keimyung Univ, Sch Med, Dept Internal Med, Div Cardiol,Dongsan Med Ctr, Daegu, South Korea; [Lee, Sang Hoon] SM Christian Hosp, Dept Internal Med, Div Cardiol, Pohang, South Korea	Keimyung University	Han, S (corresponding author), Keimyung Univ, Sch Med, Dept Internal Med, Div Cardiol,Dongsan Med Ctr, Daegu, South Korea.	swhan@dsmc.or.kr		Hwang, Jongmin/0000-0001-9710-0945	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C2594]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C2594).	Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; BEPPU S, 1985, J AM COLL CARDIOL, V6, P744, DOI 10.1016/S0735-1097(85)80476-9; BJERKELUND CJ, 1969, AM J CARDIOL, V23, P208, DOI 10.1016/0002-9149(69)90068-X; Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Da Costa A, 2017, AM HEART J, V193, P8, DOI 10.1016/j.ahj.2017.07.016; DANIEL WG, 1988, J AM COLL CARDIOL, V11, P1204, DOI 10.1016/0735-1097(88)90283-5; Di Biase L, 2016, HEART RHYTHM, V13, P1197, DOI 10.1016/j.hrthm.2016.03.024; Ezekowitz MD, 2018, EUR HEART J, V39, P2959, DOI 10.1093/eurheartj/ehy148; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961, DOI 10.1016/0735-1097(94)90644-0; Frenkel Daniel, 2016, JACC Clin Electrophysiol, V2, P295, DOI 10.1016/j.jacep.2016.01.004; Goette A, 2016, LANCET, V388, P1995, DOI 10.1016/S0140-6736(16)31474-X; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Greene HL, 2003, J AM COLL CARDIOL, V42, P20, DOI 10.1016/S0735-1097(03)00559-X; Hansen ML, 2015, EUROPACE, V17, P18, DOI 10.1093/europace/euu189; Irani WN, 1997, CIRCULATION, V95, P962; Joseph AP, 2000, ANN EMERG MED, V36, P1, DOI 10.1067/mem.2000.107655; Kanoupakis EM, 2004, AM J CARDIOL, V94, P659, DOI 10.1016/j.amjcard.2004.05.037; Kirchhof P, 2016, EUR J CARDIO-THORAC, V50, pE1, DOI 10.1093/ejcts/ezw313; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Puwanant S, 2009, J AM COLL CARDIOL, V54, P2032, DOI 10.1016/j.jacc.2009.07.037; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Scherr D, 2009, J CARDIOVASC ELECTR, V20, P379, DOI 10.1111/j.1540-8167.2008.01336.x; Wu M, 2018, HEART RHYTHM, V15, P496, DOI 10.1016/j.hrthm.2017.12.005; Wyrembak J, 2017, AM J CARDIOL, V119, P1017, DOI 10.1016/j.amjcard.2016.12.008	25	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208734	10.1371/journal.pone.0208734	http://dx.doi.org/10.1371/journal.pone.0208734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532128	Green Published, gold, Green Submitted			2022-12-26	WOS:000452640900038
J	Ma, YJ; Duan, HR; Zhang, F; Li, Y; Yang, HS; Tian, FP; Zhou, XH; Wang, CM; Ma, R				Ma, Yan-Jun; Duan, Hui-Rong; Zhang, Feng; Li, Yi; Yang, Hong-Shan; Tian, Fu-Ping; Zhou, Xue-Hui; Wang, Chun-Mei; Ma, Rui			Transcriptomic analysis of Lycium ruthenicum Murr. during fruit ripening provides insight into structural and regulatory genes in the anthocyanin biosynthetic pathway	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; FLAVONOID BIOSYNTHESIS; FACTOR FAMILY; MYB; ACCUMULATION; PROTEIN; EVOLUTION; RED; PIGMENTATION; ACTIVATION	Fruit development in Lycium ruthenicum Murr. involves a succession of physiological and biochemical changes reflecting the transcriptional modulation of thousands of genes. Although recent studies have investigated the dynamic transcriptomic responses during fruit ripening in L. ruthenicum, most have been limited in scope, and thus systematic data representing the structural genes and transcription factors involved in anthocyanin biosynthesis are lacking. In this study, the transcriptomes of three ripening stages associated with anthocyanin accumulation, including S1 (green ripeness stage), S2 (skin color change) and S3 (complete ripeness stage) in L. ruthenicum were investigated using Illumina sequencing. Of a total of 43,573 assembled unigenes, 12,734 were differentially expressed during fruit ripening in L. ruthenicum. Twenty-five significantly differentially expressed structural genes (including PAL, C4H, 4CL, CHS, CHI, F3H, F3'H, F3'5'H, DFR, ANS and UFGT) were identified that might be associated with anthocyanin biosynthesis. Additionally, several transcription factors, including MYB, bHLH, WD40, NAC, WRKY, bZIP and MADS, were correlated with the structural genes, implying their important interaction with anthocyanin biosynthesis-related genes. Our findings provide insight into anthocyanin biosynthesis and regulation patterns in L. ruthenicum and offer a systematic basis for elucidating the molecular mechanisms governing anthocyanin biosynthesis in L. ruthenicum.	[Ma, Yan-Jun; Li, Yi; Ma, Rui] Gansu Agr Univ, Coll Forestry, Lanzhou, Gansu, Peoples R China; [Ma, Yan-Jun; Zhang, Feng] Gansu Agr Univ, Coll Agron, Lanzhou, Gansu, Peoples R China; [Duan, Hui-Rong; Yang, Hong-Shan; Tian, Fu-Ping; Zhou, Xue-Hui; Wang, Chun-Mei] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University; Gansu Agricultural University; Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Ma, R (corresponding author), Gansu Agr Univ, Coll Forestry, Lanzhou, Gansu, Peoples R China.	mr031103@126.com		Duan, Hui-rong/0000-0002-3446-2559	National Natural Science Foundation of China [31560215, 31760244, 31700338]; Key Science and Technology Foundation of Gansu Province [GS-GEF/OP12-02]; Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2014-LIHPS-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Foundation of Gansu Province; Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	This work was supported by the National Natural Science Foundation of China (grant No. 31560215, 31760244 and 31700338) (http://www.nsfc.gov.cn/), the Key Science and Technology Foundation of Gansu Province (GS-GEF/OP12-02) (http://www.gsly.gov.cn/) and the Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences(CAAS-ASTIP-2014-LIHPS-08) (http://www.caas.net.cn/). YM had roles in the study conceptualization and design, also the plant material preparation. HD had roles in the RNA-seq data analysis and the manuscript writing. RM had a role in the manuscript revision.	Albert NW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01165; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Bailey PC, 2003, PLANT CELL, V15, P2497, DOI 10.1105/tpc.151140; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Cao X, 2017, J EXP BOT, V68, P5745, DOI 10.1093/jxb/erx382; Chen C., 2013, J PHARM TECHNOL DRUG, V2, P1, DOI [10.7243/2050-120X-2-1, DOI 10.7243/2050-120X-2-1]; Chen CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187738; Chen F, 2017, CRIT REV PLANT SCI, V36, P311, DOI 10.1080/07352689.2018.1441103; Chen HK, 2015, MOL BIOL REP, V42, P639, DOI 10.1007/s11033-014-3809-y; Cui Y J, 2017, Zhonghua Xue Ye Xue Za Zhi, V38, P28, DOI 10.3760/cma.j.issn.0253-2727.2017.01.006; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Dhar P, 2011, INDIA PLANT ARCH, V11, P583; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Fang ZZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01338; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Heppel SC, 2013, PLANT MOL BIOL, V82, P457, DOI 10.1007/s11103-013-0074-8; Hu B, 2016, PLANT CELL REP, V35, P831, DOI 10.1007/s00299-015-1924-4; Hu DG, 2016, PLANT PHYSIOL, V170, P1315, DOI 10.1104/pp.15.01333; Iaria DL, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01246; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jiang MM, 2016, PLANT SCI, V249, P46, DOI 10.1016/j.plantsci.2016.04.001; Jin WM, 2016, PLANT BIOTECHNOL J, V14, P2120, DOI 10.1111/pbi.12568; Jin XH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01307; Li CY, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006340; Li J, 2017, PLANT CELL ENVIRON, V40, P3069, DOI 10.1111/pce.13074; Li PH, 2016, NEW PHYTOL, V210, P905, DOI 10.1111/nph.13816; Li Q, 2014, MOL GENET GENOMICS, V289, P103, DOI 10.1007/s00438-013-0789-x; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Li YH, 2017, FOOD ANAL METHOD, V10, P1034, DOI 10.1007/s12161-016-0666-4; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massonnet M, 2017, PLANT PHYSIOL, V174, P2376, DOI 10.1104/pp.17.00311; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Miller JC, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01108; Ozga JA, 2002, PLANT PHYSIOL, V128, P1379, DOI 10.1104/pp.010800; Pantelidis GE, 2007, FOOD CHEM, V102, P777, DOI 10.1016/j.foodchem.2006.06.021; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Peng Q, 2014, INT J BIOL MACROMOL, V64, P69, DOI 10.1016/j.ijbiomac.2013.11.030; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Sakuta M, 2014, PLANT BIOTECHNOL REP, V8, P37, DOI 10.1007/s11816-013-0294-z; Salvatierra A, 2013, PHYTOCHEMISTRY, V90, P25, DOI 10.1016/j.phytochem.2013.02.016; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Shen XiaoFei, 2014, Journal of Chinese Pharmaceutical Sciences, V23, P369; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Matus JT, 2017, PLANT J, V91, P220, DOI 10.1111/tpj.13558; [汪洋 Wang Yang], 2016, [食品工业科技, Science & Technology of Food Industry], V37, P122; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xu WJ, 2014, NEW PHYTOL, V202, P132, DOI 10.1111/nph.12620; Yan Li, 2017, Scientia Agricultura Sinica, V50, P3991; [闫亚美 Yan Yamei], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P4540; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002; Zeng SH, 2014, PHYSIOL PLANTARUM, V150, P505, DOI 10.1111/ppl.12131; Zhang HN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00963; Zhang L, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3677-7; Zhang YW, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017507; Zheng J, 2011, FOOD CHEM, V126, P859, DOI 10.1016/j.foodchem.2010.11.052; Zhou H, 2015, PLANT J, V82, P105, DOI 10.1111/tpj.12792	64	14	15	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208627	10.1371/journal.pone.0208627	http://dx.doi.org/10.1371/journal.pone.0208627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532153	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900028
J	Driemeier, CE; Ling, LY; Yancy-Caballero, D; Mantelatto, PE; Dias, CSB; Archilha, NL				Driemeier, Carlos E.; Ling, Liu Y.; Yancy-Caballero, Daison; Mantelatto, Paulo E.; Dias, Carlos S. B.; Archilha, Nathaly L.			Location of water in fresh sugarcane bagasse observed by synchrotron X-ray microtomography	PLOS ONE			English	Article								Sugarcane bagasse is a vast lignocellulosic byproduct generated in the industry with similar to 50% humidity (1 kg dry matter associated with 1 kg water). Although the presence of water brings deleterious consequences for combustion, storage and sugar extraction, the location of water in fresh bagasse remains unknown. In this work, we use synchrotron X-ray microto-mography for non-invasive 3D imaging of fresh bagasse particles, which allows the visualization of intraparticle water. The sclerified fiber cells in the sheaths surrounding xylem vessels are often found full of water. We suggest this can be juice preserved from the native stalks as many sclerified fibers seem to keep their structural integrity despite the mechanical action during sugarcane crushing. The microtomograms of fresh bagasse also shows mineral particles adhered to biomass surfaces, with adhesion presumably favored by the presence of water. In summary, this work unveils the location of water in fresh bagasse, solving an old mystery of sugarcane technology.	[Driemeier, Carlos E.; Ling, Liu Y.; Yancy-Caballero, Daison; Mantelatto, Paulo E.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Bioethanol Sci & Technol Lab CTBE, Campinas, SP, Brazil; [Yancy-Caballero, Daison] Univ Sao Paulo, Inst Math & Stat IME, Sao Paulo, SP, Brazil; [Dias, Carlos S. B.; Archilha, Nathaly L.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Synchrotron Light Lab LNLS, Campinas, SP, Brazil	Universidade de Sao Paulo; Laboratorio Nacional de Luz Sincrotron (LNLS)	Driemeier, CE (corresponding author), Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Bioethanol Sci & Technol Lab CTBE, Campinas, SP, Brazil.	carlos.driemeier@ctbe.cnpem.br	Driemeier, Carlos/C-9209-2012; Driemeier, Carlos/R-2399-2019; Dias, Carlos/ABF-3515-2020; Archilha, Nathaly Lopes/X-4492-2019	Driemeier, Carlos/0000-0002-4794-3714; Driemeier, Carlos/0000-0002-4794-3714; Dias, Carlos/0000-0001-7433-4685; MANTELATTO, PAULO EDUARDO/0000-0002-7753-3185; Yancy, Daison/0000-0001-6415-244X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through the National Institute of Science and Technology of Bioethanol (INCT Bioetanol) [14/50884-5]; FAPESP [2015/01587-0, 17/01330-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through the National Institute of Science and Technology of Bioethanol (INCT Bioetanol)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CED acknowledges financial supports from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant 14/50884-5) through the National Institute of Science and Technology of Bioethanol (INCT Bioetanol). CED and DYC acknowledge financial support from FAPESP grants 2015/01587-0 and 17/01330-5 and high-performance computing resources from the Information Technology Superintendence of the University of Sao Paulo. CED acknowledges Laboratorio Nacional de Luz Sincrotron (LNLS) for the microtomography beamtime (proposal IMX20160526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Carlos Roberto Trez for the kind support in the collection of fresh sugarcane bagasse. CED acknowledges financial supports from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant 14/50884-5) through the National Institute of Science and Technology of Bioethanol (INCT Bioetanol). CED and DYC acknowledge financial support from FAPESP grants 2015/01587-0 and 17/01330-5 and high-performance computing resources from the Information Technology Superintendence of the University of Sao Paulo. CED acknowledges Laboratorio Nacional de Luz Sincrotron (LNLS) for the microtomography beamtime (proposal IMX20160526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; [Anonymous], 2017, DATABASE; Cortez LAB, SUGARCANE BIOETHANOL; Driemeier C, 2011, POWDER TECHNOL, V214, P111, DOI 10.1016/j.powtec.2011.07.043; Hugot E., 1986, HDB CANE SUGAR ENG; IEA, 2017, ENERGY TECHNOLOGY PE, DOI DOI 10.1787/ENERGY_TECH-2017-EN; Isaac A, 2013, IND CROP PROD, V49, P790, DOI 10.1016/j.indcrop.2013.07.005; Legland D, 2016, BIOINFORMATICS, V32, P3532, DOI 10.1093/bioinformatics/btw413; Maziero P, 2013, J AGR FOOD CHEM, V61, P5841, DOI 10.1021/jf401243c; Miqueles E, 2018, IEEE T IMAGE PROCESS, V27, P894, DOI 10.1109/TIP.2017.2766785; Rasul MG, 1999, FUEL, V78, P905, DOI 10.1016/S0016-2361(99)00011-3; Rein P, 2013, CANE SUGAR ENG; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Skaar C., 1988, WOOD WATER RELATIONS, P1, DOI [10.1007/978-3-642-73683-4_1, DOI 10.1007/978-3-642-73683-4, 10.1007/978-3-642-73683-4, DOI 10.1007/978-3-642-73683-4_1]; Wright M, 2016, INT SUGAR J, V118, P424; Yancy-Caballero D, 2017, ENERG FUEL, V31, P12288, DOI 10.1021/acs.energyfuels.7b02247	16	4	4	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208219	10.1371/journal.pone.0208219	http://dx.doi.org/10.1371/journal.pone.0208219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521559	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600034
J	Miller, BR; Kung, Y				Miller, Bradley R.; Kung, Yan			Structural insight into substrate and product binding in an archaeal mevalonate kinase	PLOS ONE			English	Article							PATHWAY; IDENTIFICATION; PURIFICATION; MECHANISM; COMPLEX	Mevalonate kinase (MK) is a key enzyme of the mevalonate pathway, which produces the biosynthetic precursors for steroids, including cholesterol, and isoprenoids, the largest class of natural products. Currently available crystal structures of MK from different organisms depict the enzyme in its unbound, substrate-bound, and inhibitor-bound forms; however, until now no structure has yet been determined of MK bound to its product, 5-phosphomevalonate. Here, we present crystal structures of mevalonate-bound and 5-phosphomevalonate-bound MK from Methanosarcina mazei (MmMK), a methanogenic archaeon. In contrast to the prior structure of a eukaryotic MK bound with mevalonate, we find a striking lack of direct interactions between this archaeal MK and its substrate. Further, these two MmMK structures join the prior structure of the apoenzyme to complete the first suite of structural snapshots that depict unbound, substrate-bound, and product-bound forms of the same MK. With this collection of structures, we now provide additional insight into the catalytic mechanism of this biologically essential enzyme.	[Miller, Bradley R.; Kung, Yan] Bryn Mawr Coll, Dept Chem, Bryn Mawr, PA 19010 USA; [Miller, Bradley R.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Bryn Mawr College; The Wistar Institute	Kung, Y (corresponding author), Bryn Mawr Coll, Dept Chem, Bryn Mawr, PA 19010 USA.	ykung@brybmawr.edu		Kung, Yan/0000-0002-6132-7969	National Institutes of Health [GM116029]; Bryn Mawr College; K/G Fund for Faculty Research; Howard Hughes Medical Institute; National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI [S100D021527]; DOE Office of Science, Argonne National Laboratory [DE-AC0206CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bryn Mawr College; K/G Fund for Faculty Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI; DOE Office of Science, Argonne National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds to YK from the National Institutes of Health (GM116029), Bryn Mawr College, the K/G Fund for Faculty Research, and the Howard Hughes Medical Institute. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Eiger 16M detector on 24-ID-E beam line is funded by a NIH-ORIP HEI grant (S100D021527). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC0206CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andreassi JL, 2007, PROTEIN SCI, V16, P983, DOI 10.1110/ps.072755707; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BEYTIA E, 1970, J BIOL CHEM, V245, P5450; BORK P, 1993, PROTEIN SCI, V2, P31; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Chang MCY, 2006, NAT CHEM BIOL, V2, P674, DOI 10.1038/nchembio836; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu Z, 2008, BIOCHEMISTRY-US, V47, P3715, DOI 10.1021/bi7024386; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; George KW, 2015, ADV BIOCHEM ENG BIOT, V148, P355, DOI 10.1007/10_2014_288; Huang M, 2016, BIOCHEMISTRY-US, V52, P4858; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kung Y, 2012, ACS SYNTH BIOL, V1, P498, DOI 10.1021/sb300074k; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Moutinho M, 2017, EXP CELL RES, V360, P55, DOI 10.1016/j.yexcr.2017.02.034; Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Potter D, 1997, J BIOL CHEM, V272, P5741, DOI 10.1074/jbc.272.9.5741; Potter D, 1997, J BIOL CHEM, V272, P25449, DOI 10.1074/jbc.272.41.25449; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schulte AE, 2000, ARCH BIOCHEM BIOPHYS, V378, P287, DOI 10.1006/abbi.2000.1779; Sgraja T, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-20; Yang D, 2002, J BIOL CHEM, V277, P9462, DOI 10.1074/jbc.M110787200; Zhuang N, 2012, ACTA CRYSTALLOGR F, V68, P1560, DOI 10.1107/S1744309112047070	34	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208419	10.1371/journal.pone.0208419	http://dx.doi.org/10.1371/journal.pone.0208419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521590	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600061
J	Sporri, D; Ditroilo, M; Rodriguez, ECP; Johnston, RJ; Sheehan, WB; Watsford, ML				Sporri, Daniel; Ditroilo, Massimiliano; Rodriguez, Elizabeth C. Pickering; Johnston, Richard J.; Sheehan, William B.; Watsford, Mark L.			The effect of water-based plyometric training on vertical stiffness and athletic performance	PLOS ONE			English	Article							GROUND REACTION FORCE; SPRINT PERFORMANCE; STRETCH PROTOCOLS; ELASTIC ENERGY; LEG STIFFNESS; RUGBY UNION; JUMP; STRENGTH; POWER; RELIABILITY	Since higher vertical stiffness is related to superior athletic performance, training has traditionally been aimed at augmenting this variable to enhance neuromuscular output. However, research has linked elevated stiffness with increased injury risk, therefore, this study examined the effect of a novel training intervention on vertical stiffness and athletic performance. Vertical stiffness, jump performance and athletic performance were assessed in two randomly allocated groups, prior to, and following, an eight-week period. One group was exposed to a training intervention involving aqua-based plyometrics (n = 11) over the 8 weeks while the other acted as a control group (n = 9). The training intervention involved hopping, jumping and bounding in water at a depth of 1.2m whilst control participants performed their normal training. There were no significant changes in vertical stiffness in either group. Countermovement jump height and peak power significantly increased within the aqua plyometric group (p < 0.05). Athletic performance markers improved in the aqua plyometric group as measured using an agility and a 5-bound test exhibiting superior values at the post-test (p < 0.05). The results suggest that an aqua plyometric training program can enhance athletic performance without elevating stiffness. The increase in athletic performance is likely due to a reduction in ground reaction forces created by the buoyancy of the water, causing a shorter amortization phase and a more rapid application of concentric force. The findings from this study can inform exercise professionals and medical staff regarding the ability to enhance neuromuscular performance without elevating vertical stiffness. This has implications for improving athletic performance while concurrently minimising injury risk.	[Sporri, Daniel; Rodriguez, Elizabeth C. Pickering; Johnston, Richard J.; Sheehan, William B.; Watsford, Mark L.] Univ Technol Sydney, Fac Hlth, Human Performance Res Ctr, Sydney, NSW, Australia; [Ditroilo, Massimiliano] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland	University of Technology Sydney; University College Dublin	Sheehan, WB (corresponding author), Univ Technol Sydney, Fac Hlth, Human Performance Res Ctr, Sydney, NSW, Australia.	william.b.sheehan@student.uts.edu.au	Ditroilo, Massimiliano/X-5394-2019	Ditroilo, Massimiliano/0000-0003-1021-0362; Sheehan, William/0000-0001-6976-367X				Alberton CL, 2013, INT J SPORTS MED, V34, P881, DOI 10.1055/s-0032-1331757; Alberton CL, 2015, J SPORT SCI, V33, P795, DOI 10.1080/02640414.2014.964748; Arampatzis A, 1999, J BIOMECH, V32, P1349, DOI 10.1016/S0021-9290(99)00133-5; Baker D, 2001, STRENGTH COND J, V23, P47, DOI 10.1519/00126548-200102000-00011; BOSCO C, 1982, ACTA PHYSIOL SCAND, V114, P557, DOI 10.1111/j.1748-1716.1982.tb07024.x; Bret C, 2002, J SPORT MED PHYS FIT, V42, P274; Burgess KE, 2007, J STRENGTH COND RES, V21, P986, DOI 10.1519/00124278-200708000-00055; Butler RJ, 2003, CLIN BIOMECH, V18, P511, DOI 10.1016/S0268-0033(03)00071-8; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Donoghue OA, 2011, SPORTS HEALTH, V3, P303, DOI 10.1177/1941738111403872; FARLEY CT, 1991, J APPL PHYSIOL, V71, P2127, DOI 10.1152/jappl.1991.71.6.2127; Fernandez-Pena E, 2009, J STRENGTH COND RES, V23, P1764, DOI 10.1519/JSC.0b013e3181b3e094; Flanagan EP, 2008, J STRENGTH COND RES, V22, P1677, DOI 10.1519/JSC.0b013e318182034b; Fletcher IM, 2007, J STRENGTH COND RES, V21, P784; Fletcher IM, 2004, J STRENGTH COND RES, V18, P885; Horita T, 1999, EUR J APPL PHYSIOL O, V79, P160, DOI 10.1007/s004210050490; KOMI PV, 1978, MED SCI SPORT EXER, V10, P261; Kubo K, 2006, EUR J APPL PHYSIOL, V96, P305, DOI 10.1007/s00421-005-0087-3; Kubo K, 2002, J PHYSIOL-LONDON, V538, P219, DOI 10.1113/jphysiol.2001.012703; Lockie RG, 2012, J STRENGTH COND RES, V26, P1539, DOI 10.1519/JSC.0b013e318234e8a0; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; Martel GF, 2005, MED SCI SPORT EXER, V37, P1814, DOI 10.1249/01.mss.0000184289.87574.60; Miller MG, 2002, J SPORT REHABIL, V11, P268, DOI 10.1123/jsr.11.4.268; Nelson AG, 2005, J SPORT SCI, V23, P449, DOI 10.1080/02640410410001730205; POUSSON M, 1990, J BIOMECH, V23, P343, DOI 10.1016/0021-9290(90)90062-8; Pruyn EC, 2012, J SPORT SCI, V30, P71, DOI 10.1080/02640414.2011.624540; Robinson LE, 2004, J STRENGTH COND RES, V18, P84; Ryan ED, 2009, J SPORT SCI, V27, P957, DOI 10.1080/02640410902998254; Spinks CD, 2007, J STRENGTH COND RES, V21, P77, DOI 10.1519/00124278-200702000-00015; Spurrs RW, 2003, EUR J APPL PHYSIOL, V89, P1, DOI 10.1007/s00421-002-0741-y; Turner AN, 2010, STRENGTH COND J, V32, P87, DOI 10.1519/SSC.0b013e3181e928f9; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; WILSON GJ, 1994, J APPL PHYSIOL, V76, P2714, DOI 10.1152/jappl.1994.76.6.2714; WILSON GJ, 1992, MED SCI SPORT EXER, V24, P116	34	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208439	10.1371/journal.pone.0208439	http://dx.doi.org/10.1371/journal.pone.0208439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521576	gold, Green Published, Green Submitted			2022-12-26	WOS:000452307600069
J	Pare, S; Gilmour, SJ; Grumet, R; Thomashow, MF				Pare, Sunchung; Gilmour, Sarah J.; Grumet, Rebecca; Thomashow, Michael F.			CBF-dependent and CBF-independent regulatory pathways contribute to the differences in freezing tolerance and cold-regulated gene expression of two Arabidopsis ecotypes locally adapted to sites in Sweden and Italy	PLOS ONE			English	Article							LOW-TEMPERATURE TRANSCRIPTOME; NATURAL VARIATION; THALIANA; ACCLIMATION; ROLES; PROTEINS; FAMILY; OVEREXPRESSION; ACTIVATORS; ACID	Arabidopsis thaliana (Arabidopsis) increases in freezing tolerance in response to low non-freezing temperatures, a phenomenon known as cold acclimation. The CBF regulatory pathway, which contributes to cold acclimation, includes three genes-CBF1, CBF2 and CBF3-encoding closely-related transcription factors that regulate the expression of more than 100 genes-the CBF regulon-that impart freezing tolerance. Here we compare the CBF pathways of two Arabidopsis ecotypes collected from sites in Sweden (SW) and Italy (IT). Previous studies showed that the SW ecotype was more freezing tolerant than the IT ecotype and that the IT ecotype had a nonfunctional CBF2 gene. Here we present results establishing that the difference in CBF2 alleles contributes to the difference in freezing tolerance between the two ecotypes. However, other differences in the CBF pathway as well as CBF-independent pathways contribute the large majority of the difference in freezing tolerance between the two ecotypes. The results also provided evidence that most cold-induced CBF regulon genes in both the SW and IT ecotypes are coregulated by CBF-independent pathways. Additional analysis comparing our results with those published by others examining the Col-0 accession resulted in the identification of 44 CBF regulon genes that were conserved among the three accessions suggesting that they likely have important functions in life at low temperature. The comparison further supported the conclusion that the CBF pathway can account for a large portion of the increase in freezing tolerance that occurs with cold acclimation in a given accession, but that CBF-independent pathways can also make a major contribution.	[Pare, Sunchung; Gilmour, Sarah J.; Thomashow, Michael F.] Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA; [Grumet, Rebecca] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Thomashow, Michael F.] Michigan State Univ, MSU Plant Resilience Inst, E Lansing, MI 48824 USA; [Thomashow, Michael F.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Pare, Sunchung] ARS, USDA, Salinas, CA USA	Michigan State University; United States Department of Energy (DOE); Michigan State University; Michigan State University; Michigan State University; United States Department of Agriculture (USDA)	Thomashow, MF (corresponding author), Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA.; Thomashow, MF (corresponding author), Michigan State Univ, MSU Plant Resilience Inst, E Lansing, MI 48824 USA.; Thomashow, MF (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	thomash6@msu.edu		Park, Sunchung/0000-0002-7398-9476; Thomashow, Michael/0000-0002-7832-6989	National Science Foundation [DEB 1022202]; Department of Energy [DE-FG02-91ER20021]; Michigan State University AgBioResearch	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Michigan State University AgBioResearch	Funded by National Science Foundation (www.nsf.gov) (DEB 1022202) to MFT. Department of Energy (www.energy.gov) (DE-FG02-91ER20021) to MFT. Michigan State University AgBioResearch (www.canr.msu.edu/research/) to MFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Adams WW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01026; Agren J, 2012, NEW PHYTOL, V194, P1112, DOI 10.1111/j.1469-8137.2012.04112.x; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Banerjee A, 2016, PLANT GROWTH REGUL, V79, P1, DOI 10.1007/s10725-015-0113-3; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gehan MA, 2015, PLANT J, V84, P682, DOI 10.1111/tpj.13027; Gery C, 2011, PLANT SCI, V180, P12, DOI 10.1016/j.plantsci.2010.07.010; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Hincha DK, 2003, BBA-BIOMEMBRANES, V1612, P172, DOI 10.1016/S0005-2736(03)00116-0; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jia YX, 2016, NEW PHYTOL, V212, P345, DOI 10.1111/nph.14088; Kim Y, 2013, PLANT J, V75, P364, DOI 10.1111/tpj.12205; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Oakley CG, 2014, MOL ECOL, V23, P4304, DOI 10.1111/mec.12862; Park S, 2015, PLANT J, V82, P193, DOI 10.1111/tpj.12796; Pennycooke JC, 2003, PLANT PHYSIOL, V133, P901, DOI 10.1104/pp.103.024554; Redei G. P., 1992, Methods in Arabidopsis research., P1; Shi YT, 2018, TRENDS PLANT SCI, V23, P623, DOI 10.1016/j.tplants.2018.04.002; Steponkus PL, 1993, CUR TOP PL, V10, P37; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Sun XL, 2013, PLANT CELL, V25, P38, DOI 10.1105/tpc.112.106062; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zapata L, 2016, P NATL ACAD SCI USA, V113, pE4052, DOI 10.1073/pnas.1607532113; Zhao CZ, 2016, PLANT PHYSIOL, V171, P2744, DOI 10.1104/pp.16.00533; Zhen Y, 2008, NEW PHYTOL, V177, P419, DOI 10.1111/j.1469-8137.2007.02262.x	44	27	27	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0207723	10.1371/journal.pone.0207723	http://dx.doi.org/10.1371/journal.pone.0207723			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517145	Green Submitted, gold, Green Published			2022-12-26	WOS:000452212400064
J	Schoen, ME; Nieselt, K; Garnica, S				Schoen, Max E.; Nieselt, Kay; Garnica, Sigisfredo			Belowground fungal community diversity and composition associated with Norway spruce along an altitudinal gradient	PLOS ONE			English	Article							ROOT-ASSOCIATED FUNGI; ARBUSCULAR MYCORRHIZAL FUNGI; SPECIES RICHNESS; ECTOMYCORRHIZAL FUNGI; ELEVATION GRADIENT; SPECIFICITY; FORESTS; SCALE; SENSITIVITY; GENERATION	Altitudinal gradients provide valuable information about the effects of environmental variables on changes in species richness and composition as well as the distribution of below ground fungal communities. Since most knowledge in this respect has been gathered on aboveground communities, we focused our study towards the characterization of belowground fungal communities associated with two different ages of Norway spruce (Picea abies) trees along an altitudinal gradient. By sequencing the internal transcribed spacer (ITS) region on the Illumina platform, we investigated the fungal communities in a floristically and geologically relatively well explored forest on the slope of Mt. Iseler of the Bavarian Alps. From fine roots and rhizosphere of a total of 90 of Norway spruce trees from 18 plots we detected 1285 taxa, with a range of 167 to 506 (average 377) taxa per plot. Fungal taxa are distributed over 96 different orders belonging to the phyla Ascomycota, Basidiomycota, Chrytridiomycota, Glomeromycota, and Mucoromycota. Overall the Agaricales (438 taxa) and Tremellales (81 taxa) belonging to the Basidiomycota and the Hypocreales (65 spp.) and Helotiales (61 taxa) belonging to the Ascomycota represented the taxon richest orders. The evaluation of our multivariate generalized mixed models indicate that the altitude has a significant influence on the composition of the fungal communities (p < 0.003) and that tree age determines community diversity (p < 0.05). A total of 47 ecological guilds were detected, of which the ectomycorrhizal and saprophytic guilds were the most taxon-rich. Our ITS amplicon Illumina sequencing approach allowed us to characterize a high fungal community diversity that would not be possible to capture with fruiting body surveys alone. We conclude that it is an invaluable tool for diverse monitoring tasks and inventorying biodiversity, especially in the detection of microorganisms developing very ephemeral and/or inconspicuous fruiting bodies or lacking them all together. Results suggest that the altitude mainly influences the community composition, whereas fungal diversity becomes higher in mature/older trees. Finally, we demonstrate that novel techniques from bacterial microbiome analyses are also useful for studying fungal diversity and community structure in a DNA metabarcoding approach, but that incomplete reference sequence databases so far limit effective identification.	[Schoen, Max E.; Garnica, Sigisfredo] Univ Tubingen, Inst Evolut & Ecol Plant Evolutionary Ecol, Tubingen, Germany; [Schoen, Max E.; Nieselt, Kay] Univ Tubingen, Ctr Bioinformat ZBIT, Integrat Transcript, Tubingen, Germany; [Garnica, Sigisfredo] Univ Austral Chile, Inst Bioquim & Microbiol, Valdivia, Chile; [Schoen, Max E.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Universidad Austral de Chile; Uppsala University	Schoen, ME; Garnica, S (corresponding author), Univ Tubingen, Inst Evolut & Ecol Plant Evolutionary Ecol, Tubingen, Germany.; Schoen, ME (corresponding author), Univ Tubingen, Ctr Bioinformat ZBIT, Integrat Transcript, Tubingen, Germany.; Garnica, S (corresponding author), Univ Austral Chile, Inst Bioquim & Microbiol, Valdivia, Chile.; Schoen, ME (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden.	max-emil.schon@icm.uu.se; sigisfredo.garnica@uach.cl		Schon, Max Emil/0000-0002-4453-4173	German Research Foundation (DFG) [OB 24/30-1]; Deutsche Forschungsgemeinschaft; University of Tubingen	German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This work was supported by German Research Foundation (DFG) Grant OB 24/30-1 for financing the sampling of material. We acknowledge support for publication from Deutsche Forschungsgemeinschaft and Open Access Publishing of the University of Tubingen. The funders had no role in the study design, data collection and analysis, the decision to publish or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S., 2010, FASTQC QUALITY CONTR; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Blaalid R, 2014, MOL ECOL, V23, P649, DOI 10.1111/mec.12622; Botnen S, 2014, MOL ECOL, V23, P975, DOI 10.1111/mec.12646; Braker S, 2000, HIERARCHISIERUNG TYP; Buchfink B, 2015, 151108753 ARXIV, P1; Burkhardt S, 2003, FUND INFORM, V56, P51; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO KM, 1992, COMPUT APPL BIOSCI, V8, P481; Cline ET, 2005, NEW PHYTOL, V166, P993, DOI 10.1111/j.1469-8137.2005.01387.x; Coince A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100668; Cordier T, 2012, NEW PHYTOL, V196, P510, DOI 10.1111/j.1469-8137.2012.04284.x; Davey M, 2015, ENVIRON MICROBIOL, V17, P2777, DOI 10.1111/1462-2920.12770; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egan CP, 2017, MYCORRHIZA, V27, P273, DOI 10.1007/s00572-016-0752-x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garnica S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw045; Garnica S, 2013, FEMS MICROBIOL ECOL, V83, P265, DOI 10.1111/j.1574-6941.2012.01473.x; Garnica S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-1; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; Gorzelak MA, 2012, FUNGAL ECOL, V5, P36, DOI 10.1016/j.funeco.2011.08.008; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Herbig A., 2016, MALT FAST ALIGNMENT, P050559, DOI [10.1101/050559, DOI 10.1101/050559]; Herzog SK, 2005, ECOGRAPHY, V28, P209, DOI 10.1111/j.0906-7590.2005.03935.x; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Susan G, 2015, NEW PHYTOL, V206, P1145, DOI 10.1111/nph.13315; Kernaghan G, 2001, ECOGRAPHY, V24, P181, DOI 10.1034/j.1600-0587.2001.240208.x; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Kivlin SN, 2017, DIVERS DISTRIB, V23, P1067, DOI 10.1111/ddi.12595; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Lugo MA, 2008, MICROB ECOL, V55, P705, DOI 10.1007/s00248-007-9313-3; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Matsuoka S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw044; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1083, DOI 10.1016/j.soilbio.2010.03.005; Meng H, 2013, APPL MICROBIOL BIOT, V97, P2219, DOI 10.1007/s00253-012-4063-7; Miyamoto Y, 2014, ISME J, V8, P1739, DOI 10.1038/ismej.2014.34; Mundra S, 2015, MOL ECOL, V24, P6289, DOI 10.1111/mec.13458; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peintner U, 2012, MYCOL PROG, V11, P109, DOI 10.1007/s11557-010-0734-x; Pellissier L, 2014, MOL ECOL, V23, P4274, DOI 10.1111/mec.12854; Peltzer A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0918-z; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Richter D, 1984, SAMMLUNG GEOLOGISCHE, V77; Romdal TS, 2007, ECOGRAPHY, V30, P440, DOI [10.1111/j.2007.0906-7590.04954.x, 10.1111/j.0906-7590.2007.04954.x]; Schoch CL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau061; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scholz H, 1981, WERDEN ALLGAUER LAND; Schwab C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00095; Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]; Siles JA, 2016, MICROB ECOL, V72, P207, DOI 10.1007/s00248-016-0748-2; Sinclair L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116955; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P191, DOI 10.1016/B978-012370526-6.50008-8; Song ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127234; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wu BY, 2007, MYCORRHIZA, V17, P495, DOI 10.1007/s00572-007-0114-9; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066829	72	19	20	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0208493	10.1371/journal.pone.0208493	http://dx.doi.org/10.1371/journal.pone.0208493			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517179	gold, Green Published			2022-12-26	WOS:000452212400103
J	Lei, JT; Qi, RX; Tang, YG; Wang, WN; Wei, GH; Nussinov, R; Ma, BY				Lei, Jiangtao; Qi, Ruxi; Tang, Yegen; Wang, Wenning; Wei, Guanghong; Nussinov, Ruth; Ma, Buyong			Conformational stability and dynamics of the cancer-associated isoform 133p53 are modulated by p53 peptides and p53-specific DNA	FASEB JOURNAL			English	Article						160p53 cancer; p53 aggregation; p53 response element	PRION-LIKE AGGREGATION; MUTANT P53; TRANSFER-RNA; CORE DOMAIN; MUTATIONS; DELTA-133P53; CELL; EXPRESSION; P53-BETA; PHOSPHORYLATION	p53 is a tumor suppressor protein that maintains genome stability, but its 133p53 and 160p53 isoforms promote breast cancer cell invasion. The sequence truncations in the p53 core domain raise key questions related to their physicochemical properties, including structural stabilities, interaction mechanisms, and DNA-binding abilities. Herein, we investigated the conformational dynamics of 133p53 and 160p53 with and without binding to p53-specific DNA by using molecular dynamics simulations. We observed that the core domains of the 2 truncated isoforms are much less stable than wild-type (wt) p53, and the increased solvent exposure of their aggregation-triggering segment indicates their higher aggregation propensities than wt p53. We also found that 133p53 stability is modulable by peptide or DNA interactions. Adding a p53 peptide (derived from truncated p53 sequence 107-129) may help stabilize 133p53. Most importantly, our simulations of p53 isomer-DNA complexes indicate that 133p53 dimer, but not 160p53 dimer, could form a stable complex with p53-specific DNA, which is consistent with recent experiments. This study provides physicochemical insight into 133p53, 133p53-DNA complexes, 133p53's pathologic mechanism, and peptide-based inhibitor design against p53-related cancers.Lei, J., Qi, R., Tang, Y., Wang, W., Wei, G., Nussinov, R., Ma, B. Conformational stability and dynamics of the cancer-associated isoform 133p53 are modulated by p53 peptides and p53-specific DNA.	[Lei, Jiangtao; Qi, Ruxi; Wei, Guanghong] Fudan Univ, Key Lab Computat Phys Sci, State Key Lab Surface Phys, Minist Educ,Dept Phys, Shanghai, Peoples R China; [Tang, Yegen; Wang, Wenning] Fudan Univ, Inst Biomed Sci, Dept Chem, Shanghai, Peoples R China; [Nussinov, Ruth; Ma, Buyong] NCI, Basic Sci Program, Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick, MD 21701 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Inst Mol Med, Sackler Sch Med, Dept Human Genet & Mol Med, Tel Aviv, Israel	Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Ma, BY (corresponding author), NCI, Basic Sci Program, Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick, MD 21701 USA.; Wei, GH (corresponding author), Fudan Univ, Collaborat Innovat Ctr Adv Microstruct Nanjing, Key Lab Computat Phys Sci, State Key Lab Surface Phys,Minist Educ,Dept Phys, Shanghai, Peoples R China.	ghwei@fudan.edu.cn; mabuyong@mail.nih.gov	Lei, Jiangtao/GQR-1824-2022; Ma, Buyong/F-9491-2011	Lei, Jiangtao/0000-0002-1340-6259; Ma, Buyong/0000-0002-7383-719X; Nussinov, Ruth/0000-0002-8115-6415	Ministry of Science and Technology of China [2016YFA0501702]; National Natural Science Foundation of China [11674065]; U.S. National Institutes of Health (NIH) Frederick National Laboratory for Cancer Research [HHSN261200800001E]; Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010440] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health (NIH) Frederick National Laboratory for Cancer Research; Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by the Ministry of Science and Technology of China (Grant 2016YFA0501702) and the National Natural Science Foundation of China (Grant 11674065). This work has also been funded in whole, or in part, by the U.S. National Institutes of Health (NIH) Frederick National Laboratory for Cancer Research under contract HHSN261200800001E. This research was supported, in part, by the Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. All simulations reported in this work were performed using the high-performance computational facilities at the NIH Biowulf Cluster and the National High Performance Computing Center of Fudan University. The authors declare no conflicts of interest.	Alexander RW, 2010, FEBS LETT, V584, P376, DOI 10.1016/j.febslet.2009.11.061; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Aoubala M, 2011, CELL DEATH DIFFER, V18, P248, DOI 10.1038/cdd.2010.91; Arsic N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172125; Arsic N, 2015, STEM CELL REP, V4, P531, DOI 10.1016/j.stemcr.2015.02.001; Bernard H, 2013, ONCOGENE, V32, P2150, DOI 10.1038/onc.2012.242; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Blandino G, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0705-7; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Candeias MM, 2016, EMBO REP, V17, P1542, DOI 10.15252/embr.201541956; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davidson WR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-102; Dichtel-Danjoy ML, 2013, CELL DEATH DIFFER, V20, P108, DOI 10.1038/cdd.2012.100; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gadea G, 2016, ELIFE, V5, DOI [10.7554/elife.14734, 10.7554/eLife.14734]; Gong HJ, 2018, CELL DEATH DIFFER, V25, P1063, DOI 10.1038/s41418-018-0085-8; Gong L, 2018, ONCOGENE, V37, P2150, DOI 10.1038/s41388-017-0117-8; Gong L, 2015, CELL RES, V25, P351, DOI 10.1038/cr.2015.22; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinault C, 2011, DIABETES, V60, P1210, DOI 10.2337/db09-1379; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Huang Q, 2014, BBA-PROTEINS PROTEOM, V1844, P198, DOI 10.1016/j.bbapap.2013.04.002; Ji XN, 2014, INT J MOL SCI, V15, P13275, DOI 10.3390/ijms150813275; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Joruiz S. M., 2016, COLD SPRING HARB PER, V6; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoch A, 2017, NUCLEIC ACIDS RES, V45, P10206, DOI 10.1093/nar/gkx630; Khoo KH, 2009, J MOL BIOL, V393, P161, DOI 10.1016/j.jmb.2009.08.013; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kim S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003993; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Li M, 2015, NEUROBIOL AGING, V36, P2725, DOI 10.1016/j.neurobiolaging.2015.06.021; Lukman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080221; Ma BY, 2007, NUCLEIC ACIDS RES, V35, P2986, DOI 10.1093/nar/gkm192; Ma BY, 2005, P NATL ACAD SCI USA, V102, P3988, DOI 10.1073/pnas.0500215102; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Marcel V, 2014, CELL DEATH DIFFER, V21, P1377, DOI 10.1038/cdd.2014.73; Marcel V, 2009, CELL MOL LIFE SCI, V66, P391, DOI 10.1007/s00018-008-8336-3; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Maynard AT, 2001, J AM CHEM SOC, V123, P1047, DOI 10.1021/ja0011616; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Pan YP, 2005, BIOCHEMISTRY-US, V44, P1423, DOI 10.1021/bi047845y; Pehar M, 2014, AGING CELL, V13, P449, DOI 10.1111/acel.12192; Pehar M, 2010, AGING CELL, V9, P174, DOI 10.1111/j.1474-9726.2010.00547.x; Pyrkosz AB, 2010, J MOL BIOL, V397, P1350, DOI 10.1016/j.jmb.2010.02.003; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roth I, 2016, ONCOGENE, V35, P4981, DOI 10.1038/onc.2016.45; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Silva JL, 2018, ACCOUNTS CHEM RES, V51, P181, DOI 10.1021/acs.accounts.7b00473; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Slatter TL, 2011, BLOOD, V117, P5166, DOI 10.1182/blood-2010-11-321851; Solomon H, 2017, CELL DEATH DIFFER, V24, P2187, DOI 10.1038/cdd.2017.139; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Stracquadanio G, 2016, NAT REV CANCER, V16, P251, DOI 10.1038/nrc.2016.15; Terrier O, 2012, J VIROL, V86, P8452, DOI 10.1128/JVI.07143-11; Ungewitter E, 2010, GENE DEV, V24, P2408, DOI 10.1101/gad.1987810; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2443, DOI 10.1073/pnas.1500262112; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546	75	20	20	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4225	4235		10.1096/fj.201801973R	http://dx.doi.org/10.1096/fj.201801973R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30540922	Bronze, Green Published			2022-12-26	WOS:000459794800090
J	Yi, Q; Chen, QF; Yan, HY; Zhang, M; Liang, C; Xiang, XF; Pan, X; Wang, FW				Yi, Qi; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Liang, Cai; Xiang, Xingfeng; Pan, Xuan; Wang, Fangwei			Aurora B kinase activity-dependent and -independent functions of the chromosomal passenger complex in regulating sister chromatid cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centromere; mitosis; kinetochore; cell cycle; histone modification; chromosomal passenger complex; cohesin; Haspin; heterochromatin protein 1; sister chromatid cohesion; Aurora B; INCENP	PROTECTS CENTROMERIC COHESION; MICROTUBULE-BINDING; SPINDLE CHECKPOINT; MITOTIC CHROMOSOME; INNER CENTROMERE; HISTONE H3; CENP-B; THR-3 PHOSPHORYLATION; MPS1; BUB1	The chromosomal passenger complex (CPC) is a master regulator of mitosis. CPC consists of inner centromere protein (INCENP), Survivin, Borealin, and the kinase Aurora B and plays key roles in regulating kinetochore-microtubule attachments and spindle assembly checkpoint signaling. However, the role of CPC in sister chromatid cohesion, mediated by the cohesin complex, remains incompletely understood. Here, we show that Aurora B kinase activity contributes to centromeric cohesion protection partly through promoting kinetochore localization of the kinase Bub1. Interestingly, disrupting the interaction of INCENP with heterochromatin protein 1 (HP1) in HeLa cells selectively weakens cohesion at mitotic centromeres without detectably reducing the kinase activity of Aurora B. Thus, through this INCENP-HP1 interaction, the CPC also protects centromeric cohesion independently of Aurora B kinase activity. Moreover, the requirement for the INCENP-HP1 interaction in centromeric cohesion protection can be bypassed by tethering HP1 to centromeres or by depleting the cohesin release factor Wapl. We provide further evidence suggesting that the INCENP-HP1 interaction protects centromeric cohesion by promoting the centromere localization of Haspin, a protein kinase that antagonizes Wapl activity at centromeres. Taken together, this study identifies Aurora B kinase activity-dependent and -independent roles for the CPC in regulating centromeric cohesion during mitosis in human cells.	[Yi, Qi; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Liang, Cai; Xiang, Xingfeng; Pan, Xuan; Wang, Fangwei] Zhejiang Univ, MOE, Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Zhejiang, Peoples R China; [Yi, Qi; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Liang, Cai; Xiang, Xingfeng; Pan, Xuan; Wang, Fangwei] Zhejiang Univ, Life Sci Inst, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, FW (corresponding author), Zhejiang Univ, MOE, Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, FW (corresponding author), Zhejiang Univ, Life Sci Inst, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	fwwang@zju.edu.cn		Chen, Qinfu/0000-0003-4581-5329; Cai, Liang/0000-0002-1885-4237	National Key Research and Development Program of China [2017YFA0503600]; National Natural Science Foundation of China (NSFC) [31571393, 31771499, 31561130155, 31322032, 31371359]; Natural Science Foundation of Zhejiang Province [LZ19C070001, LR13C070001, LY17C070003]; Newton Advanced Fellowship [NA140075]; Fundamental Research Funds for the Central Universities	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Newton Advanced Fellowship; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Key Research and Development Program of China Grant 2017YFA0503600 (to F. W.); National Natural Science Foundation of China (NSFC) Grants 31571393, 31771499, 31561130155, 31322032, and 31371359 (to F. W.); Natural Science Foundation of Zhejiang Province Grants LZ19C070001 and LR13C070001 (to F. W.) and LY17C070003 (to H. Y.); Newton Advanced Fellowship NA140075; and Fundamental Research Funds for the Central Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2016, DEV CELL, V36, P487, DOI 10.1016/j.devcel.2016.02.008; Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Bakhoum SF, 2018, CELL, V174, P1347, DOI 10.1016/j.cell.2018.08.027; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Baron AP, 2016, ELIFE, V5, DOI 10.7554/eLife.12187; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Goto Y, 2017, CURR BIOL, V27, P1005, DOI 10.1016/j.cub.2017.02.066; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hengeveld RCC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15542; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lara-Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049041; Liang C, 2018, EMBO REP, V19, P43, DOI 10.15252/embr.201744737; Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Liu X, 2014, J BIOL CHEM, V289, P20638, DOI 10.1074/jbc.M114.572842; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Meppelink A, 2015, CELL REP, V11, P508, DOI 10.1016/j.celrep.2015.03.052; Morales C, 2018, CURR OPIN CELL BIOL, V52, P51, DOI 10.1016/j.ceb.2018.01.010; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Nishiyama T, 2013, P NATL ACAD SCI USA, V110, P13404, DOI 10.1073/pnas.1305020110; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Ruppert JG, 2018, EMBO J, V37, DOI 10.15252/embj.201797677; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sapkota H, 2018, MOL BIOL CELL, V29, P2601, DOI 10.1091/mbc.E18-05-0315; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tanno Y, 2010, GENE DEV, V24, P2169, DOI 10.1101/gad.1945310; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Trivedi P, 2016, TRENDS BIOCHEM SCI, V41, P160, DOI 10.1016/j.tibs.2015.11.002; van der Waal MS, 2012, EMBO REP, V13, P847, DOI 10.1038/embor.2012.93; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yi Q, 2018, EMBO REP, V19, DOI 10.15252/embr.201745484; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhou LL, 2017, CURR BIOL, V27, P992, DOI 10.1016/j.cub.2017.02.019; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	92	13	14	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2021	2035		10.1074/jbc.RA118.005978	http://dx.doi.org/10.1074/jbc.RA118.005978			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30523151	Green Published, hybrid			2022-12-26	WOS:000459711400021
J	Lang, S; Herold, R; Kraft, A; Harth, V; Preisser, AM				Lang, Stephan; Herold, Robert; Kraft, Alexander; Harth, Volker; Preisser, Alexandra M.			Spiroergometric measurements under increased inspiratory oxygen concentration (FIO2)-Putting the Haldane transformation to the test	PLOS ONE			English	Article							EXERCISE PERFORMANCE; CONSUMPTION; HYPEROXIA	Spiroergometric measurements of persons who require oxygen insufflation due to illness can be performed under conditions of increased inspiratory oxygen concentration (FIO2). This increase in FIO2, however, often leads to errors in the calculation of oxygen consumption (VO2). These inconsistencies are due to the application of the Haldane Transformation (HT), an otherwise indispensable correction factor in the calculation of VO2 that becomes inaccurate at higher FIO2 concentrations. A possible solution to this problem could be the use of the Eschenbacher transformation' (ET) as an alternative correction factor. This study examines the concentration of FIO2 at which the HT and the ET are valid, providing plausible data of oxygen consumption corresponding to the wattage achieved during cycle ergometry. Ten healthy volunteers underwent spiroergometric testing under standard conditions (FIO2 = 20.9%), as well as at FIO2 = 40% and 80%. When compared with the predicted values of VO2, as calculated according to Wasserman et al. (2012), the data obtained show that both the HT and ET are valid under normal conditions and at an increased FIO2 of 40%. At FIO2 concentrations of 80%, however, the VO2 values provided by the HT begin to lose plausibility, whereas the ET continues to provide credible results. We conclude that the use of the ET in place of the HT in spiroergometric measurements with increased FIO2 allows a reliable evaluation of stress tests in patients requiring high doses of supplemental oxygen.	[Lang, Stephan; Herold, Robert; Kraft, Alexander; Harth, Volker; Preisser, Alexandra M.] Univ Med Ctr Hamburg Eppendorf, Inst Occupat & Maritime Med ZfAM, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Preisser, AM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Occupat & Maritime Med ZfAM, Hamburg, Germany.	a.preisser@uke.de	Harth, Volker/AGG-1586-2022	Harth, Volker/0000-0003-4308-223X; Preisser, Alexandra Marita/0000-0002-2957-3545	CareFusion Germany 234 GmbH Hochberg Germany; CareFusion	CareFusion Germany 234 GmbH Hochberg Germany; CareFusion	Sponsor: CareFusion Germany 234 GmbH Leibnizstrasse 7 97204 Hochberg Germany. CareFusion sponsored the Device for the FIO2-Testing [Vyntus CPX] and the additional material [Masks, Filter, Vyntus ECG, gas bottles].	Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Consolazi CF, 1963, PHYSL MEASUREMENTS M; Eschenbacher H, 2016, HALDANE ESCHENBACHER; Haldane J.S., 1912, METHODS AIR ANAL; HARRISEZE AO, 1994, AM J RESP CRIT CARE, V150, P1616, DOI 10.1164/ajrccm.150.6.7952624; Hoppe J, 2009, ERRORS VO2 TESTING; Kleinberger G, 1988, METHODISCHE FRAGEN I; Kroidl R, 2014, SPIROERGOMETRIE TECH; Kuzma J.W., 1998, BASIC STAT HLTH SCI, V3rd; Lang S, 2017, ATEMWEG LUNGENKRANK, V43, P86, DOI DOI 10.5414/ATX02177; MARCUS CL, 1992, CHEST, V101, P52, DOI 10.1378/chest.101.1.52; Meyer F J, 2013, Pneumologie, V67, P16, DOI 10.1055/s-0032-1325901; PELTONEN JE, 1995, MED SCI SPORT EXER, V27, P573; Prieur F, 2002, EUR J APPL PHYSIOL, V88, P235, DOI 10.1007/s00421-002-0707-0; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rising R, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0043-0; STANEK KA, 1979, J APPL PHYSIOL, V46, P1115, DOI 10.1152/jappl.1979.46.6.1115; Takala J, 1991, HANDBOOK OF GAS EXCH; Ulrich S, 2017, RESPIRATION, V93, P90, DOI 10.1159/000453620; Walsh ML, 1995, EUR J APPL PHYSIOL, V72, P71, DOI 10.1007/BF00964117; Wasserman K, 2012, PRINCIPLES EXERCISE, V5th; WELCH HG, 1981, J APPL PHYSIOL, V51, P725, DOI 10.1152/jappl.1981.51.3.725; WILMORE JH, 1973, J APPL PHYSIOL, V35, P85, DOI 10.1152/jappl.1973.35.1.85; WILSON BA, 1975, J APPL PHYSIOL, V39, P267, DOI 10.1152/jappl.1975.39.2.267	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0207648	10.1371/journal.pone.0207648	http://dx.doi.org/10.1371/journal.pone.0207648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540773	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600028
J	Justicia, LS; Rosen, F; Mayer, M				Justicia, Lia Schlippe; Rosen, Frank; Mayer, Martin			Performance of GPS units for deployment on semiaquatic animals	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; RADIO-COLLAR PERFORMANCE; BEAVER CASTOR-FIBER; MOVEMENT PATTERNS; HABITAT SELECTION; DIVING BEHAVIOR; RIPARIAN FOREST; FIX INTERVAL; TELEMETRY; ORIENTATION	Global Positioning System (GPS) technology is widely used in wildlife research to study animal movement and habitat use. In order to evaluate the quality and reliability of GPS data, the factors influencing the performance of these devices must be known, especially for semiaquatic species, because terrestrial and aquatic habitat might affect GPS performance differently. We evaluated the location error and fix success rate of three GPS receiver models in stationary tests and on a semi-aquatic mammal, the Eurasian beaver (Castor fiber). The location error during stationary tests was on average 15.7 m, and increased with increasing canopy closure, slope, and horizontal dilution of precision, potentially leading to the erroneous classification of GPS positions when studying habitat use in animals. In addition, the position of the GPS antenna (flat versus 90 degrees tilted) affected the location error, suggesting that animal behavior affects GPS performance. The fix success rate was significantly higher during stationary tests compared to when GPS units were deployed on beavers (94% versus 86%). Further, GPS receivers did not obtain any positions underwater and underground, the latter potentially allowing the estimation of activity periods in animals that use lodges or burrows as shelter. We discuss the possibilities for data screening, the use of buffer zones along the shoreline, and combination with other data loggers to avoid the erroneous classification of GPS positions when studying habitat use.	[Justicia, Lia Schlippe; Rosen, Frank; Mayer, Martin] Univ South Eastern Norway, Fac Technol Nat Sci & Maritime Sci, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway; [Justicia, Lia Schlippe] Univ Barcelona, Fac Biol, Barcelona, Spain; [Mayer, Martin] Aarhus Univ, Dept Biosci, Aarhus, Denmark	University of Barcelona; Aarhus University	Mayer, M (corresponding author), Univ South Eastern Norway, Fac Technol Nat Sci & Maritime Sci, Dept Nat Sci & Environm Hlth, Bo I Telemark, Norway.; Mayer, M (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	martin.mayer@bios.au.dk		Schlippe Justicia, Lia/0000-0002-4362-2139; Mayer, Martin/0000-0002-9905-3625	University of South-Eastern Norway	University of South-Eastern Norway	Funding was provided by the University of South-Eastern Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065763; Anderson D.R, 2007, MODEL BASED INFERENC, DOI [10.2307/23014412, DOI 10.2307/23014412]; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barton K., 2013, MUMIN MULTI MODEL IN; Belant JL, 2009, NORTHEAST NAT, V16, P577, DOI 10.1656/045.016.n407; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Blackie HM, 2010, J WILDLIFE MANAGE, V74, P1911, DOI 10.2193/2009-412; Bodie JR, 2000, OECOLOGIA, V122, P138, DOI 10.1007/PL00008830; Bowman JL, 2000, WILDLIFE SOC B, V28, P141; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Busher P., 1983, ACTA ZOOLOGICA FENNI; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Campbell HA, 2010, FUNCT ECOL, V24, P103, DOI 10.1111/j.1365-2435.2009.01599.x; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Coelho CM, 2007, APPL ANIM BEHAV SCI, V105, P259, DOI 10.1016/j.applanim.2006.04.024; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; DARVEAU M, 1995, J WILDLIFE MANAGE, V59, P67, DOI 10.2307/3809117; Darveau M, 2001, FOREST ECOL MANAG, V143, P95, DOI 10.1016/S0378-1127(00)00509-0; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Dussault C, 1999, WILDLIFE SOC B, V27, P965; Dussault C, 2001, WILDLIFE SOC B, V29, P171; El-Rabbany A., 2006, INT TRANSP SYST C 20; FIELD C R, 1970, Zoologica Africana, V5, P71; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; Gau RJ, 2004, WILDLIFE SOC B, V32, P693, DOI 10.2193/0091-7648(2004)032[0693:UFPOTG]2.0.CO;2; Girard I, 2002, J WILDLIFE MANAGE, V66, P1290, DOI 10.2307/3802962; Graf PM, 2016, MAMM BIOL, V81, P587, DOI 10.1016/j.mambio.2016.07.046; Graf PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136751; Graf PM, 2018, ECOL EVOL, V8, P997, DOI 10.1002/ece3.3726; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Haarberg O, 2006, J ZOOL, V270, P201, DOI 10.1111/j.1469-7998.2006.00142.x; Halley DJ, 2002, MAMMAL REV, V32, P153, DOI 10.1046/j.1365-2907.2002.00106.x; Hallworth MT, 2015, SCI REP-UK, V5, DOI 10.1038/srep11069; Hartman G, 1996, J ZOOL, V240, P317, DOI 10.1111/j.1469-7998.1996.tb05288.x; Heard DC, 2008, J WILDLIFE MANAGE, V72, P596, DOI 10.2193/2007-175; Herr J, 2004, J ZOOL, V262, P257, DOI 10.1017/S0952836903004606; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Hyzer G., 2012, EFFECTS GPS ERROR AN; Jennings SB, 1999, FORESTRY, V72, P59, DOI 10.1093/forestry/72.1.59; Jiang Z, 2008, ECOL RES, V23, P581, DOI 10.1007/s11284-007-0412-x; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lopez-Lopez P, 2014, CURR ZOOL, V60, P642, DOI 10.1093/czoolo/60.5.642; Mauritzen M, 1999, J APPL ECOL, V36, P409, DOI 10.1046/j.1365-2664.1999.00414.x; Mayer M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15540-0; McMahon LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173185; Mech L.D., 2002, CRITIQUE WILDLIFE RA; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Price-Rees SJ, 2011, HERPETOL CONSERV BIO, V6, P142; Priest TE, 2002, J HERPETOL, V36, P555; Quaglietta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029235; R Core Team, 2021, R LANGUAGE ENV STAT; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Recio MR, 2011, EUR J WILDLIFE RES, V57, P1175, DOI 10.1007/s10344-011-0530-1; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Rodgers Arthur R., 2001, P79, DOI 10.1016/B978-012497781-5/50005-0; RUDOLPH DC, 1990, SOUTHWEST NAT, V35, P472, DOI 10.2307/3672055; Sager-Fradkin KA, 2007, J WILDLIFE MANAGE, V71, P1298, DOI 10.2193/2006-367; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sharpe F, 2003, ANIM BEHAV, V66, P1059, DOI 10.1006/anbe.2003.2274; Soutullo A, 2007, J WILDLIFE MANAGE, V71, P1010, DOI 10.2193/2006-042; Steyaert S., 2015, OECOLOGIA, V179, P1; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090	71	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207938	10.1371/journal.pone.0207938	http://dx.doi.org/10.1371/journal.pone.0207938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521569	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600024
J	Khan, MI; Shin, JH; Shin, TS; Kim, MY; Cho, NJ; Kim, JD				Khan, Muhammad Imran; Shin, Jin Hyuk; Shin, Tai Sun; Kim, Min Yong; Cho, Nam Jun; Kim, Jong Deog			Anthocyanins from Cornus kousa ethanolic extract attenuate obesity in association with anti-angiogenic activities in 3T3-L1 cells by down-regulating adipogeneses and lipogenesis	PLOS ONE			English	Article							BREAST-CANCER; INSULIN-RESISTANCE; GENE-EXPRESSION; PPAR-GAMMA; ADIPOCYTES; HEALTH; PROTEIN; LIVER; RISK	Cornus kousa the Korean dogwood has been traditionally used in East Asia as therapeutic traditional medicine however biological activities of Cornus kousa have not been investigated previously. The aim of the present study was to evaluate anti-obesity activities coupled with anti-angiogenic activities of anthocyanins rich fraction of ethanolic leaf extract of Cornus kousa (ELECk) in HUVECs and 3T3- L1 cells. Dried plants leaves were extracted with 70% ethanol and anthocyanin fraction (AnT Fr) was obtained by eluting the ethanolic extract through non-polar macroporous resin and further purification by HPLC. Antiangiogenic activities were determined by antiproliferative effect of AnT Fr on HUVECs. In the presence of various concentrations of AnT Fr, 3T3-L1 preadipocytes were induced to differentiate. Lipid accumulation in differentiated adipocytes were quantified by Oil-Red O staining. AnT Fr significantly suppressed angiogenesis by inhibiting proliferation and tube formation of HUVECs via downregulating VEGRF 2, PI3K, beta-catenin, NF-kB, and Akt1 in a dose dependent manner. AnT Fr inhibited lipid accumulation by down-regulating adipogenesis and lipogenesis promoting signaling proteins, PPAR gamma, CCAAT, C/EBP alpha, aP2, FAS, and LPL, however enhanced AMPK activation to p-AMPK in 3T3 cells quantified and expressed by western blotting. AnT Fr inhibit lipid accumulation by regulating adipogenesis and lipogenesis related genes and signaling proteins. The anti-obesity activities exerted by Cornus kousa are associated with antiangiogenic activities of anthocyanins rich fraction of Cornus kousa. Hence the presence of bioactive anthocyanins, Cornus kosa, is a good candidate for nutraceutical and pharmaceutical formulation for treating or controlling obesity.	[Khan, Muhammad Imran; Shin, Jin Hyuk; Cho, Nam Jun; Kim, Jong Deog] Chonnam Natl Univ, Dept Biotechnol, Yeosu, Chonnam, South Korea; [Shin, Tai Sun] Chonnam Natl Univ, Dept Food Sci & Nutr, Gwangju, South Korea; [Kim, Min Yong] Chonnam Natl Univ, Dept Refrigerat Engn, Yeosu, Chonnam, South Korea; [Shin, Tai Sun; Kim, Min Yong; Kim, Jong Deog] Chonnam Natl Univ, Res Ctr Antiobes & Hlth Care, Yeosu, Chonnam, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Kim, JD (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Yeosu, Chonnam, South Korea.; Kim, JD (corresponding author), Chonnam Natl Univ, Res Ctr Antiobes & Hlth Care, Yeosu, Chonnam, South Korea.	pasteur@jnu.ac.kr			Chonnam National University	Chonnam National University	The research work was funded by Chonnam National University.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Blando J, 2011, CANCER PREV RES, V4, P2002, DOI 10.1158/1940-6207.CAPR-11-0182; Bronckaers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071104; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; DeFuria J, 2009, J NUTR, V139, P1510, DOI 10.3945/jn.109.105155; Ding LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057477; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Elena A, 2017, OXID MED CELL LONGEV, V11; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gungor NK, 2014, J CLIN RES PEDIATR E, V6, P129, DOI [10.4274/jcrpe.1471, 10.4274/Jcrpe.1471]; Harris HR, 2011, JNCI-J NATL CANCER I, V103, P273, DOI 10.1093/jnci/djq500; Iizukaa Y, 2016, TOXICOL REP, V3, P4, DOI 10.1016/j.toxrep.2015.11.003; Jana S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182137; Jansson PA, 2007, J INTERN MED, V262, P173, DOI 10.1111/j.1365-2796.2007.01830.x; Kim KH, 2011, ANNU REV FOOD SCI T, V2, P237, DOI 10.1146/annurev-food-022510-133656; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee DR, 2015, ASIAN PAC J TROP MED, V8, P879, DOI 10.1016/j.apjtm.2015.10.011; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Mau JL, 2001, J AGR FOOD CHEM, V49, P183, DOI 10.1021/jf000263c; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Mohamed G. A., 2014, Bulletin of the Faculty of Pharmacy, Cairo University, V52, P269, DOI 10.1016/j.bfopcu.2014.05.001; Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508; Picon-Ruiz M, 2016, CANCER RES, V76, P491, DOI 10.1158/0008-5472.CAN-15-0927; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Seeram NP, 2002, J AGR FOOD CHEM, V50, P2519, DOI 10.1021/jf0115903; Shimocka II, 2006, BMC COMPLEM ALTERN M, V6, P9, DOI [10.1186/1472-6882-6-9, DOI 10.1186/1472-6882-6-9]; Tsuda T, 2008, J AGR FOOD CHEM, V56, P642, DOI 10.1021/jf073113b; Tyler C., 2007, CURR OPIN CELL BIOL, V19, P612, DOI [10.1016/j.ceb.2007.09.014, DOI 10.1016/J.CEB.2007.09.014]; Umegaki K, 2014, TOXICOL REP, V1, P787, DOI 10.1016/j.toxrep.2014.09.013; Vareed SK, 2006, LIFE SCI, V78, P777, DOI 10.1016/j.lfs.2005.05.094; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; White AJ, 2015, CANCER-AM CANCER SOC, V121, P3700, DOI 10.1002/cncr.29552	38	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208556	10.1371/journal.pone.0208556	http://dx.doi.org/10.1371/journal.pone.0208556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521605	Green Submitted, gold, Green Published			2022-12-26	WOS:000452307600091
J	Murfitt, JC; Brown, LC; Howell, SEL				Murfitt, Justin C.; Brown, Laura C.; Howell, Stephen E. L.			Estimating lake ice thickness in Central Ontario	PLOS ONE			English	Article							SHALLOW LAKES; NORTH SLOPE; RADAR; TRENDS; ALASKA; COVER; DEPTH; VARIABILITY; SENSITIVITY	Lakes are a key geographical feature in Canada and have an impact on the regional climate. In the winter, they are important for recreational activities such as snowmobiling and ice fishing and act as part of an important supply route for northern communities. The ability to accurately report lake ice characteristics such as thickness is vital, however, it is underreported in Canada and there is a lack of lake ice thickness records for temperate latitude areas such as Central Ontario. Here, we evaluate the application of previously developed temperature models and RADARSAT-2 for estimating lake ice thickness in Central Ontario and provide insight into the regions long term ice thickness variability. The ALS Environmental Science Shallow Water Ice Profiler (SWIP) was used for validation of both temperature and radar-based models. Results indicate that the traditional approach that uses temperatures to predict ice thickness during ice growth has low RMSE values of 2.3 cm and correlations of greater than 0.9. For ice decay, similar low RMSE values of 2.1 cm and high correlations of 0.97 were found. Using RADARSAT-2 to estimate ice thickness results in R-2 values of 0.6 (p < 0.01) but high RMSE values of 11.7 cm. Uncertainty in the RADARSAT-2 approach may be linked to unexplored questions about scattering mechanisms and the interaction of radar signal with mid-latitude lake ice. The application of optimized temperature models to a long-term temperature record revealed a thinning of ice cover by 0.81 cm per decade.	[Murfitt, Justin C.; Brown, Laura C.] Univ Toronto, Dept Geog, Mississauga, ON, Canada; [Howell, Stephen E. L.] Environm & Climate Change Canada, Climate Res Div, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; Environment & Climate Change Canada	Murfitt, JC (corresponding author), Univ Toronto, Dept Geog, Mississauga, ON, Canada.	justin.murfitt@mail.utoronto.ca	Brown, Laura C/F-5932-2011	Brown, Laura C/0000-0002-3173-8433; Murfitt, Justin/0000-0002-7388-0964	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation [34864]; Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship - Master's Program; University of Toronto Mississauga Geography Department Graduate Expansion Fund	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship - Master's Program(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto Mississauga Geography Department Graduate Expansion Fund	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant - http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng. asp?id=633998 - awarded to Laura Brown; Canadian Foundation for Innovation (34864) https://www.innovation.ca/-awarded to Laura Brown; Ontario Research Fund - https://www.ontario.ca/page/ontario-research-fund-research-excellence#section-5 - awarded to Laura Brown; Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship - Master's Program - http://www.nserc-crsng.gc.ca/Students-Etudiants/PG-CS/CGSM-BESCM_eng.asp - awarded to Justin Murfitt; and a University of Toronto Mississauga Geography Department Graduate Expansion Fund http://geog.utm.utoronto.ca/grads/finance-fees-funding/ - awarded to Justin Murfitt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WP, 1976, MUSK OX, V181, P86; Ariano SS, 2017, THESIS; ASL Environmental Sciences, SHALL WAT IC PROF SW; Assur A, 1956, AIRFIELDS FLOATING I; Atwood DK, 2015, IEEE T GEOSCI REMOTE, V53, P5972, DOI 10.1109/TGRS.2015.2429917; Bates D., 1988, NONLINEAR REGRESSION; Bates D.M., 1992, STAT MODELS S; Bengtsson L., 1986, GEOGR ANNALER SER PH, V68, P113, DOI [10.1080/04353676.1986.11880164, DOI 10.1080/04353676.1986.11880164, 10.2307/521182,1986, DOI 10.2307/521182]; Benson BJ, 2012, CLIMATIC CHANGE, V112, P299, DOI 10.1007/s10584-011-0212-8; BEST DJ, 1974, ROY STAT SOC C-APP, V23, P98; Bilello M. A., 1961, ARCTIC, V14, P2, DOI [10.14430/arctic3658, DOI 10.14430/ARCTIC3658]; Bilello MA, 1980, CRREL806; Brown LC, 2011, HYDROL PROCESS, V25, P2932, DOI 10.1002/hyp.8087; Brown LC, 2010, PROG PHYS GEOG, V34, P671, DOI 10.1177/0309133310375653; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/NGEO2234, 10.1038/ngeo2234]; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Duguay CR, 2015, REMOTE SENSING OF THE CRYOSPHERE, P273; Duguay CR, 2006, HYDROL PROCESS, V20, P781, DOI 10.1002/hyp.6131; Duguay CR, 2003, INT J REMOTE SENS, V24, P475, DOI 10.1080/01431160304992; Environment and Climate Change Canada, 2012, WAT FREQ ASK QUEST; Environment Canada, 2017, HAL 3 WEATH STAT CLI; European Space Agency, 2016, SENT APPL PLATF; Geldsetzer T, 2010, CAN J REMOTE SENS, V36, pS391, DOI 10.5589/m11-001; Gilbert A, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002258; Gunn GE, 2018, IEEE T GEOSCI REMOTE, V56, P2887, DOI 10.1109/TGRS.2017.2786158; Haliburton Forest & Wild Life Reserve Ltd, 2012, HAL FOR FISH GUID; HALL DK, 1994, J GEOPHYS RES-OCEANS, V99, P22473, DOI 10.1029/94JC01391; Hampton SE, 2017, ECOL LETT, V20, P98, DOI 10.1111/ele.12699; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; HILL ID, 1973, ROY STAT SOC C-APP, V22, P424; Jeffries MO, 2005, GEOPH MONOG SERIES, V163, P63; Jeffries MO, 1996, ARCTIC, V49, P367; Kang KK, 2014, REMOTE SENS ENVIRON, V150, P1, DOI 10.1016/j.rse.2014.04.016; Kang KK, 2010, IEEE GEOSCI REMOTE S, V7, P751, DOI 10.1109/LGRS.2010.2044742; KENDALL M. G., 1948, Rank correlation methods.; Korhonen J, 2006, NORD HYDROL, V37, P347, DOI 10.2166/nh.2006.019; Lebedev V.V., 1938, PROBLEMY ARKTIKI, V5, P9; LECONTE R, 1991, ARCTIC, V44, P153; Leconte R, 2009, COLD REG SCI TECHNOL, V55, P212, DOI 10.1016/j.coldregions.2008.04.003; MacDonald Dettwiler and Associates Limited, 2016, RADARSAT 2 PROD DESC, V1, P1; Mahmud MS, 2016, REMOTE SENS ENVIRON, V178, P59, DOI 10.1016/j.rse.2016.03.003; Michel B., 1971, CAN GEOTECH J, V8, P36, DOI [10.1139/t71-004, DOI 10.1139/T71-004]; Michel B, 1971, COLD REGIONS SCI ENG, VIII; Morris K., 1995, POLAR REC, V31, P115, DOI [DOI 10.1017/S0032247400013619, 10.1017/S0032247400013619]; Mullan D, 2017, THEOR APPL CLIMATOL, V129, P1089, DOI 10.1007/s00704-016-1830-x; Murfitt J, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10101641; Murfitt J, 2017, HYDROL PROCESS, V31, P3596, DOI 10.1002/hyp.11295; Ontario Ministry of Tourism Recreation and Sport, 2016, REG TOUR PROF REG 11; Rouse WR, 2008, ATMOSPHERIC DYNAMICS, VI, P309, DOI [DOI 10.1007/978-3-540-73936-4_18, 10.1007/978-3-540-73936-4_18]; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Small D, 1997, P GEOM ER RADARSAT O; Stefan J, 1890, SITZ BER KAIS AKAD W, V98, P965, DOI [10.1002/andp.18912780206, DOI 10.1002/ANDP.18912780206]; Surdu CM, 2014, CRYOSPHERE, V8, P167, DOI 10.5194/tc-8-167-2014; Surdu CM, 2015, REMOTE SENS-BASEL, V7, P6133, DOI 10.3390/rs70506133; United States Department of the Interior, 2015, SHUTTL RAD TOP MISS, DOI [10.1016/j.rse.2016.03.003, DOI 10.1016/J.RSE.2016.03.003]; US Army Corps of Engineers, 2006, ENG DES IC ENG; Valz PD, 1994, J COMPUT GRAPH STAT, V3, P459, DOI DOI 10.1080/10618600.1994.10474658; Valz PD, 1990, THESIS; Vavrus SJ, 1996, LIMNOL OCEANOGR, V41, P822, DOI 10.4319/lo.1996.41.5.0822; Wang XLL, 2014, ATMOS OCEAN, V52, P222, DOI 10.1080/07055900.2013.818526; Wang XLL, 2001, J CLIMATE, V14, P2204, DOI 10.1175/1520-0442(2001)014<2204:COEWHI>2.0.CO;2; Willmott CJ, 2012, INT J CLIMATOL, V32, P2088, DOI 10.1002/joc.2419; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654	63	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208519	10.1371/journal.pone.0208519	http://dx.doi.org/10.1371/journal.pone.0208519			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521619	Green Submitted, Green Published, gold			2022-12-26	WOS:000452307600083
J	Diallo, K; Coulibaly, MD; Rebbetts, LS; Harrison, OB; Lucidarme, J; Gamougam, K; Tekletsion, YK; Bugri, A; Toure, A; Issaka, B; Dieng, M; Trotter, C; Collard, JM; Sow, SO; Wang, X; Mayer, LW; Borrow, R; Greenwood, BM; Maiden, MCJ; Manigart, O				Diallo, Kanny; Coulibaly, Mamadou D.; Rebbetts, Lisa S.; Harrison, Odile B.; Lucidarme, Jay; Gamougam, Kadidja; Tekletsion, Yenenesh K.; Bugri, Akalifa; Toure, Aliou; Issaka, Bassira; Dieng, Marietou; Trotter, Caroline; Collard, Jean-Marc; Sow, Samba O.; Wang, Xin; Mayer, Leonard W.; Borrow, Ray; Greenwood, Brian M.; Maiden, Martin C. J.; Manigart, Olivier		MenAfriCar Consortium	Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt	PLOS ONE			English	Article							REAL-TIME PCR; SEROGROUP; IDENTIFICATION; VACCINE; ASSAYS	Improved methods for the detection and characterization of carried Neisseria meningitidis isolates are needed. We evaluated a multiplex PCR algorithm for the detection of a variety of carriage strains in the meningitis belt. To further improve the sensitivity and specificity of the existing PCR assays, primers for gel-based PCR assays (sodC, H, Z) and primers/probe for real-time quantitative PCR (qPCR) assays (porA, cnl, sodC, H, E, Z) were modified or created using Primer Express software. Optimized multiplex PCR assays were tested on 247 well-characterised carriage isolates from six countries of the African meningitis belt. The PCR algorithm developed enabled the detection of N. meningitidis species using gel-based and real-time multiplex PCR targeting porA, sodC, cnI and characterization of capsule genes through sequential multiplex PCR assays for genogroups (A, W, X, then B, C, Y and finally H, E and Z). Targeting both porA and sodC genes together allowed the detection of meningococci with a sensitivity of 96% and 89% and a specificity of 78% and 67%, for qPCR and gel-based PCR respectively. The sensitivity and specificity ranges for capsular genogrouping of N. meningitidis are 67%-100% and 98%-100% respectively for gel-based PCR and 90%-100% and 99%-100% for qPCR. We developed a PCR algorithm that allows simple, rapid and systematic detection and characterisation of most major and minor N. meningitidis capsular groups, including uncommon capsular groups (H, E, Z).	[Diallo, Kanny; Coulibaly, Mamadou D.; Toure, Aliou; Sow, Samba O.] Ctr Dev Vaccins CVD, Bamako, Mali; [Diallo, Kanny; Rebbetts, Lisa S.; Harrison, Odile B.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford, England; [Lucidarme, Jay; Borrow, Ray] Publ Hlth England, PHE Vaccine Evaluat Unit, Manchester, Lancs, England; [Gamougam, Kadidja] CSSI, Ndjamena, Chad; [Tekletsion, Yenenesh K.] AHRI, Addis Ababa, Ethiopia; [Bugri, Akalifa] NHRC, Navrongo, Ghana; [Issaka, Bassira; Collard, Jean-Marc] Ctr Rech Med & Sanitaire CERMES, Niamey, Niger; [Dieng, Marietou] IRD, Dakar, Senegal; [Trotter, Caroline] Univ Cambridge, Dis Dynam Unit, Dept Vet Med, Cambridge, England; [Wang, Xin; Mayer, Leonard W.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA; [Greenwood, Brian M.; Manigart, Olivier] LSHTM, London, England	University of Oxford; Public Health England; Institut de Recherche pour le Developpement (IRD); University of Cambridge; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine	Manigart, O (corresponding author), LSHTM, London, England.	olivier.manigart@lshtm.ac.uk	Collard, Jean-Marc/Q-2342-2019; Aseffa, Abraham/J-3248-2016; Maiden, Martin C J/C-5055-2014	Collard, Jean-Marc/0000-0002-1490-3978; Aseffa, Abraham/0000-0002-8028-1150; Maiden, Martin C J/0000-0001-6321-5138; Diallo, Kanny/0000-0002-0905-3980; Harrison, Odile/0000-0002-1623-0295	Meningitis Research Foundation; Wellcome Trust [086546]; Bill & Melinda Gates Foundation [OPP51251]	Meningitis Research Foundation(Meningitis Research Foundation (MRF)); Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This study was funded by the Meningitis Research Foundation (www.meningitis.org) under the auspices of the MenAfriCar project. The MenAfriCar Consortium was supported by grants from the Wellcome Trust (086546) and the Bill & Melinda Gates Foundation (OPP51251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abio A, 2013, PATHOG GLOB HEALTH, V107, P373, DOI 10.1179/2047773213Y.0000000119; Ali O, 2016, LANCET GLOB HEALTH, V4, pE989, DOI 10.1016/S2214-109X(16)30244-3; Ali O, 2015, J INFECT DIS, V212, P1298, DOI 10.1093/infdis/jiv211; Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennett DE, 2006, J CLIN MICROBIOL, V44, P1127, DOI 10.1128/JCM.44.3.1127-1131.2006; Bennett JS, 2014, J CLIN MICROBIOL, V52, P1375, DOI 10.1128/JCM.03529-13; BROOME CV, 1986, J ANTIMICROB CHEMOTH, V18, P25, DOI 10.1093/jac/18.Supplement_A.25; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Gamougam K, 2015, EMERG INFECT DIS, V21, P115, DOI 10.3201/eid2101.140256; Guiver M, 2000, FEMS IMMUNOL MED MIC, V28, P173, DOI 10.1111/j.1574-695X.2000.tb01473.x; Harrison OB, 2011, MICROBIOL-SGM, V157, P2181, DOI 10.1099/mic.0.050518-0; Jolley K., PUBMLST NEISSERIA SE; Jordens JZ, 2005, J MED MICROBIOL, V54, P463, DOI 10.1099/jmm.0.45847-0; Jordens JZ, 2002, J CLIN MICROBIOL, V40, P75, DOI 10.1128/JCM.40.1.75-79.2002; KRISTIANSEN PA, 2014, BMC INFECT DIS, V14; Kristiansen PA, 2015, EXPERT REV VACCINES, V14, P1441, DOI 10.1586/14760584.2015.1084232; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LAPEYSSONNIE L, 1968, Medecine Tropicale, V28, P709; Manigart O, 2016, J CLIN MICROBIOL, V54, P2743, DOI 10.1128/JCM.01428-16; Maurice J, 2015, LANCET, V385, P2241, DOI 10.1016/S0140-6736(15)61050-9; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; Nicolas P, 2012, MED SANTE TROP, V22, P246, DOI 10.1684/mst.2012.0086; Popovic TA, 1999, LABORATORY MANUAL FO; Rozen S, 2000, Methods Mol Biol, V132, P365; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Thomas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019361; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Yaro S, 2012, OPEN J INTERNAL MED, P41; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206453	10.1371/journal.pone.0206453	http://dx.doi.org/10.1371/journal.pone.0206453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517103	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000452212400013
J	Belz, M; Rehling, N; Schmidt, U; Wiltfang, J; Kis, B; Wolff-Menzler, C				Belz, Michael; Rehling, Nico; Schmidt, Ulrike; Wiltfang, Jens; Kis, Bernhard; Wolff-Menzler, Claus			Bacterial infections among patients with psychiatric disorders: Relation with hospital stay, age, and psychiatric diagnoses	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; LENGTH-OF-STAY; SCHIZOPHRENIA; IMPACT; COSTS	The prevalence of infections is supposed to be higher in older patients and to extend the length of hospital stays. This study aimed, first, to test this supposition within a large psychiatric population which we divided into four clusters of psychiatric ICD-10 diagnoses: F00-F03 (dementias), F10 (substance disorders), F20-29 (schizophrenia, schizophreniform and other non-mood psychotic disorders), F32-F33 (major depressive disorders). Second, despite the increasing evidence for the role of infections in psychiatric disorders, it is, to the best of our knowledge, largely unknown whether the rates of infections with pathogens of the four most frequent germ families differ between psychiatric diseases. Thus, in a retrospective study, the results of clinical routine examinations (pap smear, analysis of midstream urine, stool) dependent on symptoms in 8545 patients of a German psychiatric clinic were analyzed in a 12-year dataset. Results show that a longer hospital stay was associated with an increased number of microbiological tests, but led to no significant difference between positive vs. negative findings. Consistent with previous studies, patients with infections were older than patients without infections. For the F10 diagnosis cluster we found a significantly reduced (F10: Staphylococcaceae) and for the F20-29 cluster a heightened risk of infections (Staphylococcaceae, Corynebacteriaceae). Furthermore, patients belonging to the F00-F03 cluster exhibited elevated rates of infections with all four germ families. The latter can be ascribed to patients' age as we found higher age to be associated with these infections, independently of the presence of dementia. Our results suggest that different psychiatric diagnoses are associated with a heightened or lowered risk of bacterial infections and, furthermore, that clinical routine infection-screenings for elderly psychiatric patients seems to be reasonable.	[Belz, Michael; Rehling, Nico; Schmidt, Ulrike; Wiltfang, Jens; Kis, Bernhard; Wolff-Menzler, Claus] Univ Med Ctr Gottingen UMG, Dept Psychiat & Psychotherapy, Gottingen, Lower Saxony, Germany; [Wiltfang, Jens] German Ctr Neurodegenerat Dis DZNE, Gottingen, Lower Saxony, Germany; [Wiltfang, Jens] Univ Aveiro, Med Sci Dept, Inst Biomed iBiMED, Aveiro, Portugal	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Universidade de Aveiro	Belz, M (corresponding author), Univ Med Ctr Gottingen UMG, Dept Psychiat & Psychotherapy, Gottingen, Lower Saxony, Germany.	mbelz1@gwdg.de	Cruz e Silva, Odete/AAH-5595-2020	Wiltfang, Jens/0000-0003-1492-5330				*ALZH EUR, PREVALENCE OF DEMENT; Alzheimer Europe, 2013, RESEARCH; Arefian H, 2016, AM J INFECT CONTROL, V44, P160, DOI 10.1016/j.ajic.2015.09.005; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cevizci S, 2015, WORLD J BIOL PSYCHIA, V16, P230, DOI 10.3109/15622975.2015.1012224; Cohen J, 1988, STAT POWER ANAL BEHA, DOI 10.1234/12345678; Fellerhoff B, 2011, SCHIZOPHR RES, V129, P191, DOI 10.1016/j.schres.2011.04.015; Geffers C, 2002, GESUNDHEITSBERICHTER; Ingrosso L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094728; Krause D, 2010, WORLD J BIOL PSYCHIA, V11, P739, DOI 10.3109/15622971003653246; Li H, 2017, ASIA-PAC J PUBLIC HE, V29, P440, DOI 10.1177/1010539517717366; Maheshwari P, 2015, J ALZHEIMERS DIS, V43, P957, DOI 10.3233/JAD-140621; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Nguyen TT, 2018, J PSYCHIATR RES, V99, P50, DOI 10.1016/j.jpsychires.2018.01.013; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; ROUX ADE, 2006, CHEST, V129, P1219; Shima K, 2010, MED MICROBIOL IMMUN, V199, P283, DOI 10.1007/s00430-010-0162-1; Statistisches Bundesamt, 2017, DIE 10 HAUFIGSTEN PS; Szabo G, 2015, ALCOHOL RES-CURR REV, V37, P159; van Beurden YH, 2017, J HOSP INFECT, V95, P421, DOI 10.1016/j.jhin.2016.12.019; Vrijens F, 2012, EPIDEMIOL INFECT, V140, P126, DOI 10.1017/S0950268811000100; WANG X, 2014, SCI REP UK, V4; Yolken RH, 2008, MOL PSYCHIATR, V13, P470, DOI 10.1038/mp.2008.5; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	24	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2018	13	12							e0208458	10.1371/journal.pone.0208458	http://dx.doi.org/10.1371/journal.pone.0208458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD0NQ	30513128	Green Submitted, gold, Green Published			2022-12-26	WOS:000452204800032
J	Yang, XY; Shen, H; Buckley, B; Chen, YM; Yang, N; Mussell, AL; Chernov, M; Kobzik, L; Frangou, C; Han, SX; Zhang, JM				Yang, Xinyuan; Shen, He; Buckley, Brian; Chen, Yanmin; Yang, Nuo; Mussell, Ashley L.; Chernov, Mikhail; Kobzik, Lester; Frangou, Costa; Han, Su-Xia; Zhang, Jianmin			NTRK1 is a positive regulator of YAP oncogenic function	ONCOGENE			English	Article							NERVE GROWTH-FACTOR; HIPPO PATHWAY; CANCER; PROLIFERATION; INHIBITORS; MOLECULE; COMPLEX; YAP/TAZ; CELLS	Multiple cancer signalling networks take part in regulatory crosstalks with the Hippo tumour suppressor pathway through the transcriptional cofactor Yes-associated protein (YAP). Nevertheless, how YAP is controlled by pathway crosstalks in tumourigenesis remains poorly understood. Here, we performed a targeted kinase inhibitor screen in human cancer cells to identify novel Hippo pathway regulators. Notably, we identified the nerve growth factor (NGF) receptor tyrosine kinase (NTRK1), a molecule not previously associated with Hippo signalling. NTRK1 inhibition decreased YAP-driven transcription, cancer cell proliferation and migration. Furthermore, using a complementary functional genomics approach and mouse xenograft models, we show that NTRK1 regulates YAP oncogenic activity in vivo. Mechanistically, NTRK1 inhibition was found to induce large suppressor kinase 1 (LATS1) phosphorylation and to control YAP subcellular localization. Taken together, these results provide compelling evidence of crosstalks between the NGF-NTRK1 and Hippo cancer pathways.	[Yang, Xinyuan; Han, Su-Xia] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 1, Coll Med, Xian 710061, Shaanxi, Peoples R China; [Yang, Xinyuan; Shen, He; Chen, Yanmin; Mussell, Ashley L.; Zhang, Jianmin] Roswell Pk Canc Inst, Dept Canc Genet & Genom, Buffalo, NY 14263 USA; [Buckley, Brian; Chernov, Mikhail] Roswell Pk Canc Inst, Small Mol Core, Buffalo, NY 14263 USA; [Yang, Nuo] SUNY Buffalo, Dept Anesthesiol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Kobzik, Lester; Frangou, Costa] Harvard TH Chan Sch Publ Hlth, Mol & Integrat Physiol Sci, 665 Huntington Ave, Boston, MA 02115 USA	Xi'an Jiaotong University; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Harvard T.H. Chan School of Public Health	Han, SX (corresponding author), Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 1, Coll Med, Xian 710061, Shaanxi, Peoples R China.; Zhang, JM (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet & Genom, Buffalo, NY 14263 USA.	shan87@mail.xjtu.edu.cn; Jianmin.zhang@roswellpark.org	Zhang, Jianmin/AAN-2931-2020	Han, Suxia/0000-0002-1513-7427	National Natural Science Foundation of China [81672921]; Innovation Capacity Support Plan of Shaanxi Province [2018TD-002]; Roswell Park Cancer Institute; National Cancer Institute (NCI) [P30 CA016056, R01 CA207]; Roswell Park Alliance Foundation; American Cancer Society [RSG-14-214-01-TBE]; NATIONAL CANCER INSTITUTE [R01CA207504, P30CA016056] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Capacity Support Plan of Shaanxi Province; Roswell Park Cancer Institute; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roswell Park Alliance Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Dr. Haber who kindly provided us 293AD cells and Dr. Camargo who kindly provided us the CTGF promoter luciferase reporter construct. Also, we thank the Small Molecule Screen, Flow and Image Cytometry, Laboratory Animal and Experimental Tumour Models Shared Resources/Facilities of RPCI. This work was supported by the National Natural Science Foundation of China 81672921; Innovation Capacity Support Plan of Shaanxi Province, Grant/Award Number: 2018TD-002 (to SH). This work was supported by the Roswell Park Cancer Institute and National Cancer Institute (NCI) Grant #P30 CA016056, Roswell Park Alliance Foundation, National Cancer Institute (NCI) R01 CA207504 and the American Cancer Society Research Scholar Grant RSG-14-214-01-TBE (to JZ).	Aloe L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0395-y; Arash EH, 2017, EMBO REP, V18, P420, DOI 10.15252/embr.201642455; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Benito-Gutierrez E, 2006, MOL CELL NEUROSCI, V31, P179, DOI 10.1016/j.mcn.2005.09.007; Descamps S, 2001, CANCER RES, V61, P4337; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Fiore M, 2009, REV NEUROSCIENCE, V20, P133; Gibault F, 2017, CHEMMEDCHEM, V12, P954, DOI 10.1002/cmdc.201700063; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Lange AM, 2018, CANCERS, V10, DOI 10.3390/cancers10040105; Li YW, 2016, CELL CYCLE, V15, P2497, DOI 10.1080/15384101.2016.1207836; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Mello SS, 2017, CANCER CELL, V32, P460, DOI 10.1016/j.ccell.2017.09.007; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Niederhauser O, 2000, J NEUROSCI RES, V61, P263, DOI 10.1002/1097-4547(20000801)61:3<263::AID-JNR4>3.0.CO;2-M; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Song SM, 2018, MOL CANCER THER, V17, P443, DOI 10.1158/1535-7163.MCT-17-0560; Wilson KE, 2014, J BIOL CHEM, V289, P23693, DOI 10.1074/jbc.M113.534701; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05856-2; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	30	12	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2778	2787		10.1038/s41388-018-0609-1	http://dx.doi.org/10.1038/s41388-018-0609-1			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30542115	Green Accepted			2022-12-26	WOS:000464121600008
J	Zhu, JR; Wu, GY; Ke, ZF; Cao, LX; Tang, ML; Li, ZW; Li, QJ; Zhou, JH; Tan, ZY; Song, LB; Li, J				Zhu, Jinrong; Wu, Geyan; Ke, Zunfu; Cao, Lixue; Tang, Miaoling; Li, Ziwen; Li, Qiaojia; Zhou, Junhao; Tan, Zhanyao; Song, Libing; Li, Jun			Targeting TRIM3 deletion-induced tumor-associated lymphangiogenesis prohibits lymphatic metastasis in esophageal squamous cell carcinoma	ONCOGENE			English	Article							NF-KAPPA-B; ACTININ 4 ACTN4; CANCER PROGRESSION; PROGNOSTIC MARKER; C PROMOTES; ALPHA; GROWTH; ENHANCER; SUBUNIT	Tumor-associated lymphangiogenesis has attracted increasing attention because of its potential contribution to lymph node metastasis. However, the molecular mechanisms underlying lymphangiogenesis in cancer remains elusive. In the current study, we demonstrate that tripartite motif-containing 3 (TRIM3) directly interacts with and induces E3 ligase-dependent proteasomal turnover of importin alpha 3 and alpha-Actinin-4 (ACTN4), which controls nuclear factor kappa B (NF-kappa B) activity at a well-ordered level. Heterozygous deletion-mediated TRIM3 downregulation led to NF-kappa B constitutive activation through disruption of the NF-kappa B-I kappa B-alpha negative feedback loop and enhancement of the p65 DNA-binding affinity and transcriptional activity via promoting symmetrical dimethylarginine modification of NF-kappa B/p65 at Arg30 and Arg35, which consequently promoted lymphatic metastasis of esophageal squamous cell carcinoma (ESCC) cells. Treatment with Tecfidera, a medication used to treat multiple sclerosis, restored the negative feedback inhibition of NF-kappa B by reducing the NF-kappa B/ACTN4 interaction and decreasing symmetrically dimethylated NF-kappa B levels, resulting in inhibition of ESCC lymphatic metastasis both in vitro and in vivo. Taken together, our results uncover a novel mechanism for constitutive NF-kappa B activation in cancer and may represent an attractive strategy to treat ESCC lymphatic metastasis.	[Zhu, Jinrong; Wu, Geyan; Cao, Lixue; Li, Ziwen; Li, Qiaojia; Zhou, Junhao; Tan, Zhanyao; Li, Jun] Sun Yat Sen Univ, Key Lab Liver Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Zhu, Jinrong; Tang, Miaoling; Li, Jun] Sun Yat Sen Univ, Dept Biochem, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Wu, Geyan; Song, Libing] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Ke, Zunfu] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 1, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Li, J (corresponding author), Sun Yat Sen Univ, Key Lab Liver Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.; Li, J (corresponding author), Sun Yat Sen Univ, Dept Biochem, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China.	lijun37@mail.sysu.edu.cn	wu, ge/ABE-3285-2020; Cao, Lixue/AAM-9316-2020; Song, LB/AAL-1968-2020	Cao, Lixue/0000-0002-0486-6587; 	Natural Science Foundation of China [81830082, 91740119, 91529301, 81621004, 91740118, 81773106, 81530082]; Guangzhou Science and Technology Plan Projects [201803010098]; Natural Science Foundation of Guangdong Province [2018B030311009, 2016A030308002]; Fundamental Research Funds for the Central Universities [17ykjc02]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Plan Projects; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Natural Science Foundation of China (No. 81830082, 91740119, 91529301, 81621004, 91740118, 81773106 and 81530082); Guangzhou Science and Technology Plan Projects (201803010098); Natural Science Foundation of Guangdong Province (2018B030311009 and 2016A030308002); The Fundamental Research Funds for the Central Universities [No. 17ykjc02].	Agarwal N, 2013, ONCOGENE, V32, P462, DOI 10.1038/onc.2012.69; Aksenova V, 2013, ONCOTARGET, V4, P362, DOI 10.18632/oncotarget.901; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; An HT, 2014, J BIOL CHEM, V289, P4969, DOI 10.1074/jbc.M113.515395; [Anonymous], 2011, Nat Rev Drug Discov, V10, P404, DOI 10.1038/nrd3465; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Boulay JL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-71; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Diaz GM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26519-w; Dieterich LC, 2016, ADV DRUG DELIVER REV, V99, P148, DOI 10.1016/j.addr.2015.12.011; El-Husseini AE, 2001, GENOMICS, V71, P363, DOI 10.1006/geno.2000.6452; Feng YK, 2011, EUR J CANCER, V47, P2353, DOI 10.1016/j.ejca.2011.05.006; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; He W, 2018, J CLIN INVEST, V128, P861, DOI 10.1172/JCI96218; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hirakawa S, 2011, J DERMATOL SCI, V61, P85, DOI 10.1016/j.jdermsci.2010.11.020; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Karpanen T, 2001, CANCER RES, V61, P1786; Kastrati I, 2016, J BIOL CHEM, V291, P3639, DOI 10.1074/jbc.M115.679704; Khurana S, 2012, J BIOL CHEM, V287, P35418, DOI 10.1074/jbc.M112.401364; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kumagai Y, 2018, DIS ESOPHAGUS, V31, P1, DOI DOI 10.1093/DOTE/DOY052/5036207; Lam CT, 2002, CANCER LETT, V178, P75, DOI 10.1016/S0304-3835(01)00814-X; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Lin C, 2015, ONCOGENE, V34, P332, DOI 10.1038/onc.2013.559; Liu PF, 2011, CYTOKINE, V55, P8, DOI 10.1016/j.cyto.2011.03.008; Lu T, 2015, CANCER RES, V75, P3692, DOI 10.1158/0008-5472.CAN-15-1022; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Moskaluk CA, 1998, CANCER, V83, P232, DOI 10.1002/(SICI)1097-0142(19980715)83:2<232::AID-CNCR5>3.3.CO;2-G; Mukherjee S, 2016, CANCER RES, V76, P2443, DOI 10.1158/0008-5472.CAN-15-2299; Nicolay JP, 2016, BLOOD, V128, P805, DOI 10.1182/blood-2016-01-694117; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Ribatti D, 2018, CURR OPIN IMMUNOL, V53, P161, DOI 10.1016/j.coi.2018.04.027; Saad RS, 2009, AM J CLIN PATHOL, V131, P92, DOI 10.1309/AJCPKWUQSIPVG90H; Schoppmann SF, 2013, SURGERY, V153, P526, DOI 10.1016/j.surg.2012.10.007; Schreiber J, 2015, J CELL BIOL, V211, P569, DOI 10.1083/jcb.201506048; Smith MD, 2018, EUR J IMMUNOL, V48, P380, DOI 10.1002/eji.201747277; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Su CH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-85; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Zhao X, 2017, J BIOL CHEM, V292, P1637, DOI 10.1074/jbc.M116.755546; Zhao X, 2015, J BIOL CHEM, V290, P338, DOI 10.1074/jbc.M114.597260	48	13	13	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 11	2019	38	15					2736	2749		10.1038/s41388-018-0621-5	http://dx.doi.org/10.1038/s41388-018-0621-5			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HS8LQ	30542119				2022-12-26	WOS:000464121600005
J	McNeill, B; Ostojic, A; Rayner, KJ; Ruel, M; Suuronen, EJ				McNeill, Brian; Ostojic, Aleksandra; Rayner, Katey J.; Ruel, Marc; Suuronen, Erik J.			Collagen biomaterial stimulates the production of extracellular vesicles containing microRNA-21 and enhances the proangiogenic function of CD34(+) cells	FASEB JOURNAL			English	Article						cell therapy; ischemia; Spry1; angiogenesis; culture preconditioning	ENDOTHELIAL PROGENITOR CELLS; CIRCULATING ANGIOGENIC CELLS; MARROW MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; STEM-CELLS; MYOCARDIAL-INFARCTION; CD34-POSITIVE CELLS; GROWTH-FACTOR; UP-REGULATION; THERAPEUTIC NEOVASCULARIZATION	CD34(+) cells are promising for revascularization therapy, but their clinical use is limited by low cell counts, poor engraftment, and reduced function after transplantation. In this study, a collagen type I biomaterial was used to expand and enhance the function of human peripheral blood CD34(+) cells, and potential underlying mechanisms were examined. Compared to the fibronectin control substrate, biomaterial-cultured CD34(+) cells from healthy donors had enhanced proliferation, migration toward VEGF, angiogenic potential, and increased secretion of CD63(+)CD81(+) extracellular vesicles (EVs). In the biomaterial-derived EVs, greater levels of the angiogenic microRNAs (miRs), miR-21 and -210, were detected. Notably, biomaterial-cultured CD34(+) cells had reduced mRNA and protein levels of Sprouty (Spry)1, which is an miR-21 target and negative regulator of endothelial cell proliferation and angiogenesis. Similar to the results of healthy donor cells, biomaterial culture increased miR-21 and -210 expression in CD34(+) cells from patients who underwent coronary artery bypass surgery, which also exhibited improved VEGF-mediated migration and angiogenic capacity. Therefore, collagen biomaterial culture may be useful for expanding the number and enhancing the function of CD34(+) cells in patients, possibly mediated through suppression of Spry1 activity by EV-derived miR-21. These results may provide a strategy to enhance the therapeutic potency of CD34(+) cells for vascular regeneration.McNeill, B., Ostojic, A., Rayner, K. J., Ruel, M., Suuronen, E. J. Collagen biomaterial stimulates the production of extracellular vesicles containing microRNA-21 and enhances the proangiogenic function of CD34(+) cells.	[McNeill, Brian; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Heart Inst, Div Cardiac Surg, 40 Ruskin St,H5227, Ottawa, ON K1Y 4W7, Canada; [Rayner, Katey J.] Univ Ottawa, Heart Inst, Atherosclerosis Genom & Cell Biol Grp, Ottawa, ON, Canada; [Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Rayner, Katey J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa	Suuronen, EJ (corresponding author), Univ Ottawa, Heart Inst, Div Cardiac Surg, 40 Ruskin St,H5227, Ottawa, ON K1Y 4W7, Canada.	esuuronen@ottawaheart.ca			Canadian Institutes of Health Research [MOP-77536]; Ontario Research Fund for Research Excellence from the Ontario Ministry of Research and Innovation [RE07-086]; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund for Research Excellence from the Ontario Ministry of Research and Innovation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors thank C. Eren Cimenci and D. Giroux (University of Ottawa Heart Institute) for technical assistance. This work was supported by the Canadian Institutes of Health Research Grant MOP-77536 (to M.R. and E.J.S.), and by the Ontario Research Fund for Research Excellence from the Ontario Ministry of Research and Innovation (Grant RE07-086 to E.J.S.). B.M. was supported by a Research Fellowship from the Heart and Stroke Foundation of Canada. The authors declare no conflicts of interest.	Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028; Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BENDER JG, 1991, BLOOD, V77, P2591; Benesch M, 2004, BRIT J HAEMATOL, V125, P58, DOI 10.1111/j.1365-2141.2004.04857.x; Besnier M, 2014, FASEB J, V28, P3351, DOI 10.1096/fj.13-245753; Bhatwadekar AD, 2015, DIABETES, V64, P4226, DOI 10.2337/db15-0521; Bhatwadekar AD, 2010, DIABETES, V59, P2010, DOI 10.2337/db10-0287; Chen DC, 2014, CELL TRANSPLANT, V23, P1599, DOI 10.3727/096368914X678562; Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060; Dedobbeleer C, 2009, J CARDIOVASC PHARM, V53, P480, DOI 10.1097/FJC.0b013e3181a7b572; Eidenschink L, 2012, CYTOM PART B-CLIN CY, V82B, P18, DOI 10.1002/cyto.b.20611; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fadini GP, 2010, DIABETES CARE, V33, P1097, DOI 10.2337/dc09-1999; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Frljak S, 2018, STEM CELL TRANSL MED, V7, P168, DOI 10.1002/sctm.17-0197; Grass TM, 2006, ACTA HISTOCHEM, V108, P293, DOI 10.1016/j.acthis.2006.09.005; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gupta PK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-143; Hagikura K, 2010, INT J CARDIOL, V142, P56, DOI 10.1016/j.ijcard.2008.12.108; Hazra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079067; Heiss C, 2005, J AM COLL CARDIOL, V45, P1441, DOI 10.1016/j.jacc.2004.12.074; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Ii M, 2006, CIRC RES, V98, P697, DOI 10.1161/01.RES.0000209948.50943.ea; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Krug S, 2012, BBA-MOL CELL RES, V1823, P789, DOI 10.1016/j.bbamcr.2012.01.006; Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lee SJ, 2010, MOL CELL BIOCHEM, V338, P255, DOI 10.1007/s11010-009-0359-z; Li M, 2013, EXP CLIN TRANSPLANT, V11, P435, DOI 10.6002/ect.2012.0129; Liu B, 2014, INT J CARDIOL, V177, P764, DOI 10.1016/j.ijcard.2014.11.005; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321; Lou YL, 2012, MOL CELL BIOCHEM, V370, P45, DOI 10.1007/s11010-012-1396-6; Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]; Ludwig A, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-20; Mackie AR, 2012, CIRC RES, V111, P312, DOI 10.1161/CIRCRESAHA.112.266015; Mackie AR, 2011, TEX HEART I J, V38, P474; McNeill B, 2015, FASEB J, V29, P1198, DOI 10.1096/fj.14-261586; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; Mielcarek M, 2012, BLOOD, V119, P2675, DOI 10.1182/blood-2011-12-396275; Mocharla P., 2018, CIRCULATION S21, V124; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Pelus LM, 2008, CURR OPIN HEMATOL, V15, P285, DOI 10.1097/MOH.0b013e328302f43a; Pirro Matteo, 2008, Ther Adv Cardiovasc Dis, V2, P329, DOI 10.1177/1753944708094769; Quyyumi AA, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.025; Rossi F, 2010, MICROVASC RES, V80, P274, DOI 10.1016/j.mvr.2010.05.003; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Sahoo S, 2011, CIRCULATION, V124; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Sakashita K, 2015, LEUKEMIA, V29, P606, DOI 10.1038/leu.2014.239; Salama H, 2010, WORLD J GASTROENTERO, V16, P5297, DOI 10.3748/wjg.v16.i42.5297; Scheubel RJ, 2010, INT J CARDIOL, V139, P134, DOI 10.1016/j.ijcard.2008.10.009; Taguchi A, 2008, J CEREBR BLOOD F MET, V28, P445, DOI 10.1038/sj.jcbfm.9600541; Teraa M, 2015, CIRCULATION, V131, P851, DOI 10.1161/CIRCULATIONAHA.114.012913; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Whiteley J, 2014, STEM CELL REV REP, V10, P338, DOI 10.1007/s12015-014-9496-1; Wood HB, 1997, BLOOD, V90, P2300; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zekri ARN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0106-1; Zeng L, 2014, GENE THER, V21, P37, DOI 10.1038/gt.2013.55; Zhou Y, 2016, STEM CELLS, V34, P924, DOI 10.1002/stem.2321; Zubair AC, 2010, CYTOTHERAPY, V12, P178, DOI 10.3109/14653240903493409	77	8	8	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					4166	4177		10.1096/fj.201801332R	http://dx.doi.org/10.1096/fj.201801332R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30526047				2022-12-26	WOS:000459794800085
J	Sociali, G; Grozio, A; Caffa, I; Schuster, S; Becherini, P; Damonte, P; Sturla, L; Fresia, C; Passalacqua, M; Mazzola, F; Raffaelli, N; Garten, A; Kiess, W; Cea, M; Nencioni, A; Bruzzone, S				Sociali, Giovanna; Grozio, Alessia; Caffa, Irene; Schuster, Susanne; Becherini, Pamela; Damonte, Patrizia; Sturla, Laura; Fresia, Chiara; Passalacqua, Mario; Mazzola, Francesca; Raffaelli, Nadia; Garten, Antje; Kiess, Wieland; Cea, Michele; Nencioni, Alessio; Bruzzone, Santina			SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells	FASEB JOURNAL			English	Article						nicotinamide phosphoribosyltransferase; Sirtuin 6; nicotinamide adenine dinucleotide	NAD(+) SALVAGE PATHWAY; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXIDATIVE STRESS; PROMOTES; BIOSYNTHESIS; ACTIVATION; APOPTOSIS; PROTEIN; RESTRICTION; INHIBITORS	Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme in the NAD(+) salvage pathway from nicotinamide. By controlling the biosynthesis of NAD(+), NAMPT regulates the activity of NAD(+)-converting enzymes, such as CD38, poly-ADP-ribose polymerases, and sirtuins (SIRTs). SIRT6 is involved in the regulation of a wide number of metabolic processes. In this study, we investigated the ability of SIRT6 to regulate intracellular NAMPT activity and NAD(P)(H) levels. BxPC-3 cells and MCF-7 cells were engineered to overexpress a catalytically active or a catalytically inactive SIRT6 form or were engineered to silence endogenous SIRT6 expression. In SIRT6-overexpressing cells, NAD(H) levels were up-regulated, as a consequence of NAMPT activation. By immunopurification and incubation with recombinant SIRT6, NAMPT was found to be a direct substrate of SIRT6 deacetylation, with a mechanism that up-regulates NAMPT enzymatic activity. Extracellular NAMPT release was enhanced in SIRT6-silenced cells. Also glucose-6-phosphate dehydrogenase activity and NADPH levels were increased in SIRT6-overexpressing cells. Accordingly, increased SIRT6 levels reduced cancer cell susceptibility to H2O2-induced oxidative stress and to doxorubicin. Our data demonstrate that SIRT6 affects intracellular NAMPT activity, boosts NAD(P)(H) levels, and protects against oxidative stress. The use of SIRT6 inhibitors, together with agents inducing oxidative stress, may represent a promising treatment strategy in cancer.Sociali, G., Grozio, A., Caffa, I., Schuster, S., Becherini, P., Damonte, P., Sturla, L., Fresia, C., Passalacqua, M., Mazzola, F., Raffaelli, N., Garten, A., Kiess, W., Cea, M., Nencioni, A., Bruzzone, S. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.	[Sociali, Giovanna; Grozio, Alessia; Sturla, Laura; Fresia, Chiara; Passalacqua, Mario; Bruzzone, Santina] Univ Genoa, CEBR, Dept Expt Med, Sect Biochem, Genoa, Italy; [Caffa, Irene; Becherini, Pamela; Damonte, Patrizia; Cea, Michele; Nencioni, Alessio] Univ Genoa, Dept Internal Med, Genoa, Italy; [Schuster, Susanne; Garten, Antje; Kiess, Wieland] Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig CPL, Leipzig, Germany; [Mazzola, Francesca] Polytech Univ Marche, Dept Clin Sci, Ancona, Italy; [Raffaelli, Nadia] Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Garten, Antje] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Cea, Michele; Nencioni, Alessio] San Martino Univ Hosp, Natl Inst Canc Res IST, Sci Inst Res & Healthcare IRCCS, Genoa, Italy; [Bruzzone, Santina] CNR, Inst Prot Biochem, Naples, Italy; [Grozio, Alessia] Washington Univ, Sch Med, St Louis, MO USA	University of Genoa; University of Genoa; Leipzig University; Marche Polytechnic University; Marche Polytechnic University; University of Birmingham; University of Genoa; IRCCS AOU San Martino IST; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Washington University (WUSTL)	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Sect Biochem, Viale Benedetto XV 1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	Bruzzone, Santina/A-4264-2015; cea, Michele/K-3863-2018; Caffa, Irene/J-9835-2016; Passalacqua, Mario/W-1973-2019; Mazzola, Francesca/ADC-1197-2022; Nencioni, Alessio/K-3692-2018	Bruzzone, Santina/0000-0003-2034-3716; cea, Michele/0000-0002-1530-6729; Caffa, Irene/0000-0003-1111-9915; Passalacqua, Mario/0000-0003-2779-6259; Mazzola, Francesca/0000-0001-9140-012X; FRESIA, CHIARA MARTA/0000-0002-9177-4655; NENCIONI, ALESSIO/0000-0001-5068-8884; Gaul, Susanne/0000-0003-4780-1844; Grozio, Alessia/0000-0003-4699-3303	Italian Association for Cancer Research (AIRC) [IG AIRC 17736, GR-2011-02347192]; Athero-B-Cell Grant [FP7 GA 602114]; Pancreas Grant [GA 56986]; Fondazione Umberto Veronesi; U.S. Army, Department of Defense, Breast Cancer Research Program [BC161452P1]; 5x1000 Funds from the Hospital Policlinico San Martino, Scientific Institute for Research and Healthcare (IRCCS) for Oncology; University of Genova; Ghislieri College (Pavia, Italy)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Athero-B-Cell Grant; Pancreas Grant; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); U.S. Army, Department of Defense, Breast Cancer Research Program(United States Department of Defense); 5x1000 Funds from the Hospital Policlinico San Martino, Scientific Institute for Research and Healthcare (IRCCS) for Oncology; University of Genova; Ghislieri College (Pavia, Italy)	The authors thank Prof. Antonio De Flora (University of Genoa) for helpful discussions; Prof. Giuseppe Orsomando (Polytechnic University of Marche) for providing the plasmid pTrcHisA-NMNAT1; Prof. Shin-Ichiro Imai (Washington University, St. Louis, MO, USA) for providing the plasmids of FLAG-tagged NAMPT (WT and mutant forms K53R and K79); Prof. Greg Zipfel (Washington University) for providing the SIRT1 KO mice; and Prof. Raul Mostoslavsky (Harvard Medical School, Boston, MA, USA) for providing Sirt6<SUP>+/-</SUP> mice. This work was supported by the Italian Association for Cancer Research (AIRC) Grants IG AIRC 17736 (to A.N.) and GR-2011-02347192 (to A.N. and A. Grozio); Athero-B-Cell Grant FP7 GA 602114 (to A.N.); and Pancreas Grant GA 56986 (to A.N. and S.B.); the Fondazione Umberto Veronesi (to A.N.); U.S. Army, Department of Defense, Breast Cancer Research Program Grant BC161452P1 (to A.N.); 5x1000 Funds from the Hospital Policlinico San Martino, Scientific Institute for Research and Healthcare (IRCCS) for Oncology (to M.C. and A.N.); and the University of Genova (to S.B.). I.C. and P.D. are supported by Fondazione Umberto Veronesi. G.S. is recipient of a fellowship for young investigators granted by Ghislieri College (Pavia, Italy). The authors declare no conflicts of interest.	Audrito V, 2015, BLOOD, V125, P111, DOI 10.1182/blood-2014-07-589069; Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2010, J BIOL CHEM, V285, P21165, DOI 10.1074/jbc.M109.097964; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Buonvicino D, 2018, CELL CHEM BIOL, V25, P471, DOI 10.1016/j.chembiol.2018.01.012; Cagnetta A, 2018, HAEMATOLOGICA, V103, P80, DOI 10.3324/haematol.2017.176248; Carbone F, 2017, COMPR PHYSIOL, V7, P603, DOI 10.1002/cphy.c160029; Cea M, 2016, BLOOD, V127, P1138, DOI 10.1182/blood-2015-06-649970; Dolle C, 2013, CURR TOP MED CHEM, V13, P2907; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Fresia C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26658; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Grimley R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039847; Grolla AA, 2015, PIGM CELL MELANOMA R, V28, P718, DOI 10.1111/pcmr.12420; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Hong SM, 2016, ONCOGENE, V35, P3544, DOI 10.1038/onc.2015.415; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Lerrer B, 2016, CARCINOGENESIS, V37, P108, DOI 10.1093/carcin/bgv167; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luanpitpong S, 2012, BIOCHEM PHARMACOL, V83, P1643, DOI 10.1016/j.bcp.2012.03.010; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Ming M, 2014, CANCER RES, V74, P5925, DOI 10.1158/0008-5472.CAN-14-1308; Montecucco F, 2013, CURR DRUG TARGETS, V14, P637; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Schuster S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091045; Sociali G, 2015, EUR J MED CHEM, V102, P530, DOI 10.1016/j.ejmech.2015.08.024; Soncini D, 2014, J BIOL CHEM, V289, P34189, DOI 10.1074/jbc.M114.594721; Song TY, 2015, BIOGERONTOLOGY, V16, P789, DOI 10.1007/s10522-015-9605-9; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Tao NN, 2017, BIOCHEM BIOPH RES CO, V485, P713, DOI 10.1016/j.bbrc.2017.02.111; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Tsang WP, 2003, LIFE SCI, V73, P2047, DOI 10.1016/S0024-3205(03)00566-6; Xu SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26619; Yoon MJ, 2015, CELL METAB, V21, P706, DOI 10.1016/j.cmet.2015.04.002; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zamporlini F, 2014, FEBS J, V281, P5104, DOI 10.1111/febs.13050; Zhang NN, 2016, CELL CYCLE, V15, P1009, DOI 10.1080/15384101.2016.1152427; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zoppoli G, 2010, EXP HEMATOL, V38, P979, DOI 10.1016/j.exphem.2010.07.013	56	34	35	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3704	3717		10.1096/fj.201800321R	http://dx.doi.org/10.1096/fj.201800321R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30514106	Green Submitted, Green Published, Bronze			2022-12-26	WOS:000459794800050
J	Berneau, P; Thu, TNP; Pladys, P; Beuchee, A				Berneau, Pauline; Trang Nguyen Phuc Thu; Pladys, Patrick; Beuchee, Alain			Impact of surfactant administration through a thin catheter in the delivery room: A quality control chart analysis coupled with a propensity score matched cohort study in preterm infants	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; FETAL-GROWTH RESTRICTION; BRONCHOPULMONARY DYSPLASIA; PREMATURE-INFANTS; THERAPY; VENTILATION; INTUBATION; CARE; MORTALITY; OUTCOMES	Introduction Most infants born before 30 weeks gestational age (GA) develop respiratory distress syndrome soon after birth. Methods of surfactant administration that avoid ventilation have been recently introduced. The aim of this study was to evaluate the impact of implementing a new procedure of less invasive surfactant administration (LISA) and determine whether it is associated with an improvement in respiratory outcome. Methods This single center cohort quality improvement study analyzed preterm infants born before 30 weeks GA between May 2010 and April 2016. Changes in health care practices and respiratory outcomes following the implementation of a LISA, i.e. the administration of surfactant through a thin catheter, were analyzed using quality control charts. Then, the effect of LISA on respiratory outcome was assessed by propensity score matching and logistic regression weighted by the inverse of the propensity score. Results During the study period, 379 infants were included. Of those that were not intubated at ten minutes of life, 129 received surfactant and were ventilated for one hour or more (InVent), 127 received LISA, five received surfactant with tracheal mechanical ventilation for less than one hour (InSurE), and 55 were only treated with nasal continuous positive pressure during the first hour of neonatal care (nCPAP). Quality-chart analysis revealed rapid implementation of the method with a concomitant decrease in required ventilation. LISA was associated with fewer tracheal ventilation days and a lower incidence of supplemental oxygen on day 28. When controlling for the propensity to be exposed or not to LISA, this procedure was not associated with a lower risk of death or bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age. Conclusion In this study, the successful implementation of the new method was associated with lower rates of mechanical ventilation, but without a significant reduction of grade I/II/III BPD or death.	[Berneau, Pauline; Pladys, Patrick; Beuchee, Alain] Univ Rennes 1, Dept Pediat, Rennes, France; [Trang Nguyen Phuc Thu; Pladys, Patrick; Beuchee, Alain] Univ Rennes 1, LTSI, Rennes, France; [Pladys, Patrick; Beuchee, Alain] CHU Rennes, Dept Pediat, Div Neonatol, Rennes, France; [Pladys, Patrick; Beuchee, Alain] CHU Rennes, Dept Pediat, CIC 0203, Rennes, France	Universite de Rennes; Universite de Rennes; CHU Rennes; CHU Rennes	Berneau, P (corresponding author), Univ Rennes 1, Dept Pediat, Rennes, France.	pauline.berneau@chu-rennes.tr	Beuchée, Alain/AAB-7024-2021	Beuchée, Alain/0000-0003-0064-7085; Nguyen Phuc Thu, Trang/0000-0002-0471-1569; Pladys, Patrick/0000-0002-4305-3765; , Berneau/0000-0002-5777-5291				Aldana-Aguirre JC, 2017, ARCH DIS CHILD-FETAL, V102, pF17, DOI 10.1136/archdischild-2015-310299; Barois J, 2013, ACTA PAEDIATR, V102, pE534, DOI 10.1111/apa.12413; Bose C, 2009, PEDIATRICS, V124, pE450, DOI 10.1542/peds.2008-3249; Check J, 2013, J PERINATOL, V33, P553, DOI 10.1038/jp.2012.164; Dargaville PA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-213; Dargaville PA, 2013, NEONATOLOGY, V104, P8, DOI 10.1159/000346460; Dargaville PA, 2012, NEONATOLOGY, V101, P326, DOI 10.1159/000337346; Dunn MS, 2011, PEDIATRICS, V128, pE1069, DOI 10.1542/peds.2010-3848; Eriksson L, 2015, ACTA PAEDIATR, V104, P259, DOI 10.1111/apa.12888; Rodrigo FGM, 2017, NEONATOLOGY, V112, P30, DOI 10.1159/000455966; Gopel W, 2015, ACTA PAEDIATR, V104, P241, DOI 10.1111/apa.12883; Gopel W, 2011, LANCET, V378, P1627, DOI 10.1016/S0140-6736(11)60986-0; Higgins RD, 2018, J PEDIATR-US, V197, P300, DOI 10.1016/j.jpeds.2018.01.043; Ho DE, 2011, J STAT SOFTW, V42; Isayama T, 2016, JAMA-J AM MED ASSOC, V316, P611, DOI 10.1001/jama.2016.10708; JOBE AH, 1993, NEW ENGL J MED, V328, P861; Jobe AH, 2016, AM J PERINAT, V33, P1076, DOI 10.1055/s-0036-1586107; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kanmaz HG, 2013, PEDIATRICS, V131, pE502, DOI 10.1542/peds.2012-0603; Klebermass-Schrehof K, 2013, NEONATOLOGY, V103, P252, DOI 10.1159/000346521; Kribs A, 2010, KLIN PADIATR, V222, P13, DOI 10.1055/s-0029-1241867; Kribs A, 2009, J PERINATOL, V29, P256, DOI 10.1038/jp.2008.245; Kribs A, 2015, JAMA PEDIATR, V169, P723, DOI 10.1001/jamapediatrics.2015.0504; Mohammed MA, 2008, QUAL SAF HEALTH CARE, V17, P137, DOI 10.1136/qshc.2004.012047; Nelson L.S., 1984, J QUAL TECHNOL, V16, P4; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Rigo V, 2016, EUR J PEDIATR, V175, P1933, DOI 10.1007/s00431-016-2789-4; Rojas MA, 2009, PEDIATRICS, V123, P137, DOI 10.1542/peds.2007-3501; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Sekeroglu MA, 2013, EYE, V27, P1053, DOI 10.1038/eye.2013.128; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Sweet DG, 2017, NEONATOLOGY, V111, P107, DOI 10.1159/000448985; Templin L, 2017, AM J PERINATOL; Tennant R, 2007, INT J QUAL HEALTH C, V19, P187, DOI 10.1093/intqhc/mzm015; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Zysman-Colman Z, 2013, PAED CHILD HEALT-CAN, V18, P86, DOI 10.1093/pch/18.2.86	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208252	10.1371/journal.pone.0208252	http://dx.doi.org/10.1371/journal.pone.0208252			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540816	Green Published, gold, Green Submitted			2022-12-26	WOS:000452898600066
J	Hu, FC; Chen, Z; Zhao, JT; Wang, XH; Su, WB; Qin, YH; Hu, GB				Hu, Fuchu; Chen, Zhe; Zhao, Jietang; Wang, Xianghe; Su, Wenbing; Qin, Yonghua; Hu, Guibing			Differential gene expression between the vigorous and dwarf litchi cultivars based on RNA-Seq transcriptome analysis	PLOS ONE			English	Article							GIBBERELLIN METABOLISM; XYLEM SAP; TREE SIZE; VEGETATIVE GROWTH; MOLECULAR-CLONING; QTL ANALYSIS; GC-MS; APPLE; ROOTSTOCK; IDENTIFICATION	Litchi (Litchi chinesis Sonn.) is the most economically significant member of Sapindaceae family, especially in sub-tropical regions. However, its tall tree body often brings many inconveniences to production management. In order to modify the tree size or growth for productivity optimization and simplifying management, it is urgent to reveal the dwarf mechanism of litchi for dwarfing rootstocks or cultivar breeding. However, to date, the mechanisms on litchi dwarfism is still poor known. In the present study, transcriptome profiling were performed on L. chinensis cv. 'Feizixiao' (FZX, vigorous cultivar) and 'Ziniangx' (ZNX, dwarf cultivar). A total of 55,810 unigenes were obtained, and 9,190 unigenes were differentially expressed between vigorous and dwarf litchi samples. Gene functional enrichment analysis indicated that the differentially expressed unigenes (DEGs) were related to phytohormone metabolism and signal transduction, and energy metabolism pathways. In particular, GA2ox were only up-regulated in ZNX samples, indicating GA might play an important role in regulating huge difference between vigorous and dwarf litchi cultivars. In addition, the 35S::LcGA2ox transgenic tobacco plants were dwarf and had smaller leaves or branches than wild type plants. Our study provided a series of candidate genes to reveal the mechanism of litchi dwarf.	[Hu, Fuchu; Zhao, Jietang; Su, Wenbing; Qin, Yonghua; Hu, Guibing] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Key Lab Biol & Genet Improvement Hort Crops South, Minist Agr,Coll Hort, Guangzhou, Guangdong, Peoples R China; [Hu, Fuchu; Chen, Zhe; Wang, Xianghe] Hainan Acad Agr Sci, Key Lab Trop Fruit Tree Biol Hainan Prov, Inst Trop Fruit Trees, Haikou, Hainan, Peoples R China	Ministry of Agriculture & Rural Affairs; South China Agricultural University	Hu, GB (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Key Lab Biol & Genet Improvement Hort Crops South, Minist Agr,Coll Hort, Guangzhou, Guangdong, Peoples R China.	guibing@scau.edu.cn	Zhao, Jietang/G-3881-2010; Su, Wenbing/AFK-0538-2022	Zhao, Jietang/0000-0003-4330-5480; Su, Wenbing/0000-0002-8692-9659	China Litchi and Longan Industry Technology Research System [CARS-32-05]; National Natural Science Foundation of China [31701885]; State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources [SKLCUSA-b201716]; YangFan Innovative & Entrepreneurial Research Team Project [2014YT02H013]; Guangdong Litchi Breeding, Propagation and Extension Union Construction Project	China Litchi and Longan Industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; YangFan Innovative & Entrepreneurial Research Team Project; Guangdong Litchi Breeding, Propagation and Extension Union Construction Project	China Litchi and Longan Industry Technology Research System (Project no. CARS-32-05), National Natural Science Foundation of China (31701885), State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources (SKLCUSA-b201716), YangFan Innovative & Entrepreneurial Research Team Project (No. 2014YT02H013), and the Guangdong Litchi Breeding, Propagation and Extension Union Construction Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolouri Moghaddam MR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00022; Bulley SM, 2005, PLANT BIOTECHNOL J, V3, P215, DOI 10.1111/j.1467-7652.2005.00119.x; Byrne DH, 2012, TRENDS FRUIT BREEDIN, P3; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; Chen JJ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0809-1; Chen Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04328-x; DAVIS TD, 1991, CRIT REV PLANT SCI, V10, P151, DOI 10.1080/07352689109382310; Dobrenel T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00093; Elkins R, 2012, J AM POMOL SOC, V66, P153; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Facteau TJ, 1996, SCI HORTIC-AMSTERDAM, V67, P13, DOI 10.1016/S0304-4238(96)00943-0; Fallahi E, 2001, J PLANT NUTR, V24, P827, DOI 10.1081/PLN-100103776; Fideghelli C, 2003, ACTA HORTIC, P279, DOI 10.17660/ActaHortic.2003.622.26; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Habu T, 2016, HORTICULT J, V85, P306, DOI 10.2503/hortj.MI-119; Hajagos A, 2013, TREES-STRUCT FUNCT, V27, P53, DOI 10.1007/s00468-012-0766-8; Haynes W., 2013, ENCY SYSTEMS BIOL; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hollender CA, 2016, NEW PHYTOL, V210, P227, DOI 10.1111/nph.13772; Hollender CA, 2015, NEW PHYTOL, V206, P541, DOI 10.1111/nph.13204; Hu YX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02103; JONES OP, 1976, ANN BOT-LONDON, V40, P1231, DOI 10.1093/oxfordjournals.aob.a085243; Kamboj JS, 1999, PLANT GROWTH REGUL, V28, P21, DOI 10.1023/A:1006299414481; Kamboj JS, 1999, PLANT GROWTH REGUL, V28, P199, DOI 10.1023/A:1006292309765; Kenis K, 2007, MOL BREEDING, V19, P193, DOI 10.1007/s11032-006-9022-5; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; KURIAN RM, 1992, SCI HORTIC-AMSTERDAM, V50, P245, DOI 10.1016/0304-4238(92)90177-E; LARSEN FE, 1984, SCI HORTIC-AMSTERDAM, V24, P271, DOI 10.1016/0304-4238(84)90111-0; Lastdrager J, 2014, J EXP BOT, V65, P799, DOI 10.1093/jxb/ert474; Lee DJ, 2005, PLANT PHYSIOL, V138, P243, DOI 10.1104/pp.104.056499; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JG, 2008, THE LITCHI; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacMillan J, 2001, J PLANT GROWTH REGUL, V20, P387, DOI 10.1007/s003440010038; Martin DN, 1999, PLANT PHYSIOL, V121, P775, DOI 10.1104/pp.121.3.775; Medjdoub R, 2004, SCI HORTIC-AMSTERDAM, V101, P243, DOI 10.1016/j.scienta.2003.11.005; Menzel C., 2000, P 1 INT S LITCH LONG, P37; Michalczuk L, 2002, ACTA PHYSIOL PLANT, V24, P131, DOI 10.1007/s11738-002-0002-z; MILLER S. R., 1961, CANADIAN JOUR PLANT SCI, V41, P221; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Olesen T, 2013, SCI HORTIC-AMSTERDAM, V156, P93, DOI 10.1016/j.scienta.2013.03.013; Olmstead MA, 2006, J AM SOC HORTIC SCI, V131, P577, DOI 10.21273/JASHS.131.5.577; Peng Jing, 2008, Scientia Agricultura Sinica, V41, P3716; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RICHARDS D, 1986, PLANT PHYSIOL, V82, P1090, DOI 10.1104/pp.82.4.1090; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sakamoto T, 2003, NAT BIOTECHNOL, V21, P909, DOI 10.1038/nbt847; SCHECHTER I, 1991, CAN J BOT, V69, P295, DOI 10.1139/b91-039; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Segura V, 2007, GENOME, V50, P159, DOI 10.1139/G07-002; Sorce C, 2002, SCI HORTIC-AMSTERDAM, V93, P333, DOI 10.1016/S0304-4238(01)00338-7; SOUMELIDOU K, 1994, J HORTIC SCI, V69, P719, DOI 10.1080/14620316.1994.11516505; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Tombesi S, 2011, SCI HORTIC-AMSTERDAM, V127, P353, DOI 10.1016/j.scienta.2010.11.007; Tombesi S, 2010, ANN BOT-LONDON, V105, P327, DOI 10.1093/aob/mcp281; Topp SH, 2012, PLANT SCI, V187, P19, DOI 10.1016/j.plantsci.2012.01.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trifilo P, 2007, TREES-STRUCT FUNCT, V21, P549, DOI 10.1007/s00468-007-0148-9; Waite GK, 2005, LITCHI LOGAN BOT PRO; Wang YJ, 2017, PLANT CELL REP, V36, P391, DOI 10.1007/s00299-017-2104-5; Webster AD, 2004, ACTA HORTIC, P29, DOI 10.17660/ActaHortic.2004.658.1; Webster AD, 1995, NEW ZEAL J CROP HORT, V23, P373, DOI 10.1080/01140671.1995.9513913; Webster T., 2002, Compact Fruit Tree, V35, P67; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zhang YongFu, 2011, Journal of Fruit Science, V28, P624; Zhang Z W, 1997, LITCHI PICTORIAL NAR, P12; Zhu LH, 2008, PLANT CELL REP, V27, P289, DOI 10.1007/s00299-007-0462-0; Zoric L, 2012, J PLANT GROWTH REGUL, V31, P320, DOI 10.1007/s00344-011-9243-7	75	6	7	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2018	13	12							e0208771	10.1371/journal.pone.0208771	http://dx.doi.org/10.1371/journal.pone.0208771			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD9QX	30540829	Green Published, Green Submitted, gold			2022-12-26	WOS:000452898600086
J	Felde, O; Kreizinger, Z; Sulyok, KM; Hrivnak, V; Kiss, K; Jerzsele, A; Biksi, I; Gyuranecz, M				Felde, Orsolya; Kreizinger, Zsuzsa; Sulyok, Kinga Maria; Hrivnak, Veronika; Kiss, Krisztian; Jerzsele, Akos; Biksi, Imre; Gyuranecz, Miklos			Antibiotic susceptibility testing of Mycoplasma hyopneumoniae field isolates from Central Europe for fifteen antibiotics by microbroth dilution method	PLOS ONE			English	Article							IN-VITRO SUSCEPTIBILITIES; ANTIMICROBIAL SUSCEPTIBILITY; RESISTANCE; PIGS; PHARMACOKINETICS; FLUOROQUINOLONE; RECOMMENDATIONS; MARBOFLOXACIN; ENROFLOXACIN; ORGANIZATION	Mycoplasma hyopneumoniae infections are responsible for significant economic losses in the swine industry. Commercially available vaccines are not able to inhibit the colonisation of the respiratory tract by M. hyopneumoniae absolutely, therefore vaccination can be completed with antibiotic treatment to moderate clinical signs and improve performances of the animals. Antibiotic susceptibility testing of M. hyopneumoniae is time-consuming and complicated; therefore, it is not accomplished routinely. The aim of this study was to determine the in vitro susceptibility to 15 different antibiotics of M. hyopneumoniae isolates originating from Hungarian slaughterhouses and to examine single-nucleotide polymorphisms (SNPs) in genes affecting susceptibility to antimicrobials. Minimum inhibitory concentration (MIC) values of the examined antibiotics against 44 M. hyopneumoniae strains were determined by microbroth dilution method. While all of the tested antibiotics were effective against the majority of the studied strains, high MIC values of fluoroquinolones (enrofloxacin 2.5 mu g/ml; marbofloxacin 5 mu g/ml) were observed against one strain (MycSu17) and extremely high MIC values of macrolides and lincomycin (tilmicosin, tulathromycin and lincomycin >64 mu g/ml; gamithromycin 64 mu g/ml; tylosin 32 mu g/ml and tylvalosin 2 mu g/ml) were determined against another, outlier strain (MycSu18). Amino acid changes in the genes gyrA (Gly81Ala; Ala83Val; Glu87Gly, according to Escherichia coli numbering) and parC (Ser80Phe/Tyr; Asp84Asn) correlated with decreased antibiotic susceptibility to fluoroquinolones and a SNP in the nucleotide sequence of the 23S rRNA (A2059G) was found to be associated with increased MIC values of macrolides. The correlation was more remarkable when final MIC values were evaluated. This study presented the antibiotic susceptibility profiles of M. hyopneumoniae strains circulating in the Central European region, demonstrating the high in vitro efficacy of the tested agents. The observed high MIC values correlated with the SNPs in the examined regions and support the relevance of susceptibility testing and directed antibiotic therapy.	[Felde, Orsolya; Kreizinger, Zsuzsa; Sulyok, Kinga Maria; Hrivnak, Veronika; Gyuranecz, Miklos] Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary; [Kiss, Krisztian] SCG Diagnoszt Kft, Delegyhaza, Hungary; [Jerzsele, Akos] Univ Vet Med, Dept Pharmacol & Toxicol, Budapest, Hungary; [Biksi, Imre] Univ Vet Med, Dept & Clin Prod Anim, Ullo, Hungary; [Gyuranecz, Miklos] Univ Vet Med, Dept Microbiol & Infect Dis, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; University of Veterinary Medicine Budapest; University of Veterinary Medicine Budapest	Gyuranecz, M (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary.; Gyuranecz, M (corresponding author), Univ Vet Med, Dept Microbiol & Infect Dis, Budapest, Hungary.	m.gyuranecz@gmail.com	Jerzsele, Ákos/AFW-0086-2022	Gyuranecz, Miklos/0000-0002-5698-5713; Jerzsele, Akos/0000-0002-3380-0827	Lendulet (Momentum) program of the Hungarian Academy of Sciences [LP2012-22]; MycoPath 2 pan-European antimicrobial susceptibility monitoring program; Bolyai Janos Research Fellowship of the Hungarian Academy of Sciences; Bolyai+ Fellowship of the New National Excellence Program of the Ministry of Human Capacities [UNKP-18-4]	Lendulet (Momentum) program of the Hungarian Academy of Sciences; MycoPath 2 pan-European antimicrobial susceptibility monitoring program; Bolyai Janos Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Bolyai+ Fellowship of the New National Excellence Program of the Ministry of Human Capacities	This work was funded by the Lendulet (Momentum) program (LP2012-22) of the Hungarian Academy of Sciences (http://mta.hu/lendulet/) and by the MycoPath 2 pan-European antimicrobial susceptibility monitoring program. MG and ZK was supported by the Bolyai Janos Research Fellowship of the Hungarian Academy of Sciences (http://mta.hu/bolyai-osztondij/bolyai-janos-kutatasi-osztondij-105319). MG was supported by the Bolyai+ Fellowship (UNKP-18-4) of the New National Excellence Program of the Ministry of Human Capacities (http://www.kormany.hu/hu/emberi-eroforrasok-miniszteriuma/oktatasert-felelos-allamtitkarsag). The funders provided support in the form of salaries for authors OF, ZK, KMS, VH and MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The SCG Diagnosztika Kft. provided support in the form of salaries for KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contributions' section.	Ahmad I, 2016, INT J PHOTOENERGY, V2016, DOI 10.1155/2016/8135608; Artiushin S, 1996, INT J SYST BACTERIOL, V46, P324, DOI 10.1099/00207713-46-1-324; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; El Garch F, 2016, VET MICROBIOL, V194, P11, DOI 10.1016/j.vetmic.2016.04.009; ETHERIDGE JR, 1979, AUST VET J, V55, P356, DOI 10.1111/j.1751-0813.1979.tb15888.x; European Centre for Disease Prevention and Control, 2015, EFSA J; Nguyen F, 2014, BIOL CHEM, V395, P559, DOI 10.1515/hsz-2013-0292; Felde O, MYCOPLASMA HYOPNEUMO; Felde O, 2018, VET MICROBIOL, V222, P85, DOI 10.1016/j.vetmic.2018.07.004; FRIIS NF, 1975, NORD VET MED, V27, P337; Gautier-Bouchardon AV, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0030-2018; Godinho KS, 2008, VET MICROBIOL, V129, P426, DOI 10.1016/j.vetmic.2007.11.033; Hannan PCT, 1997, RES VET SCI, V63, P157, DOI 10.1016/S0034-5288(97)90010-2; Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100; Hannan PCT, 1997, ANTIMICROB AGENTS CH, V41, P2037, DOI 10.1128/AAC.41.9.2037; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klein U, 2017, VET MICROBIOL, V204, P188, DOI 10.1016/j.vetmic.2017.04.012; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Kreizinger Z, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1266-2; Lauerman LH, 1995, AVIAN DIS, V39, P804, DOI 10.2307/1592417; Le Carrou J, 2006, ANTIMICROB AGENTS CH, V50, P1959, DOI 10.1128/AAC.01527-05; Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008; Maes D, 1996, VET QUART, V18, P104, DOI 10.1080/01652176.1996.9694628; Maes D, 2017, TRANSBOUND EMERG DIS, DOI [10.1111/tbed.12677, DOI 10.1111/TBED.12677]; MATTSSON JG, 1995, J CLIN MICROBIOL, V33, P893, DOI 10.1128/JCM.33.4.893-897.1995; MCCORMACK WM, 1993, CLIN INFECT DIS, V17, pS200, DOI 10.1093/clinids/17.Supplement_1.S200; Pallares FJ., 2015, VET RECORD OPEN, V2, DOI [10.1136/vetreco-2014-000079, DOI 10.1136/VETRECO-2014-000079]; Poulsen SM, 2001, MOL MICROBIOL, V41, P1091, DOI 10.1046/j.1365-2958.2001.02595.x; Priebe S, 2003, ANTIMICROB AGENTS CH, V47, P2703, DOI 10.1128/AAC.47.8.2703-2705.2003; Reinhardt AK, 2002, J ANTIMICROB CHEMOTH, V50, P589, DOI 10.1093/jac/dkf158; Rodvold KA, 2001, PHARMACOTHERAPY, V21, p233S, DOI 10.1592/phco.21.16.233S.33992; Schneider M, 2014, J VET PHARMACOL THER, V37, P523, DOI 10.1111/jvp.12125; Somogyi Z, 2018, MAGY ALLATORVOSOK LA, V14, P37; Stakenborg T, 2005, MICROB DRUG RESIST, V11, P290, DOI 10.1089/mdr.2005.11.290; Sulyok KM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01983-16; Tavio MM, 2014, VET REC, V175, P538, DOI 10.1136/vr.102458; Thacker EL, 1998, SWINE HEALTH PROD, V6, P107; Thongkamkoon P, 2013, J VET MED SCI, V75, P1067, DOI 10.1292/jvms.12-0520; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; Vicca J, 2007, MICROB DRUG RESIST, V13, P166, DOI 10.1089/mdr.2007.716; Vicca J, 2004, ANTIMICROB AGENTS CH, V48, P4470, DOI 10.1128/AAC.48.11.4470-4472.2004; Waites KB, 2012, J CLIN MICROBIOL, V50, P3542, DOI 10.1128/JCM.01439-12; Wayne P., 2011, M43A CLSI; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; Wyns H, 2014, RES VET SCI, V96, P160, DOI 10.1016/j.rvsc.2013.11.012; YAMAMOTO K, 1986, JPN J VET SCI, V48, P1, DOI 10.5331/seppyo.48.1	48	14	15	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0209030	10.1371/journal.pone.0209030	http://dx.doi.org/10.1371/journal.pone.0209030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533041	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000452782500059
J	Masuoka, S; Kusunoki, N; Takamatsu, R; Takahashi, H; Tsuchiya, K; Kawai, S; Nanki, T				Masuoka, Shotaro; Kusunoki, Natsuko; Takamatsu, Ryo; Takahashi, Hiroshi; Tsuchiya, Kazuaki; Kawai, Shinichi; Nanki, Toshihiro			Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis	PLOS ONE			English	Article							DNA; CELLS; EXPRESSION; MEMBRANE; SEQUENCE; CYTOMEGALOVIRUS; LYMPHOCYTES; JAPANESE; HLA-DR4; RNA	Objective The objective of the present study was to investigate Epstein-Barr virus (EBV) infection as an environmental factor for the development of rheumatoid arthritis (RA). Methods Synovial tissues were collected during surgery from 128 RA and 98 osteoarthritis (OA) patients. DNA was extracted from synovial tissues. The EBV gene was assessed by nested PCR for the amplification of EBV nuclear antigen-1 (EBNA-1). The nucleotide sequence of the PCR product was elucidated. HLA-DRB1 genotyping was also performed. Results EBV DNA was more frequently detected in the synovial tissues of RA patients (32.8%) than OA patients (15.3%) (p<0.01). The frequency of EBNA-1 variants did not significantly differ between RA and OA (RA: 17%, OA: 13%). The population with the HLA-DRB1 shared epitope (SE) was significantly higher in RA patients (70.3%) than in OA patients (44.9%) (p<0.001). In RA patients, the presence of EBV DNA was similar among SE-positive and -negative patients (SE-positive: 34.4%, -negative: 28.9%). The population with the EBNA-1 variant did not significantly differ between SE-positive and -negative patients (SE-positive: 12.9%, -negative: 27.3%). Discussion The present results indicate that EBV infection contributes to the onset of RA and chronic inflammation in synovial tissues. The frequency of EBNA-1 gene variants was low and not significantly different between RA and OA, suggesting that EBNA-1 gene variants are not a risk factor for RA. HLA-DRB1 with SE is a genetic risk factor for the development of RA. However, neither the presence of EBV nor EBNA-1 gene variants differed between SE-positive and -negative RA patients. Therefore, these two risk factors, SE and EBV, may be independent. Conclusion EBV infection may be an environmental risk factor for the development of RA, while nucleotide variants of EBNA-1 do not appear to contribute to its development.	[Masuoka, Shotaro; Nanki, Toshihiro] Toho Univ, Grad Sch Med, Dept Internal Med, Tokyo, Japan; [Masuoka, Shotaro; Kusunoki, Natsuko; Nanki, Toshihiro] Toho Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan; [Kusunoki, Natsuko; Kawai, Shinichi] Toho Univ, Sch Med, Dept Inflammat & Pain Control Res, Tokyo, Japan; [Takamatsu, Ryo; Takahashi, Hiroshi; Tsuchiya, Kazuaki] Toho Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan	Toho University; Toho University; Toho University; Toho University	Nanki, T (corresponding author), Toho Univ, Grad Sch Med, Dept Internal Med, Tokyo, Japan.; Nanki, T (corresponding author), Toho Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan.	toshihiro.nanki@med.toho-u.ac.jp			Toho University School of Medicine [29-17-16]; Toho University Graduate School of Medicine [17-01]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [S1411015]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Toho University School of Medicine(Toho University); Toho University Graduate School of Medicine(Toho University); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Project Research Grant (No. 29-17-16) from Toho University School of Medicine to SM, a Research Promotion Grant from Toho University Graduate School of Medicine (No. 17-01) to TN, the Program for the Strategic Research Foundation for Private Universities (S1411015) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan to TN, and the Private University Research Branding Project from the Ministry of Education, Culture, Sports, Science, and Technology, Japan to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAUGH MA, 1978, J EXP MED, V147, P1018, DOI 10.1084/jem.147.4.1018; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Balandraud N, 2004, AUTOIMMUN REV, V3, P362, DOI 10.1016/j.autrev.2004.02.002; Bhatia K, 1996, ONCOGENE, V13, P177; Blaschke S, 2000, J RHEUMATOL, V27, P866; Chen YY, 1998, LAB INVEST, V78, P877; Croia C, 2013, ANN RHEUM DIS, V72, P1559, DOI 10.1136/annrheumdis-2012-202352; Di Giuseppe D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4498; Edinger JW, 1999, J IMMUNOL, V162, P3694; FOX RI, 1986, J IMMUNOL, V137, P498; Gutierrez MI, 1997, J GEN VIROL, V78, P1663, DOI 10.1099/0022-1317-78-7-1663; Joseph R, 2013, RHEUMATOL INT, V33, P103, DOI 10.1007/s00296-011-2284-1; Kuwana Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026630; Mehraein Y, 2004, MODERN PATHOL, V17, P781, DOI 10.1038/modpathol.3800119; Mousavi-Jazi M, 1998, J RHEUMATOL, V25, P623; Picerno V, 2015, CLIN EXP RHEUMATOL, V33, P551; ROUDIER J, 1988, SCAND J IMMUNOL, V27, P367, DOI 10.1111/j.1365-3083.1988.tb02359.x; Saal JG, 1999, ARTHRITIS RHEUM-US, V42, P1485, DOI 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Shibue T, 2000, ARTHRITIS RHEUM, V43, P753, DOI 10.1002/1529-0131(200004)43:4<753::AID-ANR5>3.0.CO;2-O; Takeda T, 2000, ARTHRITIS RHEUM, V43, P1218, DOI 10.1002/1529-0131(200006)43:6<1218::AID-ANR4>3.0.CO;2-2; Takei M, 2001, INT IMMUNOL, V13, P559, DOI 10.1093/intimm/13.4.559; Takei M, 1997, INT IMMUNOL, V9, P739, DOI 10.1093/intimm/9.5.739; TOSATO G, 1981, NEW ENGL J MED, V305, P1238, DOI 10.1056/NEJM198111193052102; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0	26	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0208957	10.1371/journal.pone.0208957	http://dx.doi.org/10.1371/journal.pone.0208957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533036	gold, Green Submitted, Green Published			2022-12-26	WOS:000452782500055
J	Tang, BH; Hao, ZQ; Zhu, YF; Zhang, H; Li, GL				Tang, Baihua; Hao, Zhiqiang; Zhu, Yanfeng; Zhang, Hua; Li, Guanglin			Genome-wide identification and functional analysis of circRNAs in Zea mays	PLOS ONE			English	Article							CIRCULAR RNAS; MESSENGER-RNA; GENE; TRANSCRIPTS; EFFICIENT; ANNOTATION; BIOMARKER	Circular RNAs (circRNAs) are a class of endogenous noncoding RNAs, which increasingly drawn researchers' attention in recent years as their importance in regulating gene expression at the transcriptional and post-transcriptional levels. With the development of highthroughput sequencing and bioinformatics, circRNAs have been widely analysed in animals, but the understanding of characteristics and function of circRNAs is limited in plants, especially in maize. Here, 3715 unique circRNAs were predicted in Zea mays systematically, and 8 of 12 circRNAs were validated by experiments. By analysing circRNA sequence, the events of alternative circularization phenomenon were found prevailed in maize. By comparing circRNAs in different species, it showed that part circRNAs are conserved across species, for example, there are 273 circRNAs conserved between maize and rice. Although most of the circRNAs have low expression levels, we found 149 differential expressed circRNAs responding to heat, cold, or drought, and 1782 tissue-specific expressed circRNAs. The results showed that those circRNAs may have potential biological functions in specific situations. Finally, two different methods were used to search circRNA functions, which were based on circRNAs originated from protein-coding genes and circRNAs as miRNA decoys. 346 circRNAs could act as miRNA decoys, which might modulate the effects of multiple molecular functions, including binding, catalytic activity, oxidoreductase activity, and transmembrane transporter activity. In summary, maize circRNAs were identified, classified and characterized systematically. We also explored circRNA functions, suggesting that circRNAs are involved in multiple molecular processes and play important roles in regulating of gene expression. Our results provide a rich resource for further study of maize circRNAs.	[Tang, Baihua; Hao, Zhiqiang; Zhu, Yanfeng; Li, Guanglin] Shaanxi Normal Univ, Minist Educ Med Plant Resource & Nat Pharmaceut C, Key Lab, Xian, Shaanxi, Peoples R China; [Tang, Baihua; Hao, Zhiqiang; Zhu, Yanfeng; Zhang, Hua; Li, Guanglin] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China	Shaanxi Normal University; Shaanxi Normal University	Li, GL (corresponding author), Shaanxi Normal Univ, Minist Educ Med Plant Resource & Nat Pharmaceut C, Key Lab, Xian, Shaanxi, Peoples R China.; Li, GL (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China.	glli@snnu.edu.cn		Li, Guanglin/0000-0001-7617-1824	National Natural Science Foundation of China [31770333, 31370329, 11631012]; Program for New Century Excellent Talents in University [NCET-12-0896]; Natural Science Basic Research Plan of Shaanxi Province, China [2014JM3074]; Fundamental Research Funds for the Central Universities [GK201403004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Basic Research Plan of Shaanxi Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31770333, No. 31370329 and No. 11631012), the Program for New Century Excellent Talents in University (NCET-12-0896), the Natural Science Basic Research Plan of Shaanxi Province, China (No. 2014JM3074), and the Fundamental Research Funds for the Central Universities (No. GK201403004). The funding agencies had no role in the study, its design, the data collection and analysis, the decision to publish, or the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bachmayr-Heyda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08057; Bailleul B, 1996, NUCLEIC ACIDS RES, V24, P1015, DOI 10.1093/nar/24.6.1015; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Chen L, 2018, NEW PHYTOL, V217, P1292, DOI 10.1111/nph.14901; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Darbani B, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fplis.2016.00776, 10.3389/fpls.2016.00776]; Fan CY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2024-0; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Houseley JM, 2006, J HERED, V97, P253, DOI 10.1093/jhered/esj037; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li F, 2015, ONCOTARGET, V6, P6001, DOI 10.18632/oncotarget.3469; LI L, 2014, GENOME BIOL, V15; Li PF, 2015, CLIN CHIM ACTA, V444, P132, DOI 10.1016/j.cca.2015.02.018; Li XF, 1999, J BIOL CHEM, V274, P8153, DOI 10.1074/jbc.274.12.8153; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Lu TT, 2015, RNA, V21, P2076, DOI 10.1261/rna.052282.115; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salzman J, 2012, PLOS ONE, V7; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Sun XY, 2016, FEBS LETT, V590, P3510, DOI 10.1002/1873-3468.12440; Thatcher SR, 2014, PLANT CELL, V26, P3472, DOI 10.1105/tpc.114.130773; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang Y, 2015, RNA, V21, P172, DOI 10.1261/rna.048272.114; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Wu HJ, 2013, PLANT PHYSIOL, V161, P1875, DOI 10.1104/pp.113.215962; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xuan LJ, 2016, AM J TRANSL RES, V8, P932; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Ye CY, 2017, RNA BIOL, V14, P1055, DOI 10.1080/15476286.2016.1245268; Ye CY, 2015, NEW PHYTOL, V208, P88, DOI 10.1111/nph.13585; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536; Zeng RF, 2018, PLANTA, V247, P1191, DOI 10.1007/s00425-018-2857-2; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102006; ZHAO WW, 2017, SCI REP UK, V7; Zuo J, 2016, BIOCH BIOPHYSICAL RE	49	21	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2018	13	12							e0202375	10.1371/journal.pone.0202375	http://dx.doi.org/10.1371/journal.pone.0202375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD8CS	30533052	gold, Green Submitted, Green Published			2022-12-26	WOS:000452782500002
J	Carvajal, R; Orellana, R; Katselis, D; Escarate, P; Aguero, JC				Carvajal, Rodrigo; Orellana, Rafael; Katselis, Dimitrios; Escarate, Pedro; Carlos Aguero, Juan			A data augmentation approach for a class of statistical inference problems	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; FIR SYSTEMS; EM; IDENTIFICATION; REGRESSION; SELECTION; MODELS; ALGORITHM; MIXTURES	We present an algorithm for a class of statistical inference problems. The main idea is to reformulate the inference problem as an optimization procedure, based on the generation of surrogate (auxiliary) functions. This approach is motivated by the MM algorithm, combined with the systematic and iterative structure of the Expectation-Maximization algorithm. The resulting algorithm can deal with hidden variables in Maximum Likelihood and Maximum a Posteriori estimation problems, Instrumental Variables, Regularized Optimization and Constrained Optimization problems. The advantage of the proposed algorithm is to provide a systematic procedure to build surrogate functions for a class of problems where hidden variables are usually involved. Numerical examples show the benefits of the proposed approach.	[Carvajal, Rodrigo; Orellana, Rafael; Carlos Aguero, Juan] Univ Tecn Federico Santa Maria, Elect Engn Dept, Valparaiso, Chile; [Orellana, Rafael] Univ Los Andes, Merida, Venezuela; [Katselis, Dimitrios] Univ Illinois, Coordinated Sci Lab, 1101 W Springfield Ave, Urbana, IL 61801 USA; [Katselis, Dimitrios] Univ Illinois, Informat Trust Inst, Urbana, IL 61801 USA; [Escarate, Pedro] Univ Arizona, Steward Observ, Large Binocular Telescope Observ, Tucson, AZ USA; [Escarate, Pedro] Univ Austral Chile, Fac Ciencias Ingn, Inst Elect & Elect, Valdivia, Chile	Universidad Tecnica Federico Santa Maria; University of Los Andes Venezuela; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Arizona; Universidad Austral de Chile	Carvajal, R (corresponding author), Univ Tecn Federico Santa Maria, Elect Engn Dept, Valparaiso, Chile.	rodrigo.carvajalg@usm.cl	Escarate, Pedro/AAH-1677-2019; Aguero, Juan C/A-8657-2013; Orellana, Rafael/Y-5616-2018	Escarate, Pedro/0000-0002-6751-3842; Aguero, Juan C/0000-0001-7104-3233; Orellana, Rafael/0000-0002-8632-5126; Carvajal, Rodrigo/0000-0002-3336-8683	Fondo Nacional de Desarrollo Cientifico y Tecnologico-Chile [3140054, 1181158]; Comision Nacional de Investigacion Cientifica y Tecnologica, Advanced Center for Electrical and Electronic Engineering (AC3E, Proyecto Basal), Chile [FB0008]; PIIC program of the Universidad Tecnica Federico Santa Maria [015/2018]	Fondo Nacional de Desarrollo Cientifico y Tecnologico-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica, Advanced Center for Electrical and Electronic Engineering (AC3E, Proyecto Basal), Chile; PIIC program of the Universidad Tecnica Federico Santa Maria	This work was partially supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico-Chile through grants No. 3140054 and 1181158. This work was also partially supported by the Comision Nacional de Investigacion Cientifica y Tecnologica, Advanced Center for Electrical and Electronic Engineering (AC3E, Proyecto Basal FB0008), Chile. The work of R. Orellana was partially supported by the PIIC program of the Universidad Tecnica Federico Santa Maria, scholarship 015/2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero JC, 2012, AUTOMATICA, V48, P3031, DOI 10.1016/j.automatica.2012.08.033; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balakrishnan N, 2009, SORT-STAT OPER RES T, V33, P171; BARNDORFFNIELSEN O, 1982, INT STAT REV, V50, P145, DOI 10.2307/1402598; Beal MJ, 2003, P 7 VAL INT M; Carvajal R, 2015, IEEE INT WORKS MACH; Carvajal R, 2013, IEEE T VEH TECHNOL, V62, P152, DOI 10.1109/TVT.2012.2217361; CHANDRASEKHAR S, 1950, ASTROPHYS J, V111, P142, DOI 10.1086/145245; Christen A, 2016, ASTRON ASTROPHYS, V595, P1; Cure M, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201323344; DeGroot M. H., 1970, OPTIMAL STAT DECISIO; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deutsch AJ, 1969, P IAU C STELL ROT, P207; Durret R., 2010, PROBABILITY THEORY E, V4, DOI [10.1017/CBO9780511779398, DOI 10.1017/CBO9780511779398]; Fan JQ, 2018, ANN STAT, V46, P814, DOI 10.1214/17-AOS1568; Figueiredo MAT, 2007, IEEE T IMAGE PROCESS, V16, P2980, DOI 10.1109/TIP.2007.909318; Figueiredo MAT, 2003, IEEE T PATTERN ANAL, V25, P1150, DOI 10.1109/TPAMI.2003.1227989; Fletcher R., 1987, PRACTICAL METHODS OP; Garrigues PJ, 2010, P ADV NEUR INF PROC, V23, P676, DOI DOI 10.1007/978-3-319-59463-7_51; Godoy BI, 2014, INT J CONTROL, V87, P874, DOI 10.1080/00207179.2013.861611; Godoy BI, 2011, AUTOMATICA, V47, P1905, DOI 10.1016/j.automatica.2011.06.008; Goldsmith A., 2005, WIRELESS COMMUNICATI, DOI [10.1198/0003130042836, DOI 10.1198/0003130042836]; Goodwin G. C., 1977, DYNAMIC SYSTEM IDENT; Gopaluni RB, 2008, CAN J CHEM ENG, V86, P1081, DOI 10.1002/cjce.20113; Grant MC, 2008, LECT NOTES CONTR INF, V371, P95, DOI 10.1007/978-1-84800-155-8_7; HANSON MA, 1965, ANN I STAT MATH, V17, P311, DOI 10.1007/BF02868175; Hobolth A, 2005, STAT APPL GENET MOL, V4; Hunter DR, 2004, AM STAT, V58, P30, DOI 10.1198/0003130042836; Hyder MM, 2009, IEEE SIGNAL PROC LET, V16, P1091, DOI 10.1109/LSP.2009.2028107; Izmailov A, 2014, NEWTON TYPE METHODS; Kraus C, 2005, EUR PHYS J C, V40, P447, DOI 10.1140/epjc/s2005-02139-7; Lange K, 2013, OPTIMIZATION; Lemieux C, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-78165-5_1; Li Q, 2010, BAYESIAN ANAL, V5, P151, DOI 10.1214/10-BA506; Ljung L, 2014, P 53 IEEE C DEC CONT; Mahata K, 2004, AUTOMATICA, V40, P1307, DOI 10.1016/j.automatica.2004.03.001; MARKS BR, 1978, OPER RES, V26, P681, DOI 10.1287/opre.26.4.681; McLachlan GJ, 2004, FINITE MIXTURE MODEL, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; McLachlan GJ, 1997, EM ALGORITHM EXTENSI; Meng XL, 2007, STAT SINICA, V17, P839; Mengersen K., 2011, MIXTURES ESTIMATION; Molisch A. F., 2005, WIRELESS COMMUNICATI; Neal RM, 2003, ANN STAT, V31, P705, DOI 10.1214/aos/1056562461; Orellana R, 2018, 18 IFAC S SYST ID SY; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Patzold M., 2011, MOBILE RADIO CHANNEL, DOI 10.1002/9781119974116; Pollakis E, 2012, P 13 IEEE INT WORKSH; Polson NG, 2013, BIOMETRIKA, V100, P459, DOI 10.1093/biomet/ass081; REDNER RA, 1984, SIAM REV, V26, P195, DOI 10.1137/1026034; Robert C, 1999, MONTE CARLO STAT MET; Rodriguez M, 2012, IEEE T WIREL COMMUN, V11, P2204, DOI 10.1109/TWC.2012.041612.110735; Salous S, 2013, RADIO PROPAGATION MEASUREMENT AND CHANNEL MODELLING, P1, DOI 10.1002/9781118502280; Schon TB, 2011, AUTOMATICA, V47, P39, DOI 10.1016/j.automatica.2010.10.013; Semkow TM, 2018, ARXIV E PRINTS; Soderstrom T., 1988, SYSTEM IDENTIFICATIO; Sriperumbudur BK, 2011, MACH LEARN, V85, P3, DOI 10.1007/s10994-010-5226-3; SUZUKI H, 1977, IEEE T COMMUN, V25, P673, DOI 10.1109/TCOM.1977.1093888; Tanner MA, 1991, TOOLS STAT INFERENCE, DOI [10.1007/978-1-4684-0510-1, DOI 10.1007/978-1-4684-0510-1]; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vaida F, 2005, STAT SINICA, V15, P831; van Dyk DA, 2001, J COMPUT GRAPH STAT, V10, P1, DOI 10.1198/10618600152418584; Wang LY, 2003, IEEE T AUTOMAT CONTR, V48, P1892, DOI 10.1109/TAC.2003.819073; Wazwaz A. M., 2011, LINEAR NONLINEAR INT, P237, DOI DOI 10.1007/978-3-642-21449-3; WEST M, 1987, BIOMETRIKA, V74, P646, DOI 10.2307/2336707; Xu J, 2016, P 30 NEUR INF PROC S, P1385; Yang S, 2013, STAT INTERFACE, V6, P339; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	69	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208499	10.1371/journal.pone.0208499	http://dx.doi.org/10.1371/journal.pone.0208499			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532211	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700025
J	De Meulenaere, V; Neyt, S; Vandeghinste, B; Mollet, P; De Wever, O; Decrock, E; Leybaert, L; Goethals, I; Vanhove, C; Descamps, B; Deblaere, K				De Meulenaere, Valerie; Neyt, Sara; Vandeghinste, Bert; Mollet, Pieter; De Wever, Olivier; Decrock, Elke; Leybaert, Luc; Goethals, Ingeborg; Vanhove, Christian; Descamps, Benedicte; Deblaere, Karel			Species-dependent extracranial manifestations of a brain seeking breast cancer cell line	PLOS ONE			English	Article							TUMOR BARRIER PERMEABILITY; IN-VIVO; BONE METASTASES; MOUSE MODEL; TRACKING; MRI; PET	Purpose Metastatic brain tumors pose a severe problem in the treatment of patients with breast carcinoma. Preclinical models have been shown to play an important role in unraveling the underlying mechanisms behind the metastatic process and evaluation of new therapeutic approaches. As the size of the rat brain allows improved in vivo imaging, we attempted to establish a rat model for breast cancer brain metastasis that allows follow-up by 7 tesla (7T) preclinical Magnetic Resonance Imaging (MRI). Procedures Green fluorescent protein-transduced (eGFP) MDA-MB-231br breast cancer cells were labeled with micron-sized particles of iron oxide (MPIOs) and intracardially injected in the left ventricle of female nude rats and mice. 7T preclinical MRI was performed to show the initial distribution of MPIO-labeled cancer cells and to visualize metastasis in the brain. Occurrence of potential metastasis outside the brain was evaluated by 2-deoxy-2-[F-18]fluoro-Dglucose ([F-18]FDG) positron emission tomography (PET)/computed tomography (CT) and potential bone lesions were assessed using [F-18]sodium fluoride ([F-18]NaF) PET/CT. Results The first signs of brain metastasis development were visible as hyperintensities on T2-weighted (T2w) MR images acquired 3 weeks after intracardiac injection in rats and mice. Early formation of unexpected bone metastasis in rats was clinically observed and assessed using PET/CT. Almost no bone metastasis development was observed in mice after PET/ CT evaluation. Conclusions Our results suggest that the metastatic propensity of the MDA-MB-231br/eGFP cancer cell line outside the brain is species-dependent. Because of early and abundant formation of bone metastasis with the MDA-MB-231br/eGFP cancer cell line, this rat model is currently not suitable for investigating brain metastasis as a single disease model nor for evaluation of novel brain metastasis treatment strategies.	[De Meulenaere, Valerie; Deblaere, Karel] Ghent Univ Hosp, Dept Radiol, Ghent, Belgium; [Neyt, Sara; Vandeghinste, Bert; Mollet, Pieter] MOLECUBES NV, Ghent, Belgium; [De Wever, Olivier] Univ Ghent, Dept Expt Canc Res, Ghent, Belgium; [Decrock, Elke; Leybaert, Luc] Univ Ghent, Dept Basic Med Sci, Ghent, Belgium; [Goethals, Ingeborg] Ghent Univ Hosp, Dept Nucl Med, Ghent, Belgium; [Vanhove, Christian; Descamps, Benedicte] Univ Ghent, IBiTech Medisip Infin Lab, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University; Ghent University Hospital; Ghent University	De Meulenaere, V (corresponding author), Ghent Univ Hosp, Dept Radiol, Ghent, Belgium.	Valerie.DeMeulenaere@UGent.Be		Vanhove, Christian/0000-0002-3988-5980; Descamps, Benedicte/0000-0001-8879-1772				Balathasan L, 2013, AM J PATHOL, V183, P26, DOI 10.1016/j.ajpath.2013.03.003; Cook GJR, 2016, J NUCL MED, V57, p27S, DOI 10.2967/jnumed.115.157867; Cook Gary J. R., 2000, Cancer, V88, P2927, DOI 10.1002/1097-0142(20000615)88:12+<2927::AID-CNCR8>3.0.CO;2-V; Cook GJ, 1998, J CLIN ONCOL, V16, P3375, DOI 10.1200/JCO.1998.16.10.3375; Daphu I, 2013, CLIN EXP METASTAS, V30, P695, DOI 10.1007/s10585-013-9566-9; DAVIS PC, 1991, AM J NEURORADIOL, V12, P293; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Kang WJ, 2015, NUCL MED BIOL, V42, P728, DOI 10.1016/j.nucmedbio.2015.05.003; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Lin NU, 2013, CLIN CANCER RES, V19, P6404, DOI 10.1158/1078-0432.CCR-13-0790; Lin XL, 2015, J CLIN ONCOL, V33, P3475, DOI 10.1200/JCO.2015.60.9503; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Morris PG, 2010, J CLIN ONCOL, V28, P3154, DOI 10.1200/JCO.2009.27.5743; Murrell DH, 2014, J MOL MED, V92, P5, DOI 10.1007/s00109-013-1108-z; Palmieri D, 2014, CLIN CANCER RES, V20, P2727, DOI 10.1158/1078-0432.CCR-13-2588; Percy DB, 2011, INVEST RADIOL, V46, P718, DOI 10.1097/RLI.0b013e318226c427; Sakaeda T, 1998, J DRUG TARGET, V6, P261, DOI 10.3109/10611869808996834; Schirrmeister H, 2007, RADIOL CLIN N AM, V45, P669, DOI 10.1016/j.rcl.2007.05.007; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shapiro EM, 2008, FUND BIOMED TECHNOL, V3, P141; Song HT, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-88; Sundstrom T, 2013, CANCER RES, V73, P2445, DOI 10.1158/0008-5472.CAN-12-3514; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; ZHANG RD, 1992, AM J PATHOL, V141, P1115	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208340	10.1371/journal.pone.0208340	http://dx.doi.org/10.1371/journal.pone.0208340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532191	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700020
J	Karlsson, R; Gonzales-Siles, L; Gomila, M; Busquets, A; Salva-Serra, F; Jaen-Luchoro, D; Jakobsson, HE; Karlsson, A; Boulund, F; Kristiansson, E; Moore, ERB				Karlsson, Roger; Gonzales-Siles, Lucia; Gomila, Margarita; Busquets, Antonio; Salva-Serra, Francisco; Jaen-Luchoro, Daniel; Jakobsson, Hedvig E.; Karlsson, Anders; Boulund, Fredrik; Kristiansson, Erik; Moore, Edward R. B.			Proteotyping bacteria: Characterization, differentiation and identification of pneumococcus and other species within the Mitis Group of the genus Streptococcus by tandem mass spectrometry proteomics	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; GENOMICS; TAXONOMY; DATABASE; REFSEQ; PNEUMONIAE; ANNOTATION; RESISTANCE; INFLUENZA; PARALLEL	A range of methodologies may be used for analyzing bacteria, depending on the purpose and the level of resolution needed. The capability for recognition of species distinctions within the complex spectrum of bacterial diversity is necessary for progress in microbiological research. In clinical settings, accurate, rapid and cost-effective methods are essential for early and efficient treatment of infections. Characterization and identification of microorganisms, using, bottom-up proteomics, or "proteotyping", relies on recognition of species-unique or associated peptides, by tandem mass spectrometry analyses, dependent upon an accurate and comprehensive foundation of genome sequence data, allowing for differentiation of species, at amino acid-level resolution. In this study, the high resolution and accuracy of MS/MS-based proteotyping was demonstrated, through analyses of the three phylogenetically and taxonomically most closely-related species of the Mitis Group of the genus Streptococcus: i.e., the pathogenic species, Streptococcus pneumoniae (pneumococcus), and the commensal species, Streptococcus pseudopneumoniae and Streptococcus mitis. To achieve high accuracy, a genome sequence database used for matching peptides was created and carefully curated. Here, MS-based, bottom-up proteotyping was observed and confirmed to attain the level of resolution necessary for differentiating and identifying the most-closely related bacterial species, as demonstrated by analyses of species of the Streptococcus Mitis Group, even when S. pneumoniae were mixed with S. pseudopneumoniae and S. mitis, by matching and identifying more than 200 unique peptides for each species.	[Karlsson, Roger; Gonzales-Siles, Lucia; Salva-Serra, Francisco; Jaen-Luchoro, Daniel; Jakobsson, Hedvig E.; Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Karlsson, Roger; Karlsson, Anders] Nanoxis Consulting AB, Gothenburg, Sweden; [Karlsson, Roger; Gonzales-Siles, Lucia; Salva-Serra, Francisco; Jaen-Luchoro, Daniel; Jakobsson, Hedvig E.; Boulund, Fredrik; Kristiansson, Erik; Moore, Edward R. B.] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden; [Gomila, Margarita; Busquets, Antonio; Salva-Serra, Francisco] Univ Balearic Isl, Dept Biol, Microbiol, Palma De Mallorca, Spain; [Salva-Serra, Francisco; Jaen-Luchoro, Daniel; Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, CCUG, Gothenburg, Sweden; [Boulund, Fredrik; Kristiansson, Erik] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Universitat de les Illes Balears; University of Gothenburg; Chalmers University of Technology	Karlsson, R (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.; Karlsson, R (corresponding author), Nanoxis Consulting AB, Gothenburg, Sweden.; Karlsson, R (corresponding author), Univ Gothenburg, Ctr Antibiot Resistance Res CARe, Gothenburg, Sweden.	roger.karlsson@nanoxisconsulting.com	Gonzales Strömberg, Lucia/GYQ-8934-2022; Karlsson, Roger/AFX-3165-2022; Salvà-Serra, Francisco/N-7441-2019; Jaén-Luchoro, Daniel/AAB-5102-2021; Gomila, Margarita/H-3314-2015; Busquets Bisbal, Antonio/K-9206-2014	Gonzales Strömberg, Lucia/0000-0001-7441-8483; Karlsson, Roger/0000-0002-5919-2639; Salvà-Serra, Francisco/0000-0003-0173-560X; Gomila, Margarita/0000-0001-8725-190X; Boulund, Fredrik/0000-0002-3806-323X; Jaen-Luchoro, Daniel/0000-0002-5988-6227; Busquets Bisbal, Antonio/0000-0002-2793-1388	European Commission 7th Framework Programme: "Tailored-Treatment" [602860]; Swedish Vastra Gotaland [ALFGBG-437221, ALFGBG-720761]; Swedish Vastra Gotaland Region; FoU grant number [VGFOUREG-665141]; Lab Medicine Project [51060-6258]; Swedish Vastra Gotaland Region, Lab Medicine Project [51060-6268]; CCUG, through the Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Department of Clinical Microbiology, Sahlgrenska University Hospital; Nanoxis Consulting AB.; European Commission 7 th Framework Programme: "Tailored-Treatment" [602860]	European Commission 7th Framework Programme: "Tailored-Treatment"; Swedish Vastra Gotaland; Swedish Vastra Gotaland Region; FoU grant number; Lab Medicine Project; Swedish Vastra Gotaland Region, Lab Medicine Project; CCUG, through the Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg; Department of Clinical Microbiology, Sahlgrenska University Hospital; Nanoxis Consulting AB.; European Commission 7 th Framework Programme: "Tailored-Treatment"	This research was supported by the European Commission 7th Framework Programme: "Tailored-Treatment", project no. 602860; and the Swedish Vastra Gotaland regional funding: project nos. ALFGBG-437221 and ALFGBG-720761. R.K. acknowledges support from the Swedish Vastra Gotaland Region, FoU grant number VGFOUREG-665141 and Lab Medicine Project number 51060-6258. F.S.-S. and D.J.-L. acknowledge support from the Swedish Vastra Gotaland Region, Lab Medicine Project number 51060-6268. F.S.-S. and D.J.-L. were supported by stipends for Basic and Advanced Research from the CCUG, through the Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg. The CCUG is supported by the Department of Clinical Microbiology, Sahlgrenska University Hospital. Authors AK and RK are employed by Nanoxis Consulting AB. Nanoxis Consulting AB. provided support in the form of salaries for authors [AK, RK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research was supported by the European Commission 7 th Framework Programme: "Tailored-Treatment", project no. 602860; and the Swedish Vastra Gotaland regional funding: project nos. ALFGBG-437221 and ALFGBG-720761. R.K. acknowledges support from the Swedish Vastra Gotaland Region, FoU grant number VGFOUREG-665141 and Lab Medicine Project number 51060-6258. F.S.-S. and D.J.-L. acknowledge support from the Swedish Vastra Gotaland Region, Lab Medicine Project number 51060-6268. F.S.-S. and D.J.-L. were supported by stipends for Basic and Advanced Research from the CCUG, through the Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg. The CCUG is supported by the Department of Clinical Microbiology, Sahlgrenska University Hospital. The authors acknowledge the expertise and effort of the Proteomics Core Facility, Sahlgrenska Academy, University of Gothenburg. The authors thank Dr. Vincent Collins, BioKonsult Goteborg, for critical discussions.	Aho AV, INVENTORON FINDING L; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Beaz-Hidalgo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115813; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Bjornson RD, 2008, J PROTEOME RES, V7, P293, DOI 10.1021/pr0701198; Boulund F, 2017, MOL CELL PROTEOMICS, V16, P1052, DOI 10.1074/mcp.M116.061721; Bourmaud A, 2016, PROTEOMICS, V16, P2146, DOI 10.1002/pmic.201500543; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cecchini T, 2018, MOL CELL PROTEOMICS, V17, P442, DOI 10.1074/mcp.RA117.000107; Charretier Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13944; Chenau J, 2014, MOL CELL PROTEOMICS, V13, P716, DOI 10.1074/mcp.M113.032946; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Downard KM, 2013, CHEM SOC REV, V42, P8584, DOI 10.1039/c3cs60081e; Dworzanski JP, 2006, J PROTEOME RES, V5, P76, DOI 10.1021/pr050294t; Dworzanski JP, 2004, ANAL CHEM, V76, P2355, DOI 10.1021/ac0349781; Eliuk S, 2015, ANNU REV ANAL CHEM, V8, P61, DOI 10.1146/annurev-anchem-071114-040325; Emerson D, 2008, BIOSCIENCE, V58, P925, DOI 10.1641/B581006; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Fricke WF, 2014, NAT REV GENET, V15, P49, DOI 10.1038/nrg3624; Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x; Gomila M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00214; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jensen A, 2016, INT J SYST EVOL MICR, V66, P4803, DOI 10.1099/ijsem.0.001433; Karlsson R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01757; Karlsson R, 2015, SYST APPL MICROBIOL, V38, P246, DOI 10.1016/j.syapm.2015.03.006; Karlsson R, 2012, J PROTEOME RES, V11, P2710, DOI 10.1021/pr2010633; Kilian M, 2014, MBIO, V5, DOI 10.1128/mBio.01490-14; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kruh-Garcia NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103811; Lamond AI, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O112.017731; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Misra RV, 2012, J MICROBIOL METH, V88, P237, DOI 10.1016/j.mimet.2011.12.001; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Salv?-Serra F., 2018, PROTOC EXCH, DOI [10.1038/protex.2018.084, DOI 10.1038/PROTEX.2018.084]; Salva-Serra F, 2018, DIAGN MICR INFEC DIS, V90, P248, DOI 10.1016/j.diagmicrobio.2017.12.003; Schwahn AB, 2010, ANAL CHEM, V82, P4584, DOI 10.1021/ac100594j; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Tatusova T, 2015, NUCLEIC ACIDS RES, V43, pD599, DOI 10.1093/nar/gku1062; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Wang HH, 2017, CLIN CHEM, V63, P1398, DOI 10.1373/clinchem.2016.269647; Wang HH, 2016, CLIN CHEM, V62, P866, DOI 10.1373/clinchem.2015.253468; WASINGER VC, 1995, ELECTROPHORESIS, V16, P1090, DOI 10.1002/elps.11501601185	63	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208804	10.1371/journal.pone.0208804	http://dx.doi.org/10.1371/journal.pone.0208804			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532202	Green Published, Green Submitted, gold			2022-12-26	WOS:000452644700052
J	Li, YJ; Dungey, HS				Li, Yongjun; Dungey, Heidi S.			Expected benefit of genomic selection over forward selection in conifer breeding and deployment	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; NEW-ZEALAND; LINKAGE DISEQUILIBRIUM; NUCLEOTIDE DIVERSITY; PINUS-RADIATA; POPULATION; FORESTRY; ACCURACY; MODELS; GENES	Genomic selection is a proven technology in animal and plant breeding to accelerate genetic gain, but as yet is to be fully realised in forest tree breeding. This paper examines, through stochastic simulation, the potential benefits of genomic selection (GS) over forward selection (FS) in a typical conifer breeding program. Methods of speeding the deployment of selected material were also considered, including top-grafting onto mature seed orchard ortets, using additional replicates of clones in archives for crossing, and embryogenesis and clonal propagation. Genetic gain per generation was found to increase considerably when the size of the training population was larger (800 c.f. 3000 clones), or when the heritability was higher (0.2 c.f. 0.5). The largest genetic gain, of 24% was achieved where large training populations (3000 clones) and high heritability traits (0.5) were combined. The accuracy of genomic breeding values (GEBVs) increased with the increase in the number of clones in the training population, the heritability of the trait and the density of the SNP markers. Calculated accuracies of simulated GEBVs and genetic gain per unit of time suggested that 2000 clones in the training population is the minimum size for effective genomic selection for conifers. Compared with forward selection, genomic selection with 2000 clones in the training population, and a 60K SNP panel, an increase of 1.58 mm per year in diameter-at-breastheight (DBH) and 2.44 kg/m(3) per year for wood density can be expected. After one generation (9-years), this would be equivalent to 14.23 mm and 21.97 kg/m(3) for DBH and wood density respectively. Deploying clones of the selected individuals always resulted in higher additional genetic gain than deploying progeny/seedlings. Deploying genetic material selected from genomic selection with top-grafting for early coning appeared to be the best option. Application of genomic selection to conifer breeding programs, combined with deployment tools such as top-grafting and embryogenesis are powerful tools to speed the delivery of genetic gain to the forest.	[Li, Yongjun; Dungey, Heidi S.] Scion New Zealand Forest Res Inst, Rotorua, New Zealand; [Li, Yongjun] DEDJTR, AgriBio Ctr, Agr Victoria, Bundoora, Vic, Australia		Li, YJ (corresponding author), Scion New Zealand Forest Res Inst, Rotorua, New Zealand.; Li, YJ (corresponding author), DEDJTR, AgriBio Ctr, Agr Victoria, Bundoora, Vic, Australia.	Yongjun.Li@ecodev.vic.gov.au		Dungey, Heidi/0000-0003-2589-3928	Radiata Pine Breeding Company (RPBC) [RPBC1301]; Ministry of Business, Innovation and Employment (MBIE) of New Zealand [RPBC1301]; Scion Strategic Science Investment Funding	Radiata Pine Breeding Company (RPBC); Ministry of Business, Innovation and Employment (MBIE) of New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Scion Strategic Science Investment Funding	The Radiata Pine Breeding Company (RPBC) and the Ministry of Business, Innovation and Employment (MBIE) of New Zealand Jointly funded this research through the RPBC Genomic Selection Partnership with a grant number RPBC1301. The Scion Strategic Science Investment Funding also supported this research. Both funding bodies approved the overall work plan and monitored progress of the research, and approved to publish this manuscript.	Almqvist C, 2002, FOR GENET, V8, P279; Almqvist C, 2013, SCAND J FOREST RES, V28, P533, DOI 10.1080/02827581.2013.803598; Balocchi CE, 1997, FRI B, V203, P253; Bartholome J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2879-8; Beaulieu J, 2014, HEREDITY, V113, P343, DOI 10.1038/hdy.2014.36; Beaulieu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1048; Bevan MW, 2017, NATURE, V543, P346, DOI 10.1038/nature22011; Bramlett DL, 1995, 23 SO FOR TREE IMPR; Brito LF, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0492-8; Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Burdon R. D., 2003, New Zealand Journal of Forestry Science, V33, P156; Butler DG, 2014, J AGR BIOL ENVIR ST, V19, P541, DOI 10.1007/s13253-014-0191-0; Butler DG, 2018, ASREML R REFERENCE M; CARSON M J, 1986, New Zealand Journal of Forestry Science, V16, P403; Carson Mike, 2015, New Zealand Journal of Forestry, V60, P8; Carson MJ, 2009, CLONAL FORESTRY RADI; Carvajal-Rodriguez A, 2008, CURR GENOMICS, V9, P155, DOI 10.2174/138920208784340759; CECICH RA, 1994, TREE PHYSIOL, V14, P275, DOI 10.1093/treephys/14.3.275; Chalupka W, 2008, SCAND J FOREST RES, V12, P102; Chalupka W, 1991, SILVA FENNICA, V25, P235, DOI [DOI 10.14214/SF.A15620, 10.14214/sf.a15620]; Cyr DR, 2001, PROGR BIOTECHNOL, V18, P305, DOI 10.1016/S0921-0423(01)80086-1; De La Torre AR, 2014, PLANT PHYSIOL, V166, P1724, DOI 10.1104/pp.114.248708; Di Pierro EA, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0972-4; Dungey HS, 2009, SILVAE GENET, V58, P28, DOI 10.1515/sg-2009-0004; El-Dien OG, 2016, G3-GENES GENOM GENET, V6, P743, DOI 10.1534/g3.115.025957; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fernando R, 2016, GENSEL USER MANUAL P; Fernando RL, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-50; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Goading GD, 1999, 25 BIENN SO FOR TREE; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Gooding GD, 1999, 25 SO FOR TREE IMPR; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Gullberg U., 1980, SVERIGES SKOGSVARDSF, V1, P104; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hargreaves Cathy L., 2011, New Zealand Journal of Forestry Science, V41, P97; Hargreaves Cathy L., 1999, New Zealand Journal of Forestry Science, V29, P54; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hazubska-Przybyl T, 2016, DENDROBIOLOGY, V76, P105, DOI 10.12657/denbio.076.010; Hedrick PW, 2016, NEW PHYTOL, V209, P600, DOI 10.1111/nph.13639; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Isik F., 2011, BMC P S7, V5, P18, DOI DOI 10.1186/1753-6561-5-S7-I8; Isik F, 2014, NEW FOREST, V45, P379, DOI 10.1007/s11056-014-9422-z; Jayawickrama KJS, 2000, SILVAE GENET, V49, P82; Karlgren A, 2013, PLANT PHYSIOL, V163, P792, DOI 10.1104/pp.113.224139; Klapste J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185137; Klintenas M, 2012, NEW PHYTOL, V196, P1260, DOI 10.1111/j.1469-8137.2012.04332.x; Klocko A, 2013, TREE BIOT 2013 C FOR; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; Lenz PRN, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3715-5; Li YJ, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1019-6; Li Yongjun, 2015, New Zealand Journal of Forestry, V60, P23; Lin Z, 2014, CROP PASTURE SCI, V65, P1177, DOI 10.1071/CP13363; Lott LH, 2003, 27 SO FOR TREE IMPR; Mamun NHA, 2018, IN VITRO CELL DEV-PL, V54, P612, DOI 10.1007/s11627-018-9911-4; Meilan R, 1997, NEW FOREST, V14, P179, DOI 10.1023/A:1006560603966; MENZIES MI, 1992, ACTA HORTIC, V319, P359; Moritsuka E, 2012, GENETICS, V190, P1145, DOI 10.1534/genetics.111.136697; Mousavi M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3003-9; Mrode R.A, 2014, LINEAR MODELS PREDIC; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Oraguzie NC, 2007, ASS MAPPING PLANTS; Park Y-S, 2003, 12 WORLD FOR C; Park YS, 2002, ANN FOR SCI, V59, P651, DOI 10.1051/forest:2002051; Porth I, 2015, FOREST CHRON, V91, P60, DOI 10.5558/tfc2015-011; Ratcliffe B, 2015, HEREDITY, V115, P547, DOI 10.1038/hdy.2015.57; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Rezende GD, 2009, CLONAL FORESTRY EUCA; Rudolf PO, 1965, SILVICS FOREST TREES, V271, P338; Rudolph T. D., 1979, Tree Planters' Notes, V30, P24; Sargolzaei M, 2009, BIOINFORMATICS, V25, P680, DOI 10.1093/bioinformatics/btp045; SHAW DV, 1985, THEOR APPL GENET, V71, P392, DOI 10.1007/BF00251178; Shelbourne CJA, 2007, SILVAE GENET, V56, P259, DOI 10.1515/sg-2007-0037; Shi F, 2017, THEOR APPL GENET, V130, P1393, DOI 10.1007/s00122-017-2895-3; Snelling WM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r165; Stejskal J, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-018-1283-8; Thistlethwaite FR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4258-5; USDA (U.S. Department of Agriculture). Forest Service, 1974, AGR HDB, V450; White T. L., 2007, FOREST GENETICS; Williams E.R., 2002, EXPT DESIGN ANAL TRE; Williams ER, 1999, AUST NZ J STAT, V41, P277, DOI 10.1111/1467-842X.00082; WILLIAMS ER, 1989, J R STAT SOC C-APPL, V38, P149; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zapata-Valenzuela J, 2012, TREE GENET GENOMES, V8, P1307, DOI 10.1007/s11295-012-0516-5; Zimmerman RH, 1985, HORMONOAL REGULATION, V11, P79	86	13	15	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0208232	10.1371/journal.pone.0208232	http://dx.doi.org/10.1371/journal.pone.0208232			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532178	Green Submitted, gold, Green Published			2022-12-26	WOS:000452644700015
J	O'Malley, D; Vesselinov, VV; Alexandrov, BS; Alexandrov, LB				O'Malley, Daniel; Vesselinov, Velimir V.; Alexandrov, Boian S.; Alexandrov, Ludmil B.			Nonnegative/Binary matrix factorization with a D-Wave quantum annealer	PLOS ONE			English	Article								D-Wave quantum annealers represent a novel computational architecture and have attracted significant interest. Much of this interest has focused on the quantum behavior of D-Wave machines, and there have been few practical algorithms that use the D-Wave. Machine learning has been identified as an area where quantum annealing may be useful. Here, we show that the D-Wave 2X can be effectively used as part of an unsupervised machine learning method. This method takes a matrix as input and produces two low-rank matrices as output-one containing latent features in the data and another matrix describing how the features can be combined to approximately reproduce the input matrix. Despite the limited number of bits in the D-Wave hardware, this method is capable of handling a large input matrix. The D-Wave only limits the rank of the two output matrices. We apply this method to learn the features from a set of facial images and compare the performance of the D-Wave to two classical tools. This method is able to learn facial features and accurately reproduce the set of facial images. The performance of the D-Wave shows some promise, but has some limitations. It outperforms the two classical codes in a benchmark when only a short amount of computational time is allowed (200-20,000 microseconds), but these results suggest heuristics that would likely outperform the D-Wave in this benchmark.	[O'Malley, Daniel; Vesselinov, Velimir V.] Los Alamos Natl Lab, Computat Earth Sci EES 16, Los Alamos, NM 87545 USA; [O'Malley, Daniel] Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21228 USA; [Alexandrov, Boian S.] Los Alamos Natl Lab, Phys & Chem Mat T 1, Los Alamos, NM USA; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Theoret Biol & Biophys T 6, Los Alamos, NM USA; [Alexandrov, Ludmil B.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University System of Maryland; University of Maryland Baltimore County; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Diego	O'Malley, D (corresponding author), Los Alamos Natl Lab, Computat Earth Sci EES 16, Los Alamos, NM 87545 USA.; O'Malley, D (corresponding author), Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21228 USA.	omalled@lanl.gov	Alexandrov, Ludmil/AAS-1454-2021	Alexandrov, Ludmil/0000-0003-3596-4515; O'Malley, Daniel/0000-0003-0432-3088	Los Alamos National Laboratory (LANL) Laboratory Directed Research and Development project [20180481ER]; LANL Information Science & Technology Rapid Response project; National Nuclear Security Administration's Advanced Simulation and Computing program; DiaMonD project (An Integrated Multifaceted Approach to Mathematics at the Interfaces of Data, Models, and Decisions, U.S. Department of Energy Office of Science) [11145687]; LANL J. Robert Oppenheimer Fellowship	Los Alamos National Laboratory (LANL) Laboratory Directed Research and Development project(United States Department of Energy (DOE)Los Alamos National Laboratory); LANL Information Science & Technology Rapid Response project; National Nuclear Security Administration's Advanced Simulation and Computing program(National Nuclear Security Administration); DiaMonD project (An Integrated Multifaceted Approach to Mathematics at the Interfaces of Data, Models, and Decisions, U.S. Department of Energy Office of Science)(United States Department of Energy (DOE)); LANL J. Robert Oppenheimer Fellowship	The authors acknowledge the support from a Los Alamos National Laboratory (LANL) Laboratory Directed Research and Development project 20180481ER and a LANL Information Science & Technology Rapid Response project. DO was partially supported by the National Nuclear Security Administration's Advanced Simulation and Computing program. VVV was partially supported by the DiaMonD project (An Integrated Multifaceted Approach to Mathematics at the Interfaces of Data, Models, and Decisions, U.S. Department of Energy Office of Science, Grant #11145687). LBA was supported by a LANL J. Robert Oppenheimer Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, OPTIMIZATION G GUROB; [Anonymous], 2008, ARXIV08110416; [Anonymous], 2009, ARXIV09120779; Bishop C.M., 2006, PATTERN RECOGN, V4; Bixby R., 2012, DOUMENTA MATH EXTRAV, P107; Boothby T, 2016, QUANTUM INF PROCESS, V15, P495, DOI 10.1007/s11128-015-1150-6; Choi V, 2008, QUANTUM INF PROCESS, V7, P193, DOI 10.1007/s11128-008-0082-9; Choi V, 2011, QUANTUM INF PROCESS, V10, P343, DOI 10.1007/s11128-010-0200-3; Danowitz A, 2012, COMMUN ACM, V55, P55, DOI [10.1145/2133806.2133622, 10.1145/2133806.2133822]; Denchev VS, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031015; Dunning I, 2015, ARXIV150801982MATHOC; Geer D, 2005, COMPUTER, V38, P11, DOI 10.1109/MC.2005.160; Gibney E, 2017, NATURE, V541, P447, DOI 10.1038/541447b; Glover F., 1989, ORSA Journal on Computing, V1, P190, DOI [10.1287/ijoc.2.1.4, 10.1287/ijoc.1.3.190]; Golub GH., 2013, MATRIX COMPUTATIONS; Gupta MD, COMP VIS PATT REC CV; Hilton J., 2016, SYSTEMS PROGR; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; King J., 2015, ARXIV150805087; King James, 2017, ARXIV170104579; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Lokhov AY, 2016, ARXIV161205024; Mandra S, 2017, ARXIV170300622; McGeoch C.C., 2013, P ACM INT C COMPUTIN, DOI DOI 10.1145/2482767.2482797; McGeoch Catherine C., 2014, SYNTH LECT QUANTUM C, V5, P1, DOI [DOI 10.2200/S00585ED1V01Y201407QMC008, 10.2200/S00585ED1V01Y201407QMC008]; Monroe D, 2014, COMMUN ACM, V57, P13, DOI 10.1145/2601069; O'Malley D, 2016, IEEE HIGH PERF EXTR; Owens JD, 2008, P IEEE, V96, P879, DOI 10.1109/JPROC.2008.917757; Pudenz KL, 2013, QUANTUM INF PROCESS, V12, P2027, DOI 10.1007/s11128-012-0506-4; Ren DW, 2018, IEEE T IMAGE PROCESS, V27, P511, DOI 10.1109/TIP.2017.2764261; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Slawski M., 2013, ADV NEURAL INFORM PR, P3210; Strang G., 2007, COMPUTATIONAL SCI EN, V791; Tosic I, 2011, IEEE SIGNAL PROC MAG, V28, P27, DOI 10.1109/MSP.2010.939537; TURK MA, 1991, 1991 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, P586; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Zhu PF, 2018, PATTERN RECOGN, V74, P488, DOI 10.1016/j.patcog.2017.09.036; Zhu PF, 2017, IMAGE VISION COMPUT, V60, P22, DOI 10.1016/j.imavis.2016.11.014; Zhu PF, 2017, PATTERN RECOGN, V66, P364, DOI 10.1016/j.patcog.2017.01.016; Zhu PF, 2016, INFORM SCIENCES, V370, P270, DOI 10.1016/j.ins.2016.08.004; Zhu PF, 2013, IEEE I CONF COMP VIS, P2664, DOI 10.1109/ICCV.2013.331; Zhu PF, 2015, PATTERN RECOGN, V48, P438, DOI 10.1016/j.patcog.2014.08.006; Zhu PF, 2014, IEEE T INF FOREN SEC, V9, P1120, DOI 10.1109/TIFS.2014.2324277; Zuo WM, 2016, IEEE T IMAGE PROCESS, V25, P1751, DOI 10.1109/TIP.2016.2531905	47	41	41	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2018	13	12							e0206653	10.1371/journal.pone.0206653	http://dx.doi.org/10.1371/journal.pone.0206653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6JR	30532243	Green Published, gold, Green Submitted			2022-12-26	WOS:000452644700005
J	Gamage, SMKW; Rotenberg, D; Schneweis, DJ; Tsai, CW; Dietzgen, RG				Gamage, Shirani M. K. Widana; Rotenberg, Dorith; Schneweis, Derek J.; Tsai, Chi-Wei; Dietzgen, Ralf G.			Transcriptome-wide responses of adult melon thrips (Thrips palmi) associated with capsicum chlorosis virus infection	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; SALIVARY-GLAND MORPHOLOGY; FRANKLINIELLA-OCCIDENTALIS; APIS-MELLIFERA; EXPRESSION ANALYSIS; MOLECULAR-BIOLOGY; ANOPHELES-GAMBIAE; IMMUNE-RESPONSES; SERINE PROTEASES; DEVELOPMENT TIME	Thrips palmi is a widely distributed major agricultural pest in the tropics and subtropics, causing significant losses in cucurbit and solanaceous crops through feeding damage and transmission of tospoviruses. Thrips palmi is a vector of capsicum chlorosis virus (CaCV) in Australia. The present understanding of transmission biology and potential effects of CaCV on T. palmi is limited. To gain insights into molecular responses to CaCV infection, we performed RNA-Seq to identify thrips transcripts that are differentially-abundant during virus infection of adults. De-novo assembly of the transcriptome generated from whole bodies of T. palmi adults generated 166,445 contigs, of which similar to 24% contained a predicted open reading frame. We identified 1,389 differentially-expressed (DE) transcripts, with comparable numbers up- (708) and down-regulated (681) in virus-exposed thrips compared to non-exposed thrips. Approximately 59% of these DE transcripts had significant matches to NCBI non-redundant proteins (Blastx) and Blast2GO identified provisional functional categories among the up-regulated transcripts in virus-exposed thrips including innate immune response-related genes, salivary gland and/or gut-associated genes and vitellogenin genes. The majority of the immune-related proteins are known to serve functions in lysosome activity and melanisation in insects. Most of the up-regulated oral and extra-oral digestion-associated genes appear to be involved in digestion of proteins, lipids and plant cell wall components which may indirectly enhance the likelihood or frequency of virus transmission or may be involved in the regulation of host defence responses. Most of the down-regulated transcripts fell into the gene ontology functional category of 'structural constituent of cuticle'. Comparison to DE genes responsive to tomato spotted wilt virus in Frankliniella occidentalis indicates conservation of some thrips molecular responses to infection by different tospoviruses. This study assembled the first transcriptome in the genus Thrips and provides important data to broaden our understanding of networks of molecular interactions between thrips and tospoviruses.	[Gamage, Shirani M. K. Widana; Dietzgen, Ralf G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [Rotenberg, Dorith] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA; [Schneweis, Derek J.] Kansas State Univ, Dept Plant Pathol, Throckmorton Hall, Manhattan, KS 66506 USA; [Tsai, Chi-Wei] Natl Taiwan Univ, Dept Entomol, Taipei, Taiwan; [Gamage, Shirani M. K. Widana] Univ Ruhuna, Dept Bot, Matara, Sri Lanka	University of Queensland; University of North Carolina; North Carolina State University; Kansas State University; National Taiwan University; University Ruhuna	Dietzgen, RG (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.	r.dietzgen@uq.edu.au	Dietzgen, Ralf Georg/A-5565-2010; Kumari, Widana Gamage Shirani Manel/O-5603-2018	Dietzgen, Ralf Georg/0000-0002-7772-2250; Kumari, Widana Gamage Shirani Manel/0000-0003-4361-5622; Rotenberg, Dorith/0000-0002-9018-8822; TSAI, CHI-WEI/0000-0002-3880-7251				Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; An CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079533; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Badillo-Vargas IE, 2012, J VIROL, V86, P8793, DOI 10.1128/JVI.00285-12; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Celorio-Mancera MD, 2009, ARCH INSECT BIOCHEM, V70, P122, DOI 10.1002/arch.20282; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chen CC, 2005, PLANT DIS, V89, P440, DOI 10.1094/PD-89-0440; Chen WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102021; Chen Y, 2016, PLANT DIS, V100, P784, DOI 10.1094/PDIS-06-15-0713-RE; Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAS S, 2010, BMC GENOMICS, V11; Davies JR, 2009, MICROBIOL-SGM, V155, P1977, DOI 10.1099/mic.0.027854-0; De Smet L, 2017, ENTOMOL SCI, V20, P76, DOI 10.1111/ens.12227; DEANGELIS JD, 1993, ENVIRON ENTOMOL, V22, P1308, DOI 10.1093/ee/22.6.1308; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; Dietzgen RG, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110303; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feng GH, 1996, INSECT BIOCHEM MOLEC, V26, P419, DOI 10.1016/0965-1748(95)00087-9; Ford L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000377; Gamage SW, 2015, ARCH VIROL, V160, P869, DOI 10.1007/s00705-014-2324-8; Gao K, 2009, DEV COMP IMMUNOL, V33, P1219, DOI 10.1016/j.dci.2009.07.002; GERMAN TL, 1992, ANNU REV PHYTOPATHOL, V30, P315, DOI 10.1146/annurev.py.30.090192.001531; Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118; Girard YA, 2010, J MED ENTOMOL, V47, P421, DOI 10.1603/ME09249; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Grossman G.L., 1993, Insect Molecular Biology, V1, P223, DOI 10.1111/j.1365-2583.1993.tb00095.x; Guo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043567; Gupta SK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1748-1; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; Han B, 2014, J PROTEOME RES, V13, P5928, DOI 10.1021/pr500843j; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hattori M, 2010, INSECT BIOCHEM MOLEC, V40, P331, DOI 10.1016/j.ibmb.2010.02.009; Hernandez-Martinez S, 2013, CELL TISSUE RES, V351, P127, DOI 10.1007/s00441-012-1505-6; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Huo Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003949; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; IWAKI M, 1984, PLANT DIS, V68, P1006, DOI 10.1094/PD-69-1006; JERMY A, 2013, NAT REV MICROBIOL, V11; Kaloshian I, 2016, J INTEGR PLANT BIOL, V58, P350, DOI 10.1111/jipb.12438; Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003; Kato K, 2000, PHYTOPATHOLOGY, V90, P422, DOI 10.1094/PHYTO.2000.90.4.422; Kellenberger C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182741; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kritzman A, 2002, ARCH VIROL, V147, P2143, DOI 10.1007/s00705-002-0871-x; Kubo Y, 2012, ADV VIROL, V2012, DOI 10.1155/2012/640894; LAKSHMI KV, 1995, NATO ADV SCI INST SE, V276, P179; Lavazec C, 2007, INFECT IMMUN, V75, P1635, DOI 10.1128/IAI.00864-06; Li Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159393; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; Merkling SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12758; Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631; Montero-Astua M, 2016, VIROLOGY, V493, P39, DOI 10.1016/j.virol.2016.03.003; Mound L. A, 2002, THRIPS TOSPOVIRUSES, P15; Mound L.A., 2012, THRIPS CALIFORNIA 20; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Nagata T, 1999, J GEN VIROL, V80, P507, DOI 10.1099/0022-1317-80-2-507; Ngernyuang N, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0138; Ogada PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154533; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; OURTH DD, 1993, COMP BIOCHEM PHYS B, V105, P719, DOI 10.1016/0305-0491(93)90111-H; Pascale M, 2014, DEV COMP IMMUNOL, V47, P129, DOI 10.1016/j.dci.2014.07.009; Persley DM, 2006, AUSTRALAS PLANT PATH, V35, P161, DOI 10.1071/AP06015; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Ponchet M, 1999, CELL MOL LIFE SCI, V56, P1020, DOI 10.1007/s000180050491; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; Rebijith KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163635; REDDY DVR, 1992, ANN APPL BIOL, V120, P279, DOI 10.1111/j.1744-7348.1992.tb03425.x; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Rispe C, 2008, MOL BIOL EVOL, V25, P5, DOI 10.1093/molbev/msm222; Robertson AS, 2003, J BIOL CHEM, V278, P6175, DOI 10.1074/jbc.M209277200; Roca E, 1997, PLANT PATHOL, V46, P407, DOI 10.1046/j.1365-3059.1997.d01-29.x; Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, P1; Rotenberg D, 2015, CURR OPIN VIROL, V15, P80, DOI 10.1016/j.coviro.2015.08.003; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneweis DJ, 2017, VIROLOGY, V500, P226, DOI 10.1016/j.virol.2016.10.009; Seepiban C, 2011, ARCH VIROL, V156, P263, DOI 10.1007/s00705-010-0856-0; Shalileh S, 2016, ENVIRON ENTOMOL, V45, P1235, DOI 10.1093/ee/nvw102; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Shen DX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086436, 10.1371/journal.pone.0105709]; Shrestha A, 2017, J GEN VIROL, V98, P2156, DOI 10.1099/jgv.0.000874; Shrestha A, 2012, ENTOMOL EXP APPL, V145, P260, DOI 10.1111/eea.12011; Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631; Smith-Unna R, 2016, GENOME RES, V26, P1134, DOI 10.1101/gr.196469.115; Song L, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0089-y; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Stafford-Banks CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094447; Stumpf CF, 2005, ENTOMOL EXP APPL, V114, P215, DOI 10.1111/j.1570-7458.2005.00251.x; Stumpf CF, 2007, ENTOMOL EXP APPL, V123, P139, DOI 10.1111/j.1570-7458.2007.00541.x; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; Tanaka H, 2011, ISJ-INVERT SURVIV J, V8, P59; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; ULLMAN DE, 1993, PHYTOPATHOLOGY, V83, P456, DOI 10.1094/Phyto-83-456; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Antwerpen R, 2005, REPRO BIOL, V12, P265; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Viljakainen L, 2015, BRIEF FUNCT GENOMICS, V14, P407, DOI 10.1093/bfgp/elv002; Villarroel CA, 2016, PLANT J, V86, P119, DOI 10.1111/tpj.13152; Wang LH, 2003, J BIOL CHEM, V278, P49428, DOI 10.1074/jbc.M306641200; Wang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36254; Wang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08885; Wang YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157684; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; Wijkamp I, 1996, ENTOMOL EXP APPL, V81, P285, DOI 10.1007/BF00187037; Wippler J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3293-y; Yu SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162659; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang ZJ, 2013, GENOMICS, V101, P296, DOI 10.1016/j.ygeno.2013.02.005; Zhu Y, 2016, BMC MICROBIOL, V16, P1; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	133	14	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0208538	10.1371/journal.pone.0208538	http://dx.doi.org/10.1371/journal.pone.0208538			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532222	Green Published, Green Submitted, gold			2022-12-26	WOS:000452640900020
J	Torales, SL; Rivarola, M; Gonzalez, S; Inza, MV; Pomponio, MF; Fernandez, P; Acuna, CV; Zelener, N; Fornes, L; Hopp, HE; Paniego, NB; Poltri, SNM				Torales, Susana L.; Rivarola, Maximo; Gonzalez, Sergio; Virginia Inza, Maria; Pomponio, Maria F.; Fernandez, Paula; Acuna, Cintia, V; Zelener, Noga; Fornes, Luis; Esteban Hopp, H.; Paniego, Norma B.; Marcucci Poltri, Susana N.			De novo transcriptome sequencing and SSR markers development for Cedrela balansae C. DC., a native tree species of northwest Argentina	PLOS ONE			English	Article							GENETIC DIVERSITY; MELIACEAE; MICROSATELLITES; TRANSFERABILITY; ANNOTATION; FORESTS; YUNGAS; TOOL	The endangered Cedrela balansae C.DC. (Meliaceae) is a high-value timber species with great potential for forest plantations that inhabits the tropical forests in Northwestern Argentina.Research on this species is scarce because of the limited genetic and genomic information available. Here, we explored the transcriptome of C. balansae using 454 GS FLX Titanium next-generation sequencing (NGS) technology. Following de novo assembling, we identified 27,111 non-redundant unigenes longer than 200 bp, and considered these transcripts for further downstream analysis. The functional annotation was performed searching the 27,111 unigenes against the NR-Protein and the Interproscan databases. This analysis revealed 26,977 genes with homology in at least one of the Database analyzed. Furthermore, 7,774 unigenes in 142 different active biological pathways in C. balansae were identified with the KEGG database. Moreover, after in silico analyses, we detected 2,663 simple sequence repeats (SSRs) markers. A subset of 70 SSRs related to important "stress tolerance" traits based on functional annotation evidence, were selected for wet PCR-validation in C. balansae and other Cedrela species inhabiting in northwest and northeast of Argentina (C. fissilis, C. saltensis and C. angustifolia). Successful transferability was between 77% and 93% and thanks to this study, 32 polymorphic functional SSRs for all analyzed Cedrela species are now available. The gene catalog and molecular markers obtained here represent a starting point for further research, which will assist genetic breeding programs in the Cedrela genus and will contribute to identifying key populations for its preservation.	[Torales, Susana L.; Virginia Inza, Maria; Pomponio, Maria F.; Zelener, Noga] Inst Nacl Tecnol Agr, Inst Recursos Biol, Buenos Aires, DF, Argentina; [Rivarola, Maximo; Gonzalez, Sergio; Fernandez, Paula; Acuna, Cintia, V; Esteban Hopp, H.; Paniego, Norma B.; Marcucci Poltri, Susana N.] Inst Nacl Tecnol Agr, Inst Biotecnol, Buenos Aires, DF, Argentina; [Rivarola, Maximo; Fernandez, Paula; Paniego, Norma B.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Fornes, Luis] Inst Nacl Tecnol Agr, Estn Expt Agr, Famailla, Tucuman, Argentina; [Esteban Hopp, H.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Buenos Aires	Torales, SL (corresponding author), Inst Nacl Tecnol Agr, Inst Recursos Biol, Buenos Aires, DF, Argentina.	torales.susana@inta.gob.ar	Paniego, Norma/AAK-6140-2021	Rivarola, Maximo/0000-0003-2818-1037; Hopp, H. Esteban/0000-0002-2230-641X; Marcucci Poltri, Susana Noemi/0000-0002-1676-1635; Acuna, Cintia/0000-0001-6658-4780; Paniego, Norma/0000-0003-3906-5330	Instituto Nacional de tecnologia Agopecuaria [AEBIO 24500,1]; Instituto Nacional de Tecnologia Agropecuaria [AEBIO 242421, PNBIO 1131044]	Instituto Nacional de tecnologia Agopecuaria; Instituto Nacional de Tecnologia Agropecuaria	This work was supported by AEBIO 24500,1 Instituto Nacional de tecnologia Agopecuaria, AEBIO 242421, PNBIO 1131044 Instituto Nacional de Tecnologia Agropecuaria (https://inta.gob.ar ST) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Brousseau L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-238; Brown A, 2006, EDICIONES SUBTROPICO; Brown AD, 2001, INTRO BOSQUES NUBLAD, P623; Canales J, 2014, PLANT BIOTECHNOL J, V12, P286, DOI 10.1111/pbi.12136; CARDOSOSILVA CB, 2014, PLOS ONE, V9; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Soldati MC, 2013, BIOCHEM SYST ECOL, V47, P45, DOI 10.1016/j.bse.2012.10.011; Dufresnes C, 2014, MOL ECOL RESOUR, V14, P716, DOI 10.1111/1755-0998.12215; El Mujtar V, 2017, NEW ZEAL J BOT, V55, P347, DOI 10.1080/0028825X.2017.1340310; Elder J.K., 1987, NUCLEIC ACID PROTEIN, P165; Gentry AK, 1996, J TROP ECOL, V12, P722, DOI [10.1017/S0266467400009895, DOI 10.1017/S0266467400009895]; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HOISINGTON D, 1994, LAB PROTOCOLS CIMMYT; Inza MV, 2012, ECOL EVOL, V2, P2722, DOI 10.1002/ece3.336; Karan M, 2012, MOL ECOL RESOUR, V12, P344, DOI 10.1111/j.1755-0998.2011.03080.x; Kim KS, 2008, J HERED, V99, P112, DOI 10.1093/jhered/esm104; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krishnan NM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-464; Kuravadi NA, 2015, PEERJ, V3, DOI 10.7717/peerj.1066; Lewis PO, 2001, GDA GENETIC DATA ANA; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; Mabberley DJ, 1995, FLORA MALESIANA 1 1, V12; Metzgar D, 2000, GENOME RES, V10, P72; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muellner AN, 2009, MOL PHYLOGENET EVOL, V52, P461, DOI 10.1016/j.ympev.2009.03.025; Panell CM., 1992, KEW B ADDITIONAL SER, VXVI; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park SDE, 2001, THESIS; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pennington, 1981, FLORA NEOTROPICA MON, V28; PENNINGTON T D, 1975, Blumea, V22, P419; Pomponio MF, 2015, FOREST SYST, V24, DOI 10.5424/fs/2015242-07188; Quiroga P, LOCAL HIBRIDIZATION, DOI [10.14522/darwiniana.2016, DOI 10.14522/DARWINIANA.2016]; Secretaria de Ambiente y Desarrollo Sustentable de la Nacion. (SAyDS), 2007, 1 INV NAC BOSQ NAT I; Seghezzo L, 2011, J ENVIRON DEV, V20, P251, DOI 10.1177/1070496511416915; Shepherd M, 2002, THEOR APPL GENET, V104, P819, DOI 10.1007/s00122-001-0794-z; Soldati MC, 2014, BIOCHEM SYST ECOL, V53, P8, DOI 10.1016/j.bse.2013.12.003; Torales SL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-705; Torales SL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-291; Torre S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112487; Ueno S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-650; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang YW, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2460-6; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wilson J, ASSESSMENT LEVELS DY; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zelener N, 2016, MOL PHYLOGENET EVOL, V102, P45, DOI 10.1016/j.ympev.2016.05.020	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2018	13	12							e0203768	10.1371/journal.pone.0203768	http://dx.doi.org/10.1371/journal.pone.0203768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD6IO	30532149	Green Submitted, Green Published, gold			2022-12-26	WOS:000452640900002
J	Mallitt, KA; Wilson, DP; Jansson, J; McDonald, A; Wand, H; Post, JJ				Mallitt, Kylie-Ann; Wilson, David P.; Jansson, James; McDonald, Ann; Wand, Handan; Post, Jeffrey J.			Identifying missed clinical opportunities for the earlier diagnosis of HIV in Australia, a retrospective cohort data linkage study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HEALTH-CARE SETTINGS; EMERGENCY-DEPARTMENTS; IMPACT; RISK; PREVENTION; GAY; MEN; CONSEQUENCES; ADMISSIONS	Background Treatment as prevention approaches for HIV require optimal HIV testing strategies to reduce undiagnosed HIV infections. In most settings, HIV testing strategies still result in unacceptably high rates of missed and late diagnoses. This study aimed to identify clinical opportunities for targeted HIV testing in persons at risk to facilitate earlier HIV diagnosis in New South Wales, Australia; and to assess the duration between the diagnosis of specific conditions and HIV diagnosis. Methods The Australian National HIV registry was linked to cancer diagnoses, notifiable condition diagnoses, emergency department presentations and hospital admissions for all HIV diagnoses between 1993 and 2012 in NSW. Date of HIV acquisition was estimated from back-projection models and people with a likely duration from infection to diagnosis of less than 180 days were excluded. Risk factors associated with clinical opportunities for the earlier diagnosis of HIV were identified. Results Sexually transmitted infection diagnoses (particularly gonorrhoea and syphilis) and some hospital admissions (mental health and drug-related diagnoses, and non-infective digestive disorder diagnoses) were prominent among people estimated to be living with undiagnosed HIV. The length of time between a clinical opportunity for the earlier HIV diagnosis and actual HIV diagnosis was 13.3 months for notifiable conditions, and 15.2 months for hospital admissions. People with lower CD4+ cell count at diagnosis, and older people were significantly less likely to have a missed opportunity for earlier HIV diagnosis. Conclusions Additional targeted clinical HIV testing strategies are warranted for people with gonorrhoea and syphilis; and hospital presentations or admissions for mental health, drug-related and gastrointestinal diagnoses.	[Mallitt, Kylie-Ann; Wilson, David P.; Jansson, James; McDonald, Ann; Wand, Handan] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Post, Jeffrey J.] Prince Wales Hosp, Infect Dis, Sydney, NSW, Australia; [Post, Jeffrey J.] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney	Post, JJ (corresponding author), Prince Wales Hosp, Infect Dis, Sydney, NSW, Australia.; Post, JJ (corresponding author), Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia.	Jeffrey.Post@health.nsw.gov.au	Mallitt, Kylie-Ann/GPF-9322-2022; Post, Jeffrey/AAF-4960-2020; Post, Jeffrey/AAL-7115-2020; Mallitt, Kylie-Ann/E-2240-2011	Mallitt, Kylie-Ann/0000-0002-5722-7287; Post, Jeffrey/0000-0003-1475-9272; Mallitt, Kylie-Ann/0000-0002-5722-7287	NSW Ministry of Health; Australian Government Department of Health and Ageing; Australian Research Council [DP1093026]; National Health and Medical Research Council [1064192]	NSW Ministry of Health; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge funding from the NSW Ministry of Health, the Australian Government Department of Health and Ageing; and grant numbers DP1093026 from the Australian Research Council and 1064192 from the National Health and Medical Research Council to DPW. The authors acknowledge Health Protection NSW and the NSW Central Cancer Registry for provision of data. The researchers are independent from the source of funding. The views expressed in this publication do not necessarily represent the position of the New South Wales or Australian Governments. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales.	[Anonymous], 2021, HIV TESTING NEW HIV; Australasian Society for HIV Medicine, 2014, NAT HIV TEST POL; Australian Federation of AIDS Organisations, 2018, HIV AUSTR 2018; Australian Institute of Health and Welfare, 2014, PRINC DIAGN DAT CUB; Bhaijee F, 2011, PATHOLOG RES INT; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Centers for Disease Control and Prevention, 2013, SEX TRANSM DIS SURV; Commonwealth of Australia, 2014, 7 NAT HIV STRAT 2014; Croxford S, 2017, LANCET PUBLIC HEALTH, V2, pE35, DOI 10.1016/S2468-2667(16)30020-2; Currow D, 2014, CANC NSW INCIDENCE R; Czarnogorski M, 2011, AIDS RES TREAT, V88, DOI [10.1093/ajcn/30.7.1003, DOI 10.1093/AJCN/30.7.1003]; Dorell CG, 2011, AIDS PATIENT CARE ST, V25, P657, DOI 10.1089/apc.2011.0203; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; Geretti AM, 2008, BRIT MED J, V336, P1451, DOI 10.1136/bmj.39619.626782.3A; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Haukoos JS, 2013, ACAD EMERG MED, V20, P309, DOI 10.1111/acem.12082; Haukoos JS, 2012, ARCH INTERN MED, V172, P20, DOI 10.1001/archinternmed.2011.538; Health NSW, 2015, POP GROWTH LOC HLTH; Hoover JB, 2013, JAIDS-J ACQ IMM DEF, V62, P90, DOI 10.1097/QAI.0b013e3182742933; Hunter M, 2013, INTERN MED J, V43, P732, DOI 10.1111/imj.12160; Institute Kirby, 2017, HIV VIR HEP SEX TRAN; Institute Kirby, 2013, HIV VIR HEP SEX TRAN; Jansson J, 2015, AIDS, V29, P1517, DOI 10.1097/QAD.0000000000000679; Jansson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038334; Joore IK, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0556-2; Lang V, 2015, CLIN MICROBIOL, V4; Lea T, 2015, DRUG ALCOHOL REV, V34, P349, DOI 10.1111/dar.12234; Levy I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012721; Lin Y, 2017, CANB AUSTR AUSTR SOC; McCarthy M., 2013, BMJ-BRIT MED J, V346, P2874; Millett GA, 2010, JAIDS-J ACQ IMM DEF, V55, pS144, DOI 10.1097/QAI.0b013e3181fbcb04; Moore CL, 2016, JAIDS-J ACQ IMM DEF, V73, P589, DOI 10.1097/QAI.0000000000001147; Moore CL, 2016, AIDS BEHAV, V20, P2372, DOI 10.1007/s10461-016-1303-3; Nash SG, 2017, HIV TESTING ENGLAND; NSW Health, 2016, NSW HIV STRAT 2016 2; O'Shea D, 2013, IRISH J MED SCI, V182, P389, DOI 10.1007/s11845-012-0898-2; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Peterman TA, 2015, INT J STD AIDS, V26, P113, DOI 10.1177/0956462414531243; Post JJ, 2011, J MED VIROL, V83, P1406, DOI 10.1002/jmv.22109; SACKS M, 1995, PSYCHIATR SERV, V46, P131; Shoptaw S, 1998, J ADDICT DIS, V17, P19, DOI 10.1300/J069v17n04_03; Swart A, 2015, AUST NZ J PUBL HEAL, V39, P141, DOI 10.1111/1753-6405.12287; Tennant E, 2017, INTERN MED J, V47, P907, DOI 10.1111/imj.13497; UNAIDS, 2014, 90 90 90 AMB TREATM; Vodstrcil LA, 2012, SEX TRANSM DIS, V39, P492, DOI 10.1097/OLQ.0b013e318254c6fa; Walkup J, 2008, JAIDS-J ACQ IMM DEF, V47, pS15, DOI 10.1097/QAI.0b013e3181605b26; Waters L, 2011, EXPERT REV ANTI-INFE, V9, P877, DOI [10.1586/eri.11.106, 10.1586/ERI.11.106]; Weintrob AC, 2003, ARCH INTERN MED, V163, P2097, DOI 10.1001/archinte.163.17.2097; Winceslaus SJ, 2008, SEX TRANSM INFECT, V84, P101, DOI 10.1136/sti.2007.025098; Ying R, 2014, CURR HIV-AIDS REP, V11, P459, DOI 10.1007/s11904-014-0232-x	50	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208323	10.1371/journal.pone.0208323	http://dx.doi.org/10.1371/journal.pone.0208323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HD1YF	30521582	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600047
J	Da Silva, IHS; Gomez, I; Sanchez, J; de Castro, DLM; Valicente, FH; Soberon, M; Polanczyk, RA; Bravo, A				Sena Da Silva, Igor Henrique; Gomez, Isabel; Sanchez, Jorge; Martinez de Castro, Diana L.; Valicente, Fernando Hercos; Soberon, Mario; Polanczyk, Ricardo Antonio; Bravo, Alejandra			Identification of midgut membrane proteins from different instars of Helicoverpa armigera (Lepidoptera: Noctuidae) that bind to Cry1Ac toxin	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS CRY3AA; ANCHORED ALKALINE-PHOSPHATASE; SEXTA AMINOPEPTIDASE-N; MANDUCA-SEXTA; DELTA-ENDOTOXIN; PUNCTIGERA WALLENGREN; HELIOTHIS-VIRESCENS; STATISTICAL-MODEL; RECEPTOR; SUSCEPTIBILITY	Helicoverpa armigera is a polyphagous pest sensitive to Cry1Ac protein from Bacillus thuringiensis (Bt). The susceptibility of the different larval instars of H. armigera to Cry1Ac protoxin showed a significant 45-fold reduction in late instars compared to early instars. A possible hypothesis is that gut surface proteins that bind to Cry1Ac differ in both instars, although higher Cry toxin degradation in late instars could also explain the observed differences in susceptibility. Here we compared the Cry1Ac-binding proteins from second and fifth instars by pull-down assays and liquid chromatography coupled to mass spectrometry analysis (LC-MS/MS). The data show differential protein interaction patterns of Cry1Ac in the two instars analyzed. Alkaline phosphatase, and other membrane proteins, such as prohibitin and an anion selective channel protein were identified only in the second instar, suggesting that these proteins may be involved in the higher toxicity of Cry1Ac in early instars of H. armigera. Eleven Cry1Ac binindg proteins were identified exclusively in late instar larvae, like different proteases such as trypsin-like protease, azurocidin-like proteinase, and carboxypeptidase. Different aminopeptidase N isofroms were identified in both instar larvae. We compared the Cry1Ac protoxin degradation using midgut juice from late and early instars, showing that the midgut juice from late instars is more efficient to degrade Cry1Ac protoxin than that of early instars, suggesting that increased proteolytic activity on the toxin could also explain the low Cry1Ac toxicity in late instars.	[Sena Da Silva, Igor Henrique; Polanczyk, Ricardo Antonio] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Fitossanidade, Jaboticabal, SP, Brazil; [Gomez, Isabel; Sanchez, Jorge; Martinez de Castro, Diana L.; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [Valicente, Fernando Hercos] Embrapa Milho & Sorgo, Sete Lagoas, MG, Brazil	Universidade Estadual Paulista; Universidad Nacional Autonoma de Mexico; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Bravo, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.	bravo@ibt.unam.mx	Polanczyk, R A/C-4714-2012; de la Parra, Maria Alejandra Bravo/R-6740-2017; Polanczyk, Ricardo Antonio/AAS-6336-2020; Polanczyk, Ricardo A/N-7237-2017; Sena da Silva, Igor Henrique/C-7756-2019	Polanczyk, Ricardo Antonio/0000-0003-0769-9902; Polanczyk, Ricardo A/0000-0003-0769-9902; Sena da Silva, Igor Henrique/0000-0001-5564-1591	Direccion General de Asuntos del personal Academico DGAPA [IN201016]; Fronteras de la Ciencia [008]; Consejo Nacional de Ciencia y Tecnologia CONACyT [2015/24330-5, 2016/21464-3]; Sao Paulo Research Foundation FAPESP; DGAPA [IN201016]; CONACyT Fronteras de la Ciencia [008]; Sao Paulo Research Foundation (FAPESP) [2015/24330-5, 2016/21464-3]	Direccion General de Asuntos del personal Academico DGAPA; Fronteras de la Ciencia; Consejo Nacional de Ciencia y Tecnologia CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); DGAPA; CONACyT Fronteras de la Ciencia; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by: AB, IN201016, Direccion General de Asuntos del personal Academico DGAPA, http://dgapa.unam.mx; AB, Fronteras de la Ciencia 008, Consejo Nacional de Ciencia y Tecnologia CONACyT, https://www.conacyt.gob.mx; RP, 2015/24330-5 and 2016/21464-3, Sao Paulo Research Foundation FAPESP, http://www.fapesp.br/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lizbeth Cabrera, and Blanca Ines Garcia-Gomez for technical assistance. This work was funded in part by DGAPA IN201016, CONACyT Fronteras de la Ciencia 008 and Sao Paulo Research Foundation (FAPESP), grants 2015/24330-5 and 2016/21464-3.	Abdelmalek N, 2017, PESTIC BIOCHEM PHYS, V137, P91, DOI 10.1016/j.pestbp.2016.10.004; Angelucci C, 2008, INSECT BIOCHEM MOLEC, V38, P685, DOI 10.1016/j.ibmb.2008.03.010; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Bayyareddy K, 2009, INSECT BIOCHEM MOLEC, V39, P279, DOI 10.1016/j.ibmb.2009.01.002; Bird LJ, 2007, J INVERTEBR PATHOL, V94, P84, DOI 10.1016/j.jip.2006.08.005; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Candas M, 2002, BIOCHEMISTRY-US, V41, P13717, DOI 10.1021/bi026323k; Chen LZ, 2010, ARCH INSECT BIOCHEM, V73, P61, DOI 10.1002/arch.20340; Chen WB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126288; Daniel A, 2002, APPL ENVIRON MICROB, V68, P2106, DOI 10.1128/AEM.68.5.2106-2112.2002; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Griko N, 2008, COMP BIOCHEM PHYS B, V151, P59, DOI 10.1016/j.cbpb.2008.05.016; Guardiani C, 2016, BBA-BIOMEMBRANES, V1858, P813, DOI 10.1016/j.bbamem.2016.01.013; Heckel DG, 2010, PEST BIOCH PHYS, V104, P103; Herrero S, 2000, BMC GEN, V6, P96, DOI [10.1042/BJ20051517, DOI 10.1042/BJ20051517]; Huang FN, 1999, J ECON ENTOMOL, V92, P547, DOI 10.1093/jee/92.3.547; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller M, 1996, INSECT BIOCHEM MOLEC, V26, P365, DOI 10.1016/0965-1748(95)00102-6; Li H, 2012, J INVERTEBR PATHOL, V109, P110, DOI 10.1016/j.jip.2011.10.005; Lu KY, 2017, J AGR FOOD CHEM, V65, P2048, DOI 10.1021/acs.jafc.6b05769; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ochoa-Campuzano C, 2013, PESTIC BIOCHEM PHYS, V107, P299, DOI 10.1016/j.pestbp.2013.09.001; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Parra RPP, 1989, DETERMINAC NUMERO IN; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rausell C, 2000, APPL ENVIRON MICROB, V66, P1553, DOI 10.1128/AEM.66.4.1553-1558.2000; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Tay WT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005534; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Fernandez-Luna MT, 2010, ENVIRON MICROBIOL, V12, P746, DOI 10.1111/j.1462-2920.2009.02117.x; Torres-Quintero MC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22740-9; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; XIAO YT, 2014, SCI REP UK, V4; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; ZALUCKI MP, 1994, AUST J ZOOL, V42, P329, DOI 10.1071/ZO9940329; Zhang R, 2009, BIOCHEM, V47, P11263; Zhou ZS, 2016, MICROBIOLOGYOPEN, V5, P659, DOI 10.1002/mbo3.360; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200; Zuniga-Navarrete F, 2013, PEPTIDES, V41, P81, DOI 10.1016/j.peptides.2012.05.019	48	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0207789	10.1371/journal.pone.0207789	http://dx.doi.org/10.1371/journal.pone.0207789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521540	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600019
J	Vernocchi, P; Del Chierico, F; Russo, A; Majo, F; Rossitto, M; Valerio, M; Casadei, L; La Storia, A; De Filippis, F; Rizzo, C; Manetti, C; Paci, P; Ercolini, D; Marini, F; Fiscarelli, EV; Dallapiccola, B; Lucidi, V; Miccheli, A; Putignani, L				Vernocchi, Pamela; Del Chierico, Federica; Russo, Alessandra; Majo, Fabio; Rossitto, Martina; Valerio, Mariacristina; Casadei, Luca; La Storia, Antonietta; De Filippis, Francesca; Rizzo, Cristiano; Manetti, Cesare; Paci, Paola; Ercolini, Danilo; Marini, Federico; Fiscarelli, Ersilia Vita; Dallapiccola, Bruno; Lucidi, Vincenzina; Miccheli, Alfredo; Putignani, Lorenza			Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; SOCIETY STANDARDS; CHILDREN; CARE; PHOSPHATIDYLCHOLINE; RESILIENCE; GUIDELINES; MANAGEMENT; RESISTANCE; NUTRITION	Background Cystic fibrosis (CF) is a disorder affecting the respiratory, digestive, reproductive systems and sweat glands. This lethal hereditary disease has known or suspected links to the dysbiosis gut microbiota. High-throughput meta-omics-based approaches may assist in unveiling this complex network of symbiosis modifications. Objectives The aim of this study was to provide a predictive and functional model of the gut microbiota enterophenotype of pediatric patients affected by CF under clinical stability. Methods Thirty-one fecal samples were collected from CF patients and healthy children (HC) (age range, 1-6 years) and analysed using targeted-metagenomics and metabolomics to characterize the ecology and metabolism of CF-linked gut microbiota. The multidimensional data were low fused and processed by chemometric classification analysis. Results The fused metagenomics and metabolomics based gut microbiota profile was characterized by a high abundance of Propionibacterium, Staphylococcus and Clostridiaceae, including Clostridium difficile, and a low abundance of Eggerthella, Eubacterium, Ruminococcus, Dorea, Faecalibacterium prausnitzii, and Lachnospiraceae, associated with overexpression of 4-aminobutyrate (GABA), choline, ethanol, propylbutyrate, and pyridine and low levels of sarcosine, 4-methylphenol, uracil, glucose, acetate, phenol, benzaldehyde, and methylacetate. The CF gut microbiota pattern revealed an enterophenotype intrinsically linked to disease, regardless of age, and with dysbiosis uninduced by reduced pancreatic function and only partially related to oral antibiotic administration or lung colonization/infection. Conclusions All together, the results obtained suggest that the gut microbiota enterophenotypes of CF, together with endogenous and bacterial CF biomarkers, are direct expression of functional alterations at the intestinal level. Hence, it's possible to infer that CFTR impairment causes the gut ecosystem imbalance.This new understanding of CF host-gut microbiota interactions may be helpful to rationalize novel clinical interventions to improve the affected children's nutritional status and intestinal function.	[Vernocchi, Pamela; Del Chierico, Federica; Russo, Alessandra; Putignani, Lorenza] IRCCS, Bambino Gesu Childrens Hosp, Unit Human Microbiome, Rome, Italy; [Majo, Fabio; Lucidi, Vincenzina] IRCCS, Bambino Gesu Childrens Hosp, Cyst Fibrosis Unit, Rome, Italy; [Rossitto, Martina; Fiscarelli, Ersilia Vita] IRCCS, Bambino Gesu Childrens Hosp, Diagnost Cyst Fibrosis, Rome, Italy; [Valerio, Mariacristina; Casadei, Luca; Marini, Federico; Miccheli, Alfredo] Sapienza Univ Rome, Dept Chem, Rome, Italy; [La Storia, Antonietta; De Filippis, Francesca; Ercolini, Danilo] Univ Naples Federico II, Div Microbiol, Dept Agr Sci, Naples, Italy; [Rizzo, Cristiano] IRCCS, Bambino Gesu Childrens Hosp, Div Metab, Rome, Italy; [Manetti, Cesare] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy; [Paci, Paola] CNR, Inst Syst Anal & Comp Sci IASI, Rome, Italy; [Dallapiccola, Bruno] IRCCS, Bambino Gesu Childrens Hosp, Sci Directorate, Rome, Italy; [Putignani, Lorenza] IRCCS, Bambino Gesu Childrens Hosp, Unit Parasitol, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; Sapienza University Rome; University of Naples Federico II; IRCCS Bambino Gesu; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); IRCCS Bambino Gesu; IRCCS Bambino Gesu	Putignani, L (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Unit Human Microbiome, Rome, Italy.; Putignani, L (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Unit Parasitol, Rome, Italy.	lorenza.putignani@opbg.net	Marini, Federico/I-3384-2012; Rizzo, Cristiano/AAA-6155-2020; Rossitto, Martina/AAA-6738-2020; Putignani, Lorenza/K-3409-2016; Del Chierico, Federica/AAS-4078-2020; Del Chierico, Federica/J-4373-2016; Majo, Fabio/AAX-4631-2021; De Filippis, Francesca/K-3816-2016; Majo, Fabio/AAA-6269-2020; Dallapiccola, Bruno/K-8692-2016	Marini, Federico/0000-0001-8266-1117; Rizzo, Cristiano/0000-0002-5954-9749; Rossitto, Martina/0000-0001-5331-3973; Putignani, Lorenza/0000-0003-0134-2830; Del Chierico, Federica/0000-0002-4204-4736; Del Chierico, Federica/0000-0002-4204-4736; De Filippis, Francesca/0000-0002-3474-2884; Majo, Fabio/0000-0003-2548-8893; Lucidi, Vincenzina/0000-0003-3661-607X; Valerio, Mariacristina/0000-0001-7740-9945; Casadei, Luca/0000-0002-6977-5010; Dallapiccola, Bruno/0000-0002-5031-1013	Ministry of Health [201502P003534, 201602P003702]	Ministry of Health	This work was supported by the Ministry of Health, Ricerca Corrente 201502P003534 and 201602P003702 assigned to LP.	Adriaanse MPM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138062; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Auteri M, 2015, PHARMACOL RES, V93, P11, DOI 10.1016/j.phrs.2014.12.001; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibbo S, 2016, EUR REV MED PHARMACO, V20, P4742; Borowitz D, 2009, J PEDIATR-US, V155, pS106, DOI 10.1016/j.jpeds.2009.09.003; Campana S, 2005, J CLIN MICROBIOL, V43, P5136, DOI 10.1128/JCM.43.10.5136-5142.2005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen AH, 2005, AM J CLIN NUTR, V81, P686; Conway S, 2014, J CYST FIBROS, V13, pS3, DOI 10.1016/j.jcf.2014.03.009; Cribbs SK, 2017, TRANSL RES, V179, P84, DOI 10.1016/j.trsl.2016.07.022; Cuthbertson L, 2016, ISME J, V10, P1081, DOI 10.1038/ismej.2015.198; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; De Filippis F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070222; De Lisle RC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009753; Del Chierico F, 2014, J PROTEOMICS, V97, P69, DOI 10.1016/j.jprot.2013.10.013; Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572; Del Chierico F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137347; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Duytschaever G, 2011, APPL ENVIRON MICROB, V77, P8015, DOI 10.1128/AEM.05933-11; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Fink AK, 2017, PEDIATR PULM, V52, pS44, DOI 10.1002/ppul.23790; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; GIBSON LE, 1959, PEDIATRICS, V23, P545; Gilligan PH, 2014, CLIN LAB MED, V34, P197, DOI 10.1016/j.cll.2014.02.001; Grothe J, 2015, CELL PHYSIOL BIOCHEM, V35, P1437, DOI 10.1159/000373964; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; Hahn A, 2016, J MICROBIOL METH, V130, P95, DOI 10.1016/j.mimet.2016.09.002; Innis SM, 2011, AM J CLIN NUTR, V93, P564, DOI 10.3945/ajcn.110.005413; Jacobs DM, 2008, NMR BIOMED, V21, P615, DOI 10.1002/nbm.1233; Li Y, 2012, AM J PHYSIOL-GASTR L, V303, pG453, DOI 10.1152/ajpgi.00497.2011; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nichols DP, 2017, J CYST FIBROS, V16, P358, DOI 10.1016/j.jcf.2016.12.003; Nielsen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24857; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; RILEY TV, 1987, EPIDEMIOL INFECT, V99, P355, DOI 10.1017/S0950268800067832; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; Stern M, 2014, J CYST FIBROS, V13, pS43, DOI 10.1016/j.jcf.2014.03.011; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Turck D, 2016, CLIN NUTR, V35, P557, DOI 10.1016/j.clnu.2016.03.004; Turton JF, 2007, J CLIN MICROBIOL, V45, P3105, DOI 10.1128/JCM.00976-07; Vernocchi P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00156; Vitali B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-4; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xie GX, 2013, ELECTROPHORESIS, V34, P2787, DOI 10.1002/elps.201300017	50	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208171	10.1371/journal.pone.0208171	http://dx.doi.org/10.1371/journal.pone.0208171			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521551	Green Published, Green Submitted, gold			2022-12-26	WOS:000452307600029
J	Zhu, SY; Zhang, XL; Liu, Q; Luo, TK; Tang, Z; Zhou, YC				Zhu, Shiyang; Zhang, Xiaoling; Liu, Qing; Luo, Tiankuan; Tang, Zheng; Zhou, Yuanchang			The genetic diversity and relationships of cauliflower (Brassica oleracea var. botrytis) inbred lines assessed by using SSR markers	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; PHENOTYPIC VARIATION; MICROSATELLITE; L.; SEQUENCE; IDENTIFICATION; ASSOCIATION; CULTIVARS; TRAITS	Inbred lines are important germplasm in cauliflower breeding programs. To understand the genetic diversity and relationships of cauliflower inbred lines, the use of simple sequence repeat (SSR) markers will be of great value for parental line selection and breeding strategy design. In this study, the genetic diversity and relationships of 165 cauliflower inbred lines primarily derived from southeast China were assessed using SSR markers. Forty-three SSR markers were polymorphic across these inbred lines and generated a total of 111 alleles. The mean values of the number of alleles (Na), effective number of alleles (Ne), Shannon's Information index (I), and polymorphism information content (PIC) per locus were 2.581, 1.599, 0.517 and 0.316, respectively. Genetic distance values among all pairs of the inbred lines varied from 0 to 0.67 with an average of 0.30. On the basis of genetic distance data estimated with the SSR markers, the 165 cauliflower inbred lines were classified into four main clusters (from group I to group IV) by cluster analysis and four subpopulations (from POP 1 to POP 4) by structure analysis. The classification patterns of most cauliflower inbred lines were not consistent with their curd maturity, curd solidity or geographic origins. These results based on estimates by the SSR markers, suggested the genetic diversity of the 165 cauliflower inbred lines was relatively narrow. Therefore, pyramiding the valuable genes among different types of the cauliflower inbred lines is important to increase the genetic diversity to obtain desirable hybridization combinations. The information generated in this report will be useful for assessing germplasm and breeding in cauliflower.	[Zhu, Shiyang; Zhou, Yuanchang] Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab, Minist Educ Genet Breeding & Multiple Utilizat Cr, Fuzhou, Fujian, Peoples R China; [Zhu, Shiyang; Zhang, Xiaoling; Liu, Qing; Luo, Tiankuan; Tang, Zheng] Wenzhou Vocat Coll Sci & Technol, Key Lab Crop Breeding South Zhejiang, Wenzhou, Peoples R China	Fujian Agriculture & Forestry University	Zhou, YC (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab, Minist Educ Genet Breeding & Multiple Utilizat Cr, Fuzhou, Fujian, Peoples R China.	zwy_2002@163.com			Zhejiang Visiting Scholar Professional Development Project [FX2017138]; Zhejiang Wenzhou Science and Technology Project [Z20170006]	Zhejiang Visiting Scholar Professional Development Project; Zhejiang Wenzhou Science and Technology Project	This work was supported by the Zhejiang Visiting Scholar Professional Development Project (FX2017138) and the Zhejiang Wenzhou Science and Technology Project (Z20170006) to SZ.	Adeyemo O, 2011, MAYDICA, V56, P43; Akshay Chittora, 2015, Electronic Journal of Plant Breeding, V6, P842; Astarini IA, 2005, ACTA HORTIC, P149, DOI 10.17660/ActaHortic.2005.694.24; Astarini IA, 2006, SCI HORTIC-AMSTERDAM, V108, P143, DOI 10.1016/j.scienta.2006.01.033; Batley J, 2007, MOL ECOL NOTES, V7, P886, DOI 10.1111/j.1471-8286.2007.01738.x; Chandra-Shekara AC, 2007, J PLANT BIOCHEM BIOT, V16, P23, DOI 10.1007/BF03321924; Ciancaleoni S, 2014, GENET RESOUR CROP EV, V61, P451, DOI 10.1007/s10722-013-0049-2; Dashzeveg N, 2017, GENET RESOUR CROP EV, V64, P927, DOI 10.1007/s10722-016-0412-1; DOSSANTOS JB, 1994, THEOR APPL GENET, V87, P909, DOI 10.1007/BF00225784; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gao MQ, 2007, THEOR APPL GENET, V115, P277, DOI 10.1007/s00122-007-0568-3; Girke A, 2012, GENET RESOUR CROP EV, V59, P1441, DOI 10.1007/s10722-011-9772-8; Gupta S, 2014, PLANT CELL REP, V33, P881, DOI 10.1007/s00299-014-1564-0; Iniguez-Luy FL, 2008, THEOR APPL GENET, V117, P977, DOI 10.1007/s00122-008-0837-9; Izzah NK, 2013, GENET RESOUR CROP EV, V60, P1967, DOI 10.1007/s10722-013-9966-3; Kumar M, 2011, INDIAN J HORTIC, V68, P206; Leroy XJ, 2000, PLANT SYST EVOL, V225, P235, DOI 10.1007/BF00985470; Li LX, 2010, THESIS, P25; Louarn S, 2007, GENET RESOUR CROP EV, V54, P1717, DOI 10.1007/s10722-006-9181-6; Park JY, 2015, GENES GENOM, V37, P725, DOI 10.1007/s13258-015-0309-y; Pratima Singh, 2013, International Journal of Plant Sciences (Muzaffarnagar), V8, P179; Quaimruzzama AKM, 2007, INDIAN J HORTIC, V64, P50; Quiros CF, 2011, PLANT GENET GENOMICS, V9, P261, DOI 10.1007/978-1-4419-7118-0_9; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Santhosha H. M., 2011, Journal of Horticultural Sciences, V6, P21; Shi KuanYu, 2005, Journal of Nanjing Agricultural University, V28, P1; Sun DeLing, 2002, Acta Horticulturae Sinica, V29, P72; Sun GL, 2001, MOL BREEDING, V7, P13, DOI 10.1023/A:1009680506508; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tonguc M, 2004, EUPHYTICA, V137, P193, DOI 10.1023/B:EUPH.0000041577.84388.43; Verma VK, 2016, INDIAN J HORTIC, V73, P518, DOI 10.5958/0974-0112.2016.00109.2; Wang Y, 2011, ACTA HORTIC, V918, P315; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yildiz M, 2016, J PLANT BIOCHEM BIOT, V25, P234, DOI 10.1007/s13562-015-0330-x; Yousef E, 2015, EUPHYTICA, V201, P389, DOI 10.1007/s10681-014-1225-y; Zhang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128195; Zhao ZQ, 2014, SCI HORTIC-AMSTERDAM, V166, P105, DOI 10.1016/j.scienta.2013.12.024; Zhu SY, 2018, INT J AGRIC BIOL, V20, P1041, DOI 10.17957/IJAB/15.0601; [朱世杨 Zhu Shiyang], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P77	40	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2018	13	12							e0208551	10.1371/journal.pone.0208551	http://dx.doi.org/10.1371/journal.pone.0208551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1YF	30521622	Green Published, gold, Green Submitted			2022-12-26	WOS:000452307600090
J	Azais, M; Blanco, S; Bon, R; Fournier, R; Pillot, MH; Gautrais, J				Azais, Manon; Blanco, Stephane; Bon, Richard; Fournier, Richard; Pillot, Marie-Helene; Gautrais, Jacques			Traveling pulse emerges from coupled intermittent walks: A case study in sheep	PLOS ONE			English	Article							COLLECTIVE MOTION; PATTERN-FORMATION; NATURAL FLOCKS; SPEED CONTROL; MODEL; MOVEMENT	Monitoring small groups of sheep in spontaneous evolution in the field, we decipher behavioural rules that sheep follow at the individual scale in order to sustain collective motion. Individuals alternate grazing mode at null speed and moving mode at walking speed, so cohesive motion stems from synchronising when they decide to switch between the two modes. We propose a model for the individual decision making process, based on switching rates between stopped /walking states that depend on behind/ahead locations and states of the others. We parametrize this model from data. Next, we translate this (microscopic) individual-based model into its density-flow (macroscopic) equations counterpart. Numerical solving these equations display a traveling pulse propagating at constant speed even though each individual is at any moment either stopped or walking. Considering the minimal model embedded in these equations, we derive analytically the steady shape of the pulse (sech square). The parameters of the pulse (shape and speed) are expressed as functions of individual parameters. This pulse emerges from the non linear coupling of start/stop individual decisions which compensate exactly for diffusion and promotes a steady ratio of walking/stopped individuals, which in turn determines the traveling speed of the pulse. The system seems to converge to this pulse from any initial condition, and to recover the pulse after perturbation. This gives a high robustness to this coordination mechanism.	[Azais, Manon; Bon, Richard; Pillot, Marie-Helene; Gautrais, Jacques] Univ Toulouse, CNRS, UPS, CBI,CRCA, Toulouse, France; [Blanco, Stephane; Fournier, Richard] Univ Toulouse, CNRS, INPT, UPS,LAPLACE, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier	Gautrais, J (corresponding author), Univ Toulouse, CNRS, UPS, CBI,CRCA, Toulouse, France.	jacques.gautrais@univ-tlse3.fr	Gautrais, Jacques/B-4523-2008	Gautrais, Jacques/0000-0002-7002-9920	French Agence Nationale de la Recherche (ANR) [BLAN07-3 200418]	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	MHP, JG and RB received funding from the French Agence Nationale de la Recherche (ANR) Grant BLAN07-3 200418; www.agence-nationale-recherche.fr.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmediev N, 2005, LECT NOTES PHYS, V661, P1; Attanasi A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0319; Attanasi A, 2014, NAT PHYS, V10, P692, DOI [10.1038/nphys3035, 10.1038/NPHYS3035]; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Barberis L, 2016, PHYS REV LETT, V117, P1, DOI [10.1103/PhysRevLett.117.248001, DOI 10.1103/PHYREVLETT117.248001]; Bazazi S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002498; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Bertin E, 2017, J PHYS A-MATH THEOR, V50, DOI 10.1088/1751-8121/aa546b; Bertin E, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/44/445001; Bialek W, 2014, P NATL ACAD SCI USA, V111, P7212, DOI 10.1073/pnas.1324045111; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Calovi DS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1362; Carrillo JA, 2014, KINET RELAT MOD, V8, P1; Cavagna A, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/6/065001; Chate H, 2008, SOFT MATTER PHYS, V77, P1; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Edwards AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045174; Eftimie R, 2007, B MATH BIOL, V69, P1537, DOI 10.1007/s11538-006-9175-8; Eftimie R, 2007, P NATL ACAD SCI USA, V104, P6974, DOI 10.1073/pnas.0611483104; Eftimie R, 2012, J MATH BIOL, V65, P35, DOI 10.1007/s00285-011-0452-2; Gautrais J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002678; Ginelli F, 2015, P NATL ACAD SCI USA, V112, P12729, DOI 10.1073/pnas.1503749112; Ginelli F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.184502; Grossmann R, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/085014; Guttal V, 2012, ECOL LETT, V15, P1158, DOI 10.1111/j.1461-0248.2012.01840.x; Hemelrijk CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126913; Hemelrijk CK, 2015, BEHAV ECOL SOCIOBIOL, V69, P755, DOI 10.1007/s00265-015-1891-3; Hemelrijk CK, 2015, J STAT PHYS, V158, P563, DOI 10.1007/s10955-014-1154-0; Herbert-Read JE, 2016, J EXP BIOL, V219, P2971, DOI 10.1242/jeb.129411; Jansen VAA, 2012, SCIENCE, V335, DOI 10.1126/science.1215747; Jiang L, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005822; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Kerner BS, 1994, AUTOSOLITONS, V61; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; Kuwayama H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02272; Lomholt MA, 2008, P NATL ACAD SCI USA, V105, P11055, DOI 10.1073/pnas.0803117105; Lopez U, 2012, INTERFACE FOCUS, V2, P693, DOI 10.1098/rsfs.2012.0033; MERON E, 1992, PHYS REP, V218, P1, DOI 10.1016/0370-1573(92)90098-K; Mogilner A, 1999, J MATH BIOL, V38, P534, DOI 10.1007/s002850050158; Peshkov A, 2014, EUR PHYS J-SPEC TOP, V223, P1315, DOI 10.1140/epjst/e2014-02193-y; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; Pineda M, 2015, J THEOR BIOL, V370, P135, DOI 10.1016/j.jtbi.2015.01.042; Purwins HG, 2010, ADV PHYS, V59, P485, DOI 10.1080/00018732.2010.498228; Purwirs HG, 2005, LECT NOTES PHYS, V661, P267; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Rimer O, 2017, J THEOR BIOL, V419, P90, DOI 10.1016/j.jtbi.2017.02.009; Romanczuk P, 2012, INTERFACE FOCUS, V2, P746, DOI 10.1098/rsfs.2012.0030; Rosenthal SB, 2015, P NATL ACAD SCI USA, V112, P4690, DOI 10.1073/pnas.1420068112; Saragosti J, 2011, P NATL ACAD SCI USA, V108, P16235, DOI 10.1073/pnas.1101996108; Saragosti J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000890; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; Toulet S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140188; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Zhao K, 2016, SCI REP-UK, V6, DOI 10.1038/srep25720	64	1	1	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206817	10.1371/journal.pone.0206817	http://dx.doi.org/10.1371/journal.pone.0206817			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517114	Green Published, Green Submitted, gold			2022-12-26	WOS:000452212400020
J	Shrestha, B; Aihartza, J; Kindlmann, P				Shrestha, Bikram; Aihartza, Joxerra; Kindlmann, Pavel			Diet and prey selection by snow leopards in the Nepalese Himalayas	PLOS ONE			English	Article							LARGE CARNIVORES; PANTHERA-UNCIA; FOOD-HABITS; CONSERVATION; PREFERENCES; TIGER; COMMON; COMPETITION; LIVESTOCK	Visual attractiveness and rarity often results in large carnivores being adopted as flagship species for stimulating conservation awareness. Their hunting behaviour and prey selection can affect the population dynamics of their prey, which in turn affects the population dynamics of these large carnivores. Therefore, our understanding of their trophic ecology and for-aging strategies is important for predicting their population dynamics and consequently for developing effective conservation programs. Here we concentrate on an endangered species of carnivores, the snow leopard, in the Himalayas. Most previous studies on snow leopard diet lack information on prey availability and/or did not genetically check, whether the identification of snow leopard scats is correct, as their scats are similar to those of other carnivores. We studied the prey of snow leopard in three Himalayan regions in Nepal (Sagarmatha National Park (SNP), Lower Mustang (LM) and Upper Manang (UM) in the Annapurna Conservation Area, during winter and summer in 2014-2016. We collected 268 scats along 139.3 km linear transects, of which 122 were genetically confirmed to belong to snow leopard. Their diet was identified by comparing hairs in scats with our reference collection of the hairs of potential prey. We determined prey availability using 32-48 camera-traps and 4,567 trap nights. In the SNP, the most frequent prey in snow leopard faeces was the Himalayan tahr in both winter and summer. In LM and UM, its main prey was blue sheep in winter, but yak and goat in summer. In terms of relative biomass consumed, yak was the main prey everywhere in both seasons. Snow leopard preferred large prey and avoided small prey in summer but not in winter, with regional differences. It preferred domestic to wild prey only in winter, and in SNP. Unlike most other studies carried out in the same area, our study uses genetic methods for identifying the source of the scat. Studies solely based on visual identification of samples may be strongly biased. Diet studies based on frequency of occurrence of prey tend to overestimate the importance of small prey, which may be consumed more often, but contribute less energy than large prey. However, even assessments based on prey biomass are unlikely to be accurate as we do not know whether the actual size of the prey consumed corresponds to the average size used to calculate the biomass eaten. For example, large adults may be too difficult to catch and therefore mostly young animals are consumed, whose weight is much lower. We show that snow leopard consumes a diverse range of prey, which varies both regionally and seasonally. We conclude that in order to conserve snow leopards it is also necessary to conserve its main wild species of prey, which will reduce the incidence of losses of livestock.	[Shrestha, Bikram; Kindlmann, Pavel] Global Change Res Inst CAS, Dept Biodivers Res, Brno, Czech Republic; [Shrestha, Bikram; Kindlmann, Pavel] Charles Univ Prague, Fac Sci, Inst Environm Studies, Prague 2, Czech Republic; [Shrestha, Bikram] Biodivers & Environm Enhancement Nepal, Kathmandu, Nepal; [Aihartza, Joxerra] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Zool & Anim Cell Biol, Leioa, Basque Country, Spain	Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Charles University Prague; University of Basque Country	Shrestha, B (corresponding author), Global Change Res Inst CAS, Dept Biodivers Res, Brno, Czech Republic.; Shrestha, B (corresponding author), Charles Univ Prague, Fac Sci, Inst Environm Studies, Prague 2, Czech Republic.; Shrestha, B (corresponding author), Biodivers & Environm Enhancement Nepal, Kathmandu, Nepal.	pavel.kindlmann@centrum.cz	Aihartza, Joxerra/Z-3061-2019; Aihartza, Joxerra/GSO-2446-2022; Shrestha, Bikram/J-3501-2017	Aihartza, Joxerra/0000-0003-0882-8964; Shrestha, Bikram/0000-0002-7616-9385; Kindlmann, Pavel/0000-0003-4772-1182	GA CR [GB14-36098G]	GA CR(Grant Agency of the Czech Republic)	The authors thank the Department of National Parks and Wildlife Conservation (Nepal) and National Trust for Nature Conservation (Nepal) for permitting us to conduct this study at ACA and SNP. We thank GA CR (grant No. GB14-36098G), Panthera (US), and Rufford Foundation (UK) for supporting our field and laboratory work.	ACKERMAN BB, 1984, J WILDLIFE MANAGE, V48, P147, DOI 10.2307/3808462; [Anonymous], 1996, THESIS U LONDON LOND; [Anonymous], PLOS ONE; Anwar MB, 2011, EUR J WILDLIFE RES, V57, P1077, DOI 10.1007/s10344-011-0521-2; Aryal A, 2014, J MAMMAL, V95, P871, DOI 10.1644/13-MAMM-A-243; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Chetri M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170549; Chundawat RS, 1994, PROCEEDINGS OF THE S, P127; Devkota B.P., 2013, APPL ECOL ENV SCI, V1, P55, DOI DOI 10.12691/AEES-1-4-4; Dorresteijn I, 2015, P ROY SOC B-BIOL SCI, V282, P105, DOI 10.1098/rspb.2015.1602; Ewgge P, 2012, WILDLIFE BIOL, V18, P131, DOI 10.2981/11-049; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; FOX JL, 1991, BIOL CONSERV, V55, P283, DOI 10.1016/0006-3207(91)90033-6; Fox JL, 1989, REPORT 1989, P40; Hansen MM, 1999, J ZOOL, V247, P177, DOI 10.1111/j.1469-7998.1999.tb00981.x; Hayward MW, 2006, J ZOOL, V270, P615, DOI 10.1111/j.1469-7998.2006.00184.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2012, J ZOOL, V286, P221, DOI 10.1111/j.1469-7998.2011.00871.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; INAMOUNTAIN V, 2015, WILDLIFE BIOL, V18, P251; INAMOUNTAIN V, 2011, WILDLIFE BIOL, P1775; INAMOUNTAIN V, WILDLIFE BIOL; INAMOUNTAIN V, 2009, WILDLIFE BIOLOGY, V2; INAMOUNTAIN V, WILDLIFE BIOLOGY; INAMOUNTAIN V, 2015, WILDLIFE BIOL; Jackson R, 1996, ANNUAL BOOK ON AGRIC; Jackson R, 1998, P INT SNOW LEOP S, P65; Jackson R. M., 1996, THESIS U LONDON, P233; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; JOHNANSSON O, BIOL CONSERVATION; Jumabay-Uulu K, 2014, ORYX, V48, P529, DOI 10.1017/S0030605313000306; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Kerley LL, 2015, INTEGR ZOOL, V10, P354, DOI 10.1111/1749-4877.12135; KREBS JR, 1989, AN INTRODUCTION TO B, P4; Lovari S, 2013, ETHOL ECOL EVOL, V25, P305, DOI 10.1080/03949370.2013.806362; Lovari S, 2013, J ZOOL, V291, P127, DOI 10.1111/jzo.12053; Lovari S, 2009, ANIM CONSERV, V12, P559, DOI 10.1111/j.1469-1795.2009.00285.x; Lucherini Mauro, 1995, Hystrix, V7, P165; MALLON DP, 1991, BIOL CONSERV, V56, P101, DOI 10.1016/0006-3207(91)90092-N; MANLY BFJ, 2002, STATISTICAL DESIGN A; McCarthy T, 2017, IUCN RED LIST THREAT; McCarthy T, 2003, SNOW LEOPARD SURVIVA; Meena V, 2011, J ZOOL, V284, P60, DOI 10.1111/j.1469-7998.2010.00780.x; Miller Brian, 2001, Endangered Species Update, V18, P202; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; MONROYVILCHIS Z, 2011, REVISTA DE BIOLOGIA, V59, P373; MUHAMMAD BA, EUROPEAN JOURNAL OF; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; NTNC, 2008, SUSTAINABLE DEVELOPM; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Ogutu JO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169730; Oli MK, 1997, MAMMALIA, V61, P355; OLI MK, 1993, J ZOOL, V231, P365, DOI 10.1111/j.1469-7998.1993.tb01924.x; Rijal JP, 2004, QIAMP R FAST DNA STO, P1189; RIJAL JP, 2004, PROCEEDING OF FOURTH, V2004, P1189; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; SCHALLER GB, 1988, BIOL CONSERV, V45, P179, DOI 10.1016/0006-3207(88)90138-3; Shehzad W, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0UMAL.P0NE.0032104; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Shrestha B., 2008, A REPORT FOR INTERNA; SHRESTHA B, 2002, HIMALAYAN BIODIVERSI, P115; Shrestha B, 2002, WILDLIFE BIOL, P115; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SNP, 2016, NATIONAL POPULATION; *SNP, SAGARMATHA NATIONAL, P2016; Spiering PA, 2009, CONSERV GENET, V10, P2005, DOI 10.1007/s10592-009-9880-6; Sundararaj V, 2012, ECOLOGY, V93, P272, DOI 10.1890/10-2050.1; Sunquist M.E., 1989, P283; Suryawanshi KR, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170026; Valentova Kamila Anna, 2017, European Journal of Environmental Sciences, V7, P73; Weiskopf SR, 2016, WILDLIFE SOC B, V40, P233, DOI 10.1002/wsb.640	75	10	12	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2018	13	12							e0206310	10.1371/journal.pone.0206310	http://dx.doi.org/10.1371/journal.pone.0206310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD0QO	30517109	gold, Green Published, Green Submitted			2022-12-26	WOS:000452212400011
